Date,Adj Close,Close,High,Low,Open,Volume,News,trend_1d,log_returns,volatility_5d,DistRoBERTa_sentiment_scores,DistRoBERTa_sentiment_vector,DistRoBERTa_adjusted_score,DistRoBERTa_raw_score,DistRoBERTa_adjusted_predictions,DistRoBERTa_raw_predictions,FinBERT_sentiment_scores,FinBERT_sentiment_vector,FinBERT_adjusted_score,FinBERT_raw_score,FinBERT_adjusted_predictions,FinBERT_raw_predictions,DeBERTa_sentiment_scores,DeBERTa_sentiment_vector,DeBERTa_adjusted_score,DeBERTa_raw_score,DeBERTa_adjusted_predictions,DeBERTa_raw_predictions
2009-07-27,17.530086517333984,29.36068725585937,29.75190734863281,29.02671813964844,29.694656372070312,21026758.0,"Wall Street News Alert:  Stocks This Morning: Green Star Alternative Energy -- July 27, 2009",-0.024374383504262992,,,"[{'label': 'neutral', 'score': 0.9997301697731018}, {'label': 'negative', 'score': 0.00022411039390135556}, {'label': 'positive', 'score': 4.580975655699149e-05}]","(0.9997301697731018, 4.580975655699149e-05, 0.00022411039390135556)",-0.660568086678948,-0.00022411039390135556,0,0,"[{'label': 'neutral', 'score': 0.925613284111023}, {'label': 'negative', 'score': 0.04214036837220192}, {'label': 'positive', 'score': 0.03224640712141991}]","(0.925613284111023, 0.03224640712141991, 0.04214036837220192)",-0.13300699197037186,-0.04214036837220192,0,0,"[{'label': 'neutral', 'score': 0.9995421171188354}, {'label': 'positive', 'score': 0.00032344262581318617}, {'label': 'negative', 'score': 0.00013452449638862163}]","(0.9995421171188354, 0.00032344262581318617, 0.00013452449638862163)",0.4125146113465234,0.00032344262581318617,0,0
2009-07-28,17.102806091308594,28.645038604736328,29.494274139404297,28.4064884185791,29.30343437194824,23627265.0,,-0.0049967206565346735,-0.024676355814383193,,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-07-29,17.01734733581543,28.50190734863281,28.75954246520996,28.158397674560547,28.635496139526367,16696736.0,,0.002343539620140468,-0.005009246006397273,,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-07-30,17.057228088378906,28.568702697753903,29.55152702331543,28.511449813842773,28.826335906982425,24300290.0,,0.002337993519660795,0.0023407978140169536,,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-07-31,17.097103118896484,28.635496139526367,29.17938995361328,28.540075302124023,28.81679344177246,16269362.0,,0.0001110796796100168,0.0023352646653466147,,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-08-01,17.09900410970052,28.63867696126302,29.144402186075848,28.482823689778645,28.89631017049153,16279003.333333334,,0.00011106734228546873,0.00011107351071920357,0.18116658122258414,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-02,17.10090510050456,28.64185778299968,29.10941441853841,28.42557207743327,28.975826899210613,16288644.666666666,,0.00011105500770054377,0.00011106117476490598,0.047654962312872876,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-03,17.102806091308594,28.645038604736328,29.074426651000977,28.36832046508789,29.055343627929688,16298286.0,,-0.005996038153579936,0.00011104884154973833,0.019363142223359896,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-08-04,17.000253677368164,28.47328186035156,28.883588790893555,28.129770278930664,28.75954246520996,16077892.0,,-0.007707761150038184,-0.0060140865725201885,0.049834984713564554,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-08-05,16.86922264099121,28.253816604614254,28.79771041870117,27.996183395385746,28.50190734863281,13375100.0,,-0.008443113703734607,-0.007737619467151061,0.061515329372353836,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-06,16.726795196533203,28.01526641845703,28.32061004638672,27.91030502319336,28.32061004638672,11499494.0,,0.025204404010112154,-0.008478958693056614,0.06691914895625038,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-08-07,17.14837646484375,28.72137451171875,29.103052139282227,28.10114479064941,28.3492374420166,13656278.0,"ParagonReport.com Complimentary Market Update on Alumina Ltd. (NYSE: AWC), CSB Corporation (NYSE: CBS), Merck & Co. Inc. (NYSE: MRK) and NVIDIA Corporation (NASDAQ: NVDA)",0.005537089514653475,0.02489201125558723,0.22252924165313392,"[{'label': 'neutral', 'score': 0.9998563528060913}, {'label': 'positive', 'score': 7.625912985531613e-05}, {'label': 'negative', 'score': 6.733671034453437e-05}]","(0.9998563528060913, 7.625912985531613e-05, 6.733671034453437e-05)",0.06213564054755295,7.625912985531613e-05,1,1,"[{'label': 'neutral', 'score': 0.9370306134223938}, {'label': 'positive', 'score': 0.04264184087514877}, {'label': 'negative', 'score': 0.02032761462032795}]","(0.9370306134223938, 0.04264184087514877, 0.02032761462032795)",0.3543658759511382,0.04264184087514877,1,1,"[{'label': 'neutral', 'score': 0.9965335130691528}, {'label': 'positive', 'score': 0.003246019361540675}, {'label': 'negative', 'score': 0.00022043814533390105}]","(0.9965335130691528, 0.003246019361540675, 0.00022043814533390105)",0.872816473361214,0.003246019361540675,0,1
2009-08-08,17.243330001831055,28.880407333374023,29.26208559672038,28.31106821695964,28.533715565999348,15454506.333333334,,0.0055065989831624045,0.005521816188417959,0.22514991137300913,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-09,17.33828353881836,29.039440155029297,29.421119054158527,28.520991643269856,28.718193689982098,17252734.666666668,,0.0054764424109509146,0.005491493096316396,0.21511178807032127,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-10,17.433237075805664,29.19847297668457,29.58015251159668,28.73091506958008,28.902671813964844,19050963.0,"ParagonReport.com Complimentary Market Update on Freddie Mac (NYSE: FRE), Best Buy Co. Inc. (NYSE: BBY), American Express Company (NYSE: AXP), and Merck & Co. Inc. (NYSE: MRK)",-0.008823516539178034,0.005461501225084357,0.18877613466062323,"[{'label': 'neutral', 'score': 0.999806821346283}, {'label': 'positive', 'score': 0.00012740064994432032}, {'label': 'negative', 'score': 6.57453783787787e-05}]","(0.999806821346283, 0.00012740064994432032, 6.57453783787787e-05)",0.31921583943938675,0.00012740064994432032,1,1,"[{'label': 'neutral', 'score': 0.9380431175231934}, {'label': 'positive', 'score': 0.03459717333316803}, {'label': 'negative', 'score': 0.02735968865454197}]","(0.9380431175231934, 0.03459717333316803, 0.02735968865454197)",0.11681490066526797,0.03459717333316803,1,1,"[{'label': 'neutral', 'score': 0.9974028468132019}, {'label': 'positive', 'score': 0.002403208753094077}, {'label': 'negative', 'score': 0.00019393826369196177}]","(0.9974028468132019, 0.002403208753094077, 0.00019393826369196177)",0.8506528414152236,0.002403208753094077,0,1
2009-08-11,17.27941131591797,28.94083976745605,29.370229721069336,28.76908493041992,29.064884185791016,11423829.0,,0.01351799060654773,-0.008862674270665978,0.19071393609599863,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-12,17.512998580932617,29.332061767578125,29.57061004638672,28.625953674316406,28.950382232666016,12899518.0,,0.007807419838464844,0.01342743772084439,0.12817750701984376,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-13,17.649730682373047,29.56106948852539,29.56106948852539,27.375953674316406,29.322519302368164,14137939.0,,0.0,0.0077770996489121245,0.13061082930856774,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-14,17.649730682373047,29.56106948852539,29.666030883789062,29.12213706970215,29.58015251159668,16942178.0,,-0.0010759741224223174,0.0,0.13417537415691194,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-15,17.630738576253254,29.52926254272461,29.748727798461918,29.128498077392575,29.45292599995931,17822882.0,,-0.0010771330897532967,-0.0010765533981394577,0.13635081492432904,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-16,17.611746470133465,29.497455596923828,29.83142471313477,29.134859085083008,29.32569948832194,18703586.0,,-0.0010782945565006043,-0.0010777136145055646,0.10364644660627147,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-17,17.592754364013672,29.465648651123047,29.914121627807617,29.14122009277344,29.19847297668457,19584290.0,"BenchmarkJournal.com Free Analyst Review for ABK, EQR, KMB, BBD, FIG and MRK | Trends in the U.K. and Irish Pharmaceutical and Biotechnology Industry, an Industrial Info News Alert",-0.005505199668109992,-0.0010788763343321291,0.06139874011656946,"[{'label': 'neutral', 'score': 0.9998859167098999}, {'label': 'negative', 'score': 6.302202382357791e-05}, {'label': 'positive', 'score': 5.0982696848222986e-05}]","(0.9998859167098999, 5.0982696848222986e-05, 6.302202382357791e-05)",-0.10560375837430437,-6.302202382357791e-05,1,1,"[{'label': 'neutral', 'score': 0.8902214169502258}, {'label': 'positive', 'score': 0.0945655032992363}, {'label': 'negative', 'score': 0.015213117934763432}]","(0.8902214169502258, 0.0945655032992363, 0.015213117934763432)",0.7228400618671325,0.0945655032992363,0,1,"[{'label': 'neutral', 'score': 0.9992152452468872}, {'label': 'positive', 'score': 0.0006896001868881285}, {'label': 'negative', 'score': 9.514349221717566e-05}]","(0.9992152452468872, 0.0006896001868881285, 9.514349221717566e-05)",0.757517021798379,0.0006896001868881285,0,1
2009-08-18,17.49590492248535,29.30343437194824,29.45610618591309,28.912214279174805,29.45610618591309,12926032.0,,0.025073292509574314,-0.005520409126222894,0.03426319440130402,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-08-19,17.934579849243164,30.03816795349121,30.45801544189453,29.055343627929688,29.255725860595703,21322294.0,,-0.0044473015498279825,0.024764114921408405,0.19376543736967117,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-20,17.854835510253906,29.904579162597656,30.19083976745605,29.56106948852539,30.19083976745605,16164562.0,,0.03892793571267649,-0.004457220213816616,0.19985899880864655,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-08-21,18.549884796142575,31.068702697753903,31.22137451171875,30.00954246520996,30.200382232666016,21721372.0,,-0.0006142610723948646,0.038189350436048417,0.31595203060957205,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-22,18.53848648071289,31.049618403116863,31.31043306986491,30.283079147338867,30.62659072875977,19223324.33333333,,-0.0006146386209735478,-0.0006144498080199362,0.3149064059890955,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-23,18.527088165283203,31.030534108479817,31.399491628011067,30.556615829467773,31.05279922485352,16725276.666666668,,-0.0006150166339491997,-0.000614827588725967,0.30082183287842307,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-24,18.51568984985352,31.011449813842773,31.488550186157227,30.83015251159668,31.479007720947266,14227229.0,,0.013846174757737648,-0.000615205834257469,0.28353476813284423,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-25,18.772062301635746,31.44083976745605,31.5362606048584,31.011449813842773,31.402671813964844,20081566.0,,-0.008194221628112631,0.013751192238817331,0.2687827471148164,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-26,18.618244171142575,31.18320655822754,31.469465255737305,30.982824325561523,31.31679344177246,10438080.0,,0.005813940330593195,-0.008227978797788603,0.1268030289603283,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-27,18.72648811340332,31.364503860473636,31.488550186157227,30.73473358154297,31.10687065124512,10302154.0,,-0.016732574058930787,0.005797104602603488,0.130614276553831,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-28,18.41314125061035,30.83969497680664,31.412214279174805,30.648855209350582,31.412214279174805,12640452.0,,0.0011344837159015667,-0.016874145029330465,0.1891508065613314,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-29,18.434030532836918,30.8746821085612,31.33905855814616,30.661577860514324,31.20547103881836,12950066.0,,0.001133198121086304,0.001133840675550621,0.18991718357040174,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-30,18.45491981506348,30.909669240315758,31.265902837117512,30.67430051167806,30.998727798461918,13259680.0,,0.0011319154366401596,0.0011325565367444742,0.14430708656783708,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-08-31,18.47580909729004,30.944656372070312,31.192747116088867,30.6870231628418,30.79198455810547,13569294.0,,-0.01973482104685972,0.0011312753033680286,0.13983916888565612,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-01,18.11119842529297,30.333969116210938,31.040075302124023,30.209924697875977,30.81106948852539,16841465.0,,-0.030827284859356433,-0.019932153152088173,0.17072446647356032,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-09-02,17.76523208618164,29.398855209350582,29.96183204650879,29.341602325439453,29.93320655822754,14240853.0,,-0.018500509976113626,-0.03131244237511981,0.24123797497068677,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-03,17.436565399169922,28.854961395263672,29.45610618591309,28.568702697753903,29.417938232421875,17347754.0,,0.01521167929530806,-0.01867378485425718,0.22640032812403793,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-04,17.701812744140625,29.293893814086918,29.293893814086918,28.826335906982425,29.055343627929688,12744309.0,,0.0021986937863532684,0.01509714177986788,0.29476518917319605,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-05,17.740731716156006,29.358302116394043,29.372615337371823,28.84780550003052,29.16984748840332,13158321.25,,0.002193870137713412,0.0021962801963528707,0.2975507126510278,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-06,17.779650688171387,29.42271041870117,29.45133686065674,28.869275093078613,29.284351348876957,13572333.5,,0.0021890676076597735,0.002191467118588885,0.29492669958526174,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-07,17.818569660186768,29.4871187210083,29.53005838394165,28.89074468612671,29.398855209350582,13986345.75,,0.0021842860578046496,0.0021866750901164723,0.19267172078472558,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-08,17.85748863220215,29.55152702331543,29.60877990722656,28.912214279174805,29.51335906982422,14400358.0,,0.018727775776581565,0.002181903973152446,0.09163817615029089,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-09-09,18.19192314147949,30.104961395263672,30.17175674438477,29.475191116333008,29.675573348999023,13018780.0,,0.01299526662683659,0.018554570146349144,0.11618347428456136,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-10,18.42832374572754,30.496183395385746,30.60114479064941,29.837785720825195,30.200382232666016,15584913.0,,0.018147660143989577,0.012911552626643086,0.12196724909362229,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-11,18.762752532958984,31.049617767333984,31.125953674316406,30.45801544189453,30.67748069763184,15100108.0,,0.00358534766366672,0.017984956867061783,0.12912867101091596,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-12,18.8300240834554,31.16094144185384,31.224554697672527,30.578880310058597,30.737913767496742,16495170.666666666,,0.003572538869776722,0.003578935626416769,0.12356069251130694,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-13,18.897295633951824,31.2722651163737,31.323155721028645,30.699745178222656,30.79834683736165,17890233.333333332,,0.00355982126992036,0.00356617251099262,0.11755167144387157,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-14,18.96456718444824,31.383588790893555,31.42175674438477,30.82061004638672,30.85877990722656,19285296.0,,-0.005776879464063504,0.0035535001032241443,0.10716463651124351,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-15,18.855016708374023,31.202289581298828,31.412214279174805,31.10687065124512,31.31679344177246,16012602.0,,-0.016207911663962432,-0.005793630174610645,0.1352571253385117,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-16,18.549413681030277,30.69656562805176,31.26908493041992,30.4007625579834,31.23091506958008,15582712.0,,-0.004973579644536067,-0.01634069659668045,0.1403308097613692,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-17,18.457162857055664,30.543893814086918,30.88740539550781,30.25763320922852,30.562976837158203,15921426.0,,-0.004061247935140046,-0.004985989055002856,0.13061170543694947,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-18,18.382198333740234,30.41984748840332,30.87786293029785,30.324426651000977,30.70610618591309,21274086.0,Sanofi-aventis (SNY) Completes Acquisition of Merial ,-0.0006273632582909847,-0.004069517199150066,0.11277593740284977,"[{'label': 'neutral', 'score': 0.8706759214401245}, {'label': 'positive', 'score': 0.1278386414051056}, {'label': 'negative', 'score': 0.0014854808105155826}]","(0.8706759214401245, 0.1278386414051056, 0.0014854808105155826)",0.977027011124207,0.1278386414051056,0,1,"[{'label': 'neutral', 'score': 0.8200013637542725}, {'label': 'positive', 'score': 0.169415682554245}, {'label': 'negative', 'score': 0.01058301329612732}]","(0.8200013637542725, 0.169415682554245, 0.01058301329612732)",0.8824101114051996,0.169415682554245,0,1,"[{'label': 'neutral', 'score': 0.5356215238571167}, {'label': 'positive', 'score': 0.46355071663856506}, {'label': 'negative', 'score': 0.0008277056040242314}]","(0.5356215238571167, 0.46355071663856506, 0.0008277056040242314)",0.9964352107489101,0.46355071663856506,0,1
2009-09-19,18.370664596557617,30.40076319376628,30.78880437215169,30.2671750386556,30.58206049601237,18919474.33333333,,-0.0006277570900247482,-0.0006275601329654606,0.09389140802757606,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-20,18.359130859375,30.38167889912923,30.69974581400553,30.209923426310223,30.45801480611165,16564862.666666668,,-0.0006281514165298502,-0.0006279542120075532,0.10262251606882494,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-21,18.347597122192383,30.362594604492188,30.61068725585937,30.152671813964844,30.333969116210938,14210251.0,,-0.015399079223838263,-0.0006283487862872658,0.03429598883862435,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-09-22,18.06507110595703,29.895038604736328,30.37213706970215,29.85687065124512,30.37213706970215,14417546.0,,0.0,-0.015518876480572642,0.10237762776694688,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-23,18.06507110595703,29.895038604736328,30.152671813964844,29.732824325561523,29.952289581298828,21497834.0,,-0.01021385628454453,0.0,0.10691673686137543,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-24,17.88055419921875,29.58969497680664,29.96183204650879,29.389312744140625,29.799617767333984,16095079.0,,0.007739441759259963,-0.010266375637449981,0.11246671620096899,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-25,18.01894187927246,29.818702697753903,30.25763320922852,29.494274139404297,29.494274139404297,22122442.0,,0.008319992399271097,0.00770964591660181,0.14551388912308533,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-26,18.16885821024577,30.06679407755534,30.483460744222004,29.52926190694173,29.58969434102376,19750608.33333333,,0.008251341302351502,0.00828557204876014,0.1693361342185536,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-27,18.318774541219074,30.31488545735677,30.709288279215496,29.564249674479168,29.68511454264323,17378774.666666668,,0.008183813861029352,0.008217485097608081,0.12850383836157767,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-28,18.468690872192383,30.562976837158203,30.935115814208984,29.5992374420166,29.78053474426269,15006941.0,,-0.00561976489724462,0.008150508045383474,0.13037205443729982,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-29,18.36490631103516,30.39122009277344,30.744274139404297,30.229007720947266,30.55343437194824,14767997.0,,-0.006907349882187312,-0.005635615187156965,0.09751344285694594,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-09-30,18.238046646118164,30.181297302246094,30.524808883666992,29.72328186035156,30.505725860595703,21388946.0,,-0.014227021102281431,-0.00693131604894493,0.12629827284133027,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-01,17.978578567504883,29.75190734863281,30.3435115814209,29.60877990722656,30.2862606048584,17994894.0,,0.015073819596773364,-0.014329195415482181,0.1581324632587973,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-02,18.24957275390625,30.200382232666016,30.37213706970215,29.666030883789062,29.75190734863281,21461154.0,,0.001263802471580931,0.014961338515921269,0.18992066069410643,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-03,18.272637685139973,30.238549550374348,30.362595240275063,29.694656372070312,29.828243255615234,20409346.0,,0.001262207290887178,0.001263004545447315,0.17530168429573648,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-04,18.2957026163737,30.276716868082683,30.35305341084798,29.72328186035156,29.904579162597656,19357538.0,,0.0012606161320142222,0.0012614113769331661,0.17345164894591922,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-05,18.318767547607425,30.314884185791016,30.3435115814209,29.75190734863281,29.98091506958008,18305730.0,,0.023292455578394634,0.0012598222226379008,0.16459807462839895,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-06,18.745458602905277,31.02099227905273,31.068702697753903,30.219465255737305,30.47709846496582,21649794.0,,-0.009843128974822337,0.02302532644428066,0.16068168902848481,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-07,18.560945510864254,30.715648651123047,30.992366790771484,30.47709846496582,30.9064884185791,12144329.0,,0.007455734487277138,-0.009891892825273432,0.19041919980641717,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-08,18.69933319091797,30.944656372070312,31.059160232543945,30.753816604614254,30.9064884185791,11952545.0,,0.004008650934497065,0.00742807788071003,0.1911226188204783,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-09,18.774290084838867,31.068702697753903,31.18320655822754,30.8492374420166,30.97328186035156,11900354.0,,0.003071243970656412,0.004000637701038393,0.1890714789741141,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-10,18.831949869791668,31.164122263590496,31.28180694580078,30.903308232625324,31.055979410807293,11748638.666666666,,0.0030618403120585467,0.0030665373352474386,0.18714614664939455,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-11,18.889609654744465,31.25954182942708,31.380407333374023,30.95737902323405,31.13867696126302,11596923.333333334,,0.0030524940626854387,0.003057162425206276,0.10531278181900645,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-12,18.947269439697266,31.354961395263672,31.479007720947266,31.011449813842773,31.22137451171875,11445208.0,,-0.013390084451454861,0.003047844661793674,0.03006381066083122,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-10-13,18.693567276000977,30.935115814208984,31.44083976745605,30.86832046508789,31.24045753479004,21154404.0,,0.014805618873278168,-0.013480540011488877,0.11925715305063844,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-14,18.970327377319336,31.393129348754883,31.498092651367188,30.83969497680664,31.24045753479004,38314042.0,,0.012158059512701864,0.014697085654423092,0.15957356092178063,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-15,19.20098304748535,31.774808883666992,31.870229721069336,31.125953674316406,31.31679344177246,23478973.0,,-0.0027027187639994377,0.01208474395885235,0.17517522149934586,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-16,19.14908790588379,31.68893051147461,31.85114479064941,31.44083976745605,31.746183395385746,21300914.0,,0.0052193336361278375,-0.00270637770256633,0.18154621861717818,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-17,19.24903170267741,31.854325612386067,31.994274139404297,31.491730372111004,31.695292790730797,23978379.33333333,,0.005192233636462415,0.005205760123633514,0.18242954011322796,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-18,19.348975499471027,32.019720713297524,32.13740348815918,31.54262097676595,31.644402186075848,26655844.666666664,,0.005165413602210887,0.0051788004700896945,0.10818895336338423,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-19,19.44891929626465,32.185115814208984,32.28053283691406,31.5935115814209,31.5935115814209,29333310.0,,-0.0002965461617006247,0.005152118616450244,0.08312463555345166,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-20,19.44315528869629,32.17557144165039,32.614505767822266,32.08969497680664,32.356868743896484,24308989.0,,-0.0308421836492471,-0.000296590140208269,0.0596393138325416,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-10-21,18.84347915649414,31.18320655822754,32.25190734863281,31.116411209106445,32.20419692993164,25395241.0,,0.005813940330593195,-0.03132781518140731,0.25227750001931465,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-22,18.953031539916992,31.364503860473636,31.402671813964844,29.828243255615234,30.9064884185791,25450575.0,,-0.013386071409611124,0.005797104602603488,0.25355310443758616,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-23,18.69933319091797,30.944656372070312,31.44083976745605,30.70610618591309,31.25954246520996,17948153.0,,-0.004214211714166103,-0.013476472513667334,0.24974225187957907,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-24,18.620529174804688,30.81424903869629,31.469465891520183,30.607505798339844,31.17684491475423,18374130.0,,-0.004232046453907052,-0.004223116531013372,0.22944820450220857,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-25,18.541725158691406,30.683841705322266,31.49809201558431,30.5089054107666,31.094147364298504,18800107.0,,-0.004250032790105523,-0.004241026908591234,0.2219267258417948,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-26,18.462921142578125,30.55343437194824,31.52671813964844,30.41030502319336,31.011449813842773,19226084.0,,0.012804517991642313,-0.00425908985044223,0.10822915788321859,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-27,18.69933319091797,30.944656372070312,31.393129348754883,30.69656562805176,31.09732818603516,19670541.0,,-0.011717519177865364,0.012723233290046782,0.15083576614500205,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-28,18.480222702026367,30.582061767578125,31.202289581298828,30.534351348876957,31.09732818603516,15802268.0,,-0.02308896302113634,-0.011786710335954246,0.14352670238253767,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-10-29,18.05353736877441,29.875953674316406,30.562976837158203,29.48473358154297,30.562976837158203,42898518.0,,-0.01213667046230229,-0.023359688425280935,0.20869975387244433,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-30,17.834421157836914,29.51335906982422,30.324426651000977,29.417938232421875,29.742366790771484,42406377.0,,0.003556402882347239,-0.012210921230236682,0.21167227015783802,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-10-31,17.89784812927246,29.61832046508789,30.23536872863769,29.45928700764974,29.726463317871094,35743332.666666664,,0.0035437997028693723,0.003550093835533118,0.2265872738841044,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-01,17.961275100708008,29.72328186035156,30.14631080627441,29.500635782877605,29.710559844970703,29080288.333333336,,0.0035312855342426166,0.0035375352403401593,0.1835027024502364,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-02,18.024702072143555,29.828243255615234,30.057252883911133,29.54198455810547,29.694656372070312,22417244.0,,-0.01887395219134206,0.0035250651850653003,0.19567311758644154,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-03,17.684505462646484,29.26526641845703,29.84732818603516,28.902671813964844,29.666030883789062,71181522.0,,0.0642321911374694,-0.019054338569203407,0.1710495955760459,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-11-04,18.82041549682617,31.145038604736328,31.345420837402344,29.818702697753903,29.895038604736328,37948290.0,"Merck Says It Won't Seek Another Larger Merger | Fitch Downgrades Merck, Outlook Stable",0.0021445933209504335,0.06225359186515549,0.4826069564812414,"[{'label': 'negative', 'score': 0.9975493550300598}, {'label': 'neutral', 'score': 0.0014089636970311403}, {'label': 'positive', 'score': 0.0010417615994811058}]","(0.0014089636970311403, 0.0010417615994811058, 0.9975493550300598)",-0.9979135372183215,-0.9975493550300598,0,0,"[{'label': 'neutral', 'score': 0.4918573796749115}, {'label': 'negative', 'score': 0.4801647961139679}, {'label': 'positive', 'score': 0.027977732941508293}]","(0.4918573796749115, 0.027977732941508293, 0.4801647961139679)",-0.8898823407144737,-0.4801647961139679,0,1,"[{'label': 'negative', 'score': 0.9963034391403198}, {'label': 'neutral', 'score': 0.0028553742449730635}, {'label': 'positive', 'score': 0.0008411811431869864}]","(0.0028553742449730635, 0.0008411811431869864, 0.9963034391403198)",-0.9983128201745745,-0.9963034391403198,0,0
2009-11-05,18.860774993896484,31.21183204650879,31.898855209350582,31.00190734863281,31.00190734863281,23830786.0,,-0.003668604274911095,0.0021422969632771843,0.4840337758479785,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-06,18.79158592224121,31.09732818603516,31.44083976745605,30.744274139404297,31.116411209106445,20797141.0,The ETF Professor Told You To Watch This Healthcare ETF (XLV),0.008591595806563756,-0.0036753501071538366,0.4931744337882472,"[{'label': 'neutral', 'score': 0.9998620748519897}, {'label': 'negative', 'score': 7.043346704449505e-05}, {'label': 'positive', 'score': 6.745193968527019e-05}]","(0.9998620748519897, 6.745193968527019e-05, 7.043346704449505e-05)",-0.021623226343801583,-7.043346704449505e-05,1,1,"[{'label': 'neutral', 'score': 0.9332254528999329}, {'label': 'positive', 'score': 0.0532960370182991}, {'label': 'negative', 'score': 0.013478503562510014}]","(0.9332254528999329, 0.0532960370182991, 0.013478503562510014)",0.5962981266430843,0.0532960370182991,0,1,"[{'label': 'neutral', 'score': 0.9993990659713745}, {'label': 'positive', 'score': 0.00038714814581908286}, {'label': 'negative', 'score': 0.00021373011986725032}]","(0.9993990659713745, 0.00038714814581908286, 0.00021373011986725032)",0.2886075863532051,0.00038714814581908286,1,1
2009-11-07,18.95303471883138,31.364503860473636,31.612595240275063,30.89694595336914,31.202289581298828,24059460.0,,0.008518409078843258,0.008554898092125143,0.4909196172904603,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-08,19.11448351542155,31.63167953491211,31.784350713094074,31.049617767333984,31.28816795349121,27321779.0,,0.008446458688467343,0.00848233216604749,0.422205915652713,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-09,19.27593231201172,31.898855209350582,31.95610618591309,31.202289581298828,31.374046325683597,30584098.0,Leerink Swann Upgrades Merck To Outperform,0.005384357398060777,0.008410986956662607,0.0868001636680018,"[{'label': 'positive', 'score': 0.9995884299278259}, {'label': 'negative', 'score': 0.0002139831631211564}, {'label': 'neutral', 'score': 0.00019760936265811324}]","(0.00019760936265811324, 0.9995884299278259, 0.0002139831631211564)",0.9995719490965027,0.9995884299278259,0,0,"[{'label': 'positive', 'score': 0.9318094253540039}, {'label': 'negative', 'score': 0.0428178608417511}, {'label': 'neutral', 'score': 0.025372594594955444}]","(0.025372594594955444, 0.9318094253540039, 0.0428178608417511)",0.9121349023401935,0.9318094253540039,0,0,"[{'label': 'positive', 'score': 0.9986810088157654}, {'label': 'neutral', 'score': 0.0008206214406527579}, {'label': 'negative', 'score': 0.0004983770195394754}]","(0.0008206214406527579, 0.9986810088157654, 0.0004983770195394754)",0.9990024273386648,0.9986810088157654,0,0
2009-11-10,19.37973022460937,32.07061004638672,32.19465637207031,31.80343437194824,31.975191116333008,16626520.0,,-0.011603679168057353,0.005369913569724642,0.08357856914720237,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-11,19.15484619140625,31.69847297668457,32.20419692993164,31.603052139282227,32.185115814208984,18316210.0,,-0.007224566341593473,-0.011671527221895892,0.13921295727537947,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-12,19.016462326049805,31.469465255737305,31.9370231628418,31.354961395263672,31.52671813964844,14775542.0,,0.0036385702630506956,-0.007250789899897815,0.1502001924780135,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-13,19.085657119750977,31.583969116210938,31.965648651123047,31.488550186157227,31.774808883666992,15211930.0,Merck (MRK) Drugs Under Scanner Of Cholesterol Study,0.007150068256543967,0.0036319666798244454,0.13773243688035094,"[{'label': 'neutral', 'score': 0.999870777130127}, {'label': 'negative', 'score': 6.810545164626092e-05}, {'label': 'positive', 'score': 6.113911513239145e-05}]","(0.999870777130127, 6.113911513239145e-05, 6.810545164626092e-05)",-0.05390042063276977,-6.810545164626092e-05,1,1,"[{'label': 'neutral', 'score': 0.859241783618927}, {'label': 'positive', 'score': 0.08626283705234528}, {'label': 'negative', 'score': 0.0544954277575016}]","(0.859241783618927, 0.08626283705234528, 0.0544954277575016)",0.2256877018039324,0.08626283705234528,1,1,"[{'label': 'neutral', 'score': 0.9993353486061096}, {'label': 'positive', 'score': 0.00042288980330340564}, {'label': 'negative', 'score': 0.00024173318524844944}]","(0.9993353486061096, 0.00042288980330340564, 0.00024173318524844944)",0.2725704966204641,0.00042288980330340564,1,1
2009-11-14,19.222119013468426,31.809796651204422,32.23600514729818,31.65394465128581,31.99109395345052,18908680.0,Merck Sends Letter To NYT Editor About Arbiter Story,0.007099307721759403,0.007124627714268068,0.13282103730158504,"[{'label': 'neutral', 'score': 0.9997642636299133}, {'label': 'negative', 'score': 0.00014723917411174625}, {'label': 'positive', 'score': 8.850867016008124e-05}]","(0.9997642636299133, 8.850867016008124e-05, 0.00014723917411174625)",-0.24912424600560162,-0.00014723917411174625,1,1,"[{'label': 'neutral', 'score': 0.9219638705253601}, {'label': 'positive', 'score': 0.05428323522210121}, {'label': 'negative', 'score': 0.02375294640660286}]","(0.9219638705253601, 0.05428323522210121, 0.02375294640660286)",0.3912324793230066,0.05428323522210121,1,1,"[{'label': 'neutral', 'score': 0.9989293217658997}, {'label': 'positive', 'score': 0.0006676631164737046}, {'label': 'negative', 'score': 0.0004030287091154605}]","(0.9989293217658997, 0.0006676631164737046, 0.0004030287091154605)",0.24716206945226726,0.0006676631164737046,1,1
2009-11-15,19.35858090718587,32.035624186197914,32.506361643473305,31.819339116414387,32.20737902323405,22605430.0,,0.007049262835677367,0.007074226274008785,0.13806177504004505,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-16,19.49504280090332,32.261451721191406,32.77671813964844,31.98473358154297,32.42366409301758,26302180.0,JPMorgan Likes Abbott (ABT) Because of Niaspan,0.014196987967335553,0.007024532932788662,0.09847636277079352,"[{'label': 'neutral', 'score': 0.9998683929443359}, {'label': 'negative', 'score': 7.989980076672509e-05}, {'label': 'positive', 'score': 5.171398152015172e-05}]","(0.9998683929443359, 5.171398152015172e-05, 7.989980076672509e-05)",-0.2141555295868416,-7.989980076672509e-05,1,1,"[{'label': 'neutral', 'score': 0.8589130640029907}, {'label': 'positive', 'score': 0.12962891161441803}, {'label': 'negative', 'score': 0.011458028107881546}]","(0.8589130640029907, 0.12962891161441803, 0.011458028107881546)",0.8375749288993821,0.12962891161441803,0,1,"[{'label': 'neutral', 'score': 0.9989331364631653}, {'label': 'positive', 'score': 0.0008439383818767965}, {'label': 'negative', 'score': 0.00022297128452919424}]","(0.9989331364631653, 0.0008439383818767965, 0.00022297128452919424)",0.5820240615490927,0.0008439383818767965,0,1
2009-11-17,19.77182006835937,32.71946716308594,32.729007720947266,31.822519302368164,32.25190734863281,17354985.0,,0.024788474390046555,0.014097154513728321,0.060765591348163,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-11-18,20.261934280395508,33.53053283691406,33.77862548828125,32.51908493041992,32.700382232666016,29544482.0,,0.005406931739733913,0.024486224845150936,0.12117880583558532,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-19,20.371490478515625,33.71183013916016,34.08396911621094,33.167938232421875,33.48282241821289,25142358.0,,0.0319842341949862,0.00539236676195396,0.1260604101024694,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-11-20,21.023054122924805,34.790077209472656,34.99045944213867,33.71183013916016,33.82633590698242,38112721.0,"Stocks That Will Continue to Achieve New Highs (BBY, SJM, AGU, KO, TRA, MRK, CTL)",-0.00036571597326471726,0.031483389999834584,0.17875911226713015,"[{'label': 'positive', 'score': 0.9993507266044617}, {'label': 'neutral', 'score': 0.0003664942632894963}, {'label': 'negative', 'score': 0.00028275224030949175}]","(0.0003664942632894963, 0.9993507266044617, 0.00028275224030949175)",0.999434288174029,0.9993507266044617,0,0,"[{'label': 'positive', 'score': 0.9245020747184753}, {'label': 'neutral', 'score': 0.06279720366001129}, {'label': 'negative', 'score': 0.012700735591351986}]","(0.06279720366001129, 0.9245020747184753, 0.012700735591351986)",0.9728965055340513,0.9245020747184753,0,0,"[{'label': 'positive', 'score': 0.998635470867157}, {'label': 'neutral', 'score': 0.0010436037555336952}, {'label': 'negative', 'score': 0.00032094994094222784}]","(0.0010436037555336952, 0.998635470867157, 0.00032094994094222784)",0.9993574295449593,0.998635470867157,0,0
2009-11-21,21.01536496480306,34.77735392252604,35.082698822021484,33.98536809285482,34.23982238769531,33356023.666666668,,-0.00036584977036935236,-0.0003657828636603736,0.208633236402511,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-22,21.00767580668132,34.76463063557943,35.1749382019043,34.25890604654948,34.6533088684082,28599326.333333336,,-0.00036598366540950566,-0.0003659167097235888,0.23611404682764572,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-23,20.99998664855957,34.75190734863281,35.26717758178711,34.53244400024414,35.066795349121094,23842629.0,,-0.005491435569073296,-0.0003660506537761233,0.21948624103834974,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-24,20.884668350219727,34.56106948852539,35.14313125610352,34.21755599975586,34.61832046508789,22260673.0,,0.009663159189035469,-0.00550656892938782,0.2378706677046177,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-25,21.08648109436035,34.89503860473633,34.99045944213867,34.3129768371582,34.627864837646484,11693374.0,,-0.0038282486246279733,0.009616769474326145,0.08745084351316841,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-26,21.005757331848145,34.761451721191406,34.928436279296875,34.1507625579834,34.479963302612305,10547962.5,,-0.003842960432618645,-0.003835595123871388,0.09315455496433495,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-27,20.925033569335938,34.627864837646484,34.86641311645508,33.988548278808594,34.332061767578125,9402551.0,,-0.0007348583001733901,-0.0038503635778111985,0.09700612494077702,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-28,20.909656524658203,34.60241826375326,34.79961903889974,34.06806564331055,34.38931401570638,12683978.666666666,,-0.0007353987140225315,-0.0007351284408855953,0.09694026311198917,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-11-29,20.89427947998047,34.576971689860024,34.7328249613444,34.1475830078125,34.44656626383463,15965406.333333332,"Taking A Look At Two Pharma ETFs (IHE, PPH)",-0.0007359399232955156,-0.0007356692523005984,0.0880493876284977,"[{'label': 'neutral', 'score': 0.9998608827590942}, {'label': 'negative', 'score': 7.54702850827016e-05}, {'label': 'positive', 'score': 6.369323818944395e-05}]","(0.9998608827590942, 6.369323818944395e-05, 7.54702850827016e-05)",-0.08462739815969361,-7.54702850827016e-05,1,1,"[{'label': 'neutral', 'score': 0.9256411194801331}, {'label': 'positive', 'score': 0.06214864179491997}, {'label': 'negative', 'score': 0.012210249900817871}]","(0.9256411194801331, 0.06214864179491997, 0.012210249900817871)",0.6715860168873994,0.06214864179491997,0,1,"[{'label': 'neutral', 'score': 0.9993913173675537}, {'label': 'positive', 'score': 0.0004904686938971281}, {'label': 'negative', 'score': 0.00011816767801064998}]","(0.9993913173675537, 0.0004904686938971281, 0.00011816767801064998)",0.6116969558021912,0.0004904686938971281,0,1
2009-11-30,20.87890243530273,34.5515251159668,34.66603088378906,34.22710037231445,34.50381851196289,19246834.0,,0.018503280439636876,-0.0007362108600178426,0.02701764630464076,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-12-01,21.26522254943848,35.19084167480469,35.524810791015625,34.627864837646484,34.627864837646484,17421533.0,,-0.0021691981023879716,0.01833417753337725,0.14252775625989694,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-02,21.21910095214844,35.114505767822266,35.30534362792969,34.78053283691406,34.828243255615234,12601990.0,"Cowen stays Neutral On Santarus (SNTS), Cites Litigation Concerns , PRX, MRK, AZN, NVS | Google's Most Popular Stock Searches Today, SNTS, MRK, ITVI, DYAX, SNDA",-0.0008153127134356692,-0.002171554220466269,0.1382836176234636,"[{'label': 'neutral', 'score': 0.9994526505470276}, {'label': 'negative', 'score': 0.0002977015101350844}, {'label': 'positive', 'score': 0.0002496298693586141}]","(0.9994526505470276, 0.0002496298693586141, 0.0002977015101350844)",-0.08782913346013219,-0.0002977015101350844,1,1,"[{'label': 'neutral', 'score': 0.9256479740142822}, {'label': 'negative', 'score': 0.03793029487133026}, {'label': 'positive', 'score': 0.03642169013619423}]","(0.9256479740142822, 0.03642169013619423, 0.03793029487133026)",-0.020290039801672544,-0.03793029487133026,1,1,"[{'label': 'neutral', 'score': 0.9709439277648926}, {'label': 'negative', 'score': 0.020229138433933258}, {'label': 'positive', 'score': 0.008826867677271366}]","(0.9709439277648926, 0.008826867677271366, 0.020229138433933258)",-0.39242388348290336,-0.020229138433933258,1,1
2009-12-03,21.201801300048828,35.08587646484375,35.343509674072266,34.875953674316406,35.02862548828125,13639406.0,,-0.001903658712666153,-0.0008156452616121805,0.13841408846498263,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-04,21.16144561767578,35.01908493041992,35.78244400024414,34.96183013916016,35.5057258605957,17412415.0,,0.0,-0.0019054729737682703,0.1405165051688103,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-05,21.16144561767578,35.01908493041992,35.63613255818685,34.91093953450521,35.28625996907552,15090955.333333334,,0.0,0.0,0.13952848237558715,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-06,21.16144561767578,35.01908493041992,35.489821116129555,34.86004892985026,35.066794077555336,12769495.666666668,,0.0,0.0,0.01631313936362456,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-07,21.16144561767578,35.01908493041992,35.343509674072266,34.80915832519531,34.84732818603516,10448036.0,,-0.009536774500947327,0.0,0.013317585218470047,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-12-08,20.959625244140625,34.685115814208984,35.29580307006836,34.59923553466797,34.97137451171875,16286234.0,"Stock Market News for December 08, 2009 - Market News",0.02200826065892805,-0.009582540742200349,0.06596093099425,"[{'label': 'neutral', 'score': 0.9998687505722046}, {'label': 'negative', 'score': 7.876160088926554e-05}, {'label': 'positive', 'score': 5.247390072327107e-05}]","(0.9998687505722046, 5.247390072327107e-05, 7.876160088926554e-05)",-0.20030936631466545,-7.876160088926554e-05,0,0,"[{'label': 'neutral', 'score': 0.923897922039032}, {'label': 'negative', 'score': 0.0541866235435009}, {'label': 'positive', 'score': 0.021915460005402565}]","(0.923897922039032, 0.021915460005402565, 0.0541866235435009)",-0.4240509856390564,-0.0541866235435009,0,0,"[{'label': 'neutral', 'score': 0.9995900988578796}, {'label': 'positive', 'score': 0.0002618437574710697}, {'label': 'negative', 'score': 0.0001481741201132536}]","(0.9995900988578796, 0.0002618437574710697, 0.0001481741201132536)",0.2772309296060855,0.0002618437574710697,0,0
2009-12-09,21.4209041595459,35.4484748840332,35.524810791015625,34.446563720703125,34.63740539550781,18611537.0,,0.01049791743004249,0.02176957458537123,0.1837666631173302,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-10,21.645782470703125,35.82061004638672,36.183204650878906,35.67748260498047,35.696563720703125,15336642.0,SEC On Trail Of Insider Trading Transactions,-0.012520023624735402,0.01044319692922451,0.18989361375302266,"[{'label': 'neutral', 'score': 0.9998855590820312}, {'label': 'negative', 'score': 7.052242290228605e-05}, {'label': 'positive', 'score': 4.386619184515439e-05}]","(0.9998855590820312, 4.386619184515439e-05, 7.052242290228605e-05)",-0.23303220443735745,-7.052242290228605e-05,1,1,"[{'label': 'negative', 'score': 0.598356306552887}, {'label': 'neutral', 'score': 0.37925609946250916}, {'label': 'positive', 'score': 0.022387592121958733}]","(0.37925609946250916, 0.022387592121958733, 0.598356306552887)",-0.9278685069003452,-0.598356306552887,0,0,"[{'label': 'neutral', 'score': 0.9994907379150391}, {'label': 'positive', 'score': 0.00031315285013988614}, {'label': 'negative', 'score': 0.00019611298921518028}]","(0.9994907379150391, 0.00031315285013988614, 0.00019611298921518028)",0.22982075741213073,0.00031315285013988614,1,1
2009-12-11,21.593366622924805,35.37213516235352,35.667938232421875,35.181297302246094,35.667938232421875,14402769.0,,0.0062944277470891015,-0.012599059500782665,0.22637338316323066,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-12,21.72928301493327,35.59478251139323,35.801526387532554,35.30852381388346,35.63295110066732,13928933.333333334,,0.006255055750613254,0.006274700574323534,0.22725117666109151,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-13,21.86519940694173,35.817429860432945,35.93511454264323,35.43575032552084,35.59796396891276,13455097.666666666,,0.0062161732404386405,0.0062355740864497135,0.19660935078323077,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-14,22.001115798950195,36.040077209472656,36.06870269775391,35.5629768371582,35.5629768371582,12981262.0,"Large Caps Breaking Out - Johnson & Johnson (JNJ), Coke (KO), IBM (IBM), Merck (MRK), Verizon (VZ), Disney (DIS), 3M (MMM)",0.006089425034055944,0.006196932530118963,0.14411384232885252,"[{'label': 'neutral', 'score': 0.9998414516448975}, {'label': 'negative', 'score': 8.183863974409178e-05}, {'label': 'positive', 'score': 7.659925176994875e-05}]","(0.9998414516448975, 7.659925176994875e-05, 8.183863974409178e-05)",-0.033069033701945735,-8.183863974409178e-05,1,1,"[{'label': 'neutral', 'score': 0.859116792678833}, {'label': 'positive', 'score': 0.07732643932104111}, {'label': 'negative', 'score': 0.0635567307472229}]","(0.859116792678833, 0.07732643932104111, 0.0635567307472229)",0.0977384918805148,0.07732643932104111,1,1,"[{'label': 'neutral', 'score': 0.9987353682518005}, {'label': 'positive', 'score': 0.001082368427887559}, {'label': 'negative', 'score': 0.0001822706835810095}]","(0.9987353682518005, 0.001082368427887559, 0.0001822706835810095)",0.7117427700471057,0.001082368427887559,0,1
2009-12-15,22.135087966918945,36.25954055786133,36.25954055786133,35.5629768371582,35.94465637207031,13495096.0,,-0.006578910684980391,0.006070959410868091,0.13342685410164828,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-16,21.989463806152344,36.020992279052734,36.35496139526367,35.8015251159668,36.27862548828125,17476238.0,"Top 5 Large-Cap Stocks with Highest Sales Growth Estimate for Next Year (TM, SU, MRK, ESRX, POT)",-0.012450375618719544,-0.006600647104975395,0.09084493883898102,"[{'label': 'positive', 'score': 0.9989141225814819}, {'label': 'neutral', 'score': 0.0008683554478920996}, {'label': 'negative', 'score': 0.00021753857436124235}]","(0.0008683554478920996, 0.9989141225814819, 0.00021753857436124235)",0.9995645447285504,0.9989141225814819,0,0,"[{'label': 'neutral', 'score': 0.5062859058380127}, {'label': 'positive', 'score': 0.4789697825908661}, {'label': 'negative', 'score': 0.014744341373443604}]","(0.5062859058380127, 0.4789697825908661, 0.014744341373443604)",0.9402717457015288,0.4789697825908661,0,1,"[{'label': 'positive', 'score': 0.9984961748123169}, {'label': 'neutral', 'score': 0.0011302989441901445}, {'label': 'negative', 'score': 0.00037356733810156584}]","(0.0011302989441901445, 0.9984961748123169, 0.00037356733810156584)",0.9992520199134327,0.9984961748123169,0,0
2009-12-17,21.715694427490234,35.57251739501953,36.11641311645508,35.553436279296875,36.020992279052734,19433483.0,,0.0032189391195096427,-0.012528530931471072,0.14078174450918385,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-18,21.78558349609375,35.6870231628418,36.05915832519531,35.49618148803711,35.64885330200195,26643618.0,Peak Sales Of MRKs Isentress May Touch $2 Billion,0.002584675652601207,0.00321376942596383,0.1336334205764468,"[{'label': 'neutral', 'score': 0.9787331223487854}, {'label': 'positive', 'score': 0.020922303199768066}, {'label': 'negative', 'score': 0.0003445071051828563}]","(0.9787331223487854, 0.020922303199768066, 0.0003445071051828563)",0.9676014315035617,0.020922303199768066,0,1,"[{'label': 'neutral', 'score': 0.7671459913253784}, {'label': 'positive', 'score': 0.22206172347068787}, {'label': 'negative', 'score': 0.010792333632707596}]","(0.7671459913253784, 0.22206172347068787, 0.010792333632707596)",0.9073038815216742,0.22206172347068787,0,1,"[{'label': 'positive', 'score': 0.9972378015518188}, {'label': 'neutral', 'score': 0.0024418348912149668}, {'label': 'negative', 'score': 0.00032034548348747194}]","(0.0024418348912149668, 0.9972378015518188, 0.00032034548348747194)",0.9993577407303232,0.9972378015518188,0,0
2009-12-19,21.841894149780277,35.77926254272461,36.25954055786133,35.58206049601237,35.68702189127604,22928108.666666668,,0.0025780123269077424,0.0025813411230355874,0.12394073884583137,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-20,21.8982048034668,35.87150192260742,36.459922790527344,35.66793950398763,35.72519048055013,19212599.333333336,,0.002571383269142688,0.0025746949533921922,0.11253013598036994,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-21,21.95451545715332,35.963741302490234,36.66030502319336,35.75381851196289,35.76335906982422,15497090.0,"Health Brings Wealth To The Street (PFE, MRK, AET, UNH, SNY, CHTT) | New PBM President Good For Caremark (CVS) | 2010 Dogs Of The Dow ",0.0015919082522856368,0.002568082919616032,0.10844560527976091,"[{'label': 'positive', 'score': 0.7818506956100464}, {'label': 'neutral', 'score': 0.2174345701932907}, {'label': 'negative', 'score': 0.0007147738942876458}]","(0.2174345701932907, 0.7818506956100464, 0.0007147738942876458)",0.9981732547061133,0.7818506956100464,0,0,"[{'label': 'positive', 'score': 0.5188985466957092}, {'label': 'neutral', 'score': 0.46932828426361084}, {'label': 'negative', 'score': 0.01177317462861538}]","(0.46932828426361084, 0.5188985466957092, 0.01177317462861538)",0.9556291614739346,0.5188985466957092,0,0,"[{'label': 'positive', 'score': 0.9818320274353027}, {'label': 'neutral', 'score': 0.017894970253109932}, {'label': 'negative', 'score': 0.00027303220122121274}]","(0.017894970253109932, 0.9818320274353027, 0.00027303220122121274)",0.9994439857558167,0.9818320274353027,0,0
2009-12-22,21.989463806152344,36.020992279052734,36.24045944213867,35.83015441894531,36.05915832519531,14771350.0,Walmart (WMT) And Comcast (CMCSA) For 2010 | Buying Value for 2010,-0.013245064672799173,0.0015906425094634553,0.009232722251605888,"[{'label': 'neutral', 'score': 0.9998416900634766}, {'label': 'positive', 'score': 9.170076373266056e-05}, {'label': 'negative', 'score': 6.661080260528252e-05}]","(0.9998416900634766, 9.170076373266056e-05, 6.661080260528252e-05)",0.158484700188104,9.170076373266056e-05,0,0,"[{'label': 'neutral', 'score': 0.9312052726745605}, {'label': 'positive', 'score': 0.049317557364702225}, {'label': 'negative', 'score': 0.01947716251015663}]","(0.9312052726745605, 0.049317557364702225, 0.01947716251015663)",0.4337599587414094,0.049317557364702225,0,0,"[{'label': 'neutral', 'score': 0.9994100332260132}, {'label': 'positive', 'score': 0.00047982929390855134}, {'label': 'negative', 'score': 0.00011015780182788149}]","(0.9994100332260132, 0.00047982929390855134, 0.00011015780182788149)",0.6265755552148798,0.00047982929390855134,0,0
2009-12-23,21.698217391967773,35.54389190673828,36.125953674316406,35.43893051147461,36.125953674316406,13358542.0,Above Average EPS Growth Projected For MRK | FDA Indicates Role Of Vytorin and Zetia In Increased Cancer Risk Unlikely | Merck & Co. Inc (MRK) Gets A Hold Rating,-0.006979788181915163,-0.013333562853309161,0.11139655672433316,"[{'label': 'positive', 'score': 0.9991925358772278}, {'label': 'negative', 'score': 0.00046285364078357816}, {'label': 'neutral', 'score': 0.00034461342147551477}]","(0.00034461342147551477, 0.9991925358772278, 0.00046285364078357816)",0.9990739736000288,0.9991925358772278,0,0,"[{'label': 'positive', 'score': 0.9365960955619812}, {'label': 'neutral', 'score': 0.04650260508060455}, {'label': 'negative', 'score': 0.01690126582980156}]","(0.04650260508060455, 0.9365960955619812, 0.01690126582980156)",0.9645488985829359,0.9365960955619812,0,0,"[{'label': 'positive', 'score': 0.9974070191383362}, {'label': 'neutral', 'score': 0.0022714734077453613}, {'label': 'negative', 'score': 0.0003214612661395222}]","(0.0022714734077453613, 0.9974070191383362, 0.0003214612661395222)",0.9993556137316854,0.9974070191383362,0,0
2009-12-24,21.546762466430664,35.29580307006836,35.43893051147461,35.07633590698242,35.43893051147461,6586890.0,Merck Decides To Discontinue Its Collaboration With ARNA For Dyslipidemia,0.0020275689502055804,-0.007004260845938308,0.11380534721677564,"[{'label': 'neutral', 'score': 0.9997599720954895}, {'label': 'positive', 'score': 0.00014674692647531629}, {'label': 'negative', 'score': 9.334690548712388e-05}]","(0.9997599720954895, 0.00014674692647531629, 9.334690548712388e-05)",0.22241313136501653,0.00014674692647531629,1,1,"[{'label': 'neutral', 'score': 0.5580695271492004}, {'label': 'negative', 'score': 0.41694486141204834}, {'label': 'positive', 'score': 0.024985583499073982}]","(0.5580695271492004, 0.024985583499073982, 0.41694486141204834)",-0.8869252671465127,-0.41694486141204834,0,1,"[{'label': 'neutral', 'score': 0.573937714099884}, {'label': 'negative', 'score': 0.41881147027015686}, {'label': 'positive', 'score': 0.007250828202813864}]","(0.573937714099884, 0.007250828202813864, 0.41881147027015686)",-0.9659635305503388,-0.41881147027015686,0,1
2009-12-25,21.590450286865234,35.3673677444458,35.496182441711426,35.083492279052734,35.40314865112305,7551076.0,,0.002023466232899963,0.002025516206532931,0.11225160196465031,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-26,21.634138107299805,35.43893241882324,35.55343437194824,35.09064865112305,35.367366790771484,8515262.0,,0.0020193800854855924,0.002021421782555055,0.11065088369472616,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-27,21.67782592773437,35.510497093200684,35.61068630218506,35.09780502319336,35.33158493041992,9479448.0,,0.0020153104077820453,0.002017343878310701,0.11178722807857433,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-28,21.721513748168945,35.582061767578125,35.667938232421875,35.10496139526367,35.29580307006836,10443634.0,"The World's Largest M&A Deals in 2009 (PFE, WLA, GM, SGP, MRK)",-0.005095188227998899,0.0020132823940232176,0.06406161445562204,"[{'label': 'neutral', 'score': 0.9998254179954529}, {'label': 'positive', 'score': 0.00010817186557687819}, {'label': 'negative', 'score': 6.64258113829419e-05}]","(0.9998254179954529, 0.00010817186557687819, 6.64258113829419e-05)",0.23909856603386107,0.00010817186557687819,1,1,"[{'label': 'neutral', 'score': 0.8701351881027222}, {'label': 'positive', 'score': 0.12045734375715256}, {'label': 'negative', 'score': 0.009407471865415573}]","(0.8701351881027222, 0.12045734375715256, 0.009407471865415573)",0.8551190047848384,0.12045734375715256,0,1,"[{'label': 'neutral', 'score': 0.9960163235664368}, {'label': 'positive', 'score': 0.003792606061324477}, {'label': 'negative', 'score': 0.00019109135610051453}]","(0.9960163235664368, 0.003792606061324477, 0.00019109135610051453)",0.9040633180297949,0.003792606061324477,0,1
2009-12-29,21.610837936401367,35.40076446533203,35.78244400024414,35.37213516235352,35.42938995361328,7869013.0,,-0.0010782213722311984,-0.0051082129606845215,0.050601020657555666,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2009-12-30,21.587547302246094,35.36259460449219,35.48664093017578,35.124046325683594,35.19084167480469,9838205.0,,-0.014031252332770807,-0.0010788030710660065,0.04986158711727147,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2009-12-31,21.28464126586914,34.86641311645508,35.37213516235352,34.828243255615234,35.114505767822266,7403072.0,,0.003215638125995553,-0.014130620959693783,0.10707992256308094,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-01,21.353084564208984,34.97853088378906,35.41507434844971,34.84017086029053,35.11927604675293,9193187.0,,0.003205330941613268,0.003210479018639787,0.11104430155170088,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-02,21.421527862548828,35.09064865112305,35.4580135345459,34.85209846496582,35.124046325683594,10983302.0,,0.003195089621986687,0.0032002048194151853,0.11469261119692581,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-03,21.489971160888672,35.20276641845703,35.50095272064209,34.86402606964111,35.12881660461426,12773417.0,,0.0031849135377951527,0.003189996169614582,0.11913054673488305,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-04,21.55841445922852,35.314884185791016,35.54389190673828,34.875953674316406,35.13358688354492,14563532.0,"Biotech Listings To Form A Major Chunk Of IPO Market (JNJ, PFE, MRK, CDXS,TNGN, MBGI)",0.004053000863616159,0.003179852443923737,0.12300078552819303,"[{'label': 'neutral', 'score': 0.9998799562454224}, {'label': 'negative', 'score': 6.779424438718706e-05}, {'label': 'positive', 'score': 5.21927468071226e-05}]","(0.9998799562454224, 5.21927468071226e-05, 6.779424438718706e-05)",-0.13002657558767383,-6.779424438718706e-05,1,1,"[{'label': 'neutral', 'score': 0.811600923538208}, {'label': 'positive', 'score': 0.18122166395187378}, {'label': 'negative', 'score': 0.007177429273724556}]","(0.811600923538208, 0.18122166395187378, 0.007177429273724556)",0.9238061165705299,0.18122166395187378,0,1,"[{'label': 'neutral', 'score': 0.9995704293251038}, {'label': 'positive', 'score': 0.00032678269781172276}, {'label': 'negative', 'score': 0.00010282105358783156}]","(0.9995704293251038, 0.00032678269781172276, 0.00010282105358783156)",0.5213214351463961,0.00032678269781172276,0,1
2010-01-05,21.64578628540039,35.45801544189453,35.73473358154297,35.238548278808594,35.59160232543945,15452550.0,"Drug Pipeline Targeting High Growth Markets May Boost Merck Prospects (MRK, C)",0.013455360272384198,0.004044809581006986,0.006034825162746629,"[{'label': 'positive', 'score': 0.9994437098503113}, {'label': 'neutral', 'score': 0.00036881628329865634}, {'label': 'negative', 'score': 0.00018745072884485126}]","(0.00036881628329865634, 0.9994437098503113, 0.00018745072884485126)",0.9996249602128524,0.9994437098503113,1,1,"[{'label': 'positive', 'score': 0.9308906197547913}, {'label': 'neutral', 'score': 0.06005983427166939}, {'label': 'negative', 'score': 0.009049516171216965}]","(0.06005983427166939, 0.9308906197547913, 0.009049516171216965)",0.9807444839829048,0.9308906197547913,1,1,"[{'label': 'positive', 'score': 0.9982031583786011}, {'label': 'neutral', 'score': 0.0014454360352829099}, {'label': 'negative', 'score': 0.00035143765853717923}]","(0.0014454360352829099, 0.9982031583786011, 0.00035143765853717923)",0.9992961072735894,0.9982031583786011,1,1
2010-01-06,21.93704032897949,35.935115814208984,36.00190734863281,35.209922790527344,35.5057258605957,15971415.0,,0.0015931763475731608,0.013365640821387066,0.07096640536288201,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-07,21.97198486328125,35.992366790771484,36.16412353515625,35.6870231628418,35.75381851196289,12488597.0,,-0.0005302493867898482,0.0015919085884665313,0.07491050809704082,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-08,21.96034049987793,35.97328186035156,36.154579162597656,35.71564865112305,36.13549423217773,11283921.0,"Investment Mantra 2010: Be Bullish On Mega Caps In The Dogs Of The Dow. (XOM, WFC, BA, CVX, DU, MCD, MRK, PFE) ",0.0013262737296636969,-0.0005303900187114246,0.08480892243079473,"[{'label': 'negative', 'score': 0.9794735312461853}, {'label': 'neutral', 'score': 0.018478533253073692}, {'label': 'positive', 'score': 0.0020478435326367617}]","(0.018478533253073692, 0.0020478435326367617, 0.9794735312461853)",-0.9958272054277,-0.9794735312461853,0,0,"[{'label': 'neutral', 'score': 0.8412026166915894}, {'label': 'positive', 'score': 0.14721985161304474}, {'label': 'negative', 'score': 0.011577483266592026}]","(0.8412026166915894, 0.14721985161304474, 0.011577483266592026)",0.8541854209912606,0.14721985161304474,0,1,"[{'label': 'neutral', 'score': 0.8473196029663086}, {'label': 'positive', 'score': 0.1522005796432495}, {'label': 'negative', 'score': 0.0004798387235496193}]","(0.8473196029663086, 0.1522005796432495, 0.0004798387235496193)",0.9937144693644099,0.1522005796432495,0,1
2010-01-09,21.989465713500977,36.020992279052734,36.16412099202474,35.73791376749674,36.13867568969727,10869856.0,,0.001324517057486059,0.0013253950055274462,0.08737682775427578,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-10,22.018590927124023,36.06870269775391,36.17366282145182,35.760178883870445,36.1418571472168,10455791.0,,0.0013227650326368909,0.0013236406585531225,0.08932329346743273,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-11,22.04771614074707,36.11641311645508,36.183204650878906,35.78244400024414,36.14503860473633,10041726.0,,-0.00792600019793612,0.0013218909496903897,0.013762561625677502,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-01-12,21.87296485900879,35.83015441894531,36.25,35.610687255859375,36.08778762817383,11445942.0,,0.03675093104615732,-0.007957577904789185,0.06388366242437651,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-01-13,22.676815032958984,37.14694595336914,37.56679534912109,36.35496139526367,36.55534362792969,26593419.0,"Merck leads drug stocks up | Merck & Co. (MRK) Soars On Upgrade By Credit Suisse | Merck Upgraded At Credit Suisse (MRK) | Benzingas Top Upgrades (BIDU, MRK, NTAP, UPS, AAWW) | Company News for January 13, 2010 - Corporate Summary",0.027228395100396402,0.03609171818702476,0.2709202545822841,"[{'label': 'positive', 'score': 0.9995445609092712}, {'label': 'negative', 'score': 0.0002516302920412272}, {'label': 'neutral', 'score': 0.00020373387087602168}]","(0.00020373387087602168, 0.9995445609092712, 0.0002516302920412272)",0.9994966368260738,0.9995445609092712,0,0,"[{'label': 'positive', 'score': 0.6702688932418823}, {'label': 'neutral', 'score': 0.2984347343444824}, {'label': 'negative', 'score': 0.03129633516073227}]","(0.2984347343444824, 0.6702688932418823, 0.03129633516073227)",0.9107813959594591,0.6702688932418823,0,0,"[{'label': 'positive', 'score': 0.9982324242591858}, {'label': 'neutral', 'score': 0.0015054052928462625}, {'label': 'negative', 'score': 0.00026215225807391107}]","(0.0015054052928462625, 0.9982324242591858, 0.00026215225807391107)",0.9994749049934987,0.9982324242591858,0,0
2010-01-14,23.294261932373047,38.15839767456055,38.28244400024414,37.30915832519531,37.4427490234375,23081466.0,"Merck & Co (MRK) Submits New Data To FDA To Widen Gardasil Use | Stock Market News for January 14, 2010 - Market News | Top 5 Large-Cap Stocks In The Healthcare Sector With The Highest ROE (GSK, GILD, AZN, ACL, MRK) ",-0.013003305509999756,0.026864296776707913,0.29978868406363757,"[{'label': 'neutral', 'score': 0.9924877882003784}, {'label': 'positive', 'score': 0.0073472363874316216}, {'label': 'negative', 'score': 0.0001648902107262984}]","(0.9924877882003784, 0.0073472363874316216, 0.0001648902107262984)",0.9561002577441302,0.0073472363874316216,0,1,"[{'label': 'neutral', 'score': 0.5072737336158752}, {'label': 'positive', 'score': 0.46919456124305725}, {'label': 'negative', 'score': 0.023531747981905937}]","(0.5072737336158752, 0.46919456124305725, 0.023531747981905937)",0.9044834930007276,0.46919456124305725,0,1,"[{'label': 'positive', 'score': 0.5604225993156433}, {'label': 'neutral', 'score': 0.438644677400589}, {'label': 'negative', 'score': 0.0009327076841145754}]","(0.438644677400589, 0.5604225993156433, 0.0009327076841145754)",0.9966769435596875,0.5604225993156433,0,0
2010-01-15,22.991369247436523,37.66221237182617,38.42557144165039,37.22328186035156,38.14885330200195,21854258.0,"Pete Najarian Sees An Opportunity In Pharma (XLV, WLP, AET, UNH, HUM, MRK, PFE, JNJ) ",0.007284013052669407,-0.013088588601882315,0.3447809628897222,"[{'label': 'positive', 'score': 0.9993324875831604}, {'label': 'neutral', 'score': 0.00039444310823455453}, {'label': 'negative', 'score': 0.0002729846746660769}]","(0.00039444310823455453, 0.9993324875831604, 0.0002729846746660769)",0.9994538151655983,0.9993324875831604,0,0,"[{'label': 'positive', 'score': 0.6601113677024841}, {'label': 'neutral', 'score': 0.33299151062965393}, {'label': 'negative', 'score': 0.006897117476910353}]","(0.33299151062965393, 0.6601113677024841, 0.006897117476910353)",0.9793192511634831,0.6601113677024841,0,0,"[{'label': 'positive', 'score': 0.9248527884483337}, {'label': 'neutral', 'score': 0.07468095421791077}, {'label': 'negative', 'score': 0.00046630436554551125}]","(0.07468095421791077, 0.9248527884483337, 0.00046630436554551125)",0.998992122027597,0.9248527884483337,0,0
2010-01-16,23.15884017944336,37.93654441833496,38.56154537200928,37.3258581161499,38.04627704620361,21617777.0,,0.007231339878605357,0.007257612752166001,0.33936952850549323,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-17,23.326311111450195,38.21087646484375,38.69751930236816,37.42843437194824,37.94370079040527,21381296.0,,0.00717942303053924,0.00720531910843718,0.3045800877193187,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-18,23.49378204345703,38.48520851135254,38.83349323272705,37.53101062774658,37.84112453460693,21144815.0,Merck Has The Best Pharma Bet (MRK),0.007128246334636991,0.007153773664942374,0.22425278589846676,"[{'label': 'positive', 'score': 0.9666928648948669}, {'label': 'neutral', 'score': 0.03277011588215828}, {'label': 'negative', 'score': 0.0005370502476580441}]","(0.03277011588215828, 0.9666928648948669, 0.0005370502476580441)",0.9988895086075188,0.9666928648948669,0,0,"[{'label': 'positive', 'score': 0.825477659702301}, {'label': 'neutral', 'score': 0.16752852499485016}, {'label': 'negative', 'score': 0.006993848364800215}]","(0.16752852499485016, 0.825477659702301, 0.006993848364800215)",0.9831973868245916,0.825477659702301,0,0,"[{'label': 'positive', 'score': 0.9952464699745178}, {'label': 'neutral', 'score': 0.0044378358870744705}, {'label': 'negative', 'score': 0.0003157262981403619}]","(0.0044378358870744705, 0.9952464699745178, 0.0003157262981403619)",0.9993657326497081,0.9952464699745178,0,0
2010-01-19,23.661252975463867,38.75954055786133,38.96946716308594,37.63358688354492,37.738548278808594,20908334.0,,0.010093615709574089,0.007102960478166873,0.14389502075624316,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-20,23.900075912475582,39.15076446533203,39.26526641845703,38.13931274414063,38.77862548828125,21843150.0,"Stock Market News for January 20, 2010 - Market News",-0.023153834626407636,0.010043015379185215,0.02034656769763657,"[{'label': 'neutral', 'score': 0.9998704195022583}, {'label': 'negative', 'score': 7.754450052743778e-05}, {'label': 'positive', 'score': 5.1968447223771363e-05}]","(0.9998704195022583, 5.1968447223771363e-05, 7.754450052743778e-05)",-0.19747873666498053,-7.754450052743778e-05,0,0,"[{'label': 'neutral', 'score': 0.923838198184967}, {'label': 'negative', 'score': 0.0546930730342865}, {'label': 'positive', 'score': 0.021468717604875565}]","(0.923838198184967, 0.021468717604875565, 0.0546930730342865)",-0.4362339061435763,-0.0546930730342865,0,0,"[{'label': 'neutral', 'score': 0.9995922446250916}, {'label': 'positive', 'score': 0.0002602977037895471}, {'label': 'negative', 'score': 0.0001474761957069859}]","(0.9995922446250916, 0.0002602977037895471, 0.0001474761957069859)",0.27667662943081633,0.0002602977037895471,0,0
2010-01-21,23.346704483032227,38.2442741394043,39.65649032592773,38.21564865112305,39.1984748840332,26803019.0,,-0.03018959539901573,-0.023426095453971067,0.22311101155185972,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-22,22.64187431335449,37.08969497680664,38.44465637207031,36.9942741394043,38.07251739501953,18301853.0,Big Pharma Will Trade On the Following Fundamentals:   Morningstar Says Big Pharma Well Positioned,-0.0009433113908441006,-0.030654685763585505,0.308799006656502,"[{'label': 'positive', 'score': 0.9969304203987122}, {'label': 'neutral', 'score': 0.0025092745199799538}, {'label': 'negative', 'score': 0.0005603782483376563}]","(0.0025092745199799538, 0.9969304203987122, 0.0005603782483376563)",0.9988764242254711,0.9969304203987122,0,0,"[{'label': 'positive', 'score': 0.9234402775764465}, {'label': 'neutral', 'score': 0.06601216644048691}, {'label': 'negative', 'score': 0.01054756622761488}]","(0.06601216644048691, 0.9234402775764465, 0.01054756622761488)",0.9774139111176106,0.9234402775764465,0,0,"[{'label': 'positive', 'score': 0.9005153775215149}, {'label': 'neutral', 'score': 0.09910597652196884}, {'label': 'negative', 'score': 0.0003786227316595614}]","(0.09910597652196884, 0.9005153775215149, 0.0003786227316595614)",0.9991594510973474,0.9005153775215149,0,0
2010-01-23,22.620512008666992,37.054707845052086,38.26971944173177,36.97837066650391,37.87531661987305,17573248.333333332,,-0.0009442020674099301,-0.0009437565890298847,0.2920369640946186,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-24,22.59914970397949,37.01972071329752,38.09478251139323,36.96246719360352,37.67811584472656,16844643.666666668,,-0.0009450944275217184,-0.000944648106971776,0.271413962902579,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-25,22.577787399291992,36.98473358154297,37.91984558105469,36.946563720703125,37.48091506958008,16116039.0,"Merck (MRK) Doing Well, But Becoming More Transparent",-0.004643990310382549,-0.0009455413108469443,0.23049648178606366,"[{'label': 'positive', 'score': 0.9987095594406128}, {'label': 'neutral', 'score': 0.0010088469134643674}, {'label': 'negative', 'score': 0.000281592714600265}]","(0.0010088469134643674, 0.9987095594406128, 0.000281592714600265)",0.9994362458286187,0.9987095594406128,0,0,"[{'label': 'positive', 'score': 0.9331234097480774}, {'label': 'neutral', 'score': 0.056043025106191635}, {'label': 'negative', 'score': 0.010833590291440487}]","(0.056043025106191635, 0.9331234097480774, 0.010833590291440487)",0.9770464326426163,0.9331234097480774,0,0,"[{'label': 'positive', 'score': 0.9981870055198669}, {'label': 'neutral', 'score': 0.001477081561461091}, {'label': 'negative', 'score': 0.0003358658868819475}]","(0.001477081561461091, 0.9981870055198669, 0.0003358658868819475)",0.9993272745242003,0.9981870055198669,0,0
2010-01-26,22.472946166992188,36.8129768371582,37.16603088378906,36.41221237182617,36.73664093017578,20817158.0,,0.0015551846517533495,-0.004654807135196094,0.20592083503665434,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-27,22.50788688659668,36.8702278137207,37.00381851196289,36.22137451171875,36.72710037231445,18322289.0,,-0.01733953875659847,0.001553976604431807,0.03524251862438686,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-01-28,22.11761283874512,36.23091506958008,37.15649032592773,36.20228958129883,36.96564865112305,14008197.0,,0.005530697534997095,-0.017491629242164478,0.12056573029947246,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-29,22.23993682861328,36.431297302246094,37.22328186035156,35.935115814208984,36.50763320922852,16893655.0,Invest In High Quality Stocks Like Merck (MRK) : Analyst Says On CNBC,0.0010476867995511368,0.005515459386625973,0.13975183619867318,"[{'label': 'neutral', 'score': 0.9998258948326111}, {'label': 'positive', 'score': 0.00011514840298332274}, {'label': 'negative', 'score': 5.895777212572284e-05}]","(0.9998258948326111, 0.00011514840298332274, 5.895777212572284e-05)",0.32273772496815106,0.00011514840298332274,1,1,"[{'label': 'neutral', 'score': 0.8432926535606384}, {'label': 'positive', 'score': 0.14646193385124207}, {'label': 'negative', 'score': 0.01024546753615141}]","(0.8432926535606384, 0.14646193385124207, 0.01024546753615141)",0.8692407959618477,0.14646193385124207,0,1,"[{'label': 'neutral', 'score': 0.9965862035751343}, {'label': 'positive', 'score': 0.003207501256838441}, {'label': 'negative', 'score': 0.00020622997544705868}]","(0.9965862035751343, 0.003207501256838441, 0.00020622997544705868)",0.8791762084275233,0.003207501256838441,0,1
2010-01-30,22.26323890686035,36.46946589152018,37.1024169921875,36.06552251180013,36.6030527750651,14484652.333333334,,0.001046590300708741,0.0010471383587654073,0.14247062416437398,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-01-31,22.286540985107425,36.50763448079427,36.98155212402344,36.19592920939128,36.698472340901695,12075649.666666668,,0.0010454960946364707,0.0010460430069081728,0.14355428275636486,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-01,22.30984306335449,36.54580307006836,36.860687255859375,36.32633590698242,36.79389190673828,9666647.0,,0.03237593790483642,0.0010449499442267611,0.14287891036452507,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-02-02,23.03214454650879,37.72900772094727,37.90076446533203,36.35496139526367,36.60305404663086,15857288.0,,-0.020738525805695445,0.03186288164072656,0.21307191737289125,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-03,22.554492950439453,36.946563720703125,37.614505767822266,36.70801544189453,37.59542083740234,18305311.0,"Mad Money Lightning Round: Jim Prefers MRK, SYK, INTC, AAPL To COMS, ZMH, EBIX, MSFT, MOT ",-0.04183878281770762,-0.020956589175964956,0.2989148453278728,"[{'label': 'neutral', 'score': 0.9998724460601807}, {'label': 'negative', 'score': 7.299068238353357e-05}, {'label': 'positive', 'score': 5.460950342239812e-05}]","(0.9998724460601807, 5.460950342239812e-05, 7.299068238353357e-05)",-0.14405291689066624,-7.299068238353357e-05,1,1,"[{'label': 'neutral', 'score': 0.9365848302841187}, {'label': 'positive', 'score': 0.04602210223674774}, {'label': 'negative', 'score': 0.01739313453435898}]","(0.9365848302841187, 0.04602210223674774, 0.01739313453435898)",0.4514525082626942,0.04602210223674774,1,1,"[{'label': 'neutral', 'score': 0.9988335967063904}, {'label': 'positive', 'score': 0.000971734116319567}, {'label': 'negative', 'score': 0.0001946752454387024}]","(0.9988335967063904, 0.000971734116319567, 0.0001946752454387024)",0.6661973886333612,0.000971734116319567,0,1
2010-02-04,21.610837936401367,35.40076446533203,36.74618148803711,35.13358688354492,36.63167953491211,26547307.0,Merck (MRK) Is A Frontrunner Among Pharma Stocks,-0.009973062784466285,-0.04273923001066635,0.4423787811251181,"[{'label': 'neutral', 'score': 0.9998624324798584}, {'label': 'negative', 'score': 7.153132901294157e-05}, {'label': 'positive', 'score': 6.601820496143773e-05}]","(0.9998624324798584, 6.601820496143773e-05, 7.153132901294157e-05)",-0.04008100858073965,-7.153132901294157e-05,1,1,"[{'label': 'positive', 'score': 0.5526232123374939}, {'label': 'neutral', 'score': 0.43836286664009094}, {'label': 'negative', 'score': 0.00901391264051199}]","(0.43836286664009094, 0.5526232123374939, 0.00901391264051199)",0.9679012934165812,0.5526232123374939,0,0,"[{'label': 'neutral', 'score': 0.9563806653022766}, {'label': 'positive', 'score': 0.04308166354894638}, {'label': 'negative', 'score': 0.0005376381450332701}]","(0.9563806653022766, 0.04308166354894638, 0.0005376381450332701)",0.975348612923463,0.04308166354894638,0,1
2010-02-05,21.395309448242188,35.04771041870117,35.38167953491211,34.17938995361328,35.35305404663086,24074970.0,"Market Round-up (UBS, GOOG AAPL, MOT PG, PFE, MRK, LLY, CVS, WAG)",-0.0012705241126929746,-0.010023126915048067,0.4383139066291945,"[{'label': 'neutral', 'score': 0.9998753070831299}, {'label': 'negative', 'score': 6.886573100928217e-05}, {'label': 'positive', 'score': 5.575156683335081e-05}]","(0.9998753070831299, 5.575156683335081e-05, 6.886573100928217e-05)",-0.10523550424349565,-6.886573100928217e-05,1,1,"[{'label': 'neutral', 'score': 0.9494233131408691}, {'label': 'positive', 'score': 0.03331604599952698}, {'label': 'negative', 'score': 0.017260577529668808}]","(0.9494233131408691, 0.03331604599952698, 0.017260577529668808)",0.3174484050045376,0.03331604599952698,1,1,"[{'label': 'neutral', 'score': 0.9995303153991699}, {'label': 'positive', 'score': 0.0003597723552957177}, {'label': 'negative', 'score': 0.00010996761557180434}]","(0.9995303153991699, 0.0003597723552957177, 0.00010996761557180434)",0.5317936629122079,0.0003597723552957177,0,1
2010-02-06,21.368127187093098,35.00318145751953,35.38167953491211,34.30661646525065,35.20356241861979,19618629.666666668,,-0.0012721403977430379,-0.0012713319127456062,0.43554834123920594,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-07,21.34094492594401,34.95865249633789,35.38167953491211,34.43384297688802,35.054070790608726,15162289.333333334,,-0.0012737608003141792,-0.0012729502552466492,0.2756758295887994,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-08,21.31376266479492,34.91412353515625,35.38167953491211,34.56106948852539,34.904579162597656,10705949.0,,-0.0032796403354351934,-0.0012745727231392484,0.28526443945842,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-09,21.24386405944824,34.799617767333984,35.46755599975586,34.656490325927734,35.238548278808594,17965864.0,,-0.007403334454735106,-0.003285030143447598,0.060160411524117115,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-10,21.086589813232425,34.54198455810547,35.00954055786133,34.12213516235352,34.828243255615234,17627884.0,"Merck & Co. To Change Safety Procedures (MRK) | Merck & Co. (MRK) Agrees To Changes In Vioxx Settlement | Market Roundup (AAPL, MRK, FITB, PNC, TTWO, GOOG)",0.01878459286575533,-0.007430875148095251,0.04246149006195121,"[{'label': 'positive', 'score': 0.9654675722122192}, {'label': 'neutral', 'score': 0.0336679182946682}, {'label': 'negative', 'score': 0.0008645506459288299}]","(0.0336679182946682, 0.9654675722122192, 0.0008645506459288299)",0.9982106552695946,0.9654675722122192,1,1,"[{'label': 'neutral', 'score': 0.5047690868377686}, {'label': 'positive', 'score': 0.4429035782814026}, {'label': 'negative', 'score': 0.052327342331409454}]","(0.5047690868377686, 0.4429035782814026, 0.052327342331409454)",0.7886749790717502,0.4429035782814026,1,0,"[{'label': 'neutral', 'score': 0.956364095211029}, {'label': 'positive', 'score': 0.04275297373533249}, {'label': 'negative', 'score': 0.0008829889120534062}]","(0.956364095211029, 0.04275297373533249, 0.0008829889120534062)",0.9595293029655986,0.04275297373533249,1,0
2010-02-11,21.482690811157227,35.19084167480469,35.30534362792969,34.22710037231445,34.56106948852539,15123478.0,"Credit Suisse Lowers Estimates, Price Targets On Merck, Pfizer",0.0010845448510515044,0.018610341183681593,0.160693850862399,"[{'label': 'neutral', 'score': 0.7694255113601685}, {'label': 'negative', 'score': 0.13173000514507294}, {'label': 'positive', 'score': 0.09884446859359741}]","(0.7694255113601685, 0.09884446859359741, 0.13173000514507294)",-0.14262435914197294,-0.13173000514507294,1,1,"[{'label': 'negative', 'score': 0.5741792321205139}, {'label': 'neutral', 'score': 0.4010261297225952}, {'label': 'positive', 'score': 0.024794727563858032}]","(0.4010261297225952, 0.024794727563858032, 0.5741792321205139)",-0.9172093305127202,-0.5741792321205139,0,0,"[{'label': 'negative', 'score': 0.9928389191627502}, {'label': 'neutral', 'score': 0.006695539690554142}, {'label': 'positive', 'score': 0.0004656282835640013}]","(0.006695539690554142, 0.0004656282835640013, 0.9928389191627502)",-0.9990624662199301,-0.9928389191627502,0,0
2010-02-12,21.5059871673584,35.229007720947266,35.4484748840332,34.4370231628418,34.95228958129883,18766955.0,,0.0050108429029202045,0.0010839571571663708,0.15939536684730402,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-13,21.613750457763672,35.405534744262695,35.694180488586426,34.716126441955566,35.21230888366699,19517454.0,,0.004985859544009149,0.004998330410968345,0.15863444196955262,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-14,21.721513748168945,35.582061767578125,35.93988609313965,34.995229721069336,35.47232818603516,20267953.0,,0.004961124076184889,0.004973471306590626,0.1492489423534332,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-15,21.82927703857422,35.758588790893555,36.18559169769287,35.274333000183105,35.73234748840332,21018452.0,,0.004936632828205593,0.00494885825159261,0.10710606337543879,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-16,21.93704032897949,35.935115814208984,36.431297302246094,35.553436279296875,35.992366790771484,21768951.0,"Movement Expected In The Shares Of These Companies Amid Significant Events (BRK.B, BX, JPM, ORCL,YHOO)  | Merck & Co. (MRK) Reports Bigger Profit, Helped By Schering-Ploug Deal  | Merck Posts Bigger Profit (MRK) | Company News for February 16, 2010 - Corporate Summary | MRK Shares Up As 4Q Earnings Match Expectations | Stock Market News for February 16, 2010 - Market News | Merck & Co. (MRK) Reports Schering Fueled Profit Jump | Merck Reports Inline, Stock Off To Good Start In Premarket (MRK) | Top 5 Large Cap Growth Stocks (ESRX, MRK, VALE, AAPL, BHP)",-0.008497082060577432,0.004924487610950529,0.02752977692628321,"[{'label': 'positive', 'score': 0.9995777010917664}, {'label': 'negative', 'score': 0.00024013906659092754}, {'label': 'neutral', 'score': 0.0001821751066017896}]","(0.0001821751066017896, 0.9995777010917664, 0.00024013906659092754)",0.9995196343634899,0.9995777010917664,0,0,"[{'label': 'positive', 'score': 0.9383260011672974}, {'label': 'negative', 'score': 0.032076116651296616}, {'label': 'neutral', 'score': 0.029597824439406395}]","(0.029597824439406395, 0.9383260011672974, 0.032076116651296616)",0.9338910827536078,0.9383260011672974,0,0,"[{'label': 'positive', 'score': 0.9986668825149536}, {'label': 'neutral', 'score': 0.0010452985297888517}, {'label': 'negative', 'score': 0.00028782032313756645}]","(0.0010452985297888517, 0.9986668825149536, 0.00028782032313756645)",0.9994237570085613,0.9986668825149536,0,0
2010-02-17,21.750638961791992,35.6297721862793,36.183204650878906,35.45801544189453,36.00190734863281,12534918.0,"John Paulson Sells Merck (MRK), Buys Bank Of America (BAC)",-0.00133906044786738,-0.00853338807208073,0.0958036845472421,"[{'label': 'neutral', 'score': 0.9998739957809448}, {'label': 'negative', 'score': 7.637386443093419e-05}, {'label': 'positive', 'score': 4.956915290676989e-05}]","(0.9998739957809448, 4.956915290676989e-05, 7.637386443093419e-05)",-0.21283205763039686,-7.637386443093419e-05,1,1,"[{'label': 'neutral', 'score': 0.9166321754455566}, {'label': 'positive', 'score': 0.06770987063646317}, {'label': 'negative', 'score': 0.01565791480243206}]","(0.9166321754455566, 0.06770987063646317, 0.01565791480243206)",0.6243653416004772,0.06770987063646317,0,1,"[{'label': 'neutral', 'score': 0.9951386451721191}, {'label': 'positive', 'score': 0.004550309851765633}, {'label': 'negative', 'score': 0.00031101537751965225}]","(0.9951386451721191, 0.004550309851765633, 0.00031101537751965225)",0.8720450235890191,0.004550309851765633,0,1
2010-02-18,21.721513748168945,35.582061767578125,35.78244400024414,35.33396911621094,35.57251739501953,12942590.0,"Large Hacking Instance Detected (MRK, CAH)",0.005363316531626918,-0.0013399577904623168,0.09496363219418763,"[{'label': 'neutral', 'score': 0.9998772144317627}, {'label': 'negative', 'score': 7.395806460408494e-05}, {'label': 'positive', 'score': 4.892662764177658e-05}]","(0.9998772144317627, 4.892662764177658e-05, 7.395806460408494e-05)",-0.20369857713625325,-7.395806460408494e-05,1,1,"[{'label': 'negative', 'score': 0.7995656728744507}, {'label': 'neutral', 'score': 0.17794232070446014}, {'label': 'positive', 'score': 0.02249200828373432}]","(0.17794232070446014, 0.02249200828373432, 0.7995656728744507)",-0.9452787589015758,-0.7995656728744507,0,0,"[{'label': 'neutral', 'score': 0.8851017951965332}, {'label': 'negative', 'score': 0.10981849581003189}, {'label': 'positive', 'score': 0.005079702008515596}]","(0.8851017951965332, 0.005079702008515596, 0.10981849581003189)",-0.9115790829628556,-0.10981849581003189,0,1
2010-02-19,21.83801651000977,35.77289962768555,35.906490325927734,35.4484748840332,35.524810791015625,13004003.0,,-0.0032897719624385632,0.005348985169102909,0.09598673452516135,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-20,21.766171137491863,35.65521494547526,35.979644775390625,35.273537953694664,35.72519175211588,14809707.0,,-0.00330063028340308,-0.003295195159541917,0.09278729510462623,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-21,21.69432576497396,35.537530263264976,36.05279922485352,35.09860102335612,35.92557271321615,16615411.0,,-0.003311560520342042,-0.0033060893791513053,0.07947501573926274,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-22,21.62248039245605,35.41984558105469,36.125953674316406,34.92366409301758,36.125953674316406,18421115.0,,-0.016433102497549836,-0.0033170558723631858,0.05951063305539821,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-02-23,21.26715850830078,34.83778762817383,35.43893051147461,34.73282241821289,35.209922790527344,16699670.0,,0.011503619429342426,-0.01656962363662777,0.12463869168308742,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-24,21.511812210083008,35.238548278808594,35.343509674072266,34.60877990722656,35.01908493041992,17913988.0,,-0.009748122180130844,0.011437955898393581,0.15732392384179664,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-25,21.302120208740234,34.89503860473633,34.98091506958008,34.39885330200195,34.770992279052734,17854252.0,Eli Lilly Banks On Its Restructured Development Process To Offset Sales Loss (LLY),0.008476937750921697,-0.00979594617302831,0.16466423289063406,"[{'label': 'negative', 'score': 0.9965535402297974}, {'label': 'neutral', 'score': 0.0021009144838899374}, {'label': 'positive', 'score': 0.0013454677537083626}]","(0.0021009144838899374, 0.0013454677537083626, 0.9965535402297974)",-0.9973033989553167,-0.9965535402297974,0,0,"[{'label': 'positive', 'score': 0.5473605990409851}, {'label': 'neutral', 'score': 0.434533953666687}, {'label': 'negative', 'score': 0.018105439841747284}]","(0.434533953666687, 0.5473605990409851, 0.018105439841747284)",0.9359627684183451,0.5473605990409851,0,0,"[{'label': 'neutral', 'score': 0.7815611958503723}, {'label': 'positive', 'score': 0.21539168059825897}, {'label': 'negative', 'score': 0.003047115169465542}]","(0.7815611958503723, 0.21539168059825897, 0.003047115169465542)",0.9721009708119278,0.21539168059825897,0,1
2010-02-26,21.482690811157227,35.19084167480469,35.36259460449219,34.770992279052734,35.01908493041992,13800483.0,,0.003524924332987686,0.008441210278490768,0.18856201768221298,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-27,21.55841573079427,35.314886728922524,35.48027928670248,34.95865122477213,35.124046325683594,13324691.0,,0.0035125428851015307,0.0035187263478931234,0.19168326403027322,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-02-28,21.63414065043132,35.43893178304037,35.59796396891276,35.14631017049154,35.229007720947266,12848899.0,,0.0035002481134941855,0.00350638831426029,0.12900872727895277,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-01,21.70986557006836,35.5629768371582,35.71564865112305,35.33396911621094,35.33396911621094,12373107.0,Karen Finerman Thinks There Might Be Other Bidders For MIL,0.0032198026713732113,0.0034941365023510268,0.10862795601551492,"[{'label': 'neutral', 'score': 0.9997414946556091}, {'label': 'positive', 'score': 0.00018050741346087307}, {'label': 'negative', 'score': 7.789781375322491e-05}]","(0.9997414946556091, 0.00018050741346087307, 7.789781375322491e-05)",0.3970879413466061,0.00018050741346087307,1,1,"[{'label': 'neutral', 'score': 0.8667734861373901}, {'label': 'positive', 'score': 0.11945836991071701}, {'label': 'negative', 'score': 0.013768123462796211}]","(0.8667734861373901, 0.11945836991071701, 0.013768123462796211)",0.7933125294501904,0.11945836991071701,0,1,"[{'label': 'neutral', 'score': 0.9990571141242981}, {'label': 'positive', 'score': 0.0008286593365482986}, {'label': 'negative', 'score': 0.00011421280942158774}]","(0.9990571141242981, 0.0008286593365482986, 0.00011421280942158774)",0.7577342592847461,0.0008286593365482986,0,1
2010-03-02,21.77977180480957,35.67748260498047,35.963741302490234,35.610687255859375,35.85877990722656,12842402.0,,-0.004814149761810518,0.003214630206655098,0.03560822711404741,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-03,21.674915313720703,35.5057258605957,36.11641311645508,35.40076446533203,35.963741302490234,13186879.0,,-0.0018812556989638483,-0.004825775106548986,0.05866928255141411,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-04,21.63414192199707,35.43893051147461,35.667938232421875,35.19084167480469,35.582061767578125,12421839.0,,0.009423792179699192,-0.0018830274829340857,0.06107694604803905,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-03-05,21.83801651000977,35.77289962768555,35.83969497680664,35.238548278808594,35.51526641845703,10342502.0,Goldman Sachs (GS) VIP List of Top Hedge Fund Holdings,-0.0012447680127997938,0.009379665262151933,0.08686103881862979,"[{'label': 'neutral', 'score': 0.9998804330825806}, {'label': 'negative', 'score': 6.719956581946462e-05}, {'label': 'positive', 'score': 5.23067828908097e-05}]","(0.9998804330825806, 5.23067828908097e-05, 6.719956581946462e-05)",-0.12461917788786518,-6.719956581946462e-05,1,1,"[{'label': 'neutral', 'score': 0.9318452477455139}, {'label': 'positive', 'score': 0.03598793223500252}, {'label': 'negative', 'score': 0.03216683492064476}]","(0.9318452477455139, 0.03598793223500252, 0.03216683492064476)",0.056065004310430586,0.03598793223500252,1,1,"[{'label': 'neutral', 'score': 0.9976690411567688}, {'label': 'positive', 'score': 0.002206037985160947}, {'label': 'negative', 'score': 0.00012487845378927886}]","(0.9976690411567688, 0.002206037985160947, 0.00012487845378927886)",0.8928503384312478,0.002206037985160947,0,1
2010-03-06,21.81083297729492,35.728370666503906,35.833333333333336,35.29580052693685,35.60114415486654,11103524.666666666,,-0.0012463193913118309,-0.00124554338000432,0.0878103599589725,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-07,21.78364944458008,35.683841705322266,35.826971689860024,35.3530527750651,35.68702189127604,11864547.333333334,,-0.0012478746416756776,-0.001247096693235821,0.08618859860730539,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-08,21.756465911865234,35.639312744140625,35.82061004638672,35.41030502319336,35.77289962768555,12625570.0,"ThinkEquity Reiterates Buy on OraSure Technologies (OSUR, MRK, PFE) | Simple Quantitative View of Goldman's VIP List Generates Some Other Long Ideas",-0.008299909490173648,-0.001248653885569562,0.07669587250189287,"[{'label': 'positive', 'score': 0.9992087483406067}, {'label': 'neutral', 'score': 0.0005511697963811457}, {'label': 'negative', 'score': 0.00024008912441786379}]","(0.0005511697963811457, 0.9992087483406067, 0.00024008912441786379)",0.9995195569489543,0.9992087483406067,0,0,"[{'label': 'neutral', 'score': 0.913055419921875}, {'label': 'positive', 'score': 0.07055188715457916}, {'label': 'negative', 'score': 0.016392724588513374}]","(0.913055419921875, 0.07055188715457916, 0.016392724588513374)",0.6229156871284615,0.07055188715457916,0,1,"[{'label': 'positive', 'score': 0.9975390434265137}, {'label': 'neutral', 'score': 0.002171887783333659}, {'label': 'negative', 'score': 0.0002890727773774415}]","(0.002171887783333659, 0.9975390434265137, 0.0002890727773774415)",0.9994205960471886,0.9975390434265137,0,0
2010-03-09,21.57588768005371,35.343509674072266,35.59160232543945,35.14313125610352,35.5057258605957,15401198.0,Sonofi-Merck (MRK) Deal Positive,-0.009989110736011279,-0.008334545522716527,0.10060439252433194,"[{'label': 'positive', 'score': 0.9994416832923889}, {'label': 'negative', 'score': 0.0003345500153955072}, {'label': 'neutral', 'score': 0.00022373419778887182}]","(0.00022373419778887182, 0.9994416832923889, 0.0003345500153955072)",0.999330750213398,0.9994416832923889,0,0,"[{'label': 'neutral', 'score': 0.9128973484039307}, {'label': 'positive', 'score': 0.07661157846450806}, {'label': 'negative', 'score': 0.010491062887012959}]","(0.9128973484039307, 0.07661157846450806, 0.010491062887012959)",0.7591103386939997,0.07661157846450806,0,1,"[{'label': 'positive', 'score': 0.986509382724762}, {'label': 'neutral', 'score': 0.01306924968957901}, {'label': 'negative', 'score': 0.0004213453212287277}]","(0.01306924968957901, 0.986509382724762, 0.0004213453212287277)",0.9991461501617992,0.986509382724762,0,0
2010-03-10,21.36036491394043,34.99045944213867,35.38167953491211,34.828243255615234,35.25763320922852,20357505.0,,0.005726767692129736,-0.010039336657438553,0.06969545868971509,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-11,21.7076358795166,35.19084167480469,35.25763320922852,34.446563720703125,34.685115814208984,16049177.0,,0.007592139158215419,0.0057104320951365806,0.1004042475023223,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-12,21.872447967529297,35.45801544189453,35.49618148803711,35.04771041870117,35.35305404663086,17172738.0,"Merck To Continue Its M&A Spree (MRK, MIL) | Overhang On Merck & Company (MRK) Lifted By IMPROVE-IT Update | Stock Market News for March 12, 2010 - Market News",0.005292426645448265,0.007563463915881299,0.12639090390969648,"[{'label': 'negative', 'score': 0.9957919120788574}, {'label': 'neutral', 'score': 0.0034708373714238405}, {'label': 'positive', 'score': 0.0007371710380539298}]","(0.0034708373714238405, 0.0007371710380539298, 0.9957919120788574)",-0.9985205227814361,-0.9957919120788574,0,0,"[{'label': 'positive', 'score': 0.8776899576187134}, {'label': 'neutral', 'score': 0.0782162994146347}, {'label': 'negative', 'score': 0.04409370943903923}]","(0.0782162994146347, 0.8776899576187134, 0.04409370943903923)",0.9043295926911306,0.8776899576187134,0,0,"[{'label': 'positive', 'score': 0.9976933598518372}, {'label': 'neutral', 'score': 0.0019524601520970464}, {'label': 'negative', 'score': 0.00035409635165706277}]","(0.0019524601520970464, 0.9976933598518372, 0.00035409635165706277)",0.999290421814201,0.9976933598518372,0,0
2010-03-13,21.988205591837566,35.64567438761393,35.68702189127604,35.13358815511068,35.34987258911133,17532446.333333332,,0.005264564324938485,0.005278470973474254,0.13468185332610677,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-14,22.103963216145832,35.833333333333336,35.877862294514976,35.21946589152018,35.3466911315918,17892154.666666668,,0.00523699383402973,0.0052507549518577765,0.11451332046063803,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-15,22.2197208404541,36.020992279052734,36.06870269775391,35.30534362792969,35.343509674072266,18251863.0,"Benzingas News Roundup (PEP, ALKS, MRK)",0.005033101277210608,0.005223328471337454,0.015921862660182536,"[{'label': 'neutral', 'score': 0.9998807907104492}, {'label': 'negative', 'score': 6.989991379668936e-05}, {'label': 'positive', 'score': 4.9323942221235484e-05}]","(0.9998807907104492, 4.9323942221235484e-05, 6.989991379668936e-05)",-0.172582671477765,-6.989991379668936e-05,0,0,"[{'label': 'neutral', 'score': 0.9380912184715271}, {'label': 'positive', 'score': 0.035001400858163834}, {'label': 'negative', 'score': 0.02690730057656765}]","(0.9380912184715271, 0.035001400858163834, 0.02690730057656765)",0.13074253043620299,0.035001400858163834,0,0,"[{'label': 'neutral', 'score': 0.9995964169502258}, {'label': 'positive', 'score': 0.00026344117941334844}, {'label': 'negative', 'score': 0.00014012234169058502}]","(0.9995964169502258, 0.00026344117941334844, 0.00014012234169058502)",0.30557478878524297,0.00026344117941334844,0,0
2010-03-16,22.3315544128418,36.20228958129883,36.25954055786133,35.6870231628418,36.040077209472656,19187937.0,,0.0036900120155364266,0.005020477562880849,0.016903975810552356,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-03-17,22.41395378112793,36.33587646484375,36.35496139526367,35.84923553466797,36.25,12983986.0,This Healthcare ETF (XLV) Is Seeing Above Average Call Buying,0.009716403757934715,0.003683220622951998,0.010840948703282758,"[{'label': 'positive', 'score': 0.9991738200187683}, {'label': 'neutral', 'score': 0.00042018271051347256}, {'label': 'negative', 'score': 0.00040592430741526186}]","(0.00042018271051347256, 0.9991738200187683, 0.00040592430741526186)",0.999187810057738,0.9991738200187683,1,1,"[{'label': 'positive', 'score': 0.9484858512878418}, {'label': 'neutral', 'score': 0.03912791609764099}, {'label': 'negative', 'score': 0.01238628663122654}]","(0.03912791609764099, 0.9484858512878418, 0.01238628663122654)",0.9742186579412092,0.9484858512878418,1,1,"[{'label': 'positive', 'score': 0.9914542436599731}, {'label': 'neutral', 'score': 0.006574823521077633}, {'label': 'negative', 'score': 0.0019709609914571047}]","(0.006574823521077633, 0.9914542436599731, 0.0019709609914571047)",0.9960319891578578,0.9914542436599731,1,1
2010-03-18,22.631738662719727,36.68893051147461,36.6984748840332,36.14503860473633,36.32633590698242,13097275.0,,-0.010142982015710051,0.009669503066255589,0.036104490788025946,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-03-19,22.402189254760746,36.31679534912109,37.06106948852539,36.11641311645508,36.31679534912109,32252934.0,,0.0021019450160346684,-0.01019477256247572,0.11973571245810834,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-20,22.449275970458984,36.39313125610352,37.1246821085612,36.173665364583336,36.32315572102865,26907260.666666668,,0.0020975361104607457,0.0020997390203230477,0.11759055602912326,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-21,22.496362686157227,36.46946716308594,37.18829472859701,36.23091761271159,36.3295160929362,21561587.333333336,,0.0020931456618507546,0.002095339352909214,0.11474335807785027,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-22,22.54344940185547,36.54580307006836,37.25190734863281,36.28816986083984,36.33587646484375,16215914.0,"Investors Flock To Healthcare ETFs On Historic Reform | US Stocks Jump Up; Rally Driven By Health, Pharma Stocks (AXP, DD, MRK, PFE, MRK, THC, HMA) | FDA Asks Doctors To Suspend Use Of GlaxoSmithKline (GSK) Rotavirus Vaccine | Pfizer (PFE) and Merck (MRK) Advance Following Approval of Healthcare Legislation",0.005221881695732153,0.00209095808454993,0.11335744941155078,"[{'label': 'positive', 'score': 0.9989691972732544}, {'label': 'neutral', 'score': 0.0007536601624451578}, {'label': 'negative', 'score': 0.00027720152866095304}]","(0.0007536601624451578, 0.9989691972732544, 0.00027720152866095304)",0.9994451788287787,0.9989691972732544,0,0,"[{'label': 'positive', 'score': 0.4690016806125641}, {'label': 'negative', 'score': 0.43910226225852966}, {'label': 'neutral', 'score': 0.09189608693122864}]","(0.09189608693122864, 0.4690016806125641, 0.43910226225852966)",0.032925105753316475,0.4690016806125641,1,1,"[{'label': 'positive', 'score': 0.9932000041007996}, {'label': 'neutral', 'score': 0.006363688502460718}, {'label': 'negative', 'score': 0.0004363275074865669}]","(0.006363688502460718, 0.9932000041007996, 0.0004363275074865669)",0.9991217561322857,0.9932000041007996,0,0
2010-03-23,22.66117477416992,36.73664093017578,36.975189208984375,36.49809265136719,36.80343627929688,12927185.0,,-0.012727238743589237,0.005208294949904256,0.09521178931576851,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-24,22.37276077270508,36.26908493041992,36.74618148803711,36.24045944213867,36.66984558105469,12930643.0,"Before Jumping Into A Single Health Care Stock Consider This ETF | Fast Money Picks For March 24th (MPEL, APA, PLL, BAC)",-0.006051080789795832,-0.012808923870802938,0.11337241136988947,"[{'label': 'neutral', 'score': 0.9998576641082764}, {'label': 'negative', 'score': 7.13242479832843e-05}, {'label': 'positive', 'score': 7.098251080606133e-05}]","(0.9998576641082764, 7.098251080606133e-05, 7.13242479832843e-05)",-0.0024014121334098764,-7.13242479832843e-05,1,1,"[{'label': 'neutral', 'score': 0.9315335750579834}, {'label': 'positive', 'score': 0.05724325776100159}, {'label': 'negative', 'score': 0.011223191395401955}]","(0.9315335750579834, 0.05724325776100159, 0.011223191395401955)",0.6721550034013333,0.05724325776100159,0,1,"[{'label': 'neutral', 'score': 0.999215841293335}, {'label': 'positive', 'score': 0.0006725472630932927}, {'label': 'negative', 'score': 0.00011158074630657211}]","(0.999215841293335, 0.0006725472630932927, 0.00011158074630657211)",0.7154017074534276,0.0006725472630932927,0,1
2010-03-25,22.23737907409668,36.049617767333984,36.58396911621094,36.03053283691406,36.57442855834961,13808029.0,"Top Five Dow Stocks With High Yields (DD, MRK, PFE, T, VZ) | The High Yielders of the Dow",-0.009264151380644053,-0.006069462770572456,0.11740895035627316,"[{'label': 'neutral', 'score': 0.999885082244873}, {'label': 'negative', 'score': 6.629426934523508e-05}, {'label': 'positive', 'score': 4.863434878643602e-05}]","(0.999885082244873, 4.863434878643602e-05, 6.629426934523508e-05)",-0.15365990512969094,-6.629426934523508e-05,1,1,"[{'label': 'neutral', 'score': 0.8904882669448853}, {'label': 'positive', 'score': 0.0928906574845314}, {'label': 'negative', 'score': 0.016621103510260582}]","(0.8904882669448853, 0.0928906574845314, 0.016621103510260582)",0.696450803835562,0.0928906574845314,0,1,"[{'label': 'neutral', 'score': 0.9988681077957153}, {'label': 'positive', 'score': 0.000994534115307033}, {'label': 'negative', 'score': 0.0001374128769384697}]","(0.9988681077957153, 0.000994534115307033, 0.0001374128769384697)",0.7572096964260198,0.000994534115307033,0,1
2010-03-26,22.031373977661133,35.71564865112305,36.20228958129883,35.639312744140625,36.08778762817383,14149782.0,,0.004096528441096595,-0.00930733051665012,0.12084006441430944,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-27,22.1216246287028,35.861958821614586,36.22455469767253,35.71246846516927,36.011451721191406,13331154.0,,0.00407981536143386,0.004088160513646222,0.12798729343385648,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-28,22.211875279744465,36.00826899210612,36.24681981404623,35.785624186197914,35.935115814208984,12512526.0,,0.0040632381002156355,0.004071515481734925,0.1231208911224774,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-29,22.302125930786133,36.154579162597656,36.26908493041992,35.85877990722656,35.85877990722656,11693898.0,,-0.006070139757447635,0.004055005441586166,0.10385324382853095,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-30,22.16675567626953,35.935115814208984,36.22137451171875,35.79198455810547,36.22137451171875,10397313.0,,-0.008231588054362048,-0.006088637951523463,0.10391655821179228,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-03-31,21.984277725219727,35.639312744140625,35.86832046508789,35.36259460449219,35.77289962768555,13588787.0,,0.009638504438577907,-0.008265654652249934,0.09856597354857426,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-01,22.196184158325195,35.98282241821289,36.14503860473633,35.78244400024414,35.91603088378906,10621794.0,,-0.0021214276195707245,0.009592350388358983,0.11989247009718078,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-02,22.149093627929688,35.906487464904785,36.16650772094727,35.74188995361328,35.987595558166504,10708044.5,,-0.002125937642402803,-0.002123681034678635,0.1168573934831339,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-03,22.10200309753418,35.83015251159668,36.1879768371582,35.70133590698242,36.059160232543945,10794295.0,,-0.002130466882143444,-0.0021282006557514963,0.10946368158934214,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-04,22.054912567138672,35.753817558288574,36.20944595336914,35.66078186035156,36.13072490692139,10880545.5,,-0.002135015461877839,-0.0021327395551882563,0.10312492190086205,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-05,22.007822036743164,35.67748260498047,36.23091506958008,35.6202278137207,36.20228958129883,10966796.0,"U.S. Equity Market Preview (AAPL, EXC, HSP, ITMN, MRK)",-0.0037443981045775536,-0.002137297856599779,0.08322387722916477,"[{'label': 'neutral', 'score': 0.9998718500137329}, {'label': 'negative', 'score': 7.150533201638609e-05}, {'label': 'positive', 'score': 5.656806388287805e-05}]","(0.9998718500137329, 5.656806388287805e-05, 7.150533201638609e-05)",-0.11663053070956998,-7.150533201638609e-05,1,1,"[{'label': 'neutral', 'score': 0.949124276638031}, {'label': 'positive', 'score': 0.02734789252281189}, {'label': 'negative', 'score': 0.023527875542640686}]","(0.949124276638031, 0.02734789252281189, 0.023527875542640686)",0.07508519527914909,0.02734789252281189,1,1,"[{'label': 'neutral', 'score': 0.9995415210723877}, {'label': 'positive', 'score': 0.00033439105027355254}, {'label': 'negative', 'score': 0.0001241761347046122}]","(0.9995415210723877, 0.00033439105027355254, 0.0001241761347046122)",0.4584168306307177,0.00033439105027355254,1,1
2010-04-06,21.92542266845703,35.54389190673828,35.81106948852539,35.46755599975586,35.81106948852539,12864095.0,,-0.01234897159338363,-0.0037514259119177523,0.011507857969083197,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-04-07,21.6546688079834,35.10496139526367,35.696563720703125,34.885494232177734,35.667938232421875,19274921.0,,-0.0002717723501788362,-0.01242585374241503,0.07107725394470328,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-08,21.64877700805664,35.095420837402344,35.32442855834961,34.9427490234375,35.152671813964844,12922154.0,"Stock Market News for April 8, 2010 - Market News",0.005165839243987046,-0.00027180928697641315,0.07605243727571878,"[{'label': 'neutral', 'score': 0.9998722076416016}, {'label': 'negative', 'score': 7.72784260334447e-05}, {'label': 'positive', 'score': 5.048414459452033e-05}]","(0.9998722076416016, 5.048414459452033e-05, 7.72784260334447e-05)",-0.20971933569611165,-7.72784260334447e-05,1,1,"[{'label': 'neutral', 'score': 0.9258981943130493}, {'label': 'negative', 'score': 0.05232197791337967}, {'label': 'positive', 'score': 0.02177988737821579}]","(0.9258981943130493, 0.02177988737821579, 0.05232197791337967)",-0.41216358609839104,-0.05232197791337967,1,1,"[{'label': 'neutral', 'score': 0.9995878338813782}, {'label': 'positive', 'score': 0.0002643940970301628}, {'label': 'negative', 'score': 0.00014773794100619853}]","(0.9995878338813782, 0.0002643940970301628, 0.00014773794100619853)",0.2830552960157687,0.0002643940970301628,1,1
2010-04-09,21.76060676574707,35.27671813964844,35.54389190673828,35.095420837402344,35.114505767822266,10552941.0,,-0.0010819767622087125,0.005152542070819435,0.10151372723734528,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-10,21.737064361572266,35.23854955037435,35.493001302083336,35.10178248087565,35.16539637247721,10760514.666666666,,-0.0010831487039365897,-0.0010825625216224837,0.10214757952981511,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-11,21.71352195739746,35.20038096110026,35.44211069742838,35.10814412434896,35.216286977132164,10968088.333333334,,-0.0010843231871912429,-0.0010837357334257443,0.10180390815803479,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-12,21.689979553222656,35.16221237182617,35.39122009277344,35.114505767822266,35.26717758178711,11175662.0,,-0.004070490215255377,-0.001084911490891024,0.043194240342111806,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-13,21.60168838500977,35.01908493041992,35.238548278808594,34.904579162597656,35.00954055786133,12493942.0,,-0.013351571446887558,-0.00407879721057695,0.05369272949800632,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-04-14,21.31327247619629,34.5515251159668,35.0572509765625,34.360687255859375,35.0572509765625,20934534.0,,-0.004694796287044678,-0.013441505077530773,0.08494825792060626,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-15,21.213207244873047,34.389312744140625,34.828243255615234,34.3129768371582,34.56106948852539,21771152.0,"Mad Money Lightning Round: Jim Likes AMD, APC, ARMH, IMAX, YHOO, EXC, MUR",-0.009156454743186652,-0.0047058514578876215,0.08047057850443745,"[{'label': 'neutral', 'score': 0.9998855590820312}, {'label': 'negative', 'score': 6.525698699988425e-05}, {'label': 'positive', 'score': 4.928195630782284e-05}]","(0.9998855590820312, 4.928195630782284e-05, 6.525698699988425e-05)",-0.13947248185400785,-6.525698699988425e-05,1,1,"[{'label': 'neutral', 'score': 0.911324679851532}, {'label': 'positive', 'score': 0.07496872544288635}, {'label': 'negative', 'score': 0.01370654534548521}]","(0.911324679851532, 0.07496872544288635, 0.01370654534548521)",0.6908598028824374,0.07496872544288635,0,1,"[{'label': 'neutral', 'score': 0.9994902610778809}, {'label': 'positive', 'score': 0.00040761480340734124}, {'label': 'negative', 'score': 0.00010205961007159203}]","(0.9994902610778809, 0.00040761480340734124, 0.00010205961007159203)",0.5995105605755093,0.00040761480340734124,0,1
2010-04-16,21.01897430419922,34.07442855834961,34.51335906982422,33.75,34.34160232543945,21576538.0,,0.0017735421146842054,-0.009198632739617992,0.07690190173180499,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-17,21.056254069010414,34.13486099243164,34.45292663574219,33.724554697672524,34.243002573649086,18767024.666666668,,0.0017704022317662372,0.0017719712459283506,0.09096817423568743,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-18,21.093533833821613,34.19529342651367,34.39249420166016,33.699109395345054,34.144402821858726,15957511.333333334,,0.0017672734469116834,0.0017688369169539596,0.10659743189051478,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-19,21.13081359863281,34.2557258605957,34.332061767578125,33.67366409301758,34.04580307006836,13147998.0,,0.004456826125540135,0.001765713656640448,0.0799109629827036,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-20,21.224985122680664,34.40839767456055,34.73282241821289,34.22710037231445,34.39885330200195,10639506.0,,-0.03660572586005141,0.004446923886786433,0.08464061609596293,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-04-21,20.448028564453125,33.14885330200195,34.52289962768555,33.110687255859375,34.4370231628418,38975015.0,Top Stocks of New Jersey,-0.027921672982711976,-0.037292528191732816,0.28266142522048077,"[{'label': 'neutral', 'score': 0.9998794794082642}, {'label': 'negative', 'score': 7.413428102154285e-05}, {'label': 'positive', 'score': 4.640784391085617e-05}]","(0.9998794794082642, 4.640784391085617e-05, 7.413428102154285e-05)",-0.23001450427587766,-7.413428102154285e-05,1,1,"[{'label': 'neutral', 'score': 0.9128398299217224}, {'label': 'negative', 'score': 0.04740535467863083}, {'label': 'positive', 'score': 0.03975480794906616}]","(0.9128398299217224, 0.03975480794906616, 0.04740535467863083)",-0.08777572802661962,-0.04740535467863083,1,1,"[{'label': 'neutral', 'score': 0.9992802739143372}, {'label': 'positive', 'score': 0.0005602685268968344}, {'label': 'negative', 'score': 0.0001595514768268913}]","(0.9992802739143372, 0.0005602685268968344, 0.0001595514768268913)",0.5566906282084131,0.0005602685268968344,0,1
2010-04-22,19.877084732055664,32.22328186035156,33.0629768371582,32.213741302490234,32.98664093017578,40059695.0,"Stock Market News for April 22, 2010 - Market News",0.05004439372379291,-0.028318894417242432,0.31294045873010673,"[{'label': 'neutral', 'score': 0.9998730421066284}, {'label': 'negative', 'score': 7.622506382176653e-05}, {'label': 'positive', 'score': 5.060121839051135e-05}]","(0.9998730421066284, 5.060121839051135e-05, 7.622506382176653e-05)",-0.2020389227239728,-7.622506382176653e-05,0,0,"[{'label': 'neutral', 'score': 0.924558699131012}, {'label': 'negative', 'score': 0.05380967631936073}, {'label': 'positive', 'score': 0.02163163386285305}]","(0.924558699131012, 0.02163163386285305, 0.05380967631936073)",-0.42653080094695983,-0.05380967631936073,0,0,"[{'label': 'neutral', 'score': 0.9995883107185364}, {'label': 'positive', 'score': 0.0002630582021083683}, {'label': 'negative', 'score': 0.00014859656221233308}]","(0.9995883107185364, 0.0002630582021083683, 0.00014859656221233308)",0.27805250859883984,0.0002630582021083683,0,0
2010-04-23,20.8718204498291,33.83587646484375,34.12213516235352,32.00381851196289,32.290077209472656,43319185.0,"Merck To Lose $170 Million In Revenue (MRK) | Merck & Co. (MRK) Says U.S. Health-Care Legislation To Reduce 2010 Revenue By $170 Million | Market Roundup (MS, C, HLS, UBS, HBC, USB, MRK) | US Stock Ended In Positive Territory After Losing 100 Points",-0.004324113508440026,0.04883244301261472,0.5370338790957442,"[{'label': 'negative', 'score': 0.998418927192688}, {'label': 'positive', 'score': 0.0008478259551338851}, {'label': 'neutral', 'score': 0.0007333320681937039}]","(0.0007333320681937039, 0.0008478259551338851, 0.998418927192688)",-0.9983031038459688,-0.998418927192688,0,0,"[{'label': 'negative', 'score': 0.9639028310775757}, {'label': 'positive', 'score': 0.02499392442405224}, {'label': 'neutral', 'score': 0.011103312484920025}]","(0.011103312484920025, 0.02499392442405224, 0.9639028310775757)",-0.9494508920471201,-0.9639028310775757,0,0,"[{'label': 'negative', 'score': 0.997158408164978}, {'label': 'neutral', 'score': 0.002434344496577978}, {'label': 'positive', 'score': 0.0004072289157193154}]","(0.002434344496577978, 0.0004072289157193154, 0.997158408164978)",-0.9991835546442617,-0.997158408164978,0,0
2010-04-24,20.7815678914388,33.68956629435221,34.18574905395508,32.436387379964195,32.843512217203774,38170116.333333336,,-0.004342892669296828,-0.004333489525660826,0.5360030645532933,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-25,20.691315333048504,33.54325612386068,34.24936294555664,32.86895624796549,33.3969472249349,33021047.666666668,,-0.004361835653380784,-0.004352350420263309,0.5315786191963063,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-26,20.601062774658203,33.39694595336914,34.3129768371582,33.3015251159668,33.950382232666016,27871979.0,,-0.01485709168526692,-0.004371376211519777,0.4512577658480634,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-27,20.294994354248047,32.90076446533203,33.85496139526367,32.83396911621094,33.25381851196289,20457694.0,,0.002320186421894787,-0.014968563750313139,0.4030775564900979,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-04-28,20.34207534790039,32.97710037231445,33.20610809326172,32.63358688354492,32.91984558105469,17689716.0,"Afternoon Market Update - Goldman Sachs (NYSE: GS), Merck (NYSE: MRK), AstraZeneca (NYSE: AZN) | Investors Allowed To Sue Merck Over Vioxx (MRK)",0.01996518348884392,0.002317498945539863,0.0985232169153587,"[{'label': 'neutral', 'score': 0.9956568479537964}, {'label': 'positive', 'score': 0.0030771626625210047}, {'label': 'negative', 'score': 0.0012659942731261253}]","(0.9956568479537964, 0.0030771626625210047, 0.0012659942731261253)",0.4170165656528401,0.0030771626625210047,0,0,"[{'label': 'negative', 'score': 0.9037002325057983}, {'label': 'neutral', 'score': 0.07837497442960739}, {'label': 'positive', 'score': 0.017924757674336433}]","(0.07837497442960739, 0.017924757674336433, 0.9037002325057983)",-0.9611018410626366,-0.9037002325057983,0,0,"[{'label': 'neutral', 'score': 0.9232184290885925}, {'label': 'negative', 'score': 0.07124945521354675}, {'label': 'positive', 'score': 0.005532090552151203}]","(0.9232184290885925, 0.005532090552151203, 0.07124945521354675)",-0.855900516276851,-0.07124945521354675,0,0
2010-04-29,20.748214721679688,33.635494232177734,33.979007720947266,33.377864837646484,33.377864837646484,19118454.0,"Fast Money Picks For April 30th (MRK, RIG, GLW, XOM)",-0.005957350190414505,0.01976849287914037,0.20356508799989578,"[{'label': 'neutral', 'score': 0.9998852014541626}, {'label': 'negative', 'score': 6.248355202842504e-05}, {'label': 'positive', 'score': 5.2359340770635754e-05}]","(0.9998852014541626, 5.2359340770635754e-05, 6.248355202842504e-05)",-0.08815705535651643,-6.248355202842504e-05,1,1,"[{'label': 'neutral', 'score': 0.9418688416481018}, {'label': 'negative', 'score': 0.031319428235292435}, {'label': 'positive', 'score': 0.0268117506057024}]","(0.9418688416481018, 0.0268117506057024, 0.031319428235292435)",-0.07754320004278262,-0.031319428235292435,1,1,"[{'label': 'neutral', 'score': 0.998898983001709}, {'label': 'positive', 'score': 0.0010061319917440414}, {'label': 'negative', 'score': 9.49119494180195e-05}]","(0.998898983001709, 0.0010061319917440414, 9.49119494180195e-05)",0.8275964366729128,0.0010061319917440414,0,1
2010-04-30,20.62460708618164,33.435115814208984,34.16030502319336,33.42557144165039,33.71183013916016,16476342.0,"DOW Gains The Highest Since March 5, Led By Q1 Gains",0.0021879526264958244,-0.005975165992948791,0.2059022372331652,"[{'label': 'positive', 'score': 0.9996161460876465}, {'label': 'neutral', 'score': 0.00021925242617726326}, {'label': 'negative', 'score': 0.0001645870361244306}]","(0.00021925242617726326, 0.9996161460876465, 0.0001645870361244306)",0.9996707537349511,0.9996161460876465,0,0,"[{'label': 'positive', 'score': 0.8396182060241699}, {'label': 'negative', 'score': 0.08045849204063416}, {'label': 'neutral', 'score': 0.07992326468229294}]","(0.07992326468229294, 0.8396182060241699, 0.08045849204063416)",0.8251048152618964,0.8396182060241699,0,0,"[{'label': 'positive', 'score': 0.9973467588424683}, {'label': 'neutral', 'score': 0.0022189344745129347}, {'label': 'negative', 'score': 0.0004343058681115508}]","(0.0022189344745129347, 0.9973467588424683, 0.0004343058681115508)",0.9991294565842708,0.9973467588424683,0,0
2010-05-01,20.66973304748535,33.508270263671875,34.04262034098307,33.42875289916992,33.6991081237793,15324624.666666666,,0.0021831759409616947,0.0021855625437715628,0.2036777959678635,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-02,20.714859008789062,33.581424713134766,33.92493565877279,33.43193435668945,33.68638610839844,14172907.333333334,,0.0021784200666828046,0.002180796275223634,0.15008259154738782,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-03,20.759984970092773,33.654579162597656,33.8072509765625,33.435115814208984,33.67366409301758,13021190.0,"Jims Game Plan For This Week (SMG, CLNE, CPNO, JDSU, APA, DVN, RIG, MRK, PFE, SHOO, SBA, AMT, VMC, SYY) | Stock Market News for May 3, 2010 - Market News",0.015310440102893267,0.0021760507499767713,0.15019147751888653,"[{'label': 'neutral', 'score': 0.9998700618743896}, {'label': 'negative', 'score': 7.157601794460788e-05}, {'label': 'positive', 'score': 5.8316443755757064e-05}]","(0.9998700618743896, 5.8316443755757064e-05, 7.157601794460788e-05)",-0.10208116787745479,-7.157601794460788e-05,1,1,"[{'label': 'neutral', 'score': 0.9394121170043945}, {'label': 'positive', 'score': 0.040783584117889404}, {'label': 'negative', 'score': 0.01980433240532875}]","(0.9394121170043945, 0.040783584117889404, 0.01980433240532875)",0.3462613160583118,0.040783584117889404,1,1,"[{'label': 'neutral', 'score': 0.9994964599609375}, {'label': 'positive', 'score': 0.0003772707423195243}, {'label': 'negative', 'score': 0.0001262727746507153}]","(0.9994964599609375, 0.0003772707423195243, 0.0001262727746507153)",0.4984633089490128,0.0003772707423195243,1,1
2010-05-04,21.07783317565918,34.16984558105469,34.69465637207031,33.96946716308594,33.96946716308594,33995967.0,"Jim Cramers Short Term Plays | Pfizer (PFE) Breaches Above its 50 Day MA   | US Stock Futures Fall On Greece Worries | MRK Shares Rise As Q1 Profits, Sales Exceeds Expectations | Stock Market News for May 4, 2010 - Market News | Company News for May 4, 2010 - Corporate Summary | Merck & Co.s (MRK) First-Quarter Profit Down By 77%",-0.0061435100732130455,0.015194418048586622,0.12067620508656458,"[{'label': 'negative', 'score': 0.9974345564842224}, {'label': 'positive', 'score': 0.0018270068103447556}, {'label': 'neutral', 'score': 0.000738485949113965}]","(0.000738485949113965, 0.0018270068103447556, 0.9974345564842224)",-0.9963432861275658,-0.9974345564842224,0,0,"[{'label': 'negative', 'score': 0.9712098836898804}, {'label': 'positive', 'score': 0.016394739970564842}, {'label': 'neutral', 'score': 0.012395331636071205}]","(0.012395331636071205, 0.016394739970564842, 0.9712098836898804)",-0.966798980932674,-0.9712098836898804,0,0,"[{'label': 'negative', 'score': 0.8824450969696045}, {'label': 'neutral', 'score': 0.07600897550582886}, {'label': 'positive', 'score': 0.04154586046934128}]","(0.07600897550582886, 0.04154586046934128, 0.8824450969696045)",-0.9100730150336206,-0.8824450969696045,0,0
2010-05-05,20.948339462280277,33.959922790527344,34.13167953491211,33.3015251159668,33.79771041870117,22489661.0,"Merck And Ariad Re-Write Ridaforolimus Contract (MRK, ARIA) | Stock Market News for May 5, 2010 - Market News | Company News for May 5, 2010 - Corporate Summary | Benzingas Top Pre-Market Gainers (AMMD, HNSN, ACAS, ARIA, ERTS) | Goldman Downgrades MRK To Neutral | FOREX, COMMODITIES, STOCKS OUTLOOK May 5th: SPECIAL EU CRISIS MARKET CORRECTION 10:30 GMT | US Stocks Dive, Hit By Europe Crisis, Investors Take Refuge In Dollar & Bonds",-0.03708902890122765,-0.006162459080028993,0.12157266808413242,"[{'label': 'negative', 'score': 0.9949446320533752}, {'label': 'neutral', 'score': 0.004078115336596966}, {'label': 'positive', 'score': 0.0009771601762622595}]","(0.004078115336596966, 0.0009771601762622595, 0.9949446320533752)",-0.9980376768861045,-0.9949446320533752,1,1,"[{'label': 'negative', 'score': 0.8124454617500305}, {'label': 'neutral', 'score': 0.10702548921108246}, {'label': 'positive', 'score': 0.08052907884120941}]","(0.10702548921108246, 0.08052907884120941, 0.8124454617500305)",-0.8196385783005841,-0.8124454617500305,1,1,"[{'label': 'neutral', 'score': 0.640764594078064}, {'label': 'positive', 'score': 0.32421350479125977}, {'label': 'negative', 'score': 0.03502197563648224}]","(0.640764594078064, 0.32421350479125977, 0.03502197563648224)",0.8050193951066218,0.32421350479125977,0,0
2010-05-06,20.17139434814453,32.700382232666016,33.950382232666016,29.293893814086918,33.788169860839844,32246750.0,,-0.02276046932593443,-0.037794320991718186,0.31625969898099715,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-07,19.7122745513916,31.95610618591309,32.652671813964844,31.44083976745605,32.356868743896484,27703775.0,,0.007564450146230782,-0.023023487414229216,0.3310745251143359,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-08,19.86138852437337,32.197836558024086,32.85623423258463,31.739822387695312,32.360050201416016,26656508.666666668,,0.007507658835256906,0.007535983161151586,0.34529507068058884,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-09,20.010502497355144,32.43956693013509,33.05979665120443,32.03880500793457,32.36323165893555,25609242.33333333,,0.0074517139094863235,0.007479616631402281,0.31441324785802105,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-10,20.159616470336918,32.681297302246094,33.26335906982422,32.33778762817383,32.36641311645508,24561976.0,Citi Gives Thoughts  On MRKs 2010 Annual Briefing And Its $45.00 Price Target,-0.02160581874650849,0.007424087049474457,0.3397078296029334,"[{'label': 'neutral', 'score': 0.9998576641082764}, {'label': 'negative', 'score': 7.292420195881277e-05}, {'label': 'positive', 'score': 6.937538273632526e-05}]","(0.9998576641082764, 6.937538273632526e-05, 7.292420195881277e-05)",-0.024939069429404753,-7.292420195881277e-05,1,1,"[{'label': 'neutral', 'score': 0.9507973194122314}, {'label': 'negative', 'score': 0.02846216782927513}, {'label': 'positive', 'score': 0.020740486681461334}]","(0.9507973194122314, 0.020740486681461334, 0.02846216782927513)",-0.15693627152024606,-0.02846216782927513,1,1,"[{'label': 'neutral', 'score': 0.9994961023330688}, {'label': 'positive', 'score': 0.0003797715180553496}, {'label': 'negative', 'score': 0.00012418375990819186}]","(0.9994961023330688, 0.0003797715180553496, 0.00012418375990819186)",0.5071635705056514,0.0003797715180553496,0,1
2010-05-11,19.724050521850582,31.975191116333008,32.54771041870117,31.51717567443848,31.822519302368164,25819786.0,Five New Drugs On Cards for Merck (MRK),0.003879395681597623,-0.021842641833020707,0.2601731697757632,"[{'label': 'neutral', 'score': 0.9998598098754883}, {'label': 'positive', 'score': 7.84208532422781e-05}, {'label': 'negative', 'score': 6.171923450892791e-05}]","(0.9998598098754883, 7.84208532422781e-05, 6.171923450892791e-05)",0.11917802394273481,7.84208532422781e-05,1,1,"[{'label': 'neutral', 'score': 0.8195194602012634}, {'label': 'positive', 'score': 0.16955983638763428}, {'label': 'negative', 'score': 0.010920695960521698}]","(0.8195194602012634, 0.16955983638763428, 0.010920695960521698)",0.878982006331241,0.16955983638763428,0,1,"[{'label': 'neutral', 'score': 0.9980008006095886}, {'label': 'positive', 'score': 0.0018877947004511952}, {'label': 'negative', 'score': 0.00011135923705296591}]","(0.9980008006095886, 0.0018877947004511952, 0.00011135923705296591)",0.8885936345732415,0.0018877947004511952,0,1
2010-05-12,19.800561904907227,32.09923553466797,32.48091506958008,31.898855209350582,32.41412353515625,20002442.0,"US Stocks End Lower Yesterday After Soaring On Monday, Dow And S&P Down, Nasdaq Bucks Trend",-0.009809709812276662,0.0038718902309832913,0.20328530501032013,"[{'label': 'negative', 'score': 0.9974384307861328}, {'label': 'neutral', 'score': 0.002013766672462225}, {'label': 'positive', 'score': 0.0005477478262037039}]","(0.002013766672462225, 0.0005477478262037039, 0.9974384307861328)",-0.9989022937632958,-0.9974384307861328,0,0,"[{'label': 'negative', 'score': 0.9616960287094116}, {'label': 'neutral', 'score': 0.02701171673834324}, {'label': 'positive', 'score': 0.01129219401627779}]","(0.02701171673834324, 0.01129219401627779, 0.9616960287094116)",-0.9767886316554906,-0.9616960287094116,0,0,"[{'label': 'negative', 'score': 0.9319709539413452}, {'label': 'neutral', 'score': 0.06650175154209137}, {'label': 'positive', 'score': 0.0015272721648216248}]","(0.06650175154209137, 0.0015272721648216248, 0.9319709539413452)",-0.9967278520256172,-0.9319709539413452,0,0
2010-05-13,19.60633087158203,31.784351348876957,32.20419692993164,31.5935115814209,32.13740539550781,15354353.0,,-0.012909026164784601,-0.009858142013089242,0.2049787378719994,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-14,19.35322952270508,31.374046325683597,31.822519302368164,31.18320655822754,31.822519302368164,22117621.0,,-0.0010137980122363233,-0.012993071724086534,0.19281627545153637,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-15,19.33360989888509,31.34223937988281,31.73027992248535,31.024173100789387,31.68575096130371,20127154.666666668,,-0.0010148268416708336,-0.0010143122530280474,0.16053464834688666,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-16,19.313990275065105,31.31043243408203,31.63804054260254,30.86513964335124,31.548982620239254,18136688.33333333,,-0.0010158577613945297,-0.0010153421270766283,0.1107748164039858,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-17,19.29437065124512,31.27862548828125,31.545801162719727,30.70610618591309,31.412214279174805,16146222.0,,-0.013117744683093025,-0.0010163740946006084,0.09220964866573962,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-18,19.0412712097168,30.86832046508789,31.488550186157227,30.82061004638672,31.459924697875977,19165195.0,,0.008346201067852043,-0.0132045421898495,0.10507032300732964,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-19,19.200199127197266,31.125953674316406,31.393129348754883,30.60114479064941,30.725191116333008,22192134.0,,-0.02452484116025993,0.008311564122874654,0.12139827706345396,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-05-20,18.729307174682617,30.362594604492188,31.059160232543945,30.295801162719727,30.753816604614254,25881198.0,"All 30 Dow Components In The Red (MRK, GE)",0.006913924867439291,-0.024830584297296107,0.20397110950605282,"[{'label': 'neutral', 'score': 0.9998925924301147}, {'label': 'negative', 'score': 6.548442615894601e-05}, {'label': 'positive', 'score': 4.2004106944659725e-05}]","(0.9998925924301147, 4.2004106944659725e-05, 6.548442615894601e-05)",-0.21844487533990384,-6.548442615894601e-05,1,1,"[{'label': 'neutral', 'score': 0.9357849359512329}, {'label': 'positive', 'score': 0.039275892078876495}, {'label': 'negative', 'score': 0.02493922784924507}]","(0.9357849359512329, 0.039275892078876495, 0.02493922784924507)",0.2232599463440853,0.039275892078876495,1,1,"[{'label': 'neutral', 'score': 0.9995576739311218}, {'label': 'positive', 'score': 0.0002650728274602443}, {'label': 'negative', 'score': 0.00017717470473144203}]","(0.9995576739311218, 0.0002650728274602443, 0.00017717470473144203)",0.19875322377311533,0.0002650728274602443,1,1
2010-05-21,18.858800888061523,30.572519302368164,30.67748069763184,29.61832046508789,29.77099227905273,26721694.0,,-0.001872670274962235,0.006890133288080033,0.2237607866348722,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-22,18.82348505655925,30.51526705423991,30.728371302286785,29.799618403116863,29.98409652709961,22457801.333333336,,-0.001876183748498648,-0.001874425914106096,0.22293537077171563,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-23,18.788169225056965,30.45801480611165,30.77926190694173,29.980916341145832,30.197200775146484,18193908.666666668,,-0.0018797104306601867,-0.0018779459857599335,0.21065036607423923,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-24,18.752853393554688,30.4007625579834,30.83015251159668,30.162214279174805,30.41030502319336,13930016.0,"Citi Says DMARDs ""Not Immune to Tough Economy"" (JNJ, MRK, BMY, AMGN, ABT)",0.006277466464601532,-0.0018814793033048627,0.18840948186805587,"[{'label': 'negative', 'score': 0.9838833212852478}, {'label': 'neutral', 'score': 0.014396150596439838}, {'label': 'positive', 'score': 0.0017205453477799892}]","(0.014396150596439838, 0.0017205453477799892, 0.9838833212852478)",-0.9965086473257098,-0.9838833212852478,0,0,"[{'label': 'neutral', 'score': 0.8160485029220581}, {'label': 'positive', 'score': 0.11765432357788086}, {'label': 'negative', 'score': 0.06629713624715805}]","(0.8160485029220581, 0.11765432357788086, 0.06629713624715805)",0.27918880002132074,0.11765432357788086,1,1,"[{'label': 'neutral', 'score': 0.8338197469711304}, {'label': 'positive', 'score': 0.15944109857082367}, {'label': 'negative', 'score': 0.006739153992384672}]","(0.8338197469711304, 0.15944109857082367, 0.006739153992384672)",0.9188934438546317,0.15944109857082367,0,1
2010-05-25,18.870576858520508,30.591602325439453,30.61068725585937,29.675573348999023,29.866411209106445,21679766.0,,0.011229012626248456,0.00625784524355318,0.07357378864069425,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-05-26,19.08247756958008,30.935115814208984,31.345420837402344,30.38167953491211,30.51526641845703,27518803.0,"Bill Smead Likes Merck And Disney (MRK, DIS)",0.03701420132425669,0.011166435282738002,0.09611197724241716,"[{'label': 'neutral', 'score': 0.9998775720596313}, {'label': 'negative', 'score': 6.77564021316357e-05}, {'label': 'positive', 'score': 5.4707728850189596e-05}]","(0.9998775720596313, 5.4707728850189596e-05, 6.77564021316357e-05)",-0.10655098090217643,-6.77564021316357e-05,0,0,"[{'label': 'neutral', 'score': 0.9427961707115173}, {'label': 'positive', 'score': 0.03491920605301857}, {'label': 'negative', 'score': 0.022284679114818573}]","(0.9427961707115173, 0.03491920605301857, 0.022284679114818573)",0.22086833614762505,0.03491920605301857,0,0,"[{'label': 'neutral', 'score': 0.9979031085968018}, {'label': 'positive', 'score': 0.0019826043862849474}, {'label': 'negative', 'score': 0.00011426751734688878}]","(0.9979031085968018, 0.0019826043862849474, 0.00011426751734688878)",0.8910114469567983,0.0019826043862849474,1,0
2010-05-27,19.788799285888672,32.08015441894531,32.127864837646484,31.27862548828125,31.412214279174805,32049098.0,"Citigroup Outlook For U.S. Major Pharmaceuticals (MRK, PFE, BMY) | Deutsche Bank Sees A Brighter Future for Drug Stocks (MRK, PFE)",0.0020820203528815807,0.036345623776818145,0.24995562175028582,"[{'label': 'positive', 'score': 0.9990278482437134}, {'label': 'negative', 'score': 0.0007049408741295338}, {'label': 'neutral', 'score': 0.00026720837922766805}]","(0.00026720837922766805, 0.9990278482437134, 0.0007049408741295338)",0.9985897414153004,0.9990278482437134,0,0,"[{'label': 'positive', 'score': 0.9371829032897949}, {'label': 'neutral', 'score': 0.0495331771671772}, {'label': 'negative', 'score': 0.01328400056809187}]","(0.0495331771671772, 0.9371829032897949, 0.01328400056809187)",0.9720474210849995,0.9371829032897949,0,0,"[{'label': 'positive', 'score': 0.9940567016601562}, {'label': 'neutral', 'score': 0.005216178484261036}, {'label': 'negative', 'score': 0.0007271681679412723}]","(0.005216178484261036, 0.9940567016601562, 0.0007271681679412723)",0.99853803787939,0.9940567016601562,0,0
2010-05-28,19.82999992370605,32.14694595336914,32.5572509765625,31.965648651123047,32.09923553466797,26192454.0,"Fast Money Halftime Recommendations (OXY, CVX, ABT, PFE, MRK, AXP, C, BAC, JPM)",-0.001187296409014268,0.0020798559522034635,0.2394638029596582,"[{'label': 'neutral', 'score': 0.9998456239700317}, {'label': 'negative', 'score': 8.501114643877372e-05}, {'label': 'positive', 'score': 6.933314580237493e-05}]","(0.9998456239700317, 6.933314580237493e-05, 8.501114643877372e-05)",-0.10157810443617422,-8.501114643877372e-05,1,1,"[{'label': 'neutral', 'score': 0.9357416033744812}, {'label': 'positive', 'score': 0.050804782658815384}, {'label': 'negative', 'score': 0.013453626073896885}]","(0.9357416033744812, 0.050804782658815384, 0.013453626073896885)",0.5812648853519462,0.050804782658815384,0,1,"[{'label': 'neutral', 'score': 0.9993664622306824}, {'label': 'positive', 'score': 0.000530142046045512}, {'label': 'negative', 'score': 0.00010344580368837342}]","(0.9993664622306824, 0.000530142046045512, 0.00010344580368837342)",0.6734602668538485,0.000530142046045512,0,1
2010-05-29,19.80645513534546,32.10877799987793,32.533395767211914,31.920324325561523,32.04914045333862,25083355.75,,-0.0011887077574660749,-0.0011880018037927701,0.23719110599819754,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-30,19.782910346984863,32.07061004638672,32.50954055786133,31.875,31.99904537200928,23974257.5,,-0.0011901224652728795,-0.0011894148309237198,0.25187543545841296,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-05-31,19.759365558624268,32.03244209289551,32.48568534851074,31.82967567443848,31.94895029067993,22865159.25,,-0.0011915405444431048,-0.0011908312234091363,0.2616368586110451,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-01,19.735820770263672,31.994274139404297,32.46183013916016,31.784351348876957,31.898855209350582,21756061.0,,0.024753946742303395,-0.001192250993286148,0.02321457341539774,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-06-02,20.2243595123291,32.786258697509766,32.80534362792969,31.994274139404297,32.08969497680664,16971522.0,,-0.002037180729892221,0.02445253181455991,0.1820448039758439,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-03,20.18316078186035,32.71946716308594,32.97710037231445,32.433204650878906,32.85305404663086,13739385.0,,-0.03266265308587452,-0.002039258605039757,0.18364825770650536,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-06-04,19.5239315032959,31.6507625579834,32.36641311645508,31.479007720947266,32.299617767333984,19078316.0,,0.0014069043955243059,-0.03320798509605255,0.324648614149136,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-05,19.55139795939128,31.69529215494792,32.23918660481771,31.513994852701824,32.089694341023765,17655306.666666668,,0.001404927796431887,0.0014059156328229392,0.3258976452677158,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-06,19.57886441548665,31.739821751912437,32.111960093180336,31.54898198445638,31.879770914713543,16232297.333333334,,0.0014029567435058562,0.0014039418087615557,0.32688106046706866,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-07,19.60633087158203,31.784351348876957,31.98473358154297,31.583969116210938,31.66984748840332,14809288.0,,0.015010542989460978,0.0014019735192004829,0.24077534698087355,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-08,19.900632858276367,32.261451721191406,32.318702697753906,31.583969116210938,31.879770278930664,16223983.0,,-0.0029577353873280654,0.014898999621539151,0.2851803194294636,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-09,19.841768264770508,32.16603088378906,32.566795349121094,31.95610618591309,32.30915832519531,13463761.0,,0.027884881308784065,-0.002962118130769087,0.10781564779385444,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-06-10,20.395050048828125,33.0629768371582,33.1870231628418,32.433204650878906,32.57633590698242,19612901.0,,0.0060606228426719816,0.02750317759972936,0.19988193278281272,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-11,20.74618148803711,33.26335906982422,33.492366790771484,32.66221237182617,32.77671813964844,18989865.0,,0.001529929811000729,0.006042331136931698,0.19214478585664713,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-12,20.77791976928711,33.314249674479164,33.5400759379069,32.89122009277344,32.9993642171224,17430510.666666668,,0.0015275927013880218,0.0015287606607141322,0.19181508924356816,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-13,20.80965805053711,33.36514027913412,33.58778508504232,33.1202278137207,33.22201029459635,15871156.333333334,,0.0015252627211872238,0.0015264271185302847,0.19116509636704415,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-14,20.84139633178711,33.41603088378906,33.635494232177734,33.34923553466797,33.44465637207031,14311802.0,,0.028555064880387844,0.0015241006894553151,0.17911209460537,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-06-15,21.4365291595459,34.3702278137207,34.39885330200195,33.42557144165039,33.47328186035156,22954658.0,"Dorfman Recommends Merck, Cal-Maine Foods, and Paycheck (MRK, CALM, PAYX)",-0.0002775820373678031,0.028154967696077168,0.18367107427239415,"[{'label': 'neutral', 'score': 0.9998546838760376}, {'label': 'positive', 'score': 7.320968870772049e-05}, {'label': 'negative', 'score': 7.209763862192631e-05}]","(0.9998546838760376, 7.320968870772049e-05, 7.209763862192631e-05)",0.007653090220779878,7.320968870772049e-05,1,1,"[{'label': 'neutral', 'score': 0.9443356394767761}, {'label': 'positive', 'score': 0.04044385999441147}, {'label': 'negative', 'score': 0.015220489352941513}]","(0.9443356394767761, 0.04044385999441147, 0.015220489352941513)",0.4531333059167323,0.04044385999441147,1,1,"[{'label': 'neutral', 'score': 0.9994648098945618}, {'label': 'positive', 'score': 0.00040871245437301695}, {'label': 'negative', 'score': 0.00012649246491491795}]","(0.9994648098945618, 0.00040871245437301695, 0.00012649246491491795)",0.5273120243991395,0.00040871245437301695,0,1
2010-06-16,21.43057632446289,34.360687255859375,34.52289962768555,34.064884185791016,34.07442855834961,18167394.0,,-0.004165552773660198,-0.00027762057039244607,0.1926452817099357,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-17,21.3413143157959,34.21755599975586,34.58969497680664,33.683204650878906,34.48473358154297,18747358.0,,-0.005298370878603582,-0.004174252857459509,0.2057120122959822,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-18,21.228233337402344,34.036258697509766,34.35114669799805,33.85496139526367,34.2557258605957,20582510.0,,-0.005139685308173658,-0.005312457023364368,0.2190206648832041,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-19,21.11912663777669,33.86132303873698,34.39885584513346,33.67366409301758,34.300254821777344,19161003.0,,-0.005166238146473405,-0.005152938923151488,0.2286606060814662,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-20,21.010019938151043,33.686387379964195,34.44656499226888,33.492366790771484,34.344783782958984,17739496.0,,-0.0051930667660978124,-0.005179629295922215,0.03398028392849173,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-06-21,20.90091323852539,33.511451721191406,34.4942741394043,33.31106948852539,34.389312744140625,16317989.0,,0.0002846954509969805,-0.005206597602000995,0.007436039515970654,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-22,20.9068660736084,33.520992279052734,34.08396911621094,33.463741302490234,33.578243255615234,17187095.0,Late Market Roundup,0.008255070057140244,0.0002846549329370768,0.03904063392448639,"[{'label': 'neutral', 'score': 0.9998565912246704}, {'label': 'negative', 'score': 7.920362986624241e-05}, {'label': 'positive', 'score': 6.411383219528943e-05}]","(0.9998565912246704, 6.411383219528943e-05, 7.920362986624241e-05)",-0.10528931683477852,-7.920362986624241e-05,0,0,"[{'label': 'neutral', 'score': 0.7520723938941956}, {'label': 'negative', 'score': 0.19523784518241882}, {'label': 'positive', 'score': 0.05268970504403114}]","(0.7520723938941956, 0.05268970504403114, 0.19523784518241882)",-0.5749588539401461,-0.19523784518241882,0,0,"[{'label': 'neutral', 'score': 0.999231219291687}, {'label': 'positive', 'score': 0.00048438188969157636}, {'label': 'negative', 'score': 0.0002844839764293283}]","(0.999231219291687, 0.00048438188969157636, 0.0002844839764293283)",0.2599906200424483,0.00048438188969157636,0,0
2010-06-23,21.07944107055664,33.79771041870117,34.02671813964844,33.33015441894531,33.58778762817383,13624629.0,,0.0053641888755214945,0.0082211833301232,0.09333121965168402,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-24,21.192522048950195,33.979007720947266,34.064884185791016,33.55915832519531,33.568702697753906,17217592.0,,0.008986243225150164,0.005349852858923961,0.09650199089662222,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-25,21.382963180541992,34.28435134887695,34.4942741394043,33.66412353515625,33.96946716308594,35498904.0,,9.275911104200739e-05,0.008946107210291454,0.09442099512473963,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-26,21.384947458903,34.28753153483073,34.49109395345052,33.75636291503906,34.138041178385414,28467383.0,,9.275050758758212e-05,9.275480918168852e-05,0.0671151656802323,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-27,21.386931737264,34.29071172078451,34.48791376749674,33.848602294921875,34.3066151936849,21435862.0,,9.274190572854394e-05,9.274620652523293e-05,0.0678980035910229,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-06-28,21.388916015625,34.29389190673828,34.48473358154297,33.94084167480469,34.475189208984375,14404341.0,Citi (C) Has A Price Target Of $30 For Bristol Myers Squibb  (BMY) ,-0.014190309210141383,9.273760546394587e-05,0.06457926176849607,"[{'label': 'neutral', 'score': 0.6545000672340393}, {'label': 'positive', 'score': 0.34440821409225464}, {'label': 'negative', 'score': 0.0010917272884398699}]","(0.6545000672340393, 0.34440821409225464, 0.0010917272884398699)",0.9936803040598092,0.34440821409225464,0,0,"[{'label': 'neutral', 'score': 0.9245799779891968}, {'label': 'positive', 'score': 0.0573449581861496}, {'label': 'negative', 'score': 0.018074994906783104}]","(0.9245799779891968, 0.0573449581861496, 0.018074994906783104)",0.520684005610265,0.0573449581861496,0,0,"[{'label': 'neutral', 'score': 0.9996114373207092}, {'label': 'positive', 'score': 0.00024436062085442245}, {'label': 'negative', 'score': 0.0001442197972210124}]","(0.9996114373207092, 0.00024436062085442245, 0.0001442197972210124)",0.25770939289578343,0.00024436062085442245,0,0
2010-06-29,21.08540153503418,33.8072509765625,34.16030502319336,33.39694595336914,33.921756744384766,23962206.0,Good News for NVO's Victoza - Analyst Blog | Soleil Initiates MRK With Hold,-0.012983324547118784,-0.014291954377904882,0.1326216253592196,"[{'label': 'positive', 'score': 0.6649048924446106}, {'label': 'neutral', 'score': 0.3342694938182831}, {'label': 'negative', 'score': 0.0008255866123363376}]","(0.3342694938182831, 0.6649048924446106, 0.0008255866123363376)",0.9975197572041291,0.6649048924446106,0,0,"[{'label': 'positive', 'score': 0.7759349346160889}, {'label': 'neutral', 'score': 0.21187306940555573}, {'label': 'negative', 'score': 0.012191974557936192}]","(0.21187306940555573, 0.7759349346160889, 0.012191974557936192)",0.9690608849513497,0.7759349346160889,0,0,"[{'label': 'positive', 'score': 0.9949609041213989}, {'label': 'neutral', 'score': 0.004743034020066261}, {'label': 'negative', 'score': 0.0002960624697152525}]","(0.004743034020066261, 0.9949609041213989, 0.0002960624697152525)",0.9994050532080588,0.9949609041213989,0,0
2010-06-30,20.811643600463867,33.36832046508789,33.72137451171875,33.15839767456055,33.70228958129883,22218753.0,Pharmaceutical ETFs on the Rise ,-0.015155868007346262,-0.013068344602337188,0.119949686297012,"[{'label': 'neutral', 'score': 0.5874157547950745}, {'label': 'positive', 'score': 0.4116404950618744}, {'label': 'negative', 'score': 0.0009437006083317101}]","(0.5874157547950745, 0.4116404950618744, 0.0009437006083317101)",0.9954254156206892,0.4116404950618744,0,1,"[{'label': 'neutral', 'score': 0.8605663776397705}, {'label': 'positive', 'score': 0.10090337693691254}, {'label': 'negative', 'score': 0.038530319929122925}]","(0.8605663776397705, 0.10090337693691254, 0.038530319929122925)",0.44733130089576656,0.10090337693691254,1,1,"[{'label': 'neutral', 'score': 0.8384518623352051}, {'label': 'positive', 'score': 0.1608874350786209}, {'label': 'negative', 'score': 0.0006606352981179953}]","(0.8384518623352051, 0.1608874350786209, 0.0006606352981179953)",0.9918211923351686,0.1608874350786209,0,1
2010-07-01,20.496227264404297,32.86259460449219,33.29198455810547,32.10877990722656,33.23473358154297,26815386.0,,-0.00638789459730146,-0.015271891963399765,0.12498211039140317,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-02,20.36529922485352,32.652671813964844,32.91984558105469,32.10877990722656,32.88167953491211,17809188.0,"Stock Market News for July 2, 2010 - Market News",0.0031414352976306885,-0.006408384500832587,0.1035408922500844,"[{'label': 'neutral', 'score': 0.9998726844787598}, {'label': 'negative', 'score': 7.620961696375161e-05}, {'label': 'positive', 'score': 5.1139159040758386e-05}]","(0.9998726844787598, 5.1139159040758386e-05, 7.620961696375161e-05)",-0.19686453776442553,-7.620961696375161e-05,1,1,"[{'label': 'neutral', 'score': 0.9260836243629456}, {'label': 'negative', 'score': 0.051867417991161346}, {'label': 'positive', 'score': 0.022049004212021828}]","(0.9260836243629456, 0.022049004212021828, 0.051867417991161346)",-0.40340715757553813,-0.051867417991161346,1,1,"[{'label': 'neutral', 'score': 0.9995890259742737}, {'label': 'positive', 'score': 0.00026158589753322303}, {'label': 'negative', 'score': 0.00014942229609005153}]","(0.9995890259742737, 0.00026158589753322303, 0.00014942229609005153)",0.27289869930422694,0.00026158589753322303,1,1
2010-07-03,20.42927408218384,32.755248069763184,32.96517086029053,32.20419979095459,32.83874034881592,17264490.0,,0.0031315975864346876,0.0031365112993522997,0.12238327978909386,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-04,20.49324893951416,32.85782432556152,33.01049613952637,32.29961967468262,32.79580116271973,16719792.0,,0.003121821298391365,0.0031267043478210525,0.138028372475119,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-05,20.55722379684448,32.96040058135986,33.05582141876221,32.395039558410645,32.752861976623535,16175094.0,,0.00311210586003466,0.0031169585321116494,0.1312335557319598,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-06,20.621198654174805,33.0629768371582,33.10114669799805,32.49045944213867,32.709922790527344,15630396.0,,0.022510802432279355,0.003107273282325706,0.06765825853989707,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-07-07,21.08540153503418,33.8072509765625,33.83587646484375,32.843509674072266,33.17748260498047,17699882.0,"Puts Purchased on Millipore Corp. (MIL) | Stock Market News for July 7, 2010 - Market News",0.012136598254552282,0.02226117360495898,0.13587574439544228,"[{'label': 'neutral', 'score': 0.9998255372047424}, {'label': 'negative', 'score': 8.918296225601807e-05}, {'label': 'positive', 'score': 8.536705718142912e-05}]","(0.9998255372047424, 8.536705718142912e-05, 8.918296225601807e-05)",-0.021861384415121452,-8.918296225601807e-05,1,1,"[{'label': 'neutral', 'score': 0.9393722414970398}, {'label': 'positive', 'score': 0.03532033786177635}, {'label': 'negative', 'score': 0.025307392701506615}]","(0.9393722414970398, 0.03532033786177635, 0.025307392701506615)",0.16515454342824637,0.03532033786177635,1,1,"[{'label': 'neutral', 'score': 0.9993507266044617}, {'label': 'positive', 'score': 0.0005306947277858853}, {'label': 'negative', 'score': 0.0001185536602861248}]","(0.9993507266044617, 0.0005306947277858853, 0.0001185536602861248)",0.6347972133186855,0.0005306947277858853,0,1
2010-07-08,21.3413143157959,34.21755599975586,34.22710037231445,33.71183013916016,34.22710037231445,16314426.0,"Late Market Roundup | News Summary (HRB, BP, MRK) | Merck Details Global Restructuring Program | Top Yielding Big Pharmaceutical Stocks",0.012269999521735239,0.012063540268897473,0.13486868996828866,"[{'label': 'neutral', 'score': 0.9998526573181152}, {'label': 'negative', 'score': 7.781870954204351e-05}, {'label': 'positive', 'score': 6.954793207114562e-05}]","(0.9998526573181152, 6.954793207114562e-05, 7.781870954204351e-05)",-0.056123810520207026,-7.781870954204351e-05,1,1,"[{'label': 'neutral', 'score': 0.47681066393852234}, {'label': 'positive', 'score': 0.47536948323249817}, {'label': 'negative', 'score': 0.04781991243362427}]","(0.47681066393852234, 0.47536948323249817, 0.04781991243362427)",0.8171984645340903,0.47536948323249817,0,1,"[{'label': 'neutral', 'score': 0.9964364767074585}, {'label': 'positive', 'score': 0.0024019291158765554}, {'label': 'negative', 'score': 0.001161601860076189}]","(0.9964364767074585, 0.0024019291158765554, 0.001161601860076189)",0.34806130890127956,0.0024019291158765554,1,1
2010-07-09,21.603166580200195,34.63740539550781,34.73282241821289,34.08396911621094,34.26526641845703,12569083.0,,-0.0019283799347162335,0.012195333227409465,0.12619829214201517,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-10,21.561506907145183,34.57061131795248,34.681933085123696,34.122137705485024,34.357505798339844,12787137.0,,-0.0019321057687129845,-0.0019302416530878387,0.148108759152938,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-11,21.519847234090168,34.50381724039713,34.63104375203451,34.16030629475912,34.449745178222656,13005191.0,,-0.0019358460279905942,-0.0019339746927576403,0.16523546362429511,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-12,21.47818756103516,34.4370231628418,34.58015441894531,34.1984748840332,34.54198455810547,13223245.0,,0.0099750106868389,-0.0019377221996232307,0.12228120247659514,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-13,21.692428588867188,34.78053283691406,35.01908493041992,34.3797721862793,34.475189208984375,13523497.0,"Miller Tabak Likes Bristol Myers Squibb (BMY), Novartis (NVS) And Merck (MRK) | GlaxoSmithKline: Another Drug Company Runs Afoul Of The Truth ",-0.006858672347751162,0.009925588652863374,0.11370029059754881,"[{'label': 'neutral', 'score': 0.9936367273330688}, {'label': 'negative', 'score': 0.006251524202525616}, {'label': 'positive', 'score': 0.000111826928332448}]","(0.9936367273330688, 0.000111826928332448, 0.006251524202525616)",-0.9648528185753695,-0.006251524202525616,0,1,"[{'label': 'negative', 'score': 0.8452284336090088}, {'label': 'neutral', 'score': 0.13908149302005768}, {'label': 'positive', 'score': 0.015690144151449203}]","(0.13908149302005768, 0.015690144151449203, 0.8452284336090088)",-0.9635502251739889,-0.8452284336090088,0,0,"[{'label': 'neutral', 'score': 0.9448150992393494}, {'label': 'negative', 'score': 0.05212028697133064}, {'label': 'positive', 'score': 0.0030645348597317934}]","(0.9448150992393494, 0.0030645348597317934, 0.05212028697133064)",-0.8889355892417931,-0.05212028697133064,0,1
2010-07-14,21.54365539550781,34.54198455810547,34.70419692993164,34.18893051147461,34.5515251159668,11736657.0,"Ryan Recommends Bristol-Myers and Merck (BMY, MRK, PFE) | 10 Firms Expecting Clinical Trial Results",0.00801106662481858,-0.006882301144366009,0.09900342922210986,"[{'label': 'positive', 'score': 0.9746513962745667}, {'label': 'neutral', 'score': 0.02370145358145237}, {'label': 'negative', 'score': 0.0016471132403239608}]","(0.02370145358145237, 0.9746513962745667, 0.0016471132403239608)",0.9966257999489472,0.9746513962745667,0,0,"[{'label': 'neutral', 'score': 0.5827890038490295}, {'label': 'positive', 'score': 0.4077857732772827}, {'label': 'negative', 'score': 0.009425253607332706}]","(0.5827890038490295, 0.4077857732772827, 0.009425253607332706)",0.9548178116110082,0.4077857732772827,0,1,"[{'label': 'neutral', 'score': 0.998895525932312}, {'label': 'positive', 'score': 0.0009979861788451672}, {'label': 'negative', 'score': 0.00010643595305737108}]","(0.998895525932312, 0.0009979861788451672, 0.00010643595305737108)",0.8072549435893345,0.0009979861788451672,0,1
2010-07-15,21.71624183654785,34.818702697753906,34.885494232177734,34.2557258605957,34.58969497680664,11518673.0,,-0.01589479895621086,0.00797914838337319,0.11414714972835653,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-16,21.37105941772461,34.26526641845703,35.114505767822266,34.23664093017578,34.856868743896484,17374792.0,,-0.0010210669698952626,-0.01602247601465757,0.17030879478480182,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-17,21.34924062093099,34.23027928670248,34.895039876302086,34.17620849609375,34.669209798177086,15117924.0,,-0.0010221106132826871,-0.0010215886138929414,0.170246523277853,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-18,21.32742182413737,34.195292154947914,34.6755739847819,34.11577606201172,34.48155085245768,12861056.0,,-0.0010231563922898793,-0.0010226333245451226,0.14025531320953052,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-19,21.30560302734375,34.16030502319336,34.45610809326172,34.05534362792969,34.29389190673828,10604188.0,,-0.003910588135973089,-0.001023680174095715,0.1372093884880553,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-20,21.2222843170166,34.02671813964844,34.02671813964844,33.58778762817383,33.89313125610352,14684262.0,,-0.013180080494175943,-0.003918254478891063,0.10328510515391821,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-21,20.94257354736328,33.578243255615234,34.05534362792969,33.377864837646484,33.85496139526367,13429491.0,,-0.00028412915436642664,-0.013267708570166504,0.08417918689832415,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-22,20.936622619628903,33.568702697753906,33.89313125610352,33.39694595336914,33.74045944213867,16482944.0,,-0.008811870769380422,-0.0002841695267020415,0.08599417681819801,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-23,20.752124786376957,33.27289962768555,33.55915832519531,32.83396911621094,33.55915832519531,16431802.0,,0.003823727810350061,-0.00885092489850387,0.08741991398483055,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-24,20.83147684733073,33.400126139322914,33.60050710042318,32.961195627848305,33.505087534586586,14320186.666666668,,0.0038091626093467697,0.0038164359453267548,0.1073960666702967,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-25,20.910828908284504,33.52735265096029,33.64185587565104,33.08842213948568,33.45101674397787,12208571.333333334,,0.0037947079497111266,0.0038019261202755206,0.12290078473626848,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-26,20.99018096923828,33.654579162597656,33.683204650878906,33.21564865112305,33.39694595336914,10096956.0,Corporate Catalysts For The Week Starting July 26 ,-0.002551702234303665,0.003787526208173437,0.08722081578200519,"[{'label': 'neutral', 'score': 0.9998900890350342}, {'label': 'negative', 'score': 6.6868364228867e-05}, {'label': 'positive', 'score': 4.3053110857727006e-05}]","(0.9998900890350342, 4.3053110857727006e-05, 6.6868364228867e-05)",-0.21665696673355953,-6.6868364228867e-05,1,1,"[{'label': 'neutral', 'score': 0.8892968893051147}, {'label': 'negative', 'score': 0.09092696011066437}, {'label': 'positive', 'score': 0.01977616921067238}]","(0.8892968893051147, 0.01977616921067238, 0.09092696011066437)",-0.64271706984419,-0.09092696011066437,0,1,"[{'label': 'neutral', 'score': 0.9995903372764587}, {'label': 'positive', 'score': 0.00024593400303274393}, {'label': 'negative', 'score': 0.0001637536333873868}]","(0.9995903372764587, 0.00024593400303274393, 0.0001637536333873868)",0.20059275003622992,0.00024593400303274393,1,1
2010-07-27,20.936622619628903,33.568702697753906,33.959922790527344,33.39694595336914,33.70228958129883,13285810.0,Huge Call Purchase on Merck & Co. (MRK) | A Peek Into The Market At The Start Of The Trading Day | Sanofi-aventis and Merck Appoint CEO for Joint Venture | Merk and Sinopharm Sign Statement of Mutual Intent,-0.012507167748846172,-0.0025549633752716835,0.08988108284430141,"[{'label': 'neutral', 'score': 0.9997161030769348}, {'label': 'positive', 'score': 0.00023265315394382924}, {'label': 'negative', 'score': 5.129887358634733e-05}]","(0.9997161030769348, 0.00023265315394382924, 5.129887358634733e-05)",0.6386792935937349,0.00023265315394382924,0,1,"[{'label': 'positive', 'score': 0.8205732703208923}, {'label': 'neutral', 'score': 0.16451899707317352}, {'label': 'negative', 'score': 0.014907714910805225}]","(0.16451899707317352, 0.8205732703208923, 0.014907714910805225)",0.9643134549455462,0.8205732703208923,0,0,"[{'label': 'positive', 'score': 0.963636040687561}, {'label': 'neutral', 'score': 0.036024097353219986}, {'label': 'negative', 'score': 0.00033986297785304487}]","(0.036024097353219986, 0.963636040687561, 0.00033986297785304487)",0.9992948724619345,0.963636040687561,0,0
2010-07-28,20.67476463317871,33.14885330200195,33.788169860839844,33.03435134887695,33.53053283691406,10175870.0,Fast Money 360: Leerink Swann Is A Buyer Of Merck (MRK),0.009211287797736488,-0.012586040713047256,0.11378579402326526,"[{'label': 'neutral', 'score': 0.9998477697372437}, {'label': 'positive', 'score': 8.575140236644074e-05}, {'label': 'negative', 'score': 6.648642738582566e-05}]","(0.9998477697372437, 8.575140236644074e-05, 6.648642738582566e-05)",0.12654525496037738,8.575140236644074e-05,1,1,"[{'label': 'neutral', 'score': 0.9454023241996765}, {'label': 'positive', 'score': 0.03695397451519966}, {'label': 'negative', 'score': 0.017643652856349945}]","(0.9454023241996765, 0.03695397451519966, 0.017643652856349945)",0.35368426410617565,0.03695397451519966,1,1,"[{'label': 'neutral', 'score': 0.9995866417884827}, {'label': 'positive', 'score': 0.000290323281660676}, {'label': 'negative', 'score': 0.0001231148053193465}]","(0.9995866417884827, 0.000290323281660676, 0.0001231148053193465)",0.4044341380415905,0.000290323281660676,1,1
2010-07-29,20.86520195007324,33.45419692993164,33.683204650878906,33.01526641845703,33.39694595336914,15270722.0,,-0.017113469984607433,0.009169122618902008,0.13217035509387068,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-07-30,20.50813102722168,32.88167953491211,33.04389190673828,32.270992279052734,32.77671813964844,22764656.0,"Hapoalim Securities Downgrades Merck to Hold from Buy (MRK) | Company News for July 30, 2010 - Corporate Summary | US Stock Futures Point To Weak Day Today | Merck Posts Mixed Results (MRK) | ETFs To Watch July 30, 2010 (HAO, PPH, YCS, PALL) | Mercks Q2 Earnings Beat Targets, Revenue Misses | Earnings Scheduled For July 30 (MRK, AON, CVX, CVH, WY, PPC) | Stocks To Watch For July 30 (FSLR, MRK, CVX, AON, CSTR)",0.005900568095577643,-0.017261597832085467,0.17492385303112118,"[{'label': 'negative', 'score': 0.9981069564819336}, {'label': 'neutral', 'score': 0.001097891479730606}, {'label': 'positive', 'score': 0.0007951908046379685}]","(0.001097891479730606, 0.0007951908046379685, 0.9981069564819336)",-0.9984078704669961,-0.9981069564819336,0,0,"[{'label': 'negative', 'score': 0.9122856259346008}, {'label': 'positive', 'score': 0.04949933663010597}, {'label': 'neutral', 'score': 0.038215022534132004}]","(0.038215022534132004, 0.04949933663010597, 0.9122856259346008)",-0.89706776762633,-0.9122856259346008,0,0,"[{'label': 'negative', 'score': 0.9979948997497559}, {'label': 'neutral', 'score': 0.001649445854127407}, {'label': 'positive', 'score': 0.0003556687443051487}]","(0.001649445854127407, 0.0003556687443051487, 0.9979948997497559)",-0.9992874872704451,-0.9979948997497559,0,0
2010-07-31,20.62914021809896,33.07570012410482,33.199745178222656,32.503180185953774,32.93893178304037,19405781.0,,0.005865955624966675,0.005883227921469232,0.18123689225291706,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-01,20.75014940897624,33.269720713297524,33.35559844970703,32.73536809285482,33.10114542643229,16046906.0,,0.00583174685668951,0.005848817894056719,0.19332667035399442,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-02,20.87115859985352,33.463741302490234,33.511451721191406,32.96755599975586,33.26335906982422,12688031.0,"Top 4 NYSE Stocks In The Healthcare Sector With The Highest Free Cash Flow (PFE, JNJ, MRK, LLY) ",-0.007128673729261328,0.005814808044328009,0.17148722268564298,"[{'label': 'neutral', 'score': 0.9709298014640808}, {'label': 'positive', 'score': 0.02880874089896679}, {'label': 'negative', 'score': 0.00026150429039262235}]","(0.9709298014640808, 0.02880874089896679, 0.00026150429039262235)",0.9820088004976071,0.02880874089896679,0,1,"[{'label': 'positive', 'score': 0.727200984954834}, {'label': 'neutral', 'score': 0.25886964797973633}, {'label': 'negative', 'score': 0.01392942015081644}]","(0.25886964797973633, 0.727200984954834, 0.01392942015081644)",0.9624103395168877,0.727200984954834,0,0,"[{'label': 'neutral', 'score': 0.9860148429870605}, {'label': 'positive', 'score': 0.01370040513575077}, {'label': 'negative', 'score': 0.00028479794855229557}]","(0.9860148429870605, 0.01370040513575077, 0.00028479794855229557)",0.9592715319419349,0.01370040513575077,0,1
2010-08-03,20.722375869750977,33.225189208984375,33.635494232177734,32.90076446533203,33.492366790771484,15282146.0,AstraZeneca EPS Beats & Ups - Analyst Blog,0.010626095893996912,-0.007154204128106063,0.16693574296641883,"[{'label': 'neutral', 'score': 0.999675989151001}, {'label': 'positive', 'score': 0.00023063029220793396}, {'label': 'negative', 'score': 9.348764433525503e-05}]","(0.999675989151001, 0.00023063029220793396, 9.348764433525503e-05)",0.42312575889919796,0.00023063029220793396,1,1,"[{'label': 'neutral', 'score': 0.9419821500778198}, {'label': 'negative', 'score': 0.030699195340275764}, {'label': 'positive', 'score': 0.027318662032485008}]","(0.9419821500778198, 0.027318662032485008, 0.030699195340275764)",-0.05826711741647163,-0.030699195340275764,1,1,"[{'label': 'neutral', 'score': 0.9621647000312805}, {'label': 'positive', 'score': 0.03751754015684128}, {'label': 'negative', 'score': 0.00031775468960404396}]","(0.9621647000312805, 0.03751754015684128, 0.00031775468960404396)",0.9832032661094011,0.03751754015684128,0,1
2010-08-04,20.94257354736328,33.578243255615234,33.635494232177734,32.96755599975586,33.1870231628418,13764013.0,"Vertex Loss Narrows, Reaffirms Guidance  - Analyst Blog | Santarus Beats on Higher Revs - Analyst Blog | Zacks Analyst Blog Highlights: The Clorox, AstraZeneca, Merck, Dean Foods and Coach - Press Releases",-0.003410004277274155,0.010570035721185074,0.10579334974899005,"[{'label': 'negative', 'score': 0.9946550130844116}, {'label': 'neutral', 'score': 0.003092112485319376}, {'label': 'positive', 'score': 0.0022528613917529583}]","(0.003092112485319376, 0.0022528613917529583, 0.9946550130844116)",-0.995480301742151,-0.9946550130844116,0,0,"[{'label': 'neutral', 'score': 0.9190640449523926}, {'label': 'positive', 'score': 0.05144009366631508}, {'label': 'negative', 'score': 0.029495829716324806}]","(0.9190640449523926, 0.05144009366631508, 0.029495829716324806)",0.2711313225679111,0.05144009366631508,1,1,"[{'label': 'positive', 'score': 0.9967233538627625}, {'label': 'neutral', 'score': 0.0028605579864233732}, {'label': 'negative', 'score': 0.0004161394899711013}]","(0.0028605579864233732, 0.9967233538627625, 0.0004161394899711013)",0.9991653334508457,0.9967233538627625,0,0
2010-08-05,20.87115859985352,33.463741302490234,33.549617767333984,33.110687255859375,33.39694595336914,10545710.0,,-0.0025662541455685776,-0.003415831593078857,0.11648818000216868,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-06,20.81759452819824,33.377864837646484,33.39694595336914,32.91984558105469,33.225189208984375,12218422.0,"Best Stocks For A Deflationary Environment (NEM, ABX, GG, DLTR, FDO, MRK, JNJ) | Oncothyreon Phase 3 Breast Cancer Trial Shut Down",0.003621108442734794,-0.0025695526200961256,0.11580898326133714,"[{'label': 'negative', 'score': 0.8748813271522522}, {'label': 'neutral', 'score': 0.12436984479427338}, {'label': 'positive', 'score': 0.0007488063420169055}]","(0.12436984479427338, 0.0007488063420169055, 0.8748813271522522)",-0.9982896743422277,-0.8748813271522522,0,0,"[{'label': 'negative', 'score': 0.654313325881958}, {'label': 'neutral', 'score': 0.27563267946243286}, {'label': 'positive', 'score': 0.07005401700735092}]","(0.27563267946243286, 0.07005401700735092, 0.654313325881958)",-0.8065787540119519,-0.654313325881958,0,0,"[{'label': 'neutral', 'score': 0.946033239364624}, {'label': 'negative', 'score': 0.028392914682626724}, {'label': 'positive', 'score': 0.02557382732629776}]","(0.946033239364624, 0.02557382732629776, 0.028392914682626724)",-0.052237493896940664,-0.028392914682626724,1,1
2010-08-07,20.89297866821289,33.49872970581055,33.536895751953125,33.09796269734701,33.3015251159668,11744446.666666666,,0.0036080433265831507,0.003614568013870671,0.11056041685250499,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-08,20.96836280822754,33.61959457397461,33.67684555053711,33.27607981363932,33.37786102294922,11270471.333333334,,0.003595072150501947,0.0036015499524893755,0.08986317362470714,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-09,21.043746948242188,33.74045944213867,33.816795349121094,33.45419692993164,33.45419692993164,10796496.0,Cost Reduction Lowers ENZN Loss - Analyst Blog | Finally There Is A Cure For Tobacco Addiction (CIGX),0.011594984159724875,0.0035886253251996166,0.057532640478039014,"[{'label': 'positive', 'score': 0.9991563558578491}, {'label': 'neutral', 'score': 0.0005136901745572686}, {'label': 'negative', 'score': 0.0003299544914625585}]","(0.0005136901745572686, 0.9991563558578491, 0.0003299544914625585)",0.9993397518544356,0.9991563558578491,1,1,"[{'label': 'positive', 'score': 0.6196801662445068}, {'label': 'neutral', 'score': 0.36608967185020447}, {'label': 'negative', 'score': 0.014230109751224518}]","(0.36608967185020447, 0.6196801662445068, 0.014230109751224518)",0.9551037101303581,0.6196801662445068,1,1,"[{'label': 'positive', 'score': 0.9980621933937073}, {'label': 'neutral', 'score': 0.0016399567248299718}, {'label': 'negative', 'score': 0.0002978657139465213}]","(0.0016399567248299718, 0.9980621933937073, 0.0002978657139465213)",0.999403290002982,0.9980621933937073,1,1
2010-08-10,21.287744522094727,34.13167953491211,34.34160232543945,33.225189208984375,33.58778762817383,12434206.0,,-0.024601630750334034,0.011528277477660585,0.07949124876029115,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-08-11,20.764028549194336,33.29198455810547,33.874046325683594,33.225189208984375,33.6927490234375,13039321.0,"Dogs Of The Dow: 5 Highest Yielding Dow Stocks (MRK, PFE, PG, T, VZ)",0.004299270770527497,-0.024909307586128714,0.2232276760436249,"[{'label': 'neutral', 'score': 0.9998729228973389}, {'label': 'negative', 'score': 6.893436511745676e-05}, {'label': 'positive', 'score': 5.81403000978753e-05}]","(0.9998729228973389, 5.81403000978753e-05, 6.893436511745676e-05)",-0.08494269885575209,-6.893436511745676e-05,1,1,"[{'label': 'neutral', 'score': 0.9258337020874023}, {'label': 'positive', 'score': 0.05979320406913757}, {'label': 'negative', 'score': 0.014373121783137321}]","(0.9258337020874023, 0.05979320406913757, 0.014373121783137321)",0.6124084180261046,0.05979320406913757,0,1,"[{'label': 'neutral', 'score': 0.9968672394752502}, {'label': 'positive', 'score': 0.0030179040040820837}, {'label': 'negative', 'score': 0.000114822993054986}]","(0.9968672394752502, 0.0030179040040820837, 0.000114822993054986)",0.9266945423843698,0.0030179040040820837,0,1
2010-08-12,20.85329818725586,33.435115814208984,33.635494232177734,33.01526641845703,33.0629768371582,9597479.0,Merck Announces Mandatory Conversion of its 6.00% Mandatory Convertible Preferred Stock,-0.0011416099484130584,0.004290055309681055,0.22406491745924823,"[{'label': 'neutral', 'score': 0.9998519420623779}, {'label': 'positive', 'score': 8.12648213468492e-05}, {'label': 'negative', 'score': 6.671516894130036e-05}]","(0.9998519420623779, 8.12648213468492e-05, 6.671516894130036e-05)",0.09832175537528735,8.12648213468492e-05,1,1,"[{'label': 'neutral', 'score': 0.9017199873924255}, {'label': 'positive', 'score': 0.08534632623195648}, {'label': 'negative', 'score': 0.01293368823826313}]","(0.9017199873924255, 0.08534632623195648, 0.01293368823826313)",0.7367992199027964,0.08534632623195648,0,1,"[{'label': 'neutral', 'score': 0.9992589354515076}, {'label': 'positive', 'score': 0.0005977170076221228}, {'label': 'negative', 'score': 0.00014335538435261697}]","(0.9992589354515076, 0.0005977170076221228, 0.00014335538435261697)",0.6131136825361498,0.0005977170076221228,0,1
2010-08-13,20.829496383666992,33.39694595336914,33.540077209472656,33.0629768371582,33.20610809326172,9172306.0,"All Is Not Well In The Pharmaceutical Industry | U.S. Probing Pharmaceutical Corruption (GSK, PFE, BMY, LLY)",-0.00028570964064823735,-0.0011422620814184796,0.22126754731062664,"[{'label': 'negative', 'score': 0.9606766104698181}, {'label': 'neutral', 'score': 0.03878745064139366}, {'label': 'positive', 'score': 0.0005359846400097013}]","(0.03878745064139366, 0.0005359846400097013, 0.9606766104698181)",-0.9988847739974767,-0.9606766104698181,0,0,"[{'label': 'negative', 'score': 0.7206814289093018}, {'label': 'neutral', 'score': 0.2569703459739685}, {'label': 'positive', 'score': 0.022348180413246155}]","(0.2569703459739685, 0.022348180413246155, 0.7206814289093018)",-0.9398457877509836,-0.7206814289093018,0,0,"[{'label': 'negative', 'score': 0.8448752760887146}, {'label': 'neutral', 'score': 0.15222352743148804}, {'label': 'positive', 'score': 0.002901128027588129}]","(0.15222352743148804, 0.002901128027588129, 0.8448752760887146)",-0.9931559123054099,-0.8448752760887146,0,0
2010-08-14,20.823545455932617,33.387404123942055,33.492366790771484,33.04389317830404,33.19656626383463,8520554.666666666,,-0.00028579129397592686,-0.0002857504634234291,0.21752072391015112,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-15,20.81759452819824,33.377862294514976,33.44465637207031,33.02480951944987,33.187024434407554,7868803.333333334,,-0.00028587299398900455,-0.0002858321400902297,0.1845463345974324,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-16,20.811643600463867,33.36832046508789,33.39694595336914,33.0057258605957,33.17748260498047,7217052.0,,0.016299648863278463,-0.00028591386346248456,0.03451140048265133,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-08-17,21.150863647460938,33.91221237182617,33.988548278808594,33.33969497680664,33.578243255615234,11189496.0,Oppenheimer Remains Buyer Of VRTX,-0.004783302547401355,0.016168235656533865,0.1184786528077523,"[{'label': 'neutral', 'score': 0.9997988343238831}, {'label': 'positive', 'score': 0.00012384049477986991}, {'label': 'negative', 'score': 7.73627107264474e-05}]","(0.9997988343238831, 0.00012384049477986991, 7.73627107264474e-05)",0.2309992225842705,0.00012384049477986991,1,1,"[{'label': 'neutral', 'score': 0.9469416737556458}, {'label': 'negative', 'score': 0.029595371335744858}, {'label': 'positive', 'score': 0.02346288226544857}]","(0.9469416737556458, 0.02346288226544857, 0.029595371335744858)",-0.11558030379948937,-0.029595371335744858,1,1,"[{'label': 'neutral', 'score': 0.9995238780975342}, {'label': 'positive', 'score': 0.00033633815473876894}, {'label': 'negative', 'score': 0.0001397934538545087}]","(0.9995238780975342, 0.00033633815473876894, 0.0001397934538545087)",0.41279490236942695,0.00033633815473876894,1,1
2010-08-18,21.049707412719727,33.75,33.959922790527344,33.42557144165039,33.864505767822266,9571174.0,10 Highest-Rated Dow Dividend Stocks ,-0.018659916630497684,-0.004794779151034947,0.12860550300959392,"[{'label': 'neutral', 'score': 0.9998741149902344}, {'label': 'negative', 'score': 6.708836008328944e-05}, {'label': 'positive', 'score': 5.8764202549355105e-05}]","(0.9998741149902344, 5.8764202549355105e-05, 6.708836008328944e-05)",-0.06614213775075851,-6.708836008328944e-05,1,1,"[{'label': 'neutral', 'score': 0.8209637999534607}, {'label': 'positive', 'score': 0.1614716500043869}, {'label': 'negative', 'score': 0.017564574256539345}]","(0.8209637999534607, 0.1614716500043869, 0.017564574256539345)",0.8037874812312747,0.1614716500043869,0,1,"[{'label': 'neutral', 'score': 0.9948979020118713}, {'label': 'positive', 'score': 0.0049385083839297295}, {'label': 'negative', 'score': 0.00016359472647309303}]","(0.9948979020118713, 0.0049385083839297295, 0.00016359472647309303)",0.9358716502065452,0.0049385083839297295,0,1
2010-08-19,20.656909942626957,33.1202278137207,33.72137451171875,32.91984558105469,33.683204650878906,12061327.0,,-0.007778726966418571,-0.018836209391540116,0.19866256042683103,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-20,20.496227264404297,32.86259460449219,33.10114669799805,32.681297302246094,32.96755599975586,12782875.0,,0.00512970107485642,-0.007809139077358538,0.20265036855385163,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-21,20.60136604309082,33.03116989135742,33.269720713297524,32.77989832560221,33.01526641845703,12007075.666666666,,0.005103521534953019,0.005116588979933216,0.2108593371276317,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-22,20.706504821777344,33.199745178222656,33.43829472859701,32.878499348958336,33.0629768371582,11231276.333333334,,0.005077607853924469,0.005090542708674461,0.15888400496232472,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-23,20.811643600463867,33.36832046508789,33.606868743896484,32.97710037231445,33.110687255859375,10455477.0,Generic Risk For Gilead's Hepsera  - Analyst Blog,-0.015155868007346262,0.005064760274792129,0.17164653237264554,"[{'label': 'neutral', 'score': 0.9998856782913208}, {'label': 'negative', 'score': 6.680674414383247e-05}, {'label': 'positive', 'score': 4.751315645989962e-05}]","(0.9998856782913208, 4.751315645989962e-05, 6.680674414383247e-05)",-0.16876840849267669,-6.680674414383247e-05,1,1,"[{'label': 'neutral', 'score': 0.9372828006744385}, {'label': 'positive', 'score': 0.03966172784566879}, {'label': 'negative', 'score': 0.023055462166666985}]","(0.9372828006744385, 0.03966172784566879, 0.023055462166666985)",0.26478012927134553,0.03966172784566879,1,1,"[{'label': 'neutral', 'score': 0.9995359182357788}, {'label': 'positive', 'score': 0.000309833325445652}, {'label': 'negative', 'score': 0.00015432645159307867}]","(0.9995359182357788, 0.000309833325445652, 0.00015432645159307867)",0.3350287585121738,0.000309833325445652,1,1
2010-08-24,20.496227264404297,32.86259460449219,33.20610809326172,32.60496139526367,33.167938232421875,11799642.0,,0.0029036306643085356,-0.015271891963399765,0.15054895483572386,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-25,20.55573844909668,32.95801544189453,33.1297721862793,32.46183013916016,32.843509674072266,11114878.0,,-0.001737088104210471,0.002899423271300313,0.14147493598454447,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-26,20.5200309753418,32.90076446533203,33.110687255859375,32.709922790527344,32.97710037231445,8903074.0,A New Round Of Corporate Layoffs?,0.015081153769540594,-0.0017385985912375128,0.13588612855897286,"[{'label': 'neutral', 'score': 0.999057948589325}, {'label': 'negative', 'score': 0.0008625934133306146}, {'label': 'positive', 'score': 7.937846385175362e-05}]","(0.999057948589325, 7.937846385175362e-05, 0.0008625934133306146)",-0.8314631980538719,-0.0008625934133306146,0,1,"[{'label': 'negative', 'score': 0.9175511002540588}, {'label': 'neutral', 'score': 0.0713416263461113}, {'label': 'positive', 'score': 0.011107313446700573}]","(0.0713416263461113, 0.011107313446700573, 0.9175511002540588)",-0.9760787965029311,-0.9175511002540588,0,0,"[{'label': 'negative', 'score': 0.9926106333732605}, {'label': 'neutral', 'score': 0.006734179332852364}, {'label': 'positive', 'score': 0.0006551426486112177}]","(0.006734179332852364, 0.0006551426486112177, 0.9926106333732605)",-0.9986808311241023,-0.9926106333732605,0,0
2010-08-27,20.829496383666992,33.39694595336914,33.50190734863281,32.74809265136719,33.04389190673828,10004313.0,Birth Control Stocks: A Recession Play,-0.002571424840146022,0.01496856375031308,0.17522378156408613,"[{'label': 'neutral', 'score': 0.9869363903999329}, {'label': 'negative', 'score': 0.012881568633019924}, {'label': 'positive', 'score': 0.00018195902521256357}]","(0.9869363903999329, 0.00018195902521256357, 0.012881568633019924)",-0.9721424365649205,-0.012881568633019924,0,1,"[{'label': 'negative', 'score': 0.8119630813598633}, {'label': 'neutral', 'score': 0.16942091286182404}, {'label': 'positive', 'score': 0.018616024404764175}]","(0.16942091286182404, 0.018616024404764175, 0.8119630813598633)",-0.9551733861938981,-0.8119630813598633,0,0,"[{'label': 'neutral', 'score': 0.9957537651062012}, {'label': 'negative', 'score': 0.0030925183091312647}, {'label': 'positive', 'score': 0.0011536473175510764}]","(0.9957537651062012, 0.0011536473175510764, 0.0030925183091312647)",-0.4566169014690761,-0.0030925183091312647,1,1
2010-08-28,20.77593421936035,33.31106821695963,33.533714294433594,32.875319163004555,33.136131286621094,9036030.666666666,,-0.0025780541125300094,-0.00257473663156704,0.1729442668231018,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-08-29,20.72237205505371,33.22519048055013,33.565521240234375,33.00254567464193,33.228370666503906,8067748.333333334,Sunday Morning Coffee,-0.002584717654509159,-0.00258138301666107,0.11897876466592804,"[{'label': 'neutral', 'score': 0.9998658895492554}, {'label': 'negative', 'score': 8.739883924135938e-05}, {'label': 'positive', 'score': 4.6772267523920164e-05}]","(0.9998658895492554, 4.6772267523920164e-05, 8.739883924135938e-05)",-0.30279672499468757,-8.739883924135938e-05,1,1,"[{'label': 'neutral', 'score': 0.8899837732315063}, {'label': 'negative', 'score': 0.06679674983024597}, {'label': 'positive', 'score': 0.04321946203708649}]","(0.8899837732315063, 0.04321946203708649, 0.06679674983024597)",-0.21430739518273106,-0.06679674983024597,1,1,"[{'label': 'neutral', 'score': 0.9995220899581909}, {'label': 'positive', 'score': 0.00029734312556684017}, {'label': 'negative', 'score': 0.0001805936626624316}]","(0.9995220899581909, 0.00029734312556684017, 0.0001805936626624316)",0.24427804215900306,0.00029734312556684017,1,1
2010-08-30,20.66880989074707,33.139312744140625,33.59732818603516,33.1297721862793,33.32061004638672,7099466.0,Goldman Sachs Introduces And Adjusts Estimates For Major Pharmaceuticals,0.012381217026472753,-0.0025880638043312794,0.12323280023325912,"[{'label': 'neutral', 'score': 0.9984000325202942}, {'label': 'positive', 'score': 0.001478793565183878}, {'label': 'negative', 'score': 0.00012120430619688705}]","(0.9984000325202942, 0.001478793565183878, 0.00012120430619688705)",0.8484944156928281,0.001478793565183878,0,1,"[{'label': 'neutral', 'score': 0.9222543835639954}, {'label': 'negative', 'score': 0.05493781715631485}, {'label': 'positive', 'score': 0.022807810455560684}]","(0.9222543835639954, 0.022807810455560684, 0.05493781715631485)",-0.4132709155189372,-0.05493781715631485,1,1,"[{'label': 'neutral', 'score': 0.999011754989624}, {'label': 'positive', 'score': 0.0008487794548273087}, {'label': 'negative', 'score': 0.00013941462384536862}]","(0.999011754989624, 0.0008487794548273087, 0.00013941462384536862)",0.7178395886916716,0.0008487794548273087,0,1
2010-08-31,20.924718856811523,33.549617767333984,33.74045944213867,32.92938995361328,33.07251739501953,17379194.0,You'd Have To Be Sick To Touch This Drug Stock (PFE),0.013083025699982183,0.01230519659937237,0.14180516051102893,"[{'label': 'neutral', 'score': 0.9996113181114197}, {'label': 'negative', 'score': 0.00033642773632891476}, {'label': 'positive', 'score': 5.2304374548839405e-05}]","(0.9996113181114197, 5.2304374548839405e-05, 0.00033642773632891476)",-0.7308975868716555,-0.00033642773632891476,0,1,"[{'label': 'neutral', 'score': 0.8360862731933594}, {'label': 'negative', 'score': 0.14059485495090485}, {'label': 'positive', 'score': 0.023318862542510033}]","(0.8360862731933594, 0.023318862542510033, 0.14059485495090485)",-0.7154739347126716,-0.14059485495090485,0,1,"[{'label': 'negative', 'score': 0.5862205624580383}, {'label': 'neutral', 'score': 0.4115726351737976}, {'label': 'positive', 'score': 0.0022068340331315994}]","(0.4115726351737976, 0.0022068340331315994, 0.5862205624580383)",-0.9924992138493514,-0.5862205624580383,0,0
2010-09-01,21.19847869873047,33.988548278808594,34.12213516235352,33.654579162597656,33.75954055786133,13684470.0,,-0.007580000390577037,0.01299818212515027,0.1325061288128484,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-02,21.03779411315918,33.73091506958008,34.13167953491211,32.93893051147461,34.05534362792969,12121482.0,,0.006789253136918132,-0.007608874597076871,0.15065145808487662,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-03,21.180625915527344,33.959922790527344,34.1984748840332,33.66412353515625,34.093509674072266,12049904.0,,-0.0009131817410830126,0.006766309944061611,0.1452892940549602,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-04,21.161283493041992,33.928911209106445,34.18177604675293,33.69513511657715,34.10305213928223,15674490.5,,-0.0009140164041743549,-0.0009135989455374681,0.14064601646395114,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-05,21.14194107055664,33.89789962768555,34.165077209472656,33.72614669799805,34.11259460449219,19299077.0,,-0.0009148525944530865,-0.0009144343718735032,0.12624219617895735,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-06,21.12259864807129,33.86688804626465,34.14837837219238,33.757158279418945,34.12213706970215,22923663.5,,-0.0009156903161144994,-0.0009152713274933932,0.08079438581736455,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-07,21.103256225585938,33.83587646484375,34.13167953491211,33.788169860839844,34.13167953491211,26548250.0,,0.009870266448038935,-0.0009161098165999112,0.05453085375683254,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-09-08,21.31155204772949,34.16984558105469,34.35114669799805,33.72137451171875,33.73091506958008,23207750.0,Goldman Sachs: Buy MRK Puts As Hedge,0.007539894299921183,0.009821873541533386,0.076223202811016,"[{'label': 'neutral', 'score': 0.8226322531700134}, {'label': 'negative', 'score': 0.11339762806892395}, {'label': 'positive', 'score': 0.06397013366222382}]","(0.8226322531700134, 0.06397013366222382, 0.11339762806892395)",-0.27867236934309303,-0.11339762806892395,1,1,"[{'label': 'neutral', 'score': 0.9323411583900452}, {'label': 'positive', 'score': 0.05491191893815994}, {'label': 'negative', 'score': 0.012746945954859257}]","(0.9323411583900452, 0.05491191893815994, 0.012746945954859257)",0.6231995326846094,0.05491191893815994,0,1,"[{'label': 'neutral', 'score': 0.9985814094543457}, {'label': 'positive', 'score': 0.0012460389407351613}, {'label': 'negative', 'score': 0.00017264568305108696}]","(0.9985814094543457, 0.0012460389407351613, 0.00017264568305108696)",0.7566116102811877,0.0012460389407351613,0,1
2010-09-09,21.47223663330078,34.42748260498047,34.57061004638672,34.15076446533203,34.34160232543945,12119596.0,Top 10 'Buy'-Rated Stocks Under $5,0.015798189864152275,0.007511611374768847,0.084316897721184,"[{'label': 'neutral', 'score': 0.9998821020126343}, {'label': 'negative', 'score': 6.64854742353782e-05}, {'label': 'positive', 'score': 5.142476948094554e-05}]","(0.9998821020126343, 5.142476948094554e-05, 6.64854742353782e-05)",-0.12773024870228156,-6.64854742353782e-05,0,0,"[{'label': 'neutral', 'score': 0.7744309902191162}, {'label': 'positive', 'score': 0.12456455081701279}, {'label': 'negative', 'score': 0.1010044515132904}]","(0.7744309902191162, 0.12456455081701279, 0.1010044515132904)",0.10444741547077939,0.12456455081701279,0,0,"[{'label': 'neutral', 'score': 0.9955394864082336}, {'label': 'positive', 'score': 0.00430265860632062}, {'label': 'negative', 'score': 0.00015779363457113504}]","(0.9955394864082336, 0.00430265860632062, 0.00015779363457113504)",0.929247696848072,0.00430265860632062,1,0
2010-09-10,21.81146049499512,34.97137451171875,35.02862548828125,34.46564865112305,34.48473358154297,11760656.0,,-0.003910865471376387,0.015674697402864996,0.11388453054839032,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-11,21.801437377929688,34.8346061706543,35.0,34.42748133341471,34.63740539550781,11658161.666666666,,-0.0039262203911370995,-0.003918532903135528,0.1270045293622257,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-12,21.791414260864254,34.697837829589844,34.97137451171875,34.38931401570638,34.790077209472656,11555667.333333334,,-0.003941696359760462,-0.003933948228510793,0.1381307128618826,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-13,21.781391143798828,34.56106948852539,34.9427490234375,34.35114669799805,34.9427490234375,11453173.0,SurModics Stays Neutral - Analyst Blog,0.00828269210837973,-0.003949485319403342,0.14256799030594955,"[{'label': 'negative', 'score': 0.874089777469635}, {'label': 'neutral', 'score': 0.12474885582923889}, {'label': 'positive', 'score': 0.0011614164104685187}]","(0.12474885582923889, 0.0011614164104685187, 0.874089777469635)",-0.9973460957983507,-0.874089777469635,0,0,"[{'label': 'neutral', 'score': 0.9268076419830322}, {'label': 'negative', 'score': 0.042965248227119446}, {'label': 'positive', 'score': 0.030227117240428925}]","(0.9268076419830322, 0.030227117240428925, 0.042965248227119446)",-0.17403633432694948,-0.042965248227119446,1,1,"[{'label': 'neutral', 'score': 0.9994644522666931}, {'label': 'positive', 'score': 0.00037685767165385187}, {'label': 'negative', 'score': 0.00015870486095082015}]","(0.9994644522666931, 0.00037685767165385187, 0.00015870486095082015)",0.4073339664783127,0.00037685767165385187,1,1
2010-09-14,21.96179962158203,34.84732818603516,35.01908493041992,34.40839767456055,34.446563720703125,13468058.0,,-0.0002737816170698144,0.00824857885105973,0.14435751593008458,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-15,21.955787658691406,34.83778762817383,35.181297302246094,34.58015441894531,34.84732818603516,12042882.0,,-0.0021911812482801837,-0.0002738191020986993,0.08385505399455172,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-16,21.907678604125977,34.761451721191406,34.933204650878906,34.54198455810547,34.818702697753906,9526006.0,Unconfirmed Chatter that Merck & Co. Inc. (MRK) will buy Medicines Co. (MDCO) at $23.00 a share | Jefferies Initiates Hold Rating on Merck (MRK),-0.002745018768711922,-0.0021935853985062467,0.08059980680732319,"[{'label': 'neutral', 'score': 0.9997664093971252}, {'label': 'positive', 'score': 0.00014529279724229127}, {'label': 'negative', 'score': 8.828966383589432e-05}]","(0.9997664093971252, 0.00014529279724229127, 8.828966383589432e-05)",0.24403858553111424,0.00014529279724229127,1,1,"[{'label': 'neutral', 'score': 0.8859436511993408}, {'label': 'positive', 'score': 0.1007295474410057}, {'label': 'negative', 'score': 0.013326835818588734}]","(0.8859436511993408, 0.1007295474410057, 0.013326835818588734)",0.7663114428544239,0.1007295474410057,0,1,"[{'label': 'positive', 'score': 0.9904133677482605}, {'label': 'neutral', 'score': 0.00918359961360693}, {'label': 'negative', 'score': 0.00040303272544406354}]","(0.00918359961360693, 0.9904133677482605, 0.00040303272544406354)",0.9991864633543583,0.9904133677482605,0,0
2010-09-17,21.84754753112793,34.66603088378906,35.152671813964844,34.50381851196289,34.828243255615234,17186571.0,,0.001926787574246673,-0.0027487932416472858,0.07773320752963941,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-18,21.88964335123698,34.7328249613444,35.08905792236328,34.52608235677084,34.783714294433594,15134028.0,J&J Makes a Pitch for Crucell - Analyst Blog,0.001923082203353202,0.0019249337000343386,0.07066923993614048,"[{'label': 'neutral', 'score': 0.9997327923774719}, {'label': 'positive', 'score': 0.00019550234719645232}, {'label': 'negative', 'score': 7.178876694524661e-05}]","(0.9997327923774719, 0.00019550234719645232, 7.178876694524661e-05)",0.4628420987673443,0.00019550234719645232,1,1,"[{'label': 'neutral', 'score': 0.9325788021087646}, {'label': 'positive', 'score': 0.050136417150497437}, {'label': 'negative', 'score': 0.01728474162518978}]","(0.9325788021087646, 0.050136417150497437, 0.01728474162518978)",0.48726061850414704,0.050136417150497437,1,1,"[{'label': 'neutral', 'score': 0.9993959665298462}, {'label': 'positive', 'score': 0.0004988131113350391}, {'label': 'negative', 'score': 0.00010514651512494311}]","(0.9993959665298462, 0.0004988131113350391, 0.00010514651512494311)",0.6518094570617461,0.0004988131113350391,0,1
2010-09-19,21.931739171346027,34.79961903889974,35.02544403076172,34.548346201578774,34.73918533325195,13081485.0,,0.0019193910565708308,0.0019212354480351876,0.03501739570876149,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-20,21.97383499145508,34.86641311645508,34.96183013916016,34.57061004638672,34.69465637207031,11028942.0,,0.00492613747823993,0.0019175513792209114,0.03831834548393542,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-21,22.082067489624023,35.038169860839844,35.24809265136719,34.70419692993164,34.86641311645508,12841039.0,"BMY's Diabetes Candidate Encourages - Analyst Blog | Zacks Analyst Blog Highlights: ProShares UltraShort 20+ Year ETF, Pfizer, Merck, Ford and CarMax  - Press Releases | Zacks Analyst Blog Highlights: Johnson & Johnson, Crucell NV, GlaxoSmithKline, Merck and Sanofi-Aventis    - Press Releases | Under The Hood: WisdomTree LargeCap Dividend Fund",0.006535949847175507,0.0049140437636183325,0.04362132552288689,"[{'label': 'neutral', 'score': 0.9998539686203003}, {'label': 'positive', 'score': 7.880484918132424e-05}, {'label': 'negative', 'score': 6.726478750351816e-05}]","(0.9998539686203003, 7.880484918132424e-05, 6.726478750351816e-05)",0.07900383638733037,7.880484918132424e-05,1,1,"[{'label': 'neutral', 'score': 0.9355920553207397}, {'label': 'positive', 'score': 0.045967116951942444}, {'label': 'negative', 'score': 0.01844080165028572}]","(0.9355920553207397, 0.045967116951942444, 0.01844080165028572)",0.42737470638749164,0.045967116951942444,1,1,"[{'label': 'neutral', 'score': 0.9990028738975525}, {'label': 'positive', 'score': 0.0008959662518464029}, {'label': 'negative', 'score': 0.00010125664266524836}]","(0.9990028738975525, 0.0008959662518464029, 0.00010125664266524836)",0.7969227477176312,0.0008959662518464029,0,1
2010-09-22,22.226396560668945,35.26717758178711,35.35305404663086,34.95228958129883,35.02862548828125,12992790.0,,-0.008116966875026162,0.00651468314208887,0.034182198058265195,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-09-23,22.04598999023437,34.98091506958008,35.29580307006836,34.84732818603516,34.99045944213867,11111525.0,Travelers Mad As Hell ,0.018548889170239988,-0.008150088805489588,0.0905854111050403,"[{'label': 'neutral', 'score': 0.9998817443847656}, {'label': 'negative', 'score': 7.292290683835745e-05}, {'label': 'positive', 'score': 4.5247692469274625e-05}]","(0.9998817443847656, 4.5247692469274625e-05, 7.292290683835745e-05)",-0.23419712289887162,-7.292290683835745e-05,0,0,"[{'label': 'neutral', 'score': 0.5082541108131409}, {'label': 'negative', 'score': 0.317807674407959}, {'label': 'positive', 'score': 0.17393818497657776}]","(0.5082541108131409, 0.17393818497657776, 0.317807674407959)",-0.29256878667254377,-0.317807674407959,0,0,"[{'label': 'neutral', 'score': 0.9993923902511597}, {'label': 'positive', 'score': 0.00037807165062986314}, {'label': 'negative', 'score': 0.00022953942243475467}]","(0.9993923902511597, 0.00037807165062986314, 0.00022953942243475467)",0.2444528001208965,0.00037807165062986314,0,0
2010-09-24,22.45491600036621,35.6297721862793,35.67748260498047,35.04771041870117,35.13358688354492,12195052.0,"The Rapid Growth Of Layoffs In Pharma, As Industry Despairs Of Its Future (BMY, ABT, PFE, MRK)",-0.0018746703516969994,0.018378956681688863,0.15129130967604124,"[{'label': 'neutral', 'score': 0.9668624401092529}, {'label': 'positive', 'score': 0.021354764699935913}, {'label': 'negative', 'score': 0.011782852001488209}]","(0.9668624401092529, 0.021354764699935913, 0.011782852001488209)",0.28885338329223725,0.021354764699935913,1,1,"[{'label': 'negative', 'score': 0.9637136459350586}, {'label': 'neutral', 'score': 0.026243336498737335}, {'label': 'positive', 'score': 0.010042998939752579}]","(0.026243336498737335, 0.010042998939752579, 0.9637136459350586)",-0.9793726718218313,-0.9637136459350586,0,0,"[{'label': 'negative', 'score': 0.9976589679718018}, {'label': 'neutral', 'score': 0.001656366977840662}, {'label': 'positive', 'score': 0.0006846928736194968}]","(0.001656366977840662, 0.0006846928736194968, 0.9976589679718018)",-0.998628342322443,-0.9976589679718018,0,0
2010-09-25,22.41282145182292,35.56297810872396,35.70610809326172,35.17493693033854,35.32124582926432,11994290.0,FDA Restricts Use of Glaxo Drug - Analyst Blog,-0.0018781913413195846,-0.0018764297453600172,0.15796152565988147,"[{'label': 'neutral', 'score': 0.99931800365448}, {'label': 'negative', 'score': 0.0005719875916838646}, {'label': 'positive', 'score': 0.00011002334213117138}]","(0.99931800365448, 0.00011002334213117138, 0.0005719875916838646)",-0.6773560754642971,-0.0005719875916838646,0,1,"[{'label': 'neutral', 'score': 0.6964224576950073}, {'label': 'negative', 'score': 0.28347837924957275}, {'label': 'positive', 'score': 0.020099174231290817}]","(0.6964224576950073, 0.020099174231290817, 0.28347837924957275)",-0.8675845825830611,-0.28347837924957275,0,1,"[{'label': 'neutral', 'score': 0.9990382194519043}, {'label': 'positive', 'score': 0.0004886839305981994}, {'label': 'negative', 'score': 0.00047316341078840196}]","(0.9990382194519043, 0.0004886839305981994, 0.00047316341078840196)",0.01613615710308352,0.0004886839305981994,1,1
2010-09-26,22.37072690327962,35.49618403116862,35.73473358154297,35.302163441975914,35.508904774983726,11793528.0,,-0.0018817255820142635,-0.001879957354296885,0.1626600788232831,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-27,22.328632354736328,35.42938995361328,35.76335906982422,35.42938995361328,35.696563720703125,11592766.0,,0.0032318353004360005,-0.0018834982517316413,0.16083490105033166,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-28,22.40080070495605,35.54389190673828,35.76335906982422,35.32442855834961,35.582061767578125,13333285.0,,-0.0034899477527410975,0.003226624145442472,0.13925736373319927,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-09-29,22.32261276245117,35.41984558105469,35.553436279296875,35.171756744384766,35.40076446533203,9904858.0,,-0.008351229389021119,-0.003496051826469872,0.040668090831643765,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-09-30,22.136194229125977,35.124046325683594,35.85877990722656,34.96183013916016,35.5057258605957,14353408.0,,-0.005704987142084796,-0.008386296276065977,0.06602633588106081,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-01,22.00990867614746,34.92366409301758,35.152671813964844,34.685115814208984,35.07633590698242,12305511.0,Merck Announces Pivotal Phase III Data for Boceprevir will be Presented at Liver Diseases Meeting  ,-0.0007285977284543779,-0.005721322740443769,0.06936064716010906,"[{'label': 'neutral', 'score': 0.9998849630355835}, {'label': 'negative', 'score': 5.8312591136200354e-05}, {'label': 'positive', 'score': 5.670183963957243e-05}]","(0.9998849630355835, 5.670183963957243e-05, 5.8312591136200354e-05)",-0.014004777363704726,-5.8312591136200354e-05,1,1,"[{'label': 'neutral', 'score': 0.846455991268158}, {'label': 'positive', 'score': 0.14284074306488037}, {'label': 'negative', 'score': 0.010703287087380886}]","(0.846455991268158, 0.14284074306488037, 0.010703287087380886)",0.8605834811452191,0.14284074306488037,0,1,"[{'label': 'neutral', 'score': 0.9991745352745056}, {'label': 'positive', 'score': 0.000709362851921469}, {'label': 'negative', 'score': 0.00011614304821705446}]","(0.9991745352745056, 0.000709362851921469, 0.00011614304821705446)",0.7186136448023808,0.000709362851921469,0,1
2010-10-02,21.99387232462565,34.8982187906901,35.124046325683594,34.66603215535482,34.990458170572914,11429732.333333334,,-0.0007291289701655873,-0.0007288632847762944,0.07125449259654013,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-03,21.97783597310384,34.87277348836263,35.095420837402344,34.64694849650065,34.904580434163414,10553953.666666666,Structured Notes: The Retail Broker's Own Little Synthetic CDO,-0.0007296609871297032,-0.000729394913972619,0.05245660709140653,"[{'label': 'neutral', 'score': 0.9998891353607178}, {'label': 'negative', 'score': 6.557381857419387e-05}, {'label': 'positive', 'score': 4.525488839135505e-05}]","(0.9998891353607178, 4.525488839135505e-05, 6.557381857419387e-05)",-0.18333634614319688,-6.557381857419387e-05,1,1,"[{'label': 'neutral', 'score': 0.9457916021347046}, {'label': 'positive', 'score': 0.03070036880671978}, {'label': 'negative', 'score': 0.023507995530962944}]","(0.9457916021347046, 0.03070036880671978, 0.023507995530962944)",0.13268013827078504,0.03070036880671978,1,1,"[{'label': 'neutral', 'score': 0.9995890259742737}, {'label': 'positive', 'score': 0.00025421931059099734}, {'label': 'negative', 'score': 0.00015682353114243597}]","(0.9995890259742737, 0.00025421931059099734, 0.00015682353114243597)",0.23694800045131018,0.00025421931059099734,1,1
2010-10-04,21.96179962158203,34.84732818603516,35.066795349121094,34.627864837646484,34.818702697753906,9678175.0,Male Menopause: Another Treatment for Pharmaceutical Companies | Merck to Appeal Reduced Jury Verdict in Federal FOSAMAX Case ,0.013691160761806721,-0.0007299273192704086,0.05698755005762204,"[{'label': 'positive', 'score': 0.9479687809944153}, {'label': 'neutral', 'score': 0.05135403946042061}, {'label': 'negative', 'score': 0.0006772149354219437}]","(0.05135403946042061, 0.9479687809944153, 0.0006772149354219437)",0.9985722494200628,0.9479687809944153,1,1,"[{'label': 'negative', 'score': 0.6818482875823975}, {'label': 'positive', 'score': 0.216765895485878}, {'label': 'neutral', 'score': 0.10138577222824097}]","(0.10138577222824097, 0.216765895485878, 0.6818482875823975)",-0.5175551430854538,-0.6818482875823975,0,0,"[{'label': 'positive', 'score': 0.9732055068016052}, {'label': 'negative', 'score': 0.019210554659366608}, {'label': 'neutral', 'score': 0.007584006059914827}]","(0.007584006059914827, 0.9732055068016052, 0.019210554659366608)",0.9612852806290014,0.9732055068016052,1,1
2010-10-05,22.26247978210449,35.32442855834961,35.4484748840332,35.01908493041992,35.171756744384766,11181322.0,10 Dow Dividend Stocks for Weary Investors | J&J-Galapagos in Anti-Cancer Deal - Analyst Blog,-0.00027019184592974127,0.013598283590954333,0.11577797551891456,"[{'label': 'neutral', 'score': 0.9981422424316406}, {'label': 'positive', 'score': 0.0015733686741441488}, {'label': 'negative', 'score': 0.0002843477705027908}]","(0.9981422424316406, 0.0015733686741441488, 0.0002843477705027908)",0.693873872600798,0.0015733686741441488,0,1,"[{'label': 'neutral', 'score': 0.8285005688667297}, {'label': 'positive', 'score': 0.16061443090438843}, {'label': 'negative', 'score': 0.010885044001042843}]","(0.8285005688667297, 0.16061443090438843, 0.010885044001042843)",0.8730603226972549,0.16061443090438843,0,1,"[{'label': 'neutral', 'score': 0.9990605711936951}, {'label': 'positive', 'score': 0.0008109405171126127}, {'label': 'negative', 'score': 0.00012846481695305556}]","(0.9990605711936951, 0.0008109405171126127, 0.00012846481695305556)",0.7264975782135056,0.0008109405171126127,0,1
2010-10-06,22.256471633911133,35.314884185791016,35.51526641845703,35.13358688354492,35.343509674072266,7903282.0,Goldman Buying Hedges on Merck (MRK),-0.008105893707700226,-0.00027022835432282197,0.10095084121061085,"[{'label': 'neutral', 'score': 0.9995092153549194}, {'label': 'positive', 'score': 0.000397086376324296}, {'label': 'negative', 'score': 9.368133032694459e-05}]","(0.9995092153549194, 0.000397086376324296, 9.368133032694459e-05)",0.618225367898877,0.000397086376324296,0,1,"[{'label': 'neutral', 'score': 0.9270579218864441}, {'label': 'negative', 'score': 0.04459943622350693}, {'label': 'positive', 'score': 0.02834259159862995}]","(0.9270579218864441, 0.02834259159862995, 0.04459943622350693)",-0.22287349433879122,-0.04459943622350693,1,1,"[{'label': 'neutral', 'score': 0.9989033937454224}, {'label': 'positive', 'score': 0.0008194462861865759}, {'label': 'negative', 'score': 0.0002771547588054091}]","(0.9989033937454224, 0.0008194462861865759, 0.0002771547588054091)",0.49452034525931937,0.0008194462861865759,1,1
2010-10-07,22.076059341430664,35.02862548828125,35.67748260498047,34.95228958129883,35.639312744140625,14564894.0,,0.005448163384787484,-0.008138925084418252,0.1253761955561433,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-08,22.19633674621582,35.21946716308594,35.29580307006836,34.933204650878906,35.13358688354492,9097478.0,,-0.0004515534782723601,0.0054333758283549045,0.1284046015698789,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-09,22.18631362915039,35.20356369018555,35.29898325602213,34.95228958129883,35.14631017049154,8012938.0,,-0.0004517574709294921,-0.00045165545924534924,0.1280495229222421,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-10,22.17629051208496,35.18766021728516,35.302163441975914,34.97137451171875,35.15903345743815,6928398.0,,-0.00045196164798094474,-0.000451859544078481,0.07664078790544988,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-11,22.16626739501953,35.171756744384766,35.30534362792969,34.99045944213867,35.171756744384766,5843858.0,,-0.005968613019539248,-0.00045206381343091784,0.07657605484034022,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-12,22.03396224975586,34.96183013916016,35.13358688354492,34.656490325927734,34.99045944213867,11570339.0,Highest Yielding Dow Jones Industrial Average Stocks,0.014192200487199295,-0.005986496384992918,0.06411199455137324,"[{'label': 'neutral', 'score': 0.9998764991760254}, {'label': 'negative', 'score': 7.85419179010205e-05}, {'label': 'positive', 'score': 4.498439739109017e-05}]","(0.9998764991760254, 4.498439739109017e-05, 7.85419179010205e-05)",-0.27166292810219983,-7.85419179010205e-05,0,0,"[{'label': 'positive', 'score': 0.5436936616897583}, {'label': 'neutral', 'score': 0.4140656590461731}, {'label': 'negative', 'score': 0.04224066436290741}]","(0.4140656590461731, 0.5436936616897583, 0.04224066436290741)",0.8558177512914282,0.5436936616897583,1,1,"[{'label': 'neutral', 'score': 0.9769974946975708}, {'label': 'positive', 'score': 0.0225679911673069}, {'label': 'negative', 'score': 0.0004344917251728475}]","(0.9769974946975708, 0.0225679911673069, 0.0004344917251728475)",0.9622221890390018,0.0225679911673069,1,0
2010-10-13,22.34667587280273,35.45801544189453,35.67748260498047,35.095420837402344,35.171756744384766,10230890.0,,-0.00026906632371917006,0.0140924340388179,0.11930563948371295,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-14,22.340660095214844,35.4484748840332,35.667938232421875,35.152671813964844,35.5629768371582,10002531.0,,-0.005383635697417262,-0.0002691025285569076,0.1191388789929439,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-15,22.220386505126957,35.25763320922852,35.725189208984375,35.07633590698242,35.5629768371582,15746619.0,,0.0025259549726588254,-0.005398179687259963,0.12873595793250994,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-16,22.276512781778973,35.346692403157554,35.66157658894857,35.124046325683594,35.448473612467446,14201063.666666666,,0.0025195906002530516,0.002522770110481774,0.1292307836490776,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-17,22.33263905843099,35.435751597086586,35.59796396891276,35.171756744384766,35.333970387776695,12655508.333333334,,0.002513258218469987,0.0025164217535381347,0.11343568731033629,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-18,22.388765335083008,35.524810791015625,35.53435134887695,35.21946716308594,35.21946716308594,11109953.0,"CPI Tame in September - Analyst Blog | Zacks Analyst Blog Highlights: KR,TBT,PFE,MRK,GCI - Press Releases | Citigroup Expects Big Things From Merck's New Osteoporosis Medication",-0.019070688622831452,0.0025101052667165745,0.05470474952006641,"[{'label': 'positive', 'score': 0.9901250600814819}, {'label': 'neutral', 'score': 0.009280156344175339}, {'label': 'negative', 'score': 0.0005947345634922385}]","(0.009280156344175339, 0.9901250600814819, 0.0005947345634922385)",0.9987993889559754,0.9901250600814819,0,0,"[{'label': 'positive', 'score': 0.5609727501869202}, {'label': 'neutral', 'score': 0.4125829041004181}, {'label': 'negative', 'score': 0.026444297283887863}]","(0.4125829041004181, 0.5609727501869202, 0.026444297283887863)",0.9099641476264714,0.5609727501869202,0,0,"[{'label': 'neutral', 'score': 0.9286600947380066}, {'label': 'positive', 'score': 0.07101442664861679}, {'label': 'negative', 'score': 0.0003254515177104622}]","(0.9286600947380066, 0.07101442664861679, 0.0003254515177104622)",0.9908760282165977,0.07101442664861679,0,0
2010-10-19,21.96179962158203,34.84732818603516,35.35305404663086,34.64694595336914,35.30534362792969,10869961.0,,0.012869706441738606,-0.019254879732558156,0.15067834522104548,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-20,22.244434356689453,35.29580307006836,35.54389190673828,34.89503860473633,34.933204650878906,10133426.0,Viagra Treatment for Muscular Dystrophy,0.002973764191037249,0.012787595515060665,0.186658194946347,"[{'label': 'neutral', 'score': 0.9997424483299255}, {'label': 'negative', 'score': 0.00014860955707263201}, {'label': 'positive', 'score': 0.00010895041486946866}]","(0.9997424483299255, 0.00010895041486946866, 0.00014860955707263201)",-0.15398022411680767,-0.00014860955707263201,1,1,"[{'label': 'neutral', 'score': 0.7453840970993042}, {'label': 'positive', 'score': 0.1652168333530426}, {'label': 'negative', 'score': 0.08939899504184723}]","(0.7453840970993042, 0.1652168333530426, 0.08939899504184723)",0.29777346832345264,0.1652168333530426,1,1,"[{'label': 'neutral', 'score': 0.9977128505706787}, {'label': 'positive', 'score': 0.0020764165092259645}, {'label': 'negative', 'score': 0.0002107962209265679}]","(0.9977128505706787, 0.0020764165092259645, 0.0002107962209265679)",0.8156741450870553,0.0020764165092259645,0,1
2010-10-21,22.31059455871582,35.40076446533203,35.4484748840332,34.904579162597656,35.40076446533203,10870904.0,,0.0,0.002969351300737462,0.18703237895436964,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-22,22.31059455871582,35.40076446533203,35.4484748840332,35.25763320922852,35.37213516235352,6634469.0,,0.0028751133159729513,0.0,0.18600891637496816,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-23,22.374739329020183,35.50254567464193,35.61704889933268,35.36577606201172,35.445290883382164,8145475.333333333,,0.002866870737739503,0.002870988082800156,0.1863571893448995,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-24,22.438884099324543,35.60432688395182,35.785622914632164,35.47391891479492,35.518446604410805,9656481.666666666,,0.0028586752852158186,0.0028627691011972522,0.07793380796112485,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-25,22.503028869628903,35.70610809326172,35.95419692993164,35.582061767578125,35.59160232543945,11167488.0,"Stock Market News for October 25, 2010 - Market News | Citi Says Merger Should Help Merck (MRK)",-0.009353383741400306,0.0028545970434199304,0.020526173758797405,"[{'label': 'positive', 'score': 0.9682528972625732}, {'label': 'neutral', 'score': 0.031042585149407387}, {'label': 'negative', 'score': 0.000704555946867913}]","(0.031042585149407387, 0.9682528972625732, 0.000704555946867913)",0.9985457443058325,0.9682528972625732,0,0,"[{'label': 'positive', 'score': 0.6526044011116028}, {'label': 'neutral', 'score': 0.3357982337474823}, {'label': 'negative', 'score': 0.011597330681979656}]","(0.3357982337474823, 0.6526044011116028, 0.011597330681979656)",0.9650788905633754,0.6526044011116028,0,0,"[{'label': 'positive', 'score': 0.9788686633110046}, {'label': 'neutral', 'score': 0.02071036398410797}, {'label': 'negative', 'score': 0.00042091700015589595}]","(0.02071036398410797, 0.9788686633110046, 0.00042091700015589595)",0.9991403625472618,0.9788686633110046,0,0
2010-10-26,22.29254913330078,35.37213516235352,35.6202278137207,35.200382232666016,35.60114669799805,7444363.0,,-0.01645526769049411,-0.009397401325692048,0.08428712827495968,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-10-27,21.925722122192383,34.790077209472656,35.19084167480469,34.475189208984375,35.19084167480469,12701131.0,"Merck In Talks To Acquire InterMune (MRK, ITMN)",0.013165117143511904,-0.016592159412035033,0.14367027132916066,"[{'label': 'neutral', 'score': 0.9998071789741516}, {'label': 'positive', 'score': 0.00013069897249806672}, {'label': 'negative', 'score': 6.211116851773113e-05}]","(0.9998071789741516, 0.00013069897249806672, 6.211116851773113e-05)",0.3557271605061264,0.00013069897249806672,1,1,"[{'label': 'neutral', 'score': 0.6854313611984253}, {'label': 'positive', 'score': 0.30227479338645935}, {'label': 'negative', 'score': 0.012293788604438305}]","(0.6854313611984253, 0.30227479338645935, 0.012293788604438305)",0.921837148982704,0.30227479338645935,0,1,"[{'label': 'positive', 'score': 0.8826128244400024}, {'label': 'neutral', 'score': 0.1169249638915062}, {'label': 'negative', 'score': 0.00046219758223742247}]","(0.1169249638915062, 0.8826128244400024, 0.00046219758223742247)",0.9989532087971892,0.8826128244400024,0,0
2010-10-28,22.21437644958496,35.24809265136719,35.36259460449219,34.98091506958008,34.99045944213867,10344074.0,,-0.01705472985287134,0.013079210151124907,0.18456001633245228,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-10-29,21.835508346557617,34.64694595336914,35.0572509765625,34.3702278137207,35.04771041870117,15961669.0,"Markets Yawn at Data, Earnings Deluge  | Stock Market News for October 29, 2010 - Market News | Company News for October 29, 2010 - Corporate Summary | News Summary | Merck Beats on EPS, Misses on Revs - Analyst Blog | US Stock Futures Down As Investors Await Q3 GDP Data | Earnings Scheduled For October 29 (CVX, POM, CEG, MRK, PGN, NEE, SNE, D, EL, ITT, CI, WY, EIX, LNT) | Stocks To Watch For October 29 (MSFT, MRK, EXPE, CVX, MXIM)",-0.0005508034930365504,-0.017201836735791634,0.20851474409596876,"[{'label': 'negative', 'score': 0.996726393699646}, {'label': 'neutral', 'score': 0.0024796074721962214}, {'label': 'positive', 'score': 0.0007939687347970903}]","(0.0024796074721962214, 0.0007939687347970903, 0.996726393699646)",-0.9984081152331379,-0.996726393699646,0,0,"[{'label': 'negative', 'score': 0.9383735060691833}, {'label': 'neutral', 'score': 0.050537604838609695}, {'label': 'positive', 'score': 0.011088864877820015}]","(0.050537604838609695, 0.011088864877820015, 0.9383735060691833)",-0.9766418023143774,-0.9383735060691833,0,0,"[{'label': 'negative', 'score': 0.996026873588562}, {'label': 'neutral', 'score': 0.0035531704779714346}, {'label': 'positive', 'score': 0.0004199478426016867}]","(0.0035531704779714346, 0.0004199478426016867, 0.996026873588562)",-0.999157109373888,-0.996026873588562,0,0
2010-10-30,21.823483149210613,34.627862294514976,35.054070790608726,34.357505798339844,34.95547103881836,14018292.666666666,"Steve Grasso's Health Care Trades (UNH, CI, AET, AGP, HS, PFE, MRK, WLP)",-0.0005511070447220255,-0.0005509552410053367,0.20124307782491616,"[{'label': 'neutral', 'score': 0.9998801946640015}, {'label': 'negative', 'score': 6.852089427411556e-05}, {'label': 'positive', 'score': 5.120738205732778e-05}]","(0.9998801946640015, 5.120738205732778e-05, 6.852089427411556e-05)",-0.1446067106892849,-6.852089427411556e-05,1,1,"[{'label': 'neutral', 'score': 0.9511977434158325}, {'label': 'positive', 'score': 0.03202930465340614}, {'label': 'negative', 'score': 0.01677296869456768}]","(0.9511977434158325, 0.03202930465340614, 0.01677296869456768)",0.31261527203981937,0.03202930465340614,1,1,"[{'label': 'neutral', 'score': 0.9995738863945007}, {'label': 'positive', 'score': 0.0002986772742588073}, {'label': 'negative', 'score': 0.0001273336965823546}]","(0.9995738863945007, 0.0002986772742588073, 0.0001273336965823546)",0.40220461303645183,0.0002986772742588073,1,1
2010-10-31,21.81145795186361,34.608778635660805,35.050890604654946,34.344783782958984,34.86323165893555,12074916.333333334,,-0.000551410931170525,-0.000551258960026386,0.20199957554905876,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-01,21.7994327545166,34.58969497680664,35.04771041870117,34.332061767578125,34.770992279052734,10131540.0,Citigroup Reiterates Buy Rating on Merck (MRK),0.009930983037075016,-0.0005515630140873694,0.17045836638005885,"[{'label': 'positive', 'score': 0.9992489218711853}, {'label': 'neutral', 'score': 0.00048198626609519124}, {'label': 'negative', 'score': 0.00026909721782431006}]","(0.00048198626609519124, 0.9992489218711853, 0.00026909721782431006)",0.9994615460398212,0.9992489218711853,0,0,"[{'label': 'neutral', 'score': 0.8711784482002258}, {'label': 'positive', 'score': 0.11008286476135254}, {'label': 'negative', 'score': 0.018738631159067154}]","(0.8711784482002258, 0.11008286476135254, 0.018738631159067154)",0.7090760198803612,0.11008286476135254,0,1,"[{'label': 'positive', 'score': 0.9984991550445557}, {'label': 'neutral', 'score': 0.0009565696236677468}, {'label': 'negative', 'score': 0.000544294249266386}]","(0.0009565696236677468, 0.9984991550445557, 0.000544294249266386)",0.9989103692143697,0.9984991550445557,0,0
2010-11-02,22.015914916992188,34.933204650878906,35.171756744384766,34.83778762817383,34.89503860473633,10462813.0,"Sectors To Benefit From Republican Victory: Oil Services, Healthcare (MRK, PFE, DO, RIG)  | Zacks Analyst Blog Highlights: Monster Worldwide, Yahoo, Merck & Co., Johnson & Johnson and VeriSign     - Press Releases",-0.0027314133833031395,0.009881994891661104,0.15439203554066191,"[{'label': 'positive', 'score': 0.9987581968307495}, {'label': 'neutral', 'score': 0.0010436951415613294}, {'label': 'negative', 'score': 0.0001980955566978082}]","(0.0010436951415613294, 0.9987581968307495, 0.0001980955566978082)",0.9996033949468913,0.9987581968307495,0,0,"[{'label': 'neutral', 'score': 0.8784213662147522}, {'label': 'positive', 'score': 0.1070447713136673}, {'label': 'negative', 'score': 0.014533855952322483}]","(0.8784213662147522, 0.1070447713136673, 0.014533855952322483)",0.7609142942447391,0.1070447713136673,0,1,"[{'label': 'positive', 'score': 0.9843589067459106}, {'label': 'neutral', 'score': 0.015218309126794338}, {'label': 'negative', 'score': 0.00042275982559658587}]","(0.015218309126794338, 0.9843589067459106, 0.00042275982559658587)",0.9991414141023393,0.9843589067459106,0,0
2010-11-03,21.955787658691406,34.83778762817383,35.08587646484375,34.389312744140625,35.04771041870117,9966690.0,3 High Paying Dividend Stocks To Consider,0.0038345398097808085,-0.0027351504994623708,0.07937721176383035,"[{'label': 'neutral', 'score': 0.9736800193786621}, {'label': 'negative', 'score': 0.025634348392486572}, {'label': 'positive', 'score': 0.0006856709951534867}]","(0.9736800193786621, 0.0006856709951534867, 0.025634348392486572)",-0.9478973791732479,-0.025634348392486572,0,1,"[{'label': 'neutral', 'score': 0.8756800889968872}, {'label': 'positive', 'score': 0.09386280179023743}, {'label': 'negative', 'score': 0.030457131564617157}]","(0.8756800889968872, 0.09386280179023743, 0.030457131564617157)",0.5100201433074878,0.09386280179023743,0,1,"[{'label': 'neutral', 'score': 0.9991627931594849}, {'label': 'positive', 'score': 0.0007458882755599916}, {'label': 'negative', 'score': 9.129750105785206e-05}]","(0.9991627931594849, 0.0007458882755599916, 9.129750105785206e-05)",0.7818942853360795,0.0007458882755599916,0,1
2010-11-04,22.039979934692383,34.97137451171875,35.25763320922852,34.770992279052734,35.171756744384766,12430433.0,,-0.02592092357204815,0.0038272067020886313,0.07972980772078102,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-11-05,21.46868324279785,34.064884185791016,35.0572509765625,33.79771041870117,34.99045944213867,23583144.0,,-0.0007469657665265145,-0.026262791337420363,0.21876283872921634,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-06,21.45264434814453,34.03943888346354,34.7614491780599,33.845420837402344,34.66603215535482,20503491.33333333,,-0.0007475241414696359,-0.0007472448844577491,0.21861975516877186,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-07,21.43660545349121,34.01399358113607,34.46564737955729,33.89313125610352,34.34160486857096,17423838.666666668,,-0.0007480833518351728,-0.000747803676955684,0.18962688526646868,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-08,21.42056655883789,33.988548278808594,34.16984558105469,33.94084167480469,34.01717758178711,14344186.0,,-0.016002210576242546,-0.0007483633058138103,0.19185325926120894,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-09,21.077795028686523,33.44465637207031,34.10305404663086,33.377864837646484,33.921756744384766,22320933.0,Pharma & Biotech Industry Outlook - Nov. 2010 - Zacks Analyst Interviews | Pharma & Biotech Industry Outlook - Nov. 2010 - Industry Outlook | Merck Wins TEMODAR Patent Infringement Lawsuit ,-0.0025677185583364397,-0.016131628452978723,0.1866747083590608,"[{'label': 'neutral', 'score': 0.7566947937011719}, {'label': 'negative', 'score': 0.17527924478054047}, {'label': 'positive', 'score': 0.06802596896886826}]","(0.7566947937011719, 0.06802596896886826, 0.17527924478054047)",-0.44081782777633904,-0.17527924478054047,1,1,"[{'label': 'neutral', 'score': 0.6503324508666992}, {'label': 'negative', 'score': 0.290238618850708}, {'label': 'positive', 'score': 0.05942900478839874}]","(0.6503324508666992, 0.05942900478839874, 0.290238618850708)",-0.6600828857421719,-0.290238618850708,0,1,"[{'label': 'positive', 'score': 0.9881721138954163}, {'label': 'neutral', 'score': 0.00929308496415615}, {'label': 'negative', 'score': 0.0025347808841615915}]","(0.00929308496415615, 0.9881721138954163, 0.0025347808841615915)",0.9948828843373992,0.9881721138954163,0,0
2010-11-10,21.023670196533203,33.35877990722656,33.568702697753906,33.1870231628418,33.44465637207031,19982216.0,Rolls for Breakfast  11-10-2010,0.007150989318914622,-0.0025710208016661157,0.10671688007123006,"[{'label': 'neutral', 'score': 0.9998781681060791}, {'label': 'negative', 'score': 7.73924621171318e-05}, {'label': 'positive', 'score': 4.44099168817047e-05}]","(0.9998781681060791, 4.44099168817047e-05, 7.73924621171318e-05)",-0.27078736479968224,-7.73924621171318e-05,1,1,"[{'label': 'neutral', 'score': 0.9139304161071777}, {'label': 'negative', 'score': 0.04813835397362709}, {'label': 'positive', 'score': 0.037931229919195175}]","(0.9139304161071777, 0.037931229919195175, 0.04813835397362709)",-0.11859153481144148,-0.04813835397362709,1,1,"[{'label': 'neutral', 'score': 0.9995865225791931}, {'label': 'positive', 'score': 0.0002362128288950771}, {'label': 'negative', 'score': 0.0001773554686224088}]","(0.9995865225791931, 0.0002362128288950771, 0.0001773554686224088)",0.14231593820408775,0.0002362128288950771,1,1
2010-11-11,21.17401123046875,33.59732818603516,33.788169860839844,33.25381851196289,33.3015251159668,14792939.0,,-0.014200545045506581,0.0071255422373152875,0.13389046288199788,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-12,20.873329162597656,33.1202278137207,33.45419692993164,32.814884185791016,33.435115814208984,24896602.0,,-0.0016325609507530756,-0.014302337607651382,0.1549131185614171,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-13,20.839252471923828,33.06615702311198,33.42239125569662,32.85623296101888,33.330153147379555,21178333.0,,-0.001635230564317644,-0.001633895030557437,0.1533847653795044,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-14,20.80517578125,33.01208623250326,33.390585581461586,32.89758173624674,33.22519048055013,17460064.0,,-0.0016379089230503993,-0.0016365690131308753,0.12125911151307214,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-15,20.77109909057617,32.95801544189453,33.35877990722656,32.93893051147461,33.1202278137207,13741795.0,"Merck Plans New India Drug Launches | Lowe's Earnings Rise, But Sales, Outlook Miss Estimates | Week Ahead Market Report: 11/15/2010 | El Paso Pipeline Partners Acquires Assets from El Paso Corporation | EMC to Buy Isilon Systems | Caterpillar to Buy Bucyrus | Retail Sales Surprise to the Upside | Retail Sales Surprise to the Upside | Jefferies & Company Adjusts Merck Estimates | Stocks To Watch For November 15 (JWN, LOW, URBN, MRK, GYMB)",-0.012738800423067994,-0.0016392517623697997,0.12145517918739838,"[{'label': 'positive', 'score': 0.998305082321167}, {'label': 'negative', 'score': 0.0014206478372216225}, {'label': 'neutral', 'score': 0.00027430502814240754}]","(0.00027430502814240754, 0.998305082321167, 0.0014206478372216225)",0.9971579248300501,0.998305082321167,0,0,"[{'label': 'positive', 'score': 0.6403243541717529}, {'label': 'neutral', 'score': 0.18927226960659027}, {'label': 'negative', 'score': 0.170403391122818}]","(0.18927226960659027, 0.6403243541717529, 0.170403391122818)",0.5796285692408285,0.6403243541717529,0,0,"[{'label': 'positive', 'score': 0.9940904974937439}, {'label': 'neutral', 'score': 0.005293660797178745}, {'label': 'negative', 'score': 0.0006158445030450821}]","(0.005293660797178745, 0.9940904974937439, 0.0006158445030450821)",0.998761756154467,0.9940904974937439,0,0
2010-11-16,20.506502151489254,32.538169860839844,32.86259460449219,32.385494232177734,32.738548278808594,23091213.0,Goldman Sachs Adjusts MHS And ESRX Estimates,0.010850340798008274,-0.012820634664041401,0.10401801731715203,"[{'label': 'neutral', 'score': 0.9937731623649597}, {'label': 'positive', 'score': 0.005528036504983902}, {'label': 'negative', 'score': 0.0006988259265199304}]","(0.9937731623649597, 0.005528036504983902, 0.0006988259265199304)",0.7755447677840672,0.005528036504983902,0,1,"[{'label': 'neutral', 'score': 0.8838756084442139}, {'label': 'negative', 'score': 0.08435571938753128}, {'label': 'positive', 'score': 0.031768668442964554}]","(0.8838756084442139, 0.031768668442964554, 0.08435571938753128)",-0.45285104987013464,-0.08435571938753128,1,1,"[{'label': 'neutral', 'score': 0.9990214109420776}, {'label': 'positive', 'score': 0.0006013105157762766}, {'label': 'negative', 'score': 0.0003773275821004063}]","(0.9990214109420776, 0.0006013105157762766, 0.0003773275821004063)",0.22887207657441325,0.0006013105157762766,1,1
2010-11-17,20.729005813598636,32.89122009277344,34.01717758178711,32.87213516235352,33.21564865112305,20993746.0,"Consumer Price Index Tame - Analyst Blog | Merck Adding To Its List Of Late stage Revenue Generating Assets, Citigroup Reports | Consumer Price Index Tame - Analyst Blog",0.023788840852883172,0.010791898218180674,0.13263539245966285,"[{'label': 'neutral', 'score': 0.9998071789741516}, {'label': 'positive', 'score': 0.00013581718667410314}, {'label': 'negative', 'score': 5.6928944104583934e-05}]","(0.9998071789741516, 0.00013581718667410314, 5.6928944104583934e-05)",0.4092857389708094,0.00013581718667410314,0,0,"[{'label': 'neutral', 'score': 0.9342355132102966}, {'label': 'positive', 'score': 0.046771980822086334}, {'label': 'negative', 'score': 0.018992511555552483}]","(0.9342355132102966, 0.046771980822086334, 0.018992511555552483)",0.42240832799280303,0.046771980822086334,0,0,"[{'label': 'neutral', 'score': 0.9985598921775818}, {'label': 'positive', 'score': 0.0013356689596548676}, {'label': 'negative', 'score': 0.0001044114978867583}]","(0.9985598921775818, 0.0013356689596548676, 0.0001044114978867583)",0.8549921327798586,0.0013356689596548676,1,0
2010-11-18,21.222124099731445,33.67366409301758,33.72137451171875,33.25381851196289,33.53053283691406,16417654.0,Merck's Candidate Impresses - Analyst Blog | Merck's Candidate Impresses - Analyst Blog,0.0011334093621994399,0.023510295248482894,0.22062759851847605,"[{'label': 'neutral', 'score': 0.9998743534088135}, {'label': 'negative', 'score': 6.609332194784656e-05}, {'label': 'positive', 'score': 5.9526926634134725e-05}]","(0.9998743534088135, 5.9526926634134725e-05, 6.609332194784656e-05)",-0.052271790478320285,-6.609332194784656e-05,1,1,"[{'label': 'neutral', 'score': 0.9383436441421509}, {'label': 'positive', 'score': 0.03909105807542801}, {'label': 'negative', 'score': 0.02256527543067932}]","(0.9383436441421509, 0.03909105807542801, 0.02256527543067932)",0.2680305769903061,0.03909105807542801,1,1,"[{'label': 'neutral', 'score': 0.9991241097450256}, {'label': 'positive', 'score': 0.0006772074848413467}, {'label': 'negative', 'score': 0.0001986802089959383}]","(0.9991241097450256, 0.0006772074848413467, 0.0001986802089959383)",0.546334055395811,0.0006772074848413467,0,1
2010-11-19,21.246173858642575,33.71183013916016,33.74045944213867,33.32061004638672,33.683204650878906,16375105.0,,0.002453072114873318,0.0011327675387284046,0.21730503606352733,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-20,21.29829216003418,33.79452768961588,33.82951736450195,33.403307596842446,33.743638356526695,16002086.666666666,Study: Merck Drug Helps Kidney Patients,0.0024470692774660246,0.002450068244942971,0.21226908278078893,"[{'label': 'neutral', 'score': 0.9861636757850647}, {'label': 'positive', 'score': 0.01359395869076252}, {'label': 'negative', 'score': 0.0002424630947643891}]","(0.9861636757850647, 0.01359395869076252, 0.0002424630947643891)",0.964952919400302,0.01359395869076252,0,1,"[{'label': 'neutral', 'score': 0.6791576743125916}, {'label': 'positive', 'score': 0.3062622845172882}, {'label': 'negative', 'score': 0.014580054208636284}]","(0.6791576743125916, 0.3062622845172882, 0.014580054208636284)",0.9091139014474576,0.3062622845172882,0,1,"[{'label': 'neutral', 'score': 0.9697375297546387}, {'label': 'positive', 'score': 0.02986012026667595}, {'label': 'negative', 'score': 0.00040231889579445124}]","(0.9697375297546387, 0.02986012026667595, 0.00040231889579445124)",0.9734113371605959,0.02986012026667595,0,1
2010-11-21,21.35041046142578,33.87722524007162,33.918575286865234,33.48600514729818,33.80407206217448,15629068.333333334,,0.0024410957470598314,0.0024440800789657887,0.1500059439227166,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-22,21.402528762817383,33.959922790527344,34.00763320922852,33.568702697753906,33.864505767822266,15256050.0,Positive Data on Merck's Vytorin - Analyst Blog | Positive Data on Merck's Vytorin - Analyst Blog | Goldman Sachs Comments On Merck's SHARP Results | Merck Stabilizes After SHARP Results (MRK),-0.021916249456606595,0.0024381211127645326,0.15214984302848014,"[{'label': 'positive', 'score': 0.9992282390594482}, {'label': 'negative', 'score': 0.0005024777492508292}, {'label': 'neutral', 'score': 0.0002693206479307264}]","(0.0002693206479307264, 0.9992282390594482, 0.0005024777492508292)",0.9989947738109822,0.9992282390594482,0,0,"[{'label': 'positive', 'score': 0.4781900644302368}, {'label': 'negative', 'score': 0.38933065533638}, {'label': 'neutral', 'score': 0.13247926533222198}]","(0.13247926533222198, 0.4781900644302368, 0.38933065533638)",0.10242914903261567,0.4781900644302368,1,1,"[{'label': 'positive', 'score': 0.9979565143585205}, {'label': 'neutral', 'score': 0.0015203999355435371}, {'label': 'negative', 'score': 0.0005230982205830514}]","(0.0015203999355435371, 0.9979565143585205, 0.0005230982205830514)",0.998952210512878,0.9979565143585205,0,0
2010-11-23,20.9334716796875,33.21564865112305,33.75954055786133,33.1202278137207,33.72137451171875,19217176.0,Top 5 Wellington Positions | Vertex Files for Hep C Drug Approval,0.009767340742226937,-0.02215997811129721,0.17257975918632887,"[{'label': 'neutral', 'score': 0.9998549222946167}, {'label': 'positive', 'score': 7.938528869999573e-05}, {'label': 'negative', 'score': 6.570691766683012e-05}]","(0.9998549222946167, 7.938528869999573e-05, 6.570691766683012e-05)",0.09427364415827819,7.938528869999573e-05,1,1,"[{'label': 'neutral', 'score': 0.9339941740036011}, {'label': 'positive', 'score': 0.042775653302669525}, {'label': 'negative', 'score': 0.02323012426495552}]","(0.9339941740036011, 0.042775653302669525, 0.02323012426495552)",0.2961184574742564,0.042775653302669525,1,1,"[{'label': 'neutral', 'score': 0.9641223549842834}, {'label': 'positive', 'score': 0.03561023250222206}, {'label': 'negative', 'score': 0.00026743326452560723}]","(0.9641223549842834, 0.03561023250222206, 0.00026743326452560723)",0.9850919362332947,0.03561023250222206,0,1
2010-11-24,21.13792991638184,33.540077209472656,33.55915832519531,33.21564865112305,33.225189208984375,11182894.0,"Vertex Eyes Telaprevir Approval - Analyst Blog | Vertex Eyes Telaprevir Approval - Analyst Blog | Stock Market News for November 24, 2010 - Market News | Stock Market News for November 24, 2010 - Market News",-0.005120940638033377,0.009719948616453042,0.19413766776339317,"[{'label': 'neutral', 'score': 0.978894829750061}, {'label': 'positive', 'score': 0.020826544612646103}, {'label': 'negative', 'score': 0.0002786591066978872}]","(0.978894829750061, 0.020826544612646103, 0.0002786591066978872)",0.9735933269914394,0.020826544612646103,0,1,"[{'label': 'neutral', 'score': 0.9307597279548645}, {'label': 'negative', 'score': 0.05041565001010895}, {'label': 'positive', 'score': 0.018824605271220207}]","(0.9307597279548645, 0.018824605271220207, 0.05041565001010895)",-0.4562525746118582,-0.05041565001010895,1,1,"[{'label': 'neutral', 'score': 0.9988200068473816}, {'label': 'positive', 'score': 0.0009359120158478618}, {'label': 'negative', 'score': 0.00024411361664533615}]","(0.9988200068473816, 0.0009359120158478618, 0.00024411361664533615)",0.5862570948911259,0.0009359120158478618,0,1
2010-11-25,21.029688835144043,33.36832046508789,33.42557144165039,33.06774711608887,33.08205986022949,9319497.5,,-0.0051472996540077205,-0.005134097591080286,0.19305678732604337,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-26,20.92144775390625,33.196563720703125,33.29198455810547,32.91984558105469,32.93893051147461,7456101.0,,-0.0009581014017781599,-0.005160592635799053,0.1881793444803187,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-27,20.90139961242676,33.1647580464681,33.2442741394043,32.8530527750651,32.958014170328774,9626474.0,,-0.0009590202404150493,-0.0009585606743027891,0.18224205310227198,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-28,20.881351470947266,33.13295237223307,33.196563720703125,32.78625996907552,32.977097829182945,11796847.0,,-0.0009599408431129815,-0.000959480394547425,0.09658197341492865,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-11-29,20.861303329467773,33.10114669799805,33.14885330200195,32.71946716308594,32.99618148803711,13967220.0,,-0.006341973803502877,-0.0009604018813940865,0.03641305522526846,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-11-30,20.729005813598636,32.89122009277344,33.10114669799805,32.74809265136719,32.87213516235352,40543452.0,Merck Down Slightly On New CEO (MRK) | Merck Halts Isentress Study - Analyst Blog | News Summary | Bootstrap Like Spanx to Start a Business | Merck Names Kenneth Frazier as CEO | Merck Board Elects Kenneth C. Frazier as Next CEO | Merck Halts Isentress Study - Analyst Blog,0.017116325741953712,-0.006362169551916875,0.04229282086924231,"[{'label': 'negative', 'score': 0.9955610036849976}, {'label': 'neutral', 'score': 0.003975472413003445}, {'label': 'positive', 'score': 0.000463623262476176}]","(0.003975472413003445, 0.000463623262476176, 0.9955610036849976)",-0.9990690526118876,-0.9955610036849976,0,0,"[{'label': 'negative', 'score': 0.9055294990539551}, {'label': 'neutral', 'score': 0.08168542385101318}, {'label': 'positive', 'score': 0.0127850491553545}]","(0.08168542385101318, 0.0127850491553545, 0.9055294990539551)",-0.9721554032215105,-0.9055294990539551,0,0,"[{'label': 'negative', 'score': 0.8214355111122131}, {'label': 'neutral', 'score': 0.17597264051437378}, {'label': 'positive', 'score': 0.002591840922832489}]","(0.17597264051437378, 0.002591840922832489, 0.8214355111122131)",-0.9937093327874819,-0.8214355111122131,0,0
2010-12-01,21.08380699157715,33.45419692993164,33.511451721191406,33.082061767578125,33.15839767456055,34710598.0,SurModics Cut to Underperform - Analyst Blog | SurModics Cut to Underperform - Analyst Blog,0.004563607199557299,0.016971491785910137,0.14183436354281206,"[{'label': 'negative', 'score': 0.9971293807029724}, {'label': 'neutral', 'score': 0.0021931061055511236}, {'label': 'positive', 'score': 0.0006775527144782245}]","(0.0021931061055511236, 0.0006775527144782245, 0.9971293807029724)",-0.9986419162028517,-0.9971293807029724,0,0,"[{'label': 'negative', 'score': 0.931078314781189}, {'label': 'neutral', 'score': 0.04066773131489754}, {'label': 'positive', 'score': 0.028253965079784393}]","(0.04066773131489754, 0.028253965079784393, 0.931078314781189)",-0.9410966029749798,-0.931078314781189,0,0,"[{'label': 'neutral', 'score': 0.9922188520431519}, {'label': 'negative', 'score': 0.006645134650170803}, {'label': 'positive', 'score': 0.00113595777656883}]","(0.9922188520431519, 0.00113595777656883, 0.006645134650170803)",-0.7080210041805636,-0.006645134650170803,0,1
2010-12-02,21.180025100708008,33.606868743896484,33.74045944213867,33.406490325927734,33.549617767333984,39504255.0,"J&J, Merck Recall Mylanta, AlternaGel | A Peek Into The Market Before The Trading Starts | Merck to Acquire SmartCells, Inc; Transaction May Exceed $500M | Merck May Buy Biotech Firm SmartCells",0.0022714376505631943,0.004553225517517985,0.14109792998887347,"[{'label': 'neutral', 'score': 0.9995681643486023}, {'label': 'positive', 'score': 0.0003789108304772526}, {'label': 'negative', 'score': 5.2929135563317686e-05}]","(0.9995681643486023, 0.0003789108304772526, 5.2929135563317686e-05)",0.754866896417155,0.0003789108304772526,0,1,"[{'label': 'neutral', 'score': 0.7539355158805847}, {'label': 'positive', 'score': 0.23459979891777039}, {'label': 'negative', 'score': 0.011464633978903294}]","(0.7539355158805847, 0.23459979891777039, 0.011464633978903294)",0.9068160006390077,0.23459979891777039,0,1,"[{'label': 'neutral', 'score': 0.9866386651992798}, {'label': 'positive', 'score': 0.012703762389719486}, {'label': 'negative', 'score': 0.0006575573934242129}]","(0.9866386651992798, 0.012703762389719486, 0.0006575573934242129)",0.9015729876843798,0.012703762389719486,0,1
2010-12-03,21.22813606262207,33.683204650878906,33.70228958129883,33.41603088378906,33.67366409301758,11352774.0,CBST's Fast-Injection Cubicin OK'd - Analyst Blog | CBST's Fast-Injection Cubicin OK'd - Analyst Blog | Merck Strikes Deal with SmartCells  - Analyst Blog | Merck Strikes Deal with SmartCells  - Analyst Blog,-0.0004721484509927278,0.002268861835860631,0.13771807691989266,"[{'label': 'positive', 'score': 0.9957536458969116}, {'label': 'neutral', 'score': 0.003829746274277568}, {'label': 'negative', 'score': 0.00041658891132101417}]","(0.003829746274277568, 0.9957536458969116, 0.00041658891132101417)",0.9991636190346498,0.9957536458969116,0,0,"[{'label': 'neutral', 'score': 0.8193889260292053}, {'label': 'negative', 'score': 0.09381593018770218}, {'label': 'positive', 'score': 0.08679515868425369}]","(0.8193889260292053, 0.08679515868425369, 0.09381593018770218)",-0.038872317017178595,-0.09381593018770218,1,1,"[{'label': 'neutral', 'score': 0.9984564781188965}, {'label': 'positive', 'score': 0.0011891439789906144}, {'label': 'negative', 'score': 0.0003543607599567622}]","(0.9984564781188965, 0.0011891439789906144, 0.0003543607599567622)",0.5408361879103455,0.0011891439789906144,0,1
2010-12-04,21.218115488688152,33.66730117797852,33.711831410725914,33.42557271321615,33.67684427897135,11293876.666666666,,-0.0004723714804559401,-0.00047225994816949685,0.13680860721484306,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-05,21.20809491475423,33.651397705078125,33.72137324015299,33.43511454264323,33.68002446492513,11234979.333333334,,-0.0004725947207236129,-0.00047248308301038025,0.11500627314580451,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-06,21.198074340820312,33.635494232177734,33.73091506958008,33.44465637207031,33.683204650878906,11176082.0,ETFs For Biotech M&A Mania | Change at Pfizer's Helm - Analyst Blog | Change at Pfizer's Helm - Analyst Blog | Goldman Recommends Stocks For 2011 ,0.0034043135216583953,-0.00047270642880509883,0.03611868798379063,"[{'label': 'neutral', 'score': 0.9997335076332092}, {'label': 'positive', 'score': 0.00013552940799854696}, {'label': 'negative', 'score': 0.00013094795576762408}]","(0.9997335076332092, 0.00013552940799854696, 0.00013094795576762408)",0.017192650685868453,0.00013552940799854696,1,1,"[{'label': 'neutral', 'score': 0.9147943258285522}, {'label': 'negative', 'score': 0.046804286539554596}, {'label': 'positive', 'score': 0.03840140253305435}]","(0.9147943258285522, 0.03840140253305435, 0.046804286539554596)",-0.09861881404819854,-0.046804286539554596,1,1,"[{'label': 'neutral', 'score': 0.9991666078567505}, {'label': 'positive', 'score': 0.0007183807319961488}, {'label': 'negative', 'score': 0.00011503055429784581}]","(0.9991666078567505, 0.0007183807319961488, 0.00011503055429784581)",0.7239524921497942,0.0007183807319961488,0,1
2010-12-07,21.27023124694824,33.75,33.988548278808594,33.635494232177734,33.845420837402344,19084394.0,Positive Data on Roche's Drug - Analyst Blog | Positive Data on Roche's Drug - Analyst Blog,0.0008481626157407407,0.0033985319641553634,0.02943755021988615,"[{'label': 'positive', 'score': 0.9951759576797485}, {'label': 'neutral', 'score': 0.004388810135424137}, {'label': 'negative', 'score': 0.0004351575335022062}]","(0.004388810135424137, 0.9951759576797485, 0.0004351575335022062)",0.9991258483822592,0.9951759576797485,0,0,"[{'label': 'neutral', 'score': 0.9216413497924805}, {'label': 'positive', 'score': 0.05138672888278961}, {'label': 'negative', 'score': 0.02697189711034298}]","(0.9216413497924805, 0.05138672888278961, 0.02697189711034298)",0.3115780995775292,0.05138672888278961,1,1,"[{'label': 'neutral', 'score': 0.9986721277236938}, {'label': 'positive', 'score': 0.001114399405196309}, {'label': 'negative', 'score': 0.00021344920969568193}]","(0.9986721277236938, 0.001114399405196309, 0.00021344920969568193)",0.6785036979339032,0.001114399405196309,0,1
2010-12-08,21.288272857666016,33.77862548828125,33.902671813964844,33.58778762817383,33.72137451171875,8952750.0,,0.007627107542250226,0.0008478031290838643,0.02672626972868864,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-12-09,21.450639724731445,34.036258697509766,34.036258697509766,33.64503860473633,33.874046325683594,9241054.0,Best Stocks For Creating A Passive Income Stream,0.008971127838795858,0.007598168213287739,0.05423452677544812,"[{'label': 'neutral', 'score': 0.9998083710670471}, {'label': 'positive', 'score': 0.00012201125355204567}, {'label': 'negative', 'score': 6.966420187382028e-05}]","(0.9998083710670471, 0.00012201125355204567, 6.966420187382028e-05)",0.27310252928274165,0.00012201125355204567,0,0,"[{'label': 'neutral', 'score': 0.659267783164978}, {'label': 'positive', 'score': 0.33015966415405273}, {'label': 'negative', 'score': 0.01057254895567894}]","(0.659267783164978, 0.33015966415405273, 0.01057254895567894)",0.9379421812854889,0.33015966415405273,1,0,"[{'label': 'neutral', 'score': 0.9920029640197754}, {'label': 'positive', 'score': 0.007814398966729641}, {'label': 'negative', 'score': 0.00018266442930325866}]","(0.9920029640197754, 0.007814398966729641, 0.00018266442930325866)",0.9543171236096808,0.007814398966729641,1,0
2010-12-10,21.64307975769043,34.34160232543945,34.35114669799805,33.874046325683594,34.064884185791016,12588576.0,"Merck Closes on $2 Billion Notes Sale | Mad Money Lightning Round: Cramer Advises Investors To Buy BlackRock (LLY, DECK, CMI, OXPS, AXP, V, MRK, ABT, BLK) | 'Mad Money Lightning Round': Go for BlackRock",0.0010187973008072859,0.008931126332527262,0.06523422321648752,"[{'label': 'positive', 'score': 0.9917398691177368}, {'label': 'neutral', 'score': 0.00795667339116335}, {'label': 'negative', 'score': 0.0003034153487533331}]","(0.00795667339116335, 0.9917398691177368, 0.0003034153487533331)",0.9993883021970831,0.9917398691177368,0,0,"[{'label': 'neutral', 'score': 0.9177729487419128}, {'label': 'positive', 'score': 0.06676648557186127}, {'label': 'negative', 'score': 0.015460559166967869}]","(0.9177729487419128, 0.06676648557186127, 0.015460559166967869)",0.6239544004998855,0.06676648557186127,0,1,"[{'label': 'positive', 'score': 0.9948078989982605}, {'label': 'neutral', 'score': 0.0048781996592879295}, {'label': 'negative', 'score': 0.00031386344926431775}]","(0.0048781996592879295, 0.9948078989982605, 0.00031386344926431775)",0.9993691958891696,0.9948078989982605,0,0
2010-12-11,21.74234962463379,34.37658945719401,34.42430114746094,33.9376589457194,34.109414418538414,14965160.666666666,,0.0010177604092496805,0.001018278679054345,0.05929504337533068,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-12,21.84161949157715,34.41157658894857,34.49745559692383,34.00127156575521,34.153944651285805,17341745.333333332,,0.0010167256261600986,0.001017242842267316,0.06395164525447601,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-13,21.940889358520508,34.446563720703125,34.57061004638672,34.064884185791016,34.1984748840332,19718330.0,10 Best Dow Dividend Stocks for 2011,0.012465392980699803,0.0010162091107340629,0.06345745108786018,"[{'label': 'neutral', 'score': 0.9996058344841003}, {'label': 'positive', 'score': 0.0003065857745241374}, {'label': 'negative', 'score': 8.764299127506092e-05}]","(0.9996058344841003, 0.0003065857745241374, 8.764299127506092e-05)",0.5553698822693108,0.0003065857745241374,1,0,"[{'label': 'neutral', 'score': 0.8989360928535461}, {'label': 'positive', 'score': 0.07500260323286057}, {'label': 'negative', 'score': 0.02606135979294777}]","(0.8989360928535461, 0.07500260323286057, 0.02606135979294777)",0.4842600861339155,0.07500260323286057,0,0,"[{'label': 'neutral', 'score': 0.9449047446250916}, {'label': 'positive', 'score': 0.05474433675408363}, {'label': 'negative', 'score': 0.0003509722009766847}]","(0.9449047446250916, 0.05474433675408363, 0.0003509722009766847)",0.9872594524785054,0.05474433675408363,1,0
2010-12-14,22.21439552307129,34.875953674316406,35.07633590698242,34.45610809326172,34.54198455810547,17262866.0,,0.0030095634443100053,0.012388339642266993,0.08605582547577667,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-15,22.28124618530273,34.98091506958008,35.29580307006836,34.73282241821289,34.73282241821289,15964184.0,CPI: Inflation Still Tame - Analyst Blog | CPI: Inflation Still Tame - Analyst Blog,0.0049100129039828305,0.0030050437741327264,0.0783986787989794,"[{'label': 'neutral', 'score': 0.7448602318763733}, {'label': 'negative', 'score': 0.2542441487312317}, {'label': 'positive', 'score': 0.0008956171805039048}]","(0.7448602318763733, 0.0008956171805039048, 0.2542441487312317)",-0.9929793995279141,-0.2542441487312317,0,1,"[{'label': 'neutral', 'score': 0.7606552243232727}, {'label': 'negative', 'score': 0.21298326551914215}, {'label': 'positive', 'score': 0.02636147476732731}]","(0.7606552243232727, 0.02636147476732731, 0.21298326551914215)",-0.779719623370244,-0.21298326551914215,0,1,"[{'label': 'neutral', 'score': 0.9992838501930237}, {'label': 'positive', 'score': 0.0005514168296940625}, {'label': 'negative', 'score': 0.00016472449351567775}]","(0.9992838501930237, 0.0005514168296940625, 0.00016472449351567775)",0.5399665172863262,0.0005514168296940625,0,1
2010-12-16,22.39064216613769,35.152671813964844,35.19084167480469,34.73282241821289,34.91412353515625,10479476.0,,-0.009772044941206039,0.004897998103125633,0.07482917809317649,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-17,22.171838760375977,34.80915832519531,35.114505767822266,34.46564865112305,34.96183013916016,19634385.0,,0.00018275775052855226,-0.009820104723576743,0.1273839752169316,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-18,22.175893783569336,34.81551996866862,35.0731569925944,34.54516474405924,34.96819178263346,16834967.333333332,,0.00018272435623644385,0.00018274105236520963,0.12804782488436914,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-19,22.17994880676269,34.82188161214193,35.03180821736654,34.624680836995445,34.97455342610677,14035549.666666668,,0.0001826909741455988,0.00018270766417460442,0.09016399247655615,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-20,22.18400382995605,34.828243255615234,34.99045944213867,34.70419692993164,34.98091506958008,11236132.0,"World stock markets daily report (December 20, 2010)",-0.00876712688861957,0.0001826742881817848,0.08574388865977135,"[{'label': 'neutral', 'score': 0.9998725652694702}, {'label': 'negative', 'score': 8.462354890070856e-05}, {'label': 'positive', 'score': 4.279728455003351e-05}]","(0.9998725652694702, 4.279728455003351e-05, 8.462354890070856e-05)",-0.3282529490504715,-8.462354890070856e-05,1,1,"[{'label': 'neutral', 'score': 0.8696720600128174}, {'label': 'negative', 'score': 0.10305919498205185}, {'label': 'positive', 'score': 0.027268795296549797}]","(0.8696720600128174, 0.027268795296549797, 0.10305919498205185)",-0.5815358582871201,-0.10305919498205185,0,1,"[{'label': 'neutral', 'score': 0.9993544220924377}, {'label': 'positive', 'score': 0.00041649671038612723}, {'label': 'negative', 'score': 0.00022913569409865886}]","(0.9993544220924377, 0.00041649671038612723, 0.00022913569409865886)",0.29019766508928907,0.00041649671038612723,1,1
2010-12-21,21.989517211914062,34.52289962768555,35.00954055786133,34.50381851196289,34.99045944213867,10432002.0,,0.0011056389020473105,-0.008805784254094283,0.08275907706803877,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-22,22.013822555541992,34.56106948852539,34.713741302490234,34.446563720703125,34.57061004638672,9043297.0,FDA's Approves Gardasil to Prevent Anal Cancer ,0.0019326759880295501,0.0011050281335080576,0.06575526879425855,"[{'label': 'positive', 'score': 0.9982877373695374}, {'label': 'neutral', 'score': 0.0014556311070919037}, {'label': 'negative', 'score': 0.0002566697949077934}]","(0.0014556311070919037, 0.9982877373695374, 0.0002566697949077934)",0.9994859121075312,0.9982877373695374,0,0,"[{'label': 'neutral', 'score': 0.7381554245948792}, {'label': 'positive', 'score': 0.25266239047050476}, {'label': 'negative', 'score': 0.009182113222777843}]","(0.7381554245948792, 0.25266239047050476, 0.009182113222777843)",0.9298659082526818,0.25266239047050476,0,1,"[{'label': 'positive', 'score': 0.9970908164978027}, {'label': 'neutral', 'score': 0.0025749211199581623}, {'label': 'negative', 'score': 0.00033421089756302536}]","(0.0025749211199581623, 0.9970908164978027, 0.00033421089756302536)",0.9993298525936616,0.9970908164978027,0,0
2010-12-23,22.056373596191406,34.627864837646484,34.904579162597656,34.56106948852539,34.58969497680664,7592865.0,"5 Best & Worst Performers In The Dow (AA, MRK, BAC, DIS, TRV)",-0.00041335779384757035,0.0019308107726435787,0.06952048771272396,"[{'label': 'neutral', 'score': 0.9996554851531982}, {'label': 'positive', 'score': 0.00022538604389410466}, {'label': 'negative', 'score': 0.00011911288311239332}]","(0.9996554851531982, 0.00022538604389410466, 0.00011911288311239332)",0.3084861880562746,0.00022538604389410466,1,1,"[{'label': 'neutral', 'score': 0.7345394492149353}, {'label': 'negative', 'score': 0.17596176266670227}, {'label': 'positive', 'score': 0.08949883282184601}]","(0.7345394492149353, 0.08949883282184601, 0.17596176266670227)",-0.3257090932299449,-0.17596176266670227,1,1,"[{'label': 'neutral', 'score': 0.9884499311447144}, {'label': 'negative', 'score': 0.009067783132195473}, {'label': 'positive', 'score': 0.0024823108687996864}]","(0.9884499311447144, 0.0024823108687996864, 0.009067783132195473)",-0.5701661183734418,-0.009067783132195473,0,1
2010-12-24,22.04725694656372,34.61355113983154,34.84971332550049,34.52051544189453,34.56345462799072,6831676.25,,-0.000413528729170753,-0.0004134432497304618,0.0689644350702198,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-25,22.038140296936035,34.5992374420166,34.79484748840332,34.47996139526367,34.537214279174805,6070487.5,,-0.00041369980592575567,-0.0004136142557549796,0.06833827052832966,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-26,22.02902364730835,34.58492374420166,34.73998165130615,34.43940734863281,34.51097393035889,5309298.75,,-0.00041387102428818193,-0.0004137854032990302,0.017422129047143096,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-27,22.019906997680664,34.57061004638672,34.685115814208984,34.39885330200195,34.48473358154297,4548110.0,,-0.0008280295963201235,-0.0004139566925383962,0.016644374909548672,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-28,22.00167465209961,34.54198455810547,34.770992279052734,34.446563720703125,34.70419692993164,5679846.0,,0.00027620178699574397,-0.0008283726021853799,0.0029438857127705807,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2010-12-29,22.007747650146484,34.5515251159668,34.685115814208984,34.51335906982422,34.58969497680664,5243144.0,,-0.005523283254991043,0.0002761636503042724,0.0063137224854325534,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2010-12-30,21.88619041442871,34.360687255859375,34.54198455810547,34.32251739501953,34.45610809326172,5359158.0,"XOMA Shares Climb 8.6% (XOMA, NVG, MRK)",0.0008330883508847345,-0.005538592983282969,0.03740443692723624,"[{'label': 'positive', 'score': 0.9734910130500793}, {'label': 'neutral', 'score': 0.026089150458574295}, {'label': 'negative', 'score': 0.0004197909729555249}]","(0.026089150458574295, 0.9734910130500793, 0.0004197909729555249)",0.9991379272696813,0.9734910130500793,0,0,"[{'label': 'positive', 'score': 0.9371803998947144}, {'label': 'negative', 'score': 0.031594276428222656}, {'label': 'neutral', 'score': 0.031225407496094704}]","(0.031225407496094704, 0.9371803998947144, 0.031594276428222656)",0.934774768167679,0.9371803998947144,0,0,"[{'label': 'positive', 'score': 0.9986286163330078}, {'label': 'neutral', 'score': 0.0010724642779678106}, {'label': 'negative', 'score': 0.0002989975910168141}]","(0.0010724642779678106, 0.9986286163330078, 0.0002989975910168141)",0.9994013628478198,0.9986286163330078,0,0
2010-12-31,21.90442276000977,34.389312744140625,34.58969497680664,34.28435134887695,34.3129768371582,5755406.0,,0.0,0.0008327415253953186,0.04037008042469801,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-01,21.90442276000977,34.389312744140625,34.758270263671875,34.30343500773112,34.41793950398763,10669722.666666666,,0.0,0.0,0.040938458648849416,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-02,21.90442276000977,34.389312744140625,34.92684555053711,34.32251866658529,34.522902170817055,15584039.333333332,,0.0,0.0,0.041639434968283234,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-03,21.90442276000977,34.389312744140625,35.095420837402344,34.34160232543945,34.627864837646484,20498356.0,Cramer's 'Mad Money' Recap: Stellar Year for Stocks (Update 1),0.008601598766138743,0.0,0.041197684096468845,"[{'label': 'neutral', 'score': 0.793036699295044}, {'label': 'positive', 'score': 0.2048967033624649}, {'label': 'negative', 'score': 0.00206653936766088}]","(0.793036699295044, 0.2048967033624649, 0.00206653936766088)",0.980029889941804,0.2048967033624649,1,0,"[{'label': 'neutral', 'score': 0.909684956073761}, {'label': 'negative', 'score': 0.048428572714328766}, {'label': 'positive', 'score': 0.04188644513487816}]","(0.909684956073761, 0.04188644513487816, 0.048428572714328766)",-0.07243676340045206,-0.048428572714328766,0,0,"[{'label': 'positive', 'score': 0.9960669875144958}, {'label': 'neutral', 'score': 0.003483589505776763}, {'label': 'negative', 'score': 0.0004494770255405456}]","(0.003483589505776763, 0.9960669875144958, 0.0004494770255405456)",0.9990979034636462,0.9960669875144958,1,1
2011-01-04,22.09284210205078,34.685115814208984,34.73282241821289,34.20801544189453,34.58015441894531,14594553.0,,0.005777072189756497,0.008564815793218017,0.05960170142234733,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-05,22.220462799072266,34.885494232177734,34.904579162597656,34.35114669799805,34.389312744140625,15217274.0,'Mutts of the Dow' Have No Bite,0.013676182115671004,0.005760448900115899,0.06423597560506578,"[{'label': 'neutral', 'score': 0.9998387098312378}, {'label': 'negative', 'score': 0.00011153824743814766}, {'label': 'positive', 'score': 4.9728143494576216e-05}]","(0.9998387098312378, 4.9728143494576216e-05, 0.00011153824743814766)",-0.383279514014529,-0.00011153824743814766,0,0,"[{'label': 'neutral', 'score': 0.761084794998169}, {'label': 'negative', 'score': 0.18512406945228577}, {'label': 'positive', 'score': 0.0537911020219326}]","(0.761084794998169, 0.0537911020219326, 0.18512406945228577)",-0.5497054315134837,-0.18512406945228577,0,0,"[{'label': 'neutral', 'score': 0.9991865754127502}, {'label': 'negative', 'score': 0.00047437800094485283}, {'label': 'positive', 'score': 0.000339017336955294}]","(0.9991865754127502, 0.000339017336955294, 0.00047437800094485283)",-0.16641435926963208,-0.00047437800094485283,0,0
2011-01-06,22.52436637878418,35.36259460449219,35.43893051147461,34.885494232177734,34.885494232177734,12565834.0,"Enzon Pharm Upped to Neutral - Analyst Blog | Enzon Pharm Upped to Neutral - Analyst Blog | Goldman Sachs Healthcare CEO's Conference (BMY, MRK, CELG)",0.007825165057693062,0.013583507140905912,0.092314937536145,"[{'label': 'positive', 'score': 0.6542909741401672}, {'label': 'negative', 'score': 0.3373241424560547}, {'label': 'neutral', 'score': 0.008384892717003822}]","(0.008384892717003822, 0.6542909741401672, 0.3373241424560547)",0.3196470348012847,0.6542909741401672,1,0,"[{'label': 'neutral', 'score': 0.8759679198265076}, {'label': 'positive', 'score': 0.07559768855571747}, {'label': 'negative', 'score': 0.04843433201313019}]","(0.8759679198265076, 0.07559768855571747, 0.04843433201313019)",0.21900277378380248,0.07559768855571747,1,1,"[{'label': 'neutral', 'score': 0.9994101524353027}, {'label': 'positive', 'score': 0.0004443446814548224}, {'label': 'negative', 'score': 0.00014543299039360136}]","(0.9994101524353027, 0.0004443446814548224, 0.00014543299039360136)",0.5068209688650999,0.0004443446814548224,0,1
2011-01-07,22.700613021850582,35.639312744140625,35.639312744140625,35.171756744384766,35.46755599975586,13365668.0,Priority Review for Merck's HCV Drug - Analyst Blog | Priority Review for Merck's HCV Drug - Analyst Blog,-0.0013387019846227487,0.007794707242043621,0.07811656633933356,"[{'label': 'neutral', 'score': 0.9998383522033691}, {'label': 'negative', 'score': 8.4317522123456e-05}, {'label': 'positive', 'score': 7.734253449598327e-05}]","(0.9998383522033691, 7.734253449598327e-05, 8.4317522123456e-05)",-0.04314601747228388,-8.4317522123456e-05,1,1,"[{'label': 'neutral', 'score': 0.9401530623435974}, {'label': 'negative', 'score': 0.03908008709549904}, {'label': 'positive', 'score': 0.02076684683561325}]","(0.9401530623435974, 0.02076684683561325, 0.03908008709549904)",-0.3060013112946691,-0.03908008709549904,1,1,"[{'label': 'neutral', 'score': 0.9993758797645569}, {'label': 'positive', 'score': 0.0004592741606757045}, {'label': 'negative', 'score': 0.00016485439846292138}]","(0.9993758797645569, 0.0004592741606757045, 0.00016485439846292138)",0.47172935431623025,0.0004592741606757045,1,1
2011-01-08,22.670223871866863,35.59160232543945,35.72519048055013,35.26717631022135,35.49618275960287,12656591.333333334,,-0.0013404965099610134,-0.001339598846634525,0.0860111397019869,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-09,22.639834721883137,35.54389190673828,35.81106821695963,35.362595876057945,35.52480951944987,11947514.666666666,,-0.0013422958528671168,-0.0013413957791422882,0.10115258810494665,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-10,22.60944557189941,35.49618148803711,35.89694595336914,35.45801544189453,35.553436279296875,11238438.0,,-0.00672039269601385,-0.001343197538922094,0.10953259651748622,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-11,22.45749855041504,35.25763320922852,35.610687255859375,35.01908493041992,35.53435134887695,10725861.0,Merck Announces FDA Acceptance of New Drug Application for JANUMET   ,0.00541277611211658,-0.006743076220255245,0.08319263044913208,"[{'label': 'neutral', 'score': 0.9997274279594421}, {'label': 'positive', 'score': 0.00021745404228568077}, {'label': 'negative', 'score': 5.501739724422805e-05}]","(0.9997274279594421, 0.00021745404228568077, 5.501739724422805e-05)",0.5961602629681203,0.00021745404228568077,0,1,"[{'label': 'positive', 'score': 0.6634911298751831}, {'label': 'neutral', 'score': 0.32284942269325256}, {'label': 'negative', 'score': 0.013659406453371048}]","(0.32284942269325256, 0.6634911298751831, 0.013659406453371048)",0.9596562190515833,0.6634911298751831,0,0,"[{'label': 'positive', 'score': 0.8077170252799988}, {'label': 'neutral', 'score': 0.19180737435817719}, {'label': 'negative', 'score': 0.00047566444845870137}]","(0.19180737435817719, 0.8077170252799988, 0.00047566444845870137)",0.9988228934646303,0.8077170252799988,0,0
2011-01-12,22.57905960083008,35.4484748840332,35.53435134887695,35.229007720947266,35.49618148803711,13507567.0,,-0.06621803035854855,0.005398179687259902,0.06839041501651574,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-01-13,21.08391761779785,33.10114669799805,34.14122009277344,32.92938995361328,33.959922790527344,77860531.0,The Fed Takes Credit: Dave's Daily | Two Biggies Due to Report Earnings  01-13-2011 | Merck Pipeline Setback: Big Pharma Losers | Merck & Parexel Enter Pact - Analyst Blog | Merck & Parexel Enter Pact - Analyst Blog,-0.013260396389784941,-0.06851230521872209,0.4840870269855883,"[{'label': 'neutral', 'score': 0.9998350143432617}, {'label': 'negative', 'score': 0.0001081979789887555}, {'label': 'positive', 'score': 5.672859333571978e-05}]","(0.9998350143432617, 5.672859333571978e-05, 0.0001081979789887555)",-0.31207454885908403,-0.0001081979789887555,1,1,"[{'label': 'negative', 'score': 0.6599838137626648}, {'label': 'neutral', 'score': 0.3016544580459595}, {'label': 'positive', 'score': 0.03836176171898842}]","(0.3016544580459595, 0.03836176171898842, 0.6599838137626648)",-0.8901353053106119,-0.6599838137626648,0,0,"[{'label': 'neutral', 'score': 0.8783040046691895}, {'label': 'negative', 'score': 0.11533961445093155}, {'label': 'positive', 'score': 0.006356314290314913}]","(0.8783040046691895, 0.006356314290314913, 0.11533961445093155)",-0.8955377660360373,-0.11533961445093155,0,1
2011-01-14,20.804340362548828,32.66221237182617,33.15839767456055,32.5572509765625,33.04389190673828,43755467.0,"Merck's Blood Thinner in Trouble - Analyst Blog | Merck's Blood Thinner in Trouble - Analyst Blog | Stock Market News for Jan 14, 2011  - Market News | Stock Market News for Jan 14, 2011  - Market News | Merck: Analysts' Upgrades, Downgrades | Jefferies Cuts Price Target On Merck (MRK) | Jefferies Lowers PT On Merck & Co.",-0.0026292590820376485,-0.013349100486359131,0.47083536559316347,"[{'label': 'negative', 'score': 0.9886427521705627}, {'label': 'neutral', 'score': 0.010018379427492619}, {'label': 'positive', 'score': 0.001338795991614461}]","(0.010018379427492619, 0.001338795991614461, 0.9886427521705627)",-0.9972953112225176,-0.9886427521705627,0,0,"[{'label': 'negative', 'score': 0.9344404935836792}, {'label': 'neutral', 'score': 0.05247040092945099}, {'label': 'positive', 'score': 0.013089177198708057}]","(0.05247040092945099, 0.013089177198708057, 0.9344404935836792)",-0.9723719950892933,-0.9344404935836792,0,0,"[{'label': 'negative', 'score': 0.9845262765884399}, {'label': 'neutral', 'score': 0.014696878381073475}, {'label': 'positive', 'score': 0.0007768852519802749}]","(0.014696878381073475, 0.0007768852519802749, 0.9845262765884399)",-0.9984230533665818,-0.9845262765884399,0,0
2011-01-15,20.74963903427124,32.576334953308105,33.05105018615723,32.404579639434814,32.91030406951904,48268050.25,,-0.002636190309350488,-0.0026327216543626767,0.46823121623380143,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-16,20.69493770599365,32.49045753479004,32.943702697753906,32.25190830230713,32.776716232299805,52780633.5,,-0.002643158177323629,-0.0026396711778577117,0.47484628147035807,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-17,20.640236377716064,32.40458011627197,32.836355209350586,32.09923696517944,32.643128395080566,57293216.75,"Company News for January 17, 2011 - Corporate Summary | Company News for January 17, 2011 - Corporate Summary",-0.0026501629772682357,-0.002646657487412289,0.4546413239220234,"[{'label': 'neutral', 'score': 0.9998787641525269}, {'label': 'negative', 'score': 7.297694537555799e-05}, {'label': 'positive', 'score': 4.830501711694524e-05}]","(0.9998787641525269, 4.830501711694524e-05, 7.297694537555799e-05)",-0.20342619587919178,-7.297694537555799e-05,1,1,"[{'label': 'neutral', 'score': 0.8810840845108032}, {'label': 'negative', 'score': 0.10084393620491028}, {'label': 'positive', 'score': 0.018071964383125305}]","(0.8810840845108032, 0.018071964383125305, 0.10084393620491028)",-0.6960547026300102,-0.10084393620491028,0,1,"[{'label': 'neutral', 'score': 0.9995388984680176}, {'label': 'positive', 'score': 0.00032119217212311924}, {'label': 'negative', 'score': 0.00013987290731165558}]","(0.9995388984680176, 0.00032119217212311924, 0.00013987290731165558)",0.39326176043031735,0.00032119217212311924,1,1
2011-01-18,20.58553504943848,32.318702697753906,32.729007720947266,31.94656562805176,32.50954055786133,61805800.0,Ariad Pharmaceuticals Skyrocketing (ARIA) | Ariad Sarcoma Drug Delays Progression,0.0011809275421575199,-0.002653680875882344,0.07600457697484063,"[{'label': 'positive', 'score': 0.6083655953407288}, {'label': 'negative', 'score': 0.38853755593299866}, {'label': 'neutral', 'score': 0.0030969171784818172}]","(0.0030969171784818172, 0.6083655953407288, 0.38853755593299866)",0.22051092839546077,0.6083655953407288,1,0,"[{'label': 'negative', 'score': 0.9381883144378662}, {'label': 'neutral', 'score': 0.0489269457757473}, {'label': 'positive', 'score': 0.012884750962257385}]","(0.0489269457757473, 0.012884750962257385, 0.9381883144378662)",-0.9729048136657373,-0.9381883144378662,0,0,"[{'label': 'neutral', 'score': 0.8503542542457581}, {'label': 'negative', 'score': 0.12302406877279282}, {'label': 'positive', 'score': 0.02662157639861107}]","(0.8503542542457581, 0.02662157639861107, 0.12302406877279282)",-0.6442051304851704,-0.12302406877279282,0,1
2011-01-19,20.609846115112305,32.356868743896484,32.58587646484375,32.156490325927734,32.5572509765625,31174437.0,Merck Says Additional Information Provided to Investigators in Clinical Study of Vorapaxar (MRK) | Ariad Scores With SUCCEED - Analyst Blog | Ariad Scores With SUCCEED - Analyst Blog,0.004128665826707564,0.001180230795711668,0.02714382706119106,"[{'label': 'neutral', 'score': 0.999747097492218}, {'label': 'positive', 'score': 0.00019534317834768444}, {'label': 'negative', 'score': 5.752397919422947e-05}]","(0.999747097492218, 0.00019534317834768444, 5.752397919422947e-05)",0.5450260939110323,0.00019534317834768444,1,0,"[{'label': 'neutral', 'score': 0.9340962171554565}, {'label': 'positive', 'score': 0.05174550414085388}, {'label': 'negative', 'score': 0.014158269390463829}]","(0.9340962171554565, 0.05174550414085388, 0.014158269390463829)",0.5703350921556634,0.05174550414085388,1,0,"[{'label': 'neutral', 'score': 0.9991051554679871}, {'label': 'positive', 'score': 0.0007212505443021655}, {'label': 'negative', 'score': 0.0001734996767481789}]","(0.9991051554679871, 0.0007212505443021655, 0.0001734996767481789)",0.6121829921550437,0.0007212505443021655,1,0
2011-01-20,20.6949405670166,32.49045944213867,32.57633590698242,32.17557144165039,32.25190734863281,22645184.0,Bleeding Risk with MRK's Candidate  - Analyst Blog | Bleeding Risk with MRK's Candidate  - Analyst Blog | 4 Drug Stocks Poised to Stage Comeback,-0.004405331859292629,0.004120166272467887,0.04892200751226125,"[{'label': 'neutral', 'score': 0.9386136531829834}, {'label': 'positive', 'score': 0.05722449719905853}, {'label': 'negative', 'score': 0.0041618566028773785}]","(0.9386136531829834, 0.05722449719905853, 0.0041618566028773785)",0.8644045021372119,0.05722449719905853,0,1,"[{'label': 'positive', 'score': 0.5395421385765076}, {'label': 'neutral', 'score': 0.41714856028556824}, {'label': 'negative', 'score': 0.043309286236763}]","(0.41714856028556824, 0.5395421385765076, 0.043309286236763)",0.851388246153338,0.5395421385765076,0,0,"[{'label': 'positive', 'score': 0.9843922853469849}, {'label': 'neutral', 'score': 0.015196041204035282}, {'label': 'negative', 'score': 0.0004116961208637804}]","(0.015196041204035282, 0.9843922853469849, 0.0004116961208637804)",0.9991639024037045,0.9843922853469849,0,0
2011-01-21,20.603775024414062,32.34732818603516,32.652671813964844,32.328243255615234,32.614505767822266,21779850.0,"Priority Review for Vertex HCV Drug - Analyst Blog | Priority Review for Vertex HCV Drug - Analyst Blog | Deutsche Bank Lowers MRK Target To $43, Reiterates Buy Rating | Deutsche Bank Lowers PT On Merck & Co.",-0.0009832943734289592,-0.004415063926194916,0.054996560737532334,"[{'label': 'positive', 'score': 0.9990882873535156}, {'label': 'neutral', 'score': 0.0005243419436737895}, {'label': 'negative', 'score': 0.0003874262038152665}]","(0.0005243419436737895, 0.9990882873535156, 0.0003874262038152665)",0.9992247411346568,0.9990882873535156,0,0,"[{'label': 'negative', 'score': 0.8905392289161682}, {'label': 'neutral', 'score': 0.08460134267807007}, {'label': 'positive', 'score': 0.024859420955181122}]","(0.08460134267807007, 0.024859420955181122, 0.8905392289161682)",-0.9456861314823332,-0.8905392289161682,0,0,"[{'label': 'negative', 'score': 0.7886974215507507}, {'label': 'neutral', 'score': 0.19517894089221954}, {'label': 'positive', 'score': 0.01612355373799801}]","(0.19517894089221954, 0.01612355373799801, 0.7886974215507507)",-0.9599325707628003,-0.7886974215507507,0,0
2011-01-22,20.58351643880208,32.315521240234375,32.5795160929362,32.29325612386068,32.55407206217448,21378536.0,,-0.0009842621929050017,-0.0009837781244804538,0.05286265140078499,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-23,20.563257853190105,32.283714294433594,32.506360371907554,32.25826899210612,32.493638356526695,20977222.0,,-0.0009852319194345444,-0.0009847468970139502,0.049925509730761895,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-24,20.542999267578125,32.25190734863281,32.433204650878906,32.22328186035156,32.433204650878906,20575908.0,,-0.013017697729200662,-0.0009857175794201127,0.04845390399575808,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-01-25,20.275569915771484,31.832061767578125,32.299617767333984,31.76526641845703,32.22328186035156,34185760.0,Earnings Preview: Eli Lilly - Analyst Blog | Earnings Preview: Eli Lilly - Analyst Blog,-0.0047961647938351394,-0.013103170539405294,0.08334894792329989,"[{'label': 'neutral', 'score': 0.9998606443405151}, {'label': 'negative', 'score': 7.666365127079189e-05}, {'label': 'positive', 'score': 6.271867459872738e-05}]","(0.9998606443405151, 6.271867459872738e-05, 7.666365127079189e-05)",-0.10004838551136605,-7.666365127079189e-05,1,1,"[{'label': 'neutral', 'score': 0.8953309059143066}, {'label': 'negative', 'score': 0.08486145734786987}, {'label': 'positive', 'score': 0.019807584583759308}]","(0.8953309059143066, 0.019807584583759308, 0.08486145734786987)",-0.6215197116890052,-0.08486145734786987,0,1,"[{'label': 'neutral', 'score': 0.9995278120040894}, {'label': 'positive', 'score': 0.00033453479409217834}, {'label': 'negative', 'score': 0.0001376572618028149}]","(0.9995278120040894, 0.00033453479409217834, 0.0001376572618028149)",0.4169437622498786,0.00033453479409217834,1,1
2011-01-26,20.17833137512207,31.67938995361328,32.185115814208984,31.66030502319336,31.879770278930664,27418195.0,,0.0015059794845291058,-0.004807703300703779,0.0834905768065001,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-27,20.20871353149414,31.72709846496582,31.898855209350582,31.71755790710449,31.822519302368164,16217695.0,,-0.0054135059726873715,0.0015048466346483818,0.09101020558429496,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-28,20.099308013916016,31.555343627929688,31.994274139404297,31.488550186157227,31.95610618591309,16927191.0,Busy Earnings Week Ahead - Earnings Preview | AstraZeneca Revenues Disappoint - Analyst Blog | AstraZeneca Revenues Disappoint - Analyst Blog | Busy Earnings Week Ahead - Earnings Preview,0.0010079532136595287,-0.005428212094610765,0.08815666503285373,"[{'label': 'negative', 'score': 0.9925572872161865}, {'label': 'neutral', 'score': 0.006644828245043755}, {'label': 'positive', 'score': 0.0007978437351994216}]","(0.006644828245043755, 0.0007978437351994216, 0.9925572872161865)",-0.9983936384675735,-0.9925572872161865,0,0,"[{'label': 'negative', 'score': 0.6569243669509888}, {'label': 'neutral', 'score': 0.3195437788963318}, {'label': 'positive', 'score': 0.02353188395500183}]","(0.3195437788963318, 0.02353188395500183, 0.6569243669509888)",-0.930834983369848,-0.6569243669509888,0,0,"[{'label': 'neutral', 'score': 0.994309663772583}, {'label': 'positive', 'score': 0.0031942164059728384}, {'label': 'negative', 'score': 0.0024961361195892096}]","(0.994309663772583, 0.0031942164059728384, 0.0024961361195892096)",0.12267786279456878,0.0031942164059728384,1,1
2011-01-29,20.11957041422526,31.58714993794759,31.921119054158527,31.510814666748047,31.8924929300944,16230271.0,,0.0010069382669974645,0.0010074455699112046,0.09418314155719414,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-30,20.139832814534504,31.618956247965496,31.84796396891276,31.533079147338867,31.828879674275715,15533351.0,,0.001005925362256353,0.0010064316447237678,0.05490364399453736,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-01-31,20.16009521484375,31.6507625579834,31.774808883666992,31.555343627929688,31.76526641845703,14836431.0,,0.02502266616809634,0.0010054197583771864,0.046691905422137685,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-02-01,20.664554595947266,32.4427490234375,32.48091506958008,31.393129348754883,31.812976837158203,22434012.0,,-0.005294148910151973,0.024714725680603455,0.18509499781812164,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-02,20.555150985717773,32.270992279052734,32.47137451171875,32.06106948852539,32.34732818603516,14453492.0,,-0.027202849007765928,-0.005308212575212217,0.18469260199676374,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-03,19.99598693847656,31.393129348754883,31.574426651000977,31.02099227905273,31.479007720947266,42170367.0,"Merck Beats but Guides Lower - Analyst Blog | Merck Beats but Guides Lower - Analyst Blog | A Peek Into The Market Before The Trading Starts | Merck Reports Q4 EPS of $0.88 | US Stock Futures Mixed As Investors Await Earnings Reports, Economic Data; Merck Earnings In Focus | US Stock Futures Mixed As Investors Await Earnings Reports, Economic Data; Merck Earnings In Focus | Earnings Scheduled For February 3 (K, MA, CI, ITT, SUN, CAH, MRK, NYT, DOW, BX, LVS, DO, CSTR, CME, IP, GR, MCO, HOT)",-0.0003039059201565875,-0.02757969644204559,0.2963547641615833,"[{'label': 'negative', 'score': 0.9972840547561646}, {'label': 'neutral', 'score': 0.0016519504133611917}, {'label': 'positive', 'score': 0.0010640434920787811}]","(0.0016519504133611917, 0.0010640434920787811, 0.9972840547561646)",-0.9978683918085369,-0.9972840547561646,0,0,"[{'label': 'neutral', 'score': 0.8242671489715576}, {'label': 'negative', 'score': 0.1209784522652626}, {'label': 'positive', 'score': 0.054754361510276794}]","(0.8242671489715576, 0.054754361510276794, 0.1209784522652626)",-0.37684533316340535,-0.1209784522652626,1,1,"[{'label': 'neutral', 'score': 0.9775874018669128}, {'label': 'negative', 'score': 0.018625987693667412}, {'label': 'positive', 'score': 0.0037866102065891027}]","(0.9775874018669128, 0.0037866102065891027, 0.018625987693667412)",-0.6620998401487617,-0.018625987693667412,0,1
2011-02-04,19.98991203308105,31.383588790893555,31.603052139282227,31.27862548828125,31.383588790893555,26485894.0,Value In Valspar (VAL) | UBS Price Target Research Summary,0.0011148225267568538,-0.0003039521089190265,0.29587676593110224,"[{'label': 'neutral', 'score': 0.9998801946640015}, {'label': 'negative', 'score': 6.787797610741109e-05}, {'label': 'positive', 'score': 5.1933784561697394e-05}]","(0.9998801946640015, 5.1933784561697394e-05, 6.787797610741109e-05)",-0.1330770156174213,-6.787797610741109e-05,1,1,"[{'label': 'neutral', 'score': 0.9010266661643982}, {'label': 'positive', 'score': 0.08268745243549347}, {'label': 'negative', 'score': 0.016285892575979233}]","(0.9010266661643982, 0.08268745243549347, 0.016285892575979233)",0.6709034624606974,0.08268745243549347,0,1,"[{'label': 'neutral', 'score': 0.9995740056037903}, {'label': 'positive', 'score': 0.00029359813197515905}, {'label': 'negative', 'score': 0.00013235246296972036}]","(0.9995740056037903, 0.00029359813197515905, 0.00013235246296972036)",0.37855486274483274,0.00029359813197515905,1,1
2011-02-05,20.012198130289715,31.418575922648117,31.574426651000977,31.265902837117512,31.399491628011067,22715714.0,,0.0011135810814815084,0.001114201573582558,0.29593566876489674,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-06,20.03448422749837,31.453563054402668,31.545801162719727,31.253180185953777,31.415394465128585,18945534.0,,0.0011123423980311572,0.0011129615099884054,0.19436174412267768,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-07,20.05677032470703,31.488550186157227,31.51717567443848,31.24045753479004,31.431297302246094,15175354.0,,0.00818180601219862,0.0011117242036128062,0.20141851843879172,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-08,20.220870971679688,31.746183395385746,31.774808883666992,31.5362606048584,31.63167953491211,12437874.0,,-0.005410311603307052,0.008148516493046968,0.053358686986026506,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-09,20.11147117614746,31.574426651000977,31.76526641845703,31.412214279174805,31.70801544189453,14831610.0,,-0.0015109858329295442,-0.005425000343526501,0.07621188291035268,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-10,20.081079483032227,31.52671813964844,31.62213706970215,31.383588790893555,31.603052139282227,11355394.0,,0.000907975519508535,-0.0015121285232274678,0.0786664662814533,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-11,20.099308013916016,31.555343627929688,31.612594604492188,31.354961395263672,31.459924697875977,11196832.0,Two ETFs for the Recovery in Big Pharma,-0.0025199132564252586,0.0009075635590842781,0.07860992825211119,"[{'label': 'neutral', 'score': 0.9997615218162537}, {'label': 'positive', 'score': 0.000177901383722201}, {'label': 'negative', 'score': 6.0602687881328166e-05}]","(0.9997615218162537, 0.000177901383722201, 6.0602687881328166e-05)",0.4918100351589015,0.000177901383722201,1,1,"[{'label': 'positive', 'score': 0.8940171003341675}, {'label': 'neutral', 'score': 0.09465491771697998}, {'label': 'negative', 'score': 0.011328021995723248}]","(0.09465491771697998, 0.8940171003341675, 0.011328021995723248)",0.9749752404551079,0.8940171003341675,0,0,"[{'label': 'positive', 'score': 0.8295537829399109}, {'label': 'neutral', 'score': 0.1697017401456833}, {'label': 'negative', 'score': 0.0007444993825629354}]","(0.1697017401456833, 0.8295537829399109, 0.0007444993825629354)",0.9982066700644485,0.8295537829399109,0,0
2011-02-12,20.04866091410319,31.475826899210613,31.57760747273763,31.319974263509117,31.459924697875977,11804218.0,,-0.0025262792610247723,-0.002523093581721298,0.08143811644759943,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-13,19.998013814290363,31.39631017049153,31.542620340983078,31.28498713175456,31.459924697875977,12411604.0,,-0.002532677511697098,-0.002529475688991764,0.03614923828165692,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-14,19.94736671447754,31.31679344177246,31.50763320922852,31.25,31.459924697875977,13018990.0,Merck Wins First FOSAMAX State Court Trial  | Jefferies Raises PT On Merck & Company To $34.50,-0.0009140619180719627,-0.0025358901649423417,0.023652566495042583,"[{'label': 'positive', 'score': 0.999458372592926}, {'label': 'neutral', 'score': 0.0003119643952231854}, {'label': 'negative', 'score': 0.00022965879179537296}]","(0.0003119643952231854, 0.999458372592926, 0.00022965879179537296)",0.999540539079022,0.999458372592926,0,0,"[{'label': 'positive', 'score': 0.8593404293060303}, {'label': 'neutral', 'score': 0.12028004229068756}, {'label': 'negative', 'score': 0.020379506051540375}]","(0.12028004229068756, 0.8593404293060303, 0.020379506051540375)",0.953668195450733,0.8593404293060303,0,0,"[{'label': 'positive', 'score': 0.9990083575248718}, {'label': 'neutral', 'score': 0.0006854251259937882}, {'label': 'negative', 'score': 0.00030622200574725866}]","(0.0006854251259937882, 0.9990083575248718, 0.00030622200574725866)",0.9993871359189194,0.9990083575248718,0,0
2011-02-15,19.92913246154785,31.28816795349121,31.31679344177246,31.154579162597656,31.29771041870117,17764858.0,,0.005184524687285323,-0.000914479927410699,0.02422746598566941,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-02-16,20.032451629638672,31.450382232666016,31.66984748840332,31.18320655822754,31.24045753479004,14758146.0,,0.00424754403799174,0.005171131311415479,0.05297881910430808,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-17,20.117542266845703,31.583969116210938,31.63167953491211,31.202289581298828,31.450382232666016,11475600.0,,-0.007552827763061462,0.004238548685921235,0.05940672751776576,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-18,19.96560287475586,31.345420837402344,31.68893051147461,31.29771041870117,31.545801162719727,17840418.0,,-0.0038812760937245575,-0.00758149480269795,0.08283910554846967,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-19,19.88811016082764,31.2237606048584,31.59112548828125,31.16889333724976,31.471850872039795,18032857.0,,-0.003896399094381189,-0.0038888277922669535,0.08562451945416238,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-20,19.81061744689941,31.102100372314453,31.49332046508789,31.04007625579834,31.397900581359863,18225296.0,,-0.003911640406518694,-0.0039040098334162674,0.08889505281075785,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-21,19.73312473297119,30.980440139770508,31.39551544189453,30.911259174346924,31.32395029067993,18417735.0,,-0.003927001423965247,-0.0039193108811465885,0.06912179621302358,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-22,19.65563201904297,30.85877990722656,31.29771041870117,30.782442092895508,31.25,18610174.0,,-0.007730382953389513,-0.003934732340240655,0.026054230540277896,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-02-23,19.50368309020996,30.620229721069336,31.116411209106445,30.572519302368164,31.03053474426269,17581458.0,,-0.001869773167369085,-0.007760417248218046,0.02732438809717846,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-24,19.46722412109375,30.562976837158203,30.6870231628418,30.39122009277344,30.61068725585937,14612159.0,,0.004995318838812411,-0.001871523375219235,0.03395875862905817,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-25,19.56447029113769,30.715648651123047,30.782442092895508,30.534351348876957,30.591602325439453,9403180.0,,0.0039349606299017015,0.004982883628362621,0.07451446402290156,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-26,19.641454696655277,30.83651351928711,30.893765131632488,30.594783782958984,30.636131922403973,12092418.0,,0.003919537404527344,0.003927238922104632,0.08516360436974707,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-27,19.71843910217285,30.95737838745117,31.005088170369465,30.655216217041016,30.68066151936849,14781656.0,,0.0039042346109339683,0.003911876030630372,0.08594491784866608,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-02-28,19.79542350769043,31.078243255615234,31.116411209106445,30.715648651123047,30.725191116333008,17470894.0,,-0.0033773271674457,0.0038966328665569205,0.04358566691266093,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-01,19.72857093811035,30.97328186035156,31.469465255737305,30.954198837280277,31.10687065124512,23209008.0,,0.003696859150731814,-0.0033830432104372064,0.05419247252833968,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-02,19.801498413085938,31.087785720825195,31.192747116088867,30.82061004638672,30.9637393951416,13020876.0,,0.01596071845841877,0.003690042561755777,0.05141819685345651,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-03-03,20.117542266845703,31.583969116210938,31.72709846496582,31.125953674316406,31.173664093017575,39781451.0,,-0.0012084596888622423,0.015834685474232394,0.10985653372896266,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-04,20.093233108520508,31.545801162719727,31.832061767578125,31.335878372192383,31.63167953491211,40663238.0,,-0.002319011803454187,-0.0012091904650738212,0.11813912379305003,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-05,20.04663848876953,31.47264607747396,31.73664156595866,31.29771041870117,31.583969751993816,40572830.66666666,,-0.0023244021194051743,-0.0023217048756428485,0.1257108463056877,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-06,20.000043869018555,31.39949099222819,31.64122136433919,31.25954246520996,31.53625996907552,40482423.333333336,,-0.0023298175522613648,-0.002327107735451127,0.12277515398802911,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-07,19.953449249267575,31.326335906982425,31.545801162719727,31.22137451171875,31.488550186157227,40392016.0,Merck Announces New Data Analyses for VICTRELIS Will Be Presented at The International Liver Congress,0.004568978292893064,-0.0023325358000097127,0.12718425404352837,"[{'label': 'neutral', 'score': 0.9998632669448853}, {'label': 'positive', 'score': 8.915673970477656e-05}, {'label': 'negative', 'score': 4.758718569064513e-05}]","(0.9998632669448853, 8.915673970477656e-05, 4.758718569064513e-05)",0.3039956173111527,8.915673970477656e-05,1,1,"[{'label': 'neutral', 'score': 0.8953735828399658}, {'label': 'positive', 'score': 0.09380276501178741}, {'label': 'negative', 'score': 0.010823702439665794}]","(0.8953735828399658, 0.09380276501178741, 0.010823702439665794)",0.7930981958329425,0.09380276501178741,0,1,"[{'label': 'neutral', 'score': 0.9979198575019836}, {'label': 'positive', 'score': 0.0019468505633994937}, {'label': 'negative', 'score': 0.00013341345766093582}]","(0.9979198575019836, 0.0019468505633994937, 0.00013341345766093582)",0.8717341103722716,0.0019468505633994937,0,1
2011-03-08,20.044607162475582,31.469465255737305,31.574426651000977,31.31679344177246,31.469465255737305,12103771.0,,0.009399624693838675,0.004558572196352867,0.04752483592862612,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-03-09,20.233028411865234,31.76526641845703,31.94656562805176,31.402671813964844,31.402671813964844,14253848.0,,-0.011715219535697654,0.009355723112819112,0.0850966361379375,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-10,19.99598693847656,31.393129348754883,31.73664093017578,31.335878372192383,31.68893051147461,16065106.0,Health Insurers Triple S&P 500 Returns,-0.005167190482118499,-0.011784383430907567,0.12718395586879733,"[{'label': 'neutral', 'score': 0.9998407363891602}, {'label': 'positive', 'score': 0.00010144512634724379}, {'label': 'negative', 'score': 5.786263500340283e-05}]","(0.9998407363891602, 0.00010144512634724379, 5.786263500340283e-05)",0.2735741873110193,0.00010144512634724379,1,1,"[{'label': 'neutral', 'score': 0.4863523244857788}, {'label': 'positive', 'score': 0.4173479974269867}, {'label': 'negative', 'score': 0.09629962593317032}]","(0.4863523244857788, 0.4173479974269867, 0.09629962593317032)",0.6250362250166691,0.4173479974269867,0,1,"[{'label': 'neutral', 'score': 0.9994707703590393}, {'label': 'positive', 'score': 0.00036378437653183937}, {'label': 'negative', 'score': 0.00016546387632843107}]","(0.9994707703590393, 0.00036378437653183937, 0.00016546387632843107)",0.37472112403131147,0.00036378437653183937,1,1
2011-03-11,20.12511444091797,31.23091506958008,31.402671813964844,30.982824325561523,30.982824325561523,12846698.0,,-0.0035644937942448164,-0.005180586577568008,0.13130464568893008,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-12,20.053380966186523,31.119592666625977,31.3040714263916,30.91285006205241,30.99236615498861,13381632.333333334,,-0.0035772448613534914,-0.00357086173908618,0.13234104367302293,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-13,19.98164749145508,31.008270263671875,31.20547103881836,30.842875798543293,31.00190798441569,13916566.666666666,,-0.003590087483355133,-0.0035836585017623187,0.12173781763641196,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-14,19.909914016723636,30.896947860717773,31.10687065124512,30.77290153503418,31.011449813842773,14451501.0,,-0.01605936304683423,-0.0035965473129608203,0.05646241160607206,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-03-15,19.590164184570312,30.4007625579834,30.572519302368164,30.25763320922852,30.37213706970215,16905602.0,,-0.024482087841867197,-0.016189712049336936,0.08735222376074465,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-03-16,19.11056327819824,29.6564884185791,30.4007625579834,29.63740539550781,30.3435115814209,24262143.0,"Some High Dividend Paying Stocks For A Weak Market (MO, MRK, JNJ, NLY)",0.011583016052760192,-0.0247867570597369,0.1546993610157278,"[{'label': 'negative', 'score': 0.9977126121520996}, {'label': 'neutral', 'score': 0.0014845746336504817}, {'label': 'positive', 'score': 0.0008027874282561243}]","(0.0014845746336504817, 0.0008027874282561243, 0.9977126121520996)",-0.998392037962372,-0.9977126121520996,0,0,"[{'label': 'negative', 'score': 0.845217227935791}, {'label': 'neutral', 'score': 0.12155801802873611}, {'label': 'positive', 'score': 0.033224765211343765}]","(0.12155801802873611, 0.033224765211343765, 0.845217227935791)",-0.924355243782662,-0.845217227935791,0,0,"[{'label': 'negative', 'score': 0.9111917614936829}, {'label': 'neutral', 'score': 0.08291623741388321}, {'label': 'positive', 'score': 0.00589196989312768}]","(0.08291623741388321, 0.00589196989312768, 0.9111917614936829)",-0.9871506391587214,-0.9111917614936829,0,0
2011-03-17,19.3319149017334,30.0,30.17175674438477,29.732824325561523,29.828243255615234,14366613.0,ARIAD Announces Election to Co-Promote Ridaforolimus in Sarcoma Indication in U.S. upon Approval ,0.01494909922281901,0.011516446480127316,0.21973368755321354,"[{'label': 'neutral', 'score': 0.9998584985733032}, {'label': 'positive', 'score': 9.000256977742538e-05}, {'label': 'negative', 'score': 5.1543989684432745e-05}]","(0.9998584985733032, 9.000256977742538e-05, 5.1543989684432745e-05)",0.27170268383214136,9.000256977742538e-05,1,1,"[{'label': 'positive', 'score': 0.7515697479248047}, {'label': 'neutral', 'score': 0.23932228982448578}, {'label': 'negative', 'score': 0.009107972495257854}]","(0.23932228982448578, 0.7515697479248047, 0.009107972495257854)",0.9760530057585275,0.7515697479248047,0,0,"[{'label': 'neutral', 'score': 0.9910987019538879}, {'label': 'positive', 'score': 0.008682256564497948}, {'label': 'negative', 'score': 0.0002190921368310228}]","(0.9910987019538879, 0.008682256564497948, 0.0002190921368310228)",0.9507732717406493,0.008682256564497948,0,1
2011-03-18,19.620908737182617,30.44847297668457,30.51526641845703,30.209924697875977,30.324426651000977,20414830.0,Committee for Medicinal Products for Human Use (CHMP) Issues Positive Opinion for New Contraception Offering,0.005014104125410367,0.014838462687323287,0.27217419898354955,"[{'label': 'positive', 'score': 0.9992535710334778}, {'label': 'negative', 'score': 0.00040093393181450665}, {'label': 'neutral', 'score': 0.00034544029040262103}]","(0.00034544029040262103, 0.9992535710334778, 0.00040093393181450665)",0.9991978549992561,0.9992535710334778,0,0,"[{'label': 'positive', 'score': 0.7616310119628906}, {'label': 'neutral', 'score': 0.22647230327129364}, {'label': 'negative', 'score': 0.011896660551428795}]","(0.22647230327129364, 0.7616310119628906, 0.011896660551428795)",0.9692405043176822,0.7616310119628906,0,0,"[{'label': 'positive', 'score': 0.997361958026886}, {'label': 'neutral', 'score': 0.002304636174812913}, {'label': 'negative', 'score': 0.0003333540225867182}]","(0.002304636174812913, 0.997361958026886, 0.0003333540225867182)",0.9993317518513705,0.997361958026886,0,0
2011-03-19,19.71928977966309,30.60114479064941,30.70610618591309,30.33078956604004,30.423027674357098,18941831.33333333,,0.004989088317097688,0.005001575368196246,0.2790264320107944,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-20,19.817670822143555,30.753816604614254,30.89694595336914,30.4516544342041,30.52162869771321,17468832.666666668,,0.00496432088178417,0.004976684056174505,0.24977909552094574,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-21,19.916051864624023,30.9064884185791,31.087785720825195,30.572519302368164,30.620229721069336,15995834.0,,0.004322292514623485,0.004952039270677044,0.07370143971653406,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-22,20.00213432312012,31.040075302124023,31.25954246520996,30.97328186035156,31.03053474426269,17273241.0,"Zings Of The Day (SNY, MRK, AAPL, AMZN)",0.003074117458594382,0.004312978238039487,0.07133582162314307,"[{'label': 'neutral', 'score': 0.9998682737350464}, {'label': 'negative', 'score': 7.452168938471004e-05}, {'label': 'positive', 'score': 5.727027382818051e-05}]","(0.9998682737350464, 5.727027382818051e-05, 7.452168938471004e-05)",-0.1308988434193245,-7.452168938471004e-05,1,1,"[{'label': 'neutral', 'score': 0.9477657079696655}, {'label': 'positive', 'score': 0.027670880779623985}, {'label': 'negative', 'score': 0.024563437327742577}]","(0.9477657079696655, 0.027670880779623985, 0.024563437327742577)",0.059490456934732504,0.027670880779623985,1,1,"[{'label': 'neutral', 'score': 0.9995564818382263}, {'label': 'positive', 'score': 0.00032431833096779883}, {'label': 'negative', 'score': 0.00011918552627321333}]","(0.9995564818382263, 0.00032431833096779883, 0.00011918552627321333)",0.46252766767507664,0.00032431833096779883,1,1
2011-03-23,20.063627243041992,31.135496139526367,31.173664093017575,30.925573348999023,31.011449813842773,12905491.0,,0.0027582143482647323,0.0030694020209210554,0.013180896790800955,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-03-24,20.118968963623047,31.22137451171875,31.393129348754883,31.049617767333984,31.326335906982425,12035442.0,Merck Announces FDA Approves Zostavax Vaccine to Prevent Shingles in Individuals 50 to 59 Years of Age  | Portola Pharmaceuticals to Regain Global Rights for Investigational Medicine Betrixaban from Merck   ,-0.004584399576956236,0.0027544174552300658,0.016601722002690788,"[{'label': 'positive', 'score': 0.9979289770126343}, {'label': 'neutral', 'score': 0.00185093202162534}, {'label': 'negative', 'score': 0.00022007565712556243}]","(0.00185093202162534, 0.9979289770126343, 0.00022007565712556243)",0.9995590324780915,0.9979289770126343,0,0,"[{'label': 'positive', 'score': 0.8554590344429016}, {'label': 'neutral', 'score': 0.1280728280544281}, {'label': 'negative', 'score': 0.016468092799186707}]","(0.1280728280544281, 0.8554590344429016, 0.016468092799186707)",0.9622259881940469,0.8554590344429016,0,0,"[{'label': 'positive', 'score': 0.9321433901786804}, {'label': 'neutral', 'score': 0.06743081659078598}, {'label': 'negative', 'score': 0.0004257678519934416}]","(0.06743081659078598, 0.9321433901786804, 0.0004257678519934416)",0.9990868927021079,0.9321433901786804,0,0
2011-03-25,20.02673721313477,31.078243255615234,31.393129348754883,31.049617767333984,31.22137451171875,11066042.0,"March Market Madness:  Merck (MRK) | Citi Comments On MRK's Return Of Betrixaban, Maintains EPS Estimate",-0.0012281245492959043,-0.004594940163875618,0.06108160139908977,"[{'label': 'neutral', 'score': 0.9995474219322205}, {'label': 'positive', 'score': 0.00038304273039102554}, {'label': 'negative', 'score': 6.943498738110065e-05}]","(0.9995474219322205, 0.00038304273039102554, 6.943498738110065e-05)",0.6930899151322671,0.00038304273039102554,0,1,"[{'label': 'neutral', 'score': 0.9154521226882935}, {'label': 'positive', 'score': 0.06805729120969772}, {'label': 'negative', 'score': 0.016490651294589043}]","(0.9154521226882935, 0.06805729120969772, 0.016490651294589043)",0.6099100508861482,0.06805729120969772,0,1,"[{'label': 'positive', 'score': 0.9914708733558655}, {'label': 'neutral', 'score': 0.007654039654880762}, {'label': 'negative', 'score': 0.0008750379201956093}]","(0.007654039654880762, 0.9914708733558655, 0.0008750379201956093)",0.998236425604716,0.9914708733558655,0,0
2011-03-26,20.002139409383137,31.040075302124023,31.31361262003581,31.00190798441569,31.164122263590496,10541203.333333334,,-0.001229634693850202,-0.001228879312275424,0.058603110781953766,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-27,19.97754160563151,31.00190734863281,31.23409589131673,30.954198201497395,31.10687001546224,10016364.666666666,,-0.0012311485568287333,-0.0012303913148989313,0.05072566905643697,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-28,19.952943801879883,30.9637393951416,31.154579162597656,30.9064884185791,31.049617767333984,9491526.0,"Mad Money Lightning Round: Cramer Likes Alcoa, Health Care REIT (AA, SPPI, PANL, PFE, GILD, CELG, MRK, ABT, AGNC, NLY, HCN)",0.010169511153716013,-0.0012319070428163982,0.04133621787619679,"[{'label': 'neutral', 'score': 0.9998689889907837}, {'label': 'negative', 'score': 7.367453508777544e-05}, {'label': 'positive', 'score': 5.732342469855212e-05}]","(0.9998689889907837, 5.732342469855212e-05, 7.367453508777544e-05)",-0.12481958051784797,-7.367453508777544e-05,0,0,"[{'label': 'neutral', 'score': 0.9165694117546082}, {'label': 'positive', 'score': 0.07018183916807175}, {'label': 'negative', 'score': 0.013248796574771404}]","(0.9165694117546082, 0.07018183916807175, 0.013248796574771404)",0.6823997214738253,0.07018183916807175,1,0,"[{'label': 'neutral', 'score': 0.9928057789802551}, {'label': 'positive', 'score': 0.007049966137856245}, {'label': 'negative', 'score': 0.0001443080691387877}]","(0.9928057789802551, 0.007049966137856245, 0.0001443080691387877)",0.9598825218537053,0.007049966137856245,1,0
2011-03-29,20.15585708618164,31.27862548828125,31.29771041870117,30.935115814208984,31.00190734863281,10397837.0,,0.01586333758724918,0.010118149596276564,0.08957526391385758,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-03-30,20.4755973815918,31.774808883666992,31.94656562805176,31.498092651367188,31.51717567443848,18077057.0,,-0.008708667086335912,0.01573882986020488,0.12708650673048175,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-03-31,20.297292709350582,31.498092651367188,31.85114479064941,31.488550186157227,31.555343627929688,13218424.0,"VICTRELIS, Merck's Investigational Medicine, Added to Peginterferon Alfa-2a and Ribavirin Achieved Significantly Higher SVR Rates In Treatment-Failure Patients with Chronic HCV Genotype 1 Compared to Control   ",0.0018176013765714477,-0.008746809133262996,0.156086419226517,"[{'label': 'positive', 'score': 0.9996028542518616}, {'label': 'negative', 'score': 0.00023527401208411902}, {'label': 'neutral', 'score': 0.00016186886932700872}]","(0.00016186886932700872, 0.9996028542518616, 0.00023527401208411902)",0.9995293757950747,0.9996028542518616,0,0,"[{'label': 'positive', 'score': 0.9494196772575378}, {'label': 'negative', 'score': 0.030811786651611328}, {'label': 'neutral', 'score': 0.019768549129366875}]","(0.019768549129366875, 0.9494196772575378, 0.030811786651611328)",0.9371336510078255,0.9494196772575378,0,0,"[{'label': 'positive', 'score': 0.9986867308616638}, {'label': 'neutral', 'score': 0.0010105769615620375}, {'label': 'negative', 'score': 0.00030265163513831794}]","(0.0010105769615620375, 0.9986867308616638, 0.00030265163513831794)",0.9993940843807931,0.9986867308616638,0,0
2011-04-01,20.33417320251465,31.555343627929688,31.72709846496582,31.488550186157227,31.5362606048584,11993312.0,April Catalysts For Biotech And Drug Stocks,0.002015926575503349,0.0018159515380526579,0.1524268174586233,"[{'label': 'neutral', 'score': 0.9998549222946167}, {'label': 'negative', 'score': 8.953396900324151e-05}, {'label': 'positive', 'score': 5.549644265556708e-05}]","(0.9998549222946167, 5.549644265556708e-05, 8.953396900324151e-05)",-0.23469233768535003,-8.953396900324151e-05,1,1,"[{'label': 'neutral', 'score': 0.8971763849258423}, {'label': 'positive', 'score': 0.08280693739652634}, {'label': 'negative', 'score': 0.020016714930534363}]","(0.8971763849258423, 0.08280693739652634, 0.020016714930534363)",0.6106593283252506,0.08280693739652634,0,1,"[{'label': 'neutral', 'score': 0.9919484853744507}, {'label': 'positive', 'score': 0.007908130064606667}, {'label': 'negative', 'score': 0.00014329710393212736}]","(0.9919484853744507, 0.007908130064606667, 0.00014329710393212736)",0.9644045456954351,0.007908130064606667,0,1
2011-04-02,20.375164031982425,31.61895688374837,31.76526641845703,31.555343627929688,31.62849934895833,12019162.666666666,,0.002011870791707978,0.0020138973222837346,0.14769499316867155,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-03,20.416154861450195,31.68257013956706,31.80343437194824,31.62213706970215,31.72073809305827,12045013.333333334,,0.0020078312945717523,0.0020098496900097834,0.13808992268782508,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-04,20.45714569091797,31.746183395385746,31.841602325439453,31.68893051147461,31.812976837158203,12070864.0,,-0.003306328238107543,0.0020058182953761445,0.07603229307234045,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-05,20.38951873779297,31.64122009277344,31.70801544189453,31.498092651367188,31.62213706970215,9685930.0,"Mid Afternoon Top-5 and Bottom-5 Percentage Gainers (NSM, ISPH, MRK, QCOR, PK, AAU, DGW, LEDS, MERU, WMGI, ZSTN) | Merck to Acquire Inspire Pharmaceuticals, Inc. for $5.00 per Share Totaling $430M | Biotech/Pharma Stocks; Merck (NYSE:MRK) to Acquire Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) | Biotech/Pharma Stocks; Merck (NYSE:MRK) to Acquire Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH)",0.005729842561795841,-0.0033118062193186483,0.037459650461592116,"[{'label': 'neutral', 'score': 0.9997910857200623}, {'label': 'positive', 'score': 0.00015451725630555302}, {'label': 'negative', 'score': 5.4447755246656016e-05}]","(0.9997910857200623, 0.00015451725630555302, 5.4447755246656016e-05)",0.4788816094884624,0.00015451725630555302,0,0,"[{'label': 'neutral', 'score': 0.6866293549537659}, {'label': 'positive', 'score': 0.2938946485519409}, {'label': 'negative', 'score': 0.01947600021958351}]","(0.6866293549537659, 0.2938946485519409, 0.01947600021958351)",0.8756999081060506,0.2938946485519409,1,0,"[{'label': 'neutral', 'score': 0.9971484541893005}, {'label': 'positive', 'score': 0.002288493560627103}, {'label': 'negative', 'score': 0.0005630789091810584}]","(0.9971484541893005, 0.002288493560627103, 0.0005630789091810584)",0.6050748033635355,0.002288493560627103,1,0
2011-04-06,20.506345748901367,31.822519302368164,31.917938232421875,31.63167953491211,31.755725860595703,13667911.0,Experts Think Merck's Gardasil Could Be Widely Distributed (MRK),-0.0005997303431128776,0.005713489451333403,0.0511404465225233,"[{'label': 'neutral', 'score': 0.9998542070388794}, {'label': 'positive', 'score': 8.461658580927178e-05}, {'label': 'negative', 'score': 6.118131568655372e-05}]","(0.9998542070388794, 8.461658580927178e-05, 6.118131568655372e-05)",0.16073804823170976,8.461658580927178e-05,1,1,"[{'label': 'neutral', 'score': 0.8426328301429749}, {'label': 'positive', 'score': 0.14907650649547577}, {'label': 'negative', 'score': 0.008290675468742847}]","(0.8426328301429749, 0.14907650649547577, 0.008290675468742847)",0.894632726274174,0.14907650649547577,0,1,"[{'label': 'neutral', 'score': 0.7249912023544312}, {'label': 'positive', 'score': 0.2745929956436157}, {'label': 'negative', 'score': 0.0004157931252848357}]","(0.7249912023544312, 0.2745929956436157, 0.0004157931252848357)",0.9969761466377408,0.2745929956436157,0,1
2011-04-07,20.494047164916992,31.80343437194824,31.898855209350582,31.545801162719727,31.898855209350582,13178705.0,"LifeTech Capital Comments On Merck Acquisition (MRK, ISPH)",0.010201114191126634,-0.0005999102532904416,0.05340196797654125,"[{'label': 'neutral', 'score': 0.999845027923584}, {'label': 'negative', 'score': 8.686239016242325e-05}, {'label': 'positive', 'score': 6.809389014961198e-05}]","(0.999845027923584, 6.809389014961198e-05, 8.686239016242325e-05)",-0.12112126062278453,-8.686239016242325e-05,0,0,"[{'label': 'neutral', 'score': 0.9382636547088623}, {'label': 'positive', 'score': 0.04212617874145508}, {'label': 'negative', 'score': 0.019610155373811722}]","(0.9382636547088623, 0.04212617874145508, 0.019610155373811722)",0.36471267188628487,0.04212617874145508,0,0,"[{'label': 'neutral', 'score': 0.9993467926979065}, {'label': 'positive', 'score': 0.0005120494170114398}, {'label': 'negative', 'score': 0.00014113438373897225}]","(0.9993467926979065, 0.0005120494170114398, 0.00014113438373897225)",0.5678570608247492,0.0005120494170114398,1,0
2011-04-08,20.703105926513672,32.127864837646484,32.156490325927734,31.870229721069336,31.965648651123047,19267585.0,Merck Loses U.K. Appeal Against Teva to Reinstate Cosopt Patent (MRK),-0.0007920406171346081,0.010149433992334093,0.08401744356309197,"[{'label': 'negative', 'score': 0.9934116005897522}, {'label': 'neutral', 'score': 0.005115888547152281}, {'label': 'positive', 'score': 0.0014724554494023323}]","(0.005115888547152281, 0.0014724554494023323, 0.9934116005897522)",-0.9970399456289117,-0.9934116005897522,0,0,"[{'label': 'negative', 'score': 0.6153374314308167}, {'label': 'positive', 'score': 0.251268595457077}, {'label': 'neutral', 'score': 0.13339398801326752}]","(0.13339398801326752, 0.251268595457077, 0.6153374314308167)",-0.4201088207073322,-0.6153374314308167,1,0,"[{'label': 'positive', 'score': 0.9662640690803528}, {'label': 'negative', 'score': 0.024689383804798126}, {'label': 'neutral', 'score': 0.009046543389558792}]","(0.009046543389558792, 0.9662640690803528, 0.024689383804798126)",0.9501704469913995,0.9662640690803528,0,0
2011-04-09,20.686707814534504,32.10241826375326,32.20419947306315,31.90521685282389,32.022900899251304,16751511.666666668,,-0.0007926684427373981,-0.0007923544470257775,0.08792340646848215,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-10,20.67030970255534,32.076971689860024,32.25190862019857,31.94020398457845,32.080153147379555,14235438.333333334,,-0.0007932972644444118,-0.0007929827704835547,0.0793152702859453,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-11,20.65391159057617,32.0515251159668,32.299617767333984,31.975191116333008,32.13740539550781,11719365.0,"FDA Approves Merck's SYLATRON for Injection, a New Adjuvant Treatment for Melanoma with Microscopic or Gross Nodal Involvement    | Merck & Co and Sun Pharma Establish Joint Venture (MRK)",-0.0008931084613814497,-0.0007936120912311553,0.07735217113966489,"[{'label': 'positive', 'score': 0.9976034760475159}, {'label': 'neutral', 'score': 0.0021037135738879442}, {'label': 'negative', 'score': 0.0002927869209088385}]","(0.0021037135738879442, 0.9976034760475159, 0.0002927869209088385)",0.9994131916677633,0.9976034760475159,0,0,"[{'label': 'positive', 'score': 0.804600179195404}, {'label': 'neutral', 'score': 0.1831628531217575}, {'label': 'negative', 'score': 0.012236937880516052}]","(0.1831628531217575, 0.804600179195404, 0.012236937880516052)",0.9700382423259086,0.804600179195404,0,0,"[{'label': 'positive', 'score': 0.9600693583488464}, {'label': 'neutral', 'score': 0.03952017053961754}, {'label': 'negative', 'score': 0.0004104137478861958}]","(0.03952017053961754, 0.9600693583488464, 0.0004104137478861958)",0.9991453984564604,0.9600693583488464,0,0
2011-04-12,20.635467529296875,32.02289962768555,32.22328186035156,31.86068725585937,31.889312744140625,15280050.0,"Inspire Pharmaceuticals Shareholder Sues Over Merck Deal (MRK, ISPH)",-0.002681720451370417,-0.0008935075203630208,0.07786493459513463,"[{'label': 'neutral', 'score': 0.8283862471580505}, {'label': 'negative', 'score': 0.15259641408920288}, {'label': 'positive', 'score': 0.019017314538359642}]","(0.8283862471580505, 0.019017314538359642, 0.15259641408920288)",-0.7783707085622367,-0.15259641408920288,0,1,"[{'label': 'negative', 'score': 0.8491015434265137}, {'label': 'neutral', 'score': 0.13714388012886047}, {'label': 'positive', 'score': 0.013754558749496937}]","(0.13714388012886047, 0.013754558749496937, 0.8491015434265137)",-0.9681185339831062,-0.8491015434265137,0,0,"[{'label': 'negative', 'score': 0.9974126219749451}, {'label': 'neutral', 'score': 0.001685742405243218}, {'label': 'positive', 'score': 0.0009016763069666922}]","(0.001685742405243218, 0.0009016763069666922, 0.9974126219749451)",-0.9981936023384249,-0.9974126219749451,0,0
2011-04-13,20.580127716064453,31.9370231628418,32.10877990722656,31.841602325439453,32.08015441894531,8199447.0,,0.011652155570544383,-0.0026853227052599385,0.013273864709987504,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-04-14,20.81993103027344,32.30915832519531,32.48091506958008,31.746183395385746,31.812976837158203,15740960.0,,0.0191967745546098,0.011584791988134427,0.09230234840128664,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-04-15,21.219606399536133,32.92938995361328,33.36832046508789,32.87213516235352,33.3015251159668,38676230.0,"Weird Dynamic at Play  04-15-2011 | Merck Commences Tender Offer for Inspire Pharmaceuticals at $5.00 per Share     | A Peek Into The Market Before The Trading Starts | Merck Reaffirms 2011 Non-GAAP EPS Target of $3.64 to $3.76 | Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck (JNJ, MRK) |   Merck and Johnson & Johnson Reach Agreement on Distribution Rights for REMICADE and SIMPONI (MRK, JNJ)",-0.0056022525781830495,0.01901484114728658,0.15202226736850516,"[{'label': 'neutral', 'score': 0.9991982579231262}, {'label': 'positive', 'score': 0.0007276246906258166}, {'label': 'negative', 'score': 7.408207602566108e-05}]","(0.9991982579231262, 0.0007276246906258166, 7.408207602566108e-05)",0.8151890962949389,0.0007276246906258166,0,1,"[{'label': 'positive', 'score': 0.7728573679924011}, {'label': 'neutral', 'score': 0.2153923511505127}, {'label': 'negative', 'score': 0.011750271543860435}]","(0.2153923511505127, 0.7728573679924011, 0.011750271543860435)",0.9700480317759705,0.7728573679924011,0,0,"[{'label': 'positive', 'score': 0.8880718946456909}, {'label': 'neutral', 'score': 0.11085116863250732}, {'label': 'negative', 'score': 0.0010769707150757313}]","(0.11085116863250732, 0.8880718946456909, 0.0010769707150757313)",0.9975775244010715,0.8880718946456909,0,0
2011-04-16,21.10073026021321,32.744911193847656,33.15203603108724,32.681296030680336,33.07887903849284,31998339.333333336,,-0.005633814630723022,-0.005618004051860933,0.1671968764703475,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-17,20.9818541208903,32.56043243408203,32.935751597086586,32.490456899007164,32.85623296101888,25320448.666666668,,-0.005665734327672051,-0.005649744422874512,0.1794315440618426,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-18,20.862977981567383,32.375953674316406,32.71946716308594,32.299617767333984,32.63358688354492,18642558.0,Don't Fall For The 'Defensive Portfolio' Hype | J.P. Morgan Adjusting Estimates On Merck & Co,-0.0053050713536515505,-0.005681845483579827,0.18686659673875736,"[{'label': 'neutral', 'score': 0.9993409514427185}, {'label': 'negative', 'score': 0.000387839216273278}, {'label': 'positive', 'score': 0.00027118282741867006}]","(0.9993409514427185, 0.00027118282741867006, 0.000387839216273278)",-0.17701439575690062,-0.000387839216273278,1,1,"[{'label': 'neutral', 'score': 0.6860014200210571}, {'label': 'negative', 'score': 0.27678945660591125}, {'label': 'positive', 'score': 0.037209104746580124}]","(0.6860014200210571, 0.037209104746580124, 0.27678945660591125)",-0.7629982469581471,-0.27678945660591125,0,1,"[{'label': 'neutral', 'score': 0.9973357319831848}, {'label': 'negative', 'score': 0.0016249878099188209}, {'label': 'positive', 'score': 0.0010392501717433333}]","(0.9973357319831848, 0.0010392501717433333, 0.0016249878099188209)",-0.21985184589631135,-0.0016249878099188209,1,1
2011-04-19,20.75228881835937,32.20419692993164,32.54771041870117,31.98473358154297,32.385494232177734,15922474.0,,0.008592611088874772,-0.005319193211804807,0.17453032679576963,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-20,20.930612564086918,32.48091506958008,32.66221237182617,32.39503860473633,32.50954055786133,14903294.0,,0.0,0.008555904725339541,0.10029047559362375,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-21,20.930612564086918,32.48091506958008,32.71946716308594,32.404579162597656,32.700382232666016,16567832.0,Merck and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases   ,0.002129851784160456,0.0,0.09804834589547654,"[{'label': 'neutral', 'score': 0.9998248219490051}, {'label': 'positive', 'score': 0.00011882250691996887}, {'label': 'negative', 'score': 5.639185837935656e-05}]","(0.9998248219490051, 0.00011882250691996887, 5.639185837935656e-05)",0.3563101029642155,0.00011882250691996887,1,1,"[{'label': 'positive', 'score': 0.7276735901832581}, {'label': 'neutral', 'score': 0.26179149746894836}, {'label': 'negative', 'score': 0.010534846223890781}]","(0.26179149746894836, 0.7276735901832581, 0.010534846223890781)",0.9714583423750512,0.7276735901832581,0,0,"[{'label': 'neutral', 'score': 0.6735237836837769}, {'label': 'positive', 'score': 0.3258758783340454}, {'label': 'negative', 'score': 0.0006002982845529914}]","(0.6735237836837769, 0.3258758783340454, 0.0006002982845529914)",0.9963225599443706,0.3258758783340454,0,1
2011-04-22,20.975191116333008,32.55009460449219,32.745707511901855,32.3258581161499,32.564409255981445,14947938.5,,0.002125325156583785,0.0021275868652400414,0.09333857924911611,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-23,21.0197696685791,32.6192741394043,32.77194786071777,32.24713706970215,32.428436279296875,13328045.0,,0.002120817729311151,0.0021230698480172463,0.0791019084967225,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-24,21.064348220825195,32.688453674316406,32.79818820953369,32.168416023254395,32.292463302612305,11708151.5,,0.0021163293804402693,0.0021185719700607224,0.051545716795703904,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-04-25,21.10892677307129,32.75763320922852,32.82442855834961,32.08969497680664,32.156490325927734,10088258.0,"Rwanda, Merck and QIAGEN Launch Africa's First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing    | Merck's Hepatitis C Drug Increases Anemia Risk, FDA Staff Says -Bloomberg (MRK)",0.021264165095629714,0.0021140931099844383,0.015056614197920861,"[{'label': 'negative', 'score': 0.9621326923370361}, {'label': 'neutral', 'score': 0.0266718789935112}, {'label': 'positive', 'score': 0.011195351369678974}]","(0.0266718789935112, 0.011195351369678974, 0.9621326923370361)",-0.9769957283321585,-0.9621326923370361,0,0,"[{'label': 'positive', 'score': 0.6717076301574707}, {'label': 'neutral', 'score': 0.311673641204834}, {'label': 'negative', 'score': 0.016618771478533745}]","(0.311673641204834, 0.6717076301574707, 0.016618771478533745)",0.9517125263856377,0.6717076301574707,1,1,"[{'label': 'positive', 'score': 0.7957226037979126}, {'label': 'neutral', 'score': 0.2020827680826187}, {'label': 'negative', 'score': 0.0021945862099528313}]","(0.2020827680826187, 0.7957226037979126, 0.0021945862099528313)",0.9944992131077381,0.7957226037979126,1,1
2011-04-26,21.557790756225582,33.45419692993164,33.549617767333984,32.814884185791016,32.86259460449219,22532000.0, Vertex Stock Booms After FDA Reports New Drug is Effective (VRTX),0.016257921915588433,0.021041237446561042,0.1343215885187372,"[{'label': 'positive', 'score': 0.9962993264198303}, {'label': 'neutral', 'score': 0.0029523074626922607}, {'label': 'negative', 'score': 0.0007483704248443246}]","(0.0029523074626922607, 0.9962993264198303, 0.0007483704248443246)",0.9984988272332153,0.9962993264198303,0,0,"[{'label': 'positive', 'score': 0.7732262015342712}, {'label': 'negative', 'score': 0.14879222214221954}, {'label': 'neutral', 'score': 0.07798159122467041}]","(0.07798159122467041, 0.7732262015342712, 0.14879222214221954)",0.6772467483915997,0.7732262015342712,0,0,"[{'label': 'positive', 'score': 0.9960009455680847}, {'label': 'neutral', 'score': 0.0026662959717214108}, {'label': 'negative', 'score': 0.0013327118940651417}]","(0.0026662959717214108, 0.9960009455680847, 0.0013327118940651417)",0.9973274502788637,0.9960009455680847,0,0
2011-04-27,21.90827751159668,33.99809265136719,34.10305404663086,33.44465637207031,33.58778762817383,21360860.0,VICTRELIS Unanimously Recommended for Approval by FDA Advisory Committee (MRK) | VICTRELIS Unanimously Recommended for Approval by FDA Advisory Committee for Treatment of Chronic HCV Genotype 1 Infection    | Hepatitis Treatment Wins Over the U.S. FDA Panel -Bloomberg (MRK) | Deutsche Bank To Hold 36th Annual Healthcare Conference Next Week | Merck Announces New $5 Billion Share Repurchase Program (MRK),0.003929246411402725,0.016127177092392062,0.14579816404253368,"[{'label': 'positive', 'score': 0.9990115165710449}, {'label': 'neutral', 'score': 0.0007153485203161836}, {'label': 'negative', 'score': 0.00027312038582749665}]","(0.0007153485203161836, 0.9990115165710449, 0.00027312038582749665)",0.9994533681881486,0.9990115165710449,0,0,"[{'label': 'positive', 'score': 0.9101477861404419}, {'label': 'neutral', 'score': 0.06672981381416321}, {'label': 'negative', 'score': 0.023122470825910568}]","(0.06672981381416321, 0.9101477861404419, 0.023122470825910568)",0.9504484994495133,0.9101477861404419,0,0,"[{'label': 'positive', 'score': 0.9658836722373962}, {'label': 'neutral', 'score': 0.033587776124477386}, {'label': 'negative', 'score': 0.0005285589140839875}]","(0.033587776124477386, 0.9658836722373962, 0.0005285589140839875)",0.9989061419194701,0.9658836722373962,0,0
2011-04-28,21.994356155395508,34.13167953491211,34.16030502319336,33.83587646484375,34.00763320922852,14096962.0,"  Merck and Inspire Announce Expiration of Hart-Scott-Rodino Act Waiting Period Relating to Tender Offer for Shares of Inspire (ISPH, MRK)",0.00503217968541752,0.0039215470845002575,0.14116884966949647,"[{'label': 'neutral', 'score': 0.9997956156730652}, {'label': 'negative', 'score': 0.0001046045363182202}, {'label': 'positive', 'score': 9.978123125620186e-05}]","(0.9997956156730652, 9.978123125620186e-05, 0.0001046045363182202)",-0.023599026092959465,-0.0001046045363182202,1,1,"[{'label': 'neutral', 'score': 0.8083291053771973}, {'label': 'negative', 'score': 0.17435318231582642}, {'label': 'positive', 'score': 0.017317716032266617}]","(0.8083291053771973, 0.017317716032266617, 0.17435318231582642)",-0.8192973875375076,-0.17435318231582642,0,1,"[{'label': 'neutral', 'score': 0.9947165846824646}, {'label': 'negative', 'score': 0.003745133290067315}, {'label': 'positive', 'score': 0.0015383411664515734}]","(0.9947165846824646, 0.0015383411664515734, 0.003745133290067315)",-0.41767820432877156,-0.003745133290067315,1,1
2011-04-29,22.105043411254883,34.303436279296875,34.58969497680664,33.99809265136719,34.332061767578125,19843880.0,"Royal Put(z) Not to Be Confused with Married Put(z)  04-29-2011 | Married Put(z)  04-29-2011 | Merck Up On Strong Earnings Today (MRK) | Citi Reports Strong 1Q11 Results For Merck | Friday Morning Market Summary 4/29/2011 | A Peek Into The Market Before The Trading Starts | UPDATE: Merck Reports Upbeat Q1 Earnings; Shares Rise In Pre-Market trading | Merck Announces First Quarter 2011 Financial Results    | Merck Guides FY 2011 EPS $3.66-3.76 vs. $3.69 Est. (MRK) | Merck Reports EPS of $0.92 vs. $0.84 Estimate; Revenues $11.58B vs. $11.37B Estimate  | US Stock Futures Mixed As Investors Await Economic Data, Earnings Reports; Research In Motion Shares Decline In Pre-Market trading | Earnings Scheduled For April 29 (WY, AXL, NWL, ITT, MRK, PBI, MI, CPN, GT, CAT, AGP, NEE, CVX, PPC, DHI, ETR, VFC) | Stocks To Watch For April 29 (CVX, RIMM, CAT, MSFT, MRK)",0.0033379520278516124,0.0050195605859032055,0.13346865013926315,"[{'label': 'positive', 'score': 0.9993795156478882}, {'label': 'negative', 'score': 0.0003973572456743568}, {'label': 'neutral', 'score': 0.00022310369240585715}]","(0.00022310369240585715, 0.9993795156478882, 0.0003973572456743568)",0.9992051081467321,0.9993795156478882,0,0,"[{'label': 'negative', 'score': 0.9421446323394775}, {'label': 'positive', 'score': 0.04277101531624794}, {'label': 'neutral', 'score': 0.015084351412951946}]","(0.015084351412951946, 0.04277101531624794, 0.9421446323394775)",-0.9131478611025207,-0.9421446323394775,0,0,"[{'label': 'positive', 'score': 0.9827135801315308}, {'label': 'neutral', 'score': 0.015409762971103191}, {'label': 'negative', 'score': 0.0018766794819384813}]","(0.015409762971103191, 0.9827135801315308, 0.0018766794819384813)",0.9961878975266824,0.9827135801315308,0,0
2011-04-30,22.178829193115234,34.41793950398763,34.69465637207031,34.173028310139976,34.478371938069664,19652550.0,,0.0033268471715886486,0.0033323934320974792,0.12935490471874325,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-01,22.252614974975582,34.53244272867838,34.799617767333984,34.34796396891276,34.6246821085612,19461220.0,,0.0033158159586453274,0.0033213254587443485,0.08750415028109854,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-02,22.326400756835938,34.64694595336914,34.904579162597656,34.52289962768555,34.770992279052734,19269890.0,"UPDATE: J.P. Morgan Raises PT on Merck & Co. to $44 (MRK) | Citi Updates FY Estimates On Merck After Reporting Solid Earnings | JP Morgan Raises PT On Merck & Company To $44 | CEOWORLD Top 5 Analyst Calls of the Week- DNDN, INSP, MCP, SIRI, VICL",0.0027540908665014624,0.0033103307628314974,0.011740333208082225,"[{'label': 'positive', 'score': 0.9993632435798645}, {'label': 'neutral', 'score': 0.00036432588240131736}, {'label': 'negative', 'score': 0.0002724318183027208}]","(0.00036432588240131736, 0.9993632435798645, 0.0002724318183027208)",0.9994549377838197,0.9993632435798645,1,1,"[{'label': 'positive', 'score': 0.9059697985649109}, {'label': 'neutral', 'score': 0.05378733575344086}, {'label': 'negative', 'score': 0.04024286940693855}]","(0.05378733575344086, 0.9059697985649109, 0.04024286940693855)",0.9149390601730227,0.9059697985649109,1,1,"[{'label': 'positive', 'score': 0.9988528490066528}, {'label': 'neutral', 'score': 0.0008778005139902234}, {'label': 'negative', 'score': 0.0002693514688871801}]","(0.0008778005139902234, 0.9988528490066528, 0.0002693514688871801)",0.9994608237735905,0.9988528490066528,1,1
2011-05-03,22.387887954711918,34.742366790771484,34.96183013916016,34.417938232421875,34.58015441894531,18571713.0,"Morning News Summary for May 3, 2011 | Earnings Preview For Allergan (AGN, MRK, ISPH, VRX, CEPH) | Top 4 Large-Cap Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio (GSK, ABT, MRK, JNJ)",0.00411968022409655,0.002750305307174272,0.013646893914843692,"[{'label': 'neutral', 'score': 0.9996613264083862}, {'label': 'positive', 'score': 0.0002227906370535493}, {'label': 'negative', 'score': 0.00011579209967749193}]","(0.9996613264083862, 0.0002227906370535493, 0.00011579209967749193)",0.3160188803750305,0.0002227906370535493,0,0,"[{'label': 'negative', 'score': 0.8755759000778198}, {'label': 'neutral', 'score': 0.10476087778806686}, {'label': 'positive', 'score': 0.019663235172629356}]","(0.10476087778806686, 0.019663235172629356, 0.8755759000778198)",-0.956071546923318,-0.8755759000778198,0,0,"[{'label': 'neutral', 'score': 0.9985368251800537}, {'label': 'positive', 'score': 0.0009142954950220883}, {'label': 'negative', 'score': 0.000548848882317543}]","(0.9985368251800537, 0.0009142954950220883, 0.000548848882317543)",0.24976797803715048,0.0009142954950220883,0,0
2011-05-04,22.48011589050293,34.885494232177734,35.066795349121094,34.60877990722656,34.69465637207031,18234257.0,May Catalysts for Biotech and Drug Stocks,-0.008479147619420969,0.004111217575830246,0.007698111562344055,"[{'label': 'neutral', 'score': 0.9998716115951538}, {'label': 'negative', 'score': 8.214027184294537e-05}, {'label': 'positive', 'score': 4.6230125008150935e-05}]","(0.9998716115951538, 4.6230125008150935e-05, 8.214027184294537e-05)",-0.2797385356411146,-8.214027184294537e-05,0,0,"[{'label': 'neutral', 'score': 0.8730016946792603}, {'label': 'positive', 'score': 0.11526070535182953}, {'label': 'negative', 'score': 0.011737588793039322}]","(0.8730016946792603, 0.11526070535182953, 0.011737588793039322)",0.8151535991554331,0.11526070535182953,0,0,"[{'label': 'neutral', 'score': 0.9992228746414185}, {'label': 'positive', 'score': 0.0006768282037228346}, {'label': 'negative', 'score': 0.00010025100345956162}]","(0.9992228746414185, 0.0006768282037228346, 0.00010025100345956162)",0.7419799615458488,0.0006768282037228346,0,0
2011-05-05,22.28950881958008,34.58969497680664,34.96183013916016,34.51335906982422,34.78053283691406,17279214.0,,0.0038620428319618206,-0.008515300098123573,0.08475049549070031,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-06,22.37558364868164,34.72328186035156,35.066795349121094,34.627864837646484,34.856868743896484,13386733.0,"UPDATE: FDA Approves New Treatment for Rare Type of Pancreatic Cancer (PFE, MRK, GSK)",0.0008243889041472123,0.0038546042903701743,0.08575111638698761,"[{'label': 'positive', 'score': 0.9971044659614563}, {'label': 'neutral', 'score': 0.0026101076509803534}, {'label': 'negative', 'score': 0.000285478396108374}]","(0.0026101076509803534, 0.9971044659614563, 0.000285478396108374)",0.999427549079027,0.9971044659614563,0,0,"[{'label': 'positive', 'score': 0.7547239661216736}, {'label': 'neutral', 'score': 0.23412324488162994}, {'label': 'negative', 'score': 0.01115275640040636}]","(0.23412324488162994, 0.7547239661216736, 0.01115275640040636)",0.9708758444474468,0.7547239661216736,0,0,"[{'label': 'positive', 'score': 0.997197151184082}, {'label': 'neutral', 'score': 0.0024556394200772047}, {'label': 'negative', 'score': 0.0003471502859611064}]","(0.0024556394200772047, 0.997197151184082, 0.0003471502859611064)",0.9993039902379283,0.997197151184082,0,0
2011-05-07,22.39403025309245,34.75190734863281,35.01272328694662,34.567431131998696,34.72328186035156,12673813.333333334,,0.0008237098468892001,0.0008240492822554878,0.08350492145202675,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-08,22.41247685750325,34.78053283691406,34.95865122477213,34.506997426350914,34.58969497680664,11960893.666666666,,0.0008230319074027684,0.0008233707841134785,0.08148213452060223,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-09,22.430923461914062,34.80915832519531,34.904579162597656,34.446563720703125,34.45610809326172,11247974.0,,0.007949578586855558,0.0008226934023633357,0.07464496806083958,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-10,22.60924530029297,35.08587646484375,35.10496139526367,34.828243255615234,34.875953674316406,10061743.0,,-0.003807426149914673,0.00791814715487388,0.049578943103478906,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-11,22.523162841796875,34.95228958129883,35.25763320922852,34.799617767333984,35.08587646484375,12463759.0,The Father of Growth Investing: T. Rowe Price Screen,0.01556098078991912,-0.003814692847665809,0.06671090686496564,"[{'label': 'neutral', 'score': 0.9998667240142822}, {'label': 'negative', 'score': 8.066475129453465e-05}, {'label': 'positive', 'score': 5.257392695057206e-05}]","(0.9998667240142822, 5.257392695057206e-05, 8.066475129453465e-05)",-0.2108308541779928,-8.066475129453465e-05,0,0,"[{'label': 'neutral', 'score': 0.9324284791946411}, {'label': 'positive', 'score': 0.034490372985601425}, {'label': 'negative', 'score': 0.03308112174272537}]","(0.9324284791946411, 0.034490372985601425, 0.03308112174272537)",0.02085570621964172,0.034490372985601425,0,0,"[{'label': 'neutral', 'score': 0.9995442032814026}, {'label': 'positive', 'score': 0.00034173717722296715}, {'label': 'negative', 'score': 0.0001140150852734223}]","(0.9995442032814026, 0.00034173717722296715, 0.0001140150852734223)",0.4996620108964328,0.00034173717722296715,0,0
2011-05-12,22.873640060424805,35.49618148803711,35.5629768371582,34.904579162597656,35.01908493041992,16706692.0,,-0.003225754104384139,0.015441150250063729,0.11964575940926479,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-13,22.79986572265625,35.38167953491211,35.59160232543945,35.16221237182617,35.33396911621094,12047284.0,"Biotech/Pharma Stock News Alert: (OTCBB: AEMD), (NYSE: MRK), (VRTX) Progress on Potential New Treatments for Hepatitis C Virus (HCV) | Biotech/Pharma Stocks: (OTCBB: AEMD), (NYSE: MRK), (VRTX) Progress on Potential New Treatments for Hepatitis C Virus (HCV) | Biotech/Pharma Stocks: (OTCBB: AEMD), (NYSE: MRK), (VRTX) Progress on Potential New Treatments for Hepatitis C Virus (HCV)",0.0019776976228635884,-0.0032309680648106294,0.1299537854765554,"[{'label': 'positive', 'score': 0.9905043244361877}, {'label': 'neutral', 'score': 0.008971655741333961}, {'label': 'negative', 'score': 0.0005240009631961584}]","(0.008971655741333961, 0.9905043244361877, 0.0005240009631961584)",0.9989425106230239,0.9905043244361877,0,0,"[{'label': 'neutral', 'score': 0.6311821937561035}, {'label': 'positive', 'score': 0.3463899791240692}, {'label': 'negative', 'score': 0.022427845746278763}]","(0.6311821937561035, 0.3463899791240692, 0.022427845746278763)",0.8783798166253872,0.3463899791240692,0,1,"[{'label': 'neutral', 'score': 0.9852448105812073}, {'label': 'positive', 'score': 0.012132801115512848}, {'label': 'negative', 'score': 0.002622321480885148}]","(0.9852448105812073, 0.012132801115512848, 0.002622321480885148)",0.644554429995003,0.012132801115512848,0,1
2011-05-14,22.84495480855306,35.451653798421226,35.67429987589518,35.209922790527344,35.34351094563802,14577750.0,,0.0019737940550526877,0.001975744553549605,0.12875010926966027,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-15,22.89004389444987,35.521628061930336,35.756997426350914,35.25763320922852,35.3530527750651,17108216.0,,0.0019699058665644496,0.0019718486829886574,0.1231532343449461,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-16,22.93513298034668,35.59160232543945,35.83969497680664,35.30534362792969,35.36259460449219,19638682.0,"Goldman Sachs Reports on Merck & Co (MRK) | Deutsche Bank Comments on Victrelis FDA Approval | J.P. Morgan Calls Merck & Co's Hep C Treatment A ""Modest Positive"" | Bank Of America Raises PT To $29 On MRK",-0.000804276470036575,0.0019679681463366317,0.11078780601689951,"[{'label': 'positive', 'score': 0.9995249509811401}, {'label': 'negative', 'score': 0.00027610163670033216}, {'label': 'neutral', 'score': 0.00019896092999260873}]","(0.00019896092999260873, 0.9995249509811401, 0.00027610163670033216)",0.9994476868453431,0.9995249509811401,0,0,"[{'label': 'positive', 'score': 0.8905446529388428}, {'label': 'negative', 'score': 0.062385253608226776}, {'label': 'neutral', 'score': 0.04707017168402672}]","(0.04707017168402672, 0.8905446529388428, 0.062385253608226776)",0.8690664377734161,0.8905446529388428,0,0,"[{'label': 'positive', 'score': 0.9987174272537231}, {'label': 'neutral', 'score': 0.0009739501401782036}, {'label': 'negative', 'score': 0.0003085874195676297}]","(0.0009739501401782036, 0.9987174272537231, 0.0003085874195676297)",0.9993822234555753,0.9987174272537231,0,0
2011-05-17,22.91668128967285,35.5629768371582,35.6297721862793,35.00954055786133,35.48664093017578,21363061.0,"Biotech/Pharma Stocks News Alert; Hepatitis C Virus (HCV) FDA News from Aethlon Medical, Vertex Pharmaceuticals, Merck & Company  | Merck and Roche Establish Strategic Agreements in Fight Against Chronic Hepatitis C  | Biotech/Pharma Stocks Alert; Hepatitis C Virus (HCV) FDA News from (OTCBB: AEMD), (NYSE: MRK), (VRTX) | Biotech/Pharma Stocks Alert; Hepatitis C Virus (HCV) FDA News from (OTCBB: AEMD), (NYSE: MRK), (VRTX) | Piper Jaffray Discontinues Coverage On ISPH",0.00831772524057344,-0.0008046000738796238,0.03726649626061135,"[{'label': 'positive', 'score': 0.9876948595046997}, {'label': 'neutral', 'score': 0.01177519652992487}, {'label': 'negative', 'score': 0.0005299078184179962}]","(0.01177519652992487, 0.9876948595046997, 0.0005299078184179962)",0.9989275560865503,0.9876948595046997,1,1,"[{'label': 'neutral', 'score': 0.9082626104354858}, {'label': 'positive', 'score': 0.050536446273326874}, {'label': 'negative', 'score': 0.04120095819234848}]","(0.9082626104354858, 0.050536446273326874, 0.04120095819234848)",0.10176315904458991,0.050536446273326874,0,0,"[{'label': 'positive', 'score': 0.5557414293289185}, {'label': 'neutral', 'score': 0.42747312784194946}, {'label': 'negative', 'score': 0.01678547076880932}]","(0.42747312784194946, 0.5557414293289185, 0.01678547076880932)",0.9413635559623692,0.5557414293289185,1,1
2011-05-18,23.107288360595703,35.85877990722656,35.89694595336914,35.41030502319336,35.54389190673828,13604822.0,,-0.005322034807052302,0.008283323594634903,0.05327080738402097,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-19,22.98432159423828,35.667938232421875,35.92557144165039,35.4484748840332,35.877864837646484,11948353.0,Exclusive  Merck Talks To Benzinga About Collaboration With Roche (MRK) | Deutsche Bank Comments On Merck And Roche Collaboration,-0.00856073109524824,-0.005336247282918057,0.07861432079018638,"[{'label': 'neutral', 'score': 0.999657392501831}, {'label': 'positive', 'score': 0.0002605938061606139}, {'label': 'negative', 'score': 8.197275019483641e-05}]","(0.999657392501831, 0.0002605938061606139, 8.197275019483641e-05)",0.5214200062788341,0.0002605938061606139,0,1,"[{'label': 'neutral', 'score': 0.9319635033607483}, {'label': 'positive', 'score': 0.05034024640917778}, {'label': 'negative', 'score': 0.017696263268589973}]","(0.9319635033607483, 0.05034024640917778, 0.017696263268589973)",0.4798009670865709,0.05034024640917778,1,1,"[{'label': 'neutral', 'score': 0.9920923113822937}, {'label': 'positive', 'score': 0.0077345725148916245}, {'label': 'negative', 'score': 0.0001730952353682369}]","(0.9920923113822937, 0.0077345725148916245, 0.0001730952353682369)",0.9562209134640113,0.0077345725148916245,0,1
2011-05-20,22.787567138671875,35.36259460449219,35.76335906982422,35.200382232666016,35.667938232421875,11870696.0,"CHMP Issues Positive Opinion for Merck's VICTRELISTM, Oral Hepatitis C Virus Protease Inhibitor   ",-0.0014391083353505064,-0.008597584633246214,0.10394495161820867,"[{'label': 'positive', 'score': 0.9992183446884155}, {'label': 'negative', 'score': 0.0004342426545917988}, {'label': 'neutral', 'score': 0.00034740750561468303}]","(0.00034740750561468303, 0.9992183446884155, 0.0004342426545917988)",0.9991312128631689,0.9992183446884155,0,0,"[{'label': 'positive', 'score': 0.9395636320114136}, {'label': 'neutral', 'score': 0.04589265584945679}, {'label': 'negative', 'score': 0.014543650671839714}]","(0.04589265584945679, 0.9395636320114136, 0.014543650671839714)",0.9695135946747239,0.9395636320114136,0,0,"[{'label': 'positive', 'score': 0.9973293542861938}, {'label': 'neutral', 'score': 0.001973597565665841}, {'label': 'negative', 'score': 0.0006970286485739052}]","(0.001973597565665841, 0.9973293542861938, 0.0006970286485739052)",0.9986031859267603,0.9973293542861938,0,0
2011-05-21,22.754771550496415,35.31170399983724,35.6075070699056,35.11450449625651,35.44211196899414,12314384.333333334,,-0.0014411823528875077,-0.0014401448463047042,0.10079432486236214,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-22,22.721975962320965,35.26081339518229,35.45165506998698,35.02862675984701,35.216285705566406,12758072.666666666,Top Healthcare and Major Drugs stocks to watch- Sector Performance,-0.0014432623571269847,-0.001442221855036094,0.10058711150028574,"[{'label': 'neutral', 'score': 0.9992827773094177}, {'label': 'positive', 'score': 0.0005818650242872536}, {'label': 'negative', 'score': 0.00013528727868106216}]","(0.9992827773094177, 0.0005818650242872536, 0.00013528727868106216)",0.6227097699579186,0.0005818650242872536,0,1,"[{'label': 'neutral', 'score': 0.8072490692138672}, {'label': 'positive', 'score': 0.16259261965751648}, {'label': 'negative', 'score': 0.030158255249261856}]","(0.8072490692138672, 0.16259261965751648, 0.030158255249261856)",0.6870752958828588,0.16259261965751648,0,1,"[{'label': 'positive', 'score': 0.8597789406776428}, {'label': 'neutral', 'score': 0.13773773610591888}, {'label': 'negative', 'score': 0.002483326243236661}]","(0.13773773610591888, 0.8597789406776428, 0.002483326243236661)",0.9942399746840261,0.8597789406776428,0,0
2011-05-23,22.689180374145508,35.209922790527344,35.29580307006836,34.9427490234375,34.99045944213867,13201761.0,Europe's sovereign-debt crisis Effects on Drug Stocks | Vertex Hepatitis C Drug Approved by the FDA -Bloomberg,-0.000812994917698349,-0.001444304863436889,0.05140549302147744,"[{'label': 'neutral', 'score': 0.9851216077804565}, {'label': 'negative', 'score': 0.013639558106660843}, {'label': 'positive', 'score': 0.0012387996539473534}]","(0.9851216077804565, 0.0012387996539473534, 0.013639558106660843)",-0.8334762916876232,-0.013639558106660843,0,1,"[{'label': 'negative', 'score': 0.9351877570152283}, {'label': 'neutral', 'score': 0.045668043196201324}, {'label': 'positive', 'score': 0.019144196063280106}]","(0.045668043196201324, 0.019144196063280106, 0.9351877570152283)",-0.959879377397929,-0.9351877570152283,0,0,"[{'label': 'neutral', 'score': 0.9958255290985107}, {'label': 'positive', 'score': 0.0028310210909694433}, {'label': 'negative', 'score': 0.0013434780994430184}]","(0.9958255290985107, 0.0028310210909694433, 0.0013434780994430184)",0.35634046712545847,0.0028310210909694433,1,1
2011-05-24,22.67073631286621,35.181297302246094,35.343509674072266,35.10496139526367,35.200382232666016,12074742.0,FTC Files Amicus Brief In K-dur Antitrust Litigation -Bloomberg,-0.004882046927069971,-0.0008133255772950029,0.0520938894844603,"[{'label': 'neutral', 'score': 0.9998511075973511}, {'label': 'negative', 'score': 9.842756116995588e-05}, {'label': 'positive', 'score': 5.038976451032795e-05}]","(0.9998511075973511, 5.038976451032795e-05, 9.842756116995588e-05)",-0.32279706976344524,-9.842756116995588e-05,1,1,"[{'label': 'neutral', 'score': 0.6074119210243225}, {'label': 'negative', 'score': 0.3623017370700836}, {'label': 'positive', 'score': 0.030286338180303574}]","(0.6074119210243225, 0.030286338180303574, 0.3623017370700836)",-0.8457093320474017,-0.3623017370700836,0,1,"[{'label': 'neutral', 'score': 0.999427080154419}, {'label': 'positive', 'score': 0.00042812517494894564}, {'label': 'negative', 'score': 0.0001448537950636819}]","(0.999427080154419, 0.00042812517494894564, 0.0001448537950636819)",0.4943835545640024,0.00042812517494894564,1,1
2011-05-25,22.56005477905273,35.00954055786133,35.171756744384766,34.91412353515625,34.98091506958008,11801947.0,,-0.008449104177251837,-0.004894003047602849,0.02598353146592407,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-05-26,22.36943817138672,34.713741302490234,35.114505767822266,34.446563720703125,35.00954055786133,17826794.0,InSite Vision Announces Joint Patent Infringement Lawsuit with Merck Against Sandoz    | Joel Greenblatt: One Bubble After Another,-0.00467296754647995,-0.008485000193746864,0.051705925768091174,"[{'label': 'neutral', 'score': 0.9996610879898071}, {'label': 'positive', 'score': 0.00022454735881183296}, {'label': 'negative', 'score': 0.00011441119568189606}]","(0.9996610879898071, 0.00022454735881183296, 0.00011441119568189606)",0.32492516170431834,0.00022454735881183296,1,1,"[{'label': 'neutral', 'score': 0.6033502817153931}, {'label': 'negative', 'score': 0.3507471978664398}, {'label': 'positive', 'score': 0.04590250179171562}]","(0.6033502817153931, 0.04590250179171562, 0.3507471978664398)",-0.7685489144135202,-0.3507471978664398,0,1,"[{'label': 'negative', 'score': 0.7540065050125122}, {'label': 'neutral', 'score': 0.1479942798614502}, {'label': 'positive', 'score': 0.09799930453300476}]","(0.1479942798614502, 0.09799930453300476, 0.7540065050125122)",-0.7699562527976652,-0.7540065050125122,0,0
2011-05-27,22.264907836914062,34.5515251159668,34.904579162597656,34.42748260498047,34.70419692993164,10996559.0,Morgan Stanley Reports on Merck,0.0037282741602930177,-0.004683919992929845,0.04895949882426981,"[{'label': 'neutral', 'score': 0.9998806715011597}, {'label': 'negative', 'score': 6.781149568269029e-05}, {'label': 'positive', 'score': 5.155147664481774e-05}]","(0.9998806715011597, 5.155147664481774e-05, 6.781149568269029e-05)",-0.13622330879343658,-6.781149568269029e-05,1,1,"[{'label': 'neutral', 'score': 0.9161089658737183}, {'label': 'negative', 'score': 0.060729753226041794}, {'label': 'positive', 'score': 0.023161252960562706}]","(0.9161089658737183, 0.023161252960562706, 0.060729753226041794)",-0.4478251242083437,-0.060729753226041794,1,1,"[{'label': 'neutral', 'score': 0.9995848536491394}, {'label': 'positive', 'score': 0.0002672722330316901}, {'label': 'negative', 'score': 0.00014788749103900045}]","(0.9995848536491394, 0.0002672722330316901, 0.00014788749103900045)",0.28756340047177037,0.0002672722330316901,1,1
2011-05-28,22.347917079925537,34.68034267425537,34.94751834869385,34.48950481414795,34.70896816253662,12124102.25,,0.0037144257627016106,0.003721341372398866,0.07380418633079366,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-29,22.43092632293701,34.809160232543945,34.99045753479004,34.55152702331543,34.7137393951416,13251645.5,,0.003700679862082381,0.0037075443184731876,0.08797948011329829,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-30,22.513935565948486,34.93797779083252,35.03339672088623,34.61354923248291,34.71851062774658,14379188.75,,0.003687035324705457,0.0036938491932539067,0.09199539195717014,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-05-31,22.59694480895996,35.066795349121094,35.07633590698242,34.67557144165039,34.72328186035156,15506732.0,Health Canada Approves Gardasil to Prevent Anal Cancer,-0.013605473997965745,0.003680254871365764,0.05952573006790442,"[{'label': 'positive', 'score': 0.9958987832069397}, {'label': 'neutral', 'score': 0.00375759182497859}, {'label': 'negative', 'score': 0.00034357275580987334}]","(0.00375759182497859, 0.9958987832069397, 0.00034357275580987334)",0.9993102627011319,0.9958987832069397,0,0,"[{'label': 'neutral', 'score': 0.544788658618927}, {'label': 'positive', 'score': 0.44238463044166565}, {'label': 'negative', 'score': 0.012826720252633095}]","(0.544788658618927, 0.44238463044166565, 0.012826720252633095)",0.9436449893744104,0.44238463044166565,0,0,"[{'label': 'positive', 'score': 0.9959731698036194}, {'label': 'neutral', 'score': 0.003679499728605151}, {'label': 'negative', 'score': 0.0003473086399026215}]","(0.003679499728605151, 0.9959731698036194, 0.0003473086399026215)",0.9993028174218698,0.9959731698036194,0,0
2011-06-01,22.28950881958008,34.58969497680664,35.066795349121094,34.54198455810547,34.92366409301758,11847011.0,"Hapoalim Securities Terminates Healthcare Coverage Including Bristol-Myers, Eli Lilly, Merck and Pfizer | Hapoalim Cutting Ocverage On Multitude Of Names",-0.0027586492874923036,-0.013698876618169072,0.12352531609793123,"[{'label': 'neutral', 'score': 0.9997652173042297}, {'label': 'negative', 'score': 0.00018708679999690503}, {'label': 'positive', 'score': 4.770938176079653e-05}]","(0.9997652173042297, 4.770938176079653e-05, 0.00018708679999690503)",-0.5936102418391936,-0.00018708679999690503,0,1,"[{'label': 'negative', 'score': 0.9023468494415283}, {'label': 'neutral', 'score': 0.07325024157762527}, {'label': 'positive', 'score': 0.024402938783168793}]","(0.07325024157762527, 0.024402938783168793, 0.9023468494415283)",-0.9473365106887899,-0.9023468494415283,0,0,"[{'label': 'negative', 'score': 0.9593930840492249}, {'label': 'neutral', 'score': 0.03947240859270096}, {'label': 'positive', 'score': 0.0011345728999003768}]","(0.03947240859270096, 0.0011345728999003768, 0.9593930840492249)",-0.9976376049316392,-0.9593930840492249,0,0
2011-06-02,22.22801780700684,34.4942741394043,34.58969497680664,34.28435134887695,34.52289962768555,11086478.0,My Top 20 Defensive Stock Plays | FDA: Treatment With Angiotensin Receptor Blockers for High Blood Pressure Does Not Increase Risk of Cancer  | FDA Says that High Blood Pressure Drugs Do Not Increase Cancer Risk -Bloomberg,-0.009128592893952502,-0.002762461372856399,0.12048868699675704,"[{'label': 'neutral', 'score': 0.8571113348007202}, {'label': 'positive', 'score': 0.12352555245161057}, {'label': 'negative', 'score': 0.019363082945346832}]","(0.8571113348007202, 0.12352555245161057, 0.019363082945346832)",0.7289765852748966,0.12352555245161057,0,1,"[{'label': 'neutral', 'score': 0.8995350003242493}, {'label': 'positive', 'score': 0.07519803196191788}, {'label': 'negative', 'score': 0.025266941636800766}]","(0.8995350003242493, 0.07519803196191788, 0.025266941636800766)",0.49699998453743627,0.07519803196191788,1,1,"[{'label': 'neutral', 'score': 0.9964074492454529}, {'label': 'positive', 'score': 0.003131457604467869}, {'label': 'negative', 'score': 0.00046108089736662805}]","(0.9964074492454529, 0.003131457604467869, 0.00046108089736662805)",0.743311924350327,0.003131457604467869,0,1
2011-06-03,22.02510452270508,34.17938995361328,34.3797721862793,34.12213516235352,34.15076446533203,10359690.0,"Hepatitis C Virus (HCV) Updates from Biotech/Pharma Stocks | Pimco's Gross Likes P&G and Merck, Offer Better Yields and Conservative -Bloomberg | Pimco's Gross Says Procter & Gamble and Merck are Relatively Attractive to Savers -Bloomberg",-0.0024195151103621267,-0.00917051381242041,0.12293995791044275,"[{'label': 'positive', 'score': 0.9995049238204956}, {'label': 'negative', 'score': 0.0002844862174242735}, {'label': 'neutral', 'score': 0.00021057977573946118}]","(0.00021057977573946118, 0.9995049238204956, 0.0002844862174242735)",0.9994309077200298,0.9995049238204956,0,0,"[{'label': 'positive', 'score': 0.8648519515991211}, {'label': 'neutral', 'score': 0.12427044659852982}, {'label': 'negative', 'score': 0.010877631604671478}]","(0.12427044659852982, 0.8648519515991211, 0.010877631604671478)",0.9751575559092649,0.8648519515991211,0,0,"[{'label': 'positive', 'score': 0.9943848848342896}, {'label': 'neutral', 'score': 0.005317163188010454}, {'label': 'negative', 'score': 0.00029790791450068355}]","(0.005317163188010454, 0.9943848848342896, 0.00029790791450068355)",0.9994009991593854,0.9943848848342896,0,0
2011-06-04,21.97181447347005,34.096692403157554,34.316158294677734,34.036258697509766,34.122137705485024,10273230.0,,-0.002425383362055248,-0.002422446866954357,0.10648424743078766,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-05,21.918524424235027,34.01399485270182,34.25254440307617,33.950382232666016,34.09351094563802,10186770.0,,-0.0024312801484756476,-0.002428329368709388,0.08145480806389066,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-06,21.865234375,33.931297302246094,34.18893051147461,33.864505767822266,34.064884185791016,10100310.0,Merck and ARIAD Announce Presentation of Results of Phase III SUCCEED Trial at American Society of Clinical Oncology Annual Meeting ,0.00028128522389157096,-0.0024342405093402877,0.04732749169363294,"[{'label': 'neutral', 'score': 0.99986732006073}, {'label': 'negative', 'score': 7.233636279124767e-05}, {'label': 'positive', 'score': 6.028311690897681e-05}]","(0.99986732006073, 6.028311690897681e-05, 7.233636279124767e-05)",-0.09088593854776265,-7.233636279124767e-05,1,1,"[{'label': 'neutral', 'score': 0.9053301215171814}, {'label': 'positive', 'score': 0.07727137953042984}, {'label': 'negative', 'score': 0.01739848218858242}]","(0.9053301215171814, 0.07727137953042984, 0.01739848218858242)",0.6324388380280408,0.07727137953042984,0,1,"[{'label': 'neutral', 'score': 0.9812886714935303}, {'label': 'positive', 'score': 0.01852467656135559}, {'label': 'negative', 'score': 0.00018670553981792182}]","(0.9812886714935303, 0.01852467656135559, 0.00018670553981792182)",0.9800436398756228,0.01852467656135559,0,1
2011-06-07,21.87139129638672,33.94084167480469,34.46564865112305,33.931297302246094,34.16984558105469,10531457.0,Bank of America Merrill Lynch Maintains Buy on Merck & Co. | Roche and Merck Collaborate to Develop Diagnostic Tests for Merck's Investigational Cancer Therapies   ,0.006184961249301481,0.00028124567061999547,0.055869745537811676,"[{'label': 'neutral', 'score': 0.8971641659736633}, {'label': 'positive', 'score': 0.10247666388750076}, {'label': 'negative', 'score': 0.00035915954504162073}]","(0.8971641659736633, 0.10247666388750076, 0.00035915954504162073)",0.9930148943616478,0.10247666388750076,0,1,"[{'label': 'neutral', 'score': 0.8597685694694519}, {'label': 'positive', 'score': 0.13026069104671478}, {'label': 'negative', 'score': 0.009970754384994507}]","(0.8597685694694519, 0.13026069104671478, 0.009970754384994507)",0.8577957411149966,0.13026069104671478,0,1,"[{'label': 'positive', 'score': 0.9946183562278748}, {'label': 'neutral', 'score': 0.00507692527025938}, {'label': 'negative', 'score': 0.0003047818609047681}]","(0.00507692527025938, 0.9946183562278748, 0.0003047818609047681)",0.9993873258159616,0.9946183562278748,0,0
2011-06-08,22.00666046142578,34.15076446533203,34.303436279296875,33.845420837402344,33.902671813964844,12646635.0,"Merck Announces U.S. Prescribing Information for Simvastatin Revised to Include New Limits on the Use of the Highest Dose and Updated Drug Interaction Information   | UPDATE: Merck and Intercell AG Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710 ",0.0058675767820492745,0.006165912878415556,0.05920986013382754,"[{'label': 'neutral', 'score': 0.9996784925460815}, {'label': 'positive', 'score': 0.00025041765184141695}, {'label': 'negative', 'score': 7.109768921509385e-05}]","(0.9996784925460815, 0.00025041765184141695, 7.109768921509385e-05)",0.5577337679660055,0.00025041765184141695,0,1,"[{'label': 'neutral', 'score': 0.4986894726753235}, {'label': 'negative', 'score': 0.42106497287750244}, {'label': 'positive', 'score': 0.08024553954601288}]","(0.4986894726753235, 0.08024553954601288, 0.42106497287750244)",-0.6798569447184457,-0.42106497287750244,0,1,"[{'label': 'neutral', 'score': 0.9846420884132385}, {'label': 'positive', 'score': 0.014621187932789326}, {'label': 'negative', 'score': 0.0007368416991084814}]","(0.9846420884132385, 0.014621187932789326, 0.0007368416991084814)",0.904044761369896,0.014621187932789326,0,1
2011-06-09,22.135780334472656,34.35114669799805,34.713741302490234,34.15076446533203,34.23664093017578,14247979.0,5-Alpha Reductase Inhibitors May Increase Risk of Prostate Cancer -FDA,-0.015277824511349151,0.005850429595662784,0.06785842357737998,"[{'label': 'negative', 'score': 0.9884746670722961}, {'label': 'neutral', 'score': 0.00711536081507802}, {'label': 'positive', 'score': 0.004409931134432554}]","(0.00711536081507802, 0.004409931134432554, 0.9884746670722961)",-0.9911169311269458,-0.9884746670722961,1,1,"[{'label': 'neutral', 'score': 0.6130144000053406}, {'label': 'positive', 'score': 0.3567869961261749}, {'label': 'negative', 'score': 0.03019859455525875}]","(0.6130144000053406, 0.3567869961261749, 0.03019859455525875)",0.8439291008118273,0.3567869961261749,0,0,"[{'label': 'negative', 'score': 0.8784213662147522}, {'label': 'neutral', 'score': 0.11944539099931717}, {'label': 'positive', 'score': 0.002133255358785391}]","(0.11944539099931717, 0.002133255358785391, 0.8784213662147522)",-0.9951547460963335,-0.8784213662147522,1,1
2011-06-10,21.79760360717773,33.82633590698242,34.23664093017578,33.74045944213867,34.23664093017578,12472248.0,,-0.0011283690133937156,-0.015395732936608487,0.13955980605281643,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-11,21.851469039916992,33.788167317708336,34.112595876057945,33.63549677530924,33.96628443400065,11103210.666666666,,-0.001129643668305418,-0.0011290061010006429,0.13908428884404517,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-12,21.90533447265625,33.74999872843424,33.9885508219401,33.53053410847982,33.69592793782552,9734173.333333334,,-0.0011309212062850296,-0.001130282196632323,0.13872445633143118,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-13,21.959199905395508,33.71183013916016,33.864505767822266,33.42557144165039,33.42557144165039,8365136.0,,0.008774458961358794,-0.0011315611802246424,0.12337769549828298,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-14,22.151880264282227,34.00763320922852,34.23664093017578,33.71183013916016,33.88358688354492,13224607.0,Build a Wealthy Portfolio with These Economic Moats,-0.013187477095921786,0.008736187109915186,0.13678357283961762,"[{'label': 'neutral', 'score': 0.9998459815979004}, {'label': 'positive', 'score': 8.284500654553995e-05}, {'label': 'negative', 'score': 7.118118810467422e-05}]","(0.9998459815979004, 8.284500654553995e-05, 7.118118810467422e-05)",0.07572620012689191,8.284500654553995e-05,1,1,"[{'label': 'neutral', 'score': 0.5279215574264526}, {'label': 'positive', 'score': 0.4642189145088196}, {'label': 'negative', 'score': 0.007859510369598866}]","(0.5279215574264526, 0.4642189145088196, 0.007859510369598866)",0.9667025224818395,0.4642189145088196,0,1,"[{'label': 'neutral', 'score': 0.9982244372367859}, {'label': 'positive', 'score': 0.001583483419381082}, {'label': 'negative', 'score': 0.0001920768991112709}]","(0.9982244372367859, 0.001583483419381082, 0.0001920768991112709)",0.7836436226797798,0.001583483419381082,0,1
2011-06-15,21.859750747680664,33.55915832519531,33.845420837402344,33.38740539550781,33.845420837402344,12733305.0,,0.0002844044080637175,-0.013275203989867724,0.12393509844209387,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-16,21.865968704223636,33.568702697753906,33.74045944213867,33.39694595336914,33.53053283691406,10610057.0,,0.0059693171484825735,0.0002843639727964551,0.12466742657680853,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-17,21.996492385864254,33.76908493041992,34.13167953491211,33.568702697753906,33.77862548828125,15770828.0,,0.0037675439503176773,0.005951571360014405,0.1349964676054208,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-18,22.07936731974284,33.89631144205729,34.14440155029297,33.581424713134766,33.743638356526695,14280607.0,,0.003753402840154359,0.0037604645323829635,0.13661269772413184,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-19,22.162242253621415,34.023537953694664,34.15712356567383,33.594146728515625,33.70865122477213,12790386.0,,0.003739367487605789,0.003746376400265456,0.12292902851926528,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-20,22.2451171875,34.15076446533203,34.16984558105469,33.606868743896484,33.67366409301758,11300165.0,Ligand Enters into Captisol Commercial Supply Agreement with Merck   ,-0.0002794775668428351,0.0037323934332966014,0.032273448108078404,"[{'label': 'neutral', 'score': 0.999832272529602}, {'label': 'positive', 'score': 0.00011480385001050308}, {'label': 'negative', 'score': 5.287026215228252e-05}]","(0.999832272529602, 0.00011480385001050308, 5.287026215228252e-05)",0.3693688134641359,0.00011480385001050308,1,1,"[{'label': 'positive', 'score': 0.7141648530960083}, {'label': 'neutral', 'score': 0.27836379408836365}, {'label': 'negative', 'score': 0.0074714068323373795}]","(0.27836379408836365, 0.7141648530960083, 0.0074714068323373795)",0.97929315017214,0.7141648530960083,0,0,"[{'label': 'neutral', 'score': 0.7302038669586182}, {'label': 'positive', 'score': 0.2692044675350189}, {'label': 'negative', 'score': 0.0005916306399740279}]","(0.7302038669586182, 0.2692044675350189, 0.0005916306399740279)",0.9956142387234208,0.2692044675350189,0,1
2011-06-21,22.2388916015625,34.14122009277344,34.32251739501953,33.979007720947266,34.26526641845703,9013953.0,,-0.00866399193020359,-0.0002795166279760391,0.03585687454526545,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-06-22,22.04621315002441,33.845420837402344,34.064884185791016,33.79771041870117,33.94084167480469,8071277.0,,-0.014096452651793082,-0.008701742513615081,0.0858126738478399,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-06-23,21.73543930053711,33.36832046508789,33.70228958129883,32.95801544189453,33.520992279052734,20409695.0,,-0.012010327752376303,-0.014196751326463291,0.12700079198729192,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-24,21.474384307861328,32.96755599975586,33.463741302490234,32.91984558105469,33.41603088378906,17395647.0,Morgan Stanley Reiterates Equal-Weight on Merck | High Yield Big Pharmaceutical Stocks,-0.00019292822032672223,-0.012083034479568502,0.12256968281834998,"[{'label': 'neutral', 'score': 0.9215510487556458}, {'label': 'positive', 'score': 0.07812616229057312}, {'label': 'negative', 'score': 0.0003227741690352559}]","(0.9215510487556458, 0.07812616229057312, 0.0003227741690352559)",0.9917711014679862,0.07812616229057312,0,1,"[{'label': 'neutral', 'score': 0.6931144595146179}, {'label': 'positive', 'score': 0.17214195430278778}, {'label': 'negative', 'score': 0.1347436010837555}]","(0.6931144595146179, 0.17214195430278778, 0.1347436010837555)",0.12186416910996842,0.17214195430278778,1,1,"[{'label': 'positive', 'score': 0.8523769378662109}, {'label': 'neutral', 'score': 0.1410185545682907}, {'label': 'negative', 'score': 0.006604496855288744}]","(0.1410185545682907, 0.8523769378662109, 0.006604496855288744)",0.9846224922022208,0.8523769378662109,0,0
2011-06-25,21.47024472554525,32.961195627848305,33.346056620279946,32.87849807739258,33.298346201578774,15388727.0,,-0.0001929654488071296,-0.00019294683336980767,0.10409188638366516,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-26,21.466105143229168,32.95483525594076,33.228371938069664,32.83715057373047,33.18066151936849,13381807.0,,-0.00019300269165836202,-0.00019298406903472089,0.10444980757565082,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-27,21.46196556091309,32.9484748840332,33.110687255859375,32.79580307006836,33.0629768371582,11374887.0,"Stocks Shrug Off Greece, Deficit Uncertainty",0.011004897973833092,-0.0001930213190746326,0.11319449082041547,"[{'label': 'negative', 'score': 0.9977864027023315}, {'label': 'positive', 'score': 0.0012161764316260815}, {'label': 'neutral', 'score': 0.000997371505945921}]","(0.000997371505945921, 0.0012161764316260815, 0.9977864027023315)",-0.9975652186350101,-0.9977864027023315,0,0,"[{'label': 'neutral', 'score': 0.38736647367477417}, {'label': 'negative', 'score': 0.38059744238853455}, {'label': 'positive', 'score': 0.2320360541343689}]","(0.38736647367477417, 0.2320360541343689, 0.38059744238853455)",-0.2424963523825401,-0.38059744238853455,1,1,"[{'label': 'negative', 'score': 0.9980688691139221}, {'label': 'neutral', 'score': 0.0013812534743919969}, {'label': 'positive', 'score': 0.0005499229300767183}]","(0.0013812534743919969, 0.0005499229300767183, 0.9980688691139221)",-0.9988986329228772,-0.9980688691139221,0,0
2011-06-28,21.698148727416992,33.31106948852539,33.39694595336914,32.91984558105469,33.0057258605957,10468577.0,A Peek Into The Market Before The Trading Starts | UPS and Merck Expand Their Distribution and Logistics Agreement,0.005442554232866793,0.01094478470892641,0.12928468747219704,"[{'label': 'neutral', 'score': 0.9998286962509155}, {'label': 'positive', 'score': 0.00012586764933075756}, {'label': 'negative', 'score': 4.540327427093871e-05}]","(0.9998286962509155, 0.00012586764933075756, 4.540327427093871e-05)",0.46980756200594187,0.00012586764933075756,1,1,"[{'label': 'positive', 'score': 0.8193268179893494}, {'label': 'neutral', 'score': 0.17207813262939453}, {'label': 'negative', 'score': 0.008595049381256104}]","(0.17207813262939453, 0.8193268179893494, 0.008595049381256104)",0.9792370519006749,0.8193268179893494,0,0,"[{'label': 'positive', 'score': 0.9984968900680542}, {'label': 'neutral', 'score': 0.0011827880516648293}, {'label': 'negative', 'score': 0.00032038247445598245}]","(0.0011827880516648293, 0.9984968900680542, 0.00032038247445598245)",0.9993584763033975,0.9984968900680542,0,0
2011-06-29,21.81624794006348,33.492366790771484,33.67366409301758,33.225189208984375,33.34923553466797,13420793.0,,0.005413093179668884,0.005427797054857801,0.0791632258098849,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-06-30,21.93434333801269,33.67366409301758,33.845420837402344,33.492366790771484,33.606868743896484,13363258.0,,0.008784404015293833,0.005398495047786418,0.07403517423598356,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-01,22.12702178955078,33.96946716308594,34.093509674072266,33.549617767333984,33.55915832519531,10356231.0,"Merck Receives Approval to Market GARDASIL, ZOLINZA and CUBICIN in Japan",-0.0007724686610460857,0.008746045611808351,0.0668867973813831,"[{'label': 'positive', 'score': 0.9984685778617859}, {'label': 'neutral', 'score': 0.0012215393362566829}, {'label': 'negative', 'score': 0.0003098479937762022}]","(0.0012215393362566829, 0.9984685778617859, 0.0003098479937762022)",0.9993795460819835,0.9984685778617859,0,0,"[{'label': 'positive', 'score': 0.9038257002830505}, {'label': 'neutral', 'score': 0.08733395487070084}, {'label': 'negative', 'score': 0.00884037371724844}]","(0.08733395487070084, 0.9038257002830505, 0.00884037371724844)",0.9806273642264355,0.9038257002830505,0,0,"[{'label': 'positive', 'score': 0.9988301396369934}, {'label': 'neutral', 'score': 0.0008407984860241413}, {'label': 'negative', 'score': 0.0003290233144070953}]","(0.0008407984860241413, 0.9988301396369934, 0.0003290233144070953)",0.9993413995955656,0.9988301396369934,0,0
2011-07-02,22.109929084777832,33.94322681427002,34.08396816253662,33.61641216278076,33.640265464782715,10121610.0,,-0.0007730658301728198,-0.00077276716869733,0.07034135365311882,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-03,22.092836380004883,33.9169864654541,34.07442665100098,33.68320655822754,33.72137260437012,9886989.0,,-0.0007736639233159728,-0.0007733647996536618,0.06702374713469222,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-04,22.075743675231934,33.890746116638184,34.06488513946533,33.75000095367432,33.80247974395752,9652368.0,,-0.0007742629426218398,-0.0007739633556991177,0.0707564420006117,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-05,22.058650970458984,33.864505767822266,34.05534362792969,33.816795349121094,33.88358688354492,9417747.0,,0.001127022092223863,-0.000774562838983083,0.06758323856441575,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-06,22.08351325988769,33.902671813964844,33.988548278808594,33.75,33.874046325683594,11326050.0,,0.005628991754827237,0.0011263874795959608,0.013489035396564942,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-07-07,22.20781898498535,34.093509674072266,34.303436279296875,33.82633590698242,34.12213516235352,12800482.0,Goldman Sachs Suggests Buying Calls on Merck & Co.,0.010915244004162728,0.005613208183434031,0.04395740656671539,"[{'label': 'neutral', 'score': 0.9972146153450012}, {'label': 'positive', 'score': 0.0026046675629913807}, {'label': 'negative', 'score': 0.00018069536599796265}]","(0.9972146153450012, 0.0026046675629913807, 0.00018069536599796265)",0.870253628985055,0.0026046675629913807,1,0,"[{'label': 'neutral', 'score': 0.5397769808769226}, {'label': 'negative', 'score': 0.3914839029312134}, {'label': 'positive', 'score': 0.06873911619186401}]","(0.5397769808769226, 0.06873911619186401, 0.3914839029312134)",-0.7012791045400486,-0.3914839029312134,0,0,"[{'label': 'positive', 'score': 0.9578936696052551}, {'label': 'neutral', 'score': 0.04173089191317558}, {'label': 'negative', 'score': 0.0003754294593818486}]","(0.04173089191317558, 0.9578936696052551, 0.0003754294593818486)",0.9992164425217336,0.9578936696052551,1,1
2011-07-08,22.45022773742676,34.46564865112305,34.53244400024414,34.13167953491211,34.23664093017578,15752383.0,Hottest and Coldest Sectors for Friday 7/8/11 | Teva and Merck Settle Patent Dispute Over Generic Vytorin; Teva Will Not Sell Generic Until 2017,-0.004060522070390996,0.010856102700307143,0.07950277832212214,"[{'label': 'negative', 'score': 0.885493278503418}, {'label': 'neutral', 'score': 0.1108006089925766}, {'label': 'positive', 'score': 0.003706043353304267}]","(0.1108006089925766, 0.003706043353304267, 0.885493278503418)",-0.9916643135859219,-0.885493278503418,0,0,"[{'label': 'negative', 'score': 0.9121280312538147}, {'label': 'neutral', 'score': 0.07472141087055206}, {'label': 'positive', 'score': 0.013150560669600964}]","(0.07472141087055206, 0.013150560669600964, 0.9121280312538147)",-0.9715749163886644,-0.9121280312538147,0,0,"[{'label': 'neutral', 'score': 0.9248698949813843}, {'label': 'positive', 'score': 0.05463080480694771}, {'label': 'negative', 'score': 0.020499296486377716}]","(0.9248698949813843, 0.05463080480694771, 0.020499296486377716)",0.4542987129394732,0.05463080480694771,1,1
2011-07-09,22.35906473795573,34.32570012410482,34.45928827921549,34.04898198445638,34.26208623250326,14082220.333333334,,-0.004077077132068654,-0.004068788374728819,0.09231211806078174,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-10,22.2679017384847,34.185751597086586,34.38613255818685,33.96628443400065,34.28753153483073,12412057.666666668,,-0.004093767738900719,-0.004085411070826089,0.1022794747553906,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-11,22.176738739013672,34.04580307006836,34.3129768371582,33.88358688354492,34.3129768371582,10741895.0,Merck to Participate in New Research Efforts to Eradicate HIV   ,-0.0014013597682798345,-0.00410217014555846,0.11108943840374944,"[{'label': 'neutral', 'score': 0.9997820258140564}, {'label': 'positive', 'score': 0.00015786393487360328}, {'label': 'negative', 'score': 6.001389192533679e-05}]","(0.9997820258140564, 0.00015786393487360328, 6.001389192533679e-05)",0.44910509887985767,0.00015786393487360328,1,1,"[{'label': 'positive', 'score': 0.7726972103118896}, {'label': 'neutral', 'score': 0.21965292096138}, {'label': 'negative', 'score': 0.007649899460375309}]","(0.21965292096138, 0.7726972103118896, 0.007649899460375309)",0.980393598272933,0.7726972103118896,0,0,"[{'label': 'neutral', 'score': 0.9025598764419556}, {'label': 'positive', 'score': 0.09709516167640686}, {'label': 'negative', 'score': 0.00034498260356485844}]","(0.9025598764419556, 0.09709516167640686, 0.00034498260356485844)",0.9929190867662586,0.09709516167640686,0,1
2011-07-12,22.145660400390625,33.99809265136719,34.3797721862793,33.950382232666016,34.10305404663086,12410835.0,Twelve ETFs Trading Near 52-Week Highs,0.011226498463488381,-0.0014023425911795168,0.1029777346055013,"[{'label': 'positive', 'score': 0.9083049893379211}, {'label': 'neutral', 'score': 0.09013839066028595}, {'label': 'negative', 'score': 0.0015566720394417644}]","(0.09013839066028595, 0.9083049893379211, 0.0015566720394417644)",0.9965782225902666,0.9083049893379211,0,0,"[{'label': 'positive', 'score': 0.5138091444969177}, {'label': 'negative', 'score': 0.25151342153549194}, {'label': 'neutral', 'score': 0.2346774935722351}]","(0.2346774935722351, 0.5138091444969177, 0.25151342153549194)",0.34272571410146835,0.5138091444969177,1,0,"[{'label': 'neutral', 'score': 0.9974915981292725}, {'label': 'positive', 'score': 0.002374381059780717}, {'label': 'negative', 'score': 0.00013404090714175254}]","(0.9974915981292725, 0.002374381059780717, 0.00013404090714175254)",0.8931273056054404,0.002374381059780717,0,1
2011-07-13,22.3942813873291,34.3797721862793,34.799617767333984,33.99809265136719,34.064884185791016,14150201.0,Twelve Health Care ETFs Trading Near 52-Week Highs,0.007771248908870628,0.011163949034960293,0.10512861418794285,"[{'label': 'positive', 'score': 0.9953311085700989}, {'label': 'neutral', 'score': 0.003884395118802786}, {'label': 'negative', 'score': 0.0007844119099900126}]","(0.003884395118802786, 0.9953311085700989, 0.0007844119099900126)",0.9984250583514411,0.9953311085700989,0,0,"[{'label': 'negative', 'score': 0.4287058711051941}, {'label': 'positive', 'score': 0.3124985992908478}, {'label': 'neutral', 'score': 0.25879549980163574}]","(0.25879549980163574, 0.3124985992908478, 0.4287058711051941)",-0.15678166613357608,-0.4287058711051941,1,1,"[{'label': 'neutral', 'score': 0.9981672763824463}, {'label': 'positive', 'score': 0.0017031244933605194}, {'label': 'negative', 'score': 0.000129598134662956}]","(0.9981672763824463, 0.0017031244933605194, 0.000129598134662956)",0.8585731057375301,0.0017031244933605194,0,1
2011-07-14,22.56831169128418,34.64694595336914,34.885494232177734,34.3702278137207,34.51335906982422,16066888.0,5 High Dividend Names For Sound Sleeping,-0.010465413170332494,0.007741208289116633,0.11300216241764745,"[{'label': 'neutral', 'score': 0.9998775720596313}, {'label': 'negative', 'score': 6.711925379931927e-05}, {'label': 'positive', 'score': 5.535783202503808e-05}]","(0.9998775720596313, 5.535783202503808e-05, 6.711925379931927e-05)",-0.09602956908321673,-6.711925379931927e-05,1,1,"[{'label': 'neutral', 'score': 0.7659586071968079}, {'label': 'positive', 'score': 0.20906725525856018}, {'label': 'negative', 'score': 0.02497413009405136}]","(0.7659586071968079, 0.20906725525856018, 0.02497413009405136)",0.7865836415519005,0.20906725525856018,0,1,"[{'label': 'neutral', 'score': 0.9939073920249939}, {'label': 'positive', 'score': 0.005954558029770851}, {'label': 'negative', 'score': 0.00013797746214549989}]","(0.9939073920249939, 0.005954558029770851, 0.00013797746214549989)",0.9547060620890695,0.005954558029770851,0,1
2011-07-15,22.332130432128903,34.28435134887695,34.770992279052734,34.04580307006836,34.66603088378906,15304678.0,,-0.004081994306793588,-0.010520560705347565,0.1402846816729856,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-16,22.240970611572266,34.144402821858726,34.57061004638672,33.92811838785807,34.45928827921549,13915379.333333334,,-0.004098725280052079,-0.004090348387510823,0.14025986810937807,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-17,22.149810791015625,34.00445429484049,34.3702278137207,33.81043370564779,34.25254567464193,12526080.666666668,,-0.004115593969095432,-0.0041071480775463735,0.14393261321644155,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-18,22.058650970458984,33.864505767822266,34.16984558105469,33.6927490234375,34.04580307006836,11136782.0,"Merck Announces VICTRELIS First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the EU for Treatment of Chronic Hepatitis C    | Merck's ISENTRESS in Combination Therapy Demonstrated Efficacy in a Phase II Study Extending to Nearly Five Years in Previously Untreated Adults with HIV-1 ",0.00845305995228095,-0.004124086334716116,0.10518240889983993,"[{'label': 'positive', 'score': 0.9734523892402649}, {'label': 'neutral', 'score': 0.026202723383903503}, {'label': 'negative', 'score': 0.00034486970980651677}]","(0.026202723383903503, 0.9734523892402649, 0.00034486970980651677)",0.9992917012106229,0.9734523892402649,0,0,"[{'label': 'positive', 'score': 0.9286091923713684}, {'label': 'neutral', 'score': 0.059942591935396194}, {'label': 'negative', 'score': 0.011448227800428867}]","(0.059942591935396194, 0.9286091923713684, 0.011448227800428867)",0.97564355633013,0.9286091923713684,0,0,"[{'label': 'positive', 'score': 0.9978972673416138}, {'label': 'neutral', 'score': 0.0017958339303731918}, {'label': 'negative', 'score': 0.00030682163196615875}]","(0.0017958339303731918, 0.9978972673416138, 0.00030682163196615875)",0.9993852527046214,0.9978972673416138,0,0
2011-07-19,22.2451171875,34.15076446533203,34.28435134887695,33.6927490234375,33.94084167480469,11879918.0,Dow Jones Industrial Average Companies Increase Expected Dividend Distribution by 12.66% From a Year Ago,-0.005588210916871844,0.008417532908756492,0.1095602374483851,"[{'label': 'positive', 'score': 0.999610960483551}, {'label': 'neutral', 'score': 0.00020531310292426497}, {'label': 'negative', 'score': 0.00018378380627837032}]","(0.00020531310292426497, 0.999610960483551, 0.00018378380627837032)",0.9996323569266031,0.999610960483551,0,0,"[{'label': 'positive', 'score': 0.9507694840431213}, {'label': 'neutral', 'score': 0.02532373182475567}, {'label': 'negative', 'score': 0.023906832560896873}]","(0.02532373182475567, 0.9507694840431213, 0.023906832560896873)",0.9509440577274034,0.9507694840431213,0,0,"[{'label': 'positive', 'score': 0.993949294090271}, {'label': 'neutral', 'score': 0.005594185553491116}, {'label': 'negative', 'score': 0.0004565699491649866}]","(0.005594185553491116, 0.993949294090271, 0.0004565699491649866)",0.9990817231360436,0.993949294090271,0,0
2011-07-20,22.120800018310547,33.959922790527344,34.24618148803711,33.89313125610352,34.24618148803711,8728058.0,Merck and Roche Expand Agreement in Fight Against Chronic Hepatitis C,0.016577683071624588,-0.005603883382129988,0.09214940344082335,"[{'label': 'positive', 'score': 0.9991132616996765}, {'label': 'neutral', 'score': 0.0006886317278258502}, {'label': 'negative', 'score': 0.00019804354815278202}]","(0.0006886317278258502, 0.9991132616996765, 0.00019804354815278202)",0.999603639932596,0.9991132616996765,1,1,"[{'label': 'positive', 'score': 0.9427100419998169}, {'label': 'neutral', 'score': 0.03856382891535759}, {'label': 'negative', 'score': 0.018726231530308723}]","(0.03856382891535759, 0.9427100419998169, 0.018726231530308723)",0.9610452984854603,0.9427100419998169,1,1,"[{'label': 'positive', 'score': 0.9987133741378784}, {'label': 'neutral', 'score': 0.0008886472787708044}, {'label': 'negative', 'score': 0.00039804342668503523}]","(0.0008886472787708044, 0.9987133741378784, 0.00039804342668503523)",0.9992032051287026,0.9987133741378784,1,1
2011-07-21,22.487518310546875,34.52289962768555,34.80915832519531,34.08396911621094,34.1984748840332,11933576.0,"Fifteen Health Care ETFs Trading Near 52-Week Highs | Earnings Preview: Gilead Sciences EPS, Revenue Expected to Rise from Previous Quarter",-0.002487521783218974,0.016441773273105278,0.15516478518459892,"[{'label': 'positive', 'score': 0.9996054768562317}, {'label': 'negative', 'score': 0.00025513162836432457}, {'label': 'neutral', 'score': 0.00013938535994384438}]","(0.00013938535994384438, 0.9996054768562317, 0.00025513162836432457)",0.9994896656069869,0.9996054768562317,0,0,"[{'label': 'positive', 'score': 0.9511258006095886}, {'label': 'neutral', 'score': 0.026020625606179237}, {'label': 'negative', 'score': 0.022853601723909378}]","(0.026020625606179237, 0.9511258006095886, 0.022853601723909378)",0.9530716939821194,0.9511258006095886,0,0,"[{'label': 'positive', 'score': 0.9988818764686584}, {'label': 'neutral', 'score': 0.0008194354013539851}, {'label': 'negative', 'score': 0.00029870172147639096}]","(0.0008194354013539851, 0.9988818764686584, 0.00029870172147639096)",0.99940210663018,0.9988818764686584,0,0
2011-07-22,22.43157768249512,34.4370231628418,34.790077209472656,34.29389190673828,34.627864837646484,7946250.0,"Earnings Preview: Mylan Laboratories EPS, Revenue Expected to Rise from Previous Quarter",-0.0018472529202292695,-0.002490620805854268,0.15140070412815496,"[{'label': 'positive', 'score': 0.9996521472930908}, {'label': 'negative', 'score': 0.00024326260609086603}, {'label': 'neutral', 'score': 0.00010463681974215433}]","(0.00010463681974215433, 0.9996521472930908, 0.00024326260609086603)",0.9995134238967746,0.9996521472930908,0,0,"[{'label': 'positive', 'score': 0.9540089964866638}, {'label': 'neutral', 'score': 0.026025136932730675}, {'label': 'negative', 'score': 0.01996583491563797}]","(0.026025136932730675, 0.9540089964866638, 0.01996583491563797)",0.9590013329463725,0.9540089964866638,0,0,"[{'label': 'positive', 'score': 0.9989990592002869}, {'label': 'neutral', 'score': 0.0007135006599128246}, {'label': 'negative', 'score': 0.00028742579161189497}]","(0.0007135006599128246, 0.9989990592002869, 0.00028742579161189497)",0.9994247379586761,0.9989990592002869,0,0
2011-07-23,22.390140533447266,34.373409271240234,34.65966924031576,34.211195627848305,34.437024434407554,9520101.666666666,,-0.001850671578707422,-0.0018489611959739659,0.14586324740185755,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-24,22.34870338439941,34.30979537963867,34.52926127115885,34.128499348958336,34.24618403116862,11093953.333333332,Earnings Expectations for the Week of July 25,-0.0018541029142748692,-0.0018523861871315179,0.13985605483658892,"[{'label': 'neutral', 'score': 0.999869704246521}, {'label': 'positive', 'score': 6.778268289053813e-05}, {'label': 'negative', 'score': 6.251465674722567e-05}]","(0.999869704246521, 6.778268289053813e-05, 6.251465674722567e-05)",0.040430803560210476,6.778268289053813e-05,1,1,"[{'label': 'neutral', 'score': 0.7384669780731201}, {'label': 'negative', 'score': 0.22693482041358948}, {'label': 'positive', 'score': 0.034598179161548615}]","(0.7384669780731201, 0.034598179161548615, 0.22693482041358948)",-0.7354201632852944,-0.22693482041358948,0,1,"[{'label': 'neutral', 'score': 0.9992509484291077}, {'label': 'positive', 'score': 0.00044445617822930217}, {'label': 'negative', 'score': 0.00030457545653916895}]","(0.9992509484291077, 0.00044445617822930217, 0.00030457545653916895)",0.18674875024920803,0.00044445617822930217,1,1
2011-07-25,22.30726623535156,34.24618148803711,34.39885330200195,34.04580307006836,34.05534362792969,12667805.0,Ratchet Back The Risk With These ETFs,-0.0027862091059235095,-0.0018558238906571504,0.13108186607916578,"[{'label': 'neutral', 'score': 0.63374263048172}, {'label': 'positive', 'score': 0.3336028754711151}, {'label': 'negative', 'score': 0.03265450894832611}]","(0.63374263048172, 0.3336028754711151, 0.03265450894832611)",0.8216854576183514,0.3336028754711151,0,1,"[{'label': 'neutral', 'score': 0.8719072937965393}, {'label': 'positive', 'score': 0.11086701601743698}, {'label': 'negative', 'score': 0.017225701361894608}]","(0.8719072937965393, 0.11086701601743698, 0.017225701361894608)",0.7310432362695108,0.11086701601743698,0,1,"[{'label': 'neutral', 'score': 0.9836853742599487}, {'label': 'positive', 'score': 0.01601148210465908}, {'label': 'negative', 'score': 0.0003031406085938215}]","(0.9836853742599487, 0.01601148210465908, 0.0003031406085938215)",0.9628381711398609,0.01601148210465908,0,1
2011-07-26,22.2451171875,34.15076446533203,34.360687255859375,34.01717758178711,34.274810791015625,10009762.0,"Earnings Preview: Merck EPS, Revenue Expected to Rise from Previous Quarter | Merck to Acquire Rights to Vernakalant i.v. in Canada, Mexico and the United States from Astellas ",-0.016764521048950126,-0.0027900978113584263,0.0070545210117246475,"[{'label': 'positive', 'score': 0.9996579885482788}, {'label': 'negative', 'score': 0.0002152585075236857}, {'label': 'neutral', 'score': 0.0001267690968234092}]","(0.0001267690968234092, 0.9996579885482788, 0.0002152585075236857)",0.9995694284087357,0.9996579885482788,0,0,"[{'label': 'positive', 'score': 0.9545809030532837}, {'label': 'neutral', 'score': 0.027157168835401535}, {'label': 'negative', 'score': 0.018261944875121117}]","(0.027157168835401535, 0.9545809030532837, 0.018261944875121117)",0.9624565367078382,0.9545809030532837,0,0,"[{'label': 'positive', 'score': 0.9990007281303406}, {'label': 'neutral', 'score': 0.0007210001349449158}, {'label': 'negative', 'score': 0.0002782756055239588}]","(0.0007210001349449158, 0.9990007281303406, 0.0002782756055239588)",0.9994430472280842,0.9990007281303406,0,0
2011-07-27,21.872182846069336,33.578243255615234,34.12213516235352,33.50190734863281,33.959922790527344,14979378.0,Hearing Supreme Court Asked to Overturn Obama's Health Care Reform,-0.007388380469500422,-0.01690663619925717,0.10540754548505837,"[{'label': 'neutral', 'score': 0.9993451237678528}, {'label': 'negative', 'score': 0.0004563287948258221}, {'label': 'positive', 'score': 0.00019854474521707743}]","(0.9993451237678528, 0.00019854474521707743, 0.0004563287948258221)",-0.393639433946068,-0.0004563287948258221,1,1,"[{'label': 'positive', 'score': 0.4076838195323944}, {'label': 'negative', 'score': 0.37163254618644714}, {'label': 'neutral', 'score': 0.22068364918231964}]","(0.22068364918231964, 0.4076838195323944, 0.37163254618644714)",0.04626012609486722,0.4076838195323944,1,1,"[{'label': 'neutral', 'score': 0.9967367053031921}, {'label': 'positive', 'score': 0.0028730579651892185}, {'label': 'negative', 'score': 0.0003902400203514844}]","(0.9967367053031921, 0.0028730579651892185, 0.0003902400203514844)",0.760830900469039,0.0028730579651892185,0,1
2011-07-28,21.710582733154297,33.33015441894531,33.73091506958008,33.29198455810547,33.64503860473633,14503796.0,How to Profit from Exploding Government Healthcare Costs ,-0.022902956290845,-0.007415809741258741,0.10211173721459048,"[{'label': 'positive', 'score': 0.9843320846557617}, {'label': 'neutral', 'score': 0.014993548393249512}, {'label': 'negative', 'score': 0.0006743400590494275}]","(0.014993548393249512, 0.9843320846557617, 0.0006743400590494275)",0.9986307905367324,0.9843320846557617,0,0,"[{'label': 'neutral', 'score': 0.8760178089141846}, {'label': 'positive', 'score': 0.09308916330337524}, {'label': 'negative', 'score': 0.030893096700310707}]","(0.8760178089141846, 0.09308916330337524, 0.030893096700310707)",0.5016529510045669,0.09308916330337524,0,0,"[{'label': 'positive', 'score': 0.9955750703811646}, {'label': 'neutral', 'score': 0.003599486080929637}, {'label': 'negative', 'score': 0.0008255007560364902}]","(0.003599486080929637, 0.9955750703811646, 0.0008255007560364902)",0.9983430343579704,0.9955750703811646,0,0
2011-07-29,21.21334648132324,32.566795349121094,33.110687255859375,32.49045944213867,33.053436279296875,20214348.0,"6 Deeply Undervalued Biotech Stocks | Looking at T. Boone Pickens' 6 Newest Energy Stock Buys | 5 Dividend Stocks to Hold Forever | 5 Stocks You Can Buy for Less Than Bill Gates Paid | AUD/USD: Trading the Reserve Bank of Australia Interest Rate Decision | 6 Safe Stocks for an Inflation Proof Portfolio | US Debt Ceiling Negotiations At Risk as Boehner Plan Vote Looms | 6 Companies That Could Be Acquired This Year | 8 REITs at High Risk of Cutting Dividends and 3 Safer Options | 10 Stocks Near $30 That Could Trade for $40 | 5 Core Dividend Stocks Underappreciated by Investors | Invest Like a Billionaire: John Paulson's 6 New Stock Picks | Merck Cites Brand and Emerging Market Investment for Higher Quarter Costs | Merck Doubles Profits In Second Quarter | News Summary for July 29, 2011 | Merck: FDA Accepts SNDAs For Vytorin, Zetia Indications For Review | Merck to Cut Workforce by Added 12-13% From 2009 Levels | Merck Guides FY 2011 EPS $3.68-$3.76 vs $3.74 Est | Merck Reports Q2 EPS $0.95 vs $0.95 Est; Revenues $12.15B vs $11.78B Est	 | US Stock Futures Down On Debt Worries | Earnings Scheduled For July 29 | Stocks To Watch For July 29 | High Yield Birth Control Stocks",-0.0067389464995702385,-0.023169303612964612,0.14747208202286638,"[{'label': 'negative', 'score': 0.9451646208763123}, {'label': 'neutral', 'score': 0.04681820049881935}, {'label': 'positive', 'score': 0.008017243817448616}]","(0.04681820049881935, 0.008017243817448616, 0.9451646208763123)",-0.9831779346326015,-0.9451646208763123,0,0,"[{'label': 'negative', 'score': 0.9036232233047485}, {'label': 'positive', 'score': 0.06507685780525208}, {'label': 'neutral', 'score': 0.03129991888999939}]","(0.03129991888999939, 0.06507685780525208, 0.9036232233047485)",-0.8656408540181338,-0.9036232233047485,0,0,"[{'label': 'neutral', 'score': 0.5121505856513977}, {'label': 'positive', 'score': 0.367843359708786}, {'label': 'negative', 'score': 0.1200060322880745}]","(0.5121505856513977, 0.367843359708786, 0.1200060322880745)",0.5080201625470232,0.367843359708786,0,1
2011-07-30,21.070390065511067,32.347329457600914,32.98028055826823,32.09287643432617,32.92938995361328,22384581.33333333,,-0.0067846680143364155,-0.006761755730745945,0.1329002258447345,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-07-31,20.92743364969889,32.12786356608073,32.849873860677086,31.695293426513672,32.80534362792969,24554814.666666664,,-0.006831014177733342,-0.006807788510303114,0.11879823923515771,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-01,20.78447723388672,31.908397674560547,32.71946716308594,31.29771041870117,32.681297302246094,26725048.0,"Weak Data in Focus  08-01-2011 | Merck To Close Mission Bay Research Center | J.P. Morgan Maintains Overweight Rating On Merck & Co | ARIAD Announces That Merck Has Submitted for Approval of Ridaforolimus, an Investigational mTOR Inhibitor, in the EU",-0.016148361038400543,-0.006854452353739507,0.11515197926957392,"[{'label': 'negative', 'score': 0.965844988822937}, {'label': 'positive', 'score': 0.025281142443418503}, {'label': 'neutral', 'score': 0.00887391623109579}]","(0.00887391623109579, 0.025281142443418503, 0.965844988822937)",-0.9489850148313274,-0.965844988822937,0,0,"[{'label': 'positive', 'score': 0.5003325343132019}, {'label': 'negative', 'score': 0.45974892377853394}, {'label': 'neutral', 'score': 0.03991854563355446}]","(0.03991854563355446, 0.5003325343132019, 0.45974892377853394)",0.042271007519853805,0.5003325343132019,1,0,"[{'label': 'negative', 'score': 0.954572856426239}, {'label': 'neutral', 'score': 0.02810802310705185}, {'label': 'positive', 'score': 0.01731906272470951}]","(0.02810802310705185, 0.01731906272470951, 0.954572856426239)",-0.9643601055149433,-0.954572856426239,0,0
2011-08-02,20.448841094970703,31.393129348754883,31.64122009277344,31.078243255615234,31.64122009277344,27555483.0,"Aw Snap, Is Market Gonna Crackle or Pop?",-0.006079029756350932,-0.016280166710345986,0.11877932559899447,"[{'label': 'neutral', 'score': 0.9998345375061035}, {'label': 'negative', 'score': 0.00010205378930550069}, {'label': 'positive', 'score': 6.341228436212987e-05}]","(0.9998345375061035, 6.341228436212987e-05, 0.00010205378930550069)",-0.23353128582110122,-0.00010205378930550069,1,1,"[{'label': 'neutral', 'score': 0.8304469585418701}, {'label': 'negative', 'score': 0.12392695993185043}, {'label': 'positive', 'score': 0.04562610760331154}]","(0.8304469585418701, 0.04562610760331154, 0.12392695993185043)",-0.4618073472029684,-0.12392695993185043,1,1,"[{'label': 'neutral', 'score': 0.9993057250976562}, {'label': 'positive', 'score': 0.0005752183496952057}, {'label': 'negative', 'score': 0.00011902568803634495}]","(0.9993057250976562, 0.0005752183496952057, 0.00011902568803634495)",0.6571070644689652,0.0005752183496952057,0,1
2011-08-03,20.324535369873047,31.202289581298828,31.70801544189453,30.725191116333008,31.393129348754883,23115002.0,Merck and Serum Institute Announce Collaboration to Develop and Expand Global Access to Pneumococcal Conjugate Vaccine ,-0.03639143648634457,-0.006097582283529637,0.06868238180423071,"[{'label': 'positive', 'score': 0.9984312653541565}, {'label': 'neutral', 'score': 0.0013888089451938868}, {'label': 'negative', 'score': 0.0001798882003640756}]","(0.0013888089451938868, 0.9984312653541565, 0.0001798882003640756)",0.9996397232301607,0.9984312653541565,0,0,"[{'label': 'positive', 'score': 0.8966560363769531}, {'label': 'neutral', 'score': 0.09438363462686539}, {'label': 'negative', 'score': 0.00896031130105257}]","(0.09438363462686539, 0.8966560363769531, 0.00896031130105257)",0.9802116838459757,0.8966560363769531,0,0,"[{'label': 'positive', 'score': 0.998087465763092}, {'label': 'neutral', 'score': 0.0016728055197745562}, {'label': 'negative', 'score': 0.00023967727611307055}]","(0.0016728055197745562, 0.998087465763092, 0.00023967727611307055)",0.9995198422124767,0.998087465763092,0,0
2011-08-04,19.584896087646484,30.06679344177246,30.83969497680664,30.0,30.76335906982422,27442194.0,,0.006347193884364148,-0.03707012128043728,0.21010948059773585,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-05,19.70920753479004,30.25763320922852,30.534351348876957,29.341602325439453,30.314884185791016,31972698.0,,-0.018606109515085928,0.006327135281744953,0.2564641795419704,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-06,19.34249496459961,29.694656372070312,30.39122136433919,29.06488482157389,30.10814158121745,34640871.333333336,,-0.018958860143191224,-0.01878138065148461,0.25537838948571867,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-07,18.97578239440918,29.13167953491211,30.248091379801437,28.78816731770833,29.90139897664388,37309044.66666666,,-0.019325244755748518,-0.019140883642870907,0.2575176568175351,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-08,18.60906982421875,28.568702697753903,30.104961395263672,28.511449813842773,29.694656372070312,39977218.0,,0.042752119943694405,-0.019514418483193373,0.24580151108998413,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-08-09,19.404653549194336,29.790075302124023,29.809160232543945,28.120229721069336,29.00763320922852,38925445.0,"UPDATE: Jefferies Upgrades Merck & Co To Buy | News Summary for August 9, 2011 | Benzinga's Top Upgrades | Jefferies Upgrades Merck & Co. To Buy, Lowers PT To $37",-0.04516332759849664,0.041863487124444765,0.4256183577324753,"[{'label': 'positive', 'score': 0.9617173075675964}, {'label': 'neutral', 'score': 0.037667352706193924}, {'label': 'negative', 'score': 0.0006153208087198436}]","(0.037667352706193924, 0.9617173075675964, 0.0006153208087198436)",0.9987211889307795,0.9617173075675964,0,0,"[{'label': 'positive', 'score': 0.5375557541847229}, {'label': 'neutral', 'score': 0.3759714365005493}, {'label': 'negative', 'score': 0.08647279441356659}]","(0.3759714365005493, 0.5375557541847229, 0.08647279441356659)",0.7228562872394084,0.5375557541847229,0,0,"[{'label': 'neutral', 'score': 0.8884931802749634}, {'label': 'positive', 'score': 0.10662063211202621}, {'label': 'negative', 'score': 0.004886188078671694}]","(0.8884931802749634, 0.10662063211202621, 0.004886188078671694)",0.9123607314724717,0.10662063211202621,0,1
2011-08-10,18.528263092041016,28.444656372070312,29.494274139404297,28.35877990722656,29.103052139282227,35195822.0,,0.04662864931934076,-0.0462149767909684,0.5159060093259321,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-11,19.39221572875977,29.77099227905273,30.104961395263672,28.37786293029785,28.425573348999023,31264774.0,Mad Money Lightning Round: Cramer Likes Cummins,0.004487149178393995,0.04557418828601912,0.6502374528649554,"[{'label': 'neutral', 'score': 0.9998515844345093}, {'label': 'positive', 'score': 7.477594044758007e-05}, {'label': 'negative', 'score': 7.362493488471955e-05}]","(0.9998515844345093, 7.477594044758007e-05, 7.362493488471955e-05)",0.0077560564267777,7.477594044758007e-05,1,1,"[{'label': 'neutral', 'score': 0.8995118141174316}, {'label': 'positive', 'score': 0.07546845078468323}, {'label': 'negative', 'score': 0.025019679218530655}]","(0.8995118141174316, 0.07546845078468323, 0.025019679218530655)",0.5020371218425409,0.07546845078468323,0,1,"[{'label': 'neutral', 'score': 0.9981257319450378}, {'label': 'positive', 'score': 0.0017567313043400645}, {'label': 'negative', 'score': 0.00011754290608223528}]","(0.9981257319450378, 0.0017567313043400645, 0.00011754290608223528)",0.8745723486685001,0.0017567313043400645,0,1
2011-08-12,19.479228973388672,29.904579162597656,30.45801544189453,29.77099227905273,29.952289581298828,20668132.0,,0.00840248698885679,0.004477111939045571,0.6264451899111328,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-13,19.64290428161621,30.15585199991862,30.534351348876957,29.85050900777181,30.03498713175456,20218924.33333333,,0.008332473488782305,0.008367382600757048,0.587077184053126,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-14,19.80657958984375,30.407124837239586,30.61068725585937,29.930025736490887,30.117684682210285,19769716.666666668,,0.008263617118223144,0.008297950075933903,0.519734438277772,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-15,19.97025489807129,30.658397674560547,30.6870231628418,30.00954246520996,30.200382232666016,19320509.0,,-0.0009337538097640699,0.008229660376368587,0.2726834515911364,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-16,19.951610565185547,30.629770278930664,30.85877990722656,30.219465255737305,30.543893814086918,16943016.0,,0.0031152971939845397,-0.0009341900294216249,0.06437040408049387,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-17,20.013761520385746,30.725191116333008,31.049617767333984,30.41030502319336,30.896947860717773,14691178.0,,-0.03540370885592148,0.003110454710258467,0.0666792718712506,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-08-18,19.30519676208496,29.63740539550781,30.333969116210938,29.36068725585937,30.295801162719727,24211630.0,Merck and ARIAD Announce European Medicines Agency Accepts Marketing Authorization Application for Ridaforolimus |  Merck and ARIAD Announce European Medicines Agency Accepts Marketing Authorization Application for Ridaforolimus,0.006439087955261801,-0.036045616322438384,0.29552499311875835,"[{'label': 'neutral', 'score': 0.6640504598617554}, {'label': 'positive', 'score': 0.3351914584636688}, {'label': 'negative', 'score': 0.0007581213139928877}]","(0.6640504598617554, 0.3351914584636688, 0.0007581213139928877)",0.9954866958637387,0.3351914584636688,0,1,"[{'label': 'neutral', 'score': 0.5723651051521301}, {'label': 'positive', 'score': 0.40665483474731445}, {'label': 'negative', 'score': 0.02098003774881363}]","(0.5723651051521301, 0.40665483474731445, 0.02098003774881363)",0.9018787330118706,0.40665483474731445,0,1,"[{'label': 'neutral', 'score': 0.9557136297225952}, {'label': 'positive', 'score': 0.04374296963214874}, {'label': 'negative', 'score': 0.0005434348131529987}]","(0.9557136297225952, 0.04374296963214874, 0.0005434348131529987)",0.97545816509786,0.04374296963214874,0,1
2011-08-19,19.42950439453125,29.828243255615234,30.01908493041992,29.341602325439453,29.379770278930664,21733634.0,,0.0005331682715641244,0.006418445593018996,0.2910783319208221,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-20,19.43986701965332,29.844146728515625,30.190840403238933,29.48155148824056,29.666030248006184,21142107.666666668,,0.0005328841546404508,0.0005330261878620028,0.27568680222412684,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-21,19.45022964477539,29.860050201416016,30.36259587605794,29.621500651041668,29.952290217081707,20550581.33333333,,0.0005326003403583177,0.0005327422222993259,0.2773699039251026,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-22,19.46059226989746,29.875953674316406,30.534351348876957,29.761449813842773,30.238550186157227,19959055.0,,0.020121359043550897,0.0005324585591366006,0.2731395803416358,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-23,19.85215950012207,30.47709846496582,30.73473358154297,29.923664093017575,30.00954246520996,23822298.0,,0.009079543446910745,0.01992159967314751,0.13348011988056724,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-24,20.03240966796875,30.753816604614254,30.81106948852539,30.219465255737305,30.46755790710449,14063217.0,,-0.01148000754410053,0.009038572205677749,0.1357837089967039,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-25,19.80243492126465,30.4007625579834,30.77290153503418,30.25763320922852,30.77290153503418,16844294.0,12 Most Popular Healthcare Stocks Among Hedge Funds | 12 Most Popular Healthcare Stocks Among Hedge Funds,0.0018832713094592394,-0.011546411532084494,0.18515394499690313,"[{'label': 'neutral', 'score': 0.9998759031295776}, {'label': 'negative', 'score': 6.268243305385113e-05}, {'label': 'positive', 'score': 6.135080911917612e-05}]","(0.9998759031295776, 6.135080911917612e-05, 6.268243305385113e-05)",-0.010736024563619672,-6.268243305385113e-05,1,1,"[{'label': 'neutral', 'score': 0.906165599822998}, {'label': 'positive', 'score': 0.07078693062067032}, {'label': 'negative', 'score': 0.023047447204589844}]","(0.906165599822998, 0.07078693062067032, 0.023047447204589844)",0.5087632541772876,0.07078693062067032,0,1,"[{'label': 'neutral', 'score': 0.9989381432533264}, {'label': 'positive', 'score': 0.0008919266401790082}, {'label': 'negative', 'score': 0.00016988441348075867}]","(0.9989381432533264, 0.0008919266401790082, 0.00016988441348075867)",0.6800100867377216,0.0008919266401790082,0,1
2011-08-26,19.839731216430664,30.45801544189453,30.591602325439453,29.56106948852539,30.152671813964844,19337067.0,Texas Supreme Court Rules in Favor of Merck in Vioxx Case; Overturns Judgement in Favor of Garza Family,0.0056390894261208035,0.0018815001773795385,0.18394599373878895,"[{'label': 'neutral', 'score': 0.998256504535675}, {'label': 'positive', 'score': 0.0013416665606200695}, {'label': 'negative', 'score': 0.0004019196203444153}]","(0.998256504535675, 0.0013416665606200695, 0.0004019196203444153)",0.5389736111327874,0.0013416665606200695,0,1,"[{'label': 'negative', 'score': 0.9025213122367859}, {'label': 'neutral', 'score': 0.06128254532814026}, {'label': 'positive', 'score': 0.036196134984493256}]","(0.06128254532814026, 0.036196134984493256, 0.9025213122367859)",-0.9228817252909524,-0.9025213122367859,0,0,"[{'label': 'positive', 'score': 0.9261102080345154}, {'label': 'neutral', 'score': 0.07302749156951904}, {'label': 'negative', 'score': 0.0008622656459920108}]","(0.07302749156951904, 0.9261102080345154, 0.0008622656459920108)",0.9981396089517773,0.9261102080345154,0,0
2011-08-27,19.951609929402668,30.629770914713543,30.75381596883138,29.91094207763672,30.305343627929688,16925060.0,,0.005607468410300853,0.005623249282766466,0.18149431297105806,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-28,20.06348864237468,30.80152638753255,30.91602961222331,30.260814666748047,30.45801544189453,14513053.0,,0.005576200044700675,0.005591805086430225,0.1277430654251781,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-08-29,20.17536735534668,30.97328186035156,31.078243255615234,30.61068725585937,30.61068725585937,12101046.0,Zymeworks Announces Collaboration with Merck to Develop Bi-specific Antibody Therapeutics,0.0073937183014635135,0.005560710596062927,0.11787758310852511,"[{'label': 'neutral', 'score': 0.9895856976509094}, {'label': 'positive', 'score': 0.010291083715856075}, {'label': 'negative', 'score': 0.0001232529612025246}]","(0.9895856976509094, 0.010291083715856075, 0.0001232529612025246)",0.9763301369977726,0.010291083715856075,0,1,"[{'label': 'positive', 'score': 0.8412771224975586}, {'label': 'neutral', 'score': 0.15091024339199066}, {'label': 'negative', 'score': 0.007812624797224998}]","(0.15091024339199066, 0.8412771224975586, 0.007812624797224998)",0.9815976466042226,0.8412771224975586,0,0,"[{'label': 'positive', 'score': 0.9829923510551453}, {'label': 'neutral', 'score': 0.016754038631916046}, {'label': 'negative', 'score': 0.0002535846142563969}]","(0.016754038631916046, 0.9829923510551453, 0.0002535846142563969)",0.9994841888380983,0.9829923510551453,0,0
2011-08-30,20.324535369873047,31.202289581298828,31.393129348754883,30.629770278930664,30.82061004638672,13414086.0,Merck Millipore Strengthens Bioscience Business by acquiring Amnis Corporation,0.012232420762509364,0.007366518754545487,0.0319161459189732,"[{'label': 'positive', 'score': 0.999504804611206}, {'label': 'neutral', 'score': 0.0002958744007628411}, {'label': 'negative', 'score': 0.00019925637752749026}]","(0.0002958744007628411, 0.999504804611206, 0.00019925637752749026)",0.9996013692745622,0.999504804611206,1,1,"[{'label': 'positive', 'score': 0.8768237829208374}, {'label': 'neutral', 'score': 0.11592106521129608}, {'label': 'negative', 'score': 0.00725522032007575}]","(0.11592106521129608, 0.8768237829208374, 0.00725522032007575)",0.9835869412270191,0.8768237829208374,1,1,"[{'label': 'positive', 'score': 0.9988948702812195}, {'label': 'neutral', 'score': 0.000766954617574811}, {'label': 'negative', 'score': 0.0003382396243978292}]","(0.000766954617574811, 0.9988948702812195, 0.0003382396243978292)",0.9993230015678127,0.9988948702812195,1,1
2011-08-31,20.573144912719727,31.583969116210938,31.784351348876957,31.393129348754883,31.44083976745605,15088475.0,,-0.006042298444311211,0.012158209281442551,0.04514700828666841,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-01,20.448841094970703,31.393129348754883,31.95610618591309,31.354961395263672,31.5362606048584,13169063.0,,-0.016109383286669124,-0.006060626997912974,0.10643412821876493,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-09-02,20.11942672729492,30.88740539550781,31.25954246520996,30.82061004638672,31.173664093017575,14013018.0,,-0.0009267843883891893,-0.016240549985519208,0.18306435989792932,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-03,20.10077810287476,30.858779430389404,31.14980936050415,30.632155895233154,30.925572395324707,15084414.5,,-0.0009276441144724634,-0.000927214118572504,0.17760492354313975,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-04,20.08212947845459,30.830153465271,31.04007625579834,30.44370174407959,30.67748069763184,16155811.0,,-0.0009285054370766536,-0.0009280746425458091,0.1629048875821953,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-05,20.063480854034424,30.801527500152588,30.93034315109253,30.255247592926025,30.429388999938965,17227207.5,,-0.0009293683606524511,-0.0009289367652643976,0.1056624557598937,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-06,20.044832229614254,30.77290153503418,30.82061004638672,30.06679344177246,30.181297302246094,18298604.0,,0.0220154962267871,-0.0009298004911870951,0.1087047261288548,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-09-07,20.48613548278809,31.450382232666016,31.498092651367188,31.03053474426269,31.059160232543945,14616351.0,,-0.00546119735887884,0.02177665431508058,0.16119065220157244,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-08,20.37425994873047,31.27862548828125,31.66984748840332,31.154579162597656,31.25954246520996,34980354.0,Bank of America Merrill Lynch Maintains Buy on Merck & Co. | Stocks Going Ex Dividend the Third Week of September,-0.028676002841147463,-0.005476164213344004,0.17212606759464938,"[{'label': 'neutral', 'score': 0.9997254014015198}, {'label': 'positive', 'score': 0.00017796688189264387}, {'label': 'negative', 'score': 9.660208888817579e-05}]","(0.9997254014015198, 0.00017796688189264387, 9.660208888817579e-05)",0.2963364460779481,0.00017796688189264387,0,0,"[{'label': 'neutral', 'score': 0.8254696130752563}, {'label': 'negative', 'score': 0.13336056470870972}, {'label': 'positive', 'score': 0.04116978496313095}]","(0.8254696130752563, 0.04116978496313095, 0.13336056470870972)",-0.528222053751223,-0.13336056470870972,1,0,"[{'label': 'positive', 'score': 0.9976915121078491}, {'label': 'neutral', 'score': 0.0019561494700610638}, {'label': 'negative', 'score': 0.0003523208142723888}]","(0.0019561494700610638, 0.9976915121078491, 0.0003523208142723888)",0.9992939772730405,0.9976915121078491,0,0
2011-09-09,19.790000915527344,30.38167953491211,31.10687065124512,30.162214279174805,31.10687065124512,29058839.0,,0.0016750425069973448,-0.02909519265146179,0.2872281615414417,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-10,19.823152542114254,30.43257013956706,30.931934356689453,30.095420201619465,30.77608172098796,24655422.666666668,,0.001672241431517474,0.0016736411879249955,0.288959894539415,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-11,19.85630416870117,30.483460744222004,30.75699806213379,30.02862612406413,30.445292790730797,20252006.333333336,,0.00166944970854724,0.00167084479260977,0.2903855781192424,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-12,19.88945579528809,30.534351348876957,30.582061767578125,29.96183204650879,30.114503860473636,15848590.0,,-0.008124971812367742,0.0016680577263966515,0.21151689200790194,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-13,19.964933395385746,30.2862606048584,30.44847297668457,30.00954246520996,30.114503860473636,15363470.0,Merck Issues Statement on HPV Vaccine | A Peek Into The Market Before The Trading Starts | Merck and BGI Establish Strategic Collaboration focused on Biomarkers and Genomic Technologies  ,0.011972247390422904,-0.008158159282931066,0.21202529412149465,"[{'label': 'neutral', 'score': 0.9998506307601929}, {'label': 'positive', 'score': 9.622219658922404e-05}, {'label': 'negative', 'score': 5.320714626577683e-05}]","(0.9998506307601929, 9.622219658922404e-05, 5.320714626577683e-05)",0.2878621394004722,9.622219658922404e-05,1,1,"[{'label': 'positive', 'score': 0.8600795865058899}, {'label': 'neutral', 'score': 0.13126294314861298}, {'label': 'negative', 'score': 0.008657502941787243}]","(0.13126294314861298, 0.8600795865058899, 0.008657502941787243)",0.9800687617762666,0.8600795865058899,0,0,"[{'label': 'positive', 'score': 0.649366021156311}, {'label': 'neutral', 'score': 0.34989339113235474}, {'label': 'negative', 'score': 0.0007405722863040864}]","(0.34989339113235474, 0.649366021156311, 0.0007405722863040864)",0.9977216896620524,0.649366021156311,0,0
2011-09-14,20.20395851135254,30.648855209350582,30.9637393951416,30.03816795349121,30.47709846496582,16398894.0,S&P Likes Three Health Care ETFs | Bounce-Back Kings: 9 Stocks Up More Than 30% in the Past Month,0.011519260242206853,0.011901146961991913,0.11259609765914988,"[{'label': 'positive', 'score': 0.9995505213737488}, {'label': 'negative', 'score': 0.000238028762396425}, {'label': 'neutral', 'score': 0.00021143477351870388}]","(0.00021143477351870388, 0.9995505213737488, 0.000238028762396425)",0.9995238417916188,0.9995505213737488,0,0,"[{'label': 'positive', 'score': 0.951364278793335}, {'label': 'neutral', 'score': 0.02464560605585575}, {'label': 'negative', 'score': 0.023990143090486526}]","(0.02464560605585575, 0.951364278793335, 0.023990143090486526)",0.9508073320790377,0.951364278793335,0,0,"[{'label': 'positive', 'score': 0.9983993172645569}, {'label': 'neutral', 'score': 0.0013358751311898232}, {'label': 'negative', 'score': 0.0002647934015840292}]","(0.0013358751311898232, 0.9983993172645569, 0.0002647934015840292)",0.9994697047811052,0.9983993172645569,0,0
2011-09-15,20.43669319152832,31.00190734863281,31.011449813842773,30.562976837158203,30.9064884185791,13376567.0,,0.0058480017876295426,0.011453418712009686,0.1319199937073811,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-16,20.556211471557617,31.18320655822754,31.29771041870117,30.954198837280277,31.18320655822754,20506426.0,,-0.00438596142475168,0.0058309685996561994,0.1311785181909481,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-17,20.46605110168457,31.04643821716309,31.15458043416341,30.782442728678387,30.998727798461918,18328018.0,,-0.004405282825288631,-0.0043956079701455075,0.14578903169757654,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-18,20.375890731811523,30.909669876098636,31.01145044962565,30.610686620076496,30.81424903869629,16149610.0,,-0.004424775211533878,-0.00441501467522529,0.12862383385217,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-19,20.28573036193848,30.77290153503418,30.86832046508789,30.43893051147461,30.629770278930664,13971202.0,"Merck's Iss=entress Combo Showed Efficacy, Tolerability",0.007751894261157417,-0.004434593502561963,0.11783477221036263,"[{'label': 'positive', 'score': 0.8063166737556458}, {'label': 'neutral', 'score': 0.19195052981376648}, {'label': 'negative', 'score': 0.0017328091198578477}]","(0.19195052981376648, 0.8063166737556458, 0.0017328091198578477)",0.9957111311706023,0.8063166737556458,0,0,"[{'label': 'positive', 'score': 0.86262047290802}, {'label': 'neutral', 'score': 0.12809352576732635}, {'label': 'negative', 'score': 0.009286013431847095}]","(0.12809352576732635, 0.86262047290802, 0.009286013431847095)",0.9786995197826125,0.86262047290802,0,0,"[{'label': 'positive', 'score': 0.9959051609039307}, {'label': 'neutral', 'score': 0.0037326505407691}, {'label': 'negative', 'score': 0.0003622021758928895}]","(0.0037326505407691, 0.9959051609039307, 0.0003622021758928895)",0.9992728815791512,0.9959051609039307,0,0
2011-09-20,20.442983627319336,31.011449813842773,31.326335906982425,30.6870231628418,30.744274139404297,14426454.0,,-0.020000023371770145,0.007722002706904025,0.0978859798703282,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-09-21,20.03413200378418,30.39122009277344,31.402671813964844,30.362594604492188,31.173664093017575,15321131.0,,-0.022605912279794485,-0.020202731166264726,0.15752883150847571,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-22,19.58123016357422,29.704198837280277,30.03816795349121,29.36068725585937,29.75190734863281,24532213.0,,-0.0025698692430855936,-0.022865343151276175,0.2006587309748334,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-23,19.530916213989254,29.62786293029785,29.799617767333984,29.30343437194824,29.503816604614254,19813593.0,,0.006011811135732357,-0.002573177025309329,0.20362125187614577,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-24,19.64833196004232,29.805980046590168,29.9459285736084,29.398854573567707,29.61513964335124,18619222.33333333,,0.005975885242287037,0.005993812300208934,0.22857416055912344,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-25,19.76574770609538,29.984097162882488,30.09223937988281,29.494274775187176,29.72646268208821,17424851.666666668,,0.00594038617620306,0.005958100458119894,0.22196313765819498,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-26,19.88316345214844,30.162214279174805,30.238550186157227,29.58969497680664,29.837785720825195,16230481.0,,0.016766804604138173,0.005922811647554554,0.1983531352342134,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-27,20.216541290283203,30.667938232421875,31.011449813842773,30.48664093017578,30.562976837158203,15967642.0,Merck Names Cuong Viet Do as Chief Strategy Officer,-0.006222777873417671,0.016627793432704634,0.10816605849568199,"[{'label': 'neutral', 'score': 0.9998792409896851}, {'label': 'negative', 'score': 7.2952636401169e-05}, {'label': 'positive', 'score': 4.774923581862822e-05}]","(0.9998792409896851, 4.774923581862822e-05, 7.2952636401169e-05)",-0.20880703935267528,-7.2952636401169e-05,1,1,"[{'label': 'neutral', 'score': 0.9399999976158142}, {'label': 'positive', 'score': 0.03490077331662178}, {'label': 'negative', 'score': 0.0250992551445961}]","(0.9399999976158142, 0.03490077331662178, 0.0250992551445961)",0.16335855871070248,0.03490077331662178,1,1,"[{'label': 'neutral', 'score': 0.9994951486587524}, {'label': 'positive', 'score': 0.00038438831688836217}, {'label': 'negative', 'score': 0.00012043800961691886}]","(0.9994951486587524, 0.00038438831688836217, 0.00012043800961691886)",0.5228536893047357,0.00038438831688836217,0,1
2011-09-28,20.09074211120605,30.47709846496582,31.18320655822754,30.41984748840332,30.85877990722656,15477598.0,Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals for $175M   ,0.02254227592011579,-0.006242220053860287,0.12853068196706482,"[{'label': 'neutral', 'score': 0.9997721314430237}, {'label': 'positive', 'score': 0.00012649914424400777}, {'label': 'negative', 'score': 0.00010143894178327173}]","(0.9997721314430237, 0.00012649914424400777, 0.00010143894178327173)",0.10994302399177312,0.00012649914424400777,0,0,"[{'label': 'neutral', 'score': 0.9468511343002319}, {'label': 'positive', 'score': 0.03850220516324043}, {'label': 'negative', 'score': 0.014646639116108418}]","(0.9468511343002319, 0.03850220516324043, 0.014646639116108418)",0.44884449268074056,0.03850220516324043,0,0,"[{'label': 'neutral', 'score': 0.9417495727539062}, {'label': 'positive', 'score': 0.05674351006746292}, {'label': 'negative', 'score': 0.0015069651417434216}]","(0.9417495727539062, 0.05674351006746292, 0.0015069651417434216)",0.9482591296867137,0.05674351006746292,1,0
2011-09-29,20.54362297058105,31.164121627807617,31.31679344177246,30.744274139404297,30.86832046508789,20233526.0,,0.0012247402300327897,0.02229195372325716,0.1749561957089836,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-09-30,20.56879425048828,31.202289581298828,31.793893814086918,30.86832046508789,30.916030883789062,25393250.0,Merck Announces New Data Analyses for VICTRELIS will be Presented at The American Association for the Study of Liver Diseases 2011 Annual Meeting   ,-0.011518847602575606,0.0012239908475207195,0.18303287473392985,"[{'label': 'neutral', 'score': 0.9998844861984253}, {'label': 'positive', 'score': 5.9510100982151926e-05}, {'label': 'negative', 'score': 5.597962808678858e-05}]","(0.9998844861984253, 5.9510100982151926e-05, 5.597962808678858e-05)",0.030569583319880016,5.9510100982151926e-05,1,1,"[{'label': 'neutral', 'score': 0.9062029123306274}, {'label': 'positive', 'score': 0.07994741946458817}, {'label': 'negative', 'score': 0.013849719427525997}]","(0.9062029123306274, 0.07994741946458817, 0.013849719427525997)",0.7046878062356252,0.07994741946458817,0,1,"[{'label': 'neutral', 'score': 0.9990636706352234}, {'label': 'positive', 'score': 0.0008124703308567405}, {'label': 'negative', 'score': 0.0001238105760421604}]","(0.9990636706352234, 0.0008124703308567405, 0.0001238105760421604)",0.7355268592366385,0.0008124703308567405,0,1
2011-10-01,20.331863403320312,30.842875162760414,31.60305404663086,30.617048263549805,30.976463317871094,25249813.666666668,,-0.011653077627871933,-0.011585703424839545,0.2312054888256915,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-02,20.094932556152344,30.483460744222004,31.412214279174805,30.36577606201172,31.036895751953125,25106377.33333333,,-0.01179047292412598,-0.011721506863910268,0.22474293830294537,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-03,19.85800170898437,30.124046325683597,31.22137451171875,30.114503860473636,31.09732818603516,24962941.0,Merck Wins Another Federal Bellwether Trial Regarding FOSAMAX,-0.0069686753102952,-0.011860531779200364,0.23593424746289687,"[{'label': 'positive', 'score': 0.9509696364402771}, {'label': 'neutral', 'score': 0.048242948949337006}, {'label': 'negative', 'score': 0.0007873659487813711}]","(0.048242948949337006, 0.9509696364402771, 0.0007873659487813711)",0.99834544753166,0.9509696364402771,0,0,"[{'label': 'positive', 'score': 0.7199468612670898}, {'label': 'neutral', 'score': 0.18593758344650269}, {'label': 'negative', 'score': 0.09411545842885971}]","(0.18593758344650269, 0.7199468612670898, 0.09411545842885971)",0.7687757898829868,0.7199468612670898,0,0,"[{'label': 'positive', 'score': 0.9983811378479004}, {'label': 'neutral', 'score': 0.0010194203350692987}, {'label': 'negative', 'score': 0.0005993963568471372}]","(0.0010194203350692987, 0.9983811378479004, 0.0005993963568471372)",0.9987999839109492,0.9983811378479004,0,0
2011-10-04,19.71961975097656,29.914121627807617,30.0,29.14122009277344,29.837785720825195,30077600.0,,0.0035088211486955104,-0.006993069926250917,0.08963510207228895,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-05,19.78881072998047,30.01908493041992,30.314884185791016,29.58969497680664,30.0,26487152.0,"FDA Accepts New Drug Application Filing for Ridaforolimus, Investigational mTOR Inhibitor   ",-0.0012715197990981102,0.003502679597977896,0.10487272657853132,"[{'label': 'neutral', 'score': 0.9351237416267395}, {'label': 'positive', 'score': 0.06439702212810516}, {'label': 'negative', 'score': 0.00047921750228852034}]","(0.9351237416267395, 0.06439702212810516, 0.00047921750228852034)",0.985226717669869,0.06439702212810516,0,1,"[{'label': 'neutral', 'score': 0.5912753343582153}, {'label': 'positive', 'score': 0.38581255078315735}, {'label': 'negative', 'score': 0.022912081331014633}]","(0.5912753343582153, 0.38581255078315735, 0.022912081331014633)",0.8878849986970473,0.38581255078315735,0,1,"[{'label': 'positive', 'score': 0.5210107564926147}, {'label': 'neutral', 'score': 0.4782867431640625}, {'label': 'negative', 'score': 0.0007025254890322685}]","(0.4782867431640625, 0.5210107564926147, 0.0007025254890322685)",0.997306852199109,0.5210107564926147,0,0
2011-10-06,19.76365089416504,29.98091506958008,30.114503860473636,29.57061004638672,29.93320655822754,19494058.0,Merck Announces Retirement of Chairman and Former CEO Richard T. Clark    | Bristol-Myers and Quidel to Open Near 52-Week Highs,0.0060471539702494585,-0.0012723288663005667,0.106540151437752,"[{'label': 'positive', 'score': 0.9462078809738159}, {'label': 'neutral', 'score': 0.05331199988722801}, {'label': 'negative', 'score': 0.00048014186904765666}]","(0.05331199988722801, 0.9462078809738159, 0.00048014186904765666)",0.9989856386529412,0.9462078809738159,0,0,"[{'label': 'neutral', 'score': 0.5984669923782349}, {'label': 'negative', 'score': 0.37856191396713257}, {'label': 'positive', 'score': 0.02297111041843891}]","(0.5984669923782349, 0.02297111041843891, 0.37856191396713257)",-0.8855829581958323,-0.37856191396713257,0,1,"[{'label': 'positive', 'score': 0.9881342053413391}, {'label': 'neutral', 'score': 0.010804912075400352}, {'label': 'negative', 'score': 0.0010608923621475697}]","(0.010804912075400352, 0.9881342053413391, 0.0010608923621475697)",0.9978550391836544,0.9881342053413391,0,0
2011-10-07,19.88316345214844,30.162214279174805,30.80152702331543,30.124046325683597,30.44847297668457,22922590.0,,0.00780343002868338,0.006028943312901476,0.11702083617834795,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-08,20.038318634033203,30.3975830078125,30.893765767415363,30.273537317911785,30.63295110066732,20511840.666666668,,0.007743008007485432,0.007773140740096255,0.09498822651892536,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-09,20.19347381591797,30.632951736450195,30.9860045115153,30.423028310139973,30.817429224650063,18101091.333333336,,0.0076835144932386554,0.007713184769769013,0.0601242606748828,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-10,20.34862899780273,30.86832046508789,31.078243255615234,30.572519302368164,31.00190734863281,15690342.0,,-0.012982972573343113,0.0076541466320845936,0.061899583100710566,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-10-11,20.08445167541504,30.46755790710449,30.925573348999023,30.362594604492188,30.87786293029785,16332975.0,,0.02004379052540817,-0.013067987998723819,0.14500869216951306,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-12,20.487010955810547,31.078243255615234,31.26908493041992,30.67748069763184,30.77290153503418,17136267.0,,0.0039914201283298405,0.019845558262287774,0.1885163040074737,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-13,20.56879425048828,31.202289581298828,31.364503860473636,30.782442092895508,30.992366790771484,14256468.0,Under The Hood: Emerging Markets Health Care,0.008562694533756554,0.003983475544108263,0.1881693967504992,"[{'label': 'neutral', 'score': 0.9998888969421387}, {'label': 'negative', 'score': 6.65837069391273e-05}, {'label': 'positive', 'score': 4.451279528439045e-05}]","(0.9998888969421387, 4.451279528439045e-05, 6.65837069391273e-05)",-0.19866432527580252,-6.65837069391273e-05,1,1,"[{'label': 'neutral', 'score': 0.9193366765975952}, {'label': 'positive', 'score': 0.05753244459629059}, {'label': 'negative', 'score': 0.02313085086643696}]","(0.9193366765975952, 0.05753244459629059, 0.02313085086643696)",0.4264838614949687,0.05753244459629059,1,1,"[{'label': 'neutral', 'score': 0.9995847344398499}, {'label': 'positive', 'score': 0.00024096296692732722}, {'label': 'negative', 'score': 0.0001742722961353138}]","(0.9995847344398499, 0.00024096296692732722, 0.0001742722961353138)",0.1606093622688126,0.00024096296692732722,1,1
2011-10-14,20.74491310119629,31.469465255737305,31.488550186157227,31.192747116088867,31.459924697875977,11304357.0,Top 4 Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield,-0.006771778494330254,0.008526242601617974,0.18893351491226074,"[{'label': 'neutral', 'score': 0.9998711347579956}, {'label': 'positive', 'score': 6.904510519234464e-05}, {'label': 'negative', 'score': 5.989179408061318e-05}]","(0.9998711347579956, 6.904510519234464e-05, 5.989179408061318e-05)",0.07099062536282968,6.904510519234464e-05,1,1,"[{'label': 'neutral', 'score': 0.6168855428695679}, {'label': 'positive', 'score': 0.3713238537311554}, {'label': 'negative', 'score': 0.011790568009018898}]","(0.6168855428695679, 0.3713238537311554, 0.011790568009018898)",0.9384488427480019,0.3713238537311554,0,1,"[{'label': 'neutral', 'score': 0.9957658052444458}, {'label': 'positive', 'score': 0.004041340667754412}, {'label': 'negative', 'score': 0.0001929250720422715}]","(0.9957658052444458, 0.004041340667754412, 0.0001929250720422715)",0.9088743674120296,0.004041340667754412,0,1
2011-10-15,20.604432423909504,31.25636100769043,31.545801798502605,31.05279858907064,31.418575922648117,11537432.0,,-0.006817948128844623,-0.006794811026011012,0.20516541581884665,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-16,20.463951746622723,31.043256759643555,31.60305341084798,30.91285006205241,31.37722714742025,11770507.0,,-0.006864751649508371,-0.006841296523132553,0.178420996310208,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-17,20.323471069335938,30.83015251159668,31.66030502319336,30.77290153503418,31.335878372192383,12003582.0,,0.014856087452770464,-0.006888422448750996,0.1166912947146214,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-18,20.625394821166992,31.28816795349121,31.498092651367188,30.715648651123047,30.88740539550781,13546134.0,,-0.007624293838866604,0.01474681668038227,0.1644137906359924,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-19,20.4681453704834,31.049617767333984,31.545801162719727,30.935115814208984,31.29771041870117,12487339.0,,0.007990199854511316,-0.00765350735012866,0.15480461581706922,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-20,20.631696701049805,31.29771041870117,31.431297302246094,30.83015251159668,31.202289581298828,14220941.0,,0.016768283578769687,0.007958447235358138,0.16521805498120132,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-21,20.977649688720703,31.822519302368164,31.889312744140625,31.574426651000977,31.64122009277344,18822499.0,"Mylan Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",0.0017990911342182214,0.016629248017521022,0.18451844808519072,"[{'label': 'positive', 'score': 0.9995287656784058}, {'label': 'negative', 'score': 0.00029951779288239777}, {'label': 'neutral', 'score': 0.00017173470405396074}]","(0.00017173470405396074, 0.9995287656784058, 0.00029951779288239777)",0.9994008615322573,0.9995287656784058,0,0,"[{'label': 'positive', 'score': 0.923130214214325}, {'label': 'negative', 'score': 0.05160095542669296}, {'label': 'neutral', 'score': 0.02526876889169216}]","(0.02526876889169216, 0.923130214214325, 0.05160095542669296)",0.8941226934484983,0.923130214214325,0,0,"[{'label': 'positive', 'score': 0.9966762065887451}, {'label': 'neutral', 'score': 0.0029461451340466738}, {'label': 'negative', 'score': 0.0003776045923586935}]","(0.0029461451340466738, 0.9966762065887451, 0.0003776045923586935)",0.9992425592518194,0.9966762065887451,0,0
2011-10-22,21.01538912455241,31.879770914713543,31.933841705322266,31.587149302164715,31.67302703857422,17546349.333333332,,0.0017958602180216834,0.0017974747082050886,0.15774635716425484,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-23,21.053128560384117,31.93702252705892,31.978370666503903,31.59987195332845,31.704833984375,16270199.666666668,Earnings Expectations for the Week of October 24,0.0017926408855699779,0.001794249589081679,0.14212618513258585,"[{'label': 'neutral', 'score': 0.9998712539672852}, {'label': 'positive', 'score': 6.480728188762441e-05}, {'label': 'negative', 'score': 6.389374902937561e-05}]","(0.9998712539672852, 6.480728188762441e-05, 6.389374902937561e-05)",0.007098100549310613,6.480728188762441e-05,1,1,"[{'label': 'neutral', 'score': 0.705329418182373}, {'label': 'negative', 'score': 0.2635594606399536}, {'label': 'positive', 'score': 0.031111110001802444}]","(0.705329418182373, 0.031111110001802444, 0.2635594606399536)",-0.7888414174917685,-0.2635594606399536,0,1,"[{'label': 'neutral', 'score': 0.9993371367454529}, {'label': 'positive', 'score': 0.0003942290204577148}, {'label': 'negative', 'score': 0.00026865373365581036}]","(0.9993371367454529, 0.0003942290204577148, 0.00026865373365581036)",0.18943815632952557,0.0003942290204577148,1,1
2011-10-24,21.09086799621582,31.994274139404297,32.02289962768555,31.612594604492188,31.73664093017578,14994050.0,Merck Announces Presentation of Phase III Investigational Studies Evaluating DULERA Inhalation Aerosol in Chronic Obstructive Pulmonary Disease ,-0.018490881301502414,0.0017910360225734253,0.103452959427108,"[{'label': 'neutral', 'score': 0.9998599290847778}, {'label': 'positive', 'score': 7.114939944585785e-05}, {'label': 'negative', 'score': 6.894925172673538e-05}]","(0.9998599290847778, 7.114939944585785e-05, 6.894925172673538e-05)",0.01570427481426654,7.114939944585785e-05,0,0,"[{'label': 'neutral', 'score': 0.49348050355911255}, {'label': 'positive', 'score': 0.4905979633331299}, {'label': 'negative', 'score': 0.015921512618660927}]","(0.49348050355911255, 0.4905979633331299, 0.015921512618660927)",0.9371336606998453,0.4905979633331299,0,0,"[{'label': 'neutral', 'score': 0.9972274899482727}, {'label': 'positive', 'score': 0.0026632477529346943}, {'label': 'negative', 'score': 0.00010929132986348122}]","(0.9972274899482727, 0.0026632477529346943, 0.00010929132986348122)",0.9211615587015067,0.0026632477529346943,0,0
2011-10-25,20.700883865356445,31.402671813964844,32.04198455810547,31.31679344177246,31.98473358154297,16442701.0,"Merck Announces CDC Advisory Committee on Immunization Practices Votes for Expanded Use of GARDASIL in Boys and Young Men    | What Does Novartis' Earnings Release Really Mean for the Company? | Merck Earnings Preview: Analysts Expect Higher EPS, Revenue",0.0191431704142676,-0.018663974734659666,0.1995855659143057,"[{'label': 'positive', 'score': 0.9987956285476685}, {'label': 'neutral', 'score': 0.0009191723656840622}, {'label': 'negative', 'score': 0.00028517964528873563}]","(0.0009191723656840622, 0.9987956285476685, 0.00028517964528873563)",0.9994291159574878,0.9987956285476685,0,0,"[{'label': 'positive', 'score': 0.8874633312225342}, {'label': 'negative', 'score': 0.05828739330172539}, {'label': 'neutral', 'score': 0.05424927547574043}]","(0.05424927547574043, 0.8874633312225342, 0.05828739330172539)",0.8767383586598981,0.8874633312225342,0,0,"[{'label': 'positive', 'score': 0.9625230431556702}, {'label': 'neutral', 'score': 0.037008266896009445}, {'label': 'negative', 'score': 0.0004686944594141096}]","(0.037008266896009445, 0.9625230431556702, 0.0004686944594141096)",0.9990265867481379,0.9625230431556702,0,0
2011-10-26,21.09716796875,32.00381851196289,32.14694595336914,31.564884185791016,31.793893814086918,16029265.0,Deutsche Bank Maintains Buy Rating on Merck & Co,0.02295756572207358,0.018962245268481434,0.2116605248711828,"[{'label': 'positive', 'score': 0.9980523586273193}, {'label': 'neutral', 'score': 0.0015898358542472124}, {'label': 'negative', 'score': 0.00035779786412604153}]","(0.0015898358542472124, 0.9980523586273193, 0.00035779786412604153)",0.9992832647749029,0.9980523586273193,0,0,"[{'label': 'neutral', 'score': 0.8816763162612915}, {'label': 'positive', 'score': 0.1040327250957489}, {'label': 'negative', 'score': 0.014290927909314632}]","(0.8816763162612915, 0.1040327250957489, 0.014290927909314632)",0.7584434295870992,0.1040327250957489,0,1,"[{'label': 'positive', 'score': 0.9982903599739075}, {'label': 'neutral', 'score': 0.0010707303881645203}, {'label': 'negative', 'score': 0.0006389313493855298}]","(0.0010707303881645203, 0.9982903599739075, 0.0006389313493855298)",0.9987207676160159,0.9982903599739075,0,0
2011-10-27,21.581499099731445,32.738548278808594,32.97710037231445,32.270992279052734,32.51908493041992,21681024.0,,0.023316827103122807,0.02269800587658359,0.26183573027652834,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-28,22.08470916748047,33.50190734863281,33.874046325683594,33.03435134887695,33.42557144165039,26889898.0,"Merck Announces Increased Earnings | Financial Breakfast: Morning News Summary for October 28, 2011 | Merck & Co Reports Q3 EPS $0.94 vs $0.91 Est; Revenues $12.02B vs $11.61B Est			 | US Stock Futures Signal Lower Start On Wall Street | Earnings Scheduled For October 28",-0.005791329645015824,0.023049142934253124,0.28617247883971886,"[{'label': 'positive', 'score': 0.9993546605110168}, {'label': 'negative', 'score': 0.0005209632217884064}, {'label': 'neutral', 'score': 0.00012442270235624164}]","(0.00012442270235624164, 0.9993546605110168, 0.0005209632217884064)",0.9989579439493814,0.9993546605110168,0,0,"[{'label': 'negative', 'score': 0.9648941159248352}, {'label': 'neutral', 'score': 0.0179427657276392}, {'label': 'positive', 'score': 0.017163144424557686}]","(0.0179427657276392, 0.017163144424557686, 0.9648941159248352)",-0.9650465505067364,-0.9648941159248352,0,0,"[{'label': 'positive', 'score': 0.9908558130264282}, {'label': 'neutral', 'score': 0.007699554320424795}, {'label': 'negative', 'score': 0.0014446476707234979}]","(0.007699554320424795, 0.9908558130264282, 0.0014446476707234979)",0.9970882858006364,0.9908558130264282,0,0
2011-10-29,21.956810633341476,33.3078867594401,33.79134877522787,32.99618275960287,33.42239125569662,23999199.666666668,,-0.00582506451381862,-0.0058081644231765895,0.3037283944281895,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-30,21.828912099202476,33.1138661702474,33.70865122477213,32.958014170328774,33.41921106974284,21108501.333333336,,-0.005859194700950896,-0.005842096375448671,0.23954728962805139,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-10-31,21.70101356506348,32.91984558105469,33.625953674316406,32.91984558105469,33.41603088378906,18217803.0,A Look at The New DRGS ETN | Merck Can Block Teva on Generic Temodar as Court Rejects Appeal -Bloomberg | Citi Maintains Neutral Rating and $34 PT on Merck ,-0.012753570791240523,-0.0058764271272860515,0.24968698964642683,"[{'label': 'neutral', 'score': 0.9559815526008606}, {'label': 'positive', 'score': 0.025123294442892075}, {'label': 'negative', 'score': 0.01889517717063427}]","(0.9559815526008606, 0.025123294442892075, 0.01889517717063427)",0.14148872152898603,0.025123294442892075,1,1,"[{'label': 'negative', 'score': 0.847404956817627}, {'label': 'neutral', 'score': 0.1316661238670349}, {'label': 'positive', 'score': 0.020928896963596344}]","(0.1316661238670349, 0.020928896963596344, 0.847404956817627)",-0.9517952758090452,-0.847404956817627,0,0,"[{'label': 'positive', 'score': 0.9928386807441711}, {'label': 'neutral', 'score': 0.0055489614605903625}, {'label': 'negative', 'score': 0.001612336141988635}]","(0.0055489614605903625, 0.9928386807441711, 0.001612336141988635)",0.9967573342183565,0.9928386807441711,0,0
2011-11-01,21.42425346374512,32.5,33.0629768371582,32.156490325927734,32.261451721191406,28063868.0,"Which Pharma Stock Should You Short? | One Pill Makes You Stronger: Pfizer Earnings Are the ""White Knight""",0.003816810021033654,-0.012835595728721515,0.2227692321918097,"[{'label': 'positive', 'score': 0.8633221983909607}, {'label': 'neutral', 'score': 0.13505806028842926}, {'label': 'negative', 'score': 0.001619759714230895}]","(0.13505806028842926, 0.8633221983909607, 0.001619759714230895)",0.9962546395187505,0.8633221983909607,0,0,"[{'label': 'neutral', 'score': 0.849826991558075}, {'label': 'positive', 'score': 0.12862160801887512}, {'label': 'negative', 'score': 0.021551378071308136}]","(0.849826991558075, 0.12862160801887512, 0.021551378071308136)",0.7129792963114431,0.12862160801887512,0,1,"[{'label': 'neutral', 'score': 0.9658267498016357}, {'label': 'positive', 'score': 0.0331835076212883}, {'label': 'negative', 'score': 0.0009897330310195684}]","(0.9658267498016357, 0.0331835076212883, 0.0009897330310195684)",0.9420755531446663,0.0331835076212883,0,1
2011-11-02,21.50602531433105,32.624046325683594,32.9484748840332,32.404579162597656,32.90076446533203,13182373.0,"FDA Advisory Committee Unanimously Recommends Approval of Merck's VYTORIN for Use in Patients with Pre-Dialysis Chronic Kidney Disease | FDA Advisers Vote 16-0 Efficacy, Safety data Support Approval of Merck's Vytorin  | Are Upcoming Study Results Spurring Insider Buying at Ligand Pharmaceuticals?",0.009944461061355221,0.0038095444832485924,0.09413356126762586,"[{'label': 'positive', 'score': 0.8798034191131592}, {'label': 'neutral', 'score': 0.1189461499452591}, {'label': 'negative', 'score': 0.0012504489859566092}]","(0.1189461499452591, 0.8798034191131592, 0.0012504489859566092)",0.9971614698459824,0.8798034191131592,0,0,"[{'label': 'negative', 'score': 0.4571303427219391}, {'label': 'neutral', 'score': 0.30646201968193054}, {'label': 'positive', 'score': 0.2364075928926468}]","(0.30646201968193054, 0.2364075928926468, 0.4571303427219391)",-0.3182562027175868,-0.4571303427219391,1,1,"[{'label': 'positive', 'score': 0.9028701186180115}, {'label': 'neutral', 'score': 0.09514839202165604}, {'label': 'negative', 'score': 0.0019815105479210615}]","(0.09514839202165604, 0.9028701186180115, 0.0019815105479210615)",0.9956202531242662,0.9028701186180115,0,0
2011-11-03,21.71988677978516,32.9484748840332,33.139312744140625,32.76717758178711,32.91984558105469,15536181.0,,-0.014769871643098944,0.009895340293051847,0.1424961947524288,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-04,21.39908790588379,32.46183013916016,32.83396911621094,32.23282241821289,32.75763320922852,11241896.0,,0.0029394780575610923,-0.014880032248306503,0.16912698616414026,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-05,21.461991628011067,32.5572509765625,32.81170527140299,32.24554570515951,32.62086486816406,10843341.666666666,Merck Announces Interim Data for Merck's VICTRELISTM in Prior Null Responder Patients with Chronic Hepatitis C Genotype 1,0.0029308628505224795,0.0029351662395321046,0.17438126767295437,"[{'label': 'neutral', 'score': 0.9998530149459839}, {'label': 'positive', 'score': 7.530742004746571e-05}, {'label': 'negative', 'score': 7.168984302552417e-05}]","(0.9998530149459839, 7.530742004746571e-05, 7.168984302552417e-05)",0.02460982569549798,7.530742004746571e-05,1,1,"[{'label': 'neutral', 'score': 0.6231116056442261}, {'label': 'negative', 'score': 0.2888205051422119}, {'label': 'positive', 'score': 0.0880679115653038}]","(0.6231116056442261, 0.0880679115653038, 0.2888205051422119)",-0.5326579026510708,-0.2888205051422119,0,1,"[{'label': 'neutral', 'score': 0.9905375838279724}, {'label': 'positive', 'score': 0.006905233021825552}, {'label': 'negative', 'score': 0.0025571498554199934}]","(0.9905375838279724, 0.006905233021825552, 0.0025571498554199934)",0.4595124951941561,0.006905233021825552,1,1
2011-11-06,21.524895350138348,32.652671813964844,32.789441426595054,32.25826899210612,32.48409652709961,10444787.333333334,,0.002922297995888175,0.0029265762455898178,0.14777644156651645,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-07,21.587799072265625,32.74809265136719,32.76717758178711,32.270992279052734,32.34732818603516,10046233.0,JP Morgan Maintains Overweight Rating and $44 PT on Merck & Co ,0.004370558094175742,0.002918036383548647,0.146817222368605,"[{'label': 'neutral', 'score': 0.9998482465744019}, {'label': 'positive', 'score': 8.228229125961661e-05}, {'label': 'negative', 'score': 6.944509368622676e-05}]","(0.9998482465744019, 8.228229125961661e-05, 6.944509368622676e-05)",0.08460699153268797,8.228229125961661e-05,1,1,"[{'label': 'neutral', 'score': 0.9039437770843506}, {'label': 'positive', 'score': 0.08270546048879623}, {'label': 'negative', 'score': 0.013350787572562695}]","(0.9039437770843506, 0.08270546048879623, 0.013350787572562695)",0.7220214646727725,0.08270546048879623,0,1,"[{'label': 'positive', 'score': 0.9985079169273376}, {'label': 'neutral', 'score': 0.0009698737412691116}, {'label': 'negative', 'score': 0.0005222394829615951}]","(0.0009698737412691116, 0.9985079169273376, 0.0005222394829615951)",0.9989545070694601,0.9985079169273376,0,0
2011-11-08,21.68214225769043,32.89122009277344,33.024810791015625,32.48091506958008,32.77671813964844,15022870.0,,-0.019727249404910746,0.004361034942723666,0.1293368148959825,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-11-09,21.25442314147949,32.242366790771484,32.97710037231445,32.02289962768555,32.46183013916016,22488927.0,"UPDATE: Merck To Pay $49.5M To Settle Certain Vioxx-Related Lawsuits | Merck Gets Justice Dept. Requests For Information On Drug Marketing Relate To Marketing Of Integrilin, Avelox And AzaSite | Merck: FDA Declines To Approve Merck Eye-Disease Drug Tafluprost -DJ | Merck Launches NEXPLANON 68 mg in the United States",0.034921557763516305,-0.019924429106728068,0.1650668318082967,"[{'label': 'neutral', 'score': 0.7744973301887512}, {'label': 'negative', 'score': 0.14244237542152405}, {'label': 'positive', 'score': 0.08306033909320831}]","(0.7744973301887512, 0.08306033909320831, 0.14244237542152405)",-0.26333180270624296,-0.14244237542152405,0,0,"[{'label': 'negative', 'score': 0.8561090230941772}, {'label': 'neutral', 'score': 0.10697727650403976}, {'label': 'positive', 'score': 0.03691374883055687}]","(0.10697727650403976, 0.03691374883055687, 0.8561090230941772)",-0.9173285385522777,-0.8561090230941772,0,0,"[{'label': 'positive', 'score': 0.9630685448646545}, {'label': 'neutral', 'score': 0.03507514297962189}, {'label': 'negative', 'score': 0.0018563575576990843}]","(0.03507514297962189, 0.9630685448646545, 0.0018563575576990843)",0.996152327392445,0.9630685448646545,1,1
2011-11-10,21.996658325195312,33.36832046508789,33.53053283691406,32.71946716308594,32.98664093017578,27712159.0,Merk CEO Saying Will Not Make Disproportionate Changes to R&D Spending  | Merck Increase Quarterly Dividend by 11% | Citi Maintains Neutral Rating and $34 PT on Merck ,0.02859589324940653,0.034325634244688104,0.30640586443861434,"[{'label': 'positive', 'score': 0.9962479472160339}, {'label': 'neutral', 'score': 0.003438608953729272}, {'label': 'negative', 'score': 0.0003134526778012514}]","(0.003438608953729272, 0.9962479472160339, 0.0003134526778012514)",0.999370931529488,0.9962479472160339,0,0,"[{'label': 'positive', 'score': 0.5725196003913879}, {'label': 'negative', 'score': 0.2621769309043884}, {'label': 'neutral', 'score': 0.16530337929725647}]","(0.16530337929725647, 0.5725196003913879, 0.2621769309043884)",0.37180299408364137,0.5725196003913879,1,0,"[{'label': 'positive', 'score': 0.9903020262718201}, {'label': 'neutral', 'score': 0.00892341323196888}, {'label': 'negative', 'score': 0.0007745733601041138}]","(0.00892341323196888, 0.9903020262718201, 0.0007745733601041138)",0.9984369051587096,0.9903020262718201,0,0
2011-11-11,22.625667572021484,34.32251739501953,34.58969497680664,33.74045944213867,33.74045944213867,31843375.0,Morgan Stanley Maintains Equal-Weight Rating and $34 PT on Merck & Co ,-0.002780086458647474,0.028194661787424972,0.34599532918930465,"[{'label': 'neutral', 'score': 0.9998753070831299}, {'label': 'negative', 'score': 7.396560977213085e-05}, {'label': 'positive', 'score': 5.0629718316486105e-05}]","(0.9998753070831299, 5.0629718316486105e-05, 7.396560977213085e-05)",-0.18729347090002738,-7.396560977213085e-05,1,1,"[{'label': 'neutral', 'score': 0.8925695419311523}, {'label': 'positive', 'score': 0.0970386266708374}, {'label': 'negative', 'score': 0.010391810908913612}]","(0.8925695419311523, 0.0970386266708374, 0.010391810908913612)",0.8065387958380185,0.0970386266708374,0,1,"[{'label': 'positive', 'score': 0.9979592561721802}, {'label': 'neutral', 'score': 0.0016814899863675237}, {'label': 'negative', 'score': 0.0003592638822738081}]","(0.0016814899863675237, 0.9979592561721802, 0.0003592638822738081)",0.9992802620104569,0.9979592561721802,0,0
2011-11-12,22.56276512145996,34.227097829182945,34.43066151936849,33.66094207763672,33.75000127156576,26171214.666666668,,-0.00278783688622399,-0.0027839580762923106,0.3555579921524661,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-13,22.49986267089844,34.13167826334635,34.271628061930336,33.581424713134766,33.75954310099284,20499054.333333336,,-0.002795630648465834,-0.0027917301409991118,0.364735296127331,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-14,22.436960220336918,34.036258697509766,34.11259460449219,33.50190734863281,33.76908493041992,14826894.0,"Appaloosa Took Stakes in ETrade, BP, and Dana Holding in Q3; Exited Pfizer, Bank of America, Hewlett-Packard, Wells Fargo, Merck, Unitedhealth Group and MetLife in Q3",0.0016820584504103771,-0.0027995457222631925,0.29806816161054145,"[{'label': 'neutral', 'score': 0.9998447895050049}, {'label': 'negative', 'score': 9.17149445740506e-05}, {'label': 'positive', 'score': 6.356483936542645e-05}]","(0.9998447895050049, 6.356483936542645e-05, 9.17149445740506e-05)",-0.18128634967444401,-9.17149445740506e-05,1,1,"[{'label': 'neutral', 'score': 0.9250016808509827}, {'label': 'positive', 'score': 0.062320806086063385}, {'label': 'negative', 'score': 0.012677539139986038}]","(0.9250016808509827, 0.062320806086063385, 0.012677539139986038)",0.661924830427253,0.062320806086063385,0,1,"[{'label': 'neutral', 'score': 0.9666420817375183}, {'label': 'positive', 'score': 0.032652806490659714}, {'label': 'negative', 'score': 0.00070508400676772}]","(0.9666420817375183, 0.032652806490659714, 0.00070508400676772)",0.9577261034044047,0.032652806490659714,0,1
2011-11-15,22.47470092773437,34.093509674072266,34.22710037231445,33.72137451171875,33.91221237182617,9350990.0,"Merck Settles Vioxx Suits From NY, Florida, S Carolina -Reuters ",-0.017912126433958658,0.0016806453744574916,0.21426095139723889,"[{'label': 'neutral', 'score': 0.9998183846473694}, {'label': 'negative', 'score': 0.00010203626879956573}, {'label': 'positive', 'score': 7.959896174725145e-05}]","(0.9998183846473694, 7.959896174725145e-05, 0.00010203626879956573)",-0.12352948811068334,-0.00010203626879956573,1,1,"[{'label': 'neutral', 'score': 0.8737038373947144}, {'label': 'negative', 'score': 0.07338777929544449}, {'label': 'positive', 'score': 0.05290834605693817}]","(0.8737038373947144, 0.05290834605693817, 0.07338777929544449)",-0.162154089694882,-0.07338777929544449,1,1,"[{'label': 'negative', 'score': 0.5516788363456726}, {'label': 'neutral', 'score': 0.43902575969696045}, {'label': 'positive', 'score': 0.009295377880334854}]","(0.43902575969696045, 0.009295377880334854, 0.5516788363456726)",-0.9668598746801225,-0.5516788363456726,0,0
2011-11-16,22.072134017944336,33.48282241821289,33.988548278808594,33.42557144165039,33.549617767333984,13459778.0,,-0.00712449732669,-0.018074490348012992,0.12042463613020908,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-17,21.91488265991211,33.2442741394043,33.568702697753906,32.843509674072266,33.32061004638672,17371858.0,,0.003157277395305244,-0.007149997748410059,0.11945354218511703,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-18,21.984071731567383,33.34923553466797,33.606868743896484,33.33969497680664,33.33969497680664,13199979.0,,-0.007725310793427177,0.003152303661252033,0.13536297901350808,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-19,21.81423823038737,33.09160232543945,33.39694595336914,33.04071299235026,33.1647580464681,14563916.0,,-0.007785455859611183,-0.007755305586113764,0.13569386150377033,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-20,21.64440472920736,32.83396911621094,33.1870231628418,32.74173100789388,32.989821116129555,15927853.0,,-0.007846544787706333,-0.00781592074611742,0.11921078833166046,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-21,21.474571228027344,32.57633590698242,32.97710037231445,32.4427490234375,32.814884185791016,17291790.0,,-0.009666040609666087,-0.007877490906626271,0.07682615323075183,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-22,21.266990661621094,32.261451721191406,32.652671813964844,32.213741302490234,32.52862548828125,17795564.0,"Merck KGAA Says Merck & Co Has Taken Over Its Facecbook Page; Asks Court to Order Facebook to Give Information | End-of-Day Market Summary for November 22, 2011 | UPDATE: Merck Resolves Previously Disclosed Seven-Year Investigation Led by U.S. Attorney's Office for the District of Massachusetts Related to Vioxx | Merck Will Pay $950M to Settle Government Vioxx Probe",-0.018337805685274915,-0.009713060019881469,0.08227801111427416,"[{'label': 'neutral', 'score': 0.9976535439491272}, {'label': 'negative', 'score': 0.0013599838130176067}, {'label': 'positive', 'score': 0.0009864846942946315}]","(0.9976535439491272, 0.0009864846942946315, 0.0013599838130176067)",-0.15917499747345842,-0.0013599838130176067,0,0,"[{'label': 'negative', 'score': 0.7779584527015686}, {'label': 'neutral', 'score': 0.19673629105091095}, {'label': 'positive', 'score': 0.02530520036816597}]","(0.19673629105091095, 0.02530520036816597, 0.7779584527015686)",-0.9369940360889972,-0.7779584527015686,1,1,"[{'label': 'neutral', 'score': 0.9575293064117432}, {'label': 'positive', 'score': 0.026390695944428444}, {'label': 'negative', 'score': 0.016080031171441078}]","(0.9575293064117432, 0.026390695944428444, 0.016080031171441078)",0.24277109136506175,0.026390695944428444,0,0
2011-11-23,20.87700843811035,31.66984748840332,32.03244400024414,31.66984748840332,31.908397674560547,14395957.0,,-0.000451966111304537,-0.01850802745127883,0.07370333993860746,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-24,20.867570877075195,31.65553379058838,31.95133686065674,31.641221046447757,31.83683204650879,9768932.0,,-0.0004521704770365777,-0.0004520682787726906,0.1024367122582346,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-25,20.85813331604004,31.64122009277344,31.870229721069336,31.612594604492188,31.76526641845703,5141907.0,,0.01105753380088483,-0.00045227273693385767,0.11919397929050024,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-26,21.088773091634117,31.99109395345052,32.15966924031576,31.790711720784504,31.908396402994796,8864158.666666666,,0.010936601955099606,0.010996846234066887,0.1761464355511288,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-27,21.31941286722819,32.3409678141276,32.44910875956217,31.968828837076824,32.051526387532554,12586410.333333332,,0.01081828666006245,0.010877229817984356,0.1913172530880767,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-11-28,21.550052642822266,32.69084167480469,32.738548278808594,32.14694595336914,32.19465637207031,16308662.0,Is Arena Pharma Going to Cure Obesity?,0.0064214556668675295,0.010760187642556889,0.09852358001985002,"[{'label': 'neutral', 'score': 0.9994698166847229}, {'label': 'positive', 'score': 0.00027161146863363683}, {'label': 'negative', 'score': 0.0002585143956821412}]","(0.9994698166847229, 0.00027161146863363683, 0.0002585143956821412)",0.02470559131914787,0.00027161146863363683,1,1,"[{'label': 'neutral', 'score': 0.8366140723228455}, {'label': 'positive', 'score': 0.14930427074432373}, {'label': 'negative', 'score': 0.01408164482563734}]","(0.8366140723228455, 0.14930427074432373, 0.01408164482563734)",0.8276271883471173,0.14930427074432373,0,1,"[{'label': 'positive', 'score': 0.6373701691627502}, {'label': 'neutral', 'score': 0.36173564195632935}, {'label': 'negative', 'score': 0.0008941853302530944}]","(0.36173564195632935, 0.6373701691627502, 0.0008941853302530944)",0.9971980721656832,0.6373701691627502,0,0
2011-11-29,21.688438415527344,32.90076446533203,33.31106948852539,32.79580307006836,32.91984558105469,12725235.0,,0.03683288698161034,0.0064009259606226405,0.0787647993730276,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-11-30,22.487285614013672,34.11259460449219,34.16030502319336,33.58778762817383,33.58778762817383,19327426.0,,-0.001957972860118724,0.0361707658095835,0.19001981505738944,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-01,22.443254470825195,34.04580307006836,34.34160232543945,33.931297302246094,34.093509674072266,13166758.0,Are the Samsung M&A Rumors True? | These Stocks May Be Better Than Their Dow Equivalents,-0.005605439073119338,-0.0019598921947250754,0.22621035741839202,"[{'label': 'positive', 'score': 0.9955867528915405}, {'label': 'neutral', 'score': 0.0027295444160699844}, {'label': 'negative', 'score': 0.001683700829744339}]","(0.0027295444160699844, 0.9955867528915405, 0.001683700829744339)",0.9966233817046085,0.9955867528915405,0,0,"[{'label': 'positive', 'score': 0.6547883152961731}, {'label': 'neutral', 'score': 0.30165717005729675}, {'label': 'negative', 'score': 0.043554458767175674}]","(0.30165717005729675, 0.6547883152961731, 0.043554458767175674)",0.8752633795757591,0.6547883152961731,0,0,"[{'label': 'positive', 'score': 0.9969723224639893}, {'label': 'neutral', 'score': 0.0027583495248109102}, {'label': 'negative', 'score': 0.0002692867419682443}]","(0.0027583495248109102, 0.9969723224639893, 0.0002692867419682443)",0.9994599368107341,0.9969723224639893,0,0
2011-12-02,22.31744956970215,33.85496139526367,34.26526641845703,33.75,34.26526641845703,15180490.0,,-0.00206688357113018,-0.005621208504053336,0.26107294526637875,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-03,22.27132225036621,33.784987131754555,34.24936294555664,33.65139897664388,34.223917643229164,16131584.666666666,,-0.00207116442685695,-0.002069022522796044,0.2717568117587952,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-04,22.225194931030277,33.715012868245445,34.23345947265625,33.55279795328776,34.182568868001304,17082679.333333332,,-0.0020754630520999255,-0.002073312254079816,0.27868788723951776,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-05,22.179067611694336,33.64503860473633,34.21755599975586,33.45419692993164,34.14122009277344,18033774.0,,0.003970477939238161,-0.002077619810238172,0.025400848400069776,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-12-06,22.267126083374023,33.77862548828125,33.96946716308594,33.635494232177734,33.8072509765625,14559759.0,,0.005932219851146218,0.003962616394228519,0.054865888805192976,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-07,22.39922142028809,33.979007720947266,34.14122009277344,33.58778762817383,33.66412353515625,21849228.0,,-0.011794472299583055,0.005914693514197177,0.06194448811619129,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-12-08,22.135034561157227,33.578243255615234,34.093509674072266,33.463741302490234,34.036258697509766,44441698.0,,0.013924487082120823,-0.011864578879982645,0.11013459258022815,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-09,22.443254470825195,34.04580307006836,34.21755599975586,33.59732818603516,33.6927490234375,42265002.0,Are You Guaranteed Profits if These Rumors are True? | Five Biotech Stocks to Watch Going into Big Doctors' Meeting,-0.002522417703960923,0.013828432062724386,0.1522486224689932,"[{'label': 'neutral', 'score': 0.9998384714126587}, {'label': 'negative', 'score': 0.00010145409032702446}, {'label': 'positive', 'score': 6.002563895890489e-05}]","(0.9998384714126587, 6.002563895890489e-05, 0.00010145409032702446)",-0.2565551202700057,-0.00010145409032702446,1,1,"[{'label': 'neutral', 'score': 0.8968971967697144}, {'label': 'negative', 'score': 0.06300634145736694}, {'label': 'positive', 'score': 0.04009642079472542}]","(0.8968971967697144, 0.04009642079472542, 0.06300634145736694)",-0.2222047223781009,-0.06300634145736694,1,1,"[{'label': 'neutral', 'score': 0.9903221726417542}, {'label': 'positive', 'score': 0.009138844907283783}, {'label': 'negative', 'score': 0.0005390916485339403}]","(0.9903221726417542, 0.009138844907283783, 0.0005390916485339403)",0.8885936799802898,0.009138844907283783,0,1
2011-12-10,22.38664436340332,33.95992533365885,34.15712356567383,33.58778635660807,33.77862675984701,32582145.666666668,,-0.0025287963847312727,-0.0025256043593427455,0.15302697135654844,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-11,22.330034255981445,33.87404759724935,34.0966911315918,33.57824452718099,33.86450449625651,22899289.333333336,,-0.002535207408059527,-0.002531999190944867,0.1543536770817411,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-12,22.27342414855957,33.788169860839844,34.036258697509766,33.568702697753906,33.950382232666016,13216433.0,,-0.011861088273872842,-0.0025384264882020563,0.14740290251381372,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-13,22.273418426513672,33.38740539550781,33.74045944213867,33.26335906982422,33.606868743896484,19198102.0,Benzinga's Top Pre-Market Losers,0.01629033164737804,-0.011931992204285938,0.1477127460747104,"[{'label': 'neutral', 'score': 0.9998154044151306}, {'label': 'positive', 'score': 0.00010679162369342521}, {'label': 'negative', 'score': 7.785960042383522e-05}]","(0.9998154044151306, 0.00010679162369342521, 7.785960042383522e-05)",0.1566847087415845,0.00010679162369342521,1,1,"[{'label': 'neutral', 'score': 0.7532508969306946}, {'label': 'positive', 'score': 0.22835898399353027}, {'label': 'negative', 'score': 0.018390143290162086}]","(0.7532508969306946, 0.22835898399353027, 0.018390143290162086)",0.8509405606203537,0.22835898399353027,0,1,"[{'label': 'negative', 'score': 0.8479985594749451}, {'label': 'neutral', 'score': 0.1489279866218567}, {'label': 'positive', 'score': 0.003073380095884204}]","(0.1489279866218567, 0.003073380095884204, 0.8479985594749451)",-0.992777625596647,-0.8479985594749451,0,0
2011-12-14,22.63625907897949,33.931297302246094,34.12213516235352,33.3015251159668,33.33015441894531,23624330.0,,0.022497196703813855,0.01615906783027302,0.16275266062186833,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-15,23.14551544189453,34.69465637207031,35.0,34.24618148803711,34.274810791015625,33435602.0,,-0.003025289950649786,0.022247867321099575,0.22724393614515673,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-16,23.075489044189453,34.58969497680664,34.9427490234375,34.3702278137207,34.828243255615234,27763930.0,,0.0020229800683711336,-0.0030298753908185342,0.22820974879367706,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-17,23.12217140197754,34.65966924031576,35.00000127156576,34.4720090230306,34.80597941080729,24275662.0,,0.0020188958822410378,0.0020209365996594645,0.22196177858949767,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-18,23.168853759765625,34.72964350382487,35.05725351969401,34.57379023234049,34.78371556599935,20787394.0,,0.002014828153977754,0.0020168606507693964,0.170735652922969,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-19,23.21553611755371,34.799617767333984,35.114505767822266,34.67557144165039,34.761451721191406,17299126.0,Can a Picture of the CEO Predict Stock Performance?,0.016451829984091206,0.0020128011100395645,0.15647681530553725,"[{'label': 'neutral', 'score': 0.999854326248169}, {'label': 'positive', 'score': 8.337324834428728e-05}, {'label': 'negative', 'score': 6.22782827122137e-05}]","(0.999854326248169, 8.337324834428728e-05, 6.22782827122137e-05)",0.14483174656015424,8.337324834428728e-05,1,1,"[{'label': 'neutral', 'score': 0.9184987545013428}, {'label': 'positive', 'score': 0.04440946877002716}, {'label': 'negative', 'score': 0.03709172084927559}]","(0.9184987545013428, 0.04440946877002716, 0.03709172084927559)",0.08978700746496142,0.04440946877002716,1,1,"[{'label': 'neutral', 'score': 0.9989191293716431}, {'label': 'positive', 'score': 0.0007841151091270149}, {'label': 'negative', 'score': 0.00029670243384316564}]","(0.9989191293716431, 0.0007841151091270149, 0.00029670243384316564)",0.4509666580211095,0.0007841151091270149,1,1
2011-12-20,23.59747314453125,35.37213516235352,35.4484748840332,34.828243255615234,35.038169860839844,21423740.0,,0.007013787836907985,0.01631796485135243,0.11580299322510537,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-21,23.76297187805176,35.6202278137207,35.696563720703125,35.32442855834961,35.36259460449219,13790108.0,Exelixis Trading Higher After Licensing Agreement with Merck  | Merck and the ADAP Crisis Task Force Announce New Agreement to Improve Access and Care for People with HIV    | Exelixis Licenses PI3K-Delta Program to Merck   ,0.006161307115542929,0.0069893056356481525,0.09880295399746038,"[{'label': 'positive', 'score': 0.9995720982551575}, {'label': 'neutral', 'score': 0.0002555716782808304}, {'label': 'negative', 'score': 0.0001722760935081169}]","(0.0002555716782808304, 0.9995720982551575, 0.0001722760935081169)",0.9996553597140863,0.9995720982551575,0,0,"[{'label': 'positive', 'score': 0.9419938921928406}, {'label': 'negative', 'score': 0.036728303879499435}, {'label': 'neutral', 'score': 0.02127772383391857}]","(0.02127772383391857, 0.9419938921928406, 0.036728303879499435)",0.924946416813899,0.9419938921928406,0,0,"[{'label': 'positive', 'score': 0.9973616003990173}, {'label': 'neutral', 'score': 0.0023952284827828407}, {'label': 'negative', 'score': 0.00024321195087395608}]","(0.0023952284827828407, 0.9973616003990173, 0.00024321195087395608)",0.999512408224453,0.9973616003990173,0,0
2011-12-22,23.909387588500977,35.83969497680664,36.020992279052734,35.5057258605957,35.667938232421875,12090252.0,Merck & Hits 52-Week High of $37.66,0.009052213155261522,0.006142403868925943,0.09283581356601417,"[{'label': 'positive', 'score': 0.9990856647491455}, {'label': 'neutral', 'score': 0.000641245162114501}, {'label': 'negative', 'score': 0.00027306226547807455}]","(0.000641245162114501, 0.9990856647491455, 0.00027306226547807455)",0.999453525029408,0.9990856647491455,0,0,"[{'label': 'positive', 'score': 0.8095288872718811}, {'label': 'neutral', 'score': 0.16967938840389252}, {'label': 'negative', 'score': 0.02079174295067787}]","(0.16967938840389252, 0.8095288872718811, 0.02079174295067787)",0.9499187610330605,0.8095288872718811,0,0,"[{'label': 'positive', 'score': 0.8724673986434937}, {'label': 'neutral', 'score': 0.12638309597969055}, {'label': 'negative', 'score': 0.0011495824437588453}]","(0.12638309597969055, 0.8724673986434937, 0.0011495824437588453)",0.9973682232176208,0.8724673986434937,0,0
2011-12-23,24.12582397460937,36.16412353515625,36.16412353515625,35.91603088378906,35.95419692993164,10008505.0,Merck & Hits 52-Week High of $37.76,-0.0009894561385151042,0.009011487461025768,0.08343010491321387,"[{'label': 'positive', 'score': 0.9990647435188293}, {'label': 'neutral', 'score': 0.0006593418074771762}, {'label': 'negative', 'score': 0.00027589319506660104}]","(0.0006593418074771762, 0.9990647435188293, 0.00027589319506660104)",0.9994478495421265,0.9990647435188293,0,0,"[{'label': 'positive', 'score': 0.8033698201179504}, {'label': 'neutral', 'score': 0.17722803354263306}, {'label': 'negative', 'score': 0.01940207928419113}]","(0.17722803354263306, 0.8033698201179504, 0.01940207928419113)",0.9528372826094584,0.8033698201179504,0,0,"[{'label': 'positive', 'score': 0.8314762711524963}, {'label': 'neutral', 'score': 0.16728629171848297}, {'label': 'negative', 'score': 0.0012374120997264981}]","(0.16728629171848297, 0.8314762711524963, 0.0012374120997264981)",0.9970280010413815,0.8314762711524963,0,0
2011-12-24,24.10195302963257,36.12834072113037,36.16412353515625,35.93272876739502,35.97805213928223,9488225.25,,-0.0009904361316253481,-0.0009899459733801763,0.09857033761159666,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-25,24.07808208465576,36.09255790710449,36.16412353515625,35.94942665100098,36.00190734863281,8967945.5,,-0.0009914180679013438,-0.0009909269375921238,0.07464585040422292,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-26,24.054211139678955,36.05677509307861,36.16412353515625,35.966124534606934,36.0257625579834,8447665.75,,-0.0009924019531282959,-0.0009919098478606133,0.07621663714161339,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-27,24.03034019470215,36.020992279052734,36.16412353515625,35.98282241821289,36.049617767333984,7927386.0,Inside: 2012's Best Value Investment,-0.008476824446261959,-0.000992894709982168,0.07101359597319777,"[{'label': 'neutral', 'score': 0.9996917247772217}, {'label': 'positive', 'score': 0.00023417359625454992}, {'label': 'negative', 'score': 7.409576210193336e-05}]","(0.9996917247772217, 0.00023417359625454992, 7.409576210193336e-05)",0.5192790973649163,0.00023417359625454992,0,1,"[{'label': 'neutral', 'score': 0.8496531844139099}, {'label': 'positive', 'score': 0.13686081767082214}, {'label': 'negative', 'score': 0.013486039824783802}]","(0.8496531844139099, 0.13686081767082214, 0.013486039824783802)",0.820600974979767,0.13686081767082214,0,1,"[{'label': 'neutral', 'score': 0.9975929856300354}, {'label': 'positive', 'score': 0.002292029559612274}, {'label': 'negative', 'score': 0.00011505461588967592}]","(0.9975929856300354, 0.002292029559612274, 0.00011505461588967592)",0.9044033299203726,0.002292029559612274,0,1
2011-12-28,23.826635360717773,35.71564865112305,36.06870269775391,35.6870231628418,35.963741302490234,7624410.0,,0.008014937662367346,-0.008512957060726285,0.05339762335339314,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2011-12-29,24.017608642578125,36.00190734863281,36.020992279052734,35.77289962768555,35.877864837646484,7189909.0,,-0.0007951103257960322,0.007982988648866296,0.09279876020496368,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2011-12-30,23.99850845336914,35.97328186035156,36.13549423217773,35.75381851196289,35.86832046508789,8237175.0,ETF Showdown: Fun With Pharma,0.0039787946783624495,-0.0007954265936674846,0.09277067353591689,"[{'label': 'neutral', 'score': 0.9998494386672974}, {'label': 'positive', 'score': 7.554006151622161e-05}, {'label': 'negative', 'score': 7.502257358282804e-05}]","(0.9998494386672974, 7.554006151622161e-05, 7.502257358282804e-05)",0.0034370276068370577,7.554006151622161e-05,1,1,"[{'label': 'neutral', 'score': 0.8863292932510376}, {'label': 'positive', 'score': 0.10029249638319016}, {'label': 'negative', 'score': 0.013378201983869076}]","(0.8863292932510376, 0.10029249638319016, 0.013378201983869076)",0.7646147657038419,0.10029249638319016,0,1,"[{'label': 'neutral', 'score': 0.9991468191146851}, {'label': 'positive', 'score': 0.0006907757488079369}, {'label': 'negative', 'score': 0.00016238643729593605}]","(0.9991468191146851, 0.0006907757488079369, 0.00016238643729593605)",0.619330439297821,0.0006907757488079369,0,1
2011-12-31,24.09399461746216,36.11641216278076,36.30009365081787,35.83492469787598,35.9375,10702988.0,,0.003963026609179636,0.00397090020820503,0.09819089333346696,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-01,24.189480781555176,36.25954246520996,36.46469306945801,35.91603088378906,36.00667953491211,13168801.0,,0.003947383025214089,0.003955194504966068,0.10025132354863203,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-02,24.284966945648197,36.40267276763916,36.62929248809815,35.99713706970215,36.07585906982422,15634614.0,,0.003931862458089549,0.003939612550820298,0.04936918093425151,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-03,24.38045310974121,36.54580307006836,36.79389190673828,36.078243255615234,36.14503860473633,18100427.0,Merck & Hits 52-Week High of $37.98 | Can Germany's Employers Turn Europe Around? ,0.0010443345866392186,0.00392415288893093,0.033672326121030854,"[{'label': 'positive', 'score': 0.9994125366210938}, {'label': 'neutral', 'score': 0.00033854047069326043}, {'label': 'negative', 'score': 0.0002489766920916736}]","(0.00033854047069326043, 0.9994125366210938, 0.0002489766920916736)",0.999501878008154,0.9994125366210938,0,0,"[{'label': 'neutral', 'score': 0.7907959818840027}, {'label': 'positive', 'score': 0.18937568366527557}, {'label': 'negative', 'score': 0.019828353077173233}]","(0.7907959818840027, 0.18937568366527557, 0.019828353077173233)",0.8104400528218877,0.18937568366527557,0,1,"[{'label': 'positive', 'score': 0.9975232481956482}, {'label': 'neutral', 'score': 0.002151886932551861}, {'label': 'negative', 'score': 0.00032489007571712136}]","(0.002151886932551861, 0.9975232481956482, 0.00032489007571712136)",0.9993488185962246,0.9975232481956482,0,0
2012-01-04,24.40590476989746,36.58396911621094,36.58396911621094,36.16412353515625,36.49809265136719,14374682.0,Will Alnylam's Prospective Obesity Drug Change the World Forever? | Bark At The Dow's Dogs With These ETFs,0.010432972258960855,0.0010437896486403028,0.020615905439846892,"[{'label': 'neutral', 'score': 0.999738872051239}, {'label': 'positive', 'score': 0.00015094727859832346}, {'label': 'negative', 'score': 0.00011013929906766862}]","(0.999738872051239, 0.00015094727859832346, 0.00011013929906766862)",0.1563005647224825,0.00015094727859832346,0,0,"[{'label': 'neutral', 'score': 0.8680617809295654}, {'label': 'negative', 'score': 0.09903798997402191}, {'label': 'positive', 'score': 0.032900210469961166}]","(0.8680617809295654, 0.032900210469961166, 0.09903798997402191)",-0.5012784719020086,-0.09903798997402191,0,0,"[{'label': 'neutral', 'score': 0.9974512457847595}, {'label': 'negative', 'score': 0.0012918271822854877}, {'label': 'positive', 'score': 0.001256897347047925}]","(0.9974512457847595, 0.001256897347047925, 0.0012918271822854877)",-0.01370482954731013,-0.0012918271822854877,0,0
2012-01-05,24.66054344177246,36.96564865112305,37.21374130249024,36.29771041870117,36.39313125610352,21995005.0,Merck & Hits 52-Week High of $38.57,-0.006969530324221391,0.010378924398743232,0.05461129096686407,"[{'label': 'positive', 'score': 0.9990787506103516}, {'label': 'neutral', 'score': 0.0006508901715278625}, {'label': 'negative', 'score': 0.00027031442732550204}]","(0.0006508901715278625, 0.9990787506103516, 0.00027031442732550204)",0.9994590190019034,0.9990787506103516,0,0,"[{'label': 'positive', 'score': 0.7986962199211121}, {'label': 'neutral', 'score': 0.17933279275894165}, {'label': 'negative', 'score': 0.02197105810046196}]","(0.17933279275894165, 0.7986962199211121, 0.02197105810046196)",0.9464556253456852,0.7986962199211121,0,0,"[{'label': 'positive', 'score': 0.8946490287780762}, {'label': 'neutral', 'score': 0.10420383512973785}, {'label': 'negative', 'score': 0.0011471377220004797}]","(0.10420383512973785, 0.8946490287780762, 0.0011471377220004797)",0.9974388420828314,0.8946490287780762,0,0
2012-01-06,24.488664627075195,36.70801544189453,36.975189208984375,36.66984558105469,36.975189208984375,17530630.0,Merck Says FDA Approves Isentress for Children in Ages 2 & Up -Bloomberg,-0.0006931810946781893,-0.0069939309406751825,0.09990376932117387,"[{'label': 'neutral', 'score': 0.8670586943626404}, {'label': 'positive', 'score': 0.13256041705608368}, {'label': 'negative', 'score': 0.00038093229522928596}]","(0.8670586943626404, 0.13256041705608368, 0.00038093229522928596)",0.994269167612815,0.13256041705608368,0,1,"[{'label': 'neutral', 'score': 0.8102310299873352}, {'label': 'positive', 'score': 0.18034060299396515}, {'label': 'negative', 'score': 0.009428397752344608}]","(0.8102310299873352, 0.18034060299396515, 0.009428397752344608)",0.9006328987846772,0.18034060299396515,0,1,"[{'label': 'positive', 'score': 0.9889180064201355}, {'label': 'neutral', 'score': 0.010813338682055473}, {'label': 'negative', 'score': 0.00026857873308472335}]","(0.010813338682055473, 0.9889180064201355, 0.00026857873308472335)",0.9994569705309072,0.9889180064201355,0,0
2012-01-07,24.47169049580892,36.682570139567055,36.88613128662109,36.49809010823568,36.84478251139323,16545230.333333334,,-0.0006936619280123983,-0.0006934214557754709,0.10098508480312365,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-08,24.454716364542644,36.65712483723959,36.79707336425781,36.32633463541666,36.714375813802086,15559830.666666666,,-0.000694143428882175,-0.0006939026227611581,0.09940246132960004,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-09,24.437742233276367,36.63167953491211,36.70801544189453,36.154579162597656,36.58396911621094,14574431.0,Jefferies Downgrades Merck & Company to Hold ,0.0033863128106198467,-0.0006943844579777478,0.09968822359721907,"[{'label': 'negative', 'score': 0.9967296123504639}, {'label': 'neutral', 'score': 0.002721229800954461}, {'label': 'positive', 'score': 0.0005492038908414543}]","(0.002721229800954461, 0.0005492038908414543, 0.9967296123504639)",-0.9988985950931729,-0.9967296123504639,0,0,"[{'label': 'negative', 'score': 0.49312224984169006}, {'label': 'neutral', 'score': 0.47636836767196655}, {'label': 'positive', 'score': 0.030509386211633682}]","(0.47636836767196655, 0.030509386211633682, 0.49312224984169006)",-0.8834700422549459,-0.49312224984169006,0,1,"[{'label': 'negative', 'score': 0.9956051707267761}, {'label': 'neutral', 'score': 0.0038779887836426497}, {'label': 'positive', 'score': 0.0005167868221178651}]","(0.0038779887836426497, 0.0005167868221178651, 0.9956051707267761)",-0.9989624025086457,-0.9956051707267761,0,0
2012-01-10,24.520496368408203,36.7557258605957,37.02289962768555,36.64122009277344,36.975189208984375,11911778.0,"Going Nuc-lear on Hepatitis C -- Is Idenix the Next Target? | Feuerstein: Merck for Idenix Pharma was Just a Prediction, Not a Rumor",-0.002855647461888289,0.0033805921643547065,0.05902524600891159,"[{'label': 'neutral', 'score': 0.9997348189353943}, {'label': 'positive', 'score': 0.00017206702614203095}, {'label': 'negative', 'score': 9.305763524025679e-05}]","(0.9997348189353943, 0.00017206702614203095, 9.305763524025679e-05)",0.2980084556820959,0.00017206702614203095,1,1,"[{'label': 'neutral', 'score': 0.8923367857933044}, {'label': 'negative', 'score': 0.06922796368598938}, {'label': 'positive', 'score': 0.03843529522418976}]","(0.8923367857933044, 0.03843529522418976, 0.06922796368598938)",-0.28600906914297664,-0.06922796368598938,1,1,"[{'label': 'neutral', 'score': 0.9993066787719727}, {'label': 'positive', 'score': 0.0005132079822942615}, {'label': 'negative', 'score': 0.00018016908143181354}]","(0.9993066787719727, 0.0005132079822942615, 0.00018016908143181354)",0.4803142738422308,0.0005132079822942615,1,1
2012-01-11,24.45047378540039,36.65076446533203,36.7557258605957,36.488548278808594,36.66030502319336,12519198.0,How to Trade Biotechs Based on the JP Morgan Health Care Conference,0.00520692713757541,-0.0028597326021019727,0.03599326134640284,"[{'label': 'neutral', 'score': 0.9998860359191895}, {'label': 'negative', 'score': 6.582336209248751e-05}, {'label': 'positive', 'score': 4.8204310587607324e-05}]","(0.9998860359191895, 4.8204310587607324e-05, 6.582336209248751e-05)",-0.15451557583140824,-6.582336209248751e-05,1,1,"[{'label': 'neutral', 'score': 0.9313477277755737}, {'label': 'positive', 'score': 0.05547875910997391}, {'label': 'negative', 'score': 0.013173496350646019}]","(0.9313477277755737, 0.05547875910997391, 0.013173496350646019)",0.616225388015036,0.05547875910997391,0,1,"[{'label': 'neutral', 'score': 0.9995842576026917}, {'label': 'positive', 'score': 0.0002916885423474014}, {'label': 'negative', 'score': 0.00012403869186528027}]","(0.9995842576026917, 0.0002916885423474014, 0.00012403869186528027)",0.4032688664230095,0.0002916885423474014,1,1
2012-01-12,24.577781677246094,36.84160232543945,36.90839767456055,36.66030502319336,36.85114669799805,10407898.0,,-0.00751102346754775,0.005193417966356002,0.05252932944636357,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-13,24.3931827545166,36.564884185791016,36.73664093017578,36.27862548828125,36.68893051147461,10141915.0,,0.0032620120570479795,-0.0075393732507822355,0.08041062174844639,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-14,24.4727520942688,36.68415927886963,36.82967567443848,36.362117767333984,36.708014488220215,11943767.75,,0.003251405931696428,0.0032567032375403677,0.08460398945956686,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-15,24.552321434021,36.80343437194824,36.92271041870117,36.44561004638672,36.72709846496582,13745620.5,,0.0032408685524611077,0.0032461315411275314,0.08429900945173012,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-16,24.631890773773197,36.922709465026855,37.01574516296387,36.52910232543945,36.74618244171143,15547473.25,,0.0032303992531098106,0.0032356282569940484,0.08113748156839604,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-17,24.71146011352539,37.04198455810547,37.10877990722656,36.61259460449219,36.76526641845703,17349326.0,,0.0012880092487034945,0.003225192723209415,0.07653267396563952,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-18,24.74328994750977,37.08969497680664,37.16603088378906,36.8702278137207,36.8797721862793,15416709.0,"Benzinga's M&A Chatter for Wednesday January 18, 2012 | Positive Rumors Circulate About Vertex Pharmaceuticals | Hearing Wedbush Says Idenix Pharmaceuticals Takeover Target of Merck, Johnson & Johnson, Abbott Labs; $24/Share",0.010033384275234149,0.0012871804763591288,0.013871384363312046,"[{'label': 'neutral', 'score': 0.9886764287948608}, {'label': 'positive', 'score': 0.011183422990143299}, {'label': 'negative', 'score': 0.00014015252236276865}]","(0.9886764287948608, 0.011183422990143299, 0.00014015252236276865)",0.9752458890377902,0.011183422990143299,1,0,"[{'label': 'neutral', 'score': 0.6152857542037964}, {'label': 'positive', 'score': 0.3446905016899109}, {'label': 'negative', 'score': 0.04002368077635765}]","(0.6152857542037964, 0.3446905016899109, 0.04002368077635765)",0.7919303077428559,0.3446905016899109,1,0,"[{'label': 'positive', 'score': 0.688528835773468}, {'label': 'neutral', 'score': 0.3106532394886017}, {'label': 'negative', 'score': 0.0008179418509826064}]","(0.3106532394886017, 0.688528835773468, 0.0008179418509826064)",0.9976269074505539,0.688528835773468,1,1
2012-01-19,24.99155044555664,37.46183013916016,37.6240463256836,36.95610809326172,37.11832046508789,17341046.0,Merck & Hits 52-Week High of $39.01,-0.001528248255620076,0.009983384044761028,0.05308004051026767,"[{'label': 'positive', 'score': 0.9990131855010986}, {'label': 'neutral', 'score': 0.0006985468207858503}, {'label': 'negative', 'score': 0.00028828115318901837}]","(0.0006985468207858503, 0.9990131855010986, 0.00028828115318901837)",0.9994230346640955,0.9990131855010986,0,0,"[{'label': 'positive', 'score': 0.8264376521110535}, {'label': 'neutral', 'score': 0.1537313312292099}, {'label': 'negative', 'score': 0.019831106066703796}]","(0.1537313312292099, 0.8264376521110535, 0.019831106066703796)",0.953132841369672,0.8264376521110535,0,0,"[{'label': 'positive', 'score': 0.8394889831542969}, {'label': 'neutral', 'score': 0.1592785269021988}, {'label': 'negative', 'score': 0.001232528011314571}]","(0.1592785269021988, 0.8394889831542969, 0.001232528011314571)",0.997067927976279,0.8394889831542969,0,0
2012-01-20,24.953351974487305,37.404579162597656,37.59542083740234,37.13740539550781,37.51908493041992,16069927.0,Merck Announces Remicade Receives Positive Opinion From CHMP In Europe for Treatment of Ulcerative Colitis in Pediatric Patients   | What's the Future Like For Health Care?,-0.003656459827282679,-0.0015294172181138318,0.0673658783925183,"[{'label': 'positive', 'score': 0.9993510842323303}, {'label': 'negative', 'score': 0.0003591909189708531}, {'label': 'neutral', 'score': 0.0002896685909945518}]","(0.0002896685909945518, 0.9993510842323303, 0.0003591909189708531)",0.9992814099686702,0.9993510842323303,0,0,"[{'label': 'neutral', 'score': 0.744997501373291}, {'label': 'positive', 'score': 0.24391672015190125}, {'label': 'negative', 'score': 0.01108576636761427}]","(0.744997501373291, 0.24391672015190125, 0.01108576636761427)",0.9130536606217299,0.24391672015190125,0,1,"[{'label': 'positive', 'score': 0.9987730383872986}, {'label': 'neutral', 'score': 0.0009372788481414318}, {'label': 'negative', 'score': 0.00028962836950086057}]","(0.0009372788481414318, 0.9987730383872986, 0.00028962836950086057)",0.9994201997949917,0.9987730383872986,0,0
2012-01-21,24.86211331685384,37.2678108215332,37.5,37.06106948852539,37.40458043416341,15429249.666666666,,-0.003669878590921388,-0.0036631610165903977,0.08331269934723741,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-22,24.77087465922038,37.13104248046875,37.404579162597656,36.98473358154297,37.2900759379069,14788572.333333334,,-0.003683396207806297,-0.003676629116156933,0.09030591421227124,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-23,24.679636001586918,36.9942741394043,37.30915832519531,36.90839767456055,37.17557144165039,14147895.0,Merck Receives Positive Mad Money/Jim Cramer Mention -CNBC,0.00025799594074012665,-0.0036901966158187634,0.09432777627652383,"[{'label': 'positive', 'score': 0.9994242191314697}, {'label': 'neutral', 'score': 0.0003251992166042328}, {'label': 'negative', 'score': 0.00025063485372811556}]","(0.0003251992166042328, 0.9994242191314697, 0.00025063485372811556)",0.9994985672536846,0.9994242191314697,0,0,"[{'label': 'neutral', 'score': 0.7641082406044006}, {'label': 'positive', 'score': 0.2149869054555893}, {'label': 'negative', 'score': 0.02090487629175186}]","(0.7641082406044006, 0.2149869054555893, 0.02090487629175186)",0.8227587571139494,0.2149869054555893,0,1,"[{'label': 'positive', 'score': 0.9842365980148315}, {'label': 'neutral', 'score': 0.015404963865876198}, {'label': 'negative', 'score': 0.00035841341014020145}]","(0.015404963865876198, 0.9842365980148315, 0.00035841341014020145)",0.9992719576963497,0.9842365980148315,0,0
2012-01-24,24.685998916625977,37.00381851196289,37.41412353515625,36.8797721862793,37.18511581420898,13775646.0,"UPDATE: ISI Group Initiates Buy, $45 on Merck",-0.0025786754243077733,0.0002579626655104595,0.02827988162246277,"[{'label': 'neutral', 'score': 0.8666459918022156}, {'label': 'positive', 'score': 0.1329212635755539}, {'label': 'negative', 'score': 0.00043280256795696914}]","(0.8666459918022156, 0.1329212635755539, 0.00043280256795696914)",0.9935089708102158,0.1329212635755539,0,1,"[{'label': 'neutral', 'score': 0.8766138553619385}, {'label': 'positive', 'score': 0.10072248429059982}, {'label': 'negative', 'score': 0.022663699463009834}]","(0.8766138553619385, 0.10072248429059982, 0.022663699463009834)",0.6326379700944952,0.10072248429059982,0,1,"[{'label': 'positive', 'score': 0.9767392873764038}, {'label': 'neutral', 'score': 0.022928720340132713}, {'label': 'negative', 'score': 0.0003319736570119858}]","(0.022928720340132713, 0.9767392873764038, 0.0003319736570119858)",0.999320471965042,0.9767392873764038,0,0
2012-01-25,24.62234878540039,36.90839767456055,37.01335906982422,36.50763320922852,36.80343627929688,15170010.0,Merck Spokesperson Would Not Comment on Earlier Speculation of Idenix Pharmaceuticals Takeover | Idenix Pharmaceuticals Spokesperson Has No Comment on Earlier Merck Takeover Chatter | Idenix Pharmaceuticals Spiking Higher on Renewed Takeover Chatter; Merck Rumored Buyer | UPDATE: Merck: FDA Did Not Approve New Indication For Vytorin Because of Study Design | Merck Announces New FDA Approved Labeling For VYTORIN Includes Results From the Study of Heart and Renal Protection in Patients With Moderate to Severe Chronic Kidney Disease   ,0.002585342182657619,-0.0025820059345484088,0.027057977812502215,"[{'label': 'positive', 'score': 0.7564518451690674}, {'label': 'negative', 'score': 0.21542136371135712}, {'label': 'neutral', 'score': 0.028126776218414307}]","(0.028126776218414307, 0.7564518451690674, 0.21542136371135712)",0.5566883380610572,0.7564518451690674,0,0,"[{'label': 'negative', 'score': 0.8201824426651001}, {'label': 'positive', 'score': 0.09864921122789383}, {'label': 'neutral', 'score': 0.08116831630468369}]","(0.08116831630468369, 0.09864921122789383, 0.8201824426651001)",-0.7852725016385158,-0.8201824426651001,0,0,"[{'label': 'neutral', 'score': 0.953885018825531}, {'label': 'positive', 'score': 0.03335990384221077}, {'label': 'negative', 'score': 0.012755033560097218}]","(0.953885018825531, 0.03335990384221077, 0.012755033560097218)",0.4468155318602321,0.03335990384221077,1,1
2012-01-26,24.685998916625977,37.00381851196289,37.16603088378906,36.774810791015625,37.06106948852539,12983462.0,"Benzinga's M&A Chatter for Thursday January 26, 2012 | Seattle Genetics Spokesperson Would Not Comment on Earlier Merck Takeover Rumor | Benzinga's M&A Chatter for Wednesday January 25, 2012",-0.006704514867485422,0.0025820059345483793,0.04378316178192137,"[{'label': 'neutral', 'score': 0.9998413324356079}, {'label': 'negative', 'score': 9.687706915428862e-05}, {'label': 'positive', 'score': 6.175205635372549e-05}]","(0.9998413324356079, 6.175205635372549e-05, 9.687706915428862e-05)",-0.22142852195695029,-9.687706915428862e-05,0,0,"[{'label': 'neutral', 'score': 0.8738777041435242}, {'label': 'negative', 'score': 0.10277226567268372}, {'label': 'positive', 'score': 0.02335001528263092}]","(0.8738777041435242, 0.02335001528263092, 0.10277226567268372)",-0.6297241834548826,-0.10277226567268372,1,0,"[{'label': 'neutral', 'score': 0.9987581968307495}, {'label': 'positive', 'score': 0.0007193726487457752}, {'label': 'negative', 'score': 0.0005224675987847149}]","(0.9987581968307495, 0.0007193726487457752, 0.0005224675987847149)",0.15855908225927087,0.0007193726487457752,0,0
2012-01-27,24.520496368408203,36.7557258605957,37.02289962768555,36.46946716308594,36.95610809326172,12702389.0,,0.003201805418198902,-0.006727091092293861,0.057031797300273225,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-28,24.59900538126628,36.87341054280599,37.05470657348633,36.48537063598633,36.84478378295898,12909788.0,,0.003191586578997424,0.003196690554188898,0.06483860545591016,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-01-29,24.677514394124348,36.991095225016274,37.08651351928711,36.50127410888672,36.73345947265625,13117187.0,Earnings Expectations for the Week of January 30,0.0031814327608959583,0.003186504277417513,0.07051938605147243,"[{'label': 'neutral', 'score': 0.9998639822006226}, {'label': 'positive', 'score': 7.113910396583378e-05}, {'label': 'negative', 'score': 6.47922934149392e-05}]","(0.9998639822006226, 7.113910396583378e-05, 6.47922934149392e-05)",0.04669127716767166,7.113910396583378e-05,1,1,"[{'label': 'neutral', 'score': 0.8120349049568176}, {'label': 'negative', 'score': 0.1581384390592575}, {'label': 'positive', 'score': 0.029826663434505463}]","(0.8120349049568176, 0.029826663434505463, 0.1581384390592575)",-0.6826361591722041,-0.1581384390592575,0,1,"[{'label': 'neutral', 'score': 0.9993759989738464}, {'label': 'positive', 'score': 0.0003724253037944436}, {'label': 'negative', 'score': 0.000251635821769014}]","(0.9993759989738464, 0.0003724253037944436, 0.000251635821769014)",0.19355392777649813,0.0003724253037944436,1,1
2012-01-30,24.756023406982425,37.10877990722656,37.11832046508789,36.51717758178711,36.62213516235352,13324586.0,,-0.015942381477334545,0.003176382711782764,0.06943133500017969,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-01-31,24.36135482788086,36.51717758178711,37.20419692993164,36.44084167480469,37.18511581420898,17268525.0,Merck Wins Patent Ruling Over Sandoz Version of Cancidas -Bloomberg,0.009406796932838276,-0.016070828234971787,0.13723339514568744,"[{'label': 'positive', 'score': 0.9983466863632202}, {'label': 'neutral', 'score': 0.0012810329208150506}, {'label': 'negative', 'score': 0.0003722717228811234}]","(0.0012810329208150506, 0.9983466863632202, 0.0003722717228811234)",0.999254501539463,0.9983466863632202,0,0,"[{'label': 'positive', 'score': 0.6256873607635498}, {'label': 'negative', 'score': 0.1955471932888031}, {'label': 'neutral', 'score': 0.17876538634300232}]","(0.17876538634300232, 0.6256873607635498, 0.1955471932888031)",0.5237726120415115,0.6256873607635498,0,0,"[{'label': 'positive', 'score': 0.9973010420799255}, {'label': 'neutral', 'score': 0.0018795852083712816}, {'label': 'negative', 'score': 0.0008193913381546736}]","(0.0018795852083712816, 0.9973010420799255, 0.0008193913381546736)",0.998358131322192,0.9973010420799255,0,0
2012-02-01,24.590518951416016,36.860687255859375,37.22328186035156,36.564884185791016,36.78435134887695,15276801.0,,-0.004918446066609209,0.00936282853800777,0.15365708267488723,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-02,24.469566345214844,36.67938995361328,37.18511581420898,36.25954055786133,37.15649032592773,21778174.0,"FDA Approves JANUMET XR for Type 2 Diabetes | UPDATE: Merck Swings To Q4 Profit | Merck's Earnings Are Up, But a Huge Drop may be Coming | Financial Breakfast: Morning News Summary for February 2, 2012 | Merck & Reports Q4 EPS $0.97 vs $0.95 Est; Revenues $12.30B vs $12.53B Est				  | Earnings Scheduled For February 2",-0.0018210594343462834,-0.004930581430237507,0.15572425735350745,"[{'label': 'positive', 'score': 0.9975558519363403}, {'label': 'negative', 'score': 0.0023304838687181473}, {'label': 'neutral', 'score': 0.00011368067498551682}]","(0.00011368067498551682, 0.9975558519363403, 0.0023304838687181473)",0.9953385024171937,0.9975558519363403,0,0,"[{'label': 'negative', 'score': 0.8108402490615845}, {'label': 'positive', 'score': 0.1647285521030426}, {'label': 'neutral', 'score': 0.024431118741631508}]","(0.024431118741631508, 0.1647285521030426, 0.8108402490615845)",-0.6622922916223011,-0.8108402490615845,0,0,"[{'label': 'positive', 'score': 0.9954309463500977}, {'label': 'neutral', 'score': 0.0034112646244466305}, {'label': 'negative', 'score': 0.00115776841994375}]","(0.0034112646244466305, 0.9954309463500977, 0.00115776841994375)",0.9976765371656634,0.9954309463500977,0,0
2012-02-03,24.42500877380371,36.61259460449219,36.82251739501953,36.33587646484375,36.73664093017578,15730690.0,Candlesticks  Bears Appeared on Merck  | From Earlier: Threshold Pharmaceuticals and Merck KGaA Announce Global Agreement to Co-Develop and Commercialize Phase 3 Hypoxia-Targeted Drug TH-302  ,0.0002606160401949488,-0.0018227195788653883,0.15112092052759588,"[{'label': 'positive', 'score': 0.5230475664138794}, {'label': 'neutral', 'score': 0.4763205051422119}, {'label': 'negative', 'score': 0.0006319478852674365}]","(0.4763205051422119, 0.5230475664138794, 0.0006319478852674365)",0.9975865090460405,0.5230475664138794,0,0,"[{'label': 'positive', 'score': 0.6659990549087524}, {'label': 'neutral', 'score': 0.3237999677658081}, {'label': 'negative', 'score': 0.010200908407568932}]","(0.3237999677658081, 0.6659990549087524, 0.010200908407568932)",0.9698287223869694,0.6659990549087524,0,0,"[{'label': 'positive', 'score': 0.8916053175926208}, {'label': 'neutral', 'score': 0.10782519727945328}, {'label': 'negative', 'score': 0.0005694889696314931}]","(0.10782519727945328, 0.8916053175926208, 0.0005694889696314931)",0.9987233690854243,0.8916053175926208,0,0
2012-02-04,24.43137486775716,36.62213643391927,36.7620849609375,36.35177993774414,36.64440155029297,14341076.666666666,,0.00026054813717096506,0.0002605820857340585,0.14609358984770532,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-05,24.437740961710613,36.63167826334635,36.70165252685547,36.36768341064453,36.55216217041016,12951463.333333334,,0.0002604802695221653,0.00026051420039966826,0.08454986567663034,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-06,24.444107055664062,36.64122009277344,36.64122009277344,36.38358688354492,36.459922790527344,11561850.0,Idenix Pharmaceuticals Spokesperson Has No Comment on Renewed Merck Takeover Chatter | UPDATE: Idenix Pharmaceuticals Spiking Higher on Renewed Takeover Chatter; Merck Rumored Buyer | Merck Confirms Plans to File NDA for Suvorexant in 2012   ,0.005989624868665929,0.0002604463504267158,0.036115956109247324,"[{'label': 'positive', 'score': 0.6684583425521851}, {'label': 'negative', 'score': 0.3212624192237854}, {'label': 'neutral', 'score': 0.010279216803610325}]","(0.010279216803610325, 0.6684583425521851, 0.3212624192237854)",0.35080189962407765,0.6684583425521851,0,1,"[{'label': 'positive', 'score': 0.7781093120574951}, {'label': 'negative', 'score': 0.19173288345336914}, {'label': 'neutral', 'score': 0.030157767236232758}]","(0.030157767236232758, 0.7781093120574951, 0.19173288345336914)",0.6046101430916317,0.7781093120574951,1,1,"[{'label': 'neutral', 'score': 0.9111414551734924}, {'label': 'negative', 'score': 0.07816386967897415}, {'label': 'positive', 'score': 0.010694666765630245}]","(0.9111414551734924, 0.010694666765630245, 0.07816386967897415)",-0.7592878029833984,-0.07816386967897415,0,0
2012-02-07,24.590518951416016,36.860687255859375,37.00381851196289,36.49809265136719,36.51717758178711,13044875.0,"Merck Analyst: Effectiveness of Vorapaxar Was Surprise; But Ability to Reach Market is Limited Due to Bleeding Risk | Merck Announces Top-Line Results of TRA-2P Study of Vorapaxar | Benzinga's M&A Chatter for Monday February 6, 2012",-0.005436204465617034,0.005971758372542399,0.046502880621140504,"[{'label': 'negative', 'score': 0.9956727027893066}, {'label': 'positive', 'score': 0.003350336104631424}, {'label': 'neutral', 'score': 0.0009770228061825037}]","(0.0009770228061825037, 0.003350336104631424, 0.9956727027893066)",-0.9932927750928733,-0.9956727027893066,0,0,"[{'label': 'positive', 'score': 0.6061769127845764}, {'label': 'negative', 'score': 0.25342991948127747}, {'label': 'neutral', 'score': 0.1403931826353073}]","(0.1403931826353073, 0.6061769127845764, 0.25342991948127747)",0.4103585267854218,0.6061769127845764,1,0,"[{'label': 'negative', 'score': 0.9907007217407227}, {'label': 'positive', 'score': 0.0049160076305270195}, {'label': 'neutral', 'score': 0.004383204970508814}]","(0.004383204970508814, 0.0049160076305270195, 0.9907007217407227)",-0.9901246986204589,-0.9907007217407227,0,0
2012-02-08,24.45684051513672,36.66030502319336,36.832061767578125,36.46946716308594,36.78435134887695,11877194.0,,-0.00702757953229018,-0.005451034395217886,0.06411026542380632,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-09,24.284969329833984,36.40267181396485,36.7557258605957,36.39313125610352,36.63167953491211,10058390.0,,-0.006290959139417355,-0.00705238927260749,0.08249470777283417,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-10,24.132177352905277,36.17366409301758,36.26908493041992,36.049617767333984,36.20228958129883,11026113.0,Grandpa's 2012 ETF Portfolio,0.0017585692021130249,-0.0063108306070965075,0.08815166159597017,"[{'label': 'neutral', 'score': 0.9998712539672852}, {'label': 'negative', 'score': 7.434607687173411e-05}, {'label': 'positive', 'score': 5.434116246760823e-05}]","(0.9998712539672852, 5.434116246760823e-05, 7.434607687173411e-05)",-0.15545375366530198,-7.434607687173411e-05,1,1,"[{'label': 'neutral', 'score': 0.8772357702255249}, {'label': 'positive', 'score': 0.10850423574447632}, {'label': 'negative', 'score': 0.014259983785450459}]","(0.8772357702255249, 0.10850423574447632, 0.014259983785450459)",0.7676850170179392,0.10850423574447632,0,1,"[{'label': 'neutral', 'score': 0.9995923638343811}, {'label': 'positive', 'score': 0.000261131877778098}, {'label': 'negative', 'score': 0.00014651230594608933}]","(0.9995923638343811, 0.000261131877778098, 0.00014651230594608933)",0.281175535941316,0.000261131877778098,1,1
2012-02-11,24.17461903889974,36.23727798461914,36.34223937988281,36.11323165893555,36.253180185953774,11410554.333333334,,0.0017554820654179192,0.0017570247297362125,0.09169093382925324,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-12,24.217060724894207,36.3008918762207,36.4153938293457,36.17684555053711,36.304070790608726,11794995.666666666,,0.0017524057485549956,0.0017539430077058676,0.07036987312761449,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-13,24.259502410888672,36.364505767822266,36.488548278808594,36.24045944213867,36.35496139526367,12179437.0,"FDA Approves ZIOPTAN, Merck's Once-Daily, Preservative-Free Ophthalmic Medication | UPDATE: Morgan Stanley Raises PT to $37 on Merck",0.002623905390445577,0.0017508720770828938,0.07346369558419286,"[{'label': 'positive', 'score': 0.9994564652442932}, {'label': 'neutral', 'score': 0.0003179493360221386}, {'label': 'negative', 'score': 0.00022559812350664288}]","(0.0003179493360221386, 0.9994564652442932, 0.00022559812350664288)",0.9995486602555483,0.9994564652442932,0,0,"[{'label': 'positive', 'score': 0.9121205806732178}, {'label': 'neutral', 'score': 0.06582602113485336}, {'label': 'negative', 'score': 0.022053424268960953}]","(0.06582602113485336, 0.9121205806732178, 0.022053424268960953)",0.9527851895850474,0.9121205806732178,0,0,"[{'label': 'positive', 'score': 0.9989727735519409}, {'label': 'neutral', 'score': 0.0007050357526168227}, {'label': 'negative', 'score': 0.00032216584077104926}]","(0.0007050357526168227, 0.9989727735519409, 0.00032216584077104926)",0.9993552137050412,0.9989727735519409,0,0
2012-02-14,24.323156356811523,36.459922790527344,36.488548278808594,36.21183013916016,36.364505767822266,11704378.0,,-0.004972509220266276,0.002620468960628448,0.059093128353934765,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-15,24.20221328735352,36.27862548828125,36.52671813964844,36.154579162597656,36.50763320922852,12769670.0,Merck Establishes Joint Venture with Supera Farma to Commercialize Innovative Pharmaceutical Products and Branded Generics in Brazil  ,0.0031562873808231922,-0.004984913280860468,0.04973704153450074,"[{'label': 'neutral', 'score': 0.7124767303466797}, {'label': 'positive', 'score': 0.28706714510917664}, {'label': 'negative', 'score': 0.0004560724482871592}]","(0.7124767303466797, 0.28706714510917664, 0.0004560724482871592)",0.9968275782932485,0.28706714510917664,0,1,"[{'label': 'positive', 'score': 0.8946060538291931}, {'label': 'neutral', 'score': 0.09686566889286041}, {'label': 'negative', 'score': 0.008528362959623337}]","(0.09686566889286041, 0.8946060538291931, 0.008528362959623337)",0.9811138568056198,0.8946060538291931,0,0,"[{'label': 'positive', 'score': 0.941565990447998}, {'label': 'neutral', 'score': 0.05806196108460426}, {'label': 'negative', 'score': 0.0003720184904523194}]","(0.05806196108460426, 0.941565990447998, 0.0003720184904523194)",0.9992100998432549,0.941565990447998,0,0
2012-02-16,24.278600692749023,36.39313125610352,36.40267181396485,36.06870269775391,36.33587646484375,10933574.0,,0.011011985965553504,0.0031513167621956433,0.05271267009142211,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-02-17,24.54594993591309,36.79389190673828,37.09923553466797,36.564884185791016,36.85114669799805,18826586.0,,-0.002787860986773037,0.010951795522512362,0.08989123367333293,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-18,24.477519035339355,36.69131565093994,37.03959846496582,36.5076322555542,36.81536388397217,16963216.0,,-0.0027956548839565007,-0.0027917543089247495,0.09829810084061354,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-19,24.409088134765625,36.5887393951416,36.97996139526367,36.45038032531738,36.77958106994629,15099846.0,,-0.002803492481404274,-0.002799570025697527,0.10283743967151757,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-20,24.34065723419189,36.48616313934326,36.92032432556152,36.393128395080566,36.74379825592041,13236476.0,,-0.0028113741476897365,-0.0028074296266774514,0.09619409087343345,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-21,24.272226333618164,36.38358688354492,36.860687255859375,36.33587646484375,36.70801544189453,11373106.0,,0.0023604126722276634,-0.002815333482511076,0.09765316573358955,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-22,24.32952308654785,36.46946716308594,36.47900772094727,36.16412353515625,36.31679534912109,10304984.0,,0.007587561499424911,0.0023576312742076113,0.03664081800634015,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-02-23,24.51412773132324,36.74618148803711,36.7557258605957,36.35496139526367,36.35496139526367,10823954.0,"Viva Vivus, But Not In ETFs (VVUS, IBB, PJP)",-0.008049795744556276,0.007558920739122435,0.07356191364144876,"[{'label': 'neutral', 'score': 0.9998859167098999}, {'label': 'negative', 'score': 6.490119267255068e-05}, {'label': 'positive', 'score': 4.920378341921605e-05}]","(0.9998859167098999, 4.920378341921605e-05, 6.490119267255068e-05)",-0.13756989213783533,-6.490119267255068e-05,1,1,"[{'label': 'neutral', 'score': 0.9529022574424744}, {'label': 'positive', 'score': 0.02468457818031311}, {'label': 'negative', 'score': 0.022413188591599464}]","(0.9529022574424744, 0.02468457818031311, 0.022413188591599464)",0.048227118702116926,0.02468457818031311,1,1,"[{'label': 'neutral', 'score': 0.999552309513092}, {'label': 'positive', 'score': 0.00032141280826181173}, {'label': 'negative', 'score': 0.00012626079842448235}]","(0.999552309513092, 0.00032141280826181173, 0.00012626079842448235)",0.4359247606349989,0.00032141280826181173,1,1
2012-02-24,24.316797256469727,36.450382232666016,36.73664093017578,36.39313125610352,36.72710037231445,8896996.0,,-0.00043630469493782944,-0.008082370280333512,0.09423546683764326,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-25,24.306187947591145,36.434478759765625,36.66030502319336,36.2945302327474,36.55216344197592,11699348.0,,-0.000436495139816649,-0.00043639990352555,0.09247329170623086,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-26,24.295578638712566,36.418575286865234,36.58396911621094,36.19592920939128,36.37722651163737,14501700.0,,-0.00043668575102440334,-0.0004365904315508315,0.08987575770849551,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-27,24.284969329833984,36.40267181396485,36.50763320922852,36.09732818603516,36.20228958129883,17304052.0,,0.006028770347139218,-0.00043678112601391866,0.0877996937499792,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-02-28,24.431377410888672,36.62213516235352,36.72710037231445,36.25954055786133,36.40267181396485,9916071.0,"The Rick Santorum ETF Portfolio (KOL, PBS, IYZ) | FDA Approves Important Safety Label Changes For The Class Of Cholesterol-Lowering Drugs Known As Statins -Reuters",-0.005471511070570791,0.006010670023222321,0.07926842440796819,"[{'label': 'positive', 'score': 0.9905875325202942}, {'label': 'neutral', 'score': 0.00893473532050848}, {'label': 'negative', 'score': 0.00047773707774467766}]","(0.00893473532050848, 0.9905875325202942, 0.00047773707774467766)",0.9990359119779498,0.9905875325202942,0,0,"[{'label': 'positive', 'score': 0.6613830327987671}, {'label': 'neutral', 'score': 0.3283013105392456}, {'label': 'negative', 'score': 0.010315647348761559}]","(0.3283013105392456, 0.6613830327987671, 0.010315647348761559)",0.9692848961784595,0.6613830327987671,0,0,"[{'label': 'positive', 'score': 0.9466285109519958}, {'label': 'neutral', 'score': 0.05294846370816231}, {'label': 'negative', 'score': 0.0004230619815643877}]","(0.05294846370816231, 0.9466285109519958, 0.0004230619815643877)",0.9991065703417736,0.9466285109519958,0,0
2012-02-29,24.29769515991211,36.421756744384766,36.72710037231445,36.3740463256836,36.70801544189453,15971520.0,,-0.009955544476732464,-0.005486534613315602,0.06481320952588232,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-03-01,24.05580139160156,36.05915832519531,36.41221237182617,35.935115814208984,36.40267181396485,18920068.0,,0.003704764737918045,-0.01000543229272426,0.09566826158686997,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-02,24.144926071166992,36.1927490234375,36.34542083740234,35.83969497680664,35.89694595336914,13676819.0,,0.0045698056602055375,0.0036979189997263166,0.10423708799093018,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-03,24.255259831746415,36.3581428527832,36.4821891784668,35.976463317871094,36.020992279052734,15637522.333333334,,0.004549017534129697,0.004559395800296056,0.1123904955392461,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-04,24.365593592325848,36.523536682128906,36.61895751953125,36.11323165893555,36.14503860473633,17598225.666666668,,0.004528417682689281,0.004538702025655534,0.10761336350660204,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-05,24.475927352905277,36.68893051147461,36.7557258605957,36.25,36.26908493041992,19558929.0,Merck Says FDA Declines To Approve Its New Drug Application For Ezetimibe And Atorvastatin Tablets -Reuters  | Merck's Investigational Allergy Immunotherapy Tablet Significantly Reduced the Combination of Ragweed Allergy Symptoms | Merck Says FDA Says Added Data Needed on Ezetimibe/Atorvastatin -Bloomberg,-0.026267903944183393,0.004518195248684115,0.10192547379675626,"[{'label': 'positive', 'score': 0.9995341300964355}, {'label': 'neutral', 'score': 0.0002711245615500957}, {'label': 'negative', 'score': 0.00019481289200484753}]","(0.0002711245615500957, 0.9995341300964355, 0.00019481289200484753)",0.9996102685765553,0.9995341300964355,0,0,"[{'label': 'positive', 'score': 0.8370078206062317}, {'label': 'negative', 'score': 0.1160774901509285}, {'label': 'neutral', 'score': 0.04691466689109802}]","(0.04691466689109802, 0.8370078206062317, 0.1160774901509285)",0.7564174185861432,0.8370078206062317,0,0,"[{'label': 'neutral', 'score': 0.804614245891571}, {'label': 'negative', 'score': 0.15769048035144806}, {'label': 'positive', 'score': 0.03769531100988388}]","(0.804614245891571, 0.03769531100988388, 0.15769048035144806)",-0.6141448081025198,-0.15769048035144806,1,0
2012-03-06,23.833011627197266,35.725189208984375,36.62213516235352,35.59160232543945,36.24045944213867,19487874.0,Oncothyreon Analyst: Stimulax Continuation Was Expected; as Likely Outcome for Trial to be Completed Rather Than Stop Early for Positive Efficacy or Futility | Merck Down 2% After Reaffirming 2012 Guidance | Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy | Merck Issues Q1 Profit Forecast | UPDATE: Merck Confirms 2012 Full-Year Guidance | Merck Guides Q1 EPS $0.95-0.98 vs $1.01 Est; Confirms 2012 Guidance | Oncothyreon Falls 47% Pre-Market on Stimuvax Report | UPDATE: Merck Says Stimuvax Trial to Continue to Final Analysis; Says Final Result Expected in 2013,-0.0034721302737042805,-0.02661906855844395,0.21978245240637032,"[{'label': 'negative', 'score': 0.9972768425941467}, {'label': 'positive', 'score': 0.0017900438979268074}, {'label': 'neutral', 'score': 0.0009330728207714856}]","(0.0009330728207714856, 0.0017900438979268074, 0.9972768425941467)",-0.9964165684557678,-0.9972768425941467,0,0,"[{'label': 'negative', 'score': 0.970307469367981}, {'label': 'neutral', 'score': 0.017934825271368027}, {'label': 'positive', 'score': 0.011757650412619114}]","(0.017934825271368027, 0.011757650412619114, 0.970307469367981)",-0.9760552530055322,-0.970307469367981,0,0,"[{'label': 'negative', 'score': 0.701284646987915}, {'label': 'neutral', 'score': 0.20179732143878937}, {'label': 'positive', 'score': 0.09691795706748962}]","(0.20179732143878937, 0.09691795706748962, 0.701284646987915)",-0.7571595066839386,-0.701284646987915,0,0
2012-03-07,23.750247955322266,35.60114669799805,35.71564865112305,35.21946716308594,35.6202278137207,17679760.0,Merck Gives Weak Q1 Outlook | From Earlier: Merck Announces Results from Investigational Studies with VICTRELIS Presented at the Conference on Retroviruses and Opportunistic Infections to Understand Potential Use in Patients Coinfected with Chronic Hepatitis C and HIV-1  ,0.002412182550529449,-0.0034781721074330432,0.21418090501266168,"[{'label': 'negative', 'score': 0.9982665777206421}, {'label': 'positive', 'score': 0.0009164234506897628}, {'label': 'neutral', 'score': 0.0008169527282007039}]","(0.0008169527282007039, 0.0009164234506897628, 0.9982665777206421)",-0.9981656544404469,-0.9982665777206421,0,0,"[{'label': 'negative', 'score': 0.9413992166519165}, {'label': 'neutral', 'score': 0.03809354081749916}, {'label': 'positive', 'score': 0.02050727978348732}]","(0.03809354081749916, 0.02050727978348732, 0.9413992166519165)",-0.9573611783276599,-0.9413992166519165,0,0,"[{'label': 'negative', 'score': 0.9475735425949097}, {'label': 'neutral', 'score': 0.050607748329639435}, {'label': 'positive', 'score': 0.0018187823006883264}]","(0.050607748329639435, 0.0018187823006883264, 0.9475735425949097)",-0.9961685338021069,-0.9475735425949097,0,0
2012-03-08,23.807546615600582,35.6870231628418,36.078243255615234,35.639312744140625,35.89694595336914,42886256.0,,0.005347649030121306,0.002409277908281392,0.20970995414988966,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-09,23.934858322143555,35.877864837646484,36.16412353515625,35.7442741394043,35.76335906982422,46658008.0,,0.004432598946231784,0.0053334011276626805,0.21174909213550158,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-10,24.04095268249512,36.03689702351888,36.23091761271159,35.80470657348633,35.83969497680664,34903779.66666667,,0.0044130377198849415,0.004422803913822953,0.21152057795228385,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-11,24.14704704284668,36.19592920939128,36.29771169026693,35.86513900756836,35.91603088378906,23149551.333333336,,0.004393648383838951,0.004403328822267584,0.05669722140317518,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-12,24.25314140319824,36.35496139526367,36.364505767822266,35.92557144165039,35.992366790771484,11395323.0,"Benzinga's M&A Chatter for  Monday March 12, 2012 | Merck Repeats 2012 Forecast in Presentation Slides -Bloomberg | Merck Spokesperson Would Not Comment on Earlier Speculation of Idenix Pharmaceuticals Takeover Bid | Hearing Renewed Takeover Chatter in Idenix Pharmaceuticals, Merck Rumored Buyer | Positive Rumors Circulate About Idenix Pharmaceuticals",0.004724437540102632,0.004384024489819079,0.017052517324327505,"[{'label': 'neutral', 'score': 0.999122679233551}, {'label': 'positive', 'score': 0.0007501698564738035}, {'label': 'negative', 'score': 0.00012725788110401481}]","(0.999122679233551, 0.0007501698564738035, 0.00012725788110401481)",0.709929659950536,0.0007501698564738035,1,0,"[{'label': 'negative', 'score': 0.5636278390884399}, {'label': 'neutral', 'score': 0.38946905732154846}, {'label': 'positive', 'score': 0.04690311849117279}]","(0.38946905732154846, 0.04690311849117279, 0.5636278390884399)",-0.8463530213861215,-0.5636278390884399,0,0,"[{'label': 'neutral', 'score': 0.5973678827285767}, {'label': 'positive', 'score': 0.4005657732486725}, {'label': 'negative', 'score': 0.002066281856968999}]","(0.5973678827285767, 0.4005657732486725, 0.002066281856968999)",0.9897361284042481,0.4005657732486725,1,0
2012-03-13,24.63932991027832,36.52671813964844,36.54580307006836,35.97328186035156,36.13549423217773,15722725.0,,-0.0015673725830943493,0.004713312411290813,0.006420074840613153,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-03-14,24.6007137298584,36.46946716308594,36.64122009277344,36.34542083740234,36.63167953491211,12322384.0,,-0.004186291323701704,-0.0015686021965110105,0.04300033147548649,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-15,24.497732162475582,36.31679534912109,36.49809265136719,36.21183013916016,36.40267181396485,12833808.0,"A Look At The New Russell High Yield ETF (HDIV, ABT, KFT)",-0.0007882162510779678,-0.004195078373232337,0.06588938991826111,"[{'label': 'neutral', 'score': 0.9998699426651001}, {'label': 'positive', 'score': 6.997885793680325e-05}, {'label': 'negative', 'score': 6.009287972119637e-05}]","(0.9998699426651001, 6.997885793680325e-05, 6.009287972119637e-05)",0.07600404510317449,6.997885793680325e-05,1,1,"[{'label': 'neutral', 'score': 0.9237493872642517}, {'label': 'positive', 'score': 0.06368844956159592}, {'label': 'negative', 'score': 0.012562103569507599}]","(0.9237493872642517, 0.06368844956159592, 0.012562103569507599)",0.6705045916740145,0.06368844956159592,0,1,"[{'label': 'neutral', 'score': 0.9993547797203064}, {'label': 'positive', 'score': 0.0005486903246492147}, {'label': 'negative', 'score': 9.647283877711743e-05}]","(0.9993547797203064, 0.0005486903246492147, 9.647283877711743e-05)",0.7009350680693872,0.0005486903246492147,0,1
2012-03-16,24.478418350219727,36.28816986083984,36.57442855834961,36.23091506958008,36.421756744384766,19446164.0,"ETF Showdown: Dividend Dilemma (HDV, HDIV, JNJ) | Briefing Information for the March 20, 2012 Meeting of the Oncologic Drugs Advisory Committee",-0.0012271280948628284,-0.000788527056839343,0.061900616759585865,"[{'label': 'neutral', 'score': 0.9998737573623657}, {'label': 'negative', 'score': 7.73779465816915e-05}, {'label': 'positive', 'score': 4.891246135230176e-05}]","(0.9998737573623657, 4.891246135230176e-05, 7.73779465816915e-05)",-0.22539704871542948,-7.73779465816915e-05,1,1,"[{'label': 'neutral', 'score': 0.9506267309188843}, {'label': 'positive', 'score': 0.027826525270938873}, {'label': 'negative', 'score': 0.021546781063079834}]","(0.9506267309188843, 0.027826525270938873, 0.021546781063079834)",0.12718905566857353,0.027826525270938873,1,1,"[{'label': 'neutral', 'score': 0.9984476566314697}, {'label': 'positive', 'score': 0.0008224343764595687}, {'label': 'negative', 'score': 0.0007298138225451112}]","(0.9984476566314697, 0.0008224343764595687, 0.0007298138225451112)",0.059668649623073784,0.0008224343764595687,1,1
2012-03-17,24.44838015238444,36.243639628092446,36.4821891784668,36.18956629435221,36.34860102335612,16369201.0,,-0.0012286357883570752,-0.0012278816330650866,0.05175853619170263,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-18,24.418341954549152,36.199109395345054,36.389949798583984,36.14821751912435,36.27544530232748,13292238.0,,-0.0012301471912213528,-0.0012293911801049108,0.021687620457144393,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-19,24.388303756713867,36.154579162597656,36.29771041870117,36.10686874389648,36.20228958129883,10215275.0,,-0.0034309990202270467,-0.0012309044433621884,0.022046022800484916,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-03-20,24.30462455749512,36.03053283691406,36.183204650878906,35.89694595336914,35.92557144165039,14515848.0,Ariad Pharmaceuticals Falls 5% on FDA Panel Vote | FDA Panel Votes 13-1 Against Recommending Taltorvic As Maintenance Treatment For Soft-tissue And Bone Sarcoma -Reuters ,-0.0015889572552711497,-0.003436898395063474,0.016730943683167163,"[{'label': 'negative', 'score': 0.9961967468261719}, {'label': 'neutral', 'score': 0.003148300340399146}, {'label': 'positive', 'score': 0.0006548993405885994}]","(0.003148300340399146, 0.0006548993405885994, 0.9961967468261719)",-0.998686064585223,-0.9961967468261719,0,0,"[{'label': 'negative', 'score': 0.8624861836433411}, {'label': 'neutral', 'score': 0.1102895736694336}, {'label': 'positive', 'score': 0.027224253863096237}]","(0.1102895736694336, 0.027224253863096237, 0.8624861836433411)",-0.9388019905905639,-0.8624861836433411,0,0,"[{'label': 'negative', 'score': 0.9888352751731873}, {'label': 'neutral', 'score': 0.009852723218500614}, {'label': 'positive', 'score': 0.0013119559735059738}]","(0.009852723218500614, 0.0013119559735059738, 0.9888352751731873)",-0.9973499779987536,-0.9888352751731873,0,0
2012-03-21,24.26601219177246,35.97328186035156,36.14503860473633,35.906490325927734,36.14503860473633,12048856.0,UPDATE: Merck and ARIAD Pharmaceuticals Provide Update on FDA Advisory Committee Vote; Voted 13 To 1 Against The Use of Ridaforolimus,-0.002652441416812829,-0.0015902209867049634,0.015234599028617825,"[{'label': 'neutral', 'score': 0.9997844099998474}, {'label': 'positive', 'score': 0.00011258685844950378}, {'label': 'negative', 'score': 0.00010297397966496646}]","(0.9997844099998474, 0.00011258685844950378, 0.00010297397966496646)",0.04459473654223104,0.00011258685844950378,0,0,"[{'label': 'neutral', 'score': 0.5760684013366699}, {'label': 'positive', 'score': 0.2874507009983063}, {'label': 'negative', 'score': 0.136480912566185}]","(0.5760684013366699, 0.2874507009983063, 0.136480912566185)",0.3561182596474484,0.2874507009983063,0,0,"[{'label': 'positive', 'score': 0.8786771893501282}, {'label': 'neutral', 'score': 0.12021368741989136}, {'label': 'negative', 'score': 0.0011091700289398432}]","(0.12021368741989136, 0.8786771893501282, 0.0011091700289398432)",0.9974785468833077,0.8786771893501282,0,0
2012-03-22,24.201642990112305,35.877864837646484,36.1927490234375,35.81106948852539,35.82061004638672,13615092.0,,0.010904218925618226,-0.002655965372317352,0.015562120909344857,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-03-23,24.46554183959961,36.26908493041992,36.3072509765625,35.88740539550781,35.97328186035156,11283292.0,,0.00570024319527756,0.01084519660434102,0.09384195156435299,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-24,24.605004628499348,36.47582753499349,36.51399485270182,36.05916086832682,36.15139897664388,11714439.333333334,Adding Merck's Vorapaxar to Standard of Care Significantly Reduced the Risk of Cardiovascular Events,0.005667934589701142,0.005684058285189493,0.09903170480084413,"[{'label': 'positive', 'score': 0.9994813799858093}, {'label': 'negative', 'score': 0.00026320392498746514}, {'label': 'neutral', 'score': 0.00025539984926581383}]","(0.00025539984926581383, 0.9994813799858093, 0.00026320392498746514)",0.9994734576626405,0.9994813799858093,0,0,"[{'label': 'positive', 'score': 0.8544104695320129}, {'label': 'neutral', 'score': 0.10894937813282013}, {'label': 'negative', 'score': 0.03664012998342514}]","(0.10894937813282013, 0.8544104695320129, 0.03664012998342514)",0.9177597097104241,0.8544104695320129,0,0,"[{'label': 'positive', 'score': 0.9973726272583008}, {'label': 'neutral', 'score': 0.0022482718341052532}, {'label': 'negative', 'score': 0.0003790378395933658}]","(0.0022482718341052532, 0.9973726272583008, 0.0003790378395933658)",0.9992402160720901,0.9973726272583008,0,0
2012-03-25,24.74446741739909,36.682570139567055,36.72073872884115,36.23091634114584,36.3295160929362,12145586.666666666,,0.0056359901660919245,0.005651932286641761,0.08949099833801584,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-26,24.883930206298828,36.88931274414063,36.92748260498047,36.40267181396485,36.50763320922852,12576734.0,Victrelis Available for Eligible Patients in British Columbia | Merck Reports C$35M Investment and Start of Merck Lumira Fund,0.003621289571628933,0.005620167396991109,0.07697641207307353,"[{'label': 'neutral', 'score': 0.9998811483383179}, {'label': 'negative', 'score': 6.097897494328208e-05}, {'label': 'positive', 'score': 5.779724961030297e-05}]","(0.9998811483383179, 5.779724961030297e-05, 6.097897494328208e-05)",-0.026787560767632414,-6.097897494328208e-05,1,1,"[{'label': 'neutral', 'score': 0.7260976433753967}, {'label': 'positive', 'score': 0.2663118541240692}, {'label': 'negative', 'score': 0.007590542081743479}]","(0.7260976433753967, 0.2663118541240692, 0.007590542081743479)",0.9445748398926757,0.2663118541240692,0,1,"[{'label': 'neutral', 'score': 0.998731791973114}, {'label': 'positive', 'score': 0.0011656414717435837}, {'label': 'negative', 'score': 0.00010255995584884658}]","(0.998731791973114, 0.0011656414717435837, 0.00010255995584884658)",0.8382592013895652,0.0011656414717435837,0,1
2012-03-27,24.97403335571289,37.02289962768555,37.21374130249024,36.90839767456055,36.975189208984375,13298596.0,"Benzinga's M&A Chatter for Tuesday March 27, 2012 | Merck Spokesperson, Responding to Chatter of $26 Offer for Amarin, Says Company Policy is Not to Respond to Rumors Regarding Business Development Deals | Hearing Chatter Merck Making $26/Share Bid for Amarin",-0.012628832545742128,0.0036147484892275934,0.04283877088990226,"[{'label': 'neutral', 'score': 0.9998065829277039}, {'label': 'negative', 'score': 0.00013158450019545853}, {'label': 'positive', 'score': 6.184727681102231e-05}]","(0.9998065829277039, 6.184727681102231e-05, 0.00013158450019545853)",-0.3605261992816191,-0.00013158450019545853,0,0,"[{'label': 'neutral', 'score': 0.8994930386543274}, {'label': 'negative', 'score': 0.06052645668387413}, {'label': 'positive', 'score': 0.03998051583766937}]","(0.8994930386543274, 0.03998051583766937, 0.06052645668387413)",-0.20442303982244386,-0.06052645668387413,0,0,"[{'label': 'neutral', 'score': 0.996609091758728}, {'label': 'positive', 'score': 0.0017356702592223883}, {'label': 'negative', 'score': 0.0016553441528230906}]","(0.996609091758728, 0.0017356702592223883, 0.0016553441528230906)",0.02368792834202216,0.0017356702592223883,0,0
2012-03-28,24.65864562988281,36.55534362792969,37.14694595336914,36.47900772094727,36.860687255859375,17066470.0,,-0.00783083043681343,-0.012709254055401945,0.12750836366295487,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-29,24.46554183959961,36.26908493041992,36.54580307006836,36.049617767333984,36.421756744384766,18432434.0,,0.010260395680437892,-0.007861652402648142,0.13597191082443488,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-30,24.716571807861328,36.64122009277344,36.66030502319336,36.3072509765625,36.39313125610352,14794302.0,,0.0009548571708575626,0.010208115129330368,0.1530747521719912,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-03-31,24.740174611409504,36.67620722452799,36.704833984375,36.358141581217446,36.44402186075846,13859555.666666666,,0.0009539462884038551,0.0009544015847392066,0.1452323069656373,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-01,24.763777414957683,36.71119435628256,36.74936294555664,36.4090321858724,36.49491246541341,12924809.333333334,,0.0009530371421588005,0.0009534915708043937,0.14088554174663223,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-02,24.78738021850586,36.74618148803711,36.79389190673828,36.459922790527344,36.54580307006836,11990063.0,,0.005453144369061884,0.0009525832905970924,0.10143431461938308,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-03,24.922542572021484,36.946563720703125,36.946563720703125,36.6984748840332,36.78435134887695,11473609.0,Merck | Codexis and Merck Develop Prototype Enzyme-Based Method for Production of Boceprevir  ,0.004648788062758897,0.005438329810189217,0.06545576720163816,"[{'label': 'neutral', 'score': 0.9998797178268433}, {'label': 'positive', 'score': 6.145439692772925e-05}, {'label': 'negative', 'score': 5.870555105502717e-05}]","(0.9998797178268433, 6.145439692772925e-05, 5.870555105502717e-05)",0.022876556779939276,6.145439692772925e-05,1,1,"[{'label': 'neutral', 'score': 0.743129312992096}, {'label': 'positive', 'score': 0.24856671690940857}, {'label': 'negative', 'score': 0.008303973823785782}]","(0.743129312992096, 0.24856671690940857, 0.008303973823785782)",0.9353451045731728,0.24856671690940857,0,1,"[{'label': 'neutral', 'score': 0.9990946054458618}, {'label': 'positive', 'score': 0.0008122859871946275}, {'label': 'negative', 'score': 9.3095914053265e-05}]","(0.9990946054458618, 0.0008122859871946275, 9.3095914053265e-05)",0.7943499556928398,0.0008122859871946275,0,1
2012-04-04,25.038402557373047,37.11832046508789,37.16603088378906,36.73664093017578,36.832061767578125,15940918.0,Decoding Wall St.: Express Scripts and Medco Merger is No Joke,-0.0005141647084455895,0.004638015819880548,0.03579850434007342,"[{'label': 'neutral', 'score': 0.9997908473014832}, {'label': 'negative', 'score': 0.00016892213898245245}, {'label': 'positive', 'score': 4.0260474634123966e-05}]","(0.9997908473014832, 4.0260474634123966e-05, 0.00016892213898245245)",-0.6150686336875029,-0.00016892213898245245,0,1,"[{'label': 'neutral', 'score': 0.9315352439880371}, {'label': 'positive', 'score': 0.043093472719192505}, {'label': 'negative', 'score': 0.025371268391609192}]","(0.9315352439880371, 0.043093472719192505, 0.025371268391609192)",0.25885154957209466,0.043093472719192505,1,1,"[{'label': 'neutral', 'score': 0.9978196620941162}, {'label': 'positive', 'score': 0.0013443550560623407}, {'label': 'negative', 'score': 0.0008359330240637064}]","(0.9978196620941162, 0.0013443550560623407, 0.0008359330240637064)",0.23319030023282125,0.0013443550560623407,1,1
2012-04-05,25.02553367614746,37.09923553466797,37.12786483764648,36.82251739501953,36.98473358154297,14547078.0,,-0.0009644905032645638,-0.0005142969364458591,0.04113926472743889,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-06,25.001395225524902,37.063453674316406,37.14456272125244,36.81536102294922,36.94179439544678,13982075.0,,-0.0009654216432709533,-0.00096495592351631,0.04692415344177339,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-07,24.977256774902344,37.02767181396485,37.1612606048584,36.808204650878906,36.898855209350586,13417072.0,,-0.0009663545829007431,-0.0009658879628998063,0.05117414538898706,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-08,24.953118324279785,36.99188995361328,37.17795848846436,36.801048278808594,36.8559160232544,12852069.0,,-0.0009672893273750511,-0.0009668218045160951,0.039105678686534306,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-09,24.928979873657227,36.95610809326172,37.19465637207031,36.79389190673828,36.8129768371582,12287066.0,,-0.007229591955756413,-0.0009677574535964363,0.003209342262916785,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-04-10,24.748748779296875,36.68893051147461,37.10877990722656,36.68893051147461,36.9370231628418,14655337.0,,0.0007802213878187936,-0.007255852098974151,0.044650997454821456,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-11,24.76806259155273,36.71755599975586,36.92748260498047,36.64122009277344,36.84160232543945,11224709.0,,-0.0054572918189348535,0.0007799171733378876,0.049234342439846604,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-12,24.632892608642575,36.51717758178711,36.9370231628418,36.44084167480469,36.9370231628418,13421107.0,,-0.012803832207621648,-0.005472237235065075,0.0541400913108397,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-04-13,24.3175106048584,36.049617767333984,36.35496139526367,36.040077209472656,36.34542083740234,21859289.0,,0.0014998991378411244,-0.012886507734437242,0.08587159544423528,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-14,24.353981018066406,36.10368855794271,36.34223937988281,36.07506434122721,36.27862675984701,19441902.33333333,,0.0014976528096828988,0.0014987754126386684,0.0947817674518481,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-15,24.39045143127441,36.15775934855143,36.32951736450195,36.11005147298177,36.211832682291664,17024515.666666668,,0.001495413199902821,0.001496532446184526,0.09994823221422834,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-16,24.426921844482425,36.21183013916016,36.31679534912109,36.14503860473633,36.14503860473633,14607129.0,"Option Alert: Endocyte Call Volume at 818% of Average on Merck Deal | Morning Market Movers | Benzinga's Top Pre-Market Gainers | Endocyte Rises 100% Pre-Market on Merck Deal | Financial Breakfast: Morning News Summary for April 16, 2012 | Endocyte Resumes Trading | PREVIEW: Endocyte to Resume Trading at 7:30am | Merck and Endocyte Enter Exclusive Worldwide Agreement to Develop and Commercialize Phase III Cancer Candidate Vintafolide",0.01475626464675941,0.0014942961830460445,0.1017256579494681,"[{'label': 'positive', 'score': 0.9940924048423767}, {'label': 'neutral', 'score': 0.005553631577640772}, {'label': 'negative', 'score': 0.00035399154876358807}]","(0.005553631577640772, 0.9940924048423767, 0.00035399154876358807)",0.9992880630870639,0.9940924048423767,0,0,"[{'label': 'positive', 'score': 0.9222963452339172}, {'label': 'neutral', 'score': 0.06465770304203033}, {'label': 'negative', 'score': 0.013046003878116608}]","(0.06465770304203033, 0.9222963452339172, 0.013046003878116608)",0.9721043233196875,0.9222963452339172,0,0,"[{'label': 'positive', 'score': 0.992982029914856}, {'label': 'neutral', 'score': 0.006701021455228329}, {'label': 'negative', 'score': 0.0003169869596604258}]","(0.006701021455228329, 0.992982029914856, 0.0003169869596604258)",0.9993617491726553,0.992982029914856,0,0
2012-04-17,24.78738021850586,36.74618148803711,36.774810791015625,36.25,36.364505767822266,11738019.0,"Benzinga's Microcap Movers for Monday April 16, 2012 | Benzinga's Top Pre-Market Gainers",-0.0028563891814947506,0.014648450304174122,0.15463222546405547,"[{'label': 'neutral', 'score': 0.999864935874939}, {'label': 'positive', 'score': 7.231005292851478e-05}, {'label': 'negative', 'score': 6.27520857960917e-05}]","(0.999864935874939, 7.231005292851478e-05, 6.27520857960917e-05)",0.07076718333264288,7.231005292851478e-05,1,1,"[{'label': 'positive', 'score': 0.9101781845092773}, {'label': 'neutral', 'score': 0.0733368918299675}, {'label': 'negative', 'score': 0.01648489199578762}]","(0.0733368918299675, 0.9101781845092773, 0.01648489199578762)",0.9644209585689745,0.9101781845092773,0,0,"[{'label': 'positive', 'score': 0.6483950018882751}, {'label': 'neutral', 'score': 0.350990355014801}, {'label': 'negative', 'score': 0.0006145592778921127}]","(0.350990355014801, 0.6483950018882751, 0.0006145592778921127)",0.9981061626371487,0.6483950018882751,0,0
2012-04-18,24.716571807861328,36.64122009277344,36.832061767578125,36.62213516235352,36.67938995361328,8033339.0,Merck Wins Another FOSAMAX State Court Trial   ,-0.0010416150457311169,-0.0028604764461406876,0.10544496861819933,"[{'label': 'positive', 'score': 0.9899278283119202}, {'label': 'neutral', 'score': 0.009589060209691525}, {'label': 'negative', 'score': 0.00048309890553355217}]","(0.009589060209691525, 0.9899278283119202, 0.00048309890553355217)",0.999024447545443,0.9899278283119202,0,0,"[{'label': 'positive', 'score': 0.7854238152503967}, {'label': 'neutral', 'score': 0.1478007733821869}, {'label': 'negative', 'score': 0.06677543371915817}]","(0.1478007733821869, 0.7854238152503967, 0.06677543371915817)",0.843286804582613,0.7854238152503967,0,0,"[{'label': 'positive', 'score': 0.9943344593048096}, {'label': 'neutral', 'score': 0.004438312258571386}, {'label': 'negative', 'score': 0.0012272595195099711}]","(0.004438312258571386, 0.9943344593048096, 0.0012272595195099711)",0.9975345385498364,0.9943344593048096,0,0
2012-04-19,24.690826416015625,36.60305404663086,36.85114669799805,36.41221237182617,36.78435134887695,11256358.0,S&P: Bullish On Pharma ETFs Long-Term | Merck Reports Phase III Study Results Evaluating Anaemia Management Strategies Used With VICTRELIS (boceprevir) Combination Therapy   ,0.00964548057058524,-0.0010421579036815733,0.10957406062418915,"[{'label': 'negative', 'score': 0.9941018223762512}, {'label': 'neutral', 'score': 0.00343179889023304}, {'label': 'positive', 'score': 0.0024663207586854696}]","(0.00343179889023304, 0.0024663207586854696, 0.9941018223762512)",-0.9950503720680313,-0.9941018223762512,0,0,"[{'label': 'positive', 'score': 0.9190154671669006}, {'label': 'neutral', 'score': 0.06079784035682678}, {'label': 'negative', 'score': 0.020186657086014748}]","(0.06079784035682678, 0.9190154671669006, 0.020186657086014748)",0.9570131783888965,0.9190154671669006,0,0,"[{'label': 'positive', 'score': 0.9136707782745361}, {'label': 'neutral', 'score': 0.0858435407280922}, {'label': 'negative', 'score': 0.00048561583389528096}]","(0.0858435407280922, 0.9136707782745361, 0.00048561583389528096)",0.9989375650883701,0.9136707782745361,0,0
2012-04-20,24.928979873657227,36.95610809326172,37.09923553466797,36.54580307006836,36.55534362792969,15591306.0,,-0.003959025396351621,0.009599259898917393,0.11848397917803778,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-21,24.830284118652344,36.80979792277018,36.99745432535807,36.51399612426758,36.63167953491211,14122044.666666666,,-0.003974761578384696,-0.00396688308344133,0.13235913612459368,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-22,24.73158836364746,36.66348775227865,36.89567311604818,36.4821891784668,36.70801544189453,12652783.333333334,"Earnings Expectations for the Week of April 23 (AAPL, XOM, UPS)",-0.003990623354769231,-0.003982681937847408,0.09119106130636154,"[{'label': 'neutral', 'score': 0.9998273253440857}, {'label': 'positive', 'score': 0.0001103909089579247}, {'label': 'negative', 'score': 6.229513383004814e-05}]","(0.9998273253440857, 0.0001103909089579247, 6.229513383004814e-05)",0.2785157060257003,0.0001103909089579247,1,1,"[{'label': 'neutral', 'score': 0.8866839408874512}, {'label': 'negative', 'score': 0.0878385603427887}, {'label': 'positive', 'score': 0.025477470830082893}]","(0.8866839408874512, 0.025477470830082893, 0.0878385603427887)",-0.5503289240475566,-0.0878385603427887,0,1,"[{'label': 'neutral', 'score': 0.9989149570465088}, {'label': 'positive', 'score': 0.0006495015695691109}, {'label': 'negative', 'score': 0.0004356220306362957}]","(0.9989149570465088, 0.0006495015695691109, 0.0004356220306362957)",0.1971015457523265,0.0006495015695691109,1,1
2012-04-23,24.632892608642575,36.51717758178711,36.79389190673828,36.450382232666016,36.78435134887695,11183522.0,,0.0,-0.003998607139412508,0.09341672043405318,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-24,24.632892608642575,36.51717758178711,36.66984558105469,36.421756744384766,36.58396911621094,13084699.0,,0.00418071738774579,0.0,0.09345390622690855,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-25,24.735885620117188,36.66984558105469,36.72710037231445,36.38358688354492,36.54580307006836,13457054.0,,0.0010409059606066092,0.004172002470102548,0.05772878745154844,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-26,24.761619567871094,36.70801544189453,36.79389190673828,36.536258697509766,36.71755599975586,10683731.0,,-0.0002599039405012228,0.0010403645936394395,0.05545022164194599,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-27,24.75519561767578,36.6984748840332,37.15649032592773,36.58396911621094,37.02289962768555,16259196.0,Merck & Reports Q1 EPS $0.99 vs $0.98 Est; Revenues $11.7B vs $11.82B Est | US Stock Futures Flat; GDP Data In Focus | Earnings Scheduled For April 27,0.006760264032371811,-0.00025993772138369867,0.04652776985907345,"[{'label': 'negative', 'score': 0.9979392886161804}, {'label': 'neutral', 'score': 0.001519934507086873}, {'label': 'positive', 'score': 0.0005407995195128024}]","(0.001519934507086873, 0.0005407995195128024, 0.9979392886161804)",-0.9989167545233224,-0.9979392886161804,0,0,"[{'label': 'negative', 'score': 0.938088595867157}, {'label': 'neutral', 'score': 0.03250689059495926}, {'label': 'positive', 'score': 0.02940446324646473}]","(0.03250689059495926, 0.02940446324646473, 0.938088595867157)",-0.9392151437791111,-0.938088595867157,0,0,"[{'label': 'neutral', 'score': 0.5509933233261108}, {'label': 'negative', 'score': 0.4346078932285309}, {'label': 'positive', 'score': 0.014398797415196896}]","(0.5509933233261108, 0.014398797415196896, 0.4346078932285309)",-0.9358637734571226,-0.4346078932285309,0,1
2012-04-28,24.92254892985026,36.94656626383463,37.32188415527344,36.66348520914713,36.9720090230306,17759268.333333332,,0.00671486973998671,0.0067375159121284495,0.04803100357570274,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-29,25.08990224202474,37.19465764363607,37.48727798461914,36.743001302083336,36.92111841837565,19259340.666666668,,0.006670081014816864,0.006692425419942753,0.050919756882148816,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-04-30,25.25725555419922,37.4427490234375,37.65267181396485,36.82251739501953,36.8702278137207,20759413.0,New Kids: Do These New ETFs Have The Right Stuff? | FDA Considering Letting Patients Purchase Drugs Without Prescriptions,0.0033129598899359434,0.006647934449489642,0.05528448603238636,"[{'label': 'neutral', 'score': 0.9998514652252197}, {'label': 'positive', 'score': 8.452360634692013e-05}, {'label': 'negative', 'score': 6.39782811049372e-05}]","(0.9998514652252197, 8.452360634692013e-05, 6.39782811049372e-05)",0.1383506000800394,8.452360634692013e-05,1,1,"[{'label': 'neutral', 'score': 0.9158850908279419}, {'label': 'positive', 'score': 0.05757660046219826}, {'label': 'negative', 'score': 0.02653833106160164}]","(0.9158850908279419, 0.05757660046219826, 0.02653833106160164)",0.36899833166736273,0.05757660046219826,1,1,"[{'label': 'neutral', 'score': 0.9974617958068848}, {'label': 'positive', 'score': 0.0024051323998719454}, {'label': 'negative', 'score': 0.00013309417408891022}]","(0.9974617958068848, 0.0024051323998719454, 0.00013309417408891022)",0.895128216326867,0.0024051323998719454,0,1
2012-05-01,25.34092712402344,37.56679534912109,37.69084167480469,37.08015441894531,37.15649032592773,15290320.0,,-0.002032004760400749,0.003307484128971076,0.04920310032609236,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-02,25.2894344329834,37.49045944213867,37.6240463256836,37.299617767333984,37.51908493041992,12082182.0,,-0.0030542641921737293,-0.0020340720830883553,0.0605935981265835,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-03,25.212188720703125,37.375953674316406,37.57633590698242,37.270992279052734,37.50954055786133,11076731.0,,-0.008424779967752214,-0.003058937976124951,0.07391230997704101,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-04,24.99978446960449,37.06106948852539,37.31870269775391,36.84160232543945,37.31870269775391,12505155.0,"Pfizer, Merck Pulled Into Expanded Congressional Investigation, Republicans Seeking Documents Over Obama Deal -Bloomberg",-0.002574657643545243,-0.008460469016121443,0.09311294133160145,"[{'label': 'neutral', 'score': 0.975375771522522}, {'label': 'negative', 'score': 0.022872382774949074}, {'label': 'positive', 'score': 0.0017518936656415462}]","(0.975375771522522, 0.0017518936656415462, 0.022872382774949074)",-0.8577100391259638,-0.022872382774949074,0,1,"[{'label': 'neutral', 'score': 0.7651793956756592}, {'label': 'negative', 'score': 0.18141934275627136}, {'label': 'positive', 'score': 0.05340122804045677}]","(0.7651793956756592, 0.05340122804045677, 0.18141934275627136)",-0.5451741910066012,-0.18141934275627136,0,1,"[{'label': 'negative', 'score': 0.9937315583229065}, {'label': 'neutral', 'score': 0.004844564013183117}, {'label': 'positive', 'score': 0.0014238021103665233}]","(0.004844564013183117, 0.0014238021103665233, 0.9937315583229065)",-0.9971385330030346,-0.9937315583229065,0,0
2012-05-05,24.935418446858723,36.9656499226888,37.22328313191732,36.8066151936849,37.127862294514976,12379849.333333334,,-0.0025813036166319235,-0.0025779777745608373,0.06629800212444335,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-06,24.87105242411296,36.87023035685221,37.12786356608073,36.771628061930336,36.93702189127604,12254543.666666666,,-0.0025879839890626762,-0.0025846409251205787,0.0422556929451302,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-07,24.806686401367188,36.774810791015625,37.03244400024414,36.73664093017578,36.74618148803711,12129238.0,J.P. Morgan Reiterates Overweight Rating for Merck | Goldman Sachs Reiterates Neutral Rating for Merck,0.0023351980063682693,-0.0025913386086776928,0.04100227211807712,"[{'label': 'positive', 'score': 0.996574878692627}, {'label': 'negative', 'score': 0.0026291401591151953}, {'label': 'neutral', 'score': 0.0007960184011608362}]","(0.0007960184011608362, 0.996574878692627, 0.0026291401591151953)",0.9947375308555373,0.996574878692627,0,0,"[{'label': 'neutral', 'score': 0.8760101199150085}, {'label': 'negative', 'score': 0.06259459257125854}, {'label': 'positive', 'score': 0.06139524281024933}]","(0.8760101199150085, 0.06139524281024933, 0.06259459257125854)",-0.00967296841163554,-0.06259459257125854,1,1,"[{'label': 'positive', 'score': 0.8832917809486389}, {'label': 'neutral', 'score': 0.11547193676233292}, {'label': 'negative', 'score': 0.0012362247798591852}]","(0.11547193676233292, 0.8832917809486389, 0.0012362247798591852)",0.997204780918517,0.8832917809486389,0,0
2012-05-08,24.864612579345703,36.860687255859375,36.88931274414063,36.52671813964844,36.7557258605957,9183205.0,,-0.013978752346109109,0.0023324756688114694,0.060718509819073486,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-05-09,24.517038345336918,36.34542083740234,36.72710037231445,36.34542083740234,36.58396911621094,12539844.0,,0.007876059512157023,-0.014077375266968516,0.09643460632037258,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-10,24.710134506225582,36.63167953491211,36.85114669799805,36.49809265136719,36.54580307006836,9906430.0,,-0.009377393513854262,0.007845205256188164,0.1284957859300165,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-11,24.478418350219727,36.28816986083984,36.58396911621094,36.21183013916016,36.450382232666016,12692747.0,The Shorts Report: 10 Mega-Caps With Increased Short Selling,0.001665348082137941,-0.009421638084815468,0.13974974545055324,"[{'label': 'positive', 'score': 0.9332851767539978}, {'label': 'negative', 'score': 0.06517206132411957}, {'label': 'neutral', 'score': 0.0015427391044795513}]","(0.0015427391044795513, 0.9332851767539978, 0.06517206132411957)",0.869454476689325,0.9332851767539978,0,0,"[{'label': 'negative', 'score': 0.8989378213882446}, {'label': 'neutral', 'score': 0.06541885435581207}, {'label': 'positive', 'score': 0.03564339131116867}]","(0.06541885435581207, 0.03564339131116867, 0.8989378213882446)",-0.923723287335902,-0.8989378213882446,0,0,"[{'label': 'negative', 'score': 0.505263090133667}, {'label': 'neutral', 'score': 0.38000863790512085}, {'label': 'positive', 'score': 0.11472829431295395}]","(0.38000863790512085, 0.11472829431295395, 0.505263090133667)",-0.6299035851430234,-0.505263090133667,0,0
2012-05-12,24.51918347676595,36.34860229492188,36.59987258911133,36.13549423217773,36.33905919392904,14146428.0,,0.0016625793088741138,0.0016639629276503712,0.14408190068855986,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-13,24.559948603312176,36.40903472900391,36.61577606201172,36.05915832519531,36.227736155192055,15600109.0,,0.0016598197269394478,0.0016611987538711914,0.14278593759373254,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-14,24.6007137298584,36.46946716308594,36.63167953491211,35.98282241821289,36.11641311645508,17053790.0,,-0.012558873971104527,0.0016584437485501812,0.09922251085046914,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-15,24.29175567626953,36.011451721191406,36.450382232666016,35.85877990722656,36.33587646484375,11164030.0,"S&P Bullish On Biotech ETFs (FBT, IBB, XBI)",0.012983536553199468,-0.012638403195401054,0.1118151352982733,"[{'label': 'negative', 'score': 0.988171398639679}, {'label': 'positive', 'score': 0.007704014889895916}, {'label': 'neutral', 'score': 0.004124555271118879}]","(0.004124555271118879, 0.007704014889895916, 0.988171398639679)",-0.9845281552587157,-0.988171398639679,0,0,"[{'label': 'positive', 'score': 0.44558319449424744}, {'label': 'neutral', 'score': 0.43671348690986633}, {'label': 'negative', 'score': 0.11770330369472504}]","(0.43671348690986633, 0.44558319449424744, 0.11770330369472504)",0.5820837031487387,0.44558319449424744,0,1,"[{'label': 'positive', 'score': 0.7960966229438782}, {'label': 'neutral', 'score': 0.20327040553092957}, {'label': 'negative', 'score': 0.0006329463212750852}]","(0.20327040553092957, 0.7960966229438782, 0.0006329463212750852)",0.9984111388714771,0.7960966229438782,0,0
2012-05-16,24.60715103149414,36.47900772094727,36.593509674072266,36.040077209472656,36.22137451171875,16105245.0,,-0.0052314432883505116,0.012899972965869711,0.1439501377437903,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-17,24.478418350219727,36.28816986083984,36.68893051147461,36.25954055786133,36.459922790527344,14573488.0,,-0.005521971304544896,-0.005245175200540372,0.15030708492980208,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-18,24.34324836730957,36.08778762817383,36.459922790527344,35.906490325927734,36.450382232666016,19587749.0,"BMO Capital Markets Initiates Coverage on Merck & at Market Perform, Announces PT of $43",-0.0019390011997989,-0.00553727374718755,0.15295516379067228,"[{'label': 'neutral', 'score': 0.9998832941055298}, {'label': 'negative', 'score': 6.643896631430835e-05}, {'label': 'positive', 'score': 5.0320744776399806e-05}]","(0.9998832941055298, 5.0320744776399806e-05, 6.643896631430835e-05)",-0.13804608959152556,-6.643896631430835e-05,1,1,"[{'label': 'positive', 'score': 0.6069955229759216}, {'label': 'neutral', 'score': 0.37495124340057373}, {'label': 'negative', 'score': 0.018053274601697922}]","(0.37495124340057373, 0.6069955229759216, 0.018053274601697922)",0.9422340314175037,0.6069955229759216,0,0,"[{'label': 'neutral', 'score': 0.8847342729568481}, {'label': 'positive', 'score': 0.11467555165290833}, {'label': 'negative', 'score': 0.0005902507109567523}]","(0.8847342729568481, 0.11467555165290833, 0.0005902507109567523)",0.989758441812716,0.11467555165290833,0,1
2012-05-19,24.29604657491048,36.01781336466471,36.358141581217446,35.88104502360026,36.30089060465495,16307299.333333334,,-0.0019427682297270751,-0.001940883496202254,0.14997413986234556,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-20,24.248844782511394,35.9478391011556,36.256360371907554,35.85559972127279,36.15139897664388,13026849.666666668,,-0.001946549925079294,-0.001944657851719293,0.12076789740569499,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-21,24.201642990112305,35.877864837646484,36.154579162597656,35.83015441894531,36.00190734863281,9746400.0,"Merck: FDA Approves New Labeling for ISENTRESS to Include 156-Week Data Demonstrating Long-Term Efficacy, Safety and Tolerability",-0.00372348518638744,-0.0019484469155087913,0.030012093898408046,"[{'label': 'positive', 'score': 0.995137631893158}, {'label': 'neutral', 'score': 0.004558232147246599}, {'label': 'negative', 'score': 0.00030410606996156275}]","(0.004558232147246599, 0.995137631893158, 0.00030410606996156275)",0.9993890027746198,0.995137631893158,0,0,"[{'label': 'positive', 'score': 0.7795246839523315}, {'label': 'neutral', 'score': 0.2102193534374237}, {'label': 'negative', 'score': 0.010255896486341953}]","(0.2102193534374237, 0.7795246839523315, 0.010255896486341953)",0.9740284916080224,0.7795246839523315,0,0,"[{'label': 'positive', 'score': 0.9982360601425171}, {'label': 'neutral', 'score': 0.0015158671885728836}, {'label': 'negative', 'score': 0.00024809950264170766}]","(0.0015158671885728836, 0.9982360601425171, 0.00024809950264170766)",0.9995030476943573,0.9982360601425171,0,0
2012-05-22,24.111534118652344,35.7442741394043,36.011451721191406,35.639312744140625,35.935115814208984,12919325.0,Health Care SPDR In Focus Ahead Of Obamacare Decision,-0.0032033648991846124,-0.003730434613443243,0.0254864507686837,"[{'label': 'neutral', 'score': 0.999859094619751}, {'label': 'positive', 'score': 7.130653102649376e-05}, {'label': 'negative', 'score': 6.96637507644482e-05}]","(0.999859094619751, 7.130653102649376e-05, 6.96637507644482e-05)",0.011653379997365652,7.130653102649376e-05,1,1,"[{'label': 'neutral', 'score': 0.7593525648117065}, {'label': 'positive', 'score': 0.19366909563541412}, {'label': 'negative', 'score': 0.04697834327816963}]","(0.7593525648117065, 0.19366909563541412, 0.04697834327816963)",0.60956706216982,0.19366909563541412,0,1,"[{'label': 'neutral', 'score': 0.9993523955345154}, {'label': 'positive', 'score': 0.00048875214997679}, {'label': 'negative', 'score': 0.0001588227169122547}]","(0.9993523955345154, 0.00048875214997679, 0.0001588227169122547)",0.5094846170443877,0.00048875214997679,0,1
2012-05-23,24.03428840637207,35.6297721862793,35.906490325927734,35.32442855834961,35.7442741394043,11776166.0,,0.006963071502958577,-0.003208506656075223,0.013577762435874273,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-05-24,24.201642990112305,35.877864837646484,35.94465637207031,35.57251739501953,35.6870231628418,9066982.0,,-0.0013298009487763482,0.006938941269518404,0.06960679811691188,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-25,24.16946601867676,35.83015441894531,36.020992279052734,35.65839767456055,35.84923553466797,6907997.0,"Amylin Shares Jump as Sanofi, Merck Sumbit Bids | Merck Spokesperson Would Not Comment on Reports of Bid for Amylin | Amylin Spokesperson Would Not Comment on Bloomberg Report of Bids from Merck and Sanofi | Amylin Said to Get First-Round Bids from Sanofi, Merck -Bloomberg | Government of Rwanda Introduces Merck's ROTATEQ",0.00026629836489343805,-0.0013306859187009112,0.06909341539141176,"[{'label': 'positive', 'score': 0.9909466505050659}, {'label': 'neutral', 'score': 0.008537654764950275}, {'label': 'negative', 'score': 0.0005157479899935424}]","(0.008537654764950275, 0.9909466505050659, 0.0005157479899935424)",0.9989596216845411,0.9909466505050659,0,0,"[{'label': 'neutral', 'score': 0.8249126672744751}, {'label': 'negative', 'score': 0.10755718499422073}, {'label': 'positive', 'score': 0.06753016263246536}]","(0.8249126672744751, 0.06753016263246536, 0.10755718499422073)",-0.22861173525284825,-0.10755718499422073,1,1,"[{'label': 'positive', 'score': 0.9760451316833496}, {'label': 'neutral', 'score': 0.02338486537337303}, {'label': 'negative', 'score': 0.0005699964240193367}]","(0.02338486537337303, 0.9760451316833496, 0.0005699964240193367)",0.9988327102302338,0.9760451316833496,0,0
2012-05-26,24.175901889801025,35.83969593048096,36.020992279052734,35.67271041870117,35.877861976623535,7484606.5,,0.00026622746895376597,0.00026626291377734,0.06826711400623649,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-27,24.182337760925293,35.8492374420166,36.020992279052734,35.6870231628418,35.9064884185791,8061216.0,,0.0002661566107529399,0.00026619203670971134,0.06077901935788111,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-05-28,24.18877363204956,35.858778953552246,36.020992279052734,35.70133590698242,35.93511486053467,8637825.5,"Benzinga's M&A Chatter for Friday May 25, 2012",0.0002660857902608345,0.0002661211973657184,0.05139193107742472,"[{'label': 'neutral', 'score': 0.9998842477798462}, {'label': 'negative', 'score': 6.829173071309924e-05}, {'label': 'positive', 'score': 4.741788870887831e-05}]","(0.9998842477798462, 4.741788870887831e-05, 6.829173071309924e-05)",-0.1803985019438774,-6.829173071309924e-05,1,1,"[{'label': 'neutral', 'score': 0.9413610100746155}, {'label': 'negative', 'score': 0.03691760450601578}, {'label': 'positive', 'score': 0.021721431985497475}]","(0.9413610100746155, 0.021721431985497475, 0.03691760450601578)",-0.25914771847790546,-0.03691760450601578,1,1,"[{'label': 'neutral', 'score': 0.9995867609977722}, {'label': 'positive', 'score': 0.0002468154125381261}, {'label': 'negative', 'score': 0.0001664104638621211}]","(0.9995867609977722, 0.0002468154125381261, 0.0001664104638621211)",0.1945786875121185,0.0002468154125381261,1,1
2012-05-29,24.195209503173828,35.86832046508789,36.020992279052734,35.71564865112305,35.963741302490234,9214435.0,5 Healthcare Stocks With The Highest Cash,-0.00505452443535955,0.00026605039571540125,0.011336457614545832,"[{'label': 'neutral', 'score': 0.999729335308075}, {'label': 'positive', 'score': 0.00020614481763914227}, {'label': 'negative', 'score': 6.441773439291865e-05}]","(0.999729335308075, 0.00020614481763914227, 6.441773439291865e-05)",0.5238237227649647,0.00020614481763914227,0,0,"[{'label': 'neutral', 'score': 0.800711452960968}, {'label': 'positive', 'score': 0.17498859763145447}, {'label': 'negative', 'score': 0.024299951270222664}]","(0.800711452960968, 0.17498859763145447, 0.024299951270222664)",0.7561329900373602,0.17498859763145447,0,0,"[{'label': 'neutral', 'score': 0.7995126843452454}, {'label': 'positive', 'score': 0.19988305866718292}, {'label': 'negative', 'score': 0.0006042993627488613}]","(0.7995126843452454, 0.19988305866718292, 0.0006042993627488613)",0.9939716960841127,0.19988305866718292,0,0
2012-05-30,24.07291603088379,35.6870231628418,35.92557144165039,35.582061767578125,35.6870231628418,10132274.0,"Benzinga's M&A Chatter for Wednesday May 30, 2012",0.004812862748485084,-0.005067341752530035,0.03786408240760029,"[{'label': 'neutral', 'score': 0.999886155128479}, {'label': 'negative', 'score': 6.75163246341981e-05}, {'label': 'positive', 'score': 4.6370951167773455e-05}]","(0.999886155128479, 4.6370951167773455e-05, 6.75163246341981e-05)",-0.18566932361427674,-6.75163246341981e-05,1,1,"[{'label': 'neutral', 'score': 0.9375842809677124}, {'label': 'negative', 'score': 0.04190473631024361}, {'label': 'positive', 'score': 0.02051098272204399}]","(0.9375842809677124, 0.02051098272204399, 0.04190473631024361)",-0.34276227078522714,-0.04190473631024361,1,1,"[{'label': 'neutral', 'score': 0.9995908141136169}, {'label': 'positive', 'score': 0.00024319365911651403}, {'label': 'negative', 'score': 0.00016593477630522102}]","(0.9995908141136169, 0.00024319365911651403, 0.00016593477630522102)",0.18883772459289835,0.00024319365911651403,1,1
2012-05-31,24.18877601623535,35.85877990722656,36.13549423217773,35.54389190673828,35.88740539550781,14088369.0,15 Great Stocks with Great Yield | Merck CEO Says He Isn't Interested in Breaking Up the Company -Bloomberg,-0.010643963232981892,0.004801317952095619,0.05549632983780631,"[{'label': 'neutral', 'score': 0.9885922074317932}, {'label': 'positive', 'score': 0.008575969375669956}, {'label': 'negative', 'score': 0.002831781515851617}]","(0.9885922074317932, 0.008575969375669956, 0.002831781515851617)",0.5035337740489682,0.008575969375669956,0,0,"[{'label': 'neutral', 'score': 0.8067626357078552}, {'label': 'negative', 'score': 0.14621414244174957}, {'label': 'positive', 'score': 0.04702319949865341}]","(0.8067626357078552, 0.04702319949865341, 0.14621414244174957)",-0.5133114642701305,-0.14621414244174957,1,0,"[{'label': 'neutral', 'score': 0.9955381155014038}, {'label': 'positive', 'score': 0.0029797160532325506}, {'label': 'negative', 'score': 0.0014821834629401565}]","(0.9955381155014038, 0.0029797160532325506, 0.0014821834629401565)",0.3356266955058943,0.0029797160532325506,0,0
2012-06-01,23.931297302246094,35.47710037231445,35.77289962768555,35.32442855834961,35.47710037231445,14013437.0,Amylin Pharmaceuticals Spokesperson Declines Comment on Renewed Takeover Chatter | Hearing Renewed Takeover Chatter in Amylin Pharmaceuticals,0.0025102931589296427,-0.010701015411640978,0.09445220398417759,"[{'label': 'neutral', 'score': 0.9851292371749878}, {'label': 'positive', 'score': 0.014402179978787899}, {'label': 'negative', 'score': 0.00046860528527759016}]","(0.9851292371749878, 0.014402179978787899, 0.00046860528527759016)",0.936976390021588,0.014402179978787899,0,1,"[{'label': 'negative', 'score': 0.8724401593208313}, {'label': 'neutral', 'score': 0.11274999380111694}, {'label': 'positive', 'score': 0.01480985525995493}]","(0.11274999380111694, 0.01480985525995493, 0.8724401593208313)",-0.9666162749696828,-0.8724401593208313,0,0,"[{'label': 'neutral', 'score': 0.8756954669952393}, {'label': 'negative', 'score': 0.12140072882175446}, {'label': 'positive', 'score': 0.0029038565699011087}]","(0.8756954669952393, 0.0029038565699011087, 0.12140072882175446)",-0.9532783676362104,-0.12140072882175446,0,1
2012-06-02,23.991376241048176,35.566158294677734,35.76653925577799,35.35623423258463,35.47710037231445,13155544.0,,0.00250400736636794,0.0025071476360809604,0.0991906219108876,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-03,24.05145517985026,35.655216217041016,35.760178883870445,35.388039906819664,35.47710037231445,12297651.0,"Benzinga's M&A Chatter for  Friday June 1, 2012",0.0024977529745203735,0.0025008775635334077,0.10308673228641799,"[{'label': 'neutral', 'score': 0.9998874664306641}, {'label': 'negative', 'score': 6.668293644906953e-05}, {'label': 'positive', 'score': 4.594376150635071e-05}]","(0.9998874664306641, 4.594376150635071e-05, 6.668293644906953e-05)",-0.1841408415518652,-6.668293644906953e-05,1,1,"[{'label': 'neutral', 'score': 0.9432226419448853}, {'label': 'negative', 'score': 0.03580380603671074}, {'label': 'positive', 'score': 0.02097354456782341}]","(0.9432226419448853, 0.02097354456782341, 0.03580380603671074)",-0.26120030806268385,-0.03580380603671074,1,1,"[{'label': 'neutral', 'score': 0.9995855689048767}, {'label': 'positive', 'score': 0.0002457255613990128}, {'label': 'negative', 'score': 0.00016870652325451374}]","(0.9995855689048767, 0.0002457255613990128, 0.00016870652325451374)",0.18584236355370146,0.0002457255613990128,1,1
2012-06-04,24.111534118652344,35.7442741394043,35.75381851196289,35.41984558105469,35.47710037231445,11439758.0,The US Economy and the United Nations: Bold Strategies Needed - Tax Reform and Benefits Reform,0.0010678594476692842,0.002494638774150505,0.09907711521177799,"[{'label': 'neutral', 'score': 0.9993708729743958}, {'label': 'positive', 'score': 0.0005346382386051118}, {'label': 'negative', 'score': 9.451642108615488e-05}]","(0.9993708729743958, 0.0005346382386051118, 9.451642108615488e-05)",0.6995447156585151,0.0005346382386051118,0,1,"[{'label': 'neutral', 'score': 0.6001843810081482}, {'label': 'positive', 'score': 0.38938117027282715}, {'label': 'negative', 'score': 0.010434395633637905}]","(0.6001843810081482, 0.38938117027282715, 0.010434395633637905)",0.9478039550061991,0.38938117027282715,0,1,"[{'label': 'neutral', 'score': 0.9970763921737671}, {'label': 'positive', 'score': 0.002737219212576747}, {'label': 'negative', 'score': 0.00018641520000528544}]","(0.9970763921737671, 0.002737219212576747, 0.00018641520000528544)",0.8724770790745678,0.002737219212576747,0,1
2012-06-05,24.13728141784668,35.78244400024414,35.83015441894531,35.553436279296875,35.6870231628418,11067404.0,"Merck Sues Sandoz, Accord Healthcare on Proposed Emend Copy, Claims Infringement of Patents Expiring in 2015 and 2019 | Merck Gets Response Letter for Ridaforolimus, Says Added Clinical Trials Would Need to be Conducted; In Talks with EU Health Authorities -Bloomberg",0.010666670362413064,0.0010672896913462362,0.0917108231727629,"[{'label': 'neutral', 'score': 0.9902465343475342}, {'label': 'negative', 'score': 0.006366654299199581}, {'label': 'positive', 'score': 0.003386891447007656}]","(0.9902465343475342, 0.003386891447007656, 0.006366654299199581)",-0.3055056007043013,-0.006366654299199581,1,1,"[{'label': 'neutral', 'score': 0.47534558176994324}, {'label': 'negative', 'score': 0.3623688817024231}, {'label': 'positive', 'score': 0.16228558123111725}]","(0.47534558176994324, 0.16228558123111725, 0.3623688817024231)",-0.38136204798976625,-0.3623688817024231,1,1,"[{'label': 'negative', 'score': 0.9595264196395874}, {'label': 'neutral', 'score': 0.03100372664630413}, {'label': 'positive', 'score': 0.009469850920140743}]","(0.03100372664630413, 0.009469850920140743, 0.9595264196395874)",-0.9804543088392474,-0.9595264196395874,0,0
2012-06-06,24.39474105834961,36.16412353515625,36.16412353515625,35.81106948852539,36.020992279052734,13219367.0,,0.011345637142138654,0.0106101827687566,0.06091704558918953,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-06-07,24.671520233154297,36.57442855834961,36.70801544189453,36.26908493041992,36.32633590698242,55932703.0,Pfizer Plans to IPO Part of its Animal Health Segment,0.003391613500828712,0.01128175811251116,0.07824425119559537,"[{'label': 'neutral', 'score': 0.9998805522918701}, {'label': 'negative', 'score': 6.960799510125071e-05}, {'label': 'positive', 'score': 4.985183113603853e-05}]","(0.9998805522918701, 4.985183113603853e-05, 6.960799510125071e-05)",-0.1653791453368557,-6.960799510125071e-05,1,1,"[{'label': 'neutral', 'score': 0.9467828869819641}, {'label': 'positive', 'score': 0.03964013233780861}, {'label': 'negative', 'score': 0.013577048666775227}]","(0.9467828869819641, 0.03964013233780861, 0.013577048666775227)",0.48974942263079385,0.03964013233780861,1,1,"[{'label': 'neutral', 'score': 0.9961119294166565}, {'label': 'positive', 'score': 0.0037055411376059055}, {'label': 'negative', 'score': 0.00018246842955704778}]","(0.9961119294166565, 0.0037055411376059055, 0.00018246842955704778)",0.906137870082355,0.0037055411376059055,0,1
2012-06-08,24.75519561767578,36.6984748840332,36.78435134887695,36.49809265136719,36.71755599975586,53368666.0,,8.665716937346926e-05,0.0033858749513930734,0.0762696811366513,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-09,24.75733693440755,36.70165506998698,36.85432561238607,36.55852508544922,36.76208623250326,51932906.0,,8.664966055935163e-05,8.66534148577945e-05,0.08427600916427094,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-10,24.759478251139324,36.70483525594076,36.92429987589518,36.61895751953125,36.80661646525065,50497146.0,,8.664215304600647e-05,8.664590669438749e-05,0.08759124112564053,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-11,24.761619567871094,36.70801544189453,36.9942741394043,36.67938995361328,36.85114669799805,49061386.0,,0.009877804619161228,8.663839983154872e-05,0.07703564517356135,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-12,25.00622940063477,37.07061004638672,37.07061004638672,36.63167953491211,36.84160232543945,10969416.0,,-0.011583029064695254,0.009829338008246062,0.06724995966225457,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-06-13,24.9866943359375,36.64122009277344,37.01335906982422,36.51717758178711,36.64122009277344,12121692.0,,0.010156293270490092,-0.011650634906522545,0.12086749938386897,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-14,25.24045753479004,37.01335906982422,37.15649032592773,36.593509674072266,36.7557258605957,13529261.0,"Believe In The Rally? Try These ETFs (HDV, IYZ, HYD) | Johnson & Johnson to Complete Synthes Acquisition ",0.0038670161179777587,0.010105064693636416,0.1420249953747186,"[{'label': 'neutral', 'score': 0.9998076558113098}, {'label': 'positive', 'score': 0.00013316565309651196}, {'label': 'negative', 'score': 5.926093217567541e-05}]","(0.9998076558113098, 0.00013316565309651196, 5.926093217567541e-05)",0.3840671018315808,0.00013316565309651196,1,1,"[{'label': 'neutral', 'score': 0.5564118027687073}, {'label': 'positive', 'score': 0.43515485525131226}, {'label': 'negative', 'score': 0.00843329168856144}]","(0.5564118027687073, 0.43515485525131226, 0.00843329168856144)",0.9619769295156368,0.43515485525131226,0,1,"[{'label': 'positive', 'score': 0.7817686796188354}, {'label': 'neutral', 'score': 0.21776893734931946}, {'label': 'negative', 'score': 0.0004623147251550108}]","(0.21776893734931946, 0.7817686796188354, 0.0004623147251550108)",0.9988179585608399,0.7817686796188354,0,0
2012-06-15,25.33807182312012,37.15649032592773,37.30915832519531,37.08969497680664,37.23282241821289,16823544.0,US District Court Rules Against Merck in NASONEX Patent Lawsuit,-0.000770437670401415,0.0038595584309637342,0.14186490951567376,"[{'label': 'neutral', 'score': 0.9995790123939514}, {'label': 'negative', 'score': 0.0002931510971393436}, {'label': 'positive', 'score': 0.0001278010313399136}]","(0.9995790123939514, 0.0001278010313399136, 0.0002931510971393436)",-0.3928001656548882,-0.0002931510971393436,1,1,"[{'label': 'negative', 'score': 0.4961221516132355}, {'label': 'neutral', 'score': 0.4328407347202301}, {'label': 'positive', 'score': 0.07103713601827621}]","(0.4328407347202301, 0.07103713601827621, 0.4961221516132355)",-0.7494984651845121,-0.4961221516132355,0,1,"[{'label': 'negative', 'score': 0.9474602937698364}, {'label': 'neutral', 'score': 0.04263080283999443}, {'label': 'positive', 'score': 0.009908889420330524}]","(0.04263080283999443, 0.009908889420330524, 0.9474602937698364)",-0.9792997527091651,-0.9474602937698364,0,0
2012-06-16,25.318553924560547,37.12786356608073,37.29643630981445,37.04198455810547,37.137402852376304,14099407.666666668,,-0.0007710317022699175,-0.0007707346100288464,0.14289009664570998,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-17,25.299036026000977,37.099236806233726,37.2837142944336,36.9942741394043,37.04198328653971,11375271.333333334,,-0.0007716266508802539,-0.0007713291000914311,0.12645309144981184,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-18,25.279518127441406,37.07061004638672,37.270992279052734,36.946563720703125,36.946563720703125,8651135.0,"Geisinger and Merck to Collaborate on Multi-year Effort to Improve Patient Adherence, Engagement and Care Delivery    | From Earlier: U.S. District Court Rules Against Merck in NASONEX Patent Lawsuit  ",0.009781187955592591,-0.0007719245079572673,0.0759848176316478,"[{'label': 'positive', 'score': 0.9960052371025085}, {'label': 'neutral', 'score': 0.0037378768902271986}, {'label': 'negative', 'score': 0.0002569548087194562}]","(0.0037378768902271986, 0.9960052371025085, 0.0002569548087194562)",0.9994841622801593,0.9960052371025085,0,0,"[{'label': 'neutral', 'score': 0.5214765667915344}, {'label': 'positive', 'score': 0.2397068589925766}, {'label': 'negative', 'score': 0.23881658911705017}]","(0.5214765667915344, 0.2397068589925766, 0.23881658911705017)",0.0018604519361451915,0.2397068589925766,1,1,"[{'label': 'positive', 'score': 0.9848039150238037}, {'label': 'neutral', 'score': 0.013581559993326664}, {'label': 'negative', 'score': 0.0016145821427926421}]","(0.013581559993326664, 0.9848039150238037, 0.0016145821427926421)",0.9967263749667501,0.9848039150238037,0,0
2012-06-19,25.52678108215332,37.433204650878906,37.614505767822266,37.08015441894531,37.16603088378906,12472353.0,,-0.000509737702144832,0.009733661793600482,0.07359893175929512,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-20,25.513765335083008,37.41412353515625,37.57633590698242,37.21374130249024,37.375953674316406,11939026.0,Merck Statement on CDC Advisory Committee on Immunization Practices' Recommendation for Pneumococcal Vaccination in Immunocompromised Adults   ,0.006120889634955239,-0.0005098676625729874,0.0741357793470958,"[{'label': 'neutral', 'score': 0.9998738765716553}, {'label': 'negative', 'score': 7.1992319135461e-05}, {'label': 'positive', 'score': 5.4165491746971384e-05}]","(0.9998738765716553, 5.4165491746971384e-05, 7.1992319135461e-05)",-0.14130577618458046,-7.1992319135461e-05,1,1,"[{'label': 'neutral', 'score': 0.8648958802223206}, {'label': 'positive', 'score': 0.11240141838788986}, {'label': 'negative', 'score': 0.02270265482366085}]","(0.8648958802223206, 0.11240141838788986, 0.02270265482366085)",0.6639234586493594,0.11240141838788986,0,1,"[{'label': 'neutral', 'score': 0.9992263317108154}, {'label': 'positive', 'score': 0.0006519518210552633}, {'label': 'negative', 'score': 0.00012175104347988963}]","(0.9992263317108154, 0.0006519518210552633, 0.00012175104347988963)",0.6852769995803527,0.0006519518210552633,0,1
2012-06-21,25.669919967651367,37.64313125610352,37.96755599975586,37.49045944213867,37.5572509765625,18166766.0,,0.01850440432184227,0.0061022330810927075,0.07754141867381455,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-06-22,26.144933700561523,38.33969497680664,38.46374130249024,37.738548278808594,37.786258697509766,25306999.0,Merck Spikes to New 52-Week High on Heavy Volume; $40.18,-0.003235454162028018,0.01833528099726099,0.12616925386297537,"[{'label': 'positive', 'score': 0.9994882345199585}, {'label': 'neutral', 'score': 0.0003255049232393503}, {'label': 'negative', 'score': 0.00018617772730067372}]","(0.0003255049232393503, 0.9994882345199585, 0.00018617772730067372)",0.9996275232715377,0.9994882345199585,0,0,"[{'label': 'positive', 'score': 0.9293711185455322}, {'label': 'neutral', 'score': 0.03922845423221588}, {'label': 'negative', 'score': 0.03140048310160637}]","(0.03922845423221588, 0.9293711185455322, 0.03140048310160637)",0.9346348642116947,0.9293711185455322,0,0,"[{'label': 'positive', 'score': 0.9843102693557739}, {'label': 'neutral', 'score': 0.015155505388975143}, {'label': 'negative', 'score': 0.000534192135091871}]","(0.015155505388975143, 0.9843102693557739, 0.000534192135091871)",0.9989151746169477,0.9843102693557739,0,0
2012-06-23,26.06034278869629,38.21564865112305,38.37786356608073,37.786258697509766,37.88485972086588,22232900.666666668,,-0.003245956304864353,-0.003240699561066513,0.13605929525551042,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-24,25.97575187683105,38.09160232543945,38.291985829671226,37.83396911621094,37.98346074422201,19158802.333333336,,-0.0032565268487209182,-0.0032512358489061297,0.14504809983495104,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-06-25,25.89116096496582,37.96755599975586,38.20610809326172,37.88167953491211,38.082061767578125,16084704.0,"Ahead of Obamacare Ruling, S&P Likes Health Care SPDR",0.006785614782004201,-0.0032618408722556243,0.1510185621297342,"[{'label': 'neutral', 'score': 0.9998906850814819}, {'label': 'negative', 'score': 6.474430119851604e-05}, {'label': 'positive', 'score': 4.45214900537394e-05}]","(0.9998906850814819, 4.45214900537394e-05, 6.474430119851604e-05)",-0.18507907107073832,-6.474430119851604e-05,1,1,"[{'label': 'neutral', 'score': 0.7841266989707947}, {'label': 'positive', 'score': 0.20308338105678558}, {'label': 'negative', 'score': 0.01278988178819418}]","(0.7841266989707947, 0.20308338105678558, 0.01278988178819418)",0.8815056425271277,0.20308338105678558,0,1,"[{'label': 'positive', 'score': 0.7859552502632141}, {'label': 'neutral', 'score': 0.21248233318328857}, {'label': 'negative', 'score': 0.0015624308725818992}]","(0.21248233318328857, 0.7859552502632141, 0.0015624308725818992)",0.9960320106836751,0.7859552502632141,0,0
2012-06-26,26.066856384277344,38.225189208984375,38.931297302246094,37.90076446533203,37.99618148803711,11988177.0,"Leveraged ETFs for the Obamacare Ruling | Benzinga's M&A Chatter for Tuesday June 26, 2012 | Spokesperson for Amylin Pharmaceuticals Won't Comment on Rumor of Bids from Pharma Companies | Amylin Pharmaceuticals Spiking to Highs on Earlier Bid Reports | Novartis, Sanofi, Merck, Bristol, AstraZeneca Weigh Amylin Final Bids; Amylin Expects Final Bids Starting End of the Week -Reuters ",0.011732443797238142,0.0067626961177552096,0.15196057917156394,"[{'label': 'negative', 'score': 0.9897895455360413}, {'label': 'positive', 'score': 0.00852667074650526}, {'label': 'neutral', 'score': 0.0016837792936712503}]","(0.0016837792936712503, 0.00852667074650526, 0.9897895455360413)",-0.9829178959383106,-0.9897895455360413,0,0,"[{'label': 'neutral', 'score': 0.6104598045349121}, {'label': 'negative', 'score': 0.25216177105903625}, {'label': 'positive', 'score': 0.13737843930721283}]","(0.6104598045349121, 0.13737843930721283, 0.25216177105903625)",-0.294663628291167,-0.25216177105903625,1,1,"[{'label': 'neutral', 'score': 0.9854382276535034}, {'label': 'positive', 'score': 0.008770295418798923}, {'label': 'negative', 'score': 0.005791489966213703}]","(0.9854382276535034, 0.008770295418798923, 0.005791489966213703)",0.20456320250750884,0.008770295418798923,1,1
2012-06-27,26.3726806640625,38.67366409301758,38.88358688354492,38.13931274414063,38.2442741394043,13757620.0,A Peek Into The Market Before The Trading Starts | Merck and AstraZeneca Agree to Amend Partnership   ,0.0037010006540691464,0.011664152310201648,0.11181513220515472,"[{'label': 'neutral', 'score': 0.7942335605621338}, {'label': 'positive', 'score': 0.20491361618041992}, {'label': 'negative', 'score': 0.0008529056212864816}]","(0.7942335605621338, 0.20491361618041992, 0.0008529056212864816)",0.9917099670654062,0.20491361618041992,0,1,"[{'label': 'neutral', 'score': 0.7566746473312378}, {'label': 'positive', 'score': 0.22322066128253937}, {'label': 'negative', 'score': 0.020104670897126198}]","(0.7566746473312378, 0.22322066128253937, 0.020104670897126198)",0.8347506959753669,0.22322066128253937,0,1,"[{'label': 'positive', 'score': 0.9608564972877502}, {'label': 'neutral', 'score': 0.038709960877895355}, {'label': 'negative', 'score': 0.00043349069892428815}]","(0.038709960877895355, 0.9608564972877502, 0.00043349069892428815)",0.9990981062856336,0.9608564972877502,0,0
2012-06-28,26.470277786254883,38.81679534912109,38.83587646484375,38.34923553466797,38.55915832519531,13165500.0,Ultimate Stock Watch List for The Supreme Court's Health Care Ruling,0.026302848286929987,0.003694168802418197,0.10285467473312528,"[{'label': 'neutral', 'score': 0.9998656511306763}, {'label': 'negative', 'score': 7.661031122552231e-05}, {'label': 'positive', 'score': 5.774434612249024e-05}]","(0.9998656511306763, 5.774434612249024e-05, 7.661031122552231e-05)",-0.1404191374934212,-7.661031122552231e-05,0,0,"[{'label': 'neutral', 'score': 0.8869636058807373}, {'label': 'positive', 'score': 0.060089632868766785}, {'label': 'negative', 'score': 0.052946772426366806}]","(0.8869636058807373, 0.060089632868766785, 0.052946772426366806)",0.06319079613112477,0.060089632868766785,0,0,"[{'label': 'neutral', 'score': 0.9989023208618164}, {'label': 'positive', 'score': 0.0008291914127767086}, {'label': 'negative', 'score': 0.0002685273648239672}]","(0.9989023208618164, 0.0008291914127767086, 0.0002685273648239672)",0.5107538099860197,0.0008291914127767086,1,0
2012-06-29,27.166526794433597,39.83778762817383,39.83778762817383,39.01717758178711,39.01717758178711,24811924.0,ALPS Unveils Dogs of the Dow ETF,0.0007983795318124108,0.02596287696230925,0.1735956886302034,"[{'label': 'neutral', 'score': 0.9997474551200867}, {'label': 'positive', 'score': 0.00017263296467717737}, {'label': 'negative', 'score': 7.979488145792857e-05}]","(0.9997474551200867, 0.00017263296467717737, 7.979488145792857e-05)",0.36778067333173475,0.00017263296467717737,1,1,"[{'label': 'neutral', 'score': 0.9285795092582703}, {'label': 'positive', 'score': 0.052252139896154404}, {'label': 'negative', 'score': 0.019168397411704063}]","(0.9285795092582703, 0.052252139896154404, 0.019168397411704063)",0.4632244972036931,0.052252139896154404,1,1,"[{'label': 'neutral', 'score': 0.9990615248680115}, {'label': 'positive', 'score': 0.0008323871879838407}, {'label': 'negative', 'score': 0.00010611712059471756}]","(0.9990615248680115, 0.0008323871879838407, 0.00010611712059471756)",0.7738590656969052,0.0008323871879838407,0,1
2012-06-30,27.188215255737305,39.86959330240885,39.86959330240885,39.12531916300456,39.13168080647787,21548661.666666668,,0.0007977426304248039,0.0007980609964042485,0.15720014735228097,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-01,27.209903717041016,39.90139897664388,39.90139897664388,39.23346074422201,39.24618403116862,18285399.333333336,,0.0007971067443936237,0.0007974246028975089,0.1696187176925855,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-02,27.231592178344727,39.933204650878906,39.933204650878906,39.34160232543945,39.360687255859375,15022137.0,,-0.0009557471401619182,0.0007967892235335357,0.17465453106838394,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-03,27.2055778503418,39.89503860473633,40.03816986083984,39.65649032592773,39.81870269775391,7912924.0,,-0.0021526078228230453,-0.0009562041576785134,0.18216862393752775,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-04,27.147008895874023,39.809160232543945,39.96183204650879,39.53244400024414,39.790077209472656,8804195.5,,-0.002157251539362474,-0.0021549280132805012,0.021536668116862747,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-05,27.08843994140625,39.72328186035156,39.88549423217773,39.40839767456055,39.761451721191406,9695467.0,,-0.0028824897582111968,-0.00215958175831333,0.02353133160140983,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-06,27.010358810424805,39.60877990722656,39.64694595336914,39.39885330200195,39.4370231628418,10543509.0,,0.004978713699547847,-0.002886652132405868,0.02294106665083996,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-07-07,27.14483896891276,39.80598068237305,39.87277348836263,39.47519048055013,39.55788803100586,14092456.0,,0.004954048908379468,0.004966360888271399,0.05093641585890073,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-08,27.279319127400715,40.00318145751953,40.09860102335612,39.55152765909831,39.67875289916992,17641403.0,,0.004929627293666561,0.004941817986510251,0.06412052803254284,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-09,27.413799285888672,40.200382232666016,40.32442855834961,39.62786483764648,39.799617767333984,21190350.0,,-0.018039455930654397,0.004917516465976194,0.06503573650595455,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-07-10,26.919265747070312,39.475189208984375,40.27671813964844,39.3702278137207,40.24809265136719,17512499.0,"Deutsche Bank Maintains Merck & at Buy, Raises PT from $43 to $47.25 | Dendreon, Pharmacyclics and Other Biotech Takeover Targets",-0.0038675384975759997,-0.018204150590327567,0.1597621187452231,"[{'label': 'positive', 'score': 0.9968731999397278}, {'label': 'neutral', 'score': 0.002916185185313225}, {'label': 'negative', 'score': 0.00021064472093712538}]","(0.002916185185313225, 0.9968731999397278, 0.00021064472093712538)",0.999577478419563,0.9968731999397278,0,0,"[{'label': 'positive', 'score': 0.8475742936134338}, {'label': 'neutral', 'score': 0.11923720687627792}, {'label': 'negative', 'score': 0.033188462257385254}]","(0.11923720687627792, 0.8475742936134338, 0.033188462257385254)",0.9246369989281132,0.8475742936134338,0,0,"[{'label': 'positive', 'score': 0.998879611492157}, {'label': 'neutral', 'score': 0.0007838452002033591}, {'label': 'negative', 'score': 0.00033650945988483727}]","(0.0007838452002033591, 0.998879611492157, 0.00033650945988483727)",0.9993264531009284,0.998879611492157,0,0
2012-07-11,26.81515884399414,39.32251739501953,39.57061004638672,39.17938995361328,39.48473358154297,12955586.0,Study for Merck's Investigational Cat-K Inhibitor for Osteoporosis Meets Outcomes and Is Concluded Early | Merck Announces Collaboration to Improve Maternal Health through Expanded Access to Family Planning   ,0.04125216503194265,-0.003875036764057895,0.1605509798828642,"[{'label': 'positive', 'score': 0.994929850101471}, {'label': 'neutral', 'score': 0.004875054117292166}, {'label': 'negative', 'score': 0.0001950466976268217}]","(0.004875054117292166, 0.994929850101471, 0.0001950466976268217)",0.9996079955425611,0.994929850101471,1,1,"[{'label': 'positive', 'score': 0.8674569725990295}, {'label': 'neutral', 'score': 0.12140758335590363}, {'label': 'negative', 'score': 0.011135435663163662}]","(0.12140758335590363, 0.8674569725990295, 0.011135435663163662)",0.9746516460683085,0.8674569725990295,1,1,"[{'label': 'positive', 'score': 0.9970955848693848}, {'label': 'neutral', 'score': 0.0026528502348810434}, {'label': 'negative', 'score': 0.000251575285801664}]","(0.0026528502348810434, 0.9970955848693848, 0.000251575285801664)",0.9994955111001419,0.9970955848693848,1,1
2012-07-12,27.92134094238281,40.94465637207031,41.20228958129883,40.8015251159668,40.90649032592773,48160945.0,"Merck Hits 4-Year High Thursday on Positive Phase 3 Osteoporosis Drug Data -IBD | Thursday Market Movers | UPDATE: Citigroup Upgrades Merck; Raises PT | From Earlier: Update on Phase III Trial for Odanacatib, Merck's Investigational Cat-K Inhibitor for Osteoporosis  | Benzinga's Top Pre-Market Gainers | Goldman Sachs Maintains Merck & Co. at Neutral, Raises PT from $41 to $45 | Benzinga's Top Upgrades | Citigroup Upgrades Merck & from Neutral to Buy, Raises PT from $34 to $50",0.01305057597800378,0.040423993759123596,0.34323599951324985,"[{'label': 'positive', 'score': 0.9994908571243286}, {'label': 'neutral', 'score': 0.00026603922015056014}, {'label': 'negative', 'score': 0.0002430972090223804}]","(0.00026603922015056014, 0.9994908571243286, 0.0002430972090223804)",0.999513676197615,0.9994908571243286,0,0,"[{'label': 'positive', 'score': 0.9266998171806335}, {'label': 'neutral', 'score': 0.0471423901617527}, {'label': 'negative', 'score': 0.02615780383348465}]","(0.0471423901617527, 0.9266998171806335, 0.02615780383348465)",0.9450960914692688,0.9266998171806335,0,0,"[{'label': 'positive', 'score': 0.9984930753707886}, {'label': 'neutral', 'score': 0.00119771808385849}, {'label': 'negative', 'score': 0.00030922683072276413}]","(0.00119771808385849, 0.9984930753707886, 0.00030922683072276413)",0.9993808047297424,0.9984930753707886,0,0
2012-07-13,28.285724639892575,41.47900772094727,41.57442855834961,40.96374130249024,41.08778762817383,17782988.0,"Low Volume, High Returns for These ETFs (BIB, FHC, DRW) | 5 Market-Based ETFs Your Broker Forgot to Mention (HDIV, OFF, PDP) | Social Media Outlook, Friday July 13 | Jefferies & Company Maintains Merck & Co. at Hold, Raises PT from $40 to $42",-0.000920159854476653,0.01296615094817926,0.34691419386460853,"[{'label': 'positive', 'score': 0.9278648495674133}, {'label': 'neutral', 'score': 0.06782058626413345}, {'label': 'negative', 'score': 0.004314562305808067}]","(0.06782058626413345, 0.9278648495674133, 0.004314562305808067)",0.9907430645842351,0.9278648495674133,0,0,"[{'label': 'positive', 'score': 0.6616399884223938}, {'label': 'neutral', 'score': 0.22613713145256042}, {'label': 'negative', 'score': 0.11222289502620697}]","(0.22613713145256042, 0.6616399884223938, 0.11222289502620697)",0.7099669788371218,0.6616399884223938,0,0,"[{'label': 'positive', 'score': 0.9926908612251282}, {'label': 'neutral', 'score': 0.0067615751177072525}, {'label': 'negative', 'score': 0.0005476152873598039}]","(0.0067615751177072525, 0.9926908612251282, 0.0005476152873598039)",0.9988973135851873,0.9926908612251282,0,0
2012-07-14,28.259693145751957,41.44084040323893,41.56170527140299,40.98600514729818,41.13867823282877,17176859.666666668,,-0.0009210073284456248,-0.0009205834614329286,0.3518236364126675,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-15,28.233661651611328,41.4026730855306,41.54898198445638,41.00826899210612,41.189568837483726,16570731.333333334,,-0.000921856364913656,-0.0009214317162913229,0.293183294990233,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-16,28.207630157470703,41.364505767822266,41.536258697509766,41.03053283691406,41.24045944213867,15964603.0,,0.01937712299684501,-0.0009222815358102229,0.285318849671577,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-17,28.754222869873047,42.16603088378906,42.33778762817383,41.183204650878906,41.3072509765625,21110702.0,Merck Says Court Approves Proposed Erisa Settlement | Popular Drug Manufacturing Stocks Among Hedge Funds,-0.005657356734999328,0.019191777036559228,0.1518891332811479,"[{'label': 'positive', 'score': 0.45478689670562744}, {'label': 'negative', 'score': 0.3764958083629608}, {'label': 'neutral', 'score': 0.16871735453605652}]","(0.16871735453605652, 0.45478689670562744, 0.3764958083629608)",0.09418106242954605,0.45478689670562744,1,1,"[{'label': 'positive', 'score': 0.8705137968063354}, {'label': 'neutral', 'score': 0.08214813470840454}, {'label': 'negative', 'score': 0.04733804240822792}]","(0.08214813470840454, 0.8705137968063354, 0.04733804240822792)",0.896850362148347,0.8705137968063354,0,0,"[{'label': 'positive', 'score': 0.8745104074478149}, {'label': 'neutral', 'score': 0.12499351054430008}, {'label': 'negative', 'score': 0.0004960782825946808}]","(0.12499351054430008, 0.8745104074478149, 0.0004960782825946808)",0.9988661151872935,0.8745104074478149,0,0
2012-07-18,28.591556549072266,41.92748260498047,42.08969497680664,41.67938995361328,41.91793823242188,16989233.0,"Kapito: 'We Like ATT, VZ, MRK, JNJ for Yields'' | Morgan Stanley Maintains Merck & Co. at Equal-weight, Raises PT from $37 to $43",0.0,-0.005673420190727989,0.15471113958713803,"[{'label': 'positive', 'score': 0.8068222403526306}, {'label': 'neutral', 'score': 0.19246934354305267}, {'label': 'negative', 'score': 0.0007084772223606706}]","(0.19246934354305267, 0.8068222403526306, 0.0007084772223606706)",0.9982453244020532,0.8068222403526306,0,0,"[{'label': 'positive', 'score': 0.8059800267219543}, {'label': 'neutral', 'score': 0.1803787499666214}, {'label': 'negative', 'score': 0.013641200959682465}]","(0.1803787499666214, 0.8059800267219543, 0.013641200959682465)",0.9667134024864933,0.8059800267219543,0,0,"[{'label': 'positive', 'score': 0.9987595081329346}, {'label': 'neutral', 'score': 0.0009258026257157326}, {'label': 'negative', 'score': 0.000314709497615695}]","(0.0009258026257157326, 0.9987595081329346, 0.000314709497615695)",0.999369997759802,0.9987595081329346,0,0
2012-07-19,28.591556549072266,41.92748260498047,42.01335906982422,41.54580307006836,41.9370231628418,14661625.0,"Alnylam In Talks On Cholesterol Drug Partnership, CEO Says, Has Completed Phase I Clinical Trial Of Drug",-0.012061918082714299,0.0,0.1536944613032267,"[{'label': 'positive', 'score': 0.9644540548324585}, {'label': 'neutral', 'score': 0.03513719514012337}, {'label': 'negative', 'score': 0.0004087389970663935}]","(0.03513719514012337, 0.9644540548324585, 0.0004087389970663935)",0.999152752081062,0.9644540548324585,0,0,"[{'label': 'positive', 'score': 0.7164578437805176}, {'label': 'neutral', 'score': 0.2747918367385864}, {'label': 'negative', 'score': 0.008750254288315773}]","(0.2747918367385864, 0.7164578437805176, 0.008750254288315773)",0.9758682940479652,0.7164578437805176,0,0,"[{'label': 'positive', 'score': 0.7017432451248169}, {'label': 'neutral', 'score': 0.2977191209793091}, {'label': 'negative', 'score': 0.0005376350600272417}]","(0.2977191209793091, 0.7017432451248169, 0.0005376350600272417)",0.9984688888016267,0.7017432451248169,0,0
2012-07-20,28.246681213378903,41.421756744384766,41.66030502319336,41.32633590698242,41.62213516235352,13641606.0,,-0.0010750138256189986,-0.012135253322328263,0.18590541674284652,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-21,28.21631368001302,41.377227783203125,41.59033075968424,41.24681981404623,41.4949099222819,14117503.0,,-0.0010761707240258813,-0.0010755920674307747,0.18596129909969833,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-22,28.185946146647137,41.33269882202149,41.52035649617513,41.16730372111002,41.36768468221029,14593400.0,"ISENTRESS in Combination Therapy Demonstrated Long-Term Efficacy, Safety and Tolerability in Previously Untreated Adult Patients with HIV-1 ",-0.0010773301151564393,-0.0010767502115284705,0.08019373740839232,"[{'label': 'positive', 'score': 0.7292889356613159}, {'label': 'negative', 'score': 0.2607915699481964}, {'label': 'neutral', 'score': 0.009919515810906887}]","(0.009919515810906887, 0.7292889356613159, 0.2607915699481964)",0.4731911829985014,0.7292889356613159,1,0,"[{'label': 'positive', 'score': 0.9462985992431641}, {'label': 'neutral', 'score': 0.04109959304332733}, {'label': 'negative', 'score': 0.01260174810886383}]","(0.04109959304332733, 0.9462985992431641, 0.01260174810886383)",0.9737162508207174,0.9462985992431641,0,0,"[{'label': 'positive', 'score': 0.9751589894294739}, {'label': 'neutral', 'score': 0.02439299412071705}, {'label': 'negative', 'score': 0.00044806126970797777}]","(0.02439299412071705, 0.9751589894294739, 0.00044806126970797777)",0.9990814718499894,0.9751589894294739,0,0
2012-07-23,28.15557861328125,41.28816986083984,41.450382232666016,41.08778762817383,41.24045944213867,15069297.0,"From Earlier: Merck ISENTRESS in Combination Therapy Demonstrated Long-Term Efficacy, Safety and Tolerability in Previously Untreated Adult Patients with HIV-1 for up to 240 Weeks   | Earnings Expectations for the Week of July 23",-0.013404233734801112,-0.0010779108523795394,0.08075850534679513,"[{'label': 'positive', 'score': 0.9885884523391724}, {'label': 'negative', 'score': 0.0076653738506138325}, {'label': 'neutral', 'score': 0.0037461351603269577}]","(0.0037461351603269577, 0.9885884523391724, 0.0076653738506138325)",0.9846116046953006,0.9885884523391724,0,0,"[{'label': 'positive', 'score': 0.9434714913368225}, {'label': 'neutral', 'score': 0.04124562442302704}, {'label': 'negative', 'score': 0.01528281718492508}]","(0.04124562442302704, 0.9434714913368225, 0.01528281718492508)",0.9681194294532269,0.9434714913368225,0,0,"[{'label': 'positive', 'score': 0.964804470539093}, {'label': 'neutral', 'score': 0.03473789244890213}, {'label': 'negative', 'score': 0.00045772161683999}]","(0.03473789244890213, 0.964804470539093, 0.00045772161683999)",0.9990516118406799,0.964804470539093,0,0
2012-07-24,27.77817916870117,40.73473358154297,41.3740463256836,40.32442855834961,41.24045944213867,21354886.0,,-0.0016397639863625331,-0.013494881429088635,0.10234749056635002,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-25,27.732637405395508,40.66793823242188,41.020992279052734,40.41984558105469,40.94465637207031,12818717.0,,0.016658887428926555,-0.0016411098708178455,0.08724463317868004,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-07-26,28.194625854492188,41.34542083740234,41.74618148803711,41.011451721191406,41.078243255615234,17085858.0,,0.04084927610524545,0.01652165021268359,0.17023013579460333,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-07-27,29.346349716186523,43.03435134887695,43.10114669799805,41.46946716308594,41.74618148803711,31419983.0,"Merck on Call Says Expecting Multiple Generic Singulair Entrants on Day One | UPDATE: Merck Beats EPS Estimates by $0.03 and Beats Revenues Estimates While Reaffirming FY2012 Guidance | Merck Reports Q2 Vytorin Sales $445M vs $432.3M Est; Q2 Remicade Sales $518M vs $545M Est | Benzinga Market Primer, Friday July 27 | Merck says Suvorexant, Odanacatib Filings on Track | Merck & Reports Q2 EPS $1.05 vs $1.01 Est; Revenues $12.2B vs $12.15B Est | US Stock Futures Up; GDP Data In Focus | Earnings Scheduled For July 27 | Stocks To Watch For July 27",-0.004582403799880456,0.040036991547064686,0.3307419497391875,"[{'label': 'positive', 'score': 0.9995614886283875}, {'label': 'negative', 'score': 0.00025685684522613883}, {'label': 'neutral', 'score': 0.00018167159578297287}]","(0.00018167159578297287, 0.9995614886283875, 0.00025685684522613883)",0.9994861929741758,0.9995614886283875,0,0,"[{'label': 'positive', 'score': 0.8361143469810486}, {'label': 'neutral', 'score': 0.08764652907848358}, {'label': 'negative', 'score': 0.07623914629220963}]","(0.08764652907848358, 0.8361143469810486, 0.07623914629220963)",0.8328736682561804,0.8361143469810486,0,0,"[{'label': 'positive', 'score': 0.9925605058670044}, {'label': 'neutral', 'score': 0.0070192571729421616}, {'label': 'negative', 'score': 0.00042024225695058703}]","(0.0070192571729421616, 0.9925605058670044, 0.00042024225695058703)",0.9991535742102865,0.9925605058670044,0,0
2012-07-28,29.21187273661296,42.83715057373047,43.02480951944987,41.74618403116862,42.02926127115885,25470626.666666668,,-0.004603498890689899,-0.004592935197232406,0.33773366670038696,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-29,29.077395757039387,42.639949798583984,42.948472340901695,42.0229008992513,42.3123410542806,19521270.333333336,,-0.004624789102191512,-0.004614127623826819,0.30772751826858197,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-07-30,28.94291877746582,42.4427490234375,42.87213516235352,42.299617767333984,42.59542083740234,13571914.0,"UBS Maintains Merck & at Buy, Raises PT from $45 to $50 | BMO Capital Markets Maitnains Merck & at Market Perform, Raises PT from $43 to $46 | Benzinga Market Primer, Monday July 30",-0.0069694606705379206,-0.0046355165268075664,0.3149866458389399,"[{'label': 'positive', 'score': 0.9938295483589172}, {'label': 'neutral', 'score': 0.0058935172855854034}, {'label': 'negative', 'score': 0.0002769138081930578}]","(0.0058935172855854034, 0.9938295483589172, 0.0002769138081930578)",0.9994428890290293,0.9938295483589172,0,0,"[{'label': 'positive', 'score': 0.8199241757392883}, {'label': 'neutral', 'score': 0.1568891406059265}, {'label': 'negative', 'score': 0.023186715319752693}]","(0.1568891406059265, 0.8199241757392883, 0.023186715319752693)",0.9449972344904058,0.8199241757392883,0,0,"[{'label': 'positive', 'score': 0.9953145980834961}, {'label': 'neutral', 'score': 0.004427789710462093}, {'label': 'negative', 'score': 0.0002576287370175123}]","(0.004427789710462093, 0.9953145980834961, 0.0002576287370175123)",0.9994824509361008,0.9953145980834961,0,0
2012-07-31,28.74120330810547,42.14694595336914,42.64313125610352,42.14694595336914,42.41412353515625,13242423.0,,0.0024903677571276425,-0.006993860798133567,0.3216317686233477,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-01,28.812782287597656,42.25190734863281,42.738548278808594,42.08015441894531,42.41412353515625,11781092.0,,-0.00835593157292776,0.0024872719301114693,0.05703537293482838,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-02,28.5720329284668,41.89885330200195,42.20419692993164,41.52671813964844,42.02289962768555,10318503.0,,0.005465818694221444,-0.008391038070937763,0.066496944589698,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-03,28.728191375732425,42.12786483764648,42.63358688354492,42.06106948852539,42.404579162597656,10496139.0,,0.002566984622510817,0.0054509353158235675,0.0964024792437495,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-04,28.801933924357098,42.23600641886393,42.62086486816406,42.08969497680664,42.328243255615234,10174962.0,,0.0025604120840637345,0.0025636955449567437,0.09946194121312885,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-05,28.87567647298177,42.34414800008138,42.6081428527832,42.11832046508789,42.25190734863281,9853785.0,,0.002553873116474978,0.002557139813427577,0.08514057509912426,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-06,28.949419021606445,42.45228958129883,42.59542083740234,42.14694595336914,42.17557144165039,9532608.0,,-0.011013681579186913,0.002550617524262298,0.08521455545542762,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-07,28.630592346191406,41.98473358154297,42.50954055786133,41.96564865112305,42.5,11407899.0,,0.001363614144443881,-0.011074781205553923,0.10383617535297755,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-08,28.669639587402344,42.04198455810547,42.24236679077149,41.82251739501953,41.96564865112305,11308968.0,,0.0049931703446875406,0.0013626852670009003,0.09501260760051262,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-09,28.812782287597656,42.25190734863281,42.290077209472656,41.6984748840332,41.8797721862793,10466586.0,"Under The Hood: Tempting Technicals And a Dividend | Credit Suisse Maintains Merck & at Outperform, Lowers PT from $48 to $47",0.006549246105392484,0.004980745811020488,0.1011281521118462,"[{'label': 'neutral', 'score': 0.9998509883880615}, {'label': 'negative', 'score': 9.492162644164637e-05}, {'label': 'positive', 'score': 5.408945435192436e-05}]","(0.9998509883880615, 5.408945435192436e-05, 9.492162644164637e-05)",-0.2740210450945455,-9.492162644164637e-05,1,1,"[{'label': 'negative', 'score': 0.8802744746208191}, {'label': 'positive', 'score': 0.10330241173505783}, {'label': 'neutral', 'score': 0.01642310991883278}]","(0.01642310991883278, 0.10330241173505783, 0.8802744746208191)",-0.78994542639612,-0.8802744746208191,0,0,"[{'label': 'negative', 'score': 0.9945347309112549}, {'label': 'neutral', 'score': 0.004812987521290779}, {'label': 'positive', 'score': 0.0006523617194034159}]","(0.004812987521290779, 0.0006523617194034159, 0.9945347309112549)",-0.9986889666792623,-0.9945347309112549,0,0
2012-08-10,29.001483917236328,42.52862548828125,42.52862548828125,41.946563720703125,41.96564865112305,9736025.0,,-0.0011218424802917383,0.006527892973688461,0.11073962548799256,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-11,28.9689515431722,42.48091506958008,42.54134877522787,42.03880310058594,42.15648905436198,9471789.333333334,,-0.0011231024243010378,-0.0011224722165877592,0.1102958404792142,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-12,28.936419169108078,42.433204650878906,42.55407206217448,42.13104248046875,42.347329457600914,9207553.666666666,,-0.0011243652015849048,-0.0011237335764386798,0.05568662195325563,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-13,28.903886795043945,42.38549423217773,42.56679534912109,42.22328186035156,42.53816986083984,8943318.0,"Jefferies & Company Maintains Merck & Co. at Hold, Raises PT from $42 to $44 | Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield",-0.00022509016431565234,-0.0011249977743444633,0.0604305976078845,"[{'label': 'neutral', 'score': 0.7398366928100586}, {'label': 'positive', 'score': 0.2596820294857025}, {'label': 'negative', 'score': 0.00048128367052413523}]","(0.7398366928100586, 0.2596820294857025, 0.00048128367052413523)",0.9963001419017513,0.2596820294857025,0,1,"[{'label': 'positive', 'score': 0.9313597083091736}, {'label': 'neutral', 'score': 0.043175481259822845}, {'label': 'negative', 'score': 0.02546478621661663}]","(0.043175481259822845, 0.9313597083091736, 0.02546478621661663)",0.9467722944755147,0.9313597083091736,0,0,"[{'label': 'positive', 'score': 0.998371422290802}, {'label': 'neutral', 'score': 0.0013168870937079191}, {'label': 'negative', 'score': 0.0003116845909971744}]","(0.0013168870937079191, 0.998371422290802, 0.0003116845909971744)",0.9993758088249428,0.998371422290802,0,0
2012-08-14,28.89737319946289,42.375953674316406,42.59542083740234,42.25190734863281,42.46183013916016,6572742.0,,-0.007881099709936498,-0.00022511550090871911,0.053086867613840946,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-15,28.669639587402344,42.04198455810547,42.34732818603516,41.98473358154297,42.23282241821289,7808229.0,,-0.0027235144660392734,-0.007912319716429339,0.05017077119213694,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-16,28.591556549072266,41.92748260498047,42.13740539550781,41.84160232543945,42.00381851196289,8798903.0,S&P Still Bullish on Health Care ETFs,-0.013655034219697902,-0.00272722997926529,0.04907600126380693,"[{'label': 'negative', 'score': 0.9964092373847961}, {'label': 'neutral', 'score': 0.0018508922075852752}, {'label': 'positive', 'score': 0.0017399663338437676}]","(0.0018508922075852752, 0.0017399663338437676, 0.9964092373847961)",-0.9965136147434442,-0.9964092373847961,1,1,"[{'label': 'positive', 'score': 0.6332875490188599}, {'label': 'negative', 'score': 0.22163125872612}, {'label': 'neutral', 'score': 0.14508116245269775}]","(0.14508116245269775, 0.6332875490188599, 0.22163125872612)",0.48151507086218637,0.6332875490188599,0,0,"[{'label': 'positive', 'score': 0.99636310338974}, {'label': 'neutral', 'score': 0.0031023933552205563}, {'label': 'negative', 'score': 0.0005344910896383226}]","(0.0031023933552205563, 0.99636310338974, 0.0005344910896383226)",0.9989276910836213,0.99636310338974,0,0
2012-08-17,28.20113754272461,41.35496139526367,42.02289962768555,41.11641311645508,42.02289962768555,15549071.0,,0.0031533507272499474,-0.013749121693050035,0.08976477091555754,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-18,28.29006767272949,41.48536809285482,41.946563720703125,41.16412226359049,41.80343500773112,13416251.333333334,,0.0031434383635998526,0.003148389344096613,0.10556586763211397,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-19,28.37899780273437,41.61577479044596,41.8702278137207,41.21183141072592,41.583970387776695,11283431.666666668,,0.003133588122480099,0.0031385080905312482,0.11592431470890195,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-20,28.467927932739254,41.74618148803711,41.79389190673828,41.25954055786133,41.364505767822266,9150612.0,,-0.01851425927200146,0.003128688667799793,0.11666859638494474,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-08-21,27.94085693359375,40.97328186035156,41.74618148803711,40.94465637207031,41.50763320922852,11281615.0,,-0.000698637916748131,-0.018687793411909733,0.17057284896627672,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-22,27.92134094238281,40.94465637207031,41.10686874389648,40.83969497680664,40.98282241821289,9025900.0,,-0.0025634943497845415,-0.0006988820779443413,0.1504709120248965,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-23,27.84975242614746,40.83969497680664,41.011451721191406,40.65839767456055,40.94465637207031,10531876.0,,0.007476638307487259,-0.002566785727580752,0.14347288414859938,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-24,28.057981491088867,41.14503860473633,41.34542083740234,40.6870231628418,40.6870231628418,10649252.0,"UPDATE: Bank of America Merrill Lynch Downgrades Merck to Neutral, Reiterates $45 PT | Bank of America Downgrades Merck & from Buy to Neutral, Announces PO of $45",-0.0005411373309814453,0.007448826785728509,0.15788986399867133,"[{'label': 'negative', 'score': 0.9109970927238464}, {'label': 'neutral', 'score': 0.08204857259988785}, {'label': 'positive', 'score': 0.00695438077673316}]","(0.08204857259988785, 0.00695438077673316, 0.9109970927238464)",-0.9848480426743849,-0.9109970927238464,0,0,"[{'label': 'negative', 'score': 0.5512532591819763}, {'label': 'neutral', 'score': 0.2652711868286133}, {'label': 'positive', 'score': 0.183475524187088}]","(0.2652711868286133, 0.183475524187088, 0.5512532591819763)",-0.5005625794438878,-0.5512532591819763,0,0,"[{'label': 'neutral', 'score': 0.3733527958393097}, {'label': 'negative', 'score': 0.331866592168808}, {'label': 'positive', 'score': 0.29478058218955994}]","(0.3733527958393097, 0.29478058218955994, 0.331866592168808)",-0.05918164398845473,-0.331866592168808,1,1
2012-08-25,28.04279772440593,41.12277348836263,41.316794077555336,40.75063705444336,40.795166015625,9807149.0,,-0.0005414303191394296,-0.0005412837986287714,0.15201706842785714,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-26,28.02761395772298,41.10050837198893,41.288167317708336,40.81425094604492,40.9033088684082,8965046.0,Merck Provides Update on Cardiovascular Development Programs,-0.000541723624734282,-0.0005415769454623681,0.06210654941212578,"[{'label': 'neutral', 'score': 0.999724805355072}, {'label': 'positive', 'score': 0.0002129147032974288}, {'label': 'negative', 'score': 6.224896060302854e-05}]","(0.999724805355072, 0.0002129147032974288, 6.224896060302854e-05)",0.5475495585380227,0.0002129147032974288,0,1,"[{'label': 'neutral', 'score': 0.9357652068138123}, {'label': 'positive', 'score': 0.04532743990421295}, {'label': 'negative', 'score': 0.01890742778778076}]","(0.9357652068138123, 0.04532743990421295, 0.01890742778778076)",0.41130328536078237,0.04532743990421295,1,1,"[{'label': 'neutral', 'score': 0.9991766810417175}, {'label': 'positive', 'score': 0.000691681110765785}, {'label': 'negative', 'score': 0.00013160861271899194}]","(0.9991766810417175, 0.000691681110765785, 0.00013160861271899194)",0.68028603062862,0.000691681110765785,0,1
2012-08-27,28.01243019104004,41.078243255615234,41.25954055786133,40.87786483764648,41.011451721191406,8122943.0,,-0.005110315677841168,-0.0005418704099908106,0.06190616067787279,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-28,27.869287490844727,40.86832046508789,41.16412353515625,40.79198455810547,41.00190734863281,8419842.0,,0.005370104780141851,-0.005123417998061203,0.07210074947446747,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-29,28.01893615722656,41.08778762817383,41.25954055786133,40.73473358154297,40.98282241821289,7973289.0,,0.001393381826264189,0.0053557371815207986,0.05909150303942912,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-30,28.057981491088867,41.14503860473633,41.28816986083984,40.6870231628418,40.89694595336914,8964173.0,,-0.0016234119929445087,0.001392411970622209,0.06013509745665659,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-08-31,28.01243019104004,41.078243255615234,41.58396911621094,40.94465637207031,41.34542083740234,28906355.0,,0.0011614522657234143,-0.001624731154081872,0.0613518379636445,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-01,28.0449652671814,41.125953674316406,41.53864479064941,40.93511486053467,41.30009651184082,28122608.25,,0.0011601048593060965,0.0011607783018415033,0.06178315847257518,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-02,28.077500343322757,41.17366409301758,41.49332046508789,40.92557334899902,41.2547721862793,27338861.5,,0.00115876057553165,0.0011594324576512584,0.03958506067660573,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-03,28.11003541946411,41.22137451171875,41.44799613952637,40.91603183746338,41.20944786071777,26555114.75,,0.001157419403557452,0.0011580897306783231,0.02024255783938389,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-04,28.14257049560547,41.26908493041992,41.40267181396485,40.90649032592773,41.16412353515625,25771368.0,,0.004393053602999988,0.001156750110105353,0.01976086007521735,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-09-05,28.26620864868164,41.450382232666016,41.536258697509766,41.10686874389648,41.40267181396485,8734870.0,,0.018416213040917184,0.004383432310631078,0.02289289598712275,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-09-06,28.78675842285156,42.21374130249024,42.23282241821289,41.62213516235352,41.65076446533203,10349419.0,,-0.004294746133657807,0.018248688245213075,0.11771348404371158,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-07,28.663131713867188,42.03244400024414,42.404579162597656,41.90839767456055,42.39503860473633,8738538.0,,0.0015890773800637846,-0.004303995046488387,0.1347479045095928,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-08,28.70867729187012,42.099236806233726,42.38549550374349,41.89885584513346,42.24872843424479,8968120.0,,0.0015865562194630673,0.001587816132573622,0.1341844454732791,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-09,28.754222869873047,42.166029612223305,42.36641184488932,41.88931401570638,42.10241826375326,9197702.0,,0.0015840430461165227,0.0015852989687678667,0.1336024315108903,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-10,28.799768447875977,42.23282241821289,42.34732818603516,41.8797721862793,41.95610809326172,9427284.0,"Merck Announces New Phase III Data for Suvorexant, Says Patients Normal Sleep Patterns Return After Stopping Use",0.0015815980390713428,0.0015827897732480604,0.13496508052053066,"[{'label': 'positive', 'score': 0.930385947227478}, {'label': 'neutral', 'score': 0.06915602833032608}, {'label': 'negative', 'score': 0.0004580751119647175}]","(0.06915602833032608, 0.930385947227478, 0.0004580751119647175)",0.9990157854571307,0.930385947227478,0,0,"[{'label': 'positive', 'score': 0.6116771697998047}, {'label': 'neutral', 'score': 0.32681775093078613}, {'label': 'negative', 'score': 0.06150505319237709}]","(0.32681775093078613, 0.6116771697998047, 0.06150505319237709)",0.8172707148474674,0.6116771697998047,0,0,"[{'label': 'neutral', 'score': 0.5439183712005615}, {'label': 'positive', 'score': 0.4550122022628784}, {'label': 'negative', 'score': 0.0010693762451410294}]","(0.5439183712005615, 0.4550122022628784, 0.0010693762451410294)",0.9953105922469428,0.4550122022628784,0,1
2012-09-11,28.84532356262207,42.299617767333984,42.52862548828125,42.25190734863281,42.31870269775391,8975596.0,,0.0045116642862921,0.0015803486300945413,0.04180109145941301,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-12,28.975460052490234,42.49045944213867,42.52862548828125,42.28053283691406,42.31870269775391,9378028.0,,0.0029193924309647364,0.004501517237580393,0.020711914963523776,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-13,29.336753845214844,42.614505767822266,42.66221237182617,41.9942741394043,42.06106948852539,12429175.0,Simcere Pharmaceutical Group Announces Appointment of New Chief Executive Officer ,-0.023287155103370243,0.0029151392806143336,0.020513910217105392,"[{'label': 'neutral', 'score': 0.999872088432312}, {'label': 'negative', 'score': 6.66315681883134e-05}, {'label': 'positive', 'score': 6.121147453086451e-05}]","(0.999872088432312, 6.121147453086451e-05, 6.66315681883134e-05)",-0.042396469468852935,-6.66315681883134e-05,0,0,"[{'label': 'neutral', 'score': 0.8883702158927917}, {'label': 'negative', 'score': 0.07249765843153}, {'label': 'positive', 'score': 0.03913211449980736}]","(0.8883702158927917, 0.03913211449980736, 0.07249765843153)",-0.29889466811193405,-0.07249765843153,0,0,"[{'label': 'neutral', 'score': 0.9991970658302307}, {'label': 'positive', 'score': 0.000674830807838589}, {'label': 'negative', 'score': 0.00012816624075639993}]","(0.9991970658302307, 0.000674830807838589, 0.00012816624075639993)",0.6807802943219939,0.000674830807838589,0,0
2012-09-14,28.65358543395996,41.62213516235352,42.50954055786133,41.450382232666016,42.50954055786133,17331195.0,,0.0029038909046437923,-0.023562585292740877,0.18703129257687445,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-15,28.73678970336914,41.743001302083336,42.33460489908854,41.46310424804688,42.169209798177086,15400429.666666666,,0.0028954827386544605,0.002899682758147862,0.1891073278038225,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-16,28.81999397277832,41.86386744181315,42.15966924031576,41.47582626342773,41.82887903849284,13469664.333333334,,0.002887123123486206,0.0028912989027136925,0.19103568758050826,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-17,28.9031982421875,41.98473358154297,41.98473358154297,41.488548278808594,41.488548278808594,11538899.0,,0.0018181824789756467,0.0028829633880433237,0.1878464404605499,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-18,28.955753326416016,42.06106948852539,42.11832046508789,41.68893051147461,41.7557258605957,7895632.0,,0.009754983127694697,0.0018165315859923863,0.18604328170955547,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-19,29.23821449279785,42.47137451171875,42.72900772094727,42.07061004638672,42.09923553466797,10289369.0,"Pfizer, Merck Set Up Chinese Joint Ventures for Generic Drugs -WantChinaTimes",0.00853738803278288,0.009707710460542187,0.05083891652464873,"[{'label': 'neutral', 'score': 0.999798595905304}, {'label': 'positive', 'score': 0.00013656113878823817}, {'label': 'negative', 'score': 6.483514880528674e-05}]","(0.999798595905304, 0.00013656113878823817, 6.483514880528674e-05)",0.3561435557725618,0.00013656113878823817,0,0,"[{'label': 'neutral', 'score': 0.57481449842453}, {'label': 'positive', 'score': 0.41671639680862427}, {'label': 'negative', 'score': 0.008469142951071262}]","(0.57481449842453, 0.41671639680862427, 0.008469142951071262)",0.9601626012217733,0.41671639680862427,1,0,"[{'label': 'neutral', 'score': 0.9865348935127258}, {'label': 'positive', 'score': 0.013309878297150135}, {'label': 'negative', 'score': 0.00015528748917859048}]","(0.9865348935127258, 0.013309878297150135, 0.00015528748917859048)",0.9769349309703628,0.013309878297150135,1,0
2012-09-20,29.48783302307129,42.83396911621094,42.91030502319336,42.31870269775391,42.328243255615234,10443320.0,,0.0004455559644296189,0.008501150637968078,0.05797762744512298,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-21,29.50097274780273,42.85305404663086,43.17748260498047,42.80534362792969,42.89122009277344,21226821.0,,0.0017071000209993687,0.000445456733845006,0.06604576866200888,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-22,29.551335016886394,42.92620849609375,43.17748260498047,42.78307851155599,42.89122009277344,17640809.333333332,,0.001704190796854272,0.001705644581909851,0.06853545051041855,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-23,29.60169728597005,42.99936294555664,43.17748260498047,42.76081339518229,42.89122009277344,14054797.666666668,,0.001701291471585629,0.0017027403114203332,0.06881357190992299,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-24,29.65205955505371,43.07251739501953,43.17748260498047,42.738548278808594,42.89122009277344,10468786.0,,-0.0006645882342730207,0.0016998459145603883,0.05122962359739438,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-25,29.632362365722656,43.04389190673828,43.60686874389648,42.80534362792969,43.14885330200195,13419850.0,S&P Highlights Election ETFs,-0.0022167378106007444,-0.000664809170926991,0.016945992036469577,"[{'label': 'neutral', 'score': 0.9998911619186401}, {'label': 'negative', 'score': 6.566375668626279e-05}, {'label': 'positive', 'score': 4.312935197958723e-05}]","(0.9998911619186401, 4.312935197958723e-05, 6.566375668626279e-05)",-0.20713080987407315,-6.566375668626279e-05,1,1,"[{'label': 'neutral', 'score': 0.9172205328941345}, {'label': 'positive', 'score': 0.06293611973524094}, {'label': 'negative', 'score': 0.019843418151140213}]","(0.9172205328941345, 0.06293611973524094, 0.019843418151140213)",0.5205719032068952,0.06293611973524094,0,1,"[{'label': 'neutral', 'score': 0.9995734095573425}, {'label': 'positive', 'score': 0.000277581944828853}, {'label': 'negative', 'score': 0.0001489885471528396}]","(0.9995734095573425, 0.000277581944828853, 0.0001489885471528396)",0.3014587274394318,0.000277581944828853,1,1
2012-09-26,29.56666755676269,42.9484748840332,43.29198455810547,42.93893051147461,43.04389190673828,13260134.0,Merck Returns Rights for Vernakalant to Cardiome,0.004887782187706646,-0.002219198410870828,0.028701052240296725,"[{'label': 'neutral', 'score': 0.9912113547325134}, {'label': 'positive', 'score': 0.008597227744758129}, {'label': 'negative', 'score': 0.00019138137577101588}]","(0.9912113547325134, 0.008597227744758129, 0.00019138137577101588)",0.9564478580975978,0.008597227744758129,1,0,"[{'label': 'neutral', 'score': 0.8877003788948059}, {'label': 'positive', 'score': 0.10309545695781708}, {'label': 'negative', 'score': 0.009204190224409103}]","(0.8877003788948059, 0.10309545695781708, 0.009204190224409103)",0.8360780206286194,0.10309545695781708,1,0,"[{'label': 'neutral', 'score': 0.9965351819992065}, {'label': 'positive', 'score': 0.00332356127910316}, {'label': 'negative', 'score': 0.00014119382831268013}]","(0.9965351819992065, 0.00332356127910316, 0.00014119382831268013)",0.9184970804946798,0.00332356127910316,1,0
2012-09-27,29.71117401123047,43.15839767456055,43.35877990722656,42.9484748840332,43.0057258605957,10306346.0,,-0.002874210637266362,0.004875875761931659,0.042824225257298974,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-28,29.625776290893555,43.03435134887695,43.13931274414063,42.72900772094727,42.98664093017578,13097170.0,,0.0008869035203741193,-0.002878349112461913,0.05031432373707007,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-29,29.65205383300781,43.07251866658529,43.26017761230469,42.7894401550293,42.96119562784831,11719539.333333334,,0.0008861176195377207,0.0008865104538376845,0.0490646676829841,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-09-30,29.67833137512207,43.11068598429362,43.38104248046875,42.84987258911133,42.93575032552084,10341908.666666668,,0.0008853331102697155,0.000885725249093803,0.04897578969477378,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-01,29.704608917236328,43.14885330200195,43.50190734863281,42.91030502319336,42.91030502319336,8964278.0,Deutsche Bank Suspends Coverage on Merck & | Merck HPV Vaccine Shown to be Safe in a Kaiser Study,0.005528584776893513,0.0008849414340704359,0.043531576629715796,"[{'label': 'positive', 'score': 0.5882554650306702}, {'label': 'neutral', 'score': 0.40389683842658997}, {'label': 'negative', 'score': 0.007847708649933338}]","(0.40389683842658997, 0.5882554650306702, 0.007847708649933338)",0.9736699652126388,0.5882554650306702,0,0,"[{'label': 'negative', 'score': 0.9402719736099243}, {'label': 'neutral', 'score': 0.04919964820146561}, {'label': 'positive', 'score': 0.010528435930609703}]","(0.04919964820146561, 0.010528435930609703, 0.9402719736099243)",-0.9778535309304347,-0.9402719736099243,0,0,"[{'label': 'positive', 'score': 0.6615632176399231}, {'label': 'negative', 'score': 0.28111082315444946}, {'label': 'neutral', 'score': 0.05732600763440132}]","(0.05732600763440132, 0.6615632176399231, 0.28111082315444946)",0.40358849190847984,0.6615632176399231,1,0
2012-10-02,29.86884117126465,43.38740539550781,43.511451721191406,43.03435134887695,43.34923553466797,7786116.0,,0.006817629509639215,0.0055133582470701555,0.04724773128583003,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-03,30.07246398925781,43.683204650878906,43.76908493041992,43.196563720703125,43.41603088378906,8861678.0,,0.00742684885283683,0.006794494564374103,0.04636700448499874,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-10-04,30.295822143554688,44.00763320922852,44.26526641845703,43.75,43.79771041870117,9383582.0,,0.003469212107794539,0.007399405605033834,0.050587685596312375,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-05,30.40091323852539,44.16030502319336,44.3702278137207,43.75954055786133,44.29389190673828,12463864.0,,0.0004321450869538672,0.0034632082731803657,0.042267557577363724,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-06,30.41404914855957,44.17938868204752,44.35750579833984,43.73727671305338,44.214375813802086,10766348.666666666,,0.0004319584182461365,0.0004320517391579092,0.04495470591105499,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-07,30.42718505859375,44.198472340901695,44.34478378295898,43.715012868245445,44.13485972086588,9068833.333333334,,0.00043177191073421093,0.00043186515106601893,0.0530536832765998,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-08,30.44032096862793,44.21755599975586,44.332061767578125,43.6927490234375,44.05534362792969,7371318.0,Delphi Genetics Grants Merck License for the Use of the StabyExpress System,-0.003668506052823623,0.0004316787240654672,0.048760926327544425,"[{'label': 'positive', 'score': 0.565451979637146}, {'label': 'neutral', 'score': 0.4338531494140625}, {'label': 'negative', 'score': 0.0006948985392227769}]","(0.4338531494140625, 0.565451979637146, 0.0006948985392227769)",0.9975451651646967,0.565451979637146,0,0,"[{'label': 'positive', 'score': 0.7001346945762634}, {'label': 'neutral', 'score': 0.29198864102363586}, {'label': 'negative', 'score': 0.007876657880842686}]","(0.29198864102363586, 0.7001346945762634, 0.007876657880842686)",0.9777499107789521,0.7001346945762634,0,0,"[{'label': 'positive', 'score': 0.5957561731338501}, {'label': 'neutral', 'score': 0.4038236439228058}, {'label': 'negative', 'score': 0.0004201637057121843}]","(0.4038236439228058, 0.5957561731338501, 0.0004201637057121843)",0.9985904717119786,0.5957561731338501,0,0
2012-10-09,30.32865333557129,44.05534362792969,44.40839767456055,43.921756744384766,44.093509674072266,10512383.0,Part I: Must Know ETFs For Q3 Earnings  | Merck to Move Global Headquarters Within New Jersey  ,-0.012345651218424979,-0.0036752515234064575,0.040336551988059514,"[{'label': 'neutral', 'score': 0.999870777130127}, {'label': 'positive', 'score': 6.882182788103819e-05}, {'label': 'negative', 'score': 6.0389898862922564e-05}]","(0.999870777130127, 6.882182788103819e-05, 6.0389898862922564e-05)",0.06525668552378297,6.882182788103819e-05,0,0,"[{'label': 'neutral', 'score': 0.9045446515083313}, {'label': 'positive', 'score': 0.08216267824172974}, {'label': 'negative', 'score': 0.013292647898197174}]","(0.9045446515083313, 0.08216267824172974, 0.013292647898197174)",0.721489655198252,0.08216267824172974,0,0,"[{'label': 'neutral', 'score': 0.9992189407348633}, {'label': 'positive', 'score': 0.0006390927592292428}, {'label': 'negative', 'score': 0.0001419451873516664}]","(0.9992189407348633, 0.0006390927592292428, 0.0001419451873516664)",0.636521662044593,0.0006390927592292428,0,0
2012-10-10,29.954233169555664,43.511451721191406,44.26526641845703,43.32061004638672,44.05534362792969,9930114.0,,-0.0032895077144439733,-0.012422491857212876,0.08858650483295338,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-11,29.855697631835938,43.36832046508789,43.81679534912109,43.27289962768555,43.78816986083984,7359685.0,,0.003740342491629463,-0.003294930039397531,0.08339386334493651,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-12,29.96737670898437,43.53053283691406,43.89313125610352,43.47328186035156,43.511451721191406,7172826.0,"Jefferies & Company Maintains Merck & at Hold, Raises PT from $44 to $47",0.00708755591403164,0.003733364804532556,0.09604751525876154,"[{'label': 'positive', 'score': 0.8788618445396423}, {'label': 'neutral', 'score': 0.12059282511472702}, {'label': 'negative', 'score': 0.0005453675985336304}]","(0.12059282511472702, 0.8788618445396423, 0.0005453675985336304)",0.9987596926861502,0.8788618445396423,0,0,"[{'label': 'positive', 'score': 0.8764780163764954}, {'label': 'neutral', 'score': 0.10308554023504257}, {'label': 'negative', 'score': 0.020436396822333336}]","(0.10308554023504257, 0.8764780163764954, 0.020436396822333336)",0.954429549750578,0.8764780163764954,0,0,"[{'label': 'positive', 'score': 0.9984586238861084}, {'label': 'neutral', 'score': 0.0012167392997071147}, {'label': 'negative', 'score': 0.0003247004351578653}]","(0.0012167392997071147, 0.9984586238861084, 0.0003247004351578653)",0.9993498080569607,0.9984586238861084,0,0
2012-10-13,30.17976951599121,43.83905792236328,44.093512217203774,43.51463063557943,43.55598068237305,8373484.666666666,Merck BMD Data from a Phase II Study of Odanacatib Shows Significantly Increased Bone Mineral Density,0.007037675991933969,0.007062557239779504,0.11977609222313511,"[{'label': 'positive', 'score': 0.9990560412406921}, {'label': 'neutral', 'score': 0.0007102625677362084}, {'label': 'negative', 'score': 0.0002336556208319962}]","(0.0007102625677362084, 0.9990560412406921, 0.0002336556208319962)",0.999532356589754,0.9990560412406921,0,0,"[{'label': 'positive', 'score': 0.944029688835144}, {'label': 'neutral', 'score': 0.03366735205054283}, {'label': 'negative', 'score': 0.022302905097603798}]","(0.03366735205054283, 0.944029688835144, 0.022302905097603798)",0.9538401059063191,0.944029688835144,0,0,"[{'label': 'positive', 'score': 0.9874622225761414}, {'label': 'neutral', 'score': 0.012123160064220428}, {'label': 'negative', 'score': 0.0004145785642322153}]","(0.012123160064220428, 0.9874622225761414, 0.0004145785642322153)",0.9991606674764432,0.9874622225761414,0,0
2012-10-14,30.392162322998047,44.1475830078125,44.29389317830404,43.55597941080729,43.60050964355469,9574143.333333332,,0.006988493240833165,0.007013027129816489,0.13217380831467307,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-15,30.604555130004883,44.45610809326172,44.4942741394043,43.59732818603516,43.64503860473633,10774802.0,"Barclays Maintains Merck & at Overweight, Raises PT from $46 to $50 | A Peek Into The Market Before The Trading Starts | AiCuris, Merck Enter Exclusive Worldwide License Agreement ",0.012448963445891342,0.006964186899374601,0.07103468601854658,"[{'label': 'positive', 'score': 0.9961509704589844}, {'label': 'neutral', 'score': 0.0036159262526780367}, {'label': 'negative', 'score': 0.00023309131211135536}]","(0.0036159262526780367, 0.9961509704589844, 0.00023309131211135536)",0.9995321255707422,0.9961509704589844,1,1,"[{'label': 'positive', 'score': 0.9060654044151306}, {'label': 'neutral', 'score': 0.08052410185337067}, {'label': 'negative', 'score': 0.013410445302724838}]","(0.08052410185337067, 0.9060654044151306, 0.013410445302724838)",0.9708302391915136,0.9060654044151306,1,1,"[{'label': 'positive', 'score': 0.9989123344421387}, {'label': 'neutral', 'score': 0.0007543899118900299}, {'label': 'negative', 'score': 0.0003333370841573924}]","(0.0007543899118900299, 0.9989123344421387, 0.0003333370841573924)",0.9993328225607457,0.9989123344421387,1,1
2012-10-16,30.985536575317383,45.00954055786133,45.10496139526367,44.57061004638672,44.59923553466797,12528002.0,,0.004664046835908965,0.012372112254914417,0.04932314792496226,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-17,31.13005256652832,45.21946716308594,45.32442855834961,44.92366409301758,44.92366409301758,10619279.0,,0.012027826528267392,0.004653203871124127,0.04524475338381428,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-10-18,31.50449752807617,45.76335906982422,45.8015251159668,45.114505767822266,45.1240463256836,11513433.0,,-0.019391176992795453,0.011956067056684248,0.05398688910152044,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-10-19,30.893590927124023,44.875953674316406,45.79198455810547,44.73282241821289,45.7442741394043,13599372.0,,-0.0038982048168239537,-0.019581652245616043,0.20940733114894935,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-20,30.77315902709961,44.70101801554362,45.48664093017578,44.51335779825846,45.38485972086588,13964390.333333334,,-0.003913460286563167,-0.003905822620838918,0.21154366988992512,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-21,30.652727127075195,44.52608235677084,45.181297302246094,44.29389317830404,45.02544530232748,14329408.666666666,,-0.003928835628769267,-0.00392113790953157,0.1870476775633865,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-22,30.53229522705078,44.35114669799805,44.875953674316406,44.07442855834961,44.66603088378906,14694427.0,Earnings Expectations for the Week of October 22,-0.012693625285310206,-0.00393657377806232,0.17700760340830676,"[{'label': 'neutral', 'score': 0.9998637437820435}, {'label': 'positive', 'score': 7.262296276167035e-05}, {'label': 'negative', 'score': 6.368807225953788e-05}]","(0.9998637437820435, 7.262296276167035e-05, 6.368807225953788e-05)",0.06554781497141682,7.262296276167035e-05,1,1,"[{'label': 'neutral', 'score': 0.7200499176979065}, {'label': 'negative', 'score': 0.24967999756336212}, {'label': 'positive', 'score': 0.03027012199163437}]","(0.7200499176979065, 0.03027012199163437, 0.24967999756336212)",-0.78374631852452,-0.24967999756336212,0,1,"[{'label': 'neutral', 'score': 0.9993224143981934}, {'label': 'positive', 'score': 0.0004048062255606055}, {'label': 'negative', 'score': 0.0002728044055402279}]","(0.9993224143981934, 0.0004048062255606055, 0.0002728044055402279)",0.19480482442539304,0.0004048062255606055,1,1
2012-10-23,30.144737243652344,43.78816986083984,44.39885330200195,43.76908493041992,44.07442855834961,13104402.0,,-0.00021796692094962994,-0.012774877670607634,0.11321372943031931,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-24,30.138164520263672,43.77862548828125,44.07442855834961,43.70228958129883,43.84542083740234,10102406.0,S&P Likes a Trio of Biotech ETFs ,0.009154340979465166,-0.00021799067919138113,0.0739471445392342,"[{'label': 'neutral', 'score': 0.9998692274093628}, {'label': 'negative', 'score': 6.800565461162478e-05}, {'label': 'positive', 'score': 6.273757026065141e-05}]","(0.9998692274093628, 6.273757026065141e-05, 6.800565461162478e-05)",-0.04029336400505487,-6.800565461162478e-05,1,1,"[{'label': 'neutral', 'score': 0.824522852897644}, {'label': 'positive', 'score': 0.1679178774356842}, {'label': 'negative', 'score': 0.007559293881058693}]","(0.824522852897644, 0.1679178774356842, 0.007559293881058693)",0.9138429936574042,0.1679178774356842,0,1,"[{'label': 'neutral', 'score': 0.9904988408088684}, {'label': 'positive', 'score': 0.009318527765572071}, {'label': 'negative', 'score': 0.00018266648112330586}]","(0.9904988408088684, 0.009318527765572071, 0.00018266648112330586)",0.9615487324265917,0.009318527765572071,0,1
2012-10-25,30.414039611816406,44.17938995361328,44.21755599975586,43.90267181396485,43.988548278808594,11498132.0,,-0.003239774389229868,0.009112693974384526,0.12539920581323913,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-26,30.31551742553711,44.036258697509766,44.62786483764648,43.6927490234375,43.6927490234375,12513644.0,"Merck Begins Earnings Call | S&P Bullish on Select Dividend ETFs | Merck & Reports Q3 EPS $0.92 vs $0.92 Est; Revenues $11.49B vs $11.57B Est | Benzinga Market Primer, Friday, October 26 | US Stock Futures Down After Apple Earnings | Earnings Scheduled For October 26, 2012 | Stocks To Watch For October 26, 2012 | Stocks To Watch For October 26, 2012",-0.0022535133669979736,-0.003245033820929998,0.12495578921678561,"[{'label': 'negative', 'score': 0.9968506693840027}, {'label': 'neutral', 'score': 0.002358510158956051}, {'label': 'positive', 'score': 0.0007908341940492392}]","(0.002358510158956051, 0.0007908341940492392, 0.9968506693840027)",-0.9984145924338294,-0.9968506693840027,0,0,"[{'label': 'negative', 'score': 0.9591214060783386}, {'label': 'neutral', 'score': 0.029059426859021187}, {'label': 'positive', 'score': 0.011819127015769482}]","(0.029059426859021187, 0.011819127015769482, 0.9591214060783386)",-0.9756542720940791,-0.9591214060783386,0,0,"[{'label': 'positive', 'score': 0.6448536515235901}, {'label': 'neutral', 'score': 0.3496690094470978}, {'label': 'negative', 'score': 0.005477339029312134}]","(0.3496690094470978, 0.6448536515235901, 0.005477339029312134)",0.9831552267725843,0.6448536515235901,0,0
2012-10-27,30.247200775146485,43.93702239990235,44.61641387939453,43.625955200195314,43.81297760009765,12847851.2,,-0.002258603159408606,-0.002256056349393785,0.12406123934555288,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-28,30.17888412475586,43.83778610229492,44.60496292114258,43.55916137695313,43.93320617675781,13182058.4,,-0.002263715995507902,-0.0022611576506372704,0.08077499988796752,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-10-29,30.110567474365237,43.7385498046875,44.593511962890624,43.492367553710935,44.05343475341797,13516265.6,"UPDATE: BMO Capital Markets Reiterates Market Perform Rating, Raises PT on Merck & Co. | BMO Capital Markets Maintains Merck & at Market Perform, Raises PT from $46 to $50",-0.0022688520321445084,-0.00226628207387524,0.0827693641399567,"[{'label': 'positive', 'score': 0.9991544485092163}, {'label': 'neutral', 'score': 0.00065237918170169}, {'label': 'negative', 'score': 0.00019319837156217545}]","(0.00065237918170169, 0.9991544485092163, 0.00019319837156217545)",0.9996133510252109,0.9991544485092163,0,0,"[{'label': 'positive', 'score': 0.8929197788238525}, {'label': 'neutral', 'score': 0.08620723336935043}, {'label': 'negative', 'score': 0.020872963592410088}]","(0.08620723336935043, 0.8929197788238525, 0.020872963592410088)",0.9543157597482826,0.8929197788238525,0,0,"[{'label': 'positive', 'score': 0.998784601688385}, {'label': 'neutral', 'score': 0.0008378953207284212}, {'label': 'negative', 'score': 0.0003774695214815438}]","(0.0008378953207284212, 0.998784601688385, 0.0003774695214815438)",0.9992444278413721,0.998784601688385,0,0
2012-10-30,30.04225082397461,43.63931350708008,44.58206100463868,43.42557373046875,44.17366333007813,13850472.8,More Equal-Weight ETFs Your Broker Forgot to Mention ,-0.0022740114275932857,-0.002271429776668454,0.006967149319672352,"[{'label': 'neutral', 'score': 0.9998825788497925}, {'label': 'positive', 'score': 6.071827738196589e-05}, {'label': 'negative', 'score': 5.668748781317845e-05}]","(0.9998825788497925, 6.071827738196589e-05, 5.668748781317845e-05)",0.034332126383127104,6.071827738196589e-05,0,0,"[{'label': 'neutral', 'score': 0.9119651317596436}, {'label': 'positive', 'score': 0.07625095546245575}, {'label': 'negative', 'score': 0.011783935129642487}]","(0.9119651317596436, 0.07625095546245575, 0.011783935129642487)",0.7322894354638937,0.07625095546245575,0,0,"[{'label': 'neutral', 'score': 0.9995922446250916}, {'label': 'positive', 'score': 0.00025403566542081535}, {'label': 'negative', 'score': 0.00015373284986708313}]","(0.9995922446250916, 0.00025403566542081535, 0.00015373284986708313)",0.24597979440103415,0.00025403566542081535,0,0
2012-10-31,29.973934173583984,43.540077209472656,44.57061004638672,43.35877990722656,44.29389190673828,14184680.0,,0.006793723721434723,-0.002276600918011754,0.00012891621144140252,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-11-01,30.177562713623047,43.83587646484375,44.360687255859375,43.58778762817383,43.654579162597656,12749968.0,,0.0013061171779168352,0.006770750371467077,0.06417498642328369,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-02,30.21697998046875,43.89313125610352,44.41793823242188,43.88358688354492,44.13167953491211,11580924.0,,-0.002391323285117442,0.0013052649488687939,0.06285319792262394,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-03,30.144725163777668,43.788168589274086,44.243002573649086,43.66730244954427,43.994911193847656,10858048.666666666,"Moves in Smaller Health Care Stocks (GMED, SEM, UAM, VRTX)",-0.0023970554195577856,-0.0023941870650378205,0.06318179493837671,"[{'label': 'neutral', 'score': 0.9998809099197388}, {'label': 'negative', 'score': 6.518527516163886e-05}, {'label': 'positive', 'score': 5.393144965637475e-05}]","(0.9998809099197388, 5.393144965637475e-05, 6.518527516163886e-05)",-0.09447729126583765,-6.518527516163886e-05,1,1,"[{'label': 'negative', 'score': 0.47104474902153015}, {'label': 'neutral', 'score': 0.36892393231391907}, {'label': 'positive', 'score': 0.1600312739610672}]","(0.36892393231391907, 0.1600312739610672, 0.47104474902153015)",-0.49283044155369454,-0.47104474902153015,1,1,"[{'label': 'positive', 'score': 0.9438475966453552}, {'label': 'neutral', 'score': 0.05426916480064392}, {'label': 'negative', 'score': 0.0018832553178071976}]","(0.05426916480064392, 0.9438475966453552, 0.0018832553178071976)",0.9960173545911124,0.9438475966453552,0,0
2012-11-04,30.07247034708659,43.68320592244466,44.068066914876304,43.45101801554362,43.8581428527832,10135173.333333334,,-0.0024028151005165118,-0.0023999329562296758,0.06350764248364928,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-05,30.000215530395508,43.578243255615234,43.89313125610352,43.23473358154297,43.72137451171875,9412298.0,,0.005474109915505,-0.0024057064933036185,0.0638307572800242,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-06,30.164430618286133,43.81679534912109,44.1984748840332,43.58778762817383,43.59732818603516,9154594.0,,-0.031794457924259244,0.0054591814311506625,0.05541755280871098,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-11-07,29.205366134643555,42.42366409301758,43.578243255615234,42.15649032592773,43.46374130249024,25223159.0,,-0.013945102057717445,-0.03231087739073531,0.23265409468488232,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-08,28.798099517822266,41.832061767578125,42.71946716308594,41.832061767578125,42.47137451171875,17113735.0,"Futures Flat, Euro Falls Ahead of Central Banks",0.004790159131513847,-0.014043248503181985,0.23342095689035286,"[{'label': 'negative', 'score': 0.9972987771034241}, {'label': 'neutral', 'score': 0.0018603111384436488}, {'label': 'positive', 'score': 0.0008408911526203156}]","(0.0018603111384436488, 0.0008408911526203156, 0.9972987771034241)",-0.9983150831905327,-0.9972987771034241,0,0,"[{'label': 'negative', 'score': 0.9032748937606812}, {'label': 'neutral', 'score': 0.06096430495381355}, {'label': 'positive', 'score': 0.03576088696718216}]","(0.06096430495381355, 0.03576088696718216, 0.9032748937606812)",-0.9238348789234352,-0.9032748937606812,0,0,"[{'label': 'negative', 'score': 0.9800645709037781}, {'label': 'neutral', 'score': 0.01856185495853424}, {'label': 'positive', 'score': 0.0013735588872805238}]","(0.01856185495853424, 0.0013735588872805238, 0.9800645709037781)",-0.997200926180496,-0.9800645709037781,0,0
2012-11-09,28.93605232238769,42.03244400024414,42.290077209472656,41.62213516235352,41.68893051147461,14666970.0,,-0.00022701105429487467,0.0047787228258691,0.2513546880529679,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-10,28.92948341369629,42.022902170817055,42.35368982950846,41.70483271280924,41.93702189127604,12338523.333333334,,-0.00022706260001492594,-0.0002270368252045485,0.2547017097172523,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-11,28.922914505004883,42.013360341389976,42.41730244954427,41.787530263264976,42.18511327107748,10010076.666666668,,-0.0002271141691488422,-0.00022708838263000843,0.23954846495948326,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-12,28.91634559631348,42.00381851196289,42.48091506958008,41.8702278137207,42.433204650878906,7681630.0,"Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX) | UPDATE: BMO Capital Markets Upgrades Merck & Co. to Outperform, Reiterates $50 PT | BMO Capital Markets Upgrades Merck & from Market Perform to Outperform, Maintains PT at $50 | Merck Presents Early-Stage Interim Data for MK-3475  Study for Treatment of Advanced Melanoma ",-0.0077237872613226954,-0.00022713996347738285,0.11236751545640745,"[{'label': 'positive', 'score': 0.9992172718048096}, {'label': 'neutral', 'score': 0.0004884409718215466}, {'label': 'negative', 'score': 0.0002942775608971715}]","(0.0004884409718215466, 0.9992172718048096, 0.0002942775608971715)",0.9994111572575947,0.9992172718048096,0,0,"[{'label': 'positive', 'score': 0.9067457914352417}, {'label': 'neutral', 'score': 0.05016147717833519}, {'label': 'negative', 'score': 0.04309271648526192}]","(0.05016147717833519, 0.9067457914352417, 0.04309271648526192)",0.9092630670878874,0.9067457914352417,0,0,"[{'label': 'positive', 'score': 0.8350963592529297}, {'label': 'neutral', 'score': 0.10254144668579102}, {'label': 'negative', 'score': 0.06236225739121437}]","(0.10254144668579102, 0.8350963592529297, 0.06236225739121437)",0.8610247732103686,0.8350963592529297,0,0
2012-11-13,28.69299697875977,41.67938995361328,42.42366409301758,41.66984558105469,41.76526641845703,10059857.0,,-0.01442311652514799,-0.007753770193796055,0.0711870916239085,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-11-14,28.279150009155277,41.078243255615234,41.88931274414063,40.94465637207031,41.6984748840332,14888831.0,These ETFs Offer Solid Yield in Uncertain Times,-0.005807168464439753,-0.014528140744524121,0.10222771458024257,"[{'label': 'positive', 'score': 0.9954159259796143}, {'label': 'neutral', 'score': 0.003958006855100393}, {'label': 'negative', 'score': 0.0006261144881136715}]","(0.003958006855100393, 0.9954159259796143, 0.0006261144881136715)",0.9987427950574864,0.9954159259796143,0,0,"[{'label': 'positive', 'score': 0.8995996117591858}, {'label': 'neutral', 'score': 0.09087756276130676}, {'label': 'negative', 'score': 0.00952286459505558}]","(0.09087756276130676, 0.8995996117591858, 0.00952286459505558)",0.9790504253436916,0.8995996117591858,0,0,"[{'label': 'positive', 'score': 0.9929050803184509}, {'label': 'neutral', 'score': 0.006748332642018795}, {'label': 'negative', 'score': 0.0003466618072707206}]","(0.006748332642018795, 0.9929050803184509, 0.0003466618072707206)",0.999301965871152,0.9929050803184509,0,0
2012-11-15,28.114933013916016,40.83969497680664,41.16412353515625,40.60114669799805,40.99236679077149,12872794.0,,0.006308401896116897,-0.005824095631646492,0.09460782969410737,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-16,28.29228973388672,41.09732818603516,41.25,40.41984558105469,40.87786483764648,17435052.0,S&P Reiterates Bullish View on Health Care ETFs,0.002089618478864389,0.006288587217850125,0.12487329199526151,"[{'label': 'positive', 'score': 0.8213496208190918}, {'label': 'negative', 'score': 0.17696474492549896}, {'label': 'neutral', 'score': 0.0016855885041877627}]","(0.0016855885041877627, 0.8213496208190918, 0.17696474492549896)",0.6454729071368012,0.8213496208190918,0,0,"[{'label': 'positive', 'score': 0.3535938560962677}, {'label': 'neutral', 'score': 0.34045273065567017}, {'label': 'negative', 'score': 0.3059534430503845}]","(0.34045273065567017, 0.3535938560962677, 0.3059534430503845)",0.07223198867999639,0.3535938560962677,1,1,"[{'label': 'positive', 'score': 0.9964107871055603}, {'label': 'neutral', 'score': 0.002968880347907543}, {'label': 'negative', 'score': 0.0006203829543665051}]","(0.002968880347907543, 0.9964107871055603, 0.0006203829543665051)",0.9987555394996744,0.9964107871055603,0,0
2012-11-17,28.35141436258952,41.18320592244466,41.304070790608726,40.65203475952149,41.03053538004557,14833636.666666668,,0.002085261078781084,0.0020874382628555573,0.13070158527140138,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-18,28.41053899129232,41.26908365885416,41.358141581217446,40.88422393798828,41.18320592244466,12232221.333333334,,0.0020809218135157182,0.0020830899396352123,0.1313022343334255,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-19,28.46966361999512,41.35496139526367,41.41221237182617,41.11641311645508,41.33587646484375,9630806.0,,0.005076121061290265,0.002078759694666131,0.06986107242611778,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-20,28.61417579650879,41.564884185791016,41.66984558105469,41.25954055786133,41.431297302246094,11428545.0,"Merck Receives FDA Orphan Status for Melanoma Treatment | MKM Partners Upgrades Merck & from Neutral to Buy, Raises PT from $47 to $51 | Benzinga's Top Upgrades",0.00757581806509462,0.005063280992274623,0.03198714162941462,"[{'label': 'positive', 'score': 0.9995703101158142}, {'label': 'negative', 'score': 0.00023373935255222023}, {'label': 'neutral', 'score': 0.00019595472258515656}]","(0.00019595472258515656, 0.9995703101158142, 0.00023373935255222023)",0.9995324296742416,0.9995703101158142,1,1,"[{'label': 'positive', 'score': 0.9118004441261292}, {'label': 'neutral', 'score': 0.06446584314107895}, {'label': 'negative', 'score': 0.023733675479888916}]","(0.06446584314107895, 0.9118004441261292, 0.023733675479888916)",0.949261763985938,0.9118004441261292,1,1,"[{'label': 'positive', 'score': 0.9988466501235962}, {'label': 'neutral', 'score': 0.0008625804912298918}, {'label': 'negative', 'score': 0.0002907459274865687}]","(0.0008625804912298918, 0.9988466501235962, 0.0002907459274865687)",0.9994180061148032,0.9988466501235962,1,1
2012-11-21,28.83094596862793,41.8797721862793,41.91793823242188,41.63167953491211,41.79389190673828,7637824.0,,0.004442898599093085,0.007547265669911151,0.03926917029375315,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-22,28.95903778076172,42.065839767456055,42.08969497680664,41.77003860473633,41.88454055786133,6165279.0,,0.004423246563134292,0.004433058061353902,0.036352522441747054,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-23,29.087129592895508,42.25190734863281,42.261451721191406,41.90839767456055,41.975189208984375,4692734.0,,-0.0006022284891784817,0.004413492759796157,0.03100905706953377,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-24,29.06961441040039,42.226462046305336,42.274173736572266,41.90839767456055,41.97837066650391,6405620.333333333,,-0.0006025913868788255,-0.0006024099015931864,0.04702999077317761,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-25,29.052099227905277,42.20101674397787,42.286895751953125,41.90839767456055,41.98155212402344,8118506.666666666,,-0.0006029547222012702,-0.0006027730180384762,0.056504917875435615,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-26,29.03458404541016,42.17557144165039,42.299617767333984,41.90839767456055,41.98473358154297,9831393.0,,-0.007239821951247971,-0.0006031365725018058,0.04370075621786468,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-11-27,28.824373245239254,41.8702278137207,42.16603088378906,41.84160232543945,42.01335906982422,9294922.0,Merck Increases Dividend to $0.43 from $0.42,0.016408393235841486,-0.007266156644835332,0.06594181728968965,"[{'label': 'positive', 'score': 0.9993945360183716}, {'label': 'neutral', 'score': 0.00040679838275536895}, {'label': 'negative', 'score': 0.0001986935967579484}]","(0.00040679838275536895, 0.9993945360183716, 0.0001986935967579484)",0.9996024510953632,0.9993945360183716,1,1,"[{'label': 'positive', 'score': 0.9311076998710632}, {'label': 'negative', 'score': 0.039685167372226715}, {'label': 'neutral', 'score': 0.029207123443484306}]","(0.029207123443484306, 0.9311076998710632, 0.039685167372226715)",0.9182417409288994,0.9311076998710632,1,1,"[{'label': 'positive', 'score': 0.9988663196563721}, {'label': 'neutral', 'score': 0.0007978077046573162}, {'label': 'negative', 'score': 0.0003358927497174591}]","(0.0007978077046573162, 0.9988663196563721, 0.0003358927497174591)",0.9993276781305185,0.9988663196563721,1,1
2012-11-28,29.297338485717773,42.5572509765625,42.56679534912109,41.54580307006836,41.74618148803711,11124310.0,,0.0024663575032484388,0.01627523023757007,0.13938866219303914,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-29,29.369590759277344,42.66221237182617,42.89122009277344,42.4427490234375,42.89122009277344,10018356.0,,-0.009170178268387143,0.0024633210352338203,0.13825299019670031,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-11-30,29.10027885437012,42.270992279052734,42.66221237182617,42.09923553466797,42.5,15738026.0,"Citigroup Initiates Coverage on Merck & Company, Inc. at Neutral, Announces $44.00 PT",0.0010534165104921565,-0.009212483180795032,0.16040967154712815,"[{'label': 'neutral', 'score': 0.9998792409896851}, {'label': 'negative', 'score': 6.86197672621347e-05}, {'label': 'positive', 'score': 5.212451287661679e-05}]","(0.9998792409896851, 5.212451287661679e-05, 6.86197672621347e-05)",-0.1366131328669369,-6.86197672621347e-05,1,1,"[{'label': 'neutral', 'score': 0.9186071157455444}, {'label': 'positive', 'score': 0.05855024605989456}, {'label': 'negative', 'score': 0.022842692211270332}]","(0.9186071157455444, 0.05855024605989456, 0.022842692211270332)",0.43870579692875344,0.05855024605989456,1,1,"[{'label': 'neutral', 'score': 0.9388625025749207}, {'label': 'positive', 'score': 0.06060025095939636}, {'label': 'negative', 'score': 0.0005371753359213471}]","(0.9388625025749207, 0.06060025095939636, 0.0005371753359213471)",0.9824272833034685,0.06060025095939636,0,1
2012-12-01,29.130931218465168,42.315521240234375,42.70038096110026,42.19465510050456,42.477734883626304,14551305.666666666,,0.001052307991879388,0.0010528620566661586,0.16023260942929132,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-02,29.161583582560223,42.360050201416016,42.73854955037435,42.29007466634115,42.4554697672526,13364585.333333334,,0.00105120180382015,0.001051754703943359,0.1444015462731566,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-03,29.192235946655277,42.404579162597656,42.77671813964844,42.38549423217773,42.433204650878906,12177865.0,"Merck Files Debt Securities Shelf | Merck Begins Phase II/III Study of Investigational BACE Inhibitor, MK-8931",-0.0009000453935937638,0.0010506496781005489,0.07599610846493224,"[{'label': 'neutral', 'score': 0.9998588562011719}, {'label': 'negative', 'score': 8.1453392340336e-05}, {'label': 'positive', 'score': 5.9743480960605666e-05}]","(0.9998588562011719, 5.9743480960605666e-05, 8.1453392340336e-05)",-0.1537563181973488,-8.1453392340336e-05,1,1,"[{'label': 'neutral', 'score': 0.8145870566368103}, {'label': 'positive', 'score': 0.16818316280841827}, {'label': 'negative', 'score': 0.017229782417416573}]","(0.8145870566368103, 0.16818316280841827, 0.017229782417416573)",0.8141469313652234,0.16818316280841827,0,1,"[{'label': 'neutral', 'score': 0.999427318572998}, {'label': 'positive', 'score': 0.00044303512549959123}, {'label': 'negative', 'score': 0.0001296842674491927}]","(0.999427318572998, 0.00044303512549959123, 0.0001296842674491927)",0.5471280733781967,0.00044303512549959123,0,1
2012-12-04,29.165964126586918,42.36641311645508,42.72900772094727,42.34732818603516,42.34732818603516,10476751.0,,-0.0002252815817181802,-0.0009004506776499964,0.07068943565996007,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-05,29.15939712524414,42.35686874389648,42.709922790527344,42.20419692993164,42.299617767333984,12206056.0,,0.002703357713116429,-0.00022530696142551793,0.014541353932998921,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-12-06,29.23821449279785,42.47137451171875,42.54771041870117,42.34732818603516,42.41412353515625,9240216.0,,0.0026959794553719114,0.0026997102138385833,0.021963318904790093,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-07,29.317052841186523,42.58587646484375,42.59542083740234,42.13740539550781,42.49045944213867,8247236.0,,-0.0011203044552763873,0.002692351821315126,0.026143141908551215,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-08,29.284203847249348,42.538167317708336,42.655853271484375,42.22010167439779,42.468194325764976,8763550.666666666,Barron's Recap (12/8/12): Ten Stock Picks for 2013,-0.0011215609450001018,-0.001120932465398096,0.03040764457013921,"[{'label': 'neutral', 'score': 0.9998278617858887}, {'label': 'positive', 'score': 9.476258856011555e-05}, {'label': 'negative', 'score': 7.739462307654321e-05}]","(0.9998278617858887, 9.476258856011555e-05, 7.739462307654321e-05)",0.10088433309565778,9.476258856011555e-05,1,1,"[{'label': 'neutral', 'score': 0.9378530383110046}, {'label': 'positive', 'score': 0.035541366785764694}, {'label': 'negative', 'score': 0.026605568826198578}]","(0.9378530383110046, 0.035541366785764694, 0.026605568826198578)",0.1437850132363723,0.035541366785764694,1,1,"[{'label': 'neutral', 'score': 0.9994720816612244}, {'label': 'positive', 'score': 0.0003953936684411019}, {'label': 'negative', 'score': 0.00013247823517303914}]","(0.9994720816612244, 0.0003953936684411019, 0.00013247823517303914)",0.498066730712469,0.0003953936684411019,1,1
2012-12-09,29.251354853312176,42.490458170572914,42.716285705566406,42.30279795328776,42.44592920939128,9279865.333333334,,-0.0011228202563477092,-0.0011221903651428757,0.03114220043231858,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-10,29.218505859375,42.4427490234375,42.77671813964844,42.38549423217773,42.42366409301758,9796180.0,"Three More Defensive Stock Picks for 2013 (LLY, PFE, VTR)",0.015962179780322182,-0.001123451091265415,0.033198807623108784,"[{'label': 'neutral', 'score': 0.9998401403427124}, {'label': 'positive', 'score': 9.547056833980605e-05}, {'label': 'negative', 'score': 6.433584348997101e-05}]","(0.9998401403427124, 9.547056833980605e-05, 6.433584348997101e-05)",0.19482775749322995,9.547056833980605e-05,0,0,"[{'label': 'neutral', 'score': 0.8021767735481262}, {'label': 'positive', 'score': 0.18120361864566803}, {'label': 'negative', 'score': 0.016619568690657616}]","(0.8021767735481262, 0.18120361864566803, 0.016619568690657616)",0.8319755240582375,0.18120361864566803,1,0,"[{'label': 'neutral', 'score': 0.9964960217475891}, {'label': 'positive', 'score': 0.0033734708558768034}, {'label': 'negative', 'score': 0.00013056762691121548}]","(0.9964960217475891, 0.0033734708558768034, 0.00013056762691121548)",0.9254759172580044,0.0033734708558768034,1,0
2012-12-11,29.68489646911621,43.1202278137207,43.20610809326172,42.46183013916016,42.614505767822266,14235508.0,"Benzinga's M&A Chatter for Tuesday December 11, 2012 | Warburg Pincus Said to Hire Goldman Sachs to Sell Bausch & Lomb, Seeking At Least $10B; Abbott, Glaxo, Merck, Sanofi Said to Be Contacted - Bloomberg | Cardiome Reaches Deal with Merck to Retire Debt/Close Line of Credit; Will Pay Merck $20M",0.0015490490776080665,0.01583612383776947,0.11660819272608842,"[{'label': 'positive', 'score': 0.8802345395088196}, {'label': 'neutral', 'score': 0.11894892901182175}, {'label': 'negative', 'score': 0.0008165131439454854}]","(0.11894892901182175, 0.8802345395088196, 0.0008165131439454854)",0.9981465020863728,0.8802345395088196,0,0,"[{'label': 'positive', 'score': 0.6707635521888733}, {'label': 'neutral', 'score': 0.31559789180755615}, {'label': 'negative', 'score': 0.013638488948345184}]","(0.31559789180755615, 0.6707635521888733, 0.013638488948345184)",0.9601448034091682,0.6707635521888733,0,0,"[{'label': 'positive', 'score': 0.5811195373535156}, {'label': 'neutral', 'score': 0.417508989572525}, {'label': 'negative', 'score': 0.0013714184751734138}]","(0.417508989572525, 0.5811195373535156, 0.0013714184751734138)",0.9952911939268745,0.5811195373535156,0,0
2012-12-12,29.73088264465332,43.1870231628418,43.40649032592773,42.95801544189453,43.13931274414063,11790000.0,"Benzinga's Small Cap Movers for Tuesday December 11, 2012",-0.028943879629923244,0.0015478505386563757,0.11710048365417719,"[{'label': 'neutral', 'score': 0.9998852014541626}, {'label': 'negative', 'score': 6.950218084966764e-05}, {'label': 'positive', 'score': 4.524016549112275e-05}]","(0.9998852014541626, 4.524016549112275e-05, 6.950218084966764e-05)",-0.21144778830376634,-6.950218084966764e-05,0,0,"[{'label': 'neutral', 'score': 0.9213614463806152}, {'label': 'negative', 'score': 0.05223513022065163}, {'label': 'positive', 'score': 0.026403440162539482}]","(0.9213614463806152, 0.026403440162539482, 0.05223513022065163)",-0.32848626230409744,-0.05223513022065163,0,0,"[{'label': 'neutral', 'score': 0.9995905756950378}, {'label': 'positive', 'score': 0.0002445413265377283}, {'label': 'negative', 'score': 0.0001648825709708035}]","(0.9995905756950378, 0.0002445413265377283, 0.0001648825709708035)",0.1945630336960603,0.0002445413265377283,0,0
2012-12-13,29.147289276123047,41.9370231628418,42.88167953491211,41.88931274414063,42.88167953491211,14404131.0,,-0.009328752097027172,-0.0293710158933254,0.2605841487679042,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-14,28.8753719329834,41.54580307006836,41.946563720703125,41.421756744384766,41.88931274414063,13818928.0,,0.0006890103492035567,-0.00937253742594142,0.2637085586405264,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-15,28.895267486572266,41.57442855834961,41.90839640299479,41.45356369018555,41.80343500773112,13851835.333333334,,0.000688535940814537,0.0006887730905491914,0.26547683969302255,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-16,28.915163040161133,41.60305404663086,41.87022908528646,41.48537063598633,41.71755727132162,13884742.666666666,These 2 Dow Laggards Could Rebound in 2013,0.0006880621852704628,0.0006882990086950237,0.20958712064276466,"[{'label': 'positive', 'score': 0.9985464215278625}, {'label': 'neutral', 'score': 0.0012840740382671356}, {'label': 'negative', 'score': 0.0001694982493063435}]","(0.0012840740382671356, 0.9985464215278625, 0.0001694982493063435)",0.9996605676430107,0.9985464215278625,0,0,"[{'label': 'positive', 'score': 0.9154396057128906}, {'label': 'negative', 'score': 0.04840086027979851}, {'label': 'neutral', 'score': 0.036159493029117584}]","(0.036159493029117584, 0.9154396057128906, 0.04840086027979851)",0.8995666565421717,0.9154396057128906,0,0,"[{'label': 'neutral', 'score': 0.7473142147064209}, {'label': 'positive', 'score': 0.24540679156780243}, {'label': 'negative', 'score': 0.0072790393605828285}]","(0.7473142147064209, 0.24540679156780243, 0.0072790393605828285)",0.9423866440485473,0.24540679156780243,0,1
2012-12-17,28.93505859375,41.63167953491211,41.832061767578125,41.51717758178711,41.63167953491211,13917650.0,,0.013981222330701747,0.0006878255790121028,0.2074126931925641,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-18,29.339601516723636,42.21374130249024,42.36641311645508,41.3740463256836,41.593509674072266,14756888.0,"Merck, GE Healthcare Announce Collaboration on Use of Imaging Biomarkers for Investigational BACE Inhibitor Program",-0.01311033474458314,0.013884386585986685,0.13123888676092202,"[{'label': 'neutral', 'score': 0.9992479681968689}, {'label': 'positive', 'score': 0.0006848423508927226}, {'label': 'negative', 'score': 6.721684621879831e-05}]","(0.9992479681968689, 0.0006848423508927226, 6.721684621879831e-05)",0.8212458634188317,0.0006848423508927226,0,1,"[{'label': 'positive', 'score': 0.8178542852401733}, {'label': 'neutral', 'score': 0.1733384132385254}, {'label': 'negative', 'score': 0.008807326667010784}]","(0.1733384132385254, 0.8178542852401733, 0.008807326667010784)",0.978691821320476,0.8178542852401733,0,0,"[{'label': 'positive', 'score': 0.8936324119567871}, {'label': 'neutral', 'score': 0.10593122988939285}, {'label': 'negative', 'score': 0.0004362979962024838}]","(0.10593122988939285, 0.8936324119567871, 0.0004362979962024838)",0.9990240168538603,0.8936324119567871,0,0
2012-12-19,28.9549560546875,41.66030502319336,42.42366409301758,41.61259460449219,42.12786483764648,12254369.0,,-0.03435638076699743,-0.013197033785831086,0.1520236281925171,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-12-20,27.96015739440918,40.22900772094727,40.82061004638672,40.07633590698242,40.5057258605957,35263104.0,"Goldman Sachs Maintains Neutral on Merck & Company, Inc., Lowers PT to $47.00 | Mid-Morning Market Update: Rite Aid Rallies, New York Stock Exchange Acquired by ICE | Merck Says HPS2-THRIVE Study of TREDAPTIVE Did Not Achieve Primary Endpoint",-0.015180271412496133,-0.03496043702832828,0.2941794007278675,"[{'label': 'negative', 'score': 0.9947507977485657}, {'label': 'neutral', 'score': 0.0038883069064468145}, {'label': 'positive', 'score': 0.0013608428416773677}]","(0.0038883069064468145, 0.0013608428416773677, 0.9947507977485657)",-0.9972676901137888,-0.9947507977485657,0,0,"[{'label': 'negative', 'score': 0.9160318970680237}, {'label': 'neutral', 'score': 0.0515211783349514}, {'label': 'positive', 'score': 0.032446909695863724}]","(0.0515211783349514, 0.032446909695863724, 0.9160318970680237)",-0.9315811603496567,-0.9160318970680237,0,0,"[{'label': 'negative', 'score': 0.9951604008674622}, {'label': 'neutral', 'score': 0.004402207210659981}, {'label': 'positive', 'score': 0.0004373947449494153}]","(0.004402207210659981, 0.0004373947449494153, 0.9951604008674622)",-0.999121342480112,-0.9951604008674622,0,0
2012-12-21,27.53571319580078,39.61832046508789,40.51526641845703,39.5515251159668,40.47710037231445,30087242.0,,-0.0008028342803882837,-0.015296671222073807,0.2911731262560174,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-22,27.51360829671224,39.58651351928711,40.2894401550293,39.50699615478516,40.16221491495768,22322784.666666668,,-0.0008034793411469403,-0.0008031567244201473,0.2879721928269227,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-23,27.4915033976237,39.55470657348633,40.06361389160156,39.46246719360352,39.847329457600914,14558327.333333334,,-0.0008041254393251287,-0.0008038023036802241,0.2223966702907592,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-24,27.46939849853516,39.52289962768555,39.83778762817383,39.41793823242188,39.53244400024414,6793870.0,,-0.000965717441047127,-0.0008044489216114438,0.23856222950698439,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-25,27.442873001098636,39.484731674194336,39.75667953491211,39.375,39.54198455810547,7132793.0,,-0.0009666509527315848,-0.0009661840465653377,0.10260703325511464,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-26,27.41634750366211,39.446563720703125,39.67557144165039,39.332061767578125,39.5515251159668,7471716.0,"Option Alert: Merck January 45 Call; Block Trade: 7,000 Contracts @$0.03; Currently $41.31",-0.003386527771868001,-0.0009671184610663708,0.0014159685684849684,"[{'label': 'neutral', 'score': 0.9998840093612671}, {'label': 'negative', 'score': 6.999566539889202e-05}, {'label': 'positive', 'score': 4.598735540639609e-05}]","(0.9998840093612671, 4.598735540639609e-05, 6.999566539889202e-05)",-0.2069984884494515,-6.999566539889202e-05,0,0,"[{'label': 'neutral', 'score': 0.9043808579444885}, {'label': 'negative', 'score': 0.056924816220998764}, {'label': 'positive', 'score': 0.03869429603219032}]","(0.9043808579444885, 0.03869429603219032, 0.056924816220998764)",-0.19065770178388597,-0.056924816220998764,0,0,"[{'label': 'neutral', 'score': 0.9994858503341675}, {'label': 'positive', 'score': 0.0003699101216625422}, {'label': 'negative', 'score': 0.0001441905478714034}]","(0.9994858503341675, 0.0003699101216625422, 0.0001441905478714034)",0.43905714807911717,0.0003699101216625422,0,0
2012-12-27,27.3234977722168,39.3129768371582,39.51335906982422,38.931297302246094,39.32251739501953,11948877.0,,-0.013592238285346277,-0.0033922750362248306,0.01784382172233045,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2012-12-28,26.952110290527344,38.77862548828125,39.28435134887695,38.76908493041992,39.12213516235352,11862731.0,"Merck Sends Dear Doctor Letter Related to Tredaptive's Failed Study, Says Side Effects Include Muscle, Skin, Blood Damage",0.0024606226918854742,-0.013685458433587604,0.0879512857190543,"[{'label': 'negative', 'score': 0.7879266142845154}, {'label': 'neutral', 'score': 0.2102254331111908}, {'label': 'positive', 'score': 0.001847903593443334}]","(0.2102254331111908, 0.001847903593443334, 0.7879266142845154)",-0.9953204274090574,-0.7879266142845154,0,0,"[{'label': 'negative', 'score': 0.7302539348602295}, {'label': 'neutral', 'score': 0.23886241018772125}, {'label': 'positive', 'score': 0.03088364750146866}]","(0.23886241018772125, 0.03088364750146866, 0.7302539348602295)",-0.9188487121982829,-0.7302539348602295,0,0,"[{'label': 'negative', 'score': 0.9956140518188477}, {'label': 'neutral', 'score': 0.003960161469876766}, {'label': 'positive', 'score': 0.0004256900865584612}]","(0.003960161469876766, 0.0004256900865584612, 0.9956140518188477)",-0.9991452347358266,-0.9956140518188477,0,0
2012-12-29,27.01843007405599,38.87404505411784,39.22073745727539,38.57506434122721,38.89312871297201,12910032.333333334,,0.0024545828895282044,0.0024576003168041067,0.09782635207088854,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-30,27.08474985758464,38.96946461995443,39.15712356567383,38.38104375203451,38.66412226359049,13957333.666666666,,0.0024485726649610246,0.002451575321492021,0.10568042825629104,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2012-12-31,27.15106964111328,39.064884185791016,39.093509674072266,38.1870231628418,38.43511581420898,15004635.0,,0.004885199877937138,0.0024455797954233325,0.11166532219051731,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-01,27.28370857238769,39.25572395324707,39.52289962768555,38.625953674316406,39.18893241882324,15863733.0,,0.004861450719475757,0.0048733060092355915,0.12001982646707997,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-02,27.41634750366211,39.446563720703125,39.95228958129883,39.064884185791016,39.9427490234375,16722831.0,"Merck Says FDA Acknowledged Resubmission of NDA for Ezetimibe, Atorvastatin Tablets",0.0239477481171451,0.004849672026857346,0.020954223423912663,"[{'label': 'positive', 'score': 0.9862848520278931}, {'label': 'neutral', 'score': 0.013014719821512699}, {'label': 'negative', 'score': 0.0007004522485658526}]","(0.013014719821512699, 0.9862848520278931, 0.0007004522485658526)",0.9985806227397087,0.9862848520278931,1,1,"[{'label': 'positive', 'score': 0.8995080590248108}, {'label': 'negative', 'score': 0.051546383649110794}, {'label': 'neutral', 'score': 0.048945531249046326}]","(0.048945531249046326, 0.8995080590248108, 0.051546383649110794)",0.8916016132490031,0.8995080590248108,1,1,"[{'label': 'positive', 'score': 0.7351468801498413}, {'label': 'neutral', 'score': 0.2643870711326599}, {'label': 'negative', 'score': 0.00046608404954895377}]","(0.2643870711326599, 0.7351468801498413, 0.00046608404954895377)",0.9987328008824418,0.7351468801498413,1,1
2013-01-03,28.07289123535156,40.39122009277344,40.48664093017578,39.22710037231445,39.97137451171875,24673483.0,"Merck, Pfizer, Abbott, J&J, Sanofi Said to Show Interest in Bausch & Lomb Bid - Bloomberg",-0.008504562954109039,0.02366549808603216,0.1433454436202433,"[{'label': 'neutral', 'score': 0.6885635852813721}, {'label': 'positive', 'score': 0.3101629912853241}, {'label': 'negative', 'score': 0.0012734070187434554}]","(0.6885635852813721, 0.3101629912853241, 0.0012734070187434554)",0.9918223622821365,0.3101629912853241,0,1,"[{'label': 'neutral', 'score': 0.9079302549362183}, {'label': 'positive', 'score': 0.08289177715778351}, {'label': 'negative', 'score': 0.009177954867482185}]","(0.9079302549362183, 0.08289177715778351, 0.009177954867482185)",0.8006303555882278,0.08289177715778351,0,1,"[{'label': 'positive', 'score': 0.7587378025054932}, {'label': 'neutral', 'score': 0.24069125950336456}, {'label': 'negative', 'score': 0.0005709727993234992}]","(0.24069125950336456, 0.7587378025054932, 0.0005709727993234992)",0.9984960721701279,0.7587378025054932,0,0
2013-01-04,27.83416175842285,40.04771041870117,40.55343627929688,39.904579162597656,40.51526641845703,16169068.0,,0.001191339484888138,-0.00854093310459462,0.1839782385041141,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-05,27.867319742838543,40.09542083740234,40.45483525594076,39.91412099202474,40.38167953491211,14797969.666666666,,0.001189921883964371,0.001190630403119547,0.1854826155122682,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-06,27.90047772725423,40.14313125610352,40.35623423258463,39.92366282145182,40.24809265136719,13426871.333333334,,0.0011885076526986342,0.001189214488027743,0.187731324139671,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-07,27.93363571166992,40.19084167480469,40.25763320922852,39.933204650878906,40.114505767822266,12055773.0,4 Health Care ETFs Your Broker Forgot to Mention | Merck Receives FDA Acceptance of Resubmission of NDA for Sugammadex Sodium Injection,0.0014244781690747764,0.001187801936589124,0.18906103794204857,"[{'label': 'neutral', 'score': 0.8276568651199341}, {'label': 'positive', 'score': 0.17115677893161774}, {'label': 'negative', 'score': 0.00118631508667022}]","(0.8276568651199341, 0.17115677893161774, 0.00118631508667022)",0.9862330998125828,0.17115677893161774,0,1,"[{'label': 'positive', 'score': 0.7122573256492615}, {'label': 'neutral', 'score': 0.27663376927375793}, {'label': 'negative', 'score': 0.011108916252851486}]","(0.27663376927375793, 0.7122573256492615, 0.011108916252851486)",0.9692854999048884,0.7122573256492615,0,0,"[{'label': 'positive', 'score': 0.9869972467422485}, {'label': 'neutral', 'score': 0.012717497535049915}, {'label': 'negative', 'score': 0.00028523997752927244}]","(0.012717497535049915, 0.9869972467422485, 0.00028523997752927244)",0.9994221715033618,0.9869972467422485,0,0
2013-01-08,27.97342872619629,40.24809265136719,40.73473358154297,40.24809265136719,40.314884185791016,15458943.0,,0.009720214474813261,0.001423464562507228,0.06951160788762947,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-09,28.24532699584961,40.63931274414063,40.696563720703125,40.26717758178711,40.4484748840332,10556609.0,"Microbiotix, Merck Announce Licensing Pact for HCV NS5B",0.004461131106904018,0.009673277105850685,0.05983678203005057,"[{'label': 'neutral', 'score': 0.9985040426254272}, {'label': 'positive', 'score': 0.0013862464111298323}, {'label': 'negative', 'score': 0.00010973502503475174}]","(0.9985040426254272, 0.0013862464111298323, 0.00010973502503475174)",0.8532936005996281,0.0013862464111298323,0,1,"[{'label': 'neutral', 'score': 0.5207023620605469}, {'label': 'positive', 'score': 0.46726301312446594}, {'label': 'negative', 'score': 0.012034607119858265}]","(0.5207023620605469, 0.46726301312446594, 0.012034607119858265)",0.9497823205810053,0.46726301312446594,0,1,"[{'label': 'positive', 'score': 0.964849054813385}, {'label': 'neutral', 'score': 0.03475015237927437}, {'label': 'negative', 'score': 0.00040084851207211614}]","(0.03475015237927437, 0.964849054813385, 0.00040084851207211614)",0.9991694409692431,0.964849054813385,0,0
2013-01-10,28.37134552001953,40.82061004638672,41.17366409301758,40.79198455810547,40.90649032592773,13593084.0,,0.01051894994036938,0.0044512097575442125,0.05831371399652043,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-01-11,28.669775009155277,41.25,41.34542083740234,40.75381851196289,40.75381851196289,12722825.0,Three Stocks to Buy for Flu Season | Merck to Suspend Availability of TREDAPTIVE Worldwide,0.0008481728910196856,0.010464010719220065,0.07025827013010458,"[{'label': 'negative', 'score': 0.9482799768447876}, {'label': 'neutral', 'score': 0.05060857906937599}, {'label': 'positive', 'score': 0.0011113991495221853}]","(0.05060857906937599, 0.0011113991495221853, 0.9482799768447876)",-0.9976587123548322,-0.9482799768447876,0,0,"[{'label': 'negative', 'score': 0.9484378099441528}, {'label': 'neutral', 'score': 0.04292120784521103}, {'label': 'positive', 'score': 0.00864099059253931}]","(0.04292120784521103, 0.00864099059253931, 0.9484378099441528)",-0.9819429902998713,-0.9484378099441528,0,0,"[{'label': 'neutral', 'score': 0.6410711407661438}, {'label': 'negative', 'score': 0.33932963013648987}, {'label': 'positive', 'score': 0.019599242135882378}]","(0.6410711407661438, 0.019599242135882378, 0.33932963013648987)",-0.8907903841125963,-0.33932963013648987,0,1
2013-01-12,28.694096247355144,41.28498713175456,41.418575286865234,40.861960093180336,40.94465764363607,12365457.0,,0.0008474541034226068,0.0008478133956549398,0.07158356217183948,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-13,28.71841748555501,41.31997426350912,41.491729736328125,40.97010167439779,41.13549677530924,12008089.0,,0.0008467365330731361,0.0008470952169395497,0.07367291726182575,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-14,28.742738723754883,41.35496139526367,41.564884185791016,41.078243255615234,41.32633590698242,11650721.0,,-0.01084443206341156,0.0008463782539259776,0.06665193991216803,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-01-15,28.43103790283203,40.90649032592773,41.54580307006836,40.84923553466797,41.39313125610352,12446677.0,,-0.007697751578768148,-0.010903661512517135,0.12028402102805702,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-16,28.212181091308597,40.59160232543945,41.06870269775391,40.55343627929688,40.92557144165039,12481156.0,"UPDATE: Jefferies & Company Reiterates Hold Rating, Lowers PT on Merck & Co. | Jefferies Maintains Hold on Merck & Company, Inc., Lowers PT to $47.00",0.004936544043259722,-0.007727532196089655,0.09014298504571194,"[{'label': 'positive', 'score': 0.7761885523796082}, {'label': 'neutral', 'score': 0.22299301624298096}, {'label': 'negative', 'score': 0.0008184423204511404}]","(0.22299301624298096, 0.7761885523796082, 0.0008184423204511404)",0.9978933463249785,0.7761885523796082,0,0,"[{'label': 'negative', 'score': 0.8670037388801575}, {'label': 'neutral', 'score': 0.09883332252502441}, {'label': 'positive', 'score': 0.03416292369365692}]","(0.09883332252502441, 0.03416292369365692, 0.8670037388801575)",-0.9241806757562814,-0.8670037388801575,0,0,"[{'label': 'negative', 'score': 0.9925530552864075}, {'label': 'neutral', 'score': 0.006708725355565548}, {'label': 'positive', 'score': 0.0007382163894362748}]","(0.006708725355565548, 0.0007382163894362748, 0.9925530552864075)",-0.9985135953360573,-0.9925530552864075,0,0
2013-01-17,28.351451873779297,40.79198455810547,40.88740539550781,40.59160232543945,40.84923553466797,16255109.0,,0.00538015410290522,0.004924399262146374,0.10512719693593238,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-18,28.503986358642575,41.011451721191406,41.011451721191406,40.696563720703125,40.91603088378906,17222937.0,,0.0012796595933403194,0.005365732776666623,0.11802984428498806,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-19,28.540461540222168,41.06393241882324,41.06870365142822,40.68702220916748,40.889790534973145,16122144.0,,0.0012780241574666964,0.00127884152682641,0.11860972666748541,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-20,28.57693672180176,41.11641311645508,41.12595558166504,40.67748069763184,40.86355018615723,15021351.0,,0.0012763928965105371,0.001277208179745439,0.08354205114938348,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-21,28.613411903381348,41.168893814086914,41.183207511901855,40.66793918609619,40.83730983734131,13920558.0,,0.0012747657945057153,0.0012755789995919087,0.0337214391548395,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-22,28.649887084960938,41.22137451171875,41.24045944213867,40.65839767456055,40.81106948852539,12819765.0,,-0.008796276416961936,0.001273953970440843,0.029031427905368095,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-01-23,28.39786529541016,40.85877990722656,41.10686874389648,40.60114669799805,41.03053283691406,14854666.0,,0.0042035746069138645,-0.00883519203277737,0.07178515731764468,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-24,28.517240524291992,41.03053283691406,41.23091506958008,40.96374130249024,40.98282241821289,13096122.0,,0.010697748623361225,0.004194764268489594,0.079533331902801,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-25,28.82231903076172,41.46946716308594,41.46946716308594,40.76335906982422,41.14503860473633,13799330.0,FDA Approves OXYTROL for Women,-0.004065045885501315,0.010640932554058869,0.1115503436930317,"[{'label': 'positive', 'score': 0.9918498992919922}, {'label': 'neutral', 'score': 0.007779459003359079}, {'label': 'negative', 'score': 0.0003707196156028658}]","(0.007779459003359079, 0.9918498992919922, 0.0003707196156028658)",0.999252747607662,0.9918498992919922,0,0,"[{'label': 'neutral', 'score': 0.8136361241340637}, {'label': 'positive', 'score': 0.17201802134513855}, {'label': 'negative', 'score': 0.014345822855830193}]","(0.8136361241340637, 0.17201802134513855, 0.014345822855830193)",0.8460449995830723,0.17201802134513855,0,1,"[{'label': 'positive', 'score': 0.9959059953689575}, {'label': 'neutral', 'score': 0.0038248347118496895}, {'label': 'negative', 'score': 0.0002691539702937007}]","(0.0038248347118496895, 0.9959059953689575, 0.0002691539702937007)",0.9994596252065268,0.9959059953689575,0,0
2013-01-26,28.705154418945312,41.3008918762207,41.4821891784668,40.83015314737956,41.215012868245445,13339153.333333334,,-0.004081637930978746,-0.004073330644098336,0.11907247303148177,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-27,28.587989807128903,41.13231658935547,41.494911193847656,40.8969472249349,41.28498713175456,12878976.666666666,,-0.004098365977005352,-0.004089990551073426,0.12328847427857662,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-28,28.4708251953125,40.96374130249024,41.50763320922852,40.96374130249024,41.35496139526367,12418800.0,,0.01700439702417447,-0.004106787295819243,0.10639911584999473,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-01-29,28.9549560546875,41.66030502319336,41.73664093017578,41.020992279052734,41.21183013916016,16474874.0,,-0.0036646830569252993,0.016861440581338486,0.15900659301340334,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-01-30,28.848838806152344,41.50763320922852,41.76526641845703,41.46946716308594,41.66030502319336,13280885.0,Isis and Sanofi's Drug OK'd to Treat Inherited Cholesterol Disease,-0.005747094217734478,-0.003671414458546926,0.1480258405929759,"[{'label': 'neutral', 'score': 0.9997449517250061}, {'label': 'positive', 'score': 0.00018090578669216484}, {'label': 'negative', 'score': 7.412594277411699e-05}]","(0.9997449517250061, 0.00018090578669216484, 7.412594277411699e-05)",0.4186923883608976,0.00018090578669216484,1,1,"[{'label': 'positive', 'score': 0.5695460438728333}, {'label': 'neutral', 'score': 0.42126813530921936}, {'label': 'negative', 'score': 0.009185836650431156}]","(0.42126813530921936, 0.5695460438728333, 0.009185836650431156)",0.9682552941713675,0.5695460438728333,0,0,"[{'label': 'neutral', 'score': 0.8291062712669373}, {'label': 'positive', 'score': 0.17049697041511536}, {'label': 'negative', 'score': 0.0003967776137869805}]","(0.8291062712669373, 0.17049697041511536, 0.0003967776137869805)",0.9953564408486157,0.17049697041511536,0,1
2013-01-31,28.68304252624512,41.26908493041992,41.64122009277344,41.26908493041992,41.44084167480469,15237291.0,,-0.03283235859356101,-0.00576367231146618,0.15153346458808584,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-02-01,27.74131393432617,39.91412353515625,40.79198455810547,39.60877990722656,40.30534362792969,39497024.0,"Hearing Merck Defded at Credit Suisse | Merck & Company, Inc. Reports Q4 EPS of $0.83 vs $0.81 Est; Revenue of $11.74B vs $11.54B Est | US Stock Futures Up; All Eyes On Payroll Data  | Earnings Scheduled For February 1, 2013 | Stocks To Watch For February 1, 2013",-0.00780939787212021,-0.03338343618989453,0.28414478264167015,"[{'label': 'positive', 'score': 0.9965877532958984}, {'label': 'negative', 'score': 0.002318478422239423}, {'label': 'neutral', 'score': 0.0010938101913779974}]","(0.0010938101913779974, 0.9965877532958984, 0.002318478422239423)",0.9953579658457999,0.9965877532958984,0,0,"[{'label': 'negative', 'score': 0.5271170735359192}, {'label': 'positive', 'score': 0.349765419960022}, {'label': 'neutral', 'score': 0.12311746925115585}]","(0.12311746925115585, 0.349765419960022, 0.5271170735359192)",-0.2022524738392649,-0.5271170735359192,1,0,"[{'label': 'positive', 'score': 0.9650254249572754}, {'label': 'neutral', 'score': 0.028961626812815666}, {'label': 'negative', 'score': 0.006012906786054373}]","(0.028961626812815666, 0.9650254249572754, 0.006012906786054373)",0.9876155109649292,0.9650254249572754,0,0
2013-02-02,27.524667739868164,39.60241826375326,40.44529215494792,39.39249420166016,40.03498713175456,36605138.0,,-0.007870864585264297,-0.00784005091182998,0.28380298781832264,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-03,27.30802154541016,39.29071299235026,40.09859975179037,39.17620849609375,39.76463063557943,33713252.0,,-0.007933306566965916,-0.007902003340161806,0.19429140027387953,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-04,27.09137535095215,38.97900772094727,39.75190734863281,38.959922790527344,39.4942741394043,30821366.0,"UPDATE: BMO Capital Markets Reiterates Outperform Rating, Lowers PT on Merck & Co. | UPDATE: Morgan Stanley Downgrades Merck to Underweight Ahead of Key March Trial | Leerink Swann Downgrades Merck & Company, Inc. to Market Perform | Morgan Stanley Downgrades Merck & Company, Inc. to Underweight, Removes $43.00 PT",0.014198316264460777,-0.007964942673885183,0.18527910339890255,"[{'label': 'negative', 'score': 0.9196087121963501}, {'label': 'positive', 'score': 0.07811103016138077}, {'label': 'neutral', 'score': 0.002280250657349825}]","(0.002280250657349825, 0.07811103016138077, 0.9196087121963501)",-0.8434208989855306,-0.9196087121963501,0,0,"[{'label': 'negative', 'score': 0.948017418384552}, {'label': 'positive', 'score': 0.03522505983710289}, {'label': 'neutral', 'score': 0.016757527366280556}]","(0.016757527366280556, 0.03522505983710289, 0.948017418384552)",-0.9283491903221821,-0.948017418384552,0,0,"[{'label': 'negative', 'score': 0.9063206911087036}, {'label': 'neutral', 'score': 0.07772631198167801}, {'label': 'positive', 'score': 0.015953045338392258}]","(0.07772631198167801, 0.015953045338392258, 0.9063206911087036)",-0.9654049666428783,-0.9063206911087036,0,0
2013-02-05,27.47602653503418,39.53244400024414,39.58015441894531,39.05534362792969,39.16984558105469,22330050.0,"Merck Serono, Opexa Therapeutics Enter Option, License Agreement for Development of Tcelna",-0.008206640559526393,0.014098464216154084,0.26692160014274235,"[{'label': 'neutral', 'score': 0.9995347261428833}, {'label': 'positive', 'score': 0.00038284462061710656}, {'label': 'negative', 'score': 8.24548042146489e-05}]","(0.9995347261428833, 0.00038284462061710656, 8.24548042146489e-05)",0.645583897962207,0.00038284462061710656,0,1,"[{'label': 'positive', 'score': 0.5919796228408813}, {'label': 'neutral', 'score': 0.39964354038238525}, {'label': 'negative', 'score': 0.008376868441700935}]","(0.39964354038238525, 0.5919796228408813, 0.008376868441700935)",0.9720936857905713,0.5919796228408813,0,0,"[{'label': 'neutral', 'score': 0.9991341233253479}, {'label': 'positive', 'score': 0.0007662646239623427}, {'label': 'negative', 'score': 9.970065002562478e-05}]","(0.9991341233253479, 0.0007662646239623427, 9.970065002562478e-05)",0.7697352237544571,0.0007662646239623427,0,1
2013-02-06,27.25054359436035,39.20801544189453,39.5515251159668,39.10305404663086,39.45610809326172,18218222.0,,-0.00219037557940879,-0.008240500411835624,0.15680914693247708,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-07,27.19086456298828,39.12213516235352,39.40839767456055,39.00763320922852,39.21755599975586,16950666.0,Mylan Loses Appeals Court Bid to Invalidate Zetia Patents,0.004390270205651677,-0.0021927779607175736,0.15217729860304607,"[{'label': 'negative', 'score': 0.9819446802139282}, {'label': 'neutral', 'score': 0.015495100058615208}, {'label': 'positive', 'score': 0.0025602562818676233}]","(0.015495100058615208, 0.0025602562818676233, 0.9819446802139282)",-0.9947988959994848,-0.9819446802139282,0,0,"[{'label': 'negative', 'score': 0.8156528472900391}, {'label': 'neutral', 'score': 0.13158567249774933}, {'label': 'positive', 'score': 0.05276143550872803}]","(0.13158567249774933, 0.05276143550872803, 0.8156528472900391)",-0.8784878679362897,-0.8156528472900391,0,0,"[{'label': 'positive', 'score': 0.6206762194633484}, {'label': 'negative', 'score': 0.3162040710449219}, {'label': 'neutral', 'score': 0.06311974674463272}]","(0.06311974674463272, 0.6206762194633484, 0.3162040710449219)",0.32498511443041056,0.6206762194633484,1,0
2013-02-08,27.31023979187012,39.29389190673828,39.29389190673828,39.07442855834961,39.17938995361328,15365566.0,,0.0016189257035810855,0.004380661083575205,0.14936174413610592,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-09,27.354451497395832,39.35750579833984,39.39567311604818,39.11895751953125,39.22073872884115,14230302.666666666,,0.001616309019365067,0.0016176166560075633,0.13153138276819754,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-10,27.39866320292155,39.421119689941406,39.49745432535807,39.16348648071289,39.26208750406901,13095039.333333334,,0.0016137007802392296,0.0016150041977494238,0.07758183987613126,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-11,27.442874908447266,39.48473358154297,39.59923553466797,39.20801544189453,39.30343627929688,11959776.0,,0.0016915787030927225,0.0016124001641506537,0.03717048735054745,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-12,27.48929977416992,39.5515251159668,39.66603088378906,39.24618148803711,39.475189208984375,10475808.0,"Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)",-0.007237614647486857,0.0016901495952435772,0.019507692665179047,"[{'label': 'positive', 'score': 0.773807942867279}, {'label': 'neutral', 'score': 0.20105545222759247}, {'label': 'negative', 'score': 0.025136638432741165}]","(0.20105545222759247, 0.773807942867279, 0.025136638432741165)",0.9370753891544279,0.773807942867279,0,0,"[{'label': 'neutral', 'score': 0.7009530663490295}, {'label': 'negative', 'score': 0.2682614326477051}, {'label': 'positive', 'score': 0.03078555501997471}]","(0.7009530663490295, 0.03078555501997471, 0.2682614326477051)",-0.7941089107094729,-0.2682614326477051,1,0,"[{'label': 'negative', 'score': 0.9902374148368835}, {'label': 'neutral', 'score': 0.008958984166383743}, {'label': 'positive', 'score': 0.0008036548970267177}]","(0.008958984166383743, 0.0008036548970267177, 0.9902374148368835)",-0.9983781602567843,-0.9902374148368835,1,1
2013-02-13,27.29034996032715,39.26526641845703,39.58969497680664,39.13167953491211,39.52289962768555,16561858.0,Merck Shares Down 0.6% Premarket Following Outlook Update | Merck Sees Q1 Adj.EPS $0.76-0.78 vs $0.86 Est | Merck Reaffirms Outlook,0.0009721024284686563,-0.007263933246520156,0.06316970610874481,"[{'label': 'negative', 'score': 0.998339056968689}, {'label': 'neutral', 'score': 0.0011378605850040913}, {'label': 'positive', 'score': 0.0005230034585110843}]","(0.0011378605850040913, 0.0005230034585110843, 0.998339056968689)",-0.9989528014342893,-0.998339056968689,0,0,"[{'label': 'negative', 'score': 0.967409610748291}, {'label': 'neutral', 'score': 0.02124670520424843}, {'label': 'positive', 'score': 0.011343585327267647}]","(0.02124670520424843, 0.011343585327267647, 0.967409610748291)",-0.9768203355600753,-0.967409610748291,0,0,"[{'label': 'negative', 'score': 0.9966145157814026}, {'label': 'neutral', 'score': 0.003025794867426157}, {'label': 'positive', 'score': 0.0003597950271796435}]","(0.003025794867426157, 0.0003597950271796435, 0.9966145157814026)",-0.9992782260820987,-0.9966145157814026,0,0
2013-02-14,27.31686782836914,39.30343627929688,39.332061767578125,38.959922790527344,39.16030502319336,17116774.0,"Merck Resolves Securities Class-Action Suit Related to ENHANCE, to Record $493M Charge",0.005583820886019253,0.0009716302428865756,0.06219256734000481,"[{'label': 'neutral', 'score': 0.9917701482772827}, {'label': 'negative', 'score': 0.0077614206820726395}, {'label': 'positive', 'score': 0.0004683992301579565}]","(0.9917701482772827, 0.0004683992301579565, 0.0077614206820726395)",-0.8861702357637611,-0.0077614206820726395,0,1,"[{'label': 'positive', 'score': 0.7291780710220337}, {'label': 'negative', 'score': 0.1540706902742386}, {'label': 'neutral', 'score': 0.11675118654966354}]","(0.11675118654966354, 0.7291780710220337, 0.1540706902742386)",0.6511272995206434,0.7291780710220337,0,0,"[{'label': 'negative', 'score': 0.6442485451698303}, {'label': 'positive', 'score': 0.3192305862903595}, {'label': 'neutral', 'score': 0.03652087226510048}]","(0.03652087226510048, 0.3192305862903595, 0.6442485451698303)",-0.3373378294005118,-0.6442485451698303,1,0
2013-02-15,27.46939849853516,39.52289962768555,39.59923553466797,39.35114669799805,39.56106948852539,16326897.0,"BMO Capital Maintains Outperform on Merck & Company, Inc., Lowers PT to $47.00",0.004828587205235635,0.005568289148977058,0.0748131157013234,"[{'label': 'neutral', 'score': 0.9685880541801453}, {'label': 'positive', 'score': 0.01941066049039364}, {'label': 'negative', 'score': 0.012001260183751583}]","(0.9685880541801453, 0.01941066049039364, 0.012001260183751583)",0.23587861383912906,0.01941066049039364,1,1,"[{'label': 'negative', 'score': 0.9219542145729065}, {'label': 'positive', 'score': 0.052736587822437286}, {'label': 'neutral', 'score': 0.025309132412075996}]","(0.025309132412075996, 0.052736587822437286, 0.9219542145729065)",-0.8917880671637921,-0.9219542145729065,0,0,"[{'label': 'negative', 'score': 0.9923070073127747}, {'label': 'neutral', 'score': 0.007121487520635128}, {'label': 'positive', 'score': 0.0005714540020562708}]","(0.007121487520635128, 0.0005714540020562708, 0.9923070073127747)",-0.998848894352488,-0.9923070073127747,0,0
2013-02-16,27.602039337158203,39.7137393951416,39.77099132537842,39.43225288391113,39.59446620941162,15731371.0,,0.0048053839895872705,0.004816966969238601,0.08097771340198506,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-17,27.73468017578125,39.904579162597656,39.94274711608887,39.51335906982422,39.62786293029785,15135845.0,,0.004782402708181616,0.004793874987333407,0.08515600838603707,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-18,27.867321014404297,40.09541893005371,40.11450290679932,39.594465255737305,39.66125965118408,14540319.0,,0.004759640192037246,0.004771003350116284,0.029003841170311892,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-02-19,27.999961853027344,40.286258697509766,40.286258697509766,39.67557144165039,39.69465637207031,13944793.0,,0.01042165267577715,0.004748348918749112,0.005592956825647987,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-02-20,28.2917537689209,40.70610809326172,40.79198455810547,40.286258697509766,40.41984558105469,17607343.0,,-0.003750587347113864,0.01036772163032622,0.03965287345719524,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-21,28.18564796447754,40.55343627929688,40.6202278137207,40.33396911621094,40.55343627929688,12390504.0,,0.011058768639166624,-0.003757638435842247,0.0802970214765295,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-22,28.497344970703125,41.00190734863281,41.28816986083984,40.582061767578125,40.6297721862793,16132807.0,,-0.0034908128375771923,0.010998067566667923,0.09414800942897983,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-23,28.397870381673176,40.858777364095054,41.34542083740234,40.57570012410482,40.861960093180336,17534821.333333332,,-0.0035030412991148793,-0.003496919941357067,0.11397783490977818,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-24,28.29839579264323,40.71564737955729,41.40267181396485,40.56933848063151,41.09414800008138,18936835.666666668,,-0.0035153557354370216,-0.0035091913149934446,0.12414362819760646,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-25,28.19892120361328,40.57251739501953,41.459922790527344,40.5629768371582,41.32633590698242,20338850.0,"UPDATE: Jefferies Reiterates Hold Rating, Lowers PT on Merck & Co. on IMPROVE-IT Overhang Removal | Jefferies Maintains Hold on Merck & Company, Inc., Lowers PT to $46.00",-0.0023517649096329186,-0.003521549117297337,0.10344661142139029,"[{'label': 'positive', 'score': 0.9952024221420288}, {'label': 'neutral', 'score': 0.004488411359488964}, {'label': 'negative', 'score': 0.0003091641701757908}]","(0.004488411359488964, 0.9952024221420288, 0.0003091641701757908)",0.9993788838333443,0.9952024221420288,0,0,"[{'label': 'negative', 'score': 0.9180922508239746}, {'label': 'neutral', 'score': 0.05540258064866066}, {'label': 'positive', 'score': 0.026505155488848686}]","(0.05540258064866066, 0.026505155488848686, 0.9180922508239746)",-0.9438805245246017,-0.9180922508239746,0,0,"[{'label': 'negative', 'score': 0.9867262840270996}, {'label': 'neutral', 'score': 0.011831649579107761}, {'label': 'positive', 'score': 0.0014420952647924423}]","(0.011831649579107761, 0.0014420952647924423, 0.9867262840270996)",-0.9970812762379103,-0.9867262840270996,0,0
2013-02-26,28.132593154907227,40.47710037231445,40.83969497680664,40.171756744384766,40.79198455810547,14570449.0,,0.01296552795262274,-0.002354534652102266,0.10125382753818223,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-02-27,28.497344970703125,41.00190734863281,41.17366409301758,40.33396911621094,40.33396911621094,13537121.0,Still No Herbalife in 13F ETFs,-0.005585294337652362,0.012882195025750161,0.11459343206552271,"[{'label': 'neutral', 'score': 0.9998549222946167}, {'label': 'negative', 'score': 0.00010017494787462056}, {'label': 'positive', 'score': 4.4959746446693316e-05}]","(0.9998549222946167, 4.4959746446693316e-05, 0.00010017494787462056)",-0.3804410908510011,-0.00010017494787462056,1,1,"[{'label': 'neutral', 'score': 0.9227360486984253}, {'label': 'positive', 'score': 0.03932319954037666}, {'label': 'negative', 'score': 0.037940818816423416}]","(0.9227360486984253, 0.03932319954037666, 0.037940818816423416)",0.017891649351830307,0.03932319954037666,1,1,"[{'label': 'neutral', 'score': 0.9978602528572083}, {'label': 'negative', 'score': 0.0013011106057092547}, {'label': 'positive', 'score': 0.0008385769324377179}]","(0.9978602528572083, 0.0008385769324377179, 0.0013011106057092547)",-0.21616879335199732,-0.0013011106057092547,1,1
2013-02-28,28.33818244934082,40.77289962768555,41.23091506958008,40.77289962768555,41.040077209472656,14893442.0,"If The Market Falls, Try These Low Beta ETFs",-0.002340206940795749,-0.005600950417160657,0.1195066255675557,"[{'label': 'neutral', 'score': 0.9992272853851318}, {'label': 'negative', 'score': 0.0006867532501928508}, {'label': 'positive', 'score': 8.603909373050556e-05}]","(0.9992272853851318, 8.603909373050556e-05, 0.0006867532501928508)",-0.7773293319814807,-0.0006867532501928508,0,1,"[{'label': 'neutral', 'score': 0.8083949089050293}, {'label': 'negative', 'score': 0.15263105928897858}, {'label': 'positive', 'score': 0.038974061608314514}]","(0.8083949089050293, 0.038974061608314514, 0.15263105928897858)",-0.5931835075618261,-0.15263105928897858,0,1,"[{'label': 'neutral', 'score': 0.5656630992889404}, {'label': 'negative', 'score': 0.4317679703235626}, {'label': 'positive', 'score': 0.0025689518079161644}]","(0.5656630992889404, 0.0025689518079161644, 0.4317679703235626)",-0.9881706957110199,-0.4317679703235626,0,1
2013-03-01,28.27185821533203,40.67748260498047,40.71564865112305,40.39122009277344,40.39122009277344,15527482.0,,0.005551628295701973,-0.0023429495046720958,0.11788365578122746,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-02,28.42881838480632,40.9033088684082,40.93193435668945,40.52798843383789,40.57887903849284,15298284.666666666,,0.0055209778786906895,0.005536274805703332,0.11927508377384859,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-03,28.5857785542806,41.12913513183594,41.14822006225586,40.66475677490234,40.76653798421224,15069087.333333334,,0.005490664043964638,0.005505793144405171,0.11575899221731642,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-04,28.742738723754883,41.35496139526367,41.364505767822266,40.8015251159668,40.95419692993164,14839890.0,"An HIV Cure Is Great News For These Drug Manufacturers | Cardiome Ends Line of Credit Merck, to Buy Added $3M of Vernakalant IV Inventory | UPDATE: Bank of America Upgrades Merck to Buy; Pullback Creates Meaningful Upside Potential | Bank of America Upgrades Merck & Company, Inc. to Buy, Maintains $47.00 PO",-0.0020765698224925757,0.005475645298319832,0.08441328005766562,"[{'label': 'positive', 'score': 0.9994662404060364}, {'label': 'neutral', 'score': 0.0003081374743487686}, {'label': 'negative', 'score': 0.0002255882864119485}]","(0.0003081374743487686, 0.9994662404060364, 0.0002255882864119485)",0.9995486843446405,0.9994662404060364,0,0,"[{'label': 'positive', 'score': 0.9331374764442444}, {'label': 'negative', 'score': 0.03755086660385132}, {'label': 'neutral', 'score': 0.02931171841919422}]","(0.02931171841919422, 0.9331374764442444, 0.03755086660385132)",0.9226304366941579,0.9331374764442444,0,0,"[{'label': 'positive', 'score': 0.998600423336029}, {'label': 'neutral', 'score': 0.0011072641937062144}, {'label': 'negative', 'score': 0.000292361801257357}]","(0.0011072641937062144, 0.998600423336029, 0.000292361801257357)",0.9994146282652003,0.998600423336029,0,0
2013-03-05,28.68304252624512,41.26908493041992,41.65076446533203,41.125953674316406,41.60305404663086,15843769.0,,0.009942188538590998,-0.0020787288830842977,0.06711299176000096,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-06,28.96821594238281,41.67938995361328,41.73664093017578,41.08778762817383,41.31679534912109,19301121.0,"3 Sector ETFs Outpacing Larger Rivals | From Merck Presentation for Cowen Healthcare Conference: Sees V503 for Cancer Endpoint Driven Trial Filing This Year, V212 Filing for HCT, V419 Pediatric Combo Vaccine Filing Next Year | Hedging The Dow At Its All-Time High",-0.00938641600102232,0.00989309014424806,0.06861532901222524,"[{'label': 'positive', 'score': 0.9921531081199646}, {'label': 'neutral', 'score': 0.006660759449005127}, {'label': 'negative', 'score': 0.0011861745733767748}]","(0.006660759449005127, 0.9921531081199646, 0.0011861745733767748)",0.9976117433508507,0.9921531081199646,0,0,"[{'label': 'positive', 'score': 0.8781346678733826}, {'label': 'neutral', 'score': 0.10655233263969421}, {'label': 'negative', 'score': 0.01531300414353609}]","(0.10655233263969421, 0.8781346678733826, 0.01531300414353609)",0.9657215422388025,0.8781346678733826,0,0,"[{'label': 'negative', 'score': 0.9204737544059753}, {'label': 'neutral', 'score': 0.058508120477199554}, {'label': 'positive', 'score': 0.021018072962760925}]","(0.058508120477199554, 0.021018072962760925, 0.9204737544059753)",-0.9553515551558173,-0.9204737544059753,0,0
2013-03-07,28.69631004333496,41.28816986083984,41.91793823242188,41.11641311645508,41.8129768371582,14392813.0,"Merck Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., As President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire ",-0.00693328169235548,-0.00943074602178073,0.1213878164577938,"[{'label': 'neutral', 'score': 0.9998544454574585}, {'label': 'negative', 'score': 7.661485869903117e-05}, {'label': 'positive', 'score': 6.887289782753214e-05}]","(0.9998544454574585, 6.887289782753214e-05, 7.661485869903117e-05)",-0.05321383088401323,-7.661485869903117e-05,1,1,"[{'label': 'neutral', 'score': 0.929961621761322}, {'label': 'negative', 'score': 0.043166764080524445}, {'label': 'positive', 'score': 0.026871580630540848}]","(0.929961621761322, 0.026871580630540848, 0.043166764080524445)",-0.23266088764957826,-0.043166764080524445,1,1,"[{'label': 'neutral', 'score': 0.9991576671600342}, {'label': 'positive', 'score': 0.0006050062365829945}, {'label': 'negative', 'score': 0.00023740141477901489}]","(0.9991576671600342, 0.0006050062365829945, 0.00023740141477901489)",0.4363740300905791,0.0006050062365829945,1,1
2013-03-08,28.497344970703125,41.00190734863281,41.50763320922852,40.95419692993164,41.41221237182617,30678418.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield,0.0053525776167946465,-0.0069574285659784645,0.12984194918457387,"[{'label': 'neutral', 'score': 0.9998716115951538}, {'label': 'positive', 'score': 6.575879524461925e-05}, {'label': 'negative', 'score': 6.253558240132406e-05}]","(0.9998716115951538, 6.575879524461925e-05, 6.253558240132406e-05)",0.02512357051366939,6.575879524461925e-05,1,1,"[{'label': 'neutral', 'score': 0.6588398218154907}, {'label': 'positive', 'score': 0.3299674689769745}, {'label': 'negative', 'score': 0.011192694306373596}]","(0.6588398218154907, 0.3299674689769745, 0.011192694306373596)",0.9343845178249749,0.3299674689769745,0,1,"[{'label': 'neutral', 'score': 0.9958236217498779}, {'label': 'positive', 'score': 0.003977292682975531}, {'label': 'negative', 'score': 0.0001990447926800698}]","(0.9958236217498779, 0.003977292682975531, 0.0001990447926800698)",0.9046797372864013,0.003977292682975531,0,1
2013-03-09,28.64988199869792,41.22137324015299,41.56170399983724,40.93829472859701,41.269082387288414,33949855.0,,0.005324080065008831,0.005338303486162391,0.12943880111424183,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-10,28.802419026692707,41.44083913167318,41.61577479044596,40.92239252726237,41.12595240275065,37221292.0,,0.005295884352699857,0.005309957255873255,0.13480751598193322,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-11,28.9549560546875,41.66030502319336,41.66984558105469,40.90649032592773,40.98282241821289,40492729.0,,0.03160791425766086,0.005281910471488562,0.11823432614418879,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-03-12,29.870153427124023,42.97710037231445,43.33969497680664,42.82442855834961,43.33969497680664,58695860.0,"Unusual Options Alert: Merck & Co. Continues To Do Extremely Heavy Volume | Short Interest Swings in Biotech Stocks (AMGN, CELG, PCYC) | Lawyer Tells Jury in Merck Case Over Fosamax Co. Hid Product's Bone-Weakening Risks | Merck Issues Update on IMPROVE-IT Trial, Says DSMB Recommend Study to Continue",-0.009991133647766782,0.031118666823523575,0.2216618991603463,"[{'label': 'negative', 'score': 0.9942546486854553}, {'label': 'neutral', 'score': 0.002930888207629323}, {'label': 'positive', 'score': 0.0028145245742052794}]","(0.002930888207629323, 0.0028145245742052794, 0.9942546486854553)",-0.9943544045895955,-0.9942546486854553,0,0,"[{'label': 'positive', 'score': 0.683758556842804}, {'label': 'negative', 'score': 0.2345758080482483}, {'label': 'neutral', 'score': 0.08166566491127014}]","(0.08166566491127014, 0.683758556842804, 0.2345758080482483)",0.48912767066910867,0.683758556842804,1,0,"[{'label': 'negative', 'score': 0.9965270161628723}, {'label': 'neutral', 'score': 0.0023910615127533674}, {'label': 'positive', 'score': 0.001081859110854566}]","(0.0023910615127533674, 0.001081859110854566, 0.9965270161628723)",-0.9978310956574886,-0.9965270161628723,0,0
2013-03-13,29.856767654418945,42.54771041870117,42.681297302246094,42.4427490234375,42.5,18781418.0,"The Top 20 African-American CEOs in Business Today | Bank of America Reiterates Buy Rating, $47 PT on Merck & Co. Following IMPROVE-IT Trial Review",-0.0071764996265338745,-0.010041379982258736,0.23544122293627398,"[{'label': 'neutral', 'score': 0.9966384172439575}, {'label': 'positive', 'score': 0.0032295610290020704}, {'label': 'negative', 'score': 0.00013203614798840135}]","(0.9966384172439575, 0.0032295610290020704, 0.00013203614798840135)",0.9214443961982328,0.0032295610290020704,0,1,"[{'label': 'neutral', 'score': 0.7587543725967407}, {'label': 'positive', 'score': 0.2078867107629776}, {'label': 'negative', 'score': 0.033358898013830185}]","(0.7587543725967407, 0.2078867107629776, 0.033358898013830185)",0.7234445162921684,0.2078867107629776,0,1,"[{'label': 'positive', 'score': 0.9986612796783447}, {'label': 'neutral', 'score': 0.0009739200468175113}, {'label': 'negative', 'score': 0.0003648316487669945}]","(0.0009739200468175113, 0.9986612796783447, 0.0003648316487669945)",0.9992696253989151,0.9986612796783447,0,0
2013-03-14,29.642498016357425,42.24236679077149,42.700382232666016,41.60305404663086,42.66221237182617,27136283.0,Embrace These New ETFs,-0.004065982979492894,-0.007202374568639127,0.25810657340883464,"[{'label': 'neutral', 'score': 0.999731719493866}, {'label': 'positive', 'score': 0.00019847709336318076}, {'label': 'negative', 'score': 6.987743108766153e-05}]","(0.999731719493866, 0.00019847709336318076, 6.987743108766153e-05)",0.47921555464244225,0.00019847709336318076,1,1,"[{'label': 'neutral', 'score': 0.8291161060333252}, {'label': 'positive', 'score': 0.15577593445777893}, {'label': 'negative', 'score': 0.015107975341379642}]","(0.8291161060333252, 0.15577593445777893, 0.015107975341379642)",0.82317849165394,0.15577593445777893,0,1,"[{'label': 'neutral', 'score': 0.996625542640686}, {'label': 'positive', 'score': 0.003253850620239973}, {'label': 'negative', 'score': 0.0001205507360282354}]","(0.996625542640686, 0.003253850620239973, 0.0001205507360282354)",0.9285498532625331,0.003253850620239973,0,1
2013-03-15,29.5219669342041,42.07061004638672,42.07061004638672,41.78435134887695,41.82251739501953,25499831.0,Reuters Reporting Merck Saying FDA Extended Review of Sugammadex,-0.0034777287595834337,-0.004074271563411008,0.2656403990232727,"[{'label': 'neutral', 'score': 0.9723232388496399}, {'label': 'positive', 'score': 0.025871608406305313}, {'label': 'negative', 'score': 0.0018051658989861608}]","(0.9723232388496399, 0.025871608406305313, 0.0018051658989861608)",0.8695537363513468,0.025871608406305313,0,1,"[{'label': 'neutral', 'score': 0.4789913594722748}, {'label': 'negative', 'score': 0.45962345600128174}, {'label': 'positive', 'score': 0.061385225504636765}]","(0.4789913594722748, 0.061385225504636765, 0.45962345600128174)",-0.7643600666030765,-0.45962345600128174,0,1,"[{'label': 'neutral', 'score': 0.9637117981910706}, {'label': 'positive', 'score': 0.03598358854651451}, {'label': 'negative', 'score': 0.0003046574129257351}]","(0.9637117981910706, 0.03598358854651451, 0.0003046574129257351)",0.9832090306450053,0.03598358854651451,0,1
2013-03-16,29.41929880777995,41.92429987589518,42.0229008992513,41.71437708536784,41.8066151936849,21233004.0,,-0.003489865565427231,-0.003483790115494205,0.26820765573193844,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-17,29.316630681355797,41.77798970540365,41.97519175211588,41.644402821858726,41.79071299235026,16966177.0,,-0.003502087379580516,-0.0034959693513253614,0.045946254305931314,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-18,29.21396255493164,41.63167953491211,41.92748260498047,41.57442855834961,41.774810791015625,12699350.0,,0.001604435609307559,-0.0035082340425507605,0.025597221628247013,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-19,29.260826110839844,41.6984748840332,41.832061767578125,41.60305404663086,41.6984748840332,16248297.0,,0.009610918666673376,0.0016031498775607273,0.0374385605993671,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-03-20,29.54205894470215,42.09923553466797,42.261451721191406,41.8702278137207,41.98473358154297,15693066.0,,-0.007479570158268411,0.009565027590500924,0.0907188936269235,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-21,29.32110023498535,41.78435134887695,42.15649032592773,41.7557258605957,42.01335906982422,12476021.0,,0.002511978572727085,-0.007507682409236629,0.10431332511877459,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-22,29.39474105834961,41.88931274414063,42.08969497680664,41.79389190673828,41.85114669799805,10463232.0,,-0.0015945374411683625,0.0025088288281766066,0.1027593280851176,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-23,29.34787432352702,41.82251866658529,42.054707845052086,41.701653798421226,41.8797721862793,11557728.333333334,,-0.0015970840514851483,-0.0015958100690090507,0.09884432967447775,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-24,29.301007588704422,41.755724589029946,42.01972071329752,41.60941569010416,41.90839767456055,12652224.666666666,,-0.001599638809115153,-0.001598360749729601,0.10004534960225189,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-25,29.25414085388184,41.68893051147461,41.98473358154297,41.51717758178711,41.9370231628418,13746721.0,"Bank of America Reiterates Buy Rating, $47 PT on Merck & Co. Ahead of Potential Approvals",0.01602195652963614,-0.0016009195973229037,0.05676083395590932,"[{'label': 'positive', 'score': 0.7233679890632629}, {'label': 'neutral', 'score': 0.2758835256099701}, {'label': 'negative', 'score': 0.000748473743442446}]","(0.2758835256099701, 0.7233679890632629, 0.000748473743442446)",0.9979327255161654,0.7233679890632629,1,1,"[{'label': 'neutral', 'score': 0.9068142175674438}, {'label': 'positive', 'score': 0.07502572983503342}, {'label': 'negative', 'score': 0.018160061910748482}]","(0.9068142175674438, 0.07502572983503342, 0.018160061910748482)",0.6102396820259778,0.07502572983503342,1,0,"[{'label': 'positive', 'score': 0.998794674873352}, {'label': 'neutral', 'score': 0.0007216032245196402}, {'label': 'negative', 'score': 0.0004836914304178208}]","(0.0007216032245196402, 0.998794674873352, 0.0004836914304178208)",0.9990319185389613,0.998794674873352,1,1
2013-03-26,29.722848892211918,42.35686874389648,42.36641311645508,41.88931274414063,41.9370231628418,12694110.0,The Supreme Court is About to Stick it to Big Pharma | Risk On Rally? These ETFs Say No | EMA Investigating Pancreatic Risks with GLP-1 Diabetes Drugs,-0.006532926846511492,0.015894959680297065,0.12026156247346333,"[{'label': 'neutral', 'score': 0.9979752898216248}, {'label': 'negative', 'score': 0.0017037136713042855}, {'label': 'positive', 'score': 0.0003209858841728419}]","(0.9979752898216248, 0.0003209858841728419, 0.0017037136713042855)",-0.6829298615643737,-0.0017037136713042855,0,1,"[{'label': 'neutral', 'score': 0.9193916916847229}, {'label': 'negative', 'score': 0.04653546214103699}, {'label': 'positive', 'score': 0.0340728685259819}]","(0.9193916916847229, 0.0340728685259819, 0.04653546214103699)",-0.1546067696964997,-0.04653546214103699,1,1,"[{'label': 'neutral', 'score': 0.8972406387329102}, {'label': 'negative', 'score': 0.07982540130615234}, {'label': 'positive', 'score': 0.0229339636862278}]","(0.8972406387329102, 0.0229339636862278, 0.07982540130615234)",-0.5536374969244232,-0.07982540130615234,0,1
2013-03-27,29.52867317199707,42.08015441894531,42.22328186035156,41.89885330200195,42.10877990722656,11497503.0,Merck Announces FDA Acceptance of Biologics License App for Investigational Grass Pollen Allergy Immunotherapy Tablet,0.0022675064771653856,-0.006554359810757529,0.13728038957461294,"[{'label': 'neutral', 'score': 0.9992967844009399}, {'label': 'positive', 'score': 0.0006370762130245566}, {'label': 'negative', 'score': 6.613002915401012e-05}]","(0.9992967844009399, 0.0006370762130245566, 6.613002915401012e-05)",0.8119185377276058,0.0006370762130245566,0,1,"[{'label': 'positive', 'score': 0.8131512999534607}, {'label': 'neutral', 'score': 0.17888687551021576}, {'label': 'negative', 'score': 0.00796174630522728}]","(0.17888687551021576, 0.8131512999534607, 0.00796174630522728)",0.9806074295335968,0.8131512999534607,0,0,"[{'label': 'positive', 'score': 0.9919112324714661}, {'label': 'neutral', 'score': 0.007862689904868603}, {'label': 'negative', 'score': 0.00022612346219830215}]","(0.007862689904868603, 0.9919112324714661, 0.00022612346219830215)",0.9995441690390027,0.9919112324714661,0,0
2013-03-28,29.59562873840332,42.17557144165039,42.28053283691406,41.946563720703125,42.03244400024414,17440502.0,,0.0008484251144144941,0.0022649395639492364,0.13556773703286262,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-29,29.620739936828613,42.21135425567627,42.29484653472901,41.9012393951416,42.02051639556885,15674674.25,,0.0008477058994397721,0.000848065405270271,0.13292597863449515,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-30,29.645851135253903,42.24713706970215,42.309160232543945,41.85591506958008,42.00858879089356,13908846.5,,0.0008469879027978163,0.000847346799720164,0.12964562840520608,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-03-31,29.6709623336792,42.28291988372803,42.32347393035889,41.81059074401856,41.99666118621826,12143018.75,,0.0008462711213956752,0.0008466294109553916,0.055918452630402044,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-01,29.69607353210449,42.31870269775391,42.33778762817383,41.76526641845703,41.98473358154297,10377191.0,,0.012626836713151582,0.000845913235888107,0.010066460487771857,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-04-02,30.071033477783203,42.85305404663086,42.93893051147461,42.38549423217773,42.47137451171875,13400252.0,,0.010020054886777438,0.012547782980626353,0.08306739987158894,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-03,30.37234306335449,43.28244400024414,44.04580307006836,42.93893051147461,42.93893051147461,27114066.0,,-0.0008818785935384898,0.009970186979575964,0.09168217869541156,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-04,30.345558166503903,43.2442741394043,43.77862548828125,42.9484748840332,43.31106948852539,14637835.0,2 New Dividend ETFs to Consider,-0.004192400169827228,-0.0008822676772319084,0.09728264146842151,"[{'label': 'neutral', 'score': 0.9998577833175659}, {'label': 'positive', 'score': 7.130105223041028e-05}, {'label': 'negative', 'score': 7.088173879310489e-05}]","(0.9998577833175659, 7.130105223041028e-05, 7.088173879310489e-05)",0.0029491152500729987,7.130105223041028e-05,1,1,"[{'label': 'neutral', 'score': 0.9180495738983154}, {'label': 'positive', 'score': 0.06874743103981018}, {'label': 'negative', 'score': 0.013203073292970657}]","(0.9180495738983154, 0.06874743103981018, 0.013203073292970657)",0.6777793278890335,0.06874743103981018,0,1,"[{'label': 'neutral', 'score': 0.9993700385093689}, {'label': 'positive', 'score': 0.0005297760362736881}, {'label': 'negative', 'score': 0.00010024185758084059}]","(0.9993700385093689, 0.0005297760362736881, 0.00010024185758084059)",0.6817809190543833,0.0005297760362736881,0,1
2013-04-05,30.218339920043945,43.0629768371582,43.15839767456055,42.83396911621094,42.97710037231445,13206372.0,,0.0025851217661506,-0.004201212919091467,0.11479174237644309,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-06,30.29645538330078,43.17429987589518,43.23791376749674,42.85623423258463,42.99300384521485,12351204.0,,0.002578456143052131,0.002581786086399796,0.11275802595593216,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-07,30.374570846557617,43.28562291463216,43.31742986043295,42.878499348958336,43.008907318115234,11496036.0,,0.0025718248055834852,0.002575137628217305,0.08360730712650029,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-08,30.452686309814453,43.39694595336914,43.39694595336914,42.90076446533203,43.024810791015625,10640868.0,"Golden Crosses Over The Past Trading Week (50 SMA Cross Above 200 SMA) CMG, LO, MRK, PRGO, SO, WMT, YUM | Cheap Does not Always Mean BUY",0.0006596198799797718,0.0025685233235123372,0.04823268407347585,"[{'label': 'neutral', 'score': 0.9972735047340393}, {'label': 'positive', 'score': 0.0026010978035628796}, {'label': 'negative', 'score': 0.00012547247752081603}]","(0.9972735047340393, 0.0026010978035628796, 0.00012547247752081603)",0.9079631444739829,0.0026010978035628796,0,1,"[{'label': 'neutral', 'score': 0.898743748664856}, {'label': 'positive', 'score': 0.08121272921562195}, {'label': 'negative', 'score': 0.02004352957010269}]","(0.898743748664856, 0.08121272921562195, 0.02004352957010269)",0.6041029006904514,0.08121272921562195,0,1,"[{'label': 'positive', 'score': 0.9697020053863525}, {'label': 'neutral', 'score': 0.029845943674445152}, {'label': 'negative', 'score': 0.0004520118236541748}]","(0.029845943674445152, 0.9697020053863525, 0.0004520118236541748)",0.9990681648158215,0.9697020053863525,0,0
2013-04-09,30.47278594970703,43.42557144165039,43.83587646484375,43.26335906982422,43.63549423217773,11108066.0,Merck Receives Positive Mad Money/Jim Cramer Mention -CNBC,0.029224369151368623,0.0006594024264059361,0.046606419553240165,"[{'label': 'positive', 'score': 0.9994242191314697}, {'label': 'neutral', 'score': 0.0003251992166042328}, {'label': 'negative', 'score': 0.00025063485372811556}]","(0.0003251992166042328, 0.9994242191314697, 0.00025063485372811556)",0.9994985672536846,0.9994242191314697,1,1,"[{'label': 'neutral', 'score': 0.7641082406044006}, {'label': 'positive', 'score': 0.2149869054555893}, {'label': 'negative', 'score': 0.02090487629175186}]","(0.7641082406044006, 0.2149869054555893, 0.02090487629175186)",0.8227587571139494,0.2149869054555893,1,0,"[{'label': 'positive', 'score': 0.9842365980148315}, {'label': 'neutral', 'score': 0.015404963865876198}, {'label': 'negative', 'score': 0.00035841341014020145}]","(0.015404963865876198, 0.9842365980148315, 0.00035841341014020145)",0.9992719576963497,0.9842365980148315,1,1
2013-04-10,31.36333274841309,44.69465637207031,44.81870269775391,43.683204650878906,43.8072509765625,19634385.0,"Short Sellers Move Out of Amgen, Celgene, Pharmacyclics | UPDATE: Jefferies Raises PT on Merck & Co. on Positive Outlook | Merck Announces FDA Acceptance of NDA for NOXAFIL Investigational Tablet Formulation | Jefferies Maintains Hold on Merck & Company, Inc., Raises PT to $48.00",0.007899245128808794,0.028805478905892985,0.19007371459137987,"[{'label': 'positive', 'score': 0.9994686245918274}, {'label': 'neutral', 'score': 0.0002660429454408586}, {'label': 'negative', 'score': 0.00026529651950113475}]","(0.0002660429454408586, 0.9994686245918274, 0.00026529651950113475)",0.9994692657438167,0.9994686245918274,0,0,"[{'label': 'positive', 'score': 0.936318039894104}, {'label': 'neutral', 'score': 0.035500477999448776}, {'label': 'negative', 'score': 0.028181521221995354}]","(0.035500477999448776, 0.936318039894104, 0.028181521221995354)",0.9415623970022666,0.936318039894104,0,0,"[{'label': 'positive', 'score': 0.9958354234695435}, {'label': 'neutral', 'score': 0.003646136960014701}, {'label': 'negative', 'score': 0.000518482003826648}]","(0.003646136960014701, 0.9958354234695435, 0.000518482003826648)",0.9989592412877023,0.9958354234695435,0,0
2013-04-11,31.611082077026367,45.04771041870117,45.33396911621094,44.54198455810547,44.54198455810547,18379719.0,"ETF Showdown: A Pharma Fight | Court Says Merck Victory Upholding Vytorin Patents Will Stand, Says Mylan Can't Sell Copies of Vytorin, Zetia Before Apr. 2017",-0.0021182172526737477,0.007868209423963561,0.1852074323682452,"[{'label': 'positive', 'score': 0.5553862452507019}, {'label': 'neutral', 'score': 0.43858250975608826}, {'label': 'negative', 'score': 0.006031325552612543}]","(0.43858250975608826, 0.5553862452507019, 0.006031325552612543)",0.9785139409014844,0.5553862452507019,0,0,"[{'label': 'neutral', 'score': 0.571279764175415}, {'label': 'negative', 'score': 0.3674645721912384}, {'label': 'positive', 'score': 0.06125563755631447}]","(0.571279764175415, 0.06125563755631447, 0.3674645721912384)",-0.714239561543487,-0.3674645721912384,0,1,"[{'label': 'positive', 'score': 0.7680675983428955}, {'label': 'neutral', 'score': 0.20618140697479248}, {'label': 'negative', 'score': 0.02575097046792507}]","(0.20618140697479248, 0.7680675983428955, 0.02575097046792507)",0.9351212695704478,0.7680675983428955,0,0
2013-04-12,31.54412078857422,44.95228958129883,44.97137451171875,44.51335906982422,44.53244400024414,10547491.0,"Merck Sees Odanacatib US, EU Filing in 2014 | Benzinga Market Primer: Friday, April 12",-0.004599156272110769,-0.002120463847916965,0.19727066441545368,"[{'label': 'neutral', 'score': 0.9998695850372314}, {'label': 'negative', 'score': 8.105178130790591e-05}, {'label': 'positive', 'score': 4.933957097819075e-05}]","(0.9998695850372314, 4.933957097819075e-05, 8.105178130790591e-05)",-0.24320792578432798,-8.105178130790591e-05,1,1,"[{'label': 'neutral', 'score': 0.9284651875495911}, {'label': 'positive', 'score': 0.05225756764411926}, {'label': 'negative', 'score': 0.019277172163128853}]","(0.9284651875495911, 0.05225756764411926, 0.019277172163128853)",0.4610402661679736,0.05225756764411926,1,1,"[{'label': 'neutral', 'score': 0.999519944190979}, {'label': 'positive', 'score': 0.0003562525089364499}, {'label': 'negative', 'score': 0.00012375187361612916}]","(0.999519944190979, 0.0003562525089364499, 0.00012375187361612916)",0.48437190111457556,0.0003562525089364499,1,1
2013-04-13,31.3990421295166,44.74554697672526,45.08905919392904,44.45292663574219,44.60241826375326,12392984.0,,-0.004620406242460322,-0.004609764931069119,0.21453186255414292,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-14,31.253963470458984,44.538804372151695,45.20674387613932,44.39249420166016,44.67239252726237,14238477.0,,-0.004641853491308308,-0.0046311133127894324,0.2259978690787444,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-15,31.108884811401367,44.332061767578125,45.32442855834961,44.332061767578125,44.74236679077149,16083970.0,,0.010761885159289117,-0.004652660348760095,0.08602997979137132,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-16,31.443681716918945,44.80915832519531,44.89503860473633,44.3702278137207,44.50381851196289,10674614.0,,-0.004258903028761365,0.010704388222307328,0.10583258458292139,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-17,31.30976104736328,44.61832046508789,44.761451721191406,44.28435134887695,44.58015441894531,12342506.0,,-0.004277118863242401,-0.00426799798848565,0.10825620414590335,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-18,31.17584991455078,44.42748260498047,44.828243255615234,44.360687255859375,44.71374130249024,11813685.0,,0.019974158533823075,-0.004286291901588554,0.1076920770694321,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-04-19,31.798559188842773,45.314884185791016,45.314884185791016,44.52289962768555,44.71374130249024,13315154.0,"UPDATE: BMO Capital Markets Raises PT on Merck & Co. on 1Q13 Preview, Long-Term Outlook | BMO Capital Maintains Outperform on Merck & Company, Inc., Raises PT to $51.00",0.003018176996849489,0.01977729220448734,0.1782399235255173,"[{'label': 'positive', 'score': 0.9994925260543823}, {'label': 'neutral', 'score': 0.0002803798415698111}, {'label': 'negative', 'score': 0.00022709228505846113}]","(0.0002803798415698111, 0.9994925260543823, 0.00022709228505846113)",0.9995456880491439,0.9994925260543823,0,0,"[{'label': 'positive', 'score': 0.9379203915596008}, {'label': 'neutral', 'score': 0.04035921394824982}, {'label': 'negative', 'score': 0.02172037586569786}]","(0.04035921394824982, 0.9379203915596008, 0.02172037586569786)",0.9547322777376929,0.9379203915596008,0,0,"[{'label': 'positive', 'score': 0.9989618062973022}, {'label': 'neutral', 'score': 0.0006891225348226726}, {'label': 'negative', 'score': 0.0003490772796794772}]","(0.0006891225348226726, 0.9989618062973022, 0.0003490772796794772)",0.9993013639990991,0.9989618062973022,0,0
2013-04-20,31.89453379313151,45.45165252685547,45.46755599975586,44.68829472859701,44.90140024820963,13860149.0,,0.0030090950154923954,0.003013631444548321,0.16401224292456743,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-21,31.99050839742025,45.58842086791992,45.6202278137207,44.85368982950846,45.08905919392904,14405144.0,,0.0030000675272500066,0.0030045767507423534,0.15602044654542382,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-22,32.086483001708984,45.725189208984375,45.77289962768555,45.01908493041992,45.27671813964844,14950139.0,Merck & Co. Currently up $0.33 to $47.82; $0.17 Away from 52-Week and Multi-Year High,0.014816398066371693,0.0029955763050702956,0.1412072103049677,"[{'label': 'positive', 'score': 0.9996873140335083}, {'label': 'negative', 'score': 0.00017647184722591192}, {'label': 'neutral', 'score': 0.00013620192476082593}]","(0.00013620192476082593, 0.9996873140335083, 0.00017647184722591192)",0.9996470082230842,0.9996873140335083,0,0,"[{'label': 'positive', 'score': 0.9244312644004822}, {'label': 'negative', 'score': 0.05168243870139122}, {'label': 'neutral', 'score': 0.023886311799287796}]","(0.023886311799287796, 0.9244312644004822, 0.05168243870139122)",0.8941056999053372,0.9244312644004822,0,0,"[{'label': 'positive', 'score': 0.9986400008201599}, {'label': 'neutral', 'score': 0.0010027947137132287}, {'label': 'negative', 'score': 0.00035720638697966933}]","(0.0010027947137132287, 0.9986400008201599, 0.00035720638697966933)",0.9992848700989299,0.9986400008201599,0,0
2013-04-23,32.561885833740234,46.40267181396485,46.46946716308594,45.73473358154297,45.75381851196289,18500868.0,,-0.013983102192979506,0.014707707526873807,0.12702384897251556,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-24,32.10655975341797,45.75381851196289,46.55534362792969,45.67748260498047,46.44084167480469,16292418.0,,-0.012513080401521116,-0.014081786791036026,0.16326673384546822,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-25,31.70482444763184,45.181297302246094,45.8015251159668,45.114505767822266,45.75381851196289,16702081.0,"Stocks to Watch for April 25, 2013",0.010982095078303743,-0.012592028270812738,0.19182143912303976,"[{'label': 'neutral', 'score': 0.9998088479042053}, {'label': 'negative', 'score': 0.0001306211925111711}, {'label': 'positive', 'score': 6.0577363910852e-05}]","(0.9998088479042053, 6.0577363910852e-05, 0.0001306211925111711)",-0.3663407815993905,-0.0001306211925111711,1,1,"[{'label': 'neutral', 'score': 0.9297212362289429}, {'label': 'negative', 'score': 0.04302704334259033}, {'label': 'positive', 'score': 0.02725166082382202}]","(0.9297212362289429, 0.02725166082382202, 0.04302704334259033)",-0.22446888720961494,-0.04302704334259033,1,1,"[{'label': 'neutral', 'score': 0.9994664788246155}, {'label': 'positive', 'score': 0.00038994403439573944}, {'label': 'negative', 'score': 0.0001436220481991768}]","(0.9994664788246155, 0.00038994403439573944, 0.0001436220481991768)",0.4616522568275212,0.00038994403439573944,1,1
2013-04-26,32.053001403808594,45.67748260498047,45.86832046508789,44.95228958129883,45.10496139526367,11110477.0,"Weekly Preview: Focus Shifts from Earnings to Economy | Short Sellers Move into Celgene, Regeneron",-0.0003481687692363454,0.010922229771027518,0.21010187194504146,"[{'label': 'neutral', 'score': 0.5773626565933228}, {'label': 'positive', 'score': 0.4220040738582611}, {'label': 'negative', 'score': 0.0006333010387606919}]","(0.5773626565933228, 0.4220040738582611, 0.0006333010387606919)",0.9970030996955014,0.4220040738582611,0,1,"[{'label': 'neutral', 'score': 0.8244242072105408}, {'label': 'positive', 'score': 0.12515640258789062}, {'label': 'negative', 'score': 0.05041937902569771}]","(0.8244242072105408, 0.12515640258789062, 0.05041937902569771)",0.42566818085808705,0.12515640258789062,1,1,"[{'label': 'neutral', 'score': 0.9977405071258545}, {'label': 'positive', 'score': 0.0014064109418541193}, {'label': 'negative', 'score': 0.0008530965424142778}]","(0.9977405071258545, 0.0014064109418541193, 0.0008530965424142778)",0.2448827469226102,0.0014064109418541193,1,1
2013-04-27,32.04184341430664,45.66157913208008,45.88422393798828,45.14631017049154,45.29898198445638,11380965.666666666,,-0.0003482900329484543,-0.00034822939405450184,0.20882692309569237,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-04-28,32.03068542480469,45.64567565917969,45.90012741088867,45.34033075968424,45.493002573649086,11651454.333333334,Earnings Expectations for the Week of April 29 | A Look Ahead: This Week's ETFs to Watch,-0.0003484113811598781,-0.0003483507000088735,0.16310722371318023,"[{'label': 'neutral', 'score': 0.9996427297592163}, {'label': 'positive', 'score': 0.0002389498258708045}, {'label': 'negative', 'score': 0.00011837022611871362}]","(0.9996427297592163, 0.0002389498258708045, 0.00011837022611871362)",0.33745545227791485,0.0002389498258708045,1,1,"[{'label': 'neutral', 'score': 0.9279070496559143}, {'label': 'positive', 'score': 0.04192649573087692}, {'label': 'negative', 'score': 0.030166517943143845}]","(0.9279070496559143, 0.04192649573087692, 0.030166517943143845)",0.16312229421990262,0.04192649573087692,1,1,"[{'label': 'neutral', 'score': 0.9994800686836243}, {'label': 'positive', 'score': 0.0003503905318211764}, {'label': 'negative', 'score': 0.0001694908132776618}]","(0.9994800686836243, 0.0003503905318211764, 0.0001694908132776618)",0.34796347329816674,0.0003503905318211764,1,1
2013-04-29,32.019527435302734,45.6297721862793,45.91603088378906,45.53435134887695,45.6870231628418,11921943.0,"Merck Wins FOSAMAX Federal Bellwether Trial Involving Atypical Femur Fracture Claims  | Market Wrap for Monday, April 29: Stocks Start Week With a Rally | Merck, Pfizer Announce Worldwide Collaboration Deal for Development, Commercialization of Ertugliflozin",-0.01714766396487536,-0.0003484720905068185,0.13204123289323877,"[{'label': 'positive', 'score': 0.9937642812728882}, {'label': 'neutral', 'score': 0.005852716974914074}, {'label': 'negative', 'score': 0.0003829488705378026}]","(0.005852716974914074, 0.9937642812728882, 0.0003829488705378026)",0.9992295932454943,0.9937642812728882,0,0,"[{'label': 'positive', 'score': 0.9367358088493347}, {'label': 'neutral', 'score': 0.04141310229897499}, {'label': 'negative', 'score': 0.021851126104593277}]","(0.04141310229897499, 0.9367358088493347, 0.021851126104593277)",0.954409714324672,0.9367358088493347,0,0,"[{'label': 'positive', 'score': 0.9980980753898621}, {'label': 'neutral', 'score': 0.0014150963397696614}, {'label': 'negative', 'score': 0.00048682227497920394}]","(0.0014150963397696614, 0.9980980753898621, 0.00048682227497920394)",0.9990249756908649,0.9980980753898621,0,0
2013-04-30,31.47047233581543,44.84732818603516,45.64885330200195,44.84732818603516,45.5629768371582,20692446.0,"Pfizer Tanks on Earnings, Unhealthy Guidance",-0.0278723404617275,-0.017296387783957444,0.16028836596317877,"[{'label': 'negative', 'score': 0.9978654980659485}, {'label': 'neutral', 'score': 0.0012962562032043934}, {'label': 'positive', 'score': 0.000838271458633244}]","(0.0012962562032043934, 0.000838271458633244, 0.9978654980659485)",-0.9983212810761047,-0.9978654980659485,1,1,"[{'label': 'negative', 'score': 0.9443828463554382}, {'label': 'neutral', 'score': 0.04562167078256607}, {'label': 'positive', 'score': 0.009995462372899055}]","(0.04562167078256607, 0.009995462372899055, 0.9443828463554382)",-0.9790534586096837,-0.9443828463554382,1,1,"[{'label': 'negative', 'score': 0.9982669353485107}, {'label': 'neutral', 'score': 0.0012512047542259097}, {'label': 'positive', 'score': 0.00048187043284997344}]","(0.0012512047542259097, 0.00048187043284997344, 0.9982669353485107)",-0.9990350517966868,-0.9982669353485107,1,1
2013-05-01,30.59330940246582,43.59732818603516,44.18893051147461,42.5572509765625,42.74809265136719,41648358.0,"Earnings Trigger Volume Spike in Pharma ETF | May 1st Watchlist  | Merck (CC): R&D Chief Calls Erosion on Singulair Sales 'Faster Than Expected,' Says Victrelis Sales Harmed in US, France, Germany | From Merck Conference Call: Q1 Results 'Not Indicative of the Future' | UPDATE: Merck Posts 8.3% Drop In Q1 Profit, Lowers Forecast | Merck Announces New $15B Buyback Plan | Merck & Company, Inc. Lowers FY2013 EPS Guidance from $3.60-3.70 to $3.45-3.55 vs $3.63 Est | Merck & Company, Inc. Reports Q1 EPS of $0.85 vs $0.79 Est; Revenue of $10.70B vs $11.09B Est | Merck Announces New $15B Share Repurchase Program ",0.0008754216767528666,-0.028268146172111805,0.20454820194944173,"[{'label': 'negative', 'score': 0.9969348907470703}, {'label': 'positive', 'score': 0.002566841198131442}, {'label': 'neutral', 'score': 0.0004983319668099284}]","(0.0004983319668099284, 0.002566841198131442, 0.9969348907470703)",-0.9948637583786154,-0.9969348907470703,0,0,"[{'label': 'negative', 'score': 0.9681220054626465}, {'label': 'neutral', 'score': 0.017676478251814842}, {'label': 'positive', 'score': 0.014201425015926361}]","(0.017676478251814842, 0.014201425015926361, 0.9681220054626465)",-0.9710860505302055,-0.9681220054626465,0,0,"[{'label': 'negative', 'score': 0.9978476762771606}, {'label': 'neutral', 'score': 0.001650833641178906}, {'label': 'positive', 'score': 0.000501529430039227}]","(0.001650833641178906, 0.000501529430039227, 0.9978476762771606)",-0.9989952825581025,-0.9978476762771606,0,0
2013-05-02,30.62009048461914,43.63549423217773,43.90267181396485,43.40649032592773,43.79771041870117,14929389.0,,-0.0013120276868612806,0.0008750387186803116,0.20808295273110405,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-03,30.579914093017575,43.578243255615234,44.2557258605957,43.37786483764648,44.13167953491211,13492581.0,FDA Approves Merck's LIPTRUZET for Hyperlipidemia Treatment | UPDATE: Fitch Affirms Ratings on Merck; Outlook Lowered from Positive to Negative | Fitch Affirms ratings on Merck; Outlook Lowered from Positive to Negative,-0.00503613443600439,-0.0013128891487771393,0.20563210640786392,"[{'label': 'negative', 'score': 0.9979523420333862}, {'label': 'positive', 'score': 0.0011164747411385179}, {'label': 'neutral', 'score': 0.000931111047975719}]","(0.000931111047975719, 0.0011164747411385179, 0.9979523420333862)",-0.9977649692946217,-0.9979523420333862,0,0,"[{'label': 'positive', 'score': 0.5272191166877747}, {'label': 'negative', 'score': 0.36132556200027466}, {'label': 'neutral', 'score': 0.11145533621311188}]","(0.11145533621311188, 0.5272191166877747, 0.36132556200027466)",0.18670254705981082,0.5272191166877747,1,0,"[{'label': 'positive', 'score': 0.7308684587478638}, {'label': 'neutral', 'score': 0.20045600831508636}, {'label': 'negative', 'score': 0.06867553293704987}]","(0.20045600831508636, 0.7308684587478638, 0.06867553293704987)",0.8282132474228793,0.7308684587478638,0,0
2013-05-04,30.425912857055664,43.358777364095054,44.13486099243164,43.22201156616211,43.89631017049154,13919361.333333334,,-0.005061625462297385,-0.005048858499071553,0.19522862908405345,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-05,30.27191162109375,43.13931147257487,44.01399612426758,43.06615829467773,43.66094080607096,14346141.666666666,,-0.005087375853453337,-0.0050744788795914555,0.18636079488077004,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-06,30.11791038513184,42.91984558105469,43.89313125610352,42.91030502319336,43.42557144165039,14772922.0,Barron's Recap: Apple Tops the Barron's 500,0.006447323747375831,-0.005100360607594604,0.043969476334065914,"[{'label': 'neutral', 'score': 0.995938777923584}, {'label': 'positive', 'score': 0.0038286319468170404}, {'label': 'negative', 'score': 0.0002325507957721129}]","(0.995938777923584, 0.0038286319468170404, 0.0002325507957721129)",0.8854763203175372,0.0038286319468170404,0,1,"[{'label': 'positive', 'score': 0.5154770612716675}, {'label': 'neutral', 'score': 0.4555754065513611}, {'label': 'negative', 'score': 0.02894749492406845}]","(0.4555754065513611, 0.5154770612716675, 0.02894749492406845)",0.893658378944755,0.5154770612716675,0,0,"[{'label': 'positive', 'score': 0.9934879541397095}, {'label': 'neutral', 'score': 0.006248731631785631}, {'label': 'negative', 'score': 0.00026335366419516504}]","(0.006248731631785631, 0.9934879541397095, 0.00026335366419516504)",0.9994699807444236,0.9934879541397095,0,0
2013-05-07,30.312084197998047,43.196563720703125,43.225189208984375,42.82442855834961,43.03435134887695,15226078.0,,-0.006185069924017903,0.006426628659948385,0.0793082088642145,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-08,30.12459945678711,42.92938995361328,43.511451721191406,42.91030502319336,43.05343627929688,19187098.0,Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet,0.011113607084330101,-0.00620427670681853,0.08401556675650233,"[{'label': 'neutral', 'score': 0.9973486661911011}, {'label': 'positive', 'score': 0.002554106991738081}, {'label': 'negative', 'score': 9.728105214890093e-05}]","(0.9973486661911011, 0.002554106991738081, 9.728105214890093e-05)",0.9266187743637214,0.002554106991738081,0,1,"[{'label': 'positive', 'score': 0.8530229330062866}, {'label': 'neutral', 'score': 0.13703426718711853}, {'label': 'negative', 'score': 0.009942819364368916}]","(0.13703426718711853, 0.8530229330062866, 0.009942819364368916)",0.9769566304640597,0.8530229330062866,0,0,"[{'label': 'positive', 'score': 0.9789198637008667}, {'label': 'neutral', 'score': 0.02080996334552765}, {'label': 'negative', 'score': 0.0002701904741115868}]","(0.02080996334552765, 0.9789198637008667, 0.0002701904741115868)",0.9994481347661579,0.9789198637008667,0,0
2013-05-09,30.459392547607425,43.40649032592773,43.53053283691406,42.89122009277344,43.17748260498047,14856134.0,"Merck, Glaxo Reduce Prices 95% for HPV Vaccine in Poor Nations",0.010112094025082369,0.011052304728479949,0.12636700048181662,"[{'label': 'positive', 'score': 0.9970632195472717}, {'label': 'neutral', 'score': 0.0026203810703009367}, {'label': 'negative', 'score': 0.00031635689083486795}]","(0.0026203810703009367, 0.9970632195472717, 0.00031635689083486795)",0.9993656238842094,0.9970632195472717,0,0,"[{'label': 'positive', 'score': 0.7205597758293152}, {'label': 'neutral', 'score': 0.2645312547683716}, {'label': 'negative', 'score': 0.014908917248249054}]","(0.2645312547683716, 0.7205597758293152, 0.014908917248249054)",0.9594573708206048,0.7205597758293152,0,0,"[{'label': 'neutral', 'score': 0.7794342637062073}, {'label': 'negative', 'score': 0.13634225726127625}, {'label': 'positive', 'score': 0.08422353863716125}]","(0.7794342637062073, 0.08422353863716125, 0.13634225726127625)",-0.23629556165686613,-0.13634225726127625,1,1
2013-05-10,30.76740455627441,43.84542083740234,43.84542083740234,43.40649032592773,43.45419692993164,14592142.0,,0.0015959309358352083,0.010061308878129048,0.13197643438434986,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-11,30.81650225321452,43.91539510091146,43.934478759765625,43.466922760009766,43.549617767333984,13307434.0,"Short Interest in Vertex Rises, in Celgene Falls",0.001593387998635074,0.0015946587913823911,0.11240626018682814,"[{'label': 'neutral', 'score': 0.9998726844787598}, {'label': 'negative', 'score': 7.361089956248179e-05}, {'label': 'positive', 'score': 5.361991497920826e-05}]","(0.9998726844787598, 5.361991497920826e-05, 7.361089956248179e-05)",-0.157123764830752,-7.361089956248179e-05,1,1,"[{'label': 'neutral', 'score': 0.5496184825897217}, {'label': 'positive', 'score': 0.3736892640590668}, {'label': 'negative', 'score': 0.07669229060411453}]","(0.5496184825897217, 0.3736892640590668, 0.07669229060411453)",0.6594341406300753,0.3736892640590668,0,1,"[{'label': 'negative', 'score': 0.9365708827972412}, {'label': 'neutral', 'score': 0.061932843178510666}, {'label': 'positive', 'score': 0.0014962770510464907}]","(0.061932843178510666, 0.0014962770510464907, 0.9365708827972412)",-0.9968098722243118,-0.9365708827972412,0,0
2013-05-12,30.86559995015462,43.98536936442057,44.023536682128906,43.5273551940918,43.64503860473633,12022726.0,,0.0015908531523147467,0.001592119902845109,0.11265877982865576,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-13,30.914697647094727,44.05534362792969,44.11259460449219,43.58778762817383,43.74045944213867,10738018.0,,0.010396365211964072,0.0015895890858904527,0.07814456259786687,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-14,31.236099243164062,44.51335906982422,44.62786483764648,43.89313125610352,44.00763320922852,14057767.0,Moody's Downgrades Merck's Guaranteed Senior Unsecured Rating from Aa3 to A1,0.00171489882088387,0.010342694672341264,0.0748780634879156,"[{'label': 'negative', 'score': 0.998356282711029}, {'label': 'neutral', 'score': 0.0009371201740577817}, {'label': 'positive', 'score': 0.0007065850659273565}]","(0.0009371201740577817, 0.0007065850659273565, 0.998356282711029)",-0.9985855042986442,-0.998356282711029,0,0,"[{'label': 'negative', 'score': 0.6699861884117126}, {'label': 'neutral', 'score': 0.254410058259964}, {'label': 'positive', 'score': 0.0756036713719368}]","(0.254410058259964, 0.0756036713719368, 0.6699861884117126)",-0.7971976942018095,-0.6699861884117126,0,0,"[{'label': 'negative', 'score': 0.9961155652999878}, {'label': 'neutral', 'score': 0.0033402557019144297}, {'label': 'positive', 'score': 0.0005442657857201993}]","(0.0033402557019144297, 0.0005442657857201993, 0.9961155652999878)",-0.9989078203640909,-0.9961155652999878,0,0
2013-05-15,31.289669036865234,44.58969497680664,45.09542083740234,44.332061767578125,44.58969497680664,13831294.0,Merck Prices $6.5B Debt Offering,-0.00770387617471279,0.0017134300608444921,0.06191322165455915,"[{'label': 'neutral', 'score': 0.9998576641082764}, {'label': 'negative', 'score': 8.854969200911e-05}, {'label': 'positive', 'score': 5.371578663471155e-05}]","(0.9998576641082764, 5.371578663471155e-05, 8.854969200911e-05)",-0.2448514264068886,-8.854969200911e-05,1,1,"[{'label': 'neutral', 'score': 0.931939959526062}, {'label': 'positive', 'score': 0.055427610874176025}, {'label': 'negative', 'score': 0.012632387690246105}]","(0.931939959526062, 0.055427610874176025, 0.012632387690246105)",0.6287867188745551,0.055427610874176025,0,1,"[{'label': 'neutral', 'score': 0.999542236328125}, {'label': 'positive', 'score': 0.00028744307928718626}, {'label': 'negative', 'score': 0.00017038607620634139}]","(0.999542236328125, 0.00028744307928718626, 0.00017038607620634139)",0.2556783500488529,0.00028744307928718626,1,1
2013-05-16,31.04861831665039,44.24618148803711,44.56106948852539,42.9484748840332,44.446563720703125,12536910.0,,-0.008194935524328187,-0.007733704322430472,0.10149653278880048,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-17,30.79417991638184,43.88358688354492,44.57061004638672,43.01526641845703,44.16984558105469,22773459.0,,-0.005653397942602022,-0.008228698592417727,0.12267672973591015,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-18,30.62009048461914,43.63549550374349,44.35114415486654,43.021628061930336,44.064884185791016,21026652.666666668,,-0.005685540565940251,-0.005669438882530485,0.12580797981211503,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-19,30.446001052856445,43.387404123942055,44.13167826334635,43.02798970540365,43.959922790527344,19279846.33333333,,-0.005718050775582606,-0.005701764776533735,0.06341437502003296,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-20,30.27191162109375,43.13931274414063,43.91221237182617,43.03435134887695,43.85496139526367,17533040.0,ISI Suggesting the FDA Report on Merck Points to 'Some Risk' from Panel,0.046892254396433304,-0.00573446141573482,0.020015333278892995,"[{'label': 'negative', 'score': 0.6640844345092773}, {'label': 'neutral', 'score': 0.334568589925766}, {'label': 'positive', 'score': 0.001346970908343792}]","(0.334568589925766, 0.001346970908343792, 0.6640844345092773)",-0.9959515860015701,-0.6640844345092773,0,0,"[{'label': 'positive', 'score': 0.5745827555656433}, {'label': 'negative', 'score': 0.23647284507751465}, {'label': 'neutral', 'score': 0.18894442915916443}]","(0.18894442915916443, 0.5745827555656433, 0.23647284507751465)",0.41687636485095636,0.5745827555656433,0,1,"[{'label': 'neutral', 'score': 0.9278275966644287}, {'label': 'negative', 'score': 0.0691877156496048}, {'label': 'positive', 'score': 0.0029846495017409325}]","(0.9278275966644287, 0.0029846495017409325, 0.0691877156496048)",-0.9172910712990461,-0.0691877156496048,0,0
2013-05-21,31.69143486022949,45.16221237182617,45.35305404663086,43.1202278137207,43.16793823242188,49277694.0,Merck to Take Initial Delivery of ~99.5M Shares | Merck Announces $5B Accelerated Buyback Plan,-0.013099498327688574,0.04582601770698912,0.37070379288576827,"[{'label': 'neutral', 'score': 0.9483109712600708}, {'label': 'positive', 'score': 0.05144316703081131}, {'label': 'negative', 'score': 0.0002458907838445157}]","(0.9483109712600708, 0.05144316703081131, 0.0002458907838445157)",0.9904857703258504,0.05144316703081131,0,1,"[{'label': 'neutral', 'score': 0.8097529411315918}, {'label': 'positive', 'score': 0.17971666157245636}, {'label': 'negative', 'score': 0.010530443862080574}]","(0.8097529411315918, 0.17971666157245636, 0.010530443862080574)",0.8892971975786087,0.17971666157245636,0,1,"[{'label': 'neutral', 'score': 0.6128392815589905}, {'label': 'positive', 'score': 0.38634228706359863}, {'label': 'negative', 'score': 0.0008184245089069009}]","(0.6128392815589905, 0.38634228706359863, 0.0008184245089069009)",0.9957721716876552,0.38634228706359863,0,1
2013-05-22,31.276268005371094,44.57061004638672,46.08778762817383,44.360687255859375,45.41984558105469,44670895.0,"FDA Panel Votes 8-7 Merck's Suvorexant Unsafe in Higher Doses | FDA Panel Votes 13-3 Merck's Suvorexant is Safe in Low Doses | FDA Panel Finds Merck Doesn't Need to Study 10mg Suvorexant | FDA Says Merck Insomnia Drug Helps Patients Stay Asleep -Bloomberg | FDA Panel Votes 12 Yes 4 No on Effectiveness of Merck Insomnia Drug | PreMarket Info Recap for May 22, 2013 | Merck FDA Advisory Committee Meeting for Insomnia Drug Suvorexant Begins at 8 AM ET",0.013273372853181612,-0.013186053472851247,0.3825698530420866,"[{'label': 'neutral', 'score': 0.871330976486206}, {'label': 'positive', 'score': 0.12601333856582642}, {'label': 'negative', 'score': 0.0026558104436844587}]","(0.871330976486206, 0.12601333856582642, 0.0026558104436844587)",0.9587187688093258,0.12601333856582642,0,1,"[{'label': 'neutral', 'score': 0.8828067183494568}, {'label': 'positive', 'score': 0.0764167457818985}, {'label': 'negative', 'score': 0.04077653959393501}]","(0.8828067183494568, 0.0764167457818985, 0.04077653959393501)",0.304114745769495,0.0764167457818985,1,1,"[{'label': 'neutral', 'score': 0.9852493405342102}, {'label': 'positive', 'score': 0.008714991621673107}, {'label': 'negative', 'score': 0.00603566225618124}]","(0.9852493405342102, 0.008714991621673107, 0.00603566225618124)",0.1816413962173185,0.008714991621673107,1,1
2013-05-23,31.69143486022949,45.16221237182617,45.26717758178711,44.29389190673828,44.332061767578125,23663421.0,Merck Issues Update on Phase III Trial for Preladenant | Merck Issues Statement on FDA Advisory Committee Meeting Results for Suvorexant ,-0.0035917720436425262,0.01318605347285121,0.37871852779283055,"[{'label': 'neutral', 'score': 0.9998458623886108}, {'label': 'negative', 'score': 8.019334927666932e-05}, {'label': 'positive', 'score': 7.391266990453005e-05}]","(0.9998458623886108, 7.391266990453005e-05, 8.019334927666932e-05)",-0.04075557467196911,-8.019334927666932e-05,1,1,"[{'label': 'neutral', 'score': 0.9076460003852844}, {'label': 'negative', 'score': 0.05233239755034447}, {'label': 'positive', 'score': 0.040021561086177826}]","(0.9076460003852844, 0.040021561086177826, 0.05233239755034447)",-0.13330058230225333,-0.05233239755034447,1,1,"[{'label': 'neutral', 'score': 0.999173104763031}, {'label': 'positive', 'score': 0.000690976798068732}, {'label': 'negative', 'score': 0.00013589438458438963}]","(0.999173104763031, 0.000690976798068732, 0.00013589438458438963)",0.671304581813203,0.000690976798068732,0,1
2013-05-24,31.57759094238281,45.0,45.0,44.46564865112305,44.89503860473633,16554208.0,,0.002438502841525608,-0.003598237944186181,0.3745885069848699,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-25,31.654595851898197,45.10973262786865,45.35305309295654,44.68511390686035,45.10734748840332,17043597.75,,0.0024325710102050097,0.002435534518002546,0.3609212349374824,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-26,31.73160076141357,45.219465255737305,45.706106185913086,44.904579162597656,45.31965637207031,17532987.5,,0.0024266679680545276,0.0024296170987749806,0.1531304231127767,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-27,31.808605670928955,45.32919788360596,46.05915927886963,45.12404441833496,45.531965255737305,18022377.25,,0.002420793505996252,0.0024237283640090716,0.0964185510152331,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-28,31.885610580444336,45.43893051147461,46.41221237182617,45.343509674072266,45.7442741394043,18511767.0,"UPDATE: Jefferies Upgrades Merck to Buy, Raises PT Following SOTP Analysis | PreMarket Info Recap for May 28, 2013 | Jefferies Upgrades Merck & Company, Inc. to Buy, Raises PT to $54.00",-0.01574968079282424,0.0024178681056392618,0.042772851835120085,"[{'label': 'positive', 'score': 0.9990262985229492}, {'label': 'neutral', 'score': 0.0007902529323473573}, {'label': 'negative', 'score': 0.00018345033458899707}]","(0.0007902529323473573, 0.9990262985229492, 0.00018345033458899707)",0.9996328091578395,0.9990262985229492,0,0,"[{'label': 'positive', 'score': 0.8199365139007568}, {'label': 'neutral', 'score': 0.1655755341053009}, {'label': 'negative', 'score': 0.014488046988844872}]","(0.1655755341053009, 0.8199365139007568, 0.014488046988844872)",0.9652741597792884,0.8199365139007568,0,0,"[{'label': 'positive', 'score': 0.9979910850524902}, {'label': 'neutral', 'score': 0.0017466505523771048}, {'label': 'negative', 'score': 0.0002622204483486712}]","(0.0017466505523771048, 0.9979910850524902, 0.0002622204483486712)",0.999474641462435,0.9979910850524902,0,0
2013-05-29,31.3834285736084,44.72328186035156,45.29580307006836,44.3797721862793,45.1240463256836,16822182.0,"SunTrust Robinson Humphrey Initiates Coverage on Merck & Company, Inc. at Neutral, Announces $47.00 PT | Short Interest in Vertex Rises, in Biogen Idec Falls",0.004267166157452188,-0.01587502484320354,0.12992930710813308,"[{'label': 'neutral', 'score': 0.9998589754104614}, {'label': 'negative', 'score': 8.320357301272452e-05}, {'label': 'positive', 'score': 5.786126712337136e-05}]","(0.9998589754104614, 5.786126712337136e-05, 8.320357301272452e-05)",-0.1796500521668158,-8.320357301272452e-05,1,1,"[{'label': 'negative', 'score': 0.6151986122131348}, {'label': 'neutral', 'score': 0.2845405638217926}, {'label': 'positive', 'score': 0.10026086866855621}]","(0.2845405638217926, 0.10026086866855621, 0.6151986122131348)",-0.7197301277075803,-0.6151986122131348,0,0,"[{'label': 'neutral', 'score': 0.63460773229599}, {'label': 'positive', 'score': 0.3365263342857361}, {'label': 'negative', 'score': 0.02886597439646721}]","(0.63460773229599, 0.3365263342857361, 0.02886597439646721)",0.8420000984663685,0.3365263342857361,0,1
2013-05-30,31.51733016967773,44.91412353515625,45.21946716308594,44.59923553466797,44.86641311645508,15933268.0,,-0.007860646470246905,0.004258087621196765,0.13375962575617434,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-05-31,31.26959609985352,44.56106948852539,45.49618148803711,44.5515251159668,44.78053283691406,22768953.0,,0.012491064511551462,-0.007891704214741564,0.1377343016702439,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-01,31.66018295288086,45.11768468221029,46.03053283691406,45.06679280598959,45.416665395100914,28447785.33333333,,0.012336962714409015,0.012413694785838746,0.17533924117477598,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-02,32.0507698059082,45.67429987589518,46.564884185791016,45.58206049601237,46.05279795328776,34126617.666666664,,0.012186616876390357,0.012261482553127676,0.19946555597910406,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-03,32.44135665893555,46.23091506958008,47.09923553466797,46.09732818603516,46.68893051147461,39805450.0,"ISM Manufacturing Index Drops in May, Shows Contraction | Benzinga's Top Pre-Market Gainers",0.02043343443772533,0.01211295789299474,0.1401399463873615,"[{'label': 'negative', 'score': 0.9982530474662781}, {'label': 'neutral', 'score': 0.0012020479189231992}, {'label': 'positive', 'score': 0.0005449551390483975}]","(0.0012020479189231992, 0.0005449551390483975, 0.9982530474662781)",-0.9989087780759935,-0.9982530474662781,0,0,"[{'label': 'negative', 'score': 0.9737794995307922}, {'label': 'neutral', 'score': 0.01516359020024538}, {'label': 'positive', 'score': 0.011056900024414062}]","(0.01516359020024538, 0.011056900024414062, 0.9737794995307922)",-0.9775457121012021,-0.9737794995307922,0,0,"[{'label': 'negative', 'score': 0.9871920347213745}, {'label': 'neutral', 'score': 0.011810296215116978}, {'label': 'positive', 'score': 0.0009976562578231096}]","(0.011810296215116978, 0.0009976562578231096, 0.9871920347213745)",-0.9979808405877326,-0.9871920347213745,0,0
2013-06-04,33.104244232177734,47.17557144165039,47.86259460449219,45.96374130249024,45.99236679077149,38785013.0,"With Bond Yields So Low, Reluctant Investors Are Now Making the Move into These Stocks",-0.01436079669159175,0.020227472759824117,0.16648673210110532,"[{'label': 'positive', 'score': 0.5862036943435669}, {'label': 'neutral', 'score': 0.33835992217063904}, {'label': 'negative', 'score': 0.07543633133172989}]","(0.33835992217063904, 0.5862036943435669, 0.07543633133172989)",0.7719716812635798,0.5862036943435669,0,0,"[{'label': 'neutral', 'score': 0.8103561401367188}, {'label': 'negative', 'score': 0.14206798374652863}, {'label': 'positive', 'score': 0.04757590591907501}]","(0.8103561401367188, 0.04757590591907501, 0.14206798374652863)",-0.4982605977660031,-0.14206798374652863,1,1,"[{'label': 'negative', 'score': 0.938843846321106}, {'label': 'neutral', 'score': 0.05886206030845642}, {'label': 'positive', 'score': 0.0022941080387681723}]","(0.05886206030845642, 0.0022941080387681723, 0.938843846321106)",-0.9951248209082619,-0.938843846321106,0,0
2013-06-05,32.628841400146484,46.49809265136719,47.45228958129883,46.25,46.774810791015625,26119409.0,,-0.0026677723452800447,-0.01446491090991105,0.21111296956199208,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-06,32.54179763793945,46.3740463256836,46.49809265136719,45.5629768371582,46.41221237182617,20850903.0,,-0.008436268526648633,-0.0026713371914667194,0.2204950707538262,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-07,32.26728057861328,45.98282241821289,46.88931274414063,45.89694595336914,46.536258697509766,52852631.0,"UPDATE: Jefferies Raises PT on Merck & Co. Following Global Pharma Review | Jefferies Maintains Buy on Merck & Company, Inc., Raises PT to $56.00",0.0018676323778951652,-0.008472055253069417,0.22935168816883272,"[{'label': 'positive', 'score': 0.999357283115387}, {'label': 'neutral', 'score': 0.0004630651092156768}, {'label': 'negative', 'score': 0.00017964135622605681}]","(0.0004630651092156768, 0.999357283115387, 0.00017964135622605681)",0.9996405508354361,0.999357283115387,0,0,"[{'label': 'positive', 'score': 0.9295194149017334}, {'label': 'neutral', 'score': 0.047222401946783066}, {'label': 'negative', 'score': 0.02325814962387085}]","(0.047222401946783066, 0.9295194149017334, 0.02325814962387085)",0.9511782172674242,0.9295194149017334,0,0,"[{'label': 'positive', 'score': 0.9989079236984253}, {'label': 'neutral', 'score': 0.0007710217032581568}, {'label': 'negative', 'score': 0.0003210674913134426}]","(0.0007710217032581568, 0.9989079236984253, 0.0003210674913134426)",0.9993573695436295,0.9989079236984253,0,0
2013-06-08,32.32753880818685,46.06870142618815,46.80979665120443,45.97964350382487,46.49809137980143,52197736.0,,0.0018641508294488065,0.0018658905209741285,0.2097458438777834,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-09,32.387797037760414,46.15458043416341,46.73028055826823,46.0623410542806,46.4599240620931,51542841.0,,0.0018606822371133051,0.0018624154566210967,0.11206679969331752,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-10,32.448055267333984,46.24045944213867,46.65076446533203,46.14503860473633,46.421756744384766,50887946.0,Merck Loses US Appeal of Apotex Patent Win Over Nasonex,-0.018572045295120083,0.0018589533122404525,0.07237430204617114,"[{'label': 'negative', 'score': 0.9415348768234253}, {'label': 'positive', 'score': 0.05363858491182327}, {'label': 'neutral', 'score': 0.004826532211154699}]","(0.004826532211154699, 0.05363858491182327, 0.9415348768234253)",-0.8922025416186329,-0.9415348768234253,1,1,"[{'label': 'positive', 'score': 0.5476616024971008}, {'label': 'negative', 'score': 0.36199790239334106}, {'label': 'neutral', 'score': 0.0903405025601387}]","(0.0903405025601387, 0.5476616024971008, 0.36199790239334106)",0.20410241316185757,0.5476616024971008,0,0,"[{'label': 'positive', 'score': 0.9964600205421448}, {'label': 'negative', 'score': 0.0018512035021558404}, {'label': 'neutral', 'score': 0.001688737072981894}]","(0.001688737072981894, 0.9964600205421448, 0.0018512035021558404)",0.9962913298827667,0.9964600205421448,0,0
2013-06-11,31.845420837402344,45.38167953491211,45.99236679077149,45.37213516235352,45.86832046508789,56749305.0,,-0.006518116409525967,-0.01874667121511608,0.14636330119266389,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-12,31.637859344482425,45.08587646484375,45.89694595336914,45.06679534912109,45.696563720703125,17662887.0,"Short Interest Falls in Vertex, Rises in Biogen Idec (VRTX, BIIB) | FDA Says Considering New Study of Incretin Mimetic Diabetes Drug, Says May Need to Look for Cancer-Link Patterns",0.013756672311818131,-0.006539452093137913,0.14353024596134953,"[{'label': 'negative', 'score': 0.9921159148216248}, {'label': 'positive', 'score': 0.005883924663066864}, {'label': 'neutral', 'score': 0.002000165171921253}]","(0.002000165171921253, 0.005883924663066864, 0.9921159148216248)",-0.9882085659129866,-0.9921159148216248,0,0,"[{'label': 'positive', 'score': 0.7418144941329956}, {'label': 'negative', 'score': 0.16764585673809052}, {'label': 'neutral', 'score': 0.09053966403007507}]","(0.09053966403007507, 0.7418144941329956, 0.16764585673809052)",0.6313289379190233,0.7418144941329956,0,0,"[{'label': 'neutral', 'score': 0.6506556868553162}, {'label': 'negative', 'score': 0.32208696007728577}, {'label': 'positive', 'score': 0.027257394045591354}]","(0.6506556868553162, 0.027257394045591354, 0.32208696007728577)",-0.8439511403352811,-0.32208696007728577,0,1
2013-06-13,32.367652893066406,45.70610809326172,45.7442741394043,44.360687255859375,44.59923553466797,15482314.0,,0.0010438521390580976,0.013662908237730007,0.19038056454747124,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-14,32.40142822265625,45.75381851196289,46.3072509765625,45.32442855834961,45.582061767578125,14286650.0,"Dow Jones Reporting Merck to Cut Jobs, Change Organizational Structure of R&D Unit",-0.0010427636479936075,0.0010433077042540197,0.1895343059708253,"[{'label': 'neutral', 'score': 0.6960495710372925}, {'label': 'negative', 'score': 0.30333730578422546}, {'label': 'positive', 'score': 0.0006131132249720395}]","(0.6960495710372925, 0.0006131132249720395, 0.30333730578422546)",-0.9959657023867864,-0.30333730578422546,0,1,"[{'label': 'negative', 'score': 0.9334514737129211}, {'label': 'neutral', 'score': 0.05243474617600441}, {'label': 'positive', 'score': 0.014113789424300194}]","(0.05243474617600441, 0.014113789424300194, 0.9334514737129211)",-0.9702104119402353,-0.9334514737129211,0,0,"[{'label': 'negative', 'score': 0.9832533001899719}, {'label': 'neutral', 'score': 0.01599874347448349}, {'label': 'positive', 'score': 0.0007479675114154816}]","(0.01599874347448349, 0.0007479675114154816, 0.9832533001899719)",-0.9984797427890256,-0.9832533001899719,0,0
2013-06-15,32.36764399210612,45.70610809326172,46.313612620035805,45.343512217203774,45.760178883870445,13885930.0,,-0.0010438521390580976,-0.001043307704254005,0.18716346593946304,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-16,32.33385976155599,45.65839767456055,46.31997426350912,45.362595876057945,45.93829600016276,13485210.0,,-0.0010449429049446176,-0.00104439733213588,0.11914245195209291,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-17,32.30007553100586,45.610687255859375,46.32633590698242,45.38167953491211,46.11641311645508,13084490.0,"Mylan Being Sued by Pfizer, Merck, Want Blockage of Proposed Copy of Azasite",-0.0010460359527918045,-0.0010454892384065858,0.10172354754563945,"[{'label': 'neutral', 'score': 0.9600759744644165}, {'label': 'negative', 'score': 0.039253607392311096}, {'label': 'positive', 'score': 0.0006704183178953826}]","(0.9600759744644165, 0.0006704183178953826, 0.039253607392311096)",-0.9664152947520024,-0.039253607392311096,0,1,"[{'label': 'negative', 'score': 0.8048114776611328}, {'label': 'neutral', 'score': 0.17745573818683624}, {'label': 'positive', 'score': 0.017732780426740646}]","(0.17745573818683624, 0.017732780426740646, 0.8048114776611328)",-0.9568830971649765,-0.8048114776611328,0,0,"[{'label': 'negative', 'score': 0.9946178793907166}, {'label': 'neutral', 'score': 0.0045402320101857185}, {'label': 'positive', 'score': 0.000841932778712362}]","(0.0045402320101857185, 0.000841932778712362, 0.9946178793907166)",-0.9983084545083191,-0.9946178793907166,0,0
2013-06-18,32.266292572021484,45.5629768371582,45.84923553466797,45.47710037231445,45.6870231628418,12384006.0,Interesting Similarities Among 2013's Top-Performing ETFs,-0.0035601794063174997,-0.0010465834302197936,0.014825132120030404,"[{'label': 'neutral', 'score': 0.9992839694023132}, {'label': 'positive', 'score': 0.0006235534674488008}, {'label': 'negative', 'score': 9.256029443349689e-05}]","(0.9992839694023132, 0.0006235534674488008, 9.256029443349689e-05)",0.741492764528912,0.0006235534674488008,0,0,"[{'label': 'positive', 'score': 0.8550507426261902}, {'label': 'neutral', 'score': 0.13239964842796326}, {'label': 'negative', 'score': 0.012549580074846745}]","(0.13239964842796326, 0.8550507426261902, 0.012549580074846745)",0.9710705961109442,0.8550507426261902,0,0,"[{'label': 'neutral', 'score': 0.9670214056968689}, {'label': 'positive', 'score': 0.03252699226140976}, {'label': 'negative', 'score': 0.0004516745684668422}]","(0.9670214056968689, 0.03252699226140976, 0.0004516745684668422)",0.9726080759542618,0.03252699226140976,0,0
2013-06-19,32.15141677856445,45.40076446533203,45.96374130249024,45.27671813964844,45.524810791015625,18857922.0,,-0.026691928387742828,-0.003566531926910425,0.017901505890462292,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-06-20,31.29323959350586,44.18893051147461,45.24809265136719,44.093509674072266,45.24809265136719,18680495.0,,0.01489960646116083,-0.027054626547749042,0.1810036109712581,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-21,31.759492874145508,44.84732818603516,45.41984558105469,44.53244400024414,44.72328186035156,25453614.0,,-0.004184395220624094,0.014789697711362933,0.23829559738226794,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-22,31.626595815022785,44.65966924031576,45.18447748819987,44.33842341105143,44.5960553487142,23285267.33333333,,-0.0042019779571049725,-0.0041931743009585975,0.2372278992912633,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-23,31.493698755900063,44.47201029459635,44.949109395345054,44.144402821858726,44.46882883707682,21116920.666666668,,-0.0042197090816513076,-0.0042108310755905355,0.2356242207215002,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-24,31.360801696777344,44.28435134887695,44.71374130249024,43.950382232666016,44.34160232543945,18948574.0,"UPDATE: BMO Capital Markets Lowers PT on Merck Following New SGLT2 Data | BMO Capital Maintains Outperform on Merck & Company, Inc., Lowers PT to $52.00",-0.0038784974636220195,-0.0042286371788518105,0.23544433896458772,"[{'label': 'negative', 'score': 0.9966093301773071}, {'label': 'neutral', 'score': 0.0020182712469249964}, {'label': 'positive', 'score': 0.0013724060263484716}]","(0.0020182712469249964, 0.0013724060263484716, 0.9966093301773071)",-0.9972496369892115,-0.9966093301773071,0,0,"[{'label': 'negative', 'score': 0.9495154023170471}, {'label': 'neutral', 'score': 0.034460220485925674}, {'label': 'positive', 'score': 0.01602439396083355}]","(0.034460220485925674, 0.01602439396083355, 0.9495154023170471)",-0.9668073879034154,-0.9495154023170471,0,0,"[{'label': 'negative', 'score': 0.99610435962677}, {'label': 'neutral', 'score': 0.0035067384596914053}, {'label': 'positive', 'score': 0.0003889197832904756}]","(0.0035067384596914053, 0.0003889197832904756, 0.99610435962677)",-0.9992194231685723,-0.99610435962677,0,0
2013-06-25,31.23917961120605,44.11259460449219,44.54198455810547,43.96946716308594,44.39885330200195,12600104.0,,0.009950231116759363,-0.0038860383394031034,0.13433289510411872,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-26,31.55000877380371,44.5515251159668,44.761451721191406,44.16030502319336,44.46564865112305,11984823.0,"Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, VRTX)",0.01263661906949404,0.009901053517039713,0.0996334807112439,"[{'label': 'neutral', 'score': 0.9998787641525269}, {'label': 'negative', 'score': 6.822775321779773e-05}, {'label': 'positive', 'score': 5.302430872689001e-05}]","(0.9998787641525269, 5.302430872689001e-05, 6.822775321779773e-05)",-0.12538710061560154,-6.822775321779773e-05,1,1,"[{'label': 'negative', 'score': 0.7282461524009705}, {'label': 'neutral', 'score': 0.2234780490398407}, {'label': 'positive', 'score': 0.048275794833898544}]","(0.2234780490398407, 0.048275794833898544, 0.7282461524009705)",-0.8756614799985893,-0.7282461524009705,0,0,"[{'label': 'negative', 'score': 0.997273862361908}, {'label': 'neutral', 'score': 0.0020024466793984175}, {'label': 'positive', 'score': 0.0007236086530610919}]","(0.0020024466793984175, 0.0007236086530610919, 0.997273862361908)",-0.9985498787841112,-0.997273862361908,0,0
2013-06-27,31.948694229125977,45.114505767822266,45.19084167480469,44.72328186035156,44.875953674316406,12198510.0,"Aspen Pharmacare to Acquire Netherlands Plant, Portfolio of 11 Drug Brands from Merck for $1B -Reuters",-0.017555071463680242,0.01255744331031279,0.13420732511101804,"[{'label': 'neutral', 'score': 0.9998875856399536}, {'label': 'positive', 'score': 5.829344809171744e-05}, {'label': 'negative', 'score': 5.414490806288086e-05}]","(0.9998875856399536, 5.829344809171744e-05, 5.414490806288086e-05)",0.03689612842731799,5.829344809171744e-05,1,1,"[{'label': 'neutral', 'score': 0.888833224773407}, {'label': 'positive', 'score': 0.10228099673986435}, {'label': 'negative', 'score': 0.008885780349373817}]","(0.888833224773407, 0.10228099673986435, 0.008885780349373817)",0.8401360445622916,0.10228099673986435,0,1,"[{'label': 'positive', 'score': 0.7402264475822449}, {'label': 'neutral', 'score': 0.25900736451148987}, {'label': 'negative', 'score': 0.0007662191637791693}]","(0.25900736451148987, 0.7402264475822449, 0.0007662191637791693)",0.9979319116148776,0.7402264475822449,0,0
2013-06-28,31.38784408569336,44.32251739501953,45.30534362792969,44.32251739501953,45.286258697509766,17124110.0,,-0.0009328780514338643,-0.017710989190050305,0.1944407685609803,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-29,31.35855865478516,44.28116989135742,45.10496139526367,44.24936294555664,44.904579162597656,15996602.0,,-0.0009337491254985875,-0.0009333134529686692,0.19203737961743259,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-06-30,31.329273223876957,44.23982238769531,44.904579162597656,44.17620849609375,44.52289962768555,14869094.0,,-0.0009346218278129798,-0.0009341853407781772,0.18941359203025457,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-01,31.29998779296875,44.1984748840332,44.70419692993164,44.10305404663086,44.14122009277344,13741586.0,"FDA Approves New U.S. Labeling for ISENTRESS (raltegravir) to Include 240-Week Results from STARTMRK Study of ISENTRESS Containing Regimen in Previously Untreated HIV-1 Infected Adult Patients  | Merck Receives Complete Response Letter for Suvorexant, Merck's Investigational Medicine for Insomnia; FDA Says Data Does Not Support Approval of Suvorexant 30mg and 40mg | Merck Receives CRL for Suvorexant",0.004965405457190574,-0.0009350588591207404,0.17048044773186052,"[{'label': 'positive', 'score': 0.9960403442382812}, {'label': 'neutral', 'score': 0.0036383066326379776}, {'label': 'negative', 'score': 0.0003213289310224354}]","(0.0036383066326379776, 0.9960403442382812, 0.0003213289310224354)",0.9993549954004145,0.9960403442382812,0,0,"[{'label': 'positive', 'score': 0.5235857963562012}, {'label': 'neutral', 'score': 0.44758909940719604}, {'label': 'negative', 'score': 0.02882508747279644}]","(0.44758909940719604, 0.5235857963562012, 0.02882508747279644)",0.8956389589104495,0.5235857963562012,0,0,"[{'label': 'positive', 'score': 0.9756805896759033}, {'label': 'neutral', 'score': 0.02296803891658783}, {'label': 'negative', 'score': 0.0013513517333194613}]","(0.02296803891658783, 0.9756805896759033, 0.0013513517333194613)",0.9972337614031935,0.9756805896759033,0,0
2013-07-02,31.455398559570312,44.41793823242188,44.58969497680664,43.921756744384766,43.97900772094727,11859063.0,"Pfizer and Novartis Could Be Eyeing Onyx (PFE, NVS, ONXX)",0.0,0.004953118487917489,0.135725938939938,"[{'label': 'neutral', 'score': 0.9996564388275146}, {'label': 'positive', 'score': 0.0002044451393885538}, {'label': 'negative', 'score': 0.00013906742969993502}]","(0.9996564388275146, 0.0002044451393885538, 0.00013906742969993502)",0.19032115727846186,0.0002044451393885538,1,1,"[{'label': 'neutral', 'score': 0.9260574579238892}, {'label': 'positive', 'score': 0.0629403293132782}, {'label': 'negative', 'score': 0.0110022546723485}]","(0.9260574579238892, 0.0629403293132782, 0.0110022546723485)",0.7024108685602015,0.0629403293132782,0,1,"[{'label': 'neutral', 'score': 0.9992533326148987}, {'label': 'positive', 'score': 0.0006327788578346372}, {'label': 'negative', 'score': 0.00011392866144888103}]","(0.9992533326148987, 0.0006327788578346372, 0.00011392866144888103)",0.6948506382841892,0.0006327788578346372,0,1
2013-07-03,31.455398559570312,44.41793823242188,44.58969497680664,44.04580307006836,44.35114669799805,7203952.0,,0.006552102492155386,0.0,0.0406481271019284,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-07-04,31.66150379180908,44.70896911621094,44.86164093017578,44.26049613952637,44.565839767456055,7847948.0,Financial Times Reporting That China Is Investigating 33 Foreign Pharmaceutical Companies For Pricing Irregularities,0.006509451896164123,0.006530730770965669,0.05637279945717048,"[{'label': 'neutral', 'score': 0.9997918009757996}, {'label': 'negative', 'score': 0.00013731962826568633}, {'label': 'positive', 'score': 7.091829320415854e-05}]","(0.9997918009757996, 7.091829320415854e-05, 0.00013731962826568633)",-0.3188724445232394,-0.00013731962826568633,1,1,"[{'label': 'negative', 'score': 0.7333638072013855}, {'label': 'neutral', 'score': 0.2454342544078827}, {'label': 'positive', 'score': 0.021201912313699722}]","(0.2454342544078827, 0.021201912313699722, 0.7333638072013855)",-0.9438036694078153,-0.7333638072013855,0,0,"[{'label': 'negative', 'score': 0.9930474162101746}, {'label': 'neutral', 'score': 0.005593602079898119}, {'label': 'positive', 'score': 0.0013589634327217937}]","(0.005593602079898119, 0.0013589634327217937, 0.9930474162101746)",-0.9972667845650591,-0.9930474162101746,0,0
2013-07-05,31.86760902404785,45.0,45.13358688354492,44.475189208984375,44.78053283691406,8491944.0,,0.00176702428747117,0.006488356909218039,0.057293592793729455,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-06,31.923917134602863,45.0795160929362,45.23854955037435,44.67557144165039,44.92048263549805,9496067.666666666,,0.0017639074202186352,0.0017654649367251517,0.046610226579558586,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-07,31.98022524515788,45.1590321858724,45.343512217203774,44.875953674316406,45.06043243408203,10500191.333333334,,0.001760801529335508,0.0017623535624975892,0.047763513224105485,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-08,32.03653335571289,45.238548278808594,45.4484748840332,45.07633590698242,45.200382232666016,11504315.0,,0.004429457626072455,0.0017592531356655395,0.04127666180853833,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-09,32.178443908691406,45.43893051147461,45.8015251159668,45.42938995361328,45.53435134887695,10811902.0,,0.007139881038082136,0.004419676451537474,0.03413366038207369,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-07-10,32.4081916809082,45.76335906982422,45.97328186035156,45.41030502319336,45.43893051147461,8154174.0,,0.007297740441242208,0.007114512766848939,0.03796347701866699,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-07-11,32.64469528198242,46.09732818603516,46.27862548828125,45.92557144165039,46.21183013916016,11991216.0,"Short Interest Rises in Gilead Sciences, Onyx Pharmaceuticals (BIIB, GILD, ONXX)",0.004760951918953281,0.007271240780464335,0.04312663116759241,"[{'label': 'positive', 'score': 0.7247714400291443}, {'label': 'neutral', 'score': 0.2744337320327759}, {'label': 'negative', 'score': 0.0007948355050757527}]","(0.2744337320327759, 0.7247714400291443, 0.0007948355050757527)",0.9978090616064245,0.7247714400291443,0,0,"[{'label': 'positive', 'score': 0.7617985010147095}, {'label': 'neutral', 'score': 0.21680597960948944}, {'label': 'negative', 'score': 0.021395523101091385}]","(0.21680597960948944, 0.7617985010147095, 0.021395523101091385)",0.9453634158528056,0.7617985010147095,0,0,"[{'label': 'positive', 'score': 0.9969442486763}, {'label': 'neutral', 'score': 0.0024531781673431396}, {'label': 'negative', 'score': 0.0006025895709171891}]","(0.0024531781673431396, 0.9969442486763, 0.0006025895709171891)",0.9987918570881824,0.9969442486763,0,0
2013-07-12,32.80012512207031,46.31679534912109,46.431297302246094,45.98282241821289,46.183204650878906,9280564.0,"Sanofi Pasteur Vaccine Suspended as Precautionionary Measury - WHO Citing Quality Problem | UPDATE: Jefferies Lowers PT on Merck on Challenges Ahead | Jefferies Maintains Buy on Merck & Company, Inc., Lowers PT to $54.00",-0.0001373506829508777,0.0047496544310400785,0.03594780980238241,"[{'label': 'negative', 'score': 0.8891407251358032}, {'label': 'neutral', 'score': 0.07037901133298874}, {'label': 'positive', 'score': 0.04048025608062744}]","(0.07037901133298874, 0.04048025608062744, 0.8891407251358032)",-0.9129101926515082,-0.8891407251358032,0,0,"[{'label': 'negative', 'score': 0.9465880990028381}, {'label': 'neutral', 'score': 0.03599374741315842}, {'label': 'positive', 'score': 0.017418207600712776}]","(0.03599374741315842, 0.017418207600712776, 0.9465880990028381)",-0.9638628762459414,-0.9465880990028381,0,0,"[{'label': 'negative', 'score': 0.9972842931747437}, {'label': 'neutral', 'score': 0.0023706492502242327}, {'label': 'positive', 'score': 0.00034495434374548495}]","(0.0023706492502242327, 0.00034495434374548495, 0.9972842931747437)",-0.9993084518229522,-0.9972842931747437,0,0
2013-07-13,32.79561869303385,46.31043370564779,46.50445302327474,46.005087534586586,46.21819305419922,9559646.333333334,,-0.00013736955075279708,-0.00013736011641970208,0.04757117307290341,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-14,32.7911122639974,46.30407206217448,46.57760874430338,46.02735265096029,46.25318145751953,9838728.666666666,,-0.00013738842373869128,-0.00013737898681372908,0.05883171982771426,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-15,32.78660583496094,46.29771041870117,46.65076446533203,46.049617767333984,46.28816986083984,10117811.0,Health Care ETFs Looking Healthy Ahead of Earnings,-0.005976929250839625,-0.0001373978623926778,0.05529602046045375,"[{'label': 'positive', 'score': 0.9992830157279968}, {'label': 'negative', 'score': 0.0003748652816284448}, {'label': 'neutral', 'score': 0.00034212612081319094}]","(0.00034212612081319094, 0.9992830157279968, 0.0003748652816284448)",0.9992500128518972,0.9992830157279968,0,0,"[{'label': 'positive', 'score': 0.9291743040084839}, {'label': 'neutral', 'score': 0.0482858382165432}, {'label': 'negative', 'score': 0.02253982238471508}]","(0.0482858382165432, 0.9291743040084839, 0.02253982238471508)",0.9526332083140631,0.9291743040084839,0,0,"[{'label': 'positive', 'score': 0.9970937967300415}, {'label': 'neutral', 'score': 0.002444942481815815}, {'label': 'negative', 'score': 0.00046122868661768734}]","(0.002444942481815815, 0.9970937967300415, 0.00046122868661768734)",0.9990752817140588,0.9970937967300415,0,0
2013-07-16,32.59064483642578,46.020992279052734,46.593509674072266,45.83015441894531,46.33587646484375,16006733.0,Merck in Talks with FDA to Identify Steps Needed for Review of Sugammadex Sodium Injection | Eli Lilly Tries Again with Alzheimer's Drug as the Race for a Cure Continues (LLY) | Life Technologies to Collaborate with Merck Serono for Companion Diagnostics Development and Commercialization ,-0.0020734198172814326,-0.005994862585695409,0.060450854970446784,"[{'label': 'neutral', 'score': 0.9981693029403687}, {'label': 'positive', 'score': 0.0017152804648503661}, {'label': 'negative', 'score': 0.00011547073518158868}]","(0.9981693029403687, 0.0017152804648503661, 0.00011547073518158868)",0.8738542570070983,0.0017152804648503661,0,1,"[{'label': 'positive', 'score': 0.747230052947998}, {'label': 'neutral', 'score': 0.24294276535511017}, {'label': 'negative', 'score': 0.0098270857706666}]","(0.24294276535511017, 0.747230052947998, 0.0098270857706666)",0.9740387210738171,0.747230052947998,0,0,"[{'label': 'neutral', 'score': 0.9663115739822388}, {'label': 'positive', 'score': 0.03331499174237251}, {'label': 'negative', 'score': 0.0003734425117727369}]","(0.9663115739822388, 0.03331499174237251, 0.0003734425117727369)",0.9778296308486474,0.03331499174237251,0,1
2013-07-17,32.523067474365234,45.92557144165039,46.536258697509766,45.92557144165039,46.06870269775391,9964174.0,,-0.015167230343298392,-0.002075572328037808,0.04040381268104672,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-07-18,32.0297737121582,45.22900772094727,45.92557144165039,45.181297302246094,45.83015441894531,18677456.0,"BMO Capital Downgrades Merck & Company, Inc. to Market Perform",0.008227882852234728,-0.015283429222066632,0.1010885877950357,"[{'label': 'negative', 'score': 0.995226263999939}, {'label': 'neutral', 'score': 0.004163311794400215}, {'label': 'positive', 'score': 0.0006104382919147611}]","(0.004163311794400215, 0.0006104382919147611, 0.995226263999939)",-0.9987740192935048,-0.995226263999939,0,0,"[{'label': 'negative', 'score': 0.8050532937049866}, {'label': 'neutral', 'score': 0.17559505999088287}, {'label': 'positive', 'score': 0.019351612776517868}]","(0.17559505999088287, 0.019351612776517868, 0.8050532937049866)",-0.9530531353601254,-0.8050532937049866,0,0,"[{'label': 'negative', 'score': 0.9963459372520447}, {'label': 'neutral', 'score': 0.0031955514568835497}, {'label': 'positive', 'score': 0.0004584949929267168}]","(0.0031955514568835497, 0.0004584949929267168, 0.9963459372520447)",-0.9990800703165131,-0.9963459372520447,0,0
2013-07-19,32.2933235168457,45.60114669799805,45.725189208984375,45.03816986083984,45.29580307006836,14911678.0,,-0.0004882578177507325,0.008194218356411919,0.1361403964363842,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-20,32.277549743652344,45.57888158162435,45.830151875813804,45.14949162801107,45.41666793823242,13895118.0,,-0.0004884963299029059,-0.0004883770544127799,0.135687858500533,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-21,32.261775970458984,45.55661646525065,45.93511454264323,45.26081339518229,45.53753280639648,12878558.0,,-0.0004887350751932769,-0.0004886156831057024,0.13398276424405606,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-22,32.246002197265625,45.53435134887695,46.040077209472656,45.37213516235352,45.65839767456055,11861998.0,,0.004400682709427853,-0.0004888545451078537,0.13442035521022794,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-23,32.38790512084961,45.73473358154297,46.011451721191406,45.36259460449219,45.6202278137207,9685616.0,,-0.0033382027620787774,0.004391028019727595,0.06270650158963195,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-24,32.27980041503906,45.582061767578125,45.83969497680664,45.33396911621094,45.725189208984375,9370378.0,"UPDATE: Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine  | Merck Announces FDA Acceptance of NDA for Vorapaxar",0.008373459209859605,-0.0033437869919100546,0.04429473325431371,"[{'label': 'neutral', 'score': 0.9630313515663147}, {'label': 'positive', 'score': 0.0367005430161953}, {'label': 'negative', 'score': 0.0002681129553820938}]","(0.9630313515663147, 0.0367005430161953, 0.0002681129553820938)",0.9854951202127431,0.0367005430161953,1,0,"[{'label': 'positive', 'score': 0.8561947345733643}, {'label': 'neutral', 'score': 0.12741512060165405}, {'label': 'negative', 'score': 0.016390152275562286}]","(0.12741512060165405, 0.8561947345733643, 0.016390152275562286)",0.9624331053113919,0.8561947345733643,1,1,"[{'label': 'neutral', 'score': 0.6128910779953003}, {'label': 'positive', 'score': 0.38653215765953064}, {'label': 'negative', 'score': 0.0005767566617578268}]","(0.6128910779953003, 0.38653215765953064, 0.0005767566617578268)",0.9970201840338963,0.38653215765953064,1,0
2013-07-25,32.55010223388672,45.96374130249024,45.98282241821289,45.181297302246094,45.35305404663086,10522339.0,,0.006643141295226492,0.008338596280636682,0.07374893121872178,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-26,32.766334533691406,46.26908493041992,46.26908493041992,45.59160232543945,45.84923553466797,10318818.0,"Weekly Preview: Earnings Season Continues, Fed In Focus, Economic Maelstrom Expected | Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC) | Merck Statement Regarding CHMP Review of Incretin-Based Therapies for Type 2 Diabetes, Including Sitagliptin ",-0.0010311511190013688,0.006621172871317596,0.07773263012682302,"[{'label': 'neutral', 'score': 0.9971867203712463}, {'label': 'negative', 'score': 0.002691056113690138}, {'label': 'positive', 'score': 0.00012221398355904967}]","(0.9971867203712463, 0.00012221398355904967, 0.002691056113690138)",-0.9131160682519959,-0.002691056113690138,0,1,"[{'label': 'negative', 'score': 0.43987277150154114}, {'label': 'neutral', 'score': 0.3688066899776459}, {'label': 'positive', 'score': 0.1913205087184906}]","(0.3688066899776459, 0.1913205087184906, 0.43987277150154114)",-0.3937815413630609,-0.43987277150154114,1,1,"[{'label': 'negative', 'score': 0.954628586769104}, {'label': 'positive', 'score': 0.02566809393465519}, {'label': 'neutral', 'score': 0.01970335841178894}]","(0.01970335841178894, 0.02566809393465519, 0.954628586769104)",-0.9476319884787777,-0.954628586769104,0,0
2013-07-27,32.7325439453125,46.22137451171875,46.36450449625651,45.70928700764974,45.919209798177086,10474411.0,,-0.0010322154891580647,-0.0010316831210642168,0.07939096852785613,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-28,32.698753356933594,46.17366409301758,46.4599240620931,45.82697168986002,45.9891840616862,10630004.0,Earnings Expectations for the Week of July 29,-0.0010332820589039344,-0.0010327485904479804,0.08265328428838183,"[{'label': 'neutral', 'score': 0.9998703002929688}, {'label': 'positive', 'score': 6.657433550572023e-05}, {'label': 'negative', 'score': 6.303480768110603e-05}]","(0.9998703002929688, 6.657433550572023e-05, 6.303480768110603e-05)",0.027309244838630814,6.657433550572023e-05,1,1,"[{'label': 'neutral', 'score': 0.686733067035675}, {'label': 'negative', 'score': 0.2790346145629883}, {'label': 'positive', 'score': 0.034232351928949356}]","(0.686733067035675, 0.034232351928949356, 0.2790346145629883)",-0.7814493349726973,-0.2790346145629883,0,1,"[{'label': 'neutral', 'score': 0.9992054104804993}, {'label': 'positive', 'score': 0.00047078929492272437}, {'label': 'negative', 'score': 0.00032381416531279683}]","(0.9992054104804993, 0.00047078929492272437, 0.00032381416531279683)",0.18496663677548544,0.00047078929492272437,1,1
2013-07-29,32.66496276855469,46.125953674316406,46.55534362792969,45.94465637207031,46.05915832519531,10785597.0,,-0.005999185222321336,-0.001033816262831181,0.07464087291339404,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-07-30,32.4690055847168,45.84923553466797,46.832061767578125,45.64885330200195,46.078243255615234,17583554.0,"SLIDESHOW: 8 Stocks to Benefit From a Repatriation Deal In Congress | Benzinga's PreMarket Info Recap for July 30, 2013: Potash Smash! | UPDATE: Merck Posts Drop In Q2 Profit | Merck & Company, Inc. Reports Q2 EPS of $0.84 vs $0.83 Est; Revenue of $11.0B vs $11.22B Est | Benzinga Market Primer: Wednesday, July 30: Futures Higher After Asia Turnaround",0.00249744115658573,-0.00601725263004519,0.0718760487508059,"[{'label': 'negative', 'score': 0.99310702085495}, {'label': 'positive', 'score': 0.006440462078899145}, {'label': 'neutral', 'score': 0.00045242675696499646}]","(0.00045242675696499646, 0.006440462078899145, 0.99310702085495)",-0.9871132443653498,-0.99310702085495,0,0,"[{'label': 'negative', 'score': 0.9375918507575989}, {'label': 'positive', 'score': 0.05060671269893646}, {'label': 'neutral', 'score': 0.011801470071077347}]","(0.011801470071077347, 0.05060671269893646, 0.9375918507575989)",-0.8975778460516608,-0.9375918507575989,0,0,"[{'label': 'positive', 'score': 0.9254757761955261}, {'label': 'neutral', 'score': 0.055808618664741516}, {'label': 'negative', 'score': 0.01871560327708721}]","(0.055808618664741516, 0.9254757761955261, 0.01871560327708721)",0.960356335200728,0.9254757761955261,0,0
2013-07-31,32.55010223388672,45.96374130249024,46.49809265136719,45.77289962768555,46.27862548828125,22612067.0,"Bionomics Signs Option and License Agreement With Merck  | Benzinga Market Primer: Wednesday, July 31: Futures Higher Heading Into FOMC Decision",0.008511493661901598,0.0024943277330709865,0.04818947994141675,"[{'label': 'positive', 'score': 0.9989355206489563}, {'label': 'neutral', 'score': 0.0008263076306320727}, {'label': 'negative', 'score': 0.00023822623188607395}]","(0.0008263076306320727, 0.9989355206489563, 0.00023822623188607395)",0.9995231535403533,0.9989355206489563,1,1,"[{'label': 'positive', 'score': 0.9399851560592651}, {'label': 'neutral', 'score': 0.0330132320523262}, {'label': 'negative', 'score': 0.0270016361027956}]","(0.0330132320523262, 0.9399851560592651, 0.0270016361027956)",0.944153040513773,0.9399851560592651,1,1,"[{'label': 'positive', 'score': 0.9929884076118469}, {'label': 'neutral', 'score': 0.006727631203830242}, {'label': 'negative', 'score': 0.0002839322842191905}]","(0.006727631203830242, 0.9929884076118469, 0.0002839322842191905)",0.9994282891553209,0.9929884076118469,1,1
2013-08-01,32.82714080810547,46.35496139526367,46.450382232666016,45.83969497680664,46.22137451171875,14198094.0,,-0.0008233432839507197,0.008475475136379874,0.08501841718325974,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-02,32.80012512207031,46.31679534912109,46.31679534912109,45.97328186035156,46.22137451171875,9350466.0,"S&P: Heaping Praise For Some Health Care ETFs | Three Soaring, But Overlooked Health Care ETFs",-6.868906830758351e-05,-0.0008236824171938379,0.08478162798853796,"[{'label': 'positive', 'score': 0.9988898634910583}, {'label': 'neutral', 'score': 0.0006334762438200414}, {'label': 'negative', 'score': 0.00047662793076597154}]","(0.0006334762438200414, 0.9988898634910583, 0.00047662793076597154)",0.9990461398598869,0.9988898634910583,0,0,"[{'label': 'positive', 'score': 0.9164038896560669}, {'label': 'neutral', 'score': 0.06885559856891632}, {'label': 'negative', 'score': 0.01474046241492033}]","(0.06885559856891632, 0.9164038896560669, 0.01474046241492033)",0.9683390392002366,0.9164038896560669,0,0,"[{'label': 'positive', 'score': 0.9819246530532837}, {'label': 'neutral', 'score': 0.01751595363020897}, {'label': 'negative', 'score': 0.0005593346431851387}]","(0.01751595363020897, 0.9819246530532837, 0.0005593346431851387)",0.9988613867499325,0.9819246530532837,0,0
2013-08-03,32.79787572224935,46.31361389160156,46.35496266682943,45.93829472859701,46.20547103881836,8605303.0,,-6.86937868199521e-05,-6.869142750967983e-05,0.08386821297256643,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-04,32.79562632242838,46.31043243408203,46.39312998453776,45.903307596842446,46.18956756591797,7860140.0,,-6.869850598047677e-05,-6.869614634618206e-05,0.06081630106533968,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-05,32.79337692260742,46.3072509765625,46.431297302246094,45.86832046508789,46.17366409301758,7114977.0,"Hearing Unconfirmed Takeover Chatter in Inovio | Apple, Wal-Mart And Other Companies With Monster Share Buyback (AAPL, WMT)",-0.001854492828503568,-6.870086583089929e-05,0.06221439505971459,"[{'label': 'neutral', 'score': 0.9997438788414001}, {'label': 'positive', 'score': 0.00015877497207839042}, {'label': 'negative', 'score': 9.732728358358145e-05}]","(0.9997438788414001, 0.00015877497207839042, 9.732728358358145e-05)",0.2399341947847327,0.00015877497207839042,1,1,"[{'label': 'neutral', 'score': 0.7461978197097778}, {'label': 'negative', 'score': 0.17061959207057953}, {'label': 'positive', 'score': 0.08318261802196503}]","(0.7461978197097778, 0.08318261802196503, 0.17061959207057953)",-0.3445083240872179,-0.17061959207057953,1,1,"[{'label': 'neutral', 'score': 0.9911529421806335}, {'label': 'positive', 'score': 0.00450877146795392}, {'label': 'negative', 'score': 0.004338251426815987}]","(0.9911529421806335, 0.00450877146795392, 0.004338251426815987)",0.019274285052290306,0.00450877146795392,1,1
2013-08-06,32.7325439453125,46.22137451171875,46.364505767822266,45.88740539550781,46.25954055786133,10421836.0,,0.0022708410637390384,-0.0018562145292461366,0.012480332369707291,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-08-07,32.806880950927734,46.32633590698242,46.51717758178711,46.13549423217773,46.13549423217773,10130282.0,,-0.0016477864153922074,0.0022682666008980172,0.02327150744705688,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-08,32.7528190612793,46.25,46.60305404663086,45.98282241821289,46.431297302246094,9045707.0,,-0.0016505060969172298,-0.0016491455086296886,0.026255208479863748,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-09,32.69875717163086,46.17366409301758,46.54580307006836,46.049617767333984,46.22137451171875,8266834.0,,0.0005510782569955107,-0.0016518696827161736,0.027830331188174986,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-10,32.71677780151367,46.199109395345054,46.555344899495445,45.99554697672526,46.13231531778971,8981884.333333334,,0.0005507747370134402,0.0005509264691349516,0.028891121325617587,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-11,32.734798431396484,46.22455469767253,46.56488672892253,45.94147618611654,46.04325612386068,9696934.666666666,,0.0005504715511894467,0.0005506231162780418,0.026562120561636586,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-12,32.7528190612793,46.25,46.57442855834961,45.88740539550781,45.95419692993164,10411985.0,Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck ,-0.0008252942884289004,0.0005503200973033002,0.01913845602618484,"[{'label': 'positive', 'score': 0.9175505042076111}, {'label': 'neutral', 'score': 0.08181530237197876}, {'label': 'negative', 'score': 0.0006341666448861361}]","(0.08181530237197876, 0.9175505042076111, 0.0006341666448861361)",0.998618651203799,0.9175505042076111,0,0,"[{'label': 'positive', 'score': 0.7176079154014587}, {'label': 'neutral', 'score': 0.26963287591934204}, {'label': 'negative', 'score': 0.012759310193359852}]","(0.26963287591934204, 0.7176079154014587, 0.012759310193359852)",0.9650605620125724,0.7176079154014587,0,0,"[{'label': 'positive', 'score': 0.8650548458099365}, {'label': 'neutral', 'score': 0.1344773769378662}, {'label': 'negative', 'score': 0.00046775612281635404}]","(0.1344773769378662, 0.8650548458099365, 0.00046775612281635404)",0.9989191359722511,0.8650548458099365,0,0
2013-08-13,32.725772857666016,46.21183013916016,46.61259460449219,45.87786483764648,46.29771041870117,7812945.0,"Mid-Afternoon Market Update: Apple Rises Sharply On Icahn Stake, NASDAQ Pulled Upward | Mid-Day Market Update: US Stocks Edge Higher; Valspar Shares Decline On Downbeat Results | Mid-Morning Market Update: Markets Drop, Yum China Same-Store Sales Down 13% | Benzinga's Top Pre-Market Gainers",0.0028908333177864727,-0.0008256350312484816,0.016234682343496756,"[{'label': 'negative', 'score': 0.9972537159919739}, {'label': 'positive', 'score': 0.002038592239841819}, {'label': 'neutral', 'score': 0.0007076839101500809}]","(0.0007076839101500809, 0.002038592239841819, 0.9972537159919739)",-0.9959199280870099,-0.9972537159919739,0,0,"[{'label': 'negative', 'score': 0.9551473259925842}, {'label': 'positive', 'score': 0.03477936238050461}, {'label': 'neutral', 'score': 0.010073291137814522}]","(0.010073291137814522, 0.03477936238050461, 0.9551473259925842)",-0.9297334584692059,-0.9551473259925842,0,0,"[{'label': 'positive', 'score': 0.5741092562675476}, {'label': 'neutral', 'score': 0.3881790339946747}, {'label': 'negative', 'score': 0.03771165758371353}]","(0.3881790339946747, 0.5741092562675476, 0.03771165758371353)",0.8767232151436996,0.5741092562675476,1,1
2013-08-14,32.82038497924805,46.34542083740234,46.52671813964844,46.1927490234375,46.32633590698242,8940383.0,"13F from Leon Cooperman's Omega Advisors Shows New Stakes in Thermo-Fisher, McKesson, Liquidated Stakes in Freeport-McMoRan, Facebook, Covidien, Raised Stakes in DISH, Citi, Lowered Stakes in Merck, AIG, Polycom",-0.012353350112526017,0.0028866628945498365,0.021248923049320308,"[{'label': 'neutral', 'score': 0.6982190012931824}, {'label': 'positive', 'score': 0.30109986662864685}, {'label': 'negative', 'score': 0.0006810901686549187}]","(0.6982190012931824, 0.30109986662864685, 0.0006810901686549187)",0.9954861951802189,0.30109986662864685,0,0,"[{'label': 'neutral', 'score': 0.5315847396850586}, {'label': 'positive', 'score': 0.4522213339805603}, {'label': 'negative', 'score': 0.016193937510252}]","(0.5315847396850586, 0.4522213339805603, 0.016193937510252)",0.9308564921091833,0.4522213339805603,0,0,"[{'label': 'neutral', 'score': 0.9728996157646179}, {'label': 'positive', 'score': 0.02525418996810913}, {'label': 'negative', 'score': 0.0018461216241121292}]","(0.9728996157646179, 0.02525418996810913, 0.0018461216241121292)",0.8637564281997384,0.02525418996810913,0,0
2013-08-15,32.41494369506836,45.77289962768555,46.14503860473633,45.65839767456055,46.06870269775391,11885892.0,,-0.005628509692942573,-0.012430287017652973,0.09621845295609249,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-16,32.23249053955078,45.51526641845703,45.8015251159668,45.30534362792969,45.60114669799805,13834019.0,"Merck Shares Down ~0.75% Today, But Have Been Relatively Quiet/Rangebound All Day; Traders Seemed to Shrug at Earlier Report Co. to Temporarily Halt Zilmax Sales",-0.0008385607887567666,-0.005644409442957062,0.09651704438584546,"[{'label': 'negative', 'score': 0.9981258511543274}, {'label': 'neutral', 'score': 0.001259253011085093}, {'label': 'positive', 'score': 0.000614937103819102}]","(0.001259253011085093, 0.000614937103819102, 0.9981258511543274)",-0.9987685751677539,-0.9981258511543274,0,0,"[{'label': 'negative', 'score': 0.9726167917251587}, {'label': 'neutral', 'score': 0.019443219527602196}, {'label': 'positive', 'score': 0.007939877919852734}]","(0.019443219527602196, 0.007939877919852734, 0.9726167917251587)",-0.9838053665521909,-0.9726167917251587,0,0,"[{'label': 'negative', 'score': 0.9978717565536499}, {'label': 'neutral', 'score': 0.001780083985067904}, {'label': 'positive', 'score': 0.0003481612366158515}]","(0.001780083985067904, 0.0003481612366158515, 0.9978717565536499)",-0.9993024358051549,-0.9978717565536499,0,0
2013-08-17,32.205465952555336,45.477099100748696,45.73791249593099,45.2958017985026,45.49936548868815,12149498.666666666,,-0.0008392645631106282,-0.0008389125775329219,0.09367565957689616,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-18,32.1784413655599,45.43893178304037,45.67429987589518,45.28625996907552,45.39758427937826,10464978.333333334,,-0.0008399695197628145,-0.0008396169427877678,0.09365177883932144,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-19,32.15141677856445,45.40076446533203,45.610687255859375,45.27671813964844,45.29580307006836,8780458.0,,-0.0004203658384319741,-0.0008403224918309325,0.0808148956418356,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-20,32.13789749145508,45.38167953491211,46.16412353515625,45.38167953491211,45.46755599975586,14771560.0,,-0.0021026290428263358,-0.00042045421691942807,0.034973469761784705,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-21,32.070335388183594,45.286258697509766,45.83969497680664,45.13358688354492,45.38167953491211,11318400.0,,0.007374623689752981,-0.002104842670775441,0.010143952148214582,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-08-22,32.30682373046875,45.6202278137207,45.78244400024414,45.22900772094727,45.4484748840332,9044554.0,,-0.0016732907887729387,0.00734756410719168,0.06046400645087967,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-23,32.252777099609375,45.54389190673828,45.78244400024414,45.27671813964844,45.78244400024414,9616762.0,,-0.0007682068942680441,-0.0016746923034508159,0.062012204115231534,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-24,32.22799936930338,45.508904774983726,45.75699869791666,45.30216344197592,45.72519175211588,9632098.0,,-0.0007687974898000044,-0.000768502116388371,0.061919247484101964,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-25,32.2032216389974,45.47391764322917,45.7315533955892,45.32760874430338,45.66793950398763,9647434.0,,-0.0007693889941275255,-0.0007690931661433274,0.06228556039940199,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-26,32.178443908691406,45.43893051147461,45.70610809326172,45.35305404663086,45.610687255859375,9662770.0,"Chicago Tribune Running Story 'Cargill to stop buying cows fed with questionable growth drug,' Related to Merck's Zillmax",-0.010709779581033288,-0.0007696851257429734,0.05955604999619273,"[{'label': 'neutral', 'score': 0.9785313606262207}, {'label': 'negative', 'score': 0.020900338888168335}, {'label': 'positive', 'score': 0.0005682724295184016}]","(0.9785313606262207, 0.0005682724295184016, 0.020900338888168335)",-0.9470601594943185,-0.020900338888168335,1,0,"[{'label': 'negative', 'score': 0.5881953239440918}, {'label': 'neutral', 'score': 0.38435888290405273}, {'label': 'positive', 'score': 0.02744569256901741}]","(0.38435888290405273, 0.02744569256901741, 0.5881953239440918)",-0.9108386483913454,-0.5881953239440918,1,1,"[{'label': 'neutral', 'score': 0.9906710386276245}, {'label': 'negative', 'score': 0.006599836051464081}, {'label': 'positive', 'score': 0.002729140454903245}]","(0.9906710386276245, 0.002729140454903245, 0.006599836051464081)",-0.41491106703066105,-0.006599836051464081,0,0
2013-08-27,31.83382225036621,44.95228958129883,45.343509674072266,44.78053283691406,45.15267181396485,11362835.0,"Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, VRTX)",-0.0004245596964623052,-0.010767542056145125,0.06965338718025733,"[{'label': 'neutral', 'score': 0.9994984865188599}, {'label': 'positive', 'score': 0.0004081119841430336}, {'label': 'negative', 'score': 9.335417416878045e-05}]","(0.9994984865188599, 0.0004081119841430336, 9.335417416878045e-05)",0.6276750778833918,0.0004081119841430336,0,1,"[{'label': 'negative', 'score': 0.8459942936897278}, {'label': 'neutral', 'score': 0.12172979861497879}, {'label': 'positive', 'score': 0.03227585554122925}]","(0.12172979861497879, 0.03227585554122925, 0.8459942936897278)",-0.926501303569315,-0.8459942936897278,0,0,"[{'label': 'negative', 'score': 0.9947258830070496}, {'label': 'neutral', 'score': 0.004795865621417761}, {'label': 'positive', 'score': 0.0004782266914844513}]","(0.004795865621417761, 0.0004782266914844513, 0.9947258830070496)",-0.9990389374665478,-0.9947258830070496,0,0
2013-08-28,31.82029914855957,44.933204650878906,45.22900772094727,44.34160232543945,44.63740539550781,10283186.0,,0.00021241246051225193,-0.0004246498474474174,0.07163241022266627,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-29,31.82706069946289,44.9427490234375,45.22900772094727,44.64694595336914,44.81870269775391,10160779.0,,0.004033961121326933,0.0002123899041797072,0.07360978139288007,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-08-30,31.95544815063477,45.1240463256836,45.30534362792969,44.86641311645508,44.933204650878906,8725962.0,Plenty Of ETFs With Favorable Risk Traits,-0.0004229225501603654,0.0040258465155120745,0.08732217789465824,"[{'label': 'positive', 'score': 0.9117400050163269}, {'label': 'neutral', 'score': 0.08762795478105545}, {'label': 'negative', 'score': 0.0006320634856820107}]","(0.08762795478105545, 0.9117400050163269, 0.0006320634856820107)",0.9986144611228185,0.9117400050163269,0,0,"[{'label': 'neutral', 'score': 0.5236977338790894}, {'label': 'positive', 'score': 0.4664779007434845}, {'label': 'negative', 'score': 0.009824320673942566}]","(0.5236977338790894, 0.4664779007434845, 0.009824320673942566)",0.9587475336784851,0.4664779007434845,0,1,"[{'label': 'neutral', 'score': 0.5130155086517334}, {'label': 'positive', 'score': 0.48637616634368896}, {'label': 'negative', 'score': 0.0006083381595090032}]","(0.5130155086517334, 0.48637616634368896, 0.0006083381595090032)",0.9975016118423332,0.48637616634368896,0,1
2013-08-31,31.94193410873413,45.10496234893799,45.34828281402588,44.86402702331543,45.035780906677246,10268120.25,,-0.00042310148932104825,-0.00042301200712526084,0.08755041088348346,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-01,31.928420066833496,45.08587837219238,45.39122200012207,44.86164093017578,45.13835716247559,11810278.5,,-0.000423280579964832,-0.0004231910220113093,0.030771407774702098,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-02,31.91490602493286,45.06679439544678,45.43416118621826,44.85925483703613,45.240933418273926,13352436.75,,-0.0004234598222840002,-0.00042337018847682156,0.03076874159379932,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-03,31.901391983032227,45.04771041870117,45.47710037231445,44.85686874389648,45.343509674072266,14894595.0,,0.00995546866128314,-0.00042354950671391796,0.03158566991231867,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-09-04,32.218990325927734,45.49618148803711,45.6870231628418,44.95228958129883,44.97137451171875,11596330.0,Merck's Durham Site Receives US FDA License for Varicella Bulk,-0.003565406293906763,0.009906239446783094,0.07333231830604364,"[{'label': 'neutral', 'score': 0.8774372339248657}, {'label': 'positive', 'score': 0.12217676639556885}, {'label': 'negative', 'score': 0.0003859179269056767}]","(0.8774372339248657, 0.12217676639556885, 0.0003859179269056767)",0.9937025216273774,0.12217676639556885,0,1,"[{'label': 'positive', 'score': 0.6198595762252808}, {'label': 'neutral', 'score': 0.3674279749393463}, {'label': 'negative', 'score': 0.012712434865534306}]","(0.3674279749393463, 0.6198595762252808, 0.012712434865534306)",0.9598071535172326,0.6198595762252808,0,0,"[{'label': 'positive', 'score': 0.998263418674469}, {'label': 'neutral', 'score': 0.0014671027893200517}, {'label': 'negative', 'score': 0.00026944681303575635}]","(0.0014671027893200517, 0.998263418674469, 0.00026944681303575635)",0.999460314582827,0.998263418674469,0,0
2013-09-05,32.10411071777344,45.33396911621094,45.60114669799805,45.09542083740234,45.60114669799805,8277314.0,,-0.00042098520804562226,-0.003571777503402161,0.08183434714123296,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-06,32.09059524536133,45.314884185791016,45.6297721862793,44.904579162597656,45.39122009277344,27944815.0,,0.0017547736451434357,-0.0004210738471964271,0.08183200784815226,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-07,32.14690907796224,45.39440155029297,45.63931401570638,45.038167317708336,45.40076192220052,28823493.33333333,,0.0017516998084853028,0.0017532358286211356,0.08087796231227301,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-08,32.20322291056315,45.47391891479492,45.64885584513346,45.17175547281901,45.4103037516276,29702171.666666668,,0.001748636721874641,0.001750167371694194,0.07916200532483596,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-09,32.25953674316406,45.55343627929688,45.65839767456055,45.30534362792969,45.41984558105469,30580850.0,USA TD Ameritrade's Investor Movement Index for Aug 5.16 vs 4.87 Prior | Merck Reports FDA Acceptance of NDA for Investigational Fertility Treatment,0.005027232622873237,0.001747109636634479,0.03706609971559388,"[{'label': 'positive', 'score': 0.9546988010406494}, {'label': 'neutral', 'score': 0.044482387602329254}, {'label': 'negative', 'score': 0.0008188019855879247}]","(0.044482387602329254, 0.9546988010406494, 0.0008188019855879247)",0.9982861603323797,0.9546988010406494,0,0,"[{'label': 'negative', 'score': 0.8397776484489441}, {'label': 'positive', 'score': 0.10862167924642563}, {'label': 'neutral', 'score': 0.05160066485404968}]","(0.05160066485404968, 0.10862167924642563, 0.8397776484489441)",-0.7709368278225617,-0.8397776484489441,0,0,"[{'label': 'neutral', 'score': 0.961530864238739}, {'label': 'positive', 'score': 0.03653319925069809}, {'label': 'negative', 'score': 0.0019358721328899264}]","(0.961530864238739, 0.03653319925069809, 0.0019358721328899264)",0.8993543611392801,0.03653319925069809,0,1
2013-09-10,32.42170715332031,45.78244400024414,46.183204650878906,45.66793823242188,45.66793823242188,32287413.0,,0.0033347239820578933,0.0050146382811056475,0.030875859234071466,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-11,32.529823303222656,45.93511581420898,46.28816986083984,45.76335906982422,45.83015441894531,14021297.0,"US Stock Futures Flat; Apple Shares Drop In Pre-Market Trading | Merck, AstraZeneca Announce License Agreement for MK-1775",-0.006024108892370181,0.003329176120343177,0.023083873325040943,"[{'label': 'negative', 'score': 0.995633065700531}, {'label': 'neutral', 'score': 0.0039163753390312195}, {'label': 'positive', 'score': 0.0004505336983129382}]","(0.0039163753390312195, 0.0004505336983129382, 0.995633065700531)",-0.9990953897873937,-0.995633065700531,1,1,"[{'label': 'negative', 'score': 0.9586982727050781}, {'label': 'neutral', 'score': 0.029907332733273506}, {'label': 'positive', 'score': 0.011394382454454899}]","(0.029907332733273506, 0.011394382454454899, 0.9586982727050781)",-0.9765086718390191,-0.9586982727050781,1,1,"[{'label': 'negative', 'score': 0.9947510361671448}, {'label': 'neutral', 'score': 0.004693697672337294}, {'label': 'positive', 'score': 0.0005553664523176849}]","(0.004693697672337294, 0.0005553664523176849, 0.9947510361671448)",-0.9988840291776361,-0.9947510361671448,1,1
2013-09-12,32.62528610229492,45.65839767456055,45.78244400024414,45.46755599975586,45.610687255859375,9958515.0,"Watch Shares of Caterpillar, Deere, Devon, Merck, and Oracle to the Downside on a Bearish Article from Jim Cramer Tweeted Out by Carl Icahn",-0.0012538980664754795,-0.006042327038589641,0.06741064066831944,"[{'label': 'neutral', 'score': 0.9990720748901367}, {'label': 'negative', 'score': 0.0008230169769376516}, {'label': 'positive', 'score': 0.00010495587775949389}]","(0.9990720748901367, 0.00010495587775949389, 0.0008230169769376516)",-0.7737953707843158,-0.0008230169769376516,0,1,"[{'label': 'negative', 'score': 0.8812587857246399}, {'label': 'neutral', 'score': 0.09687738120555878}, {'label': 'positive', 'score': 0.021863875910639763}]","(0.09687738120555878, 0.021863875910639763, 0.8812587857246399)",-0.9515816027226004,-0.8812587857246399,0,0,"[{'label': 'negative', 'score': 0.9948089122772217}, {'label': 'neutral', 'score': 0.004779462702572346}, {'label': 'positive', 'score': 0.00041163936839438975}]","(0.004779462702572346, 0.00041163936839438975, 0.9948089122772217)",-0.9991727675484319,-0.9948089122772217,0,0
2013-09-13,32.584373474121094,45.60114669799805,45.79198455810547,45.48664093017578,45.6870231628418,8049688.0,,0.002789957035821696,-0.001254684854426053,0.06910662288934802,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-14,32.67528788248698,45.728371938069664,45.93829472859701,45.62340927124024,45.804707845052086,8660043.333333334,"Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, CELG, PCYC)",0.0027821948317757563,0.002786072329455945,0.07060943535037348,"[{'label': 'positive', 'score': 0.7171422243118286}, {'label': 'neutral', 'score': 0.18829873204231262}, {'label': 'negative', 'score': 0.0945589616894722}]","(0.18829873204231262, 0.7171422243118286, 0.0945589616894722)",0.7670104138807537,0.7171422243118286,0,0,"[{'label': 'neutral', 'score': 0.6900537014007568}, {'label': 'positive', 'score': 0.29182881116867065}, {'label': 'negative', 'score': 0.018117498606443405}]","(0.6900537014007568, 0.29182881116867065, 0.018117498606443405)",0.8830926645354235,0.29182881116867065,0,1,"[{'label': 'neutral', 'score': 0.9980849027633667}, {'label': 'negative', 'score': 0.0010606046998873353}, {'label': 'positive', 'score': 0.0008545551099814475}]","(0.9980849027633667, 0.0008545551099814475, 0.0010606046998873353)",-0.10758871862500359,-0.0010606046998873353,1,1
2013-09-15,32.76620229085287,45.85559717814128,46.08460489908854,45.76017761230469,45.92239252726237,9270398.666666666,,0.002774475699822667,0.002778331691415294,0.06356689134961654,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-16,32.85711669921875,45.98282241821289,46.23091506958008,45.89694595336914,46.040077209472656,9880754.0,,-0.0037351541435497455,0.0027706339463787924,0.062005240951955434,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-17,32.73439025878906,45.81106948852539,46.020992279052734,45.7442741394043,45.90649032592773,8073058.0,,0.00812325855974017,-0.0037421472507744185,0.047957644236665105,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-09-18,33.00027847290039,46.183204650878906,46.47900772094727,45.4484748840332,45.6202278137207,14681118.0,,-0.002892542528279912,0.008090442490750839,0.0666177632930004,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-19,32.90481948852539,46.049617767333984,46.26908493041992,45.89694595336914,46.25,9775744.0,Write A Prescription For Health Care ETFs,-0.005180244492231414,-0.0028967340140707283,0.07672662931323472,"[{'label': 'neutral', 'score': 0.9998904466629028}, {'label': 'negative', 'score': 6.29005444352515e-05}, {'label': 'positive', 'score': 4.662630817620084e-05}]","(0.9998904466629028, 4.662630817620084e-05, 6.29005444352515e-05)",-0.14858672436049716,-6.29005444352515e-05,1,1,"[{'label': 'neutral', 'score': 0.9371055364608765}, {'label': 'positive', 'score': 0.03754119202494621}, {'label': 'negative', 'score': 0.025353247299790382}]","(0.9371055364608765, 0.03754119202494621, 0.025353247299790382)",0.19378413824832796,0.03754119202494621,1,1,"[{'label': 'neutral', 'score': 0.9995835423469543}, {'label': 'positive', 'score': 0.00028394072433002293}, {'label': 'negative', 'score': 0.00013256051170174032}]","(0.9995835423469543, 0.00028394072433002293, 0.00013256051170174032)",0.36345681484781484,0.00028394072433002293,1,1
2013-09-20,32.73439025878906,45.81106948852539,46.183204650878906,45.67748260498047,46.11641311645508,29303128.0,,-0.0022912075182117317,-0.005193708476680075,0.08778195438362922,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-21,32.6593869527181,45.70610682169596,46.07506306966146,45.57251993815104,45.94465764363607,23939010.0,,-0.0022964692057210667,-0.0022938363503918545,0.08429934176920037,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-22,32.58438364664713,45.60114415486654,45.96692148844401,45.46755727132162,45.772902170817055,18574892.0,,-0.0023017551154629937,-0.002299110135110818,0.08216092916089594,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-23,32.50938034057617,45.49618148803711,45.85877990722656,45.36259460449219,45.60114669799805,13210774.0,Merck Receives CRL for Investigational Medicine Sugammadex Sodium Injection,-0.0031459220691715485,-0.0023044082257574895,0.01991721397848388,"[{'label': 'neutral', 'score': 0.9988920092582703}, {'label': 'positive', 'score': 0.0010130746522918344}, {'label': 'negative', 'score': 9.496179700363427e-05}]","(0.9988920092582703, 0.0010130746522918344, 9.496179700363427e-05)",0.8285944527113444,0.0010130746522918344,0,0,"[{'label': 'neutral', 'score': 0.5227199196815491}, {'label': 'positive', 'score': 0.4668763279914856}, {'label': 'negative', 'score': 0.010403739288449287}]","(0.5227199196815491, 0.4668763279914856, 0.010403739288449287)",0.9564040486847012,0.4668763279914856,0,0,"[{'label': 'positive', 'score': 0.9169524312019348}, {'label': 'neutral', 'score': 0.0825752541422844}, {'label': 'negative', 'score': 0.0004723661986645311}]","(0.0825752541422844, 0.9169524312019348, 0.0004723661986645311)",0.9989702345085877,0.9169524312019348,0,0
2013-09-24,32.407108306884766,45.35305404663086,46.011451721191406,45.343509674072266,45.4484748840332,13939029.0,,0.0029454881562677396,-0.0031508808847668453,0.019917883866553632,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-25,32.5025634765625,45.48664093017578,45.79198455810547,45.24809265136719,45.48664093017578,11901402.0,,0.0002097441724917289,0.0029411587055089275,0.039154278464474813,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-26,32.50938034057617,45.49618148803711,45.8015251159668,45.33396911621094,45.59160232543945,10753633.0,,0.0023071213127751687,0.00020972217925805566,0.03967053228749901,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-27,32.584373474121094,45.60114669799805,45.71564865112305,45.1240463256836,45.39122009277344,11014794.0,,-0.0012555001852786968,0.0023044639947844333,0.04292234721404233,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-28,32.54346211751302,45.54389444986979,45.70292663574219,45.1240463256836,45.41348520914713,13017766.666666666,,-0.0012570784475022898,-0.0012562889859316301,0.0399169940833731,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-29,32.502550760904946,45.48664220174154,45.69020462036133,45.1240463256836,45.43575032552084,15020739.333333332,,-0.001258660682719411,-0.0012578692334033357,0.03118374589113812,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-09-30,32.461639404296875,45.42938995361328,45.67748260498047,45.1240463256836,45.45801544189453,17023712.0,,0.023734486787434443,-0.0012594534613725506,0.024827277637214464,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-10-01,33.23210525512695,46.50763320922852,46.975189208984375,45.94465637207031,46.67938995361328,28651482.0,"Merck Shares Soar After Announcing More Job Cuts | Merck Says Interim Data for MK-3475 to be Presented at 15th World Conference on Lung Cancer | PreMarket Info Recap for October 1, 2013: Government Shutdown Gives Markets A Boost | Merck Says Will Close Summit Campus, Will Move Global HQ to Kenilworth | UPDATE: Merck Announces Global Initiative to Sharpen Commercial and R&D Focus; Cutting 8500 Jobs; Affirms FY Target | Merck Cutting 8,500 Jobs Related to Global Initiative to 'Sharpen Commercial, R&D Focus,' Sees Pretax Charge $2.5-3B, Reaffirms FY13 Outlook",-0.007591313990169035,0.0234572027491421,0.17090047246998666,"[{'label': 'positive', 'score': 0.9990987777709961}, {'label': 'neutral', 'score': 0.0004701988073065877}, {'label': 'negative', 'score': 0.0004310696676839143}]","(0.0004701988073065877, 0.9990987777709961, 0.0004310696676839143)",0.9991374551369555,0.9990987777709961,0,0,"[{'label': 'negative', 'score': 0.9015936851501465}, {'label': 'positive', 'score': 0.07421310991048813}, {'label': 'neutral', 'score': 0.024193188175559044}]","(0.024193188175559044, 0.07421310991048813, 0.9015936851501465)",-0.8478938447935758,-0.9015936851501465,0,0,"[{'label': 'positive', 'score': 0.6697114109992981}, {'label': 'neutral', 'score': 0.22036290168762207}, {'label': 'negative', 'score': 0.10992567241191864}]","(0.22036290168762207, 0.6697114109992981, 0.10992567241191864)",0.7180080969700648,0.6697114109992981,0,0
2013-10-02,32.97983932495117,46.154579162597656,46.32633590698242,45.91603088378906,46.23091506958008,14646114.0,Pharmaceutical Industry Expected To Collect Billions From Obamacare,-0.00020670880407592403,-0.007620274673742467,0.19180435247401814,"[{'label': 'neutral', 'score': 0.999823272228241}, {'label': 'positive', 'score': 0.000106610226794146}, {'label': 'negative', 'score': 7.019916665740311e-05}]","(0.999823272228241, 0.000106610226794146, 7.019916665740311e-05)",0.2059339689252459,0.000106610226794146,1,1,"[{'label': 'neutral', 'score': 0.6015969514846802}, {'label': 'positive', 'score': 0.3858664035797119}, {'label': 'negative', 'score': 0.012536663562059402}]","(0.6015969514846802, 0.3858664035797119, 0.012536663562059402)",0.9370654264687263,0.3858664035797119,0,1,"[{'label': 'positive', 'score': 0.8483313918113708}, {'label': 'neutral', 'score': 0.15083877742290497}, {'label': 'negative', 'score': 0.0008298177272081375}]","(0.15083877742290497, 0.8483313918113708, 0.0008298177272081375)",0.9980455590342874,0.8483313918113708,0,0
2013-10-03,32.973018646240234,46.14503860473633,46.51717758178711,45.8015251159668,46.011451721191406,18759724.0,,-0.002688183376465127,-0.0002067301712853357,0.1906809652607613,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-04,32.884376525878906,46.020992279052734,46.14503860473633,45.7442741394043,46.05915832519531,12126198.0,,-0.002349859214844141,-0.002691803029714271,0.19277957129817008,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-05,32.807098388671875,45.91284942626953,46.10368982950846,45.66157658894857,45.947835286458336,11296531.333333334,,-0.0023553940592789266,-0.002352624466826817,0.19421482752212813,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-06,32.729820251464844,45.80470657348633,46.0623410542806,45.57887903849284,45.83651224772135,10466864.666666666,,-0.002360955038751426,-0.0023581723633909523,0.043521038082530446,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-07,32.65254211425781,45.696563720703125,46.020992279052734,45.49618148803711,45.725189208984375,9637198.0,Merck Says Data Shows Cognigram as Sensitive Assessment,-0.002923346367166761,-0.002363746487621323,0.016030907156740676,"[{'label': 'neutral', 'score': 0.9998340606689453}, {'label': 'positive', 'score': 0.00010580694652162492}, {'label': 'negative', 'score': 6.0041635151719674e-05}]","(0.9998340606689453, 0.00010580694652162492, 6.0041635151719674e-05)",0.27594635364470355,0.00010580694652162492,0,0,"[{'label': 'neutral', 'score': 0.5563468337059021}, {'label': 'positive', 'score': 0.40208905935287476}, {'label': 'negative', 'score': 0.041564129292964935}]","(0.5563468337059021, 0.40208905935287476, 0.041564129292964935)",0.8126278347290553,0.40208905935287476,0,0,"[{'label': 'neutral', 'score': 0.9992361068725586}, {'label': 'positive', 'score': 0.0005879589007236063}, {'label': 'negative', 'score': 0.00017596759425941855}]","(0.9992361068725586, 0.0005879589007236063, 0.00017596759425941855)",0.5393075239173929,0.0005879589007236063,0,0
2013-10-08,32.55710220336914,45.5629768371582,45.94465637207031,45.45801544189453,45.64885330200195,14693694.0,"Credit Suisse Starts Pfizer, Bristol-Myers, AbbVie, Allergan at Outperform, Merck, Eli Lilly, Forest Labs at Neutral | FDA Postpones Advisory Committee Meeting for Grass Ait Tablet Due to US Government Shutdown",-0.010052359913433128,-0.002927627690053595,0.004143583370766125,"[{'label': 'neutral', 'score': 0.9964040517807007}, {'label': 'negative', 'score': 0.0035073168110102415}, {'label': 'positive', 'score': 8.855146006681025e-05}]","(0.9964040517807007, 8.855146006681025e-05, 0.0035073168110102415)",-0.9507482180150683,-0.0035073168110102415,1,0,"[{'label': 'negative', 'score': 0.8329342007637024}, {'label': 'neutral', 'score': 0.1534963697195053}, {'label': 'positive', 'score': 0.013569471426308155}]","(0.1534963697195053, 0.013569471426308155, 0.8329342007637024)",-0.9679399585090936,-0.8329342007637024,1,1,"[{'label': 'neutral', 'score': 0.9848499298095703}, {'label': 'positive', 'score': 0.013322127982974052}, {'label': 'negative', 'score': 0.0018279532669112086}]","(0.9848499298095703, 0.013322127982974052, 0.0018279532669112086)",0.7586873315382315,0.013322127982974052,0,0
2013-10-09,32.22982406616211,45.10496139526367,45.6297721862793,44.98091506958008,45.5057258605957,16090363.0,,0.004654095337489571,-0.01010322605361101,0.054115484039829236,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-10,32.37981414794922,45.314884185791016,45.4484748840332,44.80915832519531,45.41984558105469,18090995.0,,-0.004211372566351038,0.004643298522428443,0.08286090684297359,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-11,32.24346160888672,45.1240463256836,45.314884185791016,44.99045944213867,45.24809265136719,10745668.0,"Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX) | Jefferies Downgrades Merck & Company, Inc. to Hold, Lowers PT to $50.00",-0.003806295906607466,-0.004220265371857417,0.08353927708167576,"[{'label': 'negative', 'score': 0.9784705638885498}, {'label': 'neutral', 'score': 0.011802533641457558}, {'label': 'positive', 'score': 0.009726923890411854}]","(0.011802533641457558, 0.009726923890411854, 0.9784705638885498)",-0.9803138056700108,-0.9784705638885498,0,0,"[{'label': 'negative', 'score': 0.909025251865387}, {'label': 'neutral', 'score': 0.05643583834171295}, {'label': 'positive', 'score': 0.034538812935352325}]","(0.05643583834171295, 0.034538812935352325, 0.909025251865387)",-0.9267907411403036,-0.909025251865387,0,0,"[{'label': 'negative', 'score': 0.9936152696609497}, {'label': 'neutral', 'score': 0.005730498116463423}, {'label': 'positive', 'score': 0.0006542240735143423}]","(0.005730498116463423, 0.0006542240735143423, 0.9936152696609497)",-0.9986840105672817,-0.9936152696609497,0,0
2013-10-12,32.12073580423991,44.952290852864586,45.18447748819987,44.76463190714518,45.0508918762207,14386070.666666666,,-0.0038208391510278286,-0.0038135582852370353,0.0834838887723967,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-13,31.998009999593098,44.78053538004557,45.054070790608726,44.538804372151695,44.85369110107422,18026473.33333333,,-0.0038354939565001973,-0.0038281572036187963,0.08348631054343905,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-14,31.87528419494629,44.60877990722656,44.92366409301758,44.3129768371582,44.65649032592773,21666876.0,"Merck, Endocyte Report Vintafolide-PLD Generaly Well Tolerated, Showed Median PFS of Five Months | UPDATE: Bernstein Downgrades Merck & Co. on Negative Outlook | Barclays Downgrades Merck & Company, Inc. to Equalweight | Benzinga's Top Downgrades | Bernstein Downgrades Merck & Company, Inc. to Market Perform, Lowers PT to $50.00",-0.003850290116474162,-0.003842868325717004,0.060897378408132856,"[{'label': 'positive', 'score': 0.9449780583381653}, {'label': 'negative', 'score': 0.05379047617316246}, {'label': 'neutral', 'score': 0.0012314420891925693}]","(0.0012314420891925693, 0.9449780583381653, 0.05379047617316246)",0.89228640207517,0.9449780583381653,0,0,"[{'label': 'negative', 'score': 0.8426144123077393}, {'label': 'positive', 'score': 0.12320603430271149}, {'label': 'neutral', 'score': 0.034179575741291046}]","(0.034179575741291046, 0.12320603430271149, 0.8426144123077393)",-0.744867620611878,-0.8426144123077393,0,0,"[{'label': 'positive', 'score': 0.9665181040763855}, {'label': 'neutral', 'score': 0.0197015181183815}, {'label': 'negative', 'score': 0.013780312612652779}]","(0.0197015181183815, 0.9665181040763855, 0.013780312612652779)",0.971885474100436,0.9665181040763855,0,0
2013-10-15,31.7525577545166,44.4370231628418,44.68511581420898,44.29389190673828,44.38931274414063,14840728.0,,0.012883792708649977,-0.0038577215650865827,0.0027434890633772848,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-10-16,32.16163635253906,45.00954055786133,45.00954055786133,44.4370231628418,44.475189208984375,11635630.0,"Merck Confirms Development of Investigational Dosing ISENTRESS, Will Begin Phase III Trial Early 2014",-0.0012719742493016981,0.01280150270260099,0.11811183334859911,"[{'label': 'neutral', 'score': 0.9998606443405151}, {'label': 'positive', 'score': 7.70895421737805e-05}, {'label': 'negative', 'score': 6.217951158760116e-05}]","(0.9998606443405151, 7.70895421737805e-05, 6.217951158760116e-05)",0.10705917921813148,7.70895421737805e-05,1,1,"[{'label': 'neutral', 'score': 0.8131693601608276}, {'label': 'positive', 'score': 0.1750435084104538}, {'label': 'negative', 'score': 0.01178712397813797}]","(0.8131693601608276, 0.1750435084104538, 0.01178712397813797)",0.8738202207267408,0.1750435084104538,0,1,"[{'label': 'neutral', 'score': 0.9426472783088684}, {'label': 'positive', 'score': 0.057112839072942734}, {'label': 'negative', 'score': 0.0002398337092017755}]","(0.9426472783088684, 0.057112839072942734, 0.0002398337092017755)",0.9916365289508725,0.057112839072942734,0,1
2013-10-17,32.12074279785156,44.95228958129883,45.114505767822266,44.74236679077149,44.97137451171875,14544668.0,,-0.010613483245421556,-0.001272783895185777,0.11496774374541702,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-18,31.77981948852539,44.475189208984375,45.27671813964844,44.34160232543945,45.200382232666016,21622755.0,,-0.000715132971904224,-0.01067020798041805,0.13739444611003376,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-19,31.75709406534831,44.44338353474935,45.0445302327474,44.21755727132162,44.98727798461914,20241351.33333333,,-0.0007156447530634697,-0.0007153888014633011,0.13562858819701412,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-20,31.734368642171223,44.41157786051432,44.81234232584635,44.093512217203774,44.774173736572266,18859947.666666668,,-0.0007161572672539885,-0.0007159009490072902,0.13288927546818446,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-21,31.71164321899414,44.3797721862793,44.58015441894531,43.96946716308594,44.56106948852539,17478544.0,,-0.0008600733838747501,-0.0007164138303699964,0.06978526534798683,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-22,31.68436813354492,44.34160232543945,44.58015441894531,44.02671813964844,44.18893051147461,16601892.0,Merck's MK-5172/MK-8742 Receives Breakthrough Therapy Designation from FDA,0.0019367879155721172,-0.0008604434591973903,0.070419040522792,"[{'label': 'positive', 'score': 0.6391420960426331}, {'label': 'neutral', 'score': 0.3597899079322815}, {'label': 'negative', 'score': 0.0010680325794965029}]","(0.3597899079322815, 0.6391420960426331, 0.0010680325794965029)",0.9966634936507639,0.6391420960426331,0,0,"[{'label': 'positive', 'score': 0.8166059255599976}, {'label': 'neutral', 'score': 0.17625634372234344}, {'label': 'negative', 'score': 0.007137808483093977}]","(0.17625634372234344, 0.8166059255599976, 0.007137808483093977)",0.9826698324051335,0.8166059255599976,0,0,"[{'label': 'positive', 'score': 0.9985830783843994}, {'label': 'neutral', 'score': 0.0008847553981468081}, {'label': 'negative', 'score': 0.0005321612115949392}]","(0.0008847553981468081, 0.9985830783843994, 0.0005321612115949392)",0.9989347350725826,0.9985830783843994,0,0
2013-10-23,31.74573135375977,44.42748260498047,44.58015441894531,44.35114669799805,44.46564865112305,10113934.0,"How Investors Can Play the ""Losers"" in Blue Chips",-0.007302429472185306,0.0019349147600704406,0.01910132218178,"[{'label': 'neutral', 'score': 0.9998655319213867}, {'label': 'negative', 'score': 7.154444028856233e-05}, {'label': 'positive', 'score': 6.292303442023695e-05}]","(0.9998655319213867, 6.292303442023695e-05, 7.154444028856233e-05)",-0.06411517645434904,-7.154444028856233e-05,0,0,"[{'label': 'neutral', 'score': 0.9059242010116577}, {'label': 'negative', 'score': 0.050699830055236816}, {'label': 'positive', 'score': 0.043375976383686066}]","(0.9059242010116577, 0.043375976383686066, 0.050699830055236816)",-0.07785055423687107,-0.050699830055236816,0,0,"[{'label': 'neutral', 'score': 0.9932779669761658}, {'label': 'negative', 'score': 0.005469599738717079}, {'label': 'positive', 'score': 0.0012524307239800692}]","(0.9932779669761658, 0.0012524307239800692, 0.005469599738717079)",-0.6273653530937604,-0.005469599738717079,1,0
2013-10-24,31.513896942138672,44.10305404663086,44.71374130249024,44.07442855834961,44.65649032592773,11738753.0,"Merck Says Primary Endpoints Met for Investigational 9-Valent HPV Vaccine, Expecting to Submit BLA for V503 in 2013 | Merck Says Primary Endpoints Met for Investigational 9-Valent HPV Vaccine, Expecting to Submit BLA for V503 in 2013",0.006923412324390117,-0.00732922272720649,0.054651511913347176,"[{'label': 'neutral', 'score': 0.9996359348297119}, {'label': 'positive', 'score': 0.00029507093131542206}, {'label': 'negative', 'score': 6.904769543325529e-05}]","(0.9996359348297119, 0.00029507093131542206, 6.904769543325529e-05)",0.6207406577916514,0.00029507093131542206,0,1,"[{'label': 'neutral', 'score': 0.7566241025924683}, {'label': 'positive', 'score': 0.22126460075378418}, {'label': 'negative', 'score': 0.02211131900548935}]","(0.7566241025924683, 0.22126460075378418, 0.02211131900548935)",0.8182949321579558,0.22126460075378418,0,1,"[{'label': 'neutral', 'score': 0.9988442659378052}, {'label': 'positive', 'score': 0.0008591471123509109}, {'label': 'negative', 'score': 0.000296562269795686}]","(0.9988442659378052, 0.0008591471123509109, 0.000296562269795686)",0.48678746685458973,0.0008591471123509109,1,1
2013-10-25,31.73209571838379,44.40839767456055,44.446563720703125,43.75,44.13167953491211,18752912.0,"Benzinga Weekly Preview: FOMC Meeting Closely Watched | Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics (BIIB, BMRN, PCYC)",-0.008523148070599267,0.006899555555485454,0.08184146135257821,"[{'label': 'neutral', 'score': 0.9997637867927551}, {'label': 'negative', 'score': 0.00015309685841202736}, {'label': 'positive', 'score': 8.303300273837522e-05}]","(0.9997637867927551, 8.303300273837522e-05, 0.00015309685841202736)",-0.2967174728867734,-0.00015309685841202736,1,1,"[{'label': 'neutral', 'score': 0.75033038854599}, {'label': 'positive', 'score': 0.22279028594493866}, {'label': 'negative', 'score': 0.026879362761974335}]","(0.75033038854599, 0.22279028594493866, 0.026879362761974335)",0.7846805737005863,0.22279028594493866,0,1,"[{'label': 'neutral', 'score': 0.9503580331802368}, {'label': 'negative', 'score': 0.045259736478328705}, {'label': 'positive', 'score': 0.00438223872333765}]","(0.9503580331802368, 0.00438223872333765, 0.045259736478328705)",-0.8234462385698726,-0.045259736478328705,0,1
2013-10-26,31.46163749694824,44.02989832560221,44.204833984375,43.54643758138021,43.9153938293457,22037903.0,,-0.008596416602176011,-0.008559677810805688,0.10243199793884283,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-27,31.19117927551269,43.65139897664388,43.96310424804688,43.342875162760414,43.6991081237793,25322894.0,"Earnings Expectations For The Week Of October 28: Apple, Facebook, GM and More",-0.00867095575014344,-0.008633578919823385,0.1132691775383184,"[{'label': 'neutral', 'score': 0.9998563528060913}, {'label': 'positive', 'score': 7.688062032684684e-05}, {'label': 'negative', 'score': 6.673143798252568e-05}]","(0.9998563528060913, 7.688062032684684e-05, 6.673143798252568e-05)",0.07067082293645253,7.688062032684684e-05,1,1,"[{'label': 'neutral', 'score': 0.8794064521789551}, {'label': 'negative', 'score': 0.08888265490531921}, {'label': 'positive', 'score': 0.0317109189927578}]","(0.8794064521789551, 0.0317109189927578, 0.08888265490531921)",-0.47408608986811923,-0.08888265490531921,1,1,"[{'label': 'neutral', 'score': 0.9992851614952087}, {'label': 'positive', 'score': 0.0005475846701301634}, {'label': 'negative', 'score': 0.0001672756770858541}]","(0.9992851614952087, 0.0005475846701301634, 0.0001672756770858541)",0.5320045999549433,0.0005475846701301634,0,1
2013-10-28,30.92072105407715,43.27289962768555,43.72137451171875,43.13931274414063,43.48282241821289,28607885.0,"Think Silver: Top Stocks Catering to Seniors | Mid-Afternoon Market Update: Markets Mixed as JC Penney Rises | Mid-Day Market Update: Burger King Surges On Upbeat Earnings; Sohu Shares Dip | Mid-Morning Market Update: Markets Mixed; Merck Profit Beats Estimates | Merck's Q3 Call Just Beginning | UPDATE: Merck Posts Upbeat Q3 Profit | Merck & Company, Inc. Narrows FY2013 EPS Guidance from $3.45-3.55 to $3.48-3.52 vs $3.47 Est | Merck & Company, Inc. Reports Q3 EPS of $0.92 vs $0.88 Est; Revenue of $11.03B vs $11.19B Est | #PreMarket Primer: Monday, October 28: All Eyes On Apple | Earnings Scheduled For October 28, 2013 | Stocks To Watch For October 28, 2013",0.005071699954803394,-0.008708767220013866,0.10833673496106405,"[{'label': 'positive', 'score': 0.6032423377037048}, {'label': 'negative', 'score': 0.39559388160705566}, {'label': 'neutral', 'score': 0.001163808861747384}]","(0.001163808861747384, 0.6032423377037048, 0.39559388160705566)",0.20789039492373979,0.6032423377037048,1,0,"[{'label': 'negative', 'score': 0.5174925327301025}, {'label': 'positive', 'score': 0.4385645389556885}, {'label': 'neutral', 'score': 0.04394296184182167}]","(0.04394296184182167, 0.4385645389556885, 0.5174925327301025)",-0.08255573449735835,-0.5174925327301025,1,0,"[{'label': 'positive', 'score': 0.9711000323295593}, {'label': 'neutral', 'score': 0.025072302669286728}, {'label': 'negative', 'score': 0.003827589564025402}]","(0.025072302669286728, 0.9711000323295593, 0.003827589564025402)",0.9921479513390109,0.9711000323295593,0,0
2013-10-29,31.077543258666992,43.49236679077149,43.578243255615234,43.01526641845703,43.33015441894531,16652720.0,"US Stock Futures Flat Ahead Of Fed | #PreMarket Primer: Tuesday, October 29: Fed Meeting Likely Uneventful | Merck Presents Interim Data from Phase 1B Study of MK-3475 at 15th World Conference on Lung Cancer ",-0.007459436730825347,0.0050588822048417085,0.1274814984612119,"[{'label': 'negative', 'score': 0.9948270916938782}, {'label': 'neutral', 'score': 0.004556398373097181}, {'label': 'positive', 'score': 0.000616429781075567}]","(0.004556398373097181, 0.000616429781075567, 0.9948270916938782)",-0.9987614972265585,-0.9948270916938782,0,0,"[{'label': 'neutral', 'score': 0.6244656443595886}, {'label': 'positive', 'score': 0.21076996624469757}, {'label': 'negative', 'score': 0.164764404296875}]","(0.6244656443595886, 0.21076996624469757, 0.164764404296875)",0.12250692761218149,0.21076996624469757,1,1,"[{'label': 'negative', 'score': 0.7330766916275024}, {'label': 'neutral', 'score': 0.2624589502811432}, {'label': 'positive', 'score': 0.004464362747967243}]","(0.2624589502811432, 0.004464362747967243, 0.7330766916275024)",-0.9878939274729661,-0.7330766916275024,0,0
2013-10-30,30.845726013183597,43.16793823242188,43.66412353515625,43.04389190673828,43.654579162597656,10436508.0,,-0.0033155959553972684,-0.007487397463319535,0.09550430178931328,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-10-31,30.74345970153809,43.024810791015625,43.37786483764648,43.024810791015625,43.23473358154297,15713922.0,Market Wrap for October 31: Fed Worries Pull Stocks Lower,0.00310488020955614,-0.0033211047236037777,0.09270518173496176,"[{'label': 'negative', 'score': 0.997214138507843}, {'label': 'neutral', 'score': 0.001784990425221622}, {'label': 'positive', 'score': 0.0010009047109633684}]","(0.001784990425221622, 0.0010009047109633684, 0.997214138507843)",-0.99799461104546,-0.997214138507843,0,0,"[{'label': 'negative', 'score': 0.9213777184486389}, {'label': 'positive', 'score': 0.055024195462465286}, {'label': 'neutral', 'score': 0.023598087951540947}]","(0.023598087951540947, 0.055024195462465286, 0.9213777184486389)",-0.8872919139577292,-0.9213777184486389,0,0,"[{'label': 'negative', 'score': 0.9978905320167542}, {'label': 'neutral', 'score': 0.0016244316939264536}, {'label': 'positive', 'score': 0.00048503256402909756}]","(0.0016244316939264536, 0.00048503256402909756, 0.9978905320167542)",-0.9990283564998252,-0.9978905320167542,0,0
2013-11-01,30.83889961242676,43.15839767456055,43.27289962768555,42.57633590698242,42.814884185791016,21896388.0,"BMO Capital Upgrades Merck & Company, Inc. to Outperform",0.003611162793712579,0.0031000700231281035,0.09796447213182961,"[{'label': 'positive', 'score': 0.9987347722053528}, {'label': 'negative', 'score': 0.0009546097717247903}, {'label': 'neutral', 'score': 0.0003106170624960214}]","(0.0003106170624960214, 0.9987347722053528, 0.0009546097717247903)",0.998090187234285,0.9987347722053528,0,0,"[{'label': 'positive', 'score': 0.9132275581359863}, {'label': 'negative', 'score': 0.06582480669021606}, {'label': 'neutral', 'score': 0.020947609096765518}]","(0.020947609096765518, 0.9132275581359863, 0.06582480669021606)",0.8655336342466197,0.9132275581359863,0,0,"[{'label': 'positive', 'score': 0.9980722665786743}, {'label': 'neutral', 'score': 0.0014607663033530116}, {'label': 'negative', 'score': 0.00046693062176927924}]","(0.0014607663033530116, 0.9980722665786743, 0.00046693062176927924)",0.9990647725736188,0.9980722665786743,0,0
2013-11-02,30.95026842753093,43.31424967447917,43.565521240234375,42.90712483723959,43.14885457356771,20248932.0,,0.0035981692189036274,0.003604658200078865,0.08515630210788915,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-03,31.06163724263509,43.47010167439779,43.8581428527832,43.23791376749674,43.4828249613444,18601476.0,,0.0035852688150119563,0.0035917112945399714,0.08037534721524171,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-04,31.173006057739254,43.625953674316406,44.15076446533203,43.56870269775391,43.81679534912109,16954020.0,"Analysts Comment on Merck's Hep C Regiment Advances | Merck Says Investigational V503 Prevented 97% of Cervical, Vaginal, Vulvar Pre-Cancers Caused by Five Added HPV Types",-0.007873975125831979,0.00357885705944885,0.048322264137079234,"[{'label': 'positive', 'score': 0.7850522398948669}, {'label': 'neutral', 'score': 0.213796004652977}, {'label': 'negative', 'score': 0.0011517414823174477}]","(0.213796004652977, 0.7850522398948669, 0.0011517414823174477)",0.9970701204532189,0.7850522398948669,0,0,"[{'label': 'neutral', 'score': 0.7216425538063049}, {'label': 'positive', 'score': 0.24723617732524872}, {'label': 'negative', 'score': 0.03112129680812359}]","(0.7216425538063049, 0.24723617732524872, 0.03112129680812359)",0.77639330932273,0.24723617732524872,0,0,"[{'label': 'positive', 'score': 0.9518442153930664}, {'label': 'neutral', 'score': 0.04766474664211273}, {'label': 'negative', 'score': 0.0004909652634523809}]","(0.04766474664211273, 0.9518442153930664, 0.0004909652634523809)",0.9989689233928879,0.9518442153930664,0,0
2013-11-05,30.92754554748535,43.28244400024414,43.683204650878906,43.2442741394043,43.50190734863281,10920684.0,,0.013227473823250412,-0.007905138562516198,0.08081795252309809,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-11-06,31.33663749694824,43.85496139526367,43.91221237182617,43.26335906982422,43.47328186035156,12954642.0,Job Cuts Higher in October; Pharmaceutical & Financial Sectors Took Biggest Hits,-0.003046106513260988,0.013140754671210793,0.11842303098704246,"[{'label': 'negative', 'score': 0.9880688786506653}, {'label': 'positive', 'score': 0.009825680404901505}, {'label': 'neutral', 'score': 0.002105463994666934}]","(0.002105463994666934, 0.009825680404901505, 0.9880688786506653)",-0.9803071771145826,-0.9880688786506653,0,0,"[{'label': 'positive', 'score': 0.725193977355957}, {'label': 'negative', 'score': 0.24134744703769684}, {'label': 'neutral', 'score': 0.03345859795808792}]","(0.03345859795808792, 0.725193977355957, 0.24134744703769684)",0.5005957511048164,0.725193977355957,0,0,"[{'label': 'positive', 'score': 0.628636360168457}, {'label': 'neutral', 'score': 0.2857125401496887}, {'label': 'negative', 'score': 0.08565105497837067}]","(0.2857125401496887, 0.628636360168457, 0.08565105497837067)",0.7601776171269533,0.628636360168457,0,0
2013-11-07,31.241172790527344,43.72137451171875,44.12213516235352,43.683204650878906,44.036258697509766,12235819.0,,0.021388069900646327,-0.003050755338651224,0.12617027350169682,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-11-08,31.90936851501465,44.65649032592773,44.72328186035156,43.75954055786133,43.82633590698242,18260142.0,,0.0014244876740543647,0.021162555018926714,0.18785232814728856,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-09,31.954825083414715,44.72010294596354,44.8123410542806,44.08396784464518,44.13804117838541,14805095.666666668,Merck's MK-7243 Significantly Reduced Allergy Symptoms in Adults and Children in Pivotal Phase III Study ,0.001422461395329899,0.0014234740539662769,0.18977148770578228,"[{'label': 'positive', 'score': 0.9992735981941223}, {'label': 'neutral', 'score': 0.0005173482350073755}, {'label': 'negative', 'score': 0.00020908340229652822}]","(0.0005173482350073755, 0.9992735981941223, 0.00020908340229652822)",0.9995816167580561,0.9992735981941223,0,0,"[{'label': 'positive', 'score': 0.9489544034004211}, {'label': 'negative', 'score': 0.026024222373962402}, {'label': 'neutral', 'score': 0.025021415203809738}]","(0.025021415203809738, 0.9489544034004211, 0.026024222373962402)",0.9466158094424019,0.9489544034004211,0,0,"[{'label': 'positive', 'score': 0.9647349715232849}, {'label': 'neutral', 'score': 0.03475164622068405}, {'label': 'negative', 'score': 0.0005133822560310364}]","(0.03475164622068405, 0.9647349715232849, 0.0005133822560310364)",0.998936269087596,0.9647349715232849,0,0
2013-11-10,32.00028165181478,44.78371556599935,44.90140024820963,44.40839513142904,44.449746449788414,11350049.333333334,,0.0014204408730236742,0.0014214506554981038,0.15901460954282998,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-11,32.045738220214844,44.84732818603516,44.99045944213867,44.73282241821289,44.761451721191406,7895003.0,,0.012553185661871809,0.0014194330011887532,0.151242483519475,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-12,32.448001861572266,45.41030502319336,45.4484748840332,44.65649032592773,44.799617767333984,14620229.0,,-0.005253174993798323,0.012475047667717367,0.14247988072803464,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-13,32.27756118774414,45.171756744384766,45.200382232666016,44.51335906982422,44.59923553466797,14836955.0,,0.010139420622632005,-0.005267021430681036,0.10136926777066439,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-14,32.604827880859375,45.6297721862793,45.67748260498047,45.32442855834961,45.343509674072266,11822069.0,,0.005227908608325779,0.010088361546921235,0.11449381901357149,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-15,32.77528381347656,45.86832046508789,46.06870269775391,45.4484748840332,45.4484748840332,12567092.0,,-0.0004160531421395643,0.005214290536188225,0.11219833820602748,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-16,32.76165262858073,45.849236806233726,46.0623410542806,45.49618403116862,45.57888158162435,11148309.666666666,,-0.0004162263144055139,-0.0004161397162618816,0.11634824120630372,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-17,32.7480214436849,45.83015314737956,46.05597941080729,45.54389317830404,45.70928827921549,9729527.333333334,,-0.00041639963088935375,-0.0004163129606217139,0.09395247082679042,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-18,32.73439025878906,45.81106948852539,46.049617767333984,45.59160232543945,45.83969497680664,8310745.0,Investing in Companies Developing Promising Immunotherapy Drugs for Melanoma  | Merck's NDA for Noxafil Wins FDA Priority Review ,0.0012497192753127067,-0.00041648634928949694,0.07529205782131312,"[{'label': 'positive', 'score': 0.9989112615585327}, {'label': 'neutral', 'score': 0.0008606395567767322}, {'label': 'negative', 'score': 0.00022814725525677204}]","(0.0008606395567767322, 0.9989112615585327, 0.00022814725525677204)",0.9995433124682217,0.9989112615585327,0,0,"[{'label': 'positive', 'score': 0.915808379650116}, {'label': 'neutral', 'score': 0.0730489119887352}, {'label': 'negative', 'score': 0.011142702773213387}]","(0.0730489119887352, 0.915808379650116, 0.011142702773213387)",0.9759583801464841,0.915808379650116,0,0,"[{'label': 'positive', 'score': 0.9957701563835144}, {'label': 'neutral', 'score': 0.003993554040789604}, {'label': 'negative', 'score': 0.00023621642321813852}]","(0.003993554040789604, 0.9957701563835144, 0.00023621642321813852)",0.9995256728678302,0.9957701563835144,0,0
2013-11-19,32.77528381347656,45.86832046508789,45.96374130249024,45.46755599975586,45.84923553466797,8745874.0,,0.0012481594264188477,0.001248939026173094,0.03874718201294924,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-20,32.81618881225586,45.92557144165039,46.20228958129883,45.5629768371582,45.78244400024414,8647991.0,,0.010180816477094439,0.0012473811230058356,0.014472306692617308,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-11-21,33.150291442871094,46.39313125610352,46.46946716308594,45.95419692993164,46.011451721191406,13453281.0,,0.006581655940490309,0.010129341044832634,0.07021299380099931,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-22,33.36847305297852,46.6984748840332,46.79389190673828,46.22137451171875,46.26908493041992,14638359.0,Merck Announces Position Opinion from CHMP on Update for Erbitux Metastatic Colorectal Cancer Labeling,0.0049039385108443495,0.006560091411522537,0.07031105522339287,"[{'label': 'neutral', 'score': 0.9998255372047424}, {'label': 'positive', 'score': 9.53429625951685e-05}, {'label': 'negative', 'score': 7.916144386399537e-05}]","(0.9998255372047424, 9.53429625951685e-05, 7.916144386399537e-05)",0.09272842479745518,9.53429625951685e-05,1,1,"[{'label': 'neutral', 'score': 0.8717182278633118}, {'label': 'positive', 'score': 0.09326682239770889}, {'label': 'negative', 'score': 0.03501499071717262}]","(0.8717182278633118, 0.09326682239770889, 0.03501499071717262)",0.4540926750728836,0.09326682239770889,1,1,"[{'label': 'neutral', 'score': 0.8126071095466614}, {'label': 'positive', 'score': 0.18610236048698425}, {'label': 'negative', 'score': 0.0012904985342174768}]","(0.8126071095466614, 0.18610236048698425, 0.0012904985342174768)",0.9862268120465415,0.18610236048698425,0,1
2013-11-23,33.53211212158203,46.92748133341471,47.04834493001302,46.3804079691569,46.41539510091146,16145453.0,,0.004880007255332031,0.004891953371339159,0.05978716725624588,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-24,33.69575119018555,47.15648778279623,47.30279795328776,46.539441426595054,46.56170527140299,17652547.0,,0.004856308434934814,0.004868138616958532,0.051070893967843485,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-25,33.85939025878906,47.38549423217773,47.5572509765625,46.6984748840332,46.70801544189453,19159641.0,,-0.0016109551713945805,0.004844554607242143,0.0362639254452215,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-26,33.80483627319336,47.30915832519531,47.47137451171875,46.90839767456055,47.38549423217773,24040386.0, Merck Raises Quarterly Dividend to $0.44 from $0.43 | FDA Okays Merck's Noxafil DR Tablets,0.0050424083190424105,-0.0016122541549335998,0.0503711971159762,"[{'label': 'positive', 'score': 0.9994515776634216}, {'label': 'neutral', 'score': 0.0003027580969501287}, {'label': 'negative', 'score': 0.00024563688202761114}]","(0.0003027580969501287, 0.9994515776634216, 0.00024563688202761114)",0.9995085774403417,0.9994515776634216,0,0,"[{'label': 'positive', 'score': 0.9048889875411987}, {'label': 'negative', 'score': 0.0682937502861023}, {'label': 'neutral', 'score': 0.02681717462837696}]","(0.02681717462837696, 0.9048889875411987, 0.0682937502861023)",0.8596486607673027,0.9048889875411987,0,0,"[{'label': 'positive', 'score': 0.9989894032478333}, {'label': 'neutral', 'score': 0.0006624730303883553}, {'label': 'negative', 'score': 0.0003481091989669949}]","(0.0006624730303883553, 0.9989894032478333, 0.0003481091989669949)",0.9993033200602773,0.9989894032478333,0,0
2013-11-27,33.97528076171875,47.54771041870117,47.6240463256836,47.290077209472656,47.31870269775391,12120644.0,,0.0,0.005029737953137133,0.04630752120710646,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-28,33.97528076171875,47.54771041870117,47.64312934875488,47.251909255981445,47.41412162780762,9675922.0,,0.0,0.0,0.05056585245390215,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-29,33.97528076171875,47.54771041870117,47.66221237182617,47.21374130249024,47.50954055786133,7231200.0,,0.002341291257910747,0.0,0.04874474433524057,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-11-30,34.05482864379883,47.65903345743815,47.81170399983724,47.29643758138021,47.49363708496094,10001378.333333332,,0.0023358224173052277,0.002338554706077892,0.04104417601414348,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-01,34.134376525878906,47.77035649617513,47.96119562784831,47.37913386027018,47.47773361206055,12771556.666666666,,0.0023303790656427317,0.0023330986248282864,0.03309659068112028,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-02,34.213924407958984,47.88167953491211,48.110687255859375,47.46183013916016,47.46183013916016,15541735.0,,-0.008369891558206949,0.00232766794349262,0.020286052331002183,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-12-03,33.92755889892578,47.48091506958008,47.76717758178711,47.11832046508789,47.53816986083984,14257411.0,"Bloomberg Reporting Merck, Eli Lilly Rumored to Be Interested in Novartis' Veterinary Unit",-0.00904342203565452,-0.008405115786910921,0.07385526076033892,"[{'label': 'neutral', 'score': 0.8299843668937683}, {'label': 'positive', 'score': 0.1694047451019287}, {'label': 'negative', 'score': 0.0006108561647124588}]","(0.8299843668937683, 0.1694047451019287, 0.0006108561647124588)",0.9928141163497762,0.1694047451019287,0,1,"[{'label': 'neutral', 'score': 0.9255774021148682}, {'label': 'positive', 'score': 0.05716953054070473}, {'label': 'negative', 'score': 0.017253030091524124}]","(0.9255774021148682, 0.05716953054070473, 0.017253030091524124)",0.5363494632552951,0.05716953054070473,0,1,"[{'label': 'neutral', 'score': 0.9427953362464905}, {'label': 'positive', 'score': 0.056902650743722916}, {'label': 'negative', 'score': 0.0003019707801286131}]","(0.9427953362464905, 0.056902650743722916, 0.0003019707801286131)",0.9894424341221205,0.056902650743722916,0,1
2013-12-04,33.62074661254883,47.0515251159668,47.375953674316406,46.58396911621094,47.328243255615234,12001277.0,,-0.010139874455531436,-0.009084561995217299,0.09639628981639464,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-05,33.27981948852539,46.57442855834961,46.9942741394043,46.536258697509766,46.66984558105469,9140551.0,,0.01188283563379654,-0.01019163316431595,0.10099884111364929,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-06,33.67529296875,47.12786483764648,47.299617767333984,46.71755599975586,46.8797721862793,7758554.0,,0.0011473210338513117,0.011812789097405164,0.151710327112447,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-07,33.71392822265625,47.18193562825521,47.38867696126302,46.79389190673828,46.95928827921549,8432173.333333334,,0.0011460061968364557,0.0011466633640647842,0.1494555249201311,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-08,33.7525634765625,47.23600641886393,47.477736155192055,46.8702278137207,47.038804372151695,9105792.666666666,,0.001144694369995108,0.0011453500329989114,0.14269819369715883,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-09,33.79119873046875,47.290077209472656,47.56679534912109,46.946563720703125,47.11832046508789,9779412.0,Merck Agrees to settle Litigation over Jaw Injuries Caused by Fosamax -Reuters,-0.002623094166967147,0.0011440397069398573,0.12353381240350637,"[{'label': 'positive', 'score': 0.9869148135185242}, {'label': 'neutral', 'score': 0.011807615868747234}, {'label': 'negative', 'score': 0.0012776346411556005}]","(0.011807615868747234, 0.9869148135185242, 0.0012776346411556005)",0.997414198735206,0.9869148135185242,0,0,"[{'label': 'positive', 'score': 0.6788591742515564}, {'label': 'negative', 'score': 0.21639761328697205}, {'label': 'neutral', 'score': 0.10474316030740738}]","(0.10474316030740738, 0.6788591742515564, 0.21639761328697205)",0.5165686174087586,0.6788591742515564,0,0,"[{'label': 'positive', 'score': 0.9962466359138489}, {'label': 'neutral', 'score': 0.0029888306744396687}, {'label': 'negative', 'score': 0.0007645661826245487}]","(0.0029888306744396687, 0.9962466359138489, 0.0007645661826245487)",0.998466283666589,0.9962466359138489,0,0
2013-12-10,33.70256042480469,47.16603088378906,47.28053283691406,46.85114669799805,47.02289962768555,10727747.0,Merck Says Data Monitoring Committee Recommending Continuation of Phase II/III EPOCH Study for MK-8931,-0.009710705635227638,-0.0026265405065062047,0.08640738728179953,"[{'label': 'neutral', 'score': 0.9998157620429993}, {'label': 'positive', 'score': 0.00011017697397619486}, {'label': 'negative', 'score': 7.413556159008294e-05}]","(0.9998157620429993, 0.00011017697397619486, 7.413556159008294e-05)",0.1955450955920012,0.00011017697397619486,1,1,"[{'label': 'neutral', 'score': 0.8443788290023804}, {'label': 'positive', 'score': 0.13634999096393585}, {'label': 'negative', 'score': 0.01927114836871624}]","(0.8443788290023804, 0.13634999096393585, 0.01927114836871624)",0.7523325114909655,0.13634999096393585,0,1,"[{'label': 'neutral', 'score': 0.9975190162658691}, {'label': 'positive', 'score': 0.002347019501030445}, {'label': 'negative', 'score': 0.00013403639604803175}]","(0.9975190162658691, 0.002347019501030445, 0.00013403639604803175)",0.8919521352131857,0.002347019501030445,0,1
2013-12-11,33.37529754638672,46.70801544189453,47.261451721191406,46.51717758178711,47.24236679077149,15200192.0,,-0.01287031127978215,-0.009758162010362942,0.07531624498474923,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-12-12,33.24456787109375,46.10686874389648,46.54580307006836,45.83015441894531,46.34542083740234,12169062.0,"FDA Reviewing Merck's Bid for Grastek; Panel Recommends Approval of Grastek;  | #PreMarket Primer: Thursday, December 12: US Budget Deal Gaining Momentum",0.001241784419970007,-0.012953851300815954,0.10235382549914299,"[{'label': 'positive', 'score': 0.9990096092224121}, {'label': 'neutral', 'score': 0.000779034337028861}, {'label': 'negative', 'score': 0.00021135724091436714}]","(0.000779034337028861, 0.9990096092224121, 0.00021135724091436714)",0.9995769559526709,0.9990096092224121,0,0,"[{'label': 'positive', 'score': 0.9324371218681335}, {'label': 'neutral', 'score': 0.04400255158543587}, {'label': 'negative', 'score': 0.023560326546430588}]","(0.04400255158543587, 0.9324371218681335, 0.023560326546430588)",0.9507104823647735,0.9324371218681335,0,0,"[{'label': 'positive', 'score': 0.9939550757408142}, {'label': 'neutral', 'score': 0.005822914186865091}, {'label': 'negative', 'score': 0.0002220489550381899}]","(0.005822914186865091, 0.9939550757408142, 0.0002220489550381899)",0.9995533010174498,0.9939550757408142,0,0
2013-12-13,33.28584671020508,46.16412353515625,46.66030502319336,45.85877990722656,46.50763320922852,8799322.0,,-0.001998074972929307,0.0012410140433922103,0.10269439070828594,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-14,33.21934127807617,46.07188415527344,46.56170527140299,45.804707845052086,46.36768468221029,9830868.666666666,,-0.0020020752694188994,-0.002000073787692946,0.0936616239755255,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-15,33.152835845947266,45.97964477539063,46.46310551961263,45.7506357828776,46.227736155192055,10862415.333333334,,-0.002006091615831453,-0.0020040821011105105,0.09484405348016334,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-16,33.08633041381836,45.88740539550781,46.364505767822266,45.696563720703125,46.08778762817383,11893962.0,,-0.00395091639380077,-0.0020081065127798693,0.08642342174736546,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-17,32.95560073852539,45.70610809326172,45.8015251159668,45.42938995361328,45.73473358154297,14567200.0,"Merck Says Vintafolide Has Won Orphan Drug Designation for Ovarian Cancer | EMA Says Will Discuss Extension of Indication for Merck's Noxafil, Isentress, Pfizer's Vfend, Amgen's Xgeva, Vertex Pharma's Kalydeco",0.020876792396863787,-0.003958741882678335,0.029717930123354913,"[{'label': 'positive', 'score': 0.9932423233985901}, {'label': 'neutral', 'score': 0.006429716013371944}, {'label': 'negative', 'score': 0.0003279104712419212}]","(0.006429716013371944, 0.9932423233985901, 0.0003279104712419212)",0.9993399349938962,0.9932423233985901,1,1,"[{'label': 'positive', 'score': 0.8293784856796265}, {'label': 'neutral', 'score': 0.16168294847011566}, {'label': 'negative', 'score': 0.008938527666032314}]","(0.16168294847011566, 0.8293784856796265, 0.008938527666032314)",0.9786750655808372,0.8293784856796265,1,1,"[{'label': 'positive', 'score': 0.9904537200927734}, {'label': 'neutral', 'score': 0.009243997745215893}, {'label': 'negative', 'score': 0.000302353611914441}]","(0.009243997745215893, 0.9904537200927734, 0.000302353611914441)",0.9993896507527148,0.9904537200927734,1,1
2013-12-18,33.64360809326172,46.66030502319336,46.68893051147461,45.46755599975586,45.67748260498047,14200086.0,Merck Spikes Higher on Positive Jim Cramer/Mad Money Comments | Merck Collaborates with GlaxoSmithKline on MK-3475,-0.002249479406778393,0.02066185844043426,0.1649296223596634,"[{'label': 'positive', 'score': 0.9994175434112549}, {'label': 'neutral', 'score': 0.0004378012381494045}, {'label': 'negative', 'score': 0.00014468868903350085}]","(0.0004378012381494045, 0.9994175434112549, 0.00014468868903350085)",0.9997104958863252,0.9994175434112549,0,0,"[{'label': 'positive', 'score': 0.9446517825126648}, {'label': 'neutral', 'score': 0.032940447330474854}, {'label': 'negative', 'score': 0.02240770310163498}]","(0.032940447330474854, 0.9446517825126648, 0.02240770310163498)",0.9536580666753895,0.9446517825126648,0,0,"[{'label': 'positive', 'score': 0.9932871460914612}, {'label': 'neutral', 'score': 0.006408573128283024}, {'label': 'negative', 'score': 0.00030427324236370623}]","(0.006408573128283024, 0.9932871460914612, 0.00030427324236370623)",0.9993875284418867,0.9932871460914612,0,0
2013-12-19,33.567928314208984,46.55534362792969,46.70801544189453,46.3072509765625,46.51717758178711,9182995.0,,0.010862896097115387,-0.0022520132862321497,0.16533706599910236,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-20,33.93257522583008,47.06106948852539,47.18511581420898,46.40267181396485,46.62213516235352,17611745.0,,0.00027032992490664295,0.01080431867314736,0.1702968960705797,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-21,33.941749572753906,47.07379150390625,47.26463190714518,46.59987258911133,46.80661392211914,14628019.0,,0.0002702568663882467,0.00027029339235631645,0.16538264785422038,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-22,33.950923919677734,47.08651351928711,47.34414800008138,46.79707336425781,46.991092681884766,11644293.0,,0.00027018384734831365,0.00027022035357964717,0.1530460575008942,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-23,33.96009826660156,47.09923553466797,47.42366409301758,46.9942741394043,47.17557144165039,8660567.0,,0.0010129764986536573,0.00027014735426562225,0.08113523504485069,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-24,33.9944953918457,47.14694595336914,47.39503860473633,46.975189208984375,47.16603088378906,4457039.0,,0.00313703320636001,0.0010124637841762475,0.07364427663739324,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-25,34.10113906860352,47.29484748840332,47.43320655822754,47.03721237182617,47.17080116271973,4885094.5,,0.0031272230039529167,0.00313212298403144,0.019673245902851213,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-12-26,34.20778274536133,47.4427490234375,47.47137451171875,47.09923553466797,47.17557144165039,5313150.0,ALK Reports FDA Panel Will Revie Ragweed Tablet | Merck Sues to Stop Generic NuvaRing,0.0014078344067042154,0.0031223434124951367,0.023194612048601845,"[{'label': 'positive', 'score': 0.582443118095398}, {'label': 'neutral', 'score': 0.4014066755771637}, {'label': 'negative', 'score': 0.016150152310729027}]","(0.4014066755771637, 0.582443118095398, 0.016150152310729027)",0.9460396462533845,0.582443118095398,0,0,"[{'label': 'negative', 'score': 0.858674168586731}, {'label': 'neutral', 'score': 0.12272785604000092}, {'label': 'positive', 'score': 0.018597964197397232}]","(0.12272785604000092, 0.018597964197397232, 0.858674168586731)",-0.957600467398014,-0.858674168586731,0,0,"[{'label': 'negative', 'score': 0.7333346009254456}, {'label': 'neutral', 'score': 0.22801433503627777}, {'label': 'positive', 'score': 0.03865107521414757}]","(0.22801433503627777, 0.03865107521414757, 0.7333346009254456)",-0.8998658228804791,-0.7333346009254456,0,0
2013-12-27,34.25593948364258,47.50954055786133,47.614505767822266,47.261451721191406,47.49045944213867,4448026.0,WSJ Reporting Merck on 'Radically Reshaping R&D',0.001004228164300303,0.0014068443369729807,0.02044940489164069,"[{'label': 'neutral', 'score': 0.9998383522033691}, {'label': 'positive', 'score': 0.00010229963663732633}, {'label': 'negative', 'score': 5.9369551308918744e-05}]","(0.9998383522033691, 0.00010229963663732633, 5.9369551308918744e-05)",0.26554277827313527,0.00010229963663732633,1,1,"[{'label': 'positive', 'score': 0.8136383295059204}, {'label': 'neutral', 'score': 0.17011989653110504}, {'label': 'negative', 'score': 0.01624179445207119}]","(0.17011989653110504, 0.8136383295059204, 0.01624179445207119)",0.9608574925867405,0.8136383295059204,0,0,"[{'label': 'neutral', 'score': 0.9981828331947327}, {'label': 'positive', 'score': 0.0016888182144612074}, {'label': 'negative', 'score': 0.00012823827273678035}]","(0.9981828331947327, 0.0016888182144612074, 0.00012823827273678035)",0.858850538064965,0.0016888182144612074,0,1
2013-12-28,34.29033915201823,47.5572509765625,47.627227783203125,47.19783782958984,47.48091634114584,5173801.0,,0.0010032207018165298,0.0010037242645227092,0.017462287935368175,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-29,34.32473882039388,47.60496139526367,47.639949798583984,47.13422393798828,47.47137324015299,5899576.0,,0.0010022152587214534,0.0010027178122395746,0.01749484976636558,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2013-12-30,34.35913848876953,47.65267181396485,47.65267181396485,47.07061004638672,47.46183013916016,6625351.0,,0.0022026340028412092,0.001001713376310537,0.014597354404131607,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2013-12-31,34.43482971191406,47.75763320922852,47.786258697509766,47.261451721191406,47.46183013916016,8881695.0,,-0.005594407772846991,0.0022002117607889463,0.008264938337780062,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-01-01,34.242183685302734,47.49045753479004,47.76717567443848,47.15171813964844,47.52862548828125,8573373.5,,-0.00562588124662206,-0.005610115081463866,0.04975738944556287,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-02,34.049537658691406,47.22328186035156,47.74809265136719,47.04198455810547,47.59542083740234,8265052.0,,0.004849466448022101,-0.005641766122153726,0.061594321649686784,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-03,34.21466064453125,47.45228958129883,47.709922790527344,47.19465637207031,47.22328186035156,6743880.0,,6.701859871956525e-05,0.004837745663367526,0.0755030218214736,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-04,34.21695327758789,47.4554697672526,47.75445175170898,47.2105598449707,47.32506306966146,7965289.0,,6.701410752813401e-05,6.701635307353831e-05,0.07450572800273426,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-05,34.21924591064453,47.45864995320638,47.79898071289063,47.22646331787109,47.42684427897135,9186698.0,,6.700961693845908e-05,6.701186218308265e-05,0.07047089529472371,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-06,34.22153854370117,47.46183013916016,47.843509674072266,47.24236679077149,47.52862548828125,10408107.0,,0.0074386943275403065,6.700737189430737e-05,0.058957322590242854,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-07,34.47609329223633,47.814884185791016,48.09160232543945,47.65267181396485,47.671756744384766,10475598.0,,-0.006385953519059771,0.00741116368461765,0.0546129078522344,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-08,34.25593948364258,47.50954055786133,47.843509674072266,47.328243255615234,47.80534362792969,14353094.0,"UPDATE: Novartis Could Swap Its Animal-Health, Human Vaccines Units for Merck's OTC Health-Products Unit | Bloomberg Reporting Novartis Said to Be in Talks with Merck on $5B Unit Swap | Merck Receives FDA Approval for Isentress for Pediatric ",-0.005422767852590514,-0.0064064309453805745,0.07764338515907622,"[{'label': 'positive', 'score': 0.893196702003479}, {'label': 'neutral', 'score': 0.10613120347261429}, {'label': 'negative', 'score': 0.000672080204822123}]","(0.10613120347261429, 0.893196702003479, 0.000672080204822123)",0.9984962441508209,0.893196702003479,0,0,"[{'label': 'neutral', 'score': 0.7495719194412231}, {'label': 'positive', 'score': 0.22710458934307098}, {'label': 'negative', 'score': 0.023323513567447662}]","(0.7495719194412231, 0.22710458934307098, 0.023323513567447662)",0.813730860902768,0.22710458934307098,0,1,"[{'label': 'neutral', 'score': 0.6615031957626343}, {'label': 'positive', 'score': 0.33677682280540466}, {'label': 'negative', 'score': 0.001719999359920621}]","(0.6615031957626343, 0.33677682280540466, 0.001719999359920621)",0.9898374268395315,0.33677682280540466,0,1
2014-01-09,34.0701904296875,47.25190734863281,47.709922790527344,47.08015441894531,47.53816986083984,9771447.0,,0.007269833283871945,-0.005437524430022201,0.08761501296204664,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-10,34.31786346435547,47.59542083740234,47.77671813964844,47.23282241821289,47.54771041870117,8533969.0,,0.021651959166415987,0.007243535423010859,0.10540463483863509,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-01-11,35.0609130859375,48.62595494588216,48.84860102335612,47.64312871297201,47.88804117838541,18716406.666666664,,0.021193087305467713,0.021420885020769734,0.18089681376463815,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-12,35.80396270751953,49.65648905436198,49.920483907063804,48.05343500773112,48.228371938069664,28898844.33333333,,0.020753261620080142,0.020971637174528757,0.21534592261827903,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-13,36.54701232910156,50.6870231628418,50.99236679077149,48.46374130249024,48.56870269775391,39081282.0,"Benzinga's M&A Chatter for Monday January 13, 2014 | Market Wrap For January 13: Markets Showing Weakness Ahead Of Major Earning Releases | Mid-Afternoon Market Update: Markets Dip Despite Large Amount of M&A | Mid-Day Market Update: SodaStream Drops After Weak Outlook; Beam Shares Spike Higher | Mid-Morning Market Update: Markets Open Lower; Lululemon Lowers Q4 Outlook | Morning Market Movers  | Merck Initiates Rolling Submission to FDA of US Biologics License Application for MK-3475 | Merck Begins Enrollment of BLA for MK-3475, Sees Completing Application in 1H'14 | Benzinga's Top #PreMarket Gainers",-0.0022590746245719313,0.020540846529690262,0.18856421043706678,"[{'label': 'negative', 'score': 0.9977304339408875}, {'label': 'neutral', 'score': 0.001342269591987133}, {'label': 'positive', 'score': 0.0009273516479879618}]","(0.001342269591987133, 0.0009273516479879618, 0.9977304339408875)",-0.9981428039487198,-0.9977304339408875,0,0,"[{'label': 'negative', 'score': 0.9017571210861206}, {'label': 'positive', 'score': 0.06941556930541992}, {'label': 'neutral', 'score': 0.02882736176252365}]","(0.02882736176252365, 0.06941556930541992, 0.9017571210861206)",-0.8570479380398678,-0.9017571210861206,0,0,"[{'label': 'negative', 'score': 0.779560923576355}, {'label': 'neutral', 'score': 0.1962067186832428}, {'label': 'positive', 'score': 0.024232354015111923}]","(0.1962067186832428, 0.024232354015111923, 0.779560923576355)",-0.9397050095076108,-0.779560923576355,0,0
2014-01-14,36.464447021484375,50.57251739501953,50.66793823242188,49.78053283691406,50.1240463256836,22207854.0,"Merck Voluntarily Recalls All Lots of Liptruzet, Cites Packaging Defects",-0.009056532100622133,-0.0022616301831754997,0.16943335030765996,"[{'label': 'negative', 'score': 0.5207493305206299}, {'label': 'neutral', 'score': 0.4782477617263794}, {'label': 'positive', 'score': 0.0010028944816440344}]","(0.4782477617263794, 0.0010028944816440344, 0.5207493305206299)",-0.9961556676384479,-0.5207493305206299,0,0,"[{'label': 'neutral', 'score': 0.7232008576393127}, {'label': 'negative', 'score': 0.24668222665786743}, {'label': 'positive', 'score': 0.030116919428110123}]","(0.7232008576393127, 0.030116919428110123, 0.24668222665786743)",-0.7823915293528008,-0.24668222665786743,0,1,"[{'label': 'negative', 'score': 0.9980605244636536}, {'label': 'neutral', 'score': 0.0015933916438370943}, {'label': 'positive', 'score': 0.0003460800799075514}]","(0.0015933916438370943, 0.0003460800799075514, 0.9980605244636536)",-0.9993067351951949,-0.9980605244636536,0,0
2014-01-15,36.13420104980469,50.114505767822266,50.47710037231445,49.95228958129883,50.238548278808594,10991424.0,Market Wrap For January 15: Bulls Take Over As Economic Growth Remains Healthy | Bloomberg First Word Reporting Merck Has Won FDA Advisory Panel Support for Vorapaxar,-0.0003808264718472613,-0.009097791789520172,0.23498838428648872,"[{'label': 'positive', 'score': 0.9994537234306335}, {'label': 'neutral', 'score': 0.0003518475859891623}, {'label': 'negative', 'score': 0.0001943989482242614}]","(0.0003518475859891623, 0.9994537234306335, 0.0001943989482242614)",0.9996110652461155,0.9994537234306335,0,0,"[{'label': 'positive', 'score': 0.9427919983863831}, {'label': 'neutral', 'score': 0.04130837321281433}, {'label': 'negative', 'score': 0.015899673104286194}]","(0.04130837321281433, 0.9427919983863831, 0.015899673104286194)",0.966830476206049,0.9427919983863831,0,0,"[{'label': 'positive', 'score': 0.9979707598686218}, {'label': 'neutral', 'score': 0.0017179102869704366}, {'label': 'negative', 'score': 0.0003113008278887719}]","(0.0017179102869704366, 0.9979707598686218, 0.0003113008278887719)",0.9993763269117115,0.9979707598686218,0,0
2014-01-16,36.12044143676758,50.09542083740234,50.55343627929688,49.71374130249024,49.761451721191406,8142541.0,Merck Pleased with FDA Advisory Committee Recommendation for Approval of Vorapaxar,-0.010476222821224065,-0.0003808990046635874,0.2206056143968752,"[{'label': 'neutral', 'score': 0.5163784623146057}, {'label': 'positive', 'score': 0.48220181465148926}, {'label': 'negative', 'score': 0.001419744803570211}]","(0.5163784623146057, 0.48220181465148926, 0.001419744803570211)",0.9941286951509359,0.48220181465148926,0,1,"[{'label': 'positive', 'score': 0.9328984618186951}, {'label': 'neutral', 'score': 0.05285976454615593}, {'label': 'negative', 'score': 0.014241746626794338}]","(0.05285976454615593, 0.9328984618186951, 0.014241746626794338)",0.9699268460998633,0.9328984618186951,0,0,"[{'label': 'positive', 'score': 0.9967526197433472}, {'label': 'neutral', 'score': 0.0027678024489432573}, {'label': 'negative', 'score': 0.00047965458361431956}]","(0.0027678024489432573, 0.9967526197433472, 0.00047965458361431956)",0.9990380283591643,0.9967526197433472,0,0
2014-01-17,35.74203872680664,49.57061004638672,50.238548278808594,49.35114669799805,50.209922790527344,17563222.0,,-0.0005774689529635224,-0.01053148473981599,0.1976789263887215,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-18,35.72139930725098,49.54198455810547,50.143128395080566,49.3487606048584,50.06917858123779,16063717.5,,-0.0005778026160352238,-0.0005776357523767425,0.0773042527335082,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-19,35.70075988769531,49.51335906982422,50.04770851135254,49.34637451171875,49.92843437194824,14564213.0,,-0.0005781366649126362,-0.0005779696082955958,0.0812926426118502,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-20,35.68012046813965,49.48473358154297,49.95228862762451,49.3439884185791,49.78769016265869,13064708.5,,-0.0005784711002652919,-0.0005783038503548069,0.07102563195058646,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-21,35.659481048583984,49.45610809326172,49.85686874389648,49.34160232543945,49.64694595336914,11565204.0,,-0.00926104903019926,-0.0005786384792246151,0.07066176000398298,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-22,35.32923126220703,48.99809265136719,49.59923553466797,48.931297302246094,49.39885330200195,11164973.0,,0.004868521730139991,-0.009304199161716504,0.061948896762984554,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-23,35.5012321472168,49.23664093017578,49.3797721862793,48.53053283691406,48.864505767822266,16639934.0,,0.007364324568899729,0.0048567088036993,0.08075531969798669,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-24,35.76266860961914,49.59923553466797,49.78053283691406,48.78816986083984,48.921756744384766,19137842.0,Merck Shares Higher Following Bristol-Myers' Phase 3 Disappointment,0.003527008601095577,0.007337340330198383,0.10166533866574971,"[{'label': 'positive', 'score': 0.999289870262146}, {'label': 'neutral', 'score': 0.00041928517748601735}, {'label': 'negative', 'score': 0.00029082861146889627}]","(0.00041928517748601735, 0.999289870262146, 0.00029082861146889627)",0.9994180987852274,0.999289870262146,0,0,"[{'label': 'positive', 'score': 0.9355549812316895}, {'label': 'neutral', 'score': 0.03871999680995941}, {'label': 'negative', 'score': 0.025724995881319046}]","(0.03871999680995941, 0.9355549812316895, 0.025724995881319046)",0.9464776204772758,0.9355549812316895,0,0,"[{'label': 'positive', 'score': 0.9964859485626221}, {'label': 'neutral', 'score': 0.001984354807063937}, {'label': 'negative', 'score': 0.0015297089703381062}]","(0.001984354807063937, 0.9964859485626221, 0.0015297089703381062)",0.9969344990556172,0.9964859485626221,0,0
2014-01-25,35.888806660970054,49.77417246500651,50.39440027872721,49.23346201578776,49.42748133341471,23588593.33333333,,0.0035146125324642006,0.003520803292763041,0.1034649911281865,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-26,36.01494471232096,49.949109395345054,51.00826772054037,49.67875417073568,49.93320592244466,28039344.666666664,,0.0035023032934166677,0.0035084507152168647,0.10319036472826479,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-27,36.14108276367188,50.1240463256836,51.62213516235352,50.1240463256836,50.43893051147461,32490096.0,"Market Wrap For January 27: China Concerns, Declining Home Sales, Tomorrow's Fed Meeting and Obama's Speech Keep Markets Lower | Winter's Stock Knockdown May Give Way To A Spring Thaw | UPDATE: Merck Upgraded by Morgan Stanley on Oncology Optimism | Stocks Hitting 52-Week Highs | Benzinga's Top Upgrades | US Stock Futures Gain Ahead Of Home-Sales Data | Morgan Stanley Upgrades Merck & Company, Inc. to Overweight, Announces $60.00 PT",0.006472513337044077,0.003496184511628371,0.026465413808434413,"[{'label': 'negative', 'score': 0.9949177503585815}, {'label': 'positive', 'score': 0.004250665660947561}, {'label': 'neutral', 'score': 0.0008316403836943209}]","(0.0008316403836943209, 0.004250665660947561, 0.9949177503585815)",-0.99149159322333,-0.9949177503585815,0,0,"[{'label': 'positive', 'score': 0.8701567649841309}, {'label': 'negative', 'score': 0.09186721593141556}, {'label': 'neutral', 'score': 0.03797605261206627}]","(0.03797605261206627, 0.8701567649841309, 0.09186721593141556)",0.8090126280553076,0.8701567649841309,1,1,"[{'label': 'positive', 'score': 0.6860650181770325}, {'label': 'negative', 'score': 0.18070797622203827}, {'label': 'neutral', 'score': 0.13322703540325165}]","(0.13322703540325165, 0.6860650181770325, 0.18070797622203827)",0.5830327493132798,0.6860650181770325,1,1
2014-01-28,36.37500381469727,50.4484748840332,50.65839767456055,49.828243255615234,49.97137451171875,15801954.0,,-0.01248347324130131,0.0064516565713489,0.0298578668581308,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-01-29,35.920902252197266,49.81870269775391,50.41984558105469,49.40839767456055,50.286258697509766,20274713.0,,0.024899396416786367,-0.012562046388728784,0.1210161690850402,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-01-30,36.81533050537109,51.05915832519531,51.21183013916016,49.98091506958008,50.0572509765625,18205646.0,,-0.010091557232011232,0.02459445793607936,0.20983703317669516,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-01-31,36.44381332397461,50.54389190673828,51.03053283691406,50.343509674072266,50.86832046508789,17071920.0,Market Wrap For January 31: Markets End January On Sour Note | Reuters Reporting Merck Consumer Health Unit Could Get $8-10B in Sale,-0.005600647296379906,-0.010142822182766784,0.23697607615549054,"[{'label': 'neutral', 'score': 0.9997983574867249}, {'label': 'positive', 'score': 0.000147177794133313}, {'label': 'negative', 'score': 5.443008558358997e-05}]","(0.9997983574867249, 0.000147177794133313, 5.443008558358997e-05)",0.4600400970436226,0.000147177794133313,1,1,"[{'label': 'negative', 'score': 0.8979299664497375}, {'label': 'positive', 'score': 0.06957385689020157}, {'label': 'neutral', 'score': 0.03249617666006088}]","(0.03249617666006088, 0.06957385689020157, 0.8979299664497375)",-0.8561786419612808,-0.8979299664497375,0,0,"[{'label': 'neutral', 'score': 0.9959273934364319}, {'label': 'positive', 'score': 0.0030965982005000114}, {'label': 'negative', 'score': 0.0009759971871972084}]","(0.9959273934364319, 0.0030965982005000114, 0.0009759971871972084)",0.5207001460810132,0.0030965982005000114,0,1
2014-02-01,36.239699045817055,50.26081339518229,50.92557144165039,50.07633463541666,50.74109395345052,16791964.333333332,,-0.005632191212868814,-0.0056163897275006945,0.24299562314604548,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-02,36.03558476765951,49.977734883626304,50.82061004638672,49.80915959676107,50.61386744181315,16512008.666666666,,-0.005664092464677388,-0.005648111808498817,0.2396257379671366,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-03,35.83147048950195,49.69465637207031,50.71564865112305,49.54198455810547,50.48664093017578,16232053.0,"Merck Receives Canadian Approval of Grastek | Earnings Expectations For The Week Of February 3: GM, Twitter, Disney And More",0.02745771985842497,-0.005680194266583874,0.22481222535762233,"[{'label': 'positive', 'score': 0.9991897940635681}, {'label': 'neutral', 'score': 0.0004855793376918882}, {'label': 'negative', 'score': 0.0003245746192988008}]","(0.0004855793376918882, 0.9991897940635681, 0.0003245746192988008)",0.9993505353610344,0.9991897940635681,0,0,"[{'label': 'neutral', 'score': 0.916139543056488}, {'label': 'positive', 'score': 0.05820576474070549}, {'label': 'negative', 'score': 0.02565462701022625}]","(0.916139543056488, 0.05820576474070549, 0.02565462701022625)",0.388158665263063,0.05820576474070549,1,1,"[{'label': 'positive', 'score': 0.9984991550445557}, {'label': 'neutral', 'score': 0.0012135780416429043}, {'label': 'negative', 'score': 0.0002872644108720124}]","(0.0012135780416429043, 0.9984991550445557, 0.0002872644108720124)",0.9994247730940742,0.9984991550445557,0,0
2014-02-04,36.81533050537109,51.05915832519531,51.06870269775391,50.0,50.181297302246094,19054631.0,"Merck Rallies Back | SunTrust Robinson Humphrey Upgrades Merck & Company, Inc. to Buy",0.0003737807485656173,0.027087517985350116,0.24235545183622298,"[{'label': 'positive', 'score': 0.9966422319412231}, {'label': 'neutral', 'score': 0.0030633476562798023}, {'label': 'negative', 'score': 0.0002943884755950421}]","(0.0030633476562798023, 0.9966422319412231, 0.0002943884755950421)",0.9994094138592844,0.9966422319412231,0,0,"[{'label': 'positive', 'score': 0.5848773717880249}, {'label': 'neutral', 'score': 0.38823840022087097}, {'label': 'negative', 'score': 0.026884227991104126}]","(0.38823840022087097, 0.5848773717880249, 0.026884227991104126)",0.9121088083959162,0.5848773717880249,0,0,"[{'label': 'positive', 'score': 0.998578667640686}, {'label': 'neutral', 'score': 0.0010819287272170186}, {'label': 'negative', 'score': 0.0003394228115212172}]","(0.0010819287272170186, 0.998578667640686, 0.0003394228115212172)",0.9993204191319279,0.998578667640686,0,0
2014-02-05,36.82908248901367,51.078243255615234,52.671756744384766,50.70610809326172,51.79389190673828,25682602.0,"Market Wrap For February 5: Markets Unsure Of Which Direction To Take | Merck Retreats From Highs | Top Trending Tickers On StockTwits For February 5 | Stocks Hitting 52-Week Highs | Benzinga's Top #PreMarket Gainers | UPDATE: Merck Posts Drop In Q4 Profit | Merck & Company, Inc. Sees FY2014 EPS $3.35-3.53 vs $3.47 Est; Sees Sales $42.40B-43.20B vs $43.54B Est | US Stock Futures Flat; All Eyes On ADP Report | Merck & Company, Inc. Reports Q4 Adjusted EPS of $0.88, Inline; Revenue of $11.32B vs $11.36B Est | Pfizer Confirms Collaboration with Merck on Innovative Anti-Cancer Combination Studies  | Incyte Confirms Clinical Trial Collaboration with Merck to Evaluate Combination of Two Novel Immunotherapies  | Merck Confirms Collaborations with Amgen, Incyte and Pfizer to Evaluate Novel Combination Anti-cancer Regimens with MK-3475  | Amgen,Merck Announce Collaboration to Evaluate Investigational Combination Treatment for Advanced Melanoma | Earnings Scheduled For February 5, 2014 | Stocks To Watch For February 5, 2014",0.004483469014414271,0.00037371090994388025,0.22554421843421943,"[{'label': 'negative', 'score': 0.9976658821105957}, {'label': 'neutral', 'score': 0.001291482476517558}, {'label': 'positive', 'score': 0.0010426804656162858}]","(0.001291482476517558, 0.0010426804656162858, 0.9976658821105957)",-0.9979119424731342,-0.9976658821105957,0,0,"[{'label': 'negative', 'score': 0.9146896004676819}, {'label': 'neutral', 'score': 0.06038336083292961}, {'label': 'positive', 'score': 0.024927115067839622}]","(0.06038336083292961, 0.024927115067839622, 0.9146896004676819)",-0.9469419505726168,-0.9146896004676819,0,0,"[{'label': 'negative', 'score': 0.7647741436958313}, {'label': 'neutral', 'score': 0.20167744159698486}, {'label': 'positive', 'score': 0.03354838863015175}]","(0.20167744159698486, 0.03354838863015175, 0.7647741436958313)",-0.9159527953384816,-0.7647741436958313,0,0
2014-02-06,36.99420547485352,51.3072509765625,51.40267181396485,50.38167953491211,50.82061004638672,12832550.0,"Bloomberg Reporting Merck Said to Agree to Pay $100M Related to NuvaRing Settlement | #PreMarket Primer: Thursday, February 6: Markets Taking A Breather After Twitter Earnings",0.018597775684080046,0.004473448208031829,0.21491150914682225,"[{'label': 'neutral', 'score': 0.9913169145584106}, {'label': 'positive', 'score': 0.008114906027913094}, {'label': 'negative', 'score': 0.00056822644546628}]","(0.9913169145584106, 0.008114906027913094, 0.00056822644546628)",0.8691194802778052,0.008114906027913094,0,1,"[{'label': 'negative', 'score': 0.8981741666793823}, {'label': 'positive', 'score': 0.05640331283211708}, {'label': 'neutral', 'score': 0.045422524213790894}]","(0.045422524213790894, 0.05640331283211708, 0.8981741666793823)",-0.8818255950036005,-0.8981741666793823,0,0,"[{'label': 'positive', 'score': 0.9624078869819641}, {'label': 'neutral', 'score': 0.037204429507255554}, {'label': 'negative', 'score': 0.00038771828985773027}]","(0.037204429507255554, 0.9624078869819641, 0.00038771828985773027)",0.9991945989621582,0.9624078869819641,0,0
2014-02-07,37.682220458984375,52.261451721191406,52.30915832519531,50.99236679077149,51.1927490234375,15192961.0,"Market Wrap For February 7: Jobs Report Not Great, But Not Too Bad | Bloomberg Reporting Merck Has Reached Agreement in Principle to Resolve Suits Related to NuvaRing",0.0007303149157040982,0.018426951766866536,0.21392571674270144,"[{'label': 'positive', 'score': 0.999265730381012}, {'label': 'negative', 'score': 0.00044066019472666085}, {'label': 'neutral', 'score': 0.0002935526426881552}]","(0.0002935526426881552, 0.999265730381012, 0.00044066019472666085)",0.9991184207705767,0.999265730381012,0,0,"[{'label': 'positive', 'score': 0.9260448813438416}, {'label': 'negative', 'score': 0.03944212198257446}, {'label': 'neutral', 'score': 0.034512992948293686}]","(0.034512992948293686, 0.9260448813438416, 0.03944212198257446)",0.9182959027999682,0.9260448813438416,0,0,"[{'label': 'positive', 'score': 0.9850932359695435}, {'label': 'neutral', 'score': 0.00795146357268095}, {'label': 'negative', 'score': 0.006955270655453205}]","(0.00795146357268095, 0.9850932359695435, 0.006955270655453205)",0.9859779625512155,0.9850932359695435,0,0
2014-02-08,37.709739685058594,52.29961903889974,52.36641057332357,51.240458170572914,51.39631144205729,13834927.666666666,,0.0007297819450642703,0.0007300483655351755,0.18981468660935844,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-09,37.73725891113281,52.33778635660807,52.42366282145182,51.48854955037435,51.599873860677086,12476894.333333334,,0.0007292497517621275,0.0007295157837058602,0.12255751795383231,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-10,37.76477813720703,52.375953674316406,52.48091506958008,51.73664093017578,51.80343627929688,11118861.0,"Three ETFs To Buy On The Pullback (PJP, SKYY, SPY) | Merck, Samsung Bioepis Announce Deal to Develop Insulin Glargine Candidate",0.014756764764448645,0.0007289839783641912,0.1217456279793347,"[{'label': 'neutral', 'score': 0.9425517916679382}, {'label': 'positive', 'score': 0.05717235803604126}, {'label': 'negative', 'score': 0.000275867321761325}]","(0.9425517916679382, 0.05717235803604126, 0.000275867321761325)",0.9903959671497892,0.05717235803604126,0,1,"[{'label': 'positive', 'score': 0.8857079148292542}, {'label': 'neutral', 'score': 0.10442598909139633}, {'label': 'negative', 'score': 0.009865987114608288}]","(0.10442598909139633, 0.8857079148292542, 0.009865987114608288)",0.9779672295202128,0.8857079148292542,0,0,"[{'label': 'neutral', 'score': 0.9338670372962952}, {'label': 'positive', 'score': 0.0652998611330986}, {'label': 'negative', 'score': 0.0008331689168699086}]","(0.9338670372962952, 0.0652998611330986, 0.0008331689168699086)",0.9748032438180925,0.0652998611330986,0,1
2014-02-11,38.32207107543945,53.14885330200195,53.196563720703125,51.946563720703125,52.20419692993164,16089525.0,,-0.01256731219818652,0.01464894314918868,0.13907746841772486,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-12,37.840450286865234,52.48091506958008,53.13931274414063,52.33778762817383,52.90076446533203,14283926.0,Merck Finds Resistance,0.0018182007168859994,-0.012646948781476396,0.15321599776394867,"[{'label': 'neutral', 'score': 0.9990130662918091}, {'label': 'positive', 'score': 0.0008028454030863941}, {'label': 'negative', 'score': 0.00018409741460345685}]","(0.9990130662918091, 0.0008028454030863941, 0.00018409741460345685)",0.6269339797529995,0.0008028454030863941,0,1,"[{'label': 'neutral', 'score': 0.7730026245117188}, {'label': 'positive', 'score': 0.2034294605255127}, {'label': 'negative', 'score': 0.023567918688058853}]","(0.7730026245117188, 0.2034294605255127, 0.023567918688058853)",0.792350741936233,0.2034294605255127,0,1,"[{'label': 'negative', 'score': 0.9970912933349609}, {'label': 'neutral', 'score': 0.0023291264660656452}, {'label': 'positive', 'score': 0.000579550105612725}]","(0.0023291264660656452, 0.000579550105612725, 0.9970912933349609)",-0.9988381937601503,-0.9970912933349609,0,0
2014-02-13,37.909278869628906,52.57633590698242,52.681297302246094,51.91793823242188,51.95610809326172,10735083.0,,0.006170619400400695,0.0018165497908030675,0.15336181105044008,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-14,38.143184661865234,52.90076446533203,53.07251739501953,52.433204650878906,52.433204650878906,9098631.0,,0.00112733852345803,0.006151659086452693,0.15741327766867905,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-15,38.18618679046631,52.96040153503418,53.14646816253662,52.4761438369751,52.49761390686035,9758661.5,,0.0011260690624238854,0.0011267035545565935,0.15721390101523117,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-16,38.22918891906738,53.02003860473633,53.22041893005371,52.51908302307129,52.5620231628418,10418692.0,,0.0011248024571755217,0.001125435522219367,0.11293417207320826,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-17,38.27219104766846,53.07967567443848,53.2943696975708,52.56202220916748,52.62643241882324,11078722.5,,0.0011235386980873153,0.001124170340851259,0.03478199274415127,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-18,38.31519317626953,53.13931274414063,53.36832046508789,52.60496139526367,52.69084167480469,11738753.0,,-0.011671731938029237,0.0011229080008484831,0.03568713544632405,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-02-19,37.86798858642578,52.51908493041992,53.110687255859375,52.47137451171875,52.90076446533203,10791361.0,,0.013989839741427005,-0.011740381295327406,0.09133376043567124,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-02-20,38.39774703979492,53.25381851196289,53.43511581420898,52.50954055786133,52.58587646484375,10619489.0,"HB Reporting (via Bloomberg) Merck is Still Interested in More Purchases in the Pharma Group | Merck Testing Multi-Year Highs | Merck Reports FDA Acceptance for Review of BLA for V503 | FDA Accepts for Review Merck's Biologics License Application for V503, Investigational 9-valent Human Papillomavirus Vaccine",0.003941929356299474,0.01389288513992235,0.1438669550846869,"[{'label': 'positive', 'score': 0.9987055063247681}, {'label': 'neutral', 'score': 0.0010296478867530823}, {'label': 'negative', 'score': 0.0002648109511937946}]","(0.0010296478867530823, 0.9987055063247681, 0.0002648109511937946)",0.9994698321929807,0.9987055063247681,0,0,"[{'label': 'positive', 'score': 0.8665627241134644}, {'label': 'neutral', 'score': 0.11795798689126968}, {'label': 'negative', 'score': 0.01547928899526596}]","(0.11795798689126968, 0.8665627241134644, 0.01547928899526596)",0.9649012433303269,0.8665627241134644,0,0,"[{'label': 'positive', 'score': 0.9952919483184814}, {'label': 'neutral', 'score': 0.004456999246031046}, {'label': 'negative', 'score': 0.0002511221100576222}]","(0.004456999246031046, 0.9952919483184814, 0.0002511221100576222)",0.9994955072914132,0.9952919483184814,0,0
2014-02-21,38.54910659790039,53.46374130249024,53.75954055786133,53.26335906982422,53.29198455810547,12226597.0,,0.0008923645441398429,0.00393418031022708,0.14526713208440464,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-22,38.583508809407554,53.51145044962565,53.94401931762695,53.27926254272461,53.29834620157877,11998098.0,,0.0008915689396297267,0.0008919666236092461,0.14533111108302407,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-23,38.61791102091471,53.55915959676107,54.12849807739258,53.295166015625,53.304707845052086,11769599.0,,0.000890774752527901,0.0008911717281195351,0.1453903779221026,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-24,38.65231323242188,53.60686874389648,54.3129768371582,53.31106948852539,53.31106948852539,11541100.0,,-0.004805973847480914,0.000890378248144689,0.08938413130700826,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-25,38.466556549072266,53.34923553466797,53.8072509765625,53.2442741394043,53.55915832519531,8923196.0,,0.006438958034296586,-0.00481755967548823,0.050467643736349675,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-26,38.7142333984375,53.6927490234375,53.864505767822266,53.35877990722656,53.43511581420898,10626196.0,,0.006930827143737311,0.0064183165032655675,0.0630661403950944,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-27,38.98255157470703,54.064884185791016,54.07442855834961,53.43511581420898,53.66412353515625,9490164.0,,0.0058242610750110155,0.00690691936484355,0.07634735946091012,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-02-28,39.2095947265625,54.3797721862793,54.828243255615234,54.05534362792969,54.13167953491211,12457157.0,"Overvaluing Liquidity: Invest For The Future, Not For Today | CHMP Issues Positive Opinion For Tablet Formulation Of Merck's NOXAFIL",-0.003333934044276766,0.005807365637028702,0.07952578366929888,"[{'label': 'positive', 'score': 0.9788894653320312}, {'label': 'neutral', 'score': 0.019937891513109207}, {'label': 'negative', 'score': 0.0011726520024240017}]","(0.019937891513109207, 0.9788894653320312, 0.0011726520024240017)",0.9976069843294967,0.9788894653320312,0,0,"[{'label': 'positive', 'score': 0.943687915802002}, {'label': 'neutral', 'score': 0.043209388852119446}, {'label': 'negative', 'score': 0.013102732598781586}]","(0.043209388852119446, 0.943687915802002, 0.013102732598781586)",0.9726110772075751,0.943687915802002,0,0,"[{'label': 'positive', 'score': 0.9476314783096313}, {'label': 'neutral', 'score': 0.031059090048074722}, {'label': 'negative', 'score': 0.021309444680809975}]","(0.031059090048074722, 0.9476314783096313, 0.021309444680809975)",0.9560149764032204,0.9476314783096313,0,0
2014-03-01,39.07887268066406,54.198473612467446,54.608777364095054,53.83269755045573,53.931297302246094,11735853.333333334,,-0.0033450863415116464,-0.003339503985706367,0.09150056536386843,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-02,38.948150634765625,54.0171750386556,54.38931147257487,53.61005147298177,53.73091506958008,11014549.666666666,,-0.003356313499958319,-0.003350693650942512,0.08476250278512369,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-03,38.81742858886719,53.83587646484375,54.16984558105469,53.38740539550781,53.53053283691406,10293246.0,The Top Five Dow Stocks In February,0.01134349983617653,-0.003361958554701466,0.08463355262904756,"[{'label': 'neutral', 'score': 0.9998661279678345}, {'label': 'negative', 'score': 7.912367436802015e-05}, {'label': 'positive', 'score': 5.467106166179292e-05}]","(0.9998661279678345, 5.467106166179292e-05, 7.912367436802015e-05)",-0.18276214320403852,-7.912367436802015e-05,1,1,"[{'label': 'neutral', 'score': 0.8719210028648376}, {'label': 'negative', 'score': 0.08960773050785065}, {'label': 'positive', 'score': 0.0384712889790535}]","(0.8719210028648376, 0.0384712889790535, 0.08960773050785065)",-0.3992569722477128,-0.08960773050785065,1,1,"[{'label': 'neutral', 'score': 0.999438464641571}, {'label': 'positive', 'score': 0.000433867156971246}, {'label': 'negative', 'score': 0.00012761025573126972}]","(0.999438464641571, 0.000433867156971246, 0.00012761025573126972)",0.5454483017685319,0.000433867156971246,0,1
2014-03-04,39.25775909423828,54.446563720703125,54.761451721191406,54.30343627929688,54.42748260498047,11523703.0,"Merck Issues Results from Phase 2b Study of MK-8237, Says Secondary Efficacy Endpoints Average TNSS, DU Made Significant Dose, Time Dependent Reduction | Biotechs vs. Pharmaceuticals: What's the Difference?",-0.0031545228559978255,0.011279644781378937,0.10788250824177234,"[{'label': 'negative', 'score': 0.9854775667190552}, {'label': 'neutral', 'score': 0.010798037983477116}, {'label': 'positive', 'score': 0.003724433248862624}]","(0.010798037983477116, 0.003724433248862624, 0.9854775667190552)",-0.9924698226469753,-0.9854775667190552,0,0,"[{'label': 'neutral', 'score': 0.8366342782974243}, {'label': 'positive', 'score': 0.11405355483293533}, {'label': 'negative', 'score': 0.049312155693769455}]","(0.8366342782974243, 0.11405355483293533, 0.049312155693769455)",0.3962973559777885,0.11405355483293533,1,1,"[{'label': 'neutral', 'score': 0.9751192927360535}, {'label': 'negative', 'score': 0.020333049818873405}, {'label': 'positive', 'score': 0.004547720309346914}]","(0.9751192927360535, 0.004547720309346914, 0.020333049818873405)",-0.6344389433356977,-0.020333049818873405,0,1
2014-03-05,39.133914947509766,54.274810791015625,54.80915832519531,53.931297302246094,54.770992279052734,9476330.0,"Merck Announces MK-1439 Shows Antiviral Activity in Phase 2b Trial, Co. Planning to Initiate Phase 2 Development Program During 2H'14 | UPDATE: Merck Plans to Initiate Phase 3 Clinical Development Program In Second Half Of 2014  | Merck's Investigational HIV Therapy, Doravirine (MK-1439), Demonstrates Antiviral Activity in Phase 2B Study of Treatment-Nave Adults ",0.006680716140832859,-0.003159508851608145,0.103534333252864,"[{'label': 'neutral', 'score': 0.9992098808288574}, {'label': 'positive', 'score': 0.000729867781046778}, {'label': 'negative', 'score': 6.030585427652113e-05}]","(0.9992098808288574, 0.000729867781046778, 6.030585427652113e-05)",0.8473605000707293,0.000729867781046778,0,1,"[{'label': 'neutral', 'score': 0.5082851052284241}, {'label': 'positive', 'score': 0.4790210425853729}, {'label': 'negative', 'score': 0.012693888507783413}]","(0.5082851052284241, 0.4790210425853729, 0.012693888507783413)",0.9483689117206061,0.4790210425853729,0,1,"[{'label': 'neutral', 'score': 0.961113452911377}, {'label': 'positive', 'score': 0.03826247155666351}, {'label': 'negative', 'score': 0.0006240449147298932}]","(0.961113452911377, 0.03826247155666351, 0.0006240449147298932)",0.9679043035295297,0.03826247155666351,0,1
2014-03-06,39.39536285400391,54.63740539550781,55.00954055786133,54.39885330200195,54.446563720703125,11114774.0,Merck Trading Higher,0.003667491734197369,0.006658499052569435,0.10971409462909705,"[{'label': 'positive', 'score': 0.9966356158256531}, {'label': 'neutral', 'score': 0.003136115614324808}, {'label': 'negative', 'score': 0.00022832192189525813}]","(0.003136115614324808, 0.9966356158256531, 0.00022832192189525813)",0.9995419195875194,0.9966356158256531,0,0,"[{'label': 'neutral', 'score': 0.9282346963882446}, {'label': 'positive', 'score': 0.0496683306992054}, {'label': 'negative', 'score': 0.022096950560808182}]","(0.9282346963882446, 0.0496683306992054, 0.022096950560808182)",0.38418828233255364,0.0496683306992054,1,1,"[{'label': 'neutral', 'score': 0.7493972182273865}, {'label': 'positive', 'score': 0.24984771013259888}, {'label': 'negative', 'score': 0.00075502012623474}]","(0.7493972182273865, 0.24984771013259888, 0.00075502012623474)",0.9939743663171193,0.24984771013259888,0,1
2014-03-07,39.53984451293945,54.83778762817383,54.933204650878906,54.48473358154297,54.72328186035156,11144642.0,,-0.0008700281460052895,0.0036607828844844197,0.10064570472195537,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-08,39.505444844563804,54.790077209472656,54.9491081237793,54.45292663574219,54.75190734863281,10008959.333333334,,-0.0008707857541203851,-0.0008704068401584094,0.09187123772214002,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-09,39.47104517618815,54.74236679077149,54.96501159667969,54.421119689941406,54.78053283691406,8873276.666666668,,-0.0008715446828145187,-0.0008711651082752691,0.06318203358649487,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-10,39.4366455078125,54.69465637207031,54.98091506958008,54.38931274414063,54.80915832519531,7737594.0,,-0.010990958493433756,-0.000871924698698137,0.05506984667602491,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-03-11,39.00318908691406,54.093509674072266,54.80915832519531,53.97900772094727,54.770992279052734,11408004.0,,0.00211681158261302,-0.011051805331884572,0.0861484405267022,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-12,39.08575439453125,54.20801544189453,54.32251739501953,53.683204650878906,53.8072509765625,9954218.0,Merck Unchanged,-0.01795457465870193,0.0021145742936980517,0.08024353826873981,"[{'label': 'neutral', 'score': 0.999871015548706}, {'label': 'negative', 'score': 7.244674634421244e-05}, {'label': 'positive', 'score': 5.6482094805687666e-05}]","(0.999871015548706, 5.6482094805687666e-05, 7.244674634421244e-05)",-0.12382529305419997,-7.244674634421244e-05,0,0,"[{'label': 'neutral', 'score': 0.9194055199623108}, {'label': 'positive', 'score': 0.05877254158258438}, {'label': 'negative', 'score': 0.021821897476911545}]","(0.9194055199623108, 0.05877254158258438, 0.021821897476911545)",0.458476348205555,0.05877254158258438,0,0,"[{'label': 'neutral', 'score': 0.9995085000991821}, {'label': 'positive', 'score': 0.00033607264049351215}, {'label': 'negative', 'score': 0.0001554039045004174}]","(0.9995085000991821, 0.00033607264049351215, 0.0001554039045004174)",0.3676039840219156,0.00033607264049351215,0,0
2014-03-13,38.68360900878906,53.23473358154297,54.18893051147461,53.16793823242188,54.01717758178711,10605760.0,,-0.0016132377070971423,-0.01811771371251023,0.1352875067542007,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-14,38.621185302734375,53.14885330200195,53.45419692993164,52.738548278808594,52.98664093017578,12699454.0,UPDATE: FDA Approves Merck Noxafi Injection for IV Use | FDA Approves Merck Noxafi Injection for Intravenous Use ,0.0033512880377724154,-0.001614540376245395,0.13368875636068955,"[{'label': 'positive', 'score': 0.8874905109405518}, {'label': 'neutral', 'score': 0.11164433509111404}, {'label': 'negative', 'score': 0.0008651704411022365}]","(0.11164433509111404, 0.8874905109405518, 0.0008651704411022365)",0.9980521981021011,0.8874905109405518,0,0,"[{'label': 'neutral', 'score': 0.8439764976501465}, {'label': 'positive', 'score': 0.1416216939687729}, {'label': 'negative', 'score': 0.014401830732822418}]","(0.8439764976501465, 0.1416216939687729, 0.014401830732822418)",0.8153889836758038,0.1416216939687729,0,1,"[{'label': 'positive', 'score': 0.935607373714447}, {'label': 'neutral', 'score': 0.0638078972697258}, {'label': 'negative', 'score': 0.0005847191205248237}]","(0.0638078972697258, 0.935607373714447, 0.0005847191205248237)",0.9987508565282704,0.935607373714447,0,0
2014-03-15,38.75061798095703,53.32697041829427,53.59096654256185,52.954833984375,53.12022908528646,11788253.0,,0.0033400944192998514,0.003345684986818306,0.14644325003336026,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-16,38.88005065917969,53.505087534586586,53.727736155192055,53.171119689941406,53.25381724039713,10877052.0,,0.0033289753273869926,0.0033345286938571217,0.14499709179284784,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-17,39.00948333740234,53.683204650878906,53.864505767822266,53.38740539550781,53.38740539550781,9965851.0,Ligand Pharma Announces $1M Milestone Payment Triggered Following FDA Approval of Merck's Noxafil,0.001777480275682117,0.0033234465557203372,0.1474892934958098,"[{'label': 'neutral', 'score': 0.9734238982200623}, {'label': 'positive', 'score': 0.025653505697846413}, {'label': 'negative', 'score': 0.0009226352558471262}]","(0.9734238982200623, 0.025653505697846413, 0.0009226352558471262)",0.9305666494277907,0.025653505697846413,0,1,"[{'label': 'positive', 'score': 0.7340404987335205}, {'label': 'neutral', 'score': 0.20522069931030273}, {'label': 'negative', 'score': 0.060738831758499146}]","(0.20522069931030273, 0.7340404987335205, 0.060738831758499146)",0.8471554822119043,0.7340404987335205,0,0,"[{'label': 'positive', 'score': 0.5319878458976746}, {'label': 'neutral', 'score': 0.467415452003479}, {'label': 'negative', 'score': 0.000596669502556324}]","(0.467415452003479, 0.5319878458976746, 0.000596669502556324)",0.9977593434082178,0.5319878458976746,0,0
2014-03-18,39.07881546020508,53.77862548828125,53.96946716308594,53.58778762817383,53.73091506958008,7410303.0,,-0.006564951101396082,0.0017759024270699803,0.034096045642848044,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-03-19,38.82227325439453,53.42557144165039,54.30343627929688,53.09160232543945,54.08396911621094,10530723.0,,-0.007144135750217794,-0.006586595173065437,0.06850989122985425,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-20,38.544918060302734,53.04389190673828,53.32061004638672,52.77671813964844,53.27289962768555,8866918.0,,-0.016729571472070385,-0.007169777285416499,0.08491057468257175,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-03-21,37.90007781982422,52.15649032592773,54.00763320922852,52.11832046508789,53.91221237182617,24549295.0,"Mid-Day Market Update: Nike Drops On Cautious Forecast; Endocyte Shares Spike Higher | ""Premarket Prep"" Technical Update - Merck Trading Lower After Higher Open | Mid-Morning Market Update: Markets Open Higher; Tiffany Posts Downbeat Earnings | Benzinga's Volume Movers | UPDATE: Endocyte Shares Rise 158% | UPDATE: Endocyte Shares Rise 91% on European CHMP Positive Opinions for VYNFINIT | PREVIEW: Endocyte to Resume Trading at 8:30AM ET | Benzinga's Top #PreMarket Gainers | Merck, Endocyte Announce European CHMP Positive Opinions for VYNFINIT, Companion Agents FOLCEPRI, NEOCEPRI",-0.005366509975136549,-0.016871091351158395,0.1287903193407862,"[{'label': 'positive', 'score': 0.7892063856124878}, {'label': 'negative', 'score': 0.20875141024589539}, {'label': 'neutral', 'score': 0.0020421782974153757}]","(0.0020421782974153757, 0.7892063856124878, 0.20875141024589539)",0.581642808719501,0.7892063856124878,0,0,"[{'label': 'negative', 'score': 0.8439603447914124}, {'label': 'positive', 'score': 0.12907598912715912}, {'label': 'neutral', 'score': 0.026963621377944946}]","(0.026963621377944946, 0.12907598912715912, 0.8439603447914124)",-0.7346944104186743,-0.8439603447914124,0,0,"[{'label': 'neutral', 'score': 0.7957743406295776}, {'label': 'negative', 'score': 0.11632294952869415}, {'label': 'positive', 'score': 0.08790271729230881}]","(0.7957743406295776, 0.08790271729230881, 0.11632294952869415)",-0.139160922712495,-0.11632294952869415,1,1
2014-03-22,37.69668833414713,51.87659200032552,53.4541982014974,51.78435134887695,53.39058430989584,21781142.666666668,,-0.0053954647907569165,-0.005380961415514049,0.10564545138587406,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-23,37.49329884847005,51.596693674723305,52.900763193766274,51.450382232666016,52.86895624796549,19012990.333333336,,-0.005424733750708093,-0.005410072879557183,0.07717848071449798,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-24,37.28990936279297,51.31679534912109,52.34732818603516,51.11641311645508,52.34732818603516,16244838.0,"Reckitt Benckiser a Frontrunner for Merck's OTC Segment, Sanofi Rumored to Join Bidders, Final Bids Are Due Next Week - Bloomberg | Google Honors Activist Dorothy Height & Her Contributions",0.02621786909240677,-0.005439501048827549,0.07917148803673396,"[{'label': 'neutral', 'score': 0.9998025298118591}, {'label': 'positive', 'score': 0.00012809954932890832}, {'label': 'negative', 'score': 6.932942778803408e-05}]","(0.9998025298118591, 0.00012809954932890832, 6.932942778803408e-05)",0.29767728323924375,0.00012809954932890832,0,0,"[{'label': 'neutral', 'score': 0.9102545976638794}, {'label': 'positive', 'score': 0.07538654655218124}, {'label': 'negative', 'score': 0.014358844608068466}]","(0.9102545976638794, 0.07538654655218124, 0.014358844608068466)",0.6800093147417618,0.07538654655218124,1,0,"[{'label': 'neutral', 'score': 0.9685236215591431}, {'label': 'positive', 'score': 0.031124794855713844}, {'label': 'negative', 'score': 0.00035154636134393513}]","(0.9685236215591431, 0.031124794855713844, 0.00035154636134393513)",0.9776628192635411,0.031124794855713844,1,0
2014-03-25,38.267574310302734,52.66221237182617,52.93893051147461,51.34542083740234,51.41221237182617,14793254.0,,0.01503895340578539,0.025880072249204796,0.2549568403735156,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-26,38.84307098388672,53.45419692993164,53.8740463256836,52.85305404663086,52.89122009277344,13701133.0,Nanobio Announces Licensing Agreement With Unit of Merck for Use of its Nanoemulsion Adjuvant Technology | Nanobio Announces Licensing Agreement With Unit of Merck for Use of its Nanoemulsion Adjuvant Technology,-0.005176662279930837,0.014926989497034011,0.23271235754864456,"[{'label': 'neutral', 'score': 0.5222979187965393}, {'label': 'positive', 'score': 0.4767681658267975}, {'label': 'negative', 'score': 0.000933928182348609}]","(0.5222979187965393, 0.4767681658267975, 0.000933928182348609)",0.9960899138016727,0.4767681658267975,0,1,"[{'label': 'positive', 'score': 0.6803022623062134}, {'label': 'neutral', 'score': 0.29591110348701477}, {'label': 'negative', 'score': 0.023786617442965508}]","(0.29591110348701477, 0.6803022623062134, 0.023786617442965508)",0.9324329125850159,0.6803022623062134,0,0,"[{'label': 'neutral', 'score': 0.9881243109703064}, {'label': 'positive', 'score': 0.01171281561255455}, {'label': 'negative', 'score': 0.00016287824837490916}]","(0.9881243109703064, 0.01171281561255455, 0.00016287824837490916)",0.9725694767341937,0.01171281561255455,0,1
2014-03-27,38.641998291015625,53.17748260498047,53.540077209472656,52.79580307006836,53.33015441894531,11657742.0,"Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; Succeeds Peter N. Kellogg, Who Has Served in the Role Since 2007 | Merck Names Robert Davis as CFO, Succeeding Peter Kellogg",0.004485888897385525,-0.005190107617498079,0.23218371368893306,"[{'label': 'neutral', 'score': 0.9998492002487183}, {'label': 'positive', 'score': 8.758620242588222e-05}, {'label': 'negative', 'score': 6.32052106084302e-05}]","(0.9998492002487183, 8.758620242588222e-05, 6.32052106084302e-05)",0.1616868714659776,8.758620242588222e-05,1,1,"[{'label': 'neutral', 'score': 0.8952116966247559}, {'label': 'negative', 'score': 0.06265611946582794}, {'label': 'positive', 'score': 0.0421321876347065}]","(0.8952116966247559, 0.0421321876347065, 0.06265611946582794)",-0.1958608970696576,-0.06265611946582794,1,1,"[{'label': 'neutral', 'score': 0.9983779191970825}, {'label': 'positive', 'score': 0.0014106633607298136}, {'label': 'negative', 'score': 0.00021142027981113642}]","(0.9983779191970825, 0.0014106633607298136, 0.00021142027981113642)",0.7393225916012202,0.0014106633607298136,0,1
2014-03-28,38.81534194946289,53.41603088378906,54.35114669799805,53.21564865112305,53.63549423217773,9390394.0,,0.004704047859749679,0.004475857287057161,0.2143031308178486,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-29,38.997931162516274,53.66730244954427,54.31297810872396,53.30152638753256,53.5973269144694,11214228.666666666,,0.004682023397606736,0.004693018401823314,0.18790247698072535,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-30,39.180520375569664,53.91857401529948,54.27480951944987,53.387404123942055,53.55915959676107,13038063.333333332,,0.004660204212446568,0.00467109681845129,0.11293668843543891,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-03-31,39.36310958862305,54.16984558105469,54.23664093017578,53.47328186035156,53.520992279052734,14861898.0,,-0.007045907480828001,0.004649379079321297,0.06967481843347688,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-01,39.08575820922852,53.78816986083984,54.23664093017578,53.44465637207031,54.05534362792969,8085739.0,,0.0015965678896668702,-0.007070847104172263,0.08302459481325468,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-02,39.148170471191406,53.8740463256836,53.96946716308594,53.48282241821289,53.89313125610352,7398880.0,,-0.00442795946797387,0.0015952947300972695,0.08071951025970708,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-03,38.97480392456055,53.63549423217773,54.15076446533203,53.38740539550781,53.94084167480469,8712129.0,,-0.0016011125854830425,-0.004437791916356405,0.08533984458278422,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-04,38.912410736083984,53.549617767333984,54.12213516235352,53.520992279052734,54.01717758178711,10912614.0,Merck Shares Volatile This Afternoon; Reuters Earlier Reported Co. is Seeing Resistance from Beef Industry for Test of Zilmax on 200K+ Cattle ,-0.005523882538019628,-0.0016023957360673095,0.07402988559458554,"[{'label': 'negative', 'score': 0.9958227872848511}, {'label': 'neutral', 'score': 0.003089943900704384}, {'label': 'positive', 'score': 0.0010872283019125462}]","(0.003089943900704384, 0.0010872283019125462, 0.9958227872848511)",-0.9978188035330899,-0.9958227872848511,0,0,"[{'label': 'negative', 'score': 0.8589022755622864}, {'label': 'positive', 'score': 0.09735912084579468}, {'label': 'neutral', 'score': 0.043738577514886856}]","(0.043738577514886856, 0.09735912084579468, 0.8589022755622864)",-0.7963755073424568,-0.8589022755622864,0,0,"[{'label': 'negative', 'score': 0.9987137317657471}, {'label': 'neutral', 'score': 0.0008318591280840337}, {'label': 'positive', 'score': 0.0004544341645669192}]","(0.0008318591280840337, 0.0004544341645669192, 0.9987137317657471)",-0.999090375013812,-0.9987137317657471,0,0
2014-04-05,38.69746526082357,53.25381596883138,53.94401931762695,53.183841705322266,53.62277475992838,11266663.333333334,,-0.005554565304310664,-0.0055391955948866515,0.05459540476593345,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-06,38.48251978556315,52.95801417032877,53.76590347290039,52.8466911315918,53.228371938069664,11620712.666666666,Merck Presents Early Findings from MK-3475 Treatment at AARC 2014,-0.005585590833357306,-0.0055700492665764,0.049011197024480445,"[{'label': 'neutral', 'score': 0.9998724460601807}, {'label': 'positive', 'score': 7.229059701785445e-05}, {'label': 'negative', 'score': 5.532340583158657e-05}]","(0.9998724460601807, 7.229059701785445e-05, 5.532340583158657e-05)",0.13295712701909188,7.229059701785445e-05,1,1,"[{'label': 'neutral', 'score': 0.8500421643257141}, {'label': 'positive', 'score': 0.13328863680362701}, {'label': 'negative', 'score': 0.016669217497110367}]","(0.8500421643257141, 0.13328863680362701, 0.016669217497110367)",0.7776813015251526,0.13328863680362701,0,1,"[{'label': 'neutral', 'score': 0.9994947910308838}, {'label': 'positive', 'score': 0.00038814276922494173}, {'label': 'negative', 'score': 0.00011705018550856039}]","(0.9994947910308838, 0.00038814276922494173, 0.00011705018550856039)",0.5366119641541464,0.00038814276922494173,0,1
2014-04-07,38.267574310302734,52.66221237182617,53.58778762817383,52.50954055786133,52.83396911621094,11974762.0,,-0.0027178395088243946,-0.005601248578227163,0.02729433802334654,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-08,38.1635627746582,52.51908493041992,53.0629768371582,52.19465637207031,52.74809265136719,11283606.0,"Biotechs Struggling To Find A Bottom | Express Scripts Reports Spending on Hepatitis C Medications in US to Rise 1,800% by 2016",0.037427321015346,-0.0027215395402038533,0.03029404918542704,"[{'label': 'positive', 'score': 0.9987216591835022}, {'label': 'negative', 'score': 0.0010115123586729169}, {'label': 'neutral', 'score': 0.00026681795134209096}]","(0.00026681795134209096, 0.9987216591835022, 0.0010115123586729169)",0.997976435338016,0.9987216591835022,1,1,"[{'label': 'positive', 'score': 0.922858476638794}, {'label': 'negative', 'score': 0.05091268941760063}, {'label': 'neutral', 'score': 0.02622886560857296}]","(0.02622886560857296, 0.922858476638794, 0.05091268941760063)",0.8954319224222088,0.922858476638794,1,1,"[{'label': 'positive', 'score': 0.9578424692153931}, {'label': 'neutral', 'score': 0.02692105993628502}, {'label': 'negative', 'score': 0.015236452221870422}]","(0.02692105993628502, 0.9578424692153931, 0.015236452221870422)",0.9686840360299537,0.9578424692153931,1,1
2014-04-09,39.591922760009766,54.48473358154297,54.53244400024414,52.671756744384766,52.69084167480469,16881708.0,,-0.02189143536239206,0.03674391863555654,0.29599297847624045,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-10,38.72521209716797,53.29198455810547,55.47710037231445,53.225189208984375,55.238548278808594,18883388.0,"When It Comes To Drug Stocks, Do Not Always Buy The News | US Stock Futures Edge Lower Ahead Of Jobless Claims Data | Merck Announces Results from Studies Evaluating MK-5172 and MK-8742 Investigational Hepatitis C Treatments, ",0.0012533845319321005,-0.02213460832119694,0.34686435275311195,"[{'label': 'negative', 'score': 0.9967283010482788}, {'label': 'neutral', 'score': 0.0016783728497102857}, {'label': 'positive', 'score': 0.0015934210969135165}]","(0.0016783728497102857, 0.0015934210969135165, 0.9967283010482788)",-0.9968078004082901,-0.9967283010482788,0,0,"[{'label': 'negative', 'score': 0.944511890411377}, {'label': 'positive', 'score': 0.03683886677026749}, {'label': 'neutral', 'score': 0.01864929497241974}]","(0.01864929497241974, 0.03683886677026749, 0.944511890411377)",-0.9249221208611168,-0.944511890411377,0,0,"[{'label': 'negative', 'score': 0.9970282912254333}, {'label': 'neutral', 'score': 0.0025719592813402414}, {'label': 'positive', 'score': 0.0003998393367510289}]","(0.0025719592813402414, 0.0003998393367510289, 0.9970282912254333)",-0.999198259354234,-0.9970282912254333,0,0
2014-04-11,38.77373504638672,53.35877990722656,54.00763320922852,52.76717758178711,53.0057258605957,14286022.0,Top 40 Upcoming Earnings Releases   | Google Honors Chemist Percy Julian & His Contributions  | US Stock Futures Slip Ahead Of Consumer Sentiment Report | Phase 2 Trial of Merck's Investigational Chronic Hepatitis C Combination Therapy MK-5172/MK-8742 Demonstrates Antiviral Activity,-0.002086311548549723,0.001252599701267538,0.3431463652606052,"[{'label': 'negative', 'score': 0.7771244049072266}, {'label': 'neutral', 'score': 0.22196832299232483}, {'label': 'positive', 'score': 0.0009072148823179305}]","(0.22196832299232483, 0.0009072148823179305, 0.7771244049072266)",-0.9976679228472403,-0.7771244049072266,0,0,"[{'label': 'negative', 'score': 0.906674325466156}, {'label': 'positive', 'score': 0.06835673749446869}, {'label': 'neutral', 'score': 0.024968912824988365}]","(0.024968912824988365, 0.06835673749446869, 0.906674325466156)",-0.8597855184492124,-0.906674325466156,0,0,"[{'label': 'negative', 'score': 0.42005252838134766}, {'label': 'positive', 'score': 0.369683176279068}, {'label': 'neutral', 'score': 0.21026435494422913}]","(0.21026435494422913, 0.369683176279068, 0.42005252838134766)",-0.0637800112177255,-0.42005252838134766,1,1
2014-04-12,38.69284311930338,53.24745686848959,54.04898198445638,52.655853271484375,53.21883010864258,13292273.333333334,,-0.002090673344492983,-0.002088490928259543,0.33944779914003587,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-13,38.61195119222005,53.1361338297526,54.09033075968424,52.54452896118164,53.43193435668945,12298524.666666666,,-0.0020950534168265645,-0.002092861852845741,0.33890124591377285,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-14,38.53105926513672,53.024810791015625,54.13167953491211,52.433204650878906,53.64503860473633,11304776.0,"Merck Announces FDA Has Approved Grastek Sublingual Tablet for Treatment of Grass Pollen-Induced Allergic Rhinitis | Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings | Markets Falling? Get Your Defense Ready | No Legwork Mondays  Merck And Vioxx",0.008637685271568565,-0.00209725111129764,0.14999319318042761,"[{'label': 'positive', 'score': 0.9848194122314453}, {'label': 'negative', 'score': 0.014708666130900383}, {'label': 'neutral', 'score': 0.00047187076415866613}]","(0.00047187076415866613, 0.9848194122314453, 0.014708666130900383)",0.9705687785079545,0.9848194122314453,0,0,"[{'label': 'positive', 'score': 0.8190799355506897}, {'label': 'negative', 'score': 0.13548797369003296}, {'label': 'neutral', 'score': 0.045432135462760925}]","(0.045432135462760925, 0.8190799355506897, 0.13548797369003296)",0.7161271138942811,0.8190799355506897,0,0,"[{'label': 'positive', 'score': 0.994148850440979}, {'label': 'neutral', 'score': 0.004937096498906612}, {'label': 'negative', 'score': 0.0009141101618297398}]","(0.004937096498906612, 0.994148850440979, 0.0009141101618297398)",0.9981627088977848,0.994148850440979,0,0
2014-04-15,38.86387252807617,53.48282241821289,53.73091506958008,52.58587646484375,53.23473358154297,11677759.0,,0.00374666525822276,0.008600593904143434,0.07366011581614465,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-16,39.00948333740234,53.683204650878906,54.34160232543945,53.36832046508789,53.864505767822266,10098004.0,,0.0037326801551653445,0.0037396639901003978,0.07685086000228326,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-17,39.15509796142578,53.88358688354492,54.38931274414063,53.6927490234375,53.864505767822266,11804358.0,FDA Clears Merck's Ragwitek ,0.003453175619647045,0.0037257309918958892,0.07205331438842957,"[{'label': 'neutral', 'score': 0.9998787641525269}, {'label': 'negative', 'score': 6.48632922093384e-05}, {'label': 'positive', 'score': 5.634361878037453e-05}]","(0.9998787641525269, 5.634361878037453e-05, 6.48632922093384e-05)",-0.0702903271719131,-6.48632922093384e-05,1,1,"[{'label': 'negative', 'score': 0.6481221914291382}, {'label': 'neutral', 'score': 0.24069949984550476}, {'label': 'positive', 'score': 0.11117830872535706}]","(0.24069949984550476, 0.11117830872535706, 0.6481221914291382)",-0.707155971311133,-0.6481221914291382,0,0,"[{'label': 'positive', 'score': 0.9473075270652771}, {'label': 'neutral', 'score': 0.05212310329079628}, {'label': 'negative', 'score': 0.0005693816347047687}]","(0.05212310329079628, 0.9473075270652771, 0.0005693816347047687)",0.9987986169312096,0.9473075270652771,0,0
2014-04-18,39.29030513763428,54.06965637207031,54.46087741851807,53.7237606048584,53.89074611663818,10485790.5,,0.003441292233207253,0.0034472270989744903,0.060163674899207986,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-19,39.42551231384277,54.2557258605957,54.53244209289551,53.7547721862793,53.9169864654541,9167223.0,,0.0034294903546856826,0.0034353845366173253,0.03566818767182774,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-20,39.56071949005127,54.44179534912109,54.60400676727295,53.7857837677002,53.94322681427002,7848655.5,,0.003417769148356981,0.00342362306335846,0.002589423060116276,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-04-21,39.695926666259766,54.62786483764648,54.67557144165039,53.81679534912109,53.96946716308594,6530088.0,The Top 21 African-American CEOs In Business,0.009082937609071313,0.003411941849182074,0.0021130547143488635,"[{'label': 'neutral', 'score': 0.9998743534088135}, {'label': 'negative', 'score': 6.752608896931633e-05}, {'label': 'positive', 'score': 5.8071342209586874e-05}]","(0.9998743534088135, 5.8071342209586874e-05, 6.752608896931633e-05)",-0.07527818579555143,-6.752608896931633e-05,0,0,"[{'label': 'neutral', 'score': 0.9126575589179993}, {'label': 'positive', 'score': 0.05148343741893768}, {'label': 'negative', 'score': 0.03585899621248245}]","(0.9126575589179993, 0.05148343741893768, 0.03585899621248245)",0.1788871749599907,0.05148343741893768,0,0,"[{'label': 'neutral', 'score': 0.9993047714233398}, {'label': 'positive', 'score': 0.0005789296119473875}, {'label': 'negative', 'score': 0.00011620848817983642}]","(0.9993047714233398, 0.0005789296119473875, 0.00011620848817983642)",0.6656535207649588,0.0005789296119473875,1,0
2014-04-22,40.05648040771485,55.1240463256836,55.64885330200195,54.40839767456055,54.475189208984375,14642866.0,,-0.0046736991639977875,0.009041935822029284,0.03984457521891796,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-04-23,39.86927795410156,54.86641311645508,55.1240463256836,54.46564865112305,55.10496139526367,8107433.0,#Premarket Technical Update -Merck Trading Lower | Bill Ackman Talks Partnership With Valeant For Allergan Deal ,0.0005217306300029458,-0.004684655045593768,0.07779722891390028,"[{'label': 'neutral', 'score': 0.9252147078514099}, {'label': 'negative', 'score': 0.06978289783000946}, {'label': 'positive', 'score': 0.005002390593290329}]","(0.9252147078514099, 0.005002390593290329, 0.06978289783000946)",-0.8662199291129081,-0.06978289783000946,0,1,"[{'label': 'negative', 'score': 0.4769305884838104}, {'label': 'neutral', 'score': 0.4241916239261627}, {'label': 'positive', 'score': 0.09887776523828506}]","(0.4241916239261627, 0.09887776523828506, 0.4769305884838104)",-0.6565601572150626,-0.4769305884838104,0,1,"[{'label': 'negative', 'score': 0.9698930382728577}, {'label': 'neutral', 'score': 0.028965255245566368}, {'label': 'positive', 'score': 0.0011416025226935744}]","(0.028965255245566368, 0.0011416025226935744, 0.9698930382728577)",-0.997648688368608,-0.9698930382728577,0,0
2014-04-24,39.89007186889648,54.89503860473633,55.171756744384766,54.24618148803711,54.69465637207031,7037110.0,"Market Wrap For April 24: Apple's Smashing Earnings Overshadowed By Ukraine Concerns | Fitch Affirms Merck's LT IDR at A+; Outlook Negative | Bank of America Maintains Buy on Merck & Company, Inc., Raises PT to $62.00",-0.005040858822249965,0.0005215945758981341,0.07932949866806192,"[{'label': 'negative', 'score': 0.8508089780807495}, {'label': 'positive', 'score': 0.14751757681369781}, {'label': 'neutral', 'score': 0.0016734866658225656}]","(0.0016734866658225656, 0.14751757681369781, 0.8508089780807495)",-0.7044702936319374,-0.8508089780807495,0,0,"[{'label': 'positive', 'score': 0.8499539494514465}, {'label': 'negative', 'score': 0.11245584487915039}, {'label': 'neutral', 'score': 0.037590183317661285}]","(0.037590183317661285, 0.8499539494514465, 0.11245584487915039)",0.7663036150679058,0.8499539494514465,0,0,"[{'label': 'positive', 'score': 0.9678977131843567}, {'label': 'negative', 'score': 0.027766326442360878}, {'label': 'neutral', 'score': 0.0043359738774597645}]","(0.0043359738774597645, 0.9678977131843567, 0.027766326442360878)",0.9442255111417488,0.9678977131843567,0,0
2014-04-25,39.689002990722656,54.61832046508789,55.03816986083984,54.40839767456055,54.89503860473633,6526630.0,Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical Companies Report | 3 Ways To Profit From Merger Activity In The Pharmaceutical Sector,-0.0032611240106911158,-0.005053606809664023,0.09359871535970346,"[{'label': 'neutral', 'score': 0.888354480266571}, {'label': 'positive', 'score': 0.11115675419569016}, {'label': 'negative', 'score': 0.0004887508112005889}]","(0.888354480266571, 0.11115675419569016, 0.0004887508112005889)",0.9912445949136882,0.11115675419569016,0,1,"[{'label': 'positive', 'score': 0.9361661672592163}, {'label': 'neutral', 'score': 0.04254262521862984}, {'label': 'negative', 'score': 0.021291237324476242}]","(0.04254262521862984, 0.9361661672592163, 0.021291237324476242)",0.9555254631223333,0.9361661672592163,0,0,"[{'label': 'positive', 'score': 0.9978197813034058}, {'label': 'neutral', 'score': 0.001864093472249806}, {'label': 'negative', 'score': 0.00031611844315193594}]","(0.001864093472249806, 0.9978197813034058, 0.00031611844315193594)",0.9993665823597123,0.9978197813034058,0,0
2014-04-26,39.55956776936849,54.44020334879557,55.09224065144857,54.23664220174154,54.920483907063804,10287028.666666666,"Reuters Reports Merck in Talks to Sell Consumer Health Unit to Bayer, Reckitt Benckiser for Approximately $14B, According to Sources ",-0.0032717937358008346,-0.0032664530645553956,0.09317908971098313,"[{'label': 'neutral', 'score': 0.9948380589485168}, {'label': 'positive', 'score': 0.004734580870717764}, {'label': 'negative', 'score': 0.0004273172526154667}]","(0.9948380589485168, 0.004734580870717764, 0.0004273172526154667)",0.8344340618874779,0.004734580870717764,0,1,"[{'label': 'neutral', 'score': 0.9156949520111084}, {'label': 'positive', 'score': 0.07133051007986069}, {'label': 'negative', 'score': 0.012974532321095467}]","(0.9156949520111084, 0.07133051007986069, 0.012974532321095467)",0.6922003251148756,0.07133051007986069,0,1,"[{'label': 'neutral', 'score': 0.9693605899810791}, {'label': 'positive', 'score': 0.030376654118299484}, {'label': 'negative', 'score': 0.0002628018264658749}]","(0.9693605899810791, 0.030376654118299484, 0.0002628018264658749)",0.9828455291804374,0.030376654118299484,0,1
2014-04-27,39.43013254801432,54.26208623250326,55.14631144205729,54.06488672892253,54.94592920939128,14047427.333333332,"Earnings Expectations For The Week Of April 28: Big Oil, Big Pharma And More",-0.0032825335083712104,-0.003277157756099947,0.03504025775439125,"[{'label': 'neutral', 'score': 0.9997838139533997}, {'label': 'positive', 'score': 0.00013477870379574597}, {'label': 'negative', 'score': 8.137266559060663e-05}]","(0.9997838139533997, 0.00013477870379574597, 8.137266559060663e-05)",0.24707702919836924,0.00013477870379574597,1,1,"[{'label': 'neutral', 'score': 0.8984556198120117}, {'label': 'negative', 'score': 0.06021212041378021}, {'label': 'positive', 'score': 0.04133220389485359}]","(0.8984556198120117, 0.04133220389485359, 0.06021212041378021)",-0.18592783641499258,-0.06021212041378021,1,1,"[{'label': 'neutral', 'score': 0.9987706542015076}, {'label': 'positive', 'score': 0.0010507050901651382}, {'label': 'negative', 'score': 0.0001786121865734458}]","(0.9987706542015076, 0.0010507050901651382, 0.0001786121865734458)",0.7094123869351135,0.0010507050901651382,0,1
2014-04-28,39.30069732666016,54.08396911621094,55.200382232666016,53.89313125610352,54.97137451171875,17807826.0,"Market Wrap For April 28: Apple Hits New 52-Week Highs In a Volatile Start To the Trading Week | Reckitt Benckiser Confirms Talks With Merck Regarding Bid for Consumer Health Business, Bayer Also Rumored Bidder | Agenus Announces License Deal with Merck Related to Novel Checkpoint Antibody-Based Cancer Immunotherapies, Eligible for ~$100M in Milestone Payments | Benzinga's Weekend M&A Chatter",0.03599151010016513,-0.0032879328403846724,0.03250267790139322,"[{'label': 'positive', 'score': 0.9985882639884949}, {'label': 'neutral', 'score': 0.0010636821389198303}, {'label': 'negative', 'score': 0.0003479856823105365}]","(0.0010636821389198303, 0.9985882639884949, 0.0003479856823105365)",0.9993032875072354,0.9985882639884949,1,1,"[{'label': 'positive', 'score': 0.8896090984344482}, {'label': 'neutral', 'score': 0.09162759780883789}, {'label': 'negative', 'score': 0.01876339316368103}]","(0.09162759780883789, 0.8896090984344482, 0.01876339316368103)",0.9586878877613962,0.8896090984344482,1,1,"[{'label': 'positive', 'score': 0.969285786151886}, {'label': 'neutral', 'score': 0.026398539543151855}, {'label': 'negative', 'score': 0.00431575533002615}]","(0.026398539543151855, 0.969285786151886, 0.00431575533002615)",0.9911344525534396,0.969285786151886,1,1
2014-04-29,40.71520233154297,56.03053283691406,56.16412353515625,54.64694595336914,54.86641311645508,14317252.0,"Market Wrap For April 29: Dow Approaches Record Highs Despite Ongoing Ukraine Tension and Upcoming Fed Meeting  | Mid-Afternoon Market Update: Markets Show Strength as Prothena Shares Plummet | Bids for Merck Consumer-Health Unit Said to Be Over $14B, Bayer Looking to Weigh JV with Merck as Part of Offer - Bloomberg | #Premarket Technical Update -Merck Trading Higher | Mid-Day Market Update: Coach Slips After Q3 Results; Orbital Shares Spike Higher | Mid-Morning Market Update: Markets Rise; Merck Earnings Beat Street View | UPDATE: Merck Posts Upbeat Q1 Profit | #PreMarket Primer: Tuesday, April 29: US Steps Up Sanctions Against Russia | Merck & Company, Inc. Reports Q1 EPS of $0.88 vs $0.79 Est; Revenue of $10.30B vs $10.44B Est; Reaffirms Outlook",-0.0027247286709185894,0.03535894891970255,0.2777107688434332,"[{'label': 'positive', 'score': 0.9995286464691162}, {'label': 'negative', 'score': 0.00026076711947098374}, {'label': 'neutral', 'score': 0.00021057954290881753}]","(0.00021057954290881753, 0.9995286464691162, 0.00026076711947098374)",0.9994783559099011,0.9995286464691162,0,0,"[{'label': 'positive', 'score': 0.9312107563018799}, {'label': 'negative', 'score': 0.04028391093015671}, {'label': 'neutral', 'score': 0.0285053588449955}]","(0.0285053588449955, 0.9312107563018799, 0.04028391093015671)",0.9170681789845891,0.9312107563018799,0,0,"[{'label': 'positive', 'score': 0.9931930899620056}, {'label': 'neutral', 'score': 0.005366253200918436}, {'label': 'negative', 'score': 0.001440636464394629}]","(0.005366253200918436, 0.9931930899620056, 0.001440636464394629)",0.997103181953078,0.9931930899620056,0,0
2014-04-30,40.60425567626953,55.87786483764648,56.29771041870117,55.36259460449219,55.83015441894531,14211299.0,"#Premarket Prep Technical Update - Merck Trading Lower | Reckitt Benckiser Confirms it is No Longer in Talks with Merck Regarding Bid for Consumer Health Business | #PreMarket Primer: Wednesday, April 30: No BOJ Stimulus On The Horizon ",0.018101047873481275,-0.002728447500821328,0.27334146112164687,"[{'label': 'negative', 'score': 0.9932643175125122}, {'label': 'neutral', 'score': 0.005172555800527334}, {'label': 'positive', 'score': 0.001563074765726924}]","(0.005172555800527334, 0.001563074765726924, 0.9932643175125122)",-0.9968575960455867,-0.9932643175125122,0,0,"[{'label': 'negative', 'score': 0.9245327115058899}, {'label': 'neutral', 'score': 0.05881112813949585}, {'label': 'positive', 'score': 0.01665613241493702}]","(0.05881112813949585, 0.01665613241493702, 0.9245327115058899)",-0.9646061839289329,-0.9245327115058899,0,0,"[{'label': 'negative', 'score': 0.9705133438110352}, {'label': 'neutral', 'score': 0.028490159660577774}, {'label': 'positive', 'score': 0.0009965184144675732}]","(0.028490159660577774, 0.0009965184144675732, 0.9705133438110352)",-0.9979485161124668,-0.9705133438110352,0,0
2014-05-01,41.3392333984375,56.88931274414063,57.09923553466797,55.86832046508789,55.86832046508789,12287276.0,"Benzinga's M&A Chatter for Thursday May 1, 2014 | Bayer Could Be Preparing ~$14B Bid for Merck's Consumer Unit - Bloomberg",-0.023482028528835408,0.017939174374645317,0.2765291010036527,"[{'label': 'neutral', 'score': 0.9975326061248779}, {'label': 'positive', 'score': 0.0023167806211858988}, {'label': 'negative', 'score': 0.00015059950237628073}]","(0.9975326061248779, 0.0023167806211858988, 0.00015059950237628073)",0.8779276035028937,0.0023167806211858988,0,1,"[{'label': 'neutral', 'score': 0.6841236352920532}, {'label': 'positive', 'score': 0.30565670132637024}, {'label': 'negative', 'score': 0.010219625197350979}]","(0.6841236352920532, 0.30565670132637024, 0.010219625197350979)",0.9352935035694514,0.30565670132637024,0,1,"[{'label': 'neutral', 'score': 0.9970070719718933}, {'label': 'positive', 'score': 0.0028374320827424526}, {'label': 'negative', 'score': 0.00015546118083875626}]","(0.9970070719718933, 0.0028374320827424526, 0.00015546118083875626)",0.8961131138684606,0.0028374320827424526,0,1
2014-05-02,40.36850738525391,55.55343627929688,56.80343627929688,55.286258697509766,56.74618148803711,12659106.0,"Market Wrap For May 2: Markets Slip On Ukraine Tensions Despite Positive Jobs Data  | Sanofi, Merck Rumored to Each Weigh Sale of Mature-Drug Portfolios - Bloomberg | #Premarket Preo Technical Update - Merck Trading Lower | Endocyte to Resume Trading at 8:30 AM ET | Merck Endocyte Announce Independent DSMB Recommends Vintafolide PROCEED Phase 3 Trial Be Stopped for Futility Following Interim Analysis  | Merck, Endocyte Report DSMB Has Recommended Vintafolide Trial Be Suspended, Cites Trial Not Showing Efficacy",0.00234741010322956,-0.02376212487042804,0.358876971573131,"[{'label': 'negative', 'score': 0.9963306784629822}, {'label': 'neutral', 'score': 0.0023628552444279194}, {'label': 'positive', 'score': 0.0013064559316262603}]","(0.0023628552444279194, 0.0013064559316262603, 0.9963306784629822)",-0.9973808995543875,-0.9963306784629822,0,0,"[{'label': 'negative', 'score': 0.9190714955329895}, {'label': 'neutral', 'score': 0.07026805728673935}, {'label': 'positive', 'score': 0.010660454630851746}]","(0.07026805728673935, 0.010660454630851746, 0.9190714955329895)",-0.9770676814344755,-0.9190714955329895,0,0,"[{'label': 'negative', 'score': 0.9975681900978088}, {'label': 'neutral', 'score': 0.0018996173748746514}, {'label': 'positive', 'score': 0.0005321588250808418}]","(0.0018996173748746514, 0.0005321588250808418, 0.9975681900978088)",-0.9989336566695821,-0.9975681900978088,0,0
2014-05-03,40.4632682800293,55.68384297688802,56.52989832560221,55.22582626342773,56.313612620035805,11281230.666666666,,0.0023419126737584265,0.0023446592402277698,0.3531569092475405,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-04,40.55802917480469,55.81424967447917,56.256360371907554,55.1653938293457,55.88104375203451,9903355.333333334,,0.0023364409331255243,0.0023391746702163146,0.23836546681952758,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-05,40.65279006958008,55.94465637207031,55.98282241821289,55.10496139526367,55.4484748840332,8525480.0,"ETF Outlook For The Week Of May 5, 2014 (NGE, XLU, USMV, JJN)",-0.025925304161669698,0.0023337156990819153,0.23845901069915662,"[{'label': 'neutral', 'score': 0.9998748302459717}, {'label': 'negative', 'score': 7.033293513813987e-05}, {'label': 'positive', 'score': 5.488824172061868e-05}]","(0.9998748302459717, 5.488824172061868e-05, 7.033293513813987e-05)",-0.12333930893287975,-7.033293513813987e-05,1,1,"[{'label': 'neutral', 'score': 0.928703248500824}, {'label': 'negative', 'score': 0.04507790505886078}, {'label': 'positive', 'score': 0.026218868792057037}]","(0.928703248500824, 0.026218868792057037, 0.04507790505886078)",-0.2645145810697992,-0.04507790505886078,1,1,"[{'label': 'neutral', 'score': 0.9995989203453064}, {'label': 'positive', 'score': 0.0002541454741731286}, {'label': 'negative', 'score': 0.0001469607959734276}]","(0.9995989203453064, 0.0002541454741731286, 0.0001469607959734276)",0.2672226444142543,0.0002541454741731286,1,1
2014-05-06,39.59885025024414,54.4942741394043,56.078243255615234,54.42748260498047,56.05915832519531,14502538.0,"Market Wrap For May 6: Dow Suffers Triple-Digit Point Loss, Nasdaq Underperforms Once Again | #Premarket Prep Technical Update - Merck Trading Sharply Lower | Fitch Says Merck Consumer Business Sale Improves Its Core Focus | Merck Says Global Cancer Sales Could Reach $120B by 2020  | Merck CEO Says Would be Interested in Acquiring Animal Health Brands with the Right Products at the Right Price -Reuters | Merck Says May Look to M&A For Biotech Expansion- Bloomberg | UPDATE: Merck Highlights Strategic Initiative | Merck Offers Details of Plans to File Odanacatib for Osteoporoisis in 2H, Will Continue to Explore Ways to Augment Animal Health Unit | Merck Announces FDA Acceptance for Review of MK-3475 | US Stock Futures Flat Ahead Of International Trade Data  | Merck Announces Sale of Consumer Care Business to Bayer for $14.2B |  Bayer to Buy Merck Consumer Care Ops for $14.2B",-0.022237751732597046,-0.026267288507699188,0.23825255712864388,"[{'label': 'negative', 'score': 0.5213308334350586}, {'label': 'positive', 'score': 0.4779031276702881}, {'label': 'neutral', 'score': 0.0007660263800062239}]","(0.0007660263800062239, 0.4779031276702881, 0.5213308334350586)",-0.04346099858008332,-0.5213308334350586,1,0,"[{'label': 'positive', 'score': 0.5679488778114319}, {'label': 'negative', 'score': 0.3760018050670624}, {'label': 'neutral', 'score': 0.05604935437440872}]","(0.05604935437440872, 0.5679488778114319, 0.3760018050670624)",0.20334438676292269,0.5679488778114319,1,0,"[{'label': 'negative', 'score': 0.9761581420898438}, {'label': 'neutral', 'score': 0.01807836815714836}, {'label': 'positive', 'score': 0.005763508379459381}]","(0.01807836815714836, 0.005763508379459381, 0.9761581420898438)",-0.988260757104796,-0.9761581420898438,0,0
2014-05-07,38.71826553344727,53.28244400024414,54.24618148803711,52.97710037231445,53.61641311645508,24009575.0,Market Wrap For May 7: Dow Banks Triple-Digit Point Gain While Nasdaq Closes Lower | #Premarket Technical Update -  Merck Trading Lower | Merck Shares Tumble 2+% Following Morgan Stanley Downgrade,-0.018087407974112662,-0.022488738431978496,0.2332673855630336,"[{'label': 'negative', 'score': 0.9977086782455444}, {'label': 'positive', 'score': 0.0012467332417145371}, {'label': 'neutral', 'score': 0.0010446044616401196}]","(0.0010446044616401196, 0.0012467332417145371, 0.9977086782455444)",-0.9975039261464966,-0.9977086782455444,0,0,"[{'label': 'negative', 'score': 0.9669409394264221}, {'label': 'positive', 'score': 0.01934492215514183}, {'label': 'neutral', 'score': 0.013714209198951721}]","(0.013714209198951721, 0.01934492215514183, 0.9669409394264221)",-0.9607721799354982,-0.9669409394264221,0,0,"[{'label': 'neutral', 'score': 0.6606824398040771}, {'label': 'negative', 'score': 0.3081032633781433}, {'label': 'positive', 'score': 0.031214317306876183}]","(0.6606824398040771, 0.031214317306876183, 0.3081032633781433)",-0.8160170938160042,-0.3081032633781433,0,1
2014-05-08,38.017948150634766,52.31870269775391,53.20610809326172,52.21374130249024,53.0057258605957,15061227.0,"#Premarket Prep Technical Update - Merck Trading Lower Again | This Morning BMO Capital Downgraded Merck & Company to Market Perform, Lowered PT to $60.00 | Merck Announces Results Show Letermovir In CMV-Seropositive Allogeneic Human Blood Precursor Cell Recipients Met Study's Two Primary Efficacy Endpoints",0.006930496854765225,-0.018252984746247824,0.21919540019014047,"[{'label': 'negative', 'score': 0.9982659220695496}, {'label': 'neutral', 'score': 0.0011846675770357251}, {'label': 'positive', 'score': 0.0005494175129570067}]","(0.0011846675770357251, 0.0005494175129570067, 0.9982659220695496)",-0.998899861683769,-0.9982659220695496,0,0,"[{'label': 'negative', 'score': 0.8556349277496338}, {'label': 'positive', 'score': 0.11999676376581192}, {'label': 'neutral', 'score': 0.024368347600102425}]","(0.024368347600102425, 0.11999676376581192, 0.8556349277496338)",-0.7540121650221893,-0.8556349277496338,0,0,"[{'label': 'negative', 'score': 0.997329831123352}, {'label': 'neutral', 'score': 0.0023327027447521687}, {'label': 'positive', 'score': 0.0003374112711753696}]","(0.0023327027447521687, 0.0003374112711753696, 0.997329831123352)",-0.9993235995794238,-0.997329831123352,0,0
2014-05-09,38.28143310546875,52.681297302246094,53.15839767456055,51.90839767456055,52.57633590698242,12979480.0,,0.0004830044746523631,0.00690659134923668,0.24003965070933536,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-10,38.29992421468099,52.70674260457357,53.12977091471354,52.05152765909831,52.741729736328125,11477346.666666666,,0.00048277129395701325,0.0004828878655381421,0.23356598130427877,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-11,38.31841532389323,52.73218790690104,53.10114415486654,52.19465764363607,52.90712356567383,9975213.333333334,,0.00048253833829931827,0.0004826547973885086,0.20560398375768085,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-12,38.33690643310547,52.75763320922852,53.07251739501953,52.33778762817383,53.07251739501953,8473080.0,UPDATE: Merck Reports FDA Okay of Zontivity | Merck Reports FDA Okay o f Zontivity ,0.008319753650317717,0.0004824219541137835,0.1510114543246428,"[{'label': 'positive', 'score': 0.9140257239341736}, {'label': 'neutral', 'score': 0.08377782255411148}, {'label': 'negative', 'score': 0.0021965063642710447}]","(0.08377782255411148, 0.9140257239341736, 0.0021965063642710447)",0.9952052978161083,0.9140257239341736,0,0,"[{'label': 'neutral', 'score': 0.8890708088874817}, {'label': 'positive', 'score': 0.06461887806653976}, {'label': 'negative', 'score': 0.046310316771268845}]","(0.8890708088874817, 0.06461887806653976, 0.046310316771268845)",0.16504727472366645,0.06461887806653976,1,1,"[{'label': 'neutral', 'score': 0.9562321901321411}, {'label': 'positive', 'score': 0.04347820580005646}, {'label': 'negative', 'score': 0.0002896551159210503}]","(0.9562321901321411, 0.04347820580005646, 0.0002896551159210503)",0.986764026851707,0.04347820580005646,0,1
2014-05-13,38.655860900878906,53.196563720703125,53.49236679077149,52.671756744384766,52.77671813964844,9389032.0,"US Stock Futures Up Ahead Of Retail Sales Report | Merck to Sell Ophthalmology Products in Japan, Key Markets in Europe and Asia Pacific to Santen for $600M Upfront Payment",0.011121134501145784,0.008285335269777712,0.062331177722749403,"[{'label': 'positive', 'score': 0.9989978671073914}, {'label': 'neutral', 'score': 0.0008596238330937922}, {'label': 'negative', 'score': 0.00014246717910282314}]","(0.0008596238330937922, 0.9989978671073914, 0.00014246717910282314)",0.9997148204827412,0.9989978671073914,1,1,"[{'label': 'positive', 'score': 0.8710036873817444}, {'label': 'neutral', 'score': 0.06604411453008652}, {'label': 'negative', 'score': 0.06295216083526611}]","(0.06604411453008652, 0.8710036873817444, 0.06295216083526611)",0.8651924264825872,0.8710036873817444,1,1,"[{'label': 'positive', 'score': 0.9978870749473572}, {'label': 'neutral', 'score': 0.0018239772180095315}, {'label': 'negative', 'score': 0.0002889272291213274}]","(0.0018239772180095315, 0.9978870749473572, 0.0002889272291213274)",0.9994210896104668,0.9978870749473572,1,1
2014-05-14,39.08575820922852,53.78816986083984,53.96946716308594,53.082061767578125,53.082061767578125,8171780.0,"Merck VP Schechter Sells 10,527 Shares @$55.91/Share -Form 4 | R&D Tax Credit Passed In The House, Faces Challenges Ahead | The 5 Most Overvalued Dow Stocks | New Data on Merck's Investigational Anti-PD1 Antibody, MK-3475 to be Presented at ASCO 2014",-0.008515170586385384,0.011059749380340472,0.08140756752526086,"[{'label': 'neutral', 'score': 0.8738042116165161}, {'label': 'negative', 'score': 0.12532763183116913}, {'label': 'positive', 'score': 0.0008681421750225127}]","(0.8738042116165161, 0.0008681421750225127, 0.12532763183116913)",-0.9862413431533782,-0.12532763183116913,0,1,"[{'label': 'negative', 'score': 0.6457087993621826}, {'label': 'neutral', 'score': 0.21170368790626526}, {'label': 'positive', 'score': 0.14258751273155212}]","(0.21170368790626526, 0.14258751273155212, 0.6457087993621826)",-0.6382387928396211,-0.6457087993621826,0,0,"[{'label': 'neutral', 'score': 0.92060387134552}, {'label': 'negative', 'score': 0.06475614011287689}, {'label': 'positive', 'score': 0.014639893546700478}]","(0.92060387134552, 0.014639893546700478, 0.06475614011287689)",-0.631218516293364,-0.06475614011287689,0,1
2014-05-15,38.752925872802734,53.33015441894531,53.99809265136719,52.96755599975586,53.25381851196289,9346588.0,,-0.00035786377571676473,-0.008551631781183448,0.12216883615629243,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-16,38.739070892333984,53.31106948852539,53.683204650878906,53.110687255859375,53.110687255859375,9496976.0,"Chimerix Announces Has Regained Worldwide Rights to CMX157 from Merck, Says Co. Will No Longer Pursue Development",0.002863791993475422,-0.0003579278242386539,0.1231210530150312,"[{'label': 'positive', 'score': 0.7209463119506836}, {'label': 'neutral', 'score': 0.27809885144233704}, {'label': 'negative', 'score': 0.0009548531379550695}]","(0.27809885144233704, 0.7209463119506836, 0.0009548531379550695)",0.9973546153292665,0.7209463119506836,0,0,"[{'label': 'neutral', 'score': 0.9436373114585876}, {'label': 'positive', 'score': 0.03942519426345825}, {'label': 'negative', 'score': 0.01693752408027649}]","(0.9436373114585876, 0.03942519426345825, 0.01693752408027649)",0.3989812919603705,0.03942519426345825,1,1,"[{'label': 'positive', 'score': 0.9860520362854004}, {'label': 'neutral', 'score': 0.013671710155904293}, {'label': 'negative', 'score': 0.0002762670046649873}]","(0.013671710155904293, 0.9860520362854004, 0.0002762670046649873)",0.9994398072046732,0.9860520362854004,0,0
2014-05-17,38.85000991821289,53.46374130249024,53.71819305419922,53.09796396891276,53.13613255818685,8958059.333333334,,0.0028556141086543353,0.0028596991533511307,0.12220500869123556,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-18,38.9609489440918,53.61641311645508,53.75318145751953,53.08524068196615,53.16157786051432,8419142.666666666,,0.0028474827966063288,0.0028515445881649253,0.11211643943608025,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-19,39.0718879699707,53.76908493041992,53.78816986083984,53.07251739501953,53.1870231628418,7880226.0,"Merck, Endocyte Report Withrdrawal of Conditional Marketing Authorization for Vintafolide, Companion Imaging from EMA",-0.006211173514355294,0.0028434363970166712,0.07842538972890276,"[{'label': 'neutral', 'score': 0.9998860359191895}, {'label': 'negative', 'score': 6.192691944306716e-05}, {'label': 'positive', 'score': 5.192611206439324e-05}]","(0.9998860359191895, 5.192611206439324e-05, 6.192691944306716e-05)",-0.08783962311990443,-6.192691944306716e-05,1,1,"[{'label': 'neutral', 'score': 0.871660053730011}, {'label': 'positive', 'score': 0.11741953343153}, {'label': 'negative', 'score': 0.010920362547039986}]","(0.871660053730011, 0.11741953343153, 0.010920362547039986)",0.8298212342502841,0.11741953343153,0,1,"[{'label': 'neutral', 'score': 0.9965705871582031}, {'label': 'negative', 'score': 0.002203045878559351}, {'label': 'positive', 'score': 0.0012263312237337232}]","(0.9965705871582031, 0.0012263312237337232, 0.002203045878559351)",-0.284808181104534,-0.002203045878559351,1,1
2014-05-20,38.82920455932617,53.43511581420898,53.683204650878906,53.17748260498047,53.64503860473633,8232983.0,Merck Reports Animal Health Has Announced FDA Approval of BRAVECTO,0.01035709301209099,-0.006230543099456112,0.06278408010693289,"[{'label': 'positive', 'score': 0.9978331923484802}, {'label': 'neutral', 'score': 0.00193300552200526}, {'label': 'negative', 'score': 0.0002338597842026502}]","(0.00193300552200526, 0.9978331923484802, 0.0002338597842026502)",0.9995313746031332,0.9978331923484802,1,1,"[{'label': 'positive', 'score': 0.9002772569656372}, {'label': 'neutral', 'score': 0.08541969954967499}, {'label': 'negative', 'score': 0.014303028583526611}]","(0.08541969954967499, 0.9002772569656372, 0.014303028583526611)",0.9687222022833385,0.9002772569656372,1,1,"[{'label': 'positive', 'score': 0.9889304041862488}, {'label': 'neutral', 'score': 0.010815655812621117}, {'label': 'negative', 'score': 0.0002539604902267456}]","(0.010815655812621117, 0.9889304041862488, 0.0002539604902267456)",0.9994865254662415,0.9889304041862488,1,1
2014-05-21,39.23137283325195,53.988548278808594,54.02671813964844,53.55915832519531,53.625953674316406,6970143.0,,-0.0015906422302792468,0.010303825804179144,0.0930690733066813,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-22,39.16896438598633,53.90267181396485,54.17938995361328,53.47328186035156,53.81679534912109,7522544.0,,0.005664721574164593,-0.0015919086447513681,0.09733046020726087,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-23,39.39083480834961,54.20801544189453,54.3702278137207,53.864505767822266,54.036258697509766,6343544.0,#Premarket Technical Update - Merck Trading Higher,-0.0005280850391258288,0.005648737374525484,0.10147035865345311,"[{'label': 'neutral', 'score': 0.6003453135490417}, {'label': 'positive', 'score': 0.3983820378780365}, {'label': 'negative', 'score': 0.0012726441491395235}]","(0.6003453135490417, 0.3983820378780365, 0.0012726441491395235)",0.9936312811716141,0.3983820378780365,0,1,"[{'label': 'neutral', 'score': 0.9203007221221924}, {'label': 'positive', 'score': 0.04438283294439316}, {'label': 'negative', 'score': 0.035316430032253265}]","(0.9203007221221924, 0.04438283294439316, 0.035316430032253265)",0.11375767571146224,0.04438283294439316,1,1,"[{'label': 'neutral', 'score': 0.5917454361915588}, {'label': 'positive', 'score': 0.40644174814224243}, {'label': 'negative', 'score': 0.00181285641156137}]","(0.5917454361915588, 0.40644174814224243, 0.00181285641156137)",0.9911189909858202,0.40644174814224243,0,1
2014-05-24,39.37003612518311,54.179388999938965,54.384541511535645,53.86927604675293,54.10782337188721,6670729.5,,-0.0005283640602812751,-0.0005282245251392457,0.1029251555401855,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-25,39.3492374420166,54.1507625579834,54.398855209350586,53.8740463256836,54.17938804626465,6997915.0,,-0.0005286433764420929,-0.0005285036937583664,0.08163058745131348,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-26,39.3284387588501,54.12213611602783,54.41316890716553,53.87881660461426,54.25095272064209,7325100.5,,-0.0005289229880763874,-0.000528783157616922,0.04632179906057609,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-27,39.3076400756836,54.093509674072266,54.42748260498047,53.88358688354492,54.32251739501953,7652286.0,,-0.00511548107376386,-0.0005290629171833665,0.04385505452689344,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-05-28,39.10655212402344,53.81679534912109,54.13167953491211,53.81679534912109,54.11259460449219,7171569.0,,0.023049600396945077,-0.005128609939854635,0.03265652200472282,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-05-29,40.00794982910156,55.0572509765625,55.14313125610352,54.00763320922852,54.30343627929688,8922358.0,#Premarket Prep Technical Update - Merck Trading Higher,0.0027729647095863013,0.02278797103062386,0.1765507856202997,"[{'label': 'positive', 'score': 0.7203679084777832}, {'label': 'neutral', 'score': 0.2781701683998108}, {'label': 'negative', 'score': 0.0014619216090068221}]","(0.2781701683998108, 0.7203679084777832, 0.0014619216090068221)",0.9959494009583089,0.7203679084777832,0,0,"[{'label': 'neutral', 'score': 0.9331013560295105}, {'label': 'positive', 'score': 0.036269888281822205}, {'label': 'negative', 'score': 0.03062882274389267}]","(0.9331013560295105, 0.036269888281822205, 0.03062882274389267)",0.08432248471515681,0.036269888281822205,1,1,"[{'label': 'positive', 'score': 0.7539310455322266}, {'label': 'neutral', 'score': 0.2448357194662094}, {'label': 'negative', 'score': 0.0012332610785961151}]","(0.2448357194662094, 0.7539310455322266, 0.0012332610785961151)",0.9967337940424357,0.7539310455322266,0,0
2014-05-30,40.11888885498047,55.209922790527344,55.60114669799805,54.88549423217773,54.88549423217773,12071912.0,"Merck Announces Generic Name for MK-3475, Pembrolizumab",0.00040328106340905244,0.0027691271356137695,0.17367493205078452,"[{'label': 'neutral', 'score': 0.9998782873153687}, {'label': 'positive', 'score': 6.254804611671716e-05}, {'label': 'negative', 'score': 5.906345904804766e-05}]","(0.9998782873153687, 6.254804611671716e-05, 5.906345904804766e-05)",0.028653432616827002,6.254804611671716e-05,1,1,"[{'label': 'neutral', 'score': 0.5318727493286133}, {'label': 'positive', 'score': 0.44268593192100525}, {'label': 'negative', 'score': 0.025441287085413933}]","(0.5318727493286133, 0.44268593192100525, 0.025441287085413933)",0.8913060977765317,0.44268593192100525,0,1,"[{'label': 'neutral', 'score': 0.9995038509368896}, {'label': 'positive', 'score': 0.0003857811389025301}, {'label': 'negative', 'score': 0.00011030784662580118}]","(0.9995038509368896, 0.0003857811389025301, 0.00011030784662580118)",0.5552900796282583,0.0003857811389025301,0,1
2014-05-31,40.13507207234701,55.23218790690104,55.57888158162435,54.87277221679688,55.00954055786133,10292582.666666666,,0.0004031184933545013,0.0004031997674571031,0.17230706841959215,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-01,40.15125528971354,55.25445302327474,55.55661646525065,54.860050201416016,55.13358688354492,8513253.333333334,"Merck Presents Early Data for Pembrolizumab in Patients with PD-L1 Positive, Advanced Head and Neck Cancer at ASCO",0.0004029560543168684,0.0004030372629241434,0.17086395601731538,"[{'label': 'neutral', 'score': 0.999847412109375}, {'label': 'positive', 'score': 9.369006875203922e-05}, {'label': 'negative', 'score': 5.893605703022331e-05}]","(0.999847412109375, 9.369006875203922e-05, 5.893605703022331e-05)",0.22770683291402039,9.369006875203922e-05,1,1,"[{'label': 'neutral', 'score': 0.5414423942565918}, {'label': 'positive', 'score': 0.42535385489463806}, {'label': 'negative', 'score': 0.03320378437638283}]","(0.5414423942565918, 0.42535385489463806, 0.03320378437638283)",0.8551816324370144,0.42535385489463806,0,1,"[{'label': 'neutral', 'score': 0.9949769377708435}, {'label': 'positive', 'score': 0.003947326447814703}, {'label': 'negative', 'score': 0.0010756341507658362}]","(0.9949769377708435, 0.003947326447814703, 0.0010756341507658362)",0.5717130844825641,0.003947326447814703,0,1
2014-06-02,40.16743850708008,55.27671813964844,55.53435134887695,54.84732818603516,55.25763320922852,6733924.0,,-0.0003452616411071931,0.00040287488932920013,0.15557038070066043,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-03,40.153564453125,55.25763320922852,55.30534362792969,54.74236679077149,54.88549423217773,7417849.0,,0.00034538088787934936,-0.0003453212576301569,0.018841594395290834,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-04,40.16743850708008,55.27671813964844,55.35305404663086,54.875953674316406,55.13358688354492,7205419.0,ASCO Meeting Day 4: Risks And Rewards Of Immunotherapy,0.002934551422108063,0.00034532125763012404,0.0052254655482512555,"[{'label': 'neutral', 'score': 0.9998626708984375}, {'label': 'negative', 'score': 7.195032958406955e-05}, {'label': 'positive', 'score': 6.531550752697513e-05}]","(0.9998626708984375, 6.531550752697513e-05, 7.195032958406955e-05)",-0.04833556693153751,-7.195032958406955e-05,0,0,"[{'label': 'neutral', 'score': 0.9344117641448975}, {'label': 'positive', 'score': 0.039500460028648376}, {'label': 'negative', 'score': 0.026087744161486626}]","(0.9344117641448975, 0.039500460028648376, 0.026087744161486626)",0.2044989039230187,0.039500460028648376,0,0,"[{'label': 'neutral', 'score': 0.9991006851196289}, {'label': 'positive', 'score': 0.0006486467318609357}, {'label': 'negative', 'score': 0.0002507688768673688}]","(0.9991006851196289, 0.0006486467318609357, 0.0002507688768673688)",0.4423737492794144,0.0006486467318609357,0,0
2014-06-05,40.285301208496094,55.43893051147461,55.79198455810547,55.07633590698242,55.314884185791016,8007349.0,Merck Announces First Patient in Phase 3 Trial of ISENTRESS Enrolled | #Premarket Prep Technical Update - Merck Trading Higher,-0.004302901888758833,0.0029302540313069065,0.020013596357518624,"[{'label': 'neutral', 'score': 0.9788211584091187}, {'label': 'positive', 'score': 0.02094663679599762}, {'label': 'negative', 'score': 0.00023218736168928444}]","(0.9788211584091187, 0.02094663679599762, 0.00023218736168928444)",0.978073630532032,0.02094663679599762,0,0,"[{'label': 'neutral', 'score': 0.9184520244598389}, {'label': 'positive', 'score': 0.06350231915712357}, {'label': 'negative', 'score': 0.018045706674456596}]","(0.9184520244598389, 0.06350231915712357, 0.018045706674456596)",0.5574213724872725,0.06350231915712357,0,0,"[{'label': 'neutral', 'score': 0.5295888781547546}, {'label': 'positive', 'score': 0.4692035913467407}, {'label': 'negative', 'score': 0.0012075246777385473}]","(0.5295888781547546, 0.4692035913467407, 0.0012075246777385473)",0.994866087825715,0.4692035913467407,0,0
2014-06-06,40.11195755004883,55.200382232666016,55.59160232543945,55.03816986083984,55.53435134887695,7024954.0,#Premarket Prep Technical Update - Merck Trading Lower | Merck Announces Will Present New Clinical Data on JANUVIA at SSADA,0.0005185740953858351,-0.0043121860131134825,0.041540305340484696,"[{'label': 'negative', 'score': 0.9826828241348267}, {'label': 'neutral', 'score': 0.015668340027332306}, {'label': 'positive', 'score': 0.0016488578403368592}]","(0.015668340027332306, 0.0016488578403368592, 0.9826828241348267)",-0.9966497921980358,-0.9826828241348267,0,0,"[{'label': 'negative', 'score': 0.8521068096160889}, {'label': 'neutral', 'score': 0.12323971092700958}, {'label': 'positive', 'score': 0.024653516709804535}]","(0.12323971092700958, 0.024653516709804535, 0.8521068096160889)",-0.9437622438663111,-0.8521068096160889,0,0,"[{'label': 'negative', 'score': 0.9927735924720764}, {'label': 'neutral', 'score': 0.006787362042814493}, {'label': 'positive', 'score': 0.0004390421963762492}]","(0.006787362042814493, 0.0004390421963762492, 0.9927735924720764)",-0.999115914999364,-0.9927735924720764,0,0
2014-06-07,40.13275655110677,55.22900772094727,55.49936294555664,54.89822006225586,55.30852381388346,7506929.0,,0.0005183053156754963,0.0005184396823064658,0.04165318283636951,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-08,40.15355555216471,55.25763320922852,55.40712356567383,54.75827026367188,55.082696278889976,7988904.0,,0.0005180368144407275,0.0005181710418698462,0.04187822190612938,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-09,40.174354553222656,55.286258697509766,55.314884185791016,54.61832046508789,54.85686874389648,8470879.0,"Benzinga's M&A Chatter for Monday June 9, 2014 | Market Wrap For June 9: Markets Higher On St. Louis Fed Comments, Low Volume | Mid-Afternoon Market Update; Icahn's 9% Stake In Family Dollar, Tyson Foods Wins Bid For Hillshire Brands | Are Gilead Shares Overreacting To Merck's Idenix Acquisition? | Mid-Day Market Update: Idenix Pharma Surges On Merck Buyout; Pilgrim's Pride Shares Slide | Benzinga's Volume Movers | Stocks Hitting 52-Week Highs | Mid-Morning Market Update: Markets Edge Higher; Tyson Wins Bidding Battle To Buy Hillshire Brands For $63/Share | Morning Market Movers  | UPDATE: Merck Says Dual Therapy of MK-5172, MK-8742 Cures High 90's% of Patients In 12 Weeks; Triple Therapy Could Be More Effective, Faster | Hepatitis C Stocks Move After Idenix Rockets Up 235% | Merck Research Head Says Combination of Idenix Nucleotide Inhibitor IDX21437, Plus Leading Two Experimental Merck Drugs Could Produce Cures In 4-6 Weeks | Benzinga's Top #PreMarket Losers | Benzinga's Top #PreMarket Gainers | Achillion Pharmaceuticals Shares Rise 38% Premarket on News of Merck-Idenix Deal | Shares of Idenix Pharma Now Up 200+% to ~$22 | UPDATE: Merck Announces Will Purchase Idenix for $3.85Bn | Merck Announces Will Purchase Idenix for $24.50/Share",0.009492608170269692,0.0005179026796925601,0.04198566066370102,"[{'label': 'positive', 'score': 0.9995062351226807}, {'label': 'neutral', 'score': 0.00024852939532138407}, {'label': 'negative', 'score': 0.0002451995387673378}]","(0.00024852939532138407, 0.9995062351226807, 0.0002451995387673378)",0.9995094789959459,0.9995062351226807,1,1,"[{'label': 'positive', 'score': 0.9345842599868774}, {'label': 'neutral', 'score': 0.03674289211630821}, {'label': 'negative', 'score': 0.028672760352492332}]","(0.03674289211630821, 0.9345842599868774, 0.028672760352492332)",0.9404670617559777,0.9345842599868774,1,1,"[{'label': 'positive', 'score': 0.9446328282356262}, {'label': 'neutral', 'score': 0.05282203480601311}, {'label': 'negative', 'score': 0.0025450659450143576}]","(0.05282203480601311, 0.9446328282356262, 0.0025450659450143576)",0.9946260022311522,0.9446328282356262,1,1
2014-06-10,40.55571746826172,55.81106948852539,55.82061004638672,55.26717758178711,55.26717758178711,8031558.0,"ETF Outlook For Tuesday, June 10, 2014 (IAT, FXE, PBE, HYHG, IDIX, MRK)",0.005471022697253013,0.009447836475764687,0.07925752770000984,"[{'label': 'neutral', 'score': 0.9998775720596313}, {'label': 'negative', 'score': 7.040560012683272e-05}, {'label': 'positive', 'score': 5.201240492169745e-05}]","(0.9998775720596313, 5.201240492169745e-05, 7.040560012683272e-05)",-0.15024910100310535,-7.040560012683272e-05,1,1,"[{'label': 'neutral', 'score': 0.9399598836898804}, {'label': 'positive', 'score': 0.0300512183457613}, {'label': 'negative', 'score': 0.029988931491971016}]","(0.9399598836898804, 0.0300512183457613, 0.029988931491971016)",0.001037420025743156,0.0300512183457613,1,1,"[{'label': 'neutral', 'score': 0.9995993971824646}, {'label': 'positive', 'score': 0.0002813977771438658}, {'label': 'negative', 'score': 0.0001193290445371531}]","(0.9995993971824646, 0.0002813977771438658, 0.0001193290445371531)",0.40443694766136834,0.0002813977771438658,1,1
2014-06-11,40.7775993347168,56.11641311645508,56.32633590698242,55.725189208984375,55.83969497680664,12258246.0,Takeover Whispers Add To Achillion Pharmaceuticals' Momentum,-0.00867198923006508,0.005456111015949507,0.06431628838604894,"[{'label': 'neutral', 'score': 0.998887836933136}, {'label': 'positive', 'score': 0.0010448849061504006}, {'label': 'negative', 'score': 6.725082494085655e-05}]","(0.998887836933136, 0.0010448849061504006, 6.725082494085655e-05)",0.8790600408551423,0.0010448849061504006,0,1,"[{'label': 'positive', 'score': 0.5054919719696045}, {'label': 'negative', 'score': 0.31038451194763184}, {'label': 'neutral', 'score': 0.18412356078624725}]","(0.18412356078624725, 0.5054919719696045, 0.31038451194763184)",0.23913847729157572,0.5054919719696045,1,0,"[{'label': 'neutral', 'score': 0.6307796835899353}, {'label': 'positive', 'score': 0.36857765913009644}, {'label': 'negative', 'score': 0.0006425863248296082}]","(0.6307796835899353, 0.36857765913009644, 0.0006425863248296082)",0.9965192248651595,0.36857765913009644,0,1
2014-06-12,40.72869873046875,55.6297721862793,56.03053283691406,55.40076446533203,55.610687255859375,10022967.0,"UPDATE: Merck Research Head Says Company Aims to Capture Big Share of Hep C Market, Selling Best Drugs at Fair Cost | Merck Research Head Says Company Open to Big Acquisition for Biotech Products -Reuters | UPDATE: Bank Of America Reiterates On Merck & Co. On Higher Sales Estimates",-0.0010292113199393458,-0.008709809740119928,0.10795047031665655,"[{'label': 'positive', 'score': 0.9972364902496338}, {'label': 'neutral', 'score': 0.0025773721281439066}, {'label': 'negative', 'score': 0.0001860816846601665}]","(0.0025773721281439066, 0.9972364902496338, 0.0001860816846601665)",0.9996268749276461,0.9972364902496338,0,0,"[{'label': 'positive', 'score': 0.946122944355011}, {'label': 'neutral', 'score': 0.035102251917123795}, {'label': 'negative', 'score': 0.01877477392554283}]","(0.035102251917123795, 0.946122944355011, 0.01877477392554283)",0.9610844267328159,0.946122944355011,0,0,"[{'label': 'positive', 'score': 0.9986955523490906}, {'label': 'neutral', 'score': 0.0010060417698696256}, {'label': 'negative', 'score': 0.0002984873717650771}]","(0.0010060417698696256, 0.9986955523490906, 0.0002984873717650771)",0.9994024241188697,0.9986955523490906,0,0
2014-06-13,40.6867790222168,55.57251739501953,55.96374130249024,55.32442855834961,55.4484748840332,8801628.0,,-0.0009729771682715279,-0.001029741321596939,0.10933907478699334,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-14,40.64719518025717,55.518446604410805,55.87786356608073,55.244911193847656,55.43257141113281,8568622.666666666,,-0.0009739247748409342,-0.0009734508178148675,0.1103782727675533,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-15,40.60761133829752,55.464375813802086,55.791985829671226,55.1653938293457,55.41666793823242,8335617.333333333,,-0.0009748742290050441,-0.0009743993477316713,0.07969792103773264,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-16,40.56802749633789,55.41030502319336,55.70610809326172,55.08587646484375,55.40076446533203,8102612.0,,-0.0001721802083084489,-0.0009753497279457461,0.05481906144816095,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-17,40.561031341552734,55.40076446533203,55.55343627929688,55.13358688354492,55.29580307006836,6567502.0,,0.00602824021354298,-0.00017219503302222036,0.005805797051883674,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-06-18,40.80553817749024,55.73473358154297,55.77289962768555,55.16221237182617,55.37213516235352,8213176.0,5-Star Biotech Stock Watch: Synta Pharmaceuticals,-0.0018832313087153742,0.006010143066388245,0.04847621364942629,"[{'label': 'neutral', 'score': 0.9998667240142822}, {'label': 'negative', 'score': 7.277445547515526e-05}, {'label': 'positive', 'score': 6.0402206145226955e-05}]","(0.9998667240142822, 6.0402206145226955e-05, 7.277445547515526e-05)",-0.09290103220333899,-7.277445547515526e-05,1,1,"[{'label': 'neutral', 'score': 0.8711696863174438}, {'label': 'positive', 'score': 0.11220692098140717}, {'label': 'negative', 'score': 0.016623368486762047}]","(0.8711696863174438, 0.11220692098140717, 0.016623368486762047)",0.741933848703037,0.11220692098140717,0,1,"[{'label': 'neutral', 'score': 0.9991973042488098}, {'label': 'positive', 'score': 0.0006973600829951465}, {'label': 'negative', 'score': 0.00010524658864596859}]","(0.9991973042488098, 0.0006973600829951465, 0.00010524658864596859)",0.7377380668148009,0.0006973600829951465,0,1
2014-06-19,40.72869873046875,55.6297721862793,55.7442741394043,55.43893051147461,55.7442741394043,6300471.0,,0.010634635055819405,-0.001885006818276747,0.05070093093298319,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-06-20,41.161842346191406,56.22137451171875,56.564884185791016,55.76335906982422,55.92557144165039,15110064.0,"Market Wrap For June 20: Yet Again, Dow And S&P 500 Indices Hit New Highs",-0.002376109731768198,0.010578485063411542,0.08541567040543051,"[{'label': 'positive', 'score': 0.998670220375061}, {'label': 'negative', 'score': 0.0008334137382917106}, {'label': 'neutral', 'score': 0.0004964315448887646}]","(0.0004964315448887646, 0.998670220375061, 0.0008334137382917106)",0.9983323447562429,0.998670220375061,0,0,"[{'label': 'positive', 'score': 0.8963244557380676}, {'label': 'neutral', 'score': 0.06834471970796585}, {'label': 'negative', 'score': 0.035330913960933685}]","(0.06834471970796585, 0.8963244557380676, 0.035330913960933685)",0.9241545423124682,0.8963244557380676,0,0,"[{'label': 'positive', 'score': 0.95865797996521}, {'label': 'neutral', 'score': 0.040429551154375076}, {'label': 'negative', 'score': 0.0009124935604631901}]","(0.040429551154375076, 0.95865797996521, 0.0009124935604631901)",0.9980981208037581,0.95865797996521,0,0
2014-06-21,41.06403605143229,56.08778635660807,56.46946461995443,55.75381724039713,55.98918533325195,12537713.0,,-0.002381769076449448,-0.0023789371602383784,0.08970565265750897,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-22,40.96622975667318,55.9541982014974,56.37404505411784,55.74427541097005,56.05279922485352,9965362.0,,-0.0023874554439974886,-0.00238461000026239,0.09497019977658112,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-23,40.86842346191406,55.82061004638672,56.27862548828125,55.73473358154297,56.11641311645508,7393011.0,,-0.009914482556527222,-0.0023903099600043414,0.09120688750783437,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-24,40.46322250366211,55.26717758178711,56.06870269775391,55.22900772094727,55.70610809326172,8550108.0,,0.01622927011320228,-0.00996395832811424,0.11764593709793075,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-25,41.11992263793945,56.16412353515625,56.60305404663086,55.07633590698242,55.08587646484375,13911466.0,,-0.005606568404671629,0.016098983259239783,0.15376765906895662,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-26,40.88936233520508,55.84923553466797,56.078243255615234,55.582061767578125,56.06870269775391,7585738.0,#Premarket Prep Technical Update - Merck Trading Lower,-0.017085228128849328,-0.0056223442023344205,0.15831491017005217,"[{'label': 'negative', 'score': 0.9901684522628784}, {'label': 'neutral', 'score': 0.009066872298717499}, {'label': 'positive', 'score': 0.0007646208978258073}]","(0.009066872298717499, 0.0007646208978258073, 0.9901684522628784)",-0.9984567658128779,-0.9901684522628784,0,0,"[{'label': 'neutral', 'score': 0.9358273148536682}, {'label': 'negative', 'score': 0.034999582916498184}, {'label': 'positive', 'score': 0.02917313389480114}]","(0.9358273148536682, 0.02917313389480114, 0.034999582916498184)",-0.09079324222519347,-0.034999582916498184,1,1,"[{'label': 'negative', 'score': 0.9953994154930115}, {'label': 'neutral', 'score': 0.0041427649557590485}, {'label': 'positive', 'score': 0.00045776661136187613}]","(0.0041427649557590485, 0.00045776661136187613, 0.9953994154930115)",-0.9990806581112474,-0.9953994154930115,0,0
2014-06-27,40.19077301025391,54.89503860473633,55.83969497680664,54.84732818603516,55.696563720703125,18115414.0,Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly,0.0018541057971152178,-0.017232864657748013,0.1975900403133984,"[{'label': 'positive', 'score': 0.685101330280304}, {'label': 'neutral', 'score': 0.30067336559295654}, {'label': 'negative', 'score': 0.014225267805159092}]","(0.30067336559295654, 0.685101330280304, 0.014225267805159092)",0.9593172407739005,0.685101330280304,0,0,"[{'label': 'neutral', 'score': 0.9483851790428162}, {'label': 'positive', 'score': 0.03004896081984043}, {'label': 'negative', 'score': 0.021565906703472137}]","(0.9483851790428162, 0.03004896081984043, 0.021565906703472137)",0.1643529185178438,0.03004896081984043,1,1,"[{'label': 'neutral', 'score': 0.999505877494812}, {'label': 'positive', 'score': 0.00037603863165713847}, {'label': 'negative', 'score': 0.00011806034308392555}]","(0.999505877494812, 0.00037603863165713847, 0.00011806034308392555)",0.5221186478041332,0.00037603863165713847,0,1
2014-06-28,40.26528930664063,54.99681981404623,55.73791376749674,54.86323165893555,55.454833984375,15128369.333333334,,0.0018506744508868672,0.0018523890646367474,0.20177823162162764,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-29,40.339805603027344,55.09860102335612,55.63613255818685,54.87913513183594,55.21310424804688,12141324.666666668,,0.0018472557818074815,0.0018489640628477442,0.19324290906271605,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-06-30,40.41432189941406,55.200382232666016,55.53435134887695,54.89503860473633,54.97137451171875,9154280.0,"Merck Announces Investigational Data From Phase 3 Emend | US Stock Futures Fall Ahead Of Home Sales Report | Merck's Investigational Anti-PD-1 Antibody, Pembrolizumab, Under Regulatory Review by EMA for Treatment of Advanced Melanoma ",0.011408837417553526,0.0018455517031024942,0.1325599768055173,"[{'label': 'neutral', 'score': 0.8040406107902527}, {'label': 'negative', 'score': 0.19539843499660492}, {'label': 'positive', 'score': 0.0005608797655440867}]","(0.8040406107902527, 0.0005608797655440867, 0.19539843499660492)",-0.9942755488176219,-0.19539843499660492,0,1,"[{'label': 'negative', 'score': 0.9629786610603333}, {'label': 'neutral', 'score': 0.0221814326941967}, {'label': 'positive', 'score': 0.01483993325382471}]","(0.0221814326941967, 0.01483993325382471, 0.9629786610603333)",-0.9696468581388894,-0.9629786610603333,0,0,"[{'label': 'negative', 'score': 0.9965923428535461}, {'label': 'neutral', 'score': 0.002997285220772028}, {'label': 'positive', 'score': 0.0004103285609744489}]","(0.002997285220772028, 0.0004103285609744489, 0.9965923428535461)",-0.9991768757040695,-0.9965923428535461,0,0
2014-07-01,40.87541198730469,55.83015441894531,55.95419692993164,54.84732818603516,55.0572509765625,9262224.0,"Bayer Could Keep Scholl's, Coppertone Brands from Merck - Reuters",0.00922917774130631,0.01134424743213003,0.1657150161880784,"[{'label': 'neutral', 'score': 0.9936570525169373}, {'label': 'positive', 'score': 0.006200458388775587}, {'label': 'negative', 'score': 0.00014254506095312536}]","(0.9936570525169373, 0.006200458388775587, 0.00014254506095312536)",0.9550543958921472,0.006200458388775587,0,1,"[{'label': 'neutral', 'score': 0.9448825716972351}, {'label': 'negative', 'score': 0.02828546054661274}, {'label': 'positive', 'score': 0.026831943541765213}]","(0.9448825716972351, 0.026831943541765213, 0.02828546054661274)",-0.026371289230474024,-0.02828546054661274,1,1,"[{'label': 'neutral', 'score': 0.9968823194503784}, {'label': 'positive', 'score': 0.00294079864397645}, {'label': 'negative', 'score': 0.00017697131261229515}]","(0.9968823194503784, 0.00294079864397645, 0.00017697131261229515)",0.886475708550399,0.00294079864397645,0,1
2014-07-02,41.25264358520508,56.34542083740234,56.39313125610352,55.696563720703125,55.79198455810547,7274168.0,Markets Little Changed Ahead Of 4th Of July Break | Barclays Downgrades Pharmaceutical Sector,0.002540178763049516,0.009186849120005992,0.0741756614779996,"[{'label': 'negative', 'score': 0.9968727231025696}, {'label': 'neutral', 'score': 0.0023882247041910887}, {'label': 'positive', 'score': 0.0007390454993583262}]","(0.0023882247041910887, 0.0007390454993583262, 0.9968727231025696)",-0.9985183705272562,-0.9968727231025696,0,0,"[{'label': 'negative', 'score': 0.6457052826881409}, {'label': 'neutral', 'score': 0.31869497895240784}, {'label': 'positive', 'score': 0.03559976443648338}]","(0.31869497895240784, 0.03559976443648338, 0.6457052826881409)",-0.8954953743943967,-0.6457052826881409,0,0,"[{'label': 'negative', 'score': 0.9962130784988403}, {'label': 'neutral', 'score': 0.00337190181016922}, {'label': 'positive', 'score': 0.0004150307213421911}]","(0.00337190181016922, 0.0004150307213421911, 0.9962130784988403)",-0.9991671302113545,-0.9962130784988403,0,0
2014-07-03,41.3574447631836,56.488548278808594,56.72710037231445,56.364505767822266,56.66984558105469,5470665.0,Exclusive: Enanta Pharmaceuticals CEO Jay Luly Discusses Hep C Pipeline,-0.0028716143438464294,0.002536957962095785,0.07235711343467822,"[{'label': 'neutral', 'score': 0.9998151659965515}, {'label': 'positive', 'score': 0.00010267747711623088}, {'label': 'negative', 'score': 8.228742080973461e-05}]","(0.9998151659965515, 0.00010267747711623088, 8.228742080973461e-05)",0.11023743713067999,0.00010267747711623088,1,1,"[{'label': 'neutral', 'score': 0.9433861970901489}, {'label': 'positive', 'score': 0.036472566425800323}, {'label': 'negative', 'score': 0.02014126256108284}]","(0.9433861970901489, 0.036472566425800323, 0.02014126256108284)",0.28846845650558767,0.036472566425800323,1,1,"[{'label': 'neutral', 'score': 0.999479353427887}, {'label': 'positive', 'score': 0.0004129281733185053}, {'label': 'negative', 'score': 0.00010774397378554568}]","(0.999479353427887, 0.0004129281733185053, 0.00010774397378554568)",0.5861350587512254,0.0004129281733185053,0,1
2014-07-04,41.23867988586426,56.326334953308105,56.77480983734131,56.22614669799805,56.555341720581055,6533363.25,,-0.0028798842607983552,-0.0028757453386276197,0.09190394532935334,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-05,41.11991500854492,56.16412162780762,56.82251930236816,56.08778762817383,56.44083786010742,7596061.5,,-0.0028882019481307844,-0.0028840391063763926,0.10535898209769981,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-06,41.00115013122559,56.00190830230713,56.87022876739502,55.94942855834961,56.32633399963379,8658759.75,,-0.002896567820954157,-0.002892380851661859,0.08470980689215966,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-07,40.88238525390625,55.83969497680664,56.91793823242188,55.81106948852539,56.21183013916016,9721458.0,Markets Marginally Lower Ahead Of Earnings Season | #Premarket Prep Technical Update - Merck Trading Lower,-0.00598085495183406,-0.002900770992000382,0.03851532725895288,"[{'label': 'negative', 'score': 0.9979800581932068}, {'label': 'neutral', 'score': 0.0013576435158029199}, {'label': 'positive', 'score': 0.0006622446817345917}]","(0.0013576435158029199, 0.0006622446817345917, 0.9979800581932068)",-0.9986737099363243,-0.9979800581932068,1,1,"[{'label': 'negative', 'score': 0.8191887140274048}, {'label': 'neutral', 'score': 0.12462219595909119}, {'label': 'positive', 'score': 0.056189075112342834}]","(0.12462219595909119, 0.056189075112342834, 0.8191887140274048)",-0.8716232561313646,-0.8191887140274048,1,1,"[{'label': 'negative', 'score': 0.9969327449798584}, {'label': 'neutral', 'score': 0.002694864524528384}, {'label': 'positive', 'score': 0.00037239029188640416}]","(0.002694864524528384, 0.00037239029188640416, 0.9969327449798584)",-0.9992532069098693,-0.9969327449798584,1,1
2014-07-08,40.63787841796875,55.5057258605957,55.98282241821289,55.25763320922852,55.97328186035156,8667065.0,,0.006532562161295841,-0.005998811899209288,0.022083408221135813,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-07-09,40.9033432006836,55.86832046508789,56.03053283691406,55.51526641845703,55.77289962768555,7271758.0,,0.0005123742407674143,0.006511317448512729,0.07536154162804358,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-10,40.924312591552734,55.89694595336914,56.078243255615234,55.08587646484375,55.610687255859375,5851718.0,,-0.002389878038352291,0.0005122430219062279,0.07566588687924661,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-11,40.82648849487305,55.76335906982422,56.049617767333984,55.49618148803711,55.96374130249024,6399926.0,,-0.0014830087683953342,-0.002392738354985458,0.07493902616552642,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-12,40.76594670613607,55.68066151936849,56.02735265096029,55.464375813802086,55.95419947306315,7193716.333333333,,-0.0014852113498502097,-0.0014841095143107537,0.07315473585243597,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-13,40.705404917399086,55.59796396891276,56.005087534586586,55.432570139567055,55.94465764363607,7987506.666666666,,-0.0014874204836343755,-0.0014863153694975172,0.057371125523495596,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-14,40.64486312866211,55.51526641845703,55.98282241821289,55.40076446533203,55.93511581420898,8781297.0,,-0.004640763268369254,-0.0014885277916398885,0.01698145559228885,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-07-15,40.456241607666016,55.25763320922852,55.725189208984375,54.85686874389648,55.46755599975586,10645689.0,,0.004144363550283441,-0.00465156504216538,0.02177283451547234,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-07-16,40.6239128112793,55.48664093017578,55.54389190673828,55.08587646484375,55.286258697509766,7131640.0,,-0.009458326945327942,0.004135799329673353,0.05046231038449931,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-07-17,40.23967361450195,54.96183013916016,55.57251739501953,54.933204650878906,55.21946716308594,6968886.0,,0.012847244923866146,-0.009503340982807775,0.07925803529556193,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-07-18,40.756649017333984,55.66793823242188,55.75381851196289,54.98091506958008,55.26717758178711,7789470.0,,-0.0019426416033534028,0.012765419151419802,0.13607486562485513,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-19,40.677469889322914,55.55979537963867,55.67748260498047,55.009541829427086,55.25763448079427,7671744.666666667,,-0.0019464228052725133,-0.0019445309788691744,0.13648013841749412,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-20,40.59829076131185,55.45165252685547,55.60114669799805,55.038168589274086,55.24809137980143,7554019.333333333,,-0.001950218755533554,-0.0019483195477824566,0.13174272130939563,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-21,40.51911163330078,55.343509674072266,55.524810791015625,55.06679534912109,55.238548278808594,7436294.0,Idenix Pharma Shares Spiking Higher following SEC Filing Showing HSR Approval of Purchase by Merck,0.007413856481220769,-0.0019521229082097376,0.12879966630207582,"[{'label': 'positive', 'score': 0.9995560050010681}, {'label': 'neutral', 'score': 0.00022654965869151056}, {'label': 'negative', 'score': 0.00021744350669905543}]","(0.00022654965869151056, 0.9995560050010681, 0.00021744350669905543)",0.9995650144399741,0.9995560050010681,0,0,"[{'label': 'positive', 'score': 0.9254176020622253}, {'label': 'negative', 'score': 0.04594689607620239}, {'label': 'neutral', 'score': 0.028635473921895027}]","(0.028635473921895027, 0.9254176020622253, 0.04594689607620239)",0.9053972094630649,0.9254176020622253,0,0,"[{'label': 'positive', 'score': 0.51121985912323}, {'label': 'negative', 'score': 0.3513915240764618}, {'label': 'neutral', 'score': 0.13738863170146942}]","(0.13738863170146942, 0.51121985912323, 0.3513915240764618)",0.18528428694496887,0.51121985912323,1,0
2014-07-22,40.819522857666016,55.75381851196289,56.183204650878906,55.46755599975586,55.46755599975586,6821642.0,,-0.005476640633397532,0.007386508931284986,0.10882047037166269,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-23,40.5959587097168,55.4484748840332,55.82061004638672,55.39122009277344,55.6297721862793,6594435.0,,0.0017208232129853251,-0.005491692410314336,0.07653850195850423,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-24,40.66581726074219,55.54389190673828,55.82061004638672,55.26717758178711,55.64885330200195,10547282.0,Merck Announces Initiation of Phase 3 For Letermovir,-0.0010307339762692183,0.0017193442931167857,0.07747088625776033,"[{'label': 'neutral', 'score': 0.999871015548706}, {'label': 'positive', 'score': 6.914565165061504e-05}, {'label': 'negative', 'score': 5.978706758469343e-05}]","(0.999871015548706, 6.914565165061504e-05, 5.978706758469343e-05)",0.07258502047755415,6.914565165061504e-05,1,1,"[{'label': 'neutral', 'score': 0.6612666845321655}, {'label': 'positive', 'score': 0.3290807008743286}, {'label': 'negative', 'score': 0.009652693755924702}]","(0.6612666845321655, 0.3290807008743286, 0.009652693755924702)",0.943007132400033,0.3290807008743286,0,1,"[{'label': 'neutral', 'score': 0.9903691411018372}, {'label': 'positive', 'score': 0.009478721767663956}, {'label': 'negative', 'score': 0.00015208420518320054}]","(0.9903691411018372, 0.009478721767663956, 0.00015208420518320054)",0.9684171385838355,0.009478721767663956,0,1
2014-07-25,40.6239128112793,55.48664093017578,55.6870231628418,55.26717758178711,55.46755599975586,5790305.0,,-0.0010318204016046084,-0.0010312655478380772,0.07632570943949413,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-26,40.5819943745931,55.42938868204752,55.68066151936849,55.24491246541341,55.48027928670248,6864714.666666666,Benzinga Weekly Preview: FOMC In Focus As Earnings Season Progresses,-0.001032886154611087,-0.0010323530947358574,0.07501598163717628,"[{'label': 'neutral', 'score': 0.9998760223388672}, {'label': 'negative', 'score': 6.484214827651158e-05}, {'label': 'positive', 'score': 5.9063779190182686e-05}]","(0.9998760223388672, 5.9063779190182686e-05, 6.484214827651158e-05)",-0.046635130412805405,-6.484214827651158e-05,1,1,"[{'label': 'neutral', 'score': 0.861453652381897}, {'label': 'positive', 'score': 0.11090601235628128}, {'label': 'negative', 'score': 0.027640314772725105}]","(0.861453652381897, 0.11090601235628128, 0.027640314772725105)",0.6009953443661046,0.11090601235628128,0,1,"[{'label': 'neutral', 'score': 0.9867070317268372}, {'label': 'positive', 'score': 0.01294840220361948}, {'label': 'negative', 'score': 0.0003446596674621105}]","(0.9867070317268372, 0.01294840220361948, 0.0003446596674621105)",0.9481444274005975,0.01294840220361948,0,1
2014-07-27,40.5400759379069,55.37213643391927,55.67429987589518,55.22264734903971,55.493002573649086,7939124.333333333,,-0.0010339541114976125,-0.0010334199491128725,0.041147105564526346,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-07-28,40.4981575012207,55.314884185791016,55.66793823242188,55.200382232666016,55.5057258605957,9013534.0,"Markets Little Changed Ahead Of The Federal Reserve's Policy Decision | Earnings Expectations For The Week Of July 28: Exxon, Pfizer, Twitter And Much More",0.010522697030750393,-0.0010344890107893238,0.019538876985343245,"[{'label': 'negative', 'score': 0.9257850646972656}, {'label': 'neutral', 'score': 0.06784611940383911}, {'label': 'positive', 'score': 0.006368819624185562}]","(0.06784611940383911, 0.006368819624185562, 0.9257850646972656)",-0.9863352613097318,-0.9257850646972656,0,0,"[{'label': 'neutral', 'score': 0.788974940776825}, {'label': 'negative', 'score': 0.12200387567281723}, {'label': 'positive', 'score': 0.08902115374803543}]","(0.788974940776825, 0.08902115374803543, 0.12200387567281723)",-0.15629767717744755,-0.12200387567281723,0,0,"[{'label': 'neutral', 'score': 0.9959068298339844}, {'label': 'positive', 'score': 0.002891281619668007}, {'label': 'negative', 'score': 0.001201830804347992}]","(0.9959068298339844, 0.002891281619668007, 0.001201830804347992)",0.412754559441686,0.002891281619668007,0,0
2014-07-29,40.924312591552734,55.89694595336914,56.564884185791016,55.47710037231445,56.125953674316406,10823744.0,"Stocks Lower As Earnings Season Takes Back Seat To Geopolitical Uncertainties | Pharmaceutical ETFs Are Health Care Sector Standouts | Indices Remain Mixed; Merck Beats Expectations | Tuesday Morning Earnings Releases | #Premarket Prep Technical Update - Merck Trading Higher | Herbalife Falls On Downbeat Results; Windstream Shares Spike Higher | Markets Open Higher; Merck Posts Upbeat Profit | US Stock Futures Rise Ahead Of Earnings, Consumer Confidence Data | UPDATE: Merck Q2 Profit Beats Street View, Shares Rise | Merck & Company, Inc. Raises FY2014 EPS Guidance from $3.35-3.53 to $3.43-3.53 vs $3.48 Est, Reaffirms Sales Outlook | Merck & Company, Inc. Reports Q2 EPS of $0.85 vs $0.80 Est; Revenue of $10.93B vs $10.60B Est | Earnings Scheduled For July 29, 2014 | Stocks To Watch For July 29, 2014",-0.008535356702895076,0.010467718797563436,0.08164616776484296,"[{'label': 'negative', 'score': 0.7946043014526367}, {'label': 'positive', 'score': 0.2042984515428543}, {'label': 'neutral', 'score': 0.0010972681920975447}]","(0.0010972681920975447, 0.2042984515428543, 0.7946043014526367)",-0.5909542727153211,-0.7946043014526367,0,0,"[{'label': 'negative', 'score': 0.494037926197052}, {'label': 'positive', 'score': 0.47629106044769287}, {'label': 'neutral', 'score': 0.029671043157577515}]","(0.029671043157577515, 0.47629106044769287, 0.494037926197052)",-0.018289534780080295,-0.494037926197052,1,1,"[{'label': 'negative', 'score': 0.5937389135360718}, {'label': 'neutral', 'score': 0.31597912311553955}, {'label': 'positive', 'score': 0.0902819037437439}]","(0.31597912311553955, 0.0902819037437439, 0.5937389135360718)",-0.7360258592632515,-0.5937389135360718,0,0
2014-07-30,40.57499694824219,55.41984558105469,56.154579162597656,54.97137451171875,55.89694595336914,8438286.0,,-0.023071617664671897,-0.008571991469403614,0.1082397795348096,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-07-31,39.63886260986328,54.14122009277344,55.41030502319336,54.12213516235352,55.114505767822266,10604712.0,3 Reasons To Buy Merck For The Long Term,0.0010575083302824897,-0.02334193327478754,0.19754889510915088,"[{'label': 'neutral', 'score': 0.99928879737854}, {'label': 'positive', 'score': 0.0006257932400330901}, {'label': 'negative', 'score': 8.540858107153326e-05}]","(0.99928879737854, 0.0006257932400330901, 8.540858107153326e-05)",0.7598190034472114,0.0006257932400330901,0,1,"[{'label': 'neutral', 'score': 0.9096608757972717}, {'label': 'positive', 'score': 0.07752730697393417}, {'label': 'negative', 'score': 0.012811767868697643}]","(0.9096608757972717, 0.07752730697393417, 0.012811767868697643)",0.7163626505802635,0.07752730697393417,0,1,"[{'label': 'neutral', 'score': 0.9879088997840881}, {'label': 'positive', 'score': 0.011932154186069965}, {'label': 'negative', 'score': 0.0001589905732544139}]","(0.9879088997840881, 0.011932154186069965, 0.0001589905732544139)",0.9737013200289734,0.011932154186069965,0,1
2014-08-01,39.680789947509766,54.1984748840332,54.50381851196289,53.70228958129883,53.988548278808594,10627768.0,,0.001525804537247939,0.0010569495622479602,0.20052996655755115,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-02,39.741336822509766,54.28117116292318,54.55152765909831,53.727734883626304,54.10623296101888,10106737.333333334,,0.0015234800045444675,0.0015246416802163999,0.20393722690893432,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-03,39.801883697509766,54.36386744181315,54.599236806233726,53.753180185953774,54.22391764322917,9585706.666666666,,0.0015211625438254182,0.001522320686198554,0.17196654768638775,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-04,39.862430572509766,54.446563720703125,54.64694595336914,53.77862548828125,54.34160232543945,9064676.0,"Glaxo, Sanofi Trend Up On Potential Deal For Established Brands",-0.018051137685281847,0.0015200067480367406,0.17572187444407086,"[{'label': 'positive', 'score': 0.999037504196167}, {'label': 'neutral', 'score': 0.0007794126868247986}, {'label': 'negative', 'score': 0.00018312182510271668}]","(0.0007794126868247986, 0.999037504196167, 0.00018312182510271668)",0.9996334706863851,0.999037504196167,0,0,"[{'label': 'positive', 'score': 0.9445213079452515}, {'label': 'neutral', 'score': 0.034320391714572906}, {'label': 'negative', 'score': 0.021158317103981972}]","(0.034320391714572906, 0.9445213079452515, 0.021158317103981972)",0.9561794273066427,0.9445213079452515,0,0,"[{'label': 'positive', 'score': 0.9986372590065002}, {'label': 'neutral', 'score': 0.0010925045935437083}, {'label': 'negative', 'score': 0.0002702529891394079}]","(0.0010925045935437083, 0.9986372590065002, 0.0002702529891394079)",0.9994589028796079,0.9986372590065002,0,0
2014-08-05,39.142860412597656,53.46374130249024,54.360687255859375,53.26335906982422,54.12213516235352,9464698.0,Ukraine Tension Prominent As Dow Suffers Triple Digit Loss; S&P 500 & NASDAQ Also Lower | #Premarket Prep Technical Update - Merck Trading Sharply Lower | Merck Says on July 30 Was Advised by British Columbia Medical Beneficiary and Pharmaceutical Services Division of Delisting of Sitagliptin Products | Merck Successfully Completes Tender Offer to Acquire Idenix for $24.50/Share,-0.0017847766556865772,-0.01821604701955152,0.13933929764144667,"[{'label': 'negative', 'score': 0.9961205124855042}, {'label': 'positive', 'score': 0.0030320794321596622}, {'label': 'neutral', 'score': 0.0008473299676552415}]","(0.0008473299676552415, 0.0030320794321596622, 0.9961205124855042)",-0.9939306979600779,-0.9961205124855042,0,0,"[{'label': 'negative', 'score': 0.9645932912826538}, {'label': 'positive', 'score': 0.02389829233288765}, {'label': 'neutral', 'score': 0.01150838378816843}]","(0.01150838378816843, 0.02389829233288765, 0.9645932912826538)",-0.95164694828159,-0.9645932912826538,0,0,"[{'label': 'negative', 'score': 0.9969574213027954}, {'label': 'neutral', 'score': 0.0021763278637081385}, {'label': 'positive', 'score': 0.0008662251639179885}]","(0.0021763278637081385, 0.0008662251639179885, 0.9969574213027954)",-0.9982637710240977,-0.9969574213027954,0,0
2014-08-06,39.072998046875,53.36832046508789,53.56870269775391,53.16793823242188,53.32061004638672,12865038.0,,-0.0051850636714239305,-0.001786371267174594,0.1361689723332136,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-07,38.87040710449219,53.09160232543945,53.96946716308594,53.024810791015625,53.63549423217773,7561844.0,,0.016355137668765084,-0.005198552762128319,0.13005166362007464,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-08,39.506141662597656,53.959922790527344,54.01717758178711,53.03435134887695,53.31106948852539,7421412.0,,0.0006483910640564688,0.01622283302925855,0.1970624395302425,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-09,39.53175608317057,53.9949099222819,54.157126108805336,53.31424967447917,53.57506434122721,6868627.0,,0.0006479709254987386,0.0006481809493898877,0.19631883526313412,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-10,39.55737050374349,54.02989705403646,54.29707463582357,53.59414800008138,53.83905919392904,6315842.0,,0.00064755133106331,0.000647761082981592,0.13091506401626013,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-11,39.582984924316406,54.064884185791016,54.4370231628418,53.8740463256836,54.10305404663086,5763057.0,Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments,0.006530191490240053,0.0006473417601671924,0.12744978499653095,"[{'label': 'neutral', 'score': 0.9884816408157349}, {'label': 'positive', 'score': 0.011401237919926643}, {'label': 'negative', 'score': 0.00011708254896802828}]","(0.9884816408157349, 0.011401237919926643, 0.00011708254896802828)",0.9796702046475941,0.011401237919926643,0,1,"[{'label': 'positive', 'score': 0.9445891380310059}, {'label': 'neutral', 'score': 0.028115879744291306}, {'label': 'negative', 'score': 0.027294939383864403}]","(0.028115879744291306, 0.9445891380310059, 0.027294939383864403)",0.9438308744465356,0.9445891380310059,0,0,"[{'label': 'positive', 'score': 0.9980185031890869}, {'label': 'neutral', 'score': 0.0016796146519482136}, {'label': 'negative', 'score': 0.0003018581192009151}]","(0.0016796146519482136, 0.9980185031890869, 0.0003018581192009151)",0.9993952680303839,0.9980185031890869,0,0
2014-08-12,39.84146499633789,54.41793823242188,54.52289962768555,53.931297302246094,53.959922790527344,7430530.0,,0.014378420529316528,0.0065089621607288695,0.10796818104821804,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-13,40.41432189941406,55.200382232666016,55.238548278808594,54.54198455810547,54.761451721191406,11172414.0,"Merck Issues Statement Related to Role of PNEUMOVAX 23 in Updated ACIP Recommendations | UPDATE: FDA Approves Belsomra Tablets for Use as Sleep Aid | FDA Approves Belsomra Tablets for Use as Sleep Aid | Medicare Spokesperson Tells CDC Vaccine Advisory Panel, Medicare Would Need to Change Current Policy to Cover Pfizer's Prevnar 13 for Elderly Previously Vaccinated With Merck's Pneumovax -Reuters",0.016076073382380877,0.014276031337044559,0.09528524608813656,"[{'label': 'neutral', 'score': 0.9936536550521851}, {'label': 'positive', 'score': 0.006160266697406769}, {'label': 'negative', 'score': 0.00018606535741128027}]","(0.9936536550521851, 0.006160266697406769, 0.00018606535741128027)",0.9413628673053683,0.006160266697406769,1,0,"[{'label': 'neutral', 'score': 0.9158000946044922}, {'label': 'positive', 'score': 0.04557499662041664}, {'label': 'negative', 'score': 0.03862491250038147}]","(0.9158000946044922, 0.04557499662041664, 0.03862491250038147)",0.08254265583664912,0.04557499662041664,0,0,"[{'label': 'neutral', 'score': 0.9949266910552979}, {'label': 'positive', 'score': 0.0036009601317346096}, {'label': 'negative', 'score': 0.0014723637141287327}]","(0.9949266910552979, 0.0036009601317346096, 0.0014723637141287327)",0.41956643854728093,0.0036009601317346096,0,0
2014-08-14,41.06403350830078,56.08778762817383,56.09732818603516,55.343509674072266,55.39122009277344,8313050.0,,-0.0028921837245360275,0.015948221729628148,0.1156023599708241,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-15,40.94526290893555,55.92557144165039,56.29771041870117,55.37213516235352,56.10686874389648,9481046.0,,-0.0010805867964189346,-0.0028963741695258076,0.1307826552959411,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-16,40.90101877848307,55.86513900756836,56.256361643473305,55.47391764322917,56.10686874389648,9619766.333333334,,-0.0010817557273748865,-0.0010811710512612467,0.13643965577044295,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-17,40.8567746480306,55.80470657348633,56.215012868245445,55.57570012410482,56.10686874389648,9758486.666666666,,-0.0010829271900650692,-0.0010823412473996016,0.14683515497773209,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-18,40.812530517578125,55.7442741394043,56.17366409301758,55.67748260498047,56.10686874389648,9897207.0,,0.008387516152539912,-0.0010835139793862367,0.12474935610218038,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-19,41.15485382080078,56.21183013916016,56.25,55.66793823242188,56.154579162597656,7791880.0,,0.009675823044527293,0.008352536398332592,0.0712994235359713,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-20,41.55303955078125,56.7557258605957,56.84160232543945,55.84923553466797,55.99236679077149,7376243.0,,-0.01059182468169983,0.00962931204949891,0.08787795273483115,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-21,41.11293029785156,56.154579162597656,56.92748260498047,56.09732818603516,56.67938995361328,8013846.0,,0.005437555271237164,-0.010648317317572282,0.13111605168058035,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-22,41.33649063110352,56.459922790527344,56.64122009277344,56.20228958129883,56.33587646484375,5436605.0,,0.0031547530972218045,0.005422825140713206,0.13262701540466687,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-23,41.46689478556315,56.638039906819664,56.80343500773112,56.316794077555336,56.431296030680336,5430736.0,,0.00314483192895357,0.0031497873048278212,0.12911213796461316,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-24,41.59729894002279,56.81615702311198,56.9656499226888,56.43129857381185,56.52671559651693,5424867.0,,0.003134972965874208,0.0031398972880602523,0.12100792077933464,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-25,41.72770309448242,56.9942741394043,57.12786483764648,56.54580307006836,56.62213516235352,5418998.0,"#Premarket Prep Technical Update - Merck Approaches $60.00 | US Stock Futures Rise Ahead Of Economic Data | US Regulators Have Approved Merck's Pembrolizumab Soon - Reuters |  Advaxis, Merck to Collaborate on Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer",0.007868770868741352,0.003130069184268067,0.10313934702679442,"[{'label': 'positive', 'score': 0.9992735981941223}, {'label': 'neutral', 'score': 0.0004389048845041543}, {'label': 'negative', 'score': 0.00028753906372003257}]","(0.0004389048845041543, 0.9992735981941223, 0.00028753906372003257)",0.999424669381387,0.9992735981941223,0,0,"[{'label': 'positive', 'score': 0.9035767912864685}, {'label': 'neutral', 'score': 0.0827595666050911}, {'label': 'negative', 'score': 0.013663588091731071}]","(0.0827595666050911, 0.9035767912864685, 0.013663588091731071)",0.9702071814566348,0.9035767912864685,0,0,"[{'label': 'positive', 'score': 0.9802716374397278}, {'label': 'neutral', 'score': 0.018918413668870926}, {'label': 'negative', 'score': 0.0008099176338873804}]","(0.018918413668870926, 0.9802716374397278, 0.0008099176338873804)",0.9983489290371449,0.9802716374397278,0,0
2014-08-26,42.0560417175293,57.4427490234375,57.63358688354492,56.92748260498047,56.9370231628418,9663189.0,"S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue To Rally | Fast Money Halftime Report Final Trade From August 26 | Pfizer, Merck Report Collaboration on Study Evaluating Novel Anti-Cancer Combo Regimen",0.0013289041398641226,0.007837973543814769,0.033238825635299396,"[{'label': 'positive', 'score': 0.9947834610939026}, {'label': 'neutral', 'score': 0.0039014967624098063}, {'label': 'negative', 'score': 0.0013150108279660344}]","(0.0039014967624098063, 0.9947834610939026, 0.0013150108279660344)",0.997359677049943,0.9947834610939026,0,0,"[{'label': 'positive', 'score': 0.7824437618255615}, {'label': 'neutral', 'score': 0.18343140184879303}, {'label': 'negative', 'score': 0.03412476181983948}]","(0.18343140184879303, 0.7824437618255615, 0.03412476181983948)",0.9164191103828089,0.7824437618255615,0,0,"[{'label': 'positive', 'score': 0.9943596720695496}, {'label': 'neutral', 'score': 0.0048904502764344215}, {'label': 'negative', 'score': 0.0007499422645196319}]","(0.0048904502764344215, 0.9943596720695496, 0.0007499422645196319)",0.9984927444098277,0.9943596720695496,0,0
2014-08-27,42.11193084716797,57.51908493041992,57.80534362792969,57.35686874389648,57.63358688354492,6860942.0,"Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend | Biotech ETFs Hitting New Highs On Takeover News (FBT, PBE, ITMN) | Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold | UPDATE: Deutsche Bank Initiates Coverage On Merck | Deutsche Bank Initiates Coverage on Merck & Company, Inc. at Hold, Announces $63.00 PT",-0.004645024901044768,0.0013280219282542248,0.03863160612196437,"[{'label': 'negative', 'score': 0.9844490885734558}, {'label': 'positive', 'score': 0.013789191842079163}, {'label': 'neutral', 'score': 0.001761789433658123}]","(0.001761789433658123, 0.013789191842079163, 0.9844490885734558)",-0.9723729451923259,-0.9844490885734558,0,0,"[{'label': 'neutral', 'score': 0.6645137071609497}, {'label': 'positive', 'score': 0.2997121214866638}, {'label': 'negative', 'score': 0.03577417880296707}]","(0.6645137071609497, 0.2997121214866638, 0.03577417880296707)",0.786732401459716,0.2997121214866638,0,1,"[{'label': 'negative', 'score': 0.7873132228851318}, {'label': 'neutral', 'score': 0.188222736120224}, {'label': 'positive', 'score': 0.024464065209031105}]","(0.188222736120224, 0.024464065209031105, 0.7873132228851318)",-0.9397271503703529,-0.7873132228851318,0,0
2014-08-28,41.91632461547852,57.25190734863281,57.47137451171875,57.09923553466797,57.14694595336914,5492568.0,,0.0018333257375078749,-0.004655846553444306,0.07156238409044642,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-29,41.9931755065918,57.35686874389648,57.65267181396485,57.08969497680664,57.65267181396485,5990158.0,,-0.0013308939043248924,0.001831647247044656,0.07102995139069808,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-30,41.93728446960449,57.28053283691406,57.57633590698242,57.05152702331543,57.48807239532471,6078897.5,,-0.0013326675434350657,-0.001331780330196938,0.07317050318221635,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-08-31,41.88139343261719,57.20419692993164,57.5,57.01335906982422,57.32347297668457,6167637.0,,-0.0013344459161960497,-0.0013335563345555563,0.041154376550724486,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-01,41.82550239562988,57.12786102294922,57.42366409301758,56.97519111633301,57.158873558044434,6256376.5,,-0.0013362290415836935,-0.0013353370820442956,0.03641737769489553,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-02,41.76961135864258,57.0515251159668,57.34732818603516,56.9370231628418,56.9942741394043,6345116.0,,0.011540404454083272,-0.0013371225916899224,0.0224770764191957,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-09-03,42.25165939331055,57.709922790527344,58.07251739501953,57.30915832519531,57.36641311645508,9532818.0,,-0.006613759236821562,0.01147432191347825,0.0909332588703015,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-04,41.97221755981445,57.328243255615234,58.20610809326172,57.17557144165039,57.79580307006836,11327832.0,Merck Wins FDA Approval For Pembrolizumab In Melanoma | Merck & Co (MK-7655) Gets Fast Track Designation From FDA,0.018308978653875527,-0.006635727055927073,0.10675641767100684,"[{'label': 'positive', 'score': 0.9994367957115173}, {'label': 'neutral', 'score': 0.0003031338274013251}, {'label': 'negative', 'score': 0.00026006813277490437}]","(0.0003031338274013251, 0.9994367957115173, 0.00026006813277490437)",0.9994797060145316,0.9994367957115173,1,1,"[{'label': 'positive', 'score': 0.9278416633605957}, {'label': 'neutral', 'score': 0.057076867669820786}, {'label': 'negative', 'score': 0.015081520192325115}]","(0.057076867669820786, 0.9278416633605957, 0.015081520192325115)",0.9680111371628426,0.9278416633605957,1,1,"[{'label': 'positive', 'score': 0.998769223690033}, {'label': 'neutral', 'score': 0.0009582113707438111}, {'label': 'negative', 'score': 0.00027257748297415674}]","(0.0009582113707438111, 0.998769223690033, 0.00027257748297415674)",0.9994543221661915,0.998769223690033,1,1
2014-09-05,42.74068069458008,58.37786483764648,58.37786483764648,57.39503860473633,57.65267181396485,11259922.0,"Bristol-Myers Squibb Co In Patent Suit Vs. Merck & Co., Inc. Over Skin Cancer Drug | Shares of Bristol-Myers Edge Off Session Lows as Bloomberg Reporting Co. Has Filed Suit Against Merck Related to Patent for Immunotherapy Drugs",-0.0007082954359988003,0.018143387453944823,0.163813677358197,"[{'label': 'negative', 'score': 0.9942792654037476}, {'label': 'neutral', 'score': 0.004529428668320179}, {'label': 'positive', 'score': 0.0011913357302546501}]","(0.004529428668320179, 0.0011913357302546501, 0.9942792654037476)",-0.9976064873660809,-0.9942792654037476,0,0,"[{'label': 'negative', 'score': 0.9482458829879761}, {'label': 'positive', 'score': 0.02765117958188057}, {'label': 'neutral', 'score': 0.02410293184220791}]","(0.02410293184220791, 0.02765117958188057, 0.9482458829879761)",-0.9433317700351184,-0.9482458829879761,0,0,"[{'label': 'negative', 'score': 0.996075451374054}, {'label': 'positive', 'score': 0.0019830730743706226}, {'label': 'neutral', 'score': 0.0019413860281929374}]","(0.0019413860281929374, 0.0019830730743706226, 0.996075451374054)",-0.996026138696693,-0.996075451374054,0,0
2014-09-06,42.71040852864584,58.33651606241862,58.4255739847819,57.61132303873698,57.90712483723959,10448141.0,,-0.0007087974740146925,-0.0007085463957205607,0.1625683573980492,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-07,42.68013636271159,58.29516728719076,58.47328313191732,57.82760747273763,58.16157786051432,9636360.0,,-0.0007093002242220609,-0.0007090487897058641,0.1612797802723749,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-08,42.649864196777344,58.25381851196289,58.520992279052734,58.04389190673828,58.41603088378906,8824579.0,,-0.00802625177879297,-0.0007095518966407222,0.14999621381660855,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-09,42.30754470825195,57.786258697509766,58.23473358154297,57.700382232666016,58.05343627929688,7800998.0,Merck CEO Says Tax Inversion Deals Would Not Fit Corporate Strategy -Reuters,0.003302544222557734,-0.008058635534115007,0.15532856576398893,"[{'label': 'negative', 'score': 0.9878677129745483}, {'label': 'neutral', 'score': 0.010569683276116848}, {'label': 'positive', 'score': 0.0015625611413270235}]","(0.010569683276116848, 0.0015625611413270235, 0.9878677129745483)",-0.9968414931659064,-0.9878677129745483,0,0,"[{'label': 'neutral', 'score': 0.6238033771514893}, {'label': 'negative', 'score': 0.34748396277427673}, {'label': 'positive', 'score': 0.028712643310427666}]","(0.6238033771514893, 0.028712643310427666, 0.34748396277427673)",-0.8473529912496727,-0.34748396277427673,0,1,"[{'label': 'negative', 'score': 0.9945926070213318}, {'label': 'neutral', 'score': 0.004977835807949305}, {'label': 'positive', 'score': 0.0004295672697480768}]","(0.004977835807949305, 0.0004295672697480768, 0.9945926070213318)",-0.9991365674437274,-0.9945926070213318,0,0
2014-09-10,42.447265625,57.97710037231445,58.082061767578125,57.58587646484375,57.89122009277344,9655014.0,"Is Merck & Co., Inc. A Leader In A Red Hot Market? | Option Alert: Merck Jan 15 $50 Call; 32,105 Traded vs 12,719 OI; Currently $60.78",-0.010862429859980063,0.003297102800453594,0.06537038865785107,"[{'label': 'neutral', 'score': 0.9998884201049805}, {'label': 'negative', 'score': 6.387443863786757e-05}, {'label': 'positive', 'score': 4.7625380830140784e-05}]","(0.9998884201049805, 4.7625380830140784e-05, 6.387443863786757e-05)",-0.14573169611623435,-6.387443863786757e-05,0,0,"[{'label': 'positive', 'score': 0.4799828827381134}, {'label': 'neutral', 'score': 0.43679162859916687}, {'label': 'negative', 'score': 0.08322548121213913}]","(0.43679162859916687, 0.4799828827381134, 0.08322548121213913)",0.7044593562907729,0.4799828827381134,0,0,"[{'label': 'positive', 'score': 0.9427829384803772}, {'label': 'neutral', 'score': 0.05526366084814072}, {'label': 'negative', 'score': 0.0019533869344741106}]","(0.05526366084814072, 0.9427829384803772, 0.0019533869344741106)",0.9958646939216266,0.9427829384803772,0,0
2014-09-11,42.2924690246582,57.34732818603516,57.671756744384766,57.07061004638672,57.45228958129883,8158890.0,,-0.009151442754458271,-0.010921856790277155,0.09310979068478069,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-12,41.905418395996094,56.82251739501953,57.375953674316406,56.54580307006836,57.13740539550781,7358846.0,#Premarket Prep Technical Update - Merck Trading Lower,-0.00016792338432936163,-0.009193574447543196,0.09694853389236316,"[{'label': 'negative', 'score': 0.9901684522628784}, {'label': 'neutral', 'score': 0.009066872298717499}, {'label': 'positive', 'score': 0.0007646208978258073}]","(0.009066872298717499, 0.0007646208978258073, 0.9901684522628784)",-0.9984567658128779,-0.9901684522628784,0,0,"[{'label': 'neutral', 'score': 0.9358273148536682}, {'label': 'negative', 'score': 0.034999582916498184}, {'label': 'positive', 'score': 0.02917313389480114}]","(0.9358273148536682, 0.02917313389480114, 0.034999582916498184)",-0.09079324222519347,-0.034999582916498184,1,1,"[{'label': 'negative', 'score': 0.9953994154930115}, {'label': 'neutral', 'score': 0.0041427649557590485}, {'label': 'positive', 'score': 0.00045776661136187613}]","(0.0041427649557590485, 0.00045776661136187613, 0.9953994154930115)",-0.9990806581112474,-0.9953994154930115,0,0
2014-09-13,41.898380279541016,56.812975565592446,57.331424713134766,56.62213897705078,57.06424967447917,7609353.0,,-0.00016795158732818422,-0.0001679374850394441,0.09856268499944668,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-14,41.89134216308594,56.80343373616537,57.286895751953125,56.6984748840332,56.99109395345052,7859860.0,,-0.00016797979980232516,-0.00016796569277540557,0.09909893952889856,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-15,41.88430404663086,56.79389190673828,57.24236679077149,56.774810791015625,56.91793823242188,8110367.0,Merck Announces Data from Pivotal Phase 3 Fracture Outcomes Study for Odanacatib; Expects to Submit NDA to FDA in 2015,0.00789653374643975,-0.00016799390998906407,0.08653502206112137,"[{'label': 'neutral', 'score': 0.9997004270553589}, {'label': 'positive', 'score': 0.0002333935262868181}, {'label': 'negative', 'score': 6.624309025937691e-05}]","(0.9997004270553589, 0.0002333935262868181, 6.624309025937691e-05)",0.5578438241431404,0.0002333935262868181,0,1,"[{'label': 'neutral', 'score': 0.8041778206825256}, {'label': 'positive', 'score': 0.1813642978668213}, {'label': 'negative', 'score': 0.01445789821445942}]","(0.8041778206825256, 0.1813642978668213, 0.01445789821445942)",0.8523364715156363,0.1813642978668213,0,1,"[{'label': 'neutral', 'score': 0.999125063419342}, {'label': 'positive', 'score': 0.0007543218671344221}, {'label': 'negative', 'score': 0.00012061279267072678}]","(0.999125063419342, 0.0007543218671344221, 0.00012061279267072678)",0.7242930284700627,0.0007543218671344221,0,1
2014-09-16,42.21503829956055,57.24236679077149,57.30915832519531,56.564884185791016,56.78435134887695,9479579.0,#Premarket Prep Technical Update - Merck Trading Higher,-0.0018336312970308674,0.007865519287991195,0.09584102901122234,"[{'label': 'positive', 'score': 0.7203679084777832}, {'label': 'neutral', 'score': 0.2781701683998108}, {'label': 'negative', 'score': 0.0014619216090068221}]","(0.2781701683998108, 0.7203679084777832, 0.0014619216090068221)",0.9959494009583089,0.7203679084777832,0,0,"[{'label': 'neutral', 'score': 0.9331013560295105}, {'label': 'positive', 'score': 0.036269888281822205}, {'label': 'negative', 'score': 0.03062882274389267}]","(0.9331013560295105, 0.036269888281822205, 0.03062882274389267)",0.08432248471515681,0.036269888281822205,1,1,"[{'label': 'positive', 'score': 0.7539310455322266}, {'label': 'neutral', 'score': 0.2448357194662094}, {'label': 'negative', 'score': 0.0012332610785961151}]","(0.2448357194662094, 0.7539310455322266, 0.0012332610785961151)",0.9967337940424357,0.7539310455322266,0,0
2014-09-17,42.13763427734375,57.13740539550781,57.261451721191406,56.564884185791016,56.80343627929688,10764218.0,"Merck Reports Entered Into License Deal with Sun Pharma for Tildrakizumab | Merck Presents First Phase 3 Data In Japanese Patients for Omarigliptin, An Investigational Once-Weekly DPP-4 Inhibitor For Type 2 Diabetes | Sun Pharma and Merck Enter into Licensing Agreement for Tildrakizumab ",0.007181023015539622,-0.0018353144567418251,0.061076328247340585,"[{'label': 'positive', 'score': 0.9915014505386353}, {'label': 'neutral', 'score': 0.00801891926676035}, {'label': 'negative', 'score': 0.00047956459457054734}]","(0.00801891926676035, 0.9915014505386353, 0.00047956459457054734)",0.9990331173938723,0.9915014505386353,0,0,"[{'label': 'positive', 'score': 0.9193897843360901}, {'label': 'neutral', 'score': 0.06711380928754807}, {'label': 'negative', 'score': 0.013496464118361473}]","(0.06711380928754807, 0.9193897843360901, 0.013496464118361473)",0.9710651451005488,0.9193897843360901,0,0,"[{'label': 'positive', 'score': 0.9289286136627197}, {'label': 'neutral', 'score': 0.07065790891647339}, {'label': 'negative', 'score': 0.0004135172930546105}]","(0.07065790891647339, 0.9289286136627197, 0.0004135172930546105)",0.9991100859860311,0.9289286136627197,0,0
2014-09-18,42.440223693847656,57.54771041870117,57.57633590698242,57.08015441894531,57.375953674316406,8388297.0,,0.0029845973564388787,0.007155362243593636,0.07251537643906786,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-19,42.56689453125,57.71946716308594,58.10114669799805,57.71946716308594,57.96755599975586,15175774.0,,0.0004959416586499125,0.0029801522880454666,0.06835172450327197,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-20,42.58801015218099,57.74809265136719,58.1297721862793,57.64631144205729,57.8466911315918,13373144.0,,0.000495695822441545,0.0004958187202306407,0.06642668576534692,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-21,42.60912577311198,57.77671813964844,58.15839767456055,57.57315572102865,57.72582626342773,11570514.0,,0.0004954502298323894,0.0004955730058521553,0.05422578810568899,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-22,42.63024139404297,57.80534362792969,58.1870231628418,57.5,57.60496139526367,9767884.0,"Citigroup Inc, Hertz Global Holdings, Inc. Highlight Fast Money Halftime Report Final Trade From September 22",-0.0049521147967271075,0.0004953275348918036,0.046146808701468194,"[{'label': 'neutral', 'score': 0.9998540878295898}, {'label': 'negative', 'score': 7.978193025337532e-05}, {'label': 'positive', 'score': 6.616741302423179e-05}]","(0.9998540878295898, 6.616741302423179e-05, 7.978193025337532e-05)",-0.09328248365768696,-7.978193025337532e-05,1,1,"[{'label': 'neutral', 'score': 0.9136884212493896}, {'label': 'negative', 'score': 0.06802169233560562}, {'label': 'positive', 'score': 0.018289903178811073}]","(0.9136884212493896, 0.018289903178811073, 0.06802169233560562)",-0.5761889681263951,-0.06802169233560562,0,1,"[{'label': 'neutral', 'score': 0.999607503414154}, {'label': 'positive', 'score': 0.0002596030244603753}, {'label': 'negative', 'score': 0.00013287617184687406}]","(0.999607503414154, 0.0002596030244603753, 0.00013287617184687406)",0.3228880761218592,0.0002596030244603753,1,1
2014-09-23,42.41910552978516,57.51908493041992,57.9484748840332,56.95610809326172,57.39503860473633,8396681.0,,0.001327140497362872,-0.004964417149119908,0.04642717768518265,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-24,42.47539520263672,57.59542083740234,57.76717758178711,57.47137451171875,57.54771041870117,12015949.0,,-0.011928433768742227,0.0013262606248033654,0.040639551365298225,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-09-25,41.96875762939453,56.90839767456055,57.72900772094727,56.89885330200195,57.51908493041992,9109006.0,,-0.004191861012676132,-0.012000148400851587,0.0897961352133999,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-26,41.79283142089844,56.66984558105469,57.0515251159668,55.86832046508789,56.98473358154297,11303938.0,"Fast Money Halftime Report Final Trade From September 26 - Merck & Co., Inc., NCR Corporation And BP plc",0.0001122579990835847,-0.004200671492208119,0.08454707095161651,"[{'label': 'neutral', 'score': 0.9998860359191895}, {'label': 'negative', 'score': 7.109888974810019e-05}, {'label': 'positive', 'score': 4.286656985641457e-05}]","(0.9998860359191895, 4.286656985641457e-05, 7.109888974810019e-05)",-0.2477269866647139,-7.109888974810019e-05,1,1,"[{'label': 'neutral', 'score': 0.9509793519973755}, {'label': 'negative', 'score': 0.025469211861491203}, {'label': 'positive', 'score': 0.023551447317004204}]","(0.9509793519973755, 0.023551447317004204, 0.025469211861491203)",-0.039121557658047416,-0.025469211861491203,1,1,"[{'label': 'neutral', 'score': 0.999610960483551}, {'label': 'positive', 'score': 0.00023581682762596756}, {'label': 'negative', 'score': 0.00015327049186453223}]","(0.999610960483551, 0.00023581682762596756, 0.00015327049186453223)",0.21215375476519696,0.00023581682762596756,1,1
2014-09-27,41.79751586914063,56.67620722452799,57.02926127115885,55.95101801554362,56.76526769002279,10581866.0,,0.00011224539863972706,0.00011225169862587694,0.08333643190249747,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-28,41.80220031738281,56.6825688680013,57.006997426350914,56.03371556599935,56.5458017985026,9859794.0,,0.000112232801024361,0.00011223909959633993,0.08713227531689036,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-09-29,41.806884765625,56.68893051147461,56.98473358154297,56.11641311645508,56.32633590698242,9137722.0,"Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader | Merck Presents Early Data on Investigational Use of KEYTRUDA in Patients with Advanced Bladder Cancer at ESMO 2014 ",-0.002188193083982861,0.00011222650339473096,0.08375704061117974,"[{'label': 'neutral', 'score': 0.9660714268684387}, {'label': 'positive', 'score': 0.0335177406668663}, {'label': 'negative', 'score': 0.000410849810577929}]","(0.9660714268684387, 0.0335177406668663, 0.000410849810577929)",0.9757814984473898,0.0335177406668663,0,1,"[{'label': 'positive', 'score': 0.7137569785118103}, {'label': 'neutral', 'score': 0.2702540159225464}, {'label': 'negative', 'score': 0.015988992527127266}]","(0.2702540159225464, 0.7137569785118103, 0.015988992527127266)",0.9561792920778617,0.7137569785118103,0,0,"[{'label': 'positive', 'score': 0.8515806198120117}, {'label': 'neutral', 'score': 0.14736928045749664}, {'label': 'negative', 'score': 0.0010500788921490312}]","(0.14736928045749664, 0.8515806198120117, 0.0010500788921490312)",0.9975368494384615,0.8515806198120117,0,0
2014-09-30,41.71541595458984,56.564884185791016,57.23282241821289,56.536258697509766,56.67938995361328,9691170.0,,-0.00961536321636995,-0.002190590676705015,0.03089480496860354,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-10-01,41.31431198120117,56.020992279052734,56.50763320922852,55.82061004638672,56.38358688354492,9525167.0,,0.0023845861722601516,-0.009661889304964998,0.06719344996874607,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-02,41.412818908691406,56.154579162597656,56.35496139526367,55.6202278137207,56.08778762817383,8499070.0,"Markets Little Changed Ahead Of Friday's Jobs Report | Guggenheim Securities Initiates Coverage on Merck & Company, Inc. at Neutral, Announces $65.00 PT",0.017842020691295722,0.0023817475583711254,0.07392733611344544,"[{'label': 'negative', 'score': 0.9721684455871582}, {'label': 'neutral', 'score': 0.026742344722151756}, {'label': 'positive', 'score': 0.001089234370738268}]","(0.026742344722151756, 0.001089234370738268, 0.9721684455871582)",-0.9977616732070681,-0.9721684455871582,0,0,"[{'label': 'neutral', 'score': 0.7998085618019104}, {'label': 'positive', 'score': 0.16049951314926147}, {'label': 'negative', 'score': 0.039691876620054245}]","(0.7998085618019104, 0.16049951314926147, 0.039691876620054245)",0.6034607016236618,0.16049951314926147,1,0,"[{'label': 'positive', 'score': 0.7909821271896362}, {'label': 'neutral', 'score': 0.20684856176376343}, {'label': 'negative', 'score': 0.0021693359594792128}]","(0.20684856176376343, 0.7909821271896362, 0.0021693359594792128)",0.9945298317905987,0.7909821271896362,1,1
2014-10-03,42.15171051025391,57.15649032592773,57.34732818603516,56.459922790527344,56.459922790527344,9056606.0,#Premarket Prep Technical Update - Merck Trading Higher,-0.0017807463112148663,0.017684720124344668,0.15928395008649854,"[{'label': 'positive', 'score': 0.7203679084777832}, {'label': 'neutral', 'score': 0.2781701683998108}, {'label': 'negative', 'score': 0.0014619216090068221}]","(0.2781701683998108, 0.7203679084777832, 0.0014619216090068221)",0.9959494009583089,0.7203679084777832,0,0,"[{'label': 'neutral', 'score': 0.9331013560295105}, {'label': 'positive', 'score': 0.036269888281822205}, {'label': 'negative', 'score': 0.03062882274389267}]","(0.9331013560295105, 0.036269888281822205, 0.03062882274389267)",0.08432248471515681,0.036269888281822205,1,1,"[{'label': 'positive', 'score': 0.7539310455322266}, {'label': 'neutral', 'score': 0.2448357194662094}, {'label': 'negative', 'score': 0.0012332610785961151}]","(0.2448357194662094, 0.7539310455322266, 0.0012332610785961151)",0.9967337940424357,0.7539310455322266,0,0
2014-10-04,42.076647440592446,57.05470911661784,57.39503860473633,56.50127156575521,56.77798970540365,8523104.333333334,,-0.0017839230255623764,-0.0017823337247277094,0.16100623614555143,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-05,42.00158437093099,56.952927907307945,57.4427490234375,56.54262034098307,57.096056620279946,7989602.666666667,,-0.0017871110941925445,-0.0017855161111529406,0.16047996140580023,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-06,41.92652130126953,56.85114669799805,57.49045944213867,56.58396911621094,57.41412353515625,7456101.0,Merck Prices $3.1B Debt Offering  | 2 Mutual Funds Holding Hospital Stocks  | Merck CommencesTender Offers for Eight Series of Notes  | Merck Commences Public Debt Offering ,-0.01879826106993088,-0.001788709882315929,0.13392808551636806,"[{'label': 'neutral', 'score': 0.9998807907104492}, {'label': 'negative', 'score': 7.271352660609409e-05}, {'label': 'positive', 'score': 4.65247176180128e-05}]","(0.9998807907104492, 4.65247176180128e-05, 7.271352660609409e-05)",-0.21963430574220574,-7.271352660609409e-05,1,1,"[{'label': 'neutral', 'score': 0.7637999653816223}, {'label': 'positive', 'score': 0.2223449945449829}, {'label': 'negative', 'score': 0.013855066150426865}]","(0.7637999653816223, 0.2223449945449829, 0.013855066150426865)",0.8826836359852289,0.2223449945449829,0,1,"[{'label': 'neutral', 'score': 0.9983819723129272}, {'label': 'positive', 'score': 0.001489320071414113}, {'label': 'negative', 'score': 0.00012861577852163464}]","(0.9983819723129272, 0.001489320071414113, 0.00012861577852163464)",0.841012511680556,0.001489320071414113,0,1
2014-10-07,41.13838577270508,55.78244400024414,56.67938995361328,55.77289962768555,56.60305404663086,9977065.0,,0.029421803260650508,-0.01897719435103537,0.2060027927127488,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-08,42.348751068115234,57.42366409301758,57.47137451171875,55.88740539550781,55.97328186035156,12909474.0,#Premarket Prep Technical Update - Merck Trading Sharply Higher,-0.016118292976761393,0.0289972885646221,0.2756629205996145,"[{'label': 'positive', 'score': 0.999173104763031}, {'label': 'neutral', 'score': 0.000609648588579148}, {'label': 'negative', 'score': 0.0002171739615732804}]","(0.000609648588579148, 0.999173104763031, 0.0002171739615732804)",0.999565387084112,0.999173104763031,0,0,"[{'label': 'negative', 'score': 0.6204100251197815}, {'label': 'positive', 'score': 0.34823453426361084}, {'label': 'neutral', 'score': 0.031355466693639755}]","(0.031355466693639755, 0.34823453426361084, 0.6204100251197815)",-0.2809859284497801,-0.6204100251197815,1,0,"[{'label': 'positive', 'score': 0.9971721768379211}, {'label': 'neutral', 'score': 0.0025316013488918543}, {'label': 'negative', 'score': 0.0002963050501421094}]","(0.0025316013488918543, 0.9971721768379211, 0.0002963050501421094)",0.9994058858890834,0.9971721768379211,0,0
2014-10-09,41.6661491394043,56.49809265136719,57.738548278808594,56.40267181396485,57.25190734863281,9008398.0,,-0.009289000148271822,-0.016249605596257145,0.30246991161537207,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-10,41.27912902832031,55.97328186035156,57.17557144165039,55.97328186035156,56.593509674072266,11826890.0,,-0.014319803322097365,-0.009332411954134286,0.306907123526169,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-11,40.68801625569662,55.17175547281901,56.73982111612956,55.12086486816406,56.35177993774414,13057416.666666666,,-0.014527839121005102,-0.014423321130496753,0.3155324958909785,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-12,40.096903483072914,54.37022908528646,56.304070790608726,54.26844787597656,56.110050201416016,14287943.333333332,,-0.014742008651007403,-0.0146344015159196,0.3056283068766518,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-13,39.50579071044922,53.56870269775391,55.86832046508789,53.41603088378906,55.86832046508789,15518470.0,"Markets Debut Week On Negative Note; S&P 500 Falls Through Key Level | #Premarket Prep Technical Update - Merck Trading Lower | Jefferies Maintains Hold on Merck & Company, Inc., Lowers PT to $60.00 | 5 Companies That Could Develop An Enterovirus Treatment",0.003384388516350766,-0.0148517519538812,0.042076830910266705,"[{'label': 'negative', 'score': 0.9975371360778809}, {'label': 'neutral', 'score': 0.0018972804537042975}, {'label': 'positive', 'score': 0.0005655807326547801}]","(0.0018972804537042975, 0.0005655807326547801, 0.9975371360778809)",-0.9988666883214944,-0.9975371360778809,0,0,"[{'label': 'negative', 'score': 0.9579173922538757}, {'label': 'neutral', 'score': 0.023990245535969734}, {'label': 'positive', 'score': 0.018092302605509758}]","(0.023990245535969734, 0.018092302605509758, 0.9579173922538757)",-0.9629259776807517,-0.9579173922538757,0,0,"[{'label': 'negative', 'score': 0.9976963400840759}, {'label': 'neutral', 'score': 0.001884298282675445}, {'label': 'positive', 'score': 0.0004193849745206535}]","(0.001884298282675445, 0.0004193849745206535, 0.9976963400840759)",-0.9991596465940941,-0.9976963400840759,0,0
2014-10-14,39.63949966430664,53.75,54.34160232543945,53.17748260498047,53.97900772094727,11460718.0,,-0.028404058412063952,0.0033786743625173884,0.12398737687795128,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-10-15,38.5135612487793,52.22328186035156,53.31106948852539,51.80343627929688,52.83396911621094,19687518.0,Merck Announces Final Results of Tender Offers for Eight Series of Notes ,-0.023752996708551192,-0.02881525890284342,0.18147205249543627,"[{'label': 'neutral', 'score': 0.9998725652694702}, {'label': 'negative', 'score': 7.059263589326292e-05}, {'label': 'positive', 'score': 5.6838329328456894e-05}]","(0.9998725652694702, 5.6838329328456894e-05, 7.059263589326292e-05)",-0.10793535575026543,-7.059263589326292e-05,1,1,"[{'label': 'neutral', 'score': 0.9067964553833008}, {'label': 'positive', 'score': 0.07565400004386902}, {'label': 'negative', 'score': 0.01754959486424923}]","(0.9067964553833008, 0.07565400004386902, 0.01754959486424923)",0.6234137775146993,0.07565400004386902,0,1,"[{'label': 'neutral', 'score': 0.9991338849067688}, {'label': 'positive', 'score': 0.0006915719714015722}, {'label': 'negative', 'score': 0.0001746343041304499}]","(0.9991338849067688, 0.0006915719714015722, 0.0001746343041304499)",0.59678356284549,0.0006915719714015722,0,1
2014-10-16,37.598758697509766,50.98282241821289,51.61259460449219,50.08587646484375,51.536258697509766,22905298.0,Will Actavis Win Competition For Allergan's Affection?,0.011042555612895058,-0.02403964744478486,0.19561230124356294,"[{'label': 'positive', 'score': 0.9743769764900208}, {'label': 'neutral', 'score': 0.025065872818231583}, {'label': 'negative', 'score': 0.0005571783985942602}]","(0.025065872818231583, 0.9743769764900208, 0.0005571783985942602)",0.998856992760382,0.9743769764900208,0,0,"[{'label': 'neutral', 'score': 0.8629987239837646}, {'label': 'positive', 'score': 0.11688866466283798}, {'label': 'negative', 'score': 0.020112669095396996}]","(0.8629987239837646, 0.11688866466283798, 0.020112669095396996)",0.706387251223559,0.11688866466283798,0,1,"[{'label': 'positive', 'score': 0.7510325312614441}, {'label': 'neutral', 'score': 0.24798493087291718}, {'label': 'negative', 'score': 0.0009825524175539613}]","(0.24798493087291718, 0.7510325312614441, 0.0009825524175539613)",0.9973868810908761,0.7510325312614441,0,0
2014-10-17,38.013938903808594,51.54580307006836,52.12786483764648,51.078243255615234,51.38358688354492,20664569.0,,0.00018511360496440603,0.010982031746823067,0.2739974857369669,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-18,38.02098083496094,51.555344899495445,52.013360341389976,51.20228958129883,51.50127156575521,17990771.666666668,,0.00018507934425978566,0.0001850964735551936,0.2802604948241787,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-19,38.02802276611328,51.56488672892253,51.89885584513346,51.32633590698242,51.61895624796549,15316974.333333334,,0.00018504509623457825,0.00018506221919083803,0.27316174893402984,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-20,38.035064697265625,51.57442855834961,51.78435134887695,51.450382232666016,51.73664093017578,12643177.0,US FDA Accepts For Review A Biologics License Application For Merck And Sanofi Pasteur's Investigational Pediatric Hexavalent Vaccine,0.019981468834853917,0.0001850279775025983,0.20504406088504826,"[{'label': 'positive', 'score': 0.5132902264595032}, {'label': 'neutral', 'score': 0.4855547547340393}, {'label': 'negative', 'score': 0.0011549696791917086}]","(0.4855547547340393, 0.5132902264595032, 0.0011549696791917086)",0.9955098436612465,0.5132902264595032,0,0,"[{'label': 'neutral', 'score': 0.7161610126495361}, {'label': 'positive', 'score': 0.25518348813056946}, {'label': 'negative', 'score': 0.028655489906668663}]","(0.7161610126495361, 0.25518348813056946, 0.028655489906668663)",0.7980862945264042,0.25518348813056946,0,1,"[{'label': 'neutral', 'score': 0.5849421620368958}, {'label': 'positive', 'score': 0.4145295321941376}, {'label': 'negative', 'score': 0.000528267992194742}]","(0.5849421620368958, 0.4145295321941376, 0.000528267992194742)",0.9974544846912522,0.4145295321941376,0,1
2014-10-21,38.79505157470703,52.60496139526367,52.74809265136719,51.832061767578125,52.07061004638672,18119815.0,#Premarket Technical Update - Merck Trading Higher,0.00689278339675455,0.019784459322176266,0.14107854229445574,"[{'label': 'neutral', 'score': 0.6003453135490417}, {'label': 'positive', 'score': 0.3983820378780365}, {'label': 'negative', 'score': 0.0012726441491395235}]","(0.6003453135490417, 0.3983820378780365, 0.0012726441491395235)",0.9936312811716141,0.3983820378780365,0,1,"[{'label': 'neutral', 'score': 0.9203007221221924}, {'label': 'positive', 'score': 0.04438283294439316}, {'label': 'negative', 'score': 0.035316430032253265}]","(0.9203007221221924, 0.04438283294439316, 0.035316430032253265)",0.11375767571146224,0.04438283294439316,1,1,"[{'label': 'neutral', 'score': 0.5917454361915588}, {'label': 'positive', 'score': 0.40644174814224243}, {'label': 'negative', 'score': 0.00181285641156137}]","(0.5917454361915588, 0.40644174814224243, 0.00181285641156137)",0.9911189909858202,0.40644174814224243,0,1
2014-10-22,39.06245803833008,52.96755599975586,53.3015251159668,52.48091506958008,52.700382232666016,13520982.0,Drug ETFs Attractive Buys On Pullback,0.020176552940423233,0.006869136763836878,0.1353177360788645,"[{'label': 'positive', 'score': 0.9995099306106567}, {'label': 'negative', 'score': 0.00038176163798198104}, {'label': 'neutral', 'score': 0.0001083590614143759}]","(0.0001083590614143759, 0.9995099306106567, 0.00038176163798198104)",0.9992363940195894,0.9995099306106567,0,0,"[{'label': 'positive', 'score': 0.917148232460022}, {'label': 'neutral', 'score': 0.06183987855911255}, {'label': 'negative', 'score': 0.021011892706155777}]","(0.06183987855911255, 0.917148232460022, 0.021011892706155777)",0.9552061697304948,0.917148232460022,0,0,"[{'label': 'positive', 'score': 0.9962584972381592}, {'label': 'neutral', 'score': 0.003400123678147793}, {'label': 'negative', 'score': 0.00034145370591431856}]","(0.003400123678147793, 0.9962584972381592, 0.00034145370591431856)",0.9993147627478993,0.9962584972381592,0,0
2014-10-23,39.85060501098633,54.036258697509766,54.45610809326172,53.61641311645508,53.683204650878906,12419953.0,Fast Money Picks For October 23,0.017305339724640833,0.019975703435702506,0.1579331154591882,"[{'label': 'neutral', 'score': 0.9998687505722046}, {'label': 'negative', 'score': 7.701668073423207e-05}, {'label': 'positive', 'score': 5.422863250714727e-05}]","(0.9998687505722046, 5.422863250714727e-05, 7.701668073423207e-05)",-0.17362942465742945,-7.701668073423207e-05,1,1,"[{'label': 'neutral', 'score': 0.9078013300895691}, {'label': 'negative', 'score': 0.0687394067645073}, {'label': 'positive', 'score': 0.023459257557988167}]","(0.9078013300895691, 0.023459257557988167, 0.0687394067645073)",-0.49111502362048065,-0.0687394067645073,1,1,"[{'label': 'neutral', 'score': 0.9995304346084595}, {'label': 'positive', 'score': 0.0003524145868141204}, {'label': 'negative', 'score': 0.0001170871764770709}]","(0.9995304346084595, 0.0003524145868141204, 0.0001170871764770709)",0.5012279585222692,0.0003524145868141204,0,1
2014-10-24,40.54024887084961,54.97137451171875,55.01908493041992,54.036258697509766,54.1984748840332,8966059.0,Fast Money Halftime Report Final Trade From October 24,-0.006711788658055815,0.0171573077221433,0.14055261370365302,"[{'label': 'neutral', 'score': 0.9998788833618164}, {'label': 'negative', 'score': 7.194442150648683e-05}, {'label': 'positive', 'score': 4.9128273531096056e-05}]","(0.9998788833618164, 4.9128273531096056e-05, 7.194442150648683e-05)",-0.18844998840001276,-7.194442150648683e-05,1,1,"[{'label': 'neutral', 'score': 0.8634583353996277}, {'label': 'negative', 'score': 0.1181936040520668}, {'label': 'positive', 'score': 0.01834813877940178}]","(0.8634583353996277, 0.01834813877940178, 0.1181936040520668)",-0.7312449892770359,-0.1181936040520668,0,1,"[{'label': 'neutral', 'score': 0.9995571970939636}, {'label': 'positive', 'score': 0.00025062233908101916}, {'label': 'negative', 'score': 0.00019220021204091609}]","(0.9995571970939636, 0.00025062233908101916, 0.00019220021204091609)",0.13193123722377004,0.00025062233908101916,1,1
2014-10-25,40.26814524332682,54.60241826375326,54.88549677530924,53.81043243408203,54.23346201578776,11014375.0,,-0.006757141161464343,-0.00673441400608123,0.18210309179061354,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-26,39.99604161580404,54.23346201578776,54.75190862019857,53.5846061706543,54.26844914754232,13062691.0,"Earnings Expectations For The Week Of October 27: Facebook, Exxon, Pfizer And Much More",-0.006803110741078756,-0.006780074005159216,0.20173889435078338,"[{'label': 'neutral', 'score': 0.9998248219490051}, {'label': 'positive', 'score': 0.00010036594176199287}, {'label': 'negative', 'score': 7.487770199077204e-05}]","(0.9998248219490051, 0.00010036594176199287, 7.487770199077204e-05)",0.1454445891753988,0.00010036594176199287,1,1,"[{'label': 'neutral', 'score': 0.9087266325950623}, {'label': 'negative', 'score': 0.05139266327023506}, {'label': 'positive', 'score': 0.03988070785999298}]","(0.9087266325950623, 0.03988070785999298, 0.05139266327023506)",-0.12612611178584524,-0.05139266327023506,1,1,"[{'label': 'neutral', 'score': 0.9988511800765991}, {'label': 'positive', 'score': 0.0010063961381092668}, {'label': 'negative', 'score': 0.00014240213204175234}]","(0.9988511800765991, 0.0010063961381092668, 0.00014240213204175234)",0.7520850514111022,0.0010063961381092668,0,1
2014-10-27,39.72393798828125,53.864505767822266,54.61832046508789,53.35877990722656,54.30343627929688,15111007.0,"Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook | Merck Conference Call Highlights | Mid-Afternoon Market Update: NQ Mobile Climbs On SEC Filing; Huntsman Shares Slide | #Premarket Prep Technical Update - Merck Trading Lower | Mid-Day Market Update: Micron Gains On Buyback Announcement; Sarepta Shares Dip | Mid-Morning Market Update: Markets Down; Merck Posts Upbeat Earnings | #PreMarket Primer: Monday, October 27: ECB Stress Tests In-Line With Expectations | US Stock Futures Down Ahead Of Economic Data | UPDATE: Merck Q3 Earnings Top Street View | Merck & Company, Inc. Narrows FY2014 EPS Guidance from $3.43-3.53 to $3.46-3.50 vs $3.47 Est | Merck & Company, Inc. Reports Q3 EPS of $0.31 vs $0.88 Est; Revenue of $10.60B vs $10.68B Est | Merck Receives FDA Breakthrough Therapy Designation for KEYTRUDA in Advanced NSCLC | Earnings Scheduled For October 27, 2014 | Keep an Eye on These 7 Stocks for October 27, 2014",-0.01062891419044285,-0.006826357391973924,0.2209534566834828,"[{'label': 'negative', 'score': 0.9977672100067139}, {'label': 'neutral', 'score': 0.0012938969302922487}, {'label': 'positive', 'score': 0.0009389960905537009}]","(0.0012938969302922487, 0.0009389960905537009, 0.9977672100067139)",-0.9981195749364108,-0.9977672100067139,0,0,"[{'label': 'negative', 'score': 0.9351845383644104}, {'label': 'positive', 'score': 0.033204928040504456}, {'label': 'neutral', 'score': 0.031610552221536636}]","(0.031610552221536636, 0.033204928040504456, 0.9351845383644104)",-0.9314223683911481,-0.9351845383644104,0,0,"[{'label': 'negative', 'score': 0.944800853729248}, {'label': 'neutral', 'score': 0.04885192587971687}, {'label': 'positive', 'score': 0.006347221788018942}]","(0.04885192587971687, 0.006347221788018942, 0.944800853729248)",-0.9866535569983315,-0.944800853729248,0,0
2014-10-28,39.30172348022461,53.29198455810547,54.00763320922852,51.62213516235352,54.00763320922852,25111338.0,"#PreMarket Primer: Tuesday, October 28: CDC Warns That Involuntary Quarantines Could Discourage Progress On Ebola | Fast Money Traders Discuss Merck, Garmin And Sarepta Therapeutics",0.0062667794975209325,-0.010685804580023417,0.17889816549999993,"[{'label': 'negative', 'score': 0.9857087135314941}, {'label': 'neutral', 'score': 0.01285100169479847}, {'label': 'positive', 'score': 0.0014402318047359586}]","(0.01285100169479847, 0.0014402318047359586, 0.9857087135314941)",-0.9970820374948678,-0.9857087135314941,0,0,"[{'label': 'negative', 'score': 0.9383841156959534}, {'label': 'neutral', 'score': 0.050419557839632034}, {'label': 'positive', 'score': 0.011196262203156948}]","(0.050419557839632034, 0.011196262203156948, 0.9383841156959534)",-0.9764185055552054,-0.9383841156959534,0,0,"[{'label': 'negative', 'score': 0.9803187251091003}, {'label': 'neutral', 'score': 0.018331285566091537}, {'label': 'positive', 'score': 0.001349952770397067}]","(0.018331285566091537, 0.001349952770397067, 0.9803187251091003)",-0.9972496774098709,-0.9803187251091003,0,0
2014-10-29,39.54801559448242,53.625953674316406,54.01717758178711,53.082061767578125,53.45419692993164,13092559.0,,0.019750924082863365,0.0062472248886445494,0.10297991207987697,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-10-30,40.3291244506836,54.68511581420898,54.761451721191406,53.14885330200195,53.15839767456055,13484197.0,,0.010992806257248373,0.01955840540081598,0.198884199035434,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-10-31,40.77245330810547,55.286258697509766,55.46755599975586,55.01908493041992,55.29580307006836,14741273.0,,0.005638024325509883,0.010932824540465768,0.19889770141041735,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-01,41.00233459472656,55.59796396891276,55.7220090230306,54.990458170572914,55.29580307006836,13383344.333333334,,0.005606415220120066,0.005622190154112578,0.17501996458375735,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-02,41.232215881347656,55.90966924031576,55.976462046305336,54.96183141072592,55.29580307006836,12025415.666666668,,0.005575158566279367,0.005590757768500077,0.09527478466645904,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-03,41.46209716796875,56.22137451171875,56.23091506958008,54.933204650878906,55.29580307006836,10667487.0,Merck Reports Data from 48-Week Phase 2B Study of Investigational HIV Therapy Doravirine in Treatment-Naive Patients; Phase 3 Clinical Trial Enrollment Scheduled to Begin by End of 2014,0.007637485873344833,0.005559674892393163,0.09690574384156445,"[{'label': 'neutral', 'score': 0.9998832941055298}, {'label': 'negative', 'score': 6.049434523447417e-05}, {'label': 'positive', 'score': 5.614455585600808e-05}]","(0.9998832941055298, 5.614455585600808e-05, 6.049434523447417e-05)",-0.037292784292367,-6.049434523447417e-05,1,1,"[{'label': 'neutral', 'score': 0.7519781589508057}, {'label': 'positive', 'score': 0.23440930247306824}, {'label': 'negative', 'score': 0.01361255906522274}]","(0.7519781589508057, 0.23440930247306824, 0.01361255906522274)",0.8902309741504689,0.23440930247306824,0,1,"[{'label': 'neutral', 'score': 0.9994988441467285}, {'label': 'positive', 'score': 0.0003468823852017522}, {'label': 'negative', 'score': 0.0001542607060400769}]","(0.9994988441467285, 0.0003468823852017522, 0.0001542607060400769)",0.38436463063744947,0.0003468823852017522,1,1
2014-11-04,41.77875518798828,56.65076446533203,56.975189208984375,56.17366409301758,56.17366409301758,11882643.0,,0.003368672283746619,0.007608467933858942,0.037039426235431015,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-05,41.91948318481445,56.84160232543945,57.49045944213867,56.66030502319336,57.24236679077149,13287382.0,Merck Animal Health Provides Update on Zilmax Five-Step Plan; Announces Next Steps ,-0.005203921833123779,0.0033630110176731095,0.023847677646008064,"[{'label': 'neutral', 'score': 0.9997908473014832}, {'label': 'positive', 'score': 0.0001563674013596028}, {'label': 'negative', 'score': 5.280846016830765e-05}]","(0.9997908473014832, 0.0001563674013596028, 5.280846016830765e-05)",0.49508074418747994,0.0001563674013596028,0,0,"[{'label': 'neutral', 'score': 0.9204298257827759}, {'label': 'positive', 'score': 0.06214308738708496}, {'label': 'negative', 'score': 0.017427071928977966}]","(0.9204298257827759, 0.06214308738708496, 0.017427071928977966)",0.5619696610193932,0.06214308738708496,0,0,"[{'label': 'neutral', 'score': 0.9986961483955383}, {'label': 'positive', 'score': 0.001175196492113173}, {'label': 'negative', 'score': 0.00012865183816757053}]","(0.9986961483955383, 0.001175196492113173, 0.00012865183816757053)",0.8026582767646459,0.001175196492113173,0,0
2014-11-06,41.70134353637695,56.54580307006836,57.15649032592773,56.47900772094727,56.8702278137207,14003481.0,"US Stock Futures Edge Lower Ahead Of Earnings, Jobless Claims  | BIND Therapeutics Announces Joint Research Agreement with Merck ",0.0013499161412665224,-0.005217509393915195,0.07994033429393103,"[{'label': 'negative', 'score': 0.9975173473358154}, {'label': 'neutral', 'score': 0.0012454584939405322}, {'label': 'positive', 'score': 0.001237118267454207}]","(0.0012454584939405322, 0.001237118267454207, 0.9975173473358154)",-0.9975226778751733,-0.9975173473358154,0,0,"[{'label': 'negative', 'score': 0.9474753141403198}, {'label': 'neutral', 'score': 0.0343400277197361}, {'label': 'positive', 'score': 0.01818467117846012}]","(0.0343400277197361, 0.01818467117846012, 0.9474753141403198)",-0.9623373206823785,-0.9474753141403198,0,0,"[{'label': 'negative', 'score': 0.9973533153533936}, {'label': 'neutral', 'score': 0.001858091214671731}, {'label': 'positive', 'score': 0.0007886159000918269}]","(0.001858091214671731, 0.0007886159000918269, 0.9973533153533936)",-0.9984198321393001,-0.9973533153533936,0,0
2014-11-07,41.75764846801758,56.62213516235352,56.88931274414063,56.35496139526367,56.66984558105469,11122424.0,,-0.002977175177448343,0.0013490058236151259,0.07820603766624509,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-08,41.63332494099935,56.45356114705404,56.75254440307617,55.92239125569662,56.30406951904297,12514692.0,,-0.0029860652166895877,-0.0029816157792901133,0.08084075014161274,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-09,41.50900141398112,56.28498713175456,56.61577606201172,55.48982111612956,55.93829345703125,13906960.0,,-0.002995008507417402,-0.002990532404521256,0.05600879519533597,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-10,41.38467788696289,56.11641311645508,56.47900772094727,55.0572509765625,55.57251739501953,15299228.0,Merck Shares May Have Hit A Ceiling For The Most Recent Upside Move | Merck Has Said Taking No Impairment Charge Following Results of Cholesterol-Drug Study | RBC Sees Weak Merck Data As Positive For Gilead | Interim Data from C-SWIFT Study of Merck's Investigational Hepatitis C Treatment Grazoprevir/Elbasvir in Combination with a Nucleotide Inhibitor Presented at The Liver Meeting,0.009522193582972691,-0.002999502520712312,0.03798176358693812,"[{'label': 'negative', 'score': 0.990338146686554}, {'label': 'positive', 'score': 0.00838712602853775}, {'label': 'neutral', 'score': 0.0012746223947033286}]","(0.0012746223947033286, 0.00838712602853775, 0.990338146686554)",-0.9832043380543743,-0.990338146686554,0,0,"[{'label': 'negative', 'score': 0.6646637916564941}, {'label': 'positive', 'score': 0.3065299987792969}, {'label': 'neutral', 'score': 0.02880619466304779}]","(0.02880619466304779, 0.3065299987792969, 0.6646637916564941)",-0.36875626306928566,-0.6646637916564941,0,0,"[{'label': 'positive', 'score': 0.9935303330421448}, {'label': 'neutral', 'score': 0.005394312087446451}, {'label': 'negative', 'score': 0.0010754037648439407}]","(0.005394312087446451, 0.9935303330421448, 0.0010754037648439407)",0.9978375275246324,0.9935303330421448,1,1
2014-11-11,41.77875518798828,56.65076446533203,57.20419692993164,56.49809265136719,56.98473358154297,13942173.0,"Merck Announces Results From Phase 2 Study Of Investigational Chronic Hepatitis C Treatment Grazoprevir/Elbasvir In Genotype 1 Infected Treatment-Nave And Difficult-To-Cure Patients | Merck Offers Results of Phase 2 Study of Investigational Chronic Hep C Treatment Grazoprevir/Elbasvir; First Wave of Phase 3 Enrolled, Co. Will Submit NDA App in 2015",-0.0010106622884992705,0.009477143257150801,0.08613970801659741,"[{'label': 'neutral', 'score': 0.9992861151695251}, {'label': 'positive', 'score': 0.0006119122263044119}, {'label': 'negative', 'score': 0.00010193586058449}]","(0.9992861151695251, 0.0006119122263044119, 0.00010193586058449)",0.7144046122509128,0.0006119122263044119,0,1,"[{'label': 'neutral', 'score': 0.8818737268447876}, {'label': 'positive', 'score': 0.09904281049966812}, {'label': 'negative', 'score': 0.019083457067608833}]","(0.8818737268447876, 0.09904281049966812, 0.019083457067608833)",0.6768973157178584,0.09904281049966812,0,1,"[{'label': 'neutral', 'score': 0.9982933402061462}, {'label': 'positive', 'score': 0.0012356237275525928}, {'label': 'negative', 'score': 0.00047107625869102776}]","(0.9982933402061462, 0.0012356237275525928, 0.00047107625869102776)",0.4479682867662663,0.0012356237275525928,1,1
2014-11-12,41.73653030395508,56.593509674072266,56.82251739501953,56.39313125610352,56.564884185791016,6988902.0,,0.0038779564008288416,-0.0010111733520006727,0.08608093886804478,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-13,41.89838409423828,56.8129768371582,57.20419692993164,56.46946716308594,56.774810791015625,6965951.0,,-0.007893813954184804,0.0038704565111492718,0.08537774329671033,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-14,41.5676383972168,56.364505767822266,56.82251739501953,56.078243255615234,56.51717758178711,7472869.0,,0.0022007654006371475,-0.007925135040997145,0.10566548132860822,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-15,41.65912119547526,56.4885508219401,56.933841705322266,56.24999872843424,56.6698481241862,7976153.333333333,,0.0021959326679994117,0.002198347263647665,0.10187000246610581,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-16,41.750603993733726,56.612595876057945,57.045166015625,56.42175420125326,56.82251866658529,8479437.666666666,Merck Announces Positive Study Investigating Use of KEYTRUDA Compared to Chemotherapy in Patients with Ipilimumab-Refractory Advanced Melanoma,0.002191121113566462,0.0021935251317390532,0.07461191967810293,"[{'label': 'positive', 'score': 0.9970695972442627}, {'label': 'neutral', 'score': 0.0026952270418405533}, {'label': 'negative', 'score': 0.0002351118891965598}]","(0.0026952270418405533, 0.9970695972442627, 0.0002351118891965598)",0.9995285054065355,0.9970695972442627,0,0,"[{'label': 'positive', 'score': 0.9043166041374207}, {'label': 'neutral', 'score': 0.08127669990062714}, {'label': 'negative', 'score': 0.014406656846404076}]","(0.08127669990062714, 0.9043166041374207, 0.014406656846404076)",0.9686376573703456,0.9043166041374207,0,0,"[{'label': 'positive', 'score': 0.9942032694816589}, {'label': 'neutral', 'score': 0.005508629605174065}, {'label': 'negative', 'score': 0.0002880775718949735}]","(0.005508629605174065, 0.9942032694816589, 0.0002880775718949735)",0.9994206534370591,0.9942032694816589,0,0
2014-11-17,41.84208679199219,56.73664093017578,57.15649032592773,56.593509674072266,56.975189208984375,8982722.0,"Merck Announces Its Vytorin Reduces Heart Disease Risk By 6.4% Over Statin Alone | Merck Announces That IMPROVE-IT Achieved Primary Endpoint; Data To Be Presented At American Heart Association Scientific Sessions Today | Pfizer Will Study Merck's PDL-1 in Combo with Pfizer Assets; to Start 20 Clinical Dev Programs with Merck, Six Registration Programs",0.007231746830030182,0.0021887241084797846,0.075694500569556,"[{'label': 'positive', 'score': 0.9990390539169312}, {'label': 'neutral', 'score': 0.0007128164288587868}, {'label': 'negative', 'score': 0.0002481432748027146}]","(0.0007128164288587868, 0.9990390539169312, 0.0002481432748027146)",0.9995033594436112,0.9990390539169312,0,0,"[{'label': 'positive', 'score': 0.7793375253677368}, {'label': 'neutral', 'score': 0.21286797523498535}, {'label': 'negative', 'score': 0.007794615812599659}]","(0.21286797523498535, 0.7793375253677368, 0.007794615812599659)",0.9801948989126239,0.7793375253677368,0,0,"[{'label': 'positive', 'score': 0.9977778792381287}, {'label': 'neutral', 'score': 0.002004996407777071}, {'label': 'negative', 'score': 0.0002171028609154746}]","(0.002004996407777071, 0.9977778792381287, 0.0002171028609154746)",0.9995649219388681,0.9977778792381287,0,0
2014-11-18,42.14466094970703,57.14694595336914,57.375953674316406,56.44084167480469,56.76526641845703,8030824.0,,-0.004174296190792851,0.0072057231381041295,0.08777551811306149,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-19,41.96875762939453,56.90839767456055,56.9942741394043,56.421756744384766,56.89885330200195,7655011.0,,-0.004359508640287917,-0.004183032886650995,0.06419387931130993,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-20,41.78580093383789,56.66030502319336,56.67938995361328,56.16412353515625,56.49809265136719,7064673.0,"Hearing Newlink, Merck Working on Producing Ebola Vaccine",0.004715427876319105,-0.004369039006642683,0.07787713833553678,"[{'label': 'neutral', 'score': 0.9998225569725037}, {'label': 'positive', 'score': 9.855220559984446e-05}, {'label': 'negative', 'score': 7.895425369497389e-05}]","(0.9998225569725037, 9.855220559984446e-05, 7.895425369497389e-05)",0.11040697889376841,9.855220559984446e-05,1,1,"[{'label': 'neutral', 'score': 0.8859829306602478}, {'label': 'positive', 'score': 0.10070319473743439}, {'label': 'negative', 'score': 0.01331387273967266}]","(0.8859829306602478, 0.10070319473743439, 0.01331387273967266)",0.7664582499046313,0.10070319473743439,0,1,"[{'label': 'neutral', 'score': 0.9983207583427429}, {'label': 'positive', 'score': 0.0015889756614342332}, {'label': 'negative', 'score': 9.016769763547927e-05}]","(0.9983207583427429, 0.0015889756614342332, 9.016769763547927e-05)",0.8926027403813401,0.0015889756614342332,0,1
2014-11-21,41.982818603515625,56.92748260498047,57.270992279052734,56.61259460449219,57.19465637207031,11800899.0,EMA Recommends Merck's Blood Clot Preventer Vorapaxar,-0.0022907735102533685,0.004704345072741799,0.08297254106577075,"[{'label': 'neutral', 'score': 0.9997614026069641}, {'label': 'positive', 'score': 0.00015387388702947646}, {'label': 'negative', 'score': 8.475159120280296e-05}]","(0.9997614026069641, 0.00015387388702947646, 8.475159120280296e-05)",0.28966854813126647,0.00015387388702947646,1,1,"[{'label': 'neutral', 'score': 0.8292373418807983}, {'label': 'positive', 'score': 0.14592857658863068}, {'label': 'negative', 'score': 0.024834107607603073}]","(0.8292373418807983, 0.14592857658863068, 0.024834107607603073)",0.7091389406942714,0.14592857658863068,0,1,"[{'label': 'neutral', 'score': 0.8269456028938293}, {'label': 'positive', 'score': 0.17208269238471985}, {'label': 'negative', 'score': 0.0009717041975818574}]","(0.8269456028938293, 0.17208269238471985, 0.0009717041975818574)",0.9887699565365307,0.17208269238471985,0,1
2014-11-22,41.886643727620445,56.79707463582357,57.2041982014974,56.50445302327474,57.153307596842446,10832407.333333334,,-0.002296033202292091,-0.0022934013458422078,0.08536611317398222,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-23,41.79046885172526,56.66666666666666,57.137404123942055,56.39631144205729,57.111958821614586,9863915.666666666,,-0.0023013171027686753,-0.0022986731282042664,0.05887209896180841,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-24,41.69429397583008,56.536258697509766,57.07061004638672,56.28816986083984,57.07061004638672,8895424.0,"#Premarket Prep Technical Update - Merck Trading Lower | Merck Reports Submission to Japanese Pharma, Medical Devices Agency for Omarigliptin | Merck, NewLink Genetics Announce Licensing and Collaboration Agreement for Investigational Ebola Vaccine | Merck, NewLink Genetics Report Entering of Licensing, Collaboration Deal for Investigational Ebola Vaccine",0.0015189626413595649,-0.0023039692026355844,0.05525524372308091,"[{'label': 'positive', 'score': 0.9830117225646973}, {'label': 'neutral', 'score': 0.012617317028343678}, {'label': 'negative', 'score': 0.004370988346636295}]","(0.012617317028343678, 0.9830117225646973, 0.004370988346636295)",0.991146313788294,0.9830117225646973,0,0,"[{'label': 'negative', 'score': 0.8455340266227722}, {'label': 'neutral', 'score': 0.1027669832110405}, {'label': 'positive', 'score': 0.05169897526502609}]","(0.1027669832110405, 0.05169897526502609, 0.8455340266227722)",-0.8847590867561709,-0.8455340266227722,0,0,"[{'label': 'negative', 'score': 0.6704338192939758}, {'label': 'neutral', 'score': 0.3097512125968933}, {'label': 'positive', 'score': 0.019814981147646904}]","(0.3097512125968933, 0.019814981147646904, 0.6704338192939758)",-0.9425859744052602,-0.6704338192939758,0,0
2014-11-25,41.75764846801758,56.62213516235352,56.92748260498047,56.421756744384766,56.60305404663086,10824373.0,Merck Announces Increased Quarterly Dividend From $0.44 To $0.45/share,0.006909381045927245,0.0015178101844850775,0.05032221946284534,"[{'label': 'positive', 'score': 0.9995822310447693}, {'label': 'neutral', 'score': 0.00023795480956323445}, {'label': 'negative', 'score': 0.00017979338008444756}]","(0.00023795480956323445, 0.9995822310447693, 0.00017979338008444756)",0.9996403276465959,0.9995822310447693,0,0,"[{'label': 'positive', 'score': 0.9447877407073975}, {'label': 'negative', 'score': 0.032068412750959396}, {'label': 'neutral', 'score': 0.023143844678997993}]","(0.023143844678997993, 0.9447877407073975, 0.032068412750959396)",0.9343436336303399,0.9447877407073975,0,0,"[{'label': 'positive', 'score': 0.9989349246025085}, {'label': 'neutral', 'score': 0.0007835792494006455}, {'label': 'negative', 'score': 0.00028154454776085913}]","(0.0007835792494006455, 0.9989349246025085, 0.00028154454776085913)",0.9994364693608377,0.9989349246025085,0,0
2014-11-26,42.04616165161133,57.01335906982422,57.03244400024414,56.63167953491211,56.96564865112305,6582069.0,,0.0054393200456853506,0.006885620656312784,0.06404775651959013,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-27,42.27485656738281,57.32347297668457,57.55725288391113,56.79866409301758,56.96564865112305,6543712.0,,0.005409893901342746,0.005424580369459227,0.06768215054148044,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-28,42.5035514831543,57.63358688354492,58.082061767578125,56.96564865112305,56.96564865112305,6505355.0,,0.0006622629500955764,0.0053953129891499115,0.059559216450372134,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-29,42.53170267740885,57.67175547281901,58.22519175211588,57.15012741088867,57.18829472859701,7227322.333333333,,0.0006618246481517687,0.0006620437507611626,0.04318604667128019,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-11-30,42.55985387166341,57.7099240620931,58.36832173665365,57.3346061706543,57.41094080607096,7949289.666666666,,0.0006613869259820652,0.0006616057388004148,0.046554181649279346,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-01,42.58800506591797,57.74809265136719,58.511451721191406,57.51908493041992,57.63358688354492,8671257.0,"8-K from Gilead Sciences Shows UK Court Invalidated Idenix 489 Patent, Trials Will Be Held on Merck's Idenix Patents in Canada in Jan.",0.004296052480341935,0.0006611683060388396,0.04128632387780669,"[{'label': 'neutral', 'score': 0.6277304291725159}, {'label': 'negative', 'score': 0.36656704545021057}, {'label': 'positive', 'score': 0.005702505353838205}]","(0.6277304291725159, 0.005702505353838205, 0.36656704545021057)",-0.9693635681912657,-0.36656704545021057,0,1,"[{'label': 'negative', 'score': 0.7312626838684082}, {'label': 'neutral', 'score': 0.24428339302539825}, {'label': 'positive', 'score': 0.024453923106193542}]","(0.24428339302539825, 0.024453923106193542, 0.7312626838684082)",-0.9352828219454085,-0.7312626838684082,0,0,"[{'label': 'negative', 'score': 0.984495222568512}, {'label': 'neutral', 'score': 0.014062033034861088}, {'label': 'positive', 'score': 0.0014427677961066365}]","(0.014062033034861088, 0.0014427677961066365, 0.984495222568512)",-0.9970733092543212,-0.984495222568512,0,0
2014-12-02,42.770973205566406,57.99618148803711,58.1870231628418,57.51908493041992,57.85305404663086,6755408.0,"No Serious Side Effects Reported in Early Test of Experimental Ebola Vaccine Being Develped by Merck, NewLink -Reuters",-0.0032905245692216143,0.004286850791430707,0.03686849560560856,"[{'label': 'neutral', 'score': 0.999657154083252}, {'label': 'negative', 'score': 0.00026262435130774975}, {'label': 'positive', 'score': 8.025104034459218e-05}]","(0.999657154083252, 8.025104034459218e-05, 0.00026262435130774975)",-0.5318938465787442,-0.00026262435130774975,0,1,"[{'label': 'neutral', 'score': 0.9060492515563965}, {'label': 'positive', 'score': 0.05677109584212303}, {'label': 'negative', 'score': 0.03717963024973869}]","(0.9060492515563965, 0.05677109584212303, 0.03717963024973869)",0.20852915573242606,0.05677109584212303,1,1,"[{'label': 'neutral', 'score': 0.9900068044662476}, {'label': 'positive', 'score': 0.005180849693715572}, {'label': 'negative', 'score': 0.004812265746295452}]","(0.9900068044662476, 0.005180849693715572, 0.004812265746295452)",0.03688378760685202,0.005180849693715572,1,1
2014-12-03,42.63024139404297,57.80534362792969,58.13931274414063,57.54771041870117,57.97710037231445,10197564.0,,0.00561243196542224,-0.0032959502506868543,0.04258287946286873,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-04,42.86948013305664,58.1297721862793,58.56870269775391,57.738548278808594,57.738548278808594,7456101.0,"Markets Marginally Lower Ahead Of Friday's Jobs Report | Jefferies Maintains Hold on Merck & Company, Inc., Raises PT to $65.00",0.009356511926373233,0.005596740951593895,0.05551756955800535,"[{'label': 'negative', 'score': 0.9981379508972168}, {'label': 'positive', 'score': 0.0011153466766700149}, {'label': 'neutral', 'score': 0.0007466572569683194}]","(0.0007466572569683194, 0.0011153466766700149, 0.9981379508972168)",-0.9977676397378362,-0.9981379508972168,0,0,"[{'label': 'negative', 'score': 0.7102776765823364}, {'label': 'positive', 'score': 0.25864022970199585}, {'label': 'neutral', 'score': 0.031082170084118843}]","(0.031082170084118843, 0.25864022970199585, 0.7102776765823364)",-0.46612560667013414,-0.7102776765823364,0,0,"[{'label': 'negative', 'score': 0.500523030757904}, {'label': 'positive', 'score': 0.3950211703777313}, {'label': 'neutral', 'score': 0.10445578396320343}]","(0.10445578396320343, 0.3950211703777313, 0.500523030757904)",-0.11780754120945267,-0.500523030757904,0,0
2014-12-05,43.27059555053711,58.67366409301758,58.94084167480469,58.03435134887695,58.23473358154297,11708046.0,,0.002114173839338522,0.00931301090336511,0.07649240854463477,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-06,43.36207326253256,58.79771041870117,59.07761001586914,58.0852419535319,58.27926254272461,11785912.666666666,"Merck Announces Anti-PD-1 Therapy, KEYTRUDA, Achieves Overall Response Rate of 66% in Classical Hodgkin Lymphoma Study | Merck in Talks to Acquire Cubist for ~$100/Share | Merck in Talks to Acquire Cubist Pharmaceuticals for More Than $7B; Could be Announced as Early as Next Week -NYT Dealbook",0.00210971353816763,0.0021119421187702323,0.07397658902661888,"[{'label': 'positive', 'score': 0.997137188911438}, {'label': 'neutral', 'score': 0.002597627928480506}, {'label': 'negative', 'score': 0.0002652287657838315}]","(0.002597627928480506, 0.997137188911438, 0.0002652287657838315)",0.9994681609727767,0.997137188911438,0,0,"[{'label': 'positive', 'score': 0.8890740871429443}, {'label': 'neutral', 'score': 0.10116726160049438}, {'label': 'negative', 'score': 0.00975862331688404}]","(0.10116726160049438, 0.8890740871429443, 0.00975862331688404)",0.9782860076111567,0.8890740871429443,0,0,"[{'label': 'positive', 'score': 0.9983165264129639}, {'label': 'neutral', 'score': 0.0014412524178624153}, {'label': 'negative', 'score': 0.0002422308170935139}]","(0.0014412524178624153, 0.9983165264129639, 0.0002422308170935139)",0.9995148391312186,0.9983165264129639,0,0
2014-12-07,43.45355097452799,58.921756744384766,59.2143783569336,58.13613255818685,58.32379150390625,11863779.333333334,Benzinga's Weekend M&A Chatter,0.002105272017291225,0.0021074912176519012,0.07432360939161077,"[{'label': 'neutral', 'score': 0.9998791217803955}, {'label': 'negative', 'score': 6.837661931058392e-05}, {'label': 'positive', 'score': 5.242797124083154e-05}]","(0.9998791217803955, 5.242797124083154e-05, 6.837661931058392e-05)",-0.13202021543183412,-6.837661931058392e-05,1,1,"[{'label': 'neutral', 'score': 0.9388073682785034}, {'label': 'positive', 'score': 0.03901052847504616}, {'label': 'negative', 'score': 0.02218214049935341}]","(0.9388073682785034, 0.03901052847504616, 0.02218214049935341)",0.27500660222441087,0.03901052847504616,1,1,"[{'label': 'neutral', 'score': 0.9995823502540588}, {'label': 'positive', 'score': 0.0002571183431427926}, {'label': 'negative', 'score': 0.000160545707331039}]","(0.9995823502540588, 0.0002571183431427926, 0.000160545707331039)",0.23122084771766646,0.0002571183431427926,1,1
2014-12-08,43.54502868652344,59.04580307006836,59.35114669799805,58.1870231628418,58.36832046508789,11941646.0,"Benzinga's M&A Chatter for Monday December 8, 2014 | 3 Biotech ETFs Rally On Merger News | Cubist Shares Fall Almost 5% After-Hours | Mid-Afternoon Market Update: Dow Slides Over 100 Points; Oil Futures Down 4% | Fitch Says Cubist Acquisition Will Strengthen Merck's Growth Opportunities, Particularly in Non-U.S./European Markets | Mid-Day Market Update: McDonald's Drops On Weak November Sales; Acceleron Pharma Shares Jump | Merck's CEO Doesn't Think That Valuations In The Biotech Industry Are 'Rich' | Mid-Morning Market Update: Markets Mixed; Merck To Buy Cubist Pharmaceuticals For $102/Share | Benzinga's Volume Movers | Stocks Hitting 52-Week Highs | Morning Market Movers | Pharmaceutical Stocks In Play Following Merck/Cubist Deal | Benzinga's Top #PreMarket Gainers | Advaxis Announces FDA Acceptance of Investigational NDA to Begin Clinical Trials of ADXS-PSA in Combo with Merck's KEYTRUDA(R) | Merck to Acquire Cubist Pharmaceuticals for $102/Share in Cash | UPDATE: Merck Says Cubist Deal Includes $1.1B In Net Debt | US Stock Futures Point To Lower Open Monday | Merck To Acquire Cubist Pharmaceuticals For $102 Per Share In Cash | Cubist Shares Bid 28% Higher Premarket on Rumor of Merck $100/Share Bid | Must Watch Stocks for December 8, 2014",-0.030219782882104296,0.0021030590375630018,0.05095860340410262,"[{'label': 'negative', 'score': 0.9977436065673828}, {'label': 'positive', 'score': 0.0014546435559168458}, {'label': 'neutral', 'score': 0.0008018310181796551}]","(0.0008018310181796551, 0.0014546435559168458, 0.9977436065673828)",-0.9970883784959844,-0.9977436065673828,1,1,"[{'label': 'negative', 'score': 0.9430757761001587}, {'label': 'neutral', 'score': 0.03379252925515175}, {'label': 'positive', 'score': 0.023131659254431725}]","(0.03379252925515175, 0.023131659254431725, 0.9430757761001587)",-0.9521186478016647,-0.9430757761001587,1,1,"[{'label': 'positive', 'score': 0.6321697235107422}, {'label': 'neutral', 'score': 0.345415860414505}, {'label': 'negative', 'score': 0.022414423525333405}]","(0.345415860414505, 0.6321697235107422, 0.022414423525333405)",0.9315155320310619,0.6321697235107422,0,0
2014-12-09,42.229122161865234,57.261451721191406,57.38549423217773,56.05915832519531,56.67938995361328,19679554.0,"Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO | Mizuho Securities Downgrades Cubist Pharmaceuticals Post Acquisition Announcement | #Premarket Prep Technical Update - Merck Lower | Hospira, Inc. Ticks Up On Favorable Patent Ruling vs. Cubist Pharmaceuticals Inc | Merck & Co. Under Pressure Following Patent Ruling | Cellceutix Corp Shares Rise On Two Catalysts | Merck Issues Statement Regarding CUBICIN Patent Litigation; Reaffirms Transaction To Proceed As Planned",-0.0004999751511350601,-0.030685813448729865,0.25054248852861066,"[{'label': 'negative', 'score': 0.9885712265968323}, {'label': 'positive', 'score': 0.010251183062791824}, {'label': 'neutral', 'score': 0.0011776199098676443}]","(0.0011776199098676443, 0.010251183062791824, 0.9885712265968323)",-0.9794734620215716,-0.9885712265968323,0,0,"[{'label': 'positive', 'score': 0.7979315519332886}, {'label': 'negative', 'score': 0.16954632103443146}, {'label': 'neutral', 'score': 0.03252209722995758}]","(0.03252209722995758, 0.7979315519332886, 0.16954632103443146)",0.6495086331755551,0.7979315519332886,0,0,"[{'label': 'negative', 'score': 0.5206118226051331}, {'label': 'neutral', 'score': 0.39112138748168945}, {'label': 'positive', 'score': 0.0882667675614357}]","(0.39112138748168945, 0.0882667675614357, 0.5206118226051331)",-0.7100677573921957,-0.5206118226051331,0,0
2014-12-10,42.20800018310547,57.23282241821289,57.74809265136719,56.96564865112305,57.36641311645508,13889878.0,"FDA Approves Gardasil 9 for Prevention of Certain Cancers Caused by 5 Additional Types of HPV | Data Investigating KEYTRUDA, Merck's Anti-PD-1 Therapy, In Patients With Advanced Triple-Negative Breast Cancer Presented At 2014 San Antonio Breast Cancer Symposium",-0.010670227852768487,-0.0005001001803870494,0.22888430863092624,"[{'label': 'positive', 'score': 0.5846823453903198}, {'label': 'neutral', 'score': 0.4143938720226288}, {'label': 'negative', 'score': 0.0009237686754204333}]","(0.4143938720226288, 0.5846823453903198, 0.0009237686754204333)",0.996845085277519,0.5846823453903198,0,0,"[{'label': 'positive', 'score': 0.8346461653709412}, {'label': 'neutral', 'score': 0.15465638041496277}, {'label': 'negative', 'score': 0.010697441175580025}]","(0.15465638041496277, 0.8346461653709412, 0.010697441175580025)",0.9746909041655091,0.8346461653709412,0,0,"[{'label': 'positive', 'score': 0.9462576508522034}, {'label': 'neutral', 'score': 0.05314159020781517}, {'label': 'negative', 'score': 0.0006008102791383862}]","(0.05314159020781517, 0.9462576508522034, 0.0006008102791383862)",0.9987309396202247,0.9462576508522034,0,0
2014-12-11,42.07330322265625,56.62213516235352,57.80534362792969,56.47900772094727,57.04198455810547,11857177.0,"Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines | These 4 Charts Highlight Twitter Sentiment For Today's Movers | Sky News Newsdesk Tweets: 'Reuters: Geneva University Hospital suspends trials of #Ebola vaccine one week early ""as a measure of precaution""' | Global Vaccines Alliance GAVI Said Thursday it was Committing up to $300M to Buy Ebola Vaccines -Reuters",-0.02730026430368277,-0.010727562951093504,0.22189020324308087,"[{'label': 'neutral', 'score': 0.9670937657356262}, {'label': 'positive', 'score': 0.031434886157512665}, {'label': 'negative', 'score': 0.001471452065743506}]","(0.9670937657356262, 0.031434886157512665, 0.001471452065743506)",0.910567255720749,0.031434886157512665,0,1,"[{'label': 'neutral', 'score': 0.7992298007011414}, {'label': 'negative', 'score': 0.10480426251888275}, {'label': 'positive', 'score': 0.09596597403287888}]","(0.7992298007011414, 0.09596597403287888, 0.10480426251888275)",-0.044021906024527845,-0.10480426251888275,1,1,"[{'label': 'neutral', 'score': 0.9094005227088928}, {'label': 'positive', 'score': 0.08290339261293411}, {'label': 'negative', 'score': 0.007696078158915043}]","(0.9094005227088928, 0.08290339261293411, 0.007696078158915043)",0.8301076575094885,0.08290339261293411,0,1
2014-12-12,40.9246826171875,55.07633590698242,56.91793823242188,55.06679534912109,56.421756744384766,12702179.0,,-0.004446759026622305,-0.02767984082846413,0.24029822345270957,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-13,40.74270502726237,54.831424713134766,56.41221364339193,54.7773551940918,56.0050900777181,12721322.666666666,,-0.004466621013934519,-0.004456675267216888,0.21683455021151196,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-14,40.56072743733724,54.58651351928711,55.90648905436198,54.4879150390625,55.58842341105143,12740466.333333334,,-0.004486661229263553,-0.004476626169516909,0.17091064234038378,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-15,40.37874984741211,54.34160232543945,55.40076446533203,54.1984748840332,55.171756744384766,12759610.0,,-0.0026338465426376722,-0.004496756501116905,0.15952748280696225,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-16,40.27238464355469,54.1984748840332,55.6202278137207,54.17938995361328,54.360687255859375,11752272.0,,0.014612672400838835,-0.0026373212189598942,0.1684658831905558,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-17,40.86086654663086,54.99045944213867,55.15267181396485,53.96946716308594,54.4370231628418,13271662.0,,0.023425264295127323,0.014506936118617435,0.13211239498450372,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-12-18,41.81804275512695,56.27862548828125,56.27862548828125,55.42938995361328,55.90649032592773,14000651.0,"Merck Reports Acquisition of OncoEthix for $110M Upfront Payment, Could Pay Added $265M in Milestone Payment",0.010172977835715115,0.023155103712176026,0.20361679744753236,"[{'label': 'positive', 'score': 0.9819700717926025}, {'label': 'neutral', 'score': 0.017660195007920265}, {'label': 'negative', 'score': 0.0003697170177474618}]","(0.017660195007920265, 0.9819700717926025, 0.0003697170177474618)",0.9992472726403657,0.9819700717926025,0,0,"[{'label': 'neutral', 'score': 0.7501392960548401}, {'label': 'positive', 'score': 0.23453280329704285}, {'label': 'negative', 'score': 0.015327860601246357}]","(0.7501392960548401, 0.23453280329704285, 0.015327860601246357)",0.8773087338990992,0.23453280329704285,0,1,"[{'label': 'positive', 'score': 0.990788996219635}, {'label': 'neutral', 'score': 0.008970670402050018}, {'label': 'negative', 'score': 0.00024040367861744016}]","(0.008970670402050018, 0.990788996219635, 0.00024040367861744016)",0.9995148404706417,0.990788996219635,0,0
2014-12-19,42.24345779418945,56.85114669799805,57.15649032592773,56.3072509765625,56.536258697509766,18208162.0,Merck Begins Tender Offer To Acquire Cubist,-0.0034687435199822667,0.010121581372837139,0.18542547074586607,"[{'label': 'neutral', 'score': 0.9991044402122498}, {'label': 'positive', 'score': 0.0007805961649864912}, {'label': 'negative', 'score': 0.00011488790187286213}]","(0.9991044402122498, 0.0007805961649864912, 0.00011488790187286213)",0.7434060389800176,0.0007805961649864912,0,1,"[{'label': 'neutral', 'score': 0.8530084490776062}, {'label': 'positive', 'score': 0.1354372203350067}, {'label': 'negative', 'score': 0.011554285883903503}]","(0.8530084490776062, 0.1354372203350067, 0.011554285883903503)",0.8427897477736429,0.1354372203350067,0,1,"[{'label': 'neutral', 'score': 0.6347946524620056}, {'label': 'positive', 'score': 0.3646702468395233}, {'label': 'negative', 'score': 0.0005351328290998936}]","(0.6347946524620056, 0.3646702468395233, 0.0005351328290998936)",0.9970694143137461,0.3646702468395233,0,1
2014-12-20,42.09692509969076,56.653944651285805,57.04834747314453,56.16094080607096,56.4949099222819,15635776.0,,-0.003480817583418866,-0.003474773559264055,0.18113340841938377,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-21,41.950392405192055,56.45674260457357,56.94020462036133,56.01463063557943,56.45356114705404,13063390.0,,-0.0034929759956832257,-0.0034868897237134108,0.1844455295562548,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-22,41.80385971069336,56.25954055786133,56.832061767578125,55.86832046508789,56.41221237182617,10491004.0,"#Premarket Prep Technical Update - Merck Lower | NewLink Genetics Surges 3% Following Ebola Contract News | NewLink Genetics Announces Collaboration with Merck for Manufacture of Ebola Vaccine, Deal Supported by $30M Award",-0.029681109452667838,-0.0034990906794512716,0.1896601772710909,"[{'label': 'positive', 'score': 0.9978187084197998}, {'label': 'negative', 'score': 0.0014453278854489326}, {'label': 'neutral', 'score': 0.0007359645096585155}]","(0.0007359645096585155, 0.9978187084197998, 0.0014453278854489326)",0.9971072152445454,0.9978187084197998,0,0,"[{'label': 'positive', 'score': 0.94098961353302}, {'label': 'negative', 'score': 0.03140798583626747}, {'label': 'neutral', 'score': 0.027602432295680046}]","(0.027602432295680046, 0.94098961353302, 0.03140798583626747)",0.9354009391700695,0.94098961353302,0,0,"[{'label': 'positive', 'score': 0.9841804504394531}, {'label': 'neutral', 'score': 0.015127350576221943}, {'label': 'negative', 'score': 0.0006922186585143209}]","(0.015127350576221943, 0.9841804504394531, 0.0006922186585143209)",0.9985942981661816,0.9841804504394531,0,0
2014-12-23,40.563087463378906,54.58969497680664,56.29771041870117,54.41793823242188,56.00190734863281,14845339.0,"US Dept. of Health & Human Services Issues Release: 'HHS supports efforts to speed Ebola vaccine delivery' | Health Care And Biotech Sector Looking Sick | FTC Requests Public Comment on Merck & Co., Inc.'s Application to Approve Sale of Facilities",0.004369840844685889,-0.030130508370602285,0.23291340361367516,"[{'label': 'neutral', 'score': 0.86327064037323}, {'label': 'positive', 'score': 0.13450594246387482}, {'label': 'negative', 'score': 0.002223426941782236}]","(0.86327064037323, 0.13450594246387482, 0.002223426941782236)",0.9674769663394609,0.13450594246387482,0,1,"[{'label': 'negative', 'score': 0.6137735843658447}, {'label': 'neutral', 'score': 0.3412580192089081}, {'label': 'positive', 'score': 0.0449683740735054}]","(0.3412580192089081, 0.0449683740735054, 0.6137735843658447)",-0.863471960462207,-0.6137735843658447,0,0,"[{'label': 'neutral', 'score': 0.8326229453086853}, {'label': 'positive', 'score': 0.16280950605869293}, {'label': 'negative', 'score': 0.004567612428218126}]","(0.8326229453086853, 0.16280950605869293, 0.004567612428218126)",0.9454213040646255,0.16280950605869293,0,1
2014-12-24,40.74034881591797,54.828243255615234,55.209922790527344,54.62786483764648,54.66603088378906,5293448.0,,0.0027845468849525446,0.004360320814118318,0.2101199349144844,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-25,40.853790283203125,54.98091506958008,55.286258697509766,54.790077209472656,54.85210037231445,5095271.0,,0.002776814714190056,0.0027806772161270556,0.22157425808219114,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-26,40.96723175048828,55.13358688354492,55.36259460449219,54.95228958129883,55.03816986083984,4897094.0,,-0.0002884534418916457,0.002772966486442449,0.23032248085662885,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-27,40.9554074605306,55.11768341064453,55.33078893025717,54.90776062011719,54.9650141398112,5362056.666666667,,-0.00028853667128759055,-0.0002884950525877505,0.23253219309967316,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-28,40.943583170572914,55.10177993774414,55.29898325602213,54.86323165893555,54.89185841878256,5827019.333333333,,-0.0002886199487268634,-0.0002885783060018797,0.032884480857328244,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-29,40.931758880615234,55.08587646484375,55.26717758178711,54.81870269775391,54.81870269775391,6291982.0,,-0.0013857618664039968,-0.00028866160748015733,0.02665315642357714,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2014-12-30,40.875038146972656,55.00954055786133,55.1240463256836,54.67557144165039,54.89503860473633,5486070.0,,-0.01491759498561103,-0.0013867229223449575,0.024857662345828806,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2014-12-31,40.26530456542969,54.18893051147461,55.200382232666016,54.13167953491211,54.64694595336914,7842813.0,What Investors Should Be Watching In The Antibiotic Space | 19 Lesser-Known Biotech Stocks With Robust Drug Pipelines,0.0035217481809432815,-0.015029981396258326,0.10298158971503679,"[{'label': 'neutral', 'score': 0.999765932559967}, {'label': 'negative', 'score': 0.0001545371051179245}, {'label': 'positive', 'score': 7.945069228298962e-05}]","(0.999765932559967, 7.945069228298962e-05, 0.0001545371051179245)",-0.32089884031978816,-0.0001545371051179245,1,1,"[{'label': 'neutral', 'score': 0.5866973400115967}, {'label': 'positive', 'score': 0.40343180298805237}, {'label': 'negative', 'score': 0.009870854206383228}]","(0.5866973400115967, 0.40343180298805237, 0.009870854206383228)",0.9522342572225972,0.40343180298805237,0,1,"[{'label': 'neutral', 'score': 0.9946856498718262}, {'label': 'positive', 'score': 0.005070509854704142}, {'label': 'negative', 'score': 0.00024383874551858753}]","(0.9946856498718262, 0.005070509854704142, 0.00024383874551858753)",0.9082338160848658,0.005070509854704142,0,1
2015-01-01,40.40710067749024,54.37977027893066,55.171756744384766,54.27480888366699,54.62309074401856,7629387.5,,0.003509388996628445,0.003515561347210298,0.1133710392867317,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-02,40.54889678955078,54.57061004638672,55.14313125610352,54.41793823242188,54.59923553466797,7415962.0,,0.004954250941034398,0.0035032454602406567,0.12135764887320312,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-03,40.74978510538737,54.84096654256185,55.362595876057945,54.58969370524088,54.91412099202474,10519754.0,,0.004929827339299407,0.004942019023199182,0.13112281589352573,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-04,40.95067342122396,55.11132303873698,55.58206049601237,54.7614491780599,55.22900644938151,13623546.0,,0.004905643364524251,0.004917715530276422,0.1371231049690039,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-05,41.15156173706055,55.38167953491211,55.8015251159668,54.933204650878906,55.54389190673828,16727338.0,Bernstein Upgrades Merck to Outperform,0.0392832333710452,0.004893649903881726,0.012248922128313076,"[{'label': 'positive', 'score': 0.9995471835136414}, {'label': 'negative', 'score': 0.00025232447660528123}, {'label': 'neutral', 'score': 0.00020047882571816444}]","(0.00020047882571816444, 0.9995471835136414, 0.00025232447660528123)",0.9994952498484171,0.9995471835136414,1,1,"[{'label': 'positive', 'score': 0.9366469383239746}, {'label': 'negative', 'score': 0.03740333393216133}, {'label': 'neutral', 'score': 0.025949781760573387}]","(0.025949781760573387, 0.9366469383239746, 0.03740333393216133)",0.923200403516081,0.9366469383239746,1,1,"[{'label': 'positive', 'score': 0.9982267022132874}, {'label': 'negative', 'score': 0.0009227856644429266}, {'label': 'neutral', 'score': 0.0008505459409207106}]","(0.0008505459409207106, 0.9982267022132874, 0.0009227856644429266)",0.9981528576541574,0.9982267022132874,1,1
2015-01-06,42.76812744140625,57.5572509765625,57.72900772094727,55.582061767578125,55.610687255859375,25453510.0,"FDA Has Approved Merck's Request to Supplement Pneumovax BLA, Will Add 2D Barcode on Label",0.021385991571740818,0.03853127686500411,0.2413387342033646,"[{'label': 'positive', 'score': 0.9973679184913635}, {'label': 'neutral', 'score': 0.0023539531975984573}, {'label': 'negative', 'score': 0.0002781747025437653}]","(0.0023539531975984573, 0.9973679184913635, 0.0002781747025437653)",0.9994423379103241,0.9973679184913635,0,0,"[{'label': 'neutral', 'score': 0.8668678402900696}, {'label': 'positive', 'score': 0.12480029463768005}, {'label': 'negative', 'score': 0.008331896737217903}]","(0.8668678402900696, 0.12480029463768005, 0.008331896737217903)",0.8748327260120669,0.12480029463768005,0,1,"[{'label': 'positive', 'score': 0.9059682488441467}, {'label': 'neutral', 'score': 0.09363781660795212}, {'label': 'negative', 'score': 0.0003939390298910439}]","(0.09363781660795212, 0.9059682488441467, 0.0003939390298910439)",0.999130724923962,0.9059682488441467,0,0
2015-01-07,43.68277740478516,58.78816986083984,58.79771041870117,57.59542083740234,57.671756744384766,19528956.0,,0.02012657739949604,0.021160520208572873,0.237662800868643,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-08,44.56195068359375,59.97137451171875,60.0572509765625,59.01717758178711,59.16030502319336,20038808.0,,-0.004614170375474139,0.019926715086673423,0.22140414923330481,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-09,44.35634994506836,59.69465637207031,60.238548278808594,59.32251739501953,59.933204650878906,13245358.0,,-0.0013853425998515167,-0.004624848519446236,0.26306235921778814,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-10,44.294898986816406,59.611958821614586,60.35623296101888,59.30025355021159,60.02544403076172,12871676.0,,-0.0013872644363726017,-0.0013863030740707675,0.2827716466665454,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-11,44.23344802856445,59.52926127115885,60.47391764322917,59.27798970540365,60.11768341064453,12497994.0,,-0.0013891916124917996,-0.0013882275785391182,0.2012849875521664,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-12,44.1719970703125,59.446563720703125,60.59160232543945,59.2557258605957,60.209922790527344,12124312.0,Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1 | Wall Street's Hall Of Fame (And Hall Of Shame): The Best And Worst Analyst Recommendations Of 2014,-0.0017656427671212482,-0.0013901574337374311,0.15863340166365655,"[{'label': 'neutral', 'score': 0.9995431900024414}, {'label': 'negative', 'score': 0.0003847924526780844}, {'label': 'positive', 'score': 7.21072792657651e-05}]","(0.9995431900024414, 7.21072792657651e-05, 0.0003847924526780844)",-0.6843627858611802,-0.0003847924526780844,0,1,"[{'label': 'neutral', 'score': 0.8165761232376099}, {'label': 'negative', 'score': 0.12137176841497421}, {'label': 'positive', 'score': 0.06205212324857712}]","(0.8165761232376099, 0.06205212324857712, 0.12137176841497421)",-0.3234019550474114,-0.12137176841497421,1,1,"[{'label': 'neutral', 'score': 0.997512936592102}, {'label': 'positive', 'score': 0.0018181372433900833}, {'label': 'negative', 'score': 0.0006688989233225584}]","(0.997512936592102, 0.0018181372433900833, 0.0006688989233225584)",0.4620915189933025,0.0018181372433900833,1,1
2015-01-13,44.094017028808594,59.34160232543945,60.70610809326172,58.90267181396485,60.02862548828125,10516890.0,Notes From The Street: 'FLASHBACK....Oil Going To $200/Barrel' | Merck and Eli Lilly Announce Agreement For Collaboration on Cancer Clinical Trial,0.007235900898975286,-0.001767203351538687,0.02245671970411829,"[{'label': 'neutral', 'score': 0.832769513130188}, {'label': 'positive', 'score': 0.166696235537529}, {'label': 'negative', 'score': 0.0005342533113434911}]","(0.832769513130188, 0.166696235537529, 0.0005342533113434911)",0.9936105752602769,0.166696235537529,1,0,"[{'label': 'positive', 'score': 0.8849291205406189}, {'label': 'neutral', 'score': 0.10134392231702805}, {'label': 'negative', 'score': 0.013726919889450073}]","(0.10134392231702805, 0.8849291205406189, 0.013726919889450073)",0.969450113787961,0.8849291205406189,1,1,"[{'label': 'positive', 'score': 0.9964774250984192}, {'label': 'neutral', 'score': 0.0032647615298628807}, {'label': 'negative', 'score': 0.00025787169579416513}]","(0.0032647615298628807, 0.9964774250984192, 0.00025787169579416513)",0.999482567344362,0.9964774250984192,1,1
2015-01-14,44.41307067871094,59.770992279052734,60.02862548828125,58.66412353515625,58.89313125610352,10331289.0,Practice Fusion Announces Positive Results of Population Health Vaccine Initiative,-0.012132795212746099,0.00720984737305994,0.06176786221701878,"[{'label': 'positive', 'score': 0.9993634819984436}, {'label': 'neutral', 'score': 0.00033714366145431995}, {'label': 'negative', 'score': 0.00029939142405055463}]","(0.00033714366145431995, 0.9993634819984436, 0.00029939142405055463)",0.9994010152182095,0.9993634819984436,0,0,"[{'label': 'positive', 'score': 0.9224062561988831}, {'label': 'neutral', 'score': 0.06312873214483261}, {'label': 'negative', 'score': 0.014464951120316982}]","(0.06312873214483261, 0.9224062561988831, 0.014464951120316982)",0.9691207265047507,0.9224062561988831,0,0,"[{'label': 'positive', 'score': 0.9982781410217285}, {'label': 'neutral', 'score': 0.0014111768687143922}, {'label': 'negative', 'score': 0.0003107271622866392}]","(0.0014111768687143922, 0.9982781410217285, 0.0003107271622866392)",0.9993776674822108,0.9982781410217285,0,0
2015-01-15,43.87419509887695,59.04580307006836,60.10496139526367,58.99809265136719,59.91412353515625,10023701.0,#Premarket Prep Technical Update - Merck Lower | Fast Money Halftime Report Final Trade From January 14,0.01858435534754245,-0.01220699837791566,0.10933913870214318,"[{'label': 'neutral', 'score': 0.999453604221344}, {'label': 'negative', 'score': 0.00047588496818207204}, {'label': 'positive', 'score': 7.052160799503326e-05}]","(0.999453604221344, 7.052160799503326e-05, 0.00047588496818207204)",-0.741871305838108,-0.00047588496818207204,0,0,"[{'label': 'neutral', 'score': 0.8344716429710388}, {'label': 'negative', 'score': 0.14057430624961853}, {'label': 'positive', 'score': 0.02495408058166504}]","(0.8344716429710388, 0.02495408058166504, 0.14057430624961853)",-0.6984918289924528,-0.14057430624961853,0,0,"[{'label': 'negative', 'score': 0.7587491273880005}, {'label': 'neutral', 'score': 0.2392025887966156}, {'label': 'positive', 'score': 0.0020482931286096573}]","(0.2392025887966156, 0.0020482931286096573, 0.7587491273880005)",-0.9946154046441987,-0.7587491273880005,0,0
2015-01-16,44.689579010009766,60.14313125610352,60.26717758178711,58.71183013916016,59.02671813964844,11917018.0,"Barclays Issues 3 Upgrades, 1 Downgrade On Pharma Stocks | 'Merck Acquires OncoEthix' | Barclays Upgrades Merck to Equalweight",-0.001665877952153467,0.0184137763749039,0.18170330067811163,"[{'label': 'negative', 'score': 0.43959930539131165}, {'label': 'neutral', 'score': 0.3555666506290436}, {'label': 'positive', 'score': 0.204833984375}]","(0.3555666506290436, 0.204833984375, 0.43959930539131165)",-0.3642973209863874,-0.43959930539131165,1,1,"[{'label': 'positive', 'score': 0.8887404799461365}, {'label': 'neutral', 'score': 0.061725322157144547}, {'label': 'negative', 'score': 0.049534253776073456}]","(0.061725322157144547, 0.8887404799461365, 0.049534253776073456)",0.8944141795664322,0.8887404799461365,0,0,"[{'label': 'neutral', 'score': 0.9802024960517883}, {'label': 'negative', 'score': 0.011573737487196922}, {'label': 'positive', 'score': 0.008223889395594597}]","(0.9802024960517883, 0.008223889395594597, 0.011573737487196922)",-0.16920452695843452,-0.011573737487196922,1,1
2015-01-17,44.61513423919678,60.04294013977051,60.30057430267334,58.79532337188721,59.229485511779785,12371509.25,,-0.0016686577322792434,-0.0016672670697771574,0.18204433601300504,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-18,44.54068946838379,59.9427490234375,60.33397102355957,58.87881660461426,59.43225288391113,12826000.5,,-0.0016714468049143572,-0.0016700514922810092,0.1819190611802284,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-19,44.4662446975708,59.84255790710449,60.3673677444458,58.96230983734131,59.63502025604248,13280491.75,,-0.0016742452167323892,-0.001672845230605216,0.17679934356309365,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-20,44.39179992675781,59.74236679077149,60.40076446533203,59.04580307006836,59.83778762817383,13734983.0,The 5 Best Dow Stocks So Far In 2015 | #Premarket Prep Technical Update - Merck Lower,-0.00718736094130802,-0.0016756483315795508,0.14259099217420557,"[{'label': 'negative', 'score': 0.9817405939102173}, {'label': 'neutral', 'score': 0.017222896218299866}, {'label': 'positive', 'score': 0.001036528730764985}]","(0.017222896218299866, 0.001036528730764985, 0.9817405939102173)",-0.9978906128217971,-0.9817405939102173,0,0,"[{'label': 'neutral', 'score': 0.90573650598526}, {'label': 'positive', 'score': 0.0636955127120018}, {'label': 'negative', 'score': 0.030568040907382965}]","(0.90573650598526, 0.0636955127120018, 0.030568040907382965)",0.3514345739433948,0.0636955127120018,1,1,"[{'label': 'neutral', 'score': 0.9878096580505371}, {'label': 'negative', 'score': 0.006217201706022024}, {'label': 'positive', 'score': 0.005973197054117918}]","(0.9878096580505371, 0.005973197054117918, 0.006217201706022024)",-0.020016133738130895,-0.006217201706022024,1,1
2015-01-21,44.072731018066406,59.3129768371582,59.904579162597656,59.23664093017578,59.56106948852539,9517307.0,,0.006917626547725603,-0.007213314452899432,0.03934334442758575,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-01-22,44.37761306762695,59.72328186035156,59.83778762817383,58.71183013916016,59.40839767456055,8902131.0,,-0.001597652033392854,0.006893809544203537,0.08026162811133249,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-23,44.30672454833984,59.62786483764648,60.114505767822266,59.5515251159668,59.59923553466797,6528097.0,EMA Recommends Merck's Combination of Lamivudine/Raltegravir for Approval -Reuters,0.0017602742534798589,-0.0015989296403650505,0.08022957805668732,"[{'label': 'neutral', 'score': 0.9979081153869629}, {'label': 'positive', 'score': 0.0019104474922642112}, {'label': 'negative', 'score': 0.0001813690469134599}]","(0.9979081153869629, 0.0019104474922642112, 0.0001813690469134599)",0.826591822450396,0.0019104474922642112,0,1,"[{'label': 'neutral', 'score': 0.7491148710250854}, {'label': 'positive', 'score': 0.23972740769386292}, {'label': 'negative', 'score': 0.011157750152051449}]","(0.7491148710250854, 0.23972740769386292, 0.011157750152051449)",0.9110529275796843,0.23972740769386292,0,1,"[{'label': 'positive', 'score': 0.9130591750144958}, {'label': 'neutral', 'score': 0.08636721968650818}, {'label': 'negative', 'score': 0.0005736338207498193}]","(0.08636721968650818, 0.9130591750144958, 0.0005736338207498193)",0.9987442792876908,0.9130591750144958,0,0
2015-01-24,44.38471476236979,59.73282623291016,60.10814412434896,59.45928700764974,59.637404123942055,6697698.333333333,,0.001757181132772781,0.0017587267864676026,0.08223405038486097,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-25,44.46270497639974,59.83778762817383,60.10178248087565,59.36704889933268,59.67557271321615,6867299.666666667,,0.0017540988633452117,0.001755639096166919,0.08240195433398476,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-01-26,44.54069519042969,59.9427490234375,60.09542083740234,59.274810791015625,59.71374130249024,7036901.0,Merck Reports CHMP Positive Opinion for Investigational Antibiotic SIVEXTRO,-0.004138826720646124,0.0017525622286111984,0.04829197187259372,"[{'label': 'positive', 'score': 0.9992054104804993}, {'label': 'negative', 'score': 0.0004108718130737543}, {'label': 'neutral', 'score': 0.0003837537078652531}]","(0.0003837537078652531, 0.9992054104804993, 0.0004108718130737543)",0.9991779409352336,0.9992054104804993,0,0,"[{'label': 'positive', 'score': 0.9207456707954407}, {'label': 'neutral', 'score': 0.06531734764575958}, {'label': 'negative', 'score': 0.013936967588961124}]","(0.06531734764575958, 0.9207456707954407, 0.013936967588961124)",0.9701781823763173,0.9207456707954407,0,0,"[{'label': 'positive', 'score': 0.9980229139328003}, {'label': 'neutral', 'score': 0.0016765546752139926}, {'label': 'negative', 'score': 0.00030059946584515274}]","(0.0016765546752139926, 0.9980229139328003, 0.00030059946584515274)",0.9993977914737843,0.9980229139328003,0,0
2015-01-27,44.35634994506836,59.69465637207031,60.13358688354492,59.28435134887695,60.0,8347425.0,White House Budget To Support Biotech Rally,-0.017742997518755157,-0.004147415370104053,0.04271284441279255,"[{'label': 'neutral', 'score': 0.9996416568756104}, {'label': 'positive', 'score': 0.0002698924217838794}, {'label': 'negative', 'score': 8.842146780807525e-05}]","(0.9996416568756104, 0.0002698924217838794, 8.842146780807525e-05)",0.5064580504609018,0.0002698924217838794,0,0,"[{'label': 'positive', 'score': 0.5672323107719421}, {'label': 'neutral', 'score': 0.4210813641548157}, {'label': 'negative', 'score': 0.0116862952709198}]","(0.4210813641548157, 0.5672323107719421, 0.0116862952709198)",0.9596271560494479,0.5672323107719421,0,0,"[{'label': 'positive', 'score': 0.686824381351471}, {'label': 'neutral', 'score': 0.3122102618217468}, {'label': 'negative', 'score': 0.000965355895459652}]","(0.3122102618217468, 0.686824381351471, 0.000965355895459652)",0.9971928749640151,0.686824381351471,0,0
2015-01-28,43.569332122802734,58.63549423217773,60.07633590698242,58.511451721191406,59.9427490234375,9293769.0,Fast Money Halftime Report Final Trade From January 27,0.010414975841104991,-0.017902291547605056,0.13530809471819125,"[{'label': 'neutral', 'score': 0.9998810291290283}, {'label': 'negative', 'score': 7.069280400173739e-05}, {'label': 'positive', 'score': 4.825208816328086e-05}]","(0.9998810291290283, 4.825208816328086e-05, 7.069280400173739e-05)",-0.1886648130070469,-7.069280400173739e-05,1,1,"[{'label': 'neutral', 'score': 0.8440893292427063}, {'label': 'negative', 'score': 0.13811349868774414}, {'label': 'positive', 'score': 0.017797183245420456}]","(0.8440893292427063, 0.017797183245420456, 0.13811349868774414)",-0.7717002706325189,-0.13811349868774414,0,1,"[{'label': 'neutral', 'score': 0.9995574355125427}, {'label': 'positive', 'score': 0.0002507168101146817}, {'label': 'negative', 'score': 0.00019188123405911028}]","(0.9995574355125427, 0.0002507168101146817, 0.00019188123405911028)",0.13293230015374596,0.0002507168101146817,1,1
2015-01-29,44.02309799194336,59.24618148803711,59.30343627929688,57.97710037231445,58.72137451171875,9527682.0,#Premarket Prep Technical Update - Merck Lower,-0.02915118770930275,0.010361113639776105,0.1660794763226679,"[{'label': 'neutral', 'score': 0.9997453093528748}, {'label': 'negative', 'score': 0.00019641660037450492}, {'label': 'positive', 'score': 5.8319958043284714e-05}]","(0.9997453093528748, 5.8319958043284714e-05, 0.00019641660037450492)",-0.542115521968896,-0.00019641660037450492,1,0,"[{'label': 'neutral', 'score': 0.9370872378349304}, {'label': 'negative', 'score': 0.035277776420116425}, {'label': 'positive', 'score': 0.027634989470243454}]","(0.9370872378349304, 0.027634989470243454, 0.035277776420116425)",-0.12148229126012841,-0.035277776420116425,0,0,"[{'label': 'neutral', 'score': 0.9993917942047119}, {'label': 'positive', 'score': 0.00036299688508734107}, {'label': 'negative', 'score': 0.0002451756445225328}]","(0.9993917942047119, 0.00036299688508734107, 0.0002451756445225328)",0.1937299612009562,0.00036299688508734107,0,0
2015-01-30,42.7397689819336,57.51908493041992,59.093509674072266,57.28053283691406,58.71183013916016,12667071.0,What Investors Are Watching For In Regulus Therapeutics' Next Data Release,0.003317840189982769,-0.02958452591297698,0.252373040902686,"[{'label': 'neutral', 'score': 0.9998313188552856}, {'label': 'positive', 'score': 0.0001011864806059748}, {'label': 'negative', 'score': 6.74813418299891e-05}]","(0.9998313188552856, 0.0001011864806059748, 6.74813418299891e-05)",0.19983146927021078,0.0001011864806059748,1,1,"[{'label': 'neutral', 'score': 0.9460889101028442}, {'label': 'positive', 'score': 0.03195556253194809}, {'label': 'negative', 'score': 0.021955516189336777}]","(0.9460889101028442, 0.03195556253194809, 0.021955516189336777)",0.18549149042835145,0.03195556253194809,1,1,"[{'label': 'neutral', 'score': 0.999305248260498}, {'label': 'positive', 'score': 0.000521490175742656}, {'label': 'negative', 'score': 0.00017320802726317197}]","(0.999305248260498, 0.000521490175742656, 0.00017320802726317197)",0.5013430968621092,0.000521490175742656,0,1
2015-01-31,42.88157526652018,57.7099240620931,58.77544403076172,57.20101674397787,58.38422266642253,11681881.333333334,,0.0033068685286752175,0.003312348302337263,0.256344742585863,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-01,43.02338155110677,57.900763193766274,58.45737838745117,57.121500651041664,58.0566151936849,10696691.666666666,"Earnings Expectations For The Week Of February 2: Disney, Exxon, GM And More",0.003295969191883219,0.0033014128630795706,0.26784723425686163,"[{'label': 'neutral', 'score': 0.9998258948326111}, {'label': 'positive', 'score': 0.0001030265775625594}, {'label': 'negative', 'score': 7.12084656697698e-05}]","(0.9998258948326111, 0.0001030265775625594, 7.12084656697698e-05)",0.18261603006211882,0.0001030265775625594,1,1,"[{'label': 'neutral', 'score': 0.904708743095398}, {'label': 'negative', 'score': 0.06370315700769424}, {'label': 'positive', 'score': 0.031588103622198105}]","(0.904708743095398, 0.031588103622198105, 0.06370315700769424)",-0.33701992368670397,-0.06370315700769424,1,1,"[{'label': 'neutral', 'score': 0.9991012811660767}, {'label': 'positive', 'score': 0.0007302089943550527}, {'label': 'negative', 'score': 0.00016850275278557092}]","(0.9991012811660767, 0.0007302089943550527, 0.00016850275278557092)",0.625012684385876,0.0007302089943550527,0,1
2015-02-02,43.16518783569336,58.09160232543945,58.13931274414063,57.04198455810547,57.72900772094727,9711502.0,,0.0022995902711814434,0.0032905493911585594,0.25073763961893464,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-03,43.26443862915039,58.225189208984375,58.26335906982422,57.19465637207031,58.10114669799805,12028420.0,"Merck's Insomnia Medicine BELSOMRA (suvorexant) C-IV, the First and Only Orexin Receptor Antagonist, Now Available in the United States",-0.03228445277927895,0.002296950259995266,0.23178728563400286,"[{'label': 'neutral', 'score': 0.9998704195022583}, {'label': 'positive', 'score': 8.215129491873085e-05}, {'label': 'negative', 'score': 4.7457273467443883e-05}]","(0.9998704195022583, 8.215129491873085e-05, 4.7457273467443883e-05)",0.2676830851793265,8.215129491873085e-05,1,1,"[{'label': 'positive', 'score': 0.5670977234840393}, {'label': 'neutral', 'score': 0.42281657457351685}, {'label': 'negative', 'score': 0.010085689835250378}]","(0.42281657457351685, 0.5670977234840393, 0.010085689835250378)",0.9650520454936528,0.5670977234840393,0,0,"[{'label': 'neutral', 'score': 0.975307047367096}, {'label': 'positive', 'score': 0.024494802579283714}, {'label': 'negative', 'score': 0.00019808203796856105}]","(0.975307047367096, 0.024494802579283714, 0.00019808203796856105)",0.983956346855469,0.024494802579283714,0,1
2015-02-04,41.867671966552734,56.34542083740234,57.25190734863281,55.66793823242188,57.22328186035156,20380142.0,"UPDATE: Merck Posts Upbeat Q4 Earnings, Sales Decline | Merck Sees FY15 Adj. EPS $3.32-$3.47 Including Items, Sales $38.3B-$39.8B Including Items | Merck & Co Reports Q4 Adj. EPS $0.87 Vs Est $0.86, Sales $10.48B Vs Est $10.50B | Earning & Economic Calendar for Wednesday February 4, 2015 | Earnings Scheduled For February 4, 2015 | Keep an Eye on These 10 Stocks for February 4, 2015",0.002032143010439638,-0.03281709106668762,0.25472695158851827,"[{'label': 'negative', 'score': 0.9910518527030945}, {'label': 'positive', 'score': 0.008299268782138824}, {'label': 'neutral', 'score': 0.0006488421931862831}]","(0.0006488421931862831, 0.008299268782138824, 0.9910518527030945)",-0.9833906850080791,-0.9910518527030945,0,0,"[{'label': 'negative', 'score': 0.8803882002830505}, {'label': 'neutral', 'score': 0.10691361874341965}, {'label': 'positive', 'score': 0.012698158621788025}]","(0.10691361874341965, 0.012698158621788025, 0.8803882002830505)",-0.971563424980851,-0.8803882002830505,0,0,"[{'label': 'positive', 'score': 0.9960216879844666}, {'label': 'neutral', 'score': 0.0034652305766940117}, {'label': 'negative', 'score': 0.0005130995414219797}]","(0.0034652305766940117, 0.9960216879844666, 0.0005130995414219797)",0.9989702325541573,0.9960216879844666,0,0
2015-02-05,41.9527702331543,56.459922790527344,56.63167953491211,55.83015441894531,56.55534362792969,13268099.0,,-0.006422159056742729,0.002030081000891941,0.2525220071372279,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-06,41.68333053588867,56.09732818603516,57.03244400024414,55.89694595336914,56.39313125610352,10338310.0,"After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A? | Fast Money Halftime Report Final Trade From February 5 | Merck Prices $8B Debt Offering",-0.0026081486449111902,-0.006442869839798411,0.2431507387681959,"[{'label': 'neutral', 'score': 0.9998446702957153}, {'label': 'negative', 'score': 9.135684376815334e-05}, {'label': 'positive', 'score': 6.40406651655212e-05}]","(0.9998446702957153, 6.40406651655212e-05, 9.135684376815334e-05)",-0.17578260288773995,-9.135684376815334e-05,1,1,"[{'label': 'neutral', 'score': 0.878653347492218}, {'label': 'positive', 'score': 0.09819338470697403}, {'label': 'negative', 'score': 0.023153314366936684}]","(0.878653347492218, 0.09819338470697403, 0.023153314366936684)",0.6183939976342612,0.09819338470697403,0,1,"[{'label': 'positive', 'score': 0.7448064684867859}, {'label': 'neutral', 'score': 0.25384747982025146}, {'label': 'negative', 'score': 0.0013460072223097086}]","(0.25384747982025146, 0.7448064684867859, 0.0013460072223097086)",0.9963921389632044,0.7448064684867859,0,0
2015-02-07,41.574615478515625,55.95101801554362,56.78753280639648,55.69020334879557,56.25000127156576,10390465.666666666,,-0.0026149688724320555,-0.0026115557901050016,0.23178572646488882,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-08,41.46590042114258,55.804707845052086,56.54262161254883,55.48346074422201,56.10687128702799,10442621.333333334,,-0.002621824862837471,-0.002618393875688179,0.2210638578301705,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-09,41.35718536376953,55.65839767456055,56.29771041870117,55.27671813964844,55.96374130249024,10494777.0,,0.008914764146433487,-0.0026252678649254903,0.04768912353072918,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-02-10,41.72587203979492,56.154579162597656,56.62213516235352,56.078243255615234,56.29771041870117,9997291.0,,-0.0018691511329779942,0.008875262229803902,0.09221151904250376,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-11,41.64788818359375,56.049617767333984,56.25954055786133,55.725189208984375,56.06870269775391,10987127.0,,0.0023833683237493375,-0.0018709001757803653,0.08043458117609374,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-12,41.74714279174805,56.183204650878906,56.40267181396485,55.90649032592773,56.29771041870117,7553670.0,,-0.0011888167440584625,0.002380532606278346,0.07867718170807096,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-13,41.697513580322266,56.11641311645508,56.24045944213867,55.92557144165039,56.20228958129883,8278466.0,,-8.50238342047809e-05,-0.0011895239472294824,0.07531582926967252,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-14,41.69396781921387,56.1116418838501,56.24761581420898,55.947041511535645,56.16412162780762,8877922.0,,-8.50310638718578e-05,-8.502744893591882e-05,0.06928824714919109,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-15,41.69042205810547,56.10687065124512,56.2547721862793,55.9685115814209,56.125953674316406,9477378.0,,-8.503829476853182e-05,-8.503467921766743e-05,0.0256609670443153,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-16,41.68687629699707,56.10209941864014,56.26192855834961,55.98998165130615,56.0877857208252,10076834.0,,-8.504552689499001e-05,-8.504191072936695e-05,0.020892341905248794,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-17,41.68333053588867,56.09732818603516,56.26908493041992,56.011451721191406,56.049617767333984,10676290.0,,0.00017007151979992044,-8.504914347090637e-05,0.007841070282321576,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-18,41.69042205810547,56.10686874389648,56.3072509765625,55.5629768371582,55.98282241821289,11039842.0,,-0.00850335383703053,0.0001700570592784655,0.001810997370554707,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-02-19,41.33590698242188,55.6297721862793,56.28816986083984,55.16221237182617,56.154579162597656,10308338.0,NewLink Genetics Announces $20M Milestone Payment From MERCK,0.0008576418134773402,-0.008539713617044661,0.06050038746507221,"[{'label': 'neutral', 'score': 0.9992594122886658}, {'label': 'positive', 'score': 0.0006715161725878716}, {'label': 'negative', 'score': 6.911324453540146e-05}]","(0.9992594122886658, 0.0006715161725878716, 6.911324453540146e-05)",0.8133661911409117,0.0006715161725878716,0,1,"[{'label': 'positive', 'score': 0.7315813302993774}, {'label': 'neutral', 'score': 0.24409185349941254}, {'label': 'negative', 'score': 0.024326810613274574}]","(0.24409185349941254, 0.7315813302993774, 0.024326810613274574)",0.935635537450613,0.7315813302993774,0,0,"[{'label': 'neutral', 'score': 0.9233139157295227}, {'label': 'positive', 'score': 0.07637204974889755}, {'label': 'negative', 'score': 0.00031401458545587957}]","(0.9233139157295227, 0.07637204974889755, 0.00031401458545587957)",0.9918103872409786,0.07637204974889755,0,1
2015-02-20,41.371376037597656,55.67748260498047,55.8015251159668,55.08587646484375,55.48664093017578,12161830.0,,-0.00028563563143151207,0.0008572742488814133,0.06244804878714795,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-21,41.35955301920573,55.66157913208008,55.86195755004883,55.22582626342773,55.5629768371582,11108625.0,,-0.000285717242456472,-0.00028567643305822454,0.06216988786066002,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-22,41.347730000813804,55.64567565917969,55.92238998413086,55.36577606201172,55.63931274414063,10055420.0,,-0.00028579890013011425,-0.0002857580674042826,0.061882181722045335,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-23,41.33590698242188,55.6297721862793,55.98282241821289,55.5057258605957,55.71564865112305,9002215.0,"Evercore ISI Technical Analysis: The 'Single Best Idea' | UPDATE: Merck to Make Upfront Payment  NGM of $94M; Acquire 15% Stake in NGM for $106M | Merck, NGM Report Broad Strategic Deal to Discover, Develop, Commercialize Novel Biologic Therpeutics",0.0010291427469951164,-0.0002858397484189147,0.06113296430679787,"[{'label': 'positive', 'score': 0.5580646991729736}, {'label': 'neutral', 'score': 0.44108203053474426}, {'label': 'negative', 'score': 0.0008532633655704558}]","(0.44108203053474426, 0.5580646991729736, 0.0008532633655704558)",0.9969467312816535,0.5580646991729736,0,0,"[{'label': 'positive', 'score': 0.8457958102226257}, {'label': 'neutral', 'score': 0.1457284837961197}, {'label': 'negative', 'score': 0.008475656621158123}]","(0.1457284837961197, 0.8457958102226257, 0.008475656621158123)",0.9801569947022285,0.8457958102226257,0,0,"[{'label': 'positive', 'score': 0.9555693864822388}, {'label': 'neutral', 'score': 0.04406975954771042}, {'label': 'negative', 'score': 0.000360857171472162}]","(0.04406975954771042, 0.9555693864822388, 0.000360857171472162)",0.9992450135899187,0.9555693864822388,0,0
2015-02-24,41.378448486328125,55.6870231628418,55.88740539550781,55.39122009277344,55.81106948852539,8084377.0,Merck Collaborates with Medicines Patent Pool to Expand Access to Pediatric Formulations of Raltegravir in Developing Countries,0.002227562520640643,0.0010286135426516329,0.010726542674564304,"[{'label': 'positive', 'score': 0.9982321858406067}, {'label': 'neutral', 'score': 0.0015764994313940406}, {'label': 'negative', 'score': 0.00019132588931825012}]","(0.0015764994313940406, 0.9982321858406067, 0.00019132588931825012)",0.999616744022811,0.9982321858406067,1,1,"[{'label': 'positive', 'score': 0.8903793692588806}, {'label': 'neutral', 'score': 0.10281170904636383}, {'label': 'negative', 'score': 0.006808894220739603}]","(0.10281170904636383, 0.8903793692588806, 0.006808894220739603)",0.9848217046568749,0.8903793692588806,1,1,"[{'label': 'positive', 'score': 0.9955189228057861}, {'label': 'neutral', 'score': 0.004242682829499245}, {'label': 'negative', 'score': 0.00023841274378355592}]","(0.004242682829499245, 0.9955189228057861, 0.00023841274378355592)",0.999521142882363,0.9955189228057861,1,1
2015-02-25,41.47061920166016,55.81106948852539,56.26908493041992,55.40076446533203,55.78244400024414,8861050.0,Heavy News Day For Several Biotech Stocks,0.008035521867720918,0.00222508518151877,0.017934423106111517,"[{'label': 'neutral', 'score': 0.9994495511054993}, {'label': 'negative', 'score': 0.0004743727622553706}, {'label': 'positive', 'score': 7.600278331665322e-05}]","(0.9994495511054993, 7.600278331665322e-05, 0.0004743727622553706)",-0.7238148245207335,-0.0004743727622553706,0,0,"[{'label': 'positive', 'score': 0.4587457776069641}, {'label': 'negative', 'score': 0.2841455042362213}, {'label': 'neutral', 'score': 0.2571087181568146}]","(0.2571087181568146, 0.4587457776069641, 0.2841455042362213)",0.2350280285125201,0.4587457776069641,0,0,"[{'label': 'neutral', 'score': 0.9762938618659973}, {'label': 'negative', 'score': 0.020090319216251373}, {'label': 'positive', 'score': 0.003615782130509615}]","(0.9762938618659973, 0.003615782130509615, 0.020090319216251373)",-0.6949492387955519,-0.020090319216251373,0,0
2015-02-26,41.80385971069336,56.25954055786133,56.44084167480469,55.97328186035156,55.97328186035156,12040577.0,"Merck HPV Vaccine GARDASIL9, Recommended by CDC's Advisory Committee on Immunization Practices for Females Aged 9-26 and Males Aged 9-21",-0.0071234255854363895,0.008003408976400232,0.054640913246756,"[{'label': 'neutral', 'score': 0.9998810291290283}, {'label': 'negative', 'score': 6.23551313765347e-05}, {'label': 'positive', 'score': 5.65594709769357e-05}]","(0.9998810291290283, 5.65594709769357e-05, 6.23551313765347e-05)",-0.04873800428959565,-6.23551313765347e-05,1,1,"[{'label': 'positive', 'score': 0.6339892745018005}, {'label': 'neutral', 'score': 0.3501601219177246}, {'label': 'negative', 'score': 0.015850592404603958}]","(0.3501601219177246, 0.6339892745018005, 0.015850592404603958)",0.9512169283178593,0.6339892745018005,0,0,"[{'label': 'neutral', 'score': 0.9993969202041626}, {'label': 'positive', 'score': 0.000490783539135009}, {'label': 'negative', 'score': 0.00011229450319660828}]","(0.9993969202041626, 0.000490783539135009, 0.00011229450319660828)",0.6275954509553827,0.000490783539135009,0,1
2015-02-27,41.506080627441406,55.85877990722656,56.35496139526367,55.81106948852539,56.1927490234375,13686775.0,,0.00022775319120805755,-0.007148918317331136,0.08634122473584344,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-02-28,41.51553471883138,55.87150192260742,56.30089060465495,55.74427541097005,56.08142598470052,12501592.0,,0.00022770133150316538,0.00022772725938728912,0.08602403843598065,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-01,41.52498881022135,55.88422393798828,56.24681981404623,55.67748133341471,55.97010294596354,11316409.0,Fast Money Picks For March 2,0.00022764949540994453,0.0002276754114894941,0.08611722032626569,"[{'label': 'neutral', 'score': 0.9998700618743896}, {'label': 'negative', 'score': 7.834713323973119e-05}, {'label': 'positive', 'score': 5.164850881556049e-05}]","(0.9998700618743896, 5.164850881556049e-05, 7.834713323973119e-05)",-0.2053809189450739,-7.834713323973119e-05,1,1,"[{'label': 'neutral', 'score': 0.8997817039489746}, {'label': 'negative', 'score': 0.07165440171957016}, {'label': 'positive', 'score': 0.028563866391777992}]","(0.8997817039489746, 0.028563866391777992, 0.07165440171957016)",-0.4299668727054448,-0.07165440171957016,1,1,"[{'label': 'neutral', 'score': 0.9994565844535828}, {'label': 'positive', 'score': 0.00043064908822998405}, {'label': 'negative', 'score': 0.00011268569505773485}]","(0.9994565844535828, 0.00043064908822998405, 0.00011268569505773485)",0.58520713739005,0.00043064908822998405,0,1
2015-03-02,41.53444290161133,55.89694595336914,56.1927490234375,55.610687255859375,55.85877990722656,10131226.0,,-0.0040969630279676355,0.00022762358719541608,0.08505992719560573,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-03,41.36427688598633,55.66793823242188,56.011451721191406,55.29580307006836,55.95419692993164,8647362.0,,-0.007884799139533594,-0.0041053785743134135,0.053696166446269546,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-04,41.038124084472656,55.22900772094727,55.96374130249024,55.03816986083984,55.73473358154297,13975290.0,"Merck Announces Co. Eisai Enter Deal to Explore Novel Combo Regimens Anti-PD-1 Therapy with RTK Inhibitor, Microtubule Dynamics Inhibitor for Cancers",0.0017277304326100613,-0.007916048540155294,0.05830592380999521,"[{'label': 'positive', 'score': 0.9983929991722107}, {'label': 'neutral', 'score': 0.0013945946702733636}, {'label': 'negative', 'score': 0.0002123471349477768}]","(0.0013945946702733636, 0.9983929991722107, 0.0002123471349477768)",0.9995747126014636,0.9983929991722107,0,0,"[{'label': 'positive', 'score': 0.8337948322296143}, {'label': 'neutral', 'score': 0.15758748352527618}, {'label': 'negative', 'score': 0.008617768064141273}]","(0.15758748352527618, 0.8337948322296143, 0.008617768064141273)",0.9795402678897818,0.8337948322296143,0,0,"[{'label': 'neutral', 'score': 0.7116836309432983}, {'label': 'positive', 'score': 0.2877797484397888}, {'label': 'negative', 'score': 0.0005366508266888559}]","(0.7116836309432983, 0.2877797484397888, 0.0005366508266888559)",0.9962773478854885,0.2877797484397888,0,1
2015-03-05,41.10902404785156,55.32442855834961,55.610687255859375,55.15267181396485,55.42938995361328,12087737.0,,-0.01966197675275687,0.0017262396232835286,0.06311830314703279,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-03-06,40.30073928833008,54.23664093017578,55.21946716308594,54.12213516235352,55.200382232666016,11595806.0,,0.0024630610011903346,-0.019857845108467012,0.13696712338675607,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-07,40.40000534057617,54.37022908528646,55.06043370564779,53.988548278808594,54.87913513183594,10644676.0,,0.002457009237557611,0.00246003263811862,0.14407880005406065,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-08,40.499271392822266,54.50381724039713,54.90140024820963,53.85496139526367,54.55788803100586,9693546.0,,0.002450987139514819,0.0024539957255027634,0.15527946047169608,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-09,40.59853744506836,54.63740539550781,54.74236679077149,53.72137451171875,54.23664093017578,8742416.0,,-0.01187569416963139,0.0024479883695008122,0.15718640978721707,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-10,40.11640167236328,53.988548278808594,54.57061004638672,53.90267181396485,54.34160232543945,13755000.0,8 Healthcare Names Cowen & Co Are Talking About,-0.009190495093046645,-0.011946773530608298,0.16566586425265356,"[{'label': 'neutral', 'score': 0.9998874664306641}, {'label': 'negative', 'score': 6.208803097251803e-05}, {'label': 'positive', 'score': 5.0419715989846736e-05}]","(0.9998874664306641, 5.0419715989846736e-05, 6.208803097251803e-05)",-0.10371121365157625,-6.208803097251803e-05,1,1,"[{'label': 'neutral', 'score': 0.9328486323356628}, {'label': 'positive', 'score': 0.03939896076917648}, {'label': 'negative', 'score': 0.02775239758193493}]","(0.9328486323356628, 0.03939896076917648, 0.02775239758193493)",0.17343749215534363,0.03939896076917648,1,1,"[{'label': 'neutral', 'score': 0.9993500113487244}, {'label': 'positive', 'score': 0.00045673336717300117}, {'label': 'negative', 'score': 0.00019321333093103021}]","(0.9993500113487244, 0.00045673336717300117, 0.00019321333093103021)",0.40544868834735054,0.00045673336717300117,1,1
2015-03-11,39.74771881103516,53.49236679077149,54.85686874389648,53.40649032592773,54.85686874389648,16417234.0,US Stock Futures Signal Higher Start On Wall Street | Merck Announces KEYTRUDA is First Medicine to be Made Available to Patients Through UK EAMS for Advanced Melanoma,0.001962175195466951,-0.009232988248883878,0.11443250971521014,"[{'label': 'positive', 'score': 0.9991077780723572}, {'label': 'neutral', 'score': 0.0007249888149090111}, {'label': 'negative', 'score': 0.00016715477977413684}]","(0.0007249888149090111, 0.9991077780723572, 0.00016715477977413684)",0.9996654478676913,0.9991077780723572,0,0,"[{'label': 'positive', 'score': 0.9007013440132141}, {'label': 'neutral', 'score': 0.0877210944890976}, {'label': 'negative', 'score': 0.011577614583075047}]","(0.0877210944890976, 0.9007013440132141, 0.011577614583075047)",0.9746182579922936,0.9007013440132141,0,0,"[{'label': 'positive', 'score': 0.9984367489814758}, {'label': 'neutral', 'score': 0.001301636453717947}, {'label': 'negative', 'score': 0.00026158581022173166}]","(0.001301636453717947, 0.9984367489814758, 0.00026158581022173166)",0.9994761464976784,0.9984367489814758,0,0
2015-03-12,40.14797592163086,53.59732818603516,53.64503860473633,53.110687255859375,53.26335906982422,13576106.0,Measles Cases Could ~Double in W African Countries Due to Stain on Health Systems from Ebola Outbreak; Inability to Maintain Child Immunizations -Reuters,0.000534084239831591,0.0019602526442289597,0.11304179471227614,"[{'label': 'negative', 'score': 0.9958792924880981}, {'label': 'neutral', 'score': 0.0021038216073065996}, {'label': 'positive', 'score': 0.002016898011788726}]","(0.0021038216073065996, 0.002016898011788726, 0.9958792924880981)",-0.9959576997467474,-0.9958792924880981,0,0,"[{'label': 'negative', 'score': 0.9431594014167786}, {'label': 'neutral', 'score': 0.042315609753131866}, {'label': 'positive', 'score': 0.014524907805025578}]","(0.042315609753131866, 0.014524907805025578, 0.9431594014167786)",-0.9696666058634118,-0.9431594014167786,0,0,"[{'label': 'negative', 'score': 0.9909257888793945}, {'label': 'positive', 'score': 0.006078637205064297}, {'label': 'neutral', 'score': 0.002995604183524847}]","(0.002995604183524847, 0.006078637205064297, 0.9909257888793945)",-0.9878061981551336,-0.9909257888793945,0,0
2015-03-13,40.16941452026367,53.625953674316406,53.84542083740234,53.09160232543945,53.46374130249024,13700399.0,Merck Provides Regulatory Update On Sugammadex Injection,0.005456716244637645,0.0005339416676054317,0.10806389951108016,"[{'label': 'neutral', 'score': 0.9995824694633484}, {'label': 'positive', 'score': 0.0003185761743225157}, {'label': 'negative', 'score': 9.892058733385056e-05}]","(0.9995824694633484, 0.0003185761743225157, 9.892058733385056e-05)",0.5261252473365519,0.0003185761743225157,0,1,"[{'label': 'neutral', 'score': 0.9409863352775574}, {'label': 'positive', 'score': 0.04152452200651169}, {'label': 'negative', 'score': 0.0174891147762537}]","(0.9409863352775574, 0.04152452200651169, 0.0174891147762537)",0.4072856468537014,0.04152452200651169,1,1,"[{'label': 'neutral', 'score': 0.9974763989448547}, {'label': 'positive', 'score': 0.002344075357541442}, {'label': 'negative', 'score': 0.00017950395704247057}]","(0.9974763989448547, 0.002344075357541442, 0.00017950395704247057)",0.8577386048418556,0.002344075357541442,0,1
2015-03-14,40.38860575358073,53.918575286865234,54.128499348958336,53.39058430989584,53.63867696126302,13158198.666666666,,0.0054271020885099655,0.005441882307141689,0.11949092204773111,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-15,40.60779698689779,54.21119689941406,54.41157786051432,53.68956629435221,53.813612620035805,12615998.333333334,,0.005397807635418412,0.005412428436301476,0.09554315086785184,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-16,40.82698822021485,54.50381851196289,54.69465637207031,53.988548278808594,53.988548278808594,12073798.0,Merck Announced Results From Investigational IMPROVE-IT Study That Shows VYTORIN Reduced Total Cardiovascular Events By 9% Vs. SIMVASTATIN,-0.011379599546439776,0.005383291684561499,0.03709334154146966,"[{'label': 'positive', 'score': 0.9994737505912781}, {'label': 'neutral', 'score': 0.00032304474734701216}, {'label': 'negative', 'score': 0.00020320889598224312}]","(0.00032304474734701216, 0.9994737505912781, 0.00020320889598224312)",0.9995934508761981,0.9994737505912781,0,0,"[{'label': 'positive', 'score': 0.945105254650116}, {'label': 'neutral', 'score': 0.030284641310572624}, {'label': 'negative', 'score': 0.024610033258795738}]","(0.030284641310572624, 0.945105254650116, 0.024610033258795738)",0.9492427652411984,0.945105254650116,0,0,"[{'label': 'positive', 'score': 0.9979842901229858}, {'label': 'neutral', 'score': 0.001672457787208259}, {'label': 'negative', 'score': 0.00034320485428906977}]","(0.001672457787208259, 0.9979842901229858, 0.00034320485428906977)",0.9993124403444446,0.9979842901229858,0,0
2015-03-17,40.362396240234375,53.88358688354492,54.28435134887695,53.66412353515625,54.28435134887695,10479371.0,,0.0208960416230244,-0.011444842621644786,0.11597168972664196,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-03-18,41.205810546875,55.00954055786133,55.314884185791016,53.63549423217773,53.8072509765625,15645068.0,,0.009713794070228602,0.020680713844757826,0.18043685708826945,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-19,41.6060791015625,55.54389190673828,55.66793823242188,54.41793823242188,54.799617767333984,15149783.0,,0.0063563073186095696,0.009666918487983001,0.1834174833378255,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-20,41.87054061889648,55.89694595336914,56.16412353515625,55.114505767822266,55.57251739501953,27367472.0,,0.0008535424948077359,0.006336191195087252,0.1833674177130758,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-21,41.90627797444662,55.94465637207031,56.25318145751953,55.20356369018555,55.62340799967448,21968350.666666668,,0.0008528145813225126,0.0008531784345583813,0.18729913627738876,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-22,41.94201532999674,55.99236679077149,56.34223937988281,55.29262161254883,55.67429860432943,16569229.333333334,,0.0008520879083294666,0.0008524511415838724,0.12993677945457488,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-23,41.97775268554688,56.040077209472656,56.431297302246094,55.38167953491211,55.725189208984375,11170108.0,"SunTrust Names Eli Lilly, Merck, Bristol-Myers as 'Favorite' Pharma Firms",-0.0017027249453220672,0.0008517250875164538,0.06491028157583185,"[{'label': 'neutral', 'score': 0.9998422861099243}, {'label': 'positive', 'score': 8.524800068698823e-05}, {'label': 'negative', 'score': 7.24821220501326e-05}]","(0.9998422861099243, 8.524800068698823e-05, 7.24821220501326e-05)",0.08093494391132722,8.524800068698823e-05,1,1,"[{'label': 'neutral', 'score': 0.7712835669517517}, {'label': 'positive', 'score': 0.21828491985797882}, {'label': 'negative', 'score': 0.01043151505291462}]","(0.7712835669517517, 0.21828491985797882, 0.01043151505291462)",0.9087821121645353,0.21828491985797882,0,1,"[{'label': 'neutral', 'score': 0.7898783683776855}, {'label': 'positive', 'score': 0.20951621234416962}, {'label': 'negative', 'score': 0.0006054950645193458}]","(0.7898783683776855, 0.20951621234416962, 0.0006054950645193458)",0.9942367204989283,0.20951621234416962,0,1
2015-03-24,41.9062728881836,55.94465637207031,56.96564865112305,55.83015441894531,56.68893051147461,13692434.0,"Merck Announces New $10B Share Repurchase Program | Merck's Pivotal KEYNOTE-006 Study in First-Line Treatment for Advanced Melanoma Met Co-Primary Endpoints, Will be Stopped Early",-0.0063107733522002165,-0.001704176229100498,0.04688636766412816,"[{'label': 'neutral', 'score': 0.9943264126777649}, {'label': 'negative', 'score': 0.005188420414924622}, {'label': 'positive', 'score': 0.0004851025005336851}]","(0.9943264126777649, 0.0004851025005336851, 0.005188420414924622)",-0.8289942570913196,-0.005188420414924622,0,1,"[{'label': 'negative', 'score': 0.7050307989120483}, {'label': 'neutral', 'score': 0.27814751863479614}, {'label': 'positive', 'score': 0.01682165451347828}]","(0.27814751863479614, 0.01682165451347828, 0.7050307989120483)",-0.953393094575902,-0.7050307989120483,0,0,"[{'label': 'neutral', 'score': 0.9930340051651001}, {'label': 'negative', 'score': 0.003528097877278924}, {'label': 'positive', 'score': 0.003437954466789961}]","(0.9930340051651001, 0.003437954466789961, 0.003528097877278924)",-0.012940386611609954,-0.003528097877278924,1,1
2015-03-25,41.64181518554688,55.59160232543945,56.975189208984375,55.51526641845703,56.774810791015625,14712243.0,"Key Catalysts Are Coming For Merck, Analyst Predicts",-0.011328548916300937,-0.006330770458214876,0.04967103474135319,"[{'label': 'neutral', 'score': 0.9998331069946289}, {'label': 'positive', 'score': 9.907135245157406e-05}, {'label': 'negative', 'score': 6.783162098145112e-05}]","(0.9998331069946289, 9.907135245157406e-05, 6.783162098145112e-05)",0.18717300733206416,9.907135245157406e-05,0,0,"[{'label': 'positive', 'score': 0.8764098882675171}, {'label': 'neutral', 'score': 0.11223633587360382}, {'label': 'negative', 'score': 0.011353717185556889}]","(0.11223633587360382, 0.8764098882675171, 0.011353717185556889)",0.9744217557110545,0.8764098882675171,0,0,"[{'label': 'neutral', 'score': 0.9070962071418762}, {'label': 'positive', 'score': 0.09254331141710281}, {'label': 'negative', 'score': 0.0003605122910812497}]","(0.9070962071418762, 0.09254331141710281, 0.0003605122910812497)",0.992239021459146,0.09254331141710281,0,0
2015-03-26,41.17007446289063,54.96183013916016,55.53435134887695,54.78053283691406,55.38167953491211,11090879.0,Merck Announces Deal with American Diabetes Association for Education of Adults with Diabetes,0.002604193778502435,-0.011393205702076817,0.08377930374271227,"[{'label': 'positive', 'score': 0.9037185907363892}, {'label': 'neutral', 'score': 0.09578773379325867}, {'label': 'negative', 'score': 0.0004936199402436614}]","(0.09578773379325867, 0.9037185907363892, 0.0004936199402436614)",0.9989081767876719,0.9037185907363892,0,0,"[{'label': 'positive', 'score': 0.7101646065711975}, {'label': 'neutral', 'score': 0.27405664324760437}, {'label': 'negative', 'score': 0.01577877067029476}]","(0.27405664324760437, 0.7101646065711975, 0.01577877067029476)",0.9565289217727906,0.7101646065711975,0,0,"[{'label': 'positive', 'score': 0.5993162393569946}, {'label': 'neutral', 'score': 0.4001062512397766}, {'label': 'negative', 'score': 0.0005774888559244573}]","(0.4001062512397766, 0.5993162393569946, 0.0005774888559244573)",0.9980746961377817,0.5993162393569946,0,0
2015-03-27,41.27729034423828,55.10496139526367,55.5629768371582,54.99045944213867,55.181297302246094,8932628.0,EMA Recommends Approval of Merck's Gardasil 9 Vaccine,0.00340548184714867,0.002600808741472388,0.09023145239214134,"[{'label': 'neutral', 'score': 0.8562046885490417}, {'label': 'positive', 'score': 0.1425626128911972}, {'label': 'negative', 'score': 0.0012326576979830861}]","(0.8562046885490417, 0.1425626128911972, 0.0012326576979830861)",0.9828553791382366,0.1425626128911972,0,1,"[{'label': 'neutral', 'score': 0.7830947637557983}, {'label': 'positive', 'score': 0.2005809098482132}, {'label': 'negative', 'score': 0.01632433384656906}]","(0.7830947637557983, 0.2005809098482132, 0.01632433384656906)",0.8494795831719051,0.2005809098482132,0,1,"[{'label': 'positive', 'score': 0.99647456407547}, {'label': 'neutral', 'score': 0.0032543076667934656}, {'label': 'negative', 'score': 0.00027112389216199517}]","(0.0032543076667934656, 0.99647456407547, 0.00027112389216199517)",0.9994559818107369,0.99647456407547,0,0
2015-03-28,41.417860666910805,55.29262034098307,55.66157786051432,55.155853271484375,55.31488545735677,8815776.0,,0.003393923900913762,0.0033996963251157783,0.09883388984821015,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-29,41.558430989583336,55.48027928670248,55.760178883870445,55.32124710083008,55.448473612467446,8698924.0,,0.0033824441428934333,0.003388177539329818,0.10818865967892874,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-30,41.69900131225586,55.66793823242188,55.85877990722656,55.48664093017578,55.582061767578125,8582072.0,,-0.014741161114330305,0.00337673654550177,0.10368155646302882,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-03-31,41.08429718017578,54.84732818603516,55.63931274414063,54.84732818603516,55.524810791015625,10960718.0,Syndax and Merck to Partner on Immuno-Oncology Study Evaluating Entinostat in Combination with KEYTRUDA (pembrolizumab) in Lung Cancer and Melanoma,-0.010786347211532718,-0.014850891736232654,0.12820161153491963,"[{'label': 'neutral', 'score': 0.9997695088386536}, {'label': 'positive', 'score': 0.0001690347125986591}, {'label': 'negative', 'score': 6.149563705548644e-05}]","(0.9997695088386536, 0.0001690347125986591, 6.149563705548644e-05)",0.4664855438969696,0.0001690347125986591,1,1,"[{'label': 'positive', 'score': 0.8147938847541809}, {'label': 'neutral', 'score': 0.17616450786590576}, {'label': 'negative', 'score': 0.009041603654623032}]","(0.17616450786590576, 0.8147938847541809, 0.009041603654623032)",0.9780499777398849,0.8147938847541809,0,0,"[{'label': 'positive', 'score': 0.6139108538627625}, {'label': 'neutral', 'score': 0.38542139530181885}, {'label': 'negative', 'score': 0.0006677775527350605}]","(0.38542139530181885, 0.6139108538627625, 0.0006677775527350605)",0.9978268767620604,0.6139108538627625,0,0
2015-04-01,40.64115905761719,54.2557258605957,54.69465637207031,53.64503860473633,54.63740539550781,13322386.0,,0.0042208949804796,-0.010844941581690208,0.14294948016951164,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-02,40.81269454956055,54.48473358154297,54.81870269775391,54.24618148803711,54.38931274414063,7947508.0,,0.00035026282577015815,0.004212011990600667,0.14537436243307011,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-03,40.82698822021485,54.503817558288574,54.79246234893799,54.21278476715088,54.37261390686035,9274721.5,,0.00035014018467965653,0.000350201498066676,0.13847412426676486,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-04,40.84128189086914,54.52290153503418,54.76622200012207,54.17938804626465,54.35591506958008,10601935.0,,0.0003500176294422425,0.0003500788999103406,0.13036365599083413,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-05,40.85557556152344,54.541985511779785,54.73998165130615,54.14599132537842,54.339216232299805,11929148.5,,0.0003498951599677973,0.00034995638756181576,0.09032029199639224,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-06,40.86986923217773,54.56106948852539,54.71374130249024,54.11259460449219,54.32251739501953,13256362.0,Gilead Alert: What Deutsche Bank Is Saying | Merck Shares Teetering On The Brink Of A Further Downside Correction | Top 4 Large-Cap Stocks In The Drug Manufacturers Industry With The Highest ROE,0.004372133483541086,0.00034983396093145834,0.027417439795308095,"[{'label': 'negative', 'score': 0.9904807209968567}, {'label': 'neutral', 'score': 0.007280855905264616}, {'label': 'positive', 'score': 0.0022384682670235634}]","(0.007280855905264616, 0.0022384682670235634, 0.9904807209968567)",-0.9954902286744685,-0.9904807209968567,0,0,"[{'label': 'negative', 'score': 0.9426938891410828}, {'label': 'positive', 'score': 0.029530024155974388}, {'label': 'neutral', 'score': 0.02777615189552307}]","(0.02777615189552307, 0.029530024155974388, 0.9426938891410828)",-0.9392526273997301,-0.9426938891410828,0,0,"[{'label': 'negative', 'score': 0.9890928268432617}, {'label': 'neutral', 'score': 0.009487750008702278}, {'label': 'positive', 'score': 0.0014193361857905984}]","(0.009487750008702278, 0.0014193361857905984, 0.9890928268432617)",-0.9971341367854581,-0.9890928268432617,0,0
2015-04-07,41.048561096191406,54.799617767333984,55.22900772094727,54.67557144165039,55.01908493041992,9723658.0,Sector ETFs And Earnings | Arvinas in Strategic R&D Collaboration With Merck to Study Novel Protein Degradation Technology,-0.004875467712643533,0.004362603475489969,0.02848653327918495,"[{'label': 'neutral', 'score': 0.9997994303703308}, {'label': 'positive', 'score': 0.00014206326159182936}, {'label': 'negative', 'score': 5.849769149790518e-05}]","(0.9997994303703308, 0.00014206326159182936, 5.849769149790518e-05)",0.41665921908805176,0.00014206326159182936,0,0,"[{'label': 'positive', 'score': 0.7482733130455017}, {'label': 'neutral', 'score': 0.24457348883152008}, {'label': 'negative', 'score': 0.007153201382607222}]","(0.24457348883152008, 0.7482733130455017, 0.007153201382607222)",0.9810618207172077,0.7482733130455017,0,0,"[{'label': 'neutral', 'score': 0.9670084714889526}, {'label': 'positive', 'score': 0.032714907079935074}, {'label': 'negative', 'score': 0.00027661549393087626}]","(0.9670084714889526, 0.032714907079935074, 0.00027661549393087626)",0.9832311168233263,0.032714907079935074,0,0
2015-04-08,40.84843826293945,54.53244400024414,55.39122009277344,54.40839767456055,55.25763320922852,14210566.0,"Advaxis, Merck Report Initiation of Enrollment in Phase 1/2 Study of ADXS-PSA in Combo with Anti-PD-1 Therapy | Grazoprevir/Elbasvir, Merck's Investigational Chronic Hepatitis C Therapy, Granted FDA Breakthrough Therapy Designations; New Phase 2, 3 Data in Multiple HCV Patient Types Will Be Presented At The International Liver Congress TM 2015",0.004899354356622043,-0.004887391577417893,0.05218777476498693,"[{'label': 'neutral', 'score': 0.9997138381004333}, {'label': 'positive', 'score': 0.000221813956159167}, {'label': 'negative', 'score': 6.431790825445205e-05}]","(0.9997138381004333, 0.000221813956159167, 6.431790825445205e-05)",0.5504316977330631,0.000221813956159167,0,1,"[{'label': 'positive', 'score': 0.8615046739578247}, {'label': 'neutral', 'score': 0.13066549599170685}, {'label': 'negative', 'score': 0.007829798385500908}]","(0.13066549599170685, 0.8615046739578247, 0.007829798385500908)",0.9819866837572991,0.8615046739578247,0,0,"[{'label': 'positive', 'score': 0.8551009893417358}, {'label': 'neutral', 'score': 0.14437833428382874}, {'label': 'negative', 'score': 0.0005207100766710937}]","(0.14437833428382874, 0.8551009893417358, 0.0005207100766710937)",0.998782849764037,0.8551009893417358,0,0
2015-04-09,41.048561096191406,54.799617767333984,55.08587646484375,54.4942741394043,54.59923553466797,12582288.0,The Biotech Stocks JMP Is Watching,-0.0031341994102354652,0.004887391577417837,0.06246008089460705,"[{'label': 'neutral', 'score': 0.9998236298561096}, {'label': 'negative', 'score': 0.00010282473522238433}, {'label': 'positive', 'score': 7.352120155701414e-05}]","(0.9998236298561096, 7.352120155701414e-05, 0.00010282473522238433)",-0.16617073350563055,-0.00010282473522238433,1,1,"[{'label': 'neutral', 'score': 0.9086974859237671}, {'label': 'positive', 'score': 0.077191561460495}, {'label': 'negative', 'score': 0.014110919088125229}]","(0.9086974859237671, 0.077191561460495, 0.014110919088125229)",0.6908973556176076,0.077191561460495,0,1,"[{'label': 'neutral', 'score': 0.999312162399292}, {'label': 'positive', 'score': 0.0004256542306393385}, {'label': 'negative', 'score': 0.00026223520399071276}]","(0.999312162399292, 0.0004256542306393385, 0.00026223520399071276)",0.2375658331436838,0.0004256542306393385,1,1
2015-04-10,40.91990280151367,54.62786483764648,55.00954055786133,53.74045944213867,54.4370231628418,16251860.0,Biotech Investors: Nomura Says To Watch These Dates,-0.003027669146561125,-0.003139121300020324,0.06932586042480604,"[{'label': 'neutral', 'score': 0.9998605251312256}, {'label': 'negative', 'score': 7.494967576349154e-05}, {'label': 'positive', 'score': 6.444395694416016e-05}]","(0.9998605251312256, 6.444395694416016e-05, 7.494967576349154e-05)",-0.07536727908773906,-7.494967576349154e-05,1,1,"[{'label': 'neutral', 'score': 0.9487162828445435}, {'label': 'positive', 'score': 0.03252536803483963}, {'label': 'negative', 'score': 0.018758399412035942}]","(0.9487162828445435, 0.03252536803483963, 0.018758399412035942)",0.268446904511545,0.03252536803483963,1,1,"[{'label': 'neutral', 'score': 0.9995892643928528}, {'label': 'positive', 'score': 0.00026582294958643615}, {'label': 'negative', 'score': 0.00014489900786429644}]","(0.9995892643928528, 0.00026582294958643615, 0.00014489900786429644)",0.2944180108428825,0.00026582294958643615,1,1
2015-04-11,40.79601033528646,54.462469736735024,54.92048263549805,53.79771041870117,54.44656499226888,14495901.0,,-0.0030368637652855896,-0.0030322618091762846,0.07326384608242521,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-12,40.67211786905924,54.29707463582357,54.831424713134766,53.85496139526367,54.45610682169596,12739942.0,,-0.0030461143997311782,-0.003041484393233017,0.06101736735318772,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-13,40.54822540283203,54.13167953491211,54.74236679077149,53.91221237182617,54.46564865112305,10983983.0,,0.018156211692568758,-0.0030507632492178275,0.056466906148953035,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-04-14,41.28443145751953,55.114505767822266,55.33396911621094,54.01717758178711,54.332061767578125,15359698.0,Morgan Stanley's Major Pharma Q1 Preview | UPDATE: Phase III Trial of the Merck and NewLink Genetics Investigational Ebola Vaccine Initiated in Sierra Leone | Ebola vaccine trial begins in Sierra Leone,0.011945926951370289,0.017993355955918396,0.14950748254607235,"[{'label': 'neutral', 'score': 0.9998422861099243}, {'label': 'negative', 'score': 8.041400724323466e-05}, {'label': 'positive', 'score': 7.725223258603364e-05}]","(0.9998422861099243, 7.725223258603364e-05, 8.041400724323466e-05)",-0.02005359334138244,-8.041400724323466e-05,1,1,"[{'label': 'neutral', 'score': 0.8482385873794556}, {'label': 'positive', 'score': 0.13988324999809265}, {'label': 'negative', 'score': 0.011878141202032566}]","(0.8482385873794556, 0.13988324999809265, 0.011878141202032566)",0.8434629373373488,0.13988324999809265,0,1,"[{'label': 'neutral', 'score': 0.9983845949172974}, {'label': 'positive', 'score': 0.0015062689781188965}, {'label': 'negative', 'score': 0.00010909346747212112}]","(0.9983845949172974, 0.0015062689781188965, 0.00010909346747212112)",0.8649300436940556,0.0015062689781188965,0,1
2015-04-15,41.77762985229492,55.77289962768555,56.25,55.41030502319336,55.41030502319336,12690022.0,SunTrust's Latest Comments On Merck | Canine Flu Outbreak Reported in Chicago Area -Wall Street Journal,-0.01043621466279166,0.011875137571505807,0.1600236950808879,"[{'label': 'neutral', 'score': 0.977878987789154}, {'label': 'negative', 'score': 0.02178896591067314}, {'label': 'positive', 'score': 0.0003320419928058982}]","(0.977878987789154, 0.0003320419928058982, 0.02178896591067314)",-0.9699794878918083,-0.02178896591067314,0,1,"[{'label': 'neutral', 'score': 0.8218057155609131}, {'label': 'negative', 'score': 0.13585755228996277}, {'label': 'positive', 'score': 0.04233671724796295}]","(0.8218057155609131, 0.04233671724796295, 0.13585755228996277)",-0.5248251545041713,-0.13585755228996277,0,1,"[{'label': 'neutral', 'score': 0.9562916159629822}, {'label': 'negative', 'score': 0.041369132697582245}, {'label': 'positive', 'score': 0.0023392261937260628}]","(0.9562916159629822, 0.0023392261937260628, 0.041369132697582245)",-0.8929620670708259,-0.041369132697582245,0,1
2015-04-16,41.34160232543945,55.19084167480469,55.71564865112305,55.09542083740234,55.54389190673828,6717051.0,,-0.01659751610940266,-0.01049105382690883,0.18751088022533563,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-17,40.65545272827149,54.274810791015625,54.73282241821289,53.97900772094727,54.72328186035156,12223243.0,It's A Big Weekend For Biotech,0.004278004907194764,-0.016736798188291904,0.2333385119385104,"[{'label': 'neutral', 'score': 0.9984293580055237}, {'label': 'positive', 'score': 0.0014525875449180603}, {'label': 'negative', 'score': 0.00011802489461842924}]","(0.9984293580055237, 0.0014525875449180603, 0.00011802489461842924)",0.8497084428374194,0.0014525875449180603,0,1,"[{'label': 'neutral', 'score': 0.7570903301239014}, {'label': 'positive', 'score': 0.2315531224012375}, {'label': 'negative', 'score': 0.011356543749570847}]","(0.7570903301239014, 0.2315531224012375, 0.011356543749570847)",0.9064957444507767,0.2315531224012375,0,1,"[{'label': 'neutral', 'score': 0.9991758465766907}, {'label': 'positive', 'score': 0.0006774698849767447}, {'label': 'negative', 'score': 0.00014660065062344074}]","(0.9991758465766907, 0.0006774698849767447, 0.00014660065062344074)",0.6442036347855372,0.0006774698849767447,0,1
2015-04-18,40.82938003540039,54.50699869791666,54.93638483683268,54.23982238769531,54.770992279052734,11628677.666666666,,0.004259781540859781,0.004268880258473378,0.23325770548060068,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-19,41.0033073425293,54.73918660481771,55.13994725545248,54.50063705444336,54.81870269775391,11034112.333333334,"Early Findings with Merck's Pembrolizumab in Patients with Advanced Pleural Mesothelioma Presented at AACR Annual Meeting | Merck Announces New Data on Treatment of Advanced NSCLC with Pembrolizumab Presented at AACR Annual Meeting, Published in NEJM | Early Findings with KEYTRUDA in Patients with Advanced Pleural Mesothelioma Presented at AACR Annual Meeting",0.004241712771095579,0.004250734355062159,0.18752009720173698,"[{'label': 'neutral', 'score': 0.999321699142456}, {'label': 'positive', 'score': 0.0006039130967110395}, {'label': 'negative', 'score': 7.447959069395438e-05}]","(0.999321699142456, 0.0006039130967110395, 7.447959069395438e-05)",0.7804233681266356,0.0006039130967110395,0,1,"[{'label': 'neutral', 'score': 0.870065450668335}, {'label': 'positive', 'score': 0.10613574832677841}, {'label': 'negative', 'score': 0.023798801004886627}]","(0.870065450668335, 0.10613574832677841, 0.023798801004886627)",0.6336801700964246,0.10613574832677841,0,1,"[{'label': 'neutral', 'score': 0.9956451654434204}, {'label': 'positive', 'score': 0.0036033233627676964}, {'label': 'negative', 'score': 0.0007515992620028555}]","(0.9956451654434204, 0.0036033233627676964, 0.0007515992620028555)",0.6548277309324387,0.0036033233627676964,0,1
2015-04-20,41.1772346496582,54.97137451171875,55.343509674072266,54.761451721191406,54.86641311645508,10439547.0,"CAR-T Therapy Stocks Hit Hard Following AACR Data | Merck Will File ""Totality Of Data"" Regarding Hep C Drugs To FDA; Won't Limit FDA Filing To Breakthrough Status According To Phonecall With VP, Infectious Diseases Eliav Barr | Morning Market Gainers | Tetralogic Announces Co., Merck Will Collaborate Related to Evaluation of Birinapant In Combo With KEYTRUDA in Solid Tumors",0.000867913875629961,0.004232742065969184,0.15923698536065878,"[{'label': 'negative', 'score': 0.9931578040122986}, {'label': 'neutral', 'score': 0.006005370523780584}, {'label': 'positive', 'score': 0.000836792925838381}]","(0.006005370523780584, 0.000836792925838381, 0.9931578040122986)",-0.998316302868414,-0.9931578040122986,0,0,"[{'label': 'positive', 'score': 0.898091197013855}, {'label': 'neutral', 'score': 0.09029564261436462}, {'label': 'negative', 'score': 0.01161320973187685}]","(0.09029564261436462, 0.898091197013855, 0.01161320973187685)",0.9744681686803727,0.898091197013855,0,0,"[{'label': 'negative', 'score': 0.9823256134986877}, {'label': 'neutral', 'score': 0.014966603368520737}, {'label': 'positive', 'score': 0.0027077675331383944}]","(0.014966603368520737, 0.0027077675331383944, 0.9823256134986877)",-0.9945021811742014,-0.9823256134986877,0,0
2015-04-21,41.21296691894531,55.01908493041992,55.37213516235352,54.78053283691406,55.35305404663086,9699764.0,Morgan Stanley Awaits This Merck Data,0.0005202828857922905,0.0008675374561662937,0.144871345704672,"[{'label': 'neutral', 'score': 0.999790608882904}, {'label': 'negative', 'score': 0.0001442684733774513}, {'label': 'positive', 'score': 6.513464904855937e-05}]","(0.999790608882904, 6.513464904855937e-05, 0.0001442684733774513)",-0.37790183552230766,-0.0001442684733774513,1,1,"[{'label': 'neutral', 'score': 0.9343358874320984}, {'label': 'positive', 'score': 0.047642145305871964}, {'label': 'negative', 'score': 0.01802191697061062}]","(0.9343358874320984, 0.047642145305871964, 0.01802191697061062)",0.4510873575037674,0.047642145305871964,1,1,"[{'label': 'neutral', 'score': 0.9995427131652832}, {'label': 'positive', 'score': 0.0002523108560126275}, {'label': 'negative', 'score': 0.0002049074973911047}]","(0.9995427131652832, 0.0002523108560126275, 0.0002049074973911047)",0.10367772480835814,0.0002523108560126275,1,1
2015-04-22,41.23440933227539,55.04771041870117,55.238548278808594,54.69465637207031,54.92366409301758,8294501.0,"Goat Plague (PPR) Affecting Herds in Africa, Asia -Reuters | UPDATE: Organovo Shares Rise 15% Following Announcement of Deal With Merck | Organovo Announces Multi-Year Research Collaboration Agreement With Merck Sharp & Dohme Corp",-0.0031201432916711336,0.0005201475855791323,0.030989061610023277,"[{'label': 'positive', 'score': 0.9995636343955994}, {'label': 'negative', 'score': 0.00022159497893881053}, {'label': 'neutral', 'score': 0.00021479956922121346}]","(0.00021479956922121346, 0.9995636343955994, 0.00022159497893881053)",0.9995567148374908,0.9995636343955994,0,0,"[{'label': 'positive', 'score': 0.9474416971206665}, {'label': 'neutral', 'score': 0.026638871058821678}, {'label': 'negative', 'score': 0.025919437408447266}]","(0.026638871058821678, 0.9474416971206665, 0.025919437408447266)",0.9467424032273769,0.9474416971206665,0,0,"[{'label': 'positive', 'score': 0.9824811816215515}, {'label': 'neutral', 'score': 0.015830762684345245}, {'label': 'negative', 'score': 0.0016881090123206377}]","(0.015830762684345245, 0.9824811816215515, 0.0016881090123206377)",0.9965694743203511,0.9824811816215515,0,0
2015-04-23,41.10574722290039,54.875953674316406,55.200382232666016,54.42748260498047,54.88549423217773,8742416.0,"FDA Sentinel Study Finds No Association Between Venous Thromboembolism, Gardasil Vaccination -Reuters | Merck Announces 99% of Patients in Phase 2/3 Study of Grazoprevir/Elbasvir Achieved Sustained Virologic Response",0.0015649197707510616,-0.0031250210876755838,0.04871670086411716,"[{'label': 'positive', 'score': 0.6233730316162109}, {'label': 'neutral', 'score': 0.3758513331413269}, {'label': 'negative', 'score': 0.0007756196428090334}]","(0.3758513331413269, 0.6233730316162109, 0.0007756196428090334)",0.9975146316787051,0.6233730316162109,0,0,"[{'label': 'positive', 'score': 0.9099222421646118}, {'label': 'neutral', 'score': 0.0739809051156044}, {'label': 'negative', 'score': 0.016096778213977814}]","(0.0739809051156044, 0.9099222421646118, 0.016096778213977814)",0.9652344544555966,0.9099222421646118,0,0,"[{'label': 'positive', 'score': 0.7174065113067627}, {'label': 'neutral', 'score': 0.27956533432006836}, {'label': 'negative', 'score': 0.003028126433491707}]","(0.27956533432006836, 0.7174065113067627, 0.003028126433491707)",0.9915936123143944,0.7174065113067627,0,0
2015-04-24,41.17007446289063,54.96183013916016,55.524810791015625,54.875953674316406,55.200382232666016,8244092.0,Morgan Stanley Alert: Gilead Investors Don't Have The Whole Story | Analyst: Biogen Will Miss On Tecfidera Sales; No Threat To Gilead's Harvoni | Merck's Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across Broad Range of Patients with Chronic Hepatitis C Virus Infection,-0.0028935023719142,0.0015636965597916315,0.041891049531387385,"[{'label': 'negative', 'score': 0.9936562180519104}, {'label': 'neutral', 'score': 0.004890720825642347}, {'label': 'positive', 'score': 0.0014530476182699203}]","(0.004890720825642347, 0.0014530476182699203, 0.9936562180519104)",-0.9970796219703746,-0.9936562180519104,0,0,"[{'label': 'positive', 'score': 0.8537140488624573}, {'label': 'neutral', 'score': 0.0777219757437706}, {'label': 'negative', 'score': 0.06856398284435272}]","(0.0777219757437706, 0.8537140488624573, 0.06856398284435272)",0.851316022962262,0.8537140488624573,0,0,"[{'label': 'negative', 'score': 0.9826819896697998}, {'label': 'neutral', 'score': 0.013882309198379517}, {'label': 'positive', 'score': 0.0034355814568698406}]","(0.013882309198379517, 0.0034355814568698406, 0.9826819896697998)",-0.9930321057905,-0.9826819896697998,0,0
2015-04-25,41.05094782511393,54.80279795328776,55.47391891479492,54.67557271321615,55.19402058919271,9198855.0,,-0.002901899023621847,-0.002897696642611058,0.03526866173841757,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-04-26,40.93182118733724,54.64376576741537,55.42302703857422,54.47519175211588,55.1876589457194,10153618.0,"Does Apple Hide More Cash Abroad Than Anyone? | U.S. Tech, Dollar & Health Care ETFs To Watch This Week | Apple & Other Earnings Expected To Dominate The Week Of April 27",-0.002910344549628948,-0.002906117696011019,0.035454605435021026,"[{'label': 'neutral', 'score': 0.9998549222946167}, {'label': 'negative', 'score': 7.566744898213074e-05}, {'label': 'positive', 'score': 6.93262554705143e-05}]","(0.9998549222946167, 6.93262554705143e-05, 7.566744898213074e-05)",-0.043734267881178755,-7.566744898213074e-05,1,1,"[{'label': 'neutral', 'score': 0.6201338768005371}, {'label': 'positive', 'score': 0.3551414906978607}, {'label': 'negative', 'score': 0.024724645540118217}]","(0.6201338768005371, 0.3551414906978607, 0.024724645540118217)",0.8698244292845905,0.3551414906978607,0,1,"[{'label': 'neutral', 'score': 0.9610977172851562}, {'label': 'positive', 'score': 0.03231192007660866}, {'label': 'negative', 'score': 0.006590388249605894}]","(0.9610977172851562, 0.03231192007660866, 0.006590388249605894)",0.6611826632835089,0.03231192007660866,0,1
2015-04-27,40.81269454956055,54.48473358154297,55.37213516235352,54.274810791015625,55.181297302246094,11108381.0,Merck Offers Results of Trial Evaluating CV Outcomes with Sitagliptin: Says Met Primary Endpoint | Merck Earnings: The Street And The Crowd Expect A Double-Digit Year-Over-Year Decline,0.05043777689684535,-0.0029145878372802427,0.03215649463058153,"[{'label': 'negative', 'score': 0.9932645559310913}, {'label': 'positive', 'score': 0.00552069628611207}, {'label': 'neutral', 'score': 0.0012147235684096813}]","(0.0012147235684096813, 0.00552069628611207, 0.9932645559310913)",-0.9889451786080007,-0.9932645559310913,0,0,"[{'label': 'negative', 'score': 0.8856378793716431}, {'label': 'positive', 'score': 0.09488436579704285}, {'label': 'neutral', 'score': 0.019477730616927147}]","(0.019477730616927147, 0.09488436579704285, 0.8856378793716431)",-0.8064615744016715,-0.8856378793716431,0,0,"[{'label': 'negative', 'score': 0.9961750507354736}, {'label': 'neutral', 'score': 0.00258104270324111}, {'label': 'positive', 'score': 0.0012439944548532367}]","(0.00258104270324111, 0.0012439944548532367, 0.9961750507354736)",-0.9975055730871555,-0.9961750507354736,0,0
2015-04-28,42.871192932128906,57.23282241821289,57.709922790527344,54.48473358154297,54.48473358154297,36398298.0,"Morning Market Gainers | Bank Of America On Merck: 'MAGNIF-TECOS!' | Benzinga's Top #PreMarket Gainers | Merck Beats Q1 Estimates, Shares Rise | Merck Raises FY15 Adj. EPS Outlook from $3.32-$3.47 Previously to $3.35-$3.48 vs $3.37 Est., Affirms Sales Outlook | Merck Reports Q1 EPS $0.85 vs. Est. $0.74, Rev. $9.4B vs. Est. $8.99B | Earning & Economic Calendar for Thursday April 28, 2015 | Earnings Scheduled For April 28, 2015",-0.005001652642918953,0.049207007656060855,0.36333489857062523,"[{'label': 'positive', 'score': 0.9994518160820007}, {'label': 'negative', 'score': 0.00043424597242847085}, {'label': 'neutral', 'score': 0.00011393151362426579}]","(0.00011393151362426579, 0.9994518160820007, 0.00043424597242847085)",0.9991314090896792,0.9994518160820007,0,0,"[{'label': 'positive', 'score': 0.827884316444397}, {'label': 'negative', 'score': 0.09075778722763062}, {'label': 'neutral', 'score': 0.08135789632797241}]","(0.08135789632797241, 0.827884316444397, 0.09075778722763062)",0.8024088230555719,0.827884316444397,0,0,"[{'label': 'positive', 'score': 0.99803227186203}, {'label': 'neutral', 'score': 0.0016921187052503228}, {'label': 'negative', 'score': 0.00027560966555029154}]","(0.0016921187052503228, 0.99803227186203, 0.00027560966555029154)",0.9994478463595248,0.99803227186203,0,0
2015-04-29,42.656776428222656,56.946563720703125,57.66221237182617,56.51717758178711,56.61259460449219,18017216.0,What's Wall Street Been Saying About Gilead Lately?,-0.0020106911750914377,-0.005014202772580907,0.37398889922845524,"[{'label': 'neutral', 'score': 0.9997045397758484}, {'label': 'positive', 'score': 0.00015741739480290562}, {'label': 'negative', 'score': 0.00013801381282974035}]","(0.9997045397758484, 0.00015741739480290562, 0.00013801381282974035)",0.065678850005896,0.00015741739480290562,1,1,"[{'label': 'neutral', 'score': 0.8674047589302063}, {'label': 'negative', 'score': 0.09341129660606384}, {'label': 'positive', 'score': 0.03918393701314926}]","(0.8674047589302063, 0.03918393701314926, 0.09341129660606384)",-0.40896914702563647,-0.09341129660606384,1,1,"[{'label': 'neutral', 'score': 0.9954752326011658}, {'label': 'negative', 'score': 0.0031091144774109125}, {'label': 'positive', 'score': 0.0014155606040731072}]","(0.9954752326011658, 0.0014155606040731072, 0.0031091144774109125)",-0.3742929255336379,-0.0031091144774109125,1,1
2015-04-30,42.57101058959961,56.832061767578125,57.38549423217773,56.52671813964844,57.0515251159668,13636995.0,,0.005036922620904669,-0.0020127153283454238,0.37254921938444496,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-01,42.78542709350586,57.11832046508789,57.614505767822266,56.946563720703125,57.02289962768555,9806660.0,Hearing Unconfirmed Market Chatter of Potential Merck Bid for Lilly | Bank Of America Reviews Gilead Earnings,0.004343464194698607,0.00502427976245449,0.36303233916757593,"[{'label': 'neutral', 'score': 0.9980079531669617}, {'label': 'positive', 'score': 0.0018288778373971581}, {'label': 'negative', 'score': 0.0001632444909773767}]","(0.9980079531669617, 0.0018288778373971581, 0.0001632444909773767)",0.8361099731153805,0.0018288778373971581,0,1,"[{'label': 'neutral', 'score': 0.5125784277915955}, {'label': 'negative', 'score': 0.4218788743019104}, {'label': 'positive', 'score': 0.06554268300533295}]","(0.5125784277915955, 0.06554268300533295, 0.4218788743019104)",-0.7310636674856033,-0.4218788743019104,0,1,"[{'label': 'neutral', 'score': 0.8324187397956848}, {'label': 'positive', 'score': 0.1615687608718872}, {'label': 'negative', 'score': 0.006012532394379377}]","(0.8324187397956848, 0.1615687608718872, 0.006012532394379377)",0.9282433942692376,0.1615687608718872,0,1
2015-05-02,42.97126770019531,57.36641184488932,57.79580307006836,57.0578867594401,57.14376449584961,9699379.666666666,,0.004324680101524235,0.004334058579559883,0.35169365779644995,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-03,43.157108306884766,57.61450322469076,57.97710037231445,57.169209798177086,57.26462936401367,9592099.333333334,,0.004306057779130691,0.004315355546678768,0.07231490498547805,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-04,43.34294891357422,57.86259460449219,58.15839767456055,57.28053283691406,57.38549423217773,9484819.0,,-0.0024735745499241445,0.004296813241174023,0.04644015824405305,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-05,43.23572540283203,57.71946716308594,57.91984558105469,57.30915832519531,57.5572509765625,12662041.0,"Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers",-0.0038023075033910936,-0.0024766388897428234,0.049716679037338875,"[{'label': 'neutral', 'score': 0.9998637437820435}, {'label': 'negative', 'score': 7.711521902820095e-05}, {'label': 'positive', 'score': 5.91135467402637e-05}]","(0.9998637437820435, 5.91135467402637e-05, 7.711521902820095e-05)",-0.1321429595753148,-7.711521902820095e-05,1,1,"[{'label': 'neutral', 'score': 0.8817920088768005}, {'label': 'positive', 'score': 0.10867930948734283}, {'label': 'negative', 'score': 0.00952866394072771}]","(0.8817920088768005, 0.10867930948734283, 0.00952866394072771)",0.8387813670365325,0.10867930948734283,0,1,"[{'label': 'neutral', 'score': 0.5258015394210815}, {'label': 'positive', 'score': 0.47323188185691833}, {'label': 'negative', 'score': 0.000966574065387249}]","(0.5258015394210815, 0.47323188185691833, 0.000966574065387249)",0.9959233352478667,0.47323188185691833,0,1
2015-05-06,43.07134628295898,57.5,57.814884185791016,57.18511581420898,57.681297302246094,12126303.0,,0.0006638236667797677,-0.003809554650988071,0.06528081245351314,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-07,43.09992218017578,57.53816986083984,57.9484748840332,57.18511581420898,57.299617767333984,9433048.0,,0.007296818478413913,0.0006636034333081993,0.05960037296133793,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-08,43.41442489624024,57.95801544189453,58.56870269775391,57.91984558105469,58.20610809326172,10630283.0,,-0.004061032156225893,0.007270325496717318,0.07332386961779964,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-09,43.23811213175456,57.72264607747396,58.349236806233726,57.64630889892578,58.09796524047852,10481991.0,,-0.004077591385964367,-0.0040693005403541725,0.07501895901602633,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-10,43.06179936726888,57.48727671305338,58.12977091471354,57.37277221679688,57.98982238769531,10333699.0,,-0.004094286212154598,-0.004085927430091211,0.07850067031540395,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-11,42.8854866027832,57.25190734863281,57.91030502319336,57.09923553466797,57.88167953491211,10185407.0,,-0.009333337064615954,-0.004102690750181716,0.07923141094870673,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-12,42.4852294921875,56.71755599975586,56.9942741394043,56.40267181396485,56.82251739501953,13825111.0,"GSK, NewLink Vaccine Trials May Not Produce Useful Efficacy Data as Ebola Disappears in W. Africa -Reuters",-0.00437411013745003,-0.009377165579032957,0.09708325511802861,"[{'label': 'neutral', 'score': 0.9744746088981628}, {'label': 'negative', 'score': 0.021184474229812622}, {'label': 'positive', 'score': 0.00434092665091157}]","(0.9744746088981628, 0.00434092665091157, 0.021184474229812622)",-0.6598739685855691,-0.021184474229812622,0,1,"[{'label': 'neutral', 'score': 0.49008291959762573}, {'label': 'negative', 'score': 0.4277263581752777}, {'label': 'positive', 'score': 0.08219067752361298}]","(0.49008291959762573, 0.08219067752361298, 0.4277263581752777)",-0.677631176173737,-0.4277263581752777,0,1,"[{'label': 'negative', 'score': 0.9967143535614014}, {'label': 'neutral', 'score': 0.0027315139304846525}, {'label': 'positive', 'score': 0.0005541204591281712}]","(0.0027315139304846525, 0.0005541204591281712, 0.9967143535614014)",-0.9988887236013905,-0.9967143535614014,0,0
2015-05-13,42.29939651489258,56.46946716308594,57.10877990722656,56.26908493041992,56.88931274414063,7672303.0,,0.010138530143485851,-0.004383704545417508,0.037092297162280456,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-05-14,42.72826385498047,57.04198455810547,57.14694595336914,56.34542083740234,56.74618148803711,7469410.0,,0.007527612458432013,0.010087480005699779,0.11619087343487275,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-15,43.04989242553711,57.47137451171875,57.47137451171875,57.07061004638672,57.19465637207031,8033654.0,,-0.0012175498516195883,0.007499421369770881,0.13328051816935302,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-16,42.99747848510742,57.40140024820963,57.54134877522787,57.13422393798828,57.26781209309896,7867615.666666667,,-0.0012190340863904685,-0.0012182916676333005,0.12927514595852257,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-17,42.94506454467773,57.33142598470052,57.61132303873698,57.19783782958984,57.3409678141276,7701577.333333333,,-0.0012205219442438131,-0.0012197777128411084,0.09945665426621228,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-18,42.89265060424805,57.261451721191406,57.681297302246094,57.261451721191406,57.41412353515625,7535539.0,,0.008498578285183161,-0.0012212673877671997,0.08826667082218569,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-19,43.25716781616211,57.74809265136719,58.1297721862793,57.19465637207031,57.21374130249024,8518878.0,,-0.00099139164488309,0.008462668679041725,0.0801820279310451,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-20,43.21429061889648,57.69084167480469,58.0629768371582,57.671756744384766,57.89122009277344,6324575.0,,-0.005954385112040179,-0.0009918833986203792,0.06835204011291311,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-21,42.95697784423828,57.34732818603516,58.0057258605957,57.33778762817383,57.77671813964844,8424872.0,,-0.011980037860056804,-0.005972183149151524,0.08365025089050201,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-22,42.44235610961914,56.66030502319336,57.31870269775391,56.62213516235352,57.31870269775391,9421939.0,Expert Explains How To Play Merck In 2 Charts | Merck Release Confirms CHMP Positive Recommendation for KEYTRUDA | EMA Gives Positive Opinion for Merck's Melanoma Drug Keytruda,-0.0017261647842051646,-0.012052376843295168,0.11966276361074595,"[{'label': 'positive', 'score': 0.9995303153991699}, {'label': 'negative', 'score': 0.0002945480518974364}, {'label': 'neutral', 'score': 0.00017510105681139976}]","(0.00017510105681139976, 0.9995303153991699, 0.0002945480518974364)",0.9994108007058741,0.9995303153991699,0,0,"[{'label': 'positive', 'score': 0.8696847558021545}, {'label': 'neutral', 'score': 0.12092679738998413}, {'label': 'negative', 'score': 0.00938845332711935}]","(0.12092679738998413, 0.8696847558021545, 0.00938845332711935)",0.9786401104490065,0.8696847558021545,0,0,"[{'label': 'positive', 'score': 0.9977568984031677}, {'label': 'neutral', 'score': 0.001972366590052843}, {'label': 'negative', 'score': 0.0002708089887164533}]","(0.001972366590052843, 0.9977568984031677, 0.0002708089887164533)",0.9994573116824098,0.9977568984031677,0,0
2015-05-23,42.36909103393555,56.5625,57.1684160232544,56.50524616241455,57.130248069763184,9911171.75,,-0.0017291495813190607,-0.0017276563233116075,0.11941424831795074,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-24,42.29582595825195,56.46469497680664,57.01812934875488,56.38835716247559,56.94179344177246,10400404.5,,-0.001732144718634071,-0.0017306462860561356,0.07397745630594019,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-25,42.22256088256836,56.36688995361328,56.86784267425537,56.27146816253662,56.75333881378174,10889637.25,,-0.0017351502499756027,-0.0017336466158833451,0.07192350550990304,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-26,42.149295806884766,56.26908493041992,56.71755599975586,56.154579162597656,56.564884185791016,11378870.0,,0.008309287423707356,-0.0017366573668056921,0.07326635011353326,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-27,42.49953079223633,56.73664093017578,57.04198455810547,56.17366409301758,56.38358688354492,10193582.0,,0.004036328502935151,0.008274955347246404,0.07104343201560757,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-28,42.67106628417969,56.96564865112305,57.10877990722656,56.66030502319336,56.72710037231445,9987545.0,Merck Announces Has Submitted NDA for Grazoprevir/Elbasvir in US,0.01993303111194564,0.004028204382784488,0.07258560642494684,"[{'label': 'neutral', 'score': 0.9787635803222656}, {'label': 'positive', 'score': 0.02103121392428875}, {'label': 'negative', 'score': 0.00020526614389382303}]","(0.9787635803222656, 0.02103121392428875, 0.00020526614389382303)",0.9806685342170841,0.02103121392428875,1,0,"[{'label': 'neutral', 'score': 0.8369221687316895}, {'label': 'positive', 'score': 0.15465128421783447}, {'label': 'negative', 'score': 0.00842655636370182}]","(0.8369221687316895, 0.15465128421783447, 0.00842655636370182)",0.896656022257191,0.15465128421783447,1,0,"[{'label': 'neutral', 'score': 0.9868896007537842}, {'label': 'positive', 'score': 0.01289434265345335}, {'label': 'negative', 'score': 0.0002160543081117794}]","(0.9868896007537842, 0.01289434265345335, 0.0002160543081117794)",0.9670407679118838,0.01289434265345335,1,0
2015-05-29,43.52163314819336,58.10114669799805,58.32061004638672,56.74618148803711,57.13740539550781,20976349.0,"Merck Shares Spike Higher Following Report on Study Evaluating DNA Mismatch Repair as Genetic Guide for Immunotherapy Treatment with KEYTRUDA | Merck Shares Spiking Higher on Durable Anti-Tumor Activity With KEYTRUDA | Initial Study Evaluating DNA Mismatch Repair as Genetic Guide for Immunotherapy Treatment with Merck's KEYTRUDA (pembrolizumab) Showcased at 2015 ASCO Annual Meeting and Published in the New England Journal of Medicine | Amgen, Merck Report Expansion of Collaboration to Support Studies of Talimogene Laherparepvec in Combo with KEYTRUDA in Patients with Head and Neck Cancer",-0.000766426056595068,0.01973696936814284,0.1413240944590797,"[{'label': 'positive', 'score': 0.9995098114013672}, {'label': 'neutral', 'score': 0.0002798639761749655}, {'label': 'negative', 'score': 0.0002103525766870007}]","(0.0002798639761749655, 0.9995098114013672, 0.0002103525766870007)",0.9995791770852156,0.9995098114013672,0,0,"[{'label': 'positive', 'score': 0.9506465792655945}, {'label': 'neutral', 'score': 0.03319096937775612}, {'label': 'negative', 'score': 0.016162391752004623}]","(0.03319096937775612, 0.9506465792655945, 0.016162391752004623)",0.9665654907297909,0.9506465792655945,0,0,"[{'label': 'positive', 'score': 0.9952269792556763}, {'label': 'neutral', 'score': 0.004392455797642469}, {'label': 'negative', 'score': 0.00038053779280744493}]","(0.004392455797642469, 0.9952269792556763, 0.00038053779280744493)",0.999235566653945,0.9952269792556763,0,0
2015-05-30,43.48827870686849,58.05661646525065,58.50508880615234,57.02289962768555,57.44592920939128,18108951.0,,-0.0007670139160459744,-0.0007667199111999736,0.1382470900204823,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-05-31,43.45492426554362,58.01208623250326,58.68956756591797,57.299617767333984,57.75445302327474,15241553.0,"TESARO, Merck to Collaborate on Combination Study of Niraparib, KEYTRUDA",-0.0007676026779821032,-0.0007673082217203033,0.13500367359915783,"[{'label': 'neutral', 'score': 0.9998781681060791}, {'label': 'negative', 'score': 6.346961890812963e-05}, {'label': 'positive', 'score': 5.844893166795373e-05}]","(0.9998781681060791, 5.844893166795373e-05, 6.346961890812963e-05)",-0.04118066706380945,-6.346961890812963e-05,1,1,"[{'label': 'positive', 'score': 0.7077538967132568}, {'label': 'neutral', 'score': 0.2849542200565338}, {'label': 'negative', 'score': 0.007291869726032019}]","(0.2849542200565338, 0.7077538967132568, 0.007291869726032019)",0.9796044671032924,0.7077538967132568,0,0,"[{'label': 'neutral', 'score': 0.9910423755645752}, {'label': 'positive', 'score': 0.008784176781773567}, {'label': 'negative', 'score': 0.00017345626838505268}]","(0.9910423755645752, 0.008784176781773567, 0.00017345626838505268)",0.9612718521926993,0.008784176781773567,0,1
2015-06-01,43.42156982421875,57.96755599975586,58.8740463256836,57.57633590698242,58.0629768371582,12374155.0,"Merck Reports Acceptance of sBAL for KEYTRUDA in Advanced Non-Small Cell Lung Cancer, Priority Review Granted | Merck, Dynavax Partner On Investigating Combination Of Immuno-Oncology Therapies | Merck Announces New Data on Breadth of KEYTRUDA at ASCO: Anti-Tumor Activity Now Shown in 13 Different Tumor Types",-0.00839505688626636,-0.0007678974357653331,0.14096314355902176,"[{'label': 'positive', 'score': 0.9974787831306458}, {'label': 'neutral', 'score': 0.002201922470703721}, {'label': 'negative', 'score': 0.00031926349038258195}]","(0.002201922470703721, 0.9974787831306458, 0.00031926349038258195)",0.9993600639097987,0.9974787831306458,0,0,"[{'label': 'positive', 'score': 0.8589319586753845}, {'label': 'neutral', 'score': 0.13090017437934875}, {'label': 'negative', 'score': 0.010167833417654037}]","(0.13090017437934875, 0.8589319586753845, 0.010167833417654037)",0.9766014593257075,0.8589319586753845,0,0,"[{'label': 'positive', 'score': 0.9963957667350769}, {'label': 'neutral', 'score': 0.0033925706520676613}, {'label': 'negative', 'score': 0.00021173425193410367}]","(0.0033925706520676613, 0.9963957667350769, 0.00021173425193410367)",0.99957508998934,0.9963957667350769,0,0
2015-06-02,43.05703353881836,57.48091506958008,57.69084167480469,57.08015441894531,57.681297302246094,9424664.0,,0.0024900657188610125,-0.008430493845896938,0.16765672870367956,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-03,43.16425323486328,57.6240463256836,58.09160232543945,57.5,57.88167953491211,9078195.0,Merck Announces Results from Investigational IMPROVE-IT Study of VYTORIN Published in NEJoM,-0.015234349089005549,0.0024869706421172554,0.06420205827461394,"[{'label': 'neutral', 'score': 0.9998511075973511}, {'label': 'positive', 'score': 9.301424870500341e-05}, {'label': 'negative', 'score': 5.586709812632762e-05}]","(0.9998511075973511, 9.301424870500341e-05, 5.586709812632762e-05)",0.24950842647037658,9.301424870500341e-05,0,0,"[{'label': 'neutral', 'score': 0.681905210018158}, {'label': 'positive', 'score': 0.29934486746788025}, {'label': 'negative', 'score': 0.018749888986349106}]","(0.681905210018158, 0.29934486746788025, 0.018749888986349106)",0.8821112979330294,0.29934486746788025,0,0,"[{'label': 'neutral', 'score': 0.9986714124679565}, {'label': 'positive', 'score': 0.0011899258242920041}, {'label': 'negative', 'score': 0.00013865575601812452}]","(0.9986714124679565, 0.0011899258242920041, 0.00013865575601812452)",0.7912724998253275,0.0011899258242920041,0,0
2015-06-04,42.50666427612305,56.74618148803711,57.45228958129883,56.55534362792969,57.21374130249024,11350154.0,ALK Announces Merck's North American Phase III Trial of House Dust Mite SLIT-Tablet Meets Primary Endpoint,-0.008071232551459485,-0.015351583973849822,0.11498425894657152,"[{'label': 'neutral', 'score': 0.9998786449432373}, {'label': 'negative', 'score': 6.282341928454116e-05}, {'label': 'positive', 'score': 5.855340350535698e-05}]","(0.9998786449432373, 5.855340350535698e-05, 6.282341928454116e-05)",-0.03517982824921628,-6.282341928454116e-05,1,1,"[{'label': 'positive', 'score': 0.5198425650596619}, {'label': 'neutral', 'score': 0.4651724398136139}, {'label': 'negative', 'score': 0.014984977431595325}]","(0.4651724398136139, 0.5198425650596619, 0.014984977431595325)",0.9439633293311918,0.5198425650596619,0,0,"[{'label': 'neutral', 'score': 0.8083169460296631}, {'label': 'positive', 'score': 0.19118306040763855}, {'label': 'negative', 'score': 0.0004999612574465573}]","(0.8083169460296631, 0.19118306040763855, 0.0004999612574465573)",0.9947834580955208,0.19118306040763855,0,1
2015-06-05,42.1635971069336,56.28816986083984,56.68893051147461,56.10686874389648,56.64122009277344,11404126.0,,-0.0006780925613400212,-0.008103981283030479,0.11145672497398684,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-06,42.13500595092773,56.25000127156576,56.61259460449219,56.094146728515625,56.491729736328125,10414115.333333334,,-0.0006785526828670031,-0.0006783225700848895,0.11172481660169861,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-07,42.10641479492188,56.211832682291664,56.536258697509766,56.081424713134766,56.34223937988281,9424104.666666666,,-0.0006790134292509977,-0.0006787830039345764,0.1146827879026328,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-08,42.077823638916016,56.17366409301758,56.459922790527344,56.06870269775391,56.1927490234375,8434094.0,"TECOS, Merck's Cardiovascular Safety Trial of JANUVIA, Met Primary Endpoint in Patients with Type 2 Diabetes | This Technology Could Disrupt U.S. Pharma Stocks, Credit Suisse Says | UPDATE: Celgene Shares at High Following Early Rumored Bid from Merck | Hearing Unconfirmed Market Chatter of Potential Merck Bid for Celgene | Merck KGaA, Darmstadt, Germany, Illumina and Genea Create the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment",-0.0005095891240751049,-0.000679244063277892,0.10432593793870497,"[{'label': 'negative', 'score': 0.9458742737770081}, {'label': 'positive', 'score': 0.049976497888565063}, {'label': 'neutral', 'score': 0.0041491868905723095}]","(0.0041491868905723095, 0.049976497888565063, 0.9458742737770081)",-0.8996305484505902,-0.9458742737770081,0,0,"[{'label': 'positive', 'score': 0.6203925609588623}, {'label': 'negative', 'score': 0.3064674437046051}, {'label': 'neutral', 'score': 0.07313999533653259}]","(0.07313999533653259, 0.6203925609588623, 0.3064674437046051)",0.3386974469442556,0.6203925609588623,1,0,"[{'label': 'positive', 'score': 0.9478506445884705}, {'label': 'neutral', 'score': 0.0464707687497139}, {'label': 'negative', 'score': 0.0056785945780575275}]","(0.0464707687497139, 0.9478506445884705, 0.0056785945780575275)",0.9880893121158589,0.9478506445884705,0,0
2015-06-09,42.05637741088867,56.14503860473633,56.57442855834961,56.020992279052734,56.25954055786133,6754570.0,"Benzinga's M&A Chatter for  Monday June 8, 2015",0.013086349209153228,-0.000509719008739831,0.05302647252109762,"[{'label': 'neutral', 'score': 0.9998869895935059}, {'label': 'negative', 'score': 6.842131551820785e-05}, {'label': 'positive', 'score': 4.4569755118573084e-05}]","(0.9998869895935059, 4.4569755118573084e-05, 6.842131551820785e-05)",-0.21109243646613068,-6.842131551820785e-05,0,0,"[{'label': 'neutral', 'score': 0.9403552412986755}, {'label': 'negative', 'score': 0.03926755487918854}, {'label': 'positive', 'score': 0.020377211272716522}]","(0.9403552412986755, 0.020377211272716522, 0.03926755487918854)",-0.31671418676303514,-0.03926755487918854,0,0,"[{'label': 'neutral', 'score': 0.9995927214622498}, {'label': 'positive', 'score': 0.00024281450896523893}, {'label': 'negative', 'score': 0.00016441232583019882}]","(0.9995927214622498, 0.00024281450896523893, 0.00016441232583019882)",0.1925270547910328,0.00024281450896523893,0,0
2015-06-10,42.606746673583984,56.8797721862793,56.92748260498047,56.21183013916016,56.27862548828125,10713914.0,"Merck, Samsung Bioepis Report Pivotal Phase 3 Studies for Investigational Biosimilars SB4, Enbrel (Etanercept), and SB2, Remicade (Infliximab), Met Primary Endpoints | US Stock Futures Signal Higher Start On Wall Street | Merck Publishes ALK's Data On Phase II House Dust Mite SLIT-Tablet In Leading Allergy Journal | TECOS, Merck's Cardiovascular Safety Trial of JANUVIA, Met Primary Endpoint in Patients with Type 2 Diabetes",-0.011743050674177215,0.013001462708908337,0.0968270267272117,"[{'label': 'neutral', 'score': 0.8578855991363525}, {'label': 'positive', 'score': 0.14153780043125153}, {'label': 'negative', 'score': 0.0005766108515672386}]","(0.8578855991363525, 0.14153780043125153, 0.0005766108515672386)",0.9918852585552391,0.14153780043125153,0,1,"[{'label': 'positive', 'score': 0.8780178427696228}, {'label': 'neutral', 'score': 0.10654821246862411}, {'label': 'negative', 'score': 0.01543387770652771}]","(0.10654821246862411, 0.8780178427696228, 0.01543387770652771)",0.9654511209664413,0.8780178427696228,0,0,"[{'label': 'positive', 'score': 0.9933459758758545}, {'label': 'neutral', 'score': 0.0062593431212008}, {'label': 'negative', 'score': 0.0003947266668546945}]","(0.0062593431212008, 0.9933459758758545, 0.0003947266668546945)",0.9992055741183898,0.9933459758758545,0,0
2015-06-11,42.42668533325195,56.21183013916016,56.65076446533203,56.14503860473633,56.488548278808594,12199034.0,,-0.017653988023828684,-0.011812544878816274,0.13967402496938652,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-12,41.67768859863281,55.21946716308594,56.10686874389648,55.14313125610352,56.09732818603516,16571290.0,,-0.004320026299236258,-0.017811678335335295,0.18834884844683134,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-13,41.49763870239258,54.98091761271159,55.73791249593099,54.89822006225586,55.71882883707682,14578064.0,,-0.004338769899307731,-0.004329384574571509,0.18660333698942577,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-14,41.31758880615234,54.74236806233724,55.36895624796549,54.6533088684082,55.34032948811849,12584838.0,,-0.004357676856483552,-0.004348209676001894,0.18366796035432412,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-15,41.13753890991211,54.50381851196289,55.0,54.40839767456055,54.96183013916016,10591612.0,JMP Sees A 'Negative Market Tone' In Biotechnology,0.010329126518624191,-0.004367199203887428,0.09701195811141027,"[{'label': 'negative', 'score': 0.9583170413970947}, {'label': 'neutral', 'score': 0.03653647005558014}, {'label': 'positive', 'score': 0.005146479699760675}]","(0.03653647005558014, 0.005146479699760675, 0.9583170413970947)",-0.9893167108311446,-0.9583170413970947,0,0,"[{'label': 'negative', 'score': 0.9631632566452026}, {'label': 'neutral', 'score': 0.02815265581011772}, {'label': 'positive', 'score': 0.008684053085744381}]","(0.02815265581011772, 0.008684053085744381, 0.9631632566452026)",-0.9821287706437166,-0.9631632566452026,0,0,"[{'label': 'negative', 'score': 0.9882996082305908}, {'label': 'neutral', 'score': 0.011083883233368397}, {'label': 'positive', 'score': 0.0006165522499941289}]","(0.011083883233368397, 0.0006165522499941289, 0.9882996082305908)",-0.9987530747809915,-0.9882996082305908,0,0
2015-06-16,41.56245803833008,55.06679534912109,55.08587646484375,54.274810791015625,54.61832046508789,7303407.0,"Benzinga's M&A Chatter for Tuesday June 16, 2015 | New Report: Abbvie Is Jefferies' Top Global Pharma Stock | Alkermes Declines Comment on Rumored Potential Bid from Merck | Alkermes Shares Off the Highs; Shares Moving Higher on Takeover Chatter, Upcoming Presentation of Data from Late-Stage CNS Portfolio | Hearing Merck Approached Dublin Based Alkermes With $12.4B Offer-Market Sources",0.0034655704748666116,0.010276145609997294,0.15772344463066726,"[{'label': 'positive', 'score': 0.9978944659233093}, {'label': 'neutral', 'score': 0.001708193332888186}, {'label': 'negative', 'score': 0.00039736388134770095}]","(0.001708193332888186, 0.9978944659233093, 0.00039736388134770095)",0.9992039123841664,0.9978944659233093,0,0,"[{'label': 'positive', 'score': 0.4853438436985016}, {'label': 'negative', 'score': 0.46757772564888}, {'label': 'neutral', 'score': 0.04707842692732811}]","(0.04707842692732811, 0.4853438436985016, 0.46757772564888)",0.018643840816604557,0.4853438436985016,1,1,"[{'label': 'neutral', 'score': 0.7989432215690613}, {'label': 'positive', 'score': 0.11394301801919937}, {'label': 'negative', 'score': 0.08711381256580353}]","(0.7989432215690613, 0.11394301801919937, 0.08711381256580353)",0.13344090511788398,0.11394301801919937,1,1
2015-06-17,41.70649337768555,55.25763320922852,55.5057258605957,54.83778762817383,55.06679534912109,8297330.0,"Hearing Dept. of Justice Has Said Merck's Inspire Pharma to Pay $5.9M to Settle Civil Claims of Fraud | The Note Moving Pharma Giants Today | Organovo Has Upside To $6/Share, Cantor Fitzgerald Says | Piper Jaffray Initiates Coverage on Merck & Co at Neutral",0.01174239790984822,0.003459579223587219,0.10475831389743687,"[{'label': 'positive', 'score': 0.9175015091896057}, {'label': 'negative', 'score': 0.08178640156984329}, {'label': 'neutral', 'score': 0.0007120349328033626}]","(0.0007120349328033626, 0.9175015091896057, 0.08178640156984329)",0.8363106354250069,0.9175015091896057,0,0,"[{'label': 'neutral', 'score': 0.512069821357727}, {'label': 'positive', 'score': 0.2850009500980377}, {'label': 'negative', 'score': 0.20292922854423523}]","(0.512069821357727, 0.2850009500980377, 0.20292922854423523)",0.16820382330557493,0.2850009500980377,1,1,"[{'label': 'positive', 'score': 0.9985647797584534}, {'label': 'neutral', 'score': 0.0011915366631001234}, {'label': 'negative', 'score': 0.00024374882923439145}]","(0.0011915366631001234, 0.9985647797584534, 0.00024374882923439145)",0.9995119208091283,0.9985647797584534,0,0
2015-06-18,42.19621658325195,55.90649032592773,56.17366409301758,55.25763320922852,55.25763320922852,7797644.0,,-0.009387296322055592,0.011673990942642326,0.12195747610954424,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-19,41.80012130737305,55.38167953491211,56.14503860473633,55.29580307006836,55.73473358154297,13218948.0,,0.004537088218800071,-0.009431634684563742,0.14525729158525644,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-20,41.98977533976237,55.63295110066732,56.259541829427086,55.4484748840332,55.85559844970703,11733932.0,,0.00451659602418964,0.0045268266607365855,0.13262758623968532,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-21,42.179429372151695,55.88422266642253,56.37404505411784,55.60114669799805,55.97646331787109,10248916.0,Barron's Recap: Airline Stocks Ready To Soar | Barron's Says Merck Shares Could Rise More than 20% to $70,0.004496288107200791,0.0045064268130154995,0.12156737335669798,"[{'label': 'positive', 'score': 0.999625563621521}, {'label': 'negative', 'score': 0.0002143039891961962}, {'label': 'neutral', 'score': 0.0001601410040166229}]","(0.0001601410040166229, 0.999625563621521, 0.0002143039891961962)",0.9995713233765957,0.999625563621521,0,0,"[{'label': 'positive', 'score': 0.9458253979682922}, {'label': 'neutral', 'score': 0.03275218978524208}, {'label': 'negative', 'score': 0.021422427147626877}]","(0.03275218978524208, 0.9458253979682922, 0.021422427147626877)",0.955704367399204,0.9458253979682922,0,0,"[{'label': 'positive', 'score': 0.9966723918914795}, {'label': 'neutral', 'score': 0.003025609767064452}, {'label': 'negative', 'score': 0.0003020071890205145}]","(0.003025609767064452, 0.9966723918914795, 0.0003020071890205145)",0.9993941525694159,0.9966723918914795,0,0
2015-06-22,42.369083404541016,56.13549423217773,56.488548278808594,55.75381851196289,56.09732818603516,8763900.0,,0.0033996614337333335,0.004486210001913864,0.12205755377251727,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-23,42.51310348510742,56.32633590698242,56.34542083740234,55.83969497680664,56.183204650878906,8772808.0,,-0.01338305607536322,0.003393895648916634,0.09727756162799145,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-24,41.94415664672852,55.57251739501953,56.32633590698242,55.57251739501953,56.22137451171875,8288003.0,,-0.005837863009628911,-0.013473416272971073,0.12590270113094154,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-25,41.69929122924805,55.24809265136719,55.91603088378906,55.07633590698242,55.582061767578125,10428858.0,,0.010189977791826475,-0.005854969943001892,0.12752285795497814,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-26,42.124210357666016,55.81106948852539,55.84923553466797,55.200382232666016,55.55343627929688,13711718.0,,-0.006838778371566266,0.010138409988769055,0.14847172528068833,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-27,41.83612950642904,55.42938995361328,55.7506357828776,55.00954310099284,55.46119689941406,12495164.666666666,,-0.00688586930564313,-0.006862269980238642,0.14746287525733562,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-28,41.548048655192055,55.04771041870117,55.65203603108724,54.818703969319664,55.36895751953125,11278611.333333334,,-0.006933613260369911,-0.006909686300469076,0.13929494443500015,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-06-29,41.25996780395508,54.66603088378906,55.55343627929688,54.62786483764648,55.27671813964844,10062058.0,Merck Announces Phase 3 Study of Single-Dose EMEND (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint,-0.0062838564134971514,-0.006957762448952909,0.11938035900551854,"[{'label': 'neutral', 'score': 0.9998809099197388}, {'label': 'positive', 'score': 6.624028173973784e-05}, {'label': 'negative', 'score': 5.281386984279379e-05}]","(0.9998809099197388, 6.624028173973784e-05, 5.281386984279379e-05)",0.11277567156183113,6.624028173973784e-05,1,1,"[{'label': 'positive', 'score': 0.7733972072601318}, {'label': 'neutral', 'score': 0.21630406379699707}, {'label': 'negative', 'score': 0.010298753157258034}]","(0.21630406379699707, 0.7733972072601318, 0.010298753157258034)",0.9737174780082495,0.7733972072601318,0,0,"[{'label': 'neutral', 'score': 0.999321460723877}, {'label': 'positive', 'score': 0.0005722140776924789}, {'label': 'negative', 'score': 0.00010640724212862551}]","(0.999321460723877, 0.0005722140776924789, 0.00010640724212862551)",0.6864017117626774,0.0005722140776924789,0,1
2015-06-30,41.00069808959961,54.32251739501953,55.06679534912109,54.11259460449219,55.06679534912109,12415970.0,,0.01176883500246707,-0.006303682940884157,0.12002865389069739,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-01,41.48323440551758,54.96183013916016,55.21946716308594,54.01717758178711,54.32251739501953,9830345.0,,0.001215304311227714,0.011700120861953229,0.1311094813585585,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-02,41.53364562988281,55.02862548828125,55.65839767456055,54.86641311645508,55.286258697509766,8927283.0,,-0.0005201926820313913,0.001214566426718937,0.12889852209194513,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-03,41.51204204559326,55.0,55.54150867462158,54.6612606048584,55.1192741394043,8805636.5,,-0.0005204634232954545,-0.0005203280291843934,0.11949067230679321,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-04,41.49043846130371,54.97137451171875,55.42461967468262,54.45610809326172,54.95228958129883,8683990.0,,-0.0005207344465281224,-0.0005205989113960817,0.10422948199522623,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-05,41.46883487701416,54.9427490234375,55.30773067474365,54.25095558166504,54.78530502319336,8562343.5,,-0.0005210057521701167,-0.0005208700757966139,0.08452465393816075,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-06,41.44723129272461,54.91412353515625,55.19084167480469,54.04580307006836,54.61832046508789,8440697.0,9 Top Sell Ideas From Oppenheimer's Technical Analysis Division,0.007645493618520573,-0.000521141522827208,0.012319416373236938,"[{'label': 'neutral', 'score': 0.9990878105163574}, {'label': 'positive', 'score': 0.0008178568095900118}, {'label': 'negative', 'score': 9.434387175133452e-05}]","(0.9990878105163574, 0.0008178568095900118, 9.434387175133452e-05)",0.7931510605481976,0.0008178568095900118,1,0,"[{'label': 'neutral', 'score': 0.9033525586128235}, {'label': 'positive', 'score': 0.07913553714752197}, {'label': 'negative', 'score': 0.017511902377009392}]","(0.9033525586128235, 0.07913553714752197, 0.017511902377009392)",0.6376126990396995,0.07913553714752197,1,0,"[{'label': 'neutral', 'score': 0.9816523194313049}, {'label': 'positive', 'score': 0.018109401687979698}, {'label': 'negative', 'score': 0.0002382419625064358}]","(0.9816523194313049, 0.018109401687979698, 0.0002382419625064358)",0.9740302387549233,0.018109401687979698,1,0
2015-07-07,41.76410675048828,55.33396911621094,55.43893051147461,54.56106948852539,55.10496139526367,9467946.0,"Allergan, Merck Enter Licensing Agreement to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program",-0.011036389863463902,0.007616414951977363,0.057768031595350294,"[{'label': 'positive', 'score': 0.9947825074195862}, {'label': 'neutral', 'score': 0.004962223581969738}, {'label': 'negative', 'score': 0.0002552235091570765}]","(0.004962223581969738, 0.9947825074195862, 0.0002552235091570765)",0.9994870073742452,0.9947825074195862,0,0,"[{'label': 'positive', 'score': 0.9113084673881531}, {'label': 'neutral', 'score': 0.07854576408863068}, {'label': 'negative', 'score': 0.010145739652216434}]","(0.07854576408863068, 0.9113084673881531, 0.010145739652216434)",0.9779788521780075,0.9113084673881531,0,0,"[{'label': 'positive', 'score': 0.8195186257362366}, {'label': 'neutral', 'score': 0.18004091084003448}, {'label': 'negative', 'score': 0.0004405182262416929}]","(0.18004091084003448, 0.8195186257362366, 0.0004405182262416929)",0.9989255117660792,0.8195186257362366,0,0
2015-07-08,41.30318832397461,54.72328186035156,55.09542083740234,54.50381851196289,55.08587646484375,9548957.0,,0.0005230952404188666,-0.01109774264047208,0.10556706572724914,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-09,41.324798583984375,54.75190734863281,55.5057258605957,54.72328186035156,55.38167953491211,9094334.0,"Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz",0.009933822359325136,0.0005229584737962293,0.10612955593956432,"[{'label': 'positive', 'score': 0.9953730702400208}, {'label': 'neutral', 'score': 0.004317680839449167}, {'label': 'negative', 'score': 0.0003092098340857774}]","(0.004317680839449167, 0.9953730702400208, 0.0003092098340857774)",0.999378898589894,0.9953730702400208,0,0,"[{'label': 'positive', 'score': 0.8450023531913757}, {'label': 'neutral', 'score': 0.1490977704524994}, {'label': 'negative', 'score': 0.005899885203689337}]","(0.1490977704524994, 0.8450023531913757, 0.005899885203689337)",0.9861326367766585,0.8450023531913757,0,0,"[{'label': 'positive', 'score': 0.9906708002090454}, {'label': 'neutral', 'score': 0.00907038152217865}, {'label': 'negative', 'score': 0.00025887455558404326}]","(0.00907038152217865, 0.9906708002090454, 0.00025887455558404326)",0.999477511750477,0.9906708002090454,0,0
2015-07-10,41.73529815673828,55.29580307006836,55.582061767578125,54.9427490234375,55.41030502319336,8433675.0,Strong Dollar? Not So Good For Johnson & Johnson Earnings,-0.0004601669731649106,0.009884806289970929,0.13071637336702366,"[{'label': 'negative', 'score': 0.5052098631858826}, {'label': 'positive', 'score': 0.4896825850009918}, {'label': 'neutral', 'score': 0.005107562523335218}]","(0.005107562523335218, 0.4896825850009918, 0.5052098631858826)",-0.015606991703664233,-0.5052098631858826,1,0,"[{'label': 'neutral', 'score': 0.5316280722618103}, {'label': 'positive', 'score': 0.2361702024936676}, {'label': 'negative', 'score': 0.23220175504684448}]","(0.5316280722618103, 0.2361702024936676, 0.23220175504684448)",0.00847285449722909,0.2361702024936676,1,1,"[{'label': 'negative', 'score': 0.9945189356803894}, {'label': 'neutral', 'score': 0.004359274171292782}, {'label': 'positive', 'score': 0.001121802837587893}]","(0.004359274171292782, 0.001121802837587893, 0.9945189356803894)",-0.997746571038751,-0.9945189356803894,0,0
2015-07-11,41.716094970703125,55.27035776774088,55.67748133341471,54.97455596923828,55.46755727132162,8813190.666666666,,-0.00046037882429499565,-0.00046027288247835364,0.1306642074652319,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-12,41.69689178466797,55.24491246541341,55.7729008992513,55.00636291503906,55.52480951944987,9192706.333333334,,-0.00046059087057834496,-0.00046048483116267204,0.11800851623330202,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-13,41.67768859863281,55.21946716308594,55.86832046508789,55.03816986083984,55.582061767578125,9572222.0,,0.0055296373474209995,-0.0004606969751351778,0.07201682037611294,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-14,41.90815353393555,55.524810791015625,55.610687255859375,55.03816986083984,55.24809265136719,7582385.0,,0.0005155440941347422,0.005514405029819481,0.07507093924913737,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-15,41.92975997924805,55.55343627929688,55.87786483764648,55.41030502319336,55.49618148803711,6024533.0,,0.010305706241845644,0.0005154112469352787,0.04123477718023525,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-07-16,42.36186599731445,56.125953674316406,56.17366409301758,55.67748260498047,55.83015441894531,5580286.0,,0.0,0.010252964502357326,0.07489089778793312,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-17,42.36186599731445,56.125953674316406,56.22137451171875,55.90649032592773,56.011451721191406,7324367.0,,0.001020067266214658,0.0,0.07358231128021521,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-18,42.40508143107096,56.18320592244466,56.31043243408203,55.99236806233724,56.09414800008138,6873133.333333333,,0.0010190277893235326,0.0010195473511363476,0.06963236558465756,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-19,42.44829686482748,56.240458170572914,56.39949035644531,56.07824579874674,56.17684427897135,6421899.666666667,,0.0010179904287873328,0.001018508932962023,0.06858486778120527,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-20,42.491512298583984,56.29771041870117,56.488548278808594,56.16412353515625,56.25954055786133,5970666.0,,-0.005593264773049823,0.001017472627911796,0.06772862524754325,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-21,42.25383758544922,55.98282241821289,56.31679534912109,55.96374130249024,56.28816986083984,7265574.0,,-0.009204009304993519,-0.005608965651946082,0.04578122175710574,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-07-22,41.86493682861328,55.46755599975586,56.32633590698242,55.35305404663086,55.83015441894531,9031454.0,"What's Coming For Large-Cap Pharma Stocks This Earnings Season? | European Commission Approves MSD's Anti-PD-1 Therapy, KEYTRUDA (pembrolizumab), for Both First-line and Previously-treated Patients with Advanced Melanoma",-0.0010321524994314152,-0.009246627908217842,0.07622425846720886,"[{'label': 'positive', 'score': 0.9986444115638733}, {'label': 'neutral', 'score': 0.0010821393225342035}, {'label': 'negative', 'score': 0.0002734492009039968}]","(0.0010821393225342035, 0.9986444115638733, 0.0002734492009039968)",0.999452509136848,0.9986444115638733,0,0,"[{'label': 'positive', 'score': 0.877299964427948}, {'label': 'neutral', 'score': 0.11287471652030945}, {'label': 'negative', 'score': 0.009825333952903748}]","(0.11287471652030945, 0.877299964427948, 0.009825333952903748)",0.9778490502506544,0.877299964427948,0,0,"[{'label': 'neutral', 'score': 0.6694102883338928}, {'label': 'positive', 'score': 0.3288819491863251}, {'label': 'negative', 'score': 0.0017077955417335033}]","(0.6694102883338928, 0.3288819491863251, 0.0017077955417335033)",0.9896681880247779,0.3288819491863251,0,1
2015-07-23,41.82174682617188,55.41030502319336,55.84923553466797,55.286258697509766,55.84923553466797,6750797.0,"MSD Reports European Medicines Agency Acceptance of Marketing Authorisation Application for Grazoprevir/Elbasvir, an Investigational Therapy for Treatment of Chronic Hepatitis C Infection | RaNA Therapeutics Announces $55 Million in Oversubscribed Series B Financing Led by Merck",-0.011365614861995256,-0.001032685535637157,0.0717531462394035,"[{'label': 'neutral', 'score': 0.9997373223304749}, {'label': 'positive', 'score': 0.00015937103307805955}, {'label': 'negative', 'score': 0.00010329941142117605}]","(0.9997373223304749, 0.00015937103307805955, 0.00010329941142117605)",0.21346757060460483,0.00015937103307805955,0,0,"[{'label': 'positive', 'score': 0.9168606996536255}, {'label': 'neutral', 'score': 0.06773929297924042}, {'label': 'negative', 'score': 0.015400009229779243}]","(0.06773929297924042, 0.9168606996536255, 0.015400009229779243)",0.9669620116282187,0.9168606996536255,0,0,"[{'label': 'positive', 'score': 0.9980265498161316}, {'label': 'neutral', 'score': 0.0017726380610838532}, {'label': 'negative', 'score': 0.00020077168301213533}]","(0.0017726380610838532, 0.9980265498161316, 0.00020077168301213533)",0.9995977435626374,0.9980265498161316,0,0
2015-07-24,41.34639739990234,54.78053283691406,55.22900772094727,54.69465637207031,55.06679534912109,8223761.0,,-0.002438583135775997,-0.011430697065344598,0.08376316528930615,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-25,41.2455685933431,54.64694595336914,55.09223937988281,54.47519048055013,54.977736155192055,10683032.666666666,,-0.0024445443604279933,-0.0024415613223199408,0.06987993775731094,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-26,41.14473978678385,54.51335906982422,54.95547103881836,54.255724589029946,54.88867696126302,13142304.333333332,,-0.002450534801456927,-0.0024475371373050988,0.07432107497680225,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-27,41.04391098022461,54.3797721862793,54.81870269775391,54.036258697509766,54.799617767333984,15601576.0,Dollar Plagues Pharma Earnings But Did Street Get It Right? | Merck Receives Positive CHMP Opinion for Investigational Antibiotic ZERBAXA,0.009299819134329335,-0.0024535422761491287,0.06699488641831573,"[{'label': 'positive', 'score': 0.9993799924850464}, {'label': 'negative', 'score': 0.00035824120277538896}, {'label': 'neutral', 'score': 0.00026175976381637156}]","(0.00026175976381637156, 0.9993799924850464, 0.00035824120277538896)",0.9992833299943849,0.9993799924850464,0,0,"[{'label': 'positive', 'score': 0.8585367202758789}, {'label': 'negative', 'score': 0.0965690091252327}, {'label': 'neutral', 'score': 0.04489423707127571}]","(0.04489423707127571, 0.8585367202758789, 0.0965690091252327)",0.7977836250950243,0.8585367202758789,0,0,"[{'label': 'positive', 'score': 0.9976267218589783}, {'label': 'negative', 'score': 0.001349613070487976}, {'label': 'neutral', 'score': 0.0010237200185656548}]","(0.0010237200185656548, 0.9976267218589783, 0.001349613070487976)",0.9972980079241152,0.9976267218589783,0,0
2015-07-28,41.42560958862305,54.88549423217773,55.0,53.27289962768555,53.931297302246094,17173681.0,"Merck Q2 Profit Beats Estimates | UPDATE: Merck Sees FY15 Adj. EPS $3.45-$3.55 vs $3.45 Est. | Merck Narrows, Raises FY15 Adj. EPS Outlook | Merck Reports Q2 Adj. EPS $0.86 vs $0.81 Est., Sales $9.8B, Inline | Merck Boosts Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics | Merck Announces FDA Priority Review For NDA For Hepatits C Treatment | Earnings Scheduled For July 28, 2015 | 10 Stocks You Should Be Watching Today",0.01773302196991472,0.009256842063541935,0.1167096883315374,"[{'label': 'positive', 'score': 0.9995385408401489}, {'label': 'negative', 'score': 0.0003263393882662058}, {'label': 'neutral', 'score': 0.00013518170453608036}]","(0.00013518170453608036, 0.9995385408401489, 0.0003263393882662058)",0.9993472330217426,0.9995385408401489,1,1,"[{'label': 'positive', 'score': 0.9055978655815125}, {'label': 'neutral', 'score': 0.06859027594327927}, {'label': 'negative', 'score': 0.02581189200282097}]","(0.06859027594327927, 0.9055978655815125, 0.02581189200282097)",0.9445745724851206,0.9055978655815125,1,1,"[{'label': 'positive', 'score': 0.997991681098938}, {'label': 'neutral', 'score': 0.0012021379079669714}, {'label': 'negative', 'score': 0.000806247116997838}]","(0.0012021379079669714, 0.997991681098938, 0.000806247116997838)",0.998385565099363,0.997991681098938,1,1
2015-07-29,42.16021728515625,55.85877990722656,56.125953674316406,55.0,55.04771041870117,13494048.0,,-0.0003416639327178147,0.0175776263359058,0.1456323520790291,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-30,42.14581680297852,55.83969497680664,56.125953674316406,55.610687255859375,55.93511581420898,7324996.0,,0.007518765659967751,-0.0003417223131373341,0.14054748611559623,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-07-31,42.46269989013672,56.25954055786133,56.61259460449219,56.011451721191406,56.29771041870117,9172620.0,Merck Announces Global Collaboration Enabled Vaccine for Ebola Will Move from First-in-Human to Initial Phase 3 Results Within One Year | WHO Says Initial Results from Merck/Newlink VSV-EBOV Ebola Vaccine Look Promising -Reuters,0.0005088338717868799,0.00749064063046843,0.12751148305206414,"[{'label': 'positive', 'score': 0.9994231462478638}, {'label': 'neutral', 'score': 0.00035659881541505456}, {'label': 'negative', 'score': 0.00022027615341357887}]","(0.00035659881541505456, 0.9994231462478638, 0.00022027615341357887)",0.999559290546054,0.9994231462478638,0,0,"[{'label': 'positive', 'score': 0.6931095719337463}, {'label': 'neutral', 'score': 0.2977600395679474}, {'label': 'negative', 'score': 0.009130418300628662}]","(0.2977600395679474, 0.6931095719337463, 0.009130418300628662)",0.9739963020403285,0.6931095719337463,0,0,"[{'label': 'positive', 'score': 0.9970667958259583}, {'label': 'neutral', 'score': 0.0026671846862882376}, {'label': 'negative', 'score': 0.00026601608260534704}]","(0.0026671846862882376, 0.9970667958259583, 0.00026601608260534704)",0.9994665450099927,0.9970667958259583,0,0
2015-08-01,42.484307607014976,56.288167317708336,56.650763193766274,55.94147618611654,56.39312998453776,8492992.0,,0.0005085750915538238,0.000508704459729999,0.1158965338394543,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-02,42.50591532389323,56.316794077555336,56.68893178304037,55.871500651041664,56.48854955037435,7813364.0,,0.0005083165744054572,0.00050844581107271,0.1212008930723582,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-03,42.52752304077149,56.34542083740234,56.72710037231445,55.8015251159668,56.58396911621094,7133736.0,"Codexis Reports CodeEvolver Technology Transfer, License Deal with Merck; Will Receive Up to $5M Upfront Payment, Eligibile for Up to $18M in Milestones",-0.005927174049771942,0.0005081874252995248,0.051410788861963715,"[{'label': 'neutral', 'score': 0.9976402521133423}, {'label': 'positive', 'score': 0.002292727353051305}, {'label': 'negative', 'score': 6.71167581458576e-05}]","(0.9976402521133423, 0.002292727353051305, 6.71167581458576e-05)",0.9431176340611678,0.002292727353051305,0,1,"[{'label': 'positive', 'score': 0.79697185754776}, {'label': 'neutral', 'score': 0.19383390247821808}, {'label': 'negative', 'score': 0.009194258600473404}]","(0.19383390247821808, 0.79697185754776, 0.009194258600473404)",0.9771901636243346,0.79697185754776,0,0,"[{'label': 'neutral', 'score': 0.9724518656730652}, {'label': 'positive', 'score': 0.027343999594449997}, {'label': 'negative', 'score': 0.00020418610074557364}]","(0.9724518656730652, 0.027343999594449997, 0.00020418610074557364)",0.9851760763482015,0.027343999594449997,0,1
2015-08-04,42.27543640136719,56.011451721191406,56.74618148803711,55.696563720703125,56.71755599975586,7268718.0,"Guinea, Sierra Leone Each Recorded Single Cases of Ebola in Past Week; WHO Says Risks Remain -Reuters | Morning Market Gainers",0.006814312487596382,-0.005944809465862872,0.07544133050676773,"[{'label': 'neutral', 'score': 0.5841354727745056}, {'label': 'negative', 'score': 0.41299012303352356}, {'label': 'positive', 'score': 0.0028744679875671864}]","(0.5841354727745056, 0.0028744679875671864, 0.41299012303352356)",-0.9861759426042531,-0.41299012303352356,0,1,"[{'label': 'neutral', 'score': 0.6690526604652405}, {'label': 'positive', 'score': 0.24099218845367432}, {'label': 'negative', 'score': 0.08995514363050461}]","(0.6690526604652405, 0.24099218845367432, 0.08995514363050461)",0.456377889110018,0.24099218845367432,1,1,"[{'label': 'neutral', 'score': 0.8140972852706909}, {'label': 'negative', 'score': 0.1799609214067459}, {'label': 'positive', 'score': 0.00594185059890151}]","(0.8140972852706909, 0.00594185059890151, 0.1799609214067459)",-0.9360757181316155,-0.1799609214067459,0,1
2015-08-05,42.56352615356445,56.39313125610352,56.564884185791016,56.078243255615234,56.3740463256836,5976325.0,,-0.011336712998561118,0.006791199998000143,0.07148451903596897,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-08-06,42.08099365234375,55.75381851196289,56.536258697509766,55.64885330200195,56.450382232666016,7356646.0,,-0.007872722225791485,-0.011401463365387858,0.11048900650058217,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-07,41.74970626831055,55.314884185791016,55.77289962768555,55.02862548828125,55.67748260498047,10178595.0,"ALK's Partner, Torii Pharmaceutical, Reports Positive Phase II/III Trial Results for Japanese Cedar SLIT-tablet",0.002530056794730376,-0.007903875719673683,0.11494998075991489,"[{'label': 'positive', 'score': 0.9991083741188049}, {'label': 'neutral', 'score': 0.0005640062154270709}, {'label': 'negative', 'score': 0.0003276168426964432}]","(0.0005640062154270709, 0.9991083741188049, 0.0003276168426964432)",0.9993443965483347,0.9991083741188049,0,0,"[{'label': 'positive', 'score': 0.9516628384590149}, {'label': 'neutral', 'score': 0.03190113231539726}, {'label': 'negative', 'score': 0.016436075791716576}]","(0.03190113231539726, 0.9516628384590149, 0.016436075791716576)",0.9660446354194345,0.9516628384590149,0,0,"[{'label': 'positive', 'score': 0.9984956979751587}, {'label': 'neutral', 'score': 0.0012210506247356534}, {'label': 'negative', 'score': 0.00028322089929133654}]","(0.0012210506247356534, 0.9984956979751587, 0.00028322089929133654)",0.9994328656844089,0.9984956979751587,0,0
2015-08-08,41.85533650716146,55.454833984375,55.82379023234049,55.21628443400065,55.64885584513346,8550701.666666666,,0.002523671761841531,0.002526861589270884,0.12025516671759612,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-09,41.96096674601237,55.59478378295898,55.874680836995445,55.40394337972005,55.62022908528646,6922808.333333334,,0.002517318875280691,0.0025204926498275763,0.12300755362948314,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-10,42.06659698486328,55.73473358154297,55.92557144165039,55.59160232543945,55.59160232543945,5294915.0,Here's Which IT Stocks Benefit From Healthcare M&A,-0.011128209894701943,0.0025141557354298166,0.1076485966073893,"[{'label': 'neutral', 'score': 0.9998242259025574}, {'label': 'positive', 'score': 0.00012313654588069767}, {'label': 'negative', 'score': 5.26233488926664e-05}]","(0.9998242259025574, 0.00012313654588069767, 5.26233488926664e-05)",0.4011904824986124,0.00012313654588069767,1,1,"[{'label': 'neutral', 'score': 0.9311079978942871}, {'label': 'positive', 'score': 0.05599077045917511}, {'label': 'negative', 'score': 0.012901216745376587}]","(0.9311079978942871, 0.05599077045917511, 0.012901216745376587)",0.6254653910019828,0.05599077045917511,0,1,"[{'label': 'positive', 'score': 0.8861830830574036}, {'label': 'neutral', 'score': 0.11301082372665405}, {'label': 'negative', 'score': 0.000806063471827656}]","(0.11301082372665405, 0.8861830830574036, 0.000806063471827656)",0.9981824727506943,0.8861830830574036,0,0
2015-08-11,41.59846115112305,55.114505767822266,55.524810791015625,54.92366409301758,55.27671813964844,7418058.0,"Sigma-Aldrich, Merck, Darmstadt, Germany, Report Antitrust Approval in Brazil for Planned Purchase",0.008656460780525276,-0.011190591652369455,0.10653606335238174,"[{'label': 'positive', 'score': 0.86738520860672}, {'label': 'neutral', 'score': 0.1310095191001892}, {'label': 'negative', 'score': 0.0016053062863647938}]","(0.1310095191001892, 0.86738520860672, 0.0016053062863647938)",0.9963053537205471,0.86738520860672,0,0,"[{'label': 'positive', 'score': 0.7505186796188354}, {'label': 'neutral', 'score': 0.23485924303531647}, {'label': 'negative', 'score': 0.014622078277170658}]","(0.23485924303531647, 0.7505186796188354, 0.014622078277170658)",0.9617793768629483,0.7505186796188354,0,0,"[{'label': 'neutral', 'score': 0.7819267511367798}, {'label': 'positive', 'score': 0.21755161881446838}, {'label': 'negative', 'score': 0.0005216248100623488}]","(0.7819267511367798, 0.21755161881446838, 0.0005216248100623488)",0.9952160585921264,0.21755161881446838,0,1
2015-08-12,41.95856094360352,55.59160232543945,55.610687255859375,54.50381851196289,54.65649032592773,7886514.0,,0.01235839828504828,0.008619208451748172,0.11600309917427092,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-13,42.47710037231445,56.27862548828125,56.72710037231445,55.82061004638672,55.86832046508789,11483146.0,"Calls Of Note: Wall Street Research Moving The Market On Thursday | What Are Payors Saying About Managed Care Giants? | Good Data May Be Coming For Merck (And This Analyst Is Bullish) | Benzinga's Top Upgrades | US Stock Futures Rise Ahead of Jobless Claims, Retail Sales Data | BMO Capital Upgrades Merck & Co to Outperform, Raises PT to $70.00",0.0033910152060203738,0.012282656672506902,0.1418903018492825,"[{'label': 'positive', 'score': 0.9994314312934875}, {'label': 'negative', 'score': 0.00032567550078965724}, {'label': 'neutral', 'score': 0.00024286448024213314}]","(0.00024286448024213314, 0.9994314312934875, 0.00032567550078965724)",0.9993484907512507,0.9994314312934875,0,0,"[{'label': 'positive', 'score': 0.931766927242279}, {'label': 'negative', 'score': 0.03862381353974342}, {'label': 'neutral', 'score': 0.029609328135848045}]","(0.029609328135848045, 0.931766927242279, 0.03862381353974342)",0.9203953378437698,0.931766927242279,0,0,"[{'label': 'positive', 'score': 0.9984660148620605}, {'label': 'neutral', 'score': 0.001206224667839706}, {'label': 'negative', 'score': 0.0003278224030509591}]","(0.001206224667839706, 0.9984660148620605, 0.0003278224030509591)",0.999343563424563,0.9984660148620605,0,0
2015-08-14,42.62114715576172,56.46946716308594,56.84160232543945,56.17366409301758,56.3072509765625,9920787.0,,0.002985224117886957,0.003385278678732742,0.14185851434286648,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-15,42.7483762105306,56.63804117838541,56.89885457356771,56.081424713134766,56.24045689900717,8749577.333333334,,0.0029763390786866294,0.002980777184234198,0.1417711742953861,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-16,42.87560526529948,56.8066151936849,56.95610682169596,55.98918533325195,56.17366282145182,7578367.666666667,,0.0029675067723136743,0.002971918550685628,0.0670884735982315,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-17,43.00283432006836,56.975189208984375,57.01335906982422,55.89694595336914,56.10686874389648,6407158.0,,-0.0008373224322067443,0.002963112415467769,0.06542774535735855,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-18,42.96683883666992,56.92748260498047,57.20419692993164,56.832061767578125,56.9370231628418,7123675.0,"FDA Accepts Supplemental Biologics License Application for KEYTRUDA, Merck's Anti-PD-1 Therapy, for First-Line Treatment of Advanced Melanoma, and Grants Priority Review",0.0,-0.0008376731824422328,0.02792425349186855,"[{'label': 'neutral', 'score': 0.9992953538894653}, {'label': 'positive', 'score': 0.000634976546280086}, {'label': 'negative', 'score': 6.96708302712068e-05}]","(0.9992953538894653, 0.000634976546280086, 6.96708302712068e-05)",0.8022533465967278,0.000634976546280086,0,1,"[{'label': 'positive', 'score': 0.82841557264328}, {'label': 'neutral', 'score': 0.16253714263439178}, {'label': 'negative', 'score': 0.00904735829681158}]","(0.16253714263439178, 0.82841557264328, 0.00904735829681158)",0.9783934119050368,0.82841557264328,0,0,"[{'label': 'positive', 'score': 0.9350177645683289}, {'label': 'neutral', 'score': 0.06459014117717743}, {'label': 'negative', 'score': 0.00039210706017911434}]","(0.06459014117717743, 0.9350177645683289, 0.00039210706017911434)",0.9991616358302987,0.9350177645683289,0,0
2015-08-19,42.96683883666992,56.92748260498047,57.31870269775391,56.47900772094727,56.60305404663086,8369642.0,,-0.045424110837368775,0.0,0.02985485054623254,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-08-20,41.01511764526367,54.34160232543945,55.86832046508789,54.14122009277344,55.6202278137207,24831731.0,New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN and the TECOS Cardiovascular Safety Trial of JANUVIA  Will Be Presented at the European Society of Cardiology Congress,-0.020719920394936583,-0.04648813225851179,0.3401760389690853,"[{'label': 'neutral', 'score': 0.9998881816864014}, {'label': 'positive', 'score': 5.647563375532627e-05}, {'label': 'negative', 'score': 5.530011549126357e-05}]","(0.9998881816864014, 5.647563375532627e-05, 5.530011549126357e-05)",0.0105167558436077,5.647563375532627e-05,1,1,"[{'label': 'neutral', 'score': 0.842369794845581}, {'label': 'positive', 'score': 0.1488836258649826}, {'label': 'negative', 'score': 0.008746621198952198}]","(0.842369794845581, 0.1488836258649826, 0.008746621198952198)",0.8890235679779837,0.1488836258649826,0,1,"[{'label': 'neutral', 'score': 0.9987050294876099}, {'label': 'positive', 'score': 0.0011455565690994263}, {'label': 'negative', 'score': 0.00014941650442779064}]","(0.9987050294876099, 0.0011455565690994263, 0.00014941650442779064)",0.7692361216116819,0.0011455565690994263,0,1
2015-08-21,40.16527938842773,53.21564865112305,54.99045944213867,53.20610809326172,53.99809265136719,18478860.0,,-0.010638919894102029,-0.02093758992550392,0.33262544036553426,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-22,39.73795954386393,52.64949162801107,53.96310551961263,50.00318145751953,52.878499348958336,20996191.0,,-0.010753323642934699,-0.01069591782711325,0.3040826974291573,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-23,39.31063969930013,52.083334604899086,52.935751597086586,46.800254821777344,51.75890604654948,23513522.0,,-0.010870214578363856,-0.01081155848260593,0.2805118980728094,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-24,38.88331985473633,51.51717758178711,51.90839767456055,43.59732818603516,50.63931274414063,26030853.0,Sierra Leone Released its Last Confirmed Ebola Patient from Hospital on Monday -Reuters,-0.052231931194848334,-0.010929727029213224,0.24538309330367672,"[{'label': 'neutral', 'score': 0.9997722506523132}, {'label': 'negative', 'score': 0.00014576900866813958}, {'label': 'positive', 'score': 8.195543341571465e-05}]","(0.9997722506523132, 8.195543341571465e-05, 0.00014576900866813958)",-0.2802227756866216,-0.00014576900866813958,0,0,"[{'label': 'negative', 'score': 0.5830752849578857}, {'label': 'neutral', 'score': 0.3921142518520355}, {'label': 'positive', 'score': 0.024810435250401497}]","(0.3921142518520355, 0.024810435250401497, 0.5830752849578857)",-0.9183713832201869,-0.5830752849578857,1,1,"[{'label': 'neutral', 'score': 0.9732275009155273}, {'label': 'negative', 'score': 0.022430697456002235}, {'label': 'positive', 'score': 0.004341819789260626}]","(0.9732275009155273, 0.004341819789260626, 0.022430697456002235)",-0.6756509857115607,-0.022430697456002235,1,0
2015-08-25,36.85237884521485,48.82633590698242,52.87213516235352,48.66412353515625,52.85305404663086,23946590.0,,0.06351381156075171,-0.053645459818704284,0.2944606218381487,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-08-26,39.19302368164063,51.92748260498047,52.10877990722656,50.08587646484375,50.95419692993164,23989978.0,,0.009739005638796991,0.06157834246686925,0.6593363024112149,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-27,39.5747184753418,52.433204650878906,52.86259460449219,51.183204650878906,52.74809265136719,16910109.0,,0.007643333418212375,0.00969188720086733,0.6639179564455974,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-28,39.87720489501953,52.83396911621094,52.87213516235352,52.08969497680664,52.270992279052734,13411256.0,,-0.009150566431202843,0.00761427113985554,0.6593247598331929,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-29,39.51230112711588,52.35050837198893,52.83714930216471,51.78117116292318,52.37913513183594,13453211.0,,-0.009235072576309206,-0.00919269003098783,0.6571473894797323,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-30,39.14739735921224,51.86704762776693,52.80216344197592,51.47264734903971,52.48727798461914,13495166.0,,-0.00932115411101957,-0.009277980233583312,0.46175600465026145,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-08-31,38.782493591308594,51.38358688354492,52.76717758178711,51.16412353515625,52.59542083740234,13537121.0,Barron's Recap: What's Next?,-0.024512507480568203,-0.009364867922170698,0.15635049579410662,"[{'label': 'neutral', 'score': 0.9998751878738403}, {'label': 'negative', 'score': 6.889797805342823e-05}, {'label': 'positive', 'score': 5.593710739049129e-05}]","(0.9998751878738403, 5.593710739049129e-05, 6.889797805342823e-05)",-0.10382394193785718,-6.889797805342823e-05,0,0,"[{'label': 'neutral', 'score': 0.9291896224021912}, {'label': 'negative', 'score': 0.047780267894268036}, {'label': 'positive', 'score': 0.023030079901218414}]","(0.9291896224021912, 0.023030079901218414, 0.047780267894268036)",-0.349527841107811,-0.047780267894268036,0,0,"[{'label': 'neutral', 'score': 0.9993910789489746}, {'label': 'positive', 'score': 0.00044764764606952667}, {'label': 'negative', 'score': 0.00016132451128214598}]","(0.9993910789489746, 0.00044764764606952667, 0.00016132451128214598)",0.47017442641804263,0.00044764764606952667,0,0
2015-09-01,37.83185195922852,50.1240463256836,50.79198455810547,49.80915832519531,50.24809265136719,16503275.0,"Organovo CEO Keith Murphy: 'People Are Missing The Forest For The Trees' | It's Not Shopping, It's Market Research: Talking Investing Trends With TD Ameritrade's Nicole Sherrod | Hearing Buyside Volume Coming Into Staples, Drug, And Chemical Names | New Analyses from the IMPROVE-IT Study with VYTORIN (ezetimibe and simvastatin)",0.008566546100913276,-0.02481794061118224,0.182122963628415,"[{'label': 'neutral', 'score': 0.99978107213974}, {'label': 'positive', 'score': 0.00011539155821083114}, {'label': 'negative', 'score': 0.00010362738248659298}]","(0.99978107213974, 0.00011539155821083114, 0.00010362738248659298)",0.05371305187933692,0.00011539155821083114,1,1,"[{'label': 'neutral', 'score': 0.8382955193519592}, {'label': 'positive', 'score': 0.14990636706352234}, {'label': 'negative', 'score': 0.01179808471351862}]","(0.8382955193519592, 0.14990636706352234, 0.01179808471351862)",0.8540784179549257,0.14990636706352234,0,1,"[{'label': 'neutral', 'score': 0.939852774143219}, {'label': 'negative', 'score': 0.03351638838648796}, {'label': 'positive', 'score': 0.026630841195583344}]","(0.939852774143219, 0.026630841195583344, 0.03351638838648796)",-0.11447821019768235,-0.03351638838648796,1,1
2015-09-02,38.15593719482422,50.55343627929688,50.83015441894531,49.95228958129883,50.73473358154297,13761078.0,Sierra Leone to Vaccinate 200 People Who Came in Contact With Latest Ebola Victim -Reuters | FDA Approves Pediatric Indication for EMEND (aprepitant) Capsules in Combination with Other Antiemetic Agents,-0.006228814966179544,0.008530061461688198,0.1874274834549923,"[{'label': 'positive', 'score': 0.9396476745605469}, {'label': 'neutral', 'score': 0.05960831046104431}, {'label': 'negative', 'score': 0.0007440235349349678}]","(0.05960831046104431, 0.9396476745605469, 0.0007440235349349678)",0.9984176305757658,0.9396476745605469,0,0,"[{'label': 'positive', 'score': 0.8135939240455627}, {'label': 'neutral', 'score': 0.168987438082695}, {'label': 'negative', 'score': 0.017418669536709785}]","(0.168987438082695, 0.8135939240455627, 0.017418669536709785)",0.9580784462925584,0.8135939240455627,0,0,"[{'label': 'positive', 'score': 0.772024393081665}, {'label': 'neutral', 'score': 0.22612081468105316}, {'label': 'negative', 'score': 0.0018547730287536979}]","(0.22612081468105316, 0.772024393081665, 0.0018547730287536979)",0.9952065565013827,0.772024393081665,0,0
2015-09-03,37.918270111083984,50.238548278808594,51.09732818603516,50.19084167480469,50.83015441894531,12732257.0,,-0.02013290473444642,-0.006248294967799683,0.18822718801543029,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-04,37.15486907958984,49.22710037231445,49.84732818603516,48.83587646484375,49.71374130249024,15186882.0,,0.005330487472324768,-0.020338333590312316,0.20747857376803097,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-05,37.35292053222656,49.48950481414795,50.03339672088623,49.07919692993164,49.93082141876221,15309969.75,,0.005302224033538531,0.005316330709990662,0.23646106149365853,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-06,37.55097198486328,49.751909255981445,50.219465255737305,49.32251739501953,50.14790153503418,15433057.5,,0.005274258732129932,0.005288216735094719,0.1895945715831885,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-07,37.7490234375,50.01431369781494,50.40553379058838,49.56583786010742,50.36498165130615,15556145.25,,0.00524658687548801,0.005260398542998968,0.17987969889071734,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-08,37.94707489013672,50.27671813964844,50.59160232543945,49.80915832519531,50.582061767578125,15679233.0,"Merck, Samsung Bioepis Report Approval of BRENZYS, a Biosimilar of Enbrel, in Korea | MKM Partners Would Sell These Healthcare Stocks On Weaker Relative Trends",-0.014424032644043055,0.005232871490291131,0.18183342682231843,"[{'label': 'positive', 'score': 0.9958944320678711}, {'label': 'neutral', 'score': 0.003577748080715537}, {'label': 'negative', 'score': 0.0005278369062580168}]","(0.003577748080715537, 0.9958944320678711, 0.0005278369062580168)",0.99894053570922,0.9958944320678711,0,0,"[{'label': 'negative', 'score': 0.8862032890319824}, {'label': 'neutral', 'score': 0.05714764446020126}, {'label': 'positive', 'score': 0.05664912238717079}]","(0.05714764446020126, 0.05664912238717079, 0.8862032890319824)",-0.8798345919232381,-0.8862032890319824,0,0,"[{'label': 'negative', 'score': 0.8340214490890503}, {'label': 'neutral', 'score': 0.1528591513633728}, {'label': 'positive', 'score': 0.01311942283064127}]","(0.1528591513633728, 0.01311942283064127, 0.8340214490890503)",-0.969026585151271,-0.8340214490890503,0,0
2015-09-09,37.39973068237305,49.5515251159668,50.88740539550781,49.4370231628418,50.77289962768555,11650302.0,,0.015212821607381577,-0.014529070270506534,0.14059194513549367,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-10,37.96868515014648,50.30534362792969,50.76335906982422,49.48473358154297,49.63740539550781,14740539.0,,-0.01194995709490171,0.015098266975188457,0.17181955871056936,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-11,37.83793258666992,49.70419692993164,50.04771041870117,49.34160232543945,49.81870269775391,12671158.0,,0.0015998118753242593,-0.01202193180331114,0.20055494995235956,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-12,37.89846674601237,49.7837142944336,50.13676834106445,49.43066151936849,49.7900759379069,11518567.666666666,,0.0015972565653028623,0.0015985335395222488,0.19591440581877156,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-13,37.95900090535482,49.86323165893555,50.22582626342773,49.51972071329752,49.7614491780599,10365977.333333334,,0.001594709405235742,0.0015959823077322105,0.19033548582441637,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-14,38.01953506469727,49.9427490234375,50.314884185791016,49.60877990722656,49.73282241821289,9213387.0,Amgen And Biogen Lead Short Interest Surge In Biotechs,0.023118053875164822,0.0015934392064115566,0.1522125709775798,"[{'label': 'positive', 'score': 0.8847438097000122}, {'label': 'negative', 'score': 0.10827765613794327}, {'label': 'neutral', 'score': 0.006978597491979599}]","(0.006978597491979599, 0.8847438097000122, 0.10827765613794327)",0.7819228287344749,0.8847438097000122,1,1,"[{'label': 'neutral', 'score': 0.6012256145477295}, {'label': 'positive', 'score': 0.38604769110679626}, {'label': 'negative', 'score': 0.012726719491183758}]","(0.6012256145477295, 0.38604769110679626, 0.012726719491183758)",0.9361708316634486,0.38604769110679626,1,0,"[{'label': 'positive', 'score': 0.8354927897453308}, {'label': 'neutral', 'score': 0.15055346488952637}, {'label': 'negative', 'score': 0.01395374070852995}]","(0.15055346488952637, 0.8354927897453308, 0.01395374070852995)",0.9671462765264944,0.8354927897453308,1,1
2015-09-15,38.89846420288086,51.09732818603516,51.421756744384766,50.25763320922852,50.36259460449219,12358226.0,,0.005975725909151108,0.022854879993926273,0.19854424392255351,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-16,39.13092041015625,51.40267181396485,51.49809265136719,50.87786483764648,51.05915832519531,9098107.0,Merck Offers Highlights for Commitment to Infectious Disease with 40 Presentations of Data at ICAAC/ICC '15,0.0016706615009146734,0.0059579420714716905,0.14628720459686653,"[{'label': 'neutral', 'score': 0.9998469352722168}, {'label': 'positive', 'score': 8.101949788397178e-05}, {'label': 'negative', 'score': 7.200486288638785e-05}]","(0.9998469352722168, 8.101949788397178e-05, 7.200486288638785e-05)",0.058909803329366586,8.101949788397178e-05,1,1,"[{'label': 'positive', 'score': 0.6297281384468079}, {'label': 'neutral', 'score': 0.36181190609931946}, {'label': 'negative', 'score': 0.008459928445518017}]","(0.36181190609931946, 0.6297281384468079, 0.008459928445518017)",0.9734876633255966,0.6297281384468079,0,0,"[{'label': 'neutral', 'score': 0.9989238381385803}, {'label': 'positive', 'score': 0.0009523269254714251}, {'label': 'negative', 'score': 0.0001238694239873439}]","(0.9989238381385803, 0.0009523269254714251, 0.0001238694239873439)",0.7698014418100578,0.0009523269254714251,0,1
2015-09-17,39.19629669189453,51.488548278808594,52.00381851196289,50.59160232543945,51.38358688354492,23894295.0,"Merck To Submit Applications To U.S. For Approval Of Ertugliflozin By End Of 2016 | Merck Provides Diabetes Portfolio Update and Underscores Comprehensive, Long-Term Commitment to Patients with Diabetes",-0.033913977892357616,0.0016692674983777357,0.14613196792003863,"[{'label': 'neutral', 'score': 0.9997742772102356}, {'label': 'positive', 'score': 0.00015663914382457733}, {'label': 'negative', 'score': 6.913249671924859e-05}]","(0.9997742772102356, 0.00015663914382457733, 6.913249671924859e-05)",0.38758918921148683,0.00015663914382457733,0,0,"[{'label': 'positive', 'score': 0.8054689764976501}, {'label': 'neutral', 'score': 0.18752998113632202}, {'label': 'negative', 'score': 0.007001062855124474}]","(0.18752998113632202, 0.8054689764976501, 0.007001062855124474)",0.982765979012096,0.8054689764976501,0,0,"[{'label': 'neutral', 'score': 0.49971187114715576}, {'label': 'positive', 'score': 0.49931108951568604}, {'label': 'negative', 'score': 0.0009770237375050783}]","(0.49971187114715576, 0.49931108951568604, 0.0009770237375050783)",0.9960941557009946,0.49931108951568604,0,0
2015-09-18,37.866981506347656,49.74236679077149,51.40267181396485,49.53244400024414,51.22137451171875,30389799.0,"UPDATE: Merck Phase 2 Primary Efficacy Endpoint Was Similar Across Both Relebactam Groups Along With Placebo Group, All 95% Or Higher | Merck Offers Results from Phase 2 Study of Investigational Beta-Lactamase Inhibitor at ICAAC/ICC '15: Met Primary Endpoint | Eli Lilly's 'Home Run' Is Jardiance, Says Morgan Stanley",-0.007353410897198942,-0.03450239893344517,0.33226730145127703,"[{'label': 'positive', 'score': 0.9891148805618286}, {'label': 'neutral', 'score': 0.010541440919041634}, {'label': 'negative', 'score': 0.00034370640059933066}]","(0.010541440919041634, 0.9891148805618286, 0.00034370640059933066)",0.9993052636964737,0.9891148805618286,0,0,"[{'label': 'positive', 'score': 0.6279168128967285}, {'label': 'neutral', 'score': 0.3622625768184662}, {'label': 'negative', 'score': 0.009820608422160149}]","(0.3622625768184662, 0.6279168128967285, 0.009820608422160149)",0.9692017181558817,0.6279168128967285,0,0,"[{'label': 'neutral', 'score': 0.9611163139343262}, {'label': 'positive', 'score': 0.03734799101948738}, {'label': 'negative', 'score': 0.0015356382355093956}]","(0.9611163139343262, 0.03734799101948738, 0.0015356382355093956)",0.9210136365904138,0.03734799101948738,0,1
2015-09-19,37.58853403727213,49.376590728759766,50.94783782958984,49.144402821858726,50.82697296142578,26283525.33333333,,-0.007407884112960228,-0.00738058049787572,0.3348280978743303,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-20,37.31008656819662,49.01081466674805,50.49300384521485,48.756361643473305,50.43257141113281,22177251.666666668,Merck's Bezlotoxumab Met Primary Endpoint in Phase 3 Studies,-0.007463170414506163,-0.007435458750690352,0.24984407355935148,"[{'label': 'neutral', 'score': 0.999895453453064}, {'label': 'negative', 'score': 5.491717456607148e-05}, {'label': 'positive', 'score': 4.9530852265888825e-05}]","(0.999895453453064, 4.9530852265888825e-05, 5.491717456607148e-05)",-0.05156940215681012,-5.491717456607148e-05,1,1,"[{'label': 'positive', 'score': 0.8617803454399109}, {'label': 'neutral', 'score': 0.12949632108211517}, {'label': 'negative', 'score': 0.008723280392587185}]","(0.12949632108211517, 0.8617803454399109, 0.008723280392587185)",0.9799580837259702,0.8617803454399109,0,0,"[{'label': 'neutral', 'score': 0.9994760155677795}, {'label': 'positive', 'score': 0.0003299181116744876}, {'label': 'negative', 'score': 0.00019414056441746652}]","(0.9994760155677795, 0.0003299181116744876, 0.00019414056441746652)",0.2590884445794326,0.0003299181116744876,1,1
2015-09-21,37.03163909912109,48.64503860473633,50.03816986083984,48.36832046508789,50.03816986083984,18070978.0,ANI Pharmaceuticals to Acquire Two NDAs from Merck for $75M | Data in Nine Difficult-to-Treat Cancers from Merck's KEYTRUDA Development Program to be Presented at European Cancer Congress 2015,-0.004707730274572508,-0.007491159214568356,0.217513673385829,"[{'label': 'neutral', 'score': 0.9997745156288147}, {'label': 'positive', 'score': 0.0001534734619781375}, {'label': 'negative', 'score': 7.19732852303423e-05}]","(0.9997745156288147, 0.0001534734619781375, 7.19732852303423e-05)",0.3615052235481076,0.0001534734619781375,1,1,"[{'label': 'neutral', 'score': 0.6527690291404724}, {'label': 'positive', 'score': 0.33874204754829407}, {'label': 'negative', 'score': 0.008488875813782215}]","(0.6527690291404724, 0.33874204754829407, 0.008488875813782215)",0.9511053005787137,0.33874204754829407,0,1,"[{'label': 'neutral', 'score': 0.9628201127052307}, {'label': 'positive', 'score': 0.036721814423799515}, {'label': 'negative', 'score': 0.00045802845852449536}]","(0.9628201127052307, 0.036721814423799515, 0.00045802845852449536)",0.9753614634696453,0.036721814423799515,0,1
2015-09-22,36.85729598999024,48.41603088378906,48.66412353515625,47.95801544189453,48.23473358154297,13409789.0,,0.005715423891574927,-0.004718846538711888,0.19786057607676427,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-23,37.06794738769531,48.6927490234375,49.08396911621094,48.082061767578125,48.41603088378906,10538164.0,,-0.008622421288021037,0.005699152824370081,0.09037917619969771,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-24,36.74834060668945,48.27289962768555,48.53053283691406,47.91984558105469,48.21564865112305,11012698.0,"Merck and Pfizer Collaborate with Dako, an Agilent Technologies Company, on Development of Companion Diagnostic for Investigational anti-PD-L1 Antibody, Avelumab",-0.01956908284681809,-0.00865980943516562,0.09355740766765655,"[{'label': 'neutral', 'score': 0.9998668432235718}, {'label': 'positive', 'score': 7.189719326561317e-05}, {'label': 'negative', 'score': 6.12693329458125e-05}]","(0.9998668432235718, 7.189719326561317e-05, 6.12693329458125e-05)",0.07980879746706801,7.189719326561317e-05,0,0,"[{'label': 'positive', 'score': 0.6774095892906189}, {'label': 'neutral', 'score': 0.31358104944229126}, {'label': 'negative', 'score': 0.009009385481476784}]","(0.31358104944229126, 0.6774095892906189, 0.009009385481476784)",0.9737496024655552,0.6774095892906189,0,0,"[{'label': 'neutral', 'score': 0.9722819924354553}, {'label': 'positive', 'score': 0.027528243139386177}, {'label': 'negative', 'score': 0.00018970748351421207}]","(0.9722819924354553, 0.027528243139386177, 0.00018970748351421207)",0.9863115793735864,0.027528243139386177,0,0
2015-09-25,36.029205322265625,47.328243255615234,48.96946716308594,46.8797721862793,48.58778762817383,16058190.0,"Merck, Pfizer Reports FDA Orphan Drug Designation for Investigation Avelumab",-0.007930104006010725,-0.01976309258144134,0.1447029100626733,"[{'label': 'neutral', 'score': 0.9998606443405151}, {'label': 'negative', 'score': 7.625298894708976e-05}, {'label': 'positive', 'score': 6.311004108283669e-05}]","(0.9998606443405151, 6.311004108283669e-05, 7.625298894708976e-05)",-0.09430727691146491,-7.625298894708976e-05,1,1,"[{'label': 'neutral', 'score': 0.6639394760131836}, {'label': 'positive', 'score': 0.29536348581314087}, {'label': 'negative', 'score': 0.04069705680012703}]","(0.6639394760131836, 0.29536348581314087, 0.04069705680012703)",0.757799255552828,0.29536348581314087,0,1,"[{'label': 'neutral', 'score': 0.9987776875495911}, {'label': 'positive', 'score': 0.0010171086760237813}, {'label': 'negative', 'score': 0.0002051579940598458}]","(0.9987776875495911, 0.0010171086760237813, 0.0002051579940598458)",0.6642991270541494,0.0010171086760237813,0,1
2015-09-26,35.74348704020182,46.95292536417643,48.34923807779948,46.54898325602213,48.07251993815104,17744701.333333332,Merck Presents New Findings Showing Anti-Tumor Activity of KEYTRUDA in Patients with Advanced NPC,-0.007993493238765328,-0.007961714508070112,0.14484473829160938,"[{'label': 'neutral', 'score': 0.8129909634590149}, {'label': 'positive', 'score': 0.18654967844486237}, {'label': 'negative', 'score': 0.0004593700577970594}]","(0.8129909634590149, 0.18654967844486237, 0.0004593700577970594)",0.995087188973206,0.18654967844486237,0,1,"[{'label': 'positive', 'score': 0.6291481852531433}, {'label': 'neutral', 'score': 0.3522980511188507}, {'label': 'negative', 'score': 0.018553748726844788}]","(0.3522980511188507, 0.6291481852531433, 0.018553748726844788)",0.9427089908074351,0.6291481852531433,0,0,"[{'label': 'neutral', 'score': 0.9651287794113159}, {'label': 'positive', 'score': 0.03263183683156967}, {'label': 'negative', 'score': 0.002239349065348506}]","(0.9651287794113159, 0.03263183683156967, 0.002239349065348506)",0.8715645018802521,0.03263183683156967,0,1
2015-09-27,35.45776875813802,46.57760747273763,47.72900899251302,46.218194325764976,47.55725224812826,19431212.666666668,"Merck Announces New Data from KEYNOTE-028 Trial Evaluating KEYTRUDA Across Range of Cancer Types, Presented at 2015 ECC",-0.008057904040229675,-0.008025612483660327,0.1433421342578454,"[{'label': 'neutral', 'score': 0.9997451901435852}, {'label': 'positive', 'score': 0.0002054307551588863}, {'label': 'negative', 'score': 4.93390325573273e-05}]","(0.9997451901435852, 0.0002054307551588863, 4.93390325573273e-05)",0.6126775235038016,0.0002054307551588863,0,1,"[{'label': 'neutral', 'score': 0.8161436319351196}, {'label': 'positive', 'score': 0.17252464592456818}, {'label': 'negative', 'score': 0.011331743560731411}]","(0.8161436319351196, 0.17252464592456818, 0.011331743560731411)",0.8767326651800975,0.17252464592456818,0,1,"[{'label': 'neutral', 'score': 0.7320242524147034}, {'label': 'positive', 'score': 0.2672782242298126}, {'label': 'negative', 'score': 0.0006974742864258587}]","(0.7320242524147034, 0.2672782242298126, 0.0006974742864258587)",0.9947944959913326,0.2672782242298126,0,1
2015-09-28,35.17205047607422,46.20228958129883,47.10877990722656,45.88740539550781,47.04198455810547,21117724.0,"Roth Capital Upgrades ANI Pharmaceuticals To Buy On Valuation | Merck, Syndax Pharma Announce First Patients Dosed in Phase 1b/2 Trial of Entinostat, KEYTRUDA | Merck Reports Japan's PMDA Approved MARIZEV 25, 12.5mg Tablets",0.004750136087947698,-0.008090544409213887,0.08231898536280922,"[{'label': 'positive', 'score': 0.999351441860199}, {'label': 'neutral', 'score': 0.0003975694999098778}, {'label': 'negative', 'score': 0.00025097443722188473}]","(0.0003975694999098778, 0.999351441860199, 0.00025097443722188473)",0.9994978514794882,0.999351441860199,0,0,"[{'label': 'positive', 'score': 0.8854745030403137}, {'label': 'neutral', 'score': 0.09802867472171783}, {'label': 'negative', 'score': 0.01649683713912964}]","(0.09802867472171783, 0.8854745030403137, 0.01649683713912964)",0.963420484877385,0.8854745030403137,0,0,"[{'label': 'positive', 'score': 0.993187427520752}, {'label': 'neutral', 'score': 0.006499585695564747}, {'label': 'negative', 'score': 0.0003130376571789384}]","(0.006499585695564747, 0.993187427520752, 0.0003130376571789384)",0.9993698288664156,0.993187427520752,0,0
2015-09-29,35.3391227722168,46.421756744384766,47.04198455810547,45.99236679077149,46.35496139526367,13417439.0,,0.015210714604141373,0.004738889791750092,0.13759149590620515,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-09-30,35.87666702270508,47.12786483764648,47.270992279052734,46.61259460449219,47.13740539550781,13287697.0,,-0.00040496064240681297,0.01509619154294218,0.16649477266755294,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-01,35.862144470214844,47.10877990722656,47.299617767333984,46.31679534912109,47.08969497680664,15100213.0,"Merck, DNAtrix Report Phase 2 Immuno-Oncology Partnership in Patients with Aggressive Form of Brain Cancer",0.015596450773988193,-0.00040504266111139907,0.15435604828984756,"[{'label': 'neutral', 'score': 0.9998631477355957}, {'label': 'positive', 'score': 7.687579636694863e-05}, {'label': 'negative', 'score': 5.9930855059064925e-05}]","(0.9998631477355957, 7.687579636694863e-05, 5.9930855059064925e-05)",0.12386050774035433,7.687579636694863e-05,1,1,"[{'label': 'positive', 'score': 0.9128026366233826}, {'label': 'neutral', 'score': 0.07009311020374298}, {'label': 'negative', 'score': 0.017104197293519974}]","(0.07009311020374298, 0.9128026366233826, 0.017104197293519974)",0.9632130947538591,0.9128026366233826,0,0,"[{'label': 'neutral', 'score': 0.9990717172622681}, {'label': 'positive', 'score': 0.0007338885334320366}, {'label': 'negative', 'score': 0.00019437451555859298}]","(0.9990717172622681, 0.0007338885334320366, 0.00019437451555859298)",0.5812081160185121,0.0007338885334320366,0,1
2015-10-02,36.42144775390625,47.843509674072266,47.85305404663086,46.13549423217773,46.55534362792969,25453719.0,Merck PR Confirms FDA Approves KEYTRUDA for the Treatment of Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression On or After Platinum-Containing Chemotherapy | Bristol-Myers Spikes to High Following FDA Approval of Merck's Keytruda | FDA Approves Merck's Keytruda For Advanced Non-Small Cell Lung Cancer,0.0072463831671077585,0.015476076133721619,0.1610435401922569,"[{'label': 'positive', 'score': 0.9992796778678894}, {'label': 'negative', 'score': 0.00047983721015043557}, {'label': 'neutral', 'score': 0.00024049966305028647}]","(0.00024049966305028647, 0.9992796778678894, 0.00047983721015043557)",0.9990400947369569,0.9992796778678894,0,0,"[{'label': 'positive', 'score': 0.9346275925636292}, {'label': 'neutral', 'score': 0.045005932450294495}, {'label': 'negative', 'score': 0.020366471260786057}]","(0.045005932450294495, 0.9346275925636292, 0.020366471260786057)",0.9573474390422376,0.9346275925636292,0,0,"[{'label': 'positive', 'score': 0.9911686182022095}, {'label': 'neutral', 'score': 0.007864336483180523}, {'label': 'negative', 'score': 0.00096704630414024}]","(0.007864336483180523, 0.9911686182022095, 0.00096704630414024)",0.9980505764710688,0.9911686182022095,0,0
2015-10-03,36.68537521362305,48.19020207722982,48.22519175211588,46.87976964314779,47.28053410847982,22517118.33333333,,0.00719425086871262,0.007220254283277408,0.10860731804805836,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-04,36.94930267333984,48.53689448038737,48.597329457600914,47.62404505411784,48.005724589029946,19580517.666666668,,0.007142863318081564,0.007168495698262904,0.10471172789933239,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-05,37.21323013305664,48.88358688354492,48.96946716308594,48.36832046508789,48.73091506958008,16643917.0,"Agilent Company Dako, Announces FDA Approval of New Companion Diagnostic for Lung Cancer",-0.02791329442284268,0.0071174739002925706,0.08919145544038824,"[{'label': 'neutral', 'score': 0.9936516284942627}, {'label': 'positive', 'score': 0.006243494339287281}, {'label': 'negative', 'score': 0.00010488228144822642}]","(0.9936516284942627, 0.006243494339287281, 0.00010488228144822642)",0.9669577633104965,0.006243494339287281,0,0,"[{'label': 'positive', 'score': 0.8623892068862915}, {'label': 'neutral', 'score': 0.12569771707057953}, {'label': 'negative', 'score': 0.01191314309835434}]","(0.12569771707057953, 0.8623892068862915, 0.01191314309835434)",0.9727482304066469,0.8623892068862915,0,0,"[{'label': 'positive', 'score': 0.9475209712982178}, {'label': 'neutral', 'score': 0.05214596912264824}, {'label': 'negative', 'score': 0.000333086441969499}]","(0.05214596912264824, 0.9475209712982178, 0.000333086441969499)",0.9992971777896618,0.9475209712982178,0,0
2015-10-06,36.17448806762695,47.51908493041992,49.036258697509766,47.06106948852539,49.036258697509766,17285188.0,,0.023092367785320887,-0.028310275231392536,0.2726672183977185,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-07,37.00983810424805,48.61641311645508,48.77862548828125,47.49045944213867,48.14885330200195,15204594.0,"Guinea, Liberia, Sierra Leone See No New Cases for Week to October 4 -Reuters | Merck KGaA, Darmstadt, Germany, and Pfizer Announce Investigational Immunotherapy Avelumab Given FDA Fast Track Designation for Metastatic Merkel Cell Carcinoma",0.0013738474342777328,0.022829773983739626,0.2996755756855688,"[{'label': 'neutral', 'score': 0.5671675801277161}, {'label': 'positive', 'score': 0.4316362738609314}, {'label': 'negative', 'score': 0.0011961872223764658}]","(0.5671675801277161, 0.4316362738609314, 0.0011961872223764658)",0.9944727471715841,0.4316362738609314,0,1,"[{'label': 'positive', 'score': 0.7856215834617615}, {'label': 'neutral', 'score': 0.19819597899913788}, {'label': 'negative', 'score': 0.0161824282258749}]","(0.19819597899913788, 0.7856215834617615, 0.0161824282258749)",0.9596349532055493,0.7856215834617615,0,0,"[{'label': 'neutral', 'score': 0.9407322406768799}, {'label': 'positive', 'score': 0.05772259086370468}, {'label': 'negative', 'score': 0.0015452551888301969}]","(0.9407322406768799, 0.05772259086370468, 0.0015452551888301969)",0.9478551932708846,0.05772259086370468,0,1
2015-10-08,37.060691833496094,48.683204650878906,48.84542083740234,47.843509674072266,48.33969497680664,13144016.0,Ten People Quarantined Due to Possible Ebola Cases in Nigeria's Calabar City | Dynavax Reports Initiation of Immuno-Oncology Clinical Trial of SD-101 in Combo with Merck's KEYTRUDA,-0.0013719625670251003,0.0013729045693609422,0.297607972984924,"[{'label': 'neutral', 'score': 0.9997997879981995}, {'label': 'negative', 'score': 0.00014259405725169927}, {'label': 'positive', 'score': 5.7638040743768215e-05}]","(0.9997997879981995, 5.7638040743768215e-05, 0.00014259405725169927)",-0.4242877009152356,-0.00014259405725169927,1,1,"[{'label': 'positive', 'score': 0.6980328559875488}, {'label': 'neutral', 'score': 0.28605249524116516}, {'label': 'negative', 'score': 0.01591462269425392}]","(0.28605249524116516, 0.6980328559875488, 0.01591462269425392)",0.9554179455227214,0.6980328559875488,0,0,"[{'label': 'negative', 'score': 0.996823787689209}, {'label': 'neutral', 'score': 0.0026370310224592686}, {'label': 'positive', 'score': 0.0005391579470597208}]","(0.0026370310224592686, 0.0005391579470597208, 0.996823787689209)",-0.998918833009751,-0.996823787689209,0,0
2015-10-09,37.00983810424805,48.61641311645508,49.15076446533203,48.36832046508789,48.654579162597656,11445627.0,"WHO Says Nigerian Suspected of Dying from Ebola, Did Not have the Virus -Reuters | KEYTRUDA (pembrolizumab) Receives New Draft Recommendation from National Institute for Health and Care Excellence (NICE) in U.K. for First-Line Treatment for Advanced Melanoma",-0.0015701674000417906,-0.0013729045693609639,0.29448843319175544,"[{'label': 'positive', 'score': 0.9982921481132507}, {'label': 'neutral', 'score': 0.001323180040344596}, {'label': 'negative', 'score': 0.00038463756209239364}]","(0.001323180040344596, 0.9982921481132507, 0.00038463756209239364)",0.9992297056112458,0.9982921481132507,0,0,"[{'label': 'positive', 'score': 0.887535810470581}, {'label': 'neutral', 'score': 0.10047812759876251}, {'label': 'negative', 'score': 0.011986065655946732}]","(0.10047812759876251, 0.887535810470581, 0.011986065655946732)",0.9733501408380184,0.887535810470581,0,0,"[{'label': 'positive', 'score': 0.8032460808753967}, {'label': 'neutral', 'score': 0.18518424034118652}, {'label': 'negative', 'score': 0.011569676920771599}]","(0.18518424034118652, 0.8032460808753967, 0.011569676920771599)",0.9716017349687393,0.8032460808753967,0,0
2015-10-10,36.95172882080078,48.540077209472656,48.94084040323893,48.050254821777344,48.24745432535807,11701304.0,,-0.001572636702924686,-0.0015714014047723596,0.2882615068584989,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-11,36.89361953735352,48.46374130249024,48.73091634114584,47.7321891784668,47.84032948811849,11956981.0,,-0.0015751137846740397,-0.0015738745940299798,0.16882649302141467,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-12,36.83551025390625,48.38740539550781,48.520992279052734,47.41412353515625,47.433204650878906,12212658.0,Watching Volatility In Other Big Pharma Names Amid Eli Lilly Halt,-0.024452818990910775,-0.0015763555805425082,0.020609754237667446,"[{'label': 'negative', 'score': 0.989331841468811}, {'label': 'neutral', 'score': 0.008346639573574066}, {'label': 'positive', 'score': 0.002321429317817092}]","(0.008346639573574066, 0.002321429317817092, 0.989331841468811)",-0.9953180624998582,-0.989331841468811,1,1,"[{'label': 'neutral', 'score': 0.8298928737640381}, {'label': 'negative', 'score': 0.11435429006814957}, {'label': 'positive', 'score': 0.05575283616781235}]","(0.8298928737640381, 0.05575283616781235, 0.11435429006814957)",-0.3444973482124962,-0.11435429006814957,0,0,"[{'label': 'negative', 'score': 0.9928232431411743}, {'label': 'neutral', 'score': 0.006468926090747118}, {'label': 'positive', 'score': 0.0007077039335854352}]","(0.006468926090747118, 0.0007077039335854352, 0.9928232431411743)",-0.9985753761658475,-0.9928232431411743,1,1
2015-10-13,35.93477249145508,47.20419692993164,48.578243255615234,47.09923553466797,48.45419692993164,15621383.0,"Incyte, Merck Increase Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytrudaas First-line Treatment for Advanced Melanoma | Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda (pembrolizumab) as First-line Treatment for Advanced Melanoma",0.0014150298800812684,-0.024756754113078542,0.164944577876534,"[{'label': 'positive', 'score': 0.9986888766288757}, {'label': 'neutral', 'score': 0.0011042155092582107}, {'label': 'negative', 'score': 0.0002068772737402469}]","(0.0011042155092582107, 0.9986888766288757, 0.0002068772737402469)",0.9995857880606019,0.9986888766288757,0,0,"[{'label': 'positive', 'score': 0.8854526281356812}, {'label': 'neutral', 'score': 0.10548561811447144}, {'label': 'negative', 'score': 0.009061787277460098}]","(0.10548561811447144, 0.8854526281356812, 0.009061787277460098)",0.9797392034799689,0.8854526281356812,0,0,"[{'label': 'neutral', 'score': 0.5407236814498901}, {'label': 'positive', 'score': 0.4583278000354767}, {'label': 'negative', 'score': 0.000948508211877197}]","(0.5407236814498901, 0.4583278000354767, 0.000948508211877197)",0.9958695530562123,0.4583278000354767,0,1
2015-10-14,35.985626220703125,47.270992279052734,47.82442855834961,47.18511581420898,47.31870269775391,14390298.0,Biotech ETFs Get More Refined With Debut Of Cancer Immunotherapy Fund | Nurse who Contracted Ebola in West Africa Now Critically Ill from Complications -BBC | Tianjin CanSino Biotechnology to Mass Produce Ebola Vaccine -Xinhua,0.02381912500735365,0.0014140296687419228,0.17112211776141617,"[{'label': 'neutral', 'score': 0.7339012622833252}, {'label': 'positive', 'score': 0.2165406495332718}, {'label': 'negative', 'score': 0.049558136612176895}]","(0.7339012622833252, 0.2165406495332718, 0.049558136612176895)",0.6275207615183288,0.2165406495332718,0,1,"[{'label': 'positive', 'score': 0.5534811019897461}, {'label': 'neutral', 'score': 0.4370718002319336}, {'label': 'negative', 'score': 0.009447184391319752}]","(0.4370718002319336, 0.5534811019897461, 0.009447184391319752)",0.966435566945646,0.5534811019897461,0,0,"[{'label': 'positive', 'score': 0.700007438659668}, {'label': 'negative', 'score': 0.1716306209564209}, {'label': 'neutral', 'score': 0.12836188077926636}]","(0.12836188077926636, 0.700007438659668, 0.1716306209564209)",0.6061883276826732,0.700007438659668,0,0
2015-10-15,36.84276580810547,48.39694595336914,48.74045944213867,46.9942741394043,47.39503860473633,14711300.0,,0.014984193624182567,0.0235398752803811,0.2717556168202082,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-16,37.39482116699219,49.12213516235352,49.35114669799805,48.74045944213867,48.950382232666016,11624940.0,,-0.000517974853447042,0.014873039588437017,0.29231275530805245,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-17,37.37545394897461,49.0966911315918,49.29707463582357,48.6927490234375,48.9599240620931,10698997.0,,-0.0005182432904393126,-0.0005181090487633361,0.29143292250742636,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-18,37.35608673095703,49.07124710083008,49.243002573649086,48.64503860473633,48.96946589152018,9773054.0,,-0.0005185120058073345,-0.000518377624907263,0.17333947558765445,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-19,37.33671951293945,49.04580307006836,49.18893051147461,48.59732818603516,48.97900772094727,8847111.0,,-0.01964982204722805,-0.0005186464796436169,0.178268667758583,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-20,36.6030502319336,48.082061767578125,49.11259460449219,47.80534362792969,49.036258697509766,10422255.0,,0.00396900326425071,-0.01984544670109,0.19560676737901825,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-21,36.74834060668945,48.27289962768555,48.64503860473633,47.85305404663086,48.42557144165039,11810855.0,,0.028068858933508703,0.003961147550170956,0.1483888317124021,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-10-22,37.779823303222656,49.62786483764648,50.15267181396485,47.99618148803711,48.49236679077149,19335181.0,"Merck Trading Higher Off Of Abbvie, Gilead FDA Comments, Up 3.62% On The Day At $52.42/Share",0.016727509977788168,0.02768214818804052,0.2695410580002841,"[{'label': 'positive', 'score': 0.9996641874313354}, {'label': 'negative', 'score': 0.0001919570058817044}, {'label': 'neutral', 'score': 0.00014385046961251646}]","(0.00014385046961251646, 0.9996641874313354, 0.0001919570058817044)",0.9996160307521244,0.9996641874313354,0,0,"[{'label': 'positive', 'score': 0.9456681609153748}, {'label': 'negative', 'score': 0.02904626727104187}, {'label': 'neutral', 'score': 0.025285523384809494}]","(0.025285523384809494, 0.9456681609153748, 0.02904626727104187)",0.9404004569316036,0.9456681609153748,0,0,"[{'label': 'positive', 'score': 0.9982942938804626}, {'label': 'neutral', 'score': 0.001450117095373571}, {'label': 'negative', 'score': 0.0002556381223257631}]","(0.001450117095373571, 0.9982942938804626, 0.0002556381223257631)",0.9994879812934081,0.9982942938804626,0,0
2015-10-23,38.41179275512695,50.45801544189453,50.81106948852539,49.75190734863281,49.95228958129883,16457268.0,,0.00018910433443569926,0.016589146040308974,0.28573822715150543,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-24,38.41905721028646,50.46755727132162,50.78562418619792,49.85687001546224,50.04770914713541,14805515.333333334,,0.00018906858074743351,0.0001890864564649335,0.284830301703909,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-25,38.42632166544596,50.477099100748696,50.760178883870445,49.961832682291664,50.14312871297201,13153762.666666668,,0.0001890328405766918,0.00018905070953596139,0.1919216842508497,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-26,38.43358612060547,50.48664093017578,50.73473358154297,50.06679534912109,50.238548278808594,11502010.0,"Earnings Boom This Week: Big Pharma, E-Commerce Giant BABA And More | Fed Meeting A Mid-Week Bump In Flurry Of Earnings News | Merck's KEYTRUDA Shows Superior Overall Survival Compared to Chemotherapy in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer Whose Tumors Express PD-L1",0.010584014682536984,0.00018901497612056612,0.2007216899516138,"[{'label': 'positive', 'score': 0.9994078874588013}, {'label': 'negative', 'score': 0.00031823813333176076}, {'label': 'neutral', 'score': 0.0002739154442679137}]","(0.0002739154442679137, 0.9994078874588013, 0.00031823813333176076)",0.9993633493710224,0.9994078874588013,0,0,"[{'label': 'positive', 'score': 0.9480970501899719}, {'label': 'neutral', 'score': 0.02711179107427597}, {'label': 'negative', 'score': 0.024791153147816658}]","(0.02711179107427597, 0.9480970501899719, 0.024791153147816658)",0.9490359672102857,0.9480970501899719,0,0,"[{'label': 'positive', 'score': 0.998063862323761}, {'label': 'neutral', 'score': 0.0014483485138043761}, {'label': 'negative', 'score': 0.0004878357285633683}]","(0.0014483485138043761, 0.998063862323761, 0.0004878357285633683)",0.9990229134264857,0.998063862323761,0,0
2015-10-27,38.84035110473633,51.020992279052734,51.62213516235352,50.36259460449219,51.29771041870117,14626831.0,"These Three Pharma Giants Just Crushed Earnings | UPDATE: Merck Sees FY15 Sales $39.2B-$39.8B vs $39.67B Est. | Merck Sees FY EPS $3.55 to $3.60 vs $3.51 est | Merck Reports Q3 EPS $0.96 vs. Est. $0.92, Rev. $10.073B vs. Est. $10.08B | Earnings Scheduled For October 27, 2015",0.03048438610176251,0.010528396100201606,0.12112198835763414,"[{'label': 'negative', 'score': 0.9978360533714294}, {'label': 'positive', 'score': 0.0012296689674258232}, {'label': 'neutral', 'score': 0.0009342413395643234}]","(0.0009342413395643234, 0.0012296689674258232, 0.9978360533714294)",-0.9975383622119531,-0.9978360533714294,0,0,"[{'label': 'neutral', 'score': 0.6575825214385986}, {'label': 'negative', 'score': 0.24939391016960144}, {'label': 'positive', 'score': 0.09302353858947754}]","(0.6575825214385986, 0.09302353858947754, 0.24939391016960144)",-0.45666589756687404,-0.24939391016960144,0,0,"[{'label': 'negative', 'score': 0.9850054979324341}, {'label': 'neutral', 'score': 0.01065644808113575}, {'label': 'positive', 'score': 0.004338070284575224}]","(0.01065644808113575, 0.004338070284575224, 0.9850054979324341)",-0.9912304068597863,-0.9850054979324341,0,0
2015-10-28,40.02436828613281,52.57633590698242,52.614505767822266,51.09732818603516,51.51717758178711,15416080.0,,-0.004174257473442499,0.030028969464312848,0.20613159419660312,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-29,39.85730743408203,52.35686874389648,53.09160232543945,51.975189208984375,52.4427490234375,9334850.0,,-0.0038271658098749306,-0.0041829940070061584,0.21881595608980828,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-30,39.70477294921875,52.15649032592773,52.738548278808594,52.15649032592773,52.28053283691406,11546235.0,,0.0027442167231268508,-0.0038345081484949216,0.22875089460974346,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-10-31,39.81372960408529,52.29961903889974,52.75763320922852,52.07697296142578,52.24872716267904,11386135.666666666,,0.0027367066070891127,0.00274045823491576,0.22496996615321987,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-01,39.92268625895182,52.44274775187174,52.77671813964844,51.99745559692383,52.21692148844401,11226036.333333334,,0.002729237484832193,0.0027329686438152994,0.22419549615025802,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-02,40.03164291381836,52.58587646484375,52.79580307006836,51.91793823242188,52.18511581420898,11065937.0,Merck Receives Breakthrough Therapy Designation from U.S.FDA for KEYTRUDA(R) (pembrolizumab) in Advanced Colorectal Cancer,0.0,0.002725519878824852,0.05865087951594566,"[{'label': 'neutral', 'score': 0.9774364829063416}, {'label': 'positive', 'score': 0.02231927216053009}, {'label': 'negative', 'score': 0.000244208233198151}]","(0.9774364829063416, 0.02231927216053009, 0.000244208233198151)",0.9783536733751385,0.02231927216053009,0,1,"[{'label': 'positive', 'score': 0.9201840162277222}, {'label': 'neutral', 'score': 0.06940113753080368}, {'label': 'negative', 'score': 0.010414824821054935}]","(0.06940113753080368, 0.9201840162277222, 0.010414824821054935)",0.9776169400569691,0.9201840162277222,0,0,"[{'label': 'positive', 'score': 0.9986283779144287}, {'label': 'neutral', 'score': 0.0008647423819638789}, {'label': 'negative', 'score': 0.0005069380858913064}]","(0.0008647423819638789, 0.9986283779144287, 0.0005069380858913064)",0.9989852463870046,0.9986283779144287,0,0
2015-11-03,40.03164291381836,52.58587646484375,52.843509674072266,51.98473358154297,52.5572509765625,9658578.0,"GSK, Merck to Study Immunotherapy Combination as Potential Cancer Treatment",0.007621142638935799,0.0,0.04580385302096443,"[{'label': 'neutral', 'score': 0.9998805522918701}, {'label': 'positive', 'score': 6.116566510172561e-05}, {'label': 'negative', 'score': 5.824852632940747e-05}]","(0.9998805522918701, 6.116566510172561e-05, 5.824852632940747e-05)",0.024428744501447906,6.116566510172561e-05,0,0,"[{'label': 'neutral', 'score': 0.8282912969589233}, {'label': 'positive', 'score': 0.16164974868297577}, {'label': 'negative', 'score': 0.010058989748358727}]","(0.8282912969589233, 0.16164974868297577, 0.010058989748358727)",0.8828366006266912,0.16164974868297577,1,0,"[{'label': 'neutral', 'score': 0.9985169768333435}, {'label': 'positive', 'score': 0.0013909019762650132}, {'label': 'negative', 'score': 9.207307448377833e-05}]","(0.9985169768333435, 0.0013909019762650132, 9.207307448377833e-05)",0.8758265360738358,0.0013909019762650132,1,0
2015-11-04,40.336727142333984,52.98664093017578,53.21564865112305,52.65267181396485,52.92938995361328,8121162.0,"Merck, Pfizer Report Initiation of Phase III First-Line Trial of Avelumab",-0.008643979573985269,0.007592248443042188,0.043602591122753935,"[{'label': 'neutral', 'score': 0.9998598098754883}, {'label': 'negative', 'score': 7.96520835137926e-05}, {'label': 'positive', 'score': 6.0583624872379005e-05}]","(0.9998598098754883, 6.0583624872379005e-05, 7.96520835137926e-05)",-0.1359743453422303,-7.96520835137926e-05,0,0,"[{'label': 'positive', 'score': 0.5355263352394104}, {'label': 'neutral', 'score': 0.4546045660972595}, {'label': 'negative', 'score': 0.009869134984910488}]","(0.4546045660972595, 0.5355263352394104, 0.009869134984910488)",0.963809252097927,0.5355263352394104,0,0,"[{'label': 'neutral', 'score': 0.9982079267501831}, {'label': 'positive', 'score': 0.0016688044415786862}, {'label': 'negative', 'score': 0.00012325303396210074}]","(0.9982079267501831, 0.0016688044415786862, 0.00012325303396210074)",0.86244522216018,0.0016688044415786862,0,0
2015-11-05,39.988067626953125,52.52862548828125,53.1297721862793,52.17557144165039,52.91984558105469,9481046.0,Merck Announces Samsung Bioepis Will Present New Biosimilars Data at the 2015 ACR/ARHP Annual Meeting,-0.007992700687520407,-0.008681555458912225,0.09527722660888965,"[{'label': 'neutral', 'score': 0.999858021736145}, {'label': 'positive', 'score': 9.297941869590431e-05}, {'label': 'negative', 'score': 4.901568536297418e-05}]","(0.999858021736145, 9.297941869590431e-05, 4.901568536297418e-05)",0.3096144308940434,9.297941869590431e-05,1,1,"[{'label': 'neutral', 'score': 0.8773626089096069}, {'label': 'positive', 'score': 0.11239232867956161}, {'label': 'negative', 'score': 0.010245012119412422}]","(0.8773626089096069, 0.11239232867956161, 0.010245012119412422)",0.8329218156123273,0.11239232867956161,0,1,"[{'label': 'neutral', 'score': 0.9986155033111572}, {'label': 'positive', 'score': 0.0012717952486127615}, {'label': 'negative', 'score': 0.00011276280565652996}]","(0.9986155033111572, 0.0012717952486127615, 0.00011276280565652996)",0.8371136474793162,0.0012717952486127615,0,1
2015-11-06,39.66844177246094,52.10877990722656,52.36641311645508,51.536258697509766,52.28053283691406,11237704.0,UPDATE: Merck Says 'We believe that BRIDION has the potential to offer anesthesia professionals an important new option to reverse neuromuscular blockade in the surgical setting' | Merck Issues Statement on FDA Panel Meeting for BRIDION | FDA Panel Votes 13-1 In Favor Of Merck Presenting Sufficient Data To Characterize Risk Of Hypersensitivity With Sugammadex -Reuters | Are You Investing Like A Millennial Or A Baby Boomer?,-0.0022584424816664735,-0.008024813546432743,0.1113127036901007,"[{'label': 'positive', 'score': 0.9979363679885864}, {'label': 'neutral', 'score': 0.0017849821597337723}, {'label': 'negative', 'score': 0.00027870485791936517}]","(0.0017849821597337723, 0.9979363679885864, 0.00027870485791936517)",0.9994415935693606,0.9979363679885864,0,0,"[{'label': 'neutral', 'score': 0.8488937020301819}, {'label': 'positive', 'score': 0.136135995388031}, {'label': 'negative', 'score': 0.014970301650464535}]","(0.8488937020301819, 0.136135995388031, 0.014970301650464535)",0.801857342230407,0.136135995388031,0,1,"[{'label': 'positive', 'score': 0.9491121172904968}, {'label': 'neutral', 'score': 0.05003630742430687}, {'label': 'negative', 'score': 0.0008515776717104018}]","(0.05003630742430687, 0.9491121172904968, 0.0008515776717104018)",0.9982071363858925,0.9491121172904968,0,0
2015-11-07,39.578857421875,51.991095225016274,52.21692148844401,51.45038096110026,52.03880310058594,10684779.333333334,,-0.0022635545895108595,-0.002260996609179351,0.10549166536051272,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-08,39.48927307128906,51.87341054280599,52.06742986043295,51.36450322469076,51.79707336425781,10131854.666666666,,-0.0022686898929303156,-0.002266120301684988,0.10362297315947233,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-09,39.399688720703125,51.7557258605957,51.91793823242188,51.27862548828125,51.55534362792969,9578930.0,WHO Declares Sierra Leone Ebola-Free,0.0035029419302208013,-0.0022712672687609553,0.053054124721307175,"[{'label': 'neutral', 'score': 0.999645471572876}, {'label': 'negative', 'score': 0.0001807851658668369}, {'label': 'positive', 'score': 0.00017375446623191237}]","(0.999645471572876, 0.00017375446623191237, 0.0001807851658668369)",-0.019830504119681274,-0.0001807851658668369,1,1,"[{'label': 'neutral', 'score': 0.82508385181427}, {'label': 'negative', 'score': 0.10294143110513687}, {'label': 'positive', 'score': 0.07197463512420654}]","(0.82508385181427, 0.07197463512420654, 0.10294143110513687)",-0.177038031145337,-0.10294143110513687,1,1,"[{'label': 'neutral', 'score': 0.5722486972808838}, {'label': 'positive', 'score': 0.4265953004360199}, {'label': 'negative', 'score': 0.0011560340644791722}]","(0.5722486972808838, 0.4265953004360199, 0.0011560340644791722)",0.9945948312898703,0.4265953004360199,0,1
2015-11-10,39.537696838378906,51.9370231628418,52.09923553466797,51.54580307006836,51.88931274414063,7820490.0,,-0.013044309506463432,0.0034968209193364493,0.0646650414088567,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-11-11,39.02195358276367,51.25954055786133,52.48091506958008,51.22137451171875,52.299617767333984,8954741.0,Patient in Brazil Being Tested for Ebola; 46 Year Old Man Came from Guniea -Reuters,-0.012844318398056883,-0.013130133673365803,0.09591740218157245,"[{'label': 'neutral', 'score': 0.9998308420181274}, {'label': 'negative', 'score': 0.0001076333355740644}, {'label': 'positive', 'score': 6.154176662676036e-05}]","(0.9998308420181274, 6.154176662676036e-05, 0.0001076333355740644)",-0.2724488908101238,-0.0001076333355740644,1,1,"[{'label': 'neutral', 'score': 0.8580915927886963}, {'label': 'negative', 'score': 0.08127480745315552}, {'label': 'positive', 'score': 0.0606335774064064}]","(0.8580915927886963, 0.0606335774064064, 0.08127480745315552)",-0.14545461895839687,-0.08127480745315552,1,1,"[{'label': 'neutral', 'score': 0.9126846790313721}, {'label': 'negative', 'score': 0.08479230105876923}, {'label': 'positive', 'score': 0.0025229400489479303}]","(0.9126846790313721, 0.0025229400489479303, 0.08479230105876923)",-0.9422107751879083,-0.08479230105876923,0,1
2015-11-12,38.5207405090332,50.60114669799805,51.49809265136719,50.60114669799805,51.13549423217773,8989220.0,"Merck Issues Statement Regarding CUBICIN Patent Litigation; Says Reviewing Decision, Considering Next Steps",0.0,-0.01292751986756172,0.11643174689085077,"[{'label': 'neutral', 'score': 0.9998457431793213}, {'label': 'negative', 'score': 8.507059828843921e-05}, {'label': 'positive', 'score': 6.9176618126221e-05}]","(0.9998457431793213, 6.9176618126221e-05, 8.507059828843921e-05)",-0.10304224952423577,-8.507059828843921e-05,1,1,"[{'label': 'neutral', 'score': 0.8722406029701233}, {'label': 'negative', 'score': 0.07388993352651596}, {'label': 'positive', 'score': 0.05386954918503761}]","(0.8722406029701233, 0.05386954918503761, 0.07388993352651596)",-0.15670370540462325,-0.07388993352651596,1,1,"[{'label': 'neutral', 'score': 0.9910154938697815}, {'label': 'positive', 'score': 0.008598947897553444}, {'label': 'negative', 'score': 0.00038556885556317866}]","(0.9910154938697815, 0.008598947897553444, 0.00038556885556317866)",0.9141703741763453,0.008598947897553444,0,1
2015-11-13,38.5207405090332,50.60114669799805,51.25954055786133,50.47710037231445,51.011451721191406,11941436.0,Hearing Unconfirmed Market Chatter of Potential Merck Bid for Celgene | Merck Issues Update on REVEAL Outcomes Sutdy,0.004211450964120268,0.0,0.12130787340479975,"[{'label': 'neutral', 'score': 0.9994078874588013}, {'label': 'positive', 'score': 0.0004893858567811549}, {'label': 'negative', 'score': 0.00010272143117617816}]","(0.9994078874588013, 0.0004893858567811549, 0.00010272143117617816)",0.6530310189879635,0.0004893858567811549,0,1,"[{'label': 'neutral', 'score': 0.9208071231842041}, {'label': 'negative', 'score': 0.05032214894890785}, {'label': 'positive', 'score': 0.028870781883597374}]","(0.9208071231842041, 0.028870781883597374, 0.05032214894890785)",-0.27087477177326075,-0.05032214894890785,1,1,"[{'label': 'neutral', 'score': 0.9253698587417603}, {'label': 'positive', 'score': 0.0740656852722168}, {'label': 'negative', 'score': 0.0005645225755870342}]","(0.9253698587417603, 0.0740656852722168, 0.0005645225755870342)",0.9848714725078004,0.0740656852722168,0,1
2015-11-14,38.6829719543457,50.81425094604492,51.288167317708336,50.2321891784668,50.6075070699056,10374082.0,,0.004193789027278021,0.004202607624674654,0.13793612885334838,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-15,38.8452033996582,51.0273551940918,51.316794077555336,49.98727798461914,50.20356241861979,8806728.0,"Merck to Release Findings from Integrated Analysis of Six Phase 2 and 3 Clinical Trials Evaluating Investigational Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Genotype 1, 4 or 6 Infection and Compensated Cirrhosis at The Liver Meeting | Merck Announces Presentation of Phase 3 Results of Investigational Elbasvir/Grazoprevir in People with Chronic Hepatitis C Genotypes 1, 4 or 6 Infection Who Inject Drugs and Are on Opioid Agonist Therapy",0.004176274612632662,0.004185019603601085,0.1402563559770684,"[{'label': 'neutral', 'score': 0.9998645782470703}, {'label': 'negative', 'score': 7.003189239185303e-05}, {'label': 'positive', 'score': 6.537116132676601e-05}]","(0.9998645782470703, 6.537116132676601e-05, 7.003189239185303e-05)",-0.03442116656225849,-7.003189239185303e-05,1,1,"[{'label': 'neutral', 'score': 0.9041222333908081}, {'label': 'positive', 'score': 0.04816152900457382}, {'label': 'negative', 'score': 0.04771627485752106}]","(0.9041222333908081, 0.04816152900457382, 0.04771627485752106)",0.004643975238452404,0.04816152900457382,1,1,"[{'label': 'neutral', 'score': 0.9972004890441895}, {'label': 'positive', 'score': 0.002233352279290557}, {'label': 'negative', 'score': 0.0005661876639351249}]","(0.9972004890441895, 0.002233352279290557, 0.0005661876639351249)",0.5955137805372743,0.002233352279290557,0,1
2015-11-16,39.0074348449707,51.24045944213867,51.34542083740234,49.74236679077149,49.799617767333984,7239374.0,Cambodia Reports Outbreak Of Highly Pathogenic H5N1 Bird Flu -Reuters,0.00018619188752789064,0.004167578181860131,0.11763161739614997,"[{'label': 'neutral', 'score': 0.993239164352417}, {'label': 'negative', 'score': 0.0066093988716602325}, {'label': 'positive', 'score': 0.0001513939641881734}]","(0.993239164352417, 0.0001513939641881734, 0.0066093988716602325)",-0.9552141389733397,-0.0066093988716602325,0,1,"[{'label': 'negative', 'score': 0.8840470910072327}, {'label': 'neutral', 'score': 0.08678389340639114}, {'label': 'positive', 'score': 0.029169023036956787}]","(0.08678389340639114, 0.029169023036956787, 0.8840470910072327)",-0.9361180281679845,-0.8840470910072327,0,0,"[{'label': 'negative', 'score': 0.9771893620491028}, {'label': 'neutral', 'score': 0.02120433934032917}, {'label': 'positive', 'score': 0.0016063121147453785}]","(0.02120433934032917, 0.0016063121147453785, 0.9771893620491028)",-0.9967177784758446,-0.9771893620491028,0,0
2015-11-17,39.01469039916992,51.25,51.8129768371582,50.84923553466797,51.25,7468677.0,,0.009681590010480183,0.0001861745559696931,0.0355949478836514,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-11-18,39.39241790771485,51.74618148803711,51.832061767578125,51.24045944213867,51.39313125610352,11330347.0,"Shares of Sigma Aldrich Halted, is Being Taken Out by Merck KGaA | Merck, Darmstadt, Pfizer Report FDA Breakthrough Therapy Designation for Avelumab in Metastatic Merkel Cell Carcinoma",0.0009220084908526392,0.009635023733736195,0.05340578382758265,"[{'label': 'neutral', 'score': 0.9997177720069885}, {'label': 'negative', 'score': 0.00023099344980437309}, {'label': 'positive', 'score': 5.1265466026961803e-05}]","(0.9997177720069885, 5.1265466026961803e-05, 0.00023099344980437309)",-0.6367486506070497,-0.00023099344980437309,0,1,"[{'label': 'positive', 'score': 0.6525791883468628}, {'label': 'neutral', 'score': 0.32792407274246216}, {'label': 'negative', 'score': 0.01949666254222393}]","(0.32792407274246216, 0.6525791883468628, 0.01949666254222393)",0.9419807674492935,0.6525791883468628,0,0,"[{'label': 'negative', 'score': 0.8030818104743958}, {'label': 'neutral', 'score': 0.19334541261196136}, {'label': 'positive', 'score': 0.0035727648064494133}]","(0.19334541261196136, 0.0035727648064494133, 0.8030818104743958)",-0.9911417726597397,-0.8030818104743958,0,0
2015-11-19,39.4287338256836,51.79389190673828,52.03244400024414,51.450382232666016,51.946563720703125,7167482.0,US Stock Futures Edge Higher Ahead Of Jobless Claims Report | Lilly and Merck Expand Immuno-oncology Collaboration with Phase III Nonsquamous Non-Small Cell Lung Cancer Trial,-0.0033161582970831606,0.000921583702109786,0.05922385681680136,"[{'label': 'positive', 'score': 0.999315619468689}, {'label': 'neutral', 'score': 0.00037768803304061294}, {'label': 'negative', 'score': 0.0003067201469093561}]","(0.00037768803304061294, 0.999315619468689, 0.0003067201469093561)",0.9993863279465577,0.999315619468689,0,0,"[{'label': 'positive', 'score': 0.9391106963157654}, {'label': 'neutral', 'score': 0.040617380291223526}, {'label': 'negative', 'score': 0.020271888002753258}]","(0.040617380291223526, 0.9391106963157654, 0.020271888002753258)",0.9577397206617982,0.9391106963157654,0,0,"[{'label': 'positive', 'score': 0.9989270567893982}, {'label': 'neutral', 'score': 0.0006943005137145519}, {'label': 'negative', 'score': 0.00037861603777855635}]","(0.0006943005137145519, 0.9989270567893982, 0.00037861603777855635)",0.9992422417923289,0.9989270567893982,0,0
2015-11-20,39.29798889160156,51.62213516235352,52.34732818603516,51.52671813964844,52.10877990722656,9362098.0,"Hearing Merck Planning to Expand Presence in African, Wants to More Than Double Sales in Africa by '20",-0.0005545196492014305,-0.003321668936149135,0.07746869598957382,"[{'label': 'positive', 'score': 0.9995817542076111}, {'label': 'neutral', 'score': 0.00023294135462492704}, {'label': 'negative', 'score': 0.00018527760403230786}]","(0.00023294135462492704, 0.9995817542076111, 0.00018527760403230786)",0.9996293584442436,0.9995817542076111,0,0,"[{'label': 'positive', 'score': 0.8759148716926575}, {'label': 'neutral', 'score': 0.11718160659074783}, {'label': 'negative', 'score': 0.006903566885739565}]","(0.11718160659074783, 0.8759148716926575, 0.006903566885739565)",0.9843601660679938,0.8759148716926575,0,0,"[{'label': 'positive', 'score': 0.9990279674530029}, {'label': 'neutral', 'score': 0.0006445267936214805}, {'label': 'negative', 'score': 0.0003274596238043159}]","(0.0006445267936214805, 0.9990279674530029, 0.0003274596238043159)",0.9993446583368999,0.9990279674530029,0,0
2015-11-21,39.27619806925456,51.593509674072266,52.137404123942055,51.45674387613932,51.94020462036133,9276441.666666666,,-0.000554827311847626,-0.000554673452082507,0.07761855532678032,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-22,39.254407246907554,51.564884185791016,51.92748006184896,51.38676961263021,51.771629333496094,9190785.333333334,Three New Ebola Cases Reported in Liberia; 153 Persons Under Observation -Reuters | Merck Announces Initial Results for KEYTRUDA with Novel Immunotherapy Combinations from Three Investigational Studies Presented at the Society for Melanoma Research International Congress,-0.0005551353160827598,-0.0005549812854757749,0.07850595386002067,"[{'label': 'neutral', 'score': 0.9997902512550354}, {'label': 'positive', 'score': 0.00012688674905803055}, {'label': 'negative', 'score': 8.28827396617271e-05}]","(0.9997902512550354, 0.00012688674905803055, 8.28827396617271e-05)",0.2097731641758958,0.00012688674905803055,1,1,"[{'label': 'positive', 'score': 0.7619338035583496}, {'label': 'neutral', 'score': 0.22164858877658844}, {'label': 'negative', 'score': 0.016417590901255608}]","(0.22164858877658844, 0.7619338035583496, 0.016417590901255608)",0.9578144498278852,0.7619338035583496,0,0,"[{'label': 'neutral', 'score': 0.9420356750488281}, {'label': 'negative', 'score': 0.05049062520265579}, {'label': 'positive', 'score': 0.00747374352067709}]","(0.9420356750488281, 0.00747374352067709, 0.05049062520265579)",-0.7421262860172021,-0.05049062520265579,0,1
2015-11-23,39.23261642456055,51.536258697509766,51.71755599975586,51.31679534912109,51.60305404663086,9105129.0,,-0.009813010749655753,-0.0005552894607424061,0.024466733546003268,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-11-24,38.84762191772461,51.03053283691406,51.22137451171875,50.66793823242188,51.10686874389648,11011546.0,Merck Increases Qtr. Dividend From $0.45 To $0.46/Share | Benzinga's Top Initiations | Berenberg Initiates Coverage on Merck & Co at Buy | 15-Year Old Boy is First Ebola Fatality in Liberia Since Country was Declared Ebola Free in September -Reuters,0.004487660782989274,-0.009861475658060207,0.06404781230791176,"[{'label': 'positive', 'score': 0.9991586208343506}, {'label': 'neutral', 'score': 0.0006019867141731083}, {'label': 'negative', 'score': 0.0002394316252321005}]","(0.0006019867141731083, 0.9991586208343506, 0.0002394316252321005)",0.9995208483253638,0.9991586208343506,0,0,"[{'label': 'positive', 'score': 0.3434581160545349}, {'label': 'negative', 'score': 0.34112611413002014}, {'label': 'neutral', 'score': 0.31541574001312256}]","(0.31541574001312256, 0.3434581160545349, 0.34112611413002014)",0.003406449961440235,0.3434581160545349,1,1,"[{'label': 'positive', 'score': 0.9982654452323914}, {'label': 'neutral', 'score': 0.0014697464648634195}, {'label': 'negative', 'score': 0.00026488694129511714}]","(0.0014697464648634195, 0.9982654452323914, 0.00026488694129511714)",0.999469446379824,0.9982654452323914,0,0
2015-11-25,39.02195358276367,51.25954055786133,51.450382232666016,51.011451721191406,51.16412353515625,6370687.0,,0.0022338058286804547,0.004477621258119974,0.082595010730998,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-26,39.1091251373291,51.37404441833496,51.58396911621094,50.96374130249024,51.040077209472656,4747702.0,MITICURE for house Dust Mite Allergic Rhinitis Now Available in Japan,0.002228827061798688,0.0022313145937072703,0.08667924627059552,"[{'label': 'neutral', 'score': 0.999797523021698}, {'label': 'positive', 'score': 0.00015293507021851838}, {'label': 'negative', 'score': 4.952255039825104e-05}]","(0.999797523021698, 0.00015293507021851838, 4.952255039825104e-05)",0.5107860079814736,0.00015293507021851838,0,1,"[{'label': 'neutral', 'score': 0.8107026815414429}, {'label': 'positive', 'score': 0.1799328476190567}, {'label': 'negative', 'score': 0.009364516474306583}]","(0.8107026815414429, 0.1799328476190567, 0.009364516474306583)",0.9010602549152463,0.1799328476190567,0,1,"[{'label': 'neutral', 'score': 0.8589948415756226}, {'label': 'positive', 'score': 0.1405637264251709}, {'label': 'negative', 'score': 0.0004414110735524446}]","(0.8589948415756226, 0.1405637264251709, 0.0004414110735524446)",0.9937390781444905,0.1405637264251709,0,1
2015-11-27,39.19629669189453,51.488548278808594,51.71755599975586,50.91603088378906,50.91603088378906,3124717.0,,-0.005868531557230148,0.0022263469112970584,0.08948442204054506,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-28,38.96627298990885,51.18638610839844,51.68893051147461,50.80152638753256,51.13231531778971,6751356.0,,-0.005903174523207428,-0.005885819056553101,0.09804849151900183,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-29,38.73624928792318,50.88422393798828,51.66030502319336,50.68702189127604,51.34859975179037,10377995.0,,-0.005938228924909929,-0.005920667133191763,0.07858798572679805,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-11-30,38.5062255859375,50.582061767578125,51.63167953491211,50.57251739501953,51.564884185791016,14004634.0,"Deere Announces Factory Workforce Adjustments, 220 Employees On Indefinite Leave Starting Feb 2016",0.029428382845452083,-0.005955930317695164,0.07086076766805223,"[{'label': 'neutral', 'score': 0.9998735189437866}, {'label': 'negative', 'score': 8.095314842648804e-05}, {'label': 'positive', 'score': 4.55506524303928e-05}]","(0.9998735189437866, 4.55506524303928e-05, 8.095314842648804e-05)",-0.27985321987398304,-8.095314842648804e-05,0,0,"[{'label': 'negative', 'score': 0.9550580382347107}, {'label': 'neutral', 'score': 0.0373239628970623}, {'label': 'positive', 'score': 0.0076180677860975266}]","(0.0373239628970623, 0.0076180677860975266, 0.9550580382347107)",-0.9841731445530801,-0.9550580382347107,0,0,"[{'label': 'negative', 'score': 0.6104632616043091}, {'label': 'neutral', 'score': 0.3873244822025299}, {'label': 'positive', 'score': 0.002212193561717868}]","(0.3873244822025299, 0.002212193561717868, 0.6104632616043091)",-0.9927785794483365,-0.6104632616043091,0,0
2015-12-01,39.6393928527832,52.07061004638672,52.13740539550781,50.99236679077149,51.3072509765625,13620646.0,"Barclays' Biopharmaceuticals Blueprint For 2016 | Barclays On Merck: Too Much Underlying Value To Ignore | Barclays Upgrades Merck & Co to Overweight, Raises PT to $66.00",-0.013743811537554804,0.02900368007853201,0.2401022651668057,"[{'label': 'positive', 'score': 0.999333918094635}, {'label': 'negative', 'score': 0.0005032718763686717}, {'label': 'neutral', 'score': 0.0001627750607440248}]","(0.0001627750607440248, 0.999333918094635, 0.0005032718763686717)",0.9989932923451602,0.999333918094635,0,0,"[{'label': 'positive', 'score': 0.9320961236953735}, {'label': 'neutral', 'score': 0.04033912718296051}, {'label': 'negative', 'score': 0.02756470814347267}]","(0.04033912718296051, 0.9320961236953735, 0.02756470814347267)",0.9425532287471715,0.9320961236953735,0,0,"[{'label': 'positive', 'score': 0.9985491633415222}, {'label': 'neutral', 'score': 0.0010158315999433398}, {'label': 'negative', 'score': 0.00043499513412825763}]","(0.0010158315999433398, 0.9985491633415222, 0.00043499513412825763)",0.9991291250608177,0.9985491633415222,0,0
2015-12-02,39.09460067749024,51.35496139526367,52.47137451171875,51.28816986083984,52.15649032592773,10584066.0,,-0.022853957263919235,-0.01383913210161725,0.26758736501385605,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-03,38.201133728027344,50.181297302246094,51.61259460449219,49.84732818603516,51.593509674072266,14247665.0,,0.019965752232315594,-0.023119157316144206,0.3134062203553044,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-04,38.963844299316406,51.183204650878906,51.22137451171875,50.41030502319336,50.4484748840332,14343976.0,"Merck Spokesperson Declines Comment on Speculation Related to Relypsa | EXCLUSIVE: Relypsa Being Evaluated By 3-4 Potential Acquirers; Sanofi Seen As 'Natural Buyer' | EXCLUSIVE: Wedbush's Liana Moussatos Tells Benzinga Sanofi 'is a natural buyer of Relypsa' | EXCLUSIVE: Source Tells Benzinga Merck Is Not Involved With Relypsa Bid; Calls To Merck Were Not Immediately Returned | Hearing Unconfirmed Marker Chatter of Potential Merck Bid for Relypsa | Amgen, Merck Report Cancer Immunotherapy Partnership For Patients With Non-Hodgkin Lymphoma",0.00024858324197170935,0.019769050489657172,0.3537785094376978,"[{'label': 'neutral', 'score': 0.9994338154792786}, {'label': 'positive', 'score': 0.0003357997629791498}, {'label': 'negative', 'score': 0.0002304003428434953}]","(0.9994338154792786, 0.0003357997629791498, 0.0002304003428434953)",0.18615224379465148,0.0003357997629791498,1,1,"[{'label': 'neutral', 'score': 0.7473076581954956}, {'label': 'positive', 'score': 0.1452573537826538}, {'label': 'negative', 'score': 0.10743499547243118}]","(0.7473076581954956, 0.1452573537826538, 0.10743499547243118)",0.14967749685227763,0.1452573537826538,1,1,"[{'label': 'neutral', 'score': 0.9702085852622986}, {'label': 'negative', 'score': 0.015398852527141571}, {'label': 'positive', 'score': 0.014392553828656673}]","(0.9702085852622986, 0.014392553828656673, 0.015398852527141571)",-0.033778153554306564,-0.015398852527141571,1,1
2015-12-05,38.97352981567383,51.19592793782552,51.39631017049154,50.521628061930336,50.81425094604492,12600453.333333334,,0.00024852146370042433,0.00024855235027687166,0.34860763035561515,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-06,38.98321533203125,51.20865122477213,51.57124582926432,50.63295110066732,51.18002700805664,10856930.666666668,,0.00024845971612824034,0.00024849058735702535,0.25856815520230514,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-07,38.99290084838867,51.22137451171875,51.74618148803711,50.7442741394043,51.54580307006836,9113408.0,"Merck Reports Samsung Bioepis Receives Approval of RENFLEXIS, a Biosimilar of Remicade, in Korea | Must Watch Stocks for Today | Benzinga's Weekend M&A Chatter",-0.003912082301113784,0.00024842885512473765,0.24128980551928766,"[{'label': 'positive', 'score': 0.9986948370933533}, {'label': 'neutral', 'score': 0.0009714383631944656}, {'label': 'negative', 'score': 0.00033373202313669026}]","(0.0009714383631944656, 0.9986948370933533, 0.00033373202313669026)",0.9993318869280549,0.9986948370933533,0,0,"[{'label': 'neutral', 'score': 0.7875733971595764}, {'label': 'positive', 'score': 0.19803863763809204}, {'label': 'negative', 'score': 0.014387966133654118}]","(0.7875733971595764, 0.19803863763809204, 0.014387966133654118)",0.8645370600650935,0.19803863763809204,0,1,"[{'label': 'positive', 'score': 0.991370439529419}, {'label': 'neutral', 'score': 0.008361777290701866}, {'label': 'negative', 'score': 0.0002677930751815438}]","(0.008361777290701866, 0.991370439529419, 0.0002677930751815438)",0.9994598976393273,0.991370439529419,0,0
2015-12-08,38.84035110473633,51.020992279052734,51.90839767456055,50.78244400024414,51.11641311645508,7936714.0,,-0.012156325975168164,-0.003919754511160834,0.14876535938528282,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-09,38.3681869506836,50.40076446533203,51.154579162597656,50.114505767822266,50.83969497680664,10854346.0,,0.016470992316377716,-0.012230818424335883,0.0861033691726653,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-12-10,39.00016403198242,51.23091506958008,51.50763320922852,50.40076446533203,50.59160232543945,12001591.0,9 Healthcare Picks For 2016 | UPDATE: Merck Says Biothera Research Shows Imprime PGG Activates Key Immune Responses | Biothera Announces Clinical Study to Evaluate Combination Therapy of Imprime PGG | Eli Lilly and Merk Announces Expansion of Immuno Oncology Collaboration,-0.028683136859704673,0.016336816853087917,0.1649496389989945,"[{'label': 'positive', 'score': 0.9482247829437256}, {'label': 'neutral', 'score': 0.05138714239001274}, {'label': 'negative', 'score': 0.0003880919539369643}]","(0.05138714239001274, 0.9482247829437256, 0.0003880919539369643)",0.9991817695833428,0.9482247829437256,0,0,"[{'label': 'positive', 'score': 0.8749452829360962}, {'label': 'neutral', 'score': 0.11461621522903442}, {'label': 'negative', 'score': 0.010438520461320877}]","(0.11461621522903442, 0.8749452829360962, 0.010438520461320877)",0.976420349183561,0.8749452829360962,0,0,"[{'label': 'neutral', 'score': 0.9044439196586609}, {'label': 'positive', 'score': 0.09515364468097687}, {'label': 'negative', 'score': 0.000402334175305441}]","(0.9044439196586609, 0.09515364468097687, 0.000402334175305441)",0.9915790894484885,0.09515364468097687,0,0
2015-12-11,38.20888519287109,49.761451721191406,50.83969497680664,49.63740539550781,50.57251739501953,10896999.0,,0.0003195686778539248,-0.029102537311715835,0.26497819199692957,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-12,38.22109222412109,49.77735392252604,50.54707336425781,49.51972071329752,50.30216217041016,11456386.666666666,Major Pharma Group Outlook In 2016: Fundamentals To Outweigh Political Headwinds,0.0003194665863394526,0.0003195176266598959,0.26507975938161804,"[{'label': 'negative', 'score': 0.6871368885040283}, {'label': 'neutral', 'score': 0.3109380304813385}, {'label': 'positive', 'score': 0.0019250022014603019}]","(0.3109380304813385, 0.0019250022014603019, 0.6871368885040283)",-0.9944126870824639,-0.6871368885040283,0,0,"[{'label': 'positive', 'score': 0.9507631659507751}, {'label': 'neutral', 'score': 0.027572061866521835}, {'label': 'negative', 'score': 0.021664809435606003}]","(0.027572061866521835, 0.9507631659507751, 0.021664809435606003)",0.9554418219467662,0.9507631659507751,0,0,"[{'label': 'neutral', 'score': 0.8873308897018433}, {'label': 'positive', 'score': 0.11115501075983047}, {'label': 'negative', 'score': 0.001514062169007957}]","(0.8873308897018433, 0.11115501075983047, 0.001514062169007957)",0.9731237307692372,0.11115501075983047,0,1
2015-12-13,38.23329925537109,49.79325612386068,50.25445175170898,49.40203603108724,50.03180694580078,12015774.333333334,,0.00031936456003351814,0.00031941556775516203,0.2685781556078548,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-14,38.24550628662109,49.80915832519531,49.96183013916016,49.28435134887695,49.761451721191406,12575162.0,Hearing FDA Panel Has Voted IMPROVE-IT Data for Merck's Zetia to Statin Therapy Does Not Support Claim of Reduced Risk of CV Events,0.013410024774124136,0.00031931357402747675,0.26160110752087434,"[{'label': 'positive', 'score': 0.9957605004310608}, {'label': 'neutral', 'score': 0.003948730416595936}, {'label': 'negative', 'score': 0.00029073518817313015}]","(0.003948730416595936, 0.9957605004310608, 0.00029073518817313015)",0.9994162244314824,0.9957605004310608,0,0,"[{'label': 'negative', 'score': 0.48787564039230347}, {'label': 'neutral', 'score': 0.3049790561199188}, {'label': 'positive', 'score': 0.20714536309242249}]","(0.3049790561199188, 0.20714536309242249, 0.48787564039230347)",-0.40391624985769287,-0.48787564039230347,1,1,"[{'label': 'positive', 'score': 0.9952113032341003}, {'label': 'neutral', 'score': 0.003957733046263456}, {'label': 'negative', 'score': 0.0008309375261887908}]","(0.003957733046263456, 0.9952113032341003, 0.0008309375261887908)",0.9983315215114682,0.9952113032341003,0,0
2015-12-15,38.75838851928711,50.47710037231445,50.75381851196289,49.83778762817383,50.07633590698242,12142023.0,UPDATE: Merck Says Expanded Age Indication for GARDASIL 9 Includes 16-26 Age Range | Merck Announces FDA Approval for Expanded Age Indication for GARDASIL 9 in Males | FDA Approves Bridion To Reverse Effects Of Neuromuscular Blocking Drugs Used In Surgery | Fast Money Picks For December 15,0.02117203028445084,0.013320906229142369,0.24857215567862542,"[{'label': 'positive', 'score': 0.9940213561058044}, {'label': 'neutral', 'score': 0.005659820977598429}, {'label': 'negative', 'score': 0.00031874634441919625}]","(0.005659820977598429, 0.9940213561058044, 0.00031874634441919625)",0.9993588786298898,0.9940213561058044,0,0,"[{'label': 'positive', 'score': 0.8080998063087463}, {'label': 'neutral', 'score': 0.1757553666830063}, {'label': 'negative', 'score': 0.016144828870892525}]","(0.1757553666830063, 0.8080998063087463, 0.016144828870892525)",0.9608251526747908,0.8080998063087463,0,0,"[{'label': 'neutral', 'score': 0.6992648243904114}, {'label': 'positive', 'score': 0.29976579546928406}, {'label': 'negative', 'score': 0.0009693484753370285}]","(0.6992648243904114, 0.29976579546928406, 0.0009693484753370285)",0.9935534739131417,0.29976579546928406,0,1
2015-12-16,39.57897186279297,51.54580307006836,51.63167953491211,50.57251739501953,50.97328186035156,10494986.0,,-0.025175869642328395,0.020951016942782494,0.1523590487830374,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-12-17,38.58254623413086,50.24809265136719,51.76526641845703,50.24809265136719,51.63167953491211,14165921.0,,-0.01936952845363536,-0.025498203374896826,0.2805159820456277,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-18,37.835205078125,49.274810791015625,49.92366409301758,49.24618148803711,49.761451721191406,22114686.0,"Merck Reports FDA Approval of Expanded Indication for KEYTRUDA for Treatment of Patients with Advanced Melanoma | Merck Reports EMA's CHMP Has Responded to MAA for elbasvir/grazoprevir (50mg/100mg), Application Will Now Be Reviewed on Standard Timetable | Codexis +7.1% Premarket @$4.50;, Co Announces Agreement Extension With Merck",0.001484621620835044,-0.019559575858281678,0.3201891872395628,"[{'label': 'positive', 'score': 0.9989715814590454}, {'label': 'neutral', 'score': 0.0007533407770097256}, {'label': 'negative', 'score': 0.0002750932180788368}]","(0.0007533407770097256, 0.9989715814590454, 0.0002750932180788368)",0.999449398782002,0.9989715814590454,0,0,"[{'label': 'positive', 'score': 0.8947717547416687}, {'label': 'neutral', 'score': 0.09648497402667999}, {'label': 'negative', 'score': 0.008743245154619217}]","(0.09648497402667999, 0.8947717547416687, 0.008743245154619217)",0.980646153842221,0.8947717547416687,0,0,"[{'label': 'positive', 'score': 0.9973788261413574}, {'label': 'neutral', 'score': 0.0024164067581295967}, {'label': 'negative', 'score': 0.00020483038679230958}]","(0.0024164067581295967, 0.9973788261413574, 0.00020483038679230958)",0.999589346947593,0.9973788261413574,0,0
2015-12-19,37.89138539632162,49.34796524047852,49.86959330240885,49.11577479044596,49.761451721191406,18808001.666666668,Credit Suisse Offers 2016 U.S. Large-Cap Pharma Outlook | Merck's KEYTRUDA Significantly Improves Survival Compared to Chemotherapy in Previously-Treated Patients with Non-Small Cell Lung Cancer Whose Tumors Express Any Level of PD-L1,0.0014824207868833733,0.0014835206596956452,0.3208478368928872,"[{'label': 'positive', 'score': 0.9995972514152527}, {'label': 'negative', 'score': 0.00024215906159952283}, {'label': 'neutral', 'score': 0.00016055222658906132}]","(0.00016055222658906132, 0.9995972514152527, 0.00024215906159952283)",0.9995156040878924,0.9995972514152527,0,0,"[{'label': 'positive', 'score': 0.9517803192138672}, {'label': 'neutral', 'score': 0.025100870057940483}, {'label': 'negative', 'score': 0.02311878837645054}]","(0.025100870057940483, 0.9517803192138672, 0.02311878837645054)",0.9525719365287064,0.9517803192138672,0,0,"[{'label': 'positive', 'score': 0.9978845715522766}, {'label': 'neutral', 'score': 0.0016990143340080976}, {'label': 'negative', 'score': 0.00041640247218310833}]","(0.0016990143340080976, 0.9978845715522766, 0.00041640247218310833)",0.9991657776902602,0.9978845715522766,0,0
2015-12-20,37.94756571451823,49.421119689941406,49.81552251180013,48.98536809285482,49.761451721191406,15501317.333333334,,0.0014802264683974697,0.0014813230858912315,0.29556861911993837,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-21,38.00374603271485,49.4942741394043,49.761451721191406,48.85496139526367,49.761451721191406,12194633.0,Merck CEO: Using Keytruda Could Extend Patient's Life By 13 Months On Average | ALK Sells European Veterinary Business to Fidelio Capital; Terms Not Disclosed,0.0044341929829660506,0.0014791320130933317,0.21140859978263293,"[{'label': 'positive', 'score': 0.9948537945747375}, {'label': 'neutral', 'score': 0.004814463201910257}, {'label': 'negative', 'score': 0.0003317833470646292}]","(0.004814463201910257, 0.9948537945747375, 0.0003317833470646292)",0.9993332231607346,0.9948537945747375,0,0,"[{'label': 'neutral', 'score': 0.9232653379440308}, {'label': 'positive', 'score': 0.047116778790950775}, {'label': 'negative', 'score': 0.02961791679263115}]","(0.9232653379440308, 0.047116778790950775, 0.02961791679263115)",0.2280436752271897,0.047116778790950775,1,1,"[{'label': 'neutral', 'score': 0.9652572870254517}, {'label': 'positive', 'score': 0.03448808193206787}, {'label': 'negative', 'score': 0.0002546574978623539}]","(0.9652572870254517, 0.03448808193206787, 0.0002546574978623539)",0.985340390421662,0.03448808193206787,0,1
2015-12-22,38.172245025634766,49.71374130249024,49.83778762817383,48.931297302246094,49.62786483764648,13830351.0,"Merck KGaA, Pfizer Report Advancement of Clinical Development Program with Two Added Phase III Trials of Avelumab",0.01689060116593114,0.004424390914753818,0.1559170119368581,"[{'label': 'neutral', 'score': 0.9996861219406128}, {'label': 'positive', 'score': 0.00026715939748100936}, {'label': 'negative', 'score': 4.675836316891946e-05}]","(0.9996861219406128, 0.00026715939748100936, 4.675836316891946e-05)",0.7020980076303303,0.00026715939748100936,0,1,"[{'label': 'positive', 'score': 0.8990067839622498}, {'label': 'neutral', 'score': 0.09303073585033417}, {'label': 'negative', 'score': 0.007962566800415516}]","(0.09303073585033417, 0.8990067839622498, 0.007962566800415516)",0.9824413762301453,0.8990067839622498,0,0,"[{'label': 'neutral', 'score': 0.8933817148208618}, {'label': 'positive', 'score': 0.10628556460142136}, {'label': 'negative', 'score': 0.0003326547157485038}]","(0.8933817148208618, 0.10628556460142136, 0.0003326547157485038)",0.993759889859745,0.10628556460142136,0,1
2015-12-23,38.816986083984375,50.55343627929688,50.78244400024414,49.96183013916016,49.98091506958008,7469515.0,Peering Through The Fog To Find The Best Sectors Into Year End,-0.0024537664462267517,0.016749541138679606,0.10513488526181795,"[{'label': 'neutral', 'score': 0.9997434020042419}, {'label': 'positive', 'score': 0.00017206932534463704}, {'label': 'negative', 'score': 8.446467109024525e-05}]","(0.9997434020042419, 0.00017206932534463704, 8.446467109024525e-05)",0.3414933516487319,0.00017206932534463704,1,1,"[{'label': 'neutral', 'score': 0.8229154348373413}, {'label': 'positive', 'score': 0.16330480575561523}, {'label': 'negative', 'score': 0.013779820874333382}]","(0.8229154348373413, 0.16330480575561523, 0.013779820874333382)",0.8443702185042986,0.16330480575561523,0,1,"[{'label': 'neutral', 'score': 0.9989737272262573}, {'label': 'positive', 'score': 0.0008698171586729586}, {'label': 'negative', 'score': 0.00015646505926270038}]","(0.9989737272262573, 0.0008698171586729586, 0.00015646505926270038)",0.6950837566348447,0.0008698171586729586,0,1
2015-12-24,38.72173309326172,50.42938995361328,50.696563720703125,50.200382232666016,50.37213516235352,3123145.0,,-4.731552655789113e-05,-0.002456781864878441,0.11680352853664104,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-25,38.71990489959717,50.42700386047363,50.67509460449219,50.190839767456055,50.37213516235352,3609469.25,,-4.731776542287766e-05,-4.7316645972737946e-05,0.11962683243757595,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-26,38.71807670593262,50.424617767333984,50.65362548828125,50.181297302246094,50.37213516235352,4095793.5,,-4.7320004499750386e-05,-4.7318884943660834e-05,0.12214167798739645,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-27,38.71624851226807,50.422231674194336,50.63215637207031,50.17175483703613,50.37213516235352,4582117.75,,-4.73222437885394e-05,-4.732112412642931e-05,0.12462767158763617,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-28,38.71442031860352,50.41984558105469,50.610687255859375,50.16221237182617,50.37213516235352,5068442.0,,0.009462551239818238,-4.7323363521265445e-05,0.01710548231944399,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2015-12-29,39.08076095581055,50.89694595336914,51.154579162597656,50.48664093017578,50.54389190673828,6925708.0,WHO Declares End of Ebola Virus Transmission in  Republic of Guinea,-0.0016872616467484799,0.00941806173776363,0.0671975442786838,"[{'label': 'neutral', 'score': 0.9997252821922302}, {'label': 'negative', 'score': 0.000196119726751931}, {'label': 'positive', 'score': 7.853266288293526e-05}]","(0.9997252821922302, 7.853266288293526e-05, 0.000196119726751931)",-0.4281304962440729,-0.000196119726751931,1,1,"[{'label': 'neutral', 'score': 0.545457661151886}, {'label': 'negative', 'score': 0.4166957139968872}, {'label': 'positive', 'score': 0.03784659877419472}]","(0.545457661151886, 0.03784659877419472, 0.4166957139968872)",-0.8334738143805981,-0.4166957139968872,0,1,"[{'label': 'neutral', 'score': 0.9970155954360962}, {'label': 'positive', 'score': 0.002221248345449567}, {'label': 'negative', 'score': 0.000763187650591135}]","(0.9970155954360962, 0.002221248345449567, 0.000763187650591135)",0.4885548548512235,0.002221248345449567,1,1
2015-12-30,39.01482772827149,50.81106948852539,51.125953674316406,50.64885330200195,50.89694595336914,5827194.0,,-0.008075110941839516,-0.0016886866758376463,0.07101270144178827,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2015-12-31,38.69975280761719,50.40076446533203,50.84923553466797,50.24809265136719,50.38167953491211,8690959.0,,-0.0016092442336502965,-0.008107891239157896,0.09953238974644171,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-01,38.63747787475586,50.31965732574463,50.68702220916748,49.99761486053467,50.1932258605957,11017964.5,,-0.0016118380747777105,-0.0016105404579663631,0.10010263813629255,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-02,38.57520294189453,50.23855018615723,50.52480888366699,49.74713706970215,50.0047721862793,13344970.0,,-0.0016144402911083744,-0.001613138483320558,0.10036479309401555,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-03,38.5129280090332,50.157443046569824,50.3625955581665,49.49665927886963,49.81631851196289,15671975.5,,-0.0016170509232716782,-0.0016157449041707985,0.04597701286301472,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-04,38.45065307617188,50.07633590698242,50.200382232666016,49.24618148803711,49.62786483764648,17998981.0,"Pfizer, Merck KGaA Report Syndax to Collab to Investigate Safety, Tolerability, Prelim. Efficacy of Avelumab, Entinostat in Advanced Ovarian Cancer",0.012766763633189106,-0.00161835976127802,0.04609891203090587,"[{'label': 'neutral', 'score': 0.9997859597206116}, {'label': 'negative', 'score': 0.00015397543029394}, {'label': 'positive', 'score': 6.012532685417682e-05}]","(0.9997859597206116, 6.012532685417682e-05, 0.00015397543029394)",-0.438345499987358,-0.00015397543029394,0,0,"[{'label': 'neutral', 'score': 0.7528722286224365}, {'label': 'positive', 'score': 0.23728445172309875}, {'label': 'negative', 'score': 0.00984332524240017}]","(0.7528722286224365, 0.23728445172309875, 0.00984332524240017)",0.9203381719103605,0.23728445172309875,1,0,"[{'label': 'neutral', 'score': 0.7168364524841309}, {'label': 'positive', 'score': 0.2821233868598938}, {'label': 'negative', 'score': 0.00104012549854815}]","(0.7168364524841309, 0.2821233868598938, 0.00104012549854815)",0.9926535344198478,0.2821233868598938,1,0
2016-01-05,38.94154357910156,50.71564865112305,51.020992279052734,50.25763320922852,50.37213516235352,11607124.0,"Watch Stocks of Small-, Mid-Cap Cos. with Experimental Drugs as AP Reporting Merck CEO Frazier at Goldman Healthcare Conference Said Co. 'Raring to Go' on M&A Deals This Year | ANI Pharma Reports Closing of Deal to Purchase Two NDAs from Merck for $75M",-0.013734690164269451,0.012685955551366377,0.10152278965120273,"[{'label': 'positive', 'score': 0.7014493942260742}, {'label': 'neutral', 'score': 0.2976526916027069}, {'label': 'negative', 'score': 0.0008979038684628904}]","(0.2976526916027069, 0.7014493942260742, 0.0008979038684628904)",0.9974431342701854,0.7014493942260742,0,0,"[{'label': 'neutral', 'score': 0.6872875094413757}, {'label': 'positive', 'score': 0.2809206545352936}, {'label': 'negative', 'score': 0.0317918062210083}]","(0.6872875094413757, 0.2809206545352936, 0.0317918062210083)",0.7966706785900433,0.2809206545352936,0,1,"[{'label': 'neutral', 'score': 0.9679810404777527}, {'label': 'positive', 'score': 0.030424155294895172}, {'label': 'negative', 'score': 0.0015948512591421604}]","(0.9679810404777527, 0.030424155294895172, 0.0015948512591421604)",0.900380965508684,0.030424155294895172,0,1
2016-01-06,38.40669631958008,50.01908493041992,50.524810791015625,49.81870269775391,50.10496139526367,13064263.0,Why This Codexis Analyst Is Confident Stock Is Worth $6 | Washington University Initiates Clinical Study of Verastem's VS-6063 in Combination with Merck's Pembrolizumab and Gemcitabine in Pancreatic Cancer,-0.008775260724685242,-0.013829883661695777,0.14909625194192452,"[{'label': 'positive', 'score': 0.9527612328529358}, {'label': 'neutral', 'score': 0.04651445522904396}, {'label': 'negative', 'score': 0.0007243594154715538}]","(0.04651445522904396, 0.9527612328529358, 0.0007243594154715538)",0.9984806075281153,0.9527612328529358,0,0,"[{'label': 'positive', 'score': 0.5712634325027466}, {'label': 'neutral', 'score': 0.41857194900512695}, {'label': 'negative', 'score': 0.01016460545361042}]","(0.41857194900512695, 0.5712634325027466, 0.01016460545361042)",0.9650357231160105,0.5712634325027466,0,0,"[{'label': 'neutral', 'score': 0.8804916739463806}, {'label': 'positive', 'score': 0.11887533217668533}, {'label': 'negative', 'score': 0.000632996903732419}]","(0.8804916739463806, 0.11887533217668533, 0.000632996903732419)",0.989406647911436,0.11887533217668533,0,1
2016-01-07,38.069671630859375,49.58015441894531,49.92366409301758,49.08396911621094,49.16030502319336,13330560.0,,-0.01693611055970775,-0.008813990064917078,0.1588064610186949,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-08,37.42491149902344,48.74045944213867,50.114505767822266,48.53053283691406,50.10496139526367,14835698.0,,0.0011093615289555377,-0.017081166602868732,0.1878332463966117,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-09,37.46643320719401,48.7945302327474,49.80280049641927,48.45101674397787,49.7041982014974,14909477.0,,0.00110813220971294,0.0011087466421669855,0.19253439512845574,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-10,37.507954915364586,48.84860102335612,49.491095225016274,48.371500651041664,49.30343500773112,14983256.0,,0.0011069056119515155,0.0011075186844186707,0.13324014335941733,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-11,37.54947662353516,48.90267181396485,49.17938995361328,48.29198455810547,48.90267181396485,15057035.0,"Merck Acquires IOmet Pharma, Terms Not Disclosed",0.009951213545694533,0.0011062934436346478,0.13071865409817973,"[{'label': 'neutral', 'score': 0.9998829364776611}, {'label': 'negative', 'score': 6.811328785261139e-05}, {'label': 'positive', 'score': 4.8961541324388236e-05}]","(0.9998829364776611, 4.8961541324388236e-05, 6.811328785261139e-05)",-0.1635855175946367,-6.811328785261139e-05,1,1,"[{'label': 'neutral', 'score': 0.9524352550506592}, {'label': 'positive', 'score': 0.02915460616350174}, {'label': 'negative', 'score': 0.018410103395581245}]","(0.9524352550506592, 0.02915460616350174, 0.018410103395581245)",0.22589232368956444,0.02915460616350174,1,1,"[{'label': 'neutral', 'score': 0.9995255470275879}, {'label': 'positive', 'score': 0.00030721674556843936}, {'label': 'negative', 'score': 0.00016728974878787994}]","(0.9995255470275879, 0.00030721674556843936, 0.00016728974878787994)",0.29488952932114054,0.00030721674556843936,1,1
2016-01-12,37.92313003540039,49.38931274414063,49.68511581420898,48.64503860473633,49.15076446533203,11864408.0,Fast Money Traders Share Their Biotech Picks,-0.021251920891701703,0.009902026266415866,0.156852977862926,"[{'label': 'neutral', 'score': 0.9998652935028076}, {'label': 'negative', 'score': 7.430543337250128e-05}, {'label': 'positive', 'score': 6.037579441908747e-05}]","(0.9998652935028076, 6.037579441908747e-05, 7.430543337250128e-05)",-0.10342672978129594,-7.430543337250128e-05,1,1,"[{'label': 'neutral', 'score': 0.8035355806350708}, {'label': 'positive', 'score': 0.1833459734916687}, {'label': 'negative', 'score': 0.01311844028532505}]","(0.8035355806350708, 0.1833459734916687, 0.01311844028532505)",0.8664547941978362,0.1833459734916687,0,1,"[{'label': 'neutral', 'score': 0.9995638728141785}, {'label': 'positive', 'score': 0.00029151965281926095}, {'label': 'negative', 'score': 0.00014452285540755838}]","(0.9995638728141785, 0.00029151965281926095, 0.00014452285540755838)",0.3371157505021006,0.00029151965281926095,1,1
2016-01-13,37.1171875,48.33969497680664,49.67557144165039,48.26335906982422,49.53244400024414,17340837.0,WHO to Announce End of Ebola Outbreak on Thursday -AFP,0.02250298907959076,-0.0214809942759356,0.18606544842380843,"[{'label': 'neutral', 'score': 0.9998250603675842}, {'label': 'negative', 'score': 0.00012485506886150688}, {'label': 'positive', 'score': 5.009913365938701e-05}]","(0.9998250603675842, 5.009913365938701e-05, 0.00012485506886150688)",-0.4272885939575653,-0.00012485506886150688,1,1,"[{'label': 'neutral', 'score': 0.768447995185852}, {'label': 'negative', 'score': 0.19699251651763916}, {'label': 'positive', 'score': 0.034559499472379684}]","(0.768447995185852, 0.034559499472379684, 0.19699251651763916)",-0.7014968811684249,-0.19699251651763916,0,1,"[{'label': 'neutral', 'score': 0.9939239621162415}, {'label': 'positive', 'score': 0.005556759890168905}, {'label': 'negative', 'score': 0.0005192635580897331}]","(0.9939239621162415, 0.005556759890168905, 0.0005192635580897331)",0.8290778294351212,0.005556759890168905,0,1
2016-01-14,37.95244216918945,49.42748260498047,49.72328186035156,48.27289962768555,48.34923553466797,14219788.0,Sierra Leone Health Ministry Investigating Suspected Death from Ebola -Reuters,-0.012741336460777774,0.022253532235770083,0.2539836142601145,"[{'label': 'neutral', 'score': 0.9975948929786682}, {'label': 'negative', 'score': 0.0023039239458739758}, {'label': 'positive', 'score': 0.00010114683391293511}]","(0.9975948929786682, 0.00010114683391293511, 0.0023039239458739758)",-0.9158886842225104,-0.0023039239458739758,0,1,"[{'label': 'negative', 'score': 0.5313276648521423}, {'label': 'neutral', 'score': 0.4401852786540985}, {'label': 'positive', 'score': 0.0284870732575655}]","(0.4401852786540985, 0.0284870732575655, 0.5313276648521423)",-0.8982267835471569,-0.5313276648521423,0,0,"[{'label': 'neutral', 'score': 0.9344432353973389}, {'label': 'negative', 'score': 0.06330335140228271}, {'label': 'positive', 'score': 0.002253372222185135}]","(0.9344432353973389, 0.002253372222185135, 0.06330335140228271)",-0.9312542757599281,-0.06330335140228271,0,1
2016-01-15,37.46886444091797,48.79771041870117,48.950382232666016,47.80534362792969,48.1870231628418,16233939.0,"Write A Prescription For This Healthcare ETF | Merck Announces Resolution of Vioxx Class Action Lawsuit, Cash Payment ~$680M | UPDATE: Sierra Leone Ebola Victim Said to have Exposed 27 to Disease; Woman was Living in House With 22 People When She Became Ill -Reuters | UPDATE: Sierra Leone Health Ministry Confirms Death from Ebola -Reuters",0.0009776988431934987,-0.012823203427979619,0.2772527302841216,"[{'label': 'neutral', 'score': 0.998120129108429}, {'label': 'negative', 'score': 0.0017002875683829188}, {'label': 'positive', 'score': 0.00017950522305909544}]","(0.998120129108429, 0.00017950522305909544, 0.0017002875683829188)",-0.8090159469955254,-0.0017002875683829188,0,1,"[{'label': 'neutral', 'score': 0.5824418663978577}, {'label': 'negative', 'score': 0.32159507274627686}, {'label': 'positive', 'score': 0.09596306085586548}]","(0.5824418663978577, 0.09596306085586548, 0.32159507274627686)",-0.5403607156300733,-0.32159507274627686,0,1,"[{'label': 'neutral', 'score': 0.925701379776001}, {'label': 'negative', 'score': 0.04259421303868294}, {'label': 'positive', 'score': 0.031704381108284}]","(0.925701379776001, 0.031704381108284, 0.04259421303868294)",-0.14656847892516273,-0.04259421303868294,1,1
2016-01-16,37.50550174713135,48.84541988372803,49.09589767456055,47.97471332550049,48.44942760467529,15038983.25,,0.0009767438818301369,0.0009772212069771166,0.27721568133497854,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-17,37.54213905334473,48.89312934875488,49.24141311645508,48.14408302307129,48.71183204650879,13844027.5,,0.0009757907841517705,0.0009762671779113802,0.26356043645708416,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-18,37.578776359558105,48.94083881378174,49.38692855834961,48.31345272064209,48.974236488342285,12649071.75,,0.0009748395447080176,0.0009753150098034418,0.19953377266071387,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-19,37.61541366577149,48.988548278808594,49.53244400024414,48.48282241821289,49.23664093017578,11454116.0,,-0.015387569620872175,0.0009743646972140628,0.09796315107501029,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-01-20,37.03660202026367,48.23473358154297,48.683204650878906,47.04198455810547,47.98664093017578,16684579.0,"Sierra Leone Confirms Second New Ebola Case in Less than a Week -Reuters | Credit Suisse Sets Outperform Rating, $125 Target On Gilead Story | Global Vaccine's Alliance Signs $5M Advance Order for Merck's Ebola Vaccine -Reuters",0.007319498220799868,-0.015507186936664757,0.11701754352634526,"[{'label': 'positive', 'score': 0.9988049268722534}, {'label': 'neutral', 'score': 0.0008098397520370781}, {'label': 'negative', 'score': 0.00038519807276315987}]","(0.0008098397520370781, 0.9988049268722534, 0.00038519807276315987)",0.9992289794241425,0.9988049268722534,0,0,"[{'label': 'positive', 'score': 0.7620699405670166}, {'label': 'neutral', 'score': 0.19563665986061096}, {'label': 'negative', 'score': 0.042293451726436615}]","(0.19563665986061096, 0.7620699405670166, 0.042293451726436615)",0.8948399389339518,0.7620699405670166,0,0,"[{'label': 'positive', 'score': 0.9964028596878052}, {'label': 'neutral', 'score': 0.0033080987632274628}, {'label': 'negative', 'score': 0.0002890438190661371}]","(0.0033080987632274628, 0.9964028596878052, 0.0002890438190661371)",0.9994199936448783,0.9964028596878052,0,0
2016-01-21,37.30769348144531,48.58778762817383,48.96946716308594,47.79580307006836,48.45419692993164,12499706.0,,0.008444612179778327,0.0072928406944737,0.13538048496782454,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-22,37.62273788452149,48.99809265136719,49.3702278137207,48.61641311645508,49.08396911621094,11331814.0,,-0.0027912992866394137,0.008409155912125068,0.1517143614052972,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-23,37.517723083496094,48.861324310302734,49.27480824788412,48.55598068237305,49.05534362792969,10796530.666666666,,-0.0027991124472165527,-0.0027952022270350024,0.15321285686970057,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-24,37.4127082824707,48.72455596923828,49.17938868204752,48.495548248291016,49.02671813964844,10261247.333333334,,-0.0028069694704001063,-0.0028030372882211128,0.15354084600118809,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-25,37.30769348144531,48.58778762817383,49.08396911621094,48.43511581420898,48.99809265136719,9725964.0,US Big Pharma: What To Watch For In Q4 Results | Affimed to Collaborate with Merck to Evaluate AFM13 in Combination with KEYTRUDA for Patients with Hodgkin Lymphoma,0.010408418876129122,-0.002810916396869034,0.0928467884385647,"[{'label': 'neutral', 'score': 0.9996515512466431}, {'label': 'positive', 'score': 0.00028145109536126256}, {'label': 'negative', 'score': 6.701058009639382e-05}]","(0.9996515512466431, 0.00028145109536126256, 6.701058009639382e-05)",0.6153919652232364,0.00028145109536126256,0,1,"[{'label': 'positive', 'score': 0.6935862302780151}, {'label': 'neutral', 'score': 0.2969641089439392}, {'label': 'negative', 'score': 0.009449649602174759}]","(0.2969641089439392, 0.6935862302780151, 0.009449649602174759)",0.9731175893788375,0.6935862302780151,0,0,"[{'label': 'neutral', 'score': 0.9961543679237366}, {'label': 'positive', 'score': 0.0036568406503647566}, {'label': 'negative', 'score': 0.000188820282346569}]","(0.9961543679237366, 0.0036568406503647566, 0.000188820282346569)",0.9018008682250392,0.0036568406503647566,0,1
2016-01-26,37.69600677490234,49.093509674072266,49.23664093017578,48.43511581420898,48.71183013916016,9450340.0,,-0.020991223560011995,0.010354624240461912,0.10650715984745612,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-01-27,36.90472030639648,48.0629768371582,49.20801544189453,47.54771041870117,48.33969497680664,13748817.0,Bank of America Downgrades Merck & Co to Neutral | Merck Reports FDA Acceptance of Biologics License Application for Bezlotoxumab | Merck Reports FDA Acceptance of BLA for Bezlotoxumab | ACARIZAX Receives Marketing Authorization in France,-0.0232281308799825,-0.021214671793149526,0.17864844295959686,"[{'label': 'negative', 'score': 0.9942227005958557}, {'label': 'positive', 'score': 0.004512466955929995}, {'label': 'neutral', 'score': 0.0012648394331336021}]","(0.0012648394331336021, 0.004512466955929995, 0.9942227005958557)",-0.990963636602501,-0.9942227005958557,0,0,"[{'label': 'negative', 'score': 0.5554073452949524}, {'label': 'neutral', 'score': 0.2891290783882141}, {'label': 'positive', 'score': 0.1554635763168335}]","(0.2891290783882141, 0.1554635763168335, 0.5554073452949524)",-0.5626109562497091,-0.5554073452949524,0,0,"[{'label': 'negative', 'score': 0.9373309016227722}, {'label': 'neutral', 'score': 0.049613889306783676}, {'label': 'positive', 'score': 0.013055160641670227}]","(0.049613889306783676, 0.013055160641670227, 0.9373309016227722)",-0.9725266159510709,-0.9373309016227722,0,0
2016-01-28,36.0474967956543,46.946563720703125,48.225189208984375,46.73664093017578,48.024810791015625,18996991.0,Adam Feurestein Reminds Twitter Followers 'Today Is Merck's HepC elbasvir/grazoprevir PDUFA' | Adam Feuerstein @adamfeuerstein Tweet: Reminder: Today is $MRK HepC elbasvir/grazoprevir PDUFA. Co. spox knows first and most important post-approval question is: What price? | Fast Money Picks For January 28 | Abbott to Sell ALK's House Dust Mite Sublingual Allergy Immunotherapy Tablet in SE Asia,0.02987805076234525,-0.023502155617522932,0.225307800411743,"[{'label': 'neutral', 'score': 0.9998635053634644}, {'label': 'positive', 'score': 6.872694211779162e-05}, {'label': 'negative', 'score': 6.764414138160646e-05}]","(0.9998635053634644, 6.872694211779162e-05, 6.764414138160646e-05)",0.007940105104392916,6.872694211779162e-05,1,1,"[{'label': 'neutral', 'score': 0.8753103017807007}, {'label': 'positive', 'score': 0.11221687495708466}, {'label': 'negative', 'score': 0.01247281301766634}]","(0.8753103017807007, 0.11221687495708466, 0.01247281301766634)",0.7999383394047467,0.11221687495708466,0,1,"[{'label': 'neutral', 'score': 0.9981222748756409}, {'label': 'positive', 'score': 0.0015496599953621626}, {'label': 'negative', 'score': 0.000327990303048864}]","(0.9981222748756409, 0.0015496599953621626, 0.000327990303048864)",0.6506374980192767,0.0015496599953621626,0,1
2016-01-29,37.12451934814453,48.34923553466797,48.34923553466797,47.30915832519531,47.51908493041992,17734990.0,"Gilead Hits New 52-Week Low; Here Are Two Reasons Why | Merck Confirms FDA Approval Of Hep C Drug At A Cost Of $54,600 Per Patient | From Conf Call: Abbvie Says Merck's New Hep C Drug Will Crimp Viekira Pak Sales | Merck Receives FDA Approval of Hep C Drug ZEPATIER; To Cost $54,600/Patient for 12-Week Course",0.0005262813785179958,0.029440397913917286,0.35249908100645005,"[{'label': 'positive', 'score': 0.7565726041793823}, {'label': 'negative', 'score': 0.2375127375125885}, {'label': 'neutral', 'score': 0.005914628505706787}]","(0.005914628505706787, 0.7565726041793823, 0.2375127375125885)",0.5221481948253399,0.7565726041793823,0,0,"[{'label': 'neutral', 'score': 0.6295339465141296}, {'label': 'positive', 'score': 0.18654194474220276}, {'label': 'negative', 'score': 0.18392406404018402}]","(0.6295339465141296, 0.18654194474220276, 0.18392406404018402)",0.007066453169679304,0.18654194474220276,1,1,"[{'label': 'negative', 'score': 0.8988673686981201}, {'label': 'neutral', 'score': 0.09106757491827011}, {'label': 'positive', 'score': 0.010065055452287197}]","(0.09106757491827011, 0.010065055452287197, 0.8988673686981201)",-0.9778530170453648,-0.8988673686981201,0,0
2016-01-30,37.14406077067057,48.374680836995445,48.447836558024086,47.39185587565104,47.70674387613932,15816626.0,,0.000526004552117054,0.0005261429410426275,0.3525410967344801,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-01-31,37.16360219319662,48.400126139322914,48.54643758138021,47.47455342610677,47.894402821858726,13898262.0,,0.0005257280167871953,0.000525866260215385,0.33947303647714777,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-01,37.183143615722656,48.42557144165039,48.64503860473633,47.5572509765625,48.082061767578125,11979898.0,"Earnings: Pharma Tends to Top Street EstimateCan PFE, MRK Repeat? | Stock Marquee is Crowded in Week Ahead: Oil, Earnings, Labor Data | Mixed Earnings Expectations For Merck And Pfizer",-0.006699451013051113,0.0005255898702295915,0.29789777432634473,"[{'label': 'neutral', 'score': 0.9893172383308411}, {'label': 'positive', 'score': 0.01040638517588377}, {'label': 'negative', 'score': 0.00027627029339782894}]","(0.9893172383308411, 0.01040638517588377, 0.00027627029339782894)",0.9482768504156565,0.01040638517588377,0,1,"[{'label': 'negative', 'score': 0.7611574530601501}, {'label': 'positive', 'score': 0.17952246963977814}, {'label': 'neutral', 'score': 0.05932008475065231}]","(0.05932008475065231, 0.17952246963977814, 0.7611574530601501)",-0.6183133809755078,-0.7611574530601501,0,0,"[{'label': 'positive', 'score': 0.9936144351959229}, {'label': 'neutral', 'score': 0.005616223905235529}, {'label': 'negative', 'score': 0.0007693268707953393}]","(0.005616223905235529, 0.9936144351959229, 0.0007693268707953393)",0.9984526560063764,0.9936144351959229,0,0
2016-02-02,36.934024810791016,48.10114669799805,48.196563720703125,47.614505767822266,47.96755599975586,15614466.0,"Merck, Sanofi Exploring Potential End To Joint Venture In Europe | Sanofi, Merck Considering Ending JV to Sell Vaccines in Europe -Bloomberg",-0.007141482321123564,-0.006721993071007833,0.22375352045937583,"[{'label': 'neutral', 'score': 0.997459352016449}, {'label': 'positive', 'score': 0.0013536374317482114}, {'label': 'negative', 'score': 0.0011870741145685315}]","(0.997459352016449, 0.0013536374317482114, 0.0011870741145685315)",0.06555774401905085,0.0013536374317482114,1,1,"[{'label': 'neutral', 'score': 0.4938489496707916}, {'label': 'positive', 'score': 0.4841650128364563}, {'label': 'negative', 'score': 0.02198602445423603}]","(0.4938489496707916, 0.4841650128364563, 0.02198602445423603)",0.9131246492275426,0.4841650128364563,0,1,"[{'label': 'neutral', 'score': 0.9911948442459106}, {'label': 'negative', 'score': 0.00508558563888073}, {'label': 'positive', 'score': 0.0037194998003542423}]","(0.9911948442459106, 0.0037194998003542423, 0.00508558563888073)",-0.1551473688647341,-0.00508558563888073,1,1
2016-02-03,36.670257568359375,47.75763320922852,47.814884185791016,46.35496139526367,47.34732818603516,20507893.0,"Merck & Co., Inc. Falters After Q4 Report | Joe McCann: Here's How To Play Biotech Market In Earnings Season | Shares Of Merck Dip Lower Following Q4 Print | Merck Sees FY16 EPS $3.60-$3.75 vs. Est. $3.72, Rev. $38.7-$40.2B vs. Est. $40.25B | Merck Reports Q4 EPS $0.93 vs. Est. $0.91, Rev. $10.215B vs. Est. $10.35B | Merck Sees FY 2016 EPS $3.60 to $3.75 vs $3.72 est | Merck Sees FY 2016 Revenue $38.7B vs $40.2B est | Merck Q4 EPS $0.93 vs $0.91 est, Revenue $10.2B vs $10.4B est | Keep an Eye on These 10 Stocks for February 3, 2016 | Earnings Scheduled For February 3, 2016",-0.029170780622710044,-0.007167104767033822,0.06500198475018407,"[{'label': 'negative', 'score': 0.9982779026031494}, {'label': 'neutral', 'score': 0.0010994343319907784}, {'label': 'positive', 'score': 0.0006226373370736837}]","(0.0010994343319907784, 0.0006226373370736837, 0.9982779026031494)",-0.9987533546891246,-0.9982779026031494,1,1,"[{'label': 'negative', 'score': 0.9611391425132751}, {'label': 'neutral', 'score': 0.03005695901811123}, {'label': 'positive', 'score': 0.008803961798548698}]","(0.03005695901811123, 0.008803961798548698, 0.9611391425132751)",-0.9818464366427037,-0.9611391425132751,1,1,"[{'label': 'negative', 'score': 0.9912675023078918}, {'label': 'neutral', 'score': 0.007613107096403837}, {'label': 'positive', 'score': 0.0011194268008694053}]","(0.007613107096403837, 0.0011194268008694053, 0.9912675023078918)",-0.9977439710902385,-0.9912675023078918,1,1
2016-02-04,35.60056686401367,46.364505767822266,47.46183013916016,45.83015441894531,47.42366409301758,21598442.0,"How To Build A Defensive Portfolio | 25 Companies That Could Still Buy Back Mountains Of Stock | ImmunoGen, Merck Partner For Clincial Evaluation Of Mirvetuximab Soravtansine With Keytruda Combination For Ovarian Cancer Treatment",0.016258443496421023,-0.029604707336558515,0.19656100314323127,"[{'label': 'positive', 'score': 0.9919496774673462}, {'label': 'neutral', 'score': 0.007676542270928621}, {'label': 'negative', 'score': 0.0003737304068636149}]","(0.007676542270928621, 0.9919496774673462, 0.0003737304068636149)",0.9992467568458064,0.9919496774673462,0,0,"[{'label': 'neutral', 'score': 0.739203691482544}, {'label': 'positive', 'score': 0.2525635063648224}, {'label': 'negative', 'score': 0.008232728578150272}]","(0.739203691482544, 0.2525635063648224, 0.008232728578150272)",0.9368646669308666,0.2525635063648224,0,1,"[{'label': 'neutral', 'score': 0.729615330696106}, {'label': 'positive', 'score': 0.26793673634529114}, {'label': 'negative', 'score': 0.002447945298627019}]","(0.729615330696106, 0.26793673634529114, 0.002447945298627019)",0.9818928699381659,0.26793673634529114,0,1
2016-02-05,36.17937469482422,47.11832046508789,47.4427490234375,46.05915832519531,46.3740463256836,17693384.0,A Checkup On A Big Healthcare ETF,-0.0037127157464824758,0.016127690328931164,0.2619639120223967,"[{'label': 'neutral', 'score': 0.9998664855957031}, {'label': 'positive', 'score': 6.842219590907916e-05}, {'label': 'negative', 'score': 6.502916949102655e-05}]","(0.9998664855957031, 6.842219590907916e-05, 6.502916949102655e-05)",0.025425190726822835,6.842219590907916e-05,1,1,"[{'label': 'neutral', 'score': 0.8390752077102661}, {'label': 'positive', 'score': 0.10502589493989944}, {'label': 'negative', 'score': 0.05589893087744713}]","(0.8390752077102661, 0.10502589493989944, 0.05589893087744713)",0.30527896372069135,0.10502589493989944,1,1,"[{'label': 'neutral', 'score': 0.9994062185287476}, {'label': 'positive', 'score': 0.0004734155663754791}, {'label': 'negative', 'score': 0.00012031088408548385}]","(0.9994062185287476, 0.0004734155663754791, 0.00012031088408548385)",0.5947262110620952,0.0004734155663754791,0,1
2016-02-06,36.04505284627279,46.94338353474935,47.31870269775391,45.963738759358726,46.47900772094727,16457477.666666666,,-0.003726551372443172,-0.0037196249822433647,0.2576448568779638,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-07,35.91073099772135,46.768446604410805,47.19465637207031,45.86831919352213,46.58396911621094,15221571.333333334,,-0.003740490502458568,-0.003733512263802815,0.258148981890307,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-08,35.77640914916992,46.593509674072266,47.07061004638672,45.77289962768555,46.68893051147461,13985665.0,How To Invest In An Aging World With The 'Live Long & Prosper' ETF,0.006758194492987635,-0.0037475036308804313,0.25799887806282856,"[{'label': 'neutral', 'score': 0.9996494054794312}, {'label': 'positive', 'score': 0.00027484839665703475}, {'label': 'negative', 'score': 7.577117503387854e-05}]","(0.9996494054794312, 0.00027484839665703475, 7.577117503387854e-05)",0.5677869625562478,0.00027484839665703475,0,1,"[{'label': 'neutral', 'score': 0.8340590596199036}, {'label': 'positive', 'score': 0.15655136108398438}, {'label': 'negative', 'score': 0.009389631450176239}]","(0.8340590596199036, 0.15655136108398438, 0.009389631450176239)",0.8868316826748727,0.15655136108398438,0,1,"[{'label': 'neutral', 'score': 0.9992005228996277}, {'label': 'positive', 'score': 0.0007002052734605968}, {'label': 'negative', 'score': 9.934461559168994e-05}]","(0.9992005228996277, 0.0007002052734605968, 9.934461559168994e-05)",0.7514986445450103,0.0007002052734605968,0,1
2016-02-09,36.018184661865234,46.90839767456055,47.299617767333984,46.183204650878906,46.459922790527344,11160257.0,,0.007526457183216223,0.006735460267318693,0.14200466037078094,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-10,36.28927993774414,47.261451721191406,48.10114669799805,47.22328186035156,47.24236679077149,11565833.0,ALK Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet,-0.013729098304618515,0.007498274725387368,0.09443968881526849,"[{'label': 'neutral', 'score': 0.99985671043396}, {'label': 'positive', 'score': 8.435107883997262e-05}, {'label': 'negative', 'score': 5.883759513380937e-05}]","(0.99985671043396, 8.435107883997262e-05, 5.883759513380937e-05)",0.1781808784040754,8.435107883997262e-05,1,1,"[{'label': 'neutral', 'score': 0.7595542669296265}, {'label': 'positive', 'score': 0.21468663215637207}, {'label': 'negative', 'score': 0.025759076699614525}]","(0.7595542669296265, 0.21468663215637207, 0.025759076699614525)",0.7857389360602584,0.21468663215637207,0,1,"[{'label': 'neutral', 'score': 0.5998713374137878}, {'label': 'positive', 'score': 0.39930349588394165}, {'label': 'negative', 'score': 0.0008251648978330195}]","(0.5998713374137878, 0.39930349588394165, 0.0008251648978330195)",0.9958755021636251,0.39930349588394165,0,1
2016-02-11,35.79106140136719,46.61259460449219,47.12786483764648,46.28816986083984,46.57442855834961,11620643.0,,0.003684771162002918,-0.013824213946110123,0.13990322068845096,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-12,35.92293930053711,46.78435134887695,46.860687255859375,46.06870269775391,46.73664093017578,14251018.0,,0.00382418816596596,0.0036779990235002898,0.1420408744797424,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-13,36.06031608581543,46.96326351165772,47.07061100006104,46.29771041870117,46.83683204650879,13679308.0,,0.003809619464293471,0.003816894547268048,0.13936603011169857,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-14,36.19769287109375,47.14217567443848,47.280534744262695,46.52671813964844,46.9370231628418,13107598.0,,0.0037951613437682686,0.0038023812414873953,0.13398325469712796,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-15,36.33506965637207,47.32108783721924,47.49045848846436,46.7557258605957,47.037214279174805,12535888.0,,0.0037808125501299816,0.00378797788813469,0.12491888382347807,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-16,36.47244644165039,47.5,47.700382232666016,46.98473358154297,47.13740539550781,11964178.0,,0.0164725052682977,0.003773683242427422,0.000870663703388523,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-02-17,37.073238372802734,48.28244400024414,48.33015441894531,47.671756744384766,47.709922790527344,9770818.0,,-0.005533638309315046,0.016338305287883832,0.08904733788252149,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-18,36.86808395385742,48.01526641845703,48.654579162597656,47.9484748840332,48.28244400024414,10074319.0,,-0.003974524653143734,-0.005549005603368854,0.12363407092367587,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-19,36.721561431884766,47.82442855834961,48.09160232543945,47.58587646484375,47.9484748840332,9394482.0,,0.004322949814681584,-0.003982444067155318,0.1376810789032176,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-20,36.880303700764976,48.03117116292318,48.21246719360352,47.66857401529948,47.95801671346029,8977412.666666666,,0.004304342358679655,0.004313632709067109,0.1379512970503114,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-21,37.03904596964518,48.23791376749674,48.33333206176758,47.75127156575521,47.96755854288737,8560343.333333334,,0.004285894401861044,0.004295105174292657,0.1381900288059932,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-22,37.19778823852539,48.44465637207031,48.45419692993164,47.83396911621094,47.97710037231445,8143274.0,"Merck Reports Investigational One-Daily Formulation of ISENTRESS Met Primary, Secondary Endpoints in Pivotal Phase 3 Trial",-0.0045302656582051105,0.00427673611475877,0.07927217100851758,"[{'label': 'neutral', 'score': 0.999893307685852}, {'label': 'negative', 'score': 6.037559069227427e-05}, {'label': 'positive', 'score': 4.6199438656913117e-05}]","(0.999893307685852, 4.6199438656913117e-05, 6.037559069227427e-05)",-0.1330156990988363,-6.037559069227427e-05,1,1,"[{'label': 'positive', 'score': 0.6820158362388611}, {'label': 'neutral', 'score': 0.3036779463291168}, {'label': 'negative', 'score': 0.01430618017911911}]","(0.3036779463291168, 0.6820158362388611, 0.01430618017911911)",0.9589092981643379,0.6820158362388611,0,0,"[{'label': 'neutral', 'score': 0.9994631409645081}, {'label': 'positive', 'score': 0.00039041280979290605}, {'label': 'negative', 'score': 0.00014638289576396346}]","(0.9994631409645081, 0.00039041280979290605, 0.00014638289576396346)",0.4546048180020126,0.00039041280979290605,1,1
2016-02-23,37.029273986816406,48.225189208984375,48.60686874389648,48.1202278137207,48.2442741394043,8278676.0,"Will Merck Encroach On Gilead's Harvoni Territory? | 8,383 Patients Contacted to Arrange Blood Test Following Possible Exposure to ex-NHS Worker with Hepatitis C -Sky News",0.00039574609727744406,-0.0045405584093675695,0.07446486431612946,"[{'label': 'neutral', 'score': 0.9997362494468689}, {'label': 'negative', 'score': 0.00020194763783365488}, {'label': 'positive', 'score': 6.17473415331915e-05}]","(0.9997362494468689, 6.17473415331915e-05, 0.00020194763783365488)",-0.5316760168778942,-0.00020194763783365488,0,1,"[{'label': 'negative', 'score': 0.8847532272338867}, {'label': 'neutral', 'score': 0.10087218880653381}, {'label': 'positive', 'score': 0.01437462866306305}]","(0.10087218880653381, 0.01437462866306305, 0.8847532272338867)",-0.9680253957904057,-0.8847532272338867,0,0,"[{'label': 'negative', 'score': 0.5302950143814087}, {'label': 'neutral', 'score': 0.46662983298301697}, {'label': 'positive', 'score': 0.0030751386657357216}]","(0.46662983298301697, 0.0030751386657357216, 0.5302950143814087)",-0.9884690260669163,-0.5302950143814087,0,0
2016-02-24,37.04391860961914,48.2442741394043,48.3015251159668,47.35686874389648,47.86259460449219,7936190.0,AureoGen Announces Licensing Agreement with Merck,0.008702574621369094,0.0003956678104444747,0.061910321931876865,"[{'label': 'neutral', 'score': 0.9986593723297119}, {'label': 'positive', 'score': 0.0012407335452735424}, {'label': 'negative', 'score': 9.987125667976215e-05}]","(0.9986593723297119, 0.0012407335452735424, 9.987125667976215e-05)",0.8510056706730477,0.0012407335452735424,0,1,"[{'label': 'positive', 'score': 0.6371553540229797}, {'label': 'neutral', 'score': 0.34509211778640747}, {'label': 'negative', 'score': 0.01775251515209675}]","(0.34509211778640747, 0.6371553540229797, 0.01775251515209675)",0.9457862212758021,0.6371553540229797,0,0,"[{'label': 'positive', 'score': 0.9772899150848389}, {'label': 'neutral', 'score': 0.022463252767920494}, {'label': 'negative', 'score': 0.0002468703605700284}]","(0.022463252767920494, 0.9772899150848389, 0.0002468703605700284)",0.9994949134104297,0.9772899150848389,0,0
2016-02-25,37.36631393432617,48.66412353515625,48.66412353515625,48.082061767578125,48.2442741394043,9110998.0,,-0.007058865213535964,0.008664925490750798,0.07870022959713988,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-26,37.10254287719727,48.32061004638672,48.78816986083984,48.31106948852539,48.71183013916016,9695362.0,,-0.0028304348999973,-0.007083896868862714,0.10156566595656435,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-27,36.99752680460612,48.183841705322266,48.6927490234375,48.15839767456055,48.54325612386068,10966027.333333334,,-0.0028384690017223355,-0.0028344481554867457,0.0966396108514362,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-28,36.892510732014976,48.04707336425781,48.59732818603516,48.0057258605957,48.3746821085612,12236692.666666666,,-0.002846548842373301,-0.0028425050942174996,0.09350968871716336,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-02-29,36.78749465942383,47.91030502319336,48.50190734863281,47.85305404663086,48.20610809326172,13507358.0,"Watch Pharma Names Following FDA Issuance Of New Mandatory Clinical Study For Bayer's 'Essure', Requires Product Labeling, Including Box Warnings And Patient Decision Checklist | 3 Mega Biotechs Leerink Loves",0.03067121285023272,-0.0028506079673577267,0.09386505454427019,"[{'label': 'neutral', 'score': 0.9998509883880615}, {'label': 'negative', 'score': 9.326764848083258e-05}, {'label': 'positive', 'score': 5.5604137742193416e-05}]","(0.9998509883880615, 5.5604137742193416e-05, 9.326764848083258e-05)",-0.25299293905303966,-9.326764848083258e-05,0,0,"[{'label': 'neutral', 'score': 0.8965453505516052}, {'label': 'positive', 'score': 0.08809217065572739}, {'label': 'negative', 'score': 0.015362471342086792}]","(0.8965453505516052, 0.08809217065572739, 0.015362471342086792)",0.7030104972493864,0.08809217065572739,1,0,"[{'label': 'neutral', 'score': 0.9946907162666321}, {'label': 'positive', 'score': 0.004951411858201027}, {'label': 'negative', 'score': 0.00035791704431176186}]","(0.9946907162666321, 0.004951411858201027, 0.00035791704431176186)",0.8651742806355931,0.004951411858201027,1,0
2016-03-01,37.915809631347656,49.3797721862793,49.56106948852539,47.79580307006836,48.082061767578125,12686774.0,,0.010048274142807382,0.03021025296282872,0.24392769948372028,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-02,38.29679870605469,49.875953674316406,50.03816986083984,49.16030502319336,49.26526641845703,12548857.0,,-0.003252316193999834,0.009998125891964445,0.229512523789994,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-03,38.172245025634766,49.71374130249024,49.92366409301758,48.8072509765625,49.790077209472656,10279622.0,"UPDATE: Merck, Pfizer, and Verastem Combination Trial Of Avelumab and VS-6063 Expected To Begin In 2nd Half 2016 | Merck KGaA, Darmstadt, Germany, Pfizer and Verastem Report Combination Trial of Avelumab and VS-6063 in Ovarian Cancer",-0.0003838964825399891,-0.003257616469547414,0.2305948688154383,"[{'label': 'neutral', 'score': 0.9998496770858765}, {'label': 'positive', 'score': 7.90642952779308e-05}, {'label': 'negative', 'score': 7.122314855223522e-05}]","(0.9998496770858765, 7.90642952779308e-05, 7.122314855223522e-05)",0.05217433024249554,7.90642952779308e-05,1,1,"[{'label': 'neutral', 'score': 0.8521229028701782}, {'label': 'positive', 'score': 0.13226918876171112}, {'label': 'negative', 'score': 0.015607948414981365}]","(0.8521229028701782, 0.13226918876171112, 0.015607948414981365)",0.7889065380494613,0.13226918876171112,0,1,"[{'label': 'neutral', 'score': 0.9958958625793457}, {'label': 'positive', 'score': 0.0037209985312074423}, {'label': 'negative', 'score': 0.00038315937854349613}]","(0.9958958625793457, 0.0037209985312074423, 0.00038315937854349613)",0.813282340997085,0.0037209985312074423,0,1
2016-03-04,38.1575927734375,49.69465637207031,49.89503860473633,49.14122009277344,49.475189208984375,9521918.0,,0.003584230766357135,-0.0003839701896591954,0.2250811468710889,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-05,38.29435729980469,49.87277348836263,50.09860102335612,49.22073745727539,49.4720090230306,8956172.666666666,,0.00357142993729599,0.0035778227186470117,0.21206943309680307,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-06,38.43112182617188,50.05089060465495,50.30216344197592,49.300254821777344,49.46882883707682,8390427.333333334,,0.003558720217373203,0.0035650675255028247,0.07928741511308159,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-07,38.56788635253906,50.22900772094727,50.5057258605957,49.3797721862793,49.46564865112305,7824682.0,Gilead Vs. Merck: What To Know | FDA Accepts Supplemental Biologics License Application For Keytruda,-0.003609414369746617,0.0035524029557220133,0.04952912063685657,"[{'label': 'neutral', 'score': 0.9997830986976624}, {'label': 'positive', 'score': 0.00015195213200058788}, {'label': 'negative', 'score': 6.499324808828533e-05}]","(0.9997830986976624, 0.00015195213200058788, 6.499324808828533e-05)",0.4008330754804699,0.00015195213200058788,1,1,"[{'label': 'neutral', 'score': 0.7256651520729065}, {'label': 'positive', 'score': 0.2585430443286896}, {'label': 'negative', 'score': 0.01579172909259796}]","(0.7256651520729065, 0.2585430443286896, 0.01579172909259796)",0.8848725672239364,0.2585430443286896,0,1,"[{'label': 'neutral', 'score': 0.9978252649307251}, {'label': 'positive', 'score': 0.0020522100385278463}, {'label': 'negative', 'score': 0.0001225440646521747}]","(0.9978252649307251, 0.0020522100385278463, 0.0001225440646521747)",0.8873030615525817,0.0020522100385278463,0,1
2016-03-08,38.42868423461914,50.04771041870117,50.5057258605957,49.89503860473633,49.96183013916016,8665912.0,"Jimmy Carter Boosts Social Media Buzz For Merck's Blockbuster Drug | Sanofi Pasteur, Merck Report Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies",-0.0017159681995945594,-0.0036159440226767,0.05167570063338911,"[{'label': 'positive', 'score': 0.9992992877960205}, {'label': 'neutral', 'score': 0.0005146311596035957}, {'label': 'negative', 'score': 0.00018601049669086933}]","(0.0005146311596035957, 0.9992992877960205, 0.00018601049669086933)",0.999627787428172,0.9992992877960205,0,0,"[{'label': 'neutral', 'score': 0.636821985244751}, {'label': 'positive', 'score': 0.3456404209136963}, {'label': 'negative', 'score': 0.017537573352456093}]","(0.636821985244751, 0.3456404209136963, 0.017537573352456093)",0.9034216079754886,0.3456404209136963,0,1,"[{'label': 'positive', 'score': 0.9619883894920349}, {'label': 'neutral', 'score': 0.03752470761537552}, {'label': 'negative', 'score': 0.00048693927237764}]","(0.03752470761537552, 0.9619883894920349, 0.00048693927237764)",0.9989881521991785,0.9619883894920349,0,0
2016-03-09,38.36273956298828,49.96183013916016,50.46755599975586,49.71374130249024,50.171756744384766,9589829.0,,0.012987056616859925,-0.001717442159445691,0.05522226447732489,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-03-10,38.860958099365234,50.610687255859375,50.8015251159668,50.02862548828125,50.27671813964844,12856340.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",0.003016592388738377,0.012903447906396909,0.10186567283009143,"[{'label': 'neutral', 'score': 0.9998714923858643}, {'label': 'negative', 'score': 7.067055412335321e-05}, {'label': 'positive', 'score': 5.780556966783479e-05}]","(0.9998714923858643, 5.780556966783479e-05, 7.067055412335321e-05)",-0.10013521638018796,-7.067055412335321e-05,1,1,"[{'label': 'neutral', 'score': 0.9077363610267639}, {'label': 'negative', 'score': 0.06499171257019043}, {'label': 'positive', 'score': 0.027271881699562073}]","(0.9077363610267639, 0.027271881699562073, 0.06499171257019043)",-0.4088268094167923,-0.06499171257019043,1,1,"[{'label': 'neutral', 'score': 0.9993264675140381}, {'label': 'positive', 'score': 0.00047780791646800935}, {'label': 'negative', 'score': 0.00019577318744268268}]","(0.9993264675140381, 0.00047780791646800935, 0.00019577318744268268)",0.41870938390029533,0.00047780791646800935,1,1
2016-03-11,39.31918716430664,50.76335906982422,51.011451721191406,50.36259460449219,50.59160232543945,16277955.0,,-0.0007518925061989272,0.00301205160342557,0.10172659682715327,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-12,39.28962326049805,50.72519048055013,50.966922760009766,50.38167826334635,50.63295110066732,13134129.666666668,Agenus Shares Spike Higher Following Mid-Day Upgrade To Buy From Maxim,-0.0007524582739364674,-0.0007521753191415056,0.10434887500735332,"[{'label': 'positive', 'score': 0.9996055960655212}, {'label': 'neutral', 'score': 0.00021841074340045452}, {'label': 'negative', 'score': 0.0001760046579875052}]","(0.00021841074340045452, 0.9996055960655212, 0.0001760046579875052)",0.9996479137886511,0.9996055960655212,0,0,"[{'label': 'positive', 'score': 0.9420086741447449}, {'label': 'neutral', 'score': 0.037605464458465576}, {'label': 'negative', 'score': 0.020385781303048134}]","(0.037605464458465576, 0.9420086741447449, 0.020385781303048134)",0.9576352893812905,0.9420086741447449,0,0,"[{'label': 'positive', 'score': 0.998731791973114}, {'label': 'neutral', 'score': 0.0010043896036222577}, {'label': 'negative', 'score': 0.0002638594596646726}]","(0.0010043896036222577, 0.998731791973114, 0.0002638594596646726)",0.9994717505340764,0.998731791973114,0,0
2016-03-13,39.26005935668945,50.68702189127604,50.922393798828125,50.40076192220052,50.67429987589518,9990304.333333334,,-0.0007530248937481082,-0.0007527415127559566,0.09637482055549929,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-14,39.23049545288086,50.64885330200195,50.87786483764648,50.41984558105469,50.71564865112305,6846479.0,,-0.012434010456800192,-0.0007533085594071771,0.09390380490178807,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-15,38.74270248413086,50.01908493041992,50.22900772094727,49.57061004638672,50.07633590698242,9495614.0,,-0.00915681369484594,-0.012511959585667934,0.09380434238360588,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-16,38.38793563842773,49.56106948852539,49.91412353515625,49.1984748840332,49.91412353515625,10460402.0,,-0.00789377451915724,-0.009198995008440373,0.08978791496068111,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-17,38.08491516113281,49.16984558105469,49.58969497680664,48.97900772094727,49.5515251159668,10038163.0,Organovo Is A Company 3D Printing Human Tissue And Its CEO Is Excited About Creating Livers,0.013972449063506967,-0.007925095292200859,0.08367905920010982,"[{'label': 'neutral', 'score': 0.5906811356544495}, {'label': 'positive', 'score': 0.40790340304374695}, {'label': 'negative', 'score': 0.0014154859818518162}]","(0.5906811356544495, 0.40790340304374695, 0.0014154859818518162)",0.9930837006558801,0.40790340304374695,1,0,"[{'label': 'neutral', 'score': 0.9267140030860901}, {'label': 'positive', 'score': 0.060541536659002304}, {'label': 'negative', 'score': 0.01274448074400425}]","(0.9267140030860901, 0.060541536659002304, 0.01274448074400425)",0.6521988451379156,0.060541536659002304,1,0,"[{'label': 'neutral', 'score': 0.8208509087562561}, {'label': 'positive', 'score': 0.1786905825138092}, {'label': 'negative', 'score': 0.0004585659771692008}]","(0.8208509087562561, 0.1786905825138092, 0.0004585659771692008)",0.9948806234243163,0.1786905825138092,1,0
2016-03-18,38.6170654296875,49.85686874389648,50.01908493041992,49.22710037231445,49.3702278137207,15116666.0,,0.003508782936954145,0.01387573425105563,0.16697335595349425,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-19,38.7525634765625,50.031805674235024,50.14949162801107,49.38931401570638,49.5578867594401,12749164.333333334,,0.003496514426794594,0.003502641519845199,0.17366670992791303,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-20,38.8880615234375,50.20674260457357,50.27989832560221,49.55152765909831,49.74554570515951,10381662.666666668,,0.00348433141174555,0.003490415831974987,0.15093551623873683,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-21,39.0235595703125,50.38167953491211,50.41030502319336,49.71374130249024,49.933204650878906,8014161.0,,0.004356090648662421,0.003478275192890735,0.12243887756777436,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-22,39.19353866577149,50.60114669799805,51.011451721191406,50.14313125610352,50.171756744384766,9748810.0,,0.0009427968952686538,0.004346630349124362,0.07244823643219964,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-23,39.23049545288086,50.64885330200195,51.14503860473633,50.42938995361328,51.14503860473633,10424980.0,Jury Rules Merck Patents ValidBad For Gilead? | Gilead -2.5% Premarket Following Verdict Tuesday Validating Merck's Hep C Patents,-0.00018836670999112072,0.0009423527414184551,0.02047382752142427,"[{'label': 'neutral', 'score': 0.8217520117759705}, {'label': 'negative', 'score': 0.17558079957962036}, {'label': 'positive', 'score': 0.0026671586092561483}]","(0.8217520117759705, 0.0026671586092561483, 0.17558079957962036)",-0.970073613898792,-0.17558079957962036,0,1,"[{'label': 'negative', 'score': 0.49839335680007935}, {'label': 'positive', 'score': 0.3409759998321533}, {'label': 'neutral', 'score': 0.16063056886196136}]","(0.16063056886196136, 0.3409759998321533, 0.49839335680007935)",-0.1875424158912892,-0.49839335680007935,1,1,"[{'label': 'negative', 'score': 0.4202682375907898}, {'label': 'neutral', 'score': 0.37978115677833557}, {'label': 'positive', 'score': 0.19995057582855225}]","(0.37978115677833557, 0.19995057582855225, 0.4202682375907898)",-0.3552256993747084,-0.4202682375907898,1,1
2016-03-24,39.22311019897461,50.63931274414063,50.90649032592773,50.181297302246094,50.37213516235352,7929378.0,"Patent Expert: It's Not Over For Gilead, Still Has Strong Defense Against Merck",-0.0011305826863427962,-0.000188384453228025,0.030704518902547762,"[{'label': 'positive', 'score': 0.9991320967674255}, {'label': 'neutral', 'score': 0.0005295334267430007}, {'label': 'negative', 'score': 0.00033837868249975145}]","(0.0005295334267430007, 0.9991320967674255, 0.00033837868249975145)",0.9993228840855005,0.9991320967674255,0,0,"[{'label': 'positive', 'score': 0.86763596534729}, {'label': 'neutral', 'score': 0.12399783730506897}, {'label': 'negative', 'score': 0.00836623553186655}]","(0.12399783730506897, 0.86763596534729, 0.00836623553186655)",0.980899053624591,0.86763596534729,0,0,"[{'label': 'positive', 'score': 0.9893054962158203}, {'label': 'neutral', 'score': 0.010212389752268791}, {'label': 'negative', 'score': 0.0004821657494176179}]","(0.010212389752268791, 0.9893054962158203, 0.0004821657494176179)",0.9990257188123354,0.9893054962158203,0,0
2016-03-25,39.17876625061035,50.58206081390381,50.89217662811279,50.19561004638672,50.45085716247559,7531295.0,,-0.0011318623503192501,-0.0011312222770670482,0.03731461039869331,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-26,39.134422302246094,50.52480888366699,50.87786293029785,50.209922790527344,50.529579162597656,7133212.0,,-0.0011331449143852986,-0.0011325033902675995,0.03617278489258851,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-27,39.09007835388184,50.467556953430176,50.86354923248291,50.22423553466797,50.60830116271973,6735129.0,,-0.0011344303884106503,-0.0011337874084889623,0.014578540876263943,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-28,39.04573440551758,50.41030502319336,50.84923553466797,50.238548278808594,50.6870231628418,6337046.0,"Biopharma Names LLY, PFE, MRK, And More Popping Higher Following Reports China FDA To Investigate Improper Vaccine Trading | Data Shows Gilead's HCV Franchise Is Surviving New Competition",0.00927508401780147,-0.0011350743416231948,0.006707186405031895,"[{'label': 'positive', 'score': 0.9976615905761719}, {'label': 'negative', 'score': 0.0017877884674817324}, {'label': 'neutral', 'score': 0.0005506565794348717}]","(0.0005506565794348717, 0.9976615905761719, 0.0017877884674817324)",0.9964224531927922,0.9976615905761719,1,1,"[{'label': 'negative', 'score': 0.723273515701294}, {'label': 'positive', 'score': 0.24816536903381348}, {'label': 'neutral', 'score': 0.028561117127537727}]","(0.028561117127537727, 0.24816536903381348, 0.723273515701294)",-0.48907672333605756,-0.723273515701294,0,0,"[{'label': 'positive', 'score': 0.9958115816116333}, {'label': 'neutral', 'score': 0.003727152245119214}, {'label': 'negative', 'score': 0.00046131169074214995}]","(0.003727152245119214, 0.9958115816116333, 0.00046131169074214995)",0.9990739250383235,0.9958115816116333,1,1
2016-03-29,39.40787887573242,50.87786483764648,50.96374130249024,50.16221237182617,50.48664093017578,7730782.0,,-0.0018754882443834616,0.009232334559271959,0.07358762156869884,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-30,39.33396530151367,50.78244400024414,51.09732818603516,50.67748260498047,51.03053283691406,6711287.0,,-0.005824908113263263,-0.0018772491745411776,0.07508579993695531,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-03-31,39.104862213134766,50.48664093017578,51.03053283691406,50.343509674072266,50.64885330200195,8735080.0,,0.014931049047320052,-0.005841939058524456,0.08886462599231489,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-04-01,39.68873596191406,51.24045944213867,51.32633590698242,50.03816986083984,50.09542083740234,9099889.0,,0.004345122582778073,0.014820678213185936,0.13693288577082735,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-02,39.86118698120117,51.46310551961263,51.593512217203774,50.45483652750651,50.54389444986979,9647119.666666666,,0.004326324173909462,0.004335709794278006,0.1318380673891203,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-03,40.03363800048828,51.685751597086586,51.86068852742513,50.87150319417318,50.99236806233724,10194350.333333334,,0.004307687720391218,0.004316992538253555,0.12426320696928327,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-04,40.20608901977539,51.90839767456055,52.12786483764648,51.28816986083984,51.44084167480469,10741581.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today | This Data Signals The End For Merck's Anacetrapib | Make A House Call With A Familiar Healthcare ETF",-0.0029411775513091152,0.004298436192589205,0.11597851929138846,"[{'label': 'neutral', 'score': 0.9992783665657043}, {'label': 'negative', 'score': 0.00040610009455122054}, {'label': 'positive', 'score': 0.0003155689628329128}]","(0.9992783665657043, 0.0003155689628329128, 0.00040610009455122054)",-0.1254468801065963,-0.00040610009455122054,1,1,"[{'label': 'neutral', 'score': 0.873755693435669}, {'label': 'positive', 'score': 0.06895920634269714}, {'label': 'negative', 'score': 0.05728503316640854}]","(0.873755693435669, 0.06895920634269714, 0.05728503316640854)",0.09247291774803376,0.06895920634269714,1,1,"[{'label': 'neutral', 'score': 0.9977795481681824}, {'label': 'positive', 'score': 0.0012959839077666402}, {'label': 'negative', 'score': 0.0009244515676982701}]","(0.9977795481681824, 0.0012959839077666402, 0.0009244515676982701)",0.1673240876277116,0.0012959839077666402,1,1
2016-04-05,40.08784103393555,51.7557258605957,52.21374130249024,51.51717758178711,51.61259460449219,9432838.0,"Advaxis, Merck Combination Trial Evaluating ADXS-PSA Launches Third Dose-Escalation Cohort",0.025626843888827182,-0.002945511313665617,0.10070333148666782,"[{'label': 'neutral', 'score': 0.9997946619987488}, {'label': 'positive', 'score': 0.00011826689296867698}, {'label': 'negative', 'score': 8.716403681319207e-05}]","(0.9997946619987488, 0.00011826689296867698, 8.716403681319207e-05)",0.15140298585276615,0.00011826689296867698,0,0,"[{'label': 'positive', 'score': 0.6973651051521301}, {'label': 'neutral', 'score': 0.29287785291671753}, {'label': 'negative', 'score': 0.009757043793797493}]","(0.29287785291671753, 0.6973651051521301, 0.009757043793797493)",0.972403512438857,0.6973651051521301,1,1,"[{'label': 'neutral', 'score': 0.9918044805526733}, {'label': 'positive', 'score': 0.00803698692470789}, {'label': 'negative', 'score': 0.00015851073840167373}]","(0.9918044805526733, 0.00803698692470789, 0.00015851073840167373)",0.9613176051247799,0.00803698692470789,1,0
2016-04-06,41.11515808105469,53.082061767578125,53.23473358154297,51.774810791015625,51.860687255859375,13079459.0,"PPH May Be Home To Hedge Fund Hotels, But This ETF Can Endure | SocGen Picks New Favorites In Big Pharma | Societe Generale Initiates Coverage on Merck & Co at Buy | Merck Will Present New KEYTRUDA Data At AACR Meeting Apr. 16-20th | WHO Says Number of Adults with Diabetes has Quadrupled Since 1980 -AFP",-0.0037749519516291027,0.025303980680299657,0.16940508998017925,"[{'label': 'positive', 'score': 0.9983371496200562}, {'label': 'neutral', 'score': 0.001453329692594707}, {'label': 'negative', 'score': 0.00020952770137228072}]","(0.001453329692594707, 0.9983371496200562, 0.00020952770137228072)",0.9995803346881403,0.9983371496200562,0,0,"[{'label': 'neutral', 'score': 0.8096553683280945}, {'label': 'positive', 'score': 0.16260585188865662}, {'label': 'negative', 'score': 0.02773871272802353}]","(0.8096553683280945, 0.16260585188865662, 0.02773871272802353)",0.7085421085295046,0.16260585188865662,0,1,"[{'label': 'neutral', 'score': 0.7250442504882812}, {'label': 'positive', 'score': 0.26953795552253723}, {'label': 'negative', 'score': 0.005417822394520044}]","(0.7250442504882812, 0.26953795552253723, 0.005417822394520044)",0.960591318098037,0.26953795552253723,0,1
2016-04-07,40.95995330810547,52.88167953491211,53.225189208984375,52.52862548828125,52.80534362792969,11042566.0,"How One Analyst Is Playing The Biotech Rebound This Week | BZ NOTE: Relypsa Has Been Mentioned In Rumors Over Past 7 Months In Possible M&A Talk With Sanofi, Merck, Astra Zeneca",-0.0010826240215139784,-0.0037820950650207306,0.18656867251488157,"[{'label': 'neutral', 'score': 0.9998576641082764}, {'label': 'positive', 'score': 7.60295515647158e-05}, {'label': 'negative', 'score': 6.631307041971013e-05}]","(0.9998576641082764, 7.60295515647158e-05, 6.631307041971013e-05)",0.06826122077524172,7.60295515647158e-05,1,1,"[{'label': 'neutral', 'score': 0.8852021098136902}, {'label': 'positive', 'score': 0.08693122118711472}, {'label': 'negative', 'score': 0.027866706252098083}]","(0.8852021098136902, 0.08693122118711472, 0.027866706252098083)",0.5145085477809882,0.08693122118711472,0,1,"[{'label': 'neutral', 'score': 0.7072796821594238}, {'label': 'positive', 'score': 0.28748518228530884}, {'label': 'negative', 'score': 0.005235175136476755}]","(0.7072796821594238, 0.28748518228530884, 0.005235175136476755)",0.9642308776705044,0.28748518228530884,0,1
2016-04-08,40.91558837890625,52.82442855834961,53.34923553466797,52.57633590698242,53.196563720703125,7322795.0,,-0.0018665800283519055,-0.001083210482215752,0.19245948039267338,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-09,40.83922449747721,52.72582753499349,53.29516474405924,52.538167317708336,53.07569885253906,7350113.0,,-0.0018700706649067617,-0.0018683242596892662,0.19749389944619697,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-10,40.76286061604818,52.62722651163737,53.24109395345052,52.49999872843424,52.954833984375,7377431.0,,-0.001873574381395796,-0.0018718214300961864,0.19555228869027047,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-11,40.68649673461914,52.52862548828125,53.1870231628418,52.46183013916016,52.83396911621094,7404749.0,,0.005267949371912869,-0.0018753317172197411,0.01591304768208075,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-04-12,40.90082550048828,52.80534362792969,53.196563720703125,52.42366409301758,52.45228958129883,6221976.0,"Baird: Gilead Set For Q1 EPS Miss, But Hep C Trends Still Good Long Term | Notable Imbalances Before Tuesday's Open Led By Under Armour, Boeing, Caterpillar",0.011203455650396413,0.005254122265692517,0.049487369545900634,"[{'label': 'negative', 'score': 0.9605633020401001}, {'label': 'positive', 'score': 0.035653311759233475}, {'label': 'neutral', 'score': 0.003783375257626176}]","(0.003783375257626176, 0.035653311759233475, 0.9605633020401001)",-0.9284225714259869,-0.9605633020401001,0,0,"[{'label': 'positive', 'score': 0.9311597943305969}, {'label': 'negative', 'score': 0.044994525611400604}, {'label': 'neutral', 'score': 0.023845592513680458}]","(0.023845592513680458, 0.9311597943305969, 0.044994525611400604)",0.9078126794253717,0.9311597943305969,1,1,"[{'label': 'positive', 'score': 0.35794955492019653}, {'label': 'neutral', 'score': 0.32826441526412964}, {'label': 'negative', 'score': 0.31378600001335144}]","(0.32826441526412964, 0.35794955492019653, 0.31378600001335144)",0.06574544786633188,0.35794955492019653,0,0
2016-04-13,41.35906219482422,53.39694595336914,53.42557144165039,52.738548278808594,52.91984558105469,8849836.0,"Merck Says FDA Accepts Its sBLA For Keytruda And Grants Priority Review | FDA Accepts Supplemental Biologics License Application for Merck's KEYTRUDA in Recurrent or Metastatic Head and Neck Cancer, and Grants Priority Review | Merck Announces License Application for Investigational House Dust Mite SLIT-tablet Accepted for Review by FDA",0.008756302558229434,0.011141161780404264,0.09357940268270346,"[{'label': 'positive', 'score': 0.9901690483093262}, {'label': 'neutral', 'score': 0.00951068103313446}, {'label': 'negative', 'score': 0.00032030543661676347}]","(0.00951068103313446, 0.9901690483093262, 0.00032030543661676347)",0.9993532380021948,0.9901690483093262,0,0,"[{'label': 'positive', 'score': 0.8573107123374939}, {'label': 'neutral', 'score': 0.12574927508831024}, {'label': 'negative', 'score': 0.016939938068389893}]","(0.12574927508831024, 0.8573107123374939, 0.016939938068389893)",0.9612469534668913,0.8573107123374939,0,0,"[{'label': 'positive', 'score': 0.9556291103363037}, {'label': 'neutral', 'score': 0.043715011328458786}, {'label': 'negative', 'score': 0.0006558099994435906}]","(0.043715011328458786, 0.9556291103363037, 0.0006558099994435906)",0.9986284213303012,0.9556291103363037,0,0
2016-04-14,41.7212028503418,53.864505767822266,54.00763320922852,53.37786483764648,53.45419692993164,8757822.0,"After-Hours Recap: Big Banks, Liquidity Services's DoD Deal, Haemonetics' CFO & More | Merck Kgaa Says Filed Answer in Response to Trademark Right Violation Claims Made By Merck | Merck's ZEPATIER Showed Superiority on Efficacy and Safety Endpoints vs Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial",-0.005491613927423427,0.008718188471702379,0.0950665552194998,"[{'label': 'positive', 'score': 0.6841790080070496}, {'label': 'neutral', 'score': 0.3136071264743805}, {'label': 'negative', 'score': 0.002213903469964862}]","(0.3136071264743805, 0.6841790080070496, 0.002213903469964862)",0.9935491656951967,0.6841790080070496,0,0,"[{'label': 'positive', 'score': 0.9196662902832031}, {'label': 'negative', 'score': 0.05181126296520233}, {'label': 'neutral', 'score': 0.028522547334432602}]","(0.028522547334432602, 0.9196662902832031, 0.05181126296520233)",0.8933351310239604,0.9196662902832031,0,0,"[{'label': 'positive', 'score': 0.9926134347915649}, {'label': 'neutral', 'score': 0.006980614736676216}, {'label': 'negative', 'score': 0.00040596144390292466}]","(0.006980614736676216, 0.9926134347915649, 0.00040596144390292466)",0.9991823695580531,0.9926134347915649,0,0
2016-04-15,41.49209213256836,53.56870269775391,53.959922790527344,53.32061004638672,53.94084167480469,8839251.0,"Jefferies Maintains Hold on Merck & Co, Raises PT to $54.00",0.0021968925190197527,-0.005506748272605741,0.11188397352534048,"[{'label': 'positive', 'score': 0.9992502331733704}, {'label': 'neutral', 'score': 0.0005636749556288123}, {'label': 'negative', 'score': 0.0001860851189121604}]","(0.0005636749556288123, 0.9992502331733704, 0.0001860851189121604)",0.9996276198583015,0.9992502331733704,0,0,"[{'label': 'positive', 'score': 0.7916699647903442}, {'label': 'neutral', 'score': 0.18375001847743988}, {'label': 'negative', 'score': 0.024580001831054688}]","(0.18375001847743988, 0.7916699647903442, 0.024580001831054688)",0.939773346802584,0.7916699647903442,0,0,"[{'label': 'positive', 'score': 0.998778760433197}, {'label': 'neutral', 'score': 0.0008797692717052996}, {'label': 'negative', 'score': 0.0003414811217226088}]","(0.0008797692717052996, 0.998778760433197, 0.0003414811217226088)",0.9993164363856923,0.998778760433197,0,0
2016-04-16,41.58324813842773,53.6863873799642,54.04898198445638,53.333333333333336,53.81679534912109,8615608.0,Merck Announces Results From Phase 3 Studies of ZEPATIER in Chronic Hep C Patient Populations at ILC,0.0021920767619799768,0.002194482879150798,0.10282331899719666,"[{'label': 'neutral', 'score': 0.9998494386672974}, {'label': 'positive', 'score': 9.65109356911853e-05}, {'label': 'negative', 'score': 5.4026426369091496e-05}]","(0.9998494386672974, 9.65109356911853e-05, 5.4026426369091496e-05)",0.28221903679355387,9.65109356911853e-05,1,1,"[{'label': 'neutral', 'score': 0.6589569449424744}, {'label': 'positive', 'score': 0.3262794315814972}, {'label': 'negative', 'score': 0.01476361509412527}]","(0.6589569449424744, 0.3262794315814972, 0.01476361509412527)",0.9134208116070025,0.3262794315814972,0,1,"[{'label': 'neutral', 'score': 0.9993487000465393}, {'label': 'positive', 'score': 0.0005155573016963899}, {'label': 'negative', 'score': 0.0001356716820737347}]","(0.9993487000465393, 0.0005155573016963899, 0.0001356716820737347)",0.5833364747118656,0.0005155573016963899,0,1
2016-04-17,41.67440414428711,53.80407206217448,54.13804117838541,53.346056620279946,53.6927490234375,8391965.0,,0.0021872820717787995,0.002189677667075294,0.10344460839094034,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-18,41.76556015014648,53.921756744384766,54.22710037231445,53.35877990722656,53.56870269775391,8168322.0,Merck Reports Received Breakthrough Therapy Designation from FDA for KEYTRUDA in cHL,0.006193587456620021,0.002184893452769561,0.07999857249365823,"[{'label': 'positive', 'score': 0.9872829914093018}, {'label': 'neutral', 'score': 0.01235893927514553}, {'label': 'negative', 'score': 0.00035802077036350965}]","(0.01235893927514553, 0.9872829914093018, 0.00035802077036350965)",0.9992749981704924,0.9872829914093018,0,0,"[{'label': 'positive', 'score': 0.9344180226325989}, {'label': 'neutral', 'score': 0.054142773151397705}, {'label': 'negative', 'score': 0.01143918838351965}]","(0.054142773151397705, 0.9344180226325989, 0.01143918838351965)",0.9758120184520648,0.9344180226325989,0,0,"[{'label': 'positive', 'score': 0.998895525932312}, {'label': 'neutral', 'score': 0.0007534807664342225}, {'label': 'negative', 'score': 0.0003509180387482047}]","(0.0007534807664342225, 0.998895525932312, 0.0003509180387482047)",0.9992976346508602,0.998895525932312,0,0
2016-04-19,42.02422332763672,54.2557258605957,54.75190734863281,53.64503860473633,54.13167953491211,8011122.0,"Merck Animal Health To Acquire Rights To Whisper Veterinary Stethoscope System, Terms Not Disclosed | Merck Gives Statement On Blueprint Project Findings AT AACR, Encouraged By Findings And Eager To Support Greater Biomarker Testing Use",-0.004924412632015903,0.00617448602418306,0.06751730992548055,"[{'label': 'neutral', 'score': 0.9997343420982361}, {'label': 'positive', 'score': 0.00019325775792822242}, {'label': 'negative', 'score': 7.234626536956057e-05}]","(0.9997343420982361, 0.00019325775792822242, 7.234626536956057e-05)",0.4552321574703763,0.00019325775792822242,1,1,"[{'label': 'positive', 'score': 0.8236033916473389}, {'label': 'neutral', 'score': 0.16752877831459045}, {'label': 'negative', 'score': 0.008867846801877022}]","(0.16752877831459045, 0.8236033916473389, 0.008867846801877022)",0.9786951274895775,0.8236033916473389,0,0,"[{'label': 'positive', 'score': 0.9695248007774353}, {'label': 'neutral', 'score': 0.030134771019220352}, {'label': 'negative', 'score': 0.0003403497685212642}]","(0.030134771019220352, 0.9695248007774353, 0.0003403497685212642)",0.9992981503287758,0.9695248007774353,0,0
2016-04-20,41.81728744506836,53.988548278808594,54.770992279052734,53.85496139526367,54.53244400024414,8929903.0,,0.000353499603682067,-0.004936577504902105,0.06383869003503578,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-21,41.83207702636719,54.00763320922852,54.41793823242188,53.73091506958008,53.75954055786133,11040994.0,,0.0024734815359782917,0.0003534371374178926,0.06402614704543827,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-22,41.935543060302734,54.14122009277344,54.41793823242188,53.921756744384766,54.093509674072266,7433988.0,,-0.003054859662606428,0.0024704275155294077,0.06433172255232363,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-23,41.80743916829427,53.97582626342773,54.29389317830404,53.75954310099284,54.02671686808268,7848542.0,,-0.0030642204259828353,-0.0030595352710319737,0.0700468235702698,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-24,41.679335276285805,53.81043243408203,54.1698481241862,53.597329457600914,53.9599240620931,8263096.0,,-0.003073638732569398,-0.003068924761931878,0.047486671629477055,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-25,41.551231384277344,53.64503860473633,54.04580307006836,53.43511581420898,53.89313125610352,8677650.0,Pharma Names Under Pressure Amid Perrigo Warning,-0.0032017265501529755,-0.0030783720616159096,0.04073203922187352,"[{'label': 'negative', 'score': 0.9529562592506409}, {'label': 'neutral', 'score': 0.0458938367664814}, {'label': 'positive', 'score': 0.0011498694075271487}]","(0.0458938367664814, 0.0011498694075271487, 0.9529562592506409)",-0.9975896404540566,-0.9529562592506409,0,0,"[{'label': 'negative', 'score': 0.9530236124992371}, {'label': 'neutral', 'score': 0.028590010479092598}, {'label': 'positive', 'score': 0.01838637888431549}]","(0.028590010479092598, 0.01838637888431549, 0.9530236124992371)",-0.9621449664973524,-0.9530236124992371,0,0,"[{'label': 'negative', 'score': 0.9982497096061707}, {'label': 'neutral', 'score': 0.0013342497404664755}, {'label': 'positive', 'score': 0.0004160583484917879}]","(0.0013342497404664755, 0.0004160583484917879, 0.9982497096061707)",-0.9991667715829613,-0.9982497096061707,0,0
2016-04-26,41.41817855834961,53.47328186035156,53.83587646484375,53.31106948852539,53.82633590698242,7573477.0,,0.004817980125127517,-0.003206863043298489,0.039581914976484285,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-27,41.61772918701172,53.73091506958008,54.02671813964844,53.49236679077149,53.49236679077149,7274587.0,,-0.01012251338049903,0.00480641080450739,0.05616235665188585,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-04-28,41.19646453857422,53.1870231628418,53.654579162597656,53.0057258605957,53.33015441894531,9531246.0,,-0.016146417982394894,-0.010174094400667537,0.0841670430440115,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-04-29,40.531288146972656,52.328243255615234,53.09160232543945,52.06106948852539,53.09160232543945,13862944.0,,0.002796031988740536,-0.01627819176411427,0.12682834405942728,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-04-30,40.644612630208336,52.47455469767253,53.00254440307617,52.10559844970703,52.84033075968424,12623125.0,,0.0027882359917154064,0.002792130362322345,0.14027604468526975,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-01,40.75793711344401,52.62086613972982,52.91348648071289,52.15012741088867,52.58905919392904,11383306.0,Merck And Pfizer Earnings: Will They Beat Expectations Again?,0.00278048334797023,0.0027843560721570754,0.14965394718128414,"[{'label': 'positive', 'score': 0.9993613362312317}, {'label': 'negative', 'score': 0.00038331994437612593}, {'label': 'neutral', 'score': 0.00025541201466694474}]","(0.00025541201466694474, 0.9993613362312317, 0.00038331994437612593)",0.9992331643044886,0.9993613362312317,0,0,"[{'label': 'positive', 'score': 0.9209686517715454}, {'label': 'neutral', 'score': 0.05999365076422691}, {'label': 'negative', 'score': 0.01903771050274372}]","(0.05999365076422691, 0.9209686517715454, 0.01903771050274372)",0.9594945071293282,0.9209686517715454,0,0,"[{'label': 'positive', 'score': 0.9873154163360596}, {'label': 'neutral', 'score': 0.008298241533339024}, {'label': 'negative', 'score': 0.004386342130601406}]","(0.008298241533339024, 0.9873154163360596, 0.004386342130601406)",0.9911539087368698,0.9873154163360596,0,0
2016-05-02,40.87126159667969,52.76717758178711,52.82442855834961,52.19465637207031,52.33778762817383,10143487.0,"Earnings: Drug Makers Merck And Pfizer Report Q1 Results | The Market In 5 Minutes: May, She Will Stay",-0.003978355766692868,0.002776624954623704,0.14336226994678267,"[{'label': 'neutral', 'score': 0.9998739957809448}, {'label': 'negative', 'score': 7.387190271401778e-05}, {'label': 'positive', 'score': 5.211340612731874e-05}]","(0.9998739957809448, 5.211340612731874e-05, 7.387190271401778e-05)",-0.17270661783352273,-7.387190271401778e-05,1,1,"[{'label': 'neutral', 'score': 0.8999425768852234}, {'label': 'positive', 'score': 0.07865739613771439}, {'label': 'negative', 'score': 0.02139999531209469}]","(0.8999425768852234, 0.07865739613771439, 0.02139999531209469)",0.572245588216651,0.07865739613771439,0,1,"[{'label': 'neutral', 'score': 0.999276340007782}, {'label': 'positive', 'score': 0.0005475535290315747}, {'label': 'negative', 'score': 0.00017608060443308204}]","(0.999276340007782, 0.0005475535290315747, 0.00017608060443308204)",0.5133435633003289,0.0005475535290315747,0,1
2016-05-03,40.70866394042969,52.5572509765625,52.91030502319336,52.33778762817383,52.614505767822266,7966058.0,"TheStreet's Adam Feuerstein Tweets '$MRK $BMY are not working with $NWBO on cancer immunotherapy combination clinical trials, per their respective spokespersons.'",-0.0049019536684558555,-0.003986290475718175,0.13180434882561204,"[{'label': 'neutral', 'score': 0.9998613595962524}, {'label': 'negative', 'score': 0.00010056065366370603}, {'label': 'positive', 'score': 3.801275306614116e-05}]","(0.9998613595962524, 3.801275306614116e-05, 0.00010056065366370603)",-0.4513701587744306,-0.00010056065366370603,1,1,"[{'label': 'neutral', 'score': 0.7945237755775452}, {'label': 'negative', 'score': 0.14062727987766266}, {'label': 'positive', 'score': 0.06484897434711456}]","(0.7945237755775452, 0.06484897434711456, 0.14062727987766266)",-0.36879349303132475,-0.14062727987766266,1,1,"[{'label': 'neutral', 'score': 0.9644004702568054}, {'label': 'negative', 'score': 0.03303956985473633}, {'label': 'positive', 'score': 0.0025599778164178133}]","(0.9644004702568054, 0.0025599778164178133, 0.03303956985473633)",-0.8561791941816086,-0.03303956985473633,0,1
2016-05-04,40.50910186767578,52.299617767333984,52.51908493041992,51.975189208984375,52.20419692993164,8075888.0,,-0.01313629414842315,-0.004914007651517676,0.06311807790913829,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-05-05,39.97697067260742,51.61259460449219,51.90839767456055,50.89694595336914,51.79389190673828,11764010.0,"Mid-Afternoon Market Update: U.S. Stocks Turn Lower; Zynga Shares Rise Following Earnings Beat | Merck Lower After Mixed Q1 Report | Mid-Day Market Update: Fitbit Slides  On Weak Outlook; Atlas Air Worldwide Shares Shares Spike Higher | Mid-Morning Market Update: Markets Edge Higher; Merck Profit Beats Views | Merck Launch of Zepatier  in EU May be Delayed Until Late 2016, Early 2017 as Regulator Inspects Record-Keeping of Third Party Manufacturer -Reuters | Merck's Q1 Adjusted Profit beats, But Revenue Miss, Narrows Adjusted EPS FY16 Forecast | Merck Sees FY 2016 EPS $3.65 to $3.77 vs $3.71 est | Merck Q1 EPS $0.89 vs $0.85 est, Revenue $9.3B vs $9.5B est | 12 Stocks To Watch For May 5, 2016 | Earnings Scheduled For May 5, 2016",-0.00905895166361516,-0.013223338393307874,0.10514768654481847,"[{'label': 'negative', 'score': 0.9953078627586365}, {'label': 'positive', 'score': 0.0040166350081563}, {'label': 'neutral', 'score': 0.0006754950736649334}]","(0.0006754950736649334, 0.0040166350081563, 0.9953078627586365)",-0.9919612998237662,-0.9953078627586365,0,0,"[{'label': 'negative', 'score': 0.9285565614700317}, {'label': 'positive', 'score': 0.050542935729026794}, {'label': 'neutral', 'score': 0.02090047299861908}]","(0.02090047299861908, 0.050542935729026794, 0.9285565614700317)",-0.8967562829444472,-0.9285565614700317,0,0,"[{'label': 'negative', 'score': 0.6585155129432678}, {'label': 'neutral', 'score': 0.2971796989440918}, {'label': 'positive', 'score': 0.04430482164025307}]","(0.2971796989440918, 0.04430482164025307, 0.6585155129432678)",-0.8739227667153161,-0.6585155129432678,0,0
2016-05-06,39.61481857299805,51.14503860473633,51.49809265136719,50.6297721862793,51.35496139526367,11031562.0,What's M&A Like In The Biotech Sector Right Now?,0.0031094352494568434,-0.009100233468612108,0.09510453517810499,"[{'label': 'neutral', 'score': 0.9998829364776611}, {'label': 'negative', 'score': 6.185825623106211e-05}, {'label': 'positive', 'score': 5.515666998689994e-05}]","(0.9998829364776611, 5.515666998689994e-05, 6.185825623106211e-05)",-0.057271208560856775,-6.185825623106211e-05,1,1,"[{'label': 'neutral', 'score': 0.9359212517738342}, {'label': 'negative', 'score': 0.03419917821884155}, {'label': 'positive', 'score': 0.02987956814467907}]","(0.9359212517738342, 0.02987956814467907, 0.03419917821884155)",-0.06741096415427991,-0.03419917821884155,1,1,"[{'label': 'neutral', 'score': 0.9994999170303345}, {'label': 'positive', 'score': 0.0003517756122164428}, {'label': 'negative', 'score': 0.00014839397044852376}]","(0.9994999170303345, 0.0003517756122164428, 0.00014839397044852376)",0.4066253703079584,0.0003517756122164428,1,1
2016-05-07,39.7380002339681,51.304070790608726,51.612595876057945,50.7729008992513,51.27544530232748,10140447.666666666,,0.0030997966325413333,0.003104610953641589,0.09695444988048368,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-08,39.86118189493815,51.46310297648112,51.727099100748696,50.916029612223305,51.19592920939128,9249333.333333334,,0.0030902175864732403,0.003095002168313898,0.11570894925036414,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-09,39.9843635559082,51.62213516235352,51.84160232543945,51.05915832519531,51.11641311645508,8358219.0,,0.010720910275336159,0.0030854526779863717,0.1261019750357325,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-10,40.41304016113281,52.17557144165039,52.22328186035156,51.89885330200195,51.975189208984375,6797538.0,,-0.0067666541424599635,0.010663848788529993,0.11273438252699837,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-11,40.13956832885742,51.82251739501953,52.28053283691406,51.774810791015625,52.19465637207031,6888399.0,,-0.0034984271579118144,-0.006789651749884465,0.098473613136268,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-12,39.99913787841797,51.64122009277344,52.11832046508789,51.459922790527344,52.08969497680664,8640026.0,"Berenberg Unimpressed With Pfizer, Initiates Coverage At Hold | Merck To Present Final Stage Data On Investigational Medicines Ertugliflozin And MK-1293",-0.004434591602132043,-0.003504560964162786,0.10726085210818538,"[{'label': 'negative', 'score': 0.992149829864502}, {'label': 'neutral', 'score': 0.006668230518698692}, {'label': 'positive', 'score': 0.001181852538138628}]","(0.006668230518698692, 0.001181852538138628, 0.992149829864502)",-0.9976204271763889,-0.992149829864502,0,0,"[{'label': 'neutral', 'score': 0.8679748177528381}, {'label': 'positive', 'score': 0.11811189353466034}, {'label': 'negative', 'score': 0.013913292437791824}]","(0.8679748177528381, 0.11811189353466034, 0.013913292437791824)",0.7892327538066121,0.11811189353466034,0,1,"[{'label': 'negative', 'score': 0.9844194054603577}, {'label': 'neutral', 'score': 0.014523890800774097}, {'label': 'positive', 'score': 0.0010566168930381536}]","(0.014523890800774097, 0.0010566168930381536, 0.9844194054603577)",-0.9978556213057018,-0.9844194054603577,0,0
2016-05-13,39.8217658996582,51.41221237182617,52.01335906982422,51.364505767822266,51.62213516235352,7467210.0,,0.00476367739393116,-0.004444453570137934,0.11257936586323547,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-14,40.011460622151695,51.65712356567383,52.096056620279946,51.288168589274086,51.51717376708984,7300892.333333333,,0.0047410923594361125,0.004752366987968391,0.11620566277017176,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-15,40.20115534464518,51.90203475952149,52.17875417073568,51.21183141072592,51.41221237182617,7134574.666666667,,0.004718720469869823,0.00472988877857478,0.08606170691627459,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-16,40.39085006713867,52.14694595336914,52.261451721191406,51.13549423217773,51.3072509765625,6968257.0,Merck To Present New And Updated Data On KEYTRUDA,-0.006038401291469523,0.004707622207803338,0.07586785319823033,"[{'label': 'neutral', 'score': 0.9998323917388916}, {'label': 'positive', 'score': 0.00011497742525534704}, {'label': 'negative', 'score': 5.2558683819370344e-05}]","(0.9998323917388916, 0.00011497742525534704, 5.2558683819370344e-05)",0.37256888548211015,0.00011497742525534704,1,1,"[{'label': 'neutral', 'score': 0.8771917223930359}, {'label': 'positive', 'score': 0.11418551206588745}, {'label': 'negative', 'score': 0.008622824214398861}]","(0.8771917223930359, 0.11418551206588745, 0.008622824214398861)",0.8595726564568235,0.11418551206588745,0,1,"[{'label': 'neutral', 'score': 0.9990888833999634}, {'label': 'positive', 'score': 0.0007824490894563496}, {'label': 'negative', 'score': 0.00012868033081758767}]","(0.9990888833999634, 0.0007824490894563496, 0.00012868033081758767)",0.7175366573523682,0.0007824490894563496,0,1
2016-05-17,40.14695358276367,51.832061767578125,52.07061004638672,51.50763320922852,51.91793823242188,12360112.0,,0.006443292140461237,-0.0060567061618496025,0.08724990971116656,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-18,40.405643463134766,52.16603088378906,52.433204650878906,51.68893051147461,51.89885330200195,7745978.0,,-0.0016462142775450581,0.006422622871573259,0.08042835076712641,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-19,40.3391227722168,52.08015441894531,52.46183013916016,51.60305404663086,51.67938995361328,9153127.0,JPMorgan's Take On Big Pharma's New ASCO Abstracts,0.009710455960446805,-0.001647570777199349,0.08395431926902754,"[{'label': 'neutral', 'score': 0.9998568296432495}, {'label': 'positive', 'score': 8.003225229913369e-05}, {'label': 'negative', 'score': 6.313033372862265e-05}]","(0.9998568296432495, 8.003225229913369e-05, 6.313033372862265e-05)",0.1180610035029271,8.003225229913369e-05,1,1,"[{'label': 'neutral', 'score': 0.9247031211853027}, {'label': 'positive', 'score': 0.058702368289232254}, {'label': 'negative', 'score': 0.01659449003636837}]","(0.9247031211853027, 0.058702368289232254, 0.01659449003636837)",0.5592249024624627,0.058702368289232254,0,1,"[{'label': 'neutral', 'score': 0.9992426633834839}, {'label': 'positive', 'score': 0.0005904916324652731}, {'label': 'negative', 'score': 0.00016694425721652806}]","(0.9992426633834839, 0.0005904916324652731, 0.00016694425721652806)",0.559185775348825,0.0005904916324652731,0,1
2016-05-20,40.73083114624024,52.58587646484375,52.99618148803711,52.12786483764648,52.31870269775391,9047489.0,,-0.0011492141644236606,0.009663612486500989,0.10100228218667286,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-21,40.68402608235677,52.52544403076172,52.89758173624674,52.1755739847819,52.37277348836263,7977550.666666667,,-0.0011505363771249374,-0.0011498750173777972,0.10192351254038044,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-22,40.637221018473305,52.46501159667969,52.79898198445638,52.22328313191732,52.42684427897135,6907612.333333334,,-0.001151861635838384,-0.0011511987522089605,0.0834481482426814,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-23,40.59041595458984,52.404579162597656,52.700382232666016,52.270992279052734,52.48091506958008,5837674.0,Chardan Initiates Asterias Biotherapeutics At Buy On Potential Cell Therapy Competitiveness,0.012381687384340832,-0.0011525255383172464,0.07773344112573222,"[{'label': 'neutral', 'score': 0.963901698589325}, {'label': 'positive', 'score': 0.03587517887353897}, {'label': 'negative', 'score': 0.00022311173961497843}]","(0.963901698589325, 0.03587517887353897, 0.00022311173961497843)",0.9876386534749833,0.03587517887353897,1,0,"[{'label': 'positive', 'score': 0.6808011531829834}, {'label': 'neutral', 'score': 0.312194287776947}, {'label': 'negative', 'score': 0.007004530634731054}]","(0.312194287776947, 0.6808011531829834, 0.007004530634731054)",0.9796322397458191,0.6808011531829834,1,1,"[{'label': 'neutral', 'score': 0.6539798974990845}, {'label': 'positive', 'score': 0.345519095659256}, {'label': 'negative', 'score': 0.0005010243039578199}]","(0.6539798974990845, 0.345519095659256, 0.0005010243039578199)",0.9971040741560862,0.345519095659256,1,0
2016-05-24,41.09298324584961,53.05343627929688,53.33015441894531,52.65267181396485,52.700382232666016,6614138.0,,0.017446022473978327,0.012305661204751068,0.10655580880623451,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-05-25,41.80990219116211,53.97900772094727,54.07442855834961,53.21564865112305,53.25381851196289,10052626.0,,-0.0031819174089434076,0.017295587761832962,0.14149755819564105,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-26,41.67686080932617,53.8072509765625,54.12213516235352,53.75954055786133,53.88358688354492,5995084.0,"Celgene Rallies Of Possible Interest From Merck | Celgene Shares Spiking, Traders Passing Vague Comments Of Possible Interest From Merck",0.0015960726107050272,-0.0031869904723796066,0.14787885080798366,"[{'label': 'positive', 'score': 0.956166684627533}, {'label': 'negative', 'score': 0.039756890386343}, {'label': 'neutral', 'score': 0.004076431039720774}]","(0.004076431039720774, 0.956166684627533, 0.039756890386343)",0.9201607605567745,0.956166684627533,0,0,"[{'label': 'negative', 'score': 0.7003191709518433}, {'label': 'positive', 'score': 0.2315077930688858}, {'label': 'neutral', 'score': 0.06817299127578735}]","(0.06817299127578735, 0.2315077930688858, 0.7003191709518433)",-0.5031099077237353,-0.7003191709518433,0,0,"[{'label': 'negative', 'score': 0.8640446066856384}, {'label': 'neutral', 'score': 0.13259246945381165}, {'label': 'positive', 'score': 0.003362929681316018}]","(0.13259246945381165, 0.003362929681316018, 0.8640446066856384)",-0.9922460215289314,-0.8640446066856384,0,0
2016-05-27,41.74338150024414,53.89313125610352,54.23664093017578,53.654579162597656,53.91221237182617,7869222.0,Merck Gets Favorable Opinion From CHMP For Its ZEPATIER | Merck Receives Positive CHMP Opinion for ZEPATIER in the European Union,-0.0009738096503757291,0.0015948002404991856,0.14206145557491287,"[{'label': 'positive', 'score': 0.999566376209259}, {'label': 'negative', 'score': 0.0003081677423324436}, {'label': 'neutral', 'score': 0.00012545705249067396}]","(0.00012545705249067396, 0.999566376209259, 0.0003081677423324436)",0.9993835871826189,0.999566376209259,0,0,"[{'label': 'positive', 'score': 0.9319309592247009}, {'label': 'neutral', 'score': 0.05735666677355766}, {'label': 'negative', 'score': 0.010712331160902977}]","(0.05735666677355766, 0.9319309592247009, 0.010712331160902977)",0.9772717182201107,0.9319309592247009,0,0,"[{'label': 'positive', 'score': 0.9990155696868896}, {'label': 'neutral', 'score': 0.0006497144931927323}, {'label': 'negative', 'score': 0.00033465330488979816}]","(0.0006497144931927323, 0.9990155696868896, 0.00033465330488979816)",0.9993302582074022,0.9990155696868896,0,0
2016-05-28,41.70273208618164,53.84064960479736,54.208014488220215,53.618797302246094,53.90982723236084,8382663.5,,-0.0009747588799797109,-0.0009742841110412537,0.1415504977257102,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-29,41.66208267211914,53.78816795349121,54.17938804626465,53.58301544189453,53.90744209289551,8896105.0,,-0.0009757099619293862,-0.0009752342663665559,0.13184066097031755,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-30,41.62143325805664,53.73568630218506,54.15076160430908,53.54723358154297,53.905056953430176,9409546.5,,-0.000976662901651975,-0.0009761862767496023,0.026882897056513824,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-05-31,41.58078384399414,53.683204650878906,54.12213516235352,53.511451721191406,53.90267181396485,9922988.0,,0.0012442504048610326,-0.0009771401476279876,0.018248828743837296,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-01,41.63252258300781,53.75,53.931297302246094,53.38740539550781,53.625953674316406,7012168.0,,0.008698716274527616,0.0012434769668266728,0.01575468216213928,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-06-02,41.99466323852539,54.21755599975586,54.2557258605957,53.77862548828125,53.85496139526367,7645684.0,,-0.0031678471395551913,0.00866110042445487,0.06625908059586127,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-03,41.86163330078125,54.04580307006836,54.35114669799805,53.70228958129883,54.23664093017578,5697871.0,"Ouch! Jobs Report Miss Sends Rate Hike Odds Down, Raises Questions",0.0031190953917538057,-0.003172875389264034,0.07273279661770789,"[{'label': 'negative', 'score': 0.9982209801673889}, {'label': 'neutral', 'score': 0.0009630281128920615}, {'label': 'positive', 'score': 0.0008159211138263345}]","(0.0009630281128920615, 0.0008159211138263345, 0.9982209801673889)",-0.9983665846320993,-0.9982209801673889,0,0,"[{'label': 'negative', 'score': 0.9272623658180237}, {'label': 'neutral', 'score': 0.05008607730269432}, {'label': 'positive', 'score': 0.022651514038443565}]","(0.05008607730269432, 0.022651514038443565, 0.9272623658180237)",-0.9523082786370777,-0.9272623658180237,0,0,"[{'label': 'negative', 'score': 0.9974319338798523}, {'label': 'neutral', 'score': 0.0020060765091329813}, {'label': 'positive', 'score': 0.0005619777948595583}]","(0.0020060765091329813, 0.0005619777948595583, 0.9974319338798523)",-0.9988737851237659,-0.9974319338798523,0,0
2016-06-04,41.99220657348633,54.21437708536784,54.4815533955892,53.81997426350912,54.17938868204752,6210378.0,"New Data Evaluating KEYTRUDA in Combination with Chemotherapy for First-Line Treatment of NSCLC Demonstrate Response Rates Ranging of 48%71%; Data to be Presented at #ASCO16 | New KEYTRUDA Data from KEYNOTE-010 and KEYNOTE-001 in Advanced NSCLC, Including Survival Data, to be Presented at #ASCO16",0.003109396886254624,0.003114241105091723,0.07167749067703538,"[{'label': 'neutral', 'score': 0.999871015548706}, {'label': 'positive', 'score': 7.779876614222303e-05}, {'label': 'negative', 'score': 5.111449718242511e-05}]","(0.999871015548706, 7.779876614222303e-05, 5.111449718242511e-05)",0.20699397619465817,7.779876614222303e-05,1,1,"[{'label': 'neutral', 'score': 0.7803961038589478}, {'label': 'positive', 'score': 0.20514799654483795}, {'label': 'negative', 'score': 0.014455906115472317}]","(0.7803961038589478, 0.20514799654483795, 0.014455906115472317)",0.8683456355706652,0.20514799654483795,0,1,"[{'label': 'neutral', 'score': 0.994670569896698}, {'label': 'positive', 'score': 0.00511067034676671}, {'label': 'negative', 'score': 0.0002188130165450275}]","(0.994670569896698, 0.00511067034676671, 0.0002188130165450275)",0.9178858431001623,0.00511067034676671,0,1
2016-06-05,42.122779846191406,54.38295110066732,54.611960093180336,53.9376589457194,54.12213643391927,6722885.0,"Merck Announces New Data from Phase 2 Study Evaluating KEYTRUDA for the Treatment of Cancers Deficient in DNA Mismatch Repair Show Durable Responses Across a Range of Cancers at #ASCO16 | Lilly Announces Encouraging Data of Early-Phase Immuno-Oncology Studies of ALIMTA and CYRAMZA with Merck's KEYTRUDA in NSCLC Presented at #ASCO16 | Merck Announces New Data for KEYTRUDA in Combination with Talimogene Laherparepvec, Dabrafenib Plus Trametinib, or Low-Dose Ipilimumab in Advanced Melanoma Presented at #ASCO16",0.0030997585068054216,0.003104572709356591,0.06754679165231722,"[{'label': 'positive', 'score': 0.8100626468658447}, {'label': 'neutral', 'score': 0.18940290808677673}, {'label': 'negative', 'score': 0.000534400693140924}]","(0.18940290808677673, 0.8100626468658447, 0.000534400693140924)",0.9986814640029834,0.8100626468658447,0,0,"[{'label': 'positive', 'score': 0.9388887882232666}, {'label': 'neutral', 'score': 0.047196291387081146}, {'label': 'negative', 'score': 0.013914856128394604}]","(0.047196291387081146, 0.9388887882232666, 0.013914856128394604)",0.9707917655208739,0.9388887882232666,0,0,"[{'label': 'positive', 'score': 0.9819930791854858}, {'label': 'neutral', 'score': 0.017263934016227722}, {'label': 'negative', 'score': 0.0007430222467519343}]","(0.017263934016227722, 0.9819930791854858, 0.0007430222467519343)",0.9984878499005602,0.9819930791854858,0,0
2016-06-06,42.25335311889648,54.5515251159668,54.74236679077149,54.05534362792969,54.064884185791016,7235392.0,"4 Key Takeaways From ASCO | Merck, Pfizer Offers Results from Pivotal Avelumab Study | Merck Reports Response Rates from KEYNOTE-055 Show Nearly One in Five Patients Respond with KEYTRUDA",-0.0029735625444262145,0.0030949641603940934,0.0664920265899051,"[{'label': 'neutral', 'score': 0.9997902512550354}, {'label': 'positive', 'score': 0.00015321541286539286}, {'label': 'negative', 'score': 5.644920383929275e-05}]","(0.9997902512550354, 0.00015321541286539286, 5.644920383929275e-05)",0.4615285618860341,0.00015321541286539286,1,1,"[{'label': 'positive', 'score': 0.5721082091331482}, {'label': 'neutral', 'score': 0.4030783772468567}, {'label': 'negative', 'score': 0.024813400581479073}]","(0.4030783772468567, 0.5721082091331482, 0.024813400581479073)",0.9168621132904144,0.5721082091331482,0,0,"[{'label': 'neutral', 'score': 0.7544560432434082}, {'label': 'positive', 'score': 0.2444840967655182}, {'label': 'negative', 'score': 0.0010599271627143025}]","(0.7544560432434082, 0.2444840967655182, 0.0010599271627143025)",0.9913667036504696,0.2444840967655182,0,1
2016-06-07,42.12770080566406,54.38931274414063,54.80915832519531,54.3129768371582,54.58015441894531,6552515.0,"Merck Says Ruling Reversal in Gilead Case 'Doesn't Reflect the Facts,' Co. Will Appeal Ruling Overturn | Goldman Confident In Merck's Keytruda | FDA Staff Has Said Overall Clinical Results from Merck's Bezlotoxumab Trial Could Negatively Impact Cure Rate of Initial Episode of Infection with C. Difficile | US Judge Rules Gilead Won't have to Pay $200M Jury Verdict to Merck in Hepatitis C Patent Dispute -Reuters",0.010877179644142119,-0.0029779923652748126,0.05374549554737587,"[{'label': 'positive', 'score': 0.509676456451416}, {'label': 'negative', 'score': 0.46224021911621094}, {'label': 'neutral', 'score': 0.02808327227830887}]","(0.02808327227830887, 0.509676456451416, 0.46224021911621094)",0.04880689726565394,0.509676456451416,0,1,"[{'label': 'negative', 'score': 0.8808271288871765}, {'label': 'neutral', 'score': 0.08581818640232086}, {'label': 'positive', 'score': 0.03335462138056755}]","(0.08581818640232086, 0.03335462138056755, 0.8808271288871765)",-0.9270284680900736,-0.8808271288871765,0,0,"[{'label': 'negative', 'score': 0.8489879369735718}, {'label': 'neutral', 'score': 0.10959777235984802}, {'label': 'positive', 'score': 0.04141426458954811}]","(0.10959777235984802, 0.04141426458954811, 0.8489879369735718)",-0.9069762754026338,-0.8489879369735718,0,0
2016-06-08,42.58592987060547,54.98091506958008,55.21946716308594,54.360687255859375,54.360687255859375,8164025.0,,-0.007636205772918834,0.010818448627040374,0.07775648945083662,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-09,42.26074981689453,54.56106948852539,55.171756744384766,54.32251739501953,54.875953674316406,9670630.0,"UPDATE: Merck To Pay $500M Cash Upfront, Afferent Holders Eligible FOr Addition $750M Tied To 'clinical development and commercial milestones for multiple indications and candidates, including AF-219' | Merck To Acquire Afferent Pharmaceuticals | Hearing FDA Panel Has Said Merck Has Provided Substantial Evidence of Safety, Effectiveness of Bezlotoxumab | BZ NOTE: Relypsa Shares Still Up $0.20-$0.40 from Where Stock Was Trading Prior to Apparent Rumor Manipulation Ahead of Negative StreetSweeper Report (See Body of This Headline for More) | Hearing Merck May Be Interested In RLYP, Unconfirmed Takeover Chatter | Agenus Reports Lead Product Candidate Selection in its Collab with Merck, Received First Milestone Payment of $2M",-0.006470805098589744,-0.007665510874067149,0.11105284716227787,"[{'label': 'positive', 'score': 0.9988483190536499}, {'label': 'neutral', 'score': 0.0009012889349833131}, {'label': 'negative', 'score': 0.0002504092699382454}]","(0.0009012889349833131, 0.9988483190536499, 0.0002504092699382454)",0.9994987296793814,0.9988483190536499,0,0,"[{'label': 'positive', 'score': 0.9480748772621155}, {'label': 'neutral', 'score': 0.027099277824163437}, {'label': 'negative', 'score': 0.024825824424624443}]","(0.027099277824163437, 0.9480748772621155, 0.024825824424624443)",0.9489653478888784,0.9480748772621155,0,0,"[{'label': 'positive', 'score': 0.9932031631469727}, {'label': 'neutral', 'score': 0.006419699639081955}, {'label': 'negative', 'score': 0.00037709547905251384}]","(0.006419699639081955, 0.9932031631469727, 0.00037709547905251384)",0.9992409360476345,0.9932031631469727,0,0
2016-06-10,41.98727416992188,54.20801544189453,54.46564865112305,53.97900772094727,54.21755599975586,9989222.0,,-0.004107253801102802,-0.006491831512198818,0.12149803503767796,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-11,41.92766443888346,53.98536936442057,54.33842213948568,53.82633590698242,54.01399358113607,8827024.666666666,,-0.00412419290810095,-0.0041157117351948965,0.1182577496831154,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-12,41.868054707845054,53.76272328694662,54.21119562784831,53.67366409301758,53.810431162516274,7664827.333333334,"Merck, Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin Met Primary Endpoints, Showing Significant A1C Reductions in Patients with Type 2 Diabetes at the American Diabetes Association's 76th Scientific Sessions",-0.004141272314009032,-0.004132720846992152,0.11908738031274847,"[{'label': 'positive', 'score': 0.9985004663467407}, {'label': 'neutral', 'score': 0.0009055905393324792}, {'label': 'negative', 'score': 0.0005939854891039431}]","(0.0009055905393324792, 0.9985004663467407, 0.0005939854891039431)",0.9988109522818138,0.9985004663467407,0,0,"[{'label': 'positive', 'score': 0.939911961555481}, {'label': 'neutral', 'score': 0.03842303529381752}, {'label': 'negative', 'score': 0.021665019914507866}]","(0.03842303529381752, 0.939911961555481, 0.021665019914507866)",0.9549385637717992,0.939911961555481,0,0,"[{'label': 'positive', 'score': 0.9974122643470764}, {'label': 'neutral', 'score': 0.0021346528083086014}, {'label': 'negative', 'score': 0.00045315647730603814}]","(0.0021346528083086014, 0.9974122643470764, 0.00045315647730603814)",0.9990917483102447,0.9974122643470764,0,0
2016-06-13,41.80844497680664,53.540077209472656,54.08396911621094,53.520992279052734,53.60686874389648,6502630.0,"Merck Reports MK-1293 Met Primary Endpoint in Two Phase 3 Studies | Has Cancer Research Become Cancerous? Same Cancer Strategy Targeted By 'Too Many Drugmakers,' Say Regulators",0.002495082011597974,-0.004149871130436365,0.026448283695263742,"[{'label': 'neutral', 'score': 0.9938888549804688}, {'label': 'negative', 'score': 0.005902630276978016}, {'label': 'positive', 'score': 0.00020856726041529328}]","(0.9938888549804688, 0.00020856726041529328, 0.005902630276978016)",-0.9317425891933265,-0.005902630276978016,0,1,"[{'label': 'neutral', 'score': 0.7483956217765808}, {'label': 'negative', 'score': 0.20087265968322754}, {'label': 'positive', 'score': 0.05073174089193344}]","(0.7483956217765808, 0.05073174089193344, 0.20087265968322754)",-0.5967340732041091,-0.20087265968322754,0,1,"[{'label': 'negative', 'score': 0.5456048846244812}, {'label': 'neutral', 'score': 0.4503858685493469}, {'label': 'positive', 'score': 0.004009194206446409}]","(0.4503858685493469, 0.004009194206446409, 0.5456048846244812)",-0.9854108751545292,-0.5456048846244812,0,0
2016-06-14,41.91276168823242,53.67366409301758,53.73091506958008,53.07251739501953,53.21564865112305,9006722.0,Jefferies Shares Pharma Stock Catalyst Outlook,-0.0028444455310570995,0.0024919744624621962,0.053723995509229155,"[{'label': 'neutral', 'score': 0.9998451471328735}, {'label': 'negative', 'score': 8.899958629626781e-05}, {'label': 'positive', 'score': 6.578835018444806e-05}]","(0.9998451471328735, 6.578835018444806e-05, 8.899958629626781e-05)",-0.14995507169069017,-8.899958629626781e-05,1,1,"[{'label': 'neutral', 'score': 0.9309991002082825}, {'label': 'positive', 'score': 0.046713728457689285}, {'label': 'negative', 'score': 0.02228718437254429}]","(0.9309991002082825, 0.046713728457689285, 0.02228718437254429)",0.35400320203361446,0.046713728457689285,1,1,"[{'label': 'neutral', 'score': 0.9995388984680176}, {'label': 'positive', 'score': 0.00033475871896371245}, {'label': 'negative', 'score': 0.00012638993212021887}]","(0.9995388984680176, 0.00033475871896371245, 0.00012638993212021887)",0.4518473302561378,0.00033475871896371245,1,1
2016-06-15,41.79354095458984,53.520992279052734,53.931297302246094,53.38740539550781,53.82633590698242,8015942.0,,0.025138189336764597,-0.002848498653996264,0.04561445947516795,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-06-16,42.84415817260742,54.86641311645508,55.02862548828125,53.55915832519531,54.3797721862793,23110706.0,Cramer Talks About Merck's 'Fabulous News' And Why The Market Can't Rally | Merck Rallies Of Drug Trial Results | Merck Announces Keytruda Met Primary and Secondary Endpoint,-0.02799998414784333,0.024827422368261236,0.19645518731685818,"[{'label': 'neutral', 'score': 0.7814918756484985}, {'label': 'positive', 'score': 0.21466338634490967}, {'label': 'negative', 'score': 0.0038447577971965075}]","(0.7814918756484985, 0.21466338634490967, 0.0038447577971965075)",0.9648090206221689,0.21466338634490967,0,1,"[{'label': 'neutral', 'score': 0.7909066081047058}, {'label': 'positive', 'score': 0.167844757437706}, {'label': 'negative', 'score': 0.041248619556427}]","(0.7909066081047058, 0.167844757437706, 0.041248619556427)",0.6054526437000977,0.167844757437706,0,1,"[{'label': 'negative', 'score': 0.5266469717025757}, {'label': 'neutral', 'score': 0.32905876636505127}, {'label': 'positive', 'score': 0.14429424703121185}]","(0.32905876636505127, 0.14429424703121185, 0.5266469717025757)",-0.5698751455350244,-0.5266469717025757,0,0
2016-06-17,41.64453125,53.33015441894531,54.799617767333984,53.14885330200195,54.799617767333984,18323651.0,,0.001491015614009694,-0.028399458212894947,0.3013464177401614,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-18,41.706624348958336,53.40967051188151,54.53562291463216,53.28244145711263,54.45292536417643,15254513.333333334,,0.0014887957962315742,0.001489905153901028,0.3010181363656829,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-19,41.76871744791666,53.48918660481771,54.271628061930336,53.416029612223305,54.10623296101888,12185375.666666668,,0.001486582578338193,0.0014876886385216768,0.3004757883598515,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-20,41.830810546875,53.56870269775391,54.00763320922852,53.549617767333984,53.75954055786133,9116238.0,UPDATE: Merck Says Pivotal Phase 3 Studies for Relebacatam Ongoing in Treatment of Serious Bacterial Infections | Merck Offers Results of Phase 2 Study for Relebactam in Combo with Imipenem/Cilastatin,0.001959379077292191,0.0014854787083175465,0.30008814423700203,"[{'label': 'neutral', 'score': 0.9983879327774048}, {'label': 'positive', 'score': 0.0014891171595081687}, {'label': 'negative', 'score': 0.0001229929766850546}]","(0.9983879327774048, 0.0014891171595081687, 0.0001229929766850546)",0.847413679842637,0.0014891171595081687,0,1,"[{'label': 'positive', 'score': 0.7075366377830505}, {'label': 'neutral', 'score': 0.281026154756546}, {'label': 'negative', 'score': 0.011437136679887772}]","(0.281026154756546, 0.7075366377830505, 0.011437136679887772)",0.9681848293049878,0.7075366377830505,0,0,"[{'label': 'neutral', 'score': 0.997012734413147}, {'label': 'positive', 'score': 0.0028007852379232645}, {'label': 'negative', 'score': 0.0001865014637587592}]","(0.997012734413147, 0.0028007852379232645, 0.0001865014637587592)",0.8751365487258069,0.0028007852379232645,0,1
2016-06-21,41.91276168823242,53.67366409301758,54.07442855834961,53.66412353515625,53.950382232666016,6710344.0,,0.014044476461612672,0.0019574619978897207,0.21303594710839607,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-22,42.50140380859375,54.42748260498047,54.64694595336914,53.53053283691406,53.56870269775391,13076420.0,,0.011220200285425034,0.013946766595243281,0.08767639113076581,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-23,42.9782829284668,55.03816986083984,55.03816986083984,54.4942741394043,54.84732818603516,7302883.0,,-0.03120670288993707,0.011157720759013917,0.09618068971102511,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-06-24,41.63707733154297,53.32061004638672,54.45610809326172,53.21564865112305,53.47328186035156,18087013.0,,-0.0034001355589961466,-0.03170400552228535,0.28926869833792834,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-25,41.495505015055336,53.13931274414063,54.01399612426758,53.00254440307617,53.29834620157877,16631934.666666666,,-0.003411735923628246,-0.0034059291563112064,0.2890979533868379,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-26,41.35393269856771,52.95801544189453,53.57188415527344,52.7894401550293,53.12341054280599,15176856.333333334,,-0.003423415714001083,-0.0034175691660687023,0.2874333423247516,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-27,41.21236038208008,52.77671813964844,53.1297721862793,52.57633590698242,52.9484748840332,13721778.0,Merck Gets CHMP Positive Opinion For KEYTRUDA For Advanced Non-Small Cell Lung Cancer Treatment | Merck Receives CHMP Positive Opinion for KEYTRUDA for the Treatment of Advanced Non-Small Cell Lung Cancer,0.0048815693417467165,-0.0034292890098965674,0.24783588119543284,"[{'label': 'positive', 'score': 0.9995241165161133}, {'label': 'negative', 'score': 0.0002721630153246224}, {'label': 'neutral', 'score': 0.00020375203166622669}]","(0.00020375203166622669, 0.9995241165161133, 0.0002721630153246224)",0.9994555630564015,0.9995241165161133,0,0,"[{'label': 'positive', 'score': 0.844386637210846}, {'label': 'neutral', 'score': 0.1443510353565216}, {'label': 'negative', 'score': 0.011262309737503529}]","(0.1443510353565216, 0.844386637210846, 0.011262309737503529)",0.973675396252937,0.844386637210846,0,0,"[{'label': 'positive', 'score': 0.9981535077095032}, {'label': 'neutral', 'score': 0.001539332326501608}, {'label': 'negative', 'score': 0.00030708598205819726}]","(0.001539332326501608, 0.9981535077095032, 0.00030708598205819726)",0.9993848811179962,0.9981535077095032,0,0
2016-06-28,41.41353225708008,53.03435134887695,53.1202278137207,52.58587646484375,52.90076446533203,13372585.0,,0.026448363716897738,0.004869693116191529,0.2229234592372729,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-06-29,42.50886154174805,54.4370231628418,54.52289962768555,53.41603088378906,53.56870269775391,10284862.0,"Merck, Moderna Therapeutics Report Strategic Collaboration Related to Advancement of Novel mRNA-Based Personalized Cancer Vaccines with KEYTRUDA",0.009815954617476152,0.02610465296454515,0.20303402063706247,"[{'label': 'neutral', 'score': 0.9977454543113708}, {'label': 'positive', 'score': 0.002141872188076377}, {'label': 'negative', 'score': 0.00011268175148870796}]","(0.9977454543113708, 0.002141872188076377, 0.00011268175148870796)",0.9000407579421721,0.002141872188076377,0,1,"[{'label': 'positive', 'score': 0.8482679128646851}, {'label': 'neutral', 'score': 0.14459668099880219}, {'label': 'negative', 'score': 0.007135387044399977}]","(0.14459668099880219, 0.8482679128646851, 0.007135387044399977)",0.9833169054990591,0.8482679128646851,0,0,"[{'label': 'positive', 'score': 0.8375710248947144}, {'label': 'neutral', 'score': 0.16189830005168915}, {'label': 'negative', 'score': 0.0005306510138325393}]","(0.16189830005168915, 0.8375710248947144, 0.0005306510138325393)",0.9987336834441781,0.8375710248947144,0,0
2016-06-30,42.92612457275391,54.97137451171875,55.03816986083984,54.30343627929688,54.53244400024414,9723030.0,"Merck And Premier Join Hands To Prevent Fractures For Osteoporosis Patients | Merck, Premier Report Collaboration to Prevent Fractures for Osteoporosis Patients",0.005728148306058617,0.009768091097498724,0.19348677109450985,"[{'label': 'neutral', 'score': 0.9976552724838257}, {'label': 'positive', 'score': 0.002234733197838068}, {'label': 'negative', 'score': 0.00010995127377100289}]","(0.9976552724838257, 0.002234733197838068, 0.00010995127377100289)",0.9062123069416267,0.002234733197838068,0,1,"[{'label': 'positive', 'score': 0.7777636051177979}, {'label': 'neutral', 'score': 0.21177218854427338}, {'label': 'negative', 'score': 0.010464229620993137}]","(0.21177218854427338, 0.7777636051177979, 0.010464229620993137)",0.9734487183532136,0.7777636051177979,0,0,"[{'label': 'positive', 'score': 0.9356176257133484}, {'label': 'neutral', 'score': 0.06353108584880829}, {'label': 'negative', 'score': 0.0008513205102644861}]","(0.06353108584880829, 0.9356176257133484, 0.0008513205102644861)",0.9981818499936437,0.9356176257133484,0,0
2016-07-01,43.1720085144043,55.286258697509766,55.343509674072266,54.790077209472656,54.904579162597656,8245978.0,"Merck Animal Health Announces Agreement to Acquire Controlling Interest In Brazilian Animal Health Company Valle S.A., Will Acquire 93% Of Shares For $400M",0.0002588842956246139,0.005711804846688682,0.17294069525507935,"[{'label': 'neutral', 'score': 0.9997527003288269}, {'label': 'positive', 'score': 0.00017515323997940868}, {'label': 'negative', 'score': 7.204533176263794e-05}]","(0.9997527003288269, 0.00017515323997940868, 7.204533176263794e-05)",0.4171055985079256,0.00017515323997940868,1,1,"[{'label': 'neutral', 'score': 0.6954056620597839}, {'label': 'positive', 'score': 0.2926987409591675}, {'label': 'negative', 'score': 0.011895603500306606}]","(0.6954056620597839, 0.2926987409591675, 0.011895603500306606)",0.9218921577718965,0.2926987409591675,0,1,"[{'label': 'neutral', 'score': 0.7512480020523071}, {'label': 'positive', 'score': 0.248313307762146}, {'label': 'negative', 'score': 0.0004387315711937845}]","(0.7512480020523071, 0.248313307762146, 0.0004387315711937845)",0.996472538899624,0.248313307762146,0,1
2016-07-02,43.183186531066895,55.30057144165039,55.384063720703125,54.87595462799072,54.96183109283447,8121737.75,,0.0002588172918923069,0.00025885079086778015,0.15811908954183101,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-03,43.19436454772949,55.314884185791016,55.424617767333984,54.96183204650879,55.01908302307129,7997497.5,,0.0002587503228344746,0.0002587838044749208,0.16932758445776605,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-04,43.20554256439209,55.32919692993164,55.46517181396485,55.047709465026855,55.076334953308105,7873257.25,,0.00025868338842420795,0.00025871685274309015,0.06891626010797904,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-05,43.21672058105469,55.343509674072266,55.5057258605957,55.13358688354492,55.13358688354492,7749017.0,,0.02000004273513405,0.0002586499356454346,0.03871284660391056,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-07-06,44.081050872802734,56.450382232666016,56.55534362792969,55.41030502319336,55.60114669799805,15015430.0,"Merck, Pfizer Report Initiation of Phase III Trial to Evaluate Avelumab as First-Line Treatment for Ovarian Cancer",-0.006423244452052013,0.019802669193369146,0.13874805981611743,"[{'label': 'neutral', 'score': 0.9997795224189758}, {'label': 'positive', 'score': 0.00012247053382452577}, {'label': 'negative', 'score': 9.79967080638744e-05}]","(0.9997795224189758, 0.00012247053382452577, 9.79967080638744e-05)",0.11100889887777503,0.00012247053382452577,1,1,"[{'label': 'positive', 'score': 0.8465071320533752}, {'label': 'neutral', 'score': 0.14509893953800201}, {'label': 'negative', 'score': 0.008393893949687481}]","(0.14509893953800201, 0.8465071320533752, 0.008393893949687481)",0.9803628871778722,0.8465071320533752,0,0,"[{'label': 'neutral', 'score': 0.9824330806732178}, {'label': 'positive', 'score': 0.017362868413329124}, {'label': 'negative', 'score': 0.00020398090418893844}]","(0.9824330806732178, 0.017362868413329124, 0.00020398090418893844)",0.9767766091116267,0.017362868413329124,0,1
2016-07-07,43.79790878295898,56.08778762817383,56.31679534912109,55.6202278137207,56.1927490234375,9800791.0,,0.009697153867860448,-0.0064439622513412405,0.15753246074071117,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-08,44.22262191772461,56.63167953491211,56.84160232543945,56.10686874389648,56.27862548828125,9934411.0,,-5.617805344392012e-05,0.009650438234287842,0.16193472495000238,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-09,44.22013473510742,56.62849807739258,56.89885457356771,56.23409525553385,56.36768468221029,9185894.666666666,,-5.618120959491529e-05,-5.617963148987947e-05,0.16249393767668685,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-10,44.21764755249024,56.62531661987305,56.95610682169596,56.361321767171226,56.45674387613932,8437378.333333334,,-5.618436610043766e-05,-5.618278781820804e-05,0.16304346354719457,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-11,44.21516036987305,56.62213516235352,57.01335906982422,56.488548278808594,56.54580307006836,7688862.0,,0.004381548852861527,-5.618594450106071e-05,0.09147466537721011,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-12,44.40889739990234,56.8702278137207,57.0515251159668,56.3740463256836,56.55534362792969,8804562.0,,-0.0008389348967872623,0.00437197781481617,0.06821823307276603,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-13,44.37163925170898,56.82251739501953,57.20419692993164,56.7557258605957,57.04198455810547,7119274.0,,0.0016792785989927727,-0.0008392869996090738,0.03326511675331604,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-14,44.4461669921875,56.91793823242188,57.18511581420898,56.7557258605957,57.12786483764648,7698084.0,,-0.0003353060741939828,0.0016778701872096251,0.033148695543465154,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-15,44.43125915527344,56.89885330200195,57.18511581420898,56.536258697509766,57.06106948852539,8554510.0,,-0.0034098985544955907,-0.00033536230184499287,0.03377288863056205,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-16,44.27975336710612,56.704833984375,57.045166015625,56.36768341064453,56.80661646525065,8766380.666666666,,-0.003421565746588996,-0.003415725508557261,0.0462732219322815,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-17,44.1282475789388,56.51081466674805,56.905216217041016,56.1991081237793,56.55216344197592,8978251.333333334,,-0.003433313052928338,-0.003427432689244304,0.03460463709812048,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-18,43.97674179077149,56.31679534912109,56.76526641845703,56.03053283691406,56.29771041870117,9190122.0,BMO Analysts Say Merck's Fundamentals Don't Justify Its Valuations | Benzinga's Top Downgrades | BMO Capital Downgrades Merck & Co to Market Perform,-0.006099663282329953,-0.003439220397238602,0.03738621109131615,"[{'label': 'negative', 'score': 0.9684431552886963}, {'label': 'neutral', 'score': 0.030295470729470253}, {'label': 'positive', 'score': 0.0012613828293979168}]","(0.030295470729470253, 0.0012613828293979168, 0.9684431552886963)",-0.9973984182195417,-0.9684431552886963,1,1,"[{'label': 'negative', 'score': 0.9532903432846069}, {'label': 'neutral', 'score': 0.03578644618391991}, {'label': 'positive', 'score': 0.010923227295279503}]","(0.03578644618391991, 0.010923227295279503, 0.9532903432846069)",-0.9773427223416692,-0.9532903432846069,1,1,"[{'label': 'negative', 'score': 0.9962459206581116}, {'label': 'neutral', 'score': 0.0034244353882968426}, {'label': 'positive', 'score': 0.0003296305949334055}]","(0.0034244353882968426, 0.0003296305949334055, 0.9962459206581116)",-0.9993384734463555,-0.9962459206581116,1,1
2016-07-19,43.70849990844727,55.97328186035156,56.774810791015625,55.87786483764648,56.3740463256836,9307602.0,,0.002216170314849245,-0.006118342223980535,0.03250399619474251,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-20,43.80535888671875,56.09732818603516,56.41221237182617,56.06870269775391,56.29771041870117,6786848.0,,0.0,0.0022137182315716242,0.04849081700266104,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-21,43.80535888671875,56.09732818603516,56.40267181396485,55.87786483764648,56.29771041870117,6337361.0,"Merck Animal Health Receives FDA Approval of BRAVECTO For Cats And Dogs, Topical Treatment for Fleas and Ticks Effective for up to 12 Weeks | Merck Provides Regulatory Update on Biologics Licensing Application for Investigational Agent Bezlotoxumab | The Market In 5 Minutes: Jam-Packed Day Of Earnings And Economic Data | Benzinga's M&A Chatter for Wednesday July 20, 2016",0.0005102825608077517,0.0,0.051869884479566294,"[{'label': 'positive', 'score': 0.8652133941650391}, {'label': 'neutral', 'score': 0.1341399997472763}, {'label': 'negative', 'score': 0.0006465844926424325}]","(0.1341399997472763, 0.8652133941650391, 0.0006465844926424325)",0.9985064917917911,0.8652133941650391,0,0,"[{'label': 'neutral', 'score': 0.8070048689842224}, {'label': 'positive', 'score': 0.17737017571926117}, {'label': 'negative', 'score': 0.01562497764825821}]","(0.8070048689842224, 0.17737017571926117, 0.01562497764825821)",0.8380790670063754,0.17737017571926117,0,1,"[{'label': 'positive', 'score': 0.9934943318367004}, {'label': 'neutral', 'score': 0.006213636603206396}, {'label': 'negative', 'score': 0.00029202341102063656}]","(0.006213636603206396, 0.9934943318367004, 0.00029202341102063656)",0.9994123014278097,0.9934943318367004,0,0
2016-07-22,43.82770538330078,56.125953674316406,56.3740463256836,55.86832046508789,56.28816986083984,6570436.0,"Merck Presents Data On Its Investigational Once-Daily Formulation Of ISENTRESS | Merck Reports Investigational Once-Daily Formulation of ISENTRESS Showed Non-Inferior Efficacy, Safety to Regimen Containing Approved Twice-Daily Formulation",-0.0014734053227824023,0.0005101524109353101,0.05329396627154066,"[{'label': 'neutral', 'score': 0.9904500842094421}, {'label': 'positive', 'score': 0.009376682341098785}, {'label': 'negative', 'score': 0.00017317396122962236}]","(0.9904500842094421, 0.009376682341098785, 0.00017317396122962236)",0.9637326561264802,0.009376682341098785,0,1,"[{'label': 'positive', 'score': 0.7605619430541992}, {'label': 'neutral', 'score': 0.12376420944929123}, {'label': 'negative', 'score': 0.11567379534244537}]","(0.12376420944929123, 0.7605619430541992, 0.11567379534244537)",0.7359756278507703,0.7605619430541992,0,0,"[{'label': 'neutral', 'score': 0.6512431502342224}, {'label': 'positive', 'score': 0.3433854579925537}, {'label': 'negative', 'score': 0.0053713577799499035}]","(0.6512431502342224, 0.3433854579925537, 0.0053713577799499035)",0.9691971165176959,0.3433854579925537,0,1
2016-07-23,43.76313018798828,56.04325739542643,56.31043243408203,55.6870231628418,56.173665364583336,7187952.666666667,,-0.001475579449397206,-0.001474491851801236,0.050216968088874235,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-24,43.69855499267578,55.96056111653646,56.24681854248047,55.5057258605957,56.05916086832682,7805469.333333333,,-0.0014777600016870902,-0.001476669188883037,0.024470889618001906,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-25,43.63397979736328,55.87786483764648,56.183204650878906,55.32442855834961,55.94465637207031,8422986.0,"Merck Gets Breakthrough Therapy Status From FDA And PRIME Status From EMA For Investigational Ebola Zaire Vaccine | NewLink Genetics Announces Merck Receives Breakthrough Therapy Designation from FDA, PRIME Status from EMA for Investigational Ebola Zaire Vaccine | Merck Reports Received Breakthrough Therapy Designation from FDA, PRIME Status from EMA for V920 | Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine",-0.0034153358464782467,-0.001478852965890275,0.015327075143722715,"[{'label': 'positive', 'score': 0.9430378079414368}, {'label': 'neutral', 'score': 0.05633663013577461}, {'label': 'negative', 'score': 0.0006255140760913491}]","(0.05633663013577461, 0.9430378079414368, 0.0006255140760913491)",0.9986742854967511,0.9430378079414368,0,0,"[{'label': 'positive', 'score': 0.6890723705291748}, {'label': 'neutral', 'score': 0.28324809670448303}, {'label': 'negative', 'score': 0.027679482474923134}]","(0.28324809670448303, 0.6890723705291748, 0.027679482474923134)",0.9227641132452995,0.6890723705291748,0,0,"[{'label': 'positive', 'score': 0.9922515749931335}, {'label': 'neutral', 'score': 0.007414690684527159}, {'label': 'negative', 'score': 0.00033376069040969014}]","(0.007414690684527159, 0.9922515749931335, 0.00033376069040969014)",0.9993274921995904,0.9922515749931335,0,0
2016-07-26,43.484962463378906,55.6870231628418,56.11641311645508,55.47710037231445,56.011451721191406,7494038.0,,0.004112407306772241,-0.003421181419475375,0.022065336789906305,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-07-27,43.66378021240234,55.91603088378906,56.03053283691406,55.27671813964844,55.71564865112305,8267462.0,Can Keytruda Deliver Earnings Growth For Merck?,-0.0029009993960998365,0.004103974471440494,0.04509620516172216,"[{'label': 'positive', 'score': 0.999541163444519}, {'label': 'negative', 'score': 0.0002625322958920151}, {'label': 'neutral', 'score': 0.00019638807862065732}]","(0.00019638807862065732, 0.999541163444519, 0.0002625322958920151)",0.9994748323155626,0.999541163444519,0,0,"[{'label': 'neutral', 'score': 0.5392524600028992}, {'label': 'positive', 'score': 0.4515989124774933}, {'label': 'negative', 'score': 0.009148618206381798}]","(0.5392524600028992, 0.4515989124774933, 0.009148618206381798)",0.9602879338591235,0.4515989124774933,0,1,"[{'label': 'positive', 'score': 0.9986814856529236}, {'label': 'neutral', 'score': 0.0009790508775040507}, {'label': 'negative', 'score': 0.00033944693859666586}]","(0.0009790508775040507, 0.9986814856529236, 0.00033944693859666586)",0.9993204407885306,0.9986814856529236,0,0
2016-07-28,43.5371208190918,55.75381851196289,55.90649032592773,55.4484748840332,55.83969497680664,7639606.0,,0.003936292692519033,-0.0029052154506700656,0.04761869592347109,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-29,43.70849990844727,55.97328186035156,56.488548278808594,55.60114669799805,56.3072509765625,8898778.0,"Weak GDP Data, Plunging Oil Renew Questions About Strength Of Economy | A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead Of GDP Report | Investors Greet Merck Q2 Results As Key Launches Help Beat | Merck Reports EC Granted Marketing Authorization for Co.'s ZEPATIER for Treatment of Chronic Hep C Infection | Merck Narrows, Raises FY16 Adj. EPS Outlook from $3.60-$3.75 to $3.67-$3.77 vs $3.72 Est., Sales from $38.7B-$40.2B to $39.1B-$40.1B vs $39.5B Est. | Merck Reports Q2 Adj. EPS $0.93 vs $0.91 Est., Sales $9.844B vs $9.78B Est. | 12 Stocks You Should Be Watching Today | Earnings Scheduled For July 29, 2016",0.0,0.003928565762772445,0.05864855592408703,"[{'label': 'negative', 'score': 0.9977015852928162}, {'label': 'positive', 'score': 0.0017729498213157058}, {'label': 'neutral', 'score': 0.0005254317075014114}]","(0.0005254317075014114, 0.0017729498213157058, 0.9977015852928162)",-0.9964522361320326,-0.9977015852928162,0,0,"[{'label': 'negative', 'score': 0.8969086408615112}, {'label': 'neutral', 'score': 0.056929007172584534}, {'label': 'positive', 'score': 0.04616227000951767}]","(0.056929007172584534, 0.04616227000951767, 0.8969086408615112)",-0.9021022290532071,-0.8969086408615112,0,0,"[{'label': 'negative', 'score': 0.8611002564430237}, {'label': 'neutral', 'score': 0.08261696994304657}, {'label': 'positive', 'score': 0.05628276616334915}]","(0.08261696994304657, 0.05628276616334915, 0.8611002564430237)",-0.8772971272055059,-0.8611002564430237,0,0
2016-07-30,43.70849990844727,55.97328186035156,56.42493565877279,55.67430114746094,56.24999872843424,9031524.666666666,,0.0,0.0,0.05714757211305908,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-07-31,43.70849990844727,55.97328186035156,56.36132303873698,55.74745559692383,56.19274648030599,9164271.333333334,,0.0,0.0,0.04726407813090303,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-01,43.70849990844727,55.97328186035156,56.29771041870117,55.82061004638672,56.13549423217773,9297018.0,"Merck's Q2 Good, But Not Good Enough, Says BMO",-0.005625615924694644,0.0,0.038611666183731325,"[{'label': 'positive', 'score': 0.9652655124664307}, {'label': 'negative', 'score': 0.02813079208135605}, {'label': 'neutral', 'score': 0.006603702437132597}]","(0.006603702437132597, 0.9652655124664307, 0.02813079208135605)",0.9433644116601345,0.9652655124664307,0,0,"[{'label': 'negative', 'score': 0.6639719009399414}, {'label': 'positive', 'score': 0.2964787483215332}, {'label': 'neutral', 'score': 0.03954927623271942}]","(0.03954927623271942, 0.2964787483215332, 0.6639719009399414)",-0.38262575271409005,-0.6639719009399414,1,0,"[{'label': 'negative', 'score': 0.909828245639801}, {'label': 'neutral', 'score': 0.08541741967201233}, {'label': 'positive', 'score': 0.0047543891705572605}]","(0.08541741967201233, 0.0047543891705572605, 0.909828245639801)",-0.9896031501373452,-0.909828245639801,0,0
2016-08-02,43.46259689331055,55.65839767456055,56.040077209472656,55.582061767578125,55.99236679077149,7153962.0,"Benzinga's M&A Chatter for Tuesday August 2, 2016 | 6 Stocks Moving In Tuesday's After-Hours Session | Merck Reports KEYTRUDA Has Received EC Approval for Patients with NSCLC Whose Tumors Express PD-L1 | Wall Street Journal Reports Biogen Drawing Interest From Merck, Allergan On Possibility Of Huge Deal",-0.01165784758111691,-0.005641499299147146,0.05422562906215006,"[{'label': 'positive', 'score': 0.9990184307098389}, {'label': 'neutral', 'score': 0.000723466684576124}, {'label': 'negative', 'score': 0.00025810705847106874}]","(0.000723466684576124, 0.9990184307098389, 0.00025810705847106874)",0.9994834121512599,0.9990184307098389,0,0,"[{'label': 'positive', 'score': 0.9352566003799438}, {'label': 'neutral', 'score': 0.0464363619685173}, {'label': 'negative', 'score': 0.018307095393538475}]","(0.0464363619685173, 0.9352566003799438, 0.018307095393538475)",0.9616027844292275,0.9352566003799438,0,0,"[{'label': 'positive', 'score': 0.9930289387702942}, {'label': 'neutral', 'score': 0.006597691681236029}, {'label': 'negative', 'score': 0.0003733948979061097}]","(0.006597691681236029, 0.9930289387702942, 0.0003733948979061097)",0.999248250411236,0.9930289387702942,0,0
2016-08-03,42.9559211730957,55.00954055786133,55.6297721862793,54.56106948852539,55.5057258605957,10099890.0,"Terms Of The Trade: Dogs Of The Dow Investing Strategy | Biogen Shares Down $3 Over Last Min Following Reuters Report Co. Not Soliciting Offers; Allergan, Merck Shares Relatively Quiet, Not Impacted | The Market In 5 Minutes: Downtrend Continues | Why Is Biogen Attractive? Credit Suisse Sees 12-24% Upside Takeout Potential",0.003295812237381974,-0.011726333068805902,0.08286929543013342,"[{'label': 'negative', 'score': 0.9978341460227966}, {'label': 'neutral', 'score': 0.0013254430377855897}, {'label': 'positive', 'score': 0.0008403434767387807}]","(0.0013254430377855897, 0.0008403434767387807, 0.9978341460227966)",-0.9983170823214681,-0.9978341460227966,0,0,"[{'label': 'negative', 'score': 0.9558769464492798}, {'label': 'neutral', 'score': 0.027544893324375153}, {'label': 'positive', 'score': 0.016578104346990585}]","(0.027544893324375153, 0.016578104346990585, 0.9558769464492798)",-0.9659046362432566,-0.9558769464492798,0,0,"[{'label': 'negative', 'score': 0.7685858011245728}, {'label': 'neutral', 'score': 0.1954602301120758}, {'label': 'positive', 'score': 0.035953935235738754}]","(0.1954602301120758, 0.035953935235738754, 0.7685858011245728)",-0.9106223506165347,-0.7685858011245728,0,0
2016-08-04,43.09749221801758,55.19084167480469,55.5629768371582,55.09542083740234,55.09542083740234,5807387.0,"Celgene Shares Spiking, Traders Circulating Takeover Chatter By Merck | Benzinga's M&A Chatter for Wednesday August 3, 2016",0.10408020543065251,0.0032903929522628897,0.09409085671598355,"[{'label': 'positive', 'score': 0.9985241293907166}, {'label': 'neutral', 'score': 0.0010153569746762514}, {'label': 'negative', 'score': 0.00046059637679718435}]","(0.0010153569746762514, 0.9985241293907166, 0.00046059637679718435)",0.999077871032626,0.9985241293907166,1,1,"[{'label': 'neutral', 'score': 0.7778008580207825}, {'label': 'positive', 'score': 0.12648312747478485}, {'label': 'negative', 'score': 0.09571601450443268}]","(0.7778008580207825, 0.12648312747478485, 0.09571601450443268)",0.13846638963722843,0.12648312747478485,0,0,"[{'label': 'neutral', 'score': 0.7555058002471924}, {'label': 'negative', 'score': 0.2419595569372177}, {'label': 'positive', 'score': 0.002534630475565791}]","(0.7555058002471924, 0.002534630475565791, 0.2419595569372177)",-0.9792663334667623,-0.2419595569372177,0,0
2016-08-05,47.58309173583984,60.93511581420898,61.06870269775391,55.19084167480469,55.19084167480469,76374048.0,"BMO Capital Upgrades Merck & Co to Outperform, Raises PT to $72.00 | 25 Biggest Mid-Day Gainers For Friday | Benzinga's Volume Movers | Stocks Hitting 52-Week Highs | Option Alert: MRK Oct16 60.0 Puts Sweep: 594 @  ASK  $1.71: 605 traded vs 1589 OI: $61.04 Ref | Bristol's Opdivo Misses Endpoint In Late-Stage Trial; Merck Rallies Sharply Amid Keytruda Potential | The Market In 5 Minutes: Blowout Jobs Report Pushes Markets Higher | UPDATE: Merck's KEYTRUDA is Viewed as Strongest Competitor to Bristol's Opdivo | Merck Spike in Price Likely Attributed to Negative Results on Bristol-Myers' Opdivo | Merck Shares Spiking ~$6 Over Last Min | Merck Reports Acceptance of FDA Filing for NDA for MK-1293",-0.005219763852522782,0.09901259506263674,0.733535309261345,"[{'label': 'positive', 'score': 0.9995923638343811}, {'label': 'negative', 'score': 0.0002648085937835276}, {'label': 'neutral', 'score': 0.000142822609632276}]","(0.000142822609632276, 0.9995923638343811, 0.0002648085937835276)",0.9994703071576905,0.9995923638343811,0,0,"[{'label': 'positive', 'score': 0.8286213874816895}, {'label': 'negative', 'score': 0.13581925630569458}, {'label': 'neutral', 'score': 0.03555934503674507}]","(0.03555934503674507, 0.8286213874816895, 0.13581925630569458)",0.7183460544086389,0.8286213874816895,0,0,"[{'label': 'positive', 'score': 0.9980054497718811}, {'label': 'neutral', 'score': 0.0014852611348032951}, {'label': 'negative', 'score': 0.0005093111540190876}]","(0.0014852611348032951, 0.9980054497718811, 0.0005093111540190876)",0.9989798625439511,0.9980054497718811,0,0
2016-08-06,47.334723154703774,60.61704889933268,60.756997426350914,56.49809265136719,56.72392018636068,59665399.66666667,"BMO Capital Upgrades Merck To Outperform, Bullish On Co",-0.005247152750779968,-0.005233434412006059,0.7420619326759319,"[{'label': 'positive', 'score': 0.9994458556175232}, {'label': 'negative', 'score': 0.0003557064919732511}, {'label': 'neutral', 'score': 0.0001984053960768506}]","(0.0001984053960768506, 0.9994458556175232, 0.0003557064919732511)",0.9992884458167424,0.9994458556175232,0,0,"[{'label': 'positive', 'score': 0.9064882397651672}, {'label': 'negative', 'score': 0.0627567246556282}, {'label': 'neutral', 'score': 0.03075500577688217}]","(0.03075500577688217, 0.9064882397651672, 0.0627567246556282)",0.8705038933204454,0.9064882397651672,0,0,"[{'label': 'positive', 'score': 0.9984984397888184}, {'label': 'neutral', 'score': 0.0011577720288187265}, {'label': 'negative', 'score': 0.00034377400879748166}]","(0.0011577720288187265, 0.9984984397888184, 0.00034377400879748166)",0.9993116550260918,0.9984984397888184,0,0
2016-08-07,47.08635457356771,60.29898198445638,60.44529215494792,57.80534362792969,58.25699869791666,42956751.333333336,,-0.005274830592634124,-0.0052609674030253606,0.74136929057933,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-08,46.83798599243164,59.98091506958008,60.13358688354492,59.11259460449219,59.790077209472656,26248103.0,"Results from Merck's Phase 3 Study Of Zepatier Hep C Treatment Published In Annals Of Internal Medicine | Technical Alert: Merck Surrenders Some Of Friday's Huge Gain | After Roaring To New Highs on Jobs Data, Market Faces Retail Sales, Job Openings | CheckMate Miss Is A Game Changer; Credit Suisse Downgrades Bristol, Upgrades Merck | 8 Biggest Price Target Changes For Monday | The Market in 5 Minutes: Can The Momentum Continue? | Benzinga's Top Upgrades | Citi Doesn't See Merck's Lung Cancer Success Lasting Long | FDA Approves Merck's KEYTRUDA (pembrolizumab) for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma with Disease Progression on or After Platinum-Containing Chemotherapy | Credit Suisse Upgrades Merck & Co to Outperform, Raises PT to $73.00 | Watch These 5 Huge Put Purchases In Monday Trade",-0.0058860427775076374,-0.005288791627896667,0.7274710224435823,"[{'label': 'positive', 'score': 0.9995113611221313}, {'label': 'negative', 'score': 0.0002697375894058496}, {'label': 'neutral', 'score': 0.00021894549718126655}]","(0.00021894549718126655, 0.9995113611221313, 0.0002697375894058496)",0.9994604067035204,0.9995113611221313,0,0,"[{'label': 'positive', 'score': 0.926108181476593}, {'label': 'neutral', 'score': 0.0409545861184597}, {'label': 'negative', 'score': 0.03293730318546295}]","(0.0409545861184597, 0.926108181476593, 0.03293730318546295)",0.9313123231124554,0.926108181476593,0,0,"[{'label': 'positive', 'score': 0.9941800832748413}, {'label': 'neutral', 'score': 0.004743105731904507}, {'label': 'negative', 'score': 0.001076808082871139}]","(0.004743105731904507, 0.9941800832748413, 0.001076808082871139)",0.9978361203178364,0.9941800832748413,0,0
2016-08-09,46.562286376953125,59.62786483764648,60.24809265136719,59.57061004638672,59.98091506958008,12821651.0,"Bernstein Says Merck's Lung Cancer Drug Will Lead The Market Near-Term, But Long-Term Market Share Harder To Predict",0.0024003449024371667,-0.00590343380375875,0.7414228531042157,"[{'label': 'negative', 'score': 0.9964385032653809}, {'label': 'neutral', 'score': 0.0018066877964884043}, {'label': 'positive', 'score': 0.0017547663301229477}]","(0.0018066877964884043, 0.0017547663301229477, 0.9964385032653809)",-0.9964841150835769,-0.9964385032653809,0,0,"[{'label': 'positive', 'score': 0.8785772323608398}, {'label': 'neutral', 'score': 0.11194678395986557}, {'label': 'negative', 'score': 0.0094760088250041}]","(0.11194678395986557, 0.8785772323608398, 0.0094760088250041)",0.9786589173136725,0.8785772323608398,0,0,"[{'label': 'neutral', 'score': 0.9933521747589111}, {'label': 'positive', 'score': 0.004033092875033617}, {'label': 'negative', 'score': 0.002614725613966584}]","(0.9933521747589111, 0.004033092875033617, 0.002614725613966584)",0.2133583014358667,0.004033092875033617,1,1
2016-08-10,46.67405319213867,59.770992279052734,60.209922790527344,59.22710037231445,59.24618148803711,9259499.0,"Argus: Bristol-Myers Selloff Is Overdone, Reiterating $90 Target",0.015804595775489167,0.002397468676315566,0.05568649164074843,"[{'label': 'negative', 'score': 0.9947245717048645}, {'label': 'positive', 'score': 0.0042265732772648335}, {'label': 'neutral', 'score': 0.0010487905237823725}]","(0.0010487905237823725, 0.0042265732772648335, 0.9947245717048645)",-0.9915379780112461,-0.9947245717048645,0,0,"[{'label': 'negative', 'score': 0.8578667640686035}, {'label': 'neutral', 'score': 0.07988129556179047}, {'label': 'positive', 'score': 0.06225194036960602}]","(0.07988129556179047, 0.06225194036960602, 0.8578667640686035)",-0.8646871538001942,-0.8578667640686035,0,0,"[{'label': 'negative', 'score': 0.9348861575126648}, {'label': 'neutral', 'score': 0.06204872205853462}, {'label': 'positive', 'score': 0.0030651292763650417}]","(0.06204872205853462, 0.0030651292763650417, 0.9348861575126648)",-0.9934642036968505,-0.9348861575126648,0,0
2016-08-11,47.41170883178711,60.71564865112305,60.81106948852539,59.61832046508789,59.74236679077149,10862520.0,Biogen Cancels Out Of Citigroup Conference Following Weeks Of Rumors,-0.004400410322963779,0.015681003666453544,0.14670249557503376,"[{'label': 'negative', 'score': 0.5517638921737671}, {'label': 'neutral', 'score': 0.44757547974586487}, {'label': 'positive', 'score': 0.0006606567185372114}]","(0.44757547974586487, 0.0006606567185372114, 0.5517638921737671)",-0.9976081558292008,-0.5517638921737671,0,0,"[{'label': 'negative', 'score': 0.9427906274795532}, {'label': 'neutral', 'score': 0.047919612377882004}, {'label': 'positive', 'score': 0.00928979367017746}]","(0.047919612377882004, 0.00928979367017746, 0.9427906274795532)",-0.9804852752691645,-0.9427906274795532,0,0,"[{'label': 'negative', 'score': 0.9957283139228821}, {'label': 'neutral', 'score': 0.003784600645303726}, {'label': 'positive', 'score': 0.00048704701475799084}]","(0.003784600645303726, 0.00048704701475799084, 0.9957283139228821)",-0.9990222053707352,-0.9957283139228821,0,0
2016-08-12,47.20309066772461,60.4484748840332,60.54389190673828,60.04771041870117,60.24809265136719,6544026.0,,-0.0001578716586505126,-0.00441012062514883,0.14477309731038596,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-13,47.19563293457031,60.43893178304037,60.63931274414063,60.13676834106445,60.31488672892253,6685785.666666667,,-0.0001578965860466821,-0.00015788412169258186,0.13618647718963156,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-14,47.188175201416016,60.42938868204752,60.73473358154297,60.22582626342773,60.38168080647787,6827545.333333333,,-0.00015792152131540843,-0.00015790905302499062,0.12180067104285512,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-15,47.18071746826172,60.41984558105469,60.83015441894531,60.314884185791016,60.4484748840332,6969305.0,,-0.004421953821967594,-0.00015793399223185586,0.12350074589282116,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-16,46.97209930419922,60.15267181396485,60.41984558105469,59.96183013916016,60.114505767822266,5952745.0,Mirror Image: Bristol-Myers Loss Is Merck's Potential Gain,0.003965713768232087,-0.0044317595775122546,0.037066512342316484,"[{'label': 'negative', 'score': 0.6713511943817139}, {'label': 'positive', 'score': 0.3268827199935913}, {'label': 'neutral', 'score': 0.0017660718876868486}]","(0.0017660718876868486, 0.3268827199935913, 0.6713511943817139)",-0.34507791152707024,-0.6713511943817139,1,0,"[{'label': 'negative', 'score': 0.6125614047050476}, {'label': 'neutral', 'score': 0.3620849847793579}, {'label': 'positive', 'score': 0.025353631004691124}]","(0.3620849847793579, 0.025353631004691124, 0.6125614047050476)",-0.9205109471154481,-0.6125614047050476,0,0,"[{'label': 'neutral', 'score': 0.930952250957489}, {'label': 'positive', 'score': 0.06415830552577972}, {'label': 'negative', 'score': 0.004889507777988911}]","(0.930952250957489, 0.06415830552577972, 0.004889507777988911)",0.85837327660246,0.06415830552577972,0,1
2016-08-17,47.15836715698242,60.39122009277344,60.524810791015625,59.73282241821289,60.14313125610352,8668532.0,"UPDATE: Reuters Says Merck, Sanofi, Pfizer, Gilead, Celgene Have Each Submitted Expressions of Interest for Medivation",0.005372114652613738,0.003957871053190463,0.047091699449848874,"[{'label': 'neutral', 'score': 0.999847412109375}, {'label': 'negative', 'score': 7.994225597940385e-05}, {'label': 'positive', 'score': 7.25563513697125e-05}]","(0.999847412109375, 7.25563513697125e-05, 7.994225597940385e-05)",-0.04843260366819441,-7.994225597940385e-05,1,1,"[{'label': 'neutral', 'score': 0.6622053980827332}, {'label': 'positive', 'score': 0.3261302709579468}, {'label': 'negative', 'score': 0.011664360761642456}]","(0.6622053980827332, 0.3261302709579468, 0.011664360761642456)",0.9309381519637334,0.3261302709579468,0,1,"[{'label': 'neutral', 'score': 0.9987866282463074}, {'label': 'positive', 'score': 0.001119213062338531}, {'label': 'negative', 'score': 9.423551091458648e-05}]","(0.9987866282463074, 0.001119213062338531, 9.423551091458648e-05)",0.8446814920850716,0.001119213062338531,0,1
2016-08-18,47.41170883178711,60.71564865112305,60.725189208984375,60.19084167480469,60.19084167480469,7259077.0,,-0.004243275250321323,0.005357736316419927,0.06142384337594901,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-19,47.21054458618164,60.45801544189453,60.53435134887695,59.99045944213867,60.286258697509766,8887040.0,,0.0009995768739731812,-0.00425230349133885,0.07190676401506638,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-20,47.25773366292318,60.51844787597656,60.59796396891276,60.05725351969401,60.30852381388346,8176915.333333333,,0.0009985787177800465,0.0009990776296707467,0.07211947657396145,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-21,47.30492273966471,60.578880310058594,60.66157658894857,60.12404759724935,60.33078893025717,7466790.666666667,,0.0009975825530734361,0.0009980804697178596,0.05858342046871876,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-22,47.35211181640625,60.63931274414063,60.725189208984375,60.19084167480469,60.35305404663086,6756666.0,,0.0004720615552163556,0.0009970852982727064,0.05407504614676377,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-23,47.37446975708008,60.66793823242188,60.95419692993164,60.46755599975586,60.79198455810547,6076723.0,,-0.013368997070877164,0.00047195016921298353,0.03651975991863927,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-08-24,46.741119384765625,59.85686874389648,60.85877990722656,59.64694595336914,60.6870231628418,7842079.0,The 2015 Flash Crash Was One Year Ago Today. Why Did It Happen? | Write A Prescription For More Pharma M&A With This ETF,-0.006535926468978927,-0.013459166665354556,0.10176677068779325,"[{'label': 'neutral', 'score': 0.9997242093086243}, {'label': 'negative', 'score': 0.00021537748398259282}, {'label': 'positive', 'score': 6.0377013141987845e-05}]","(0.9997242093086243, 6.0377013141987845e-05, 0.00021537748398259282)",-0.5620958949241677,-0.00021537748398259282,0,1,"[{'label': 'neutral', 'score': 0.9344322681427002}, {'label': 'positive', 'score': 0.048290759325027466}, {'label': 'negative', 'score': 0.017276911064982414}]","(0.9344322681427002, 0.048290759325027466, 0.017276911064982414)",0.47300518800757074,0.048290759325027466,1,1,"[{'label': 'neutral', 'score': 0.8467451930046082}, {'label': 'negative', 'score': 0.1510901004076004}, {'label': 'positive', 'score': 0.002164720557630062}]","(0.8467451930046082, 0.002164720557630062, 0.1510901004076004)",-0.9717500494405826,-0.1510901004076004,0,1
2016-08-25,46.43562316894531,59.46564865112305,60.209922790527344,59.41793823242188,59.98091506958008,8329190.0,,0.008504504231724245,-0.00655737916296047,0.10188323321424637,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-26,46.83053588867188,59.97137451171875,60.10496139526367,59.332061767578125,59.61832046508789,8167902.0,,0.0008485815952909538,0.008468544670598122,0.13204605242547868,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-27,46.87027104695638,60.022265116373696,60.20038096110026,59.478371938069664,59.75827026367188,7393080.666666667,,0.0008478621151048499,0.0008482217534847652,0.13183612882959225,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-28,46.91000620524088,60.07315572102865,60.29580052693685,59.6246821085612,59.89822006225586,6618259.333333334,,0.000847143853925063,0.0008475028830602747,0.1323140250662441,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-29,46.94974136352539,60.1240463256836,60.39122009277344,59.770992279052734,60.03816986083984,5843438.0,,-0.004761134936912748,0.0008467852300934398,0.08433802436414063,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-30,46.726219177246094,59.83778762817383,60.14313125610352,59.64694595336914,60.07633590698242,6474544.0,,0.0012757140597638027,-0.004772505244591674,0.07482264602694935,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-08-31,46.78581619262695,59.91412353515625,60.22900772094727,59.56106948852539,60.19084167480469,9285804.0,"Shares Of Celgene Spiking Higher, Hearing Unconfirmed Rumors That Big Restructuring Under Way & Speculation Is That They Are Prepping Deal With Merck",0.0017518639858276972,0.001274901027973358,0.04076266720167946,"[{'label': 'positive', 'score': 0.9990503191947937}, {'label': 'neutral', 'score': 0.0007063301745802164}, {'label': 'negative', 'score': 0.0002433177432976663}]","(0.0007063301745802164, 0.9990503191947937, 0.0002433177432976663)",0.9995130205290945,0.9990503191947937,0,0,"[{'label': 'positive', 'score': 0.649716317653656}, {'label': 'negative', 'score': 0.29619407653808594}, {'label': 'neutral', 'score': 0.054089583456516266}]","(0.054089583456516266, 0.649716317653656, 0.29619407653808594)",0.37373755832088773,0.649716317653656,1,0,"[{'label': 'positive', 'score': 0.9969117045402527}, {'label': 'neutral', 'score': 0.0020798237528651953}, {'label': 'negative', 'score': 0.0010084507521241903}]","(0.0020798237528651953, 0.9969117045402527, 0.0010084507521241903)",0.9979788949110288,0.9969117045402527,0,0
2016-09-01,46.86778259277344,60.01908493041992,60.09542083740234,59.53244400024414,59.828243255615234,6858846.0,,0.0012718605602019912,0.0017503312619366219,0.04267009199817095,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-02,46.92740249633789,60.09542083740234,60.37213516235352,59.72328186035156,59.72328186035156,7978634.0,"Merck Remains Stable Following Discontinuation Of Odanacatib Development Program | Merck Provides Update on Odanacatib Development Program, Will Discontinue Development and Not Seek Regulatory Approval For Its Use",0.0010320621488831647,0.0012710524307058238,0.04330788199709849,"[{'label': 'neutral', 'score': 0.9996591806411743}, {'label': 'positive', 'score': 0.00023413605231326073}, {'label': 'negative', 'score': 0.00010661834676284343}]","(0.9996591806411743, 0.00023413605231326073, 0.00010661834676284343)",0.3742217441540277,0.00023413605231326073,1,1,"[{'label': 'neutral', 'score': 0.8632630705833435}, {'label': 'negative', 'score': 0.11446923762559891}, {'label': 'positive', 'score': 0.02226765640079975}]","(0.8632630705833435, 0.02226765640079975, 0.11446923762559891)",-0.6742992217374673,-0.11446923762559891,0,1,"[{'label': 'neutral', 'score': 0.8751885890960693}, {'label': 'positive', 'score': 0.12259276956319809}, {'label': 'negative', 'score': 0.0022186487913131714}]","(0.8751885890960693, 0.12259276956319809, 0.0022186487913131714)",0.9644479836770803,0.12259276956319809,0,1
2016-09-03,46.97583293914795,60.157443046569824,60.41984558105469,59.76622104644776,59.81870174407959,8061714.0,,0.0010309980947738598,0.0010315299388945409,0.04353480173874495,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-04,47.02426338195801,60.219465255737305,60.46755599975586,59.809160232543945,59.91412162780762,8144794.0,,0.001029936232480552,0.0010304669812580933,0.0046619024913775705,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-09-05,47.07269382476807,60.28148746490479,60.51526641845703,59.85209941864014,60.009541511535645,8227874.0,,0.0010288765552373272,0.0010294062120527218,0.004966936779652132,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-09-06,47.121124267578125,60.343509674072266,60.5629768371582,59.89503860473633,60.10496139526367,8310954.0,,-0.005850674477512011,0.001028347624526203,0.001711848388693236,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-09-07,46.84543228149414,59.99045944213867,60.582061767578125,59.73282241821289,60.41030502319336,9084169.0,"Technical Alert: Merck Range-Bound For Third Day In A Row | UDPATE: Merck To Continue Distributing Product On Behalf of Aralez For 12 Months, Considerations Also Include Sales-Based Milestones And Graduated Royalties | Merck Gets FDA Priority Review and Breakthrough Therapy Designation for KEYTRUDA",0.005885106318849147,-0.005867856724700567,0.04896948611502887,"[{'label': 'neutral', 'score': 0.9995920062065125}, {'label': 'positive', 'score': 0.00034527727984823287}, {'label': 'negative', 'score': 6.262473470997065e-05}]","(0.9995920062065125, 0.00034527727984823287, 6.262473470997065e-05)",0.6929422632158404,0.00034527727984823287,0,1,"[{'label': 'positive', 'score': 0.9332654476165771}, {'label': 'neutral', 'score': 0.05359698832035065}, {'label': 'negative', 'score': 0.013137533329427242}]","(0.05359698832035065, 0.9332654476165771, 0.013137533329427242)",0.9722369147309844,0.9332654476165771,0,0,"[{'label': 'neutral', 'score': 0.5256983637809753}, {'label': 'positive', 'score': 0.4731401801109314}, {'label': 'negative', 'score': 0.0011614089598879218}]","(0.5256983637809753, 0.4731401801109314, 0.0011614089598879218)",0.9951026562564836,0.4731401801109314,0,1
2016-09-08,47.121124267578125,60.343509674072266,60.39122009277344,59.475189208984375,59.58969497680664,9627242.0,Another Election Year View On Healthcare ETFs,-0.0118595162974632,0.005867856724700656,0.06647188433779146,"[{'label': 'neutral', 'score': 0.9998764991760254}, {'label': 'negative', 'score': 6.329217285383493e-05}, {'label': 'positive', 'score': 6.021949229761958e-05}]","(0.9998764991760254, 6.021949229761958e-05, 6.329217285383493e-05)",-0.024877654693162082,-6.329217285383493e-05,0,0,"[{'label': 'neutral', 'score': 0.8457829356193542}, {'label': 'positive', 'score': 0.1265973001718521}, {'label': 'negative', 'score': 0.027619795873761177}]","(0.8457829356193542, 0.1265973001718521, 0.027619795873761177)",0.6418063031663885,0.1265973001718521,0,0,"[{'label': 'neutral', 'score': 0.9995321035385132}, {'label': 'positive', 'score': 0.00031710456823930144}, {'label': 'negative', 'score': 0.00015080455341376364}]","(0.9995321035385132, 0.00031710456823930144, 0.00015080455341376364)",0.35541092731430496,0.00031710456823930144,0,0
2016-09-09,46.562286376953125,59.62786483764648,59.83778762817383,59.46564865112305,59.81870269775391,13191700.0,"Barclays Raises Target On Merck, Lowers Target On Bristol-Myers",0.003733926714970995,-0.011930401359981893,0.11050222686849437,"[{'label': 'positive', 'score': 0.997453510761261}, {'label': 'negative', 'score': 0.0018907221965491772}, {'label': 'neutral', 'score': 0.0006557830492965877}]","(0.0006557830492965877, 0.997453510761261, 0.0018907221965491772)",0.9962160742330937,0.997453510761261,0,0,"[{'label': 'neutral', 'score': 0.5400868058204651}, {'label': 'positive', 'score': 0.2371477335691452}, {'label': 'negative', 'score': 0.2227654606103897}]","(0.5400868058204651, 0.2371477335691452, 0.2227654606103897)",0.03127171201168264,0.2371477335691452,1,1,"[{'label': 'neutral', 'score': 0.981185257434845}, {'label': 'negative', 'score': 0.013844477944076061}, {'label': 'positive', 'score': 0.004970233421772718}]","(0.981185257434845, 0.004970233421772718, 0.013844477944076061)",-0.47166519590682027,-0.013844477944076061,1,1
2016-09-10,46.73615010579427,59.850510915120445,60.08587900797526,59.3352419535319,59.599236806233726,12507705.333333334,,0.003720036371781498,0.00372697291522486,0.1166126671215682,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-11,46.91001383463541,60.0731569925944,60.333970387776695,59.20483525594076,59.37977091471354,11823710.666666666,,0.0037062489907332104,0.003713134148862018,0.12163517436439603,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-12,47.08387756347656,60.29580307006836,60.582061767578125,59.07442855834961,59.16030502319336,11139716.0,,-0.02183892214837688,0.0036993977729371315,0.11583343245192884,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-09-13,46.393333435058594,58.97900772094727,59.904579162597656,58.55915832519531,59.51335906982422,10714123.0,"Presidential Merck: 'Jimmy Carter' Oncology Drug Expected To Dominate, Hep C Drug Approved Across EU",-0.007442148120757952,-0.022080921229308208,0.18894012146258962,"[{'label': 'positive', 'score': 0.9978297352790833}, {'label': 'neutral', 'score': 0.0019298851257190108}, {'label': 'negative', 'score': 0.00024040666176006198}]","(0.0019298851257190108, 0.9978297352790833, 0.00024040666176006198)",0.9995182569808319,0.9978297352790833,0,0,"[{'label': 'positive', 'score': 0.8542159199714661}, {'label': 'neutral', 'score': 0.13634070754051208}, {'label': 'negative', 'score': 0.00944329984486103}]","(0.13634070754051208, 0.8542159199714661, 0.00944329984486103)",0.9781318843632114,0.8542159199714661,0,0,"[{'label': 'positive', 'score': 0.9977502226829529}, {'label': 'neutral', 'score': 0.0020264803897589445}, {'label': 'negative', 'score': 0.00022333086235448718}]","(0.0020264803897589445, 0.9977502226829529, 0.00022333086235448718)",0.9995524313012882,0.9977502226829529,0,0
2016-09-14,46.04808044433594,58.540077209472656,59.48473358154297,58.49236679077149,59.08396911621094,10922046.0,,0.016788881481930387,-0.007469979072436794,0.1804630310757676,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-15,46.82116317749024,59.52289962768555,59.74236679077149,58.32061004638672,58.43511581420898,9429694.0,"Seattle Genetics No Longer On Goldman Sachs' Sell List | UPDATE: Pfizer, Merck's VERTIS SITA2 Also Achieved 4 Secondary Endpoints | Merck, Pfizer Reports Ertugliflozin Met Primary Endpoint of A1C Reduction",-0.001603030485777903,0.01664950602011399,0.2303200594200426,"[{'label': 'positive', 'score': 0.9984002709388733}, {'label': 'neutral', 'score': 0.0013304552994668484}, {'label': 'negative', 'score': 0.00026926127611659467}]","(0.0013304552994668484, 0.9984002709388733, 0.00026926127611659467)",0.9994607600063269,0.9984002709388733,0,0,"[{'label': 'positive', 'score': 0.8184046745300293}, {'label': 'neutral', 'score': 0.16619610786437988}, {'label': 'negative', 'score': 0.015399175696074963}]","(0.16619610786437988, 0.8184046745300293, 0.015399175696074963)",0.9630628338022207,0.8184046745300293,0,0,"[{'label': 'positive', 'score': 0.9169461131095886}, {'label': 'neutral', 'score': 0.08166493475437164}, {'label': 'negative', 'score': 0.0013890026602894068}]","(0.08166493475437164, 0.9169461131095886, 0.0013890026602894068)",0.9969749547056688,0.9169461131095886,0,0
2016-09-16,46.7461051940918,59.42748260498047,59.75190734863281,59.21755599975586,59.58969497680664,13029050.0,,-0.005084574152070563,-0.0016043167139061384,0.22638264589817075,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-17,46.5084228515625,59.12531916300456,59.726462046305336,58.98218790690104,59.61832046508789,12629203.333333334,,-0.005110559169124641,-0.0050975445839861406,0.2205749854544721,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-18,46.2707405090332,58.82315572102865,59.70101674397787,58.74681981404623,59.64694595336914,12229356.666666666,,-0.0051368111464290865,-0.005123662740083463,0.15602652567755923,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-19,46.03305816650391,58.520992279052734,59.67557144165039,58.511451721191406,59.67557144165039,11829510.0,,0.009946204685023271,-0.005150049916976022,0.15028861019895465,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-20,46.49090576171875,59.10305404663086,59.5515251159668,58.864505767822266,59.064884185791016,9653757.0,"Some Traders Attributing After-Hours Upside in Clovis to Janney Capital Analyst Comment During Bloomberg Interview There Are 'Many Suitors' for Co, Including Lilly, Roche, Merck | New 5-Year Contraceptive Coming To U.S. Adds To Long-Acting Reversible Contraceptives List | Citi Research Reevaluates Bristol-Myers, Lowers Price Target",0.012269910932389695,0.009897066746564865,0.10326504765827273,"[{'label': 'positive', 'score': 0.9691759943962097}, {'label': 'neutral', 'score': 0.01871476322412491}, {'label': 'negative', 'score': 0.012109190225601196}]","(0.01871476322412491, 0.9691759943962097, 0.012109190225601196)",0.9753197329066614,0.9691759943962097,0,0,"[{'label': 'positive', 'score': 0.8113176822662354}, {'label': 'negative', 'score': 0.10053660720586777}, {'label': 'neutral', 'score': 0.08814564347267151}]","(0.08814564347267151, 0.8113176822662354, 0.10053660720586777)",0.7794897532059182,0.8113176822662354,0,0,"[{'label': 'positive', 'score': 0.8383091688156128}, {'label': 'neutral', 'score': 0.152631476521492}, {'label': 'negative', 'score': 0.009059274569153786}]","(0.152631476521492, 0.8383091688156128, 0.009059274569153786)",0.978617861828871,0.8383091688156128,0,0
2016-09-21,47.06135559082031,59.828243255615234,59.9427490234375,59.02671813964844,59.40839767456055,7565512.0,"The Market In 5 Minutes: We're Waiting For You, Mrs. Yellen | Clovis Upgraded At Credit Suisse Following Acquisition Rumor",0.005103670295400646,0.01219524571187551,0.1411852809541568,"[{'label': 'positive', 'score': 0.9993115663528442}, {'label': 'neutral', 'score': 0.0004052282893098891}, {'label': 'negative', 'score': 0.0002832134487107396}]","(0.0004052282893098891, 0.9993115663528442, 0.0002832134487107396)",0.9994333434819118,0.9993115663528442,0,0,"[{'label': 'neutral', 'score': 0.8863661289215088}, {'label': 'positive', 'score': 0.1022425964474678}, {'label': 'negative', 'score': 0.011391335166990757}]","(0.8863661289215088, 0.1022425964474678, 0.011391335166990757)",0.7995082101772258,0.1022425964474678,0,1,"[{'label': 'positive', 'score': 0.8675400018692017}, {'label': 'neutral', 'score': 0.1317559778690338}, {'label': 'negative', 'score': 0.0007040086202323437}]","(0.1317559778690338, 0.8675400018692017, 0.0007040086202323437)",0.9983783162066722,0.8675400018692017,0,0
2016-09-22,47.30152893066406,60.13358688354492,60.5629768371582,59.95228958129883,60.03816986083984,8853294.0,,-0.0009520632233924877,0.005090690713763808,0.12998236479479602,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-23,47.25650405883789,60.07633590698242,60.35305404663086,59.828243255615234,59.99045944213867,8048430.0,,-0.004288430799564873,-0.000952516723446473,0.11533472397107496,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-24,47.053846995035805,59.81870269775391,60.139949798583984,59.56742986043295,59.88231658935547,7805294.0,,-0.004306900644941543,-0.004297652492765059,0.11105303092545835,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-25,46.851189931233726,59.56106948852539,59.92684555053711,59.30661646525065,59.774173736572266,7562158.0,,-0.004325530274068404,-0.0043162020579728235,0.11245369549746749,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-26,46.64853286743164,59.30343627929688,59.71374130249024,59.04580307006836,59.66603088378906,7319022.0,"vTv Therapeutics Shares Initiated With Buy Rating, $13 Target",0.00675779812736865,-0.004334912445162718,0.06506030723346642,"[{'label': 'neutral', 'score': 0.9998413324356079}, {'label': 'positive', 'score': 8.864000847097486e-05}, {'label': 'negative', 'score': 7.000322511885315e-05}]","(0.9998413324356079, 8.864000847097486e-05, 7.000322511885315e-05)",0.11747606834784459,8.864000847097486e-05,1,1,"[{'label': 'neutral', 'score': 0.9153177738189697}, {'label': 'positive', 'score': 0.0739043727517128}, {'label': 'negative', 'score': 0.010777833871543407}]","(0.9153177738189697, 0.0739043727517128, 0.010777833871543407)",0.7454522195083306,0.0739043727517128,0,1,"[{'label': 'positive', 'score': 0.99488765001297}, {'label': 'neutral', 'score': 0.004888699855655432}, {'label': 'negative', 'score': 0.00022361242736224085}]","(0.004888699855655432, 0.99488765001297, 0.00022361242736224085)",0.9995505780392558,0.99488765001297,0,0
2016-09-27,46.96375274658203,59.70419692993164,59.828243255615234,58.99809265136719,59.45610809326172,7693158.0,,0.01166697772047544,0.006735066562356382,0.07608525890959239,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-09-28,47.511695861816406,60.40076446533203,60.57251739501953,59.63740539550781,60.114505767822266,12361160.0,Merck Shares Indicated Up 1+% Premarket; Shares Could Be Higher Amid Positive Trial News from Incyte; Incyte Shares Up ~5% in Pre-Open,-0.02195892583021351,0.011599443310001914,0.12037385182527946,"[{'label': 'positive', 'score': 0.9996821880340576}, {'label': 'negative', 'score': 0.0001872306311270222}, {'label': 'neutral', 'score': 0.0001305559417232871}]","(0.0001305559417232871, 0.9996821880340576, 0.0001872306311270222)",0.9996254898337086,0.9996821880340576,0,0,"[{'label': 'positive', 'score': 0.9492156505584717}, {'label': 'neutral', 'score': 0.02848941646516323}, {'label': 'negative', 'score': 0.022294871509075165}]","(0.02848941646516323, 0.9492156505584717, 0.022294871509075165)",0.9541026658946983,0.9492156505584717,0,0,"[{'label': 'positive', 'score': 0.998568058013916}, {'label': 'neutral', 'score': 0.0011485721915960312}, {'label': 'negative', 'score': 0.00028340029530227184}]","(0.0011485721915960312, 0.998568058013916, 0.00028340029530227184)",0.9994325476667332,0.998568058013916,0,0
2016-09-29,46.468387603759766,59.07442855834961,60.13358688354492,58.74045944213867,60.13358688354492,11454640.0,,0.008076194205517277,-0.022203611700600402,0.20682273657405215,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-09-30,46.84368133544922,59.5515251159668,59.85686874389648,59.02671813964844,59.05534362792969,14258354.0,,0.0005875316081692004,0.008043756282035755,0.218295685245622,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-01,46.87120310465495,59.58651351928711,59.80597813924154,58.966285705566406,59.16030502319336,12132591.0,,0.000587186617471542,0.000587359079048091,0.2149545871125157,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-02,46.89872487386068,59.62150192260742,59.755087534586586,58.905853271484375,59.26526641845703,10006828.0,,0.0005868420316838481,0.0005870142908650073,0.20888023889221752,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-03,46.926246643066406,59.65649032592773,59.70419692993164,58.84542083740234,59.3702278137207,7881065.0,,-0.0009597411940754853,0.0005866699072354494,0.18238248913948307,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-04,46.88121032714844,59.59923553466797,60.06679534912109,59.10305404663086,59.61832046508789,8276475.0,,0.005443502008694293,-0.000960202040541114,0.05669021030795932,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-05,47.13640594482422,59.92366409301758,60.15267181396485,59.61832046508789,59.828243255615234,8249122.0,,-0.0022292842997310588,0.00542873969984202,0.038612456218858414,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-06,47.03133010864258,59.790077209472656,59.81870269775391,58.91221237182617,59.62786483764648,11979164.0,,0.0017554985737172227,-0.0022317728531254318,0.04610208781326734,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-07,47.1138916015625,59.89503860473633,60.10496139526367,59.18893051147461,59.89503860473633,11292410.0,Merck Animal Health Announces USDA Approval of Innovative Canine Flu Bivalent Vaccine,0.006000737739068631,0.0017539594870756656,0.04669106791570908,"[{'label': 'positive', 'score': 0.9972653388977051}, {'label': 'neutral', 'score': 0.0024680045899003744}, {'label': 'negative', 'score': 0.0002666998188942671}]","(0.0024680045899003744, 0.9972653388977051, 0.0002666998188942671)",0.9994652806956709,0.9972653388977051,0,0,"[{'label': 'positive', 'score': 0.7268475294113159}, {'label': 'neutral', 'score': 0.2520624101161957}, {'label': 'negative', 'score': 0.021090025082230568}]","(0.2520624101161957, 0.7268475294113159, 0.021090025082230568)",0.9436048505506283,0.7268475294113159,0,0,"[{'label': 'positive', 'score': 0.9513217806816101}, {'label': 'neutral', 'score': 0.04834940284490585}, {'label': 'negative', 'score': 0.000328872527461499}]","(0.04834940284490585, 0.9513217806816101, 0.000328872527461499)",0.9993088376993122,0.9513217806816101,0,0
2016-10-08,47.39660898844401,60.25445302327474,60.699745178222656,59.637404123942055,60.35305404663086,14635774.333333332,Exclusive: Interview With DelMar Pharmaceutical CEO Jeffrey Bacha,0.005964943676437892,0.005982805016313092,0.05851542841636284,"[{'label': 'neutral', 'score': 0.9998624324798584}, {'label': 'negative', 'score': 7.271461799973622e-05}, {'label': 'positive', 'score': 6.481524906121194e-05}]","(0.9998624324798584, 6.481524906121194e-05, 7.271461799973622e-05)",-0.057437479635049506,-7.271461799973622e-05,1,1,"[{'label': 'neutral', 'score': 0.9397183060646057}, {'label': 'positive', 'score': 0.03328317403793335}, {'label': 'negative', 'score': 0.026998478919267654}]","(0.9397183060646057, 0.03328317403793335, 0.026998478919267654)",0.10425552071585904,0.03328317403793335,1,1,"[{'label': 'neutral', 'score': 0.9994237422943115}, {'label': 'positive', 'score': 0.0004463494406081736}, {'label': 'negative', 'score': 0.00012999039608985186}]","(0.9994237422943115, 0.0004463494406081736, 0.00012999039608985186)",0.5489105981825073,0.0004463494406081736,0,1
2016-10-09,47.67932637532552,60.61386744181315,61.29452896118164,60.08587773640951,60.81106948852539,17979138.666666664,New Data on the Combination of Lilly's ALIMTA and Merck's KEYTRUDA Show a Near-Doubling of Objective Response Rate Compared to Standard of Care Alone in First-Line Metastatic NSCLC Presented at ESMO 2016 | Merck Announces Two Major Studies to Be Presented at ESMO 2016 Demonstrate Potential of KEYTRUDA for the First-Line Treatment of Metastatic NSLCL in a Broad Range of Patients | Merck Announces KEYTRUDA Showed Continued Overall Survival Benefit Compared to Chemotherapy with Longer Follow-Up in Patients with Previously Treated Metastatic NSCLC in Data to Be Presented at ESMO 2016 | Merck Presents Longer-Term Follow-Up of Overall Survival Data for KEYTRUDA in Patients with Advanced Melanoma from KEYNOTE-002 at ESMO 2016 | Merck Announces New KEYTRUDA Data in Advanced Urothelial Cancer Demonstrate Overall Response Rate of 24 Percent in Cisplatin-Ineligible Patients,0.005929574100900872,0.005947223830246975,0.05707017842046992,"[{'label': 'positive', 'score': 0.9995124340057373}, {'label': 'negative', 'score': 0.0002942451974377036}, {'label': 'neutral', 'score': 0.00019330701616127044}]","(0.00019330701616127044, 0.9995124340057373, 0.0002942451974377036)",0.9994113958156947,0.9995124340057373,0,0,"[{'label': 'positive', 'score': 0.9196434617042542}, {'label': 'neutral', 'score': 0.054558515548706055}, {'label': 'negative', 'score': 0.025798076763749123}]","(0.054558515548706055, 0.9196434617042542, 0.025798076763749123)",0.9454263945171006,0.9196434617042542,0,0,"[{'label': 'positive', 'score': 0.9969576597213745}, {'label': 'neutral', 'score': 0.0025874983984977007}, {'label': 'negative', 'score': 0.0004548144352156669}]","(0.0025874983984977007, 0.9969576597213745, 0.0004548144352156669)",0.99908801133533,0.9969576597213745,0,0
2016-10-10,47.96204376220703,60.97328186035156,61.88931274414063,60.53435134887695,61.26908493041992,21322503.0,The ESMO Conference Proves Its Ability To Move Stocks | Technical Alert: Merck Reaches Highest Level Since December 2001 | Bristol-Myers' Opdivo Vs. Merck's Keytruda In Front-Line Lung Treatment | SunTrust Cuts Target On Bristol-Myers As Opdivo Estimates Revised Lower,-0.030829440845657283,0.00591206336310699,0.05825612848930934,"[{'label': 'positive', 'score': 0.9994058609008789}, {'label': 'negative', 'score': 0.00037831428926438093}, {'label': 'neutral', 'score': 0.0002158094575861469}]","(0.0002158094575861469, 0.9994058609008789, 0.00037831428926438093)",0.9992432080870005,0.9994058609008789,0,0,"[{'label': 'positive', 'score': 0.6819406151771545}, {'label': 'negative', 'score': 0.29069122672080994}, {'label': 'neutral', 'score': 0.027368132025003433}]","(0.027368132025003433, 0.6819406151771545, 0.29069122672080994)",0.4022584616321756,0.6819406151771545,0,0,"[{'label': 'positive', 'score': 0.9968001842498779}, {'label': 'neutral', 'score': 0.0024284173268824816}, {'label': 'negative', 'score': 0.000771427876316011}]","(0.0024284173268824816, 0.9968001842498779, 0.000771427876316011)",0.9984533884746944,0.9968001842498779,0,0
2016-10-11,46.48339080810547,59.093509674072266,60.63931274414063,58.921756744384766,60.6202278137207,14625259.0,Technical Alert: Merck Surrenders Monday's Gains | Aetna and Merck Sign a Unique Value-Based Contract for Januvia and Janumet,-0.00435975474547849,-0.031314666941149386,0.25870279219086767,"[{'label': 'positive', 'score': 0.9993436932563782}, {'label': 'neutral', 'score': 0.00043028092477470636}, {'label': 'negative', 'score': 0.00022595658083446324}]","(0.00043028092477470636, 0.9993436932563782, 0.00022595658083446324)",0.9995478922736974,0.9993436932563782,0,0,"[{'label': 'positive', 'score': 0.9421533942222595}, {'label': 'neutral', 'score': 0.04305805638432503}, {'label': 'negative', 'score': 0.014788541942834854}]","(0.04305805638432503, 0.9421533942222595, 0.014788541942834854)",0.9690920809634505,0.9421533942222595,0,0,"[{'label': 'positive', 'score': 0.9848566651344299}, {'label': 'neutral', 'score': 0.008931196294724941}, {'label': 'negative', 'score': 0.00621213810518384}]","(0.008931196294724941, 0.9848566651344299, 0.00621213810518384)",0.9874637601650308,0.9848566651344299,0,0
2016-10-12,46.28074264526367,58.83587646484375,59.761451721191406,58.75954055786133,59.54198455810547,10607751.0,,0.013785287774374018,-0.004369286189459284,0.25623301601720155,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-13,46.91873550415039,59.64694595336914,60.06679534912109,59.10305404663086,59.39885330200195,15239492.0,"7 Biggest Price Target Changes For Thursday | Benzinga's Top Upgrades | A Peek Into The Markets: U.S. Stock Futures Tumble Ahead Of Jobless Claims Report | Bank of America Upgrades Merck & Company to Buy, Raises  Price Target to $70.00",-0.005919063264477453,0.013691134990242326,0.2791533990481449,"[{'label': 'positive', 'score': 0.9987493753433228}, {'label': 'negative', 'score': 0.0006778181996196508}, {'label': 'neutral', 'score': 0.0005728242103941739}]","(0.0005728242103941739, 0.9987493753433228, 0.0006778181996196508)",0.9986435866384288,0.9987493753433228,0,0,"[{'label': 'negative', 'score': 0.5164759159088135}, {'label': 'positive', 'score': 0.3178604543209076}, {'label': 'neutral', 'score': 0.16566361486911774}]","(0.16566361486911774, 0.3178604543209076, 0.5164759159088135)",-0.23805202394954966,-0.5164759159088135,1,0,"[{'label': 'positive', 'score': 0.9722962975502014}, {'label': 'neutral', 'score': 0.0249224454164505}, {'label': 'negative', 'score': 0.0027812051121145487}]","(0.0249224454164505, 0.9722962975502014, 0.0027812051121145487)",0.994295417329349,0.9722962975502014,0,0
2016-10-14,46.64103317260742,59.29389190673828,59.98091506958008,59.28435134887695,59.84732818603516,12790002.0,,-0.003325819385522138,-0.005936650353175743,0.27037848517962637,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-15,46.48591232299805,59.0966911315918,59.72328186035156,58.86132303873698,59.63422393798828,13087075.0,,-0.0033369173699991667,-0.003331362215861889,0.25572744399247344,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-16,46.33079147338867,58.89949035644531,59.46564865112305,58.43829472859701,59.421119689941406,13384148.0,,-0.0033480896685705343,-0.0033424972953909017,0.12844842629724337,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-17,46.1756706237793,58.70228958129883,59.20801544189453,58.01526641845703,59.20801544189453,13681221.0,,0.009265258827511771,-0.0033537070626489226,0.12679132208738772,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-18,46.603492736816406,59.24618148803711,59.75190734863281,58.99809265136719,59.064884185791016,10467424.0,,-0.0035432290361148595,0.009222599613597273,0.09548747196716352,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-19,46.43836975097656,59.036258697509766,59.446563720703125,58.97900772094727,59.28435134887695,5850670.0,"Fed Speakers And Beige Book, Bank Earnings, Rising Crude Take Center Stage | Roche Group, Competitor To Bristol-Myers And Merck, Has PDUFA DateFor Tecentriq Drug | Merck Announces Pivotal Phase 3 Study of Letermovir Met Primary Endpoint",0.0008081545096824431,-0.0035495211394216243,0.08958229108877377,"[{'label': 'neutral', 'score': 0.9969282746315002}, {'label': 'negative', 'score': 0.002342557068914175}, {'label': 'positive', 'score': 0.0007292642258107662}]","(0.9969282746315002, 0.0007292642258107662, 0.002342557068914175)",-0.5251909822598801,-0.002342557068914175,0,1,"[{'label': 'positive', 'score': 0.9013363718986511}, {'label': 'neutral', 'score': 0.08308897167444229}, {'label': 'negative', 'score': 0.015574617311358452}]","(0.08308897167444229, 0.9013363718986511, 0.015574617311358452)",0.966028071438478,0.9013363718986511,0,0,"[{'label': 'positive', 'score': 0.932644784450531}, {'label': 'neutral', 'score': 0.06534948945045471}, {'label': 'negative', 'score': 0.002005751710385084}]","(0.06534948945045471, 0.932644784450531, 0.002005751710385084)",0.995708017846705,0.932644784450531,0,0
2016-10-20,46.47589492797852,59.08396911621094,59.41793823242188,58.864505767822266,59.11259460449219,6626923.0,,-0.011627911481209166,0.0008078281286591236,0.08720813681761963,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-21,45.93547821044922,58.39694595336914,59.064884185791016,58.23473358154297,58.73091506958008,7762222.0,"Merck Has An Upcoming PDUFA Date For Bezlotoxumab | Are The Drugs Working? Pharma Giants Eli Lilly And Merck To Update Investors On Cancer Treatments | Merck Has An Oct 23rd Pdufa Date For Bezlotoxumab; Drug Won FDA Advisory Panel Backing In June | Jim Cramer Gives His Opinion On Merck And Smith & Wesson | Merck Reports KEYNOTE-045 Studying KEYTRUDA in Advanced Bladder Cancer Meets Primary Endpoint, Stops Early",-0.0024509840746132433,-0.011696044320649926,0.12081006694050636,"[{'label': 'neutral', 'score': 0.5922711491584778}, {'label': 'positive', 'score': 0.40680965781211853}, {'label': 'negative', 'score': 0.0009191895369440317}]","(0.5922711491584778, 0.40680965781211853, 0.0009191895369440317)",0.9954911724155877,0.40680965781211853,0,1,"[{'label': 'neutral', 'score': 0.7138774394989014}, {'label': 'positive', 'score': 0.2725001871585846}, {'label': 'negative', 'score': 0.013622359372675419}]","(0.7138774394989014, 0.2725001871585846, 0.013622359372675419)",0.9047795461222968,0.2725001871585846,0,1,"[{'label': 'positive', 'score': 0.9817445874214172}, {'label': 'neutral', 'score': 0.017341136932373047}, {'label': 'negative', 'score': 0.000914266100153327}]","(0.017341136932373047, 0.9817445874214172, 0.000914266100153327)",0.9981391993836378,0.9817445874214172,0,0
2016-10-22,45.82289250691732,58.25381596883138,58.931297302246094,58.110687255859375,58.68320592244466,8648236.0,,-0.0024570061575768126,-0.002453992653070854,0.12020798808902593,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-23,45.71030680338541,58.11068598429362,58.79771041870117,57.98664093017578,58.63549677530924,9534250.0,,-0.0024630579060182455,-0.002460029550551436,0.07412938183841832,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-24,45.59772109985352,57.96755599975586,58.66412353515625,57.86259460449219,58.58778762817383,10420264.0,Merck Reports FDA Approval Of KEYTRUDA | Big News Out Of Merck This Weekend,0.019753094381642564,-0.0024660962232018724,0.07482060114035385,"[{'label': 'neutral', 'score': 0.8971009254455566}, {'label': 'positive', 'score': 0.10248532146215439}, {'label': 'negative', 'score': 0.0004137899086344987}]","(0.8971009254455566, 0.10248532146215439, 0.0004137899086344987)",0.99195736672315,0.10248532146215439,1,0,"[{'label': 'neutral', 'score': 0.4592134356498718}, {'label': 'negative', 'score': 0.34900158643722534}, {'label': 'positive', 'score': 0.1917850375175476}]","(0.4592134356498718, 0.1917850375175476, 0.34900158643722534)",-0.29071826475653745,-0.34900158643722534,0,0,"[{'label': 'positive', 'score': 0.9936699271202087}, {'label': 'neutral', 'score': 0.006079840939491987}, {'label': 'negative', 'score': 0.00025025088689289987}]","(0.006079840939491987, 0.9936699271202087, 0.00025025088689289987)",0.9994964366506882,0.9936699271202087,1,1
2016-10-25,46.4984130859375,59.11259460449219,59.34160232543945,56.82251739501953,57.50954055786133,15917548.0,"Technical Alert: Merck Higher After Q3 Report | 6 Big Pharma Companies Left To Report September Quarterly Figures | Epic Earnings: Many US Companies Beating Expectations As Season Continues | The Market In 5 Minutes: UA, GM, P&G Earnings On The Street's Mind | A Peek Into The Markets: U.S. Stock Futures Rise; GM, Apple Earnings In Focus | Merck's Q3 Results, Guidance Look Strong | Merck Narrows and Raises Guidance; Sees FY EPS $3.71 to $3.78 vs $3.75 est, Revenue $39.7B to $40.2B vs $39.7B est | Merck Q3 EPS $1.07 vs $0.99 est, Revenue $10.54B vs $10.18B est | 12 Stocks You Should Be Watching Today | Earnings Scheduled For October 25, 2016",-0.017433388668000514,0.019560533662157667,0.18402116496438958,"[{'label': 'positive', 'score': 0.9995667338371277}, {'label': 'negative', 'score': 0.00024756338098086417}, {'label': 'neutral', 'score': 0.00018566536891739815}]","(0.00018566536891739815, 0.9995667338371277, 0.00024756338098086417)",0.9995047812745433,0.9995667338371277,0,0,"[{'label': 'positive', 'score': 0.8812820911407471}, {'label': 'negative', 'score': 0.0761275589466095}, {'label': 'neutral', 'score': 0.04259027913212776}]","(0.04259027913212776, 0.8812820911407471, 0.0761275589466095)",0.8409718161088863,0.8812820911407471,0,0,"[{'label': 'positive', 'score': 0.9794710278511047}, {'label': 'neutral', 'score': 0.01927758753299713}, {'label': 'negative', 'score': 0.0012514302507042885}]","(0.01927758753299713, 0.9794710278511047, 0.0012514302507042885)",0.9974479420954091,0.9794710278511047,0,0
2016-10-26,45.68778991699219,58.082061767578125,59.01717758178711,57.77671813964844,58.91221237182617,10435774.0,,0.006899904005447573,-0.017587139743503538,0.2106336764540776,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-27,46.003028869628906,58.48282241821289,59.21755599975586,58.20610809326172,58.34923553466797,10847534.0,,-0.03997385414744489,0.006876208602698642,0.21711818772470706,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-10-28,44.16410827636719,56.14503860473633,58.27289962768555,55.77289962768555,58.225189208984375,21335603.0,,-0.0006798212312720063,-0.040794759628049966,0.36997067027584357,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-29,44.13408788045248,56.10687001546224,57.66221364339193,55.74745432535807,57.611321767171226,19203412.0,,-0.0006802837025764325,-0.0006800524145066671,0.37152777632039435,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-30,44.10406748453776,56.06870142618815,57.05152765909831,55.7220090230306,56.99745432535807,17071221.0,,-0.00068074680353233,-0.0006805152005299181,0.3035685193465984,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-10-31,44.07404708862305,56.03053283691406,56.44084167480469,55.696563720703125,56.38358688354492,14939030.0,,0.00987740525166414,-0.0006809786168477073,0.30268509925266585,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-01,44.509376525878906,56.58396911621094,56.860687255859375,55.83015441894531,56.29771041870117,15036075.0,The Election Can't Come Soon Enough For Biotechs,-0.007757153100609527,0.009828942546959348,0.31191616694292973,"[{'label': 'neutral', 'score': 0.9995336532592773}, {'label': 'negative', 'score': 0.000410110893426463}, {'label': 'positive', 'score': 5.620665615424514e-05}]","(0.9995336532592773, 5.620665615424514e-05, 0.000410110893426463)",-0.7589339873449599,-0.000410110893426463,0,1,"[{'label': 'neutral', 'score': 0.902816891670227}, {'label': 'positive', 'score': 0.06150100380182266}, {'label': 'negative', 'score': 0.03568210080265999}]","(0.902816891670227, 0.06150100380182266, 0.03568210080265999)",0.2656727535536229,0.06150100380182266,1,1,"[{'label': 'neutral', 'score': 0.9977587461471558}, {'label': 'negative', 'score': 0.0016148529248312116}, {'label': 'positive', 'score': 0.0006263692048378289}]","(0.9977587461471558, 0.0006263692048378289, 0.0016148529248312116)",-0.44104674271592675,-0.0016148529248312116,1,1
2016-11-02,44.16410827636719,56.14503860473633,56.78435134887695,56.05915832519531,56.35496139526367,11239486.0,"Merck Reports Publishing of New Research on Early Development of Verubecestat, Says 'Results of First Phase 3 Trial Anticipated in Late 2017'",-0.0069680260713265345,-0.007787396315075075,0.09997189752537644,"[{'label': 'neutral', 'score': 0.9998669624328613}, {'label': 'positive', 'score': 7.983479008544236e-05}, {'label': 'negative', 'score': 5.3102223319001496e-05}]","(0.9998669624328613, 7.983479008544236e-05, 5.3102223319001496e-05)",0.20109197643180424,7.983479008544236e-05,1,1,"[{'label': 'neutral', 'score': 0.77418452501297}, {'label': 'positive', 'score': 0.2128884494304657}, {'label': 'negative', 'score': 0.012927073985338211}]","(0.77418452501297, 0.2128884494304657, 0.012927073985338211)",0.8855076587313705,0.2128884494304657,0,1,"[{'label': 'neutral', 'score': 0.9924145340919495}, {'label': 'positive', 'score': 0.00745041249319911}, {'label': 'negative', 'score': 0.00013505808601621538}]","(0.9924145340919495, 0.00745041249319911, 0.00013505808601621538)",0.9643903210471125,0.00745041249319911,0,1
2016-11-03,43.85637283325195,55.75381851196289,56.50763320922852,55.6202278137207,56.46946716308594,11866504.0,BZ NOTE Related to Traders Passing Around CNBC Story on New Cancer Drugs Possibly Damaging the Heart: NBC News via AP Published the Same Story ~7 p.m. EDT Wed. Evening | Traders Passing Around Recent CNBC Article on Cancer Treatments: 'New cancer drugs may damage the heart',0.006674613009217799,-0.006992416131410492,0.11199776991252482,"[{'label': 'neutral', 'score': 0.9707951545715332}, {'label': 'negative', 'score': 0.028917286545038223}, {'label': 'positive', 'score': 0.00028758469852618873}]","(0.9707951545715332, 0.00028758469852618873, 0.028917286545038223)",-0.9803057033788799,-0.028917286545038223,0,1,"[{'label': 'neutral', 'score': 0.9105275869369507}, {'label': 'negative', 'score': 0.048511046916246414}, {'label': 'positive', 'score': 0.040961336344480515}]","(0.9105275869369507, 0.040961336344480515, 0.048511046916246414)",-0.08438034504754022,-0.048511046916246414,1,1,"[{'label': 'neutral', 'score': 0.9867029190063477}, {'label': 'negative', 'score': 0.011541634798049927}, {'label': 'positive', 'score': 0.001755405217409134}]","(0.9867029190063477, 0.001755405217409134, 0.011541634798049927)",-0.7359705294759871,-0.011541634798049927,0,1
2016-11-04,44.14910125732422,56.125953674316406,56.55534362792969,55.92557144165039,56.00190734863281,11861893.0,,0.00697041811724654,0.006652436405279479,0.12566351530388903,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-05,44.45683924357096,56.5171750386556,56.85432561238607,56.20228958129883,56.26590220133463,11568348.0,,0.006922167714002113,0.006946237055924386,0.13368884219160482,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-06,44.76457722981771,56.90839640299479,57.153307596842446,56.47900772094727,56.52989705403646,11274803.0,,0.0068745807133410485,0.006898319502035854,0.12375299552677145,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-07,45.07231521606445,57.299617767333984,57.45228958129883,56.7557258605957,56.79389190673828,10981258.0,,0.0076602694499096615,0.006851058525269337,0.098195232491268,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-08,45.417579650878906,57.738548278808594,57.99618148803711,56.79389190673828,57.08015441894531,8323321.0,,0.060651181363618765,0.007631078564477393,0.005909851564293598,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-11-09,48.17221450805664,61.24045944213867,62.02289962768555,59.88549423217773,61.03053283691406,29187953.0,"Technical Alert: Merck Reaches $65 And Retreats | Stocks Hitting 52-Week Highs | Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5% | Biotech Is Getting A Big Boost Following Clinton's Loss",0.012153307571238968,0.058883041546584865,0.36778809137154356,"[{'label': 'positive', 'score': 0.9995030164718628}, {'label': 'negative', 'score': 0.0002602982858661562}, {'label': 'neutral', 'score': 0.00023662576859351248}]","(0.00023662576859351248, 0.9995030164718628, 0.0002602982858661562)",0.9994792801815713,0.9995030164718628,0,0,"[{'label': 'positive', 'score': 0.9339470863342285}, {'label': 'neutral', 'score': 0.040351368486881256}, {'label': 'negative', 'score': 0.02570158988237381}]","(0.040351368486881256, 0.9339470863342285, 0.02570158988237381)",0.9464354184623025,0.9339470863342285,0,0,"[{'label': 'positive', 'score': 0.9883362650871277}, {'label': 'neutral', 'score': 0.010738263837993145}, {'label': 'negative', 'score': 0.0009255046606995165}]","(0.010738263837993145, 0.9883362650871277, 0.0009255046606995165)",0.9981288983583477,0.9883362650871277,0,0
2016-11-10,48.75765609741211,61.98473358154297,62.46183013916016,61.564884185791016,61.58396911621094,18719690.0,2 Big Medical Marijuana Stocks Riding High Post-Election,-0.015548042990656737,0.012080049086768891,0.3602876150917479,"[{'label': 'neutral', 'score': 0.9983950257301331}, {'label': 'positive', 'score': 0.0014644069597125053}, {'label': 'negative', 'score': 0.00014051776088308543}]","(0.9983950257301331, 0.0014644069597125053, 0.00014051776088308543)",0.8248917733276125,0.0014644069597125053,0,1,"[{'label': 'positive', 'score': 0.8505440354347229}, {'label': 'neutral', 'score': 0.11073824763298035}, {'label': 'negative', 'score': 0.03871771693229675}]","(0.11073824763298035, 0.8505440354347229, 0.03871771693229675)",0.9129216637750613,0.8505440354347229,0,0,"[{'label': 'neutral', 'score': 0.5839431881904602}, {'label': 'positive', 'score': 0.4145084619522095}, {'label': 'negative', 'score': 0.0015483640599995852}]","(0.5839431881904602, 0.4145084619522095, 0.0015483640599995852)",0.9925569587460432,0.4145084619522095,0,1
2016-11-11,47.99956512451172,61.020992279052734,61.55534362792969,60.66793823242188,61.14503860473633,14734566.0,Technical Alert - Merck Lower,-0.002189216368356854,-0.01567018147474854,0.43402728399029644,"[{'label': 'neutral', 'score': 0.9996343851089478}, {'label': 'negative', 'score': 0.0003139353066217154}, {'label': 'positive', 'score': 5.169141877559014e-05}]","(0.9996343851089478, 5.169141877559014e-05, 0.0003139353066217154)",-0.7172448555590676,-0.0003139353066217154,0,1,"[{'label': 'neutral', 'score': 0.8131935000419617}, {'label': 'negative', 'score': 0.11394639313220978}, {'label': 'positive', 'score': 0.07286016643047333}]","(0.8131935000419617, 0.07286016643047333, 0.11394639313220978)",-0.2199399571295564,-0.11394639313220978,1,1,"[{'label': 'negative', 'score': 0.6577255725860596}, {'label': 'neutral', 'score': 0.33954542875289917}, {'label': 'positive', 'score': 0.0027290317229926586}]","(0.33954542875289917, 0.0027290317229926586, 0.6577255725860596)",-0.9917358991664607,-0.6577255725860596,0,0
2016-11-12,47.89448801676432,60.887404123942055,61.42175547281901,60.55979537963867,61.11959330240885,13359869.333333334,Merck Announes KEYTRUDA Significantly Improves Overall Survival Compared to Chemotherapy in Previously Treated Patients with Advanced Bladder Cancer | Merck Presents New Findings for ZEPATIER in Patients with Chronic Hepatitis C at The Liver Meeting,-0.002194019551872191,-0.002191616205659097,0.4478782956650677,"[{'label': 'positive', 'score': 0.9995998740196228}, {'label': 'negative', 'score': 0.00023329505347646773}, {'label': 'neutral', 'score': 0.00016687082825228572}]","(0.00016687082825228572, 0.9995998740196228, 0.00023329505347646773)",0.9995333320383984,0.9995998740196228,0,0,"[{'label': 'positive', 'score': 0.9487975835800171}, {'label': 'neutral', 'score': 0.027018673717975616}, {'label': 'negative', 'score': 0.024183794856071472}]","(0.027018673717975616, 0.9487975835800171, 0.024183794856071472)",0.9502892955773871,0.9487975835800171,0,0,"[{'label': 'positive', 'score': 0.9984250068664551}, {'label': 'neutral', 'score': 0.001253193593584001}, {'label': 'negative', 'score': 0.00032176298554986715}]","(0.001253193593584001, 0.9984250068664551, 0.00032176298554986715)",0.9993556665307712,0.9984250068664551,0,0
2016-11-13,47.78941090901693,60.75381596883138,61.288167317708336,60.45165252685547,61.09414800008138,11985172.666666668,"Merck Announces Findings for Investigational Triple-Combination Chronic Hepatitis C Therapy Showing High Rates of Sustained Virologic Response in People with Genotypes 1, 2 or 3 Infection",-0.0021988438582889076,-0.002196429939038893,0.4594059829924791,"[{'label': 'negative', 'score': 0.9828577041625977}, {'label': 'positive', 'score': 0.013648048043251038}, {'label': 'neutral', 'score': 0.0034941781777888536}]","(0.0034941781777888536, 0.013648048043251038, 0.9828577041625977)",-0.9726081901423249,-0.9828577041625977,0,0,"[{'label': 'positive', 'score': 0.8495259284973145}, {'label': 'neutral', 'score': 0.10494529455900192}, {'label': 'negative', 'score': 0.04552879557013512}]","(0.10494529455900192, 0.8495259284973145, 0.04552879557013512)",0.8982658951550226,0.8495259284973145,0,0,"[{'label': 'positive', 'score': 0.9924669861793518}, {'label': 'neutral', 'score': 0.007161261513829231}, {'label': 'negative', 'score': 0.0003717832441907376}]","(0.007161261513829231, 0.9924669861793518, 0.0003717832441907376)",0.9992510702530149,0.9924669861793518,0,0
2016-11-14,47.68433380126953,60.6202278137207,61.154579162597656,60.343509674072266,61.06870269775391,10610476.0,Gilead Responds To CMS Blog Highlighting High Cost Of Harvoni: Most Payers Receive Substantial Discounts Off The List Price,0.0018889036209848841,-0.002201264865040459,0.15578688587939907,"[{'label': 'positive', 'score': 0.9992753863334656}, {'label': 'neutral', 'score': 0.0004090635047759861}, {'label': 'negative', 'score': 0.00031560289789922535}]","(0.0004090635047759861, 0.9992753863334656, 0.00031560289789922535)",0.9993685359285963,0.9992753863334656,0,0,"[{'label': 'negative', 'score': 0.7726037502288818}, {'label': 'neutral', 'score': 0.17291206121444702}, {'label': 'positive', 'score': 0.054484155029058456}]","(0.17291206121444702, 0.054484155029058456, 0.7726037502288818)",-0.868250630476656,-0.7726037502288818,0,0,"[{'label': 'positive', 'score': 0.7785841822624207}, {'label': 'neutral', 'score': 0.2204810529947281}, {'label': 'negative', 'score': 0.0009347675368189812}]","(0.2204810529947281, 0.7785841822624207, 0.0009347675368189812)",0.9976016810442909,0.7785841822624207,0,0
2016-11-15,47.7744026184082,60.73473358154297,60.81106948852539,60.19084167480469,60.76335906982422,7640339.0,,-0.016025127681589747,0.0018871218858712503,0.10666150610708806,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-11-16,47.00881576538086,59.761451721191406,61.020992279052734,59.58969497680664,60.78244400024414,11297650.0,Vetr Opts To Hold On Merck Despite Biotech Optimism,0.0011176357417727162,-0.016154918517717665,0.10998522106978616,"[{'label': 'positive', 'score': 0.9961316585540771}, {'label': 'neutral', 'score': 0.0034385849721729755}, {'label': 'negative', 'score': 0.00042973802192136645}]","(0.0034385849721729755, 0.9961316585540771, 0.00042973802192136645)",0.9991375583613857,0.9961316585540771,0,0,"[{'label': 'neutral', 'score': 0.8241338729858398}, {'label': 'positive', 'score': 0.1637827754020691}, {'label': 'negative', 'score': 0.012083394452929497}]","(0.8241338729858398, 0.1637827754020691, 0.012083394452929497)",0.8625842086298663,0.1637827754020691,0,1,"[{'label': 'positive', 'score': 0.6925784945487976}, {'label': 'neutral', 'score': 0.3055291175842285}, {'label': 'negative', 'score': 0.001892324653454125}]","(0.3055291175842285, 0.6925784945487976, 0.001892324653454125)",0.9945503119753026,0.6925784945487976,0,0
2016-11-17,47.06135559082031,59.828243255615234,59.91412353515625,59.274810791015625,59.64694595336914,8762642.0,,-0.013237636858594144,0.001117011651907315,0.11607684478617618,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-18,46.43836975097656,59.036258697509766,59.75190734863281,58.90267181396485,59.70419692993164,8066351.0,,0.002316683747952717,-0.01332603536499088,0.1336979965516751,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-19,46.54595565795898,59.17302703857422,59.67875289916992,58.89949162801107,59.50381596883138,7765854.666666667,,0.002311329129322646,0.0023140043735361973,0.1446149012682203,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-20,46.653541564941406,59.30979537963867,59.60559844970703,58.89631144205729,59.30343500773112,7465358.333333333,,0.002305999206185195,0.002308662116922337,0.14587438216960608,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-21,46.76112747192383,59.446563720703125,59.53244400024414,58.89313125610352,59.10305404663086,7164862.0,,-0.009630790397059346,0.0023033444704446946,0.10918812096694168,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-22,46.31076431274414,58.8740463256836,59.78053283691406,58.40649032592773,59.63740539550781,10052626.0,"Merck Increases Qtr. Dividend From $0.46 To $0.47/Share | QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck KGaA, Darmstadt, Germany, and Pfizer to Generate Real World Insights On Usage of Anti-Cancer Therapies Across Europe",-0.0009724314895193244,-0.009677466385093283,0.12181276612289349,"[{'label': 'positive', 'score': 0.9994780421257019}, {'label': 'neutral', 'score': 0.00033544201869517565}, {'label': 'negative', 'score': 0.00018656488100532442}]","(0.00033544201869517565, 0.9994780421257019, 0.00018656488100532442)",0.9996267450508947,0.9994780421257019,0,0,"[{'label': 'positive', 'score': 0.9315072894096375}, {'label': 'neutral', 'score': 0.058539699763059616}, {'label': 'negative', 'score': 0.009953021071851254}]","(0.058539699763059616, 0.9315072894096375, 0.009953021071851254)",0.9788562067650818,0.9315072894096375,0,0,"[{'label': 'positive', 'score': 0.9988466501235962}, {'label': 'neutral', 'score': 0.0008785797981545329}, {'label': 'negative', 'score': 0.0002748074184637517}]","(0.0008785797981545329, 0.9988466501235962, 0.0002748074184637517)",0.9994499018785168,0.9988466501235962,0,0
2016-11-23,46.26573944091797,58.81679534912109,58.8740463256836,57.08015441894531,57.56679534912109,9588152.0,,0.004623610513883916,-0.0009729046077618003,0.08241593653657377,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-24,46.47965240478516,59.08874130249024,59.20801544189453,58.00095558166504,58.27767181396485,6628757.0,,0.004602331127295017,0.004612954460461058,0.0891337027053747,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-25,46.69356536865234,59.360687255859375,59.54198455810547,58.921756744384766,58.988548278808594,3669362.0,,-0.0021968528940553332,0.004591772784325185,0.09462388240349143,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-26,46.59098561604818,59.23028055826823,59.433841705322266,58.8804079691569,58.97582626342773,5048565.0,,-0.0022016896824058186,-0.00219926951533075,0.09362707931380126,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-27,46.48840586344401,59.099873860677086,59.32569885253906,58.83905919392904,58.96310424804688,6427768.0,,-0.002206547815966086,-0.002204116964537124,0.05616626727197082,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-11-28,46.38582611083984,58.96946716308594,59.21755599975586,58.79771041870117,58.950382232666016,7806971.0,FDA Grants Priority Review to Merck's Supplemental Biologics License Application (sBLA) Seeking Approval for KEYTRUDA for New Indication in Microsatellite Instability-High Cancer,0.0063106414260847695,-0.0022089858296542404,0.059181371297751084,"[{'label': 'positive', 'score': 0.9987131357192993}, {'label': 'neutral', 'score': 0.0009830656927078962}, {'label': 'negative', 'score': 0.00030385347781702876}]","(0.0009830656927078962, 0.9987131357192993, 0.00030385347781702876)",0.9993916950740522,0.9987131357192993,0,0,"[{'label': 'positive', 'score': 0.8847028017044067}, {'label': 'neutral', 'score': 0.10145631432533264}, {'label': 'negative', 'score': 0.01384093426167965}]","(0.10145631432533264, 0.8847028017044067, 0.01384093426167965)",0.9691925196121961,0.8847028017044067,0,0,"[{'label': 'positive', 'score': 0.9778359532356262}, {'label': 'neutral', 'score': 0.021775173023343086}, {'label': 'negative', 'score': 0.0003888911160174757}]","(0.021775173023343086, 0.9778359532356262, 0.0003888911160174757)",0.9992049044383549,0.9778359532356262,0,0
2016-11-29,46.678558349609375,59.34160232543945,59.59923553466797,59.08396911621094,59.11259460449219,10516575.0,,-0.0160797297770738,0.006290812706052027,0.06715606098211181,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-11-30,45.927978515625,58.38740539550781,59.46564865112305,58.196563720703125,59.45610809326172,13132174.0,,-0.007027286456968119,-0.016210411408896442,0.12854065663103834,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-01,45.60523223876953,57.97710037231445,58.55915832519531,57.87213516235352,58.49236679077149,8802047.0,"CNBC's Meg Tirrell Tweets: $MRK CEO: We are now at the equivalent stage in immunotherapy where we were w first effective treatments for HIV #ForbesHealth | Forbes Healthcare Summit Concludes Today; Presenters Include Express Scripts, Allergan, IBM, Bristol-Myers Squibb, Merck, Anthem, Eli Lilly, And Regeneron | FDA Grants Priority Review to Supplemental Biologics License Application for Merck's KEYTRUDA in Relapsed or Refractory Classical Hodgkin Lymphoma",0.006089543015494643,-0.00705209412314239,0.13050922488805702,"[{'label': 'neutral', 'score': 0.9968681931495667}, {'label': 'positive', 'score': 0.0030478413682430983}, {'label': 'negative', 'score': 8.399035141337663e-05}]","(0.9968681931495667, 0.0030478413682430983, 8.399035141337663e-05)",0.9463634326926165,0.0030478413682430983,0,1,"[{'label': 'positive', 'score': 0.5037661194801331}, {'label': 'neutral', 'score': 0.48497432470321655}, {'label': 'negative', 'score': 0.011259585618972778}]","(0.48497432470321655, 0.5037661194801331, 0.011259585618972778)",0.956275636312925,0.5037661194801331,0,0,"[{'label': 'neutral', 'score': 0.9231554865837097}, {'label': 'positive', 'score': 0.0755784884095192}, {'label': 'negative', 'score': 0.0012660268694162369}]","(0.9231554865837097, 0.0755784884095192, 0.0012660268694162369)",0.967049649156593,0.0755784884095192,0,1
2016-12-02,45.88294982910156,58.33015441894531,58.70228958129883,57.85305404663086,58.25381851196289,8376769.0,,-0.00479851850882983,0.00607107667820911,0.15048352154607106,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-03,45.66277694702149,58.0502560933431,58.7054697672526,57.6017812093099,58.4033088684082,10120676.0,,-0.004821655311083383,-0.004810068361704109,0.1511652881395882,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-04,45.442604064941406,57.77035776774088,58.70864995320638,57.35050837198893,58.55279922485352,11864583.0,,-0.004845016309705236,-0.004833316991890406,0.12596091935904952,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-05,45.22243118286133,57.49045944213867,58.71183013916016,57.09923553466797,58.70228958129883,13608490.0,"Pressure Biosciences CEO On Biological Samples: It's All About How You Break Open A Cell | Merck Says Will Present Updated KEYTRUDA Findings at ASH: Data Showed KEYNOTE-013 Overall Response Rate of 41%, with 86% of Responses Ongoing at the Time of Analysis | Biothera, Merck Further Expand Research Collaboration to Include Phase 2 Clinical Trial in Head and Neck Cancer",0.0004979171945922636,-0.004856791450454566,0.08276948553085073,"[{'label': 'neutral', 'score': 0.9974462985992432}, {'label': 'positive', 'score': 0.002496176864951849}, {'label': 'negative', 'score': 5.754219455411658e-05}]","(0.9974462985992432, 0.002496176864951849, 5.754219455411658e-05)",0.9549345928715836,0.002496176864951849,0,1,"[{'label': 'positive', 'score': 0.8034728169441223}, {'label': 'neutral', 'score': 0.18778684735298157}, {'label': 'negative', 'score': 0.008740303106606007}]","(0.18778684735298157, 0.8034728169441223, 0.008740303106606007)",0.9784778086173734,0.8034728169441223,0,0,"[{'label': 'positive', 'score': 0.7132667303085327}, {'label': 'neutral', 'score': 0.2847651541233063}, {'label': 'negative', 'score': 0.0019681344274431467}]","(0.2847651541233063, 0.7132667303085327, 0.0019681344274431467)",0.9944965366637443,0.7132667303085327,0,0
2016-12-06,45.24494552612305,57.51908493041992,57.6240463256836,56.8797721862793,57.42366409301758,11171261.0,Merck KEYTRUDA Findings Show ORR Of 33.3% and 20% In Small Cell Lung Cancer and Malignant Pleural Mesothelioma Respectively In KEYNOTE-028 | Merck Announces KEYTRUDA Treatment Results in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) Presented at ASH 2016,-0.0036496861081596623,0.0004977932749586814,0.07720413877918984,"[{'label': 'neutral', 'score': 0.9998767375946045}, {'label': 'negative', 'score': 6.698272773064673e-05}, {'label': 'positive', 'score': 5.6256958487210795e-05}]","(0.9998767375946045, 5.6256958487210795e-05, 6.698272773064673e-05)",-0.08703177988034963,-6.698272773064673e-05,1,1,"[{'label': 'positive', 'score': 0.5317950248718262}, {'label': 'neutral', 'score': 0.3389251232147217}, {'label': 'negative', 'score': 0.12927986681461334}]","(0.3389251232147217, 0.5317950248718262, 0.12927986681461334)",0.6088798154629256,0.5317950248718262,0,0,"[{'label': 'neutral', 'score': 0.995172917842865}, {'label': 'positive', 'score': 0.0038690660148859024}, {'label': 'negative', 'score': 0.0009580061887390912}]","(0.995172917842865, 0.0038690660148859024, 0.0009580061887390912)",0.6030694597774379,0.0038690660148859024,0,1
2016-12-07,45.0798225402832,57.30915832519531,57.30915832519531,55.93511581420898,56.96564865112305,14723981.0,"Merck Canada Says Zostavax II Showed Vaccine Effectiveness Against Shingles In Observational Effectiveness Study | What If Trump Keeps Badmouthing Drug Pricing? | Technical Alert: Merck Lower | Pfizer, J&J, Other Big Pharma Names Dip Lower Just After the Open | Merck Announces KEYTRUDA Demonstrated Improved Health-Related Quality of Life vs Chemotherapy in First-Line Treatment of Patients with Metastatic NSCLC at WCLC 2016",0.0009990513372204633,-0.0036563624618507783,0.036663460894970294,"[{'label': 'positive', 'score': 0.9784024357795715}, {'label': 'negative', 'score': 0.020893190056085587}, {'label': 'neutral', 'score': 0.000704438250977546}]","(0.000704438250977546, 0.9784024357795715, 0.020893190056085587)",0.9581841658946245,0.9784024357795715,0,0,"[{'label': 'positive', 'score': 0.6443436741828918}, {'label': 'negative', 'score': 0.31827545166015625}, {'label': 'neutral', 'score': 0.037380822002887726}]","(0.037380822002887726, 0.6443436741828918, 0.31827545166015625)",0.338730255579713,0.6443436741828918,1,0,"[{'label': 'positive', 'score': 0.9726224541664124}, {'label': 'neutral', 'score': 0.019240006804466248}, {'label': 'negative', 'score': 0.008137522265315056}]","(0.019240006804466248, 0.9726224541664124, 0.008137522265315056)",0.9834056803685616,0.9726224541664124,0,0
2016-12-08,45.12485504150391,57.36641311645508,57.59542083740234,56.774810791015625,56.9942741394043,8998757.0,,0.018463039044208637,0.0009985526175699622,0.045925211697664704,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-12-09,45.95800018310547,58.42557144165039,58.6927490234375,57.63358688354492,57.71946716308594,11021187.0,"European Crohn's, Colitis Organisation Issues New Statement Support a Switch to Biosimilar from Reference Product in Inflammatory Bowel Disease",0.0026675523685724773,0.018294666428015856,0.14795243951005452,"[{'label': 'neutral', 'score': 0.9505802989006042}, {'label': 'positive', 'score': 0.04879213869571686}, {'label': 'negative', 'score': 0.0006275068153627217}]","(0.9505802989006042, 0.04879213869571686, 0.0006275068153627217)",0.974604964933549,0.04879213869571686,0,1,"[{'label': 'neutral', 'score': 0.6244624257087708}, {'label': 'positive', 'score': 0.35474714636802673}, {'label': 'negative', 'score': 0.020790424197912216}]","(0.6244624257087708, 0.35474714636802673, 0.020790424197912216)",0.8892764621841653,0.35474714636802673,0,1,"[{'label': 'neutral', 'score': 0.9392733573913574}, {'label': 'positive', 'score': 0.060399334877729416}, {'label': 'negative', 'score': 0.0003273255715612322}]","(0.9392733573913574, 0.060399334877729416, 0.0003273255715612322)",0.9892197078140148,0.060399334877729416,0,1
2016-12-10,46.08059565226237,58.581424713134766,58.8804079691569,57.919846852620445,58.021629333496094,10228060.666666666,,0.00266045546429721,0.0026640007654091203,0.1341672418870887,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-11,46.20319112141927,58.73727798461914,59.068066914876304,58.20610682169596,58.32379150390625,9434934.333333334,,0.0026533962218200447,0.002656922717082415,0.13171330456225167,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-12,46.32578659057617,58.89313125610352,59.2557258605957,58.49236679077149,58.625953674316406,8641808.0,"10 Notable Stocks Trading Ex-Dividend Tuesday, December 13 | Merck Reports New KEYTRUDA Data In Combination With HALAVEN For Metastatic Triple-Negative Breast Cancer",0.0011341141657652807,0.002649882180787979,0.11452897248371965,"[{'label': 'neutral', 'score': 0.9991100430488586}, {'label': 'positive', 'score': 0.0007934290915727615}, {'label': 'negative', 'score': 9.652521839598194e-05}]","(0.9991100430488586, 0.0007934290915727615, 9.652521839598194e-05)",0.7830782607269534,0.0007934290915727615,0,1,"[{'label': 'positive', 'score': 0.894146203994751}, {'label': 'neutral', 'score': 0.060971084982156754}, {'label': 'negative', 'score': 0.044882673770189285}]","(0.060971084982156754, 0.894146203994751, 0.044882673770189285)",0.9044061906231932,0.894146203994751,0,0,"[{'label': 'neutral', 'score': 0.9983643889427185}, {'label': 'positive', 'score': 0.0014658113941550255}, {'label': 'negative', 'score': 0.00016985955880954862}]","(0.9983643889427185, 0.0014658113941550255, 0.00016985955880954862)",0.7923059543220641,0.0014658113941550255,0,1
2016-12-13,46.73420715332031,58.959922790527344,59.12213516235352,58.44465637207031,58.96946716308594,8218626.0,,0.0001618789867229469,0.0011334715441197421,0.11420193362876041,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-14,46.74176788330078,58.96946716308594,59.88549423217773,58.76908493041992,59.01717758178711,11612574.0,,0.009223279993934725,0.0001618658857337004,0.01830168066436966,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-12-15,47.17288589477539,59.51335906982422,59.770992279052734,59.00763320922852,59.16030502319336,8917851.0,Gilead To Pay Merck $2.54B In Hep. C Royalties,0.0011223589151256933,0.00918100528915528,0.056047006849063226,"[{'label': 'neutral', 'score': 0.9996873140335083}, {'label': 'negative', 'score': 0.00022180235828272998}, {'label': 'positive', 'score': 9.098774171434343e-05}]","(0.9996873140335083, 9.098774171434343e-05, 0.00022180235828272998)",-0.4182185323947609,-0.00022180235828272998,1,1,"[{'label': 'neutral', 'score': 0.8922550082206726}, {'label': 'positive', 'score': 0.09597719460725784}, {'label': 'negative', 'score': 0.011767785996198654}]","(0.8922550082206726, 0.09597719460725784, 0.011767785996198654)",0.7815622420591695,0.09597719460725784,0,1,"[{'label': 'neutral', 'score': 0.9973338842391968}, {'label': 'positive', 'score': 0.002513088984414935}, {'label': 'negative', 'score': 0.00015304259432014078}]","(0.9973338842391968, 0.002513088984414935, 0.00015304259432014078)",0.8851950177247062,0.002513088984414935,0,1
2016-12-16,47.225830078125,59.58015441894531,60.14313125610352,59.20801544189453,59.790077209472656,18406758.0,European Medicines Agency's CHMP Recommends Merck's KEYTRUDA For First-Line Treatment Of Patients With NSCLC,-0.006940003508641631,0.0011217295412367509,0.05793713027652526,"[{'label': 'neutral', 'score': 0.7817655205726624}, {'label': 'positive', 'score': 0.21549880504608154}, {'label': 'negative', 'score': 0.0027357020881026983}]","(0.7817655205726624, 0.21549880504608154, 0.0027357020881026983)",0.974928785332554,0.21549880504608154,0,1,"[{'label': 'neutral', 'score': 0.6741094589233398}, {'label': 'positive', 'score': 0.3118242025375366}, {'label': 'negative', 'score': 0.014066305011510849}]","(0.6741094589233398, 0.3118242025375366, 0.014066305011510849)",0.9136746564525582,0.3118242025375366,0,1,"[{'label': 'neutral', 'score': 0.9924506545066833}, {'label': 'positive', 'score': 0.007350682746618986}, {'label': 'negative', 'score': 0.00019866290676873177}]","(0.9924506545066833, 0.007350682746618986, 0.00019866290676873177)",0.94736950302982,0.007350682746618986,0,1
2016-12-17,46.89808654785156,59.16666793823242,59.90140024820963,58.83269755045573,59.51654052734375,16441862.666666666,,-0.006988503749181103,-0.006964197334794752,0.09086875954241358,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-18,46.570343017578125,58.75318145751953,59.65966924031576,58.45737965901693,59.24300384521485,14476967.333333334,,-0.0070376866487111825,-0.007013037712118894,0.10672297116716979,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-19,46.24259948730469,58.33969497680664,59.41793823242188,58.082061767578125,58.96946716308594,12512072.0,"Jefferies' 2017 Global Pharma Outlook | Jefferies' Huge Pharma Pair Trade: Bristol-Myers Upgraded To Buy, Merck Downgraded To Sell | Benzinga's Top Upgrades, Downgrades For December 19, 2016 | A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Yellen Speech | Merck Gets Approval for KEYTRUDA in Japan | Jefferies Downgrades Merck & Co to Underperform, Lowers Target to $48.00",-0.010467782803837951,-0.007062567972087378,0.11503674847504596,"[{'label': 'positive', 'score': 0.9958076477050781}, {'label': 'negative', 'score': 0.0038122020196169615}, {'label': 'neutral', 'score': 0.00038011977449059486}]","(0.00038011977449059486, 0.9958076477050781, 0.0038122020196169615)",0.9923726964392177,0.9958076477050781,0,0,"[{'label': 'positive', 'score': 0.755886435508728}, {'label': 'negative', 'score': 0.1921541839838028}, {'label': 'neutral', 'score': 0.051959387958049774}]","(0.051959387958049774, 0.755886435508728, 0.1921541839838028)",0.5946287953639381,0.755886435508728,0,0,"[{'label': 'neutral', 'score': 0.5897427201271057}, {'label': 'positive', 'score': 0.3507779538631439}, {'label': 'negative', 'score': 0.05947937071323395}]","(0.5897427201271057, 0.3507779538631439, 0.05947937071323395)",0.7100387139966314,0.3507779538631439,0,1
2016-12-20,45.75852584838867,57.72900772094727,58.85496139526367,57.60496139526367,58.38740539550781,10875201.0,What Does Biogen's New CEO Mean For The Buyout Argument?,-0.01768594887319134,-0.01052295540319274,0.06838128690168573,"[{'label': 'neutral', 'score': 0.9997414946556091}, {'label': 'positive', 'score': 0.00019111148139927536}, {'label': 'negative', 'score': 6.728724838467315e-05}]","(0.9997414946556091, 0.00019111148139927536, 6.728724838467315e-05)",0.47919830379249045,0.00019111148139927536,0,0,"[{'label': 'neutral', 'score': 0.9144743084907532}, {'label': 'negative', 'score': 0.05164066702127457}, {'label': 'positive', 'score': 0.03388505056500435}]","(0.9144743084907532, 0.03388505056500435, 0.05164066702127457)",-0.20760558294478187,-0.05164066702127457,0,0,"[{'label': 'neutral', 'score': 0.983956515789032}, {'label': 'negative', 'score': 0.013048556633293629}, {'label': 'positive', 'score': 0.002994950395077467}]","(0.983956515789032, 0.002994950395077467, 0.013048556633293629)",-0.626646419666069,-0.013048556633293629,1,0
2016-12-21,44.94924545288086,56.70801544189453,58.024810791015625,56.62213516235352,57.814884185791016,12630706.0,,0.0025240039699533138,-0.01784421409046738,0.07466985682573281,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-22,45.06269073486328,56.85114669799805,57.25190734863281,56.450382232666016,56.88931274414063,10584800.0,"Meet The New Dogs: 2017's Dogs Of The Dow Include Coca-Cola, Boeing",-0.00033570000832707793,0.0025208240216106088,0.11660289290597631,"[{'label': 'neutral', 'score': 0.9998953342437744}, {'label': 'negative', 'score': 6.271618622122332e-05}, {'label': 'positive', 'score': 4.191806146991439e-05}]","(0.9998953342437744, 4.191806146991439e-05, 6.271618622122332e-05)",-0.19876976430032178,-6.271618622122332e-05,1,1,"[{'label': 'neutral', 'score': 0.9018736481666565}, {'label': 'positive', 'score': 0.0858791396021843}, {'label': 'negative', 'score': 0.01224726252257824}]","(0.9018736481666565, 0.0858791396021843, 0.01224726252257824)",0.7503778339491854,0.0858791396021843,0,1,"[{'label': 'neutral', 'score': 0.9993742108345032}, {'label': 'positive', 'score': 0.000526398653164506}, {'label': 'negative', 'score': 9.939618757925928e-05}]","(0.9993742108345032, 0.000526398653164506, 9.939618757925928e-05)",0.6823361871723786,0.000526398653164506,0,1
2016-12-23,45.04758071899414,56.832061767578125,57.11832046508789,56.536258697509766,57.03244400024414,7955892.0,"NewLink CFO: 'Ebola Vaccine Highly Unlikely To Drive Future Profit In Company' | Where Does Merck's Ebola Vaccine Breakthrough Leave Competitors? | Shares of NewLink Genetics Up 10%, Earlier Today, Traders Attributed Move To Partnership With Merck, Whose Ebola Vaccine Was Shown To Provide 100% Protection | 6 Worst Biotech Stocks Of 2016",0.0009654028974269616,-0.0003357563681885412,0.12907598005304124,"[{'label': 'positive', 'score': 0.9995860457420349}, {'label': 'negative', 'score': 0.00023819504713173956}, {'label': 'neutral', 'score': 0.00017577038670424372}]","(0.00017577038670424372, 0.9995860457420349, 0.00023819504713173956)",0.9995235261610707,0.9995860457420349,0,0,"[{'label': 'positive', 'score': 0.9537761211395264}, {'label': 'neutral', 'score': 0.02338505908846855}, {'label': 'negative', 'score': 0.02283884584903717}]","(0.02338505908846855, 0.9537761211395264, 0.02283884584903717)",0.9532285565529233,0.9537761211395264,0,0,"[{'label': 'positive', 'score': 0.5939508676528931}, {'label': 'negative', 'score': 0.31079864501953125}, {'label': 'neutral', 'score': 0.09525047987699509}]","(0.09525047987699509, 0.5939508676528931, 0.31079864501953125)",0.3129620062430258,0.5939508676528931,1,0
2016-12-24,45.091068267822266,56.88692760467529,57.18511390686035,56.610209465026855,57.05629920959473,7490606.25,,0.0009644717935629693,0.0009649371957520758,0.13960677036034455,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-25,45.13455581665039,56.94179344177246,57.25190734863281,56.684160232543945,57.08015441894531,7025320.5,,0.000963542484015237,0.0009640069894790593,0.13494265100548067,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-26,45.17804336547852,56.99665927886963,57.31870079040527,56.75811100006104,57.1040096282959,6560034.75,,0.0009626149636020576,0.0009630785749295536,0.016071420838761275,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2016-12-27,45.22153091430664,57.0515251159668,57.38549423217773,56.832061767578125,57.12786483764648,6094749.0,,-0.008697076669353487,0.0009621519469319,0.009224129991552801,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2016-12-28,44.82822799682617,56.55534362792969,57.11832046508789,56.49809265136719,56.98473358154297,6470981.0,Merck Gets A Strong Sell From Vetr Crowd | Technical Alert: Merck Lower,-0.0038805734172491935,-0.00873511696080156,0.06885366211701174,"[{'label': 'positive', 'score': 0.9995412826538086}, {'label': 'negative', 'score': 0.0003050569794140756}, {'label': 'neutral', 'score': 0.00015366813750006258}]","(0.00015366813750006258, 0.9995412826538086, 0.0003050569794140756)",0.9993897922764292,0.9995412826538086,0,0,"[{'label': 'positive', 'score': 0.9251794815063477}, {'label': 'neutral', 'score': 0.04493735730648041}, {'label': 'negative', 'score': 0.029883233830332756}]","(0.04493735730648041, 0.9251794815063477, 0.029883233830332756)",0.9374214209172677,0.9251794815063477,0,0,"[{'label': 'positive', 'score': 0.9932292699813843}, {'label': 'neutral', 'score': 0.003913286607712507}, {'label': 'negative', 'score': 0.0028574680909514427}]","(0.003913286607712507, 0.9932292699813843, 0.0028574680909514427)",0.9942626119157427,0.9932292699813843,0,0
2016-12-29,44.65426635742188,56.33587646484375,56.860687255859375,56.27862548828125,56.57442855834961,6833065.0,Prima BioMed Announces First Clinical Data from Combination of IMP321 With Keytruda Show No Safety Concerns,-0.002879379571335862,-0.0038881223781324368,0.06885409809475189,"[{'label': 'neutral', 'score': 0.997660756111145}, {'label': 'positive', 'score': 0.002086932770907879}, {'label': 'negative', 'score': 0.0002522864961065352}]","(0.997660756111145, 0.002086932770907879, 0.0002522864961065352)",0.7842985480976028,0.002086932770907879,0,1,"[{'label': 'neutral', 'score': 0.6681126952171326}, {'label': 'positive', 'score': 0.2610751986503601}, {'label': 'negative', 'score': 0.07081208378076553}]","(0.6681126952171326, 0.2610751986503601, 0.07081208378076553)",0.5732763047619296,0.2610751986503601,0,1,"[{'label': 'neutral', 'score': 0.9791863560676575}, {'label': 'positive', 'score': 0.020382067188620567}, {'label': 'negative', 'score': 0.0004316113772802055}]","(0.9791863560676575, 0.020382067188620567, 0.0004316113772802055)",0.9585261801835147,0.020382067188620567,0,1
2016-12-30,44.52569580078125,56.17366409301758,56.25,55.87786483764648,56.08778762817383,11289685.0,UPDATE: Merck Says It Will Defend Itself Vigorously In Response To Government Notice; Given They Were Neither A Manufacturer Or A Marketer Of The Subject Drug | Merck Says NPPA Alleges Overcharging Of Price Of Polybion Syrup Formulation From Jan. 2006-June 2009,0.005435707868799127,-0.0028835329593969524,0.06384243132512646,"[{'label': 'neutral', 'score': 0.9955847859382629}, {'label': 'negative', 'score': 0.00423041358590126}, {'label': 'positive', 'score': 0.00018482276936993003}]","(0.9955847859382629, 0.00018482276936993003, 0.00423041358590126)",-0.916279558103712,-0.00423041358590126,0,1,"[{'label': 'negative', 'score': 0.6081182360649109}, {'label': 'neutral', 'score': 0.2982296943664551}, {'label': 'positive', 'score': 0.09365206956863403}]","(0.2982296943664551, 0.09365206956863403, 0.6081182360649109)",-0.7330976565499256,-0.6081182360649109,0,0,"[{'label': 'neutral', 'score': 0.9288749098777771}, {'label': 'positive', 'score': 0.06476601958274841}, {'label': 'negative', 'score': 0.006359053310006857}]","(0.9288749098777771, 0.06476601958274841, 0.006359053310006857)",0.8211867334155074,0.06476601958274841,0,1
2016-12-31,44.76772499084473,56.47900772094727,56.591126441955566,55.99475383758545,56.17605113983154,11608303.25,,0.005406320688889028,0.005420987727613356,0.08452308487344792,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-01,45.0097541809082,56.78435134887695,56.93225288391113,56.111642837524414,56.26431465148926,11926921.5,,0.005377249553379399,0.00539175899706672,0.09843024543901963,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-02,45.25178337097168,57.08969497680664,57.2733793258667,56.22853183746338,56.35257816314697,12245539.75,,0.005348489391189372,0.0053628437662663585,0.07652917530582669,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-03,45.49381256103516,57.39503860473633,57.614505767822266,56.34542083740234,56.44084167480469,12564158.0,,-0.000332518818418339,0.005334237018329608,0.058649455559198975,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-04,45.47869110107422,57.375953674316406,58.0057258605957,57.290077209472656,57.72900772094727,9863671.0,Merck Acquires Biocontrol,-0.00033262942396148964,-0.00033257411505909363,0.04054044746066333,"[{'label': 'neutral', 'score': 0.9998651742935181}, {'label': 'positive', 'score': 7.604758866364136e-05}, {'label': 'negative', 'score': 5.876737122889608e-05}]","(0.9998651742935181, 7.604758866364136e-05, 5.876737122889608e-05)",0.12817729908104813,7.604758866364136e-05,1,1,"[{'label': 'neutral', 'score': 0.9320712685585022}, {'label': 'positive', 'score': 0.05124524608254433}, {'label': 'negative', 'score': 0.01668347232043743}]","(0.9320712685585022, 0.05124524608254433, 0.01668347232043743)",0.5087947273945594,0.05124524608254433,0,1,"[{'label': 'neutral', 'score': 0.5343084931373596}, {'label': 'positive', 'score': 0.4648981988430023}, {'label': 'negative', 'score': 0.0007933178567327559}]","(0.5343084931373596, 0.4648981988430023, 0.0007933178567327559)",0.9965929469260902,0.4648981988430023,0,1
2017-01-05,45.46355438232422,57.35686874389648,57.80534362792969,57.25190734863281,57.46183013916016,10581446.0,,0.0026617878086501565,-0.00033268475739904135,0.04952309515059462,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-06,45.58456039428711,57.50954055786133,57.69084167480469,56.80343627929688,57.33778762817383,10730053.0,,0.004590453169004381,0.0026582515253149217,0.04510579528212845,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-07,45.793816884358726,57.77353541056315,58.01526896158854,56.978371938069664,57.40458170572917,10553989.0,,0.004569477197920617,0.004579949171993434,0.04227019830262601,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-08,46.003073374430336,58.037530263264976,58.3396962483724,57.153307596842446,57.47137578328451,10377925.0,,0.0045486920533025655,0.004559068832138369,0.03909796271510562,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-09,46.21232986450195,58.3015251159668,58.66412353515625,57.328243255615234,57.53816986083984,10201861.0,"Option Alert: Merck Jan 61.5 Calls Sweep: 745 @  ASK  $0.64: 843 traded vs 562 OI:  Earnings 2/2 Before Open  $61.29 Ref | Exclusive: Ziopharm CEO Talks Partnerships, Balance Sheet And JPM Healthcare Conference Presentation | Incyte, Merck to Advance Clinical Development Program Investigating the Combination of Epacadostat with KEYTRUDA | The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know",-0.01931259383140984,0.004538378018689219,0.03396916088184587,"[{'label': 'neutral', 'score': 0.9998586177825928}, {'label': 'positive', 'score': 7.61961200623773e-05}, {'label': 'negative', 'score': 6.517674046335742e-05}]","(0.9998586177825928, 7.61961200623773e-05, 6.517674046335742e-05)",0.07794550918784005,7.61961200623773e-05,0,0,"[{'label': 'neutral', 'score': 0.8519128561019897}, {'label': 'positive', 'score': 0.136198028922081}, {'label': 'negative', 'score': 0.011889062821865082}]","(0.8519128561019897, 0.136198028922081, 0.011889062821865082)",0.8394314766823542,0.136198028922081,0,0,"[{'label': 'neutral', 'score': 0.9836041331291199}, {'label': 'positive', 'score': 0.012216338887810707}, {'label': 'negative', 'score': 0.004179559648036957}]","(0.9836041331291199, 0.012216338887810707, 0.004179559648036957)",0.4901701009067784,0.012216338887810707,0,0
2017-01-10,45.319854736328125,57.17557144165039,58.43511581420898,57.14694595336914,58.39694595336914,16036706.0,"Bristol-Myers Shares Down 2.2% After Hours as Merck Shares Trade Up ~2.5% Following News KEYTRUDA Accepted for Supplemental BLA | Merck Reports KEYTRUDA Has FDA PDUFA Date Of May 10, 2017 Under Accelerated Approval | Merck Receives FDA Acceptance Of Supplemental Biologics License Application for KEYTRUDA",0.028538053818618913,-0.01950151834206928,0.1679491590538626,"[{'label': 'negative', 'score': 0.5283921957015991}, {'label': 'positive', 'score': 0.4694772958755493}, {'label': 'neutral', 'score': 0.0021305126138031483}]","(0.0021305126138031483, 0.4694772958755493, 0.5283921957015991)",-0.05904068650594165,-0.5283921957015991,0,0,"[{'label': 'negative', 'score': 0.9659042358398438}, {'label': 'neutral', 'score': 0.021812334656715393}, {'label': 'positive', 'score': 0.012283461168408394}]","(0.021812334656715393, 0.012283461168408394, 0.9659042358398438)",-0.9748852675085224,-0.9659042358398438,0,0,"[{'label': 'neutral', 'score': 0.9333032369613647}, {'label': 'negative', 'score': 0.05531319975852966}, {'label': 'positive', 'score': 0.011383559554815292}]","(0.9333032369613647, 0.011383559554815292, 0.05531319975852966)",-0.6586472964500504,-0.05531319975852966,0,0
2017-01-11,46.61319351196289,58.8072509765625,60.26717758178711,57.96755599975586,59.48473358154297,34281862.0,"All The Markets Trump Moved During His Speech Today | Here's What Merck's Keytruda News Means For Bristol-Myers | 15 Biggest Mid-Day Gainers For Wednesday | 22 Stocks Moving In Wednesday's Pre-Market Session | Lilly and Merck Expand Immuno-Oncology Collaboration, Financial Terms Not Disclosed",0.009411021091896402,0.028138428763916295,0.2673868307151526,"[{'label': 'neutral', 'score': 0.9650892615318298}, {'label': 'positive', 'score': 0.03448982164263725}, {'label': 'negative', 'score': 0.00042091135401278734}]","(0.9650892615318298, 0.03448982164263725, 0.00042091135401278734)",0.9758864212875062,0.03448982164263725,0,1,"[{'label': 'neutral', 'score': 0.8484096527099609}, {'label': 'positive', 'score': 0.1310713142156601}, {'label': 'negative', 'score': 0.02051900513470173}]","(0.8484096527099609, 0.1310713142156601, 0.02051900513470173)",0.7292834367968135,0.1310713142156601,0,1,"[{'label': 'positive', 'score': 0.9405052661895752}, {'label': 'neutral', 'score': 0.05885301157832146}, {'label': 'negative', 'score': 0.000641777878627181}]","(0.05885301157832146, 0.9405052661895752, 0.000641777878627181)",0.9986361793671411,0.9405052661895752,0,0
2017-01-12,47.0518684387207,59.360687255859375,60.343509674072266,59.274810791015625,59.66603088378906,26079899.0,"Favorable News On Keytruda Drives Piper Jaffray's Upgrade Of Merck | 8 Biggest Price Target Changes For Thursday | Benzinga's Top Upgrades, Downgrades For January 12, 2017 | Merck's Leadership Position In Immuno Oncology Is Improving | The Market In 5 Minutes: Jobless Claims Lower, Trump Conference Shakes Sectors | Guggenheim Upgrades Merck & Co to Buy, Announces $70.00 Target | Morgan Stanley Upgrades Merck & Co to Overweight, Raises Target to $71.00",0.0020897050121559935,0.009367013322806686,0.269668883448779,"[{'label': 'positive', 'score': 0.9994568228721619}, {'label': 'negative', 'score': 0.00032697312417440116}, {'label': 'neutral', 'score': 0.00021620054030790925}]","(0.00021620054030790925, 0.9994568228721619, 0.00032697312417440116)",0.9993459123352794,0.9994568228721619,0,0,"[{'label': 'positive', 'score': 0.9346819519996643}, {'label': 'neutral', 'score': 0.03471862152218819}, {'label': 'negative', 'score': 0.030599402263760567}]","(0.03471862152218819, 0.9346819519996643, 0.030599402263760567)",0.936600034531673,0.9346819519996643,0,0,"[{'label': 'positive', 'score': 0.997401237487793}, {'label': 'neutral', 'score': 0.002196857938542962}, {'label': 'negative', 'score': 0.0004019679909106344}]","(0.002196857938542962, 0.997401237487793, 0.0004019679909106344)",0.9991942940477571,0.997401237487793,0,0
2017-01-13,47.15019607543945,59.48473358154297,59.80915832519531,59.2557258605957,59.475189208984375,10447617.0,,-0.003448826265909927,0.002087524615698967,0.27073486758957005,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-14,46.98758125305176,59.27958106994629,59.6636438369751,59.04103088378906,59.377384185791016,10611000.25,,-0.0034607618322169357,-0.003454787176592589,0.2773225801613025,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-15,46.82496643066406,59.07442855834961,59.51812934875488,58.82633590698242,59.279579162597656,10774383.5,,-0.0034727802977229704,-0.003466764120775184,0.2091492168761828,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-16,46.66235160827637,58.86927604675293,59.37261486053467,58.61164093017578,59.1817741394043,10937766.75,,-0.003484882529109942,-0.0034788243964963715,0.08977615721692128,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-17,46.49973678588867,58.66412353515625,59.22710037231445,58.39694595336914,59.08396911621094,11101150.0,,-0.005042316363783913,-0.003490968876481917,0.03947522580149687,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-18,46.265281677246094,58.36832046508789,58.950382232666016,58.28244400024414,58.56870269775391,8522022.0,,-0.01373219427216899,-0.005055071736756299,0.01123479776512444,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-01-19,45.62994003295898,57.56679534912109,58.28244400024414,57.31870269775391,58.25381851196289,11944999.0,,0.03646608295523309,-0.013827353015106628,0.07149542235612329,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-01-20,47.29389953613281,59.66603088378906,60.03816986083984,59.30343627929688,59.54198455810547,26451834.0,"UPDATE: Merck's Payment To Bristol-Myers Will Be Recorded In Its Q4 And FY16 Results, Excluded From Non-GAAP Results | Merck Announces Setlement With Bristol-Myers Resolving KEYTRUDA Patent Litigation, Will Pay $625M And Provide Royalties On KEYTRUDA In Any Market In Which It's Approved | Bristol-Myers Squibb Falls 10% After Opdivo Decision | Wall Street's M&A Chatter From January 19",-0.0038381591259740687,0.035816929690892424,0.30782139061898256,"[{'label': 'neutral', 'score': 0.9901372194290161}, {'label': 'negative', 'score': 0.00951660517603159}, {'label': 'positive', 'score': 0.0003461670712567866}]","(0.9901372194290161, 0.0003461670712567866, 0.00951660517603159)",-0.9298032921013745,-0.00951660517603159,0,1,"[{'label': 'negative', 'score': 0.7188336253166199}, {'label': 'neutral', 'score': 0.21509839594364166}, {'label': 'positive', 'score': 0.06606796383857727}]","(0.21509839594364166, 0.06606796383857727, 0.7188336253166199)",-0.8316528727896007,-0.7188336253166199,0,0,"[{'label': 'negative', 'score': 0.8895675539970398}, {'label': 'neutral', 'score': 0.09486813843250275}, {'label': 'positive', 'score': 0.015564304776489735}]","(0.09486813843250275, 0.015564304776489735, 0.8895675539970398)",-0.9656087571647746,-0.8895675539970398,0,0
2017-01-21,47.11237589518229,59.4370231628418,59.87277475992838,59.13804117838541,59.35432561238607,21198350.0,,-0.0038529473510112502,-0.003845543760369582,0.3082427913594168,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-22,46.93085225423177,59.20801544189453,59.70737965901693,58.97264607747396,59.16666666666666,15944866.0,,-0.003867849973319943,-0.003860389073850385,0.30866218096360204,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-23,46.74932861328125,58.97900772094727,59.54198455810547,58.8072509765625,58.97900772094727,10691382.0,,-0.009707138474223725,-0.003875349449172173,0.3071102708696385,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-24,46.29553985595703,58.40649032592773,58.864505767822266,57.9484748840332,58.76908493041992,10990900.0,,-0.002123844884213496,-0.009754559876522335,0.2949384296831704,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-25,46.19720458984375,58.28244400024414,58.56870269775391,57.97710037231445,58.511451721191406,15255736.0,Dow 10K's Hottest Stocks: Where Are They Now? | Which Pharma Players Dominate The Lung Cancer Space?,0.001964604523525478,-0.0021261034412093393,0.04647756614507513,"[{'label': 'neutral', 'score': 0.9998757839202881}, {'label': 'negative', 'score': 6.263157411012799e-05}, {'label': 'positive', 'score': 6.163622310850769e-05}]","(0.9998757839202881, 6.163622310850769e-05, 6.263157411012799e-05)",-0.00800972596198097,-6.263157411012799e-05,1,1,"[{'label': 'neutral', 'score': 0.9240568280220032}, {'label': 'negative', 'score': 0.04636482149362564}, {'label': 'positive', 'score': 0.029578428715467453}]","(0.9240568280220032, 0.029578428715467453, 0.04636482149362564)",-0.22103864045771723,-0.04636482149362564,1,1,"[{'label': 'neutral', 'score': 0.999019980430603}, {'label': 'positive', 'score': 0.0008288372773677111}, {'label': 'negative', 'score': 0.00015110681124497205}]","(0.999019980430603, 0.0008288372773677111, 0.00015110681124497205)",0.6916011576560547,0.0008288372773677111,0,1
2017-01-26,46.28795623779297,58.39694595336914,58.549617767333984,57.76717758178711,58.225189208984375,13317460.0,Merck Shares Falling As Ketruda Brain Tumor Trial Put On Hold Due To Adverse Event | Merck's Keytruda Gains Momentum At The Expense Of Bristol-Myers,0.008986956123265324,0.0019626772119158463,0.06693415912419759,"[{'label': 'negative', 'score': 0.9968097805976868}, {'label': 'neutral', 'score': 0.0016266731545329094}, {'label': 'positive', 'score': 0.0015636059688404202}]","(0.0016266731545329094, 0.0015636059688404202, 0.9968097805976868)",-0.9968676930096909,-0.9968097805976868,0,0,"[{'label': 'negative', 'score': 0.9710288047790527}, {'label': 'neutral', 'score': 0.016136130318045616}, {'label': 'positive', 'score': 0.012835158035159111}]","(0.016136130318045616, 0.012835158035159111, 0.9710288047790527)",-0.9739086733120179,-0.9710288047790527,0,0,"[{'label': 'negative', 'score': 0.992954432964325}, {'label': 'neutral', 'score': 0.0055263591930270195}, {'label': 'positive', 'score': 0.0015192345017567277}]","(0.0055263591930270195, 0.0015192345017567277, 0.992954432964325)",-0.9969446460947976,-0.992954432964325,0,0
2017-01-27,46.703948974609375,58.921756744384766,59.15076446533203,58.49236679077149,58.56870269775391,6972554.0,"A CEO Who's Who Of Trump's Manufacturing Council | Andrew Left Furthers Comments Following ESRX Release Today, Points To Comment Made By Merck President Of U.S. Commercial To Highlight Thesis That Drug Co.'s Offer Incentives To PBM's To Stay On Preferred Drug Lists | WSJ Reporting Merck Raised List Prices By 9.6% Last Year",-0.0017273960406755512,0.008946813758936835,0.11052178248007019,"[{'label': 'positive', 'score': 0.9986329674720764}, {'label': 'neutral', 'score': 0.0011821965454146266}, {'label': 'negative', 'score': 0.00018482498126104474}]","(0.0011821965454146266, 0.9986329674720764, 0.00018482498126104474)",0.9996299125172629,0.9986329674720764,0,0,"[{'label': 'positive', 'score': 0.7169461250305176}, {'label': 'neutral', 'score': 0.261508971452713}, {'label': 'negative', 'score': 0.02154497615993023}]","(0.261508971452713, 0.7169461250305176, 0.02154497615993023)",0.9416513587632953,0.7169461250305176,0,0,"[{'label': 'neutral', 'score': 0.8815152049064636}, {'label': 'positive', 'score': 0.11482329666614532}, {'label': 'negative', 'score': 0.0036614977288991213}]","(0.8815152049064636, 0.11482329666614532, 0.0036614977288991213)",0.938194639276814,0.11482329666614532,0,1
2017-01-28,46.62327194213867,58.81997553507487,59.06170527140299,58.3746821085612,58.61323165893555,7391893.666666667,,-0.0017303851010478247,-0.0017288897095691735,0.10798759411086499,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-29,46.54259490966797,58.718194325764976,58.97264607747396,58.256997426350914,58.65776062011719,7811233.333333333,,-0.0017333845238023198,-0.0017318839466497584,0.07477058860185773,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-01-30,46.46191787719727,58.61641311645508,58.88358688354492,58.13931274414063,58.70228958129883,8230573.0,"Taking A Clinical Road Less Traveled: Neurotrope Hopes To Succeed In Alzheimer's Where Competitors Fail | Mixing It Up: Markets Await Host Of Economic Data, Key Earnings, And Fed Meeting | The Market In 5 Minutes: Walgreens-Rite Aid, Personal Income And Trump's Executive Order | Can Merck And Pfizer Beat Low Expectations?",0.009116070405320443,-0.0017348885730711285,0.07376366870583784,"[{'label': 'positive', 'score': 0.5671182870864868}, {'label': 'neutral', 'score': 0.352670818567276}, {'label': 'negative', 'score': 0.08021091669797897}]","(0.352670818567276, 0.5671182870864868, 0.08021091669797897)",0.7521789030093382,0.5671182870864868,0,0,"[{'label': 'neutral', 'score': 0.7614550590515137}, {'label': 'positive', 'score': 0.22428327798843384}, {'label': 'negative', 'score': 0.01426168717443943}]","(0.7614550590515137, 0.22428327798843384, 0.01426168717443943)",0.8804276823474194,0.22428327798843384,0,1,"[{'label': 'neutral', 'score': 0.8412742614746094}, {'label': 'positive', 'score': 0.1557500660419464}, {'label': 'negative', 'score': 0.00297564803622663}]","(0.8412742614746094, 0.1557500660419464, 0.00297564803622663)",0.9625057848564964,0.1557500660419464,0,1
2017-01-31,46.88546371459961,59.15076446533203,59.38931274414063,58.1297721862793,58.26335906982422,10292513.0,Merck Announces EU Approves KEYTRUDA For First-Line Pateitns,0.0017744723371274302,0.009074769844958105,0.09340849382110153,"[{'label': 'positive', 'score': 0.9981764554977417}, {'label': 'neutral', 'score': 0.0015899122226983309}, {'label': 'negative', 'score': 0.00023369162227027118}]","(0.0015899122226983309, 0.9981764554977417, 0.00023369162227027118)",0.9995318725016079,0.9981764554977417,0,0,"[{'label': 'positive', 'score': 0.6104285717010498}, {'label': 'neutral', 'score': 0.3716367483139038}, {'label': 'negative', 'score': 0.017934657633304596}]","(0.3716367483139038, 0.6104285717010498, 0.017934657633304596)",0.9429162726396216,0.6104285717010498,0,0,"[{'label': 'positive', 'score': 0.9972821474075317}, {'label': 'neutral', 'score': 0.0025246317964047194}, {'label': 'negative', 'score': 0.00019320228602737188}]","(0.0025246317964047194, 0.9972821474075317, 0.00019320228602737188)",0.999612617422402,0.9972821474075317,0,0
2017-02-01,46.96866989135742,59.2557258605957,59.41793823242188,58.74045944213867,59.21755599975586,11547702.0,Earnings: Facebook and Merck Scheduled to Open Their Books | Ringing up the iPhones: Strong Apple Results Put A Charge Into Markets,0.033494376327651926,0.0017728998210724094,0.07450198618416831,"[{'label': 'positive', 'score': 0.998778760433197}, {'label': 'neutral', 'score': 0.000989255029708147}, {'label': 'negative', 'score': 0.0002319224295206368}]","(0.000989255029708147, 0.998778760433197, 0.0002319224295206368)",0.9995356957968536,0.998778760433197,1,1,"[{'label': 'positive', 'score': 0.8335111737251282}, {'label': 'negative', 'score': 0.14023683965206146}, {'label': 'neutral', 'score': 0.026251984760165215}]","(0.026251984760165215, 0.8335111737251282, 0.14023683965206146)",0.7119648251385146,0.8335111737251282,1,1,"[{'label': 'positive', 'score': 0.9984208345413208}, {'label': 'neutral', 'score': 0.001238668686710298}, {'label': 'negative', 'score': 0.00034045803477056324}]","(0.001238668686710298, 0.9984208345413208, 0.00034045803477056324)",0.9993182394285777,0.9984208345413208,1,1
2017-02-02,48.54186248779297,61.24045944213867,61.26908493041992,59.66603088378906,59.770992279052734,19901730.0,"Q4 2016 Real-Time Call Brief | The Market In 5 Minutes: Facebook Beats, Trump Tweets | Merck CEO Says Trump Focus On Patients Being Able To Afford Co-Pays Rather Than Overall Cost of Drugs | Merck Sees FY17 Adj. EPS $3.72-$3.87 vs $3.85 Est., Sales $38.6B-$40.1B vs $40B Est. | Merck Reports Q4 Adj. EPS $0.89, Inline, Sales $10.1B vs $10.22B Est.",0.0017139224006448644,0.032945658738961665,0.2316364989628662,"[{'label': 'neutral', 'score': 0.9495788216590881}, {'label': 'positive', 'score': 0.044291019439697266}, {'label': 'negative', 'score': 0.00613013468682766}]","(0.9495788216590881, 0.044291019439697266, 0.00613013468682766)",0.7568427461440119,0.044291019439697266,0,1,"[{'label': 'neutral', 'score': 0.8692832589149475}, {'label': 'positive', 'score': 0.09220673143863678}, {'label': 'negative', 'score': 0.0385100319981575}]","(0.8692832589149475, 0.09220673143863678, 0.0385100319981575)",0.41078663538394095,0.09220673143863678,1,1,"[{'label': 'neutral', 'score': 0.8264299035072327}, {'label': 'positive', 'score': 0.11188414692878723}, {'label': 'negative', 'score': 0.06168598309159279}]","(0.8264299035072327, 0.11188414692878723, 0.06168598309159279)",0.2892096919631295,0.11188414692878723,1,1
2017-02-03,48.62505722045898,61.34542083740234,61.38358688354492,60.37213516235352,60.93511581420898,12209724.0,FDA to Review Two of Merck's Supplemental Biologics License Applications,0.0033701391522206856,0.001712455311725617,0.22361022751694568,"[{'label': 'neutral', 'score': 0.9998278617858887}, {'label': 'negative', 'score': 9.826572932070121e-05}, {'label': 'positive', 'score': 7.395074499072507e-05}]","(0.9998278617858887, 7.395074499072507e-05, 9.826572932070121e-05)",-0.14118849214161902,-9.826572932070121e-05,1,1,"[{'label': 'neutral', 'score': 0.829624354839325}, {'label': 'positive', 'score': 0.12322613596916199}, {'label': 'negative', 'score': 0.047149527817964554}]","(0.829624354839325, 0.12322613596916199, 0.047149527817964554)",0.4465227395753555,0.12322613596916199,1,1,"[{'label': 'neutral', 'score': 0.9776647686958313}, {'label': 'negative', 'score': 0.015377606265246868}, {'label': 'positive', 'score': 0.006957630626857281}]","(0.9776647686958313, 0.006957630626857281, 0.015377606265246868)",-0.37698170290578736,-0.015377606265246868,1,1
2017-02-04,48.788927714029946,61.55216344197592,61.580787658691406,60.57251739501953,60.95419947306315,11339290.0,,0.00335881946324191,0.0033644729602693873,0.21112242566525716,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-05,48.952798207600914,61.75890604654948,61.77798843383789,60.77289962768555,60.97328313191732,10468856.0,,0.0033475755612921996,0.003353191228443722,0.2161636452866811,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-06,49.11666870117188,61.96564865112305,61.975189208984375,60.97328186035156,60.99236679077149,9598422.0,,-0.011395153744572662,0.003341984903514746,0.21329598906639805,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-07,48.55698013305664,61.25954055786133,61.95610809326172,61.11641311645508,61.79389190673828,8840194.0,,0.0018691907706052558,-0.01146057598147229,0.10287560767229188,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-08,48.647743225097656,61.3740463256836,61.52671813964844,60.90649032592773,60.97328186035156,6190326.0,,0.0010883321716582725,0.0018674460073952843,0.1030379874427433,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-09,48.70070266723633,61.44084167480469,61.85114669799805,61.35496139526367,61.3740463256836,7391439.0,,-0.00372735023482655,0.0010877403675478277,0.0996979491996066,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-10,48.5191650390625,61.21183013916016,61.61259460449219,61.03053283691406,61.3740463256836,8940907.0,,0.0032216329141591077,-0.0037343141146448104,0.09567450805312569,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-11,48.67547353108724,61.4090321858724,61.69529215494792,61.11323038736979,61.3517812093099,8458722.333333334,,0.0032112873252153717,0.0032164545736695664,0.09525439298266,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-12,48.83178202311198,61.60623423258463,61.77798970540365,61.19592793782552,61.3295160929362,7976537.666666667,,0.0032010079688971705,0.00320614215421187,0.04550671737195358,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-13,48.98809051513672,61.80343627929688,61.860687255859375,61.27862548828125,61.3072509765625,7494353.0,,0.01374091127927216,0.0031958956496997465,0.04778558301065578,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-02-14,49.6612434387207,62.65267181396485,62.709922790527344,61.47900772094727,61.67938995361328,10629550.0,"Merck Says APECS Study in People with Prodromal Alzheimer's Disease to Continue | Meg Tirrell Tweets: $MRK stops study of BACE inhibitor in mild to moderate Alzheimer's for lack of efficacy, prodromal study continues | Merck's Doravirine Meets Primary Efficacy Endpoint In Pivotal Phase 3 Trial",-0.0076150044124394045,0.013647360961448305,0.09873447316019858,"[{'label': 'negative', 'score': 0.992423415184021}, {'label': 'neutral', 'score': 0.006883381865918636}, {'label': 'positive', 'score': 0.0006931033567525446}]","(0.006883381865918636, 0.0006931033567525446, 0.992423415184021)",-0.9986041852213455,-0.992423415184021,0,0,"[{'label': 'positive', 'score': 0.8781920075416565}, {'label': 'neutral', 'score': 0.08049877732992172}, {'label': 'negative', 'score': 0.04130924865603447}]","(0.08049877732992172, 0.8781920075416565, 0.04130924865603447)",0.9101485759206988,0.8781920075416565,0,0,"[{'label': 'neutral', 'score': 0.857526957988739}, {'label': 'negative', 'score': 0.1318901926279068}, {'label': 'positive', 'score': 0.01058285403996706}]","(0.857526957988739, 0.01058285403996706, 0.1318901926279068)",-0.8514406157869665,-0.1318901926279068,0,1
2017-02-15,49.28305816650391,62.17557144165039,62.85305404663086,61.8797721862793,61.92748260498047,18662050.0,"Merck Still Sees Path Forward For Failed Alzheimer's Drug | Merck, On Its Alzheimer's Drug Program, Tells Benzinga Too Early To Speculate What Verubecestat Trial Results Mean For Validity Of 'Amyloid Hypothesis', Hopes By Evaluating Drug In People W/Less Impairment Will Be Able To Slow Disease Progression | Deutsche Bank Casts Doubt On Pfizer's Rumored Takeover Approach To Bristol-Myers",0.0015346998055641979,-0.007644146598055044,0.11951158082770907,"[{'label': 'neutral', 'score': 0.6144912242889404}, {'label': 'negative', 'score': 0.35166293382644653}, {'label': 'positive', 'score': 0.03384588286280632}]","(0.6144912242889404, 0.03384588286280632, 0.35166293382644653)",-0.8244092928744171,-0.35166293382644653,0,1,"[{'label': 'neutral', 'score': 0.4104889929294586}, {'label': 'positive', 'score': 0.2953803837299347}, {'label': 'negative', 'score': 0.2941305935382843}]","(0.4104889929294586, 0.2953803837299347, 0.2941305935382843)",0.0021200456646997333,0.2953803837299347,1,1,"[{'label': 'neutral', 'score': 0.49756303429603577}, {'label': 'positive', 'score': 0.489039808511734}, {'label': 'negative', 'score': 0.01339708548039198}]","(0.49756303429603577, 0.489039808511734, 0.01339708548039198)",0.9466715695420173,0.489039808511734,0,1
2017-02-16,49.358699798583984,62.270992279052734,62.41412353515625,61.50763320922852,62.15649032592773,12938922.0,"After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?",0.0019920402926568033,0.0015335233573269302,0.12002596044535689,"[{'label': 'neutral', 'score': 0.9998444318771362}, {'label': 'negative', 'score': 0.00010562626994214952}, {'label': 'positive', 'score': 4.995406197849661e-05}]","(0.9998444318771362, 4.995406197849661e-05, 0.00010562626994214952)",-0.35783577060401545,-0.00010562626994214952,1,1,"[{'label': 'neutral', 'score': 0.8363991379737854}, {'label': 'negative', 'score': 0.1351388692855835}, {'label': 'positive', 'score': 0.028462039306759834}]","(0.8363991379737854, 0.028462039306759834, 0.1351388692855835)",-0.6520552416040569,-0.1351388692855835,0,1,"[{'label': 'neutral', 'score': 0.9959654808044434}, {'label': 'negative', 'score': 0.003083097981289029}, {'label': 'positive', 'score': 0.0009513873956166208}]","(0.9959654808044434, 0.0009513873956166208, 0.003083097981289029)",-0.5283723663679201,-0.003083097981289029,0,1
2017-02-17,49.457027435302734,62.39503860473633,62.5572509765625,61.88931274414063,62.21374130249024,9482618.0,The Market In 5 Minutes,0.000344083707471493,0.0019900588114169213,0.12006938692037224,"[{'label': 'neutral', 'score': 0.9998738765716553}, {'label': 'negative', 'score': 7.572230242658406e-05}, {'label': 'positive', 'score': 5.038898598286323e-05}]","(0.9998738765716553, 5.038898598286323e-05, 7.572230242658406e-05)",-0.20088064092621746,-7.572230242658406e-05,1,1,"[{'label': 'neutral', 'score': 0.9242247939109802}, {'label': 'negative', 'score': 0.044892992824316025}, {'label': 'positive', 'score': 0.0308822114020586}]","(0.9242247939109802, 0.0308822114020586, 0.044892992824316025)",-0.18489928948790313,-0.044892992824316025,1,1,"[{'label': 'neutral', 'score': 0.9995952248573303}, {'label': 'positive', 'score': 0.00027319006039761007}, {'label': 'negative', 'score': 0.0001315801200689748}]","(0.9995952248573303, 0.00027319006039761007, 0.0001315801200689748)",0.34985269953779524,0.00027319006039761007,1,1
2017-02-18,49.474042892456055,62.41650772094727,62.60973262786865,61.898855209350586,62.14217662811279,9047121.75,,0.0003439653545968138,0.00034402452424824655,0.12079947619235987,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-19,49.491058349609375,62.4379768371582,62.662214279174805,61.90839767456055,62.07061195373535,8611625.5,,0.00034384708311305755,0.0003439062120759243,0.06281223755795079,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-20,49.508073806762695,62.45944595336914,62.71469593048096,61.91794013977051,61.99904727935791,8176129.25,,0.0003437288929358399,0.00034378798125230003,0.012591720428273667,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-21,49.525089263916016,62.48091506958008,62.76717758178711,61.92748260498047,61.92748260498047,7740633.0,"Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer? | Boeing, Pfizer And Others Band Together To Ask Congress For More Taxes",-0.0029016428783764964,0.0003436698316934984,0.011686943712993387,"[{'label': 'neutral', 'score': 0.999853253364563}, {'label': 'positive', 'score': 8.047197479754686e-05}, {'label': 'negative', 'score': 6.623592344112694e-05}]","(0.999853253364563, 8.047197479754686e-05, 6.623592344112694e-05)",0.09703670713937841,8.047197479754686e-05,0,0,"[{'label': 'neutral', 'score': 0.528612494468689}, {'label': 'positive', 'score': 0.4449425935745239}, {'label': 'negative', 'score': 0.02644493244588375}]","(0.528612494468689, 0.4449425935745239, 0.02644493244588375)",0.8877996086610961,0.4449425935745239,0,0,"[{'label': 'neutral', 'score': 0.9896786212921143}, {'label': 'positive', 'score': 0.009899602271616459}, {'label': 'negative', 'score': 0.00042171767563559115}]","(0.9896786212921143, 0.009899602271616459, 0.00042171767563559115)",0.9182822201441649,0.009899602271616459,0,0
2017-02-22,49.38139724731445,62.299617767333984,62.738548278808594,62.10877990722656,62.5,9096221.0,,0.008577120823960071,-0.002905860805327749,0.02307063784798317,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-02-23,49.80493927001953,62.83396911621094,63.082061767578125,62.35686874389648,62.51908493041992,7184669.0,"Merck Says Will Record Intangible Asset Impairment Charge Related To MK-3682 Program,  Previously Reported Q4 And FY Non-GAAP EPS Remain Unchanged | Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market'",0.004707693533115406,0.00854054631035839,0.06774728035547782,"[{'label': 'negative', 'score': 0.9955565333366394}, {'label': 'positive', 'score': 0.0030973036773502827}, {'label': 'neutral', 'score': 0.0013462159549817443}]","(0.0013462159549817443, 0.0030973036773502827, 0.9955565333366394)",-0.9937970424534465,-0.9955565333366394,0,0,"[{'label': 'positive', 'score': 0.8334594964981079}, {'label': 'negative', 'score': 0.08845023810863495}, {'label': 'neutral', 'score': 0.07809028774499893}]","(0.07809028774499893, 0.8334594964981079, 0.08845023810863495)",0.8081151878792885,0.8334594964981079,0,0,"[{'label': 'positive', 'score': 0.9771921038627625}, {'label': 'neutral', 'score': 0.017051978036761284}, {'label': 'negative', 'score': 0.005755915772169828}]","(0.017051978036761284, 0.9771921038627625, 0.005755915772169828)",0.9882884635663489,0.9771921038627625,0,0
2017-02-24,50.03940963745117,63.1297721862793,63.1297721862793,62.6240463256836,62.64313125610352,8849626.0,Merck Reports First Phase 3 Trial of V212 Reduced Incidence of Confirmed Herpes Zoster Cases by ~64% in Immunocompromised Subjects | Merck Receives Positive CHMP Opinion For New Pergoveris Fertility Pen,-0.0015618783331764897,0.004696646999477585,0.0707248976996074,"[{'label': 'positive', 'score': 0.9993222951889038}, {'label': 'neutral', 'score': 0.00040774792432785034}, {'label': 'negative', 'score': 0.0002699152973946184}]","(0.00040774792432785034, 0.9993222951889038, 0.0002699152973946184)",0.9994599491781487,0.9993222951889038,0,0,"[{'label': 'positive', 'score': 0.9366243481636047}, {'label': 'negative', 'score': 0.040275633335113525}, {'label': 'neutral', 'score': 0.02310008928179741}]","(0.02310008928179741, 0.9366243481636047, 0.040275633335113525)",0.917543998161768,0.9366243481636047,0,0,"[{'label': 'positive', 'score': 0.994759738445282}, {'label': 'neutral', 'score': 0.004740036092698574}, {'label': 'negative', 'score': 0.0005001953686587512}]","(0.004740036092698574, 0.994759738445282, 0.0005001953686587512)",0.9989948447603192,0.994759738445282,0,0
2017-02-25,49.96125284830729,63.03117116292318,63.05979665120443,62.6017812093099,62.68448003133138,8391824.666666666,"Big Business Delivers Christmas Wish List To Trump, 10 Months Early",-0.0015643216132103952,-0.0015630993366784955,0.07504776830817135,"[{'label': 'neutral', 'score': 0.9638486504554749}, {'label': 'positive', 'score': 0.03581954166293144}, {'label': 'negative', 'score': 0.0003317746159154922}]","(0.9638486504554749, 0.03581954166293144, 0.0003317746159154922)",0.9816452262287544,0.03581954166293144,0,1,"[{'label': 'neutral', 'score': 0.8908153772354126}, {'label': 'positive', 'score': 0.08347519487142563}, {'label': 'negative', 'score': 0.025709377601742744}]","(0.8908153772354126, 0.08347519487142563, 0.025709377601742744)",0.529065745839492,0.08347519487142563,0,1,"[{'label': 'neutral', 'score': 0.9773957133293152}, {'label': 'positive', 'score': 0.022345904260873795}, {'label': 'negative', 'score': 0.00025838418514467776}]","(0.9773957133293152, 0.022345904260873795, 0.00025838418514467776)",0.9771384809779147,0.022345904260873795,0,1
2017-02-26,49.88309605916341,62.932570139567055,62.98982111612956,62.5795160929362,62.72582880655924,7934023.333333333,Merck Says Letermovir for Prevention of CMV)Infection in Bone Marrow Transplant Recipients is Highly Effective Through Week 24 Post-Transplant in Pivotal Phase 3 Study,-0.0015667725493722503,-0.0015655464417823782,0.07855954061194798,"[{'label': 'positive', 'score': 0.9993795156478882}, {'label': 'neutral', 'score': 0.0003724433481693268}, {'label': 'negative', 'score': 0.0002479900431353599}]","(0.0003724433481693268, 0.9993795156478882, 0.0002479900431353599)",0.9995038350951259,0.9993795156478882,0,0,"[{'label': 'positive', 'score': 0.8985537886619568}, {'label': 'neutral', 'score': 0.09133075922727585}, {'label': 'negative', 'score': 0.01011545117944479}]","(0.09133075922727585, 0.8985537886619568, 0.01011545117944479)",0.9777356804083952,0.8985537886619568,0,0,"[{'label': 'positive', 'score': 0.9959126114845276}, {'label': 'neutral', 'score': 0.0038115333300083876}, {'label': 'negative', 'score': 0.0002757773327175528}]","(0.0038115333300083876, 0.9959126114845276, 0.0002757773327175528)",0.9994463349787785,0.9959126114845276,0,0
2017-02-27,49.80493927001953,62.83396911621094,62.91984558105469,62.5572509765625,62.76717758178711,7476222.0,,0.0003037358723053838,-0.0015680012210166467,0.07435816773256947,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-02-28,49.82007598876953,62.85305404663086,63.1202278137207,62.64313125610352,62.79580307006836,8112044.0,,0.005161699192992514,0.0003036897539037203,0.04309944821436009,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-01,50.07722091674805,63.17748260498047,63.74045944213867,62.87213516235352,63.04389190673828,11193374.0,Merck's Odactra Approved For House Dust Mite Allergies,-0.0019634578740528623,0.005148423288267516,0.046170800131659744,"[{'label': 'positive', 'score': 0.9989356398582458}, {'label': 'neutral', 'score': 0.0007818944868631661}, {'label': 'negative', 'score': 0.0002824809344019741}]","(0.0007818944868631661, 0.9989356398582458, 0.0002824809344019741)",0.9994345960536066,0.9989356398582458,0,0,"[{'label': 'positive', 'score': 0.804164469242096}, {'label': 'neutral', 'score': 0.1861068159341812}, {'label': 'negative', 'score': 0.009728720411658287}]","(0.1861068159341812, 0.804164469242096, 0.009728720411658287)",0.976093373097772,0.804164469242096,0,0,"[{'label': 'positive', 'score': 0.9980217218399048}, {'label': 'neutral', 'score': 0.0016384535701945424}, {'label': 'negative', 'score': 0.00033982068998739123}]","(0.0016384535701945424, 0.9980217218399048, 0.00033982068998739123)",0.9993192432290084,0.9980217218399048,0,0
2017-03-02,49.9788932800293,63.05343627929688,63.53053283691406,62.97710037231445,63.33969497680664,9062790.0,Why Bermuda Could Be The Next Switzerland,0.0075665433284851985,-0.001965387984338397,0.047188864707346435,"[{'label': 'neutral', 'score': 0.9998611211776733}, {'label': 'positive', 'score': 7.189452298916876e-05}, {'label': 'negative', 'score': 6.697223579976708e-05}]","(0.9998611211776733, 7.189452298916876e-05, 6.697223579976708e-05)",0.03544611563148162,7.189452298916876e-05,0,0,"[{'label': 'neutral', 'score': 0.91632479429245}, {'label': 'negative', 'score': 0.0505315437912941}, {'label': 'positive', 'score': 0.03314368054270744}]","(0.91632479429245, 0.03314368054270744, 0.0505315437912941)",-0.20780181214908405,-0.0505315437912941,0,0,"[{'label': 'neutral', 'score': 0.9990758895874023}, {'label': 'positive', 'score': 0.0008349000127054751}, {'label': 'negative', 'score': 8.918658568290994e-05}]","(0.9990758895874023, 0.0008349000127054751, 8.918658568290994e-05)",0.8069735329168238,0.0008349000127054751,1,0
2017-03-03,50.357078552246094,63.53053283691406,63.56870269775391,62.79580307006836,63.05343627929688,8716111.0,,-0.0005507136520382817,0.007538060626349822,0.06728248271222884,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-04,50.32934315999349,63.49554570515951,63.61959330240885,62.82442855834961,63.05343627929688,8845574.0,,-0.0005510171046803358,-0.0005508653504990624,0.06430961269131093,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-05,50.30160776774088,63.46055857340495,63.670483907063804,62.85305404663086,63.05343627929688,8975037.0,,-0.0005513208919220644,-0.0005511689703947653,0.06607178276183777,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-06,50.27387237548828,63.42557144165039,63.72137451171875,62.88167953491211,63.05343627929688,9104500.0,"Merck, Pfizer Report U.S. FDA and EMA Filing Acceptances of 3 Marketing Applications for Ertugliflozin-Containing Medicines For Adult Type 2 Diabetes Patients",-0.007672629810256833,-0.0005514729251670193,0.06072102946083087,"[{'label': 'neutral', 'score': 0.9998666048049927}, {'label': 'negative', 'score': 6.850369391031563e-05}, {'label': 'positive', 'score': 6.480364390881732e-05}]","(0.9998666048049927, 6.480364390881732e-05, 6.850369391031563e-05)",-0.027755786455794497,-6.850369391031563e-05,1,1,"[{'label': 'positive', 'score': 0.8845486044883728}, {'label': 'neutral', 'score': 0.09384884685277939}, {'label': 'negative', 'score': 0.021602461114525795}]","(0.09384884685277939, 0.8845486044883728, 0.021602461114525795)",0.9523203979236005,0.8845486044883728,0,0,"[{'label': 'neutral', 'score': 0.6199273467063904}, {'label': 'positive', 'score': 0.3794819712638855}, {'label': 'negative', 'score': 0.0005906422156840563}]","(0.6199273467063904, 0.3794819712638855, 0.0005906422156840563)",0.9968919506708115,0.3794819712638855,0,1
2017-03-07,49.88814163208008,62.93893051147461,63.27289962768555,62.20419692993164,62.433204650878906,8728478.0,,-0.0024257135087004636,-0.007702215866758391,0.08563302761578137,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-08,49.76712417602539,62.786258697509766,63.09160232543945,62.28053283691406,62.93893051147461,8821645.0,Here's Your March PDUFA Date Preview | Everything We Know About Merck's Keytruda | REMINDER: Merck's PDUFA Date For Keytruda In Microsatellite Instability-High Cancer Today,0.0013677589113485933,-0.0024286603180883807,0.04915944736012692,"[{'label': 'neutral', 'score': 0.9998338222503662}, {'label': 'positive', 'score': 9.690054866950959e-05}, {'label': 'negative', 'score': 6.923929322510958e-05}]","(0.9998338222503662, 9.690054866950959e-05, 6.923929322510958e-05)",0.16649381105072478,9.690054866950959e-05,1,1,"[{'label': 'neutral', 'score': 0.937214195728302}, {'label': 'positive', 'score': 0.046538591384887695}, {'label': 'negative', 'score': 0.01624719426035881}]","(0.937214195728302, 0.046538591384887695, 0.01624719426035881)",0.48245628868422447,0.046538591384887695,1,1,"[{'label': 'neutral', 'score': 0.9941824078559875}, {'label': 'negative', 'score': 0.004102461505681276}, {'label': 'positive', 'score': 0.0017151993233710527}]","(0.9941824078559875, 0.0017151993233710527, 0.004102461505681276)",-0.4103474321481024,-0.004102461505681276,1,1
2017-03-09,49.83518600463867,62.87213516235352,63.0057258605957,62.51908493041992,62.9484748840332,8106280.0,,-0.0044012235982861395,0.001366824381173023,0.05512153406131615,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-10,49.6158561706543,62.59542083740234,63.16793823242188,62.5,63.04389190673828,9247447.0,"Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump | Feuerstein on Benzinga's PreMarket Prep Discussing Stocks Which Could Be Impacted by Drug Pricing Changes: Believes Worst Case Scenario Would Create Vulnerabilities for Drugs with High Levels of Competition",-0.0073679015692227545,-0.004410937495367452,0.05565598157918056,"[{'label': 'negative', 'score': 0.9887969493865967}, {'label': 'neutral', 'score': 0.00874872412532568}, {'label': 'positive', 'score': 0.002454371890053153}]","(0.00874872412532568, 0.002454371890053153, 0.9887969493865967)",-0.9950479321694278,-0.9887969493865967,0,0,"[{'label': 'neutral', 'score': 0.7851912379264832}, {'label': 'negative', 'score': 0.1594102829694748}, {'label': 'positive', 'score': 0.05539841949939728}]","(0.7851912379264832, 0.05539841949939728, 0.1594102829694748)",-0.48420693516897845,-0.1594102829694748,1,1,"[{'label': 'neutral', 'score': 0.9701145887374878}, {'label': 'negative', 'score': 0.026131246238946915}, {'label': 'positive', 'score': 0.003754175966605544}]","(0.9701145887374878, 0.003754175966605544, 0.026131246238946915)",-0.7487620592552278,-0.026131246238946915,0,1
2017-03-11,49.367000579833984,62.13422393798828,62.87849807739258,62.02608108520508,62.77989705403646,11125009.0,,-0.007422590485307261,-0.0073951786216706296,0.05971928033301178,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-12,49.11814498901367,61.67302703857422,62.58905792236328,61.55216217041016,62.51590220133463,13002571.0,,-0.0074780973394672785,-0.007450274988960291,0.0587850857737639,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-13,48.86928939819336,61.21183013916016,62.299617767333984,61.078243255615234,62.25190734863281,14880133.0,,0.0007794313385614999,-0.007506198492468683,0.060902007043739034,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-14,48.90738296508789,61.25954055786133,61.55534362792969,61.11641311645508,61.1927490234375,8271759.0,"Merck Says Submission Of Additional Data Is Considered Major Amendment to sBLA Under PDUFA; Thus, Extending  Target Action Date By 3 Months To June 9th, 2017 | FDA Has Approved Merck's Keytruda For Intravenous Use In Hodgkin Lymphoma",0.00778818071388927,0.0007791277397017004,0.05700121748083072,"[{'label': 'positive', 'score': 0.9602383971214294}, {'label': 'neutral', 'score': 0.03937651216983795}, {'label': 'negative', 'score': 0.00038515645428560674}]","(0.03937651216983795, 0.9602383971214294, 0.00038515645428560674)",0.9991981115748163,0.9602383971214294,0,0,"[{'label': 'positive', 'score': 0.890102744102478}, {'label': 'neutral', 'score': 0.0992259532213211}, {'label': 'negative', 'score': 0.010671264491975307}]","(0.0992259532213211, 0.890102744102478, 0.010671264491975307)",0.9763064555811807,0.890102744102478,0,0,"[{'label': 'neutral', 'score': 0.9529895782470703}, {'label': 'positive', 'score': 0.04654092714190483}, {'label': 'negative', 'score': 0.0004695738316513598}]","(0.9529895782470703, 0.04654092714190483, 0.0004695738316513598)",0.9800225982737134,0.04654092714190483,0,1
2017-03-15,49.28828430175781,61.73664093017578,61.9942741394043,61.27862548828125,61.450382232666016,9458200.0,Prima Biomed Completes Recruitment For Second Patient Cohort In Melanoma Trial,-0.008037066490194878,0.0077580093863904385,0.10916649435879515,"[{'label': 'neutral', 'score': 0.9922435879707336}, {'label': 'positive', 'score': 0.00757072027772665}, {'label': 'negative', 'score': 0.0001856969902291894}]","(0.9922435879707336, 0.00757072027772665, 0.0001856969902291894)",0.9521178441504531,0.00757072027772665,0,1,"[{'label': 'positive', 'score': 0.5829595923423767}, {'label': 'neutral', 'score': 0.39993640780448914}, {'label': 'negative', 'score': 0.017103981226682663}]","(0.39993640780448914, 0.5829595923423767, 0.017103981226682663)",0.9429927694995663,0.5829595923423767,0,0,"[{'label': 'neutral', 'score': 0.9706530570983887}, {'label': 'positive', 'score': 0.029137423262000084}, {'label': 'negative', 'score': 0.00020960885740350932}]","(0.9706530570983887, 0.029137423262000084, 0.00020960885740350932)",0.985715158074542,0.029137423262000084,0,1
2017-03-16,48.89215469360352,61.24045944213867,61.82251739501953,61.05915832519531,61.61259460449219,10074634.0,,-0.0043627625302116585,-0.008069537808871602,0.11105784272750058,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-17,48.67885208129883,60.97328186035156,61.73664093017578,60.96374130249024,61.3072509765625,15142762.0,,0.0010954646940001705,-0.004372307149380002,0.10509880924121837,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-18,48.73217646280924,61.0400759379069,61.609414418538414,60.99872843424479,61.272263844807945,14626447.333333334,,0.0010942659642705825,0.0010948651103941669,0.09546109478725696,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-19,48.785500844319664,61.10687001546224,61.48218790690104,61.03371556599935,61.23727671305338,14110132.666666666,,0.0010930698551314256,0.0010936676916767037,0.09576511543700018,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-20,48.83882522583008,61.17366409301758,61.35496139526367,61.06870269775391,61.20228958129883,13593818.0,Leerink Presents: Your 2017 Biopharma Catalyst Tracker,-0.00311967049275491,0.0010924728892547032,0.06689869201423915,"[{'label': 'neutral', 'score': 0.9998852014541626}, {'label': 'negative', 'score': 5.935105218668468e-05}, {'label': 'positive', 'score': 5.5471406085416675e-05}]","(0.9998852014541626, 5.5471406085416675e-05, 5.935105218668468e-05)",-0.03378821669254101,-5.935105218668468e-05,1,1,"[{'label': 'neutral', 'score': 0.907016396522522}, {'label': 'positive', 'score': 0.08058327436447144}, {'label': 'negative', 'score': 0.012400351464748383}]","(0.907016396522522, 0.08058327436447144, 0.012400351464748383)",0.7332788143253581,0.08058327436447144,0,1,"[{'label': 'neutral', 'score': 0.9995688796043396}, {'label': 'positive', 'score': 0.0002979162090923637}, {'label': 'negative', 'score': 0.00013324183237273246}]","(0.9995688796043396, 0.0002979162090923637, 0.00013324183237273246)",0.38193506993412357,0.0002979162090923637,1,1
2017-03-21,48.68646240234375,60.98282241821289,61.65076446533203,60.70610809326172,61.3740463256836,11057134.0,,-0.006415250676501933,-0.003124546809054204,0.042679643182449815,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-03-22,48.3741340637207,60.59160232543945,61.17366409301758,60.35305404663086,61.049617767333984,10007352.0,,-0.0034645525530063006,-0.006435916830241346,0.05434894324561399,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-23,48.2065315246582,60.38167953491211,60.89694595336914,60.29580307006836,60.45801544189453,9915128.0,,-0.0015802945220689387,-0.003470568013139821,0.05149799849110432,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-24,48.130348205566406,60.286258697509766,60.6202278137207,59.98091506958008,60.26717758178711,9575052.0,European Medicines Agency's CHMP Recommends Approval of Merck's KEYTRUDA,5.2772515466491637e-05,-0.0015815445045244095,0.043737655771413704,"[{'label': 'neutral', 'score': 0.8718462586402893}, {'label': 'positive', 'score': 0.12670917809009552}, {'label': 'negative', 'score': 0.0014445476699620485}]","(0.8718462586402893, 0.12670917809009552, 0.0014445476699620485)",0.9774560175852136,0.12670917809009552,0,1,"[{'label': 'positive', 'score': 0.5213025808334351}, {'label': 'neutral', 'score': 0.45979130268096924}, {'label': 'negative', 'score': 0.018906094133853912}]","(0.45979130268096924, 0.5213025808334351, 0.018906094133853912)",0.9300044778621938,0.5213025808334351,0,0,"[{'label': 'positive', 'score': 0.9809128642082214}, {'label': 'neutral', 'score': 0.018778426572680473}, {'label': 'negative', 'score': 0.00030869984766468406}]","(0.018778426572680473, 0.9809128642082214, 0.00030869984766468406)",0.999370784624038,0.9809128642082214,0,0
2017-03-25,48.13289006551107,60.2894401550293,60.58206049601237,59.96501159667969,60.19084167480469,9183589.0,,5.2769730675063425e-05,5.277112304621916e-05,0.03834206646940496,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-26,48.13543192545573,60.29262161254883,60.54389317830404,59.9491081237793,60.114505767822266,8792126.0,,5.276694617752509e-05,5.2768338401881516e-05,0.04351794811080102,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-27,48.13797378540039,60.29580307006836,60.5057258605957,59.933204650878906,60.03816986083984,8400663.0,,0.0023737546250097194,5.2765554051285625e-05,0.024802627557896674,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-28,48.25224304199219,60.43893051147461,60.49618148803711,60.0,60.30534362792969,10673880.0,,0.004736329632031098,0.002370941720051227,0.022381611082790374,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-03-29,48.48077774047852,60.725189208984375,61.17366409301758,60.55343627929688,60.75381851196289,8525794.0,,-0.0029855370499079575,0.004725148513913914,0.033138863604708274,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-30,48.336036682128906,60.54389190673828,60.76335906982422,60.41984558105469,60.59160232543945,5577456.0,,0.0014184796655177946,-0.002990002656016036,0.04583482493803962,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-03-31,48.40460968017578,60.6297721862793,60.71564865112305,60.35305404663086,60.36259460449219,7979472.0,"UPDATE: Incyte, Merck Announce Clinical Program for Epacadostat, KEYTRUDA Includes 7 Registrational Trials Across 5 Tumor Types | Incyte, Merck Offer Added Details on Previously Announced Collab. Investigating Epacadostat, KEYTRUDA",-0.0003672307444152695,0.0014174745735931853,0.045375442673967085,"[{'label': 'neutral', 'score': 0.9998045563697815}, {'label': 'positive', 'score': 0.00013957569899503142}, {'label': 'negative', 'score': 5.588213389273733e-05}]","(0.9998045563697815, 0.00013957569899503142, 5.588213389273733e-05)",0.42819243345622615,0.00013957569899503142,1,1,"[{'label': 'neutral', 'score': 0.8881804943084717}, {'label': 'positive', 'score': 0.10003016144037247}, {'label': 'negative', 'score': 0.011789364740252495}]","(0.8881804943084717, 0.10003016144037247, 0.011789364740252495)",0.7891358487567041,0.10003016144037247,0,1,"[{'label': 'neutral', 'score': 0.9968206882476807}, {'label': 'positive', 'score': 0.0030636333394795656}, {'label': 'negative', 'score': 0.00011567975889192894}]","(0.9968206882476807, 0.0030636333394795656, 0.00011567975889192894)",0.9272297157828322,0.0030636333394795656,0,1
2017-04-01,48.38683573404948,60.6075070699056,60.74109395345052,60.343512217203774,60.41666666666666,7640479.0,,-0.00036736565237738186,-0.00036729819013767037,0.04608752640146841,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-02,48.36906178792318,60.5852419535319,60.76653925577799,60.333970387776695,60.47073872884115,7301486.0,,-0.00036750065949678974,-0.00036743314766946353,0.045163641710939506,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-03,48.35128784179688,60.5629768371582,60.79198455810547,60.32442855834961,60.524810791015625,6962493.0,"Benzinga Premarket Prep Host Dennis Dick Tweets: Notable opening imbalances: $PFE -243K, $MRK -93K, $BABA +115K, $KO +104K, $T +111K, $CAT -55K, $IBM -42K",0.003151127714838437,-0.000367568204413162,0.02500352274733728,"[{'label': 'negative', 'score': 0.9726780652999878}, {'label': 'neutral', 'score': 0.026709498837590218}, {'label': 'positive', 'score': 0.0006124761421233416}]","(0.026709498837590218, 0.0006124761421233416, 0.9726780652999878)",-0.998741432047175,-0.9726780652999878,0,0,"[{'label': 'negative', 'score': 0.7004079222679138}, {'label': 'neutral', 'score': 0.27890172600746155}, {'label': 'positive', 'score': 0.02069034054875374}]","(0.27890172600746155, 0.02069034054875374, 0.7004079222679138)",-0.9426143658481838,-0.7004079222679138,0,0,"[{'label': 'neutral', 'score': 0.9963401556015015}, {'label': 'negative', 'score': 0.0026866095140576363}, {'label': 'positive', 'score': 0.0009731730679050088}]","(0.9963401556015015, 0.0009731730679050088, 0.0026866095140576363)",-0.46817984614642233,-0.0026866095140576363,1,1
2017-04-04,48.50362777709961,60.75381851196289,60.84923553466797,60.46755599975586,60.67748260498047,6650189.0,,-0.0015706146500660638,0.0031461733171322397,0.024994758824611187,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-05,48.42744827270508,60.65839767456055,61.21183013916016,60.60114669799805,60.77289962768555,8083538.0,There Is Value To Be Had With The Right Healthcare ETFs,-0.005191169113594007,-0.0015718493582587323,0.028318957448908035,"[{'label': 'neutral', 'score': 0.9997629523277283}, {'label': 'positive', 'score': 0.0001755679550115019}, {'label': 'negative', 'score': 6.146990199340507e-05}]","(0.9997629523277283, 0.0001755679550115019, 6.146990199340507e-05)",0.48134949606692934,0.0001755679550115019,0,0,"[{'label': 'neutral', 'score': 0.7730745077133179}, {'label': 'positive', 'score': 0.21965356171131134}, {'label': 'negative', 'score': 0.007271991576999426}]","(0.7730745077133179, 0.21965356171131134, 0.007271991576999426)",0.9359085702634793,0.21965356171131134,0,0,"[{'label': 'neutral', 'score': 0.9347609281539917}, {'label': 'positive', 'score': 0.06491988152265549}, {'label': 'negative', 'score': 0.00031925205257721245}]","(0.9347609281539917, 0.06491988152265549, 0.00031925205257721245)",0.9902128665700609,0.06491988152265549,0,0
2017-04-06,48.176063537597656,60.343509674072266,61.040077209472656,60.29580307006836,60.57251739501953,7915125.0,,-0.0017393982522824743,-0.0052046900452375,0.04756842195760872,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-07,48.09225845336914,60.238548278808594,60.42938995361328,60.06679534912109,60.38167953491211,8091713.0,"Pre-Market Imbalance Update: AmEx 89K Shares to Sell, Ford 71K Shares to Buy, Merck 40K to Buy, BofA 29K to Sell, Morgan Stanley 22K to Sell, Nike, GE 20K to Sell | Merck Reports Received CRL from FDA Related to TECOS Study with Sitagliptin",-0.0030624491039530086,-0.0017409127619008315,0.04764794155553743,"[{'label': 'neutral', 'score': 0.9990799427032471}, {'label': 'positive', 'score': 0.000780927250161767}, {'label': 'negative', 'score': 0.00013909874542150646}]","(0.9990799427032471, 0.000780927250161767, 0.00013909874542150646)",0.697619967067732,0.000780927250161767,0,1,"[{'label': 'neutral', 'score': 0.693993091583252}, {'label': 'negative', 'score': 0.20327867567539215}, {'label': 'positive', 'score': 0.10272824764251709}]","(0.693993091583252, 0.10272824764251709, 0.20327867567539215)",-0.32858873564900903,-0.20327867567539215,1,1,"[{'label': 'negative', 'score': 0.8778752684593201}, {'label': 'neutral', 'score': 0.11375045031309128}, {'label': 'positive', 'score': 0.008374311029911041}]","(0.11375045031309128, 0.008374311029911041, 0.8778752684593201)",-0.981101686875299,-0.8778752684593201,0,0
2017-04-08,47.94498062133789,60.054070790608726,60.42938995361328,59.933207194010414,60.37849807739258,7926338.666666667,"Barron's Picks And Pans: Gold, Energy, Dividends And More",-0.0030718565081640256,-0.0030671479970764957,0.048705696156176356,"[{'label': 'neutral', 'score': 0.9998651742935181}, {'label': 'positive', 'score': 6.83858452248387e-05}, {'label': 'negative', 'score': 6.636576290475205e-05}]","(0.9998651742935181, 6.83858452248387e-05, 6.636576290475205e-05)",0.01499115556486675,6.83858452248387e-05,1,1,"[{'label': 'neutral', 'score': 0.9359602928161621}, {'label': 'negative', 'score': 0.03716173395514488}, {'label': 'positive', 'score': 0.02687796764075756}]","(0.9359602928161621, 0.02687796764075756, 0.03716173395514488)",-0.16058423225140894,-0.03716173395514488,1,1,"[{'label': 'neutral', 'score': 0.9991804957389832}, {'label': 'positive', 'score': 0.0007204905268736184}, {'label': 'negative', 'score': 9.902537567541003e-05}]","(0.9991804957389832, 0.0007204905268736184, 9.902537567541003e-05)",0.7583320217035429,0.0007204905268736184,0,1
2017-04-09,47.79770278930664,59.86959330240885,60.42938995361328,59.79961903889974,60.37531661987305,7760964.333333333,,-0.003081321886855912,-0.003076584344005487,0.023104074120380486,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-10,47.65042495727539,59.68511581420898,60.42938995361328,59.66603088378906,60.37213516235352,7595590.0,Cardiovascular Players Could Be Eyeing Esperion,0.00047960849016983,-0.0030860789336494446,0.01974354672502084,"[{'label': 'neutral', 'score': 0.9995854496955872}, {'label': 'positive', 'score': 0.00027893096557818353}, {'label': 'negative', 'score': 0.00013565816334448755}]","(0.9995854496955872, 0.00027893096557818353, 0.00013565816334448755)",0.3455778076140032,0.00027893096557818353,1,1,"[{'label': 'neutral', 'score': 0.785520076751709}, {'label': 'negative', 'score': 0.14627885818481445}, {'label': 'positive', 'score': 0.06820113211870193}]","(0.785520076751709, 0.06820113211870193, 0.14627885818481445)",-0.3640326818162507,-0.14627885818481445,1,1,"[{'label': 'neutral', 'score': 0.9993730187416077}, {'label': 'positive', 'score': 0.0004792778054252267}, {'label': 'negative', 'score': 0.00014774168084841222}]","(0.9993730187416077, 0.0004792778054252267, 0.00014774168084841222)",0.5287493161450617,0.0004792778054252267,0,1
2017-04-11,47.67327499389648,59.71374130249024,59.88549423217773,59.332061767578125,59.62786483764648,6858950.0,,0.007510349536869964,0.0004794935147786503,0.024649178765208182,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-04-12,48.03132629394531,60.16221237182617,60.314884185791016,59.42748260498047,59.51335906982422,9965642.0,Healthcare Sector Earnings: Making A Comeback In Q1 2017?,-0.0069785595393312555,0.007482287279110534,0.07287142993305218,"[{'label': 'positive', 'score': 0.9991706609725952}, {'label': 'neutral', 'score': 0.0005326259997673333}, {'label': 'negative', 'score': 0.00029674405232071877}]","(0.0005326259997673333, 0.9991706609725952, 0.00029674405232071877)",0.9994061956381393,0.9991706609725952,0,0,"[{'label': 'positive', 'score': 0.9031608700752258}, {'label': 'neutral', 'score': 0.06068689748644829}, {'label': 'negative', 'score': 0.03615229204297066}]","(0.06068689748644829, 0.9031608700752258, 0.03615229204297066)",0.9230239849690907,0.9031608700752258,0,0,"[{'label': 'positive', 'score': 0.9973451495170593}, {'label': 'neutral', 'score': 0.0023699563462287188}, {'label': 'negative', 'score': 0.0002849572629202157}]","(0.0023699563462287188, 0.9973451495170593, 0.0002849572629202157)",0.9994287316291206,0.9973451495170593,0,0
2017-04-13,47.69613265991211,59.74236679077149,60.114505767822266,59.69465637207031,59.91412353515625,6217260.0,,0.0007586630392506923,-0.007003023568177808,0.08652335047832231,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-14,47.7323169708252,59.78769111633301,60.07633686065674,59.65410327911377,59.895039558410645,6060505.5,,0.0007580879059760444,0.0007583753999187812,0.08511056720704382,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-15,47.76850128173828,59.83301544189453,60.03816795349121,59.61355018615723,59.87595558166504,5903751.0,,0.0007575136440438828,0.0007578007024806616,0.08140280320271343,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-16,47.80468559265137,59.878339767456055,59.99999904632568,59.57299709320069,59.85687160491944,5746996.5,,0.000756940251475664,0.0007572268753950428,0.08142334948278875,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-17,47.84086990356445,59.92366409301758,59.96183013916016,59.53244400024414,59.83778762817383,5590242.0,,-0.008439501626780933,0.0007566539166867237,0.05509435382456316,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-04-18,47.43712615966797,59.41793823242188,59.59923553466797,59.15076446533203,59.59923553466797,7749436.0,,0.005941876428795462,-0.008475315865877972,0.0655465921111426,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-19,47.71898651123047,59.770992279052734,59.770992279052734,59.16030502319336,59.40839767456055,10845857.0,Exclusive: Leading Biosciences Execs Talk About How The Company Could Save Hospitals Millions Of Dollars Per Year,-0.0014367582261781064,0.0059242930986515095,0.08272766444756988,"[{'label': 'positive', 'score': 0.8945954442024231}, {'label': 'neutral', 'score': 0.1040414422750473}, {'label': 'negative', 'score': 0.001363122370094061}]","(0.1040414422750473, 0.8945954442024231, 0.001363122370094061)",0.9969571754298668,0.8945954442024231,0,0,"[{'label': 'neutral', 'score': 0.8170316815376282}, {'label': 'positive', 'score': 0.17274059355258942}, {'label': 'negative', 'score': 0.010227685794234276}]","(0.8170316815376282, 0.17274059355258942, 0.010227685794234276)",0.8882026345687245,0.17274059355258942,0,1,"[{'label': 'positive', 'score': 0.9921201467514038}, {'label': 'neutral', 'score': 0.00755036948248744}, {'label': 'negative', 'score': 0.00032942648977041245}]","(0.00755036948248744, 0.9921201467514038, 0.00032942648977041245)",0.9993361345530241,0.9921201467514038,0,0
2017-04-20,47.65042495727539,59.68511581420898,59.875953674316406,59.39885330200195,59.790077209472656,9392490.0,What Would A $5.8 Billion NIH Cut Look Like? Devastation,-0.010551578524865032,-0.0014377913529658164,0.08283555285090885,"[{'label': 'neutral', 'score': 0.9982957243919373}, {'label': 'negative', 'score': 0.0015486807096749544}, {'label': 'positive', 'score': 0.00015565557987429202}]","(0.9982957243919373, 0.00015565557987429202, 0.0015486807096749544)",-0.817341705590909,-0.0015486807096749544,0,1,"[{'label': 'neutral', 'score': 0.9012377858161926}, {'label': 'negative', 'score': 0.05064701288938522}, {'label': 'positive', 'score': 0.048115167766809464}]","(0.9012377858161926, 0.048115167766809464, 0.05064701288938522)",-0.025635775817764453,-0.05064701288938522,1,1,"[{'label': 'neutral', 'score': 0.9479067325592041}, {'label': 'negative', 'score': 0.05047060549259186}, {'label': 'positive', 'score': 0.0016226308653131127}]","(0.9479067325592041, 0.0016226308653131127, 0.05047060549259186)",-0.9377028198376895,-0.05047060549259186,0,1
2017-04-21,47.14762878417969,59.05534362792969,59.761451721191406,59.036258697509766,59.50381851196289,11002323.0,Merck Reports Study in US Veterans Affairs System Evaluating Use of ZEPATIER Showed High Sustained Virologic Response Rates in Patients with Chronic Hep C | Atara Bio Partners With Merck To Evaluate KEYTRUDA In Combination With ATA129 In NPC,0.0013464673652087453,-0.010607641144366393,0.10760235925194511,"[{'label': 'positive', 'score': 0.9964189529418945}, {'label': 'negative', 'score': 0.002391487592831254}, {'label': 'neutral', 'score': 0.0011895557399839163}]","(0.0011895557399839163, 0.9964189529418945, 0.002391487592831254)",0.9952113284047153,0.9964189529418945,0,0,"[{'label': 'positive', 'score': 0.8961417078971863}, {'label': 'neutral', 'score': 0.08436595648527145}, {'label': 'negative', 'score': 0.019492361694574356}]","(0.08436595648527145, 0.8961417078971863, 0.019492361694574356)",0.9574232494357378,0.8961417078971863,0,0,"[{'label': 'positive', 'score': 0.9883821606636047}, {'label': 'neutral', 'score': 0.011261118575930595}, {'label': 'negative', 'score': 0.00035676464904099703}]","(0.011261118575930595, 0.9883821606636047, 0.00035676464904099703)",0.9992783440807124,0.9883821606636047,0,0
2017-04-22,47.21111297607422,59.13485972086588,59.72646458943685,59.08396911621094,59.54834747314453,10425189.333333334,,0.0013446568286716541,0.00134556169090881,0.1088911466533505,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-23,47.27459716796875,59.214375813802086,59.69147745768229,59.13167953491211,59.59287643432617,9848055.666666666,,0.0013428511546964817,0.001343753587287371,0.09751757793766141,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-24,47.33808135986328,59.29389190673828,59.65649032592773,59.17938995361328,59.63740539550781,9270922.0,"Earnings: Caterpillar, Lockheed Martin, and Eli Lilly Report Tomorrow",0.002574832062044047,0.0013419503364376674,0.0821653245062459,"[{'label': 'neutral', 'score': 0.9998745918273926}, {'label': 'negative', 'score': 7.000147888902575e-05}, {'label': 'positive', 'score': 5.543342558667064e-05}]","(0.9998745918273926, 5.543342558667064e-05, 7.000147888902575e-05)",-0.11614034676590151,-7.000147888902575e-05,1,1,"[{'label': 'neutral', 'score': 0.8832263350486755}, {'label': 'negative', 'score': 0.05973401665687561}, {'label': 'positive', 'score': 0.05703972280025482}]","(0.8832263350486755, 0.05703972280025482, 0.05973401665687561)",-0.023072771918980193,-0.05973401665687561,1,1,"[{'label': 'neutral', 'score': 0.7295116186141968}, {'label': 'positive', 'score': 0.2663204073905945}, {'label': 'negative', 'score': 0.0041679204441607}]","(0.7295116186141968, 0.2663204073905945, 0.0041679204441607)",0.969182252871873,0.2663204073905945,0,1
2017-04-25,47.45998001098633,59.446563720703125,60.04771041870117,59.39885330200195,59.62786483764648,11205006.0,Watching Volatility in Vaccine Names Here as Traders Circulating WSJ Article from Mon. Evening 'Vaunted Ebola Vaccine Faces Questions' | Mark Your Calendar For These Days In May To Play The Volatility Around FDA Decision Dates,0.0064205483214361805,0.0025715228611772967,0.08743383376303505,"[{'label': 'neutral', 'score': 0.9991592168807983}, {'label': 'negative', 'score': 0.0007542743114754558}, {'label': 'positive', 'score': 8.6475774878636e-05}]","(0.9991592168807983, 8.6475774878636e-05, 0.0007542743114754558)",-0.7942889896006131,-0.0007542743114754558,0,1,"[{'label': 'neutral', 'score': 0.9346080422401428}, {'label': 'negative', 'score': 0.03348519280552864}, {'label': 'positive', 'score': 0.031906820833683014}]","(0.9346080422401428, 0.031906820833683014, 0.03348519280552864)",-0.024137075523534147,-0.03348519280552864,1,1,"[{'label': 'negative', 'score': 0.5462016463279724}, {'label': 'neutral', 'score': 0.45030704140663147}, {'label': 'positive', 'score': 0.0034913441631942987}]","(0.45030704140663147, 0.0034913441631942987, 0.5462016463279724)",-0.9872971123023611,-0.5462016463279724,0,0
2017-04-26,47.76470184326172,59.828243255615234,60.0,59.57061004638672,59.761451721191406,9284546.0,,-0.00191384448037,0.006400024404087495,0.03475706578156381,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-27,47.67327499389648,59.71374130249024,60.02862548828125,59.58969497680664,59.904579162597656,6920258.0,,-0.003994927939574909,-0.0019156782207536758,0.04753727395466341,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-28,47.48282241821289,59.475189208984375,59.78053283691406,59.29389190673828,59.71374130249024,9915862.0,,0.0002673967600928327,-0.004002928980359513,0.0640925878304818,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-29,47.49552281697592,59.491092681884766,59.73282368977865,59.28116989135742,59.608778635660805,10179748.333333334,,0.00026732527817967597,0.00026736101595091315,0.06405757712202065,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-04-30,47.50822321573893,59.50699615478516,59.68511454264323,59.26844787597656,59.50381596883138,10443634.666666666,,0.0002672538344737918,0.0002672895531442266,0.0617832617383585,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-01,47.52092361450195,59.52289962768555,59.63740539550781,59.2557258605957,59.39885330200195,10707521.0,"Earnings Preview: Q1 Results From Pfizer, Merck, And Gilead Sciences This Week | Feuerstein On Neurotrope: The Study Failed And There Was Never 'A Lot Of Hope Here' | Looking For Action? Week Ahead Brings Heavy Load With Earnings, Data, Fed Meeting",0.005129851365434233,0.0002672181285294399,0.03040226468454647,"[{'label': 'negative', 'score': 0.7837704420089722}, {'label': 'neutral', 'score': 0.2108774334192276}, {'label': 'positive', 'score': 0.005352108273655176}]","(0.2108774334192276, 0.005352108273655176, 0.7837704420089722)",-0.9864352925366578,-0.7837704420089722,0,0,"[{'label': 'negative', 'score': 0.634915828704834}, {'label': 'neutral', 'score': 0.29799017310142517}, {'label': 'positive', 'score': 0.06709395349025726}]","(0.29799017310142517, 0.06709395349025726, 0.634915828704834)",-0.8088517989579479,-0.634915828704834,0,0,"[{'label': 'negative', 'score': 0.8297903537750244}, {'label': 'neutral', 'score': 0.16219249367713928}, {'label': 'positive', 'score': 0.008017141371965408}]","(0.16219249367713928, 0.008017141371965408, 0.8297903537750244)",-0.9808616145871103,-0.8297903537750244,0,0
2017-05-02,47.76470184326172,59.828243255615234,60.343509674072266,59.45610809326172,59.64694595336914,13647580.0,"Apple Earnings In Focus, But Fed Meeting, Auto Sales Also Could Grab Headlines | A Peek Into The Markets: U.S. Stock Futures Mostly Lower; Apple Earnings In Focus | Merck Raises FY 2017 Guidance , Sees FY 2017 EPS $3.76 to $3.88 vs $3.81 Est, Sales $39.1B to $40.3B vs $39.7B Est | Merck Q1 EPS $0.88 vs $0.83 Est, Sales $9.43B vs $9.25B Est | 12 Stocks To Watch For May 2, 2017 | Earnings Scheduled For May 2, 2017",0.014832549766109407,0.005116738503488819,0.05124591351455164,"[{'label': 'negative', 'score': 0.9982327222824097}, {'label': 'neutral', 'score': 0.0009055270347744226}, {'label': 'positive', 'score': 0.0008616360719315708}]","(0.0009055270347744226, 0.0008616360719315708, 0.9982327222824097)",-0.9982751657744303,-0.9982327222824097,0,0,"[{'label': 'negative', 'score': 0.9331547021865845}, {'label': 'neutral', 'score': 0.049066875129938126}, {'label': 'positive', 'score': 0.017778463661670685}]","(0.049066875129938126, 0.017778463661670685, 0.9331547021865845)",-0.9626083844792355,-0.9331547021865845,0,0,"[{'label': 'neutral', 'score': 0.9307813048362732}, {'label': 'positive', 'score': 0.05958913266658783}, {'label': 'negative', 'score': 0.009629609994590282}]","(0.9307813048362732, 0.05958913266658783, 0.009629609994590282)",0.7217629322818911,0.05958913266658783,1,0
2017-05-03,48.47316360473633,60.71564865112305,60.75381851196289,59.52289962768555,59.63740539550781,11978430.0,"Ahead Of Merck's Keytruda PDUFA Date, Analyst Says Expect Approval",-0.003928942276138911,0.014723623283887342,0.09975713367734346,"[{'label': 'positive', 'score': 0.9256436824798584}, {'label': 'neutral', 'score': 0.07361268252134323}, {'label': 'negative', 'score': 0.00074361776933074}]","(0.07361268252134323, 0.9256436824798584, 0.00074361776933074)",0.998394585571001,0.9256436824798584,0,0,"[{'label': 'neutral', 'score': 0.9032179713249207}, {'label': 'positive', 'score': 0.08275225013494492}, {'label': 'negative', 'score': 0.01402982883155346}]","(0.9032179713249207, 0.08275225013494492, 0.01402982883155346)",0.7100738281017923,0.08275225013494492,0,1,"[{'label': 'positive', 'score': 0.9832979440689087}, {'label': 'neutral', 'score': 0.015582777559757233}, {'label': 'negative', 'score': 0.0011192701058462262}]","(0.015582777559757233, 0.9832979440689087, 0.0011192701058462262)",0.9977260249216903,0.9832979440689087,0,0
2017-05-04,48.28271865844727,60.47710037231445,60.96374130249024,60.32442855834961,60.75381851196289,9023280.0,,0.00930892575358864,-0.003936680846090426,0.1135231530707203,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-05,48.732177734375,61.040077209472656,61.154579162597656,60.524810791015625,60.59160232543945,9795237.0,"Pre-Market Imbalance Update: IBM 110K Shares to Sell, Twitter 100K to Sell, Ford 63K Shares to Buy, Merck 62K to Sell, Disney 38K to Sell, P&G 20K to Sell | Merck Reports EC Approval of KEYTRUDA for Patients with Relapsed, Refractory Classical Hodgkin Lymphoma Who Who Failed Autologous Stem Cell Transplant and Brentuximab Vedotin (BV), or Who are Transplant-Ineligible and Have Failed BV",0.00020842069608149484,0.009265864732528432,0.1163790410555041,"[{'label': 'neutral', 'score': 0.9891525506973267}, {'label': 'positive', 'score': 0.010502511635422707}, {'label': 'negative', 'score': 0.00034492998383939266}]","(0.9891525506973267, 0.010502511635422707, 0.00034492998383939266)",0.9364034403786251,0.010502511635422707,0,1,"[{'label': 'neutral', 'score': 0.6241834759712219}, {'label': 'positive', 'score': 0.23346851766109467}, {'label': 'negative', 'score': 0.14234794676303864}]","(0.6241834759712219, 0.23346851766109467, 0.14234794676303864)",0.24246029518073628,0.23346851766109467,1,1,"[{'label': 'neutral', 'score': 0.5765178799629211}, {'label': 'negative', 'score': 0.3731469511985779}, {'label': 'positive', 'score': 0.050335220992565155}]","(0.5765178799629211, 0.050335220992565155, 0.3731469511985779)",-0.7622793860146451,-0.3731469511985779,0,1
2017-05-06,48.742332458496094,61.05279922485352,61.288167317708336,60.65203730265299,60.7220090230306,10425050.0,Near-Term Events Cast Shadow Of Uncertainty On Bristol-Myers,0.00020837726594644592,0.00020839897950563865,0.11653316527436,"[{'label': 'neutral', 'score': 0.9592933654785156}, {'label': 'negative', 'score': 0.040355753153562546}, {'label': 'positive', 'score': 0.00035079734516330063}]","(0.9592933654785156, 0.00035079734516330063, 0.040355753153562546)",-0.9827645751916866,-0.040355753153562546,0,1,"[{'label': 'negative', 'score': 0.7942134737968445}, {'label': 'neutral', 'score': 0.1598915308713913}, {'label': 'positive', 'score': 0.04589495807886124}]","(0.1598915308713913, 0.04589495807886124, 0.7942134737968445)",-0.8907403941265253,-0.7942134737968445,0,0,"[{'label': 'neutral', 'score': 0.9978240728378296}, {'label': 'negative', 'score': 0.001607678597792983}, {'label': 'positive', 'score': 0.0005682214978151023}]","(0.9978240728378296, 0.0005682214978151023, 0.001607678597792983)",-0.4777136147362455,-0.001607678597792983,1,1
2017-05-07,48.75248718261719,61.065521240234375,61.42175547281901,60.77926381429037,60.85241572062174,11054863.0,,0.00020833385390768092,0.00020835555841950494,0.1215268589421494,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-08,48.76264190673828,61.078243255615234,61.55534362792969,60.90649032592773,60.98282241821289,11684676.0,Array BioPharma Reports Strategic Partnership with Merck,-0.011248246940675317,0.0002083121554239078,0.07711536326799127,"[{'label': 'neutral', 'score': 0.999504804611206}, {'label': 'positive', 'score': 0.0004219995462335646}, {'label': 'negative', 'score': 7.31173058738932e-05}]","(0.999504804611206, 0.0004219995462335646, 7.31173058738932e-05)",0.7046462645629191,0.0004219995462335646,0,1,"[{'label': 'positive', 'score': 0.6776610612869263}, {'label': 'neutral', 'score': 0.314780056476593}, {'label': 'negative', 'score': 0.007558806333690882}]","(0.314780056476593, 0.6776610612869263, 0.007558806333690882)",0.9779375739353899,0.6776610612869263,0,0,"[{'label': 'neutral', 'score': 0.9124209880828857}, {'label': 'positive', 'score': 0.08713456988334656}, {'label': 'negative', 'score': 0.0004444022197276354}]","(0.9124209880828857, 0.08713456988334656, 0.0004444022197276354)",0.9898513944830363,0.08713456988334656,0,1
2017-05-09,48.21415710449219,60.39122009277344,61.32633590698242,60.26717758178711,61.24045944213867,10712970.0,UPDATE: Merck 10-Q Filing Shows Co. Eliminated ~545 Positions in Q1'17 Under Restructuring Program Activities | Merck 10-Q Just Out,0.010270228478000019,-0.011311986896207044,0.11598814659385347,"[{'label': 'neutral', 'score': 0.5498266816139221}, {'label': 'positive', 'score': 0.4412260055541992}, {'label': 'negative', 'score': 0.008947261609137058}]","(0.5498266816139221, 0.4412260055541992, 0.008947261609137058)",0.9602496982305672,0.4412260055541992,0,1,"[{'label': 'negative', 'score': 0.9696822762489319}, {'label': 'neutral', 'score': 0.021894482895731926}, {'label': 'positive', 'score': 0.008423198945820332}]","(0.021894482895731926, 0.008423198945820332, 0.9696822762489319)",-0.9827765017997815,-0.9696822762489319,0,0,"[{'label': 'negative', 'score': 0.9786310195922852}, {'label': 'neutral', 'score': 0.019527306780219078}, {'label': 'positive', 'score': 0.0018415938830003142}]","(0.019527306780219078, 0.0018415938830003142, 0.9786310195922852)",-0.996243456762198,-0.9786310195922852,0,0
2017-05-10,48.709320068359375,61.011451721191406,61.020992279052734,60.200382232666016,60.238548278808594,10094126.0,"Merck Press Release Confirms FDA Approval For KEYTRUDA | Andy Biotech Tweets: '$MRK FDA approves Keytruda chemo combo in 1L NSCLC' | Reminder: Merck Has Keytruda PDUFA Date Today | OncoSec Medical +21.5% Premarket @$1.30 Following Announcement of  Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse IL-12 and KEYTRUDA | OncoSec Medical Reports Clinical Trial Collaboration, Supply Deal with Merck to Evaluate Combo of ImmunoPulse IL-12 and KEYTRUDA",0.007663413778326274,0.010217848015775821,0.1210142836521727,"[{'label': 'positive', 'score': 0.9951321482658386}, {'label': 'neutral', 'score': 0.004585845861583948}, {'label': 'negative', 'score': 0.0002819219371303916}]","(0.004585845861583948, 0.9951321482658386, 0.0002819219371303916)",0.9994335584646239,0.9951321482658386,0,0,"[{'label': 'positive', 'score': 0.8120322227478027}, {'label': 'neutral', 'score': 0.1790073662996292}, {'label': 'negative', 'score': 0.008960433304309845}]","(0.1790073662996292, 0.8120322227478027, 0.008960433304309845)",0.9781717089957962,0.8120322227478027,0,0,"[{'label': 'neutral', 'score': 0.7017678618431091}, {'label': 'positive', 'score': 0.2971709370613098}, {'label': 'negative', 'score': 0.001061199582181871}]","(0.7017678618431091, 0.2971709370613098, 0.001061199582181871)",0.9928833988575119,0.2971709370613098,0,1
2017-05-11,49.08259582519531,61.47900772094727,62.261451721191406,61.364505767822266,61.78435134887695,19404663.0,"Here's What The FDA Approval Of Keytruda Means For Merck, And For Bristol-Myers",-0.013347808899445292,0.007634198984728191,0.13306541760174379,"[{'label': 'neutral', 'score': 0.9997465014457703}, {'label': 'positive', 'score': 0.00018398200336378068}, {'label': 'negative', 'score': 6.946073699509725e-05}]","(0.9997465014457703, 0.00018398200336378068, 6.946073699509725e-05)",0.45186248462481093,0.00018398200336378068,1,1,"[{'label': 'neutral', 'score': 0.9224756360054016}, {'label': 'positive', 'score': 0.06546324491500854}, {'label': 'negative', 'score': 0.012061088345944881}]","(0.9224756360054016, 0.06546324491500854, 0.012061088345944881)",0.6888438032650667,0.06546324491500854,0,1,"[{'label': 'positive', 'score': 0.8931465148925781}, {'label': 'neutral', 'score': 0.1062721312046051}, {'label': 'negative', 'score': 0.0005813449970446527}]","(0.1062721312046051, 0.8931465148925781, 0.0005813449970446527)",0.9986990558913169,0.8931465148925781,0,0
2017-05-12,48.42744827270508,60.65839767456055,61.70801544189453,60.37213516235352,61.44084167480469,10838521.0,"Sympathy Moves, Explained: Unsympathetic Earnings Season Continues As Nvidia, Advanced Micro Devices Diverge",-0.00031460868710298575,-0.013437691621633777,0.17066240564487273,"[{'label': 'negative', 'score': 0.9947709441184998}, {'label': 'positive', 'score': 0.0030292682349681854}, {'label': 'neutral', 'score': 0.0021997743751853704}]","(0.0021997743751853704, 0.0030292682349681854, 0.9947709441184998)",-0.9939281066540903,-0.9947709441184998,0,0,"[{'label': 'negative', 'score': 0.7974942922592163}, {'label': 'positive', 'score': 0.11888792365789413}, {'label': 'neutral', 'score': 0.08361777663230896}]","(0.08361777663230896, 0.11888792365789413, 0.7974942922592163)",-0.7405276497232942,-0.7974942922592163,0,0,"[{'label': 'negative', 'score': 0.8249800205230713}, {'label': 'neutral', 'score': 0.17232362926006317}, {'label': 'positive', 'score': 0.0026963548734784126}]","(0.17232362926006317, 0.0026963548734784126, 0.8249800205230713)",-0.9934845189409047,-0.8249800205230713,0,0
2017-05-13,48.4122174580892,60.63931401570638,61.36768468221029,60.39440027872721,61.13231658935547,10129129.666666666,,-0.000314707696878439,-0.000314658186798275,0.17040409874361212,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-14,48.396986643473305,60.62023035685221,61.02735392252604,60.416665395100914,60.82379150390625,9419738.333333334,,-0.00031480676899155294,-0.00031475722773780727,0.14648263874925954,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-15,48.38175582885742,60.60114669799805,60.6870231628418,60.43893051147461,60.51526641845703,8710347.0,WHO Confirms Second Ebola Case in Congo -Reuters,0.004408724614094964,-0.0003148563310443588,0.12038574672561318,"[{'label': 'neutral', 'score': 0.9905418753623962}, {'label': 'positive', 'score': 0.00884295254945755}, {'label': 'negative', 'score': 0.0006151851266622543}]","(0.9905418753623962, 0.00884295254945755, 0.0006151851266622543)",0.8699141104246151,0.00884295254945755,0,1,"[{'label': 'neutral', 'score': 0.7240578532218933}, {'label': 'negative', 'score': 0.23123180866241455}, {'label': 'positive', 'score': 0.04471033811569214}]","(0.7240578532218933, 0.04471033811569214, 0.23123180866241455)",-0.675944116274162,-0.23123180866241455,0,1,"[{'label': 'neutral', 'score': 0.6761599183082581}, {'label': 'negative', 'score': 0.23183804750442505}, {'label': 'positive', 'score': 0.09200212359428406}]","(0.6761599183082581, 0.09200212359428406, 0.23183804750442505)",-0.43180536693675925,-0.23183804750442505,1,1
2017-05-16,48.59505462646485,60.86832046508789,60.94465637207031,60.24809265136719,60.53435134887695,8248494.0,,-0.012384351851764808,0.004399034657527879,0.10657474294782374,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-17,47.99323272705078,60.114505767822266,60.86832046508789,60.0,60.86832046508789,8296911.0,"Incyte Issues Release Highlighting Co.'s IDO1 Enzyme Inhibitor in Combo with Merck's Anti-PD-1 Therapy is 'well-tolerated and demonstrates durable clinical responses across multiple solid tumors' | Merck's Glucophage SR Has Received Label Extension to Include Patients at High Risk of Type-2 Diabetes within UK | Aduro Biotech Reports Clinical Collaboration with Merck for Evaluation of CRS-207, KEYTRUDA Combo for Treatment of Mesothelioma",0.014126965261062656,-0.012461677015094964,0.09999592296020016,"[{'label': 'positive', 'score': 0.9995653033256531}, {'label': 'neutral', 'score': 0.00021987236686982214}, {'label': 'negative', 'score': 0.0002148490893887356}]","(0.00021987236686982214, 0.9995653033256531, 0.0002148490893887356)",0.9995702073323425,0.9995653033256531,0,0,"[{'label': 'positive', 'score': 0.9348186254501343}, {'label': 'neutral', 'score': 0.05511508136987686}, {'label': 'negative', 'score': 0.01006626058369875}]","(0.05511508136987686, 0.9348186254501343, 0.01006626058369875)",0.9786931493296458,0.9348186254501343,0,0,"[{'label': 'positive', 'score': 0.9977056384086609}, {'label': 'neutral', 'score': 0.002064888132736087}, {'label': 'negative', 'score': 0.0002295115264132619}]","(0.002064888132736087, 0.9977056384086609, 0.0002295115264132619)",0.9995400271722502,0.9977056384086609,0,0
2017-05-18,48.67123031616211,60.96374130249024,61.54580307006836,60.02862548828125,60.02862548828125,12528316.0,"Merck Issues Release Confirming FDA Has Approved KEYTRUDA for Certain Patients with Locally Advanced or Metastatic Urothelial Carcinoma | FDA Has Granted Approval for Merck's Pembrolizumab for Treatment of Locally Advanced or Metastatic Urothelial Carcinoma | WHO Says Congo Ebola Cases Present High National, Low Global Risk -Reuters",-0.0017217019989452572,0.014028109619603551,0.1518354768969426,"[{'label': 'positive', 'score': 0.9994186162948608}, {'label': 'neutral', 'score': 0.00029232242377474904}, {'label': 'negative', 'score': 0.00028910941909998655}]","(0.00029232242377474904, 0.9994186162948608, 0.00028910941909998655)",0.9994216121138936,0.9994186162948608,0,0,"[{'label': 'positive', 'score': 0.8589428067207336}, {'label': 'neutral', 'score': 0.11901866644620895}, {'label': 'negative', 'score': 0.022038592025637627}]","(0.11901866644620895, 0.8589428067207336, 0.022038592025637627)",0.9499680877326165,0.8589428067207336,0,0,"[{'label': 'positive', 'score': 0.9897514581680298}, {'label': 'neutral', 'score': 0.009516453370451927}, {'label': 'negative', 'score': 0.0007321031298488379}]","(0.009516453370451927, 0.9897514581680298, 0.0007321031298488379)",0.9985217258348245,0.9897514581680298,0,0
2017-05-19,48.587432861328125,60.85877990722656,61.10686874389648,60.59160232543945,61.10686874389648,9739798.0,The Most Notable Abstracts Released Ahead Of ASCO 2017 | Merck Reports Received CHMP Opinion Recommending Approval of ISENTRESS 600 mg in EU,0.0013588224906256577,-0.0017231858312211131,0.15296806456328582,"[{'label': 'neutral', 'score': 0.9977394342422485}, {'label': 'positive', 'score': 0.002031265525147319}, {'label': 'negative', 'score': 0.00022928348334971815}]","(0.9977394342422485, 0.002031265525147319, 0.00022928348334971815)",0.7971435412478307,0.002031265525147319,0,1,"[{'label': 'neutral', 'score': 0.8569207191467285}, {'label': 'positive', 'score': 0.12888893485069275}, {'label': 'negative', 'score': 0.014190342277288437}]","(0.8569207191467285, 0.12888893485069275, 0.014190342277288437)",0.8016436403352039,0.12888893485069275,0,1,"[{'label': 'positive', 'score': 0.9923545122146606}, {'label': 'neutral', 'score': 0.007334097754210234}, {'label': 'negative', 'score': 0.00031140007195062935}]","(0.007334097754210234, 0.9923545122146606, 0.00031140007195062935)",0.9993725984380116,0.9923545122146606,0,0
2017-05-20,48.653456370035805,60.94147618611654,61.23409525553385,60.61386744181315,60.99872716267904,8668322.666666666,,0.0013569785975878408,0.0013579001268029882,0.15267068395594932,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-21,48.71947987874349,61.02417246500651,61.361321767171226,60.63613255818685,60.89058558146159,7596847.333333334,,0.0013551397020154642,0.0013560587341932026,0.15005935393570904,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-22,48.78550338745117,61.10686874389648,61.488548278808594,60.65839767456055,60.78244400024414,6525372.0,UPDATE: Merck Says Highest Dose of MK-7264 Evaluated Reduced Awake Cough Frequency by 37% from Baseline Relative to Placebo | Merck Reports Presentation of Phase 2 Results for MK-7264 for Treatment of Chronic Cough,0.007963768070253074,0.00135422232889515,0.09774695887775789,"[{'label': 'positive', 'score': 0.9993506073951721}, {'label': 'neutral', 'score': 0.00041500016232021153}, {'label': 'negative', 'score': 0.0002343979722354561}]","(0.00041500016232021153, 0.9993506073951721, 0.0002343979722354561)",0.9995310094269585,0.9993506073951721,0,0,"[{'label': 'positive', 'score': 0.8973821401596069}, {'label': 'negative', 'score': 0.07727532088756561}, {'label': 'neutral', 'score': 0.025342604145407677}]","(0.025342604145407677, 0.8973821401596069, 0.07727532088756561)",0.8414308124116939,0.8973821401596069,0,0,"[{'label': 'neutral', 'score': 0.7161094546318054}, {'label': 'positive', 'score': 0.19897150993347168}, {'label': 'negative', 'score': 0.08491896837949753}]","(0.7161094546318054, 0.19897150993347168, 0.08491896837949753)",0.4017483863204432,0.19897150993347168,1,1
2017-05-23,49.17401885986328,61.593509674072266,61.63167953491211,61.06870269775391,61.06870269775391,6009861.0,"FDA Approves Pembrolizumab for Pancreatic Cancers with Mismatch Repair Deficiency | FDA Reports Approval for Merck's Solid Tumor with a Specific Genetic Feature Treatment | Zymeworks: Early But Compelling Data, Large Biopharma Partners And A Potential June Catalyst | Pre-Market Imbalance Update: Ford 397K Shares to Buy, GE 200K to Buy, Nike 57K to Buy, GM 32K to Buy, Alibaba 30K to Buy, Merck 25K Shares to Sell | Companies Holding Annual Meetings Today Include Waste Connections, Eastman Kodak, Alarm.com, Amyris, Achillion Pharma, GNC, Amazon, Nokia, Merck, Nvidia, Pinnacle Foods, Wendy's, & Xerox | Merck Gets Priority FDA Review for KYTRUDA sBLA",0.005886958238102945,0.007932224628413465,0.0562829176443236,"[{'label': 'positive', 'score': 0.99713134765625}, {'label': 'neutral', 'score': 0.002579823601990938}, {'label': 'negative', 'score': 0.00028876596479676664}]","(0.002579823601990938, 0.99713134765625, 0.00028876596479676664)",0.9994209742497604,0.99713134765625,0,0,"[{'label': 'neutral', 'score': 0.8003075122833252}, {'label': 'positive', 'score': 0.179216206073761}, {'label': 'negative', 'score': 0.02047630585730076}]","(0.8003075122833252, 0.179216206073761, 0.02047630585730076)",0.7949216456912552,0.179216206073761,0,1,"[{'label': 'positive', 'score': 0.9831547737121582}, {'label': 'neutral', 'score': 0.016248174011707306}, {'label': 'negative', 'score': 0.0005970518104732037}]","(0.016248174011707306, 0.9831547737121582, 0.0005970518104732037)",0.9987861739211391,0.9831547737121582,0,0
2017-05-24,49.46349334716797,61.95610809326172,62.21374130249024,61.58396911621094,61.80343627929688,7289259.0,,0.0016941250587540918,0.005869697807282876,0.04958219334498728,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-25,49.54729843139648,62.06106948852539,62.13740539550781,61.6984748840332,61.98473358154297,7436503.0,Merck Reports Exclusive Global License Deal with Teijin Pharma for Investigational Antibody Candidate Targeting Tau,-0.00184504986404459,0.0016926916475869247,0.04868838426781029,"[{'label': 'positive', 'score': 0.9974416494369507}, {'label': 'neutral', 'score': 0.0022115272004157305}, {'label': 'negative', 'score': 0.0003467595379333943}]","(0.0022115272004157305, 0.9974416494369507, 0.0003467595379333943)",0.9993049437439554,0.9974416494369507,0,0,"[{'label': 'positive', 'score': 0.9028319716453552}, {'label': 'neutral', 'score': 0.0889144018292427}, {'label': 'negative', 'score': 0.00825357437133789}]","(0.0889144018292427, 0.9028319716453552, 0.00825357437133789)",0.9818818893408574,0.9028319716453552,0,0,"[{'label': 'positive', 'score': 0.9832852482795715}, {'label': 'neutral', 'score': 0.016364026814699173}, {'label': 'negative', 'score': 0.00035074909101240337}]","(0.016364026814699173, 0.9832852482795715, 0.00035074909101240337)",0.9992868315272113,0.9832852482795715,0,0
2017-05-26,49.45587539672852,61.946563720703125,62.22328186035156,61.85114669799805,62.02289962768555,3862614.0,Reminder: Merck Has Isentress sNDA PDUFA Date Tomorrow May 27,-0.0001540281003909127,-0.0018467540650915118,0.061722379455707015,"[{'label': 'neutral', 'score': 0.9998676776885986}, {'label': 'negative', 'score': 7.643437857041135e-05}, {'label': 'positive', 'score': 5.5932850955286995e-05}]","(0.9998676776885986, 5.5932850955286995e-05, 7.643437857041135e-05)",-0.1548837101795207,-7.643437857041135e-05,1,1,"[{'label': 'neutral', 'score': 0.9533765912055969}, {'label': 'negative', 'score': 0.024611394852399826}, {'label': 'positive', 'score': 0.022012043744325638}]","(0.9533765912055969, 0.022012043744325638, 0.024611394852399826)",-0.05575202486795451,-0.024611394852399826,1,1,"[{'label': 'neutral', 'score': 0.9993665814399719}, {'label': 'positive', 'score': 0.0003754397912416607}, {'label': 'negative', 'score': 0.00025801631272770464}]","(0.9993665814399719, 0.0003754397912416607, 0.00025801631272770464)",0.18536955880313816,0.0003754397912416607,1,1
2017-05-27,49.44825839996338,61.93702220916748,62.206583976745605,61.78196716308594,61.956106185913086,4176987.75,,-0.0001540518287013346,-0.00015403996393697418,0.06509338895835368,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-28,49.44064140319824,61.92748069763184,62.18988609313965,61.71278762817383,61.88931274414063,4491361.5,,-0.00015407556432400635,-0.000154063695903073,0.04690926609311477,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-05-29,49.43302440643311,61.91793918609619,62.17318820953369,61.64360809326172,61.82251930236816,4805735.25,Congo Approves Use of Merck Ebola Vaccine -DJ,-0.0001540993072616199,-0.0001540874351831238,0.019876378023346818,"[{'label': 'positive', 'score': 0.8635101318359375}, {'label': 'neutral', 'score': 0.13500960171222687}, {'label': 'negative', 'score': 0.0014802672667428851}]","(0.13500960171222687, 0.8635101318359375, 0.0014802672667428851)",0.9965773787355825,0.8635101318359375,0,0,"[{'label': 'positive', 'score': 0.5145062208175659}, {'label': 'neutral', 'score': 0.4715358316898346}, {'label': 'negative', 'score': 0.01395792979747057}]","(0.4715358316898346, 0.5145062208175659, 0.01395792979747057)",0.9471754904046904,0.5145062208175659,0,0,"[{'label': 'positive', 'score': 0.9835846424102783}, {'label': 'neutral', 'score': 0.016088712960481644}, {'label': 'negative', 'score': 0.00032667332561686635}]","(0.016088712960481644, 0.9835846424102783, 0.00032667332561686635)",0.9993359699794233,0.9835846424102783,0,0
2017-05-30,49.42540740966797,61.90839767456055,62.15649032592773,61.57442855834961,61.7557258605957,5120109.0,Tracking The Busy June PDUFA Calendar | A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Economic Data | Merck Gets FDA Approval of ISENTRESS for the Treatment of HIV-1,0.0035450305827591146,-0.00015411118177979195,0.012016825241977377,"[{'label': 'negative', 'score': 0.9865167140960693}, {'label': 'neutral', 'score': 0.010695187374949455}, {'label': 'positive', 'score': 0.0027881332207471132}]","(0.010695187374949455, 0.0027881332207471132, 0.9865167140960693)",-0.9943634497934402,-0.9865167140960693,0,0,"[{'label': 'negative', 'score': 0.90388023853302}, {'label': 'positive', 'score': 0.05022286996245384}, {'label': 'neutral', 'score': 0.04589681699872017}]","(0.04589681699872017, 0.05022286996245384, 0.90388023853302)",-0.8947223428678472,-0.90388023853302,0,0,"[{'label': 'negative', 'score': 0.9279417991638184}, {'label': 'neutral', 'score': 0.06799805164337158}, {'label': 'positive', 'score': 0.0040602111257612705}]","(0.06799805164337158, 0.0040602111257612705, 0.9279417991638184)",-0.9912871193818569,-0.9279417991638184,0,0
2017-05-31,49.600616455078125,62.12786483764648,62.49045944213867,62.0515251159668,62.09923553466797,8162138.0,,0.0023037560003112936,0.0035387617728894097,0.026216544413563313,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-01,49.71489334106445,62.270992279052734,62.270992279052734,61.88931274414063,62.10877990722656,7923404.0,,0.0032179065297056777,0.002301106422996191,0.027615970095158152,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-02,49.87487411499024,62.47137451171875,62.57633590698242,62.19465637207031,62.46183013916016,6600933.0,Merck Gives Update on KEYTRUDA Effectiveness with Over 2 Years of Follow Up,-0.0020365569451893765,0.0032127401488090336,0.028501459653689557,"[{'label': 'positive', 'score': 0.9084710478782654}, {'label': 'neutral', 'score': 0.09106987714767456}, {'label': 'negative', 'score': 0.00045910224434919655}]","(0.09106987714767456, 0.9084710478782654, 0.00045910224434919655)",0.9989897964232185,0.9084710478782654,0,0,"[{'label': 'neutral', 'score': 0.8552363514900208}, {'label': 'positive', 'score': 0.13405483961105347}, {'label': 'negative', 'score': 0.010708758607506752}]","(0.8552363514900208, 0.13405483961105347, 0.010708758607506752)",0.8520517762850996,0.13405483961105347,0,1,"[{'label': 'neutral', 'score': 0.9601240754127502}, {'label': 'positive', 'score': 0.03893141448497772}, {'label': 'negative', 'score': 0.0009444663883186877}]","(0.9601240754127502, 0.03893141448497772, 0.0009444663883186877)",0.9526296915511568,0.03893141448497772,0,1
2017-06-03,49.77329889933268,62.34414800008138,62.51590347290039,62.04198455810547,62.4268430074056,6485618.0,"Combination of Incyte's Epacadostat + Merck's KEYTRUDA Demonstrates Activity in Clinical Trial of Patients with Advanced Non-Small Cell Lung Cancer #ASCO17 | Merck Announces New Data Show Durability of Response for KEYTRUDA in Advanced Microsatellite Instability-High or Mismatch Repair Deficient Solid Tumors, Regardless of Tumor Type #ASCO17",-0.002040712973368542,-0.0020386335471759814,0.037989405594601504,"[{'label': 'positive', 'score': 0.996178150177002}, {'label': 'neutral', 'score': 0.0034547564573585987}, {'label': 'negative', 'score': 0.0003670768055599183}]","(0.0034547564573585987, 0.996178150177002, 0.0003670768055599183)",0.999263301261958,0.996178150177002,0,0,"[{'label': 'positive', 'score': 0.9365252256393433}, {'label': 'neutral', 'score': 0.05164960399270058}, {'label': 'negative', 'score': 0.011825201101601124}]","(0.05164960399270058, 0.9365252256393433, 0.011825201101601124)",0.9750615368155862,0.9365252256393433,0,0,"[{'label': 'positive', 'score': 0.971774160861969}, {'label': 'neutral', 'score': 0.027471115812659264}, {'label': 'negative', 'score': 0.0007547983550466597}]","(0.027471115812659264, 0.971774160861969, 0.0007547983550466597)",0.9984477616879309,0.971774160861969,0,0
2017-06-04,49.67172368367513,62.21692148844401,62.45547103881836,61.88931274414063,62.39185587565104,6370303.0,Merck Announces Presentation of New Monotherapy Data for KEYTRUDA in Heavily Pre-Treated Patients with Advanced Gastric Cancer#ASCO17 | Merck Announces KEYTRUDA Shows Continued Overall Survival Benefit Over Chemotherapy as Second-Line Treatment for Advanced Urothelial Carcinoma Patients Post-Platinum Failure #ASCO17,-0.0020448859987551474,-0.0020427980652873564,0.04456621844329893,"[{'label': 'positive', 'score': 0.9994634985923767}, {'label': 'negative', 'score': 0.0002749333216343075}, {'label': 'neutral', 'score': 0.0002615924458950758}]","(0.0002615924458950758, 0.9994634985923767, 0.0002749333216343075)",0.9994499894915354,0.9994634985923767,0,0,"[{'label': 'positive', 'score': 0.954043984413147}, {'label': 'neutral', 'score': 0.02600366249680519}, {'label': 'negative', 'score': 0.019952375441789627}]","(0.02600366249680519, 0.954043984413147, 0.019952375441789627)",0.9590298767753891,0.954043984413147,0,0,"[{'label': 'positive', 'score': 0.9980803728103638}, {'label': 'neutral', 'score': 0.0016560506774112582}, {'label': 'negative', 'score': 0.00026356973103247583}]","(0.0016560506774112582, 0.9980803728103638, 0.00026356973103247583)",0.9994719861166053,0.9980803728103638,0,0
2017-06-05,49.57014846801758,62.08969497680664,62.39503860473633,61.73664093017578,62.35686874389648,6254988.0,Dynavax +21% Premarket @$7.15; Co on Friday Presented Updated Data for SD-101 in Combination with KEYTRUDA | Merck Gives Update on Phase 2 I-SPY 2 Trial,-0.006147228377505869,-0.0020469796327779724,0.042045296857529384,"[{'label': 'neutral', 'score': 0.9996732473373413}, {'label': 'positive', 'score': 0.00026281122700311244}, {'label': 'negative', 'score': 6.398450932465494e-05}]","(0.9996732473373413, 0.00026281122700311244, 6.398450932465494e-05)",0.6084128266564641,0.00026281122700311244,0,1,"[{'label': 'neutral', 'score': 0.7431679368019104}, {'label': 'positive', 'score': 0.24774344265460968}, {'label': 'negative', 'score': 0.009088649414479733}]","(0.7431679368019104, 0.24774344265460968, 0.009088649414479733)",0.929224970748322,0.24774344265460968,0,1,"[{'label': 'neutral', 'score': 0.9989619255065918}, {'label': 'positive', 'score': 0.0009103256743401289}, {'label': 'negative', 'score': 0.00012779621465597302}]","(0.9989619255065918, 0.0009103256743401289, 0.00012779621465597302)",0.7537934302116369,0.0009103256743401289,0,1
2017-06-06,49.26544952392578,61.70801544189453,62.06106948852539,61.50763320922852,62.02289962768555,8218206.0,,-0.00943251477802273,-0.006166200375966827,0.052868799484125296,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-06-07,48.80073928833008,61.125953674316406,61.68893051147461,61.06870269775391,61.64122009277344,7971717.0,,-0.01342490377751797,-0.009477282683901073,0.053573238553461196,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-06-08,48.14559555053711,60.30534362792969,61.3072509765625,59.95228958129883,61.125953674316406,19411056.0,,0.018829144791558866,-0.013515832521678225,0.07848710183998785,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-06-09,49.05213165283203,61.44084167480469,61.488548278808594,60.24809265136719,60.30534362792969,11266419.0,,0.0,0.0186540706943218,0.1994086296932299,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-10,49.05213165283203,61.44084167480469,61.564884185791016,60.5852419535319,60.68384297688802,10794784.0,,0.0,0.0,0.2002361621374524,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-11,49.05213165283203,61.44084167480469,61.64122009277344,60.92239125569662,61.06234232584635,10323149.0,"Merck, Pfizer Announce that Investigational SGLT-2 Inhibitor Ertugliflozin Met Primary Endpoint in Two Phase 3 Studies at #2017ADA",0.0,0.0,0.1971102407128369,"[{'label': 'neutral', 'score': 0.999219536781311}, {'label': 'positive', 'score': 0.0007106772973202169}, {'label': 'negative', 'score': 6.977837620070204e-05}]","(0.999219536781311, 0.0007106772973202169, 6.977837620070204e-05)",0.821185549498522,0.0007106772973202169,0,1,"[{'label': 'positive', 'score': 0.8408979773521423}, {'label': 'neutral', 'score': 0.15070469677448273}, {'label': 'negative', 'score': 0.00839738268405199}]","(0.15070469677448273, 0.8408979773521423, 0.00839738268405199)",0.9802250593157742,0.8408979773521423,0,0,"[{'label': 'neutral', 'score': 0.9987473487854004}, {'label': 'positive', 'score': 0.0008742388454265893}, {'label': 'negative', 'score': 0.00037835969123989344}]","(0.9987473487854004, 0.0008742388454265893, 0.00037835969123989344)",0.3958803556535918,0.0008742388454265893,1,1
2017-06-12,49.05213165283203,61.44084167480469,61.71755599975586,61.25954055786133,61.44084167480469,9851514.0,"Merck Reports Update On Multiple Myeloma Studies KEYNOTE-183, 185 Of KEYTRUDA In Combo With Other Therapies: Has Accepted External Data Monitoring Committee Recommendation To Pause New Enrollment | Pre-Market Imbalance Update: Pfizer 74K Shares To Sell, Citi 61K To Sell, JP Morgan 35K Shares To Buy, Merck 33K To Buy",-0.017394073442346964,0.0,0.1819297182620256,"[{'label': 'positive', 'score': 0.956878125667572}, {'label': 'neutral', 'score': 0.04261451214551926}, {'label': 'negative', 'score': 0.0005073570064269006}]","(0.04261451214551926, 0.956878125667572, 0.0005073570064269006)",0.9989401196997267,0.956878125667572,0,0,"[{'label': 'neutral', 'score': 0.7280787825584412}, {'label': 'negative', 'score': 0.23714874684810638}, {'label': 'positive', 'score': 0.034772396087646484}]","(0.7280787825584412, 0.034772396087646484, 0.23714874684810638)",-0.7442464700447203,-0.23714874684810638,0,1,"[{'label': 'neutral', 'score': 0.9634987115859985}, {'label': 'positive', 'score': 0.03439982980489731}, {'label': 'negative', 'score': 0.0021014611702412367}]","(0.9634987115859985, 0.03439982980489731, 0.0021014611702412367)",0.8848555152927294,0.03439982980489731,0,1
2017-06-13,48.55331802368164,60.37213516235352,60.91603088378906,60.14313125610352,60.81106948852539,12631544.0,,0.0015805443545392208,-0.017547127759923772,0.20323570512651046,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-14,48.63005065917969,60.46755599975586,60.725189208984375,60.13358688354492,60.13358688354492,10834853.0,,-0.002840414613221567,0.0015792966088826847,0.12783699494395911,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-15,48.49192810058594,60.29580307006836,60.53435134887695,60.0,60.40076446533203,8244406.0,Merck Reports Expansion Of Distribution Deal With Public Health England,-0.003481612227316361,-0.0028444562458983993,0.12492198097169019,"[{'label': 'positive', 'score': 0.9186052083969116}, {'label': 'neutral', 'score': 0.08099641650915146}, {'label': 'negative', 'score': 0.0003983603382948786}]","(0.08099641650915146, 0.9186052083969116, 0.0003983603382948786)",0.9991330603017284,0.9186052083969116,0,0,"[{'label': 'positive', 'score': 0.9178546071052551}, {'label': 'neutral', 'score': 0.07359939068555832}, {'label': 'negative', 'score': 0.008546032942831516}]","(0.07359939068555832, 0.9178546071052551, 0.008546032942831516)",0.9815500279827356,0.9178546071052551,0,0,"[{'label': 'positive', 'score': 0.9987027645111084}, {'label': 'neutral', 'score': 0.0010197109077125788}, {'label': 'negative', 'score': 0.00027746849809773266}]","(0.0010197109077125788, 0.9987027645111084, 0.00027746849809773266)",0.999444496519692,0.9987027645111084,0,0
2017-06-16,48.32310104370117,60.08587646484375,60.79198455810547,59.81870269775391,60.36259460449219,15617296.0,Cerveau Technologies Reports FDA Accepted IND For MK-6240; BZ NOTE: Merck Is A Development Partner For The Candidate,0.0037584129296278743,-0.0034876871436008705,0.12068619804326398,"[{'label': 'positive', 'score': 0.8737412691116333}, {'label': 'neutral', 'score': 0.12556764483451843}, {'label': 'negative', 'score': 0.0006911198724992573}]","(0.12556764483451843, 0.8737412691116333, 0.0006911198724992573)",0.9984192720187272,0.8737412691116333,0,0,"[{'label': 'neutral', 'score': 0.7366812229156494}, {'label': 'positive', 'score': 0.2532179653644562}, {'label': 'negative', 'score': 0.010100812651216984}]","(0.7366812229156494, 0.2532179653644562, 0.010100812651216984)",0.9232807266740714,0.2532179653644562,0,1,"[{'label': 'neutral', 'score': 0.9310412406921387}, {'label': 'positive', 'score': 0.06866574287414551}, {'label': 'negative', 'score': 0.00029305912903510034}]","(0.9310412406921387, 0.06866574287414551, 0.00029305912903510034)",0.9915004576494358,0.06866574287414551,0,1
2017-06-17,48.504720052083336,60.31170399983724,60.82379150390625,59.92366409301758,60.30852381388346,13355327.666666668,,0.003744340153183108,0.0037513677427165096,0.1318428674941106,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-18,48.68633906046549,60.53753153483073,60.85559844970703,60.02862548828125,60.25445302327474,11093359.333333334,,0.0037303723701314177,0.0037373475612513052,0.05572642044046866,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-19,48.867958068847656,60.76335906982422,60.88740539550781,60.13358688354492,60.200382232666016,8831391.0,Merck Receives FDA Orphan Designation for Keytruda in Treatment of Esophageal Carcinoma,0.013348002825080436,0.0037234317864075894,0.060133002865976275,"[{'label': 'neutral', 'score': 0.8697548508644104}, {'label': 'positive', 'score': 0.1295711249113083}, {'label': 'negative', 'score': 0.0006739982054568827}]","(0.8697548508644104, 0.1295711249113083, 0.0006739982054568827)",0.9896503118223837,0.1295711249113083,1,0,"[{'label': 'positive', 'score': 0.9229395985603333}, {'label': 'neutral', 'score': 0.06377053260803223}, {'label': 'negative', 'score': 0.01328993495553732}]","(0.06377053260803223, 0.9229395985603333, 0.01328993495553732)",0.9716096651947542,0.9229395985603333,1,1,"[{'label': 'positive', 'score': 0.9983918070793152}, {'label': 'neutral', 'score': 0.0011816472979262471}, {'label': 'negative', 'score': 0.0004265719617251307}]","(0.0011816472979262471, 0.9983918070793152, 0.0004265719617251307)",0.9991458467912161,0.9983918070793152,1,1
2017-06-20,49.52024459838867,61.57442855834961,61.98473358154297,60.66793823242188,60.76335906982422,10755624.0,Merck Subsidiary Announces Collaboration With Serimmune,0.014411852478170025,0.013259703117356471,0.09452371018366731,"[{'label': 'neutral', 'score': 0.9997273087501526}, {'label': 'positive', 'score': 0.00020131529890932143}, {'label': 'negative', 'score': 7.135338091757149e-05}]","(0.9997273087501526, 0.00020131529890932143, 7.135338091757149e-05)",0.47662943200611774,0.00020131529890932143,0,0,"[{'label': 'neutral', 'score': 0.9093210697174072}, {'label': 'positive', 'score': 0.06673689186573029}, {'label': 'negative', 'score': 0.023941978812217712}]","(0.9093210697174072, 0.06673689186573029, 0.023941978812217712)",0.4719391930398156,0.06673689186573029,0,0,"[{'label': 'positive', 'score': 0.8281683921813965}, {'label': 'neutral', 'score': 0.17122691869735718}, {'label': 'negative', 'score': 0.0006046739290468395}]","(0.17122691869735718, 0.8281683921813965, 0.0006046739290468395)",0.998540797345443,0.8281683921813965,1,1
2017-06-21,50.23391342163086,62.46183013916016,62.59542083740234,61.60305404663086,61.60305404663086,11679960.0,Leap Therapeutics Reports Collab With Merck For Evaluation Of KEYTRUDA In Combo With DKN-01 In Esophagogastric Cancer,0.008554846178641455,0.014308988857889718,0.0875550218023668,"[{'label': 'neutral', 'score': 0.9996002316474915}, {'label': 'positive', 'score': 0.0002851865137927234}, {'label': 'negative', 'score': 0.00011457412620075047}]","(0.9996002316474915, 0.0002851865137927234, 0.00011457412620075047)",0.4267863579434889,0.0002851865137927234,1,1,"[{'label': 'neutral', 'score': 0.5066267251968384}, {'label': 'positive', 'score': 0.480532705783844}, {'label': 'negative', 'score': 0.012840578332543373}]","(0.5066267251968384, 0.480532705783844, 0.012840578332543373)",0.9479478166089177,0.480532705783844,0,1,"[{'label': 'neutral', 'score': 0.9961404204368591}, {'label': 'positive', 'score': 0.003740474581718445}, {'label': 'negative', 'score': 0.00011905399878742173}]","(0.9961404204368591, 0.003740474581718445, 0.00011905399878742173)",0.9383064556698697,0.003740474581718445,0,1
2017-06-22,50.663673400878906,62.99618148803711,63.33015441894531,62.38549423217773,62.50954055786133,14087111.0,"Merck, Premier Report Expanded Collaboration To Address Chronic Care, Vaccination Rates",0.0021206158069684935,0.008518460848738882,0.08003582099237394,"[{'label': 'positive', 'score': 0.9834929704666138}, {'label': 'neutral', 'score': 0.016164660453796387}, {'label': 'negative', 'score': 0.00034233019687235355}]","(0.016164660453796387, 0.9834929704666138, 0.00034233019687235355)",0.9993040904374106,0.9834929704666138,0,0,"[{'label': 'positive', 'score': 0.6531198024749756}, {'label': 'neutral', 'score': 0.3386869728565216}, {'label': 'negative', 'score': 0.00819325726479292}]","(0.3386869728565216, 0.6531198024749756, 0.00819325726479292)",0.9752212446310465,0.6531198024749756,0,0,"[{'label': 'positive', 'score': 0.9963471293449402}, {'label': 'neutral', 'score': 0.003447270253673196}, {'label': 'negative', 'score': 0.00020562812278512865}]","(0.003447270253673196, 0.9963471293449402, 0.00020562812278512865)",0.9995873211503471,0.9963471293449402,0,0
2017-06-23,50.77111053466797,63.1297721862793,63.34923553466797,62.82442855834961,63.01526641845703,14769988.0,,-0.0012091902812062692,0.0021183704750319843,0.08690298014495051,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-24,50.709716796875,63.05343627929688,63.3524169921875,62.82124710083008,63.05025355021159,12493347.666666668,,-0.0012106541924899548,-0.0012099219416449323,0.10805968988848487,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-25,50.64832305908203,62.97710037231445,63.35559844970703,62.81806564331055,63.08524068196615,10216707.333333334,,-0.0012121216526504311,-0.0012113876262931306,0.10744927935269764,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-06-26,50.58692932128906,62.90076446533203,63.35877990722656,62.814884185791016,63.1202278137207,7940067.0,"A Surprisingly Clean, Straightforward Approval Gives Portola Pharma Shares A Shot Of Upside",-0.00576455004282245,-0.001212856866273085,0.06718434120090658,"[{'label': 'positive', 'score': 0.9990693926811218}, {'label': 'neutral', 'score': 0.000668237975332886}, {'label': 'negative', 'score': 0.0002623666077852249}]","(0.000668237975332886, 0.9990693926811218, 0.0002623666077852249)",0.9994749159018584,0.9990693926811218,0,0,"[{'label': 'positive', 'score': 0.8656623959541321}, {'label': 'neutral', 'score': 0.12469092011451721}, {'label': 'negative', 'score': 0.009646640159189701}]","(0.12469092011451721, 0.8656623959541321, 0.009646640159189701)",0.9779583215500113,0.8656623959541321,0,0,"[{'label': 'positive', 'score': 0.9987584352493286}, {'label': 'neutral', 'score': 0.00086415302939713}, {'label': 'negative', 'score': 0.00037743497523479164}]","(0.00086415302939713, 0.9987584352493286, 0.00037743497523479164)",0.9992444771797654,0.9987584352493286,0,0
2017-06-27,50.29530715942383,62.53816986083984,63.23473358154297,62.53816986083984,63.23473358154297,8511437.0,"Ransomware Rears Its Head Again As 150 Countries Hit By New Virus | Hearing Merck Has Confirmed Co.'s Computer Network Was Compromised | Merck Announces REVEAL Met its Primary Endpoint, Says Will Consult With External Experts and Consider Whether to File NDA | Ablynx Achieves 2.5M Milestone Iin Immuno-oncology Collaboration With Merck",-0.005798033744772215,-0.005781229190829459,0.044662965320238404,"[{'label': 'negative', 'score': 0.7199573516845703}, {'label': 'neutral', 'score': 0.20916558802127838}, {'label': 'positive', 'score': 0.07087709754705429}]","(0.20916558802127838, 0.07087709754705429, 0.7199573516845703)",-0.8207536416353168,-0.7199573516845703,0,0,"[{'label': 'positive', 'score': 0.9238853454589844}, {'label': 'neutral', 'score': 0.05624761804938316}, {'label': 'negative', 'score': 0.019866997376084328}]","(0.05624761804938316, 0.9238853454589844, 0.019866997376084328)",0.957897858422469,0.9238853454589844,0,0,"[{'label': 'negative', 'score': 0.8460003733634949}, {'label': 'positive', 'score': 0.09334171563386917}, {'label': 'neutral', 'score': 0.06065791845321655}]","(0.06065791845321655, 0.09334171563386917, 0.8460003733634949)",-0.801261506905327,-0.8460003733634949,0,0
2017-06-28,50.003692626953125,62.17557144165039,62.88167953491211,62.15649032592773,62.74809265136719,7056498.0,Russia In The Spotlight As Second Wave Of Ransomware Grips Globe,-0.012584366615450584,-0.005814907597481664,0.039880832452550564,"[{'label': 'neutral', 'score': 0.9806612730026245}, {'label': 'negative', 'score': 0.018953710794448853}, {'label': 'positive', 'score': 0.0003849662025459111}]","(0.9806612730026245, 0.0003849662025459111, 0.018953710794448853)",-0.9601869142748767,-0.018953710794448853,1,0,"[{'label': 'negative', 'score': 0.8074158430099487}, {'label': 'neutral', 'score': 0.13688941299915314}, {'label': 'positive', 'score': 0.05569479987025261}]","(0.13688941299915314, 0.05569479987025261, 0.8074158430099487)",-0.870944008558627,-0.8074158430099487,1,1,"[{'label': 'neutral', 'score': 0.9201208353042603}, {'label': 'negative', 'score': 0.07698346674442291}, {'label': 'positive', 'score': 0.002895741257816553}]","(0.9201208353042603, 0.002895741257816553, 0.07698346674442291)",-0.9274969962712858,-0.07698346674442291,1,0
2017-06-29,49.37444305419922,61.39313125610352,62.09923553466797,61.154579162597656,62.03244400024414,8751114.0,Aduro Biotech Initiates Phase 2 Clinical Trial Of CRS-207 In Combination With KEYTRUDA,-0.003885647932025789,-0.012664220403890671,0.0745185686304002,"[{'label': 'neutral', 'score': 0.9998817443847656}, {'label': 'positive', 'score': 6.144742656033486e-05}, {'label': 'negative', 'score': 5.677973967976868e-05}]","(0.9998817443847656, 6.144742656033486e-05, 5.677973967976868e-05)",0.03948066276989785,6.144742656033486e-05,1,1,"[{'label': 'positive', 'score': 0.5085451602935791}, {'label': 'neutral', 'score': 0.48275843262672424}, {'label': 'negative', 'score': 0.008696385659277439}]","(0.48275843262672424, 0.5085451602935791, 0.008696385659277439)",0.9663739862842724,0.5085451602935791,0,0,"[{'label': 'neutral', 'score': 0.991844117641449}, {'label': 'positive', 'score': 0.007992910221219063}, {'label': 'negative', 'score': 0.00016294924716930836}]","(0.991844117641449, 0.007992910221219063, 0.00016294924716930836)",0.9600411832006449,0.007992910221219063,0,1
2017-06-30,49.18258285522461,61.154579162597656,61.76526641845703,61.06870269775391,61.536258697509766,8762223.0,Benzinga's Option Alert Recap From June 30,0.0009361890624092521,-0.0038932166746261463,0.06724168089355088,"[{'label': 'neutral', 'score': 0.9998769760131836}, {'label': 'negative', 'score': 7.088869460858405e-05}, {'label': 'positive', 'score': 5.205127308727242e-05}]","(0.9998769760131836, 5.205127308727242e-05, 7.088869460858405e-05)",-0.15322455239222027,-7.088869460858405e-05,1,1,"[{'label': 'neutral', 'score': 0.9370958805084229}, {'label': 'positive', 'score': 0.03499987721443176}, {'label': 'negative', 'score': 0.027904223650693893}]","(0.9370958805084229, 0.03499987721443176, 0.027904223650693893)",0.11280112848209765,0.03499987721443176,1,1,"[{'label': 'neutral', 'score': 0.9995521903038025}, {'label': 'positive', 'score': 0.0002679459284991026}, {'label': 'negative', 'score': 0.00017977495735976845}]","(0.9995521903038025, 0.0002679459284991026, 0.00017977495735976845)",0.1969328970887614,0.0002679459284991026,1,1
2017-07-01,49.22862879435221,61.21183141072592,61.73345947265625,61.020992279052734,61.332696278889976,7473357.666666667,,0.0009353134322036338,0.0009357511107447691,0.07756164609115249,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-02,49.27467473347982,61.26908365885416,61.70165252685547,60.97328186035156,61.12913386027018,6184492.333333334,,0.000934439438445739,0.0009348762991451378,0.08946179806123629,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-03,49.32072067260742,61.32633590698242,61.66984558105469,60.92557144165039,60.92557144165039,4895627.0,Watch These 5 Huge Put Purchases In Monday Trade,-0.0008557611808316213,0.0009340031217003441,0.09402670229067948,"[{'label': 'neutral', 'score': 0.9377947449684143}, {'label': 'positive', 'score': 0.06182992830872536}, {'label': 'negative', 'score': 0.0003752813790924847}]","(0.9377947449684143, 0.06182992830872536, 0.0003752813790924847)",0.9879340852325434,0.06182992830872536,0,1,"[{'label': 'neutral', 'score': 0.9365712404251099}, {'label': 'positive', 'score': 0.04197608679533005}, {'label': 'negative', 'score': 0.021452652290463448}]","(0.9365712404251099, 0.04197608679533005, 0.021452652290463448)",0.32356680584658437,0.04197608679533005,1,1,"[{'label': 'neutral', 'score': 0.9553964138031006}, {'label': 'positive', 'score': 0.044252533465623856}, {'label': 'negative', 'score': 0.00035099146771244705}]","(0.9553964138031006, 0.044252533465623856, 0.00035099146771244705)",0.9842617161653913,0.044252533465623856,0,1
2017-07-04,49.27851104736328,61.273855209350586,61.750953674316406,60.95896911621094,61.22137451171875,5857900.5,,-0.0008564941352641904,-0.0008561275534641774,0.03344560827793104,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-05,49.23630142211914,61.22137451171875,61.832061767578125,60.99236679077149,61.51717758178711,6820174.0,"Merck Announces FDA Placed Clinical Hold On KEYNOTE-183, KEYNOTE-185 and KEYNOTE-023 Following Review Of Data By Data Monitoring Committee; FDA Has Determined Risk Of KEYTRUDA In Compination With Pomalidomide Of Lenalidomide Outweigh Potential Benefits | Healthcare Repeal Bad For GlaxoSmithKline, Other HIV Treatment Stocks",-0.016521218761558484,-0.0008568611359370137,0.01557566450528242,"[{'label': 'negative', 'score': 0.9199486374855042}, {'label': 'neutral', 'score': 0.07777481526136398}, {'label': 'positive', 'score': 0.0022765896283090115}]","(0.07777481526136398, 0.0022765896283090115, 0.9199486374855042)",-0.9950628337603954,-0.9199486374855042,1,1,"[{'label': 'negative', 'score': 0.9269602298736572}, {'label': 'positive', 'score': 0.05104292184114456}, {'label': 'neutral', 'score': 0.02199687622487545}]","(0.02199687622487545, 0.05104292184114456, 0.9269602298736572)",-0.8956180831285719,-0.9269602298736572,1,1,"[{'label': 'negative', 'score': 0.9790982007980347}, {'label': 'neutral', 'score': 0.01698855683207512}, {'label': 'positive', 'score': 0.003913204185664654}]","(0.01698855683207512, 0.003913204185664654, 0.9790982007980347)",-0.9920383341112313,-0.9790982007980347,1,1
2017-07-06,48.42285537719727,60.209922790527344,60.98282241821289,60.10496139526367,60.84923553466797,11887150.0,Merck Falls As FDA Puts Hold On 3 Keytruda Myeloma Studies | Merck to Present New Data from Clinical Trials Evaluating ISENTRESS HD and Investigational HIV Therapies Doravirine and MK-8591 at IAS 2017,0.0009509195263205579,-0.016659216130609878,0.11939462445647268,"[{'label': 'negative', 'score': 0.984264075756073}, {'label': 'neutral', 'score': 0.008516889065504074}, {'label': 'positive', 'score': 0.007219057995826006}]","(0.008516889065504074, 0.007219057995826006, 0.984264075756073)",-0.985437860211483,-0.984264075756073,0,0,"[{'label': 'negative', 'score': 0.9612507820129395}, {'label': 'neutral', 'score': 0.027250682935118675}, {'label': 'positive', 'score': 0.011498582549393177}]","(0.027250682935118675, 0.011498582549393177, 0.9612507820129395)",-0.9763585914968617,-0.9612507820129395,0,0,"[{'label': 'negative', 'score': 0.957790732383728}, {'label': 'neutral', 'score': 0.040824517607688904}, {'label': 'positive', 'score': 0.001384714269079268}]","(0.040824517607688904, 0.001384714269079268, 0.957790732383728)",-0.9971126986748641,-0.957790732383728,0,0
2017-07-07,48.46890640258789,60.26717758178711,60.43893051147461,59.933204650878906,60.314884185791016,7591083.0,,-0.0017416224061096472,0.0009504676887659612,0.11942951639302979,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-08,48.38448842366537,60.16221491495768,60.45801417032877,59.8695920308431,60.37213643391927,7406076.0,,-0.0017446609467053759,-0.0017431407936403126,0.11487925930482755,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-09,48.30007044474284,60.05725224812826,60.47709782918295,59.80597941080729,60.42938868204752,7221069.0,,-0.001747710108277568,-0.0017461846400916108,0.11359280800066829,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-10,48.21565246582031,59.95228958129883,60.49618148803711,59.74236679077149,60.48664093017578,7036062.0,The Royalty-Amassing Strategy Of Royalty Pharma,-0.007798801397264836,-0.0017492391353793111,0.1121998785681651,"[{'label': 'neutral', 'score': 0.9998940229415894}, {'label': 'negative', 'score': 6.272159953368828e-05}, {'label': 'positive', 'score': 4.3309384636813775e-05}]","(0.9998940229415894, 4.3309384636813775e-05, 6.272159953368828e-05)",-0.18308058770499466,-6.272159953368828e-05,1,1,"[{'label': 'neutral', 'score': 0.9171997308731079}, {'label': 'positive', 'score': 0.07394929975271225}, {'label': 'negative', 'score': 0.008850917220115662}]","(0.9171997308731079, 0.07394929975271225, 0.008850917220115662)",0.7862102892068454,0.07394929975271225,0,1,"[{'label': 'neutral', 'score': 0.9984750151634216}, {'label': 'positive', 'score': 0.0014216728741303086}, {'label': 'negative', 'score': 0.00010328594362363219}]","(0.9984750151634216, 0.0014216728741303086, 0.00010328594362363219)",0.8645393666751493,0.0014216728741303086,0,1
2017-07-11,47.83963394165039,59.48473358154297,60.09542083740234,59.38931274414063,59.9427490234375,7207620.0,,0.007058039193857261,-0.007829371090585456,0.051429101473560605,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-12,48.177284240722656,59.904579162597656,60.238548278808594,59.790077209472656,59.790077209472656,8610368.0,J&J To Commence Pharma Q2 Earnings Season: What's Up?,0.0017521431037646974,0.007033247819201303,0.08423579652402863,"[{'label': 'neutral', 'score': 0.9997695088386536}, {'label': 'positive', 'score': 0.00013975193724036217}, {'label': 'negative', 'score': 9.066363418241963e-05}]","(0.9997695088386536, 0.00013975193724036217, 9.066363418241963e-05)",0.21304247258477188,0.00013975193724036217,1,1,"[{'label': 'neutral', 'score': 0.794654130935669}, {'label': 'negative', 'score': 0.16025429964065552}, {'label': 'positive', 'score': 0.04509161040186882}]","(0.794654130935669, 0.04509161040186882, 0.16025429964065552)",-0.5608229022673891,-0.16025429964065552,0,1,"[{'label': 'neutral', 'score': 0.9972254037857056}, {'label': 'positive', 'score': 0.002467236015945673}, {'label': 'negative', 'score': 0.0003074577252846211}]","(0.9972254037857056, 0.002467236015945673, 0.0003074577252846211)",0.778384388362591,0.002467236015945673,0,1
2017-07-13,48.261714935302734,60.00954055786133,60.10496139526367,59.42748260498047,59.91412353515625,7125562.0,"Shares of Eli Lilly, AstraZeneca, Merck, Gilead, Abbvie, Other Large Cap Biotech Spiking Higher",0.0027031732790393274,0.001750609891713251,0.08645705996285899,"[{'label': 'positive', 'score': 0.9991962313652039}, {'label': 'neutral', 'score': 0.0005410904414020479}, {'label': 'negative', 'score': 0.0002626642817631364}]","(0.0005410904414020479, 0.9991962313652039, 0.0002626642817631364)",0.9994743870250049,0.9991962313652039,0,0,"[{'label': 'negative', 'score': 0.4837871491909027}, {'label': 'neutral', 'score': 0.3038244843482971}, {'label': 'positive', 'score': 0.21238839626312256}]","(0.3038244843482971, 0.21238839626312256, 0.4837871491909027)",-0.38984241072527454,-0.4837871491909027,1,1,"[{'label': 'positive', 'score': 0.9937997460365295}, {'label': 'neutral', 'score': 0.005439209286123514}, {'label': 'negative', 'score': 0.0007611029432155192}]","(0.005439209286123514, 0.9937997460365295, 0.0007611029432155192)",0.9984694693260925,0.9937997460365295,0,0
2017-07-14,48.39215850830078,60.171756744384766,60.49618148803711,59.98091506958008,60.04771041870117,6309903.0,,-0.0023786904734356944,0.0026995262769915936,0.08818996678984707,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-15,48.27705001831055,60.02862675984701,60.46755599975586,59.875953674316406,60.11768468221029,6787232.0,,-0.002384362132926626,-0.0023815240519825575,0.08925988706814496,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-16,48.16194152832031,59.88549677530924,60.43893051147461,59.770992279052734,60.1876589457194,7264561.0,,-0.002390060903640418,-0.002387209250924338,0.06258451496447333,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-17,48.04683303833008,59.74236679077149,60.41030502319336,59.66603088378906,60.25763320922852,7741890.0,5 Biggest Price Target Changes For Monday,-0.003194411019453857,-0.0023929216583630686,0.040455171204426224,"[{'label': 'neutral', 'score': 0.9995447993278503}, {'label': 'positive', 'score': 0.0003197066835127771}, {'label': 'negative', 'score': 0.00013551389565691352}]","(0.9995447993278503, 0.0003197066835127771, 0.00013551389565691352)",0.40462315695794326,0.0003197066835127771,1,1,"[{'label': 'neutral', 'score': 0.8229240775108337}, {'label': 'negative', 'score': 0.12311697751283646}, {'label': 'positive', 'score': 0.05395893007516861}]","(0.8229240775108337, 0.05395893007516861, 0.12311697751283646)",-0.390555939425565,-0.12311697751283646,1,1,"[{'label': 'neutral', 'score': 0.9994505047798157}, {'label': 'positive', 'score': 0.0003916127316188067}, {'label': 'negative', 'score': 0.00015783235721755773}]","(0.9994505047798157, 0.0003916127316188067, 0.00015783235721755773)",0.42548451001055976,0.0003916127316188067,1,1
2017-07-18,47.89335632324219,59.5515251159668,59.761451721191406,59.41793823242188,59.63740539550781,6408415.0,,0.0033648547585608296,-0.0031995240419682865,0.03796689041247552,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-19,48.05450820922852,59.75190734863281,59.95228958129883,59.58015441894531,59.63740539550781,5972657.0,,0.005110190477236274,0.0033592063020648558,0.04260479226215108,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-20,48.30007553100586,60.0572509765625,60.343509674072266,59.98091506958008,60.02862548828125,6974545.0,"Hearing Merck Has Said Corning Will Make Initial $500M Investment Related To Modernization Of Pharmaceutical Glass Packaging | Trump Says Merck, Pfizer And Corning Announce That Glass Packaging Will Be Made In America | Merck Reports FDA Granted Tentative Approvaal For LUSDUNA Nexvue",-0.004925287963755287,0.005097177766671995,0.06090611876183664,"[{'label': 'positive', 'score': 0.9868534803390503}, {'label': 'neutral', 'score': 0.01285608485341072}, {'label': 'negative', 'score': 0.00029044540133327246}]","(0.01285608485341072, 0.9868534803390503, 0.00029044540133327246)",0.999411543962821,0.9868534803390503,0,0,"[{'label': 'positive', 'score': 0.8034034967422485}, {'label': 'neutral', 'score': 0.18734824657440186}, {'label': 'negative', 'score': 0.00924821849912405}]","(0.18734824657440186, 0.8034034967422485, 0.00924821849912405)",0.977239404468919,0.8034034967422485,0,0,"[{'label': 'positive', 'score': 0.7555546164512634}, {'label': 'neutral', 'score': 0.2438460886478424}, {'label': 'negative', 'score': 0.0005992621299810708}]","(0.2438460886478424, 0.7555546164512634, 0.0005992621299810708)",0.9984149730710753,0.7555546164512634,0,0
2017-07-21,48.06218338012695,59.761451721191406,60.114505767822266,59.71374130249024,59.91412353515625,7237907.0,Merck Reports EMA CHMP Recommended Approval For Co.'s KEYTRUDA For Treatment Of Certain Patients With Locally-Advanced Or Metastatic Urothelial Carcinoma | Merck and Pfizer's Avelumab Recommended for Approval by the EU Medicines Agency,-0.00031935185425134604,-0.004937457168854698,0.06953464981701038,"[{'label': 'positive', 'score': 0.9953281879425049}, {'label': 'neutral', 'score': 0.004355552606284618}, {'label': 'negative', 'score': 0.0003163103829137981}]","(0.004355552606284618, 0.9953281879425049, 0.0003163103829137981)",0.9993646117998024,0.9953281879425049,0,0,"[{'label': 'positive', 'score': 0.888691782951355}, {'label': 'neutral', 'score': 0.09446317702531815}, {'label': 'negative', 'score': 0.01684507727622986}]","(0.09446317702531815, 0.888691782951355, 0.01684507727622986)",0.9627953802521164,0.888691782951355,0,0,"[{'label': 'positive', 'score': 0.9879084229469299}, {'label': 'neutral', 'score': 0.011804427020251751}, {'label': 'negative', 'score': 0.00028710084734484553}]","(0.011804427020251751, 0.9879084229469299, 0.00028710084734484553)",0.9994189391867664,0.9879084229469299,0,0
2017-07-22,48.046836853027344,59.74236679077149,60.08269882202149,59.68829600016276,59.8346061706543,7544377.333333333,,-0.0003194538724380947,-0.0003194028579137983,0.06734185515425102,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-23,48.03149032592773,59.72328186035156,60.0508918762207,59.66285069783529,59.75508880615234,7850847.666666667,,-0.00031955595582552486,-0.0003195049086958975,0.06157854961236618,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-24,48.016143798828125,59.70419692993164,60.01908493041992,59.63740539550781,59.67557144165039,8157318.0,"UPDATE: Merck Reports No Safety Signals Identified In Phase 3 KEYTRUDA Study | Merck Reports Update On Phase 3 KEYTRUDA Study, Did Not Meet Primary Endpoint | What You Need To Know About Dow Components Reporting This Week | Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers | Merck Gives Results from ONCEMRK, A Study of ISENTRESS HD",-0.0033561864705074665,-0.0003196070247098757,0.05642619459930415,"[{'label': 'neutral', 'score': 0.9451865553855896}, {'label': 'negative', 'score': 0.054322972893714905}, {'label': 'positive', 'score': 0.0004905161913484335}]","(0.9451865553855896, 0.0004905161913484335, 0.054322972893714905)",-0.9821023547474886,-0.054322972893714905,0,1,"[{'label': 'neutral', 'score': 0.9105989933013916}, {'label': 'negative', 'score': 0.04682343825697899}, {'label': 'positive', 'score': 0.04257762432098389}]","(0.9105989933013916, 0.04257762432098389, 0.04682343825697899)",-0.047491761435078106,-0.04682343825697899,1,1,"[{'label': 'negative', 'score': 0.5183995366096497}, {'label': 'neutral', 'score': 0.47101521492004395}, {'label': 'positive', 'score': 0.010585232637822628}]","(0.47101521492004395, 0.010585232637822628, 0.5183995366096497)",-0.9599790646037653,-0.5183995366096497,0,0
2017-07-25,47.85498809814453,59.50381851196289,60.114505767822266,59.39885330200195,59.97137451171875,6241783.0,"UPDATE: Merck Plans to Submit New Drug Applications with the U.S. FDA in Q4 2017 For Doravirine | Merck's Doravirine Meets Primary Efficacy Endpoint of Non-Inferiority to Efavirenz, Both in Combination with Other Antiretroviral Agents, in Pivotal Phase 3 Trial for Treatment of HIV-1 Infection",-0.008980118624984126,-0.0033618310974722954,0.034456512828465485,"[{'label': 'neutral', 'score': 0.9998051524162292}, {'label': 'positive', 'score': 0.00013861774641554803}, {'label': 'negative', 'score': 5.62851746508386e-05}]","(0.9998051524162292, 0.00013861774641554803, 5.62851746508386e-05)",0.42242861889517713,0.00013861774641554803,0,0,"[{'label': 'positive', 'score': 0.9089502096176147}, {'label': 'neutral', 'score': 0.08000756055116653}, {'label': 'negative', 'score': 0.01104218140244484}]","(0.08000756055116653, 0.9089502096176147, 0.01104218140244484)",0.9759950592847804,0.9089502096176147,0,0,"[{'label': 'neutral', 'score': 0.9862542152404785}, {'label': 'positive', 'score': 0.013158573769032955}, {'label': 'negative', 'score': 0.0005871569155715406}]","(0.9862542152404785, 0.013158573769032955, 0.0005871569155715406)",0.9145688317276333,0.013158573769032955,0,0
2017-07-26,47.425235748291016,58.96946716308594,59.48473358154297,58.89313125610352,59.45610809326172,9816302.0,,0.03058247854965413,-0.009020682920979427,0.06012660763052676,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-07-27,48.87561798095703,60.77289962768555,61.593509674072266,59.92366409301758,60.75381851196289,22894922.0,"Merck Shares Up 3.3% After Announcing Oncology Collaboration With AstraZeneca | Why Is AstraZeneca Sinking Today? | Samsung, Amazon  Everyone Is Getting Into Pharmaceuticals | AstraZeneca, Merck Announce Strategic Oncology Collaboration; Merck to pay AstraZeneca up to $8.5B in Total Consideration",0.006594460158841261,0.030124155554243384,0.24359021163375458,"[{'label': 'positive', 'score': 0.999582827091217}, {'label': 'neutral', 'score': 0.00023716178839094937}, {'label': 'negative', 'score': 0.00018003251170739532}]","(0.00023716178839094937, 0.999582827091217, 0.00018003251170739532)",0.9996398495703693,0.999582827091217,0,0,"[{'label': 'positive', 'score': 0.9468481540679932}, {'label': 'neutral', 'score': 0.031596630811691284}, {'label': 'negative', 'score': 0.021555157378315926}]","(0.031596630811691284, 0.9468481540679932, 0.021555157378315926)",0.9554830985736236,0.9468481540679932,0,0,"[{'label': 'positive', 'score': 0.9833923578262329}, {'label': 'neutral', 'score': 0.015265672467648983}, {'label': 'negative', 'score': 0.0013420390896499157}]","(0.015265672467648983, 0.9833923578262329, 0.0013420390896499157)",0.9972743125580804,0.9833923578262329,0,0
2017-07-28,49.19793319702149,61.17366409301758,61.41221237182617,60.32442855834961,60.88740539550781,13982521.0,"A Peek Into The Markets: U.S. Stock Futures Down; Amazon Earnings Miss Views | Merck Raises FY17 Sales Outlook From Feb. 2 Indication Of $38.6B-$40.1B To $39.4B-$40.4B vs $40.1B Est. | UPDATE: Merck Raises FY17 Adj. EPS Outlook From $3.72-$3.87 To $3.76-$3.88 vs $3.85 Est. | Merck Raises FY17 Adj. EPS Outlook | Merck Reports Q2 Adj. EPS $1.01 vs $0.87 Est., Sales $9.93B vs $9.75B Est. | 10 Stocks To Watch For July 28, 2017 | Earnings Scheduled For July 28, 2017",-0.0011958695316568143,0.006572811827037805,0.24183144868297998,"[{'label': 'negative', 'score': 0.9975776076316833}, {'label': 'neutral', 'score': 0.0015859660925343633}, {'label': 'positive', 'score': 0.0008365305257029831}]","(0.0015859660925343633, 0.0008365305257029831, 0.9975776076316833)",-0.998324281490551,-0.9975776076316833,0,0,"[{'label': 'negative', 'score': 0.9491829872131348}, {'label': 'neutral', 'score': 0.03875621035695076}, {'label': 'positive', 'score': 0.012060770764946938}]","(0.03875621035695076, 0.012060770764946938, 0.9491829872131348)",-0.9749059056772112,-0.9491829872131348,0,0,"[{'label': 'negative', 'score': 0.7303882837295532}, {'label': 'neutral', 'score': 0.14824363589286804}, {'label': 'positive', 'score': 0.12136811763048172}]","(0.14824363589286804, 0.12136811763048172, 0.7303882837295532)",-0.7150168347741486,-0.7303882837295532,0,0
2017-07-29,49.13910166422526,61.10050837198893,61.39631017049154,60.41666793823242,61.02735392252604,13414085.666666666,,-0.001197301347858814,-0.0011965851542095824,0.2430777870407481,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-30,49.08027013142904,61.02735265096029,61.3804079691569,60.508907318115234,61.16730244954427,12845650.333333334,,-0.001198736596802009,-0.0011980186857544922,0.23905155080055132,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-07-31,49.02143859863281,60.95419692993164,61.364505767822266,60.60114669799805,61.3072509765625,12277215.0,Merck To Collaborate With Generex Biotech For KEYTRUDA In Combination With AE37 Study,0.0006262056226206713,-0.0011994556562156164,0.2153047773842858,"[{'label': 'neutral', 'score': 0.9991607666015625}, {'label': 'positive', 'score': 0.0007693568477407098}, {'label': 'negative', 'score': 6.988309905864298e-05}]","(0.9991607666015625, 0.0007693568477407098, 6.988309905864298e-05)",0.8334609801996216,0.0007693568477407098,0,1,"[{'label': 'positive', 'score': 0.6876487135887146}, {'label': 'neutral', 'score': 0.30562999844551086}, {'label': 'negative', 'score': 0.006721284240484238}]","(0.30562999844551086, 0.6876487135887146, 0.006721284240484238)",0.9806406260019963,0.6876487135887146,0,0,"[{'label': 'neutral', 'score': 0.9862582683563232}, {'label': 'positive', 'score': 0.013567720539867878}, {'label': 'negative', 'score': 0.00017398125783074647}]","(0.9862582683563232, 0.013567720539867878, 0.00017398125783074647)",0.9746783534685808,0.013567720539867878,0,1
2017-08-01,49.052127838134766,60.99236679077149,61.32633590698242,60.84923553466797,61.10686874389648,6802463.0,August PDUFA Dates: Biotech Investors Stay Tuned To A Month Of Plenty,-0.0075093895514125025,0.0006260096376934634,0.053422283158775244,"[{'label': 'neutral', 'score': 0.9995243549346924}, {'label': 'positive', 'score': 0.0003715486382134259}, {'label': 'negative', 'score': 0.00010418266901979223}]","(0.9995243549346924, 0.0003715486382134259, 0.00010418266901979223)",0.5620104565928066,0.0003715486382134259,0,1,"[{'label': 'neutral', 'score': 0.8526087999343872}, {'label': 'positive', 'score': 0.10767921060323715}, {'label': 'negative', 'score': 0.03971199318766594}]","(0.8526087999343872, 0.10767921060323715, 0.03971199318766594)",0.4611348280457298,0.10767921060323715,1,1,"[{'label': 'neutral', 'score': 0.9995530247688293}, {'label': 'positive', 'score': 0.00032660007127560675}, {'label': 'negative', 'score': 0.00012031961523462087}]","(0.9995530247688293, 0.00032660007127560675, 0.00012031961523462087)",0.461560459893201,0.00032660007127560675,1,1
2017-08-02,48.68377685546875,60.53435134887695,61.03053283691406,60.27671813964844,61.020992279052734,7372575.0,,0.0012610345247192952,-0.007537726970743895,0.049847411486778785,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-03,48.74517440795898,60.610687255859375,60.81106948852539,60.286258697509766,60.314884185791016,7355702.0,,-0.006612108911424502,0.0012602400884872023,0.05539852957296212,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-04,48.42285537719727,60.209922790527344,60.77289962768555,60.0572509765625,60.71564865112305,5597368.0,,-0.0013734870702863178,-0.006634065744386259,0.06539348627574713,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-05,48.35634994506836,60.12722524007162,60.58206049601237,59.96819305419922,60.4993642171224,6070994.0,,-0.0013753761316199964,-0.0013744311682222948,0.0651523974171767,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-06,48.28984451293945,60.04452768961588,60.3912213643392,59.87913513183594,60.28307978312174,6544620.0,,-0.0013772703964498238,-0.0013763228295150475,0.059997511412740956,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-07,48.22333908081055,59.96183013916016,60.200382232666016,59.790077209472656,60.06679534912109,7018246.0,"Merck Animal Health to Acquire Austrian Manufacturing Facility, Terms Not Disclosed",-0.008274955699076767,-0.0013782197050588704,0.045748619548007144,"[{'label': 'neutral', 'score': 0.999866247177124}, {'label': 'negative', 'score': 8.354162855539471e-05}, {'label': 'positive', 'score': 5.0178517994936556e-05}]","(0.999866247177124, 5.0178517994936556e-05, 8.354162855539471e-05)",-0.2494995064031023,-8.354162855539471e-05,0,0,"[{'label': 'neutral', 'score': 0.9460562467575073}, {'label': 'positive', 'score': 0.03650623559951782}, {'label': 'negative', 'score': 0.0174375232309103}]","(0.9460562467575073, 0.03650623559951782, 0.0174375232309103)",0.35349246663640743,0.03650623559951782,0,0,"[{'label': 'neutral', 'score': 0.9992024302482605}, {'label': 'positive', 'score': 0.0006117571028880775}, {'label': 'negative', 'score': 0.00018578843446448445}]","(0.9992024302482605, 0.0006117571028880775, 0.00018578843446448445)",0.5340994946038923,0.0006117571028880775,0,0
2017-08-08,47.82429504394531,59.46564865112305,59.84732818603516,59.35114669799805,59.67557144165039,8048745.0,Merck 10-Q Just Out | Nice Recommends Erbitux In Combination With Platinum-Based Chemotherapy For The Treatment Of Recurrent And/Or Metastatic Head And Neck Cancer In The Oral Cavity,0.0027278973693725416,-0.008309383200569589,0.0538260715860693,"[{'label': 'neutral', 'score': 0.9970076680183411}, {'label': 'positive', 'score': 0.0029017601627856493}, {'label': 'negative', 'score': 9.060055890586227e-05}]","(0.9970076680183411, 0.0029017601627856493, 9.060055890586227e-05)",0.9394454296575261,0.0029017601627856493,0,1,"[{'label': 'neutral', 'score': 0.5181224346160889}, {'label': 'positive', 'score': 0.47145479917526245}, {'label': 'negative', 'score': 0.010422800667583942}]","(0.5181224346160889, 0.47145479917526245, 0.010422800667583942)",0.9567408791320322,0.47145479917526245,0,1,"[{'label': 'neutral', 'score': 0.8201166987419128}, {'label': 'positive', 'score': 0.17938117682933807}, {'label': 'negative', 'score': 0.0005020853132009506}]","(0.8201166987419128, 0.17938117682933807, 0.0005020853132009506)",0.9944176539026394,0.17938117682933807,0,1
2017-08-09,47.95473861694336,59.62786483764648,59.84732818603516,59.3702278137207,59.58969497680664,6866810.0,,-0.0049608194234987074,0.0027241834100104126,0.06313825141398452,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-10,47.71686172485352,59.332061767578125,59.71374130249024,59.32251739501953,59.51335906982422,8137825.0,,0.003216437359871165,-0.0049731651349958425,0.06619234309712166,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-11,47.87033081054688,59.52289962768555,60.07633590698242,59.40839767456055,59.56106948852539,6341448.0,,0.0015496452703038298,0.003211275690388899,0.07864892464700388,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-12,47.94451522827149,59.61513900756836,60.08905919392904,59.51335906982422,59.71692148844401,6151585.333333333,,0.001547247585401124,0.0015484458090717188,0.08217435537545842,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-13,48.018699645996094,59.70737838745117,60.10178248087565,59.61832046508789,59.87277348836263,5961722.666666667,,0.0015448573086605097,0.0015460518311154882,0.05262721826176846,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-14,48.0928840637207,59.799617767333984,60.114505767822266,59.72328186035156,60.02862548828125,5771860.0,"Merck Higher Despite Trump Bashing | Doug Kass Tweets: I am buying $MRK just on principle.  @maddow @MSNBC @carlquintanilla @jimcramer @tomkeene @andrewrsorkin @BeckyQuick | Merck CEO Quits Manufacturing Council To Stand Against Violence; Trump Promptly Calls Him Out About Drug Pricing | Donald Trump Tweets: Now that Ken Frazier of Merck Pharma has resigned from President's Manufacturing Council,he will have more time to LOWER RIPOFF DRUG PRICES! | CNBC Now Tweets: JUST IN: Merck CEO resigns from Trump's manufacturing council amid fallout from the President's comments.",-0.002712598807191401,0.001543665244163546,0.050550360906390604,"[{'label': 'positive', 'score': 0.7941728234291077}, {'label': 'neutral', 'score': 0.2032882571220398}, {'label': 'negative', 'score': 0.0025388975627720356}]","(0.2032882571220398, 0.7941728234291077, 0.0025388975627720356)",0.9936265590278722,0.7941728234291077,0,0,"[{'label': 'negative', 'score': 0.9347487092018127}, {'label': 'neutral', 'score': 0.052187927067279816}, {'label': 'positive', 'score': 0.013063342310488224}]","(0.052187927067279816, 0.013063342310488224, 0.9347487092018127)",-0.9724347410657108,-0.9347487092018127,0,0,"[{'label': 'neutral', 'score': 0.9380722641944885}, {'label': 'negative', 'score': 0.04630991071462631}, {'label': 'positive', 'score': 0.015617838129401207}]","(0.9380722641944885, 0.015617838129401207, 0.04630991071462631)",-0.495610984706174,-0.04630991071462631,1,1
2017-08-15,47.9624252319336,59.63740539550781,60.14313125610352,59.62786483764648,59.85686874389648,6619168.0,"Martin Shkreli Calls Merck CEO Ken Frazier 'Self-Indulgent,' 'Pathetic' | The Market In 5 Minutes",0.003199969194531671,-0.002716284570175554,0.03513210294112486,"[{'label': 'negative', 'score': 0.6743246912956238}, {'label': 'neutral', 'score': 0.3221588432788849}, {'label': 'positive', 'score': 0.0035164577420800924}]","(0.3221588432788849, 0.0035164577420800924, 0.6743246912956238)",-0.9896245374094735,-0.6743246912956238,0,0,"[{'label': 'negative', 'score': 0.9150177240371704}, {'label': 'neutral', 'score': 0.07442496716976166}, {'label': 'positive', 'score': 0.010557235218584538}]","(0.07442496716976166, 0.010557235218584538, 0.9150177240371704)",-0.9771877250718332,-0.9150177240371704,0,0,"[{'label': 'negative', 'score': 0.9559165239334106}, {'label': 'neutral', 'score': 0.04311337321996689}, {'label': 'positive', 'score': 0.0009700392838567495}]","(0.04311337321996689, 0.0009700392838567495, 0.9559165239334106)",-0.9979725093419741,-0.9559165239334106,0,0
2017-08-16,48.11590194702149,59.828243255615234,60.04771041870117,59.475189208984375,59.57061004638672,6352138.0,"You Can't Quit, Because You're Fired! Trump Disbands Manufacturing Council, Policy Forum | Market Reaction To Bristol-Myers' Mixed Clinical Results: 'A Little Excessive'",-0.013716097978686555,0.003194860189313476,0.03506792866965388,"[{'label': 'negative', 'score': 0.9743717312812805}, {'label': 'neutral', 'score': 0.024257013574242592}, {'label': 'positive', 'score': 0.0013712566578760743}]","(0.024257013574242592, 0.0013712566578760743, 0.9743717312812805)",-0.9971893076869099,-0.9743717312812805,1,1,"[{'label': 'negative', 'score': 0.9511555433273315}, {'label': 'neutral', 'score': 0.030381841585040092}, {'label': 'positive', 'score': 0.018462570384144783}]","(0.030381841585040092, 0.018462570384144783, 0.9511555433273315)",-0.9619178517334536,-0.9511555433273315,1,1,"[{'label': 'negative', 'score': 0.9893145561218262}, {'label': 'neutral', 'score': 0.009874429553747177}, {'label': 'positive', 'score': 0.0008110305061563849}]","(0.009874429553747177, 0.0008110305061563849, 0.9893145561218262)",-0.9983617623519487,-0.9893145561218262,1,1
2017-08-17,47.45594024658203,59.00763320922852,60.13358688354492,58.97900772094727,59.875953674316406,9589305.0,"AstraZeneca, Merck Issue Release Confirming Added, Broad Approval Of LYNPARZA In US For Ovarian Cancer",-0.005659761255408451,-0.013811032739780462,0.11001629308309842,"[{'label': 'positive', 'score': 0.9986020922660828}, {'label': 'neutral', 'score': 0.0011227561626583338}, {'label': 'negative', 'score': 0.0002751822175923735}]","(0.0011227561626583338, 0.9986020922660828, 0.0002751822175923735)",0.9994490169620995,0.9986020922660828,0,0,"[{'label': 'positive', 'score': 0.8459759950637817}, {'label': 'neutral', 'score': 0.14282742142677307}, {'label': 'negative', 'score': 0.011196538805961609}]","(0.14282742142677307, 0.8459759950637817, 0.011196538805961609)",0.9738756472855836,0.8459759950637817,0,0,"[{'label': 'positive', 'score': 0.9987924098968506}, {'label': 'neutral', 'score': 0.0009426405886188149}, {'label': 'negative', 'score': 0.0002648635709192604}]","(0.0009426405886188149, 0.9987924098968506, 0.0002648635709192604)",0.9994697729990997,0.9987924098968506,0,0
2017-08-18,47.18735122680664,58.67366409301758,58.988548278808594,58.35877990722656,58.94084167480469,8825942.0,,0.0026020501075713857,-0.005675838394686871,0.10705744466362128,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-19,47.31013615926107,58.82633590698242,59.05852381388346,58.44465764363607,58.84860229492188,8398183.333333334,,0.0025952970146952397,0.0025986706362899166,0.11039434312736315,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-20,47.43292109171549,58.97900772094727,59.128499348958336,58.53053538004557,58.75636291503906,7970424.666666667,,0.0025885788836459683,0.0025919350470114347,0.11825972318848468,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-21,47.55570602416992,59.13167953491211,59.1984748840332,58.61641311645508,58.66412353515625,7542666.0,,0.007261588999171989,0.0025852342839243,0.11656817947096304,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-22,47.90103912353516,59.56106948852539,59.63740539550781,59.08396911621094,59.13167953491211,5779930.0,,-0.004325530274068404,0.007235350606821183,0.07415720428178027,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-23,47.69382858276367,59.30343627929688,59.73282241821289,59.30343627929688,59.39885330200195,6743775.0,,0.009010461828221085,-0.004334912445162718,0.0656923857425364,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-24,48.123573303222656,59.83778762817383,60.02862548828125,59.34160232543945,59.39885330200195,8122105.0,"Playing The US Pharma Space: Buy Portola, Hold Corvus, Sell Teva",0.0036676380776708476,0.008970109829335894,0.08205802641835752,"[{'label': 'neutral', 'score': 0.9998776912689209}, {'label': 'negative', 'score': 6.711894093314186e-05}, {'label': 'positive', 'score': 5.519352635019459e-05}]","(0.9998776912689209, 5.519352635019459e-05, 6.711894093314186e-05)",-0.09749958322173392,-6.711894093314186e-05,1,1,"[{'label': 'neutral', 'score': 0.9246814846992493}, {'label': 'positive', 'score': 0.06192773953080177}, {'label': 'negative', 'score': 0.01339074969291687}]","(0.9246814846992493, 0.06192773953080177, 0.01339074969291687)",0.6444233061249462,0.06192773953080177,0,1,"[{'label': 'neutral', 'score': 0.9990556836128235}, {'label': 'positive', 'score': 0.0007959717186167836}, {'label': 'negative', 'score': 0.00014845197438262403}]","(0.9990556836128235, 0.0007959717186167836, 0.00014845197438262403)",0.6856242055699525,0.0007959717186167836,0,1
2017-08-25,48.30007553100586,60.0572509765625,60.39122009277344,59.89503860473633,59.99045944213867,5528095.0,"Jon Najarian Sees Unusual Options Activity In Marathon Petroleum, Caesars And Merck",0.002012494181780487,0.00366092869319485,0.08173731018214964,"[{'label': 'negative', 'score': 0.642914891242981}, {'label': 'positive', 'score': 0.25686895847320557}, {'label': 'neutral', 'score': 0.10021613538265228}]","(0.10021613538265228, 0.25686895847320557, 0.642914891242981)",-0.42904296725435065,-0.642914891242981,1,0,"[{'label': 'negative', 'score': 0.703233540058136}, {'label': 'neutral', 'score': 0.24571587145328522}, {'label': 'positive', 'score': 0.051050569862127304}]","(0.24571587145328522, 0.051050569862127304, 0.703233540058136)",-0.8646383526029099,-0.703233540058136,0,0,"[{'label': 'positive', 'score': 0.5436606407165527}, {'label': 'neutral', 'score': 0.42178937792778015}, {'label': 'negative', 'score': 0.03454996645450592}]","(0.42178937792778015, 0.5436606407165527, 0.03454996645450592)",0.8804934879228716,0.5436606407165527,0,0
2017-08-26,48.39727528889974,60.17811584472656,60.44529215494792,59.961832682291664,60.06679534912109,6304768.0,,0.0020084521834470336,0.002010471828226611,0.08229712909617658,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-27,48.49447504679362,60.29898071289063,60.4993642171224,60.02862675984701,60.14313125610352,7081441.0,,0.0020044263888894737,0.002006437939917502,0.07546753185409626,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-28,48.5916748046875,60.41984558105469,60.55343627929688,60.09542083740234,60.21946716308594,7858114.0,,-0.0031585294247632786,0.0020024202066975545,0.04787124728713332,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-08-29,48.43820190429688,60.22900772094727,60.314884185791016,59.84732818603516,60.238548278808594,6879806.0,"Merck Announces Presentation of Results of REVEAL Outcomes Study of Anacetrapib, Investigational Medicine for Cardiovascular Disease",0.0,-0.003163528107259102,0.04123877441800339,"[{'label': 'neutral', 'score': 0.9998537302017212}, {'label': 'positive', 'score': 8.612810779595748e-05}, {'label': 'negative', 'score': 6.0050551837775856e-05}]","(0.9998537302017212, 8.612810779595748e-05, 6.0050551837775856e-05)",0.17839509558728886,8.612810779595748e-05,1,1,"[{'label': 'neutral', 'score': 0.6960076093673706}, {'label': 'positive', 'score': 0.28809136152267456}, {'label': 'negative', 'score': 0.015901003032922745}]","(0.6960076093673706, 0.28809136152267456, 0.015901003032922745)",0.8953855103816951,0.28809136152267456,0,1,"[{'label': 'neutral', 'score': 0.9992251396179199}, {'label': 'positive', 'score': 0.0006615194142796099}, {'label': 'negative', 'score': 0.00011325824016239494}]","(0.9992251396179199, 0.0006615194142796099, 0.00011325824016239494)",0.70763679227697,0.0006615194142796099,0,1
2017-08-30,48.43820190429688,60.22900772094727,60.27671813964844,60.01908493041992,60.24809265136719,5263580.0,Born On The Battlefield: AcelRx Awaits FDA Ruling On Device That Delivers Potent Opioid To Wounded Soldiers,0.011723721176567293,0.0,0.03589733643997924,"[{'label': 'neutral', 'score': 0.9988452196121216}, {'label': 'negative', 'score': 0.0006604013033211231}, {'label': 'positive', 'score': 0.0004944168031215668}]","(0.9988452196121216, 0.0004944168031215668, 0.0006604013033211231)",-0.1437321594401184,-0.0006604013033211231,0,0,"[{'label': 'neutral', 'score': 0.5020478367805481}, {'label': 'negative', 'score': 0.33107075095176697}, {'label': 'positive', 'score': 0.16688142716884613}]","(0.5020478367805481, 0.16688142716884613, 0.33107075095176697)",-0.329729100498384,-0.33107075095176697,0,0,"[{'label': 'positive', 'score': 0.876646101474762}, {'label': 'neutral', 'score': 0.12208845466375351}, {'label': 'negative', 'score': 0.0012654757592827082}]","(0.12208845466375351, 0.876646101474762, 0.0012654757592827082)",0.9971170769537641,0.876646101474762,1,1
2017-08-31,49.00608444213867,60.93511581420898,60.99236679077149,60.06679534912109,60.4484748840332,13522344.0,"Merck Shares Down 0.5% Over Last Few Mins., Remain Up ~0.1% For Session | Merck Shares Move To Session Lows, Up 0.4% For Session, As Traders Circulating FDA.gov Alert 'FDA Alerts Healthcare Professionals and Oncology Clinical Investigators about Two Clinical Trials on Hold Evaluating KEYTRUDA in Patients w/ MM'",-0.0004697699823617148,0.011655530803275124,0.08789966147277255,"[{'label': 'positive', 'score': 0.992630124092102}, {'label': 'negative', 'score': 0.006603975314646959}, {'label': 'neutral', 'score': 0.000765856122598052}]","(0.000765856122598052, 0.992630124092102, 0.006603975314646959)",0.9867819256397119,0.992630124092102,0,0,"[{'label': 'negative', 'score': 0.9615525007247925}, {'label': 'positive', 'score': 0.024158986285328865}, {'label': 'neutral', 'score': 0.014288529753684998}]","(0.014288529753684998, 0.024158986285328865, 0.9615525007247925)",-0.9509816277811506,-0.9615525007247925,0,0,"[{'label': 'neutral', 'score': 0.7252548336982727}, {'label': 'negative', 'score': 0.264389306306839}, {'label': 'positive', 'score': 0.010355831123888493}]","(0.7252548336982727, 0.010355831123888493, 0.264389306306839)",-0.9246149997722922,-0.264389306306839,0,1
2017-09-01,48.98305892944336,60.90649032592773,61.16412353515625,60.6870231628418,60.86832046508789,6481985.0,,-0.0008224995053634089,-0.00046988035884892534,0.09049565732690668,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-02,48.94277191162109,60.85639476776123,61.16650867462158,60.653626441955566,60.858778953552246,6757373.25,,-0.0008231765676832717,-0.000822837943671175,0.09269653068668343,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-03,48.90248489379883,60.80629920959473,61.168893814086914,60.620229721069336,60.8492374420166,7032761.5,,-0.0008238547456050284,-0.0008235155635624719,0.08666804887111222,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-04,48.86219787597656,60.75620365142822,61.171278953552246,60.58683300018311,60.83969593048096,7308149.75,,-0.0008245340418883511,-0.0008241943004346219,0.08799838366041011,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-05,48.8219108581543,60.70610809326172,61.17366409301758,60.55343627929688,60.83015441894531,7583538.0,Merck's KEYTRUDA Approved by the European Commission for a Type of Bladder Cancer,0.005972950925055958,-0.0008248741570519692,0.002513003022071776,"[{'label': 'positive', 'score': 0.9940897226333618}, {'label': 'neutral', 'score': 0.0054121422581374645}, {'label': 'negative', 'score': 0.0004981207894161344}]","(0.0054121422581374645, 0.9940897226333618, 0.0004981207894161344)",0.9989983372656116,0.9940897226333618,1,1,"[{'label': 'neutral', 'score': 0.5412188172340393}, {'label': 'positive', 'score': 0.4477899372577667}, {'label': 'negative', 'score': 0.010991280898451805}]","(0.5412188172340393, 0.4477899372577667, 0.010991280898451805)",0.952084869809517,0.4477899372577667,1,0,"[{'label': 'positive', 'score': 0.9577091336250305}, {'label': 'neutral', 'score': 0.04182969033718109}, {'label': 'negative', 'score': 0.0004611638723872602}]","(0.04182969033718109, 0.9577091336250305, 0.0004611638723872602)",0.9990374072884711,0.9577091336250305,1,1
2017-09-06,49.11351776123047,61.06870269775391,61.38358688354492,60.84923553466797,60.96374130249024,7491838.0,"Merck Announces Acquisition of Rigontec for EUR 115M Cash, May Make up to EUR 349M of Additional Payments | Eisai Signs Agreement with Merck to Expand Enrollment of Combination Study for Lenvima  and Pembrolizumab in Endometrial Carcinoma",0.005000001873970018,0.005955183567612094,0.04812640461712812,"[{'label': 'positive', 'score': 0.9951554536819458}, {'label': 'neutral', 'score': 0.004625111818313599}, {'label': 'negative', 'score': 0.0002194324042648077}]","(0.004625111818313599, 0.9951554536819458, 0.0002194324042648077)",0.9995590959600607,0.9951554536819458,0,0,"[{'label': 'positive', 'score': 0.9477436542510986}, {'label': 'neutral', 'score': 0.03889235109090805}, {'label': 'negative', 'score': 0.013364078477025032}]","(0.03889235109090805, 0.9477436542510986, 0.013364078477025032)",0.9721902591729424,0.9477436542510986,0,0,"[{'label': 'positive', 'score': 0.9985053539276123}, {'label': 'neutral', 'score': 0.0012914621038362384}, {'label': 'negative', 'score': 0.0002031797484960407}]","(0.0012914621038362384, 0.9985053539276123, 0.0002031797484960407)",0.9995931150247647,0.9985053539276123,0,0
2017-09-07,49.35908508300781,61.3740463256836,61.46946716308594,60.86832046508789,61.154579162597656,7185507.0,"Wall Street's M&A Chatter From September 6: Cabelas, Merck-Rigontec, Altice-Charter, Amazon-Kohl's",-0.0007773712433428605,0.0049875433756858215,0.05500753343129822,"[{'label': 'neutral', 'score': 0.9998905658721924}, {'label': 'negative', 'score': 6.51436421321705e-05}, {'label': 'positive', 'score': 4.4268261262914166e-05}]","(0.9998905658721924, 4.4268261262914166e-05, 6.51436421321705e-05)",-0.19079624996446373,-6.51436421321705e-05,1,1,"[{'label': 'neutral', 'score': 0.9492606520652771}, {'label': 'positive', 'score': 0.034560710191726685}, {'label': 'negative', 'score': 0.01617860421538353}]","(0.9492606520652771, 0.034560710191726685, 0.01617860421538353)",0.3622852652058544,0.034560710191726685,1,1,"[{'label': 'neutral', 'score': 0.9995331764221191}, {'label': 'positive', 'score': 0.00031577315530739725}, {'label': 'negative', 'score': 0.00015109074593055993}]","(0.9995331764221191, 0.00031577315530739725, 0.00015109074593055993)",0.3527417925013223,0.00031577315530739725,1,1
2017-09-08,49.32072067260742,61.32633590698242,61.57442855834961,61.011451721191406,61.05915832519531,7719358.0,"Merck Reports KEYTRUDA Plus Pemetrexed, Carboplatin Showed Continued Benefit in Overall Response Rates and Progression-Free Survival Compared to Pem/Carbo Alone in Patients with First-Line Nonsquamous NSCLC | European Society for Medical Oncology(ESMO) 2017 Congress Begins Today, Day 1 Of 5 | Merck Reports Updated Data For KEYTRUDA In Patients With Advanced Gastric Cancer Across Treatment Settings",0.004460346082697601,-0.0007776735530492625,0.05487616130288156,"[{'label': 'positive', 'score': 0.9996128678321838}, {'label': 'negative', 'score': 0.0002561188885010779}, {'label': 'neutral', 'score': 0.0001310057268710807}]","(0.0001310057268710807, 0.9996128678321838, 0.0002561188885010779)",0.9994876951042534,0.9996128678321838,0,0,"[{'label': 'positive', 'score': 0.9293472766876221}, {'label': 'neutral', 'score': 0.052697066217660904}, {'label': 'negative', 'score': 0.017955651506781578}]","(0.052697066217660904, 0.9293472766876221, 0.017955651506781578)",0.9620910038967033,0.9293472766876221,0,0,"[{'label': 'positive', 'score': 0.9987789988517761}, {'label': 'neutral', 'score': 0.0009277289500460029}, {'label': 'negative', 'score': 0.00029332880512811244}]","(0.0009277289500460029, 0.9987789988517761, 0.00029332880512811244)",0.9994127976583717,0.9987789988517761,0,0
2017-09-09,49.54070663452149,61.59987258911133,61.82251993815104,61.24681981404623,61.361321767171226,8741437.666666666,"What Pharmaceuticals Spend On Lobbying To Influence Trump | Incyte, Merck Announce Positive Progression-Free Survival Data from ECHO-202 Trial of Epacadostat in Combination with KEYTRUDA in Patients with Advanced Melanoma at ESMO 2017",0.00444053973866928,0.0044504282195742696,0.05228664708086904,"[{'label': 'positive', 'score': 0.9973354935646057}, {'label': 'neutral', 'score': 0.002381269121542573}, {'label': 'negative', 'score': 0.0002831773890648037}]","(0.002381269121542573, 0.9973354935646057, 0.0002831773890648037)",0.9994322933254766,0.9973354935646057,0,0,"[{'label': 'positive', 'score': 0.8966311812400818}, {'label': 'neutral', 'score': 0.09102959930896759}, {'label': 'negative', 'score': 0.01233918871730566}]","(0.09102959930896759, 0.8966311812400818, 0.01233918871730566)",0.9728501849452273,0.8966311812400818,0,0,"[{'label': 'positive', 'score': 0.6779923439025879}, {'label': 'neutral', 'score': 0.32090824842453003}, {'label': 'negative', 'score': 0.0010993860196322203}]","(0.32090824842453003, 0.6779923439025879, 0.0010993860196322203)",0.996762186988323,0.6779923439025879,0,0
2017-09-10,49.76069259643555,61.87340927124024,62.07061131795248,61.48218790690104,61.66348520914713,9763517.333333334,,0.004420908518710693,0.004430709631993728,0.041872753807989854,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-11,49.98067855834961,62.14694595336914,62.31870269775391,61.71755599975586,61.96564865112305,10785597.0,"Morgan Stanley Healthcare Conference Begins Today, Presenters Include: Veeva Systems, Quorum Health, Neurocrine Biosciences, Vertex Pharma, Merck, Ocular Therapeutix, Biogen, Gilead, and Bristol-Myers | Merck Reports Findings From Phase 3 Study OF KEYTRUDA vs Standard Of Care In Patients With Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma",0.005066768462400236,0.004411165008867857,0.0381575021457836,"[{'label': 'neutral', 'score': 0.999882698059082}, {'label': 'negative', 'score': 6.279025546973571e-05}, {'label': 'positive', 'score': 5.441583562060259e-05}]","(0.999882698059082, 5.441583562060259e-05, 6.279025546973571e-05)",-0.07145038087379275,-6.279025546973571e-05,1,1,"[{'label': 'neutral', 'score': 0.7871519923210144}, {'label': 'positive', 'score': 0.20141759514808655}, {'label': 'negative', 'score': 0.011430379003286362}]","(0.7871519923210144, 0.20141759514808655, 0.011430379003286362)",0.8925958393650736,0.20141759514808655,0,1,"[{'label': 'neutral', 'score': 0.9990993738174438}, {'label': 'positive', 'score': 0.0007002645870670676}, {'label': 'negative', 'score': 0.00020035479974467307}]","(0.9990993738174438, 0.0007002645870670676, 0.00020035479974467307)",0.555073313591563,0.0007002645870670676,0,1
2017-09-12,50.23391342163086,62.46183013916016,62.614505767822266,62.13740539550781,62.13740539550781,7707202.0,This Analyst Predicts Bullish Growth Outlook For Incyte,-0.00015274220816264268,0.005053975585242294,0.03832316766531747,"[{'label': 'positive', 'score': 0.9539284110069275}, {'label': 'negative', 'score': 0.04525281861424446}, {'label': 'neutral', 'score': 0.0008187933708541095}]","(0.0008187933708541095, 0.9539284110069275, 0.04525281861424446)",0.9094201987132974,0.9539284110069275,0,0,"[{'label': 'positive', 'score': 0.6730713248252869}, {'label': 'neutral', 'score': 0.1949218362569809}, {'label': 'negative', 'score': 0.13200676441192627}]","(0.1949218362569809, 0.6730713248252869, 0.13200676441192627)",0.6720646948993516,0.6730713248252869,0,0,"[{'label': 'positive', 'score': 0.9963105320930481}, {'label': 'neutral', 'score': 0.0033092438243329525}, {'label': 'negative', 'score': 0.0003802475694101304}]","(0.0033092438243329525, 0.9963105320930481, 0.0003802475694101304)",0.9992369798594125,0.9963105320930481,0,0
2017-09-13,50.22624588012695,62.45228958129883,62.54771041870117,62.30915832519531,62.36641311645508,5898878.0,,0.01023681835248624,-0.0001527538744416851,0.033918191751016846,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-09-14,51.1074104309082,63.09160232543945,63.13931274414063,61.9370231628418,62.01335906982422,10437137.0,,0.0006049911467290966,0.010184776984848808,0.05825999822599728,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-15,51.13832473754883,63.1297721862793,63.33969497680664,62.738548278808594,63.13931274414063,15390718.0,,-0.0008565223713294009,0.000604808213363699,0.06559745417397009,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-16,51.09452565511068,63.07570012410482,63.349236806233726,62.75763320922852,63.09160232543945,13943570.0,,-0.0008572566308117742,-0.0008568893962073212,0.0737723735457723,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-17,51.05072657267253,63.021628061930336,63.358778635660805,62.77671813964844,63.04389190673828,12496422.0,,-0.0008579921502716663,-0.0008576242854086,0.07515998506603781,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-18,51.006927490234375,62.96755599975586,63.36832046508789,62.79580307006836,62.99618148803711,11049274.0,,-0.0006061223996485762,-0.0008583604362093753,0.07646141259201426,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-19,50.97600555419922,62.92938995361328,63.1297721862793,62.671756744384766,62.99618148803711,7345746.0,,-0.002426081264690182,-0.0006063061660905909,0.010085259006767594,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-09-20,50.85234069824219,62.77671813964844,63.27289962768555,62.20419692993164,63.04389190673828,9903600.0,,-0.0028879703753037916,-0.002429028968385835,0.011729822486264434,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-09-21,50.70548248291016,62.59542083740234,62.91030502319336,62.51908493041992,62.83396911621094,6255198.0,Merck and Pfizer Get European Commission Approval for Bavencio,-0.00716465961940176,-0.0028921486080954037,0.016687295370038824,"[{'label': 'positive', 'score': 0.9953110814094543}, {'label': 'neutral', 'score': 0.004435555078089237}, {'label': 'negative', 'score': 0.000253329606493935}]","(0.004435555078089237, 0.9953110814094543, 0.000253329606493935)",0.9994910834423352,0.9953110814094543,0,0,"[{'label': 'neutral', 'score': 0.5143574476242065}, {'label': 'positive', 'score': 0.4734208285808563}, {'label': 'negative', 'score': 0.012221787124872208}]","(0.5143574476242065, 0.4734208285808563, 0.012221787124872208)",0.9496675673443045,0.4734208285808563,0,0,"[{'label': 'positive', 'score': 0.9980212450027466}, {'label': 'neutral', 'score': 0.0016643691342324018}, {'label': 'negative', 'score': 0.0003144154616165906}]","(0.0016643691342324018, 0.9980212450027466, 0.0003144154616165906)",0.999370120743818,0.9980212450027466,0,0
2017-09-22,50.34218215942383,62.14694595336914,62.69084167480469,62.08969497680664,62.6240463256836,7824263.0,Agilent Technologies Receives FDA Approval For Use Of Dako PD-L1 For Treatment With Merck's KEYTRUDA In Gastric or Gastroesophageal Junction Cancer | REMINDER: Merck's KEYTRUDA In Gastric Or Gastroesophageal Cancer Indication Has PDUFA Date Today,0.0002559011172057194,-0.007190449048615947,0.042003223489667584,"[{'label': 'positive', 'score': 0.9985016584396362}, {'label': 'neutral', 'score': 0.001171998679637909}, {'label': 'negative', 'score': 0.0003263701219111681}]","(0.001171998679637909, 0.9985016584396362, 0.0003263701219111681)",0.9993464938656533,0.9985016584396362,0,0,"[{'label': 'neutral', 'score': 0.7007222771644592}, {'label': 'positive', 'score': 0.2872893810272217}, {'label': 'negative', 'score': 0.011988316662609577}]","(0.7007222771644592, 0.2872893810272217, 0.011988316662609577)",0.9198849980793814,0.2872893810272217,0,1,"[{'label': 'positive', 'score': 0.9949870109558105}, {'label': 'neutral', 'score': 0.004758334252983332}, {'label': 'negative', 'score': 0.0002547134645283222}]","(0.004758334252983332, 0.9949870109558105, 0.0002547134645283222)",0.9994881374880527,0.9949870109558105,0,0
2017-09-23,50.35506693522135,62.16284942626953,62.59542083740234,62.08015314737956,62.47455469767253,7163149.666666667,Cramer's Guide To Profit From Market Rotations,0.0002558356485774274,0.00025586838009959896,0.04581232695789353,"[{'label': 'neutral', 'score': 0.999583899974823}, {'label': 'positive', 'score': 0.00033981032902374864}, {'label': 'negative', 'score': 7.622773409821093e-05}]","(0.999583899974823, 0.00033981032902374864, 7.622773409821093e-05)",0.6335540381752757,0.00033981032902374864,0,1,"[{'label': 'neutral', 'score': 0.9118661880493164}, {'label': 'positive', 'score': 0.048259928822517395}, {'label': 'negative', 'score': 0.03987389802932739}]","(0.9118661880493164, 0.048259928822517395, 0.03987389802932739)",0.09515110250786153,0.048259928822517395,1,1,"[{'label': 'neutral', 'score': 0.9984727501869202}, {'label': 'positive', 'score': 0.001353545463643968}, {'label': 'negative', 'score': 0.00017367448890581727}]","(0.9984727501869202, 0.001353545463643968, 0.00017367448890581727)",0.7725612625531021,0.001353545463643968,0,1
2017-09-24,50.36795171101888,62.17875289916992,62.5,62.07061131795248,62.32506306966146,6502036.333333334,,0.00025577021343898545,0.0002558029282183696,0.04847471513255528,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-25,50.380836486816406,62.19465637207031,62.404579162597656,62.06106948852539,62.17557144165039,5840923.0,,-0.0064437121886246505,0.0002557375098141703,0.051992853244229364,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-26,50.05619430541992,61.79389190673828,62.328243255615234,61.7557258605957,62.11832046508789,7311058.0,,-0.002933903281568907,-0.006464562519291822,0.06172273768844684,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-27,49.90933609008789,61.61259460449219,61.78435134887695,61.3740463256836,61.71755599975586,7013111.0,,-0.0043363498778928415,-0.0029382156125084486,0.047428704961707556,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-28,49.69292068481445,61.34542083740234,61.6984748840332,61.23091506958008,61.32633590698242,7359894.0,,-0.004044191856222642,-0.004345779111869588,0.04655088773818422,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-09-29,49.491943359375,61.09732818603516,61.57442855834961,60.42938995361328,61.34542083740234,11999181.0,"Merck To Offer New, Updated Data On KEYTRUDA At World Conference On Lung Cancer, No Further Details Given | Merck Reports Discontinuation Of MK-3682B, MK-3682C Development Programs",0.002707055026073949,-0.004052391715443666,0.039070213962763084,"[{'label': 'neutral', 'score': 0.9998683929443359}, {'label': 'positive', 'score': 7.540552905993536e-05}, {'label': 'negative', 'score': 5.611556116491556e-05}]","(0.9998683929443359, 7.540552905993536e-05, 5.611556116491556e-05)",0.14666824812690732,7.540552905993536e-05,1,1,"[{'label': 'neutral', 'score': 0.6984885334968567}, {'label': 'negative', 'score': 0.2759436070919037}, {'label': 'positive', 'score': 0.02556779608130455}]","(0.6984885334968567, 0.02556779608130455, 0.2759436070919037)",-0.8304024603234214,-0.2759436070919037,0,1,"[{'label': 'neutral', 'score': 0.996040940284729}, {'label': 'positive', 'score': 0.002051424002274871}, {'label': 'negative', 'score': 0.0019076640019193292}]","(0.996040940284729, 0.002051424002274871, 0.0019076640019193292)",0.03631139297819207,0.002051424002274871,1,1
2017-09-30,49.62592188517253,61.26272201538086,61.622137705485024,60.6075070699056,61.31997553507487,10355148.333333334,,0.0026997466633000523,0.002703397551786059,0.0546763893780024,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-01,49.75990041097005,61.42811584472656,61.669846852620445,60.78562418619792,61.2945302327474,8711115.666666668,,0.002692477655732977,0.0026961088931780138,0.05694327718728818,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-02,49.89387893676758,61.593509674072266,61.71755599975586,60.96374130249024,61.26908493041992,7067083.0,"Galena Biopharma Shares Up 10.6% Following Earlier SEC Filing Showing SELLAS Life Sciences Entered Collab., Supply Deal With Merck For Initiation Of Phase 1/2 Trial With Galinpepimut-S, KEYTRUDA",-0.002788490712679736,0.002688859430973979,0.059975292752864125,"[{'label': 'positive', 'score': 0.9995885491371155}, {'label': 'negative', 'score': 0.0002190054365200922}, {'label': 'neutral', 'score': 0.00019245294970460236}]","(0.00019245294970460236, 0.9995885491371155, 0.0002190054365200922)",0.9995619048175456,0.9995885491371155,0,0,"[{'label': 'positive', 'score': 0.9339879155158997}, {'label': 'neutral', 'score': 0.037949200719594955}, {'label': 'negative', 'score': 0.02806277386844158}]","(0.037949200719594955, 0.9339879155158997, 0.02806277386844158)",0.9416605087900302,0.9339879155158997,0,0,"[{'label': 'positive', 'score': 0.9980865716934204}, {'label': 'neutral', 'score': 0.0016192231560125947}, {'label': 'negative', 'score': 0.00029427523259073496}]","(0.0016192231560125947, 0.9980865716934204, 0.00029427523259073496)",0.999410495036044,0.9980865716934204,0,0
2017-10-03,49.75474548339844,61.421756744384766,61.62213516235352,60.85877990722656,61.593509674072266,6819441.0,,0.0035730555428754554,-0.002792385795527086,0.05366741314447946,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-04,49.93251800537109,61.64122009277344,61.66030502319336,61.38358688354492,61.46946716308594,6722606.0,,0.0,0.003566687344694956,0.0409493298365748,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-05,49.93251800537109,61.64122009277344,61.832061767578125,61.38358688354492,61.46946716308594,9589200.0,,-0.0007740018550795241,0.0,0.04157054754285263,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-06,49.89387893676758,61.593509674072266,61.92748260498047,61.421756744384766,61.73664093017578,7847843.0,Heaps Of Healthy Health Care ETFs,-0.0011360655348167724,-0.0007743015491678078,0.0411684113598297,"[{'label': 'neutral', 'score': 0.9998761415481567}, {'label': 'positive', 'score': 6.401360587915406e-05}, {'label': 'negative', 'score': 5.979535490041599e-05}]","(0.9998761415481567, 6.401360587915406e-05, 5.979535490041599e-05)",0.0340706436123655,6.401360587915406e-05,1,1,"[{'label': 'neutral', 'score': 0.6916322112083435}, {'label': 'positive', 'score': 0.29175809025764465}, {'label': 'negative', 'score': 0.016609663143754005}]","(0.6916322112083435, 0.29175809025764465, 0.016609663143754005)",0.892273670248955,0.29175809025764465,0,1,"[{'label': 'neutral', 'score': 0.999243974685669}, {'label': 'positive', 'score': 0.0006587516982108355}, {'label': 'negative', 'score': 9.731174213811755e-05}]","(0.999243974685669, 0.0006587516982108355, 9.731174213811755e-05)",0.7425831300791258,0.0006587516982108355,0,1
2017-10-07,49.8371950785319,61.52353541056315,61.87659200032552,61.34223937988281,61.727099100748696,7136216.0,,-0.0011373576476409021,-0.0011367113464357365,0.03735733308507557,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-08,49.78051122029623,61.45356114705404,61.82570139567057,61.26272201538086,61.71755727132162,6424589.0,,-0.0011386527030007826,-0.0011380049296908865,0.03160420071684039,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-09,49.72382736206055,61.38358688354492,61.774810791015625,61.183204650878906,61.70801544189453,5712962.0,"Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result | Pre-Market Imbalance Update: GE Shares 198K To Buy, Macy's 75K To Buy, Pfizer 71K To Sell, Merck 56K To Buy, Citi 50K To Buy, P&G 40K To Buy, ExxonMobil 38K To Sell, Barrick Gold 30K To Buy, BofA 28K To Buy, Chevron 25K To Sell, JP Morgan 10K To Buy",0.0020208386635818102,-0.0011393014605095085,0.007842693428855229,"[{'label': 'neutral', 'score': 0.9997450709342957}, {'label': 'positive', 'score': 0.00016620525275357068}, {'label': 'negative', 'score': 8.86096604517661e-05}]","(0.9997450709342957, 0.00016620525275357068, 8.86096604517661e-05)",0.30451746848613975,0.00016620525275357068,0,0,"[{'label': 'neutral', 'score': 0.9201787710189819}, {'label': 'negative', 'score': 0.04133370518684387}, {'label': 'positive', 'score': 0.038487572222948074}]","(0.9201787710189819, 0.038487572222948074, 0.04133370518684387)",-0.0356563194207495,-0.04133370518684387,0,0,"[{'label': 'neutral', 'score': 0.9758301973342896}, {'label': 'positive', 'score': 0.01995963230729103}, {'label': 'negative', 'score': 0.00421011820435524}]","(0.9758301973342896, 0.01995963230729103, 0.00421011820435524)",0.651620880213341,0.01995963230729103,1,0
2017-10-10,49.824310302734375,61.50763320922852,61.51717758178711,61.25,61.364505767822266,5157208.0,5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings,-0.010549150863841191,0.002018799515859945,0.02190869996429304,"[{'label': 'positive', 'score': 0.9991787075996399}, {'label': 'neutral', 'score': 0.0005737028550356627}, {'label': 'negative', 'score': 0.00024761175154708326}]","(0.0005737028550356627, 0.9991787075996399, 0.00024761175154708326)",0.999504492233689,0.9991787075996399,0,0,"[{'label': 'positive', 'score': 0.7796223759651184}, {'label': 'neutral', 'score': 0.21089228987693787}, {'label': 'negative', 'score': 0.009485369548201561}]","(0.21089228987693787, 0.7796223759651184, 0.009485369548201561)",0.9759592537213502,0.7796223759651184,0,0,"[{'label': 'positive', 'score': 0.9127517938613892}, {'label': 'neutral', 'score': 0.08665851503610611}, {'label': 'negative', 'score': 0.0005896459333598614}]","(0.08665851503610611, 0.9127517938613892, 0.0005896459333598614)",0.9987088159856354,0.9127517938613892,0,0
2017-10-11,49.29871368408203,60.85877990722656,61.39313125610352,60.85877990722656,61.39313125610352,10586477.0,UPDATE: Merck Says Co. Will Not Submit Apps For Regulatory Approval For Anacetrapib | Merck Offers Update On Anacetrapid Development Program,0.000783952927973495,-0.010605187597528697,0.07597771609658663,"[{'label': 'neutral', 'score': 0.9997047781944275}, {'label': 'positive', 'score': 0.00015727411664556712}, {'label': 'negative', 'score': 0.0001378330052830279}]","(0.9997047781944275, 0.00015727411664556712, 0.0001378330052830279)",0.0658781504000546,0.00015727411664556712,1,1,"[{'label': 'neutral', 'score': 0.9014082551002502}, {'label': 'negative', 'score': 0.06830460578203201}, {'label': 'positive', 'score': 0.0302871223539114}]","(0.9014082551002502, 0.0302871223539114, 0.06830460578203201)",-0.38560520387369746,-0.06830460578203201,1,1,"[{'label': 'neutral', 'score': 0.6889879703521729}, {'label': 'negative', 'score': 0.30538398027420044}, {'label': 'positive', 'score': 0.005627986043691635}]","(0.6889879703521729, 0.005627986043691635, 0.30538398027420044)",-0.9638085562409573,-0.30538398027420044,0,1
2017-10-12,49.33736038208008,60.90649032592773,61.049617767333984,60.64885330200195,60.86832046508789,6454108.0,,-0.006893344100197106,0.0007836457973835593,0.07914649902457092,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-13,48.99726867675781,60.48664093017578,61.22137451171875,60.47710037231445,61.020992279052734,7693787.0,"Pharma Stock Roundup: Pfizer Mulls Options For Consumer Healthcare, Eli Lilly's Pipeline Setback | Bank Of America Sees NewLink Genetics As 'Undervalued'",-0.0002629253775019377,-0.0069172129506828595,0.08548768653717832,"[{'label': 'negative', 'score': 0.9725199341773987}, {'label': 'positive', 'score': 0.025993771851062775}, {'label': 'neutral', 'score': 0.0014862987445667386}]","(0.0014862987445667386, 0.025993771851062775, 0.9725199341773987)",-0.9479350725100175,-0.9725199341773987,0,0,"[{'label': 'negative', 'score': 0.8656808733940125}, {'label': 'positive', 'score': 0.09691345691680908}, {'label': 'neutral', 'score': 0.03740571811795235}]","(0.03740571811795235, 0.09691345691680908, 0.8656808733940125)",-0.798641122505852,-0.8656808733940125,0,0,"[{'label': 'negative', 'score': 0.9885558485984802}, {'label': 'neutral', 'score': 0.010520607233047485}, {'label': 'positive', 'score': 0.0009235849138349295}]","(0.010520607233047485, 0.0009235849138349295, 0.9885558485984802)",-0.9981331902765144,-0.9885558485984802,0,0
2017-10-14,48.98438262939453,60.47073745727539,61.0846061706543,60.43893178304037,60.8746821085612,7731445.333333333,,-0.0002629945254368191,-0.00026295994843886136,0.08701311768132969,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-15,48.97149658203125,60.454833984375,60.94783782958984,60.400763193766274,60.728371938069664,7769103.666666667,,-0.0002630637097523251,-0.00026302911456160415,0.07994828177766454,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-16,48.95861053466797,60.43893051147461,60.81106948852539,60.36259460449219,60.582061767578125,7806762.0,Merck Reports 9.9% Passive Stake in KalVista Pharmaceuticals -13G | Aeglea BioTherapeutics Announces Clinical Collaboration with Merck to Evaluate the Combination of Aeglea's AEB1102 (pegzilarginase) with Merck's KEYTRUDA (pembrolizumab) for the Treatment of Small Cell Lung Cancer,-0.0018945066061892223,-0.0002630983170794911,0.04962203292996796,"[{'label': 'neutral', 'score': 0.9990910291671753}, {'label': 'positive', 'score': 0.0008358299965038896}, {'label': 'negative', 'score': 7.312614616239443e-05}]","(0.9990910291671753, 0.0008358299965038896, 7.312614616239443e-05)",0.8390986259295414,0.0008358299965038896,0,1,"[{'label': 'positive', 'score': 0.845819354057312}, {'label': 'neutral', 'score': 0.14624345302581787}, {'label': 'negative', 'score': 0.007937232032418251}]","(0.14624345302581787, 0.845819354057312, 0.007937232032418251)",0.9814063348693534,0.845819354057312,0,0,"[{'label': 'positive', 'score': 0.9927091598510742}, {'label': 'neutral', 'score': 0.007030173670500517}, {'label': 'negative', 'score': 0.00026069930754601955}]","(0.007030173670500517, 0.9927091598510742, 0.00026069930754601955)",0.9994749099277456,0.9927091598510742,0,0
2017-10-17,48.86585235595703,60.32442855834961,60.41030502319336,60.0,60.314884185791016,7365868.0,,0.004587165535779227,-0.0018963034536144806,0.04574045646253141,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-18,49.09001541137695,60.60114669799805,61.17366409301758,60.5057258605957,61.154579162597656,8265471.0,"Benzinga's Top Upgrades, Downgrades For October 18, 2017 | Boosted By Keytruda, Citi Upgrades Merck To Buy For The First Time Ever | Merck Reports FDA Accepted Regulatory Submission For LYNPARZA In Metastatic Breast Cancer, Grants Priority Review | UPDATE: Merck Highlights KEYTRUDA Data 'Showed Median Overall Survival of 30.0 Months for KEYTRUDA Group Compared to 14.2 Months for Chemotherapy Group' | Merck Reports KEYTRUDA More Than Doubled Median Overall Survival Compared to Chemotherapy After 2 Years of Follow Up in First-Line Treatment of Patients with Metastatic NSCLC with High Levels of PD-L1 | Citigroup Upgrades Merck & Co to Buy",0.003778933789627959,0.004576676556178278,0.03891205508185252,"[{'label': 'positive', 'score': 0.9996265172958374}, {'label': 'negative', 'score': 0.00022225829889066517}, {'label': 'neutral', 'score': 0.00015120893658604473}]","(0.00015120893658604473, 0.9996265172958374, 0.00022225829889066517)",0.9995554161702934,0.9996265172958374,0,0,"[{'label': 'positive', 'score': 0.9443615674972534}, {'label': 'negative', 'score': 0.029897527769207954}, {'label': 'neutral', 'score': 0.025740887969732285}]","(0.025740887969732285, 0.9443615674972534, 0.029897527769207954)",0.9386250989814349,0.9443615674972534,0,0,"[{'label': 'positive', 'score': 0.9806264042854309}, {'label': 'neutral', 'score': 0.018870634958148003}, {'label': 'negative', 'score': 0.0005029207095503807}]","(0.018870634958148003, 0.9806264042854309, 0.0005029207095503807)",0.9989748126027057,0.9806264042854309,0,0
2017-10-19,49.2755126953125,60.83015441894531,61.09732818603516,60.67748260498047,60.725189208984375,10554618.0,OncoSec Shares Spike 17% After New Data Defended | White House 'Shenanigans' Represent A Buying Opportunity: Cramer,0.0020391615338016564,0.003771811556660174,0.04481792182487258,"[{'label': 'positive', 'score': 0.9995701909065247}, {'label': 'negative', 'score': 0.0002453440974932164}, {'label': 'neutral', 'score': 0.00018445127352606505}]","(0.00018445127352606505, 0.9995701909065247, 0.0002453440974932164)",0.9995092212735177,0.9995701909065247,0,0,"[{'label': 'positive', 'score': 0.6830216646194458}, {'label': 'neutral', 'score': 0.25041463971138}, {'label': 'negative', 'score': 0.06656364351511002}]","(0.25041463971138, 0.6830216646194458, 0.06656364351511002)",0.8223987509019818,0.6830216646194458,0,0,"[{'label': 'positive', 'score': 0.9971519708633423}, {'label': 'neutral', 'score': 0.002557468833401799}, {'label': 'negative', 'score': 0.00029054537299089134}]","(0.002557468833401799, 0.9971519708633423, 0.00029054537299089134)",0.9994174193133711,0.9971519708633423,0,0
2017-10-20,49.3759994506836,60.95419692993164,61.05915832519531,60.65839767456055,60.92557144165039,10798802.0,"Fierce Pharma Reports Merck Lays Off 1,800 U.S. Sales Reps To Overhaul Primary Care Marketing",-0.0025046973244573097,0.0020370852660056,0.043076300317775144,"[{'label': 'negative', 'score': 0.9913756251335144}, {'label': 'neutral', 'score': 0.00788132008165121}, {'label': 'positive', 'score': 0.0007430672412738204}]","(0.00788132008165121, 0.0007430672412738204, 0.9913756251335144)",-0.998502059789852,-0.9913756251335144,0,0,"[{'label': 'negative', 'score': 0.966421902179718}, {'label': 'neutral', 'score': 0.02385193109512329}, {'label': 'positive', 'score': 0.009726217947900295}]","(0.02385193109512329, 0.009726217947900295, 0.966421902179718)",-0.9800722498003096,-0.966421902179718,0,0,"[{'label': 'negative', 'score': 0.9986568689346313}, {'label': 'neutral', 'score': 0.000980203039944172}, {'label': 'positive', 'score': 0.00036286935210227966}]","(0.000980203039944172, 0.00036286935210227966, 0.9986568689346313)",-0.9992735491838738,-0.9986568689346313,0,0
2017-10-21,49.25232823689779,60.8015251159668,61.22773361206055,60.57251993815104,60.98282368977865,11245180.0,,-0.002510986585840613,-0.002507839326406714,0.051471099494003976,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-22,49.12865702311198,60.64885330200195,61.39630889892578,60.48664220174154,61.0400759379069,11691558.0,A Preview Of Next Week's Blue-Chip Earnings,-0.0025173075112337566,-0.002514144399917858,0.053937602216623255,"[{'label': 'neutral', 'score': 0.999879002571106}, {'label': 'negative', 'score': 6.527591176563874e-05}, {'label': 'positive', 'score': 5.562192382058129e-05}]","(0.999879002571106, 5.562192382058129e-05, 6.527591176563874e-05)",-0.07985244647471436,-6.527591176563874e-05,1,1,"[{'label': 'neutral', 'score': 0.924740195274353}, {'label': 'positive', 'score': 0.05367937311530113}, {'label': 'negative', 'score': 0.021580388769507408}]","(0.924740195274353, 0.05367937311530113, 0.021580388769507408)",0.4265092466665513,0.05367937311530113,1,1,"[{'label': 'neutral', 'score': 0.9986947178840637}, {'label': 'positive', 'score': 0.0009107872028835118}, {'label': 'negative', 'score': 0.0003945467178709805}]","(0.9986947178840637, 0.0009107872028835118, 0.0003945467178709805)",0.395485382555707,0.0009107872028835118,1,1
2017-10-23,49.00498580932617,60.49618148803711,61.564884185791016,60.40076446533203,61.09732818603516,12137936.0,"The Week Ahead: Earnings Season Starts In Earnest | 8 Firms To Debut On The Markets This Week | AstraZeneca, Merck Rapidly Advance LYNPARZA in Japan With a NDA To Japan's Pharmaceuticals and Medical Devices Agency",-0.004574079192186553,-0.0025204812571018756,0.04810934087347222,"[{'label': 'positive', 'score': 0.9993994235992432}, {'label': 'neutral', 'score': 0.00033863744465634227}, {'label': 'negative', 'score': 0.0002619826409500092}]","(0.00033863744465634227, 0.9993994235992432, 0.0002619826409500092)",0.9994758572466345,0.9993994235992432,0,0,"[{'label': 'positive', 'score': 0.7961050271987915}, {'label': 'neutral', 'score': 0.19433675706386566}, {'label': 'negative', 'score': 0.009558125399053097}]","(0.19433675706386566, 0.7961050271987915, 0.009558125399053097)",0.9762726510000287,0.7961050271987915,0,0,"[{'label': 'positive', 'score': 0.995479941368103}, {'label': 'neutral', 'score': 0.004322569817304611}, {'label': 'negative', 'score': 0.00019751051149796695}]","(0.004322569817304611, 0.995479941368103, 0.00019751051149796695)",0.9996032640668419,0.995479941368103,0,0
2017-10-24,48.78083801269531,60.21946716308594,60.41030502319336,59.51335906982422,60.41030502319336,10711713.0,Healthcare ETFs Set To Soar As Q3 Earnings Unfold,-0.010457950160431547,-0.004584572302185271,0.0386973480475357,"[{'label': 'positive', 'score': 0.998297393321991}, {'label': 'negative', 'score': 0.001132941571995616}, {'label': 'neutral', 'score': 0.0005696461885236204}]","(0.0005696461885236204, 0.998297393321991, 0.001132941571995616)",0.9977328253257076,0.998297393321991,0,0,"[{'label': 'positive', 'score': 0.9218534231185913}, {'label': 'neutral', 'score': 0.060016050934791565}, {'label': 'negative', 'score': 0.018130561336874962}]","(0.060016050934791565, 0.9218534231185913, 0.018130561336874962)",0.9614236803249834,0.9218534231185913,0,0,"[{'label': 'neutral', 'score': 0.997978150844574}, {'label': 'positive', 'score': 0.001763664884492755}, {'label': 'negative', 'score': 0.0002581605804152787}]","(0.997978150844574, 0.001763664884492755, 0.0002581605804152787)",0.744626245048287,0.001763664884492755,0,0
2017-10-25,48.27069091796875,59.58969497680664,60.238548278808594,59.475189208984375,60.209922790527344,11545502.0,,-0.007365879480427763,-0.01051301879437483,0.054985434994950046,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-26,47.91512680053711,59.15076446533203,59.81870269775391,58.97900772094727,59.4370231628418,11260026.0,,-0.060493674133488044,-0.007393141525813499,0.054614471429211206,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-10-27,45.016563415527344,55.57251739501953,57.77671813964844,55.171756744384766,57.77671813964844,30980242.0,"Merck Announces It Has Withdawn KEYTRUDA European Application | A Peek Into The Markets: U.S. Stock Futures Climb After Amazon, Alphabet Results | Merck Raises FY17 Sales Guidance From $39.4B-$40.4B As Of Jul. 28 To $40B-$40.5B vs $40.3B Est. | Merck Raises FY17 Adj. EPS Outlook From $3.76-$3.88 As Of Jul. 28 To $3.91-$3.97 vs $3.87 Est. | Merck Reports Q3 Adj. EPS $1.11 vs $1.03 Est., Sales $10.3B vs $10.55B Est. | 12 Stocks To Watch For October 27, 2017 | Earnings Scheduled For October 27, 2017",-0.020203754319455335,-0.06240072692455606,0.4014583066966594,"[{'label': 'positive', 'score': 0.9995070695877075}, {'label': 'neutral', 'score': 0.00024711579317227006}, {'label': 'negative', 'score': 0.00024577847216278315}]","(0.00024711579317227006, 0.9995070695877075, 0.00024577847216278315)",0.9995083215363882,0.9995070695877075,0,0,"[{'label': 'positive', 'score': 0.7914444208145142}, {'label': 'negative', 'score': 0.11186010390520096}, {'label': 'neutral', 'score': 0.0966954380273819}]","(0.0966954380273819, 0.7914444208145142, 0.11186010390520096)",0.7523313548331669,0.7914444208145142,0,0,"[{'label': 'positive', 'score': 0.9957636594772339}, {'label': 'neutral', 'score': 0.003743178676813841}, {'label': 'negative', 'score': 0.0004931905423291028}]","(0.003743178676813841, 0.9957636594772339, 0.0004931905423291028)",0.9990099128707232,0.9957636594772339,0,0
2017-10-28,44.10706329345703,54.4497439066569,56.345419565836586,54.08715057373047,56.25,34273791.666666664,,-0.020620363068876765,-0.020410641505207106,0.37891048006974787,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-29,43.19756317138672,53.32697041829427,54.91412099202474,53.00254440307617,54.72328186035156,37567341.333333336,,-0.021054514808466516,-0.020835931301185426,0.35092308021095014,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-10-30,42.288063049316406,52.20419692993164,53.48282241821289,51.91793823242188,53.196563720703125,40860891.0,"35 Stocks Moving In Monday's Mid-Day Session | The Bull Thesis For Merck Is Evaporating | Analyst Grows Cautious On Merck's Keytruda After Company Withdraws European Application | 8 Technical Levels Highlighted On Monday's PreMarket Prep | 5 Biggest Price Target Changes For Monday | Benzinga's Top Upgrades, Downgrades For October 30, 2017 | Barclays Downgrades Merck & Co to Equal-Weight | 30 Stocks Moving In Monday's Pre-Market Session | SunTrust Robinson Humphrey Downgrades Merck & Co to Hold | Morgan Stanley Downgrades Merck & Co to Equal-Weight | 8 Stocks To Watch For October 30, 2017",0.006945771422863277,-0.02127932217821399,0.3320718989207832,"[{'label': 'positive', 'score': 0.9870671629905701}, {'label': 'neutral', 'score': 0.010306984186172485}, {'label': 'negative', 'score': 0.0026258130092173815}]","(0.010306984186172485, 0.9870671629905701, 0.0026258130092173815)",0.994693681630781,0.9870671629905701,0,0,"[{'label': 'negative', 'score': 0.9341689944267273}, {'label': 'neutral', 'score': 0.04396940395236015}, {'label': 'positive', 'score': 0.02186165377497673}]","(0.04396940395236015, 0.02186165377497673, 0.9341689944267273)",-0.9542657888298904,-0.9341689944267273,0,0,"[{'label': 'neutral', 'score': 0.64848792552948}, {'label': 'positive', 'score': 0.22393694519996643}, {'label': 'negative', 'score': 0.1275751143693924}]","(0.64848792552948, 0.22393694519996643, 0.1275751143693924)",0.2741352059119336,0.22393694519996643,1,1
2017-10-31,42.581787109375,52.56679534912109,53.23473358154297,52.50954055786133,52.64313125610352,19313802.0,"Benzinga's Top Upgrades, Downgrades For October 31, 2017 | The Market In 5 Minutes: A Halloween Scare For Under Armour, Qualcomm And Other Big Tech Names | A Peek Into The Markets: U.S. Stock Futures Rise Ahead Of Mastercard, Kellogg Earnings | Jefferies Upgrades Merck & Co to Hold | 40 Biggest Movers From Yesterday",0.004538003072553468,0.006921760670549046,0.39369674908000235,"[{'label': 'positive', 'score': 0.9989839196205139}, {'label': 'neutral', 'score': 0.0007220194675028324}, {'label': 'negative', 'score': 0.00029400683706626296}]","(0.0007220194675028324, 0.9989839196205139, 0.00029400683706626296)",0.9994115614299447,0.9989839196205139,0,0,"[{'label': 'positive', 'score': 0.7395997643470764}, {'label': 'neutral', 'score': 0.1804853081703186}, {'label': 'negative', 'score': 0.07991490513086319}]","(0.1804853081703186, 0.7395997643470764, 0.07991490513086319)",0.8049701656182143,0.7395997643470764,0,0,"[{'label': 'neutral', 'score': 0.904795229434967}, {'label': 'positive', 'score': 0.08846144378185272}, {'label': 'negative', 'score': 0.006743298843502998}]","(0.904795229434967, 0.08846144378185272, 0.006743298843502998)",0.8583411150001456,0.08846144378185272,0,1
2017-11-01,42.77501678466797,52.80534362792969,53.2442741394043,52.74809265136719,52.99618148803711,17206483.0,,0.0005420945365481812,0.004527737382050473,0.23143477957469819,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-02,42.7982063293457,52.83396911621094,53.024810791015625,52.51908493041992,52.93893051147461,12909788.0,"Pre-Market Imbalance Update: Alibaba 278K Shares To Buy, BofA 111K Shares To Sell, Merck 85K To Buy, GE 8.5K To Buy",0.012461635678220116,0.000541947656384469,0.2208442613247818,"[{'label': 'neutral', 'score': 0.9998173117637634}, {'label': 'positive', 'score': 9.889816283248365e-05}, {'label': 'negative', 'score': 8.384360990021378e-05}]","(0.9998173117637634, 9.889816283248365e-05, 8.384360990021378e-05)",0.08238156337845466,9.889816283248365e-05,1,1,"[{'label': 'neutral', 'score': 0.9295487999916077}, {'label': 'positive', 'score': 0.05168161541223526}, {'label': 'negative', 'score': 0.018769584596157074}]","(0.9295487999916077, 0.05168161541223526, 0.018769584596157074)",0.4671606844476406,0.05168161541223526,1,1,"[{'label': 'neutral', 'score': 0.9969770908355713}, {'label': 'positive', 'score': 0.002669482957571745}, {'label': 'negative', 'score': 0.0003534770221449435}]","(0.9969770908355713, 0.002669482957571745, 0.0003534770221449435)",0.7661384705608499,0.002669482957571745,0,1
2017-11-03,43.33153533935547,53.49236679077149,53.70228958129883,52.66221237182617,52.76717758178711,10281718.0,,-0.001070288184334776,0.012384628592509233,0.2059064245498081,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-04,43.28516006469727,53.43511454264323,53.67048263549805,52.79262034098307,53.00254567464193,9900141.333333334,,-0.0010714349284787446,-0.001070861351739539,0.0849709125343852,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-05,43.23878479003906,53.377862294514976,53.63867568969727,52.923028310139976,53.23791376749674,9518564.666666666,,-0.0010725841325822582,-0.0010720093252041662,0.09035266931374988,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-06,43.19240951538086,53.32061004638672,53.60686874389648,53.05343627929688,53.47328186035156,9136988.0,"Pharma Stock Roundup: Pfizer, Teva, Novartis, And More",-0.005189703182459919,-0.001073159762587551,0.09332989334143696,"[{'label': 'neutral', 'score': 0.9998469352722168}, {'label': 'positive', 'score': 8.246994548244402e-05}, {'label': 'negative', 'score': 7.056195318000391e-05}]","(0.9998469352722168, 8.246994548244402e-05, 7.056195318000391e-05)",0.07781379180759113,8.246994548244402e-05,1,1,"[{'label': 'neutral', 'score': 0.9396183490753174}, {'label': 'positive', 'score': 0.04232310131192207}, {'label': 'negative', 'score': 0.01805858127772808}]","(0.9396183490753174, 0.04232310131192207, 0.01805858127772808)",0.4018523332497048,0.04232310131192207,1,1,"[{'label': 'neutral', 'score': 0.9995946288108826}, {'label': 'positive', 'score': 0.0002717174356803298}, {'label': 'negative', 'score': 0.0001336731802439317}]","(0.9995946288108826, 0.0002717174356803298, 0.0001336731802439317)",0.34052158588246323,0.0002717174356803298,1,1
2017-11-07,42.968257904052734,53.04389190673828,53.61641311645508,52.843509674072266,53.32061004638672,15008513.0,,0.017808956660480463,-0.005203216465582353,0.10671261011843186,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-11-08,43.73347091674805,53.988548278808594,54.12213516235352,52.91984558105469,52.95801544189453,15859279.0,,-0.0065394247092479445,0.017652235153997553,0.14310692156721563,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-09,43.44747543334961,53.63549423217773,54.064884185791016,53.07251739501953,53.959922790527344,14818825.0,"Pharma ETFs Down Post Q3 Earnings | Merck Reports Received FDA Approval For PREVYMIS For Prevention Of CMV Infection, Disease In Adult Allogeneic Stem Cell Transplant Patients",-0.012986991742591719,-0.006560900424092436,0.15497358199238023,"[{'label': 'negative', 'score': 0.9979450106620789}, {'label': 'positive', 'score': 0.0012908449862152338}, {'label': 'neutral', 'score': 0.0007641646079719067}]","(0.0007641646079719067, 0.0012908449862152338, 0.9979450106620789)",-0.9974163357351148,-0.9979450106620789,0,0,"[{'label': 'negative', 'score': 0.9677349328994751}, {'label': 'positive', 'score': 0.020236510783433914}, {'label': 'neutral', 'score': 0.012028559111058712}]","(0.012028559111058712, 0.020236510783433914, 0.9677349328994751)",-0.9590342192320918,-0.9677349328994751,0,0,"[{'label': 'positive', 'score': 0.8285396695137024}, {'label': 'neutral', 'score': 0.09513521194458008}, {'label': 'negative', 'score': 0.07632508128881454}]","(0.09513521194458008, 0.8285396695137024, 0.07632508128881454)",0.8313005756470844,0.8285396695137024,0,0
2017-11-10,42.88321685791016,52.93893051147461,53.71183013916016,52.6240463256836,53.71183013916016,17547607.0,,-0.002283099922803783,-0.013072060043399926,0.18446471215282736,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-11,42.78531392415365,52.81806564331055,53.46692021687826,52.59542083740234,53.400126139322914,16410317.333333334,,-0.002288324396055902,-0.0022857101691581318,0.1844260953279221,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-12,42.68741099039713,52.69720077514648,53.22201029459635,52.56679534912109,53.08842213948568,15273027.666666668,,-0.002293572834727471,-0.002290946611410001,0.18228031614949863,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-13,42.58950805664063,52.57633590698242,52.97710037231445,52.53816986083984,52.77671813964844,14135738.0,Merck Receives a Positive CHMP Opinion for PREVYMIS in the European Union,-0.0019963619269583303,-0.002296207101594274,0.07494629779492408,"[{'label': 'positive', 'score': 0.9995808005332947}, {'label': 'negative', 'score': 0.0002893334603868425}, {'label': 'neutral', 'score': 0.0001298372371820733}]","(0.0001298372371820733, 0.9995808005332947, 0.0002893334603868425)",0.9994212579203038,0.9995808005332947,0,0,"[{'label': 'positive', 'score': 0.9477317929267883}, {'label': 'neutral', 'score': 0.037256523966789246}, {'label': 'negative', 'score': 0.015011712908744812}]","(0.037256523966789246, 0.9477317929267883, 0.015011712908744812)",0.9688147199794058,0.9477317929267883,0,0,"[{'label': 'positive', 'score': 0.998846173286438}, {'label': 'neutral', 'score': 0.000734628876671195}, {'label': 'negative', 'score': 0.0004191355546936393}]","(0.000734628876671195, 0.998846173286438, 0.0004191355546936393)",0.9991611125674327,0.998846173286438,0,0
2017-11-14,42.504486083984375,52.47137451171875,52.65267181396485,52.24236679077149,52.45228958129883,13315678.0,,-0.003455165867736198,-0.001998357313548151,0.07708383056975246,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-15,42.35762405395508,52.290077209472656,52.57633590698242,51.90839767456055,52.25190734863281,12290315.0,13G Filing Shows Merck Reporting 6.5% Stake In Spero Therapeutics | Merck Revisits Low Of Move And Rebounds,0.006751836399409804,-0.0034611487385055903,0.009053297774225484,"[{'label': 'negative', 'score': 0.9971319437026978}, {'label': 'positive', 'score': 0.001632337342016399}, {'label': 'neutral', 'score': 0.0012357773957774043}]","(0.0012357773957774043, 0.001632337342016399, 0.9971319437026978)",-0.9967312861042468,-0.9971319437026978,0,0,"[{'label': 'neutral', 'score': 0.9283866882324219}, {'label': 'negative', 'score': 0.046469829976558685}, {'label': 'positive', 'score': 0.025143509730696678}]","(0.9283866882324219, 0.025143509730696678, 0.046469829976558685)",-0.29779815231409146,-0.046469829976558685,0,0,"[{'label': 'positive', 'score': 0.8975361585617065}, {'label': 'neutral', 'score': 0.09488318860530853}, {'label': 'negative', 'score': 0.0075806500390172005}]","(0.09488318860530853, 0.8975361585617065, 0.0075806500390172005)",0.983249344245995,0.8975361585617065,1,1
2017-11-16,42.64361190795898,52.64313125610352,52.83396911621094,52.24236679077149,52.34732818603516,12572122.0,"Cue Biopharma Reports Strategic Research Collab, License Deal With Merck; Terms Not Disclosed, However cue Will Receive Up-Front Payment, Co. Eligible To Earn Up To $374M Milestone Payments In Addition To Tiered Royalities",0.000543764924278208,0.006729144834586696,0.06620554578139264,"[{'label': 'neutral', 'score': 0.7305678129196167}, {'label': 'positive', 'score': 0.26899632811546326}, {'label': 'negative', 'score': 0.00043586661922745407}]","(0.7305678129196167, 0.26899632811546326, 0.00043586661922745407)",0.9967645542905023,0.26899632811546326,0,1,"[{'label': 'positive', 'score': 0.5991196036338806}, {'label': 'neutral', 'score': 0.39148396253585815}, {'label': 'negative', 'score': 0.009396377019584179}]","(0.39148396253585815, 0.5991196036338806, 0.009396377019584179)",0.9691170739361891,0.5991196036338806,0,0,"[{'label': 'neutral', 'score': 0.9671874046325684}, {'label': 'positive', 'score': 0.03256034851074219}, {'label': 'negative', 'score': 0.0002522622235119343}]","(0.9671874046325684, 0.03256034851074219, 0.0002522622235119343)",0.9846240687426563,0.03256034851074219,0,1
2017-11-17,42.666805267333984,52.671756744384766,52.89122009277344,52.24236679077149,52.48091506958008,10358537.0,"Merck Will Miss a Promised Deadline for Filing an Ebola Vaccine License with the FDA, According to STAT News",-0.006642532588670209,0.0005436171377033399,0.06486043551003055,"[{'label': 'negative', 'score': 0.9827883839607239}, {'label': 'neutral', 'score': 0.01609721966087818}, {'label': 'positive', 'score': 0.0011143727460876107}]","(0.01609721966087818, 0.0011143727460876107, 0.9827883839607239)",-0.9977347908856004,-0.9827883839607239,0,0,"[{'label': 'negative', 'score': 0.8411872982978821}, {'label': 'neutral', 'score': 0.1432434618473053}, {'label': 'positive', 'score': 0.015569306910037994}]","(0.1432434618473053, 0.015569306910037994, 0.8411872982978821)",-0.9636552392700618,-0.8411872982978821,0,0,"[{'label': 'negative', 'score': 0.8830926418304443}, {'label': 'neutral', 'score': 0.11493707448244095}, {'label': 'positive', 'score': 0.001970237120985985}]","(0.11493707448244095, 0.001970237120985985, 0.8830926418304443)",-0.9955478030593257,-0.8830926418304443,0,0
2017-11-18,42.38338470458984,52.32188288370768,52.560431162516274,51.88613255818685,52.17557144165039,12906784.0,,-0.006686950877794662,-0.006664692394266599,0.07987130888060896,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-19,42.0999641418457,51.9720090230306,52.22964223225912,51.52989832560221,51.8702278137207,15455031.0,,-0.006731967211851236,-0.006709408706067912,0.0900458687164918,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-20,41.81654357910156,51.62213516235352,51.89885330200195,51.17366409301758,51.564884185791016,18003278.0,,0.003142376540862839,-0.006754729115563535,0.09642436216930804,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-21,41.94795989990234,51.78435134887695,52.33778762817383,51.6984748840332,51.8702278137207,14369442.0,,0.0018426577704813356,0.0031374495945493104,0.07575566480016227,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-22,42.02526092529297,51.8797721862793,52.07061004638672,51.68893051147461,51.74618148803711,7730258.0,,-0.00018393421574207768,0.00184096215928632,0.08031400945792283,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-23,42.017526626586914,51.870229721069336,52.0992374420166,51.66030502319336,51.875,6139970.0,,-0.00018396805376176794,-0.0001839511337144535,0.07482790723616714,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-24,42.00979232788086,51.860687255859375,52.12786483764648,51.63167953491211,52.00381851196289,4549682.0,5 Biggest Price Target Changes For Friday,0.001226605804932093,-0.0001839849779598604,0.0604520878064878,"[{'label': 'neutral', 'score': 0.999521017074585}, {'label': 'positive', 'score': 0.0003556294250302017}, {'label': 'negative', 'score': 0.00012329730088822544}]","(0.999521017074585, 0.0003556294250302017, 0.00012329730088822544)",0.48510995851492333,0.0003556294250302017,1,1,"[{'label': 'neutral', 'score': 0.8089069724082947}, {'label': 'negative', 'score': 0.13742363452911377}, {'label': 'positive', 'score': 0.05366939678788185}]","(0.8089069724082947, 0.05366939678788185, 0.13742363452911377)",-0.4382903822499722,-0.13742363452911377,1,1,"[{'label': 'neutral', 'score': 0.9994538426399231}, {'label': 'positive', 'score': 0.0003853481903206557}, {'label': 'negative', 'score': 0.00016085669631138444}]","(0.9994538426399231, 0.0003853481903206557, 0.00016085669631138444)",0.41100235370194266,0.0003853481903206557,1,1
2017-11-25,42.06132507324219,51.92429987589518,52.11832173665365,51.66030502319336,51.97519175211588,6561423.0,,0.0012251030863748423,0.0012258541386345294,0.02243673626077754,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-26,42.11285781860352,51.98791249593099,52.108778635660805,51.68893051147461,51.94656499226888,8573164.0,,0.0012236040452823294,0.001224353259935987,0.01459297605385547,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-27,42.16439056396485,52.0515251159668,52.09923553466797,51.71755599975586,51.91793823242188,10584905.0,,0.006966143996388419,0.0012228560519555488,0.012245131061438999,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-11-28,42.458106994628906,52.41412353515625,52.60496139526367,51.91793823242188,52.41412353515625,13446783.0,"Merck Raises Qtr. Dividend From $0.47 To $0.48/Share | Merck Reports $10B Buyback Plan | Bank of America Reinstates Buy on Merck & Co, Announces $64.00 | Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement; Peregrine Board Reconstituted with Four New Independent Directors | UPDATE: Merck, Pfizer On JAVELIN Trial Of Avelumab, Say, 'Safety profile was consistent with that observed in previously reported studies of avelumab; no new safety signals were identified' | UPDATE: Merck, Pfizer Says Phase III JAVELIN Study Investigating Avelumab 'did not meet its pre-specified primary endpoint of superior overall survival compared to chemotherapy' | Merck, Pfizer Offer Update Related To Phase III JAVELIN Gastric 300 Study In Patients With Pre-Treated Advanced Gastric Cancer",0.007828138591655575,0.006941992512239605,0.04416480833118128,"[{'label': 'positive', 'score': 0.9991773962974548}, {'label': 'neutral', 'score': 0.0005886073922738433}, {'label': 'negative', 'score': 0.00023397950280923396}]","(0.0005886073922738433, 0.9991773962974548, 0.00023397950280923396)",0.9995317653801531,0.9991773962974548,1,1,"[{'label': 'positive', 'score': 0.8907934427261353}, {'label': 'negative', 'score': 0.060236576944589615}, {'label': 'neutral', 'score': 0.0489700511097908}]","(0.0489700511097908, 0.8907934427261353, 0.060236576944589615)",0.8733235004181144,0.8907934427261353,1,1,"[{'label': 'positive', 'score': 0.998044490814209}, {'label': 'neutral', 'score': 0.001699088141322136}, {'label': 'negative', 'score': 0.0002564501774031669}]","(0.001699088141322136, 0.998044490814209, 0.0002564501774031669)",0.999486226714064,0.998044490814209,1,1
2017-11-29,42.790470123291016,52.82442855834961,53.10114669799805,52.41412353515625,52.51908493041992,10980525.0,,-0.0016257682645095285,0.007797657683924902,0.05364917688173401,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-11-30,42.72090148925781,52.738548278808594,53.33015441894531,52.50954055786133,52.66221237182617,16139619.0,,0.010855839388867809,-0.001627091259851494,0.06458764100901095,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-12-01,43.1846809387207,53.31106948852539,53.41603088378906,52.69084167480469,52.86259460449219,12672835.0,FDA Decisions In November: The Month In Review,0.0020881786804321724,0.010797337773061024,0.08070629267307194,"[{'label': 'neutral', 'score': 0.9998908042907715}, {'label': 'negative', 'score': 6.478154682554305e-05}, {'label': 'positive', 'score': 4.4454372982727364e-05}]","(0.9998908042907715, 4.4454372982727364e-05, 6.478154682554305e-05)",-0.18608507053809495,-6.478154682554305e-05,1,1,"[{'label': 'neutral', 'score': 0.6418125629425049}, {'label': 'negative', 'score': 0.3399111032485962}, {'label': 'positive', 'score': 0.018276406452059746}]","(0.6418125629425049, 0.018276406452059746, 0.3399111032485962)",-0.8979506210736735,-0.3399111032485962,0,1,"[{'label': 'neutral', 'score': 0.9995675683021545}, {'label': 'positive', 'score': 0.0002482522977516055}, {'label': 'negative', 'score': 0.00018423084111418575}]","(0.9995675683021545, 0.0002482522977516055, 0.00018423084111418575)",0.14803226041440423,0.0002482522977516055,1,1
2017-12-02,43.27485783894857,53.42239252726237,53.6482187906901,52.89758427937826,53.03116989135742,13143596.666666666,,0.002083827276739316,0.00208600146574674,0.07834142493541979,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-03,43.36503473917643,53.53371556599935,53.88040669759115,53.10432688395182,53.199745178222656,13614358.333333334,,0.002079493970481678,0.002081659120199774,0.0791243826310794,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-04,43.4552116394043,53.64503860473633,54.11259460449219,53.31106948852539,53.36832046508789,14085120.0,,-0.008004280820395763,0.0020773348156763985,0.07305034701810001,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-05,43.107383728027344,53.21564865112305,53.921756744384766,53.16793823242188,53.578243255615234,12405386.0,,-0.025461709658876387,-0.008036487049716231,0.10588029023155573,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-12-06,42.00979232788086,51.860687255859375,53.36832046508789,51.70801544189453,51.946563720703125,21217703.0,Merck Announces Publication Of Phase 3 PREVYMIS Study Results In NE Journal Of Medicine,0.007727712194688505,-0.025791468511806696,0.19289667394234378,"[{'label': 'neutral', 'score': 0.9998762607574463}, {'label': 'negative', 'score': 6.346786540234461e-05}, {'label': 'positive', 'score': 6.0293605201877654e-05}]","(0.9998762607574463, 6.0293605201877654e-05, 6.346786540234461e-05)",-0.02564821010100915,-6.346786540234461e-05,1,1,"[{'label': 'neutral', 'score': 0.901146411895752}, {'label': 'positive', 'score': 0.07215872406959534}, {'label': 'negative', 'score': 0.026694834232330322}]","(0.901146411895752, 0.07215872406959534, 0.026694834232330322)",0.4599115157636099,0.07215872406959534,1,1,"[{'label': 'neutral', 'score': 0.9991614818572998}, {'label': 'positive', 'score': 0.0007203092100098729}, {'label': 'negative', 'score': 0.00011824082321254537}]","(0.9991614818572998, 0.0007203092100098729, 0.00011824082321254537)",0.7179874341947989,0.0007203092100098729,0,1
2017-12-07,42.33444213867188,52.261451721191406,53.28244400024414,52.17557144165039,52.33778762817383,17250604.0,Loncar Investment's Brad Loncar Tweets: Roche is trading slightly down in Europe and $MRK seems not to be doing anything in this early pre-market hour. IMpower150 basically in line with high expectations.,0.014606541622621738,0.007698006367380156,0.21017217798080134,"[{'label': 'negative', 'score': 0.9983924031257629}, {'label': 'neutral', 'score': 0.0010744842002168298}, {'label': 'positive', 'score': 0.0005330431158654392}]","(0.0010744842002168298, 0.0005330431158654392, 0.9983924031257629)",-0.9989327669690046,-0.9983924031257629,0,0,"[{'label': 'negative', 'score': 0.9494032263755798}, {'label': 'neutral', 'score': 0.029854901134967804}, {'label': 'positive', 'score': 0.020741812884807587}]","(0.029854901134967804, 0.020741812884807587, 0.9494032263755798)",-0.9572397692192075,-0.9494032263755798,0,0,"[{'label': 'negative', 'score': 0.9867952466011047}, {'label': 'neutral', 'score': 0.012309521436691284}, {'label': 'positive', 'score': 0.0008952105417847633}]","(0.012309521436691284, 0.0008952105417847633, 0.9867952466011047)",-0.998187264976976,-0.9867952466011047,0,0
2017-12-08,42.95280838012695,53.024810791015625,53.024810791015625,52.15649032592773,52.77671813964844,10923723.0,,0.00461877974910923,0.01450089361894589,0.24915752339210331,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-09,43.15119043986002,53.26972071329752,53.36514155069987,52.4427490234375,53.10432561238607,10695538.666666666,,0.004597544702740988,0.004608145916904478,0.2523368453940756,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-10,43.3495724995931,53.51463063557943,53.70547231038412,52.72900772094727,53.431933085123696,10467354.333333334,,0.004576504020922257,0.004587008276212872,0.24729774433750645,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-11,43.54795455932617,53.75954055786133,54.04580307006836,53.01526641845703,53.75954055786133,10239170.0,"3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise | Merck Reports FDA Accepted sBLA, Assigned Priority Review For KEYTRUDA For Treatment Of Relapsed, Refractory PMBCL",0.012957096139069042,0.004566063667822189,0.06829442883065649,"[{'label': 'positive', 'score': 0.999309778213501}, {'label': 'neutral', 'score': 0.00041615377995185554}, {'label': 'negative', 'score': 0.000274109625024721}]","(0.00041615377995185554, 0.999309778213501, 0.000274109625024721)",0.9994515525342902,0.999309778213501,1,1,"[{'label': 'positive', 'score': 0.9149394035339355}, {'label': 'neutral', 'score': 0.04917394742369652}, {'label': 'negative', 'score': 0.03588661178946495}]","(0.04917394742369652, 0.9149394035339355, 0.03588661178946495)",0.9245148718879784,0.9149394035339355,1,1,"[{'label': 'positive', 'score': 0.967058539390564}, {'label': 'neutral', 'score': 0.03242766857147217}, {'label': 'negative', 'score': 0.0005137833068147302}]","(0.03242766857147217, 0.967058539390564, 0.0005137833068147302)",0.9989379950319736,0.967058539390564,1,1
2017-12-12,44.11222839355469,54.45610809326172,54.5515251159668,54.036258697509766,54.26526641845703,14454750.0,,-0.0028035755640739212,0.012873871101180101,0.07965114462589072,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-13,43.988548278808594,54.30343627929688,54.74236679077149,54.05534362792969,54.332061767578125,13982940.0,Merck's Keytruda Gets FDA Priority Review For Rare Lymphoma | PreMarket Opening NYSE Imbalance Update: AT&T 168k Shares To Sell; Nike 54k Shares To Sell; Square 33k To Buy; Disney 41k To Buy; US Steel 53k Shares To Sell; Pfizer 50k Shares To Sell; Merck 28k Shares To Buy;,-0.01581446711419215,-0.0028075129429270245,0.08809729784865793,"[{'label': 'neutral', 'score': 0.9994372725486755}, {'label': 'positive', 'score': 0.0004844681534450501}, {'label': 'negative', 'score': 7.828573870938271e-05}]","(0.9994372725486755, 0.0004844681534450501, 7.828573870938271e-05)",0.7217762869318396,0.0004844681534450501,0,0,"[{'label': 'neutral', 'score': 0.8665671944618225}, {'label': 'positive', 'score': 0.10524725914001465}, {'label': 'negative', 'score': 0.028185511007905006}]","(0.8665671944618225, 0.10524725914001465, 0.028185511007905006)",0.5775324011236613,0.10524725914001465,0,0,"[{'label': 'neutral', 'score': 0.993513822555542}, {'label': 'positive', 'score': 0.0059915888123214245}, {'label': 'negative', 'score': 0.0004946286207996309}]","(0.993513822555542, 0.0059915888123214245, 0.0004946286207996309)",0.8474831823324726,0.0059915888123214245,0,0
2017-12-14,43.66114807128906,53.44465637207031,54.14122009277344,53.39694595336914,53.81679534912109,10623890.0,UPDATE: Merck Says Progression Free Survival Did Not Show Statistical Significance In PD-L1 Positive Population | Merck Announces KEYTRUDA Did NOT Meet Primary Endpoint In Phase 3 KEYNOTE-061 Study | Merck Says PREVYMIS Expected To Be Available In Canada By Year-End,0.0041064379113611256,-0.015940850022441527,0.17161164434051515,"[{'label': 'negative', 'score': 0.8151817917823792}, {'label': 'neutral', 'score': 0.18309299647808075}, {'label': 'positive', 'score': 0.0017251858953386545}]","(0.18309299647808075, 0.0017251858953386545, 0.8151817917823792)",-0.9957762978099588,-0.8151817917823792,0,0,"[{'label': 'negative', 'score': 0.9181627035140991}, {'label': 'neutral', 'score': 0.05752044543623924}, {'label': 'positive', 'score': 0.02431684359908104}]","(0.05752044543623924, 0.02431684359908104, 0.9181627035140991)",-0.9483981510822942,-0.9181627035140991,0,0,"[{'label': 'negative', 'score': 0.6752894520759583}, {'label': 'neutral', 'score': 0.31925249099731445}, {'label': 'positive', 'score': 0.005458035971969366}]","(0.31925249099731445, 0.005458035971969366, 0.6752894520759583)",-0.9839645799131173,-0.6752894520759583,0,0
2017-12-15,43.840431213378906,53.66412353515625,53.78816986083984,53.196563720703125,53.654579162597656,23664574.0,"Lightning Round: Jim Cramer Shares His Thoughts On T-Mobile, Electronic Arts, And More",-0.00011854555807904326,0.004098029506403124,0.17093974084488484,"[{'label': 'neutral', 'score': 0.9998683929443359}, {'label': 'negative', 'score': 6.736847717547789e-05}, {'label': 'positive', 'score': 6.426089385058731e-05}]","(0.9998683929443359, 6.426089385058731e-05, 6.736847717547789e-05)",-0.02360858599161141,-6.736847717547789e-05,1,1,"[{'label': 'neutral', 'score': 0.9229053854942322}, {'label': 'positive', 'score': 0.0609644390642643}, {'label': 'negative', 'score': 0.016130175441503525}]","(0.9229053854942322, 0.0609644390642643, 0.016130175441503525)",0.5815485804057883,0.0609644390642643,0,1,"[{'label': 'neutral', 'score': 0.9993845224380493}, {'label': 'positive', 'score': 0.0005048765451647341}, {'label': 'negative', 'score': 0.00011056597577407956}]","(0.9993845224380493, 0.0005048765451647341, 0.00011056597577407956)",0.6406943881439356,0.0005048765451647341,0,1
2017-12-16,43.83523686726888,53.65776189168295,53.889949798583984,53.33969370524088,53.70228958129883,19826902.666666668,,-0.00011855961279490488,-0.00011855258515902573,0.16721423800663068,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-17,43.83004252115885,53.65140024820963,53.991729736328125,53.48282368977865,53.75,15989231.333333334,,-0.00011857367084314288,-0.00011856664154139282,0.12154305764011147,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-18,43.82484817504883,53.64503860473633,54.093509674072266,53.625953674316406,53.79771041870117,12151560.0,,0.00017784604335219526,-0.00011858070125657603,0.12326684132634196,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-19,43.8326416015625,53.654579162597656,54.02671813964844,53.44465637207031,53.64503860473633,9921521.0,,-0.0021340574264501685,0.00017783023061936223,0.029479299825356565,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-20,43.73909759521485,53.540077209472656,53.90267181396485,53.41603088378906,53.70228958129883,13766423.0,3 Biotech Pipeline Areas To Keep An Eye On In 2018,0.008732822665282662,-0.0021363377718360945,0.014989910305416286,"[{'label': 'neutral', 'score': 0.999843955039978}, {'label': 'positive', 'score': 8.170978253474459e-05}, {'label': 'negative', 'score': 7.428714161505923e-05}]","(0.999843955039978, 8.170978253474459e-05, 7.428714161505923e-05)",0.047581969709591214,8.170978253474459e-05,0,0,"[{'label': 'neutral', 'score': 0.9103797078132629}, {'label': 'positive', 'score': 0.07569441199302673}, {'label': 'negative', 'score': 0.013925919309258461}]","(0.9103797078132629, 0.07569441199302673, 0.013925919309258461)",0.6892241055818688,0.07569441199302673,1,0,"[{'label': 'neutral', 'score': 0.99955815076828}, {'label': 'positive', 'score': 0.0003176007012370974}, {'label': 'negative', 'score': 0.00012425378372427076}]","(0.99955815076828, 0.0003176007012370974, 0.00012425378372427076)",0.4375805250222393,0.0003176007012370974,0,0
2017-12-21,44.12105941772461,54.00763320922852,54.1984748840332,53.511451721191406,53.511451721191406,10439966.0,Merck Reports FDA Granted Breakthrough Therapy Designation For Avelumab In Combo With INLYTA In Advanced Renal Cell Carcinoma,-0.00424028433277356,0.008694912120267217,0.06724550488307872,"[{'label': 'positive', 'score': 0.9993576407432556}, {'label': 'neutral', 'score': 0.0004009219410363585}, {'label': 'negative', 'score': 0.00024148901866283268}]","(0.0004009219410363585, 0.9993576407432556, 0.00024148901866283268)",0.9995168282735093,0.9993576407432556,0,0,"[{'label': 'positive', 'score': 0.9449095129966736}, {'label': 'neutral', 'score': 0.04080280289053917}, {'label': 'negative', 'score': 0.014287764206528664}]","(0.04080280289053917, 0.9449095129966736, 0.014287764206528664)",0.9702089141700058,0.9449095129966736,0,0,"[{'label': 'positive', 'score': 0.9979280233383179}, {'label': 'neutral', 'score': 0.0018110045930370688}, {'label': 'negative', 'score': 0.00026091799372807145}]","(0.0018110045930370688, 0.9979280233383179, 0.00026091799372807145)",0.9994772172222628,0.9979280233383179,0,0
2017-12-22,43.93397903442383,53.77862548828125,54.22710037231445,53.55915832519531,54.00763320922852,11890608.0,FDA Approves Merck's SGLT2 Inhibitor STEGLATRO and Fixed-Dose Combination STEGLUJAN for Adults with Type 2 Diabetes,-8.871986893789531e-05,-0.004249299832933583,0.07823156898651659,"[{'label': 'positive', 'score': 0.9975885152816772}, {'label': 'neutral', 'score': 0.0020620746072381735}, {'label': 'negative', 'score': 0.0003494751581456512}]","(0.0020620746072381735, 0.9975885152816772, 0.0003494751581456512)",0.9992996054634785,0.9975885152816772,0,0,"[{'label': 'positive', 'score': 0.7895092368125916}, {'label': 'neutral', 'score': 0.19994400441646576}, {'label': 'negative', 'score': 0.010546759702265263}]","(0.19994400441646576, 0.7895092368125916, 0.010546759702265263)",0.9736349461832465,0.7895092368125916,0,0,"[{'label': 'positive', 'score': 0.9704231023788452}, {'label': 'neutral', 'score': 0.028947222977876663}, {'label': 'negative', 'score': 0.0006297246436588466}]","(0.028947222977876663, 0.9704231023788452, 0.0006297246436588466)",0.9987030064150274,0.9704231023788452,0,0
2017-12-23,43.93007850646973,53.77385425567627,54.17223358154297,53.59255599975586,53.9813928604126,10072144.5,,-8.872774085143481e-05,-8.872380477824637e-05,0.07821761409475776,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-24,43.926177978515625,53.76908302307129,54.11736679077149,53.625953674316406,53.95515251159668,8253681.0,,-8.873561416201246e-05,-8.87316773902999e-05,0.07830526405836788,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-25,43.92227745056152,53.76431179046631,54.0625,53.65935134887695,53.92891216278076,6435217.5,,-8.874348887000023e-05,-8.873955139953301e-05,0.07537807429291661,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-26,43.91837692260742,53.75954055786133,54.00763320922852,53.6927490234375,53.90267181396485,4616754.0,"Merck Shares Down 0.12%, Pfizer Shares Up 0.11%; Earlier Companies Together Announced FDA Approvla For Their Collaboration Treatment STEGLATRO, STEGLUJAN and SEGLUROMET | Merck's Diabetes Drugs Get FDA Nod As Adjunct Therapies",0.0,-8.874742680638988e-05,0.029537075826870502,"[{'label': 'positive', 'score': 0.9714431762695312}, {'label': 'negative', 'score': 0.02615143544971943}, {'label': 'neutral', 'score': 0.0024053642991930246}]","(0.0024053642991930246, 0.9714431762695312, 0.02615143544971943)",0.9475710170393761,0.9714431762695312,0,0,"[{'label': 'negative', 'score': 0.9621691107749939}, {'label': 'neutral', 'score': 0.023910759016871452}, {'label': 'positive', 'score': 0.013920163735747337}]","(0.023910759016871452, 0.013920163735747337, 0.9621691107749939)",-0.9714776832421916,-0.9621691107749939,0,0,"[{'label': 'neutral', 'score': 0.9920834302902222}, {'label': 'positive', 'score': 0.007230122573673725}, {'label': 'negative', 'score': 0.0006863927119411528}]","(0.9920834302902222, 0.007230122573673725, 0.0006863927119411528)",0.8265922095322928,0.007230122573673725,0,1
2017-12-27,43.91837692260742,53.75954055786133,54.036258697509766,53.683204650878906,53.8072509765625,5931994.0,,0.004614858103189568,0.0,0.0006299603896665493,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-12-28,44.12105941772461,54.00763320922852,54.1984748840332,53.72137451171875,53.75954055786133,6061108.0,,-0.005830364470354481,0.004604242293307994,0.03316497894500752,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2017-12-29,43.86381912231445,53.6927490234375,54.3797721862793,53.6927490234375,54.22710037231445,8841557.0,,-0.0002221455390575445,-0.00584742739967167,0.058866146688612,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-30,43.85407638549805,53.68082141876221,54.32252025604248,53.64026737213135,54.16984844207764,9270293.75,,-0.00022219489866308383,-0.00022217021703259174,0.05884586225514022,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2017-12-31,43.84433364868164,53.668893814086914,54.265268325805664,53.5877857208252,54.11259651184082,9699030.5,,-0.0002222442802084032,-0.000222219587606777,0.058821753274890774,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-01,43.834590911865234,53.65696620941162,54.20801639556885,53.53530406951904,54.055344581604,10127767.25,,-0.0002222936837081338,-0.00022226898012817116,0.058762540676339535,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-02,43.82484817504883,53.64503860473633,54.15076446533203,53.48282241821289,53.99809265136719,10556504.0,4 Reasons To Consider Adding Celldex To Your Portfolio | Merck's KEYTRUDA Approved in Japan for Use in the Treatment of Patients with Urothelial Carcinoma,-0.0014229816767374842,-0.0002223183946112136,0.03993483846086142,"[{'label': 'positive', 'score': 0.9970259070396423}, {'label': 'neutral', 'score': 0.0026762003544718027}, {'label': 'negative', 'score': 0.00029786760569550097}]","(0.0026762003544718027, 0.9970259070396423, 0.00029786760569550097)",0.9994026661887181,0.9970259070396423,0,0,"[{'label': 'positive', 'score': 0.654568612575531}, {'label': 'neutral', 'score': 0.3359641432762146}, {'label': 'negative', 'score': 0.00946719292551279}]","(0.3359641432762146, 0.654568612575531, 0.00946719292551279)",0.9714858962511235,0.654568612575531,0,0,"[{'label': 'positive', 'score': 0.6773661375045776}, {'label': 'neutral', 'score': 0.3220372796058655}, {'label': 'negative', 'score': 0.0005965527379885316}]","(0.3220372796058655, 0.6773661375045776, 0.0005965527379885316)",0.9982401605676114,0.6773661375045776,0,0
2018-01-03,43.76250076293945,53.56870269775391,53.683204650878906,53.39694595336914,53.654579162597656,11090460.0,,0.01620947346787794,-0.0014239950766440738,0.008531584250467726,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-01-04,44.47185516357422,54.4370231628418,54.790077209472656,53.79771041870117,53.85496139526367,15751650.0,,-0.0010516919044459981,0.01607950257832134,0.11815306389350812,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-05,44.425086975097656,54.3797721862793,54.761451721191406,53.99809265136719,54.761451721191406,9955057.0,"Lower Jobs Growth in December, But Some Positive Signs For Economy",-0.0019301784948616034,-0.0010522453204263517,0.11962736475005117,"[{'label': 'positive', 'score': 0.9920650124549866}, {'label': 'negative', 'score': 0.007563462480902672}, {'label': 'neutral', 'score': 0.00037157934275455773}]","(0.00037157934275455773, 0.9920650124549866, 0.007563462480902672)",0.9848674529176698,0.9920650124549866,0,0,"[{'label': 'negative', 'score': 0.8071094155311584}, {'label': 'positive', 'score': 0.16726237535476685}, {'label': 'neutral', 'score': 0.025628218427300453}]","(0.025628218427300453, 0.16726237535476685, 0.8071094155311584)",-0.6566764823873086,-0.8071094155311584,0,0,"[{'label': 'positive', 'score': 0.4941922426223755}, {'label': 'negative', 'score': 0.32037216424942017}, {'label': 'neutral', 'score': 0.18543557822704315}]","(0.18543557822704315, 0.4941922426223755, 0.32037216424942017)",0.21339022047438033,0.4941922426223755,1,1
2018-01-06,44.339332580566406,54.27480951944987,54.716922760009766,53.96946589152018,54.70419947306315,10517553.333333334,,-0.0019339112888421659,-0.00193204368986531,0.12277167784386138,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-07,44.25357818603516,54.169846852620445,54.672393798828125,53.94083913167318,54.6469472249349,11080049.666666666,,-0.0019376585485833236,-0.0019357837097320643,0.12555162689635113,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-08,44.16782379150391,54.064884185791016,54.62786483764648,53.91221237182617,54.58969497680664,11642546.0,Alzheimer's Takes Another Hit As Pfizer Ends Research In The Area | Merck's KEYTRUDA  Improved Recurrence-Free Survival Compared to Placebo as Adjuvant Therapy in Patients with Stage 3 Resected High-Risk Melanoma | Merck Announces FDA Accepts NDA For Doravirine,0.0024709328477077724,-0.0019395382374313374,0.12647366046674782,"[{'label': 'positive', 'score': 0.9994939565658569}, {'label': 'negative', 'score': 0.0003382337454240769}, {'label': 'neutral', 'score': 0.00016776438860688359}]","(0.00016776438860688359, 0.9994939565658569, 0.0003382337454240769)",0.9993234189723001,0.9994939565658569,0,0,"[{'label': 'positive', 'score': 0.8494530320167542}, {'label': 'negative', 'score': 0.12211282551288605}, {'label': 'neutral', 'score': 0.0284341499209404}]","(0.0284341499209404, 0.8494530320167542, 0.12211282551288605)",0.7486267666437411,0.8494530320167542,0,0,"[{'label': 'positive', 'score': 0.8775827288627625}, {'label': 'negative', 'score': 0.0953182652592659}, {'label': 'neutral', 'score': 0.02709903009235859}]","(0.02709903009235859, 0.8775827288627625, 0.0953182652592659)",0.8040535145196688,0.8775827288627625,0,0
2018-01-09,44.276981353759766,54.1984748840332,54.48473358154297,53.97900772094727,54.20801544189453,11142022.0,Merck Announces Breakthrough Designation from the FDA for LENVIMA and KEYTRUDA as Combination Therapy for Renal Cell Carcinoma,0.008802767211402465,0.0024678851126055455,0.030309592764107964,"[{'label': 'neutral', 'score': 0.9995248317718506}, {'label': 'positive', 'score': 0.00042072474025189877}, {'label': 'negative', 'score': 5.446129580377601e-05}]","(0.9995248317718506, 0.00042072474025189877, 5.446129580377601e-05)",0.7707790563214484,0.00042072474025189877,1,0,"[{'label': 'positive', 'score': 0.9072304368019104}, {'label': 'neutral', 'score': 0.08171290904283524}, {'label': 'negative', 'score': 0.01105659268796444}]","(0.08171290904283524, 0.9072304368019104, 0.01105659268796444)",0.9759190921076026,0.9072304368019104,1,1,"[{'label': 'positive', 'score': 0.9981992840766907}, {'label': 'neutral', 'score': 0.0014755141455680132}, {'label': 'negative', 'score': 0.0003252293390687555}]","(0.0014755141455680132, 0.9981992840766907, 0.0003252293390687555)",0.9993485801606288,0.9981992840766907,1,1
2018-01-10,44.6667366027832,54.67557144165039,54.74236679077149,53.8740463256836,53.959922790527344,9497395.0,,0.005235586752216521,0.008764248737176102,0.07456742787356661,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-11,44.90059280395508,54.96183013916016,54.97137451171875,54.54198455810547,54.67557144165039,7447402.0,A Strategy That Beat The S&P 500: Here Are Your 2018 'Dogs Of The Dow' | Key Takeaways From The J.P. Morgan Healthcare Conference,0.0184028027929649,0.005221928719033568,0.07362211702085789,"[{'label': 'neutral', 'score': 0.9995131492614746}, {'label': 'positive', 'score': 0.00041516509372740984}, {'label': 'negative', 'score': 7.175368955358863e-05}]","(0.9995131492614746, 0.00041516509372740984, 7.175368955358863e-05)",0.7052745056574253,0.00041516509372740984,1,0,"[{'label': 'neutral', 'score': 0.806507408618927}, {'label': 'positive', 'score': 0.18021810054779053}, {'label': 'negative', 'score': 0.013274467550218105}]","(0.806507408618927, 0.18021810054779053, 0.013274467550218105)",0.8627909311380448,0.18021810054779053,1,0,"[{'label': 'neutral', 'score': 0.9358153939247131}, {'label': 'positive', 'score': 0.06370463222265244}, {'label': 'negative', 'score': 0.00048004367272369564}]","(0.9358153939247131, 0.06370463222265244, 0.00048004367272369564)",0.9850417980296048,0.06370463222265244,1,0
2018-01-12,45.72687911987305,55.97328186035156,56.11641311645508,55.238548278808594,55.29580307006836,12935569.0,"FDA Approves AstraZeneca and Merck's Lynparza, For Breast Cancer With A Certain Inherited Genetic Mutation",0.014532909290904556,0.018235520410615828,0.12088465869855322,"[{'label': 'positive', 'score': 0.948465883731842}, {'label': 'neutral', 'score': 0.05109856650233269}, {'label': 'negative', 'score': 0.00043558707693591714}]","(0.05109856650233269, 0.948465883731842, 0.00043558707693591714)",0.9990819129481069,0.948465883731842,0,0,"[{'label': 'neutral', 'score': 0.5804592967033386}, {'label': 'positive', 'score': 0.40663233399391174}, {'label': 'negative', 'score': 0.012908372096717358}]","(0.5804592967033386, 0.40663233399391174, 0.012908372096717358)",0.9384642686188887,0.40663233399391174,0,1,"[{'label': 'positive', 'score': 0.9958536624908447}, {'label': 'neutral', 'score': 0.003755170153453946}, {'label': 'negative', 'score': 0.0003912474785465747}]","(0.003755170153453946, 0.9958536624908447, 0.0003912474785465747)",0.9992145556285781,0.9958536624908447,0,0
2018-01-13,46.3914270401001,56.786736488342285,57.30200481414795,56.04007530212402,56.20229148864746,22301597.25,,0.014324729299379904,0.01442831868407252,0.1029911792969023,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-14,47.05597496032715,57.60019111633301,58.48759651184082,56.84160232543945,57.10877990722656,31667625.5,,0.014122429322288497,0.014223099758608797,0.08171150966151575,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-01-15,47.7205228805542,58.41364574432373,59.67318820953369,57.64312934875488,58.015268325805664,41033653.75,,0.013925763708555531,0.01402363685724379,0.07622923688190739,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-01-16,48.38507080078125,59.22710037231445,60.85877990722656,58.44465637207031,58.921756744384766,50399682.0,Watching Shares Of AstraZeneca and Merck As White House Doctor Says Pres. Trump Takes Crestor For Cholesterol and Propecia For Hair Loss | Early Keytruda Results Win Merck An Upgrade | Merck Shares Up 5.8% On Earlier News That Phase 3 KEYNOTE-189 Trial Met Dual Primary Endpoints Of Overall Survival And Progression-Free Survival | SunTrust Robinson Humphrey Upgrades Merck & Co to Buy,-0.000644466141342387,0.013829691156125458,0.029387570253948062,"[{'label': 'positive', 'score': 0.9996094107627869}, {'label': 'negative', 'score': 0.00024157865846063942}, {'label': 'neutral', 'score': 0.00014908003504388034}]","(0.00014908003504388034, 0.9996094107627869, 0.00024157865846063942)",0.9995167706767976,0.9996094107627869,0,0,"[{'label': 'positive', 'score': 0.950210690498352}, {'label': 'neutral', 'score': 0.02606327086687088}, {'label': 'negative', 'score': 0.02372606471180916}]","(0.02606327086687088, 0.950210690498352, 0.02372606471180916)",0.9512780176230449,0.950210690498352,0,0,"[{'label': 'positive', 'score': 0.9980556964874268}, {'label': 'neutral', 'score': 0.001654681982472539}, {'label': 'negative', 'score': 0.00028958957409486175}]","(0.001654681982472539, 0.9980556964874268, 0.00028958957409486175)",0.9994198608875347,0.9980556964874268,0,0
2018-01-17,48.353885650634766,59.18893051147461,59.72328186035156,59.05534362792969,59.4370231628418,22940615.0,,-0.014509065886277688,-0.0006446738989126695,0.10492249885447051,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-18,47.652305603027344,58.33015441894531,59.274810791015625,57.85305404663086,59.16030502319336,20861278.0,,0.002453746999849584,-0.014615351707452163,0.2039765452489002,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-19,47.76923370361328,58.47328186035156,58.66412353515625,57.86259460449219,58.66412353515625,12745671.0,"Will Johnson & Johnson's Pharma Segment Pull Up Its Q4 Earnings? | Merck Reports First-Time Data For KEYTRUDA In Patients With Previously-Treated Advanced HCC: 'showed an overall response rate (ORR) of 16.3 percent (95% CI, 9.8-24.9) (n=17/104) with KEYTRUDA as monotherapy' | Merck Reports LYNPARZA For Treatment Of Advanced Ovarian Cancer Received Approval In Japan",-0.0001631827242034048,0.0024507414782024063,0.18828001875204758,"[{'label': 'positive', 'score': 0.9996387958526611}, {'label': 'negative', 'score': 0.00023799554037395865}, {'label': 'neutral', 'score': 0.00012323117698542774}]","(0.00012323117698542774, 0.9996387958526611, 0.00023799554037395865)",0.9995239502658275,0.9996387958526611,0,0,"[{'label': 'positive', 'score': 0.897622287273407}, {'label': 'negative', 'score': 0.06847929954528809}, {'label': 'neutral', 'score': 0.03389845788478851}]","(0.03389845788478851, 0.897622287273407, 0.06847929954528809)",0.8582358201671407,0.897622287273407,0,0,"[{'label': 'positive', 'score': 0.9934210181236267}, {'label': 'negative', 'score': 0.004297906532883644}, {'label': 'neutral', 'score': 0.0022810189984738827}]","(0.0022810189984738827, 0.9934210181236267, 0.004297906532883644)",0.9913845344080984,0.9934210181236267,0,0
2018-01-20,47.76144027709961,58.46374003092448,58.65140024820963,57.888039906819664,58.495548248291016,12775574.0,,-0.00016320935715079864,-0.00016319603995281802,0.16094634863509252,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-21,47.75364685058594,58.4541982014974,58.63867696126302,57.91348520914713,58.32697296142578,12805477.0,,-0.0001632359987933471,-0.00016322267724721098,0.10812572946197839,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-22,47.745853424072266,58.44465637207031,58.625953674316406,57.93893051147461,58.15839767456055,12835380.0,,0.0073469497515685,-0.00016324932323899985,0.10873412523557624,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-23,48.09663772583008,58.8740463256836,59.28435134887695,58.082061767578125,58.23473358154297,11718212.0,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,-0.00842784756618072,0.007320092382511787,0.0517091250672277,"[{'label': 'positive', 'score': 0.9992363452911377}, {'label': 'neutral', 'score': 0.0005355105386115611}, {'label': 'negative', 'score': 0.00022815968259237707}]","(0.0005355105386115611, 0.9992363452911377, 0.00022815968259237707)",0.9995434361471429,0.9992363452911377,0,0,"[{'label': 'neutral', 'score': 0.537089467048645}, {'label': 'positive', 'score': 0.44612231850624084}, {'label': 'negative', 'score': 0.016788247972726822}]","(0.537089467048645, 0.44612231850624084, 0.016788247972726822)",0.9274665596837717,0.44612231850624084,0,0,"[{'label': 'positive', 'score': 0.9987634420394897}, {'label': 'neutral', 'score': 0.0009041573503054678}, {'label': 'negative', 'score': 0.0003324461285956204}]","(0.0009041573503054678, 0.9987634420394897, 0.0003324461285956204)",0.9993345060618652,0.9987634420394897,0,0
2018-01-24,47.691287994384766,58.37786483764648,59.26526641845703,58.16793823242188,59.16984558105469,14129241.0,,0.0019613933028118334,-0.008463562682755693,0.08865672551939306,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-25,47.78483581542969,58.49236679077149,58.56870269775391,58.15839767456055,58.49236679077149,9853610.0,,0.012071798971436327,0.001959472282475069,0.09017102701056119,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-26,48.36167526245117,59.1984748840332,59.23664093017578,58.53053283691406,58.67366409301758,11060278.0,,-0.002202894068003631,0.011999515948845331,0.12323317948276108,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-27,48.2551383972168,59.068066914876304,59.255724589029946,58.60050837198893,58.81997426350912,10439582.333333334,,-0.002207757523956866,-0.00220532400839782,0.1268451086816736,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-28,48.14860153198242,58.9376589457194,59.27480824788412,58.670483907063804,58.96628443400065,9818886.666666666,,-0.002212642502088558,-0.0022101982135613978,0.12010589072825162,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-01-29,48.04206466674805,58.8072509765625,59.29389190673828,58.74045944213867,59.11259460449219,9198191.0,"The Week Ahead: Big Tech Earnings, Fed Rate Decision Likely To Dominate Headlines | PFE, LLY, MRK Write Up 'Scripts For Q4 | Fed, Earnings Are Meaty Filling Between Slices Of Job, Price Data",-0.015901369281513696,-0.0022150940123877067,0.09777394682642553,"[{'label': 'neutral', 'score': 0.9838961362838745}, {'label': 'negative', 'score': 0.014875845983624458}, {'label': 'positive', 'score': 0.001228031818754971}]","(0.9838961362838745, 0.001228031818754971, 0.014875845983624458)",-0.8474861975699389,-0.014875845983624458,1,0,"[{'label': 'negative', 'score': 0.5758156776428223}, {'label': 'neutral', 'score': 0.30232954025268555}, {'label': 'positive', 'score': 0.12185487151145935}]","(0.30232954025268555, 0.12185487151145935, 0.5758156776428223)",-0.6506807642685443,-0.5758156776428223,1,1,"[{'label': 'neutral', 'score': 0.981623649597168}, {'label': 'positive', 'score': 0.015624242834746838}, {'label': 'negative', 'score': 0.0027521424926817417}]","(0.981623649597168, 0.015624242834746838, 0.0027521424926817417)",0.7004696578087208,0.015624242834746838,0,0
2018-01-30,47.27814483642578,57.87213516235352,58.44465637207031,57.671756744384766,58.0057258605957,13666654.0,Hang On: Rate Fears In Focus As Futures Point Lower After Monday's Big Losses,-0.023083241375078205,-0.016029152483016,0.15731969401718413,"[{'label': 'negative', 'score': 0.9883783459663391}, {'label': 'positive', 'score': 0.009853947907686234}, {'label': 'neutral', 'score': 0.0017676616553217173}]","(0.0017676616553217173, 0.009853947907686234, 0.9883783459663391)",-0.9802572047244751,-0.9883783459663391,0,0,"[{'label': 'negative', 'score': 0.9581359624862671}, {'label': 'neutral', 'score': 0.02572525665163994}, {'label': 'positive', 'score': 0.016138751059770584}]","(0.02572525665163994, 0.016138751059770584, 0.9581359624862671)",-0.9668702249265387,-0.9581359624862671,0,0,"[{'label': 'negative', 'score': 0.9981043338775635}, {'label': 'neutral', 'score': 0.001486998051404953}, {'label': 'positive', 'score': 0.0004086045955773443}]","(0.001486998051404953, 0.0004086045955773443, 0.9981043338775635)",-0.9991815737586692,-0.9981043338775635,0,0
2018-01-31,46.18680191040039,56.536258697509766,58.01526641845703,56.20228958129883,57.98664093017578,15582712.0,,0.010295371165120321,-0.023353831567198502,0.15745798791124285,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-01,46.66231536865234,57.11832046508789,57.57633590698242,56.364505767822266,56.459922790527344,14009664.0,,-0.021717298711533543,0.010242734797106773,0.20875299209878118,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-02,45.6489372253418,55.87786483764648,57.22328186035156,55.610687255859375,56.68893051147461,12852777.0,"Merck Sees FY18 Adj. EPS $4.08-$4.23 vs $4.11 Est., Sales $41.2B-$42.7B vs $41.1B Est. | Merck Reports Q4 Adj. EPS $0.98 vs $0.94 Est., Sales $10.4B vs $10.49B Est. | 12 Stocks To Watch For February 2, 2018 | Earnings Scheduled For February 2, 2018",-0.01229508616404618,-0.02195659009513829,0.22809282038377993,"[{'label': 'neutral', 'score': 0.9980490207672119}, {'label': 'positive', 'score': 0.0011451098835095763}, {'label': 'negative', 'score': 0.0008058244711719453}]","(0.9980490207672119, 0.0011451098835095763, 0.0008058244711719453)",0.17390918947296785,0.0011451098835095763,1,1,"[{'label': 'neutral', 'score': 0.8266137838363647}, {'label': 'negative', 'score': 0.1321651190519333}, {'label': 'positive', 'score': 0.04122112691402435}]","(0.8266137838363647, 0.04122112691402435, 0.1321651190519333)",-0.5245167610109324,-0.1321651190519333,0,1,"[{'label': 'neutral', 'score': 0.8998722434043884}, {'label': 'positive', 'score': 0.08710520714521408}, {'label': 'negative', 'score': 0.013022487051784992}]","(0.8998722434043884, 0.08710520714521408, 0.013022487051784992)",0.7398824140269618,0.08710520714521408,0,1
2018-02-03,45.08767954508463,55.19084167480469,56.89885457356771,54.82824452718099,56.32633590698242,15417442.666666666,,-0.012448137082051995,-0.012371296051622677,0.21544180722788253,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-04,44.52642186482748,54.50381851196289,56.57442728678385,54.0458017985026,55.96374130249024,17982108.333333332,,-0.012605046427912407,-0.012526264175375768,0.2134511914403412,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-05,43.96516418457031,53.81679534912109,56.25,53.26335906982422,55.60114669799805,20546774.0,,-0.016666725735854277,-0.012685163994733389,0.18980570929600662,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-06,43.232398986816406,52.91984558105469,54.16984558105469,51.84160232543945,52.614505767822266,32494498.0,"Leerink Swann Maintains Market Perform on Merck & Co, Lowers Price Target to $67.00",0.007573046764057546,-0.016807178386743303,0.06625841119394277,"[{'label': 'positive', 'score': 0.951897144317627}, {'label': 'neutral', 'score': 0.047390736639499664}, {'label': 'negative', 'score': 0.0007120702066458762}]","(0.047390736639499664, 0.951897144317627, 0.0007120702066458762)",0.998505010877936,0.951897144317627,0,0,"[{'label': 'neutral', 'score': 0.7428364753723145}, {'label': 'negative', 'score': 0.12980563938617706}, {'label': 'positive', 'score': 0.1273578554391861}]","(0.7428364753723145, 0.1273578554391861, 0.12980563938617706)",-0.009518395869729603,-0.12980563938617706,1,1,"[{'label': 'negative', 'score': 0.9883330464363098}, {'label': 'neutral', 'score': 0.00920027494430542}, {'label': 'positive', 'score': 0.002466620411723852}]","(0.00920027494430542, 0.002466620411723852, 0.9883330464363098)",-0.9950209502601656,-0.9883330464363098,0,0
2018-02-07,43.55980682373047,53.32061004638672,54.11259460449219,52.56679534912109,52.64313125610352,14349740.0,,-0.020579813041908677,0.007544515202106547,0.15295904614497854,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-08,42.66334915161133,52.22328186035156,53.8740463256836,52.20419692993164,53.47328186035156,21871760.0,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,0.0025579948020527463,-0.02079452837018731,0.17366268659363238,"[{'label': 'negative', 'score': 0.9905226826667786}, {'label': 'neutral', 'score': 0.008372684009373188}, {'label': 'positive', 'score': 0.0011046869913116097}]","(0.008372684009373188, 0.0011046869913116097, 0.9905226826667786)",-0.9977719715588478,-0.9905226826667786,0,0,"[{'label': 'negative', 'score': 0.7838441729545593}, {'label': 'neutral', 'score': 0.12384413182735443}, {'label': 'positive', 'score': 0.09231166541576385}]","(0.12384413182735443, 0.09231166541576385, 0.7838441729545593)",-0.7892802595769575,-0.7838441729545593,0,0,"[{'label': 'negative', 'score': 0.801360011100769}, {'label': 'neutral', 'score': 0.19578182697296143}, {'label': 'positive', 'score': 0.0028581381775438786}]","(0.19578182697296143, 0.0028581381775438786, 0.801360011100769)",-0.9928921321158726,-0.801360011100769,0,0
2018-02-09,42.772491455078125,52.35686874389648,52.87213516235352,50.91603088378906,52.6240463256836,19472364.0,,0.00340198183286284,0.0025547287019413905,0.19703652479219513,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-10,42.91800181070963,52.5349858601888,53.02480824788412,51.42493693033854,52.6876589457194,17401411.333333332,,0.0033904475917504316,0.0033962081835284073,0.20600988241996435,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-11,43.06351216634115,52.71310297648112,53.17748133341471,51.93384297688802,52.75127156575521,15330458.666666668,,0.003378991298838738,0.003384712982586397,0.18026215303782994,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-12,43.209022521972656,52.89122009277344,53.33015441894531,52.4427490234375,52.814884185791016,13259506.0,,-0.009561622131398098,0.0033732953352077146,0.1702783049301629,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-13,42.79587936401367,52.38549423217773,52.83396911621094,52.261451721191406,52.700382232666016,17857291.0,"Merck Discontinues Alzheimer's MK-8931 Study, Unlikely That Positive Benefit/Risk Could Be Established | DZ Bank Upgrades Merck & Co to Buy",0.0,-0.009607627935233867,0.09094276571195606,"[{'label': 'positive', 'score': 0.9994545578956604}, {'label': 'neutral', 'score': 0.0002842804533429444}, {'label': 'negative', 'score': 0.0002612004755064845}]","(0.0002842804533429444, 0.9994545578956604, 0.0002612004755064845)",0.9994774505186713,0.9994545578956604,0,0,"[{'label': 'positive', 'score': 0.8011307716369629}, {'label': 'neutral', 'score': 0.17445693910121918}, {'label': 'negative', 'score': 0.02441231720149517}]","(0.17445693910121918, 0.8011307716369629, 0.02441231720149517)",0.9408575578148358,0.8011307716369629,0,0,"[{'label': 'positive', 'score': 0.6154630184173584}, {'label': 'negative', 'score': 0.24457389116287231}, {'label': 'neutral', 'score': 0.1399630904197693}]","(0.1399630904197693, 0.6154630184173584, 0.24457389116287231)",0.4312479186916649,0.6154630184173584,1,0
2018-02-14,42.79587936401367,52.38549423217773,52.57633590698242,51.73664093017578,51.82251739501953,11996142.0,"Cramer Looks At The Dow's Biggest Losers | BMO Capital Maintains Outperform on Merck & Co, Lowers price target to $65.00 | Credit Suisse Maintains Outperform on Merck & Co, Lowers price target to $65.00",0.019854297925737563,0.0,0.08931311749886148,"[{'label': 'negative', 'score': 0.5436458587646484}, {'label': 'positive', 'score': 0.4512188732624054}, {'label': 'neutral', 'score': 0.005135240498930216}]","(0.005135240498930216, 0.4512188732624054, 0.5436458587646484)",-0.09290407281191031,-0.5436458587646484,0,0,"[{'label': 'negative', 'score': 0.732268750667572}, {'label': 'neutral', 'score': 0.19410009682178497}, {'label': 'positive', 'score': 0.07363114506006241}]","(0.19410009682178497, 0.07363114506006241, 0.732268750667572)",-0.8172697491328449,-0.732268750667572,0,0,"[{'label': 'negative', 'score': 0.6999053359031677}, {'label': 'neutral', 'score': 0.29564177989959717}, {'label': 'positive', 'score': 0.004452966619282961}]","(0.29564177989959717, 0.004452966619282961, 0.6999053359031677)",-0.9873559618639094,-0.6999053359031677,0,0
2018-02-15,43.64555358886719,53.42557144165039,53.42557144165039,52.31870269775391,52.89122009277344,10584695.0,"Merck Reports Co., AstraZeneca Won Orphan Drug Designation By FDA For Selumetinib For Treatment Of NF1 | AstraZeneca Says Selumetinib Granted Orphan Drug Designation by FDA for Neurofibromatosis Type 1",0.00535808396214189,0.0196597719219912,0.1674614441270835,"[{'label': 'positive', 'score': 0.9973270893096924}, {'label': 'neutral', 'score': 0.0019900044426321983}, {'label': 'negative', 'score': 0.0006829475751146674}]","(0.0019900044426321983, 0.9973270893096924, 0.0006829475751146674)",0.9986313813491366,0.9973270893096924,0,0,"[{'label': 'positive', 'score': 0.9324808716773987}, {'label': 'neutral', 'score': 0.054050836712121964}, {'label': 'negative', 'score': 0.013468327932059765}]","(0.054050836712121964, 0.9324808716773987, 0.013468327932059765)",0.9715242046029104,0.9324808716773987,0,0,"[{'label': 'positive', 'score': 0.9957956075668335}, {'label': 'neutral', 'score': 0.0038696432020515203}, {'label': 'negative', 'score': 0.00033471823553554714}]","(0.0038696432020515203, 0.9957956075668335, 0.00033471823553554714)",0.999327962964553,0.9957956075668335,0,0
2018-02-16,43.87941360473633,53.71183013916016,54.3797721862793,53.35877990722656,53.40649032592773,12294402.0,,-0.005818085125573907,0.005343780500287266,0.16805465401115868,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-17,43.62411785125733,53.39933013916016,54.17700481414795,53.12738609313965,53.4422721862793,12749155.5,,-0.005852133335485973,-0.005835076118251439,0.18154206948498167,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-18,43.36882209777832,53.08683013916016,53.9742374420166,52.895992279052734,53.47805404663086,13203909.0,,-0.005886582400584518,-0.005869324169285524,0.16803491113565247,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-19,43.11352634429932,52.77433013916016,53.77147006988525,52.66459846496582,53.51383590698242,13658662.5,,-0.005921439441788679,-0.005903976622033685,0.17880484275626565,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-20,42.85823059082031,52.46183013916016,53.56870269775391,52.433204650878906,53.549617767333984,14113416.0,"Gilead, Merck Quiet As Traders Circulate Reuters Article From Feb. 17th Titled 'Gilead wins reversal of $2.54 billion hepatitis C drug patent verdict'",-0.0078210200083564,-0.005939040681833462,0.07973197089098474,"[{'label': 'positive', 'score': 0.9990310668945312}, {'label': 'neutral', 'score': 0.0005962872528471053}, {'label': 'negative', 'score': 0.00037265021819621325}]","(0.0005962872528471053, 0.9990310668945312, 0.00037265021819621325)",0.9992542548885593,0.9990310668945312,0,0,"[{'label': 'negative', 'score': 0.3690697252750397}, {'label': 'neutral', 'score': 0.34797072410583496}, {'label': 'positive', 'score': 0.282959520816803}]","(0.34797072410583496, 0.282959520816803, 0.3690697252750397)",-0.13206494183254397,-0.3690697252750397,1,1,"[{'label': 'positive', 'score': 0.9932212829589844}, {'label': 'neutral', 'score': 0.006268323864787817}, {'label': 'negative', 'score': 0.0005103664007037878}]","(0.006268323864787817, 0.9932212829589844, 0.0005103664007037878)",0.9989728285276359,0.9932212829589844,0,0
2018-02-21,42.523048400878906,52.0515251159668,52.90076446533203,52.0515251159668,52.50954055786133,11244935.0,Merck to Acquire Viralytics for ~$394M,0.00036665458653520946,-0.007851764592931559,0.01396303190131194,"[{'label': 'neutral', 'score': 0.9998769760131836}, {'label': 'positive', 'score': 7.012284913798794e-05}, {'label': 'negative', 'score': 5.2960233006160706e-05}]","(0.9998769760131836, 7.012284913798794e-05, 5.2960233006160706e-05)",0.1394392781920041,7.012284913798794e-05,1,1,"[{'label': 'neutral', 'score': 0.9150280952453613}, {'label': 'positive', 'score': 0.07466196268796921}, {'label': 'negative', 'score': 0.01030992716550827}]","(0.9150280952453613, 0.07466196268796921, 0.01030992716550827)",0.757333226710943,0.07466196268796921,0,1,"[{'label': 'neutral', 'score': 0.995222270488739}, {'label': 'positive', 'score': 0.004611193668097258}, {'label': 'negative', 'score': 0.00016657824744470417}]","(0.995222270488739, 0.004611193668097258, 0.00016657824744470417)",0.9302694852791823,0.004611193668097258,0,1
2018-02-22,42.53863143920898,52.07061004638672,52.54771041870117,51.92748260498047,52.09923553466797,11334958.0,,0.005497509963004986,0.00036658738516833075,0.049808854692164346,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-23,42.772491455078125,52.35686874389648,52.48091506958008,52.07061004638672,52.30915832519531,9499177.0,"Pharma Stock Roundup: AstraZeneca, Merck, AbbVie And More | Merck, AstraZeneca Reports LYNPARZA Received Positive EU CHMP Opinion In Platinum-Sensitive Relapsed Ovarian Cancer",0.007229220502275865,0.005482453810800248,0.08825360170677109,"[{'label': 'positive', 'score': 0.9994214773178101}, {'label': 'negative', 'score': 0.0003529206442181021}, {'label': 'neutral', 'score': 0.00022558138880413026}]","(0.00022558138880413026, 0.9994214773178101, 0.0003529206442181021)",0.9992939994363979,0.9994214773178101,0,0,"[{'label': 'positive', 'score': 0.9496899843215942}, {'label': 'neutral', 'score': 0.029049940407276154}, {'label': 'negative', 'score': 0.021260038018226624}]","(0.029049940407276154, 0.9496899843215942, 0.021260038018226624)",0.9562077603809234,0.9496899843215942,0,0,"[{'label': 'positive', 'score': 0.9985538125038147}, {'label': 'neutral', 'score': 0.0010200128890573978}, {'label': 'negative', 'score': 0.0004261986759956926}]","(0.0010200128890573978, 0.9985538125038147, 0.0004261986759956926)",0.999146732324519,0.9985538125038147,0,0
2018-02-24,43.08170064290365,52.73536809285482,52.859414418538414,52.20737838745117,52.36641057332357,10574460.0,,0.007177333972370849,0.007203214945793337,0.10616097524214074,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-25,43.39090983072917,53.11386744181315,53.23791376749674,52.344146728515625,52.42366282145182,11649743.0,,0.007126186948690814,0.007151699495944066,0.10175784898297988,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-26,43.70011901855469,53.49236679077149,53.61641311645508,52.48091506958008,52.48091506958008,12725026.0,,-0.023902952233959454,0.007100915666039676,0.046645534390681115,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-02-27,42.655555725097656,52.21374130249024,53.39694595336914,52.19465637207031,53.34923553466797,9734453.0,,-0.009137448503267967,-0.02419326332577864,0.21986628608021497,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-02-28,42.26578903198242,51.73664093017578,52.64313125610352,51.72710037231445,52.53816986083984,11807606.0,,-0.009590523836032575,-0.009179451045672152,0.2237446982994182,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-01,41.86044692993164,51.24045944213867,52.299617767333984,50.97328186035156,51.774810791015625,13648523.0,,0.012290451304270077,-0.009636809080648588,0.2097932364919261,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-02,42.37493133544922,51.8702278137207,51.9370231628418,50.6870231628418,51.03053283691406,9355706.0,,0.00024529074736879007,0.012215536904239365,0.23138346690311462,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-03,42.38532257080078,51.88295110066732,52.02608108520508,50.99236679077149,51.272263844807945,10818329.666666666,,0.0002452305945728326,0.00024526066851213537,0.2137287411815502,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-04,42.39571380615234,51.89567438761393,52.11513900756836,51.29771041870117,51.51399485270182,12280953.333333332,,0.0002451704712725277,0.0002452005304655555,0.14176454776749603,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-05,42.40610504150391,51.90839767456055,52.20419692993164,51.60305404663086,51.7557258605957,13743577.0,7 Biotech Stocks With Clinical Trial Outcomes In March,-0.0018382543418231524,0.00024514042190386853,0.1229815565098462,"[{'label': 'negative', 'score': 0.7811575531959534}, {'label': 'neutral', 'score': 0.21782885491847992}, {'label': 'positive', 'score': 0.0010136171476915479}]","(0.21782885491847992, 0.0010136171476915479, 0.7811575531959534)",-0.9974081960928163,-0.7811575531959534,0,0,"[{'label': 'neutral', 'score': 0.729338526725769}, {'label': 'positive', 'score': 0.24461865425109863}, {'label': 'negative', 'score': 0.02604282833635807}]","(0.729338526725769, 0.24461865425109863, 0.02604282833635807)",0.8075616220867847,0.24461865425109863,0,1,"[{'label': 'neutral', 'score': 0.999542236328125}, {'label': 'positive', 'score': 0.00033572822576388717}, {'label': 'negative', 'score': 0.00012204008817207068}]","(0.999542236328125, 0.00033572822576388717, 0.00012204008817207068)",0.4668041257694206,0.00033572822576388717,1,1
2018-03-06,42.32817077636719,51.8129768371582,52.20419692993164,51.35496139526367,51.9942741394043,9716951.0,,0.0031307286654458275,-0.001839946004791536,0.08983253182402166,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-07,42.460670471191406,51.975189208984375,52.08015441894531,51.28816986083984,51.3740463256836,12817564.0,"Eisai, Merck Report Global Strategic Oncology Collaboration For LENVIMA, Will Jointly Develop, Commercialize | Height Casts 65% Odds That Congress Rolls Back Pharma Discounts",0.005324042949334839,0.0031258381390730046,0.028084139960416747,"[{'label': 'negative', 'score': 0.9619002342224121}, {'label': 'positive', 'score': 0.0353056825697422}, {'label': 'neutral', 'score': 0.0027940894942730665}]","(0.0027940894942730665, 0.0353056825697422, 0.9619002342224121)",-0.9291907880303906,-0.9619002342224121,0,0,"[{'label': 'positive', 'score': 0.7908141016960144}, {'label': 'neutral', 'score': 0.20131252706050873}, {'label': 'negative', 'score': 0.007873302325606346}]","(0.20131252706050873, 0.7908141016960144, 0.007873302325606346)",0.9802843959076805,0.7908141016960144,1,1,"[{'label': 'positive', 'score': 0.9985796213150024}, {'label': 'neutral', 'score': 0.0011394944740459323}, {'label': 'negative', 'score': 0.00028091183048672974}]","(0.0011394944740459323, 0.9985796213150024, 0.00028091183048672974)",0.9994375354292914,0.9985796213150024,1,1
2018-03-08,42.68673706054688,52.25190734863281,52.30915832519531,51.8702278137207,52.02289962768555,7705001.0,,0.006939429345040753,0.005309920336759022,0.04449751017812508,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-03-09,42.98296737670898,52.614505767822266,52.66221237182617,52.19465637207031,52.50954055786133,9240006.0,'Pharma Bro' Martin Shkreli Gets 7 Years In Prison For Securities Fraud,0.0013299424272443035,0.006915462319659643,0.05689823146347317,"[{'label': 'neutral', 'score': 0.9334663152694702}, {'label': 'negative', 'score': 0.06495155394077301}, {'label': 'positive', 'score': 0.0015821106499060988}]","(0.9334663152694702, 0.0015821106499060988, 0.06495155394077301)",-0.9524418004136889,-0.06495155394077301,0,1,"[{'label': 'negative', 'score': 0.7526332139968872}, {'label': 'neutral', 'score': 0.2042272388935089}, {'label': 'positive', 'score': 0.04313960298895836}]","(0.2042272388935089, 0.04313960298895836, 0.7526332139968872)",-0.8915780934755763,-0.7526332139968872,0,0,"[{'label': 'negative', 'score': 0.9788140654563904}, {'label': 'neutral', 'score': 0.020015927031636238}, {'label': 'positive', 'score': 0.0011700193863362074}]","(0.020015927031636238, 0.0011700193863362074, 0.9788140654563904)",-0.9976121665556967,-0.9788140654563904,0,0
2018-03-10,43.04012934366862,52.68448003133138,52.96119435628256,52.36641184488932,52.73218790690104,9916350.333333334,,0.0013281760295915657,0.0013290588371436991,0.054353927461752154,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-11,43.09729131062826,52.75445429484049,53.26017634073893,52.538167317708336,52.95483525594076,10592694.666666666,Immutep Announces Clinical Trial Collaboration and Supply Agreement With Merck to Evaluate Combination of IMP321 with Keytruda,0.001326414317889373,0.001327294784021966,0.03925796503634845,"[{'label': 'neutral', 'score': 0.7216699719429016}, {'label': 'positive', 'score': 0.2777661979198456}, {'label': 'negative', 'score': 0.000563854118809104}]","(0.7216699719429016, 0.2777661979198456, 0.000563854118809104)",0.9959483058715428,0.2777661979198456,0,1,"[{'label': 'positive', 'score': 0.8861078023910522}, {'label': 'neutral', 'score': 0.10484710335731506}, {'label': 'negative', 'score': 0.009045081213116646}]","(0.10484710335731506, 0.8861078023910522, 0.009045081213116646)",0.979790980113479,0.8861078023910522,0,0,"[{'label': 'positive', 'score': 0.9949158430099487}, {'label': 'neutral', 'score': 0.004890013951808214}, {'label': 'negative', 'score': 0.0001941055670613423}]","(0.004890013951808214, 0.9949158430099487, 0.0001941055670613423)",0.9996098811647117,0.9949158430099487,0,0
2018-03-12,43.15445327758789,52.82442855834961,53.55915832519531,52.709922790527344,53.17748260498047,11269039.0,"The Market In 5 Minutes: Coincheck, Gun Violence, Oil And More",0.00018060882288181633,0.0013255354075315928,0.04257276571846638,"[{'label': 'neutral', 'score': 0.9998733997344971}, {'label': 'negative', 'score': 7.790675590513274e-05}, {'label': 'positive', 'score': 4.867391544394195e-05}]","(0.9998733997344971, 4.867391544394195e-05, 7.790675590513274e-05)",-0.23094237176681306,-7.790675590513274e-05,1,1,"[{'label': 'neutral', 'score': 0.9217212200164795}, {'label': 'negative', 'score': 0.05728369206190109}, {'label': 'positive', 'score': 0.020995045080780983}]","(0.9217212200164795, 0.020995045080780983, 0.05728369206190109)",-0.46358242743460726,-0.05728369206190109,1,1,"[{'label': 'neutral', 'score': 0.999419093132019}, {'label': 'positive', 'score': 0.0004057250916957855}, {'label': 'negative', 'score': 0.00017530731565784663}]","(0.999419093132019, 0.0004057250916957855, 0.00017530731565784663)",0.39656613490355686,0.0004057250916957855,1,1
2018-03-13,43.162254333496094,52.83396911621094,53.196563720703125,52.48091506958008,53.1870231628418,12272080.0,Merck's Supplemental Biologics License Application for KEYTRUDA Granted Priority Review by the FDA for Treatment of Advanced Cervical Cancer,-0.010294360159502006,0.00018059251507180908,0.042445549970686225,"[{'label': 'positive', 'score': 0.7877626419067383}, {'label': 'neutral', 'score': 0.21139824390411377}, {'label': 'negative', 'score': 0.000839098880533129}]","(0.21139824390411377, 0.7877626419067383, 0.000839098880533129)",0.9978719324669625,0.7877626419067383,0,0,"[{'label': 'positive', 'score': 0.64702308177948}, {'label': 'neutral', 'score': 0.33657053112983704}, {'label': 'negative', 'score': 0.01640639454126358}]","(0.33657053112983704, 0.64702308177948, 0.01640639454126358)",0.9505406523923224,0.64702308177948,0,0,"[{'label': 'positive', 'score': 0.5528769493103027}, {'label': 'neutral', 'score': 0.4463842213153839}, {'label': 'negative', 'score': 0.0007388266967609525}]","(0.4463842213153839, 0.5528769493103027, 0.0007388266967609525)",0.997330904469198,0.5528769493103027,0,0
2018-03-14,43.09148025512695,52.290077209472656,52.89122009277344,51.82251739501953,52.738548278808594,11692222.0,,0.008211690946508962,-0.010347713560315486,0.08123248107444594,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-15,43.44533920288086,52.71946716308594,53.17748260498047,52.375953674316406,52.433204650878906,10560277.0,"Jim Cramer Shares His Thoughts On Merck, Five Below And More",0.0076017583674551515,0.008178158459615096,0.10572370899815806,"[{'label': 'neutral', 'score': 0.9998705387115479}, {'label': 'negative', 'score': 7.11954926373437e-05}, {'label': 'positive', 'score': 5.8230780268786475e-05}]","(0.9998705387115479, 5.8230780268786475e-05, 7.11954926373437e-05)",-0.1001706382904206,-7.11954926373437e-05,1,1,"[{'label': 'neutral', 'score': 0.936489462852478}, {'label': 'positive', 'score': 0.0382147952914238}, {'label': 'negative', 'score': 0.025295788422226906}]","(0.936489462852478, 0.0382147952914238, 0.025295788422226906)",0.20341502335177142,0.0382147952914238,1,1,"[{'label': 'neutral', 'score': 0.9994794726371765}, {'label': 'positive', 'score': 0.000402590463636443}, {'label': 'negative', 'score': 0.00011790116695920005}]","(0.9994794726371765, 0.000402590463636443, 0.00011790116695920005)",0.5469622947662937,0.000402590463636443,0,1
2018-03-16,43.77560043334961,53.1202278137207,53.29198455810547,52.5572509765625,52.66221237182617,22010620.0,,-0.0062271506035590715,0.0075730105994552144,0.1186743241663648,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-17,43.50300216674805,52.7894401550293,53.23791376749674,52.2900759379069,52.81170399983724,18804334.0,,-0.006266170994046654,-0.006246620174595941,0.13048831420141946,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-18,43.23040390014648,52.45865249633789,53.18384297688802,52.0229008992513,52.96119562784831,15598048.0,,-0.006305683484998122,-0.0062858858444089566,0.13740298863982647,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-19,42.95780563354492,52.12786483764648,53.1297721862793,51.7557258605957,53.110687255859375,12391762.0,,0.00018302222604070842,-0.006325648279137196,0.12318059223064523,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-20,42.965667724609375,52.13740539550781,52.42366409301758,51.8702278137207,52.24236679077149,8153440.0,Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season,0.0009150900076296379,0.00018300547951628833,0.09762465366000911,"[{'label': 'neutral', 'score': 0.9998250603675842}, {'label': 'positive', 'score': 9.516043064650148e-05}, {'label': 'negative', 'score': 7.980632653925568e-05}]","(0.9998250603675842, 9.516043064650148e-05, 7.980632653925568e-05)",0.08775440748978844,9.516043064650148e-05,1,1,"[{'label': 'neutral', 'score': 0.9082930684089661}, {'label': 'positive', 'score': 0.06522656232118607}, {'label': 'negative', 'score': 0.026480307802557945}]","(0.9082930684089661, 0.06522656232118607, 0.026480307802557945)",0.4225011110546695,0.06522656232118607,1,1,"[{'label': 'neutral', 'score': 0.9969784021377563}, {'label': 'positive', 'score': 0.0016378815053030849}, {'label': 'negative', 'score': 0.0013837686274200678}]","(0.9969784021377563, 0.0016378815053030849, 0.0013837686274200678)",0.08409738610406461,0.0016378815053030849,1,1
2018-03-21,43.00498580932617,52.18511581420898,52.74809265136719,51.92748260498047,52.25190734863281,10489746.0,,-0.01042243009236453,0.0009146715680223511,0.05957153918663693,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-03-22,42.556758880615234,51.64122009277344,52.46183013916016,51.55534362792969,51.7557258605957,13387990.0,,-0.013118953988037184,-0.010477123977592302,0.07672733607560214,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-03-23,41.99846649169922,50.96374130249024,52.20419692993164,50.89694595336914,51.832061767578125,12408634.0,"Merck Announces Anticancer Agent Lenvima Approved for Additional Indication of Unresectable HCC in Japan,",0.003931833809274511,-0.013205767569755358,0.09973145128315951,"[{'label': 'positive', 'score': 0.9985425472259521}, {'label': 'neutral', 'score': 0.0012312664184719324}, {'label': 'negative', 'score': 0.00022622759570367634}]","(0.0012312664184719324, 0.9985425472259521, 0.00022622759570367634)",0.9995469870476396,0.9985425472259521,0,0,"[{'label': 'positive', 'score': 0.9064682722091675}, {'label': 'neutral', 'score': 0.06746400892734528}, {'label': 'negative', 'score': 0.026067759841680527}]","(0.06746400892734528, 0.9064682722091675, 0.026067759841680527)",0.9440927557847778,0.9064682722091675,0,0,"[{'label': 'positive', 'score': 0.9974886178970337}, {'label': 'neutral', 'score': 0.002321298001334071}, {'label': 'negative', 'score': 0.0001900925417430699}]","(0.002321298001334071, 0.9974886178970337, 0.0001900925417430699)",0.9996189303434981,0.9974886178970337,0,0
2018-03-24,42.16359329223633,51.16412226359049,52.02926127115885,50.77926127115885,51.74618403116862,11755346.0,,0.003916435037582197,0.003924124352317463,0.12057941007276365,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-25,42.32872009277344,51.36450322469076,51.85432561238607,50.66157658894857,51.66030629475912,11102058.0,,0.0039011564119233134,0.0039087857712788105,0.1306790485662764,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-26,42.49384689331055,51.564884185791016,51.67938995361328,50.54389190673828,51.57442855834961,10448770.0,"Stocks That Made New 52-Wk Lows Today Include: Charter Comms., Vornado Realty, Colgate-Palmolive, Merck, Hasbro, Ventas, Dentsply Sirona, Johnson Controls, Goodyear Tire, Clorox, GE, Kinder Morgan, Comcast, DISH Network, Stericycle and Patterson Cos. | The Week Ahead In Biotech: Earnings, PDUFA Dates And More",-0.005366332714995782,0.0038935666341179194,0.13779961449392228,"[{'label': 'neutral', 'score': 0.9997668862342834}, {'label': 'positive', 'score': 0.0001576474605826661}, {'label': 'negative', 'score': 7.544174150098115e-05}]","(0.9997668862342834, 0.0001576474605826661, 7.544174150098115e-05)",0.35267922472094737,0.0001576474605826661,1,1,"[{'label': 'negative', 'score': 0.6217921376228333}, {'label': 'neutral', 'score': 0.3483748435974121}, {'label': 'positive', 'score': 0.029833069071173668}]","(0.3483748435974121, 0.029833069071173668, 0.6217921376228333)",-0.9084348832282579,-0.6217921376228333,0,0,"[{'label': 'negative', 'score': 0.8789123892784119}, {'label': 'neutral', 'score': 0.11585301160812378}, {'label': 'positive', 'score': 0.005234599579125643}]","(0.11585301160812378, 0.005234599579125643, 0.8789123892784119)",-0.9881589834154395,-0.8789123892784119,0,0
2018-03-27,42.26581573486328,51.28816986083984,52.06106948852539,51.020992279052734,51.51717758178711,16956535.0,Merck Reports Received Fast-Track Designation For Tepotinib In NSLCL In Japan,0.024930222539633288,-0.005380783198988293,0.12290453177545038,"[{'label': 'positive', 'score': 0.9957430958747864}, {'label': 'neutral', 'score': 0.004014978650957346}, {'label': 'negative', 'score': 0.00024192161799874157}]","(0.004014978650957346, 0.9957430958747864, 0.00024192161799874157)",0.9995142063108384,0.9957430958747864,1,1,"[{'label': 'positive', 'score': 0.9155415296554565}, {'label': 'neutral', 'score': 0.07586201280355453}, {'label': 'negative', 'score': 0.008596443571150303}]","(0.07586201280355453, 0.9155415296554565, 0.008596443571150303)",0.9813957572998845,0.9155415296554565,1,1,"[{'label': 'positive', 'score': 0.998779833316803}, {'label': 'neutral', 'score': 0.0009660040959715843}, {'label': 'negative', 'score': 0.0002541686117183417}]","(0.0009660040959715843, 0.998779833316803, 0.0002541686117183417)",0.9994911712489711,0.998779833316803,1,1
2018-03-28,43.31951904296875,52.56679534912109,52.80534362792969,51.54580307006836,51.57442855834961,13302788.0,,-0.011254369535132851,0.024624534702035166,0.175577860699248,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-29,42.83198165893555,51.975189208984375,52.87213516235352,51.975189208984375,52.82442855834961,10218524.0,,-0.005507602797918882,-0.011318179161752947,0.21655567325768582,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-03-30,42.59608459472656,51.68893051147461,52.69083786010742,51.61497974395752,52.59542083740234,11174169.0,"The Week Ahead In Biotech: PDUFA Dates, Clinical Trials And Conferences",-0.0055381044776349345,-0.0055228255618960794,0.2246613706231993,"[{'label': 'neutral', 'score': 0.9998806715011597}, {'label': 'negative', 'score': 6.497361755464226e-05}, {'label': 'positive', 'score': 5.436546780401841e-05}]","(0.9998806715011597, 5.436546780401841e-05, 6.497361755464226e-05)",-0.08889082498614942,-6.497361755464226e-05,1,1,"[{'label': 'neutral', 'score': 0.9477207660675049}, {'label': 'positive', 'score': 0.029599027708172798}, {'label': 'negative', 'score': 0.022680195048451424}]","(0.9477207660675049, 0.029599027708172798, 0.022680195048451424)",0.1323438317346579,0.029599027708172798,1,1,"[{'label': 'neutral', 'score': 0.9995749592781067}, {'label': 'positive', 'score': 0.0002814660838339478}, {'label': 'negative', 'score': 0.00014355068560689688}]","(0.9995749592781067, 0.0002814660838339478, 0.00014355068560689688)",0.3244940156325913,0.0002814660838339478,1,1
2018-03-31,42.36018753051758,51.40267181396485,52.50954055786133,51.25477027893066,52.36641311645508,12129814.0,,-0.005568945881758684,-0.005553496633453675,0.2276732077411579,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-01,42.124290466308594,51.11641311645508,52.328243255615234,50.89456081390381,52.13740539550781,13085459.0,,-0.00560013271779461,-0.005584510272605886,0.2279454502054037,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-02,41.88839340209961,50.83015441894531,52.14694595336914,50.53435134887695,51.90839767456055,14041104.0,"The Week Ahead: Switch's Lockup Expires, Spotify Debuts, And More | What's NeuVax? Wainwright Says Sellas' Cancer Vaccine Candidate Makes It A Buy",0.015393228576446061,-0.005615872250844301,0.040817584461579785,"[{'label': 'positive', 'score': 0.9909430146217346}, {'label': 'neutral', 'score': 0.00855420995503664}, {'label': 'negative', 'score': 0.0005028175073675811}]","(0.00855420995503664, 0.9909430146217346, 0.0005028175073675811)",0.9989856883935095,0.9909430146217346,1,1,"[{'label': 'neutral', 'score': 0.8435767292976379}, {'label': 'positive', 'score': 0.14652688801288605}, {'label': 'negative', 'score': 0.009896376170217991}]","(0.8435767292976379, 0.14652688801288605, 0.009896376170217991)",0.8734666966336464,0.14652688801288605,1,0,"[{'label': 'neutral', 'score': 0.95101398229599}, {'label': 'positive', 'score': 0.048666562885046005}, {'label': 'negative', 'score': 0.0003194820892531425}]","(0.95101398229599, 0.048666562885046005, 0.0003194820892531425)",0.9869561998964905,0.048666562885046005,1,0
2018-04-03,42.53317260742188,51.61259460449219,51.66984558105469,50.41030502319336,50.89694595336914,9688341.0,"Stocks That Made New 52-Wk Lows Today Include: Incyte, Merck, Mallinckrodt, Celgene, Cerner, Willams Cos., AMD, Albemarle, Kinder Morgan, Western Union, Walgreens, Kraft Heinz, Nielsen, and Alliance Data Systems | Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates | REMINDER: Merck Has FDA PDUFA Date Today For Keytruda sBLA in Primary Mediastinal Large B-Cell Lymphoma | AstraZeneca, Merck Announces EMA Accepts Regulatory Submission for LYNPARZA in BRCA-Mutated HER2-Negative Metastatic Breast Cancer",0.00831948009790441,0.015275954783734707,0.14798677326325765,"[{'label': 'neutral', 'score': 0.9932251572608948}, {'label': 'positive', 'score': 0.006659164093434811}, {'label': 'negative', 'score': 0.0001156487560365349}]","(0.9932251572608948, 0.006659164093434811, 0.0001156487560365349)",0.9658592027245272,0.006659164093434811,0,1,"[{'label': 'neutral', 'score': 0.8019036054611206}, {'label': 'negative', 'score': 0.11822949349880219}, {'label': 'positive', 'score': 0.07986683398485184}]","(0.8019036054611206, 0.07986683398485184, 0.11822949349880219)",-0.1936565912213383,-0.11822949349880219,1,1,"[{'label': 'neutral', 'score': 0.6505716443061829}, {'label': 'negative', 'score': 0.33961671590805054}, {'label': 'positive', 'score': 0.009811601601541042}]","(0.6505716443061829, 0.009811601601541042, 0.33961671590805054)",-0.9438419778255567,-0.33961671590805054,0,1
2018-04-04,42.88703155517578,52.04198455810547,52.18511581420898,50.95419692993164,51.020992279052734,9330030.0,,-0.0001833242514162,0.008285063974437833,0.15600202656754789,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-05,42.87917709350586,52.03244400024414,52.843509674072266,51.946563720703125,52.53816986083984,13074638.0,"Merck Spokesperson Tells Benzinga FDA Postponed PDUFA Date On sBLA For Keytruda In Mediastinal B-Cell Lymphoma To July 3rd After Co. Submitted Add'l Data; PDUFA Decision Was Originally Scheduled For April 3rd | Recro Pharma CEO Talks Non-Opioid Pain Management Opportunity, CDMO Business | Benzinga's Top Upgrades, Downgrades For April 5, 2018 | Barclays Upgrades Merck & Co to Overweight",-0.02145609605518126,-0.00018334105736077407,0.1452968838797792,"[{'label': 'neutral', 'score': 0.46708232164382935}, {'label': 'negative', 'score': 0.4090189039707184}, {'label': 'positive', 'score': 0.12389884889125824}]","(0.46708232164382935, 0.12389884889125824, 0.4090189039707184)",-0.5350169956775769,-0.4090189039707184,0,1,"[{'label': 'negative', 'score': 0.6528093218803406}, {'label': 'positive', 'score': 0.26251929998397827}, {'label': 'neutral', 'score': 0.08467142283916473}]","(0.08467142283916473, 0.26251929998397827, 0.6528093218803406)",-0.4263933330320527,-0.6528093218803406,1,0,"[{'label': 'neutral', 'score': 0.901542603969574}, {'label': 'positive', 'score': 0.08871397376060486}, {'label': 'negative', 'score': 0.00974341668188572}]","(0.901542603969574, 0.08871397376060486, 0.00974341668188572)",0.8020785105496596,0.08871397376060486,0,1
2018-04-06,41.95915603637695,50.91603088378906,52.08015441894531,50.47710037231445,51.79389190673828,13100838.0,Incyte Falls 20% After Cancer Drug Fails Phase 3 Trial | UPDATE: Incyte Shares Down 20.5% After its Phase 3 ECGI-301/KEYNOT-252 Study With Merck Did Not Meet the Primary Endpoint | 'The first real test of the cancer immunotherapy combination thesis fails. $INCY $MRK' -Adam Feuerstein Tweet | Incyte and Merck Says Phase 3 ECHO-301/KEYNOTE-252 Study Did Not Meet The Primary Endpoint Of Improving Progression-Free Survival,0.017491260925154635,-0.021689624532420574,0.22462891041405283,"[{'label': 'negative', 'score': 0.998212456703186}, {'label': 'neutral', 'score': 0.0012062698369845748}, {'label': 'positive', 'score': 0.0005813208990730345}]","(0.0012062698369845748, 0.0005813208990730345, 0.998212456703186)",-0.9988359541036217,-0.998212456703186,0,0,"[{'label': 'negative', 'score': 0.9731470942497253}, {'label': 'neutral', 'score': 0.01792500726878643}, {'label': 'positive', 'score': 0.008927902206778526}]","(0.01792500726878643, 0.008927902206778526, 0.9731470942497253)",-0.98181828834052,-0.9731470942497253,0,0,"[{'label': 'negative', 'score': 0.9975947737693787}, {'label': 'neutral', 'score': 0.002027043141424656}, {'label': 'positive', 'score': 0.00037822467857040465}]","(0.002027043141424656, 0.00037822467857040465, 0.9975947737693787)",-0.9992420142044752,-0.9975947737693787,0,0
2018-04-07,42.69307327270508,51.80661646525065,52.98346201578776,51.0050900777181,52.02289962768555,16851350.666666668,,0.017190576073597755,0.0173400495263826,0.25109011800313413,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-08,43.4269905090332,52.69720204671224,53.88676961263021,51.53307978312174,52.25190734863281,20601863.33333333,,0.016900054402739385,0.017044489947210868,0.2564368950584893,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-09,44.16090774536133,53.58778762817383,54.790077209472656,52.06106948852539,52.48091506958008,24352376.0,31 Stocks Moving In Monday's Mid-Day Session | Cantor Fitzgerald Double Downgrades NewLink Genetics After Incyte's Disappointing Trial | 20 Stocks Moving In Monday's Pre-Market Session | A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street | Merck Reports its KEYTRUDA Monotherapey Met its Primary Endpoint in the Phase 3 KEYNOTE-042 Study,0.005876043772806774,0.01675883731356606,0.27163187360495256,"[{'label': 'positive', 'score': 0.9904981255531311}, {'label': 'negative', 'score': 0.008150055073201656}, {'label': 'neutral', 'score': 0.0013518292689695954}]","(0.0013518292689695954, 0.9904981255531311, 0.008150055073201656)",0.9836778252215107,0.9904981255531311,0,0,"[{'label': 'positive', 'score': 0.9302816390991211}, {'label': 'negative', 'score': 0.03864353150129318}, {'label': 'neutral', 'score': 0.031074902042746544}]","(0.031074902042746544, 0.9302816390991211, 0.03864353150129318)",0.9202342292803748,0.9302816390991211,0,0,"[{'label': 'negative', 'score': 0.8228734135627747}, {'label': 'neutral', 'score': 0.11249642819166183}, {'label': 'positive', 'score': 0.06463011354207993}]","(0.11249642819166183, 0.06463011354207993, 0.8228734135627747)",-0.8543552525297307,-0.8228734135627747,0,0
2018-04-10,44.42040252685547,53.90267181396485,54.18893051147461,53.47328186035156,54.08396911621094,13481891.0,40 Biggest Movers From Yesterday,-0.005133662772848929,0.0058588471600789895,0.26650983970555253,"[{'label': 'neutral', 'score': 0.9871394038200378}, {'label': 'positive', 'score': 0.012630533427000046}, {'label': 'negative', 'score': 0.00023001132649369538}]","(0.9871394038200378, 0.012630533427000046, 0.00023001132649369538)",0.9642299247967377,0.012630533427000046,0,1,"[{'label': 'neutral', 'score': 0.700263261795044}, {'label': 'positive', 'score': 0.2782788574695587}, {'label': 'negative', 'score': 0.021457817405462265}]","(0.700263261795044, 0.2782788574695587, 0.021457817405462265)",0.8568222095984125,0.2782788574695587,0,1,"[{'label': 'neutral', 'score': 0.9993826150894165}, {'label': 'positive', 'score': 0.0004604108980856836}, {'label': 'negative', 'score': 0.00015685246034990996}]","(0.9993826150894165, 0.0004604108980856836, 0.00015685246034990996)",0.4917810746212429,0.0004604108980856836,1,1
2018-04-11,44.19235610961914,53.625953674316406,53.950382232666016,53.33015441894531,53.49236679077149,9445834.0,PreMarket Prep Opening NYSE Imbalance Update: Pfizer 149k Shares To Buy: ExxonMobil 81k Shares To Buy; Merck 50k Shares To Buy; General Electric 114k Shares To Sell; Ford 42k Shares To Buy,0.009608526900731143,-0.0051468852922982354,0.15776415290530096,"[{'label': 'neutral', 'score': 0.9998465776443481}, {'label': 'negative', 'score': 8.104930020635948e-05}, {'label': 'positive', 'score': 7.237723184516653e-05}]","(0.9998465776443481, 7.237723184516653e-05, 8.104930020635948e-05)",-0.05652261212735068,-8.104930020635948e-05,1,1,"[{'label': 'neutral', 'score': 0.9173956513404846}, {'label': 'positive', 'score': 0.06139902397990227}, {'label': 'negative', 'score': 0.02120536006987095}]","(0.9173956513404846, 0.06139902397990227, 0.02120536006987095)",0.4865802750349504,0.06139902397990227,1,1,"[{'label': 'neutral', 'score': 0.9987519979476929}, {'label': 'positive', 'score': 0.0010914094746112823}, {'label': 'negative', 'score': 0.00015655615425202996}]","(0.9987519979476929, 0.0010914094746112823, 0.00015655615425202996)",0.7491018171796504,0.0010914094746112823,0,1
2018-04-12,44.61697769165039,54.14122009277344,54.57061004638672,53.56870269775391,54.00763320922852,12511967.0,,0.007578422179815732,0.009562658589996853,0.14528885393394148,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-13,44.955108642578125,54.5515251159668,54.70419692993164,54.04580307006836,54.46564865112305,10536278.0,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More | Mylan Shares Quiet Premarket; Co. Looking For Deal For Merck's Consumer Products Unit",0.00862924964683282,0.007549850201327125,0.1257294058558732,"[{'label': 'neutral', 'score': 0.9998382329940796}, {'label': 'positive', 'score': 8.287905802717432e-05}, {'label': 'negative', 'score': 7.891785207903013e-05}]","(0.9998382329940796, 8.287905802717432e-05, 7.891785207903013e-05)",0.024482580943876113,8.287905802717432e-05,1,1,"[{'label': 'neutral', 'score': 0.8642570972442627}, {'label': 'positive', 'score': 0.1223241314291954}, {'label': 'negative', 'score': 0.01341883186250925}]","(0.8642570972442627, 0.1223241314291954, 0.01341883186250925)",0.8022905712810634,0.1223241314291954,0,1,"[{'label': 'neutral', 'score': 0.9991245865821838}, {'label': 'positive', 'score': 0.0007109128055162728}, {'label': 'negative', 'score': 0.00016448067617602646}]","(0.9991245865821838, 0.0007109128055162728, 0.00016448067617602646)",0.6242131575893058,0.0007109128055162728,0,1
2018-04-14,45.34303665161133,55.022263844807945,55.314884185791016,54.21437708536784,54.68511454264323,14900184.666666666,,0.00855542276793399,0.008592230484717004,0.09508790474818438,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-15,45.73096466064453,55.493002573649086,55.92557144165039,54.38295110066732,54.90458043416341,19264091.33333333,"Merck Announces KEYTRUDA Reduced Risk of Disease Recurrence or Death by More than 40% vs Placebo as Adjuvant Therapy in Resected, High-Risk Stage III Melanoma",0.008482848413480624,0.00851903254707527,0.09793502909993482,"[{'label': 'positive', 'score': 0.999225378036499}, {'label': 'neutral', 'score': 0.0004305328766349703}, {'label': 'negative', 'score': 0.00034412191598676145}]","(0.0004305328766349703, 0.999225378036499, 0.00034412191598676145)",0.9993114597514168,0.999225378036499,0,0,"[{'label': 'positive', 'score': 0.9475538730621338}, {'label': 'neutral', 'score': 0.028445202857255936}, {'label': 'negative', 'score': 0.024000905454158783}]","(0.028445202857255936, 0.9475538730621338, 0.024000905454158783)",0.9505927900621071,0.9475538730621338,0,0,"[{'label': 'positive', 'score': 0.9972870349884033}, {'label': 'neutral', 'score': 0.001939010457135737}, {'label': 'negative', 'score': 0.0007739738211967051}]","(0.001939010457135737, 0.9972870349884033, 0.0007739738211967051)",0.9984490450696599,0.9972870349884033,0,0
2018-04-16,46.11889266967773,55.96374130249024,56.536258697509766,54.5515251159668,55.1240463256836,23627998.0,"Dynavax Reports Interim Data for SD-101 in Combination with KEYTRUDA, Results Showed 'Encouraging Response Rates' | UPDATE: Merck Says KEYTRUDA Combination Improved Overall Survival in Patients Regardless of PD-L1 Expression, Including Patients Who Tested Negative for PD-L1 | Merck's KEYTRUDAPlus Pemetrexed and Platinum Chemotherapy Reduced the Risk of Death by Half Compared with Chemotherapy Alone as First-Line Treatment for Advanced Nonsquamous NSCLC in Phase 3 KEYNOTE-189 Study | Merck Sunday Announced Updated Overall Survival Data for LYNPARZA (olaparib) in gBRCA-Mutated HER2-Negative Metastatic Breast Cancer Presented at #AACR18",0.010571171827876369,0.0084470712407167,0.011330720097527454,"[{'label': 'positive', 'score': 0.9996187686920166}, {'label': 'negative', 'score': 0.00021615228615701199}, {'label': 'neutral', 'score': 0.00016504833183716983}]","(0.00016504833183716983, 0.9996187686920166, 0.00021615228615701199)",0.9995676240514874,0.9996187686920166,1,1,"[{'label': 'positive', 'score': 0.9534987211227417}, {'label': 'neutral', 'score': 0.028074320405721664}, {'label': 'negative', 'score': 0.018426956608891487}]","(0.028074320405721664, 0.9534987211227417, 0.018426956608891487)",0.9620815520546839,0.9534987211227417,1,1,"[{'label': 'positive', 'score': 0.9971587657928467}, {'label': 'neutral', 'score': 0.0024378884118050337}, {'label': 'negative', 'score': 0.00040334503864869475}]","(0.0024378884118050337, 0.9971587657928467, 0.00040334503864869475)",0.99919133849558,0.9971587657928467,1,1
2018-04-17,46.6064338684082,56.55534362792969,57.21374130249024,56.25954055786133,57.09923553466797,16070451.0,"One Up, One Down: Morgan Stanley Flips Merck, Bristol-Myers Ratings | Stock Market Gets Lift From Earnings As Geopolitical Fears Wane | Benzinga's Top Upgrades, Downgrades For April 17, 2018 | Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine | Morgan Stanley Upgrades Merck & Co to Overweight | Morgan Stanley Upgrades Merck to Overweight from Equal Weight; Raises PT to $68 from $63",-0.005905173495330119,0.010515687670145074,0.017252957226359385,"[{'label': 'positive', 'score': 0.9994831085205078}, {'label': 'negative', 'score': 0.00033591801184229553}, {'label': 'neutral', 'score': 0.00018092138634528965}]","(0.00018092138634528965, 0.9994831085205078, 0.00033591801184229553)",0.999328042369813,0.9994831085205078,0,0,"[{'label': 'positive', 'score': 0.9382233619689941}, {'label': 'neutral', 'score': 0.034759581089019775}, {'label': 'negative', 'score': 0.027017023414373398}]","(0.034759581089019775, 0.9382233619689941, 0.027017023414373398)",0.9440201139042831,0.9382233619689941,0,0,"[{'label': 'positive', 'score': 0.9787880182266235}, {'label': 'neutral', 'score': 0.019987182691693306}, {'label': 'negative', 'score': 0.0012247714912518859}]","(0.019987182691693306, 0.9787880182266235, 0.0012247714912518859)",0.9975004989647034,0.9787880182266235,0,0
2018-04-18,46.33119583129883,56.22137451171875,56.88931274414063,55.90649032592773,56.68893051147461,11779730.0,"Benzinga's Top Analyst Calls From April 18, 2018",-0.004752242080659537,-0.0059226779776903075,0.10695886165297627,"[{'label': 'neutral', 'score': 0.999873161315918}, {'label': 'negative', 'score': 7.14580382918939e-05}, {'label': 'positive', 'score': 5.527113171410747e-05}]","(0.999873161315918, 5.527113171410747e-05, 7.14580382918939e-05)",-0.12772834049982246,-7.14580382918939e-05,1,1,"[{'label': 'neutral', 'score': 0.9422829747200012}, {'label': 'negative', 'score': 0.03350929543375969}, {'label': 'positive', 'score': 0.02420775406062603}]","(0.9422829747200012, 0.02420775406062603, 0.03350929543375969)",-0.16115760342251112,-0.03350929543375969,1,1,"[{'label': 'neutral', 'score': 0.9995817542076111}, {'label': 'positive', 'score': 0.0002813597966451198}, {'label': 'negative', 'score': 0.0001368939847452566}]","(0.9995817542076111, 0.0002813597966451198, 0.0001368939847452566)",0.345402285233678,0.0002813597966451198,1,1
2018-04-19,46.11102294921875,55.95419692993164,56.60305404663086,55.7442741394043,56.22137451171875,11041204.0,"Stock Market Seems Directionless, Volatility Low As Investors Await News",0.0032401019439724115,-0.004763569885618995,0.12696090367245322,"[{'label': 'negative', 'score': 0.9970556497573853}, {'label': 'neutral', 'score': 0.0021738093346357346}, {'label': 'positive', 'score': 0.0007705639582127333}]","(0.0021738093346357346, 0.0007705639582127333, 0.9970556497573853)",-0.9984555147026186,-0.9970556497573853,0,0,"[{'label': 'neutral', 'score': 0.7401814460754395}, {'label': 'negative', 'score': 0.20050612092018127}, {'label': 'positive', 'score': 0.05931245535612106}]","(0.7401814460754395, 0.05931245535612106, 0.20050612092018127)",-0.543431757604232,-0.20050612092018127,0,1,"[{'label': 'negative', 'score': 0.99700528383255}, {'label': 'neutral', 'score': 0.002465901430696249}, {'label': 'positive', 'score': 0.0005287508247420192}]","(0.002465901430696249, 0.0005287508247420192, 0.99700528383255)",-0.9989398841415498,-0.99700528383255,0,0
2018-04-20,46.26043319702149,56.13549423217773,56.55534362792969,55.97328186035156,56.16412353515625,10109951.0,AstraZeneca Shares Are Looking Very Weak Right Now,0.008045801968339815,0.0032348641246648996,0.11870491820313818,"[{'label': 'negative', 'score': 0.9976511597633362}, {'label': 'neutral', 'score': 0.0016508210683241487}, {'label': 'positive', 'score': 0.0006980089819990098}]","(0.0016508210683241487, 0.0006980089819990098, 0.9976511597633362)",-0.9986016736351346,-0.9976511597633362,0,0,"[{'label': 'negative', 'score': 0.9630382061004639}, {'label': 'neutral', 'score': 0.025728462263941765}, {'label': 'positive', 'score': 0.0112333158031106}]","(0.025728462263941765, 0.0112333158031106, 0.9630382061004639)",-0.976940071529213,-0.9630382061004639,0,0,"[{'label': 'negative', 'score': 0.9982781410217285}, {'label': 'neutral', 'score': 0.0012956426944583654}, {'label': 'positive', 'score': 0.00042632859549485147}]","(0.0012956426944583654, 0.00042632859549485147, 0.9982781410217285)",-0.9991462367327579,-0.9982781410217285,0,0
2018-04-21,46.63263448079427,56.58714930216471,56.98473230997721,56.21819305419922,56.54262161254883,13662496.333333332,,0.007981583726284406,0.00801360707753587,0.11732314415321064,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-22,47.004835764567055,57.038804372151695,57.41412099202474,56.46310424804688,56.921119689941406,17215041.666666664,,0.007918382493436175,0.00794989936946327,0.10683249243742064,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-23,47.37703704833984,57.49045944213867,57.843509674072266,56.70801544189453,57.299617767333984,20767587.0,"Merck Reports EMA Validated Type II Variation For Co.'s KEYTRUDA In Combo With Pemetrexed, Platinum Chemotherapy As First-Line Therapy In Metastatic Nonsquamous NSCLC | Keytruda Is Key To The Merck Thesis, Goldman Sachs Says In Upgrade | Benzinga's Top Upgrades, Downgrades For April 23, 2018 | Goldman Sachs Upgrades Merck & Co to Buy",-0.0026556026068725444,0.00788719662237455,0.08807430333657489,"[{'label': 'positive', 'score': 0.9952341914176941}, {'label': 'neutral', 'score': 0.00443275598809123}, {'label': 'negative', 'score': 0.00033303865347988904}]","(0.00443275598809123, 0.9952341914176941, 0.00033303865347988904)",0.9993309569792568,0.9952341914176941,0,0,"[{'label': 'positive', 'score': 0.8869901299476624}, {'label': 'neutral', 'score': 0.09847048670053482}, {'label': 'negative', 'score': 0.014539423398673534}]","(0.09847048670053482, 0.8869901299476624, 0.014539423398673534)",0.9677449877384374,0.8869901299476624,0,0,"[{'label': 'neutral', 'score': 0.626600980758667}, {'label': 'positive', 'score': 0.3701441287994385}, {'label': 'negative', 'score': 0.0032548762392252684}]","(0.626600980758667, 0.3701441287994385, 0.0032548762392252684)",0.98256622971511,0.3701441287994385,0,1
2018-04-24,47.251220703125,57.33778762817383,58.20610809326172,57.03244400024414,57.64313125610352,13974975.0,,-0.007655236526011298,-0.0026591349745712246,0.07438689006849504,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-25,46.88951110839844,56.89885330200195,57.17557144165039,56.23091506958008,57.15649032592773,14057034.0,,-0.0036894028323055457,-0.007684688252044634,0.11753166067856954,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-26,46.71651077270508,56.68893051147461,57.33778762817383,56.40267181396485,57.08015441894531,14148105.0,Earnings Preview: Oil Giants Chevron And ExxonMobil Report Friday Morning,0.0010099145643771075,-0.003696225465064982,0.11351949531239751,"[{'label': 'neutral', 'score': 0.999847412109375}, {'label': 'negative', 'score': 8.231574611272663e-05}, {'label': 'positive', 'score': 7.023998477961868e-05}]","(0.999847412109375, 7.023998477961868e-05, 8.231574611272663e-05)",-0.0791563926341745,-8.231574611272663e-05,1,1,"[{'label': 'neutral', 'score': 0.5230345726013184}, {'label': 'negative', 'score': 0.4338158667087555}, {'label': 'positive', 'score': 0.04314958676695824}]","(0.5230345726013184, 0.04314958676695824, 0.4338158667087555)",-0.8190661967129016,-0.4338158667087555,0,1,"[{'label': 'neutral', 'score': 0.9994076490402222}, {'label': 'positive', 'score': 0.00045505925663746893}, {'label': 'negative', 'score': 0.00013729790225625038}]","(0.9994076490402222, 0.00045505925663746893, 0.00013729790225625038)",0.5364354082841958,0.00045505925663746893,0,1
2018-04-27,46.76368713378906,56.74618148803711,56.91793823242188,56.593509674072266,56.62213516235352,8034073.0,"Upcoming Earnings: McDonald's Reports On Monday As It Continues On New Growth Plan | BMO Sees Balanced Risk-Reward In Bristol-Myers, Takes Neutral Position",-0.003363030369072693,0.0010094049437501544,0.09314808789657578,"[{'label': 'positive', 'score': 0.9981095790863037}, {'label': 'neutral', 'score': 0.0010452254209667444}, {'label': 'negative', 'score': 0.0008451608591713011}]","(0.0010452254209667444, 0.9981095790863037, 0.0008451608591713011)",0.9983079096071611,0.9981095790863037,0,0,"[{'label': 'positive', 'score': 0.6565278768539429}, {'label': 'neutral', 'score': 0.28048259019851685}, {'label': 'negative', 'score': 0.0629894807934761}]","(0.28048259019851685, 0.6565278768539429, 0.0629894807934761)",0.8249118520241662,0.6565278768539429,0,0,"[{'label': 'positive', 'score': 0.9350181818008423}, {'label': 'neutral', 'score': 0.0627119168639183}, {'label': 'negative', 'score': 0.00226989365182817}]","(0.0627119168639183, 0.9350181818008423, 0.00226989365182817)",0.9951564653146112,0.9350181818008423,0,0
2018-04-28,46.60641860961914,56.55534235636393,57.02289962768555,56.45356114705404,56.72073618570963,9932804.333333334,,-0.003374378506466561,-0.0033686980663640304,0.049164133591119374,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-04-29,46.44915008544922,56.36450322469076,57.12786102294922,56.313612620035805,56.81933720906576,11831535.666666666,"The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap",-0.0033858034889870437,-0.0033800845614947264,0.04885612706680821,"[{'label': 'neutral', 'score': 0.9994656443595886}, {'label': 'positive', 'score': 0.0004572542675305158}, {'label': 'negative', 'score': 7.7038501331117e-05}]","(0.9994656443595886, 0.0004572542675305158, 7.7038501331117e-05)",0.7116243908924477,0.0004572542675305158,0,1,"[{'label': 'neutral', 'score': 0.9347544312477112}, {'label': 'positive', 'score': 0.04427693784236908}, {'label': 'negative', 'score': 0.020968548953533173}]","(0.9347544312477112, 0.04427693784236908, 0.020968548953533173)",0.3572413975812315,0.04427693784236908,1,1,"[{'label': 'neutral', 'score': 0.9988917708396912}, {'label': 'positive', 'score': 0.0009009215864352882}, {'label': 'negative', 'score': 0.00020730661344714463}]","(0.9988917708396912, 0.0009009215864352882, 0.00020730661344714463)",0.6258773897485429,0.0009009215864352882,0,1
2018-04-30,46.2918815612793,56.17366409301758,57.23282241821289,56.17366409301758,56.91793823242188,13730267.0,"The Week Ahead: Tesla And Apple Earnings, Dropbox Quiet Period Expires, Fed Rate Decision And More | Upcoming Earnings: Tech Giant Apple Reports After Tuesday's Close | Pharmaceutical Earnings: Pfizer And Merck Are Slated To Report Tuesday Morning | Busy Week Begins With McDonald's Beating Estimates; Fed Meeting, Jobs Data Loom | Merck is Granted Priority Review of its sBLA for KEYTRUDA in Combination with Pemetrexed and Platinum Chemotherapy",-0.015118037044222815,-0.00339154829246921,0.03179810574516105,"[{'label': 'negative', 'score': 0.7991037368774414}, {'label': 'neutral', 'score': 0.19900372624397278}, {'label': 'positive', 'score': 0.0018925138283520937}]","(0.19900372624397278, 0.0018925138283520937, 0.7991037368774414)",-0.9952746000329352,-0.7991037368774414,1,1,"[{'label': 'neutral', 'score': 0.8583011627197266}, {'label': 'positive', 'score': 0.10803326964378357}, {'label': 'negative', 'score': 0.03366556018590927}]","(0.8583011627197266, 0.10803326964378357, 0.03366556018590927)",0.5248293831872606,0.10803326964378357,0,0,"[{'label': 'neutral', 'score': 0.846699059009552}, {'label': 'positive', 'score': 0.1445755511522293}, {'label': 'negative', 'score': 0.008725341409444809}]","(0.846699059009552, 0.1445755511522293, 0.008725341409444809)",0.8861671153553847,0.1445755511522293,0,0
2018-05-01,45.592044830322266,55.32442855834961,56.52671813964844,54.274810791015625,56.29771041870117,13756782.0,"Apple Results, Fed Decision, Jobs Report In Focus; Merck, Pfizer Reports Mixed | Benzinga Pro's 5 Stocks To Watch Today | Benzinga's Daily Biotech Pulse: Karyopharm's STORM Study, Inogen Rallies On Earnings | Merck Raises FY18 EPS Guidance From $4.08-$4.23 to $4.16-$4.28 vs $4.19 Est., Raises Sales From $41.2B-$42.7B to $41.8B-$43.0B vs $41.9B Est. | Merck Reports Q1 Adj. EPS $1.05 Beats $1.00 Est., Sales $10.04B Misses $10.10B Est. | 15 Stocks To Watch For May 1, 2018 | Earnings Scheduled For May 1, 2018",-0.0117282208530158,-0.015233479553445754,0.09676572015698358,"[{'label': 'positive', 'score': 0.9988709092140198}, {'label': 'negative', 'score': 0.0006720824167132378}, {'label': 'neutral', 'score': 0.0004569469310808927}]","(0.0004569469310808927, 0.9988709092140198, 0.0006720824167132378)",0.9986552205911289,0.9988709092140198,0,0,"[{'label': 'positive', 'score': 0.4950164258480072}, {'label': 'neutral', 'score': 0.3870166838169098}, {'label': 'negative', 'score': 0.1179668977856636}]","(0.3870166838169098, 0.4950164258480072, 0.1179668977856636)",0.6151056864438856,0.4950164258480072,0,1,"[{'label': 'positive', 'score': 0.9799913167953491}, {'label': 'neutral', 'score': 0.018378393724560738}, {'label': 'negative', 'score': 0.0016302794683724642}]","(0.018378393724560738, 0.9799913167953491, 0.0016302794683724642)",0.9966783952704837,0.9799913167953491,0,0
2018-05-02,45.05733489990234,54.67557144165039,55.343509674072266,54.40839767456055,55.03816986083984,10921837.0,,0.004013989379519375,-0.011797538953581736,0.09021089061709708,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-03,45.23818588256836,54.89503860473633,55.15267181396485,53.78816986083984,54.52289962768555,11864932.0,Moderna Snd Merck Expand mRNA Cancer Vaccines Collaboration | Merck Says Phase 3 KEYNOTE-407 Met A Pre-Specified Secondary Endpoint Related To Overall Response Rate In A Cohort Of Participants At An Interim Analysis,0.0038240758338629107,0.004005954817404832,0.1210652264039088,"[{'label': 'neutral', 'score': 0.9998410940170288}, {'label': 'positive', 'score': 0.00010618656233418733}, {'label': 'negative', 'score': 5.273889473755844e-05}]","(0.9998410940170288, 0.00010618656233418733, 5.273889473755844e-05)",0.3363065211918838,0.00010618656233418733,1,1,"[{'label': 'positive', 'score': 0.9085525870323181}, {'label': 'neutral', 'score': 0.07960217446088791}, {'label': 'negative', 'score': 0.011845211498439312}]","(0.07960217446088791, 0.9085525870323181, 0.011845211498439312)",0.9742606696423047,0.9085525870323181,0,0,"[{'label': 'neutral', 'score': 0.9344645738601685}, {'label': 'positive', 'score': 0.06524021923542023}, {'label': 'negative', 'score': 0.0002952217182610184}]","(0.9344645738601685, 0.06524021923542023, 0.0002952217182610184)",0.9909904712941605,0.06524021923542023,0,1
2018-05-04,45.41118240356445,55.10496139526367,55.25763320922852,54.22710037231445,54.50381851196289,9149983.0,PreMarket Prep Opening NYSE Imbalance Update: Alibaba 91k Shares To Sell; Merck 51k To Sell; Twitter 129k To Sell,-0.002135645851671061,0.0038167826431014,0.14002190426147348,"[{'label': 'neutral', 'score': 0.9998124241828918}, {'label': 'negative', 'score': 0.00011145098687848076}, {'label': 'positive', 'score': 7.621455006301403e-05}]","(0.9998124241828918, 7.621455006301403e-05, 0.00011145098687848076)",-0.1877618948568686,-0.00011145098687848076,1,1,"[{'label': 'neutral', 'score': 0.8954092860221863}, {'label': 'positive', 'score': 0.060058463364839554}, {'label': 'negative', 'score': 0.044532179832458496}]","(0.8954092860221863, 0.060058463364839554, 0.044532179832458496)",0.14844811216135784,0.060058463364839554,1,1,"[{'label': 'neutral', 'score': 0.9987504482269287}, {'label': 'negative', 'score': 0.0006390188354998827}, {'label': 'positive', 'score': 0.0006104888743720949}]","(0.9987504482269287, 0.0006104888743720949, 0.0006390188354998827)",-0.02283296125536589,-0.0006390188354998827,1,1
2018-05-05,45.31420008341471,54.98727671305338,55.31806564331055,54.30661646525065,54.71056111653646,9604640.333333334,,-0.00214021659636664,-0.0021379295953640734,0.1409382154191094,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-06,45.217217763264976,54.8695920308431,55.37849807739258,54.38613255818685,54.91730372111002,10059297.666666666,,-0.0021448069477924374,-0.002142510132933995,0.1020573827457286,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-07,45.120235443115234,54.75190734863281,55.43893051147461,54.46564865112305,55.1240463256836,10513955.0,,-0.01080514550246487,-0.002147110340358312,0.052648212556972405,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-05-08,44.6327018737793,54.16030502319336,54.790077209472656,53.683204650878906,54.74236679077149,10749546.0,"OncoSec Announces Clinical Collaboration with Merck  to Evaluate Combination of ImmunoPulse IL-12 and KEYTRUDA for Triple Negative Breast Cancer | Jim Cramer Advises His Viewers On Prestige Brands, CVS Health And More | AstraZeneca and Merck Announce LYNPARZA Tablets Receive EU Approval for the Treatment of Platinum-Sensitive Relapsed Ovarian Cancer",0.02096550317411875,-0.010863945029020267,0.08326581587104212,"[{'label': 'positive', 'score': 0.9938920736312866}, {'label': 'neutral', 'score': 0.005857518408447504}, {'label': 'negative', 'score': 0.0002504156727809459}]","(0.005857518408447504, 0.9938920736312866, 0.0002504156727809459)",0.999496217744488,0.9938920736312866,1,1,"[{'label': 'positive', 'score': 0.6886622905731201}, {'label': 'neutral', 'score': 0.2958983778953552}, {'label': 'negative', 'score': 0.015439343638718128}]","(0.2958983778953552, 0.6886622905731201, 0.015439343638718128)",0.956144559567737,0.6886622905731201,1,1,"[{'label': 'positive', 'score': 0.9716662168502808}, {'label': 'neutral', 'score': 0.02793394960463047}, {'label': 'negative', 'score': 0.00039982673479244113}]","(0.02793394960463047, 0.9716662168502808, 0.00039982673479244113)",0.9991773671399572,0.9716662168502808,1,1
2018-05-09,45.568450927734375,55.29580307006836,55.73473358154297,54.22710037231445,54.360687255859375,8684042.0,"Jim Cramer Gives His Opinion On Exxon Mobil, Pfizer And Cisco",0.001898180140917196,0.020748751318991197,0.18781572872212823,"[{'label': 'neutral', 'score': 0.9997126460075378}, {'label': 'positive', 'score': 0.0001915317989187315}, {'label': 'negative', 'score': 9.57603842834942e-05}]","(0.9997126460075378, 0.0001915317989187315, 9.57603842834942e-05)",0.33335892946249623,0.0001915317989187315,1,1,"[{'label': 'neutral', 'score': 0.9495370388031006}, {'label': 'positive', 'score': 0.03286326676607132}, {'label': 'negative', 'score': 0.017599722370505333}]","(0.9495370388031006, 0.03286326676607132, 0.017599722370505333)",0.3024700806814205,0.03286326676607132,1,1,"[{'label': 'neutral', 'score': 0.9989317059516907}, {'label': 'positive', 'score': 0.0009042488527484238}, {'label': 'negative', 'score': 0.00016396536375395954}]","(0.9989317059516907, 0.0009042488527484238, 0.00016396536375395954)",0.6930103321582339,0.0009042488527484238,0,1
2018-05-10,45.65494918823242,55.40076446533203,56.040077209472656,55.27671813964844,55.46755599975586,8624097.0,,0.028074407328855005,0.0018963808735228559,0.18616337334264407,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-05-11,46.93669128417969,56.95610809326172,57.22328186035156,55.46755599975586,55.49618148803711,13344498.0,,-5.5858056774557555e-05,0.02768754508371149,0.2565540733482593,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-12,46.93406677246094,56.95292663574219,57.25826899210612,55.88104248046875,56.00826899210612,12210352.666666666,,-5.58611770713579e-05,-5.585961689389965e-05,0.25200757620775127,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-13,46.93144226074219,56.949745178222656,57.29325612386068,56.29452896118164,56.52035649617513,11076207.333333334,,-5.586429771678462e-05,-5.5862737365006695e-05,0.20944192938420644,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-14,46.92881774902344,56.946563720703125,57.328243255615234,56.70801544189453,57.03244400024414,9942062.0,"WHO Says 39 Cases Of Ebola Reported In Congo Outbreak So Far, Including 19 Deaths",-0.008042898674990957,-5.586585818475298e-05,0.1939585526878202,"[{'label': 'neutral', 'score': 0.9993754029273987}, {'label': 'negative', 'score': 0.0005393660394474864}, {'label': 'positive', 'score': 8.529421029379591e-05}]","(0.9993754029273987, 8.529421029379591e-05, 0.0005393660394474864)",-0.7269100752637213,-0.0005393660394474864,0,1,"[{'label': 'negative', 'score': 0.8385671973228455}, {'label': 'neutral', 'score': 0.1325983703136444}, {'label': 'positive', 'score': 0.028834423050284386}]","(0.1325983703136444, 0.028834423050284386, 0.8385671973228455)",-0.9335154042302095,-0.8385671973228455,0,0,"[{'label': 'negative', 'score': 0.9162575602531433}, {'label': 'neutral', 'score': 0.08134286105632782}, {'label': 'positive', 'score': 0.002399642253294587}]","(0.08134286105632782, 0.002399642253294587, 0.9162575602531433)",-0.9947757613030247,-0.9162575602531433,0,0
2018-05-15,46.55136489868164,56.488548278808594,57.06106948852539,56.20228958129883,56.71755599975586,7148932.0,,0.009290569628826968,-0.00807541726438767,0.21826782364575378,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-16,46.98386764526367,57.01335906982422,57.261451721191406,56.40267181396485,56.60305404663086,8941222.0,First Batch of Experimental Ebola Vaccine Arrives in Congo; Vaccinations Could Begin this Weekend,-0.01138072396694436,0.009247677742187826,0.0973857379996419,"[{'label': 'neutral', 'score': 0.9998422861099243}, {'label': 'negative', 'score': 8.426295971730724e-05}, {'label': 'positive', 'score': 7.346889469772577e-05}]","(0.9998422861099243, 7.346889469772577e-05, 8.426295971730724e-05)",-0.06843300650723036,-8.426295971730724e-05,1,1,"[{'label': 'neutral', 'score': 0.6515985727310181}, {'label': 'positive', 'score': 0.3284739553928375}, {'label': 'negative', 'score': 0.01992751471698284}]","(0.6515985727310181, 0.3284739553928375, 0.01992751471698284)",0.885606023931521,0.3284739553928375,0,1,"[{'label': 'neutral', 'score': 0.9791243672370911}, {'label': 'positive', 'score': 0.020637428387999535}, {'label': 'negative', 'score': 0.00023820952628739178}]","(0.9791243672370911, 0.020637428387999535, 0.00023820952628739178)",0.977178227820826,0.020637428387999535,0,1
2018-05-17,46.44914627075195,56.364505767822266,57.04198455810547,56.183204650878906,56.8129768371582,8222398.0,WHO Says Will Convene Emergency Meeting On Fri. To Determine If Ebola Outbreak In Congo Is A Public Emergency Of Int'l. Concern | WHO Says Ebola Outbreak has Spread to DR Congo city,0.0011849928162052388,-0.01144597998553442,0.12802795530418204,"[{'label': 'neutral', 'score': 0.9992049336433411}, {'label': 'negative', 'score': 0.0007192092598415911}, {'label': 'positive', 'score': 7.5905816629529e-05}]","(0.9992049336433411, 7.5905816629529e-05, 0.0007192092598415911)",-0.8090696079706746,-0.0007192092598415911,0,1,"[{'label': 'negative', 'score': 0.8292126655578613}, {'label': 'neutral', 'score': 0.14982615411281586}, {'label': 'positive', 'score': 0.020961251109838486}]","(0.14982615411281586, 0.020961251109838486, 0.8292126655578613)",-0.9506894984687435,-0.8292126655578613,0,0,"[{'label': 'neutral', 'score': 0.9853938817977905}, {'label': 'negative', 'score': 0.012306890450417995}, {'label': 'positive', 'score': 0.0022991697769612074}]","(0.9853938817977905, 0.0022991697769612074, 0.012306890450417995)",-0.6851759144945341,-0.012306890450417995,0,1
2018-05-18,46.50419998168945,56.431297302246094,56.73664093017578,54.85686874389648,56.25954055786133,10151242.0,"Merck, Bristol Myers Shares Move On Alleged FDA Alert On Keytruda | WHO Official Says WHO Is Considering Using Mapp Biopharma's ZMapp Treatment For Ebola In Congo | Merck Shares Dip Lower, Bristol-Myers Squibb Shares Spike Higher Following FDA Alert On Issue Found In Trials Of Keytruda, Tecentriq | WHO Emergency Committee Says Ebola Outbreak In Congo Doesn't Yet Constitute A Public Health Emergency Of Intl. Concern | WHO Says Ebola Vaccinations In Congo Will Begin Sun. | WHO Raises Risk Assessment of Congo's Ebola Outbreak to 'Very High'",-0.0032127083890179805,0.0011842912663843966,0.1295550359456878,"[{'label': 'negative', 'score': 0.9900336861610413}, {'label': 'positive', 'score': 0.008969714865088463}, {'label': 'neutral', 'score': 0.0009965646313503385}]","(0.0009965646313503385, 0.008969714865088463, 0.9900336861610413)",-0.9820426740171752,-0.9900336861610413,0,0,"[{'label': 'negative', 'score': 0.5730434060096741}, {'label': 'positive', 'score': 0.39053985476493835}, {'label': 'neutral', 'score': 0.03641670197248459}]","(0.03641670197248459, 0.39053985476493835, 0.5730434060096741)",-0.18940091497440856,-0.5730434060096741,1,0,"[{'label': 'negative', 'score': 0.7425537705421448}, {'label': 'neutral', 'score': 0.24349786341190338}, {'label': 'positive', 'score': 0.01394837349653244}]","(0.24349786341190338, 0.01394837349653244, 0.7425537705421448)",-0.9631240344619055,-0.7425537705421448,0,0
2018-05-19,46.35479609171549,56.25,56.69211196899414,55.14312871297201,56.3295160929362,9728234.333333334,12 Dow 30 Companies With Above-Average Salaries,-0.0032230631510415404,-0.0032178802166344424,0.12877095499645122,"[{'label': 'neutral', 'score': 0.999852180480957}, {'label': 'positive', 'score': 8.897423685993999e-05}, {'label': 'negative', 'score': 5.889290332561359e-05}]","(0.999852180480957, 8.897423685993999e-05, 5.889290332561359e-05)",0.20343487739452007,8.897423685993999e-05,1,1,"[{'label': 'neutral', 'score': 0.7053797841072083}, {'label': 'positive', 'score': 0.2728734314441681}, {'label': 'negative', 'score': 0.02174673229455948}]","(0.7053797841072083, 0.2728734314441681, 0.02174673229455948)",0.8523744470263432,0.2728734314441681,0,1,"[{'label': 'neutral', 'score': 0.9477161169052124}, {'label': 'negative', 'score': 0.03675093874335289}, {'label': 'positive', 'score': 0.015532947145402431}]","(0.9477161169052124, 0.015532947145402431, 0.03675093874335289)",-0.4058227738293225,-0.03675093874335289,1,1
2018-05-20,46.20539220174154,56.06870269775391,56.6475830078125,55.42938868204752,56.39949162801107,9305226.666666666,"4,000 Doses Of Ebola Vaccine Sent to Congolese City of Mbandaka on Saturday; Vaccination Campaign to Start Monday",-0.0032334848769982965,-0.003228268406667019,0.11973899917268975,"[{'label': 'neutral', 'score': 0.9997993111610413}, {'label': 'negative', 'score': 0.00012430721835698932}, {'label': 'positive', 'score': 7.64425567467697e-05}]","(0.9997993111610413, 7.64425567467697e-05, 0.00012430721835698932)",-0.2384294656643098,-0.00012430721835698932,1,1,"[{'label': 'neutral', 'score': 0.7519494295120239}, {'label': 'positive', 'score': 0.22743050754070282}, {'label': 'negative', 'score': 0.020620107650756836}]","(0.7519494295120239, 0.22743050754070282, 0.020620107650756836)",0.8337427412962386,0.22743050754070282,0,1,"[{'label': 'neutral', 'score': 0.9982903599739075}, {'label': 'positive', 'score': 0.0013523073866963387}, {'label': 'negative', 'score': 0.0003573289723135531}]","(0.9982903599739075, 0.0013523073866963387, 0.0003573289723135531)",0.5819824836662992,0.0013523073866963387,0,1
2018-05-21,46.05598831176758,55.88740539550781,56.60305404663086,55.71564865112305,56.46946716308594,8882219.0,,-0.002048865339371606,-0.0032387238857752893,0.07279190847440634,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-22,45.96162033081055,55.77289962768555,56.431297302246094,55.725189208984375,56.08778762817383,9357068.0,Hearing A Suspected Ebola Case Is Being Treated At A Main Hospital In Congo's Capital City Kinshasa,0.012318225651311843,-0.0020509671353163704,0.030336283967762452,"[{'label': 'neutral', 'score': 0.9996688365936279}, {'label': 'negative', 'score': 0.00025740679120644927}, {'label': 'positive', 'score': 7.380752504104748e-05}]","(0.9996688365936279, 7.380752504104748e-05, 0.00025740679120644927)",-0.5543216496360893,-0.00025740679120644927,0,0,"[{'label': 'negative', 'score': 0.5801864862442017}, {'label': 'neutral', 'score': 0.32531023025512695}, {'label': 'positive', 'score': 0.09450326859951019}]","(0.32531023025512695, 0.09450326859951019, 0.5801864862442017)",-0.7198615573423036,-0.5801864862442017,0,0,"[{'label': 'neutral', 'score': 0.9065532088279724}, {'label': 'negative', 'score': 0.07882789522409439}, {'label': 'positive', 'score': 0.014618904329836369}]","(0.9065532088279724, 0.014618904329836369, 0.07882789522409439)",-0.6871181378148882,-0.07882789522409439,0,0
2018-05-23,46.52779006958008,56.459922790527344,56.76526641845703,55.75381851196289,55.77289962768555,10375619.0,Merck's KEYTRUDA (pembrolizumab) Significantly Improved Overall Survival And Progression-Free Survival As First-Line Treatment For Squamous Non-Small Cell Lung Cancer (NSCLC) In Pivotal Phase 3 KEYNOTE-407 Trial,-0.0006759847384874833,0.012242973660151452,0.108049099238186,"[{'label': 'positive', 'score': 0.9996627569198608}, {'label': 'negative', 'score': 0.00019656676158774644}, {'label': 'neutral', 'score': 0.00014067419397179037}]","(0.00014067419397179037, 0.9996627569198608, 0.00019656676158774644)",0.9996068111644666,0.9996627569198608,0,0,"[{'label': 'positive', 'score': 0.9556599259376526}, {'label': 'neutral', 'score': 0.027373455464839935}, {'label': 'negative', 'score': 0.0169666837900877}]","(0.027373455464839935, 0.9556599259376526, 0.0169666837900877)",0.9651116191549868,0.9556599259376526,0,0,"[{'label': 'positive', 'score': 0.9987643957138062}, {'label': 'neutral', 'score': 0.0008123501902446151}, {'label': 'negative', 'score': 0.00042323628440499306}]","(0.0008123501902446151, 0.9987643957138062, 0.00042323628440499306)",0.999152839224884,0.9987643957138062,0,0
2018-05-24,46.496337890625,56.421756744384766,56.68893051147461,56.11641311645508,56.536258697509766,7261382.0,,-0.0006765096133530531,-0.0006762133191880274,0.1045810080067266,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-25,46.46488571166992,56.38358688354492,56.73664093017578,56.14503860473633,56.431297302246094,6985339.0,"Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended | Eisai, Merck Provide Update on sNDA for Lenvatinib",-0.002919278955772971,-0.0006767385492389366,0.10015691776540547,"[{'label': 'positive', 'score': 0.813710629940033}, {'label': 'neutral', 'score': 0.1852000206708908}, {'label': 'negative', 'score': 0.001089320401661098}]","(0.1852000206708908, 0.813710629940033, 0.001089320401661098)",0.9973261647814183,0.813710629940033,0,0,"[{'label': 'neutral', 'score': 0.7889896035194397}, {'label': 'positive', 'score': 0.19902168214321136}, {'label': 'negative', 'score': 0.011988701298832893}]","(0.7889896035194397, 0.19902168214321136, 0.011988701298832893)",0.8863686127358212,0.19902168214321136,0,1,"[{'label': 'positive', 'score': 0.9545925259590149}, {'label': 'neutral', 'score': 0.04503855109214783}, {'label': 'negative', 'score': 0.0003689223376568407}]","(0.04503855109214783, 0.9545925259590149, 0.0003689223376568407)",0.9992273565842582,0.9545925259590149,0,0
2018-05-26,46.3292407989502,56.21898746490479,56.60066795349121,55.95181274414063,56.297709465026855,7546071.5,,-0.0029278260968840196,-0.002923548361666116,0.09931423823003262,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-27,46.19359588623047,56.05438804626465,56.46469497680664,55.75858688354492,56.16412162780762,8106804.0,,-0.002936423434045594,-0.0029321205640612294,0.10129912918313629,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-05-28,46.05795097351074,55.88978862762451,56.32872200012207,55.56536102294922,56.03053379058838,8667536.5,,-0.002945071410751061,-0.00294074318381974,0.019612821459184297,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-05-29,45.922306060791016,55.725189208984375,56.1927490234375,55.37213516235352,55.89694595336914,9228269.0,,0.022602783237486466,-0.0029494166670487655,0.01604314090360238,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-05-30,46.96028900146485,56.98473358154297,57.06106948852539,55.83969497680664,55.96374130249024,11572016.0,"30 Stocks Moving In Wednesday's Mid-Day Session | Mid-Morning Market Update: Markets Open Higher; Michael Kors Beats Q4 Estimates | Benzinga's Daily Biotech Pulse: Chinese Cheer For Gilead, Immutep Presents Positive Phase 1 Data, FDA Accepts Exelixis sNDA",-0.003181506534318655,0.022351125386526175,0.17952409251361387,"[{'label': 'positive', 'score': 0.9982262253761292}, {'label': 'neutral', 'score': 0.0014055116334930062}, {'label': 'negative', 'score': 0.00036823106347583234}]","(0.0014055116334930062, 0.9982262253761292, 0.00036823106347583234)",0.9992625012864808,0.9982262253761292,0,0,"[{'label': 'positive', 'score': 0.9387686848640442}, {'label': 'neutral', 'score': 0.044337037950754166}, {'label': 'negative', 'score': 0.016894210129976273}]","(0.044337037950754166, 0.9387686848640442, 0.016894210129976273)",0.9646439969188466,0.9387686848640442,0,0,"[{'label': 'positive', 'score': 0.9946383833885193}, {'label': 'neutral', 'score': 0.004905027337372303}, {'label': 'negative', 'score': 0.00045654652058146894}]","(0.004905027337372303, 0.9946383833885193, 0.00045654652058146894)",0.9990824060964251,0.9946383833885193,0,0
2018-05-31,46.81087112426758,56.80343627929688,57.13740539550781,56.593509674072266,56.89885330200195,12786019.0,"Merck, Premier Inc. Report Expansion Of Preventative, Chronic Disease Care Collaboration To Include New Effort Designed To Help Reduce Recurrence Of C. Diff | 41 Biggest Movers From Yesterday",0.017302164844049978,-0.003186578286297558,0.1799988164792418,"[{'label': 'positive', 'score': 0.9972401857376099}, {'label': 'neutral', 'score': 0.002463090466335416}, {'label': 'negative', 'score': 0.00029668465140275657}]","(0.002463090466335416, 0.9972401857376099, 0.00029668465140275657)",0.9994051655428294,0.9972401857376099,0,0,"[{'label': 'positive', 'score': 0.9361072778701782}, {'label': 'neutral', 'score': 0.05068479850888252}, {'label': 'negative', 'score': 0.01320787612348795}]","(0.05068479850888252, 0.9361072778701782, 0.01320787612348795)",0.9721738854206133,0.9361072778701782,0,0,"[{'label': 'positive', 'score': 0.8633697032928467}, {'label': 'neutral', 'score': 0.13576284050941467}, {'label': 'negative', 'score': 0.0008674735436215997}]","(0.13576284050941467, 0.8633697032928467, 0.0008674735436215997)",0.9979925104661732,0.8633697032928467,0,0
2018-06-01,47.62080764770508,57.786258697509766,58.024810791015625,56.88931274414063,57.14694595336914,11556925.0,"Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates | EMA Says CHMP Has Recommended Restricting Use Of Merck's Keytruda, Tecentriq As First-Line Treatments For Urothelial Cancer",0.008036116125784901,0.017154186844446993,0.20019520213606332,"[{'label': 'negative', 'score': 0.8520633578300476}, {'label': 'neutral', 'score': 0.14398834109306335}, {'label': 'positive', 'score': 0.0039483243599534035}]","(0.14398834109306335, 0.0039483243599534035, 0.8520633578300476)",-0.9907750689807128,-0.8520633578300476,0,0,"[{'label': 'negative', 'score': 0.49370837211608887}, {'label': 'neutral', 'score': 0.4765758514404297}, {'label': 'positive', 'score': 0.029715783894062042}]","(0.4765758514404297, 0.029715783894062042, 0.49370837211608887)",-0.886456199803336,-0.49370837211608887,0,1,"[{'label': 'neutral', 'score': 0.9982165694236755}, {'label': 'positive', 'score': 0.0009629600099287927}, {'label': 'negative', 'score': 0.0008205230114981532}]","(0.9982165694236755, 0.0009629600099287927, 0.0008205230114981532)",0.07986451046597413,0.0009629600099287927,1,1
2018-06-02,48.00349044799805,58.2506357828776,58.57188415527344,57.38549677530924,57.67493565877279,14508128.0,,0.007972051791825144,0.008003998497182025,0.18348727145761992,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-03,48.386173248291016,58.715012868245445,59.11895751953125,57.88168080647787,58.20292536417643,17459331.0,"The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines | Merck Announces KEYTRUDA Showed Overall Response Rate of Nearly 40 Percent as First-Line Therapy in Patients with Advanced Clear Cell RCC in Phase 2 KEYNOTE-427 Study at #ASCO2018 | Eisai, Merck Announce Data from Investigational Studies of LENVIMA and KEYTRUDA Combination Therapy in Four Different Tumor Types AT #asco2018 | Merck Announces KEYTRUDA Plus Chemotherapy Significantly Improved Overall Survival in First-Line Treatment of Metastatic Squamous NSCLC in Phase 3 KEYNOTE-407 Study | Merck Announces KEYTRUDA Monotherapy Significantly Improved Overall Survival in KEYNOTE-042 Study as First-Line Treatment for Locally Advanced or Metastatic NSCLC Patients Whose Tumors Expressed PD-L1 (TPS 1%)",0.007909000827605761,0.007940442867794354,0.15570374498162748,"[{'label': 'positive', 'score': 0.9995577931404114}, {'label': 'negative', 'score': 0.000248083466431126}, {'label': 'neutral', 'score': 0.00019407240324653685}]","(0.00019407240324653685, 0.9995577931404114, 0.000248083466431126)",0.999503736730828,0.9995577931404114,0,0,"[{'label': 'positive', 'score': 0.9432883858680725}, {'label': 'neutral', 'score': 0.03043241985142231}, {'label': 'negative', 'score': 0.026279205456376076}]","(0.03043241985142231, 0.9432883858680725, 0.026279205456376076)",0.9457919062239319,0.9432883858680725,0,0,"[{'label': 'positive', 'score': 0.9971946477890015}, {'label': 'neutral', 'score': 0.0024526258930563927}, {'label': 'negative', 'score': 0.0003526823129504919}]","(0.0024526258930563927, 0.9971946477890015, 0.0003526823129504919)",0.9992929010938971,0.9971946477890015,0,0
2018-06-04,48.768856048583984,59.17938995361328,59.66603088378906,58.37786483764648,58.73091506958008,20410534.0,"Merck and Astrazeneca Pres Relase Announces LYNPARZA In Combo With Abiraterone Delayed Metastatic Prostate Cancer Disease Progression | Merck Gives an Update on its Pivotal Trial of JAVELIN into ASCO | Donald Trump Tweets: 'We had Repeal & Replace done (and the saving to our country of one trillion dollars) except for one person, but it is getting done anyway'...'less expensive plans will be announced this month. Drug prices coming down & Right to Try!' | Merck Says 'KEYTRUDA Showed Promising Anti-Tumor Activity in Patients with Advanced Small Cell Lung Cancer (SCLC) in Phase 2 KEYNOTE-158 Study' | Merck Announces New Analysis of Four-Year Data for KEYTRUDA from Phase 3 KEYNOTE-006 Study Showed 86 Percent of Patients Were Progression-Free 20 Months After Completing Two Years of KEYTRUDA | Five Additional Ebola Cases Detected by Congo Health Officials",-0.010158041481489502,0.007877888617226776,0.11446727496338867,"[{'label': 'positive', 'score': 0.9918525815010071}, {'label': 'neutral', 'score': 0.0077220359817147255}, {'label': 'negative', 'score': 0.0004253808001521975}]","(0.0077220359817147255, 0.9918525815010071, 0.0004253808001521975)",0.9991426176609511,0.9918525815010071,0,0,"[{'label': 'neutral', 'score': 0.539692223072052}, {'label': 'positive', 'score': 0.2775132656097412}, {'label': 'negative', 'score': 0.1827944964170456}]","(0.539692223072052, 0.2775132656097412, 0.1827944964170456)",0.20577269602328285,0.2775132656097412,1,1,"[{'label': 'positive', 'score': 0.9426735639572144}, {'label': 'neutral', 'score': 0.05532567575573921}, {'label': 'negative', 'score': 0.002000759355723858}]","(0.05532567575573921, 0.9426735639572144, 0.002000759355723858)",0.9957641288508673,0.9426735639572144,0,0
2018-06-05,48.273475646972656,58.578243255615234,59.475189208984375,58.26335906982422,59.16030502319336,13098218.0,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",0.008796208111065853,-0.010209986457071244,0.15842127068759054,"[{'label': 'positive', 'score': 0.9968851208686829}, {'label': 'neutral', 'score': 0.002832128433510661}, {'label': 'negative', 'score': 0.0002827505813911557}]","(0.002832128433510661, 0.9968851208686829, 0.0002827505813911557)",0.9994328927164892,0.9968851208686829,0,0,"[{'label': 'neutral', 'score': 0.9297968745231628}, {'label': 'positive', 'score': 0.048591867089271545}, {'label': 'negative', 'score': 0.021611271426081657}]","(0.9297968745231628, 0.048591867089271545, 0.021611271426081657)",0.38432178722735194,0.048591867089271545,1,1,"[{'label': 'neutral', 'score': 0.9967381358146667}, {'label': 'positive', 'score': 0.00313745834864676}, {'label': 'negative', 'score': 0.00012435104872565717}]","(0.9967381358146667, 0.00313745834864676, 0.00012435104872565717)",0.9237533322297561,0.00313745834864676,0,1
2018-06-06,48.69809722900391,59.093509674072266,59.10305404663086,58.41603088378906,58.6927490234375,7912190.0,,0.0009688845962196524,0.008757746850114628,0.1304304859778861,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-07,48.74526977539063,59.15076446533203,59.1984748840332,58.6927490234375,59.16030502319336,7910933.0,,0.009517659530641707,0.0009684155304952119,0.12797505065866976,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-08,49.20921325683594,59.71374130249024,59.78053283691406,59.13167953491211,59.16984558105469,10142754.0,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",-0.001331642646525049,0.00947265196162322,0.132048527938129,"[{'label': 'neutral', 'score': 0.9997870326042175}, {'label': 'positive', 'score': 0.00014125606685411185}, {'label': 'negative', 'score': 7.176445797085762e-05}]","(0.9997870326042175, 0.00014125606685411185, 7.176445797085762e-05)",0.3262202500925802,0.00014125606685411185,1,1,"[{'label': 'neutral', 'score': 0.9455364942550659}, {'label': 'positive', 'score': 0.03678948059678078}, {'label': 'negative', 'score': 0.01767401210963726}]","(0.9455364942550659, 0.03678948059678078, 0.01767401210963726)",0.3509776464426221,0.03678948059678078,1,1,"[{'label': 'neutral', 'score': 0.9995962977409363}, {'label': 'positive', 'score': 0.00026918077492155135}, {'label': 'negative', 'score': 0.00013453872816171497}]","(0.9995962977409363, 0.00026918077492155135, 0.00013453872816171497)",0.33350394452473786,0.00026918077492155135,1,1
2018-06-09,49.14368438720703,59.63422393798828,59.8473269144694,59.16666666666666,59.41157658894857,9276058.0,,-0.0013334182831764639,-0.0013325300705026625,0.1283929701414687,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-10,49.078155517578125,59.55470657348633,59.91412099202474,59.201653798421226,59.653307596842446,8409362.0,,-0.0013351986614833587,-0.0013343080764010693,0.08558327656787858,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-11,49.01262664794922,59.475189208984375,59.98091506958008,59.23664093017578,59.89503860473633,7542666.0,,0.0017648571001953426,-0.0013360908334558044,0.07433957265691432,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-12,49.09912490844727,59.58015441894531,59.74236679077149,59.16984558105469,59.51335906982422,8308230.0,Merck Press Release Confirms FDA Approval Of KEYTRUDA For Cervical Cancer | Merck Receives FDA Approval For KEYTRUDA in Advanced Cervical Cancer,0.0024022670434828263,0.0017633015698269331,0.07433872538214449,"[{'label': 'positive', 'score': 0.9990912675857544}, {'label': 'neutral', 'score': 0.0006379488622769713}, {'label': 'negative', 'score': 0.00027084065368399024}]","(0.0006379488622769713, 0.9990912675857544, 0.00027084065368399024)",0.9994579729380352,0.9990912675857544,0,0,"[{'label': 'positive', 'score': 0.7523211240768433}, {'label': 'neutral', 'score': 0.23397020995616913}, {'label': 'negative', 'score': 0.013708574697375298}]","(0.23397020995616913, 0.7523211240768433, 0.013708574697375298)",0.9642087644400434,0.7523211240768433,0,0,"[{'label': 'positive', 'score': 0.9982160925865173}, {'label': 'neutral', 'score': 0.0015104693593457341}, {'label': 'negative', 'score': 0.0002734203008003533}]","(0.0015104693593457341, 0.9982160925865173, 0.0002734203008003533)",0.9994523321531746,0.9982160925865173,0,0
2018-06-13,49.217079162597656,59.72328186035156,60.07633590698242,59.4942741394043,59.70419692993164,9873732.0,Merck's KEYTRUDA Receives FDA Approval For Treatment of Primary Mediastinal Large B-Cell Lymphoma | FDA Grants Priority Review To Merck's Supplemental Biologics License Application (sBLA) For GARDASIL 9 In Women And Men Ages 27-45 For Prevention Of Certain HPV-Related Cancers And Diseases,-0.016456269441304027,0.002399386212769489,0.029912323837297965,"[{'label': 'positive', 'score': 0.9990124702453613}, {'label': 'neutral', 'score': 0.0007055888418108225}, {'label': 'negative', 'score': 0.00028196244966238737}]","(0.0007055888418108225, 0.9990124702453613, 0.00028196244966238737)",0.9994356769327696,0.9990124702453613,0,0,"[{'label': 'positive', 'score': 0.9076426029205322}, {'label': 'neutral', 'score': 0.07909397780895233}, {'label': 'negative', 'score': 0.013263379223644733}]","(0.07909397780895233, 0.9076426029205322, 0.013263379223644733)",0.9711949330750069,0.9076426029205322,0,0,"[{'label': 'positive', 'score': 0.9912125468254089}, {'label': 'neutral', 'score': 0.008491713553667068}, {'label': 'negative', 'score': 0.00029571738559752703}]","(0.008491713553667068, 0.9912125468254089, 0.00029571738559752703)",0.9994034999076223,0.9912125468254089,0,0
2018-06-14,48.781246185302734,58.74045944213867,59.52289962768555,58.41603088378906,59.22710037231445,12528211.0,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",0.007634789948786433,-0.0165931779232295,0.12351499171322584,"[{'label': 'neutral', 'score': 0.9931707382202148}, {'label': 'positive', 'score': 0.006497539114207029}, {'label': 'negative', 'score': 0.0003317442606203258}]","(0.9931707382202148, 0.006497539114207029, 0.0003317442606203258)",0.9028465382347054,0.006497539114207029,0,1,"[{'label': 'positive', 'score': 0.49940693378448486}, {'label': 'neutral', 'score': 0.484894722700119}, {'label': 'negative', 'score': 0.015698395669460297}]","(0.484894722700119, 0.49940693378448486, 0.015698395669460297)",0.9390478227584952,0.49940693378448486,0,1,"[{'label': 'neutral', 'score': 0.9966101050376892}, {'label': 'positive', 'score': 0.0030822805128991604}, {'label': 'negative', 'score': 0.00030755181796848774}]","(0.9966101050376892, 0.0030822805128991604, 0.00030755181796848774)",0.8185445249501364,0.0030822805128991604,0,1
2018-06-15,49.15368270874024,59.18893051147461,59.2557258605957,58.41603088378906,58.76908493041992,17246517.0,"Mid-Afternoon Market Update: Crude Oil Down Over 3%; Canada Goose Shares Gain Following Strong Q4 Results | 30 Stocks Moving In Friday's Mid-Day Session | Mid-Day Market Update: Dow Down Over 200 Points; Affimed Shares Plummet | Affimed Shares Slide On Updated Hodgkin Lymphoma Drug Combo Data | Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",-0.005588695849015818,0.007605792439742732,0.14554465175050155,"[{'label': 'negative', 'score': 0.9979082345962524}, {'label': 'positive', 'score': 0.0012446942273527384}, {'label': 'neutral', 'score': 0.000847084098495543}]","(0.000847084098495543, 0.0012446942273527384, 0.9979082345962524)",-0.9975085010683635,-0.9979082345962524,0,0,"[{'label': 'negative', 'score': 0.9570043087005615}, {'label': 'neutral', 'score': 0.02790040336549282}, {'label': 'positive', 'score': 0.015095233917236328}]","(0.02790040336549282, 0.015095233917236328, 0.9570043087005615)",-0.9689430284545019,-0.9570043087005615,0,0,"[{'label': 'neutral', 'score': 0.831742525100708}, {'label': 'negative', 'score': 0.10899441689252853}, {'label': 'positive', 'score': 0.059263091534376144}]","(0.831742525100708, 0.059263091534376144, 0.10899441689252853)",-0.29556675255153286,-0.10899441689252853,1,1
2018-06-16,48.87897872924805,58.858141581217446,59.02035649617513,58.21564865112305,58.6927490234375,14827768.0,,-0.005620104905974752,-0.005604371039524489,0.14885341552848275,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-17,48.60427474975586,58.52735265096029,58.78498713175456,58.01526641845703,58.61641311645508,12409019.0,,-0.0056518690026847885,-0.00563595711751348,0.14604155158026438,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-18,48.32957077026367,58.196563720703125,58.549617767333984,57.814884185791016,58.540077209472656,9990270.0,40 Biggest Movers From Friday,0.000655878258088029,-0.0056679012509454904,0.13617958163696978,"[{'label': 'neutral', 'score': 0.9997864365577698}, {'label': 'positive', 'score': 0.00014573827502317727}, {'label': 'negative', 'score': 6.776005466235802e-05}]","(0.9997864365577698, 0.00014573827502317727, 6.776005466235802e-05)",0.365240423546519,0.00014573827502317727,1,1,"[{'label': 'neutral', 'score': 0.8128206133842468}, {'label': 'positive', 'score': 0.13073447346687317}, {'label': 'negative', 'score': 0.056444935500621796}]","(0.8128206133842468, 0.13073447346687317, 0.056444935500621796)",0.3968894782606792,0.13073447346687317,1,1,"[{'label': 'neutral', 'score': 0.9994146823883057}, {'label': 'positive', 'score': 0.00045730423880741}, {'label': 'negative', 'score': 0.00012810212501790375}]","(0.9994146823883057, 0.00045730423880741, 0.00012810212501790375)",0.5623480271692788,0.00045730423880741,0,1
2018-06-19,48.36126327514648,58.23473358154297,58.50190734863281,57.85305404663086,57.87213516235352,10501589.0,,0.004096323004115189,0.0006556632639449086,0.09345176149678704,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-20,48.55936813354492,58.47328186035156,58.66412353515625,58.0057258605957,58.26335906982422,12757094.0,,-0.0016318054959351233,0.004087955914788818,0.07224375925129026,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-21,48.48013305664063,58.37786483764648,58.46374130249024,58.024810791015625,58.46374130249024,9336527.0,,0.004740055596770175,-0.001633138340682994,0.06653637109574138,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-22,48.70993041992188,58.654579162597656,59.08396911621094,58.41603088378906,58.47328186035156,12885998.0,,-0.002114840066859369,0.004728856907569675,0.06797950258109252,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-23,48.60691324869792,58.53053410847982,58.98854955037435,58.23155212402344,58.51463063557943,12276411.333333334,Merck Presents New Data from Comparative Trials with Sitagliptin Clinical Trial Program with JANUVIA at #ADA2018,-0.002119322094138755,-0.0021170794990312157,0.05026462073292486,"[{'label': 'neutral', 'score': 0.9986453652381897}, {'label': 'positive', 'score': 0.0012943194014951587}, {'label': 'negative', 'score': 6.030897930031642e-05}]","(0.9986453652381897, 0.0012943194014951587, 6.030897930031642e-05)",0.9109586361022477,0.0012943194014951587,0,1,"[{'label': 'neutral', 'score': 0.8436198234558105}, {'label': 'positive', 'score': 0.145427405834198}, {'label': 'negative', 'score': 0.010952790267765522}]","(0.8436198234558105, 0.145427405834198, 0.010952790267765522)",0.8599210061020253,0.145427405834198,0,1,"[{'label': 'neutral', 'score': 0.9992294311523438}, {'label': 'positive', 'score': 0.0006591053097508848}, {'label': 'negative', 'score': 0.00011153524974361062}]","(0.9992294311523438, 0.0006591053097508848, 0.00011153524974361062)",0.7105388540235344,0.0006591053097508848,0,1
2018-06-24,48.50389607747396,58.40648905436198,58.89312998453776,58.04707336425781,58.55597941080729,11666824.666666666,,-0.0021238231594845726,-0.002121571035257018,0.055554579385335805,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-25,48.40087890625,58.28244400024414,58.79771041870117,57.86259460449219,58.59732818603516,11057238.0,Merck's Supplemental Biologics License Application for KEYTRUDA is Accepted by the FDA,-0.005893944474395966,-0.002126081670242515,0.04788424388485208,"[{'label': 'neutral', 'score': 0.9998794794082642}, {'label': 'negative', 'score': 6.470301741501316e-05}, {'label': 'positive', 'score': 5.582995800068602e-05}]","(0.9998794794082642, 5.582995800068602e-05, 6.470301741501316e-05)",-0.07361520267566087,-6.470301741501316e-05,1,1,"[{'label': 'neutral', 'score': 0.8479410409927368}, {'label': 'positive', 'score': 0.1443520486354828}, {'label': 'negative', 'score': 0.007706893142312765}]","(0.8479410409927368, 0.1443520486354828, 0.007706893142312765)",0.8986328189291902,0.1443520486354828,0,1,"[{'label': 'positive', 'score': 0.6749458909034729}, {'label': 'neutral', 'score': 0.32449349761009216}, {'label': 'negative', 'score': 0.0005606008926406503}]","(0.32449349761009216, 0.6749458909034729, 0.0005606008926406503)",0.9983402057583486,0.6749458909034729,0,0
2018-06-26,48.11561584472656,57.93893051147461,58.225189208984375,57.83396911621094,58.04389190673828,12571913.0,Incyte Downgraded As RBC Analyst Awaits More Revenue Visibility,-0.01383396463985571,-0.005911382317341487,0.061182596871376296,"[{'label': 'negative', 'score': 0.998468816280365}, {'label': 'neutral', 'score': 0.0008992896764539182}, {'label': 'positive', 'score': 0.0006318965461105108}]","(0.0008992896764539182, 0.0006318965461105108, 0.998468816280365)",-0.9987350693718897,-0.998468816280365,1,1,"[{'label': 'negative', 'score': 0.9337570071220398}, {'label': 'neutral', 'score': 0.04957857355475426}, {'label': 'positive', 'score': 0.01666438765823841}]","(0.04957857355475426, 0.01666438765823841, 0.9337570071220398)",-0.9649326335670485,-0.9337570071220398,1,1,"[{'label': 'negative', 'score': 0.992752194404602}, {'label': 'neutral', 'score': 0.006575576029717922}, {'label': 'positive', 'score': 0.0006722048274241388}]","(0.006575576029717922, 0.0006722048274241388, 0.992752194404602)",-0.99864669152893,-0.992752194404602,1,1
2018-06-27,47.44998550415039,57.13740539550781,58.28244400024414,57.06106948852539,57.91984558105469,10948770.0,"UPDATE: Merck Says Non-Inferiority Was Not Demonstrated For Second Primary Outcome Of Blood Loss Of Greater Than Equal To 1,000 ml Of Blood Loss | Merck Reports Study Results From Heat-Stable Formulation Of Carbetocin For Prevention Of Excessive Bleeding After Childbirth: Showed Clinical Non-Inferiority To Oxycontin For Primary Outcome Of Greater Than Equal To 500 ml Of Blood Loss | AstraZeneca Reports LYNPARZA Phase III Trial First-Line SOLO-1 Trial For Ovarian Cancer Met Primary Endpoint | Merck To Report Q2 Earnings On Fri., Jul. 27, 2018 Before Market Open | AstraZeneca, Merck Announce LYNPARZA S Met Primary Endpoint of Progression-Free Survival in Women with BRCA-Mutated Advanced Ovarian Cancer and Showed a Safety Profile Consistent with Previous Trials",0.007014047322553652,-0.013930545695801,0.08139074319830712,"[{'label': 'neutral', 'score': 0.9878430366516113}, {'label': 'positive', 'score': 0.011700490489602089}, {'label': 'negative', 'score': 0.00045642536133527756}]","(0.9878430366516113, 0.011700490489602089, 0.00045642536133527756)",0.924910994378548,0.011700490489602089,0,1,"[{'label': 'positive', 'score': 0.9322298765182495}, {'label': 'neutral', 'score': 0.044024888426065445}, {'label': 'negative', 'score': 0.023745236918330193}]","(0.044024888426065445, 0.9322298765182495, 0.023745236918330193)",0.9503224789336413,0.9322298765182495,0,0,"[{'label': 'neutral', 'score': 0.5504241585731506}, {'label': 'positive', 'score': 0.40739697217941284}, {'label': 'negative', 'score': 0.042178936302661896}]","(0.5504241585731506, 0.40739697217941284, 0.042178936302661896)",0.812361225293087,0.40739697217941284,0,1
2018-06-28,47.78279113769531,57.53816986083984,57.96755599975586,57.24236679077149,57.35686874389648,10691591.0,U.S. Supreme Court Agrees To Hear Merck Appeal Of Lower Court Ruling THat Revived Fosamax Warning Label Suits,0.006633435181166881,0.006989563313959353,0.11995438954618705,"[{'label': 'positive', 'score': 0.6428062319755554}, {'label': 'neutral', 'score': 0.2023444026708603}, {'label': 'negative', 'score': 0.1548493653535843}]","(0.2023444026708603, 0.6428062319755554, 0.1548493653535843)",0.6117387858316797,0.6428062319755554,0,0,"[{'label': 'negative', 'score': 0.5936852693557739}, {'label': 'positive', 'score': 0.2969343364238739}, {'label': 'neutral', 'score': 0.10938041657209396}]","(0.10938041657209396, 0.2969343364238739, 0.5936852693557739)",-0.33319604801662145,-0.5936852693557739,1,0,"[{'label': 'positive', 'score': 0.9873673915863037}, {'label': 'neutral', 'score': 0.011875811964273453}, {'label': 'negative', 'score': 0.0007567678694613278}]","(0.011875811964273453, 0.9873673915863037, 0.0007567678694613278)",0.998468273724067,0.9873673915863037,0,0
2018-06-29,48.09977340698242,57.91984558105469,58.654579162597656,57.58587646484375,57.75763320922852,14956951.0,,-0.0013179357550226793,0.006611530764343247,0.14022008748412362,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-06-30,48.03637949625651,57.84351094563802,58.36513900756836,57.4491081237793,57.76399485270182,13153413.0,,-0.001319675001892806,-0.0013188049961698172,0.14017300495585985,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-01,47.9729855855306,57.76717631022135,58.07569885253906,57.31233978271485,57.77035649617513,11349875.0,,-0.0013214188453098687,-0.0013205465397970006,0.13478073472593,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-02,47.90959167480469,57.69084167480469,57.786258697509766,57.17557144165039,57.77671813964844,9546337.0,"Merck's Supplemental Biologics License for KEYTRUDA in Combination with Chemotherapy is Granted Priority Review by the FDA | AstraZeneca, Merck Announce LYNPARZA Approved in Japan for BRCA-Mutated Metastatic Breast Cancer",0.0041349419055672215,-0.0013222926890861853,0.07064338082829574,"[{'label': 'positive', 'score': 0.9960618615150452}, {'label': 'neutral', 'score': 0.0036484128795564175}, {'label': 'negative', 'score': 0.0002897053782362491}]","(0.0036484128795564175, 0.9960618615150452, 0.0002897053782362491)",0.9994184675613256,0.9960618615150452,0,0,"[{'label': 'positive', 'score': 0.5571615099906921}, {'label': 'neutral', 'score': 0.41925278306007385}, {'label': 'negative', 'score': 0.023585697636008263}]","(0.41925278306007385, 0.5571615099906921, 0.023585697636008263)",0.9187746498777177,0.5571615099906921,0,0,"[{'label': 'positive', 'score': 0.9869369864463806}, {'label': 'neutral', 'score': 0.01281812135130167}, {'label': 'negative', 'score': 0.0002448826562613249}]","(0.01281812135130167, 0.9869369864463806, 0.0002448826562613249)",0.9995038752960811,0.9869369864463806,0,0
2018-07-03,48.107696533203125,57.92938995361328,58.49236679077149,57.77671813964844,57.95801544189453,5106590.0,,0.007659371143200358,0.004126416526503841,0.05981316945046729,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-04,48.47616767883301,58.37309265136719,58.8072509765625,58.03435134887695,58.27290153503418,7311844.0,,0.007601151105765628,0.007630187086330335,0.06560914017401877,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-05,48.84463882446289,58.81679534912109,59.12213516235352,58.29198455810547,58.58778762817383,9517098.0,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,0.00908501297469865,0.00757240791901371,0.07116803285374843,"[{'label': 'neutral', 'score': 0.9997866749763489}, {'label': 'positive', 'score': 0.00012902515300083905}, {'label': 'negative', 'score': 8.426114800386131e-05}]","(0.9997866749763489, 0.00012902515300083905, 8.426114800386131e-05)",0.2098775438746591,0.00012902515300083905,1,1,"[{'label': 'neutral', 'score': 0.9096217155456543}, {'label': 'positive', 'score': 0.0785176157951355}, {'label': 'negative', 'score': 0.011860688216984272}]","(0.9096217155456543, 0.0785176157951355, 0.011860688216984272)",0.7375324012410379,0.0785176157951355,0,1,"[{'label': 'neutral', 'score': 0.9989087581634521}, {'label': 'positive', 'score': 0.000963414553552866}, {'label': 'negative', 'score': 0.00012773810885846615}]","(0.9989087581634521, 0.000963414553552866, 0.00012773810885846615)",0.7658657431560889,0.000963414553552866,0,1
2018-07-06,49.28839874267578,59.35114669799805,59.64694595336914,58.959922790527344,58.96946716308594,8543191.0,,-0.0009646359221933741,0.009043992504801153,0.06630457725873216,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-07,49.24085108439128,59.29389444986979,59.7041982014974,59.02671686808268,59.17938995361328,8603660.666666666,,-0.0009655673431377419,-0.0009651014828463835,0.06402910815039639,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-08,49.19330342610677,59.23664220174154,59.76145044962565,59.09351094563802,59.38931274414063,8664130.333333334,,-0.0009665005645200865,-0.0009660338035750133,0.07922305026974907,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-09,49.145755767822266,59.17938995361328,59.81870269775391,59.16030502319336,59.59923553466797,8724600.0,Health Care Sector Outlook: Checking In Ahead Of Q2 Earnings Reports,0.004514642129620856,-0.0009669679273525817,0.0810597262707585,"[{'label': 'neutral', 'score': 0.9998334646224976}, {'label': 'negative', 'score': 8.837949280859903e-05}, {'label': 'positive', 'score': 7.812677358742803e-05}]","(0.9998334646224976, 7.812677358742803e-05, 8.837949280859903e-05)",-0.061575575761127196,-8.837949280859903e-05,1,1,"[{'label': 'neutral', 'score': 0.5409635305404663}, {'label': 'positive', 'score': 0.3651691973209381}, {'label': 'negative', 'score': 0.0938672423362732}]","(0.5409635305404663, 0.3651691973209381, 0.0938672423362732)",0.5910248763415418,0.3651691973209381,0,1,"[{'label': 'neutral', 'score': 0.9790019989013672}, {'label': 'positive', 'score': 0.02048434130847454}, {'label': 'negative', 'score': 0.0005136358086019754}]","(0.9790019989013672, 0.02048434130847454, 0.0005136358086019754)",0.9510775913567157,0.02048434130847454,0,1
2018-07-10,49.36763381958008,59.446563720703125,59.761451721191406,59.26526641845703,59.53244400024414,11266524.0,,-0.0064205483214361805,0.004504481701827877,0.07196150293841666,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-11,49.0506591796875,59.064884185791016,59.35114669799805,58.76908493041992,59.29389190673828,6055344.0,FDA Grants Merck Priority Review To Co.'s  Supplemental Biologics License Application For Its KEYTRUDA Hepatocellular Carcinoma Therapy,0.012277904776728524,-0.006441248694544777,0.06143276377536308,"[{'label': 'positive', 'score': 0.9942071437835693}, {'label': 'neutral', 'score': 0.005513136740773916}, {'label': 'negative', 'score': 0.0002796775661408901}]","(0.005513136740773916, 0.9942071437835693, 0.0002796775661408901)",0.9994375439470152,0.9942071437835693,1,1,"[{'label': 'positive', 'score': 0.8185315132141113}, {'label': 'neutral', 'score': 0.16954465210437775}, {'label': 'negative', 'score': 0.011923904530704021}]","(0.16954465210437775, 0.8185315132141113, 0.011923904530704021)",0.9712834565807649,0.8185315132141113,1,1,"[{'label': 'positive', 'score': 0.6668550968170166}, {'label': 'neutral', 'score': 0.33257028460502625}, {'label': 'negative', 'score': 0.0005746278911828995}]","(0.33257028460502625, 0.6668550968170166, 0.0005746278911828995)",0.9982780872055582,0.6668550968170166,1,1
2018-07-12,49.65290832519531,59.790077209472656,59.96183013916016,59.29389190673828,59.58015441894531,8424453.0,Cue Biopharma Produces Immuno-STAT Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck,0.0036705647263138488,0.012203142630167023,0.11187754521771173,"[{'label': 'neutral', 'score': 0.9998836517333984}, {'label': 'negative', 'score': 5.875646820641123e-05}, {'label': 'positive', 'score': 5.7562399888411164e-05}]","(0.9998836517333984, 5.7562399888411164e-05, 5.875646820641123e-05)",-0.010265474016018334,-5.875646820641123e-05,1,1,"[{'label': 'positive', 'score': 0.6194905042648315}, {'label': 'neutral', 'score': 0.3725372850894928}, {'label': 'negative', 'score': 0.0079722311347723}]","(0.3725372850894928, 0.6194905042648315, 0.0079722311347723)",0.9745889893215886,0.6194905042648315,0,0,"[{'label': 'neutral', 'score': 0.9893584251403809}, {'label': 'positive', 'score': 0.010505774058401585}, {'label': 'negative', 'score': 0.00013571321323979646}]","(0.9893584251403809, 0.010505774058401585, 0.00013571321323979646)",0.9744935628309287,0.010505774058401585,0,1
2018-07-13,49.83517074584961,60.00954055786133,60.15267181396485,59.39885330200195,59.41793823242188,7705106.0,,-0.0015900732608439556,0.0036638446429226048,0.10982312571957073,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-14,49.75592422485352,59.91412099202474,60.1240463256836,59.42429860432943,59.627862294514976,6713383.333333333,,-0.0015926056204562313,-0.0015913387690097245,0.11117915537372684,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-15,49.67667770385742,59.81870142618815,60.09542083740234,59.4497439066569,59.83778635660807,5721660.666666667,,-0.0015951460590351808,-0.0015938751648888647,0.11256193092995688,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-16,49.59743118286133,59.72328186035156,60.06679534912109,59.475189208984375,60.04771041870117,4729938.0,PreMarket Prep Opening NYSE Imbalance Update: ExxonMobil 55k Shares To Sell; Pfizer 50k To Sell; Merck 26k To Sell; Coca-Cola 54k To Sell; Johnson & Johnson 54k To Sell; Ford 103k To Sell; Kroger 90k To Sell,-0.00095860399460913,-0.001596419659075621,0.09570392674862516,"[{'label': 'neutral', 'score': 0.9998397827148438}, {'label': 'negative', 'score': 9.672209853306413e-05}, {'label': 'positive', 'score': 6.347547605400905e-05}]","(0.9998397827148438, 6.347547605400905e-05, 9.672209853306413e-05)",-0.2075351175868417,-9.672209853306413e-05,1,1,"[{'label': 'neutral', 'score': 0.9050722718238831}, {'label': 'positive', 'score': 0.05968983843922615}, {'label': 'negative', 'score': 0.035237886011600494}]","(0.9050722718238831, 0.05968983843922615, 0.035237886011600494)",0.25758494232411494,0.05968983843922615,1,1,"[{'label': 'neutral', 'score': 0.9954226613044739}, {'label': 'negative', 'score': 0.0024861369747668505}, {'label': 'positive', 'score': 0.0020911507308483124}]","(0.9954226613044739, 0.0020911507308483124, 0.0024861369747668505)",-0.08629264082176676,-0.0024861369747668505,1,1
2018-07-17,49.54989242553711,59.66603088378906,59.933204650878906,59.59923553466797,59.66603088378906,5292086.0,,0.006556831198230916,-0.0009590637492569375,0.03646151075506842,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-07-18,49.87478256225586,60.0572509765625,60.09542083740234,59.51335906982422,59.73282241821289,6645578.0,,-0.006831898172520117,0.006535428684721321,0.05675367716656369,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-19,49.53404998779297,59.64694595336914,60.0572509765625,59.39885330200195,59.86641311645508,7631641.0,"UPDATE: Merck Says 'Going forward, we will continue to evaluate our portfolio of products to look for opportunities to further reduce costs for patients and the health care system' | UPDATE: Merck, Responding To Responsibility On Drug Pricing, Says 'We are also lowering our price on ZEPATIER by 60 percent and several other medicines by 10 percent to reduce out-of-pocket costs for patients across the country' | Merck Says 'We commit to not increase the average net price across our portfolio of products by more than inflation annually'",0.00016001443839301104,-0.0068553424290367085,0.0760161322001024,"[{'label': 'positive', 'score': 0.9995554089546204}, {'label': 'negative', 'score': 0.00023307252558879554}, {'label': 'neutral', 'score': 0.00021152354020159692}]","(0.00021152354020159692, 0.9995554089546204, 0.00023307252558879554)",0.9995337563296514,0.9995554089546204,0,0,"[{'label': 'positive', 'score': 0.6906130313873291}, {'label': 'negative', 'score': 0.23646453022956848}, {'label': 'neutral', 'score': 0.07292238622903824}]","(0.07292238622903824, 0.6906130313873291, 0.23646453022956848)",0.4898710959692404,0.6906130313873291,1,0,"[{'label': 'positive', 'score': 0.6683464646339417}, {'label': 'neutral', 'score': 0.3231965899467468}, {'label': 'negative', 'score': 0.008456992916762829}]","(0.3231965899467468, 0.6683464646339417, 0.008456992916762829)",0.9750090138505852,0.6683464646339417,0,0
2018-07-20,49.54197311401367,59.65649032592773,59.67557144165039,59.16984558105469,59.21755599975586,7204686.0,Merck Announces Plans To Cut Drug Prices,0.0009063689518663043,0.0001600016374483777,0.07601835614741008,"[{'label': 'positive', 'score': 0.744378387928009}, {'label': 'neutral', 'score': 0.2549508213996887}, {'label': 'negative', 'score': 0.0006707875872962177}]","(0.2549508213996887, 0.744378387928009, 0.0006707875872962177)",0.9981993468100081,0.744378387928009,0,0,"[{'label': 'negative', 'score': 0.6125580072402954}, {'label': 'neutral', 'score': 0.26246222853660583}, {'label': 'positive', 'score': 0.12497975677251816}]","(0.26246222853660583, 0.12497975677251816, 0.6125580072402954)",-0.6610892001176313,-0.6125580072402954,0,0,"[{'label': 'neutral', 'score': 0.6716797947883606}, {'label': 'negative', 'score': 0.2323819398880005}, {'label': 'positive', 'score': 0.09593825042247772}]","(0.6716797947883606, 0.09593825042247772, 0.2323819398880005)",-0.41558117195440786,-0.2323819398880005,1,1
2018-07-21,49.58687464396159,59.71056111653646,59.75190734863281,59.32887903849284,59.37976964314779,7225261.666666667,,0.0009055481911012332,0.0009059584475546388,0.07590963140227722,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-22,49.63177617390951,59.76463190714518,59.828243255615234,59.48791249593099,59.54198328653971,7245837.333333333,,0.0009047289154686316,0.0009051384296919422,0.07564494601127147,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-23,49.67667770385742,59.81870269775391,59.904579162597656,59.64694595336914,59.70419692993164,7266413.0,"Morgan Stanley: Newly Public Neon Therapeutics Has Outperformance Potential | Leap Therapeutics Announces Collaboration with Merck and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors",0.011644580863323747,0.0009043198949466287,0.054014859991135394,"[{'label': 'positive', 'score': 0.998870313167572}, {'label': 'neutral', 'score': 0.0008869934245012701}, {'label': 'negative', 'score': 0.00024263483646791428}]","(0.0008869934245012701, 0.998870313167572, 0.00024263483646791428)",0.9995142994854533,0.998870313167572,1,1,"[{'label': 'positive', 'score': 0.9484024047851562}, {'label': 'neutral', 'score': 0.035095520317554474}, {'label': 'negative', 'score': 0.01650208793580532}]","(0.035095520317554474, 0.9484024047851562, 0.01650208793580532)",0.9657953962069953,0.9484024047851562,1,1,"[{'label': 'positive', 'score': 0.9977394342422485}, {'label': 'neutral', 'score': 0.002038331003859639}, {'label': 'negative', 'score': 0.00022222133702598512}]","(0.002038331003859639, 0.9977394342422485, 0.00022222133702598512)",0.9995546495483396,0.9977394342422485,1,1
2018-07-24,50.255149841308594,60.51526641845703,60.53435134887695,59.9427490234375,60.01908493041992,9931058.0,Merck Announces Week 96 Data from Pivotal Phase 3 DRIVE-FORWARD Study of Its Investigational HIV Therapy Doravirine,0.016871648089470094,0.011577304497956216,0.0772573217397033,"[{'label': 'neutral', 'score': 0.9998428821563721}, {'label': 'positive', 'score': 0.0001040613351506181}, {'label': 'negative', 'score': 5.3012096032034606e-05}]","(0.9998428821563721, 0.0001040613351506181, 5.3012096032034606e-05)",0.32500238095149864,0.0001040613351506181,0,0,"[{'label': 'neutral', 'score': 0.6123812198638916}, {'label': 'positive', 'score': 0.3741210103034973}, {'label': 'negative', 'score': 0.013497760519385338}]","(0.6123812198638916, 0.3741210103034973, 0.013497760519385338)",0.9303554856709818,0.3741210103034973,1,0,"[{'label': 'neutral', 'score': 0.9983957409858704}, {'label': 'positive', 'score': 0.0014341900823637843}, {'label': 'negative', 'score': 0.00017004252003971487}]","(0.9983957409858704, 0.0014341900823637843, 0.00017004252003971487)",0.7880076495329253,0.0014341900823637843,1,0
2018-07-25,51.10302734375,61.536258697509766,61.61259460449219,60.45801544189453,60.524810791015625,11023598.0,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile | Merck Reports Phase 3 KEYNOTE-048 Trial Investigating KEYTRUDA Met Primarry Endpoint Of Improving Overall SurvivalIn Head And Neck Squamous Cell Carcinoma Patients | Merck Announces KEYTRUDA Monotherapy Met a Primary Endpoint in the Phase 3 KEYNOTE-048 Trial, Significantly Improving OS as First-Line Therapy in Head and Neck Squamous Cell Carcinoma Patients Whose Tumors Expressed PD-L1",-0.007443017362267201,0.016730902700023934,0.11877321916091926,"[{'label': 'positive', 'score': 0.9994397759437561}, {'label': 'neutral', 'score': 0.0003219748323317617}, {'label': 'negative', 'score': 0.00023822765797376633}]","(0.0003219748323317617, 0.9994397759437561, 0.00023822765797376633)",0.9995233912177411,0.9994397759437561,0,0,"[{'label': 'positive', 'score': 0.9510457515716553}, {'label': 'neutral', 'score': 0.034336674958467484}, {'label': 'negative', 'score': 0.014617572538554668}]","(0.034336674958467484, 0.9510457515716553, 0.014617572538554668)",0.9697253231564454,0.9510457515716553,0,0,"[{'label': 'positive', 'score': 0.9982263445854187}, {'label': 'neutral', 'score': 0.0014928344171494246}, {'label': 'negative', 'score': 0.0002807899727486074}]","(0.0014928344171494246, 0.9982263445854187, 0.0002807899727486074)",0.9994375804377745,0.9982263445854187,0,0
2018-07-26,50.7226676940918,61.078243255615234,62.21374130249024,61.05915832519531,61.65076446533203,11677235.0,Merck Q2 Earnings Preview | Sutro Pharma Earlier Reported Merck Was Part Of $85.4M Series E Funding Round | Merck Reports KEYTRUDA Approved By China National Drug Admin.,-0.008123702673643825,-0.007470854831857964,0.15243500201495774,"[{'label': 'positive', 'score': 0.9468743801116943}, {'label': 'neutral', 'score': 0.05260081961750984}, {'label': 'negative', 'score': 0.0005248644156381488}]","(0.05260081961750984, 0.9468743801116943, 0.0005248644156381488)",0.9988919889504451,0.9468743801116943,0,0,"[{'label': 'neutral', 'score': 0.8471713662147522}, {'label': 'positive', 'score': 0.13964508473873138}, {'label': 'negative', 'score': 0.013183597475290298}]","(0.8471713662147522, 0.13964508473873138, 0.013183597475290298)",0.8274722089558038,0.13964508473873138,0,1,"[{'label': 'neutral', 'score': 0.9656751155853271}, {'label': 'positive', 'score': 0.03399800881743431}, {'label': 'negative', 'score': 0.0003268802829552442}]","(0.9656751155853271, 0.03399800881743431, 0.0003268802829552442)",0.9809537457208254,0.03399800881743431,0,1
2018-07-27,50.31060791015625,60.582061767578125,61.08778762817383,59.52289962768555,59.58969497680664,8815357.0,"Benzinga Pro's 5 Stocks To Watch Today | Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter | Endo Int'l. Reports Par Pharma Has Begun Shipping Authorized Generic Version Of Merck's INVANZ | Merck Narrows FY18 Sales Guidance From $41.8B-$43B To $42B-$42.8B vs $42.07B Estimate | Merck Raises FY18 Adj. EPS From $4.16-$4.28 To $4.22-$4.30 vs $4.23 Estimate | Merck & Co Q2 EPS $1.06 Beats $1.03 Estimate, Sales $10.465B Beat $10.29B Estimate | 12 Stocks To Watch For July 27, 2018 | Earnings Scheduled For July 27, 2018",0.006930217301470841,-0.00815687974884071,0.177520356591466,"[{'label': 'positive', 'score': 0.9875702261924744}, {'label': 'neutral', 'score': 0.011327061802148819}, {'label': 'negative', 'score': 0.0011027043219655752}]","(0.011327061802148819, 0.9875702261924744, 0.0011027043219655752)",0.9977693243378438,0.9875702261924744,0,0,"[{'label': 'positive', 'score': 0.8201655149459839}, {'label': 'neutral', 'score': 0.11838193982839584}, {'label': 'negative', 'score': 0.06145250052213669}]","(0.11838193982839584, 0.8201655149459839, 0.06145250052213669)",0.8605915499820935,0.8201655149459839,0,0,"[{'label': 'negative', 'score': 0.739816427230835}, {'label': 'positive', 'score': 0.13346487283706665}, {'label': 'neutral', 'score': 0.1267186999320984}]","(0.1267186999320984, 0.13346487283706665, 0.739816427230835)",-0.6943370416229246,-0.739816427230835,0,0
2018-07-28,50.65927251180013,61.00190862019857,61.36768595377604,59.88867568969727,60.01590347290039,9253281.333333334,,0.006882519942686202,0.00690631372001205,0.17876876938723968,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-29,51.00793711344401,61.42175547281901,61.64758427937826,60.25445175170898,60.44211196899414,9691205.666666666,,0.006835474652075681,0.006858943517300136,0.16889755085745087,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-07-30,51.35660171508789,61.84160232543945,61.92748260498047,60.6202278137207,60.86832046508789,10129130.0,Benzinga Pro's 5 Stocks To Watch Today | BioLineRx Expands its Immuno-Oncology Collaboration in Pancreatic Cancer with Merck,0.016355522547243748,0.006812218711994386,0.12763858795158442,"[{'label': 'positive', 'score': 0.9505609273910522}, {'label': 'neutral', 'score': 0.04880201071500778}, {'label': 'negative', 'score': 0.0006370352930389345}]","(0.04880201071500778, 0.9505609273910522, 0.0006370352930389345)",0.9986605621163415,0.9505609273910522,0,0,"[{'label': 'positive', 'score': 0.9379724264144897}, {'label': 'neutral', 'score': 0.04984034597873688}, {'label': 'negative', 'score': 0.012187270447611809}]","(0.04984034597873688, 0.9379724264144897, 0.012187270447611809)",0.9743469008675906,0.9379724264144897,0,0,"[{'label': 'positive', 'score': 0.9290078282356262}, {'label': 'neutral', 'score': 0.07061398029327393}, {'label': 'negative', 'score': 0.00037816716940142214}]","(0.07061398029327393, 0.9290078282356262, 0.00037816716940142214)",0.9991861999830617,0.9290078282356262,0,0
2018-07-31,52.196571350097656,62.85305404663086,63.09160232543945,61.90839767456055,61.92748260498047,16184683.0,"Benzinga Pro's 5 Stocks To Watch Today | A Peek Into The Markets: US Stock Futures Up Ahead Of Earnings, Economic Data | Eisai and Merck Announce FDA Grants Breakthrough Therapy Designation For LENVIMA In Combination With KEYTRUDA As Therapy For Previously Treated Patients With Advanced And/Or Metastatic Non-MSI-H/pMMR Endometrial Carcinoma | Eisai, Merck Announce FDA Breakthrough Therapy Designation for LENVIMA",-0.0057689257903550326,0.016223211714219647,0.13902261440371327,"[{'label': 'neutral', 'score': 0.9468559622764587}, {'label': 'positive', 'score': 0.05280790477991104}, {'label': 'negative', 'score': 0.00033617232111282647}]","(0.9468559622764587, 0.05280790477991104, 0.00033617232111282647)",0.9873486439335928,0.05280790477991104,0,1,"[{'label': 'positive', 'score': 0.6571388244628906}, {'label': 'neutral', 'score': 0.3259481191635132}, {'label': 'negative', 'score': 0.016913078725337982}]","(0.3259481191635132, 0.6571388244628906, 0.016913078725337982)",0.9498166872748521,0.6571388244628906,0,0,"[{'label': 'positive', 'score': 0.9465946555137634}, {'label': 'neutral', 'score': 0.052609317004680634}, {'label': 'negative', 'score': 0.0007960926159285009}]","(0.052609317004680634, 0.9465946555137634, 0.0007960926159285009)",0.9983193996405387,0.9465946555137634,0,0
2018-08-01,51.89545822143555,62.49045944213867,63.110687255859375,62.45228958129883,62.700382232666016,7949604.0,"WHO Chief Says That It Has Started Moving Staff, Supplies To The Area Of Democratic Republic Of Congo's New Ebola Outbreak | 4 Samples From Northeastern Democratic Rep. Of Congo Test Positive For Ebola Virus, 20 Deaths From Hemorrhagic Fever Recorded In Northeastern Congo",-0.004122821727120332,-0.005785630318511885,0.12434613557290727,"[{'label': 'neutral', 'score': 0.9993288516998291}, {'label': 'positive', 'score': 0.00039971701335161924}, {'label': 'negative', 'score': 0.00027144321938976645}]","(0.9993288516998291, 0.00039971701335161924, 0.00027144321938976645)",0.19112245884699158,0.00039971701335161924,1,1,"[{'label': 'negative', 'score': 0.5208530426025391}, {'label': 'positive', 'score': 0.26538416743278503}, {'label': 'neutral', 'score': 0.2137627750635147}]","(0.2137627750635147, 0.26538416743278503, 0.5208530426025391)",-0.32492595352778625,-0.5208530426025391,1,0,"[{'label': 'neutral', 'score': 0.8349353671073914}, {'label': 'negative', 'score': 0.1207929402589798}, {'label': 'positive', 'score': 0.04427177459001541}]","(0.8349353671073914, 0.04427177459001541, 0.1207929402589798)",-0.4635828180418063,-0.1207929402589798,1,1
2018-08-02,51.681488037109375,62.23282241821289,62.433204650878906,61.89885330200195,62.30915832519531,7226379.0,"Health Ministry Officials Say Ebola In Latest Congo Outbreak Is of the Zaire Strain Which Has Been Successfully Treated By A Vaccine In The Past | UPDATE: W.H.O. Says Depending On The Strain Of Ebola In Congo Outbreak, Merck Vaccine May Be 'An Option'",0.010886258708108963,-0.004131343988525542,0.1436108414186979,"[{'label': 'neutral', 'score': 0.9933806657791138}, {'label': 'positive', 'score': 0.006345115602016449}, {'label': 'negative', 'score': 0.0002742508368100971}]","(0.9933806657791138, 0.006345115602016449, 0.0002742508368100971)",0.9171368319477067,0.006345115602016449,0,1,"[{'label': 'neutral', 'score': 0.8382409811019897}, {'label': 'positive', 'score': 0.14395247399806976}, {'label': 'negative', 'score': 0.017806481570005417}]","(0.8382409811019897, 0.14395247399806976, 0.017806481570005417)",0.7798393108131602,0.14395247399806976,0,1,"[{'label': 'neutral', 'score': 0.9869390726089478}, {'label': 'positive', 'score': 0.010610993951559067}, {'label': 'negative', 'score': 0.0024500172585248947}]","(0.9869390726089478, 0.010610993951559067, 0.0024500172585248947)",0.6248349811332647,0.010610993951559067,0,1
2018-08-03,52.24412155151367,62.91030502319336,62.99618148803711,61.9942741394043,62.21374130249024,7333066.0,"Merck Reports Co., AstraZeneca's Selumetinib Granted Orphan Designation In Europe For Neruofibromatosis Type 1",0.0014662046201938822,0.010827429958678575,0.15116095140307387,"[{'label': 'neutral', 'score': 0.9993492960929871}, {'label': 'positive', 'score': 0.0005814092583023012}, {'label': 'negative', 'score': 6.934413249837235e-05}]","(0.9993492960929871, 0.0005814092583023012, 6.934413249837235e-05)",0.7868804573939976,0.0005814092583023012,0,1,"[{'label': 'positive', 'score': 0.9263813495635986}, {'label': 'neutral', 'score': 0.05784030258655548}, {'label': 'negative', 'score': 0.015778351575136185}]","(0.05784030258655548, 0.9263813495635986, 0.015778351575136185)",0.9665059935039341,0.9263813495635986,0,0,"[{'label': 'positive', 'score': 0.973588764667511}, {'label': 'neutral', 'score': 0.025431007146835327}, {'label': 'negative', 'score': 0.000980283715762198}]","(0.025431007146835327, 0.973588764667511, 0.000980283715762198)",0.9979882724217676,0.973588764667511,0,0
2018-08-04,52.320719401041664,63.00254440307617,63.1424929300944,62.22328186035156,62.49681981404623,7755444.666666667,,0.0014640580115729692,0.0014651307917064398,0.15141878105413226,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-05,52.397317250569664,63.09478378295898,63.288804372151695,62.45228958129883,62.77989832560221,8177823.333333333,Congo Health Ministry Says Ebola Outbreak Likely to have Killed 33; Merck Vaccine Being Deployed to Control Spread of Outbreak,0.0014619176792825808,0.0014629873235479061,0.10321933244528488,"[{'label': 'neutral', 'score': 0.9952389001846313}, {'label': 'negative', 'score': 0.004385777749121189}, {'label': 'positive', 'score': 0.00037522322963923216}]","(0.9952389001846313, 0.00037522322963923216, 0.004385777749121189)",-0.8423763274516589,-0.004385777749121189,0,1,"[{'label': 'negative', 'score': 0.5121678709983826}, {'label': 'positive', 'score': 0.3670644760131836}, {'label': 'neutral', 'score': 0.12076763808727264}]","(0.12076763808727264, 0.3670644760131836, 0.5121678709983826)",-0.165034186331284,-0.5121678709983826,1,0,"[{'label': 'neutral', 'score': 0.8317342400550842}, {'label': 'negative', 'score': 0.162943035364151}, {'label': 'positive', 'score': 0.0053226519376039505}]","(0.8317342400550842, 0.0053226519376039505, 0.162943035364151)",-0.9367351475757656,-0.162943035364151,0,1
2018-08-06,52.473915100097656,63.1870231628418,63.43511581420898,62.681297302246094,63.0629768371582,8600202.0,,0.005436395906592928,0.0014608501179631868,0.08554083570888572,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-07,52.75918960571289,63.53053283691406,63.921756744384766,63.0057258605957,63.0629768371582,8471298.0,"Stocks That Made New 52-Week Highs Earlier Today Include: SL Green Realty, Verisk Analytics, Medtronics, Pfizer, Conoco Phillips, Archer-Daniels, Eli Lilly, Merck, Phillips 66, Costco, Advance Auto Parts, Norfolk Southern, CSX, Zoetis, Apple, and Disney | Stocks Which Set New 52-Week High Yesterday, August 6th | The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",0.0016521409561148451,0.00542167204541988,0.06538621045462141,"[{'label': 'positive', 'score': 0.9984307885169983}, {'label': 'neutral', 'score': 0.00122781319078058}, {'label': 'negative', 'score': 0.00034142908407375216}]","(0.00122781319078058, 0.9984307885169983, 0.00034142908407375216)",0.999316302399973,0.9984307885169983,0,0,"[{'label': 'neutral', 'score': 0.7490572929382324}, {'label': 'positive', 'score': 0.23206233978271484}, {'label': 'negative', 'score': 0.018880371004343033}]","(0.7490572929382324, 0.23206233978271484, 0.018880371004343033)",0.8495244516557062,0.23206233978271484,0,1,"[{'label': 'neutral', 'score': 0.7328022122383118}, {'label': 'positive', 'score': 0.2641772925853729}, {'label': 'negative', 'score': 0.003020555479452014}]","(0.7328022122383118, 0.2641772925853729, 0.003020555479452014)",0.9773908697144956,0.2641772925853729,0,1
2018-08-08,52.84635162353516,63.63549423217773,63.921756744384766,63.1202278137207,63.46374130249024,6821746.0,"Stocks Which Set New 52-Week High Yesterday, August 7th | The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",-0.010346330578671813,0.0016507776725964713,0.02780056203972683,"[{'label': 'positive', 'score': 0.9934700727462769}, {'label': 'negative', 'score': 0.004967613145709038}, {'label': 'neutral', 'score': 0.0015623500803485513}]","(0.0015623500803485513, 0.9934700727462769, 0.004967613145709038)",0.9900492274762824,0.9934700727462769,0,0,"[{'label': 'neutral', 'score': 0.7622330784797668}, {'label': 'positive', 'score': 0.17910365760326385}, {'label': 'negative', 'score': 0.05866333469748497}]","(0.7622330784797668, 0.17910365760326385, 0.05866333469748497)",0.5065476992426067,0.17910365760326385,0,0,"[{'label': 'positive', 'score': 0.9972537159919739}, {'label': 'neutral', 'score': 0.00241566589102149}, {'label': 'negative', 'score': 0.00033059180714190006}]","(0.00241566589102149, 0.9972537159919739, 0.00033059180714190006)",0.9993372153018901,0.9972537159919739,0,0
2018-08-09,52.29957580566406,62.97710037231445,63.8072509765625,62.786258697509766,63.8072509765625,7495086.0,CDC Says There's No Recommendation To Avoid Travel To Democratic Republic Of The Congo Following Ebola Outbreaks | Perrigo Announces Rx-To-OTC Switch Licensing For Nasonex,0.0010605685880893708,-0.010400225925239414,0.09542087175523056,"[{'label': 'neutral', 'score': 0.9997642636299133}, {'label': 'negative', 'score': 0.00014297569578047842}, {'label': 'positive', 'score': 9.271719318348914e-05}]","(0.9997642636299133, 9.271719318348914e-05, 0.00014297569578047842)",-0.21323724622287069,-0.00014297569578047842,1,1,"[{'label': 'neutral', 'score': 0.7840248346328735}, {'label': 'positive', 'score': 0.188346266746521}, {'label': 'negative', 'score': 0.027628876268863678}]","(0.7840248346328735, 0.188346266746521, 0.027628876268863678)",0.7441476284435605,0.188346266746521,0,1,"[{'label': 'neutral', 'score': 0.9917908906936646}, {'label': 'negative', 'score': 0.007080884650349617}, {'label': 'positive', 'score': 0.001128327683545649}]","(0.9917908906936646, 0.001128327683545649, 0.007080884650349617)",-0.725106956026253,-0.007080884650349617,0,1
2018-08-10,52.35504913330078,63.04389190673828,63.45419692993164,62.671756744384766,62.88167953491211,7796806.0,,0.0032793641046964498,0.001060006582552831,0.09505230840507617,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-11,52.52673848470052,63.2506357828776,63.578243255615234,62.7958017985026,62.95483525594076,8522406.0,,0.0032686450275223114,0.00327399871707057,0.09783272457196153,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-12,52.69842783610026,63.45737965901693,63.70228958129883,62.919846852620445,63.0279909769694,9248006.0,,0.0032579957957646843,0.0032633146196800167,0.09157685285583207,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-13,52.8701171875,63.66412353515625,63.82633590698242,63.04389190673828,63.10114669799805,9973606.0,,-0.0038968988747671543,0.003252700026739966,0.0943152185727172,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-14,52.6640853881836,63.41603088378906,63.88358688354492,63.225189208984375,63.55915832519531,6912608.0,,0.013692384059510596,-0.0039045115688892537,0.04935743854167311,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-08-15,53.38519287109375,64.28434753417969,64.47518920898438,63.42557144165039,63.67366409301758,11413873.0,Agenus Receives Milestone Payment From Merck Of $4M For Initiation Of Phase 1 Clinical Trial Of An Undisclosed Antibody Candidate Discovered By Agenus,0.021968274404162984,0.0135994903657722,0.0992019297855674,"[{'label': 'positive', 'score': 0.9794048070907593}, {'label': 'neutral', 'score': 0.02011818438768387}, {'label': 'negative', 'score': 0.00047695881221443415}]","(0.02011818438768387, 0.9794048070907593, 0.00047695881221443415)",0.9990264972187233,0.9794048070907593,1,1,"[{'label': 'positive', 'score': 0.8325411677360535}, {'label': 'neutral', 'score': 0.15978257358074188}, {'label': 'negative', 'score': 0.00767628476023674}]","(0.15978257358074188, 0.8325411677360535, 0.00767628476023674)",0.9817278616685944,0.8325411677360535,1,1,"[{'label': 'positive', 'score': 0.9868718385696411}, {'label': 'neutral', 'score': 0.012864688411355019}, {'label': 'negative', 'score': 0.0002634309639688581}]","(0.012864688411355019, 0.9868718385696411, 0.0002634309639688581)",0.9994662718026612,0.9868718385696411,1,1
2018-08-16,54.55796813964844,65.69656372070312,65.8396987915039,64.28434753417969,64.50381469726562,19378358.0,"Eisai And Merck Announce FDA Approval Of LENVIMA (lenvatinib) Capsules For First-line Treatment Of Unresectable Hepatocellular Carcinoma (HCC) | Stocks Which Set New 52-Week High Yesterday, August 15th | The Daily Biotech Pulse: No Anxiety For Biohaven, Strongbridge's About-Face, Bristol-Myers Squibb's FDA Wait",0.0030501754736394697,0.02173044864230461,0.15987655406400858,"[{'label': 'positive', 'score': 0.997572124004364}, {'label': 'neutral', 'score': 0.00204326119273901}, {'label': 'negative', 'score': 0.00038455831236205995}]","(0.00204326119273901, 0.997572124004364, 0.00038455831236205995)",0.9992293086079261,0.997572124004364,0,0,"[{'label': 'positive', 'score': 0.708617627620697}, {'label': 'neutral', 'score': 0.2781431972980499}, {'label': 'negative', 'score': 0.013239124789834023}]","(0.2781431972980499, 0.708617627620697, 0.013239124789834023)",0.9633192465246769,0.708617627620697,0,0,"[{'label': 'positive', 'score': 0.9262998104095459}, {'label': 'neutral', 'score': 0.07134344428777695}, {'label': 'negative', 'score': 0.0023568158503621817}]","(0.07134344428777695, 0.9262998104095459, 0.0023568158503621817)",0.9949242469526027,0.9262998104095459,0,0
2018-08-17,54.72438049316406,65.8969497680664,66.0687026977539,65.55343627929688,65.62976837158203,8223761.0,"Stocks Which Set New 52-Week High Yesterday, August 16th | The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns | Eisai And Merck Announce FDA Approval Of LENVIMA",0.005357649728974222,0.0030455331260170653,0.16025474175762694,"[{'label': 'positive', 'score': 0.9979667663574219}, {'label': 'neutral', 'score': 0.0016712030628696084}, {'label': 'negative', 'score': 0.00036206794902682304}]","(0.0016712030628696084, 0.9979667663574219, 0.00036206794902682304)",0.9992746519251278,0.9979667663574219,0,0,"[{'label': 'negative', 'score': 0.46501097083091736}, {'label': 'neutral', 'score': 0.278492271900177}, {'label': 'positive', 'score': 0.2564968168735504}]","(0.278492271900177, 0.2564968168735504, 0.46501097083091736)",-0.2889977870104087,-0.46501097083091736,1,1,"[{'label': 'positive', 'score': 0.9962232112884521}, {'label': 'neutral', 'score': 0.002546300645917654}, {'label': 'negative', 'score': 0.001230482361279428}]","(0.002546300645917654, 0.9962232112884521, 0.001230482361279428)",0.9975327529105095,0.9962232112884521,0,0
2018-08-18,55.017578125,66.25000254313152,66.38040669759114,65.62659200032552,65.69974517822266,9122316.0,,0.005329098286981086,0.005343348581284127,0.15738887089797582,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-19,55.31077575683594,66.60305531819661,66.69211069742839,65.69974772135417,65.76972198486328,10020871.0,,0.005300849538784618,0.005314948889464217,0.12356949610129285,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-20,55.60397338867188,66.95610809326172,67.00381469726562,65.77290344238281,65.8396987915039,10919426.0,FDA Approves Expanded Label for Merck's KEYTRUDA in Combination with Pemetrexed and Platinum Chemotherapy for First-Line Treatment,-0.014251138123198866,0.005286849488846983,0.12157127796764682,"[{'label': 'positive', 'score': 0.9990990161895752}, {'label': 'neutral', 'score': 0.0006777560920454562}, {'label': 'negative', 'score': 0.00022330092906486243}]","(0.0006777560920454562, 0.9990990161895752, 0.00022330092906486243)",0.9995530952821934,0.9990990161895752,0,0,"[{'label': 'positive', 'score': 0.8785097002983093}, {'label': 'neutral', 'score': 0.1133735403418541}, {'label': 'negative', 'score': 0.008116699755191803}]","(0.1133735403418541, 0.8785097002983093, 0.008116699755191803)",0.9816908232042222,0.8785097002983093,0,0,"[{'label': 'positive', 'score': 0.9976816177368164}, {'label': 'neutral', 'score': 0.0020279514137655497}, {'label': 'negative', 'score': 0.00029040934168733656}]","(0.0020279514137655497, 0.9976816177368164, 0.00029040934168733656)",0.9994180010384911,0.9976816177368164,0,0
2018-08-21,54.81153869628906,66.00190734863281,67.03244018554688,65.92557525634766,66.99427795410156,10285701.0,"Incyte Has Quietly Risen 13 Percent In The Last Two Weeks, And That Uptrend Looks Like It Will Continue | Stocks Which Set New 52-Week High Tues., Aug. 21, 2018 | The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows | Rexahn Reports Clinical Collaboration With Merck For Evaluation Of RX-5902 In Combo With KEYTRUDA For Triple-Negative Breast Cancer",-0.0018794354688624509,-0.014353660800972563,0.13650076017902202,"[{'label': 'positive', 'score': 0.9994286894798279}, {'label': 'negative', 'score': 0.0003088513622060418}, {'label': 'neutral', 'score': 0.00026239786529913545}]","(0.00026239786529913545, 0.9994286894798279, 0.0003088513622060418)",0.9993821351112895,0.9994286894798279,0,0,"[{'label': 'positive', 'score': 0.9434177875518799}, {'label': 'neutral', 'score': 0.03789742663502693}, {'label': 'negative', 'score': 0.018684742972254753}]","(0.03789742663502693, 0.9434177875518799, 0.018684742972254753)",0.9611585202627506,0.9434177875518799,0,0,"[{'label': 'positive', 'score': 0.9987553358078003}, {'label': 'neutral', 'score': 0.0009706646669656038}, {'label': 'negative', 'score': 0.00027403043350204825}]","(0.0009706646669656038, 0.9987553358078003, 0.00027403043350204825)",0.9994514066497704,0.9987553358078003,0,0
2018-08-22,54.708534240722656,65.87786102294922,66.22137451171875,65.69656372070312,66.0114517211914,6176178.0,"Stocks Which Set New 52-Week High Yesterday, August 21st | The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin",-0.0010139271081953452,-0.001881203823723229,0.1361651012202049,"[{'label': 'positive', 'score': 0.997821569442749}, {'label': 'neutral', 'score': 0.001132429693825543}, {'label': 'negative', 'score': 0.0010460615158081055}]","(0.001132429693825543, 0.997821569442749, 0.0010460615158081055)",0.9979055052273458,0.997821569442749,0,0,"[{'label': 'positive', 'score': 0.5437836050987244}, {'label': 'neutral', 'score': 0.4329039454460144}, {'label': 'negative', 'score': 0.023312460631132126}]","(0.4329039454460144, 0.5437836050987244, 0.023312460631132126)",0.9177830281677979,0.5437836050987244,0,0,"[{'label': 'positive', 'score': 0.9498782157897949}, {'label': 'neutral', 'score': 0.04920899495482445}, {'label': 'negative', 'score': 0.0009127683006227016}]","(0.04920899495482445, 0.9498782157897949, 0.0009127683006227016)",0.9980799811611678,0.9498782157897949,0,0
2018-08-23,54.65306091308594,65.81106567382812,66.02098846435547,65.59160614013672,65.71565246582031,5806654.0,"Morgan Stanley Maintains Overweight on Merck & Co, Raises Price Target to $74 | Eisai and Merck Announce European Commission Grants Marketing Authorization for LENVIMA",0.0010149561997999533,-0.0010144414800054755,0.12748059720850674,"[{'label': 'positive', 'score': 0.9992170333862305}, {'label': 'negative', 'score': 0.00055793795036152}, {'label': 'neutral', 'score': 0.00022504176013171673}]","(0.00022504176013171673, 0.9992170333862305, 0.00055793795036152)",0.9988838729386962,0.9992170333862305,0,0,"[{'label': 'positive', 'score': 0.8804547190666199}, {'label': 'negative', 'score': 0.06197415292263031}, {'label': 'neutral', 'score': 0.057571087032556534}]","(0.057571087032556534, 0.8804547190666199, 0.06197415292263031)",0.8684799356967552,0.8804547190666199,0,0,"[{'label': 'positive', 'score': 0.9988786578178406}, {'label': 'neutral', 'score': 0.0007315115653909743}, {'label': 'negative', 'score': 0.0003897745336871594}]","(0.0007315115653909743, 0.9988786578178406, 0.0003897745336871594)",0.9992198802222343,0.9988786578178406,0,0
2018-08-24,54.708534240722656,65.87786102294922,66.0782470703125,65.62023162841797,65.8396987915039,5194098.0,30 Stocks Moving In Friday's Pre-Market Session,-0.0002413891569597328,0.001014441480005355,0.1165462593138205,"[{'label': 'neutral', 'score': 0.9998162388801575}, {'label': 'negative', 'score': 0.00010488369298400357}, {'label': 'positive', 'score': 7.896022725617513e-05}]","(0.9998162388801575, 7.896022725617513e-05, 0.00010488369298400357)",-0.14100801208961014,-0.00010488369298400357,1,1,"[{'label': 'neutral', 'score': 0.7922160625457764}, {'label': 'negative', 'score': 0.1101740375161171}, {'label': 'positive', 'score': 0.09760987013578415}]","(0.7922160625457764, 0.09760987013578415, 0.1101740375161171)",-0.060467470856220486,-0.1101740375161171,1,1,"[{'label': 'neutral', 'score': 0.9968128800392151}, {'label': 'positive', 'score': 0.00285646365955472}, {'label': 'negative', 'score': 0.00033073037047870457}]","(0.9968128800392151, 0.00285646365955472, 0.00033073037047870457)",0.7924629831995286,0.00285646365955472,0,1
2018-08-25,54.69532775878906,65.86195882161458,66.135498046875,65.5438944498698,65.94784037272136,5238672.666666667,,-0.00024144743975344928,-0.00024141829601158108,0.09957676291547948,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-26,54.68212127685547,65.84605662027995,66.1927490234375,65.46755727132161,66.0559819539388,5283247.333333333,,-0.000241505750698857,-0.000241476592879214,0.017015947206749336,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-27,54.66891479492188,65.83015441894531,66.25,65.39122009277344,66.16412353515625,5327822.0,,-0.0052181783834715,-0.00024153491790874907,0.011579025834109254,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-08-28,54.38365173339844,65.48664093017578,65.71565246582031,65.24809265136719,65.69656372070312,6219251.0,,0.002622717049583123,-0.005231840625026576,0.03863400444192856,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-29,54.52626800537109,65.65839385986328,65.74427795410156,65.14312744140625,65.24809265136719,5753206.0,,-0.003923784597611637,0.0026192837289975043,0.04502644050019845,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-08-30,54.31232833862305,65.40076446533203,65.78244018554688,65.21946716308594,65.51526641845703,4972341.0,"Merck Announces FDA Aproval of DELSTRIGO | The Daily Biotech Pulse: Verastem Gets New CFO, Mesoblast Earnings, Vertex's Precision Medicine Collaboration",0.0007294502502213841,-0.003931502836816859,0.050155797222611,"[{'label': 'positive', 'score': 0.9098755121231079}, {'label': 'neutral', 'score': 0.08967442065477371}, {'label': 'negative', 'score': 0.0004501047369558364}]","(0.08967442065477371, 0.9098755121231079, 0.0004501047369558364)",0.999011112664261,0.9098755121231079,0,0,"[{'label': 'neutral', 'score': 0.7139445543289185}, {'label': 'positive', 'score': 0.27259451150894165}, {'label': 'negative', 'score': 0.0134609155356884}]","(0.7139445543289185, 0.27259451150894165, 0.0134609155356884)",0.9058859629075435,0.27259451150894165,0,1,"[{'label': 'positive', 'score': 0.7395692467689514}, {'label': 'neutral', 'score': 0.2597777247428894}, {'label': 'negative', 'score': 0.0006530177779495716}]","(0.2597777247428894, 0.7395692467689514, 0.0006530177779495716)",0.9982356170322726,0.7395692467689514,0,0
2018-08-31,54.3519401550293,65.44847106933594,65.60114288330078,65.03816986083984,65.21946716308594,6018978.0,"The Daily Biotech Pulse: FDA Blessings for Merck's HIV Drug Combo, Veracyte's Test Gets Medicare Coverage",-0.002332702528728343,0.0007291843306963861,0.05201387688219478,"[{'label': 'positive', 'score': 0.9664605855941772}, {'label': 'neutral', 'score': 0.03299757465720177}, {'label': 'negative', 'score': 0.0005418656510300934}]","(0.03299757465720177, 0.9664605855941772, 0.0005418656510300934)",0.9988792879473422,0.9664605855941772,0,0,"[{'label': 'neutral', 'score': 0.7786170244216919}, {'label': 'positive', 'score': 0.21214604377746582}, {'label': 'negative', 'score': 0.009236922487616539}]","(0.7786170244216919, 0.21214604377746582, 0.009236922487616539)",0.9165525456321123,0.21214604377746582,0,1,"[{'label': 'positive', 'score': 0.9215929508209229}, {'label': 'neutral', 'score': 0.0779951885342598}, {'label': 'negative', 'score': 0.00041184338624589145}]","(0.0779951885342598, 0.9215929508209229, 0.00041184338624589145)",0.9991066350439098,0.9215929508209229,0,0
2018-09-01,54.22515296936035,65.2957992553711,65.5200366973877,64.98330307006836,65.2242374420166,6025528.0,,-0.0023381567528983926,-0.0023354275178228447,0.05167753487544903,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-02,54.098365783691406,65.14312744140625,65.43893051147461,64.92843627929688,65.22900772094727,6032078.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",-0.0023436365425065935,-0.00234089450976798,0.04218776548270697,"[{'label': 'neutral', 'score': 0.9998811483383179}, {'label': 'negative', 'score': 6.475794361904263e-05}, {'label': 'positive', 'score': 5.413567487266846e-05}]","(0.9998811483383179, 5.413567487266846e-05, 6.475794361904263e-05)",-0.08934263151486745,-6.475794361904263e-05,1,1,"[{'label': 'neutral', 'score': 0.9455358982086182}, {'label': 'negative', 'score': 0.028489142656326294}, {'label': 'positive', 'score': 0.02597500942647457}]","(0.9455358982086182, 0.02597500942647457, 0.028489142656326294)",-0.046161247971501174,-0.028489142656326294,1,1,"[{'label': 'neutral', 'score': 0.9994373917579651}, {'label': 'positive', 'score': 0.000404135265853256}, {'label': 'negative', 'score': 0.00015851118951104581}]","(0.9994373917579651, 0.000404135265853256, 0.00015851118951104581)",0.4365513618728367,0.000404135265853256,1,1
2018-09-03,53.97157859802246,64.9904556274414,65.35782432556152,64.87356948852539,65.23377799987793,6038628.0,,-0.0023491420777234863,-0.002346387157095898,0.02693727598159375,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-04,53.84479141235352,64.83778381347656,65.27671813964844,64.8187026977539,65.2385482788086,6045178.0,"Benzinga Pro's 5 Stocks To Watch Today | FDA Grants Priority Review to Merck's Supplemental Biologics License Application for KEYTRUDA, Application Based on Data from Phase 2 KEYNOTE-017 Trial",0.00986018809618449,-0.0023519056408240827,0.021815203805256794,"[{'label': 'positive', 'score': 0.9889203906059265}, {'label': 'neutral', 'score': 0.010693508200347424}, {'label': 'negative', 'score': 0.000386075465939939}]","(0.010693508200347424, 0.9889203906059265, 0.000386075465939939)",0.9992195027947752,0.9889203906059265,1,1,"[{'label': 'positive', 'score': 0.769435465335846}, {'label': 'neutral', 'score': 0.21721775829792023}, {'label': 'negative', 'score': 0.013346774503588676}]","(0.21721775829792023, 0.769435465335846, 0.013346774503588676)",0.965899138165612,0.769435465335846,1,1,"[{'label': 'neutral', 'score': 0.8773577809333801}, {'label': 'positive', 'score': 0.12215295433998108}, {'label': 'negative', 'score': 0.0004892192082479596}]","(0.8773577809333801, 0.12215295433998108, 0.0004892192082479596)",0.9920220068823947,0.12215295433998108,1,0
2018-09-05,54.37570571899414,65.47709655761719,65.54389190673828,64.79962158203125,64.83778381347656,6664337.0,"The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results | Ebola-Related Stocks Unaffected Amid Earlier Report Officials In Congo Announced The First Ebola Case In A Major Eastern City, Butembo | Eisai And Merck Announce China National Medical Products Administration (NMPA) Approval Of LENVIMA For Treatment Of Unresectable Hepatocellular Carcinoma (HCC) | Eisai, Merck Announce China NMPA Approval of First Approval for LENVIMA for Treatment of Unresectable HCC",0.01107558026402045,0.009811893643639553,0.08629588057953057,"[{'label': 'positive', 'score': 0.9985277652740479}, {'label': 'neutral', 'score': 0.0007996609783731401}, {'label': 'negative', 'score': 0.0006725557032041252}]","(0.0007996609783731401, 0.9985277652740479, 0.0006725557032041252)",0.9986538120753478,0.9985277652740479,0,0,"[{'label': 'positive', 'score': 0.8142762780189514}, {'label': 'negative', 'score': 0.1343132108449936}, {'label': 'neutral', 'score': 0.051410529762506485}]","(0.051410529762506485, 0.8142762780189514, 0.1343132108449936)",0.7168148868993889,0.8142762780189514,0,0,"[{'label': 'positive', 'score': 0.9887951612472534}, {'label': 'neutral', 'score': 0.010399024933576584}, {'label': 'negative', 'score': 0.0008057659724727273}]","(0.010399024933576584, 0.9887951612472534, 0.0008057659724727273)",0.9983715335135416,0.9887951612472534,0,0
2018-09-06,54.97795486450195,66.2022933959961,66.35496520996094,65.66793823242188,65.81106567382812,10099995.0,,0.0041798875152741066,0.01101469517092529,0.1111484983389344,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-07,55.20775604248047,66.47901153564453,66.58396911621094,65.69656372070312,65.99236297607422,9971930.0,"Health Care Has Been On Fire. Will The Uptrend Continue? | Barclays Maintains Overweight on Merck & Co, Raises Price Target to $75",-0.0005263075143882444,0.004171176052307253,0.1015282306390371,"[{'label': 'positive', 'score': 0.8737061023712158}, {'label': 'negative', 'score': 0.12523099780082703}, {'label': 'neutral', 'score': 0.0010629250900819898}]","(0.0010629250900819898, 0.8737061023712158, 0.12523099780082703)",0.7492715051242785,0.8737061023712158,0,0,"[{'label': 'positive', 'score': 0.6535829305648804}, {'label': 'negative', 'score': 0.2710372507572174}, {'label': 'neutral', 'score': 0.07537978142499924}]","(0.07537978142499924, 0.6535829305648804, 0.2710372507572174)",0.41373278188744245,0.6535829305648804,1,0,"[{'label': 'positive', 'score': 0.9970297813415527}, {'label': 'neutral', 'score': 0.0023201697040349245}, {'label': 'negative', 'score': 0.0006500228773802519}]","(0.0023201697040349245, 0.9970297813415527, 0.0006500228773802519)",0.998696930869741,0.9970297813415527,0,0
2018-09-08,55.178704579671226,66.44402313232422,66.8416035970052,65.91284942626953,66.25953928629558,9186873.0,,-0.000526584659851686,-0.0005264460628029003,0.09489928781930904,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-09,55.14965311686198,66.4090347290039,67.09923807779948,66.12913513183594,66.52671559651692,8401816.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs",-0.0005268620973500077,-0.0005267233542453627,0.08726696811049173,"[{'label': 'neutral', 'score': 0.999872088432312}, {'label': 'negative', 'score': 6.540882168337703e-05}, {'label': 'positive', 'score': 6.240251968847588e-05}]","(0.999872088432312, 6.240251968847588e-05, 6.540882168337703e-05)",-0.023521402425115377,-6.540882168337703e-05,1,1,"[{'label': 'neutral', 'score': 0.9396828413009644}, {'label': 'positive', 'score': 0.03797700256109238}, {'label': 'negative', 'score': 0.022340185940265656}]","(0.9396828413009644, 0.03797700256109238, 0.022340185940265656)",0.259243128026013,0.03797700256109238,1,1,"[{'label': 'neutral', 'score': 0.9995262622833252}, {'label': 'positive', 'score': 0.0003365268057677895}, {'label': 'negative', 'score': 0.00013728041085414588}]","(0.9995262622833252, 0.0003365268057677895, 0.00013728041085414588)",0.42052207717348494,0.0003365268057677895,1,1
2018-09-10,55.120601654052734,66.3740463256836,67.35687255859375,66.34542083740234,66.79389190673828,7616759.0,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street | Merck's KEYTRUDA in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC Approved by the European Commission | European Commission Approves Merck's KEYTRUDA in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Patients with Metastatic Nonsquamous NSCLC,-0.006900520116660435,-0.0005270009379534997,0.08037092337515475,"[{'label': 'positive', 'score': 0.9993076324462891}, {'label': 'neutral', 'score': 0.00048145613982342184}, {'label': 'negative', 'score': 0.00021091259259264916}]","(0.00048145613982342184, 0.9993076324462891, 0.00021091259259264916)",0.9995779716271609,0.9993076324462891,0,0,"[{'label': 'positive', 'score': 0.907124936580658}, {'label': 'neutral', 'score': 0.0678982213139534}, {'label': 'negative', 'score': 0.02497682347893715}]","(0.0678982213139534, 0.907124936580658, 0.02497682347893715)",0.9464075178286537,0.907124936580658,0,0,"[{'label': 'positive', 'score': 0.9982854723930359}, {'label': 'neutral', 'score': 0.0013639623066410422}, {'label': 'negative', 'score': 0.00035056998603977263}]","(0.0013639623066410422, 0.9982854723930359, 0.00035056998603977263)",0.9992979023965436,0.9982854723930359,0,0
2018-09-11,54.740234375,65.91603088378906,66.6030502319336,65.90648651123047,66.6030502319336,6094644.0,"The Daily Biotech Pulse: Advaxis Posts Narrower Loss, Endocyte Announces $175M Offering, Leadership Transition At Insulet | A Peek Into The Markets: US Stock Futures Down Ahead Of Job Openings, Wholesale Inventories Data | IMV Inc. Announces Phase 2 Basket Trial With Merck To Evaluate DPX-Survivac In Combination With KEYTRUDA Across Five Solid Tumor Indications | Merck's ZERBAXA Met Primary Endpoints of Non-Inferiority Compared to Meropenem in Pivotal Phase 3 Study, Co. To Submit Supplemental New Drug App. In U.S. And EU",0.011291188421511465,-0.006924438803361514,0.06271091014338627,"[{'label': 'negative', 'score': 0.9972134232521057}, {'label': 'neutral', 'score': 0.0016808095388114452}, {'label': 'positive', 'score': 0.0011057810625061393}]","(0.0016808095388114452, 0.0011057810625061393, 0.9972134232521057)",-0.9977847144325641,-0.9972134232521057,0,0,"[{'label': 'positive', 'score': 0.5172155499458313}, {'label': 'negative', 'score': 0.423929899930954}, {'label': 'neutral', 'score': 0.058854520320892334}]","(0.058854520320892334, 0.5172155499458313, 0.423929899930954)",0.09911927006297515,0.5172155499458313,0,1,"[{'label': 'positive', 'score': 0.7735520005226135}, {'label': 'neutral', 'score': 0.12816858291625977}, {'label': 'negative', 'score': 0.09827940911054611}]","(0.12816858291625977, 0.7735520005226135, 0.09827940911054611)",0.7745449222759728,0.7735520005226135,1,1
2018-09-12,55.358306884765625,66.6603012084961,66.81298065185547,65.9542007446289,66.22137451171875,6382320.0,FDA Grants Priority Review to Merck's Application for KEYTRUDA Monotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Patients Whose Tumors Express PD-L1,0.01388495460668108,0.011227918767798271,0.10450775893129732,"[{'label': 'positive', 'score': 0.9985264539718628}, {'label': 'neutral', 'score': 0.0012089097872376442}, {'label': 'negative', 'score': 0.00026463778340257704}]","(0.0012089097872376442, 0.9985264539718628, 0.00026463778340257704)",0.9994700838131475,0.9985264539718628,0,0,"[{'label': 'positive', 'score': 0.8433617949485779}, {'label': 'neutral', 'score': 0.1446552574634552}, {'label': 'negative', 'score': 0.0119829922914505}]","(0.1446552574634552, 0.8433617949485779, 0.0119829922914505)",0.9719809076521845,0.8433617949485779,0,0,"[{'label': 'positive', 'score': 0.7043332457542419}, {'label': 'neutral', 'score': 0.29459434747695923}, {'label': 'negative', 'score': 0.0010724328458309174}]","(0.29459434747695923, 0.7043332457542419, 0.0010724328458309174)",0.9969593869786837,0.7043332457542419,0,0
2018-09-13,56.12696838378906,67.58587646484375,67.69084167480469,66.39312744140625,66.94656372070312,10750594.0,"Stocks That Will Be Trading Ex Dividend For Fri., Sep. 14, 2018",-0.012000520171548242,0.013789441736876068,0.1389928599996741,"[{'label': 'neutral', 'score': 0.9998747110366821}, {'label': 'negative', 'score': 7.614462083438411e-05}, {'label': 'positive', 'score': 4.9128349928651005e-05}]","(0.9998747110366821, 4.9128349928651005e-05, 7.614462083438411e-05)",-0.21565921795561765,-7.614462083438411e-05,1,1,"[{'label': 'neutral', 'score': 0.9455587863922119}, {'label': 'negative', 'score': 0.032886210829019547}, {'label': 'positive', 'score': 0.02155500464141369}]","(0.9455587863922119, 0.02155500464141369, 0.032886210829019547)",-0.20813653937906257,-0.032886210829019547,1,1,"[{'label': 'neutral', 'score': 0.9988909363746643}, {'label': 'positive', 'score': 0.000961475889198482}, {'label': 'negative', 'score': 0.00014763859508093446}]","(0.9988909363746643, 0.000961475889198482, 0.00014763859508093446)",0.733772126911039,0.000961475889198482,0,1
2018-09-14,55.83176803588867,66.77481079101562,67.5,66.46946716308594,67.5,7792928.0,"Stocks Which Set New 52-Week High Yesterday, September 13th | The Daily Biotech Pulse: FDA Nod For STAAR, Supernus Opens Wallet, Principia Biopharma To Debut",0.0020958281328003945,-0.012073107723829178,0.17822028267560727,"[{'label': 'positive', 'score': 0.99720299243927}, {'label': 'neutral', 'score': 0.002417696639895439}, {'label': 'negative', 'score': 0.0003793412761297077}]","(0.002417696639895439, 0.99720299243927, 0.0003793412761297077)",0.9992394787611828,0.99720299243927,0,0,"[{'label': 'positive', 'score': 0.5278922915458679}, {'label': 'neutral', 'score': 0.459421306848526}, {'label': 'negative', 'score': 0.012686388567090034}]","(0.459421306848526, 0.5278922915458679, 0.012686388567090034)",0.953063674044862,0.5278922915458679,0,0,"[{'label': 'positive', 'score': 0.9938620328903198}, {'label': 'neutral', 'score': 0.0057655200362205505}, {'label': 'negative', 'score': 0.0003724265843629837}]","(0.0057655200362205505, 0.9938620328903198, 0.0003724265843629837)",0.9992508274465567,0.9938620328903198,0,0
2018-09-15,55.94878005981445,66.91475931803386,67.41094207763672,66.4662857055664,67.21692148844402,7534875.333333333,,0.002091444823900052,0.0020936349488423337,0.17768466898350874,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-16,56.06579208374024,67.05470784505208,67.32188415527344,66.46310424804688,66.93384297688802,7276822.666666667,"The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs",0.002087079811631162,0.0020892607978241695,0.16111946463921115,"[{'label': 'neutral', 'score': 0.9998761415481567}, {'label': 'negative', 'score': 6.678509089397267e-05}, {'label': 'positive', 'score': 5.7067743910010904e-05}]","(0.9998761415481567, 5.7067743910010904e-05, 6.678509089397267e-05)",-0.07845881767131918,-6.678509089397267e-05,1,1,"[{'label': 'neutral', 'score': 0.9447024464607239}, {'label': 'negative', 'score': 0.03270935267210007}, {'label': 'positive', 'score': 0.02258821204304695}]","(0.9447024464607239, 0.02258821204304695, 0.03270935267210007)",-0.1830304947639177,-0.03270935267210007,1,1,"[{'label': 'neutral', 'score': 0.9995229244232178}, {'label': 'positive', 'score': 0.00033964720205403864}, {'label': 'negative', 'score': 0.00013743570889346302}]","(0.9995229244232178, 0.00033964720205403864, 0.00013743570889346302)",0.4238497932340046,0.00033964720205403864,1,1
2018-09-17,56.182804107666016,67.19465637207031,67.23282623291016,66.45992279052734,66.65076446533203,7018770.0,Accenture and Merck Collaborate with Amazon Web Services to Launch a Research Platform to Drive Innovation in Drug Discovery and Scientific Research,0.0,0.002084904886197436,0.1455473579868766,"[{'label': 'positive', 'score': 0.9090374112129211}, {'label': 'neutral', 'score': 0.09039545059204102}, {'label': 'negative', 'score': 0.0005671371472999454}]","(0.09039545059204102, 0.9090374112129211, 0.0005671371472999454)",0.998753002833325,0.9090374112129211,0,0,"[{'label': 'positive', 'score': 0.7696605920791626}, {'label': 'neutral', 'score': 0.2230105996131897}, {'label': 'negative', 'score': 0.007328770123422146}]","(0.2230105996131897, 0.7696605920791626, 0.007328770123422146)",0.981135468566399,0.7696605920791626,0,0,"[{'label': 'positive', 'score': 0.9869290590286255}, {'label': 'neutral', 'score': 0.012838364578783512}, {'label': 'negative', 'score': 0.00023254769621416926}]","(0.012838364578783512, 0.9869290590286255, 0.00023254769621416926)",0.9995288558739926,0.9869290590286255,0,0
2018-09-18,56.182804107666016,67.19465637207031,67.65267181396484,66.69847106933594,67.18511199951172,7126819.0,,-0.006248198945016077,0.0,0.09789397212643647,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-19,55.83176803588867,66.77481079101562,67.33778381347656,66.45037841796875,66.93701934814453,8325522.0,,0.011431841749627641,-0.006267800632863971,0.057445362577878564,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-09-20,56.47003173828125,67.53816986083984,67.58587646484375,66.84160614013672,67.12786102294922,6435454.0,"Merck Reports Received Positive CHMP Opinion For ELSTRIGO, PIFELTRO In EU For Treatment Of HIV-1 Infection | Merck Or Pfizer: Which Is The Better Large-Cap Pharma Stock?",0.004521052740381297,0.011366992013363785,0.10040128676652155,"[{'label': 'positive', 'score': 0.9992262125015259}, {'label': 'neutral', 'score': 0.0004458458861336112}, {'label': 'negative', 'score': 0.00032796498271636665}]","(0.0004458458861336112, 0.9992262125015259, 0.00032796498271636665)",0.9993437774757906,0.9992262125015259,0,0,"[{'label': 'positive', 'score': 0.6092402935028076}, {'label': 'neutral', 'score': 0.3810936212539673}, {'label': 'negative', 'score': 0.009666051715612411}]","(0.3810936212539673, 0.6092402935028076, 0.009666051715612411)",0.9687640891379095,0.6092402935028076,0,0,"[{'label': 'positive', 'score': 0.9984121322631836}, {'label': 'neutral', 'score': 0.0013007159577682614}, {'label': 'negative', 'score': 0.00028711967752315104}]","(0.0013007159577682614, 0.9984121322631836, 0.00028711967752315104)",0.99942501273138,0.9984121322631836,0,0
2018-09-21,56.72532653808594,67.84351348876953,68.30152893066406,67.66221618652344,67.66221618652344,17850689.0,"Democratic Republic Of Congo Confirms Ebola Case In Ituri Province Almost 200 KM Away From Closest Other Case And 50 KM From The Ugandan Border | The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping, Opiant Snags BARDA Funding | XOMA Reports Purchase Of Royalty Interest Position From Agenus On 7 Assets Being Developed By Merck, Incyte For $15M",-0.0015002349388455454,0.004510863480685113,0.10221325938275916,"[{'label': 'negative', 'score': 0.9932461977005005}, {'label': 'neutral', 'score': 0.005115668289363384}, {'label': 'positive', 'score': 0.001638139714486897}]","(0.005115668289363384, 0.001638139714486897, 0.9932461977005005)",-0.9967068740498151,-0.9932461977005005,0,0,"[{'label': 'positive', 'score': 0.678763210773468}, {'label': 'neutral', 'score': 0.30648142099380493}, {'label': 'negative', 'score': 0.014755364507436752}]","(0.30648142099380493, 0.678763210773468, 0.014755364507436752)",0.9574478174533099,0.678763210773468,0,0,"[{'label': 'neutral', 'score': 0.8696473836898804}, {'label': 'positive', 'score': 0.12626446783542633}, {'label': 'negative', 'score': 0.004088112153112888}]","(0.8696473836898804, 0.12626446783542633, 0.004088112153112888)",0.9372760837802777,0.12626446783542633,0,1
2018-09-22,56.640228271484375,67.74173227945964,68.21246846516927,67.57315572102864,67.66539510091145,14149746.666666668,,-0.0015024890253768574,-0.0015013614180780475,0.10588000011501456,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-23,56.55513000488281,67.63995107014973,68.12340799967448,67.48409525553386,67.66857401529948,10448804.333333334,,-0.0015047498955806946,-0.0015036188938977368,0.10785068546259317,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-24,56.47003173828125,67.53816986083984,68.03434753417969,67.39503479003906,67.6717529296875,6747862.0,"Stocks Which Set New 52-Week High Friday, September 21 | OpGen Reports Partnership With New York State Dept. Of Health, Merck's ILUM Health Solutions To Detect Antimicrobial-Resistant Infections",-0.0018366847360416648,-0.0015058831687092377,0.09067156182232096,"[{'label': 'positive', 'score': 0.9989261031150818}, {'label': 'neutral', 'score': 0.0007928897393867373}, {'label': 'negative', 'score': 0.0002809305442497134}]","(0.0007928897393867373, 0.9989261031150818, 0.0002809305442497134)",0.9994376930209931,0.9989261031150818,0,0,"[{'label': 'positive', 'score': 0.9306206703186035}, {'label': 'neutral', 'score': 0.05412415415048599}, {'label': 'negative', 'score': 0.015255213715136051}]","(0.05412415415048599, 0.9306206703186035, 0.015255213715136051)",0.9677437304985949,0.9306206703186035,0,0,"[{'label': 'positive', 'score': 0.9900578856468201}, {'label': 'neutral', 'score': 0.009555705823004246}, {'label': 'negative', 'score': 0.00038639275589957833}]","(0.009555705823004246, 0.9900578856468201, 0.00038639275589957833)",0.999219758719748,0.9900578856468201,0,0
2018-09-25,56.366310119628906,67.41412353515625,68.11068725585938,67.29007720947266,67.60496520996094,6770499.0,,-0.0045293717683721245,-0.001838373509598058,0.04335384704540429,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-26,56.11101150512695,67.10877990722656,67.89122009277344,66.96565246582031,67.6812973022461,7260963.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates | Merck Board Rescinds Mandatory CEO Retirement Policy; Current CEO Kenneth Frazier To Continue In Role Beyond December 2019,0.005545309832263956,-0.004539660451950214,0.0210855607219317,"[{'label': 'neutral', 'score': 0.9998723268508911}, {'label': 'negative', 'score': 6.983962521189824e-05}, {'label': 'positive', 'score': 5.778858394478448e-05}]","(0.9998723268508911, 5.778858394478448e-05, 6.983962521189824e-05)",-0.0944230225178456,-6.983962521189824e-05,0,0,"[{'label': 'neutral', 'score': 0.7939868569374084}, {'label': 'negative', 'score': 0.18788409233093262}, {'label': 'positive', 'score': 0.018129071220755577}]","(0.7939868569374084, 0.018129071220755577, 0.18788409233093262)",-0.8240008462740097,-0.18788409233093262,0,0,"[{'label': 'neutral', 'score': 0.999169111251831}, {'label': 'positive', 'score': 0.000462880328996107}, {'label': 'negative', 'score': 0.0003680388617794961}]","(0.999169111251831, 0.000462880328996107, 0.0003680388617794961)",0.11414042216076782,0.000462880328996107,0,0
2018-09-27,56.42215347290039,67.48091888427734,67.91984558105469,66.87023162841797,67.10877990722656,6315458.0,,0.0031108466511450324,0.005529991206620418,0.05946129586780456,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-28,56.59768295288086,67.69084167480469,67.93893432617188,67.41412353515625,67.48091888427734,7135622.0,,0.002772275680293239,0.0031060179792817173,0.06466345904005061,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-29,56.75458653767904,67.87849934895833,68.1583989461263,67.40140024820964,67.59224192301433,7421970.666666667,,0.0027646114153013477,0.002768440011455133,0.06488557008431499,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-09-30,56.91149012247721,68.06615702311198,68.37786356608073,67.38867696126302,67.7035649617513,7708319.333333333,,0.0027569894109038887,0.0027607969059691723,0.060235624663061586,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-10-01,57.06839370727539,68.25381469726562,68.59732818603516,67.3759536743164,67.81488800048828,7994668.0,,0.0030756198969748376,0.0027531958864694984,0.01919398326499705,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-10-02,57.2439079284668,68.46373748779297,68.864501953125,67.83396911621094,68.67366027832031,10894589.0,"Stocks Which Set New 52-Week High Yesterday, October 1st | The Daily Biotech Pulse: TransEnterix's Positive Pre-Announcement, Merit Medical Opens Wallet, GW Pharma To Offer ADS Shares",-0.005296155567855725,0.0030708998536624487,0.00285693374456783,"[{'label': 'positive', 'score': 0.9983136653900146}, {'label': 'neutral', 'score': 0.0013752776430919766}, {'label': 'negative', 'score': 0.00031105693778954446}]","(0.0013752776430919766, 0.9983136653900146, 0.00031105693778954446)",0.9993770293668187,0.9983136653900146,0,0,"[{'label': 'neutral', 'score': 0.5389356017112732}, {'label': 'positive', 'score': 0.4510144591331482}, {'label': 'negative', 'score': 0.010049992240965366}]","(0.5389356017112732, 0.4510144591331482, 0.010049992240965366)",0.9564052608653159,0.4510144591331482,0,0,"[{'label': 'positive', 'score': 0.9980480670928955}, {'label': 'neutral', 'score': 0.0016264027217403054}, {'label': 'negative', 'score': 0.0003255446790717542}]","(0.0016264027217403054, 0.9980480670928955, 0.0003255446790717542)",0.9993478499927618,0.9980480670928955,0,0
2018-10-03,56.94072723388672,68.10114288330078,69.1030502319336,68.08206176757812,68.78816986083984,10037325.0,"Stocks Which Set New 52-Week High Yesterday, October 2nd | The Daily Biotech Pulse: Endologix's Q3 Sales, Obseva's Positive Trial Results, Kala To Offer Shares",-0.002101689271962961,-0.005310229915037378,0.05788837789594651,"[{'label': 'positive', 'score': 0.9991238713264465}, {'label': 'neutral', 'score': 0.0005540992715395987}, {'label': 'negative', 'score': 0.0003220760263502598}]","(0.0005540992715395987, 0.9991238713264465, 0.0003220760263502598)",0.9993554908553017,0.9991238713264465,0,0,"[{'label': 'neutral', 'score': 0.5146675705909729}, {'label': 'positive', 'score': 0.47388359904289246}, {'label': 'negative', 'score': 0.011448807083070278}]","(0.5146675705909729, 0.47388359904289246, 0.011448807083070278)",0.9528207597985993,0.47388359904289246,0,1,"[{'label': 'positive', 'score': 0.9977254271507263}, {'label': 'neutral', 'score': 0.001952695893123746}, {'label': 'negative', 'score': 0.0003219102800358087}]","(0.001952695893123746, 0.9977254271507263, 0.0003219102800358087)",0.9993549198159989,0.9977254271507263,0,0
2018-10-04,56.82107162475586,67.95801544189453,68.09160614013672,67.23282623291016,67.86259460449219,10837054.0,"Stocks Which Set New 52-Week High Yesterday, October 3rd | The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut | A Peek Into The Markets: US Stock Futures Drop Ahead Of Jobless Claims, Factory Orders Data | Merck Reports DELSTRIGO Phase 3 DRIVE-SHIFT Trial Met Primary Efficacy Endpoint",-0.002667783940823089,-0.0021039009202024994,0.059916183009841605,"[{'label': 'negative', 'score': 0.9957801103591919}, {'label': 'neutral', 'score': 0.0021870566997677088}, {'label': 'positive', 'score': 0.0020328375976532698}]","(0.0021870566997677088, 0.0020328375976532698, 0.9957801103591919)",-0.9959254134719022,-0.9957801103591919,0,0,"[{'label': 'negative', 'score': 0.8544168472290039}, {'label': 'positive', 'score': 0.11187545955181122}, {'label': 'neutral', 'score': 0.03370772302150726}]","(0.03370772302150726, 0.11187545955181122, 0.8544168472290039)",-0.7684438574813407,-0.8544168472290039,0,0,"[{'label': 'positive', 'score': 0.9806305766105652}, {'label': 'neutral', 'score': 0.012957043945789337}, {'label': 'negative', 'score': 0.006412427872419357}]","(0.012957043945789337, 0.9806305766105652, 0.006412427872419357)",0.9870067913083925,0.9806305766105652,0,0
2018-10-05,56.669471740722656,67.77671813964844,68.40648651123047,67.34732818603516,67.96755981445312,7790308.0,REMINDER: Merck Has FDA PDUFA Date Tomorrow October 6th For GARDASIL sBLA,0.002017906343840745,-0.0026713488180268837,0.05786017505146989,"[{'label': 'neutral', 'score': 0.9998728036880493}, {'label': 'negative', 'score': 6.946302892174572e-05}, {'label': 'positive', 'score': 5.77383216295857e-05}]","(0.9998728036880493, 5.77383216295857e-05, 6.946302892174572e-05)",-0.09217439312822844,-6.946302892174572e-05,1,1,"[{'label': 'neutral', 'score': 0.9052629470825195}, {'label': 'positive', 'score': 0.08288007229566574}, {'label': 'negative', 'score': 0.011856959201395512}]","(0.9052629470825195, 0.08288007229566574, 0.011856959201395512)",0.7496869172692345,0.08288007229566574,0,1,"[{'label': 'neutral', 'score': 0.999329686164856}, {'label': 'positive', 'score': 0.000402697769459337}, {'label': 'negative', 'score': 0.00026763754431158304}]","(0.999329686164856, 0.000402697769459337, 0.00026763754431158304)",0.20148159044162986,0.000402697769459337,1,1
2018-10-06,56.78382873535156,67.91348520914714,68.40966796875,67.44592793782552,67.87213897705078,8286815.333333333,,0.0020138425980863596,0.002015873105631271,0.05513838517889081,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-10-07,56.89818572998047,68.05025227864583,68.41284942626953,67.54452768961589,67.77671813964844,8783322.666666666,,0.0020097951869257093,0.002011817535397419,0.05053284864465932,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-10-08,57.012542724609375,68.18701934814453,68.41603088378906,67.64312744140625,67.6812973022461,9279830.0,,0.012314642867972138,0.002007778250546321,0.0383848101550657,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-10-09,57.71464157104492,69.02671813964844,69.33206176757812,67.71946716308594,68.18701934814453,8249122.0,,-0.026126640928347926,0.01223943446705082,0.08708871534274817,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-10-10,56.20673751831055,67.22328186035156,69.55152893066406,67.16603088378906,69.1603012084961,13259191.0,"Stocks That Made New 52-Week Highs So Far Today Include: NextEra Energy, WEC Energy, Verizon, CMS Energy, Ameren, FirstEnergy, McCormick, AES, Merck, Public Service Enterprise, Express Scripts, and Public Service Enterprise | Stocks Which Set New 52-Week High Yesterday, October 9th | The Daily Biotech Pulse: Novartis Blood Disorder Drug Improves Patient Outcomes, Audentes To Offer Shares",-0.029524496969160454,-0.02647400528013846,0.2313234986898947,"[{'label': 'positive', 'score': 0.9993168115615845}, {'label': 'neutral', 'score': 0.00045959933777339756}, {'label': 'negative', 'score': 0.0002236107102362439}]","(0.00045959933777339756, 0.9993168115615845, 0.0002236107102362439)",0.9995525729520213,0.9993168115615845,0,0,"[{'label': 'positive', 'score': 0.8300737142562866}, {'label': 'neutral', 'score': 0.15797655284404755}, {'label': 'negative', 'score': 0.011949732899665833}]","(0.15797655284404755, 0.8300737142562866, 0.011949732899665833)",0.9716166267340235,0.8300737142562866,0,0,"[{'label': 'positive', 'score': 0.9200981855392456}, {'label': 'neutral', 'score': 0.07912659645080566}, {'label': 'negative', 'score': 0.0007752297096885741}]","(0.07912659645080566, 0.9200981855392456, 0.0007752297096885741)",0.9983163164516395,0.9200981855392456,0,0
2018-10-11,54.54726028442383,65.2385482788086,67.29962158203125,64.71373748779297,67.1469497680664,13491952.0,"Credit Suisse Maintains Outperform on Merck & Co, Raises Price Target to $81 | Stocks Which Set New 52-Week High Yesterday, October 10th | The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr's Gene-Edited Therapy, Endra To Offer Shares",0.021061877707814116,-0.029969118287896414,0.30056433206833916,"[{'label': 'positive', 'score': 0.9994753003120422}, {'label': 'negative', 'score': 0.0003095002903137356}, {'label': 'neutral', 'score': 0.00021517809364013374}]","(0.00021517809364013374, 0.9994753003120422, 0.0003095002903137356)",0.9993808661821478,0.9994753003120422,0,0,"[{'label': 'positive', 'score': 0.8921402096748352}, {'label': 'neutral', 'score': 0.0775594636797905}, {'label': 'negative', 'score': 0.030300375074148178}]","(0.0775594636797905, 0.8921402096748352, 0.030300375074148178)",0.9343038986464508,0.8921402096748352,0,0,"[{'label': 'positive', 'score': 0.9989305138587952}, {'label': 'neutral', 'score': 0.0007025400991551578}, {'label': 'negative', 'score': 0.0003669758443720639}]","(0.0007025400991551578, 0.9989305138587952, 0.0003669758443720639)",0.9992655323401621,0.9989305138587952,0,0
2018-10-12,55.69614410400391,66.61259460449219,66.85114288330078,65.28626251220703,65.55343627929688,10648938.0,"Barclays Maintains Overweight on Merck & Co, Raises Price Target to $78 | The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",-0.0016712010603693937,0.02084314234887584,0.3633931419223286,"[{'label': 'negative', 'score': 0.9802621603012085}, {'label': 'positive', 'score': 0.018437154591083527}, {'label': 'neutral', 'score': 0.001300673233345151}]","(0.001300673233345151, 0.018437154591083527, 0.9802621603012085)",-0.9630776664884927,-0.9802621603012085,0,0,"[{'label': 'negative', 'score': 0.638393759727478}, {'label': 'neutral', 'score': 0.3079022467136383}, {'label': 'positive', 'score': 0.05370396748185158}]","(0.3079022467136383, 0.05370396748185158, 0.638393759727478)",-0.8448081380113868,-0.638393759727478,0,0,"[{'label': 'positive', 'score': 0.9922267198562622}, {'label': 'neutral', 'score': 0.006363432388752699}, {'label': 'negative', 'score': 0.0014099155087023973}]","(0.006363432388752699, 0.9922267198562622, 0.0014099155087023973)",0.9971621104566368,0.9922267198562622,0,0
2018-10-13,55.60306167602539,66.5012715657552,66.8988545735677,65.44847615559895,65.70928700764973,9398219.666666666,,-0.0016739986486859213,-0.0016725990746539478,0.36031349833210763,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-10-14,55.50997924804688,66.38994852701823,66.94656626383464,65.61068979899089,65.86513773600261,8147501.333333334,4 Major Market Opportunities For The Cannabis Industry,-0.0016768056190264943,-0.0016754013500558291,0.3306771912266263,"[{'label': 'neutral', 'score': 0.9969738721847534}, {'label': 'positive', 'score': 0.0029066309798508883}, {'label': 'negative', 'score': 0.00011941377306357026}]","(0.9969738721847534, 0.0029066309798508883, 0.00011941377306357026)",0.921076003288742,0.0029066309798508883,0,1,"[{'label': 'neutral', 'score': 0.7464199662208557}, {'label': 'positive', 'score': 0.24554362893104553}, {'label': 'negative', 'score': 0.00803644210100174}]","(0.7464199662208557, 0.24554362893104553, 0.00803644210100174)",0.9366161381034861,0.24554362893104553,0,1,"[{'label': 'neutral', 'score': 0.9983953833580017}, {'label': 'positive', 'score': 0.0015028974739834666}, {'label': 'negative', 'score': 0.00010173648479394615}]","(0.9983953833580017, 0.0015028974739834666, 0.00010173648479394615)",0.8731966449576323,0.0015028974739834666,0,1
2018-10-15,55.41689682006836,66.27862548828125,66.99427795410156,65.77290344238281,66.02098846435547,6896783.0,OncoSec Initiates KEYNOTE-890 Phase 2 Clinical Trial Of TAVO In Combination With Merck's KEYTRUDA For Treatment Of Late-Stage Triple Negative Breast Cancer,0.025338334059299628,-0.0016782130310928477,0.28628616440773097,"[{'label': 'neutral', 'score': 0.9998759031295776}, {'label': 'positive', 'score': 6.70623267069459e-05}, {'label': 'negative', 'score': 5.701093323295936e-05}]","(0.9998759031295776, 6.70623267069459e-05, 5.701093323295936e-05)",0.08101176255749963,6.70623267069459e-05,1,1,"[{'label': 'positive', 'score': 0.6463378071784973}, {'label': 'neutral', 'score': 0.34380361437797546}, {'label': 'negative', 'score': 0.009858548641204834}]","(0.34380361437797546, 0.6463378071784973, 0.009858548641204834)",0.9699524431863392,0.6463378071784973,0,0,"[{'label': 'neutral', 'score': 0.9912956953048706}, {'label': 'positive', 'score': 0.008525311015546322}, {'label': 'negative', 'score': 0.0001789843663573265}]","(0.9912956953048706, 0.008525311015546322, 0.0001789843663573265)",0.9588744732331953,0.008525311015546322,0,1
2018-10-16,56.82107162475586,67.95801544189453,68.04389190673828,66.55534362792969,66.65076446533203,10719992.0,"Citigroup Maintains Buy on Merck & Co, Raises Price Target to $79 | U.S. FDA Grants Merck And AstraZeneca's LYNPARZA Orphan Drug Designation For Pancreatic Cancer | AstraZeneca, Merck Receive FDA Orphan Drug for Lynparza in Pancreatic Cancer",0.008424574957004816,0.02502264013436293,0.21524685055149895,"[{'label': 'positive', 'score': 0.999565064907074}, {'label': 'negative', 'score': 0.0002342860389035195}, {'label': 'neutral', 'score': 0.00020069572201464325}]","(0.00020069572201464325, 0.999565064907074, 0.0002342860389035195)",0.9995313338847803,0.999565064907074,0,0,"[{'label': 'positive', 'score': 0.8777607083320618}, {'label': 'neutral', 'score': 0.08414454758167267}, {'label': 'negative', 'score': 0.03809474781155586}]","(0.08414454758167267, 0.8777607083320618, 0.03809474781155586)",0.9168105675278477,0.8777607083320618,0,0,"[{'label': 'positive', 'score': 0.9989226460456848}, {'label': 'neutral', 'score': 0.0007025894592516124}, {'label': 'negative', 'score': 0.00037477712612599134}]","(0.0007025894592516124, 0.9989226460456848, 0.00037477712612599134)",0.9992499187580481,0.9989226460456848,0,0
2018-10-17,57.299766540527344,68.53053283691406,68.64503479003906,67.5572509765625,67.83396911621094,9793036.0,"World Health Organization's Emergency Committee Has Said The Ebola Outbreak In Congo Is Not Yet A Health Emergency Of Int'l. Concern, Warns Situation Likely To Deteriorate Significantly Unless Response Is Intensified",0.005430265337880579,0.008389286281608729,0.18509020280026567,"[{'label': 'negative', 'score': 0.9937147498130798}, {'label': 'neutral', 'score': 0.0046462141908705235}, {'label': 'positive', 'score': 0.0016390375094488263}]","(0.0046462141908705235, 0.0016390375094488263, 0.9937147498130798)",-0.9967066232523055,-0.9937147498130798,0,0,"[{'label': 'negative', 'score': 0.9677153825759888}, {'label': 'neutral', 'score': 0.01872353069484234}, {'label': 'positive', 'score': 0.013561151921749115}]","(0.01872353069484234, 0.013561151921749115, 0.9677153825759888)",-0.972360182996345,-0.9677153825759888,0,0,"[{'label': 'negative', 'score': 0.9703893065452576}, {'label': 'neutral', 'score': 0.02755899913609028}, {'label': 'positive', 'score': 0.002051636576652527}]","(0.02755899913609028, 0.002051636576652527, 0.9703893065452576)",-0.9957804397456447,-0.9703893065452576,0,0
2018-10-18,57.61091995239258,68.90267181396484,69.08396911621094,68.14885711669922,68.84542083740234,12812848.0,"Merck Says 'Pivotal Phase 3 KEYNOTE-426 Trial Met Both Primary Endpoints; Data to be Filed with Global Regulatory Authorities' | Merck Reports KEYTRUDA In Combo With Pfizer's Inlyta Improved Overall Survival, Progression-Free Survival As First-Line Therapy For Advanced, Metastatic Renal Cell Carcinoma",0.0019388319019453758,0.005415574606111336,0.17385759527788083,"[{'label': 'positive', 'score': 0.999483585357666}, {'label': 'neutral', 'score': 0.000294173281872645}, {'label': 'negative', 'score': 0.00022221042308956385}]","(0.000294173281872645, 0.999483585357666, 0.00022221042308956385)",0.9995554483648541,0.999483585357666,0,0,"[{'label': 'positive', 'score': 0.955000102519989}, {'label': 'neutral', 'score': 0.028484275564551353}, {'label': 'negative', 'score': 0.016515608876943588}]","(0.028484275564551353, 0.955000102519989, 0.016515608876943588)",0.9660003257112622,0.955000102519989,0,0,"[{'label': 'positive', 'score': 0.99856036901474}, {'label': 'neutral', 'score': 0.00121410156134516}, {'label': 'negative', 'score': 0.00022552465088665485}]","(0.00121410156134516, 0.99856036901474, 0.00022552465088665485)",0.999548402410733,0.99856036901474,0,0
2018-10-19,57.72262191772461,69.03626251220703,69.33206176757812,68.64503479003906,68.9885482788086,15210043.0,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",0.0010135870767444422,0.0019369547932472052,0.16398881613015467,"[{'label': 'neutral', 'score': 0.9928487539291382}, {'label': 'positive', 'score': 0.006984381005167961}, {'label': 'negative', 'score': 0.00016686131129972637}]","(0.9928487539291382, 0.006984381005167961, 0.00016686131129972637)",0.9533336156389268,0.006984381005167961,0,1,"[{'label': 'neutral', 'score': 0.9149839878082275}, {'label': 'positive', 'score': 0.0745149552822113}, {'label': 'negative', 'score': 0.010501052252948284}]","(0.9149839878082275, 0.0745149552822113, 0.010501052252948284)",0.7529629405707996,0.0745149552822113,0,1,"[{'label': 'neutral', 'score': 0.6960979700088501}, {'label': 'positive', 'score': 0.3034428060054779}, {'label': 'negative', 'score': 0.00045925992890261114}]","(0.6960979700088501, 0.3034428060054779, 0.00045925992890261114)",0.9969775794219065,0.3034428060054779,0,1
2018-10-20,57.78112538655599,69.10623677571614,69.59605662027995,68.61640930175781,69.20165252685547,14302090.666666666,Merck Announces KEYTRUDA Showed a Complete Response Rate of Nearly 40% in Patients with High-Risk Non-Muscle Invasive Bladder Cancer Unresponsive to Standard of Care at ESMO 2018 | ImmunoGen Presents Encouraging Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYTRUDA at ESMO 2018 | Dynavax Announces SD-101 in Combination with Merck's KEYTRUDA Continues to Show a 70% Overall Response Rate in Advanced Melanoma Patients According to Data Presented Today at ESMO 2018 | Merck Announces First Presentation of Early Data for Investigational STING Agonist (MK-1454) in Patients with Advanced Solid Tumors or Lymphomas at ESMO 2018,0.0010125607582456718,0.0010130737442056125,0.15504015275436875,"[{'label': 'positive', 'score': 0.9978629946708679}, {'label': 'neutral', 'score': 0.001327216043137014}, {'label': 'negative', 'score': 0.0008097556419670582}]","(0.001327216043137014, 0.9978629946708679, 0.0008097556419670582)",0.9983783363635117,0.9978629946708679,0,0,"[{'label': 'positive', 'score': 0.9373964667320251}, {'label': 'neutral', 'score': 0.04568003863096237}, {'label': 'negative', 'score': 0.01692354306578636}]","(0.04568003863096237, 0.9373964667320251, 0.01692354306578636)",0.9645327712045525,0.9373964667320251,0,0,"[{'label': 'positive', 'score': 0.9966171383857727}, {'label': 'neutral', 'score': 0.0030460013076663017}, {'label': 'negative', 'score': 0.0003369170590303838}]","(0.0030460013076663017, 0.9966171383857727, 0.0003369170590303838)",0.9993241071497923,0.9966171383857727,0,0
2018-10-21,57.83962885538737,69.17621103922527,69.86005147298177,68.58778381347656,69.41475677490234,13394138.333333334,"The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs | AstraZeneca, Merck Announce Solo-1 Phase III Trial Demonstrates Lynparza Maintenance Therapy Cut the Risk of Disease Progression or Death by 70% in Patients with Newly-Diagnosed, Advanced BRCA-Mutated Ovarian Cancer at ESMO | Leap Therapeutics Presents Promising Esophagogastric Cancer Data at ESMO 2018",0.0010115365160637674,0.0010120484643909972,0.0516703103195343,"[{'label': 'positive', 'score': 0.9685020446777344}, {'label': 'neutral', 'score': 0.031134065240621567}, {'label': 'negative', 'score': 0.0003639237838797271}]","(0.031134065240621567, 0.9685020446777344, 0.0003639237838797271)",0.9992487634085082,0.9685020446777344,0,0,"[{'label': 'positive', 'score': 0.9091718792915344}, {'label': 'neutral', 'score': 0.08027743548154831}, {'label': 'negative', 'score': 0.010550647974014282}]","(0.08027743548154831, 0.9091718792915344, 0.010550647974014282)",0.9770568890915771,0.9091718792915344,0,0,"[{'label': 'positive', 'score': 0.9332766532897949}, {'label': 'neutral', 'score': 0.06285256147384644}, {'label': 'negative', 'score': 0.0038708129432052374}]","(0.06285256147384644, 0.9332766532897949, 0.0038708129432052374)",0.9917391593475368,0.9332766532897949,0,0
2018-10-22,57.89813232421875,69.24618530273438,70.1240463256836,68.55915832519531,69.62786102294922,12486186.0,"11 Stocks That Moved From ESMO 2018 | Benzinga's Week Ahead: Can Tech Earnings Restore The Rally? Amazon, Google To Report | BMO Capital Maintains Outperform on Merck & Co, Raises Price Target to $82 | Merck Reports Presentation Of KEYTRUDA Showing Improved Overall Survival In Patients With Recurrent Or Metastatic Head And Neck Cancer; Results Being Presented At ESMO 2018 Congress | European Medicines Agency Adopts Positive Opinion for Merck's KEYTRUDA as Adjuvant Therapy in Melanoma | REMINDER: ESMO 2018 Event Continues Today, Clinical Updates Presented Today Include: CytomX Therapeutics, Mirati Therapeutics, Merck, NuCana, Protagonist Therapeutics, SELLAS Life Sciences, Epizyme, Kura Oncology, Intra-Cellular Therapies, and AVEO Pharma",-0.0064765834647754865,0.0010110252577439326,0.030295005555371204,"[{'label': 'positive', 'score': 0.9995976090431213}, {'label': 'negative', 'score': 0.00025391060626134276}, {'label': 'neutral', 'score': 0.00014851873856969178}]","(0.00014851873856969178, 0.9995976090431213, 0.00025391060626134276)",0.9994921033748083,0.9995976090431213,0,0,"[{'label': 'positive', 'score': 0.9433643221855164}, {'label': 'neutral', 'score': 0.04171028360724449}, {'label': 'negative', 'score': 0.014925427734851837}]","(0.04171028360724449, 0.9433643221855164, 0.014925427734851837)",0.9688498645924323,0.9433643221855164,0,0,"[{'label': 'positive', 'score': 0.99850994348526}, {'label': 'neutral', 'score': 0.0011509533505886793}, {'label': 'negative', 'score': 0.00033907187753356993}]","(0.0011509533505886793, 0.99850994348526, 0.00033907187753356993)",0.9993210748124722,0.99850994348526,0,0
2018-10-23,57.52314758300781,68.7977066040039,69.1030502319336,67.95801544189453,68.85496520996094,12116871.0,"Stocks Which Set New 52-Week High Yesterday, October 22nd | The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",-0.021636597385093107,-0.006497647529502556,0.05532163626674474,"[{'label': 'positive', 'score': 0.999427318572998}, {'label': 'neutral', 'score': 0.0003132524434477091}, {'label': 'negative', 'score': 0.0002594802645035088}]","(0.0003132524434477091, 0.999427318572998, 0.0002594802645035088)",0.9994808768810286,0.999427318572998,0,0,"[{'label': 'positive', 'score': 0.8836261630058289}, {'label': 'neutral', 'score': 0.10392501205205917}, {'label': 'negative', 'score': 0.01244872435927391}]","(0.10392501205205917, 0.8836261630058289, 0.01244872435927391)",0.9722149911021851,0.8836261630058289,0,0,"[{'label': 'positive', 'score': 0.9984872341156006}, {'label': 'neutral', 'score': 0.0012022210285067558}, {'label': 'negative', 'score': 0.00031052768463268876}]","(0.0012022210285067558, 0.9984872341156006, 0.00031052768463268876)",0.999378197075506,0.9984872341156006,0,0
2018-10-24,56.27854537963867,67.30915832519531,69.31298065185547,67.01335906982422,68.53053283691406,15348170.0,Merck's Q3 Earnings Preview,-0.008222302775248217,-0.021874100649218457,0.15782763971650943,"[{'label': 'neutral', 'score': 0.9998375177383423}, {'label': 'negative', 'score': 8.454080671072006e-05}, {'label': 'positive', 'score': 7.798855222063139e-05}]","(0.9998375177383423, 7.798855222063139e-05, 8.454080671072006e-05)",-0.04031428249745443,-8.454080671072006e-05,1,1,"[{'label': 'neutral', 'score': 0.8870331645011902}, {'label': 'positive', 'score': 0.06528931111097336}, {'label': 'negative', 'score': 0.04767753183841705}]","(0.8870331645011902, 0.06528931111097336, 0.04767753183841705)",0.15590219937762137,0.06528931111097336,1,1,"[{'label': 'neutral', 'score': 0.9992904663085938}, {'label': 'positive', 'score': 0.0004674483498092741}, {'label': 'negative', 'score': 0.00024210993433371186}]","(0.9992904663085938, 0.0004674483498092741, 0.00024210993433371186)",0.31757562488010266,0.0004674483498092741,1,1
2018-10-25,55.81580352783203,66.75572204589844,67.33778381347656,63.07251739501953,63.8740463256836,21553692.0,"Snapping Back, But Can Rally Attempt Last? Strong Earnings Might Power Market | The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price | A Peek Into The Markets: US Stock Futures Rise Ahead Of Earnings, Economic Reports | Merck Raises Qtr. Dividend From $0.48 To $0.55/Share; Adds $10B To Buyback | UPDATE: Merck Raises FY18 Adj. EPS Guidance From $4.22-$4.30 As Of Jul. 27, 2018 To $4.30-$4.36 vs $4.29 Estimate | Merck Raises Guidance | Merck & Co Q3 EPS $1.19 Beats $1.14 Estimate, Sales $10.794B Miss $10.88B Estimate",0.006289396587764346,-0.008256292349986373,0.1487907499864589,"[{'label': 'positive', 'score': 0.9994578957557678}, {'label': 'negative', 'score': 0.00029135061777196825}, {'label': 'neutral', 'score': 0.0002507166936993599}]","(0.0002507166936993599, 0.9994578957557678, 0.00029135061777196825)",0.9994171526133602,0.9994578957557678,0,0,"[{'label': 'positive', 'score': 0.8532817959785461}, {'label': 'negative', 'score': 0.09161501377820969}, {'label': 'neutral', 'score': 0.055103152990341187}]","(0.055103152990341187, 0.8532817959785461, 0.09161501377820969)",0.806084616156564,0.8532817959785461,0,0,"[{'label': 'positive', 'score': 0.9956305027008057}, {'label': 'neutral', 'score': 0.003671809332445264}, {'label': 'negative', 'score': 0.0006977434386499226}]","(0.003671809332445264, 0.9956305027008057, 0.0006977434386499226)",0.9985993703553954,0.9956305027008057,0,0
2018-10-26,56.16685104370117,67.17557525634766,67.53816986083984,65.72518920898438,66.57442474365234,17764229.0,"BMO Capital Maintains Outperform on Merck & Co, Lowers Price Target to $80",0.0049715855046493194,0.006269700872682404,0.16966804684840256,"[{'label': 'positive', 'score': 0.9594365358352661}, {'label': 'negative', 'score': 0.0396418459713459}, {'label': 'neutral', 'score': 0.0009216428152285516}]","(0.0009216428152285516, 0.9594365358352661, 0.0396418459713459)",0.9206431713602642,0.9594365358352661,0,0,"[{'label': 'negative', 'score': 0.5285394191741943}, {'label': 'positive', 'score': 0.40713736414909363}, {'label': 'neutral', 'score': 0.06432323902845383}]","(0.06432323902845383, 0.40713736414909363, 0.5285394191741943)",-0.12974785437542996,-0.5285394191741943,1,0,"[{'label': 'negative', 'score': 0.985475480556488}, {'label': 'neutral', 'score': 0.013437430374324322}, {'label': 'positive', 'score': 0.0010869991965591908}]","(0.013437430374324322, 0.0010869991965591908, 0.985475480556488)",-0.9977963905604209,-0.985475480556488,0,0
2018-10-27,56.44608942667643,67.5095443725586,68.25381724039714,66.25636037190755,67.08333079020183,18424119.666666668,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",0.004946991115328722,0.004959267981644387,0.18164748302779532,"[{'label': 'neutral', 'score': 0.9998741149902344}, {'label': 'negative', 'score': 6.72901442158036e-05}, {'label': 'positive', 'score': 5.847791180713102e-05}]","(0.9998741149902344, 5.847791180713102e-05, 6.72901442158036e-05)",-0.07006733416524784,-6.72901442158036e-05,1,1,"[{'label': 'neutral', 'score': 0.9465845823287964}, {'label': 'positive', 'score': 0.03003484383225441}, {'label': 'negative', 'score': 0.023380538448691368}]","(0.9465845823287964, 0.03003484383225441, 0.023380538448691368)",0.12457657512519107,0.03003484383225441,1,1,"[{'label': 'neutral', 'score': 0.999504804611206}, {'label': 'positive', 'score': 0.0003621182986535132}, {'label': 'negative', 'score': 0.00013306073378771544}]","(0.999504804611206, 0.0003621182986535132, 0.00013306073378771544)",0.4625752502817937,0.0003621182986535132,1,1
2018-10-28,56.725327809651695,67.84351348876953,68.96946461995442,66.78753153483073,67.5922368367513,19084010.33333333,,0.004922638864601567,0.004934794961087464,0.1937543653652094,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-10-29,57.00456619262695,68.17748260498047,69.68511199951172,67.3187026977539,68.10114288330078,19743901.0,"Benzinga's Week Ahead: Can Facebook, Apple Earnings Rescue The Stock Market?",0.01987397493710665,0.004910562294087354,0.09645487254067145,"[{'label': 'neutral', 'score': 0.9988586902618408}, {'label': 'positive', 'score': 0.0009884170722216368}, {'label': 'negative', 'score': 0.00015287309361156076}]","(0.9988586902618408, 0.0009884170722216368, 0.00015287309361156076)",0.7321047737234186,0.0009884170722216368,1,0,"[{'label': 'neutral', 'score': 0.8398355841636658}, {'label': 'positive', 'score': 0.1420024335384369}, {'label': 'negative', 'score': 0.01816197670996189}]","(0.8398355841636658, 0.1420024335384369, 0.01816197670996189)",0.7732083340887717,0.1420024335384369,1,0,"[{'label': 'positive', 'score': 0.8632332682609558}, {'label': 'neutral', 'score': 0.13527315855026245}, {'label': 'negative', 'score': 0.001493629184551537}]","(0.13527315855026245, 0.8632332682609558, 0.001493629184551537)",0.9965454314212641,0.8632332682609558,1,1
2018-10-30,58.13747787475586,69.53244018554688,69.61832427978516,68.22518920898438,68.40648651123047,19845976.0,"Merck Reports FDA Approved KEYTRUDA In Combo With Carboplatin, Either Paclitaxel Or Nab-Paclitaxel For First-Line Treatment Of Patients With Metastatic Squamous Non-Small Cell Lung Cancer | Wild Times: Market Seems To Seek Solid Ground After Monday's Manic | The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio | REMINDER: Merck Has PDUFA Date for KEYTRUDA+carboplatin-paclitaxel sBLA Today",0.010155088637439932,0.01967906567952877,0.10271528794645743,"[{'label': 'positive', 'score': 0.9982866644859314}, {'label': 'neutral', 'score': 0.0014781998470425606}, {'label': 'negative', 'score': 0.0002351417497266084}]","(0.0014781998470425606, 0.9982866644859314, 0.0002351417497266084)",0.999529020301293,0.9982866644859314,0,0,"[{'label': 'positive', 'score': 0.5330936312675476}, {'label': 'neutral', 'score': 0.23522011935710907}, {'label': 'negative', 'score': 0.2316863089799881}]","(0.23522011935710907, 0.5330936312675476, 0.2316863089799881)",0.39410986929129344,0.5330936312675476,1,0,"[{'label': 'positive', 'score': 0.9883008003234863}, {'label': 'neutral', 'score': 0.011029718443751335}, {'label': 'negative', 'score': 0.0006694872281514108}]","(0.011029718443751335, 0.9883008003234863, 0.0006694872281514108)",0.9986460923314312,0.9883008003234863,0,0
2018-10-31,58.72786331176758,70.2385482788086,71.0782470703125,69.43701934814453,70.0477066040039,16624529.0,"Citigroup Maintains Buy on Merck & Co, Raises Price Target to $84 | The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",-0.006656740862541299,0.010103872171472765,0.10189525738417768,"[{'label': 'positive', 'score': 0.9995070695877075}, {'label': 'negative', 'score': 0.00028103950899094343}, {'label': 'neutral', 'score': 0.00021185082732699811}]","(0.00021185082732699811, 0.9995070695877075, 0.00028103950899094343)",0.9994378018573459,0.9995070695877075,0,0,"[{'label': 'positive', 'score': 0.5153205990791321}, {'label': 'neutral', 'score': 0.45483747124671936}, {'label': 'negative', 'score': 0.02984197624027729}]","(0.45483747124671936, 0.5153205990791321, 0.02984197624027729)",0.8905208185914342,0.5153205990791321,0,0,"[{'label': 'positive', 'score': 0.9988871216773987}, {'label': 'neutral', 'score': 0.0008006119751371443}, {'label': 'negative', 'score': 0.00031223928090184927}]","(0.0008006119751371443, 0.9988871216773987, 0.00031223928090184927)",0.9993750210556532,0.9988871216773987,0,0
2018-11-01,58.33692932128906,69.77098846435547,70.64885711669922,69.34160614013672,70.41984558105469,14507988.0,"Stocks Which Set New 52-Week High Yesterday, October 31st | Citigroup Maintains Buy on Merck & Co, Raises Price Target to $84 | Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates | The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",-0.011624683721407809,-0.006678995780460082,0.15170278937495163,"[{'label': 'positive', 'score': 0.9994646906852722}, {'label': 'neutral', 'score': 0.00029193665250204504}, {'label': 'negative', 'score': 0.00024342512188013643}]","(0.00029193665250204504, 0.9994646906852722, 0.00024342512188013643)",0.9995130076108593,0.9994646906852722,0,0,"[{'label': 'positive', 'score': 0.5077919960021973}, {'label': 'neutral', 'score': 0.4678099751472473}, {'label': 'negative', 'score': 0.02439802512526512}]","(0.4678099751472473, 0.5077919960021973, 0.02439802512526512)",0.908310850798829,0.5077919960021973,0,0,"[{'label': 'positive', 'score': 0.9987843632698059}, {'label': 'neutral', 'score': 0.0008429280132986605}, {'label': 'negative', 'score': 0.00037269663880579174}]","(0.0008429280132986605, 0.9987843632698059, 0.00037269663880579174)",0.9992539778704264,0.9987843632698059,0,0
2018-11-02,57.65877532958984,68.95992279052734,70.32442474365234,68.3396987915039,70.20037841796875,13517838.0,,0.0039204687834498595,-0.01169277859252149,0.20103636683704315,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-03,57.88482666015625,69.23027801513672,70.28307596842448,67.8625971476237,69.68829345703125,13319346.666666666,,0.003905158730552313,0.003912803772800625,0.20064604825077464,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-04,58.110877990722656,69.5006332397461,70.24172719319661,67.38549550374348,69.17620849609375,13120855.333333334,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",0.0038899677888800006,0.0038975533918034393,0.1406210319486834,"[{'label': 'neutral', 'score': 0.9998729228973389}, {'label': 'negative', 'score': 6.767052400391549e-05}, {'label': 'positive', 'score': 5.937607784289867e-05}]","(0.9998729228973389, 5.937607784289867e-05, 6.767052400391549e-05)",-0.06528664317222597,-6.767052400391549e-05,1,1,"[{'label': 'neutral', 'score': 0.945859968662262}, {'label': 'positive', 'score': 0.028619082644581795}, {'label': 'negative', 'score': 0.02552090771496296}]","(0.945859968662262, 0.028619082644581795, 0.02552090771496296)",0.057225258243375994,0.028619082644581795,1,1,"[{'label': 'neutral', 'score': 0.9994434714317322}, {'label': 'positive', 'score': 0.0004108125576749444}, {'label': 'negative', 'score': 0.00014575289969798177}]","(0.9994434714317322, 0.0004108125576749444, 0.00014575289969798177)",0.4762416611840854,0.0004108125576749444,1,1
2018-11-05,58.33692932128906,69.77098846435547,70.20037841796875,66.90839385986328,68.66412353515625,12922364.0,,0.0025985719226731306,0.0038824214279172898,0.11718742204247594,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-06,58.488525390625,69.9522933959961,70.41984558105469,69.41793823242188,69.59923553466797,10737913.0,,0.024143978914549984,0.002595201472296937,0.10873843212820587,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-11-07,59.900672912597656,71.64122009277344,71.87976837158203,70.45801544189453,70.70610809326172,19566684.0,"Merck Reports Early Phase 1 Data From MK-4280, MK-7684 Trial To Be Presented At SITC Meeting Nov. 9, 2018",0.005327705880987306,0.023857121142182757,0.1442882090269617,"[{'label': 'neutral', 'score': 0.9998798370361328}, {'label': 'positive', 'score': 6.083872358431108e-05}, {'label': 'negative', 'score': 5.9349484217818826e-05}]","(0.9998798370361328, 6.083872358431108e-05, 5.9349484217818826e-05)",0.012390894196076573,6.083872358431108e-05,1,1,"[{'label': 'neutral', 'score': 0.9393754601478577}, {'label': 'positive', 'score': 0.037964459508657455}, {'label': 'negative', 'score': 0.022660035640001297}]","(0.9393754601478577, 0.037964459508657455, 0.022660035640001297)",0.25244620728185563,0.037964459508657455,1,1,"[{'label': 'neutral', 'score': 0.9995624423027039}, {'label': 'positive', 'score': 0.00031560659408569336}, {'label': 'negative', 'score': 0.00012194157170597464}]","(0.9995624423027039, 0.00031560659408569336, 0.00012194157170597464)",0.44261417946825404,0.00031560659408569336,1,1
2018-11-08,60.21979141235352,72.02290344238281,72.22328186035156,71.2022933959961,71.45992279052734,13634690.0,"Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 7, 2018 | The Daily Biotech Pulse: Nantkwest Reports Positive Cancer Vaccine Trial Results, Sarepta Offering",-0.008214139001074768,0.0053135638634459,0.1423449404261493,"[{'label': 'positive', 'score': 0.999292254447937}, {'label': 'neutral', 'score': 0.00039721603388898075}, {'label': 'negative', 'score': 0.0003104480274487287}]","(0.00039721603388898075, 0.999292254447937, 0.0003104480274487287)",0.9993788571665924,0.999292254447937,0,0,"[{'label': 'positive', 'score': 0.9195353984832764}, {'label': 'neutral', 'score': 0.0617893785238266}, {'label': 'negative', 'score': 0.018675250932574272}]","(0.0617893785238266, 0.9195353984832764, 0.018675250932574272)",0.9601896419653692,0.9195353984832764,0,0,"[{'label': 'positive', 'score': 0.9976059198379517}, {'label': 'neutral', 'score': 0.0019679670222103596}, {'label': 'negative', 'score': 0.0004260957648511976}]","(0.0019679670222103596, 0.9976059198379517, 0.0004260957648511976)",0.9991461280636497,0.9976059198379517,0,0
2018-11-09,59.72515106201172,71.4312973022461,72.5095443725586,71.3740463256836,72.385498046875,15359802.0,"FDA Approves Merck's KEYTRUDA For Patients With Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated With Sorafenib | Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 8, 2018 | The Daily Biotech Pulse: SITC Presentations Pick Up Pace, Sandoz' Voluntary Recall",-0.0007569799823974869,-0.008248060928170165,0.18394579724912766,"[{'label': 'positive', 'score': 0.9991034865379333}, {'label': 'neutral', 'score': 0.0006194898160174489}, {'label': 'negative', 'score': 0.00027702789520844817}]","(0.0006194898160174489, 0.9991034865379333, 0.00027702789520844817)",0.9994456007672602,0.9991034865379333,0,0,"[{'label': 'positive', 'score': 0.9207953810691833}, {'label': 'neutral', 'score': 0.05690454691648483}, {'label': 'negative', 'score': 0.022300126031041145}]","(0.05690454691648483, 0.9207953810691833, 0.022300126031041145)",0.9527086581090641,0.9207953810691833,0,0,"[{'label': 'positive', 'score': 0.9985325336456299}, {'label': 'neutral', 'score': 0.0011559105478227139}, {'label': 'negative', 'score': 0.0003115928266197443}]","(0.0011559105478227139, 0.9985325336456299, 0.0003115928266197443)",0.9993760931893944,0.9985325336456299,0,0
2018-11-10,59.67994435628256,71.37722524007161,72.28053538004558,71.12913513183594,72.15331013997395,15132875.333333334,,-0.0007575534351833182,-0.0007572666364143383,0.1893541039862962,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-11,59.63473765055338,71.32315317789714,72.05152638753255,70.88422393798828,71.92112223307292,14905948.666666666,,-0.000758127757470497,-0.0007578405237860631,0.1929983945352589,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-12,59.58953094482422,71.26908111572266,71.82251739501953,70.63931274414062,71.68893432617188,14679022.0,"October's biggest Losers And Most Surprising Winners | Merck Announces the FDA Has Accepted a Supplemental New Drug Application for LYNPARZA | AstraZeneca, Merck Announce FDA Accepts Regulatory Submission for Lynparza Maintenance Therapy in Newly-diagnosed, BRCA-mutated Advanced Ovarian Cancer and Grants Priority Review",-0.00107104078080104,-0.0007584152816480763,0.07636395062860515,"[{'label': 'positive', 'score': 0.9985058307647705}, {'label': 'neutral', 'score': 0.001226515625603497}, {'label': 'negative', 'score': 0.0002676477888599038}]","(0.001226515625603497, 0.9985058307647705, 0.0002676477888599038)",0.9994640470645105,0.9985058307647705,0,0,"[{'label': 'positive', 'score': 0.8582180738449097}, {'label': 'neutral', 'score': 0.12090406566858292}, {'label': 'negative', 'score': 0.020877912640571594}]","(0.12090406566858292, 0.8582180738449097, 0.020877912640571594)",0.9525014038022425,0.8582180738449097,0,0,"[{'label': 'neutral', 'score': 0.6852707266807556}, {'label': 'positive', 'score': 0.3125893771648407}, {'label': 'negative', 'score': 0.0021398765966296196}]","(0.6852707266807556, 0.3125893771648407, 0.0021398765966296196)",0.9864017941068077,0.3125893771648407,0,1
2018-11-13,59.525691986083984,71.1927490234375,71.82251739501953,70.62023162841797,71.77481079101562,16587430.0,Merck Reports Commencement Of Rolling Submission Of Licensure Application For V920 To FDA | World Health Organization's Emergency Response Chief Says We Expect Democratic Republic Of Congo's Ebola Outbreak To Last At Least Another Six Months,-0.006969604482768672,-0.001071614754847746,0.05266258073954739,"[{'label': 'neutral', 'score': 0.9993983507156372}, {'label': 'negative', 'score': 0.00045160306035541}, {'label': 'positive', 'score': 0.00015001141582615674}]","(0.9993983507156372, 0.00015001141582615674, 0.00045160306035541)",-0.5013038357112822,-0.00045160306035541,0,1,"[{'label': 'neutral', 'score': 0.7208153605461121}, {'label': 'positive', 'score': 0.15263719856739044}, {'label': 'negative', 'score': 0.12654739618301392}]","(0.7208153605461121, 0.15263719856739044, 0.12654739618301392)",0.09345000718145369,0.15263719856739044,1,1,"[{'label': 'neutral', 'score': 0.9785795211791992}, {'label': 'positive', 'score': 0.020605431869626045}, {'label': 'negative', 'score': 0.0008150949724949896}]","(0.9785795211791992, 0.020605431869626045, 0.0008150949724949896)",0.923895898686096,0.020605431869626045,0,1
2018-11-14,59.11082458496094,70.69656372070312,71.52671813964844,70.30534362792969,71.51717376708984,9936193.0,"The Daily Biotech Pulse: Mallinckrodt Faces FDA Panel, Reshape's Earnings, Vapotherm To Debut | Merck Reports KEYTRUDA Significantly Improved Overall Survival Compared To Chemotherapy In Patients With Advanced Esophageal Or Esophagogastric Junction Carcnimoa Whose Tumors Express PD-L1",0.01012287483515606,-0.006994005619702892,0.04376866005411566,"[{'label': 'positive', 'score': 0.9996182918548584}, {'label': 'negative', 'score': 0.00022954291489440948}, {'label': 'neutral', 'score': 0.00015219146735034883}]","(0.00015219146735034883, 0.9996182918548584, 0.00022954291489440948)",0.9995408443026788,0.9996182918548584,1,1,"[{'label': 'positive', 'score': 0.951945960521698}, {'label': 'negative', 'score': 0.02529977820813656}, {'label': 'neutral', 'score': 0.022754289209842682}]","(0.022754289209842682, 0.951945960521698, 0.02529977820813656)",0.948222279810563,0.951945960521698,1,1,"[{'label': 'positive', 'score': 0.9983842372894287}, {'label': 'neutral', 'score': 0.0011885175481438637}, {'label': 'negative', 'score': 0.00042724821832962334}]","(0.0011885175481438637, 0.9983842372894287, 0.00042724821832962334)",0.9991444867734727,0.9983842372894287,1,1
2018-11-15,59.70920944213867,71.41221618652344,71.44084167480469,69.78053283691406,70.13359069824219,12549171.0,"NewLink Genetics Announces Merck Has Begun Rolling Submission Of Licensure Application For Ebola vaccine V920 To U.S. FDA; In 2014, Co. Entered Ito License Agreement With Merck To Develop, Manufacture And Commercialize Ebola Vaccine",0.016301462093203288,0.010071981706032783,0.0980534451524494,"[{'label': 'positive', 'score': 0.9748928546905518}, {'label': 'neutral', 'score': 0.024549275636672974}, {'label': 'negative', 'score': 0.0005579121643677354}]","(0.024549275636672974, 0.9748928546905518, 0.0005579121643677354)",0.9988560936475214,0.9748928546905518,1,1,"[{'label': 'positive', 'score': 0.8413169980049133}, {'label': 'neutral', 'score': 0.14994925260543823}, {'label': 'negative', 'score': 0.008733674883842468}]","(0.14994925260543823, 0.8413169980049133, 0.008733674883842468)",0.979451401751939,0.8413169980049133,1,1,"[{'label': 'positive', 'score': 0.8181524872779846}, {'label': 'neutral', 'score': 0.18137741088867188}, {'label': 'negative', 'score': 0.0004700837889686227}]","(0.18137741088867188, 0.8181524872779846, 0.0004700837889686227)",0.9988515249747978,0.8181524872779846,1,1
2018-11-16,60.68255615234375,72.57633972167969,72.75763702392578,71.135498046875,71.3167953491211,14384010.0,,0.0012708940283433,0.016170019803866165,0.14910146103058047,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-17,60.759674072265625,72.66857655843098,72.87213897705078,71.4662857055664,71.78753407796223,15326231.666666666,,0.0012692809068187295,0.0012700871261133943,0.14613148956296038,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-18,60.8367919921875,72.7608133951823,72.98664093017578,71.79707336425781,72.25827280680339,16268453.333333334,,0.001267671875111344,0.0012684760507953852,0.14201293217789843,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-19,60.913909912109375,72.8530502319336,73.10114288330078,72.12786102294922,72.72901153564453,17210675.0,Merck and Pfizer's Avelumab in Platinum-Resistant/Refractory Ovarian Cancer Did Not Meet Primary Endpoints,-0.020563106379257713,0.0012668690575212075,0.10859016573699506,"[{'label': 'neutral', 'score': 0.9974230527877808}, {'label': 'negative', 'score': 0.0024668804835528135}, {'label': 'positive', 'score': 0.0001100979425245896}]","(0.9974230527877808, 0.0001100979425245896, 0.0024668804835528135)",-0.9145526858816764,-0.0024668804835528135,1,0,"[{'label': 'negative', 'score': 0.4544936418533325}, {'label': 'neutral', 'score': 0.40950530767440796}, {'label': 'positive', 'score': 0.1360011249780655}]","(0.40950530767440796, 0.1360011249780655, 0.4544936418533325)",-0.5393655198407629,-0.4544936418533325,1,0,"[{'label': 'negative', 'score': 0.9848570823669434}, {'label': 'neutral', 'score': 0.014412996359169483}, {'label': 'positive', 'score': 0.0007298772688955069}]","(0.014412996359169483, 0.0007298772688955069, 0.9848570823669434)",-0.998518898283384,-0.9848570823669434,1,1
2018-11-20,59.66131591796875,71.35496520996094,72.86259460449219,71.23091888427734,72.52862548828125,14240014.0,"Stocks Which Set New 52-Week High Yesterday, Mon., Nov. 19, 2018 | The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",0.0001336521310885763,-0.020777470808594878,0.20968045140476366,"[{'label': 'positive', 'score': 0.9991318583488464}, {'label': 'neutral', 'score': 0.0005488500464707613}, {'label': 'negative', 'score': 0.00031928307726047933}]","(0.0005488500464707613, 0.9991318583488464, 0.00031928307726047933)",0.9993610831704992,0.9991318583488464,0,0,"[{'label': 'neutral', 'score': 0.7805406451225281}, {'label': 'positive', 'score': 0.2043617069721222}, {'label': 'negative', 'score': 0.015097582712769508}]","(0.7805406451225281, 0.2043617069721222, 0.015097582712769508)",0.862411085587243,0.2043617069721222,0,1,"[{'label': 'positive', 'score': 0.9981558918952942}, {'label': 'neutral', 'score': 0.0015436469111591578}, {'label': 'negative', 'score': 0.0003004196914844215}]","(0.0015436469111591578, 0.9981558918952942, 0.0003004196914844215)",0.9993982316742392,0.9981558918952942,0,0
2018-11-21,59.6693000793457,71.364501953125,71.63167572021484,70.78244018554688,71.4885482788086,9489116.0,Stocks Of Vaccination Providers Do Not React Following Update From Health Ministry Suggesting 13 New Cases Of Ebola Were Reported In Eastern Congo Wed. | October's Biggest Losers And Most Surprising Winners,-0.0008022332531670253,0.00013364320043827657,0.15469338374236766,"[{'label': 'neutral', 'score': 0.9990578293800354}, {'label': 'positive', 'score': 0.000648687535431236}, {'label': 'negative', 'score': 0.0002935049997176975}]","(0.9990578293800354, 0.000648687535431236, 0.0002935049997176975)",0.37697447439168513,0.000648687535431236,1,1,"[{'label': 'negative', 'score': 0.888155460357666}, {'label': 'positive', 'score': 0.05597720667719841}, {'label': 'neutral', 'score': 0.05586741492152214}]","(0.05586741492152214, 0.05597720667719841, 0.888155460357666)",-0.8814208879076285,-0.888155460357666,0,0,"[{'label': 'negative', 'score': 0.9346024990081787}, {'label': 'neutral', 'score': 0.0637233778834343}, {'label': 'positive', 'score': 0.0016741004073992372}]","(0.0637233778834343, 0.0016741004073992372, 0.9346024990081787)",-0.9964239191528568,-0.9346024990081787,0,0
2018-11-22,59.62142181396485,71.3072509765625,71.74140930175781,70.70133590698242,71.11164093017578,6589981.0,,-0.0008028773480738647,-0.0008025552144667734,0.15144433753354875,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-23,59.573543548583984,71.25,71.85114288330078,70.62023162841797,70.73473358154297,3690846.0,,0.003437350089089912,-0.0008031998267106008,0.14776099063799414,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-24,59.77831904093424,71.49491119384766,71.99427286783855,70.86832173665364,71.00827026367188,6262917.666666666,,0.0034255751879125568,0.003431455904328123,0.1534911594442546,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-11-25,59.98309453328451,71.73982238769531,72.1374028523763,71.11641184488933,71.28180694580078,8834989.333333332,"The Week Ahead In Biotech: ASH 2018, PDUFA Dates, Clinical Trials And Earnings | 9 Policy Catalysts For Health Care Investors To Watch Before Year's End",0.0034138806829505475,0.003419721270109677,0.034588217423626666,"[{'label': 'neutral', 'score': 0.999840497970581}, {'label': 'negative', 'score': 8.24083253974095e-05}, {'label': 'positive', 'score': 7.7134020102676e-05}]","(0.999840497970581, 7.7134020102676e-05, 8.24083253974095e-05)",-0.033058968001261256,-8.24083253974095e-05,1,1,"[{'label': 'neutral', 'score': 0.8884178996086121}, {'label': 'positive', 'score': 0.09868554025888443}, {'label': 'negative', 'score': 0.012896518222987652}]","(0.8884178996086121, 0.09868554025888443, 0.012896518222987652)",0.7688424393948091,0.09868554025888443,0,1,"[{'label': 'neutral', 'score': 0.9987431168556213}, {'label': 'positive', 'score': 0.0010165284620597959}, {'label': 'negative', 'score': 0.00024037716502789408}]","(0.9987431168556213, 0.0010165284620597959, 0.00024037716502789408)",0.6175096047825652,0.0010165284620597959,0,1
2018-11-26,60.187870025634766,71.98473358154297,72.28053283691406,71.364501953125,71.55534362792969,11407061.0,"Data Dive, Trade Talks And Powell: Busy Post-Holiday Week On The Way",0.011930028278200857,0.0034080666208769136,0.03671522862855525,"[{'label': 'neutral', 'score': 0.9997616410255432}, {'label': 'positive', 'score': 0.00014876003842800856}, {'label': 'negative', 'score': 8.960701961768791e-05}]","(0.9997616410255432, 0.00014876003842800856, 8.960701961768791e-05)",0.2481593693998633,0.00014876003842800856,0,0,"[{'label': 'neutral', 'score': 0.7328463792800903}, {'label': 'negative', 'score': 0.15572160482406616}, {'label': 'positive', 'score': 0.11143198609352112}]","(0.7328463792800903, 0.11143198609352112, 0.15572160482406616)",-0.16578335547886272,-0.15572160482406616,0,0,"[{'label': 'neutral', 'score': 0.9974305033683777}, {'label': 'positive', 'score': 0.001944054034538567}, {'label': 'negative', 'score': 0.000625397777184844}]","(0.9974305033683777, 0.001944054034538567, 0.000625397777184844)",0.5132052881230177,0.001944054034538567,1,0
2018-11-27,60.90592956542969,72.84351348876953,73.01526641845703,71.63167572021484,71.63167572021484,15325533.0,"The Daily Biotech Pulse: Abeona Fires CEO, Loxo Passes FDA Muster, Bristol-Myers Flunks Lung Cancer Trial",0.011658354930928717,0.011859426457266262,0.0733951700610171,"[{'label': 'positive', 'score': 0.7327203750610352}, {'label': 'neutral', 'score': 0.26157230138778687}, {'label': 'negative', 'score': 0.005707277916371822}]","(0.26157230138778687, 0.7327203750610352, 0.005707277916371822)",0.9845420796651925,0.7327203750610352,1,1,"[{'label': 'negative', 'score': 0.5577727556228638}, {'label': 'neutral', 'score': 0.4176843762397766}, {'label': 'positive', 'score': 0.02454289048910141}]","(0.4176843762397766, 0.02454289048910141, 0.5577727556228638)",-0.9157058868228232,-0.5577727556228638,0,0,"[{'label': 'neutral', 'score': 0.8647662401199341}, {'label': 'negative', 'score': 0.11539549380540848}, {'label': 'positive', 'score': 0.01983831822872162}]","(0.8647662401199341, 0.01983831822872162, 0.11539549380540848)",-0.7066071283457593,-0.11539549380540848,0,0
2018-11-28,61.61598587036133,73.6927490234375,73.8167953491211,72.77671813964844,73.28244018554688,12625675.0,Merck Receives European Commission Approval For DELSTRIGO As Part OF An HIV-1 Treatment Regimen,0.008804897704289116,0.011590919925840692,0.07223006962446775,"[{'label': 'positive', 'score': 0.9956508278846741}, {'label': 'neutral', 'score': 0.004045464564114809}, {'label': 'negative', 'score': 0.0003036761190742254}]","(0.004045464564114809, 0.9956508278846741, 0.0003036761190742254)",0.9993901807404787,0.9956508278846741,0,0,"[{'label': 'positive', 'score': 0.8781002163887024}, {'label': 'neutral', 'score': 0.1140676811337471}, {'label': 'negative', 'score': 0.00783204659819603}]","(0.1140676811337471, 0.8781002163887024, 0.00783204659819603)",0.9823190848207954,0.8781002163887024,0,0,"[{'label': 'positive', 'score': 0.9976282715797424}, {'label': 'neutral', 'score': 0.002112969057634473}, {'label': 'negative', 'score': 0.0002588074712548405}]","(0.002112969057634473, 0.9976282715797424, 0.0002588074712548405)",0.9994812890622835,0.9976282715797424,0,0
2018-11-29,62.15851593017578,74.34160614013672,74.885498046875,73.5782470703125,73.65457916259766,11429174.0,"Merck Is Up 40% In 2018: What's Driving The Rally? | Ebola Outbreak In Eastern Congo Now World's Second Largest Ever With 426 Cases | Merk shares rise after the European Commission approved Co's HIV treatments in Europe. | Stocks Which Set New 52-Week High Yesterday, Wed., Nov. 28, 2018 | The Daily Biotech Pulse: Twist In Protagonist Tale, Catalyst's Autoimmune Disorder Drug Approved",0.018354485784889588,0.008766360637248474,0.06653075871461676,"[{'label': 'positive', 'score': 0.9996323585510254}, {'label': 'negative', 'score': 0.00019715234520845115}, {'label': 'neutral', 'score': 0.00017049182497430593}]","(0.00017049182497430593, 0.9996323585510254, 0.00019715234520845115)",0.9996056280734668,0.9996323585510254,1,1,"[{'label': 'positive', 'score': 0.9032823443412781}, {'label': 'neutral', 'score': 0.08043710142374039}, {'label': 'negative', 'score': 0.016280539333820343}]","(0.08043710142374039, 0.9032823443412781, 0.016280539333820343)",0.9645906992923551,0.9032823443412781,1,1,"[{'label': 'positive', 'score': 0.9975214600563049}, {'label': 'neutral', 'score': 0.002170070307329297}, {'label': 'negative', 'score': 0.0003084001946263015}]","(0.002170070307329297, 0.9975214600563049, 0.0003084001946263015)",0.9993818581565624,0.9975214600563049,1,1
2018-11-30,63.29940032958984,75.70610809326172,75.84923553466797,74.1603012084961,74.27481079101562,22380669.0,"Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates | Stocks Which Set New 52-Week High Yesterday, Thurs., Nov. 29, 2018 | The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings",-0.0005041511004806983,0.018188075377910954,0.08515492031254358,"[{'label': 'positive', 'score': 0.9938043355941772}, {'label': 'neutral', 'score': 0.005851769354194403}, {'label': 'negative', 'score': 0.0003438954590819776}]","(0.005851769354194403, 0.9938043355941772, 0.0003438954590819776)",0.9993081605975044,0.9938043355941772,0,0,"[{'label': 'neutral', 'score': 0.6084754467010498}, {'label': 'positive', 'score': 0.3765629231929779}, {'label': 'negative', 'score': 0.01496157143265009}]","(0.6084754467010498, 0.3765629231929779, 0.01496157143265009)",0.9235727437847474,0.3765629231929779,0,1,"[{'label': 'positive', 'score': 0.9656440615653992}, {'label': 'neutral', 'score': 0.03371444717049599}, {'label': 'negative', 'score': 0.0006414461531676352}]","(0.03371444717049599, 0.9656440615653992, 0.0006414461531676352)",0.9986723465310329,0.9656440615653992,0,0
2018-12-01,63.26748275756836,75.66794077555339,75.87786102294922,74.33841959635417,74.80916086832683,19314814.666666668,,-0.0005044053970168805,-0.0005042782273760394,0.10792704746008898,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-02,63.23556518554688,75.62977345784505,75.90648651123047,74.51653798421223,75.34351094563802,16248960.333333334,,-0.0005046599502192416,-0.0005045326522131125,0.1281602308074772,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-03,63.20364761352539,75.59160614013672,75.93511199951172,74.69465637207031,75.87786102294922,13183106.0,,-0.012749366846377699,-0.0005047873339106449,0.13257152592520385,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-04,62.39785385131836,74.62786102294922,76.51717376708984,74.52290344238281,75.66793823242188,15482942.0,"Ahead Of Mid-Week Pause, Investors Fret Over Trade Pact Details | Stocks Which Set New 52-Week High Yesterday, Mon., Dec. 3, 2018 | The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO",0.0010228875105900116,-0.012831337484996649,0.17628192889022337,"[{'label': 'positive', 'score': 0.9961538910865784}, {'label': 'neutral', 'score': 0.003240997204557061}, {'label': 'negative', 'score': 0.0006051369127817452}]","(0.003240997204557061, 0.9961538910865784, 0.0006051369127817452)",0.998785790956925,0.9961538910865784,0,0,"[{'label': 'neutral', 'score': 0.8030881285667419}, {'label': 'positive', 'score': 0.13568368554115295}, {'label': 'negative', 'score': 0.061228178441524506}]","(0.8030881285667419, 0.13568368554115295, 0.061228178441524506)",0.3781159021793546,0.13568368554115295,1,1,"[{'label': 'negative', 'score': 0.8820264935493469}, {'label': 'neutral', 'score': 0.10686036199331284}, {'label': 'positive', 'score': 0.011113127693533897}]","(0.10686036199331284, 0.011113127693533897, 0.8820264935493469)",-0.9751144671466505,-0.8820264935493469,0,0
2018-12-05,62.461687088012695,74.70419692993164,75.64885330200195,73.43511581420898,74.5515251159668,16406230.0,,0.0010218422808831033,0.0010223647176355434,0.09083004844071986,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-06,62.52552032470703,74.78053283691406,74.78053283691406,72.34732818603516,73.43511199951172,17329518.0,"The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering | Ra Pharma Reports Received Development Milestone Payment Under Deal With Merck; Says Is Eligible To Earn Up To $59M In Added Milestone Payments",-0.02105393855759152,0.0010213205554435276,0.09371581289541488,"[{'label': 'positive', 'score': 0.9989396929740906}, {'label': 'neutral', 'score': 0.0007102753152139485}, {'label': 'negative', 'score': 0.0003500479506328702}]","(0.0007102753152139485, 0.9989396929740906, 0.0003500479506328702)",0.9992994064958398,0.9989396929740906,0,0,"[{'label': 'positive', 'score': 0.865699052810669}, {'label': 'neutral', 'score': 0.1198316439986229}, {'label': 'negative', 'score': 0.014469289220869541}]","(0.1198316439986229, 0.865699052810669, 0.014469289220869541)",0.9671215413463461,0.865699052810669,0,0,"[{'label': 'neutral', 'score': 0.8796178698539734}, {'label': 'positive', 'score': 0.08933132141828537}, {'label': 'negative', 'score': 0.031050778925418854}]","(0.8796178698539734, 0.08933132141828537, 0.031050778925418854)",0.48412963660269354,0.08933132141828537,0,0
2018-12-07,61.20911407470703,73.20610809326172,74.71373748779297,72.614501953125,74.63740539550781,13228799.0,,0.0030413592973732627,-0.021278733533887897,0.16024499828512848,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-08,61.39527638753256,73.42875417073567,74.54834493001302,72.53816731770833,74.39249420166016,14207072.0,,0.0030321374778642407,0.0030367437202363378,0.17027099496911674,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-09,61.58143870035807,73.65140024820964,74.38295237223308,72.46183268229167,74.1475830078125,15185345.0,,0.003022971412948334,0.0030275498202882076,0.16622189160483422,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-10,61.7676010131836,73.8740463256836,74.21755981445312,72.385498046875,73.90267181396484,16163618.0,"Merck Names Frank Clyburn Chief Commercial Officer, Michael Nally Chief Marketing Officer; BZ NOTE: These Positions Are Both New Roles For Merck | Merck Reports FDA Orphan Drug Designation For M7824 In Biliary Tract Cancer",-0.004004102524275213,0.00301841142236942,0.16955866722979882,"[{'label': 'neutral', 'score': 0.9998800754547119}, {'label': 'negative', 'score': 6.623478839173913e-05}, {'label': 'positive', 'score': 5.358994167181663e-05}]","(0.9998800754547119, 5.358994167181663e-05, 6.623478839173913e-05)",-0.105527854836106,-6.623478839173913e-05,1,1,"[{'label': 'neutral', 'score': 0.8839936256408691}, {'label': 'positive', 'score': 0.06551258265972137}, {'label': 'negative', 'score': 0.05049379542469978}]","(0.8839936256408691, 0.06551258265972137, 0.05049379542469978)",0.12946518530293213,0.06551258265972137,1,1,"[{'label': 'neutral', 'score': 0.9987381100654602}, {'label': 'positive', 'score': 0.0011120194103568792}, {'label': 'negative', 'score': 0.0001498404162703082}]","(0.9987381100654602, 0.0011120194103568792, 0.0001498404162703082)",0.7625086192484388,0.0011120194103568792,0,1
2018-12-11,61.52025604248047,73.5782470703125,74.72328186035156,73.03434753417969,74.35114288330078,13867660.0,"Gabelli Names Clovis As Top Pick, Calls The Biotech A Likely Takeout Candidate | Merck And Roche Enter Into Collaboration Agreement To Develop Companion Diagnostic Test To Identify Patients Eligible For PD-1 Therapy Based On The Status Of A Biomaker In Advanced Solid Tumors | The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",0.011671551199247452,-0.004012140406298216,0.16721808682563336,"[{'label': 'positive', 'score': 0.9098999500274658}, {'label': 'neutral', 'score': 0.08963784575462341}, {'label': 'negative', 'score': 0.00046221973025240004}]","(0.08963784575462341, 0.9098999500274658, 0.00046221973025240004)",0.998984536603986,0.9098999500274658,0,0,"[{'label': 'positive', 'score': 0.7358629703521729}, {'label': 'neutral', 'score': 0.25285252928733826}, {'label': 'negative', 'score': 0.011284537613391876}]","(0.25285252928733826, 0.7358629703521729, 0.011284537613391876)",0.969793012777038,0.7358629703521729,0,0,"[{'label': 'positive', 'score': 0.977790355682373}, {'label': 'neutral', 'score': 0.0218818262219429}, {'label': 'negative', 'score': 0.00032783448114059865}]","(0.0218818262219429, 0.977790355682373, 0.00032783448114059865)",0.9993296628476241,0.977790355682373,0,0
2018-12-12,62.2383041381836,74.43701934814453,75.15267181396484,74.1603012084961,74.20801544189453,11219678.0,Merck and Instituto Butantan Announce Collaboration Agreement To Develop Dengue Infections Vaccine; Instituto Butantan To Receive $26M Upfront And Is Eligible For Up To $75M In Milestones,0.012818900501188477,0.01160396403523554,0.0878994698017663,"[{'label': 'positive', 'score': 0.984514057636261}, {'label': 'neutral', 'score': 0.015186880715191364}, {'label': 'negative', 'score': 0.0002990801876876503}]","(0.015186880715191364, 0.984514057636261, 0.0002990801876876503)",0.9993926153577753,0.984514057636261,0,0,"[{'label': 'positive', 'score': 0.926361083984375}, {'label': 'neutral', 'score': 0.06162299960851669}, {'label': 'negative', 'score': 0.012015930376946926}]","(0.06162299960851669, 0.926361083984375, 0.012015930376946926)",0.9743899729148306,0.926361083984375,0,0,"[{'label': 'positive', 'score': 0.9971398115158081}, {'label': 'neutral', 'score': 0.0026328456588089466}, {'label': 'negative', 'score': 0.0002274233993375674}]","(0.0026328456588089466, 0.9971398115158081, 0.0002274233993375674)",0.9995439525354832,0.9971398115158081,0,0
2018-12-13,63.03611373901367,75.39122009277344,75.45801544189453,74.42748260498047,74.66603088378906,11272498.0,,-0.0320212822154294,0.012737433865943719,0.11002130743865748,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-12-14,61.44536590576172,72.97709655761719,74.45610809326172,72.7385482788086,74.26526641845703,13896375.0,"Stocks Trading Ex Dividend For Fri., Dec. 14 2018 | A Peek Into The Markets: US Stock Futures Tumble Ahead Of Economic Reports | Merck Reports Purchase Of Antelliq Group For 2.1B In Cash, Assume 1.15B In Co. Debt",-0.005448051876092365,-0.03254517770699155,0.29318157936699324,"[{'label': 'negative', 'score': 0.7694461941719055}, {'label': 'neutral', 'score': 0.22966355085372925}, {'label': 'positive', 'score': 0.0008901996770873666}]","(0.22966355085372925, 0.0008901996770873666, 0.7694461941719055)",-0.9976888027511216,-0.7694461941719055,0,0,"[{'label': 'negative', 'score': 0.9555196166038513}, {'label': 'neutral', 'score': 0.026840440928936005}, {'label': 'positive', 'score': 0.017639905214309692}]","(0.026840440928936005, 0.017639905214309692, 0.9555196166038513)",-0.9637471456244853,-0.9555196166038513,0,0,"[{'label': 'negative', 'score': 0.8694929480552673}, {'label': 'neutral', 'score': 0.1261598765850067}, {'label': 'positive', 'score': 0.004347188863903284}]","(0.1261598765850067, 0.004347188863903284, 0.8694929480552673)",-0.9900503795139696,-0.8694929480552673,0,0
2018-12-15,61.11060460408529,72.57951354980469,74.09351348876953,72.30279795328777,73.67366282145183,14541524.0,,-0.0054778957362351995,-0.00546294663362155,0.2904986561769677,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-16,60.77584330240885,72.18193054199219,73.73091888427734,71.86704762776692,73.08205922444661,15186673.0,,-0.005508068360421645,-0.005492954425547996,0.2908416556427579,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-17,60.44108200073242,71.78434753417969,73.36832427978516,71.4312973022461,72.4904556274414,15831822.0,Merck's KEYTRUDA as Adjuvant Therapy for Adults with Resected Stage III Melanoma Approved by the European Commission,-0.01196322467684382,-0.00552329370284221,0.25702558028221273,"[{'label': 'positive', 'score': 0.9944157600402832}, {'label': 'neutral', 'score': 0.005065439268946648}, {'label': 'negative', 'score': 0.0005187412025406957}]","(0.005065439268946648, 0.9944157600402832, 0.0005187412025406957)",0.9989572354725005,0.9944157600402832,0,0,"[{'label': 'positive', 'score': 0.8072625398635864}, {'label': 'neutral', 'score': 0.1837976723909378}, {'label': 'negative', 'score': 0.008939811959862709}]","(0.1837976723909378, 0.8072625398635864, 0.008939811959862709)",0.9780941283986977,0.8072625398635864,0,0,"[{'label': 'neutral', 'score': 0.9239600300788879}, {'label': 'positive', 'score': 0.07567906379699707}, {'label': 'negative', 'score': 0.0003609753621276468}]","(0.9239600300788879, 0.07567906379699707, 0.0003609753621276468)",0.9905056502832079,0.07567906379699707,0,1
2018-12-18,59.71801376342773,70.92557525634766,72.30915832519531,70.19084167480469,72.13740539550781,16163828.0,,-0.007534026500918585,-0.012035359939990057,0.18595944304076606,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-19,59.2680892944336,70.39122009277344,71.80343627929688,69.72328186035156,71.2595443725586,19765594.0,"FDA Approves Merck's KEYTRUDA For Treatment Of Recurrent Locally Advanced Or Metastatic Merkel Cell Carcinoma | AstraZeneca, Merck Report FDA Approval For LYNPARZA For First-Line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer | Merck Announces FDA Approval Of LYNPARZA For Ovarian Cancer | Merck Receives FDA Approval For Pembrolizumab In Merkel Cell Carcinoma",-0.003795555280015278,-0.007562550636618168,0.04507749713401158,"[{'label': 'positive', 'score': 0.9989408850669861}, {'label': 'neutral', 'score': 0.0007823958294466138}, {'label': 'negative', 'score': 0.0002766699471976608}]","(0.0007823958294466138, 0.9989408850669861, 0.0002766699471976608)",0.9994462268085478,0.9989408850669861,0,0,"[{'label': 'positive', 'score': 0.8958088159561157}, {'label': 'neutral', 'score': 0.0799175351858139}, {'label': 'negative', 'score': 0.024273641407489777}]","(0.0799175351858139, 0.8958088159561157, 0.024273641407489777)",0.9472359434456707,0.8958088159561157,0,0,"[{'label': 'positive', 'score': 0.9956278800964355}, {'label': 'neutral', 'score': 0.004048990085721016}, {'label': 'negative', 'score': 0.000323107757139951}]","(0.004048990085721016, 0.9956278800964355, 0.000323107757139951)",0.9993511573138025,0.9956278800964355,0,0
2018-12-20,59.04314041137695,70.1240463256836,70.73473358154297,69.31298065185547,70.08587646484375,20321454.0,"Merck Extends PDUFA Date For Supplemental Biologics Licence For Keytruda By Three Months To April 11, 2019 | The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum | AstraZeneca, Merck Report LYNPARZA Met Primary Endpoint In Phase 3 SOLO-3 Trial For Treatment of Relapsed BRCA-Mutated Advanced Ovarian Cancer",-0.00802835377241019,-0.0038027766785600553,0.05037337102358192,"[{'label': 'neutral', 'score': 0.9434952735900879}, {'label': 'positive', 'score': 0.05107223242521286}, {'label': 'negative', 'score': 0.005432456731796265}]","(0.9434952735900879, 0.05107223242521286, 0.005432456731796265)",0.8077166050165805,0.05107223242521286,0,0,"[{'label': 'positive', 'score': 0.7318435907363892}, {'label': 'neutral', 'score': 0.2584797441959381}, {'label': 'negative', 'score': 0.009676692076027393}]","(0.2584797441959381, 0.7318435907363892, 0.009676692076027393)",0.9739003981406256,0.7318435907363892,0,0,"[{'label': 'neutral', 'score': 0.8916316628456116}, {'label': 'positive', 'score': 0.1064823716878891}, {'label': 'negative', 'score': 0.0018858828116208315}]","(0.8916316628456116, 0.1064823716878891, 0.0018858828116208315)",0.9651949213294866,0.1064823716878891,0,0
2018-12-21,58.56912612915039,69.56106567382812,71.04007720947266,68.91221618652344,69.60877990722656,37919994.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",-0.008001820965407,-0.008060754537614848,0.04919277716514638,"[{'label': 'neutral', 'score': 0.5480196475982666}, {'label': 'positive', 'score': 0.42595818638801575}, {'label': 'negative', 'score': 0.026022130623459816}]","(0.5480196475982666, 0.42595818638801575, 0.026022130623459816)",0.8848528148503462,0.42595818638801575,0,0,"[{'label': 'negative', 'score': 0.736702561378479}, {'label': 'neutral', 'score': 0.2442701756954193}, {'label': 'positive', 'score': 0.01902724988758564}]","(0.2442701756954193, 0.01902724988758564, 0.736702561378479)",-0.949645363716142,-0.736702561378479,1,1,"[{'label': 'negative', 'score': 0.8123309016227722}, {'label': 'neutral', 'score': 0.18441416323184967}, {'label': 'positive', 'score': 0.003254907438531518}]","(0.18441416323184967, 0.003254907438531518, 0.8123309016227722)",-0.9920182342498634,-0.8123309016227722,1,1
2018-12-22,58.10046641031901,69.00445048014323,70.54707336425781,68.4891866048177,69.47519175211589,29135273.666666668,,-0.00806636658667512,-0.008034007349560989,0.046313117452372474,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-12-23,57.63180669148763,68.44783528645833,70.05406951904297,68.06615702311198,69.3416035970052,20350553.333333336,The Week Ahead In Biotech: Focus Shifts To Year-End Clinical Trial Results,-0.00813196197301818,-0.008099075736373387,0.029569340128519143,"[{'label': 'neutral', 'score': 0.8443630337715149}, {'label': 'positive', 'score': 0.1551714986562729}, {'label': 'negative', 'score': 0.0004654935037251562}]","(0.8443630337715149, 0.1551714986562729, 0.0004654935037251562)",0.99401821511371,0.1551714986562729,0,0,"[{'label': 'neutral', 'score': 0.8823010921478271}, {'label': 'negative', 'score': 0.06971089541912079}, {'label': 'positive', 'score': 0.04798804223537445}]","(0.8823010921478271, 0.04798804223537445, 0.06971089541912079)",-0.1845628653634384,-0.06971089541912079,0,0,"[{'label': 'neutral', 'score': 0.9993755221366882}, {'label': 'positive', 'score': 0.0004438534961082041}, {'label': 'negative', 'score': 0.00018061850278172642}]","(0.9993755221366882, 0.0004438534961082041, 0.00018061850278172642)",0.4215321003894612,0.0004438534961082041,0,0
2018-12-24,57.16314697265625,67.89122009277344,69.56106567382812,67.64312744140625,69.20801544189453,11565833.0,,0.020028121157417575,-0.00816520672850958,0.03044463772941973,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2018-12-25,58.30801200866699,69.2509536743164,70.10018920898438,67.6812973022461,68.46374130249023,12819922.0,,0.01963487157068947,0.019830196678314913,0.19821358330434996,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-26,59.45287704467773,70.61068725585938,70.63931274414062,67.71946716308594,67.71946716308594,14074011.0,,0.018648669207108223,0.019444594161621972,0.24117770606469208,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-27,60.56159591674805,71.92748260498047,71.92748260498047,69.42748260498047,69.92366027832031,13577154.0,,-0.00013269437790573905,0.018476914816910217,0.23821677276279318,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-28,60.55356597900391,71.91793823242188,73.07251739501953,71.40267181396484,72.40457916259766,13180696.0,,0.004599515320119137,-0.000132703182583611,0.20853659383587195,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-29,60.83208084106445,72.24872589111328,73.11068471272786,71.66666666666667,72.38549550374348,12016298.0,,0.004578456638667087,0.0045889698731285304,0.15056433325708185,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2018-12-30,61.110595703125,72.57951354980469,73.1488520304362,71.93066151936848,72.36641184488933,10851900.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",0.004557589910883281,0.0045680073882251055,0.1421301037120269,"[{'label': 'neutral', 'score': 0.9998811483383179}, {'label': 'negative', 'score': 6.308517185971141e-05}, {'label': 'positive', 'score': 5.5740463722031564e-05}]","(0.9998811483383179, 5.5740463722031564e-05, 6.308517185971141e-05)",-0.061810804560159464,-6.308517185971141e-05,1,1,"[{'label': 'neutral', 'score': 0.9485455751419067}, {'label': 'positive', 'score': 0.02802564948797226}, {'label': 'negative', 'score': 0.023428717628121376}]","(0.9485455751419067, 0.02802564948797226, 0.023428717628121376)",0.08933997476791583,0.02802564948797226,1,1,"[{'label': 'neutral', 'score': 0.9995757937431335}, {'label': 'positive', 'score': 0.0002782561059575528}, {'label': 'negative', 'score': 0.00014591225772164762}]","(0.9995757937431335, 0.0002782561059575528, 0.00014591225772164762)",0.3120078241761499,0.0002782561059575528,1,1
2018-12-31,61.38911056518555,72.9103012084961,73.18701934814453,72.19465637207031,72.34732818603516,9687502.0,Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates,-0.005365772549131224,0.004547235546696023,0.11185513722086808,"[{'label': 'neutral', 'score': 0.9998801946640015}, {'label': 'negative', 'score': 6.648629641858861e-05}, {'label': 'positive', 'score': 5.333924127626233e-05}]","(0.9998801946640015, 5.333924127626233e-05, 6.648629641858861e-05)",-0.10971830709248907,-6.648629641858861e-05,1,1,"[{'label': 'neutral', 'score': 0.947795569896698}, {'label': 'positive', 'score': 0.029710624366998672}, {'label': 'negative', 'score': 0.022493811324238777}]","(0.947795569896698, 0.029710624366998672, 0.022493811324238777)",0.1382413763735261,0.029710624366998672,1,1,"[{'label': 'neutral', 'score': 0.9995591044425964}, {'label': 'positive', 'score': 0.0002712681598495692}, {'label': 'negative', 'score': 0.0001695712999207899}]","(0.9995591044425964, 0.0002712681598495692, 0.0001695712999207899)",0.23068910387866584,0.0002712681598495692,1,1
2019-01-01,61.05971336364746,72.51908111572266,72.84828186035156,71.68893051147461,72.09446716308594,12403813.5,,-0.005394719386324631,-0.00538022001102747,0.07016623139941501,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-02,60.730316162109375,72.12786102294922,72.5095443725586,71.1832046508789,71.84160614013672,15120125.0,,-0.02050530662179791,-0.005409323431785147,0.08662565453115839,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-01-03,59.48501968383789,70.64885711669922,72.4904556274414,70.46755981445312,72.09923553466797,13910628.0,"Amunix Reports Licensing Deal With Merck For ProTIA Immune Activator Platform, No Terms Disclosed | Cocrystal Pharma Announces Exclusive Worldwide License And Collaboration Agreement With Merck To Develop Influenza A/B Agents; Cococrystal Will Receive Upfront Payment On An Undisclosed Amount, Is Eligible For Up To $156M In Milestones Plus Royalties | The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen | Merck Reports KEYTRUDA Received 5 New Approvals In Japan, Including Advanced Non-Small Cell Lung Cancer, As Adjuvant Therapy for Melanoma, In Advanced Microsatellite Instability-High Tumors | Merck Reports Exercise Of Its Option For NGM Bio's NGM313 For Treatment Of NASH, Type 2 Diabetes | Merck Exercises Option for NGM Bio's Investigational Insulin Sensitizer NGM313 for Treatment of NASH and Type 2 Diabetes",0.0301188314969395,-0.020718459296543958,0.16434505607896335,"[{'label': 'positive', 'score': 0.997533917427063}, {'label': 'neutral', 'score': 0.0021431201603263617}, {'label': 'negative', 'score': 0.0003229957656003535}]","(0.0021431201603263617, 0.997533917427063, 0.0003229957656003535)",0.9993526210795756,0.997533917427063,1,1,"[{'label': 'positive', 'score': 0.8168061375617981}, {'label': 'neutral', 'score': 0.17323434352874756}, {'label': 'negative', 'score': 0.009959455579519272}]","(0.17323434352874756, 0.8168061375617981, 0.009959455579519272)",0.9759074260899561,0.8168061375617981,1,1,"[{'label': 'positive', 'score': 0.9938564896583557}, {'label': 'neutral', 'score': 0.005886228755116463}, {'label': 'negative', 'score': 0.0002573141537141055}]","(0.005886228755116463, 0.9938564896583557, 0.0002573141537141055)",0.999482324553331,0.9938564896583557,1,1
2019-01-04,61.27664566040039,72.77671813964844,72.99618530273438,71.22137451171875,71.3167953491211,14753115.0,,-0.0036711783253084397,0.02967416597227137,0.29562654420824436,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-05,61.051682790120445,72.50954182942708,72.9866434733073,71.4662857055664,71.76526896158855,15100457.333333334,,-0.003684705536408652,-0.00367793363883154,0.2943714976859971,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-06,60.82671991984049,72.24236551920573,72.9771016438802,71.71119689941406,72.21374257405598,15447799.666666666,,-0.0036983328037663676,-0.0036915107858904793,0.2930666703306194,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-07,60.60175704956055,71.97518920898438,72.96755981445312,71.95610809326172,72.66221618652344,15795142.0,5 Top-Selling Drugs With Growth Potential In 2019,0.007424157816698276,-0.0037051885449582572,0.29161125091761264,"[{'label': 'neutral', 'score': 0.6975479125976562}, {'label': 'positive', 'score': 0.301787406206131}, {'label': 'negative', 'score': 0.0006646688561886549}]","(0.6975479125976562, 0.301787406206131, 0.0006646688561886549)",0.9956047988359696,0.301787406206131,0,1,"[{'label': 'positive', 'score': 0.7495583295822144}, {'label': 'neutral', 'score': 0.24086421728134155}, {'label': 'negative', 'score': 0.009577465243637562}]","(0.24086421728134155, 0.7495583295822144, 0.009577465243637562)",0.974767451860613,0.7495583295822144,0,0,"[{'label': 'positive', 'score': 0.9980630278587341}, {'label': 'neutral', 'score': 0.0016267560422420502}, {'label': 'negative', 'score': 0.00031023239716887474}]","(0.0016267560422420502, 0.9980630278587341, 0.00031023239716887474)",0.9993785242263212,0.9980630278587341,0,0
2019-01-08,61.05168151855469,72.5095443725586,72.71946716308594,71.84160614013672,72.39503479003906,11896686.0,,-0.0076325990472824465,0.007396734403908109,0.23017892605563833,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-09,60.585693359375,71.95610809326172,72.81488800048828,71.87023162841797,72.41412353515625,11916284.0,How 7 New Laws Affected Stocks In The Last Week,-0.012332593007360176,-0.007661876401403912,0.0900032801008047,"[{'label': 'neutral', 'score': 0.998473584651947}, {'label': 'negative', 'score': 0.0011986978352069855}, {'label': 'positive', 'score': 0.0003276495262980461}]","(0.998473584651947, 0.0003276495262980461, 0.0011986978352069855)",-0.5706750185947551,-0.0011986978352069855,0,1,"[{'label': 'negative', 'score': 0.866688072681427}, {'label': 'neutral', 'score': 0.11831950396299362}, {'label': 'positive', 'score': 0.014992352575063705}]","(0.11831950396299362, 0.014992352575063705, 0.866688072681427)",-0.9659914133384503,-0.866688072681427,0,0,"[{'label': 'neutral', 'score': 0.9261020421981812}, {'label': 'negative', 'score': 0.07141238451004028}, {'label': 'positive', 'score': 0.0024855907540768385}]","(0.9261020421981812, 0.0024855907540768385, 0.07141238451004028)",-0.932729124304336,-0.07141238451004028,0,1
2019-01-10,59.83853149414063,71.0687026977539,72.21373748779297,70.10496520996094,72.21373748779297,19134070.0,,0.005639113282205688,-0.012409270506284292,0.11616403451837261,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-11,60.17596054077149,71.46946716308594,71.50763702392578,70.75381469726562,71.27862548828125,9878029.0,,-0.006809074552988018,0.005623273005078828,0.13507702769963256,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-12,59.766215006510414,70.98282623291016,71.34860229492188,70.41984558105469,71.14821879069011,11808514.666666666,,-0.006855755906069534,-0.0068323620722938305,0.1391077227610288,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-13,59.35646947224935,70.49618530273438,71.18956756591797,70.08587646484375,71.01781209309895,13739000.333333332,,-0.006903081749544051,-0.006879364565937321,0.10640946550495496,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-14,58.94672393798828,70.0095443725586,71.03053283691406,69.75190734863281,70.88740539550781,15669486.0,"Merck Reports KEYTRUDA Reduced Risk Of Death By 31% Vs Chemotherapy In Previously-Treated Patients With Advanced Esophageal, Esophagogastric Junction Carcinoma Whose Tumors Expressed PD-L1",0.015401320642512317,-0.0069270182389963774,0.10565147044751588,"[{'label': 'positive', 'score': 0.9993345141410828}, {'label': 'negative', 'score': 0.0003676845517475158}, {'label': 'neutral', 'score': 0.00029772313428111374}]","(0.00029772313428111374, 0.9993345141410828, 0.0003676845517475158)",0.9992644118373886,0.9993345141410828,0,0,"[{'label': 'positive', 'score': 0.7891795635223389}, {'label': 'negative', 'score': 0.16684618592262268}, {'label': 'neutral', 'score': 0.04397430270910263}]","(0.04397430270910263, 0.7891795635223389, 0.16684618592262268)",0.6509588031086228,0.7891795635223389,0,0,"[{'label': 'positive', 'score': 0.9970560073852539}, {'label': 'neutral', 'score': 0.0023366971872746944}, {'label': 'negative', 'score': 0.0006073232507333159}]","(0.0023366971872746944, 0.9970560073852539, 0.0006073232507333159)",0.9987825086237335,0.9970560073852539,0,0
2019-01-15,59.85459518432617,71.08778381347656,71.45992279052734,69.75190734863281,69.75190734863281,13102096.0,"Bank Of America, JPMorgan, Merck, Stratasys: 'Fast Money' Picks For January 15",0.0014765576352239382,0.01528392414338213,0.16016653392890803,"[{'label': 'neutral', 'score': 0.9998483657836914}, {'label': 'negative', 'score': 7.983833347680047e-05}, {'label': 'positive', 'score': 7.174976781243458e-05}]","(0.9998483657836914, 7.174976781243458e-05, 7.983833347680047e-05)",-0.05335884278234108,-7.983833347680047e-05,1,1,"[{'label': 'neutral', 'score': 0.9383251667022705}, {'label': 'positive', 'score': 0.04136627912521362}, {'label': 'negative', 'score': 0.020308615639805794}]","(0.9383251667022705, 0.04136627912521362, 0.020308615639805794)",0.3414300675442944,0.04136627912521362,1,1,"[{'label': 'neutral', 'score': 0.9995049238204956}, {'label': 'positive', 'score': 0.0003800460253842175}, {'label': 'negative', 'score': 0.00011502212146297097}]","(0.9995049238204956, 0.0003800460253842175, 0.00011502212146297097)",0.5353281272669939,0.0003800460253842175,0,1
2019-01-16,59.94296646118164,71.1927490234375,72.29962158203125,71.05915832519531,71.3167953491211,15272504.0,,0.013268996983938918,0.0014754685958867217,0.1536542236726285,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-17,60.73835372924805,72.13740539550781,72.29962158203125,70.90648651123047,70.90648651123047,16969321.0,,0.003571370402341824,0.013181734915975568,0.16889326033662116,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-18,60.95525741577149,72.39503479003906,72.83396911621094,72.01335906982422,72.65267181396484,14980741.0,,-0.00013178469889541132,0.003565008202415232,0.14395484063065275,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-19,60.94723033905029,72.38549423217773,72.80295753479004,71.98711776733398,72.51669883728027,13877747.25,,-0.00013180206839130806,-0.00013179338326182728,0.11210673272072556,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-20,60.9392032623291,72.3759536743164,72.77194595336914,71.96087646484375,72.3807258605957,12774753.5,,-0.00013181944246647934,-0.0001318107550472663,0.0884485258624272,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-21,60.93117618560791,72.36641311645508,72.74093437194824,71.93463516235352,72.24475288391113,11671759.75,,-0.0001318368211227363,-0.00013182813141272568,0.09155286708854343,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-22,60.92314910888672,72.35687255859375,72.70992279052734,71.90839385986328,72.10877990722656,10568766.0,,-0.00514310477901636,-0.00013184551236031534,0.026244872773279037,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-01-23,60.60978317260742,71.98473358154297,72.24236297607422,71.3167953491211,72.0896987915039,14369233.0,"Benzinga's Top Upgrades, Downgrades For January 23, 2019 | BMO Capital Downgrades Merck & Co to Market Perform, Announces $80 Price Target",-0.030090142395754273,-0.0051563760657018665,0.03567081340896518,"[{'label': 'neutral', 'score': 0.9816777110099792}, {'label': 'negative', 'score': 0.016819104552268982}, {'label': 'positive', 'score': 0.0015032292576506734}]","(0.9816777110099792, 0.0015032292576506734, 0.016819104552268982)",-0.8359129057198129,-0.016819104552268982,1,0,"[{'label': 'negative', 'score': 0.7104606628417969}, {'label': 'positive', 'score': 0.22189894318580627}, {'label': 'neutral', 'score': 0.06764040887355804}]","(0.06764040887355804, 0.22189894318580627, 0.7104606628417969)",-0.5240056695908879,-0.7104606628417969,1,1,"[{'label': 'negative', 'score': 0.544618546962738}, {'label': 'neutral', 'score': 0.44372332096099854}, {'label': 'positive', 'score': 0.011658151634037495}]","(0.44372332096099854, 0.011658151634037495, 0.544618546962738)",-0.958085062115866,-0.544618546962738,1,1
2019-01-24,58.78604888916016,69.8187026977539,71.71755981445312,69.06488800048828,71.71755981445312,21986621.0,Bristol-Myers Squibb Withdraws Regulatory Application For Lung Cancer Combo Drug,-0.0030066842037455538,-0.030552142107898153,0.2099060695629486,"[{'label': 'neutral', 'score': 0.5519816279411316}, {'label': 'negative', 'score': 0.43471360206604004}, {'label': 'positive', 'score': 0.013304783962666988}]","(0.5519816279411316, 0.013304783962666988, 0.43471360206604004)",-0.9406060805646737,-0.43471360206604004,0,1,"[{'label': 'negative', 'score': 0.7207168340682983}, {'label': 'neutral', 'score': 0.250710129737854}, {'label': 'positive', 'score': 0.02857300639152527}]","(0.250710129737854, 0.02857300639152527, 0.7207168340682983)",-0.9237331007344485,-0.7207168340682983,0,0,"[{'label': 'neutral', 'score': 0.9954090714454651}, {'label': 'positive', 'score': 0.0029008649289608}, {'label': 'negative', 'score': 0.0016901412745937705}]","(0.9954090714454651, 0.0029008649289608, 0.0016901412745937705)",0.2637164056606221,0.0029008649289608,1,1
2019-01-25,58.60929107666016,69.60877990722656,70.45801544189453,68.8167953491211,70.43893432617188,14054099.0,,-0.00013707795826612375,-0.0030112133594683422,0.20471077985403083,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-26,58.60125859578451,69.59923807779948,70.21310424804688,68.79453023274739,70.01908620198567,13828290.0,,-0.00013709675120906857,-0.00013708735430810974,0.2046983770699596,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-01-27,58.59322611490885,69.58969624837239,69.96819305419922,68.7722651163737,69.59923807779948,13602481.0,"Barron's On: The Cost Of Climate Change | The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",-0.00013711554930521437,-0.00013710614982771738,0.20468596852402401,"[{'label': 'neutral', 'score': 0.9998639822006226}, {'label': 'negative', 'score': 7.255936361616477e-05}, {'label': 'positive', 'score': 6.340707477647811e-05}]","(0.9998639822006226, 6.340707477647811e-05, 7.255936361616477e-05)",-0.06731285270014023,-7.255936361616477e-05,1,1,"[{'label': 'neutral', 'score': 0.9454094767570496}, {'label': 'positive', 'score': 0.032771818339824677}, {'label': 'negative', 'score': 0.021818656474351883}]","(0.9454094767570496, 0.032771818339824677, 0.021818656474351883)",0.20064236302682562,0.032771818339824677,1,1,"[{'label': 'neutral', 'score': 0.9991733431816101}, {'label': 'positive', 'score': 0.000613384647294879}, {'label': 'negative', 'score': 0.0002132403024006635}]","(0.9991733431816101, 0.000613384647294879, 0.0002132403024006635)",0.4840700066476269,0.000613384647294879,1,1
2019-01-28,58.5851936340332,69.58015441894531,69.72328186035156,68.75,69.17938995361328,13376672.0,Evelo Biosciences Announces First Patient Does in Investigator-Sponsored Phase 2a Clinical Trial of EDP1503 in Combination with KEYTRUDA in Patients with Metastatic Melanoma,0.004251201478945746,-0.00013712495050148513,0.21174794950288242,"[{'label': 'neutral', 'score': 0.9997738003730774}, {'label': 'positive', 'score': 0.0001642396382521838}, {'label': 'negative', 'score': 6.20144055574201e-05}]","(0.9997738003730774, 0.0001642396382521838, 6.20144055574201e-05)",0.451816157508273,0.0001642396382521838,1,1,"[{'label': 'positive', 'score': 0.586767852306366}, {'label': 'neutral', 'score': 0.4005296230316162}, {'label': 'negative', 'score': 0.01270249206572771}]","(0.4005296230316162, 0.586767852306366, 0.01270249206572771)",0.9576209492763724,0.586767852306366,0,0,"[{'label': 'neutral', 'score': 0.9610787630081177}, {'label': 'positive', 'score': 0.03860316425561905}, {'label': 'negative', 'score': 0.0003180305357091129}]","(0.9610787630081177, 0.03860316425561905, 0.0003180305357091129)",0.9836577197892202,0.03860316425561905,0,1
2019-01-29,58.834251403808594,69.8759536743164,70.30534362792969,69.31298065185547,69.56106567382812,11966693.0,How To Approach Q4 Earnings: The Technical Perspective,0.0019118264755975712,0.004242190650808954,0.04123219198339048,"[{'label': 'neutral', 'score': 0.9998608827590942}, {'label': 'negative', 'score': 7.667653699172661e-05}, {'label': 'positive', 'score': 6.247618875931948e-05}]","(0.9998608827590942, 6.247618875931948e-05, 7.667653699172661e-05)",-0.10204865305917567,-7.667653699172661e-05,1,1,"[{'label': 'neutral', 'score': 0.9211301803588867}, {'label': 'positive', 'score': 0.06257106363773346}, {'label': 'negative', 'score': 0.016298726201057434}]","(0.9211301803588867, 0.06257106363773346, 0.016298726201057434)",0.586692794937786,0.06257106363773346,0,1,"[{'label': 'neutral', 'score': 0.99955815076828}, {'label': 'positive', 'score': 0.0003112353733740747}, {'label': 'negative', 'score': 0.0001306272897636518}]","(0.99955815076828, 0.0003112353733740747, 0.0001306272897636518)",0.4087425769987002,0.0003112353733740747,1,1
2019-01-30,58.94672393798828,70.0095443725586,70.42938995361328,69.67557525634766,70.09542083740234,13941230.0,,0.01444723145767718,0.0019100012613195163,0.03085250015829172,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-01-31,59.79834747314453,71.02098846435547,71.39312744140625,69.7614517211914,69.79962158203125,16797658.0,Merck's Q4 Earnings Preview,0.02713961952173966,0.014343864596466959,0.09578917143757157,"[{'label': 'neutral', 'score': 0.9998303651809692}, {'label': 'negative', 'score': 8.713606803212315e-05}, {'label': 'positive', 'score': 8.250555401900783e-05}]","(0.9998303651809692, 8.250555401900783e-05, 8.713606803212315e-05)",-0.0272958602796173,-8.713606803212315e-05,0,0,"[{'label': 'neutral', 'score': 0.8887167572975159}, {'label': 'positive', 'score': 0.062465958297252655}, {'label': 'negative', 'score': 0.04881732165813446}]","(0.8887167572975159, 0.062465958297252655, 0.04881732165813446)",0.12264768476081817,0.062465958297252655,0,0,"[{'label': 'neutral', 'score': 0.9992926120758057}, {'label': 'positive', 'score': 0.0004652004281524569}, {'label': 'negative', 'score': 0.00024215431767515838}]","(0.9992926120758057, 0.0004652004281524569, 0.00024215431767515838)",0.3153242581504579,0.0004652004281524569,0,0
2019-02-01,61.42125701904297,72.94847106933594,73.94084167480469,71.87976837158203,72.4904556274414,15941757.0,"Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates | Merck & Co shares are trading higher after the company reported inline Q4 EPS figures and beat sales estimates. | The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of  Titan's Opioid Disorder Treatment Implant | Merck Sees FY19 Adj. EPS $4.57-$4.72 vs $4.69 Estimate, Sales $43.2B-$44.7B vs $44.54B Est. | Merck Q4 EPS $1.04, Inline, Sales $10.998B Beat $10.96B Estimate | 12 Stocks To Watch For February 1, 2019 | Earnings Scheduled For February 1, 2019",0.0018312673747980228,0.026777870607608598,0.17749805948234398,"[{'label': 'positive', 'score': 0.9996474981307983}, {'label': 'negative', 'score': 0.00023965135915204883}, {'label': 'neutral', 'score': 0.0001129010779550299}]","(0.0001129010779550299, 0.9996474981307983, 0.00023965135915204883)",0.999520643186035,0.9996474981307983,0,0,"[{'label': 'positive', 'score': 0.9300342202186584}, {'label': 'neutral', 'score': 0.03859739378094673}, {'label': 'negative', 'score': 0.0313684307038784}]","(0.03859739378094673, 0.9300342202186584, 0.0313684307038784)",0.934744447243248,0.9300342202186584,0,0,"[{'label': 'positive', 'score': 0.9978323578834534}, {'label': 'neutral', 'score': 0.0017159068956971169}, {'label': 'negative', 'score': 0.0004517819033935666}]","(0.0017159068956971169, 0.9978323578834534, 0.0004517819033935666)",0.9990948831392031,0.9978323578834534,0,0
2019-02-02,61.533730824788414,73.08205922444661,73.75000254313152,71.99109141031902,72.48409525553386,14569226.333333334,"Barron's Picks And Pans: Corning, Merck, Microsoft And More",0.0018279199646032977,0.0018295926489678024,0.17126110579632187,"[{'label': 'neutral', 'score': 0.9998787641525269}, {'label': 'negative', 'score': 6.366983870975673e-05}, {'label': 'positive', 'score': 5.756524842581712e-05}]","(0.9998787641525269, 5.756524842581712e-05, 6.366983870975673e-05)",-0.05035332945414573,-6.366983870975673e-05,1,1,"[{'label': 'neutral', 'score': 0.9464148879051208}, {'label': 'positive', 'score': 0.02813098207116127}, {'label': 'negative', 'score': 0.025454159826040268}]","(0.9464148879051208, 0.02813098207116127, 0.025454159826040268)",0.04995456110308067,0.02813098207116127,1,1,"[{'label': 'neutral', 'score': 0.999415397644043}, {'label': 'positive', 'score': 0.00048400822561234236}, {'label': 'negative', 'score': 0.0001005781305138953}]","(0.999415397644043, 0.00048400822561234236, 0.0001005781305138953)",0.6558998359784637,0.00048400822561234236,0,1
2019-02-03,61.64620463053385,73.2156473795573,73.55916341145833,72.10241444905598,72.4777348836263,13196695.666666668,,0.0018245847696755023,0.0018262513519890127,0.1769821607886842,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-02-04,61.7586784362793,73.34923553466797,73.36832427978516,72.21373748779297,72.47137451171875,11824165.0,UPDATE: Financial Terms Of Codexis/Merck Deal Were Not Disclosed | Codexis Reports Secured Multi-Year Technology Upgrade Package For CodeEvolver Protein Engineering Platform License With Merck | Merck Announces the European Medicines Agency Gave a Positive Opinion on KEYTRUDA in Combination with Chemotherapy for First-Line Treatment of Adults with Metastatic Squamous Non-Small Cell Lung Cancer,0.0036424887749997893,0.0018229222368653733,0.1772133228126925,"[{'label': 'positive', 'score': 0.9992733597755432}, {'label': 'neutral', 'score': 0.000457802671007812}, {'label': 'negative', 'score': 0.00026889648870564997}]","(0.000457802671007812, 0.9992733597755432, 0.00026889648870564997)",0.9994619607384871,0.9992733597755432,0,0,"[{'label': 'positive', 'score': 0.947287917137146}, {'label': 'neutral', 'score': 0.03831439092755318}, {'label': 'negative', 'score': 0.014397640712559223}]","(0.03831439092755318, 0.947287917137146, 0.014397640712559223)",0.970057487928275,0.947287917137146,0,0,"[{'label': 'positive', 'score': 0.9965780377388}, {'label': 'neutral', 'score': 0.0031239783857017756}, {'label': 'negative', 'score': 0.00029792924760840833}]","(0.0031239783857017756, 0.9965780377388, 0.00029792924760840833)",0.9994022741896185,0.9965780377388,0,0
2019-02-05,61.983642578125,73.61640930175781,74.79007720947266,73.53053283691406,73.83587646484375,12955690.0,"Merck Says CEO Frazier Plans To Testify At Feb 26 Senate Drug Pricing Hearing | Codexis shares are trading higher after the company reported a multi-year agreement with Merck to perform technology upgrades. | The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results | FDA Accepts For Review New Drug Application For Merck's Investigational Combination Of Imipenem/Cilastatin And Relebactam; Acceps Supplemental NDA For ZERBAXA",0.003110876200247693,0.003635870978060612,0.1743713957183524,"[{'label': 'positive', 'score': 0.999622106552124}, {'label': 'negative', 'score': 0.000238030610489659}, {'label': 'neutral', 'score': 0.0001398197200614959}]","(0.0001398197200614959, 0.999622106552124, 0.000238030610489659)",0.9995238721864337,0.999622106552124,0,0,"[{'label': 'positive', 'score': 0.9393081665039062}, {'label': 'neutral', 'score': 0.04404696449637413}, {'label': 'negative', 'score': 0.016644831746816635}]","(0.04404696449637413, 0.9393081665039062, 0.016644831746816635)",0.9651764641624125,0.9393081665039062,0,0,"[{'label': 'positive', 'score': 0.9961321353912354}, {'label': 'neutral', 'score': 0.0035268960054963827}, {'label': 'negative', 'score': 0.000340990285621956}]","(0.0035268960054963827, 0.9961321353912354, 0.000340990285621956)",0.999315605655917,0.9961321353912354,0,0
2019-02-06,62.176456451416016,73.84542083740234,74.1603012084961,73.12023162841797,73.32061004638672,8375721.0,Drugmakers Offered C$9.6B in Price Cuts; Freeze of Drug Prices in Response to Proposed Crackdown by Canada Regulator,-0.007365276012657005,0.003106047436746126,0.01375622631803061,"[{'label': 'negative', 'score': 0.847883403301239}, {'label': 'positive', 'score': 0.10197265446186066}, {'label': 'neutral', 'score': 0.050144046545028687}]","(0.050144046545028687, 0.10197265446186066, 0.847883403301239)",-0.78528819471446,-0.847883403301239,1,1,"[{'label': 'negative', 'score': 0.7066403031349182}, {'label': 'positive', 'score': 0.2612896263599396}, {'label': 'neutral', 'score': 0.032070089131593704}]","(0.032070089131593704, 0.2612896263599396, 0.7066403031349182)",-0.4601063188607028,-0.7066403031349182,0,1,"[{'label': 'positive', 'score': 0.7616727352142334}, {'label': 'neutral', 'score': 0.2088940590620041}, {'label': 'negative', 'score': 0.029433201998472214}]","(0.2088940590620041, 0.7616727352142334, 0.029433201998472214)",0.9255897330206524,0.7616727352142334,0,0
2019-02-07,61.71852111816406,73.30152893066406,73.59732818603516,72.6240463256836,73.41603088378906,9661407.0,"Bank Of America Reiterates Buy And $84 Target On Merck Due To 'Keytruda driven upside, undemanding valuation + optionality (animal health spin + OM expansion)'",0.009112200552510684,-0.007392533580171856,0.07203975596068456,"[{'label': 'positive', 'score': 0.9994813799858093}, {'label': 'negative', 'score': 0.0003143305948469788}, {'label': 'neutral', 'score': 0.00020433466124814004}]","(0.00020433466124814004, 0.9994813799858093, 0.0003143305948469788)",0.9993712103552346,0.9994813799858093,0,0,"[{'label': 'positive', 'score': 0.864908754825592}, {'label': 'neutral', 'score': 0.09438619017601013}, {'label': 'negative', 'score': 0.04070504382252693}]","(0.09438619017601013, 0.864908754825592, 0.04070504382252693)",0.9101050715364749,0.864908754825592,0,0,"[{'label': 'positive', 'score': 0.9987592697143555}, {'label': 'neutral', 'score': 0.0008846326381899416}, {'label': 'negative', 'score': 0.0003560558834578842}]","(0.0008846326381899416, 0.9987592697143555, 0.0003560558834578842)",0.9992872576882056,0.9987592697143555,0,0
2019-02-08,62.28091049194336,73.96946716308594,73.9885482788086,73.06298065185547,73.23473358154297,9266940.0,,-0.003482984137579907,0.009070934943955628,0.09462882752902091,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-02-09,62.06398137410482,73.71183268229167,74.08396911621094,72.94847615559895,73.5687026977539,10779274.0,"Third Point Dissolves Stakes in Netflix, Microsoft; Cuts Stake in PayPal, Merck, Visa, American Express, Baxter; Raises Stakes in Campbell Soup, Salesforce",-0.003495157716464886,-0.0034890638479594597,0.10260527531395482,"[{'label': 'neutral', 'score': 0.9997618794441223}, {'label': 'negative', 'score': 0.0001822328194975853}, {'label': 'positive', 'score': 5.592612797045149e-05}]","(0.9997618794441223, 5.592612797045149e-05, 0.0001822328194975853)",-0.5303461947155497,-0.0001822328194975853,0,1,"[{'label': 'neutral', 'score': 0.5517836809158325}, {'label': 'negative', 'score': 0.4023800790309906}, {'label': 'positive', 'score': 0.04583624377846718}]","(0.5517836809158325, 0.04583624377846718, 0.4023800790309906)",-0.7954726704678592,-0.4023800790309906,0,1,"[{'label': 'negative', 'score': 0.6269378066062927}, {'label': 'neutral', 'score': 0.3374086320400238}, {'label': 'positive', 'score': 0.03565359115600586}]","(0.3374086320400238, 0.03565359115600586, 0.6269378066062927)",-0.8923813642120467,-0.6269378066062927,0,0
2019-02-10,61.847052256266274,73.45419820149739,74.17938995361328,72.83397165934245,73.90267181396484,12291608.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",-0.0035074166909770193,-0.003501280050040185,0.10350078027573241,"[{'label': 'neutral', 'score': 0.9998811483383179}, {'label': 'negative', 'score': 6.308517185971141e-05}, {'label': 'positive', 'score': 5.5740463722031564e-05}]","(0.9998811483383179, 5.5740463722031564e-05, 6.308517185971141e-05)",-0.061810804560159464,-6.308517185971141e-05,1,1,"[{'label': 'neutral', 'score': 0.9485455751419067}, {'label': 'positive', 'score': 0.02802564948797226}, {'label': 'negative', 'score': 0.023428717628121376}]","(0.9485455751419067, 0.02802564948797226, 0.023428717628121376)",0.08933997476791583,0.02802564948797226,1,1,"[{'label': 'neutral', 'score': 0.9995757937431335}, {'label': 'positive', 'score': 0.0002782561059575528}, {'label': 'negative', 'score': 0.00014591225772164762}]","(0.9995757937431335, 0.0002782561059575528, 0.00014591225772164762)",0.3120078241761499,0.0002782561059575528,1,1
2019-02-11,61.63012313842773,73.19656372070312,74.27481079101562,72.71946716308594,74.23664093017578,13803942.0,Hemispherx Biopharma Announces Commencement Of A New 45 Subject Clinical Trial Combining Ampligen And Merck's Keytruda In The Treatment Of Recurrent Ovarian Cancer | Merck Granted FDA Priority Review for its Supplemental Biologics License Application for KEYTRUDA for the First-Line Treatment of Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma,0.023595322919902188,-0.0035135820975539483,0.09981115730461253,"[{'label': 'positive', 'score': 0.8621963858604431}, {'label': 'neutral', 'score': 0.13722054660320282}, {'label': 'negative', 'score': 0.0005830605514347553}]","(0.13722054660320282, 0.8621963858604431, 0.0005830605514347553)",0.9986484134413272,0.8621963858604431,1,1,"[{'label': 'positive', 'score': 0.8351299166679382}, {'label': 'neutral', 'score': 0.15508076548576355}, {'label': 'negative', 'score': 0.009789278730750084}]","(0.15508076548576355, 0.8351299166679382, 0.009789278730750084)",0.9768278936398626,0.8351299166679382,1,1,"[{'label': 'positive', 'score': 0.8652471899986267}, {'label': 'neutral', 'score': 0.13406062126159668}, {'label': 'negative', 'score': 0.0006922144675627351}]","(0.13406062126159668, 0.8652471899986267, 0.0006922144675627351)",0.9984012404009044,0.8652471899986267,1,1
2019-02-12,63.08432769775391,74.92366027832031,75.31488800048828,73.5782470703125,73.75,13676086.0,,0.006367870779930011,0.023321256047162956,0.1890202327756556,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-02-13,63.48604202270508,75.40076446533203,75.54389190673828,74.85687255859375,74.96183013916016,10980106.0,,-0.0010124528871956887,0.006347681553723005,0.18572025953467156,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-02-14,63.4217529296875,75.32442474365234,75.90648651123047,75.08587646484375,75.50572204589844,8577042.0,Merck Highlights 3 New Phase 3 Trials,0.011021052225364262,-0.0010129657638248818,0.18032365598219616,"[{'label': 'neutral', 'score': 0.9998812675476074}, {'label': 'positive', 'score': 6.504750490421429e-05}, {'label': 'negative', 'score': 5.358949783840217e-05}]","(0.9998812675476074, 6.504750490421429e-05, 5.358949783840217e-05)",0.09658038218202736,6.504750490421429e-05,1,1,"[{'label': 'neutral', 'score': 0.8084510564804077}, {'label': 'positive', 'score': 0.18321678042411804}, {'label': 'negative', 'score': 0.008332116529345512}]","(0.8084510564804077, 0.18321678042411804, 0.008332116529345512)",0.9130027198081982,0.18321678042411804,0,1,"[{'label': 'neutral', 'score': 0.9990984201431274}, {'label': 'positive', 'score': 0.0008047622977755964}, {'label': 'negative', 'score': 9.682844392955303e-05}]","(0.9990984201431274, 0.0008047622977755964, 9.682844392955303e-05)",0.7852053277600777,0.0008047622977755964,0,1
2019-02-15,64.12073516845703,76.15457916259766,76.45992279052734,75.63931274414062,76.0114517211914,10886100.0,Merck Reports FDA Granted Priority Review For Co.'s Supplemental Biologics License Application for KEYTRUDA Combo With Inlyta For First-Line Treatment for Advanced Renal Cell Carcinoma,-0.001785486548277739,0.010960762992023984,0.16967840372810059,"[{'label': 'positive', 'score': 0.9989702701568604}, {'label': 'neutral', 'score': 0.0007568730507045984}, {'label': 'negative', 'score': 0.0002729041734710336}]","(0.0007568730507045984, 0.9989702701568604, 0.0002729041734710336)",0.9994537782584225,0.9989702701568604,0,0,"[{'label': 'positive', 'score': 0.916272759437561}, {'label': 'neutral', 'score': 0.04460548236966133}, {'label': 'negative', 'score': 0.03912171721458435}]","(0.04460548236966133, 0.916272759437561, 0.03912171721458435)",0.9181035306972402,0.916272759437561,0,0,"[{'label': 'positive', 'score': 0.9822161197662354}, {'label': 'neutral', 'score': 0.017501655966043472}, {'label': 'negative', 'score': 0.00028219824889674783}]","(0.017501655966043472, 0.9822161197662354, 0.00028219824889674783)",0.9994255496549513,0.9822161197662354,0,0
2019-02-16,64.00624752044678,76.01860618591309,76.45992279052734,75.5939884185791,76.0424633026123,10577961.75,,-0.001788680212736751,-0.0017870824292837045,0.16311310073602414,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-02-17,63.89175987243652,75.88263320922852,76.45992279052734,75.54866409301758,76.0734748840332,10269823.5,Merck Announces KEYTRUDA in Combination with Inlyta Reduced Risk of Death by Nearly Half Compared to Sunitinib as First-Line Treatment for Advanced RCC at ASCO GU 2019,-0.0017918853225567016,-0.0017902818113051458,0.09239528551238502,"[{'label': 'positive', 'score': 0.9994619488716125}, {'label': 'negative', 'score': 0.00034025232889689505}, {'label': 'neutral', 'score': 0.0001978002255782485}]","(0.0001978002255782485, 0.9994619488716125, 0.00034025232889689505)",0.9993193607125723,0.9994619488716125,0,0,"[{'label': 'positive', 'score': 0.9482710957527161}, {'label': 'neutral', 'score': 0.02820482850074768}, {'label': 'negative', 'score': 0.02352406457066536}]","(0.02820482850074768, 0.9482710957527161, 0.02352406457066536)",0.9515863722498117,0.9482710957527161,0,0,"[{'label': 'positive', 'score': 0.9983880519866943}, {'label': 'neutral', 'score': 0.0012821962591260672}, {'label': 'negative', 'score': 0.00032974701025523245}]","(0.0012821962591260672, 0.9983880519866943, 0.00032974701025523245)",0.9993396592899688,0.9983880519866943,0,0
2019-02-18,63.77727222442627,75.74666023254395,76.45992279052734,75.50333976745605,76.1044864654541,9961685.25,,-0.0017951019393743595,-0.0017934926694691815,0.08930385563317537,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-02-19,63.662784576416016,75.61068725585938,76.45992279052734,75.45801544189453,76.135498046875,9653547.0,Merck Reports Phase 3 KEYNOTE-240 Trial Evaluating KEYTRUDA Did Not Meet Co-Primary Endpoints | Merck Says US Patent & Trademark Office Issued Formal Notice Allowing Co.'s Patent Application Directed To Its Proxy-CRISPR Technology | FDA Approves Merck's KEYTRUDA For Adjuvant Treatment Of Patients With Melanoma With Involvement Of Lymph Nodes Following Complete Resection,0.0023977735003598223,-0.0017967150656338627,0.09053489424662102,"[{'label': 'neutral', 'score': 0.9657138586044312}, {'label': 'positive', 'score': 0.03300658240914345}, {'label': 'negative', 'score': 0.0012796076480299234}]","(0.9657138586044312, 0.03300658240914345, 0.0012796076480299234)",0.9253572563241274,0.03300658240914345,0,1,"[{'label': 'positive', 'score': 0.6858724355697632}, {'label': 'neutral', 'score': 0.2329944670200348}, {'label': 'negative', 'score': 0.08113310486078262}]","(0.2329944670200348, 0.6858724355697632, 0.08113310486078262)",0.7884419327264836,0.6858724355697632,0,0,"[{'label': 'neutral', 'score': 0.7919979691505432}, {'label': 'positive', 'score': 0.1971197873353958}, {'label': 'negative', 'score': 0.010882201604545116}]","(0.7919979691505432, 0.1971197873353958, 0.010882201604545116)",0.8953644466574089,0.1971197873353958,0,1
2019-02-20,63.8154411315918,75.79198455810547,75.8969497680664,75.20037841796875,75.38167572021484,8993517.0,"The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering | FDA Grants Priority Review To Merck's Supplemental Biologics License Application For KEYTRUDA Monotherapy For Third-Line Treatment of Patients with Advanced Small Cell Lung Cancer",0.005035832251129859,0.002394903428419644,0.029723360634237257,"[{'label': 'positive', 'score': 0.9991099238395691}, {'label': 'neutral', 'score': 0.0005247824592515826}, {'label': 'negative', 'score': 0.0003652285085991025}]","(0.0005247824592515826, 0.9991099238395691, 0.0003652285085991025)",0.9992691594028305,0.9991099238395691,1,1,"[{'label': 'positive', 'score': 0.8736234903335571}, {'label': 'negative', 'score': 0.07045590132474899}, {'label': 'neutral', 'score': 0.05592052638530731}]","(0.05592052638530731, 0.8736234903335571, 0.07045590132474899)",0.8507415754495161,0.8736234903335571,1,1,"[{'label': 'positive', 'score': 0.7173476815223694}, {'label': 'negative', 'score': 0.17869462072849274}, {'label': 'neutral', 'score': 0.10395769774913788}]","(0.10395769774913788, 0.7173476815223694, 0.17869462072849274)",0.601146909516189,0.7173476815223694,1,1
2019-02-21,64.13680267333984,76.17366027832031,76.364501953125,75.52481079101562,75.55343627929688,7740633.0,"Mid-Afternoon Market Update: Dow Falls 150 Points; Delphi Technologies Shares Spike Higher | 50 Stocks Moving In Thursday's Mid-Day Session | Mid-Day Market Update: Immune Design Jumps Following Acquisition News; Carbon Black Shares Slide | Mid-Morning Market Update: Markets Open Lower; Domino's Pizza Misses Q4 Views | Merck To Buy Immune Design For $300M | 31 Stocks Moving In Thursday's Pre-Market Session | Merck To Acquire Immune Design At $5.85/Share In Cash, Or ~$300M",0.011775064566796011,0.005023194856674786,0.050066137373580455,"[{'label': 'negative', 'score': 0.9976385831832886}, {'label': 'neutral', 'score': 0.0015085672494024038}, {'label': 'positive', 'score': 0.000852797762490809}]","(0.0015085672494024038, 0.000852797762490809, 0.9976385831832886)",-0.998291827493427,-0.9976385831832886,0,0,"[{'label': 'negative', 'score': 0.6458675861358643}, {'label': 'positive', 'score': 0.30435532331466675}, {'label': 'neutral', 'score': 0.04977709800004959}]","(0.04977709800004959, 0.30435532331466675, 0.6458675861358643)",-0.359402261747907,-0.6458675861358643,0,0,"[{'label': 'neutral', 'score': 0.7407193183898926}, {'label': 'positive', 'score': 0.23065054416656494}, {'label': 'negative', 'score': 0.02863016538321972}]","(0.7407193183898926, 0.23065054416656494, 0.02863016538321972)",0.7791569960377448,0.23065054416656494,1,0
2019-02-22,64.89202880859375,77.07061004638672,77.15648651123047,76.11640930175781,76.11640930175781,8337469.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs | Cantor Fitzgerald Initiates Coverage On Merck & Co with Overweight Rating, Announces $95 Price Target | The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data | 65 Biggest Movers From Yesterday",-0.001609515295245926,0.011706277945404867,0.08916179705656024,"[{'label': 'neutral', 'score': 0.9973565340042114}, {'label': 'positive', 'score': 0.0024460251443088055}, {'label': 'negative', 'score': 0.00019743343000300229}]","(0.9973565340042114, 0.0024460251443088055, 0.00019743343000300229)",0.8506249109242034,0.0024460251443088055,0,1,"[{'label': 'negative', 'score': 0.6033807396888733}, {'label': 'positive', 'score': 0.33110854029655457}, {'label': 'neutral', 'score': 0.06551067531108856}]","(0.06551067531108856, 0.33110854029655457, 0.6033807396888733)",-0.2913593609084145,-0.6033807396888733,1,0,"[{'label': 'positive', 'score': 0.9948298335075378}, {'label': 'neutral', 'score': 0.0038952352479100227}, {'label': 'negative', 'score': 0.0012749002780765295}]","(0.0038952352479100227, 0.9948298335075378, 0.0012749002780765295)",0.9974402284522204,0.9948298335075378,0,0
2019-02-23,64.78758239746094,76.94656372070312,77.19783528645833,76.18638610839844,76.46310170491536,8805401.0,,-0.0016121100109661951,-0.001610811956506233,0.088536509028408,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-02-24,64.68313598632812,76.82251739501953,77.2391840616862,76.25636291503906,76.80979410807292,9273333.0,,-0.0016147131061294247,-0.0016134108585708475,0.08789942582881408,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-02-25,64.57868957519531,76.69847106933594,77.28053283691406,76.32633972167969,77.15648651123047,9741265.0,"Pharma M&A Wave: Spark Therapeutics, Clementia Pharma Among The Rare Disease Biotechs Acquired",0.004478752757131139,-0.0016160181603849329,0.0945193272470036,"[{'label': 'neutral', 'score': 0.9998635053634644}, {'label': 'negative', 'score': 6.826973549323156e-05}, {'label': 'positive', 'score': 6.815062806708738e-05}]","(0.9998635053634644, 6.815062806708738e-05, 6.826973549323156e-05)",-0.0008730912529163488,-6.826973549323156e-05,1,1,"[{'label': 'neutral', 'score': 0.7548522353172302}, {'label': 'positive', 'score': 0.23615090548992157}, {'label': 'negative', 'score': 0.00899679958820343}]","(0.7548522353172302, 0.23615090548992157, 0.00899679958820343)",0.9266009886950703,0.23615090548992157,0,1,"[{'label': 'neutral', 'score': 0.9988701939582825}, {'label': 'positive', 'score': 0.0009947353973984718}, {'label': 'negative', 'score': 0.00013506258255802095}]","(0.9988701939582825, 0.0009947353973984718, 0.00013506258255802095)",0.7609084368105844,0.0009947353973984718,0,1
2019-02-26,64.86791229248047,77.04198455810547,77.385498046875,76.33587646484375,76.83206176757812,8927912.0,"Sellas Reviews Strategic Options To Fund Clinical Development Programs | It Could Be Time For This Pharma ETF | The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote | UPDATE: Merck, AstraZeneca Report Phase III POLO Trial Met Primary Endpoint | Merck, AstraZeneca Report LYNPARZA Reduced the Risk of Disease Progression or Death as 1st-Line Maintenance Treatment in Germline BRCA-Mutated Metastatic Pancreatic Cancer | AstraZeneca, Merck Announce Phase III POLO Trial Met its Primary Endpoint of Progression-free Survival",-0.0014862279805194015,0.004468752990538885,0.09361940658039784,"[{'label': 'positive', 'score': 0.8409305810928345}, {'label': 'neutral', 'score': 0.1583806574344635}, {'label': 'negative', 'score': 0.0006887877243570983}]","(0.1583806574344635, 0.8409305810928345, 0.0006887877243570983)",0.9983631847130012,0.8409305810928345,0,0,"[{'label': 'positive', 'score': 0.9031338691711426}, {'label': 'neutral', 'score': 0.07263968884944916}, {'label': 'negative', 'score': 0.024226438254117966}]","(0.07263968884944916, 0.9031338691711426, 0.024226438254117966)",0.9477518326800493,0.9031338691711426,0,0,"[{'label': 'neutral', 'score': 0.926452100276947}, {'label': 'positive', 'score': 0.07181550562381744}, {'label': 'negative', 'score': 0.0017324198270216584}]","(0.926452100276947, 0.07181550562381744, 0.0017324198270216584)",0.9528900423390013,0.07181550562381744,0,1
2019-02-27,64.7715072631836,76.92748260498047,77.5667953491211,76.74618530273438,76.85114288330078,7852978.0,"The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",0.008310589694238016,-0.0014873335128423105,0.042964081518190776,"[{'label': 'neutral', 'score': 0.5252923965454102}, {'label': 'negative', 'score': 0.424399733543396}, {'label': 'positive', 'score': 0.05030785873532295}]","(0.5252923965454102, 0.05030785873532295, 0.424399733543396)",-0.788046959629054,-0.424399733543396,0,0,"[{'label': 'neutral', 'score': 0.8859500885009766}, {'label': 'positive', 'score': 0.09744933247566223}, {'label': 'negative', 'score': 0.016600612550973892}]","(0.8859500885009766, 0.09744933247566223, 0.016600612550973892)",0.7088887233203514,0.09744933247566223,1,0,"[{'label': 'negative', 'score': 0.997329831123352}, {'label': 'neutral', 'score': 0.0018516563577577472}, {'label': 'positive', 'score': 0.0008185581536963582}]","(0.0018516563577577472, 0.0008185581536963582, 0.997329831123352)",-0.9983598467672943,-0.997329831123352,0,0
2019-02-28,65.3097915649414,77.5667953491211,78.01526641845703,76.84160614013672,76.84160614013672,11588365.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",0.004428516839311349,0.008276246885176086,0.07231281233002052,"[{'label': 'negative', 'score': 0.9966211318969727}, {'label': 'neutral', 'score': 0.002356719458475709}, {'label': 'positive', 'score': 0.0010220359545201063}]","(0.002356719458475709, 0.0010220359545201063, 0.9966211318969727)",-0.9979510991756279,-0.9966211318969727,0,0,"[{'label': 'negative', 'score': 0.9530359506607056}, {'label': 'neutral', 'score': 0.03247770294547081}, {'label': 'positive', 'score': 0.014486433006823063}]","(0.03247770294547081, 0.014486433006823063, 0.9530359506607056)",-0.9700545780617287,-0.9530359506607056,0,0,"[{'label': 'negative', 'score': 0.9942547678947449}, {'label': 'neutral', 'score': 0.004857024177908897}, {'label': 'positive', 'score': 0.0008881873218342662}]","(0.004857024177908897, 0.0008881873218342662, 0.9942547678947449)",-0.9982149553143529,-0.9942547678947449,0,0
2019-03-01,65.5990219116211,77.9103012084961,78.17748260498047,77.4522933959961,78.01526641845703,10624205.0,Merck Reports Positive CHMP Opinion For Use In Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer,-0.0011430827628936121,0.004418739813136056,0.06794402989794363,"[{'label': 'positive', 'score': 0.9993153810501099}, {'label': 'negative', 'score': 0.0003917801659554243}, {'label': 'neutral', 'score': 0.00029279582668095827}]","(0.00029279582668095827, 0.9993153810501099, 0.0003917801659554243)",0.9992162101440208,0.9993153810501099,0,0,"[{'label': 'positive', 'score': 0.8951402306556702}, {'label': 'neutral', 'score': 0.09024529904127121}, {'label': 'negative', 'score': 0.014614435844123363}]","(0.09024529904127121, 0.8951402306556702, 0.014614435844123363)",0.9678716990804759,0.8951402306556702,0,0,"[{'label': 'neutral', 'score': 0.7925090193748474}, {'label': 'positive', 'score': 0.2069733589887619}, {'label': 'negative', 'score': 0.0005175980040803552}]","(0.7925090193748474, 0.2069733589887619, 0.0005175980040803552)",0.9950108861457686,0.2069733589887619,0,1
2019-03-02,65.52403259277344,77.82124328613281,78.2379150390625,77.2487309773763,78.1011454264323,9923721.666666666,,-0.001144390896401301,-0.0011437365802874858,0.06606154779603886,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-03,65.44904327392578,77.73218536376953,78.29834747314453,77.04516855875652,78.18702443440755,9223238.333333334,,-0.0011457020273714133,-0.001145046211668757,0.06962365303312146,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-04,65.37405395507812,77.64312744140625,78.35877990722656,76.84160614013672,78.27290344238281,8522755.0,BioXcel Therapeutics Announces Merck and Pfizer Join its Clinical Collaboration with Nektar Therapeutics to Evaluate a Triple Therapy for Pancreatic Cancer | Merck Says the European Medicines Agency Adopts Positive Opinion for Merck's KEYTRUDA for Six-Week Dosing Schedule Across All Current Monotherapy Indications,0.004055581103761089,-0.0011463588456657988,0.06864966704752269,"[{'label': 'positive', 'score': 0.9986623525619507}, {'label': 'neutral', 'score': 0.0010625256691128016}, {'label': 'negative', 'score': 0.0002751245629042387}]","(0.0010625256691128016, 0.9986623525619507, 0.0002751245629042387)",0.9994491656000412,0.9986623525619507,0,0,"[{'label': 'positive', 'score': 0.905704915523529}, {'label': 'neutral', 'score': 0.08255501091480255}, {'label': 'negative', 'score': 0.011740055866539478}]","(0.08255501091480255, 0.905704915523529, 0.011740055866539478)",0.9744070625865408,0.905704915523529,0,0,"[{'label': 'positive', 'score': 0.9978468418121338}, {'label': 'neutral', 'score': 0.0019206551369279623}, {'label': 'negative', 'score': 0.00023253126710187644}]","(0.0019206551369279623, 0.9978468418121338, 0.00023253126710187644)",0.9995340425353457,0.9978468418121338,0,0
2019-03-05,65.63919067382812,77.95801544189453,78.27290344238281,77.5,77.74809265136719,8698190.0,Merck Begins Tender Offer To Acquire Immune Design,-0.011505549018688676,0.004047379402348372,0.046808132078048625,"[{'label': 'neutral', 'score': 0.998599112033844}, {'label': 'positive', 'score': 0.0012633554870262742}, {'label': 'negative', 'score': 0.00013751559890806675}]","(0.998599112033844, 0.0012633554870262742, 0.00013751559890806675)",0.8036713009657876,0.0012633554870262742,0,0,"[{'label': 'neutral', 'score': 0.8431384563446045}, {'label': 'positive', 'score': 0.1468411684036255}, {'label': 'negative', 'score': 0.010020377114415169}]","(0.8431384563446045, 0.1468411684036255, 0.010020377114415169)",0.8722392147632803,0.1468411684036255,0,0,"[{'label': 'positive', 'score': 0.9399663209915161}, {'label': 'neutral', 'score': 0.05962696298956871}, {'label': 'negative', 'score': 0.0004067562404088676}]","(0.05962696298956871, 0.9399663209915161, 0.0004067562404088676)",0.9991349045389385,0.9399663209915161,0,0
2019-03-06,64.88398742675781,77.06106567382812,78.01526641845703,76.62213897705078,77.86259460449219,8167169.0,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",-0.0038385046039086197,-0.011572249962020529,0.09057073781039417,"[{'label': 'neutral', 'score': 0.9361079931259155}, {'label': 'positive', 'score': 0.0632510781288147}, {'label': 'negative', 'score': 0.0006408496992662549}]","(0.9361079931259155, 0.0632510781288147, 0.0006408496992662549)",0.9799395723043249,0.0632510781288147,0,1,"[{'label': 'neutral', 'score': 0.7609016299247742}, {'label': 'positive', 'score': 0.22824907302856445}, {'label': 'negative', 'score': 0.01084931194782257}]","(0.7609016299247742, 0.22824907302856445, 0.01084931194782257)",0.9092481369215938,0.22824907302856445,0,1,"[{'label': 'neutral', 'score': 0.9990885257720947}, {'label': 'positive', 'score': 0.0008085168665274978}, {'label': 'negative', 'score': 0.0001029029008350335}]","(0.9990885257720947, 0.0008085168665274978, 0.0001029029008350335)",0.7741920802687566,0.0008085168665274978,0,1
2019-03-07,64.6349105834961,76.76526641845703,77.39503479003906,76.3740463256836,77.3187026977539,10925505.0,"Merck & Co Option Alert: Jun, 2020 $85 Calls at the Ask: 1000 @ $4.901 vs 113 OI; Earnings 4/30 Before Open [est] Ref=$80.62",-0.008079586737014744,-0.0038458905694726065,0.09063198366827366,"[{'label': 'neutral', 'score': 0.9998643398284912}, {'label': 'negative', 'score': 8.139791316352785e-05}, {'label': 'positive', 'score': 5.427521682577208e-05}]","(0.9998643398284912, 5.427521682577208e-05, 8.139791316352785e-05)",-0.19991207057650137,-8.139791316352785e-05,1,1,"[{'label': 'neutral', 'score': 0.8136747479438782}, {'label': 'positive', 'score': 0.100307896733284}, {'label': 'negative', 'score': 0.08601739257574081}]","(0.8136747479438782, 0.100307896733284, 0.08601739257574081)",0.07669653545441193,0.100307896733284,1,1,"[{'label': 'neutral', 'score': 0.9905475974082947}, {'label': 'negative', 'score': 0.005650028120726347}, {'label': 'positive', 'score': 0.003802347695454955}]","(0.9905475974082947, 0.003802347695454955, 0.005650028120726347)",-0.19547259453103746,-0.005650028120726347,1,1
2019-03-08,64.11271667480469,76.14503479003906,76.90839385986328,75.42938995361328,76.53626251220703,11716326.0,,0.0044695236161940875,-0.008112403481286778,0.09626645832053818,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-09,64.39926401774089,76.48536682128906,77.04516347249348,75.75381724039714,76.58397165934245,10853088.333333334,,0.004449635863618182,0.004459564958128448,0.11382316159044976,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-10,64.68581136067708,76.82569885253906,77.1819330851237,76.07824452718098,76.63168080647786,9989850.666666666,,0.004429924313519631,0.004439765502801748,0.11537821462124632,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-11,64.97235870361328,77.16603088378906,77.3187026977539,76.40267181396484,76.67938995361328,9126613.0,,0.00445161536540421,0.004420141080820688,0.09370273291728701,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-12,65.2615966796875,77.5095443725586,77.82442474365234,77.08015441894531,77.4522933959961,9261281.0,,0.004554925909983639,0.004441736233602809,0.0891156438098608,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-13,65.55885314941406,77.86259460449219,78.25381469726562,77.47137451171875,77.87213897705078,8059749.0,,-0.001347984627272501,0.004544583628619304,0.0007727969387864084,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-03-14,65.91474914550781,77.75763702392578,78.01526641845703,77.22328186035156,77.58587646484375,8530406.0,Merck Reports EC Approved KEYTRUDA In Combo With Chemo For First-Line Treatment Of Adults With Metastatic Squamous Non-Small Cell Lung Cancer,0.000981666820220747,-0.0013488939758339459,0.04125734299453376,"[{'label': 'positive', 'score': 0.999242901802063}, {'label': 'neutral', 'score': 0.0005192766548134387}, {'label': 'negative', 'score': 0.00023788992257323116}]","(0.0005192766548134387, 0.999242901802063, 0.00023788992257323116)",0.9995239729976947,0.999242901802063,0,0,"[{'label': 'positive', 'score': 0.9167702198028564}, {'label': 'neutral', 'score': 0.07306374609470367}, {'label': 'negative', 'score': 0.010166056454181671}]","(0.07306374609470367, 0.9167702198028564, 0.010166056454181671)",0.978065252780413,0.9167702198028564,0,0,"[{'label': 'positive', 'score': 0.8089299201965332}, {'label': 'neutral', 'score': 0.19045449793338776}, {'label': 'negative', 'score': 0.0006156353047117591}]","(0.19045449793338776, 0.8089299201965332, 0.0006156353047117591)",0.9984790595154819,0.8089299201965332,0,0
2019-03-15,65.97946166992188,77.83396911621094,78.15839385986328,77.09923553466797,77.76717376708984,17341046.0,"Enigma Biomedical Reports Exclusive License Deal With Merck For Global Development, Commercialization Of MK-6884, An Alzheimer's Treatment",-0.000899019596503346,0.0009811853004499781,0.042522007830404135,"[{'label': 'positive', 'score': 0.7677579522132874}, {'label': 'neutral', 'score': 0.23161877691745758}, {'label': 'negative', 'score': 0.0006232105079106987}]","(0.23161877691745758, 0.7677579522132874, 0.0006232105079106987)",0.9983778610456726,0.7677579522132874,0,0,"[{'label': 'positive', 'score': 0.8303699493408203}, {'label': 'neutral', 'score': 0.1623682975769043}, {'label': 'negative', 'score': 0.007261794526129961}]","(0.1623682975769043, 0.8303699493408203, 0.007261794526129961)",0.9826611286420315,0.8303699493408203,0,0,"[{'label': 'positive', 'score': 0.9912766218185425}, {'label': 'neutral', 'score': 0.008526054210960865}, {'label': 'negative', 'score': 0.00019727069593500346}]","(0.008526054210960865, 0.9912766218185425, 0.00019727069593500346)",0.9996020657781826,0.9912766218185425,0,0
2019-03-16,65.92014567057292,77.76399485270183,78.13294982910156,77.1374028523763,77.6940180460612,16346668.666666666,,-0.0008998285600124731,-0.0008994239569909075,0.04493936483298558,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-17,65.86082967122395,77.6940205891927,78.10750579833984,77.17557017008464,77.62086232503255,15352291.333333334,,-0.0009006389806893752,-0.0009002336487563575,0.03882334073633946,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-18,65.801513671875,77.6240463256836,78.08206176757812,77.21373748779297,77.5477066040039,14357914.0,"Morgan Stanley Drops Bearish Exelixis Stance, Sees 'Limited Downside Risk'",0.0068837887159057705,-0.0009010447996586926,0.01448516451375919,"[{'label': 'negative', 'score': 0.9980828762054443}, {'label': 'positive', 'score': 0.0011860356898978353}, {'label': 'neutral', 'score': 0.0007311006775125861}]","(0.0007311006775125861, 0.0011860356898978353, 0.9980828762054443)",-0.9976261931582596,-0.9980828762054443,0,0,"[{'label': 'negative', 'score': 0.6348775625228882}, {'label': 'neutral', 'score': 0.1892305463552475}, {'label': 'positive', 'score': 0.1758919656276703}]","(0.1892305463552475, 0.1758919656276703, 0.6348775625228882)",-0.566111059874447,-0.6348775625228882,0,0,"[{'label': 'negative', 'score': 0.9162454009056091}, {'label': 'neutral', 'score': 0.08245152235031128}, {'label': 'positive', 'score': 0.0013030359987169504}]","(0.08245152235031128, 0.0013030359987169504, 0.9162454009056091)",-0.9971597444967304,-0.9162454009056091,0,0
2019-03-19,66.25448608398438,78.15839385986328,78.24427795410156,77.25190734863281,77.80534362792969,10224393.0,,0.0020754800413924634,0.006860203617058406,0.053345818091709074,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-20,66.39199829101562,78.32061004638672,78.9312973022461,77.65267181396484,78.10114288330078,11894590.0,Merck and NGM Bio Announce Extension Of Strategic Collaboration To 2022,0.010599437599549332,0.0020733292081847993,0.053846367228936626,"[{'label': 'neutral', 'score': 0.7004679441452026}, {'label': 'positive', 'score': 0.29911008477211}, {'label': 'negative', 'score': 0.00042195344576612115}]","(0.7004679441452026, 0.29911008477211, 0.00042195344576612115)",0.997182582215401,0.29911008477211,1,0,"[{'label': 'positive', 'score': 0.8606141805648804}, {'label': 'neutral', 'score': 0.12968198955059052}, {'label': 'negative', 'score': 0.009703803807497025}]","(0.12968198955059052, 0.8606141805648804, 0.009703803807497025)",0.9777005554711251,0.8606141805648804,1,1,"[{'label': 'positive', 'score': 0.9967350363731384}, {'label': 'neutral', 'score': 0.0030412834603339434}, {'label': 'negative', 'score': 0.0002236029104096815}]","(0.0030412834603339434, 0.9967350363731384, 0.0002236029104096815)",0.9995514299157479,0.9967350363731384,1,1
2019-03-21,67.09571075439453,79.15076446533203,79.36068725585938,78.10114288330078,78.3396987915039,9473291.0,"FedEx's Struggles May Be Less About Global Demand And More About 'NotPetya' | Watching Stocks With Alzheimer's Treatment Candidates: Merck, Roche, AbbVie, Neurotrope, AC Immune, Denali, INmune Bio, BioXcel Therapeutics, Intra-Cellular, Anavex, Pain Therapeutics, Grifols",-0.007956663529793245,0.010543657373981859,0.08003040275366081,"[{'label': 'negative', 'score': 0.9930769205093384}, {'label': 'neutral', 'score': 0.006179962307214737}, {'label': 'positive', 'score': 0.0007430572877638042}]","(0.006179962307214737, 0.0007430572877638042, 0.9930769205093384)",-0.9985046440917582,-0.9930769205093384,0,0,"[{'label': 'neutral', 'score': 0.9153748750686646}, {'label': 'negative', 'score': 0.04413878172636032}, {'label': 'positive', 'score': 0.040486376732587814}]","(0.9153748750686646, 0.040486376732587814, 0.04413878172636032)",-0.04315980094198934,-0.04413878172636032,1,1,"[{'label': 'negative', 'score': 0.9930452704429626}, {'label': 'neutral', 'score': 0.006507756654173136}, {'label': 'positive', 'score': 0.00044696812983602285}]","(0.006507756654173136, 0.00044696812983602285, 0.9930452704429626)",-0.9991002081093696,-0.9930452704429626,0,0
2019-03-22,66.56185913085938,78.52098846435547,79.62786102294922,78.26335906982422,79.11259460449219,10639191.0,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",0.0002430713412928635,-0.007988486693598265,0.11357150822139954,"[{'label': 'positive', 'score': 0.99395751953125}, {'label': 'neutral', 'score': 0.005389837548136711}, {'label': 'negative', 'score': 0.0006526223733089864}]","(0.005389837548136711, 0.99395751953125, 0.0006526223733089864)",0.9986876820458329,0.99395751953125,0,0,"[{'label': 'positive', 'score': 0.7521200180053711}, {'label': 'neutral', 'score': 0.1862238347530365}, {'label': 'negative', 'score': 0.06165619194507599}]","(0.1862238347530365, 0.7521200180053711, 0.06165619194507599)",0.8484689250160548,0.7521200180053711,0,0,"[{'label': 'positive', 'score': 0.8083966970443726}, {'label': 'neutral', 'score': 0.1485038548707962}, {'label': 'negative', 'score': 0.04309939965605736}]","(0.1485038548707962, 0.8083966970443726, 0.04309939965605736)",0.8987678280075065,0.8083966970443726,0,0
2019-03-23,66.57803599039714,78.54007466634114,79.40521494547527,78.23155212402344,78.84541829427083,9719012.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs",0.0002430122719741451,0.00024304180424069782,0.11193442332598101,"[{'label': 'neutral', 'score': 0.9998762607574463}, {'label': 'negative', 'score': 6.642721564276144e-05}, {'label': 'positive', 'score': 5.728575342800468e-05}]","(0.9998762607574463, 5.728575342800468e-05, 6.642721564276144e-05)",-0.07389251331869394,-6.642721564276144e-05,1,1,"[{'label': 'neutral', 'score': 0.947675347328186}, {'label': 'positive', 'score': 0.02941899001598358}, {'label': 'negative', 'score': 0.02290566824376583}]","(0.947675347328186, 0.02941899001598358, 0.02290566824376583)",0.12447901216830505,0.02941899001598358,1,1,"[{'label': 'neutral', 'score': 0.9995629191398621}, {'label': 'positive', 'score': 0.00030861253617331386}, {'label': 'negative', 'score': 0.0001284749887418002}]","(0.9995629191398621, 0.00030861253617331386, 0.0001284749887418002)",0.412131523237818,0.00030861253617331386,1,1
2019-03-24,66.59421284993489,78.55916086832683,79.1825688680013,78.19974517822266,78.57824198404948,8798833.0,,0.00024295323135722858,0.00024298274927475377,0.10475063259338638,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-25,66.61038970947266,78.5782470703125,78.95992279052734,78.16793823242188,78.31106567382812,7878654.0,These Are Some Of The Best-Performing Leveraged ETFs Of The Year,0.006921659963368769,0.00024292372300028045,0.10439968336829078,"[{'label': 'neutral', 'score': 0.9978971481323242}, {'label': 'positive', 'score': 0.001994725549593568}, {'label': 'negative', 'score': 0.00010813542758114636}]","(0.9978971481323242, 0.001994725549593568, 0.00010813542758114636)",0.8971539928175081,0.001994725549593568,0,1,"[{'label': 'positive', 'score': 0.6985285878181458}, {'label': 'neutral', 'score': 0.29152628779411316}, {'label': 'negative', 'score': 0.00994512066245079}]","(0.29152628779411316, 0.6985285878181458, 0.00994512066245079)",0.9719252230720622,0.6985285878181458,0,0,"[{'label': 'positive', 'score': 0.9875234961509705}, {'label': 'neutral', 'score': 0.011820291168987751}, {'label': 'negative', 'score': 0.000656243646517396}]","(0.011820291168987751, 0.9875234961509705, 0.000656243646517396)",0.9986718131933127,0.9875234961509705,0,0
2019-03-26,67.07144165039062,79.12213897705078,79.6469497680664,78.78816986083984,78.96946716308594,9242731.0,Merck Shares Unaffected As Traders Circulate Business Insider Interview From Mon. Highlighting CEO Hinted He Could Step Down,-0.0075977535550407075,0.006897815241848109,0.08382985063763333,"[{'label': 'negative', 'score': 0.980983316898346}, {'label': 'neutral', 'score': 0.018327822908759117}, {'label': 'positive', 'score': 0.0006889120559208095}]","(0.018327822908759117, 0.0006889120559208095, 0.980983316898346)",-0.9985964519814222,-0.980983316898346,0,0,"[{'label': 'negative', 'score': 0.8331298828125}, {'label': 'neutral', 'score': 0.15234889090061188}, {'label': 'positive', 'score': 0.014521162956953049}]","(0.15234889090061188, 0.014521162956953049, 0.8331298828125)",-0.9657378752036541,-0.8331298828125,0,0,"[{'label': 'neutral', 'score': 0.9682928919792175}, {'label': 'negative', 'score': 0.029579490423202515}, {'label': 'positive', 'score': 0.0021275419276207685}]","(0.9682928919792175, 0.0021275419276207685, 0.029579490423202515)",-0.8657999964121192,-0.029579490423202515,0,1
2019-03-27,66.56185913085938,78.52098846435547,79.25572204589844,78.06298065185547,79.12213897705078,10020766.0,"The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO",0.004131791759016772,-0.007626763518363786,0.08168992239557994,"[{'label': 'positive', 'score': 0.9868202805519104}, {'label': 'neutral', 'score': 0.012563648633658886}, {'label': 'negative', 'score': 0.0006160055054351687}]","(0.012563648633658886, 0.9868202805519104, 0.0006160055054351687)",0.9987523134117448,0.9868202805519104,0,0,"[{'label': 'positive', 'score': 0.572540819644928}, {'label': 'neutral', 'score': 0.41225722432136536}, {'label': 'negative', 'score': 0.015201937407255173}]","(0.41225722432136536, 0.572540819644928, 0.015201937407255173)",0.9482700986958978,0.572540819644928,0,0,"[{'label': 'neutral', 'score': 0.9615984559059143}, {'label': 'positive', 'score': 0.0379633903503418}, {'label': 'negative', 'score': 0.000438085466157645}]","(0.9615984559059143, 0.0379633903503418, 0.000438085466157645)",0.9771839255214552,0.0379633903503418,0,1
2019-03-28,66.83685302734375,78.84542083740234,79.1030502319336,78.41603088378906,78.99809265136719,7161298.0,,0.00653514703814735,0.004123279347066769,0.08689593568967359,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-29,67.27366638183594,79.36068725585938,79.48473358154297,78.9217529296875,79.19847106933594,10147994.0,Congo Health Ministry Says Has Recorded 15 New Confirmed Cases Of Ebola | Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,0.000521023401606278,0.0065138855457899745,0.09545497348904779,"[{'label': 'neutral', 'score': 0.999649167060852}, {'label': 'negative', 'score': 0.00021780666429549456}, {'label': 'positive', 'score': 0.00013294485688675195}]","(0.999649167060852, 0.00013294485688675195, 0.00021780666429549456)",-0.24194280647082175,-0.00021780666429549456,1,1,"[{'label': 'neutral', 'score': 0.9088541865348816}, {'label': 'negative', 'score': 0.047012943774461746}, {'label': 'positive', 'score': 0.044132839888334274}]","(0.9088541865348816, 0.044132839888334274, 0.047012943774461746)",-0.031598871284959675,-0.047012943774461746,1,1,"[{'label': 'neutral', 'score': 0.9095426201820374}, {'label': 'negative', 'score': 0.07218805700540543}, {'label': 'positive', 'score': 0.018269386142492294}]","(0.9095426201820374, 0.018269386142492294, 0.07218805700540543)",-0.5960667136562353,-0.07218805700540543,0,1
2019-03-30,67.30871327718098,79.40203603108723,79.65967051188152,78.99490865071614,79.43065897623698,9705423.333333334,,0.0005207520775875989,0.0005208877160418819,0.09514698356041705,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-03-31,67.34376017252605,79.44338480631511,79.83460744222005,79.0680643717448,79.66284688313802,9262852.666666666,,0.0005204810360065745,0.0005206165332790723,0.08506516049813556,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-01,67.3788070678711,79.48473358154297,80.0095443725586,79.14122009277344,79.89503479003906,8820282.0,"Biotech Winners, Losers In Q1 | Advaxis Shares Surge After Positive Clinical Trial Updates | AstraZeneca's Rare Pediatric Genetic Disorder Drug Granted Breakthrough Therapy Designation | Syndax Pharmaceuticals Highlights Presentation Of Updated Phase 2 Data From ENCORE 601 Trial Of Entinostat In Combination With KEYTRUDA At American Association For Cancer Research 2019 Annual Meeting | Advaxis Says its Phase 1/2 KEYNOTE-046 Study Prolonged Survival in Metastatic Castration-Resistant Prostate Cancer | Alkermes, Merck, Sage Therapeutics and Takeda Pharma Announce a Partnership to Qualify Biomarkers for Schizophrenia Drug Development | Merck's KEYTRUDA Approved in China for First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer in Combination with Chemotherapy | Merck and AstraZeneca's Selumetinib is Granted Breakthrough Therapy Designation in Neurofibromatosis Type 1 | AstraZeneca, Merck Announce Selumetinib Granted US Breakthrough Therapy Designation in Neurofibromatosis Type 1",-0.001080414577418817,0.0005203456327334246,0.04382203135240977,"[{'label': 'positive', 'score': 0.9994575381278992}, {'label': 'neutral', 'score': 0.0003185065579600632}, {'label': 'negative', 'score': 0.00022399307636078447}]","(0.0003185065579600632, 0.9994575381278992, 0.00022399307636078447)",0.9995518711322176,0.9994575381278992,0,0,"[{'label': 'positive', 'score': 0.915343701839447}, {'label': 'neutral', 'score': 0.06893107295036316}, {'label': 'negative', 'score': 0.015725279226899147}]","(0.06893107295036316, 0.915343701839447, 0.015725279226899147)",0.9662210221870154,0.915343701839447,0,0,"[{'label': 'positive', 'score': 0.9937673807144165}, {'label': 'neutral', 'score': 0.005886595696210861}, {'label': 'negative', 'score': 0.0003460315056145191}]","(0.005886595696210861, 0.9937673807144165, 0.0003460315056145191)",0.999303838975793,0.9937673807144165,0,0
2019-04-02,67.30599975585938,79.39885711669922,79.885498046875,79.1030502319336,79.63740539550781,5875088.0,"The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",-0.00036052771186840507,-0.0010809986459770467,0.046706621966656876,"[{'label': 'neutral', 'score': 0.9993494153022766}, {'label': 'positive', 'score': 0.0005079210386611521}, {'label': 'negative', 'score': 0.0001426033559255302}]","(0.9993494153022766, 0.0005079210386611521, 0.0001426033559255302)",0.5615741481420239,0.0005079210386611521,0,1,"[{'label': 'neutral', 'score': 0.6028960943222046}, {'label': 'positive', 'score': 0.3125063478946686}, {'label': 'negative', 'score': 0.08459758013486862}]","(0.6028960943222046, 0.3125063478946686, 0.08459758013486862)",0.573927255997447,0.3125063478946686,0,1,"[{'label': 'negative', 'score': 0.9835733771324158}, {'label': 'neutral', 'score': 0.015506397001445293}, {'label': 'positive', 'score': 0.000920187565498054}]","(0.015506397001445293, 0.000920187565498054, 0.9835733771324158)",-0.998130637723812,-0.9835733771324158,0,0
2019-04-03,67.28175354003906,79.37023162841797,79.8282470703125,78.95992279052734,79.45610809326172,6550734.0,,-0.01598948017511894,-0.0003605927176086817,0.011526297287835769,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-04-04,66.20594024658203,78.10114288330078,79.38931274414062,77.4904556274414,79.20801544189453,10257719.0,"Myriad Genetics, AstraZeneca, Merck Report Expansion Of Companion Diagnostic Partnership",-0.008552220976073456,-0.01611869110808648,0.11421788408129264,"[{'label': 'neutral', 'score': 0.9622275233268738}, {'label': 'positive', 'score': 0.03758692741394043}, {'label': 'negative', 'score': 0.0001856454910011962}]","(0.9622275233268738, 0.03758692741394043, 0.0001856454910011962)",0.9901703550103197,0.03758692741394043,0,1,"[{'label': 'neutral', 'score': 0.6607086658477783}, {'label': 'positive', 'score': 0.32987213134765625}, {'label': 'negative', 'score': 0.009419245645403862}]","(0.6607086658477783, 0.32987213134765625, 0.009419245645403862)",0.9444769523535723,0.32987213134765625,0,1,"[{'label': 'neutral', 'score': 0.8017096519470215}, {'label': 'positive', 'score': 0.19785504043102264}, {'label': 'negative', 'score': 0.0004353156837169081}]","(0.8017096519470215, 0.19785504043102264, 0.0004353156837169081)",0.9956093105862898,0.19785504043102264,0,1
2019-04-05,65.63973999023438,77.4332046508789,78.3969497680664,77.39503479003906,78.21565246582031,10324162.0,,-0.0008215324664448128,-0.008589001069009674,0.11330662697564625,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-06,65.58581288655598,77.36959075927734,78.11068979899089,77.15330505371094,77.89440409342448,10411530.333333334,,-0.0008222079369591934,-0.0008218701091771401,0.10942723632487134,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-07,65.53188578287761,77.30597686767578,77.82442982991536,76.91157531738281,77.57315572102864,10498898.666666666,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts",-0.0008228845191420328,-0.0008225461352972746,0.11008245603687748,"[{'label': 'neutral', 'score': 0.9998745918273926}, {'label': 'negative', 'score': 6.597369065275416e-05}, {'label': 'positive', 'score': 5.952307765255682e-05}]","(0.9998745918273926, 5.952307765255682e-05, 6.597369065275416e-05)",-0.05140063036925508,-6.597369065275416e-05,1,1,"[{'label': 'neutral', 'score': 0.9472860097885132}, {'label': 'positive', 'score': 0.028436310589313507}, {'label': 'negative', 'score': 0.02427767403423786}]","(0.9472860097885132, 0.028436310589313507, 0.02427767403423786)",0.07889057495413968,0.028436310589313507,1,1,"[{'label': 'neutral', 'score': 0.9995656609535217}, {'label': 'positive', 'score': 0.0002920630795415491}, {'label': 'negative', 'score': 0.00014227964857127517}]","(0.9995656609535217, 0.0002920630795415491, 0.00014227964857127517)",0.34485078551002324,0.0002920630795415491,1,1
2019-04-08,65.47795867919922,77.24236297607422,77.53816986083984,76.66984558105469,77.25190734863281,10586267.0,,-0.0018529655993380686,-0.0008232232744583723,0.10880500514463053,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-09,65.35664367675781,77.09923553466797,77.27098846435547,76.58396911621094,76.87976837158203,10785282.0,,0.0002475866976476592,-0.001854684463753568,0.05377457619938545,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-10,65.3728256225586,77.11832427978516,77.59542083740234,76.95610809326172,77.15648651123047,6894268.0,"AstraZeneca, Merck Announce Lynparza Approved in EU for the treatment of Germline BRCA-mutated HER2-negative Advanced Breast Cancer",-0.012125777338128321,0.0002475560531192717,0.011799952413710655,"[{'label': 'positive', 'score': 0.9993313550949097}, {'label': 'neutral', 'score': 0.00039802753599360585}, {'label': 'negative', 'score': 0.00027067147311754525}]","(0.00039802753599360585, 0.9993313550949097, 0.00027067147311754525)",0.9994584415278811,0.9993313550949097,0,0,"[{'label': 'positive', 'score': 0.806084930896759}, {'label': 'neutral', 'score': 0.18156154453754425}, {'label': 'negative', 'score': 0.012353592552244663}]","(0.18156154453754425, 0.806084930896759, 0.012353592552244663)",0.9698118008908353,0.806084930896759,0,0,"[{'label': 'positive', 'score': 0.9628188014030457}, {'label': 'neutral', 'score': 0.03682546690106392}, {'label': 'negative', 'score': 0.00035575724905356765}]","(0.03682546690106392, 0.9628188014030457, 0.00035575724905356765)",0.999261281881134,0.9628188014030457,0,0
2019-04-11,64.58012390136719,76.1832046508789,77.22328186035156,75.75381469726562,77.22328186035156,10410518.0,"Merck Reports FDA Approval For Expanded Monotherapy Label For KEYTRUDA | NYC Mandates Measles Vaccinations; Merck Is The Exclusive Manufacturer | The Daily Biotech Pulse: NASH Cheer For Intercept, Gilead Layoffs, BioDelivery Licenses Constipation Drug",-0.005135253820921067,-0.01219989433634393,0.08169400320291681,"[{'label': 'positive', 'score': 0.9968276619911194}, {'label': 'neutral', 'score': 0.0028327798936516047}, {'label': 'negative', 'score': 0.00033954769605770707}]","(0.0028327798936516047, 0.9968276619911194, 0.00033954769605770707)",0.9993189754080176,0.9968276619911194,0,0,"[{'label': 'neutral', 'score': 0.6755446791648865}, {'label': 'positive', 'score': 0.3091852068901062}, {'label': 'negative', 'score': 0.01527007669210434}]","(0.6755446791648865, 0.3091852068901062, 0.01527007669210434)",0.9058725348928695,0.3091852068901062,0,1,"[{'label': 'positive', 'score': 0.981967568397522}, {'label': 'neutral', 'score': 0.017642373219132423}, {'label': 'negative', 'score': 0.0003900978481397033}]","(0.017642373219132423, 0.981967568397522, 0.0003900978481397033)",0.9992057926322689,0.981967568397522,0,0
2019-04-12,64.24848937988281,75.79198455810547,76.75572204589844,75.66793823242188,76.34542083740234,10164762.0,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug",-0.003776916130967076,-0.005148484551701127,0.07988029384117305,"[{'label': 'positive', 'score': 0.9993473887443542}, {'label': 'neutral', 'score': 0.00032908827415667474}, {'label': 'negative', 'score': 0.00032355671282857656}]","(0.00032908827415667474, 0.9993473887443542, 0.00032355671282857656)",0.9993526735686399,0.9993473887443542,0,0,"[{'label': 'positive', 'score': 0.48991936445236206}, {'label': 'neutral', 'score': 0.4143655002117157}, {'label': 'negative', 'score': 0.09571514278650284}]","(0.4143655002117157, 0.48991936445236206, 0.09571514278650284)",0.6731232821720898,0.48991936445236206,0,1,"[{'label': 'positive', 'score': 0.9988529682159424}, {'label': 'neutral', 'score': 0.0008497255621477962}, {'label': 'negative', 'score': 0.00029724324122071266}]","(0.0008497255621477962, 0.9988529682159424, 0.00029724324122071266)",0.999405007900089,0.9988529682159424,0,0
2019-04-13,64.00582631429036,75.50572458902995,76.45355987548828,75.40394337972005,76.12277475992839,11384005.0,,-0.003791235308761216,-0.0037840666890810917,0.07519347747981206,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-14,63.76316324869792,75.21946461995442,76.15139770507812,75.13994852701823,75.90012868245442,12603248.0,,-0.0038056634744988104,-0.0037984402575469305,0.07200605473988744,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-15,63.52050018310547,74.9332046508789,75.84923553466797,74.8759536743164,75.67748260498047,13822491.0,"Measles Cases Worldwide Rose Nearly Four-Fold In First Quarter Of 2019 To 112,163 Against Same Period Last Year, Provisional Data Shows",-0.012351902354442662,-0.0038129234369086193,0.05799558415392346,"[{'label': 'positive', 'score': 0.9995762705802917}, {'label': 'negative', 'score': 0.00028968139667995274}, {'label': 'neutral', 'score': 0.00013398966984823346}]","(0.00013398966984823346, 0.9995762705802917, 0.00028968139667995274)",0.9994205595337912,0.9995762705802917,0,0,"[{'label': 'positive', 'score': 0.9509050846099854}, {'label': 'neutral', 'score': 0.02748812548816204}, {'label': 'negative', 'score': 0.021606862545013428}]","(0.02748812548816204, 0.9509050846099854, 0.021606862545013428)",0.9555648388521654,0.9509050846099854,0,0,"[{'label': 'positive', 'score': 0.9520077705383301}, {'label': 'negative', 'score': 0.03549385443329811}, {'label': 'neutral', 'score': 0.012498334050178528}]","(0.012498334050178528, 0.9520077705383301, 0.03549385443329811)",0.9281138308317864,0.9520077705383301,0,0
2019-04-16,62.73590087890625,74.00763702392578,75.65839385986328,73.8740463256836,75.60114288330078,12531250.0,"Shares of several drug companies are trading lower. Weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and Washington's recent efforts to curb prescription drug prices. | The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",-0.04693150098311098,-0.012428821152282525,0.059600424564002184,"[{'label': 'negative', 'score': 0.9978450536727905}, {'label': 'neutral', 'score': 0.001691163401119411}, {'label': 'positive', 'score': 0.0004637457022909075}]","(0.001691163401119411, 0.0004637457022909075, 0.9978450536727905)",-0.9990709373641078,-0.9978450536727905,1,1,"[{'label': 'negative', 'score': 0.9009437561035156}, {'label': 'neutral', 'score': 0.07025468349456787}, {'label': 'positive', 'score': 0.028801536187529564}]","(0.07025468349456787, 0.028801536187529564, 0.9009437561035156)",-0.9380442441035483,-0.9009437561035156,1,1,"[{'label': 'negative', 'score': 0.9960625767707825}, {'label': 'neutral', 'score': 0.003506278619170189}, {'label': 'positive', 'score': 0.0004311803204473108}]","(0.003506278619170189, 0.0004311803204473108, 0.9960625767707825)",-0.9991346050742838,-0.9960625767707825,1,1
2019-04-17,59.791603088378906,70.53434753417969,74.06488800048828,70.37213897705078,74.05534362792969,34181463.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,-0.009875525117256988,-0.0480685006634579,0.3047976285174917,"[{'label': 'negative', 'score': 0.998666524887085}, {'label': 'neutral', 'score': 0.0008321406203322113}, {'label': 'positive', 'score': 0.0005013396148569882}]","(0.0008321406203322113, 0.0005013396148569882, 0.998666524887085)",-0.9989964857104229,-0.998666524887085,0,0,"[{'label': 'negative', 'score': 0.9734947085380554}, {'label': 'neutral', 'score': 0.017114929854869843}, {'label': 'positive', 'score': 0.00939041469246149}]","(0.017114929854869843, 0.00939041469246149, 0.9734947085380554)",-0.9808921419797313,-0.9734947085380554,0,0,"[{'label': 'negative', 'score': 0.9980025887489319}, {'label': 'neutral', 'score': 0.0016259982949122787}, {'label': 'positive', 'score': 0.00037139729829505086}]","(0.0016259982949122787, 0.00037139729829505086, 0.9980025887489319)",-0.9992559956419428,-0.9980025887489319,0,0
2019-04-18,59.20112991333008,69.83778381347656,70.65839385986328,68.9217529296875,70.114501953125,32768445.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,0.0009222694716869909,-0.009924611552341684,0.2942871857177027,"[{'label': 'negative', 'score': 0.998666524887085}, {'label': 'neutral', 'score': 0.0008321406203322113}, {'label': 'positive', 'score': 0.0005013396148569882}]","(0.0008321406203322113, 0.0005013396148569882, 0.998666524887085)",-0.9989964857104229,-0.998666524887085,0,0,"[{'label': 'negative', 'score': 0.9734947085380554}, {'label': 'neutral', 'score': 0.017114929854869843}, {'label': 'positive', 'score': 0.00939041469246149}]","(0.017114929854869843, 0.00939041469246149, 0.9734947085380554)",-0.9808921419797313,-0.9734947085380554,0,0,"[{'label': 'negative', 'score': 0.9980025887489319}, {'label': 'neutral', 'score': 0.0016259982949122787}, {'label': 'positive', 'score': 0.00037139729829505086}]","(0.0016259982949122787, 0.00037139729829505086, 0.9980025887489319)",-0.9992559956419428,-0.9980025887489319,0,0
2019-04-19,59.25573348999024,69.90219306945801,70.60114288330078,69.04341316223145,70.03816604614258,28213444.0,,0.0009214196744506333,0.0009218444425054021,0.30781637737114975,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-20,59.31033706665039,69.96660232543945,70.54389190673828,69.16507339477539,69.96183013916016,23658443.0,,0.0009205714418124099,0.0009209954279285247,0.3199248889930771,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-21,59.36494064331055,70.0310115814209,70.48664093017578,69.28673362731934,69.88549423217773,19103442.0,,0.0009197247694553219,0.0009201479757898294,0.3368941270389653,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-22,59.4195442199707,70.09542083740234,70.42938995361328,69.40839385986328,69.80915832519531,14548441.0,Merck's KEYTRUDA in Combination with Inlyta Approved by the FDA as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma,0.015518614489808869,0.0009193020817804863,0.07699317028061377,"[{'label': 'positive', 'score': 0.9978965520858765}, {'label': 'neutral', 'score': 0.0018052543746307492}, {'label': 'negative', 'score': 0.00029815759626217186}]","(0.0018052543746307492, 0.9978965520858765, 0.00029815759626217186)",0.9994026063384825,0.9978965520858765,1,1,"[{'label': 'positive', 'score': 0.8483668565750122}, {'label': 'neutral', 'score': 0.14231453835964203}, {'label': 'negative', 'score': 0.009318642318248749}]","(0.14231453835964203, 0.8483668565750122, 0.009318642318248749)",0.978270257966881,0.8483668565750122,1,1,"[{'label': 'positive', 'score': 0.6459636688232422}, {'label': 'neutral', 'score': 0.35325247049331665}, {'label': 'negative', 'score': 0.0007838916499167681}]","(0.35325247049331665, 0.6459636688232422, 0.0007838916499167681)",0.9975758960749901,0.6459636688232422,1,1
2019-04-23,60.34164047241211,71.1832046508789,71.80343627929688,70.03816986083984,70.32442474365234,19281523.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing' | OncoSec Announces Triple Combination Immunotherapy Clinical Trial Of TAVO, Epacadostat And KEYTRUDA In Squamous Cell Head And Neck (SCCHN) Cancer",0.001742634744979301,0.015399432239391253,0.10278970849206816,"[{'label': 'positive', 'score': 0.9994744658470154}, {'label': 'negative', 'score': 0.00037461332976818085}, {'label': 'neutral', 'score': 0.00015090504894033074}]","(0.00015090504894033074, 0.9994744658470154, 0.00037461332976818085)",0.9992506602494916,0.9994744658470154,0,0,"[{'label': 'positive', 'score': 0.9311019778251648}, {'label': 'negative', 'score': 0.04106428101658821}, {'label': 'neutral', 'score': 0.027833659201860428}]","(0.027833659201860428, 0.9311019778251648, 0.04106428101658821)",0.915520044759602,0.9311019778251648,0,0,"[{'label': 'positive', 'score': 0.9932892918586731}, {'label': 'neutral', 'score': 0.005201376974582672}, {'label': 'negative', 'score': 0.0015093761030584574}]","(0.005201376974582672, 0.9932892918586731, 0.0015093761030584574)",0.9969654641654254,0.9932892918586731,0,0
2019-04-24,60.44679641723633,71.3072509765625,71.66984558105469,70.59160614013672,71.3072509765625,12779102.0,,0.02154426781523207,0.0017411181187469184,0.10149265135834643,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-04-25,61.74908065795898,72.84351348876953,73.30152893066406,71.04962158203125,71.16412353515625,13994154.0,"Merck Offers Update On Phase 3 KEYNOTE-062 Trial Evaluating KEYTRUDA as Monotherapy, In Combination with Chemotherapy for First-Line Treatment of Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma",0.0037988027539487073,0.0213154704258703,0.15297913261662613,"[{'label': 'neutral', 'score': 0.9997630715370178}, {'label': 'positive', 'score': 0.00016932113794609904}, {'label': 'negative', 'score': 6.761367694707587e-05}]","(0.9997630715370178, 0.00016932113794609904, 6.761367694707587e-05)",0.42926347081951327,0.00016932113794609904,1,1,"[{'label': 'neutral', 'score': 0.5664061903953552}, {'label': 'positive', 'score': 0.4226153492927551}, {'label': 'negative', 'score': 0.010978413745760918}]","(0.5664061903953552, 0.4226153492927551, 0.010978413745760918)",0.9493608318125845,0.4226153492927551,0,1,"[{'label': 'neutral', 'score': 0.992302656173706}, {'label': 'positive', 'score': 0.007484348025172949}, {'label': 'negative', 'score': 0.00021307944552972913}]","(0.992302656173706, 0.007484348025172949, 0.00021307944552972913)",0.944636192717441,0.007484348025172949,0,1
2019-04-26,61.9836540222168,73.12023162841797,73.46373748779297,72.60496520996094,73.12976837158203,8888193.0,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",0.0006524753282767143,0.003791605524245778,0.1457232985786567,"[{'label': 'negative', 'score': 0.964987576007843}, {'label': 'neutral', 'score': 0.030202716588974}, {'label': 'positive', 'score': 0.004809696227312088}]","(0.030202716588974, 0.004809696227312088, 0.964987576007843)",-0.9900810275198509,-0.964987576007843,0,0,"[{'label': 'negative', 'score': 0.7602410316467285}, {'label': 'positive', 'score': 0.18995024263858795}, {'label': 'neutral', 'score': 0.04980878531932831}]","(0.04980878531932831, 0.18995024263858795, 0.7602410316467285)",-0.6001852515821965,-0.7602410316467285,0,0,"[{'label': 'negative', 'score': 0.9908816814422607}, {'label': 'positive', 'score': 0.005117518361657858}, {'label': 'neutral', 'score': 0.004000850021839142}]","(0.004000850021839142, 0.005117518361657858, 0.9908816814422607)",-0.989723850455572,-0.9908816814422607,0,0
2019-04-27,62.02409998575846,73.16794077555339,73.524169921875,72.72900899251302,73.11386617024739,8390567.666666666,,0.0006520498818158294,0.000652262558795803,0.14662342716533294,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-28,62.06454594930013,73.2156499226888,73.58460235595703,72.85305277506511,73.09796396891277,7892942.333333333,,0.0006516249898184242,0.0006518373896570052,0.14067023214319557,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-04-29,62.1049919128418,73.26335906982422,73.64503479003906,72.97709655761719,73.08206176757812,7395317.0,"This Week, Market Eyes China Talks, Fed Meeting As Earnings Continue | AstraZeneca, Merck Announce Lynparza Receives Positive EU CHMP Opinion for 1st-line Maintenance Treatment of BRCA-mutated Advanced Ovarian Cancer",0.02513679639479213,0.000651412774439736,0.1427654710802366,"[{'label': 'positive', 'score': 0.9993894100189209}, {'label': 'neutral', 'score': 0.00032085058046504855}, {'label': 'negative', 'score': 0.00028973224107176065}]","(0.00032085058046504855, 0.9993894100189209, 0.00028973224107176065)",0.9994203495325175,0.9993894100189209,1,1,"[{'label': 'positive', 'score': 0.9282260537147522}, {'label': 'neutral', 'score': 0.05013462156057358}, {'label': 'negative', 'score': 0.021639354526996613}]","(0.05013462156057358, 0.9282260537147522, 0.021639354526996613)",0.9544370089925641,0.9282260537147522,1,1,"[{'label': 'positive', 'score': 0.9968875050544739}, {'label': 'neutral', 'score': 0.0028136377222836018}, {'label': 'negative', 'score': 0.0002988798951264471}]","(0.0028136377222836018, 0.9968875050544739, 0.0002988798951264471)",0.9994005535983295,0.9968875050544739,1,1
2019-04-30,63.66611862182617,75.10496520996094,75.28626251220703,72.51908111572266,74.00763702392578,11269039.0,"Alphabet Revenue Disappoints Ahead Of Apple Earnings After The Bell | Merck & Co shares are trading higher after the company reported better-than-expected Q1 EPS and sales and issued strong FY19 guidance. | The Daily Biotech Pulse: Earnings Deluge, G1 Therapeutics Positive FDA Meeting, Mustang Bio Offering | A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Fed Meeting | Merck & Co. Sees FY19 Adj. EPS $4.67-$4.79 vs $4.67 Est., Sales $43.9B-$45.1B vs $44.42B Est. | Merck & Co Q1 Adj. EPS $1.22 Beats $1.06 Estimate, Sales $10.82B Beat $10.48B Estimate | 15 Stocks To Watch For April 30, 2019 | Earnings Scheduled For April 30, 2019",0.0001269788640125443,0.0248260635827499,0.16744417297282763,"[{'label': 'positive', 'score': 0.9990596175193787}, {'label': 'negative', 'score': 0.0008544455631636083}, {'label': 'neutral', 'score': 8.596004045102745e-05}]","(8.596004045102745e-05, 0.9990596175193787, 0.0008544455631636083)",0.9982909620042156,0.9990596175193787,0,0,"[{'label': 'positive', 'score': 0.8900507092475891}, {'label': 'negative', 'score': 0.07397592067718506}, {'label': 'neutral', 'score': 0.03597332164645195}]","(0.03597332164645195, 0.8900507092475891, 0.07397592067718506)",0.8465272257407296,0.8900507092475891,0,0,"[{'label': 'positive', 'score': 0.9462849497795105}, {'label': 'neutral', 'score': 0.0285927914083004}, {'label': 'negative', 'score': 0.025122247636318207}]","(0.0285927914083004, 0.9462849497795105, 0.025122247636318207)",0.9482765874019684,0.9462849497795105,0,0
2019-05-01,63.67419052124024,75.114501953125,76.0782470703125,74.83778381347656,75.08587646484375,15288643.0,"BMO Capital Maintains Market Perform on Merck & Company, Inc. Common Stock (new), Raises Price Target to $84 | Bank of America Maintains Buy on Merck & Company, Inc. Common Stock (new), Raises Price Target to $91",0.010162605754885933,0.00012697080287901906,0.1725892399841932,"[{'label': 'positive', 'score': 0.9985654950141907}, {'label': 'neutral', 'score': 0.0012335911160334945}, {'label': 'negative', 'score': 0.00020096995285712183}]","(0.0012335911160334945, 0.9985654950141907, 0.00020096995285712183)",0.9995975636749803,0.9985654950141907,0,0,"[{'label': 'positive', 'score': 0.7739022970199585}, {'label': 'neutral', 'score': 0.19739776849746704}, {'label': 'negative', 'score': 0.028699930757284164}]","(0.19739776849746704, 0.7739022970199585, 0.028699930757284164)",0.928482803152025,0.7739022970199585,0,0,"[{'label': 'positive', 'score': 0.9978057742118835}, {'label': 'neutral', 'score': 0.0018739205552265048}, {'label': 'negative', 'score': 0.00032028043642640114}]","(0.0018739205552265048, 0.9978057742118835, 0.00032028043642640114)",0.9993582364974146,0.9978057742118835,0,0
2019-05-02,64.32128143310547,75.87786102294922,76.17366027832031,75.0095443725586,75.0095443725586,11579142.0,"UBS Maintains Buy on Merck & Company, Inc. Common Stock (new), Raises Price Target to $88",0.006036219731549954,0.010111313691652453,0.16929197143205296,"[{'label': 'positive', 'score': 0.9995230436325073}, {'label': 'neutral', 'score': 0.0002874827478080988}, {'label': 'negative', 'score': 0.00018948319484479725}]","(0.0002874827478080988, 0.9995230436325073, 0.00018948319484479725)",0.9996209246363129,0.9995230436325073,0,0,"[{'label': 'positive', 'score': 0.7301819920539856}, {'label': 'neutral', 'score': 0.2472568154335022}, {'label': 'negative', 'score': 0.022561224177479744}]","(0.2472568154335022, 0.7301819920539856, 0.022561224177479744)",0.9400559880421632,0.7301819920539856,0,0,"[{'label': 'positive', 'score': 0.9989510774612427}, {'label': 'neutral', 'score': 0.0006525213248096406}, {'label': 'negative', 'score': 0.0003963799390476197}]","(0.0006525213248096406, 0.9989510774612427, 0.0003963799390476197)",0.999206722474526,0.9989510774612427,0,0
2019-05-03,64.70955657958984,76.33587646484375,76.46946716308594,75.62023162841797,75.8969497680664,7942582.0,"Canopy Growth, Lockheed Martin, Merck And More: 'Fast Money Halftime Report' Picks For May 3",-0.00216664254658979,0.00601807473872371,0.16010587749083507,"[{'label': 'neutral', 'score': 0.99982750415802}, {'label': 'positive', 'score': 9.077004506252706e-05}, {'label': 'negative', 'score': 8.162167068803683e-05}]","(0.99982750415802, 9.077004506252706e-05, 8.162167068803683e-05)",0.05306736657651896,9.077004506252706e-05,1,1,"[{'label': 'neutral', 'score': 0.9220837354660034}, {'label': 'positive', 'score': 0.06019865348935127}, {'label': 'negative', 'score': 0.017717568203806877}]","(0.9220837354660034, 0.06019865348935127, 0.017717568203806877)",0.5452149034233096,0.06019865348935127,0,1,"[{'label': 'neutral', 'score': 0.9994542002677917}, {'label': 'positive', 'score': 0.00042633916018530726}, {'label': 'negative', 'score': 0.00011953424836974591}]","(0.9994542002677917, 0.00042633916018530726, 0.00011953424836974591)",0.5620440692058717,0.00042633916018530726,0,1
2019-05-04,64.56934611002605,76.1704839070638,76.35814412434895,75.3180669148763,75.57570139567058,8597232.666666666,,-0.0021713470795555823,-0.002168993112389815,0.16961578703169267,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-05,64.42913564046223,76.00509134928386,76.24682108561198,75.01590220133464,75.25445302327473,9251883.333333334,,-0.0021760720873274897,-0.0021737078716439397,0.08677219173755647,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-06,64.28892517089844,75.8396987915039,76.135498046875,74.71373748779297,74.9332046508789,9906534.0,,-0.019879259120879806,-0.0021784431725849177,0.09193771912338779,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-05-07,63.01091003417969,74.33206176757812,75.65839385986328,73.8740463256836,75.27671813964844,10523387.0,Merck's BELSOMRA C-IV Meets Primary Efficacy Endpoint In Phase 3 Trial For Treatment Of Insomnia In People With Mild-To-Moderate Alzheimer's Disease Dementia | Ebola Death Toll in Congo Rises to 979,0.0035943274104954072,-0.02007950992793546,0.15243879598218812,"[{'label': 'negative', 'score': 0.9797073602676392}, {'label': 'neutral', 'score': 0.014637256041169167}, {'label': 'positive', 'score': 0.0056554535403847694}]","(0.014637256041169167, 0.0056554535403847694, 0.9797073602676392)",-0.9885210737382533,-0.9797073602676392,0,0,"[{'label': 'positive', 'score': 0.9364412426948547}, {'label': 'neutral', 'score': 0.03231928497552872}, {'label': 'negative', 'score': 0.03123948536813259}]","(0.03231928497552872, 0.9364412426948547, 0.03123948536813259)",0.9354343132767253,0.9364412426948547,0,0,"[{'label': 'positive', 'score': 0.8558424115180969}, {'label': 'neutral', 'score': 0.09836031496524811}, {'label': 'negative', 'score': 0.04579729586839676}]","(0.09836031496524811, 0.8558424115180969, 0.04579729586839676)",0.8984133118956229,0.8558424115180969,0,0
2019-05-08,63.23740005493164,74.59923553466797,75.10496520996094,74.33206176757812,74.74236297607422,10567508.0,Merck Reports Results From Phase 2 Trial Of V114 In Infants: Met Primary Dndpoint,0.0019186180713572515,0.0035878832527208404,0.14294050130634056,"[{'label': 'neutral', 'score': 0.9998855590820312}, {'label': 'negative', 'score': 6.190220301505178e-05}, {'label': 'positive', 'score': 5.261659680400044e-05}]","(0.9998855590820312, 5.261659680400044e-05, 6.190220301505178e-05)",-0.08108368430094673,-6.190220301505178e-05,1,1,"[{'label': 'neutral', 'score': 0.5817357897758484}, {'label': 'positive', 'score': 0.39603257179260254}, {'label': 'negative', 'score': 0.022231625393033028}]","(0.5817357897758484, 0.39603257179260254, 0.022231625393033028)",0.8936957762934411,0.39603257179260254,0,1,"[{'label': 'neutral', 'score': 0.999441921710968}, {'label': 'positive', 'score': 0.0004313443787395954}, {'label': 'negative', 'score': 0.00012670893920585513}]","(0.999441921710968, 0.0004313443787395954, 0.00012670893920585513)",0.5458894871466713,0.0004313443787395954,0,1
2019-05-09,63.35871887207031,74.74236297607422,74.91412353515625,73.7022933959961,74.12213897705078,8105861.0,,-0.001787247064832798,0.0019167798745283223,0.1500871633590308,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-10,63.24550247192383,74.60877990722656,74.74236297607422,73.29198455810547,74.50381469726562,9027158.0,Shares of several healthcare companies are trading lower in sympathy with the overall market. The S&P 500 is trading lower 1%,-0.004348379469377103,-0.0017888460963951843,0.15037212799052535,"[{'label': 'negative', 'score': 0.9974064230918884}, {'label': 'neutral', 'score': 0.002217600354924798}, {'label': 'positive', 'score': 0.0003759040264412761}]","(0.002217600354924798, 0.0003759040264412761, 0.9974064230918884)",-0.9992465209771215,-0.9974064230918884,0,0,"[{'label': 'negative', 'score': 0.9729175567626953}, {'label': 'neutral', 'score': 0.019221557304263115}, {'label': 'positive', 'score': 0.007860958576202393}]","(0.019221557304263115, 0.007860958576202393, 0.9729175567626953)",-0.9839699617125358,-0.9729175567626953,0,0,"[{'label': 'negative', 'score': 0.9970577955245972}, {'label': 'neutral', 'score': 0.0026187514886260033}, {'label': 'positive', 'score': 0.00032340301549993455}]","(0.0026187514886260033, 0.00032340301549993455, 0.9970577955245972)",-0.9993514956649007,-0.9970577955245972,0,0
2019-05-11,62.97048314412435,74.2843526204427,74.48791249593098,73.295166015625,74.10305277506511,9232007.0,,-0.004367370453391604,-0.004357861168047832,0.1497699106718459,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-12,62.69546381632487,73.95992533365886,74.23346201578777,73.29834747314453,73.70229085286458,9436856.0,,-0.004386528046374506,-0.004376935274634501,0.05770629646513218,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-13,62.42044448852539,73.635498046875,73.97901153564453,73.30152893066406,73.30152893066406,9641705.0,,0.0032395826080613773,-0.004396177088058803,0.04385869426360724,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-14,62.622676849365234,73.8740463256836,74.50381469726562,73.8167953491211,74.06488800048828,8113826.0,,0.0016791597570914008,0.00323434646588653,0.05254546041687202,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-15,62.727806091308594,73.99809265136719,74.31298065185547,73.28244018554688,73.34923553466797,7284543.0,"13F From Loeb's Third Point Shows Liquidated Stake In Merck, Cut Stake In American Express | The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",0.020373895333144036,0.0016777515445352484,0.06005137369385227,"[{'label': 'negative', 'score': 0.910472571849823}, {'label': 'positive', 'score': 0.0473213754594326}, {'label': 'neutral', 'score': 0.042206067591905594}]","(0.042206067591905594, 0.0473213754594326, 0.910472571849823)",-0.9011867310450787,-0.910472571849823,0,0,"[{'label': 'positive', 'score': 0.7332237362861633}, {'label': 'neutral', 'score': 0.1915593445301056}, {'label': 'negative', 'score': 0.07521694153547287}]","(0.1915593445301056, 0.7332237362861633, 0.07521694153547287)",0.8139209379267089,0.7332237362861633,1,1,"[{'label': 'negative', 'score': 0.9942499399185181}, {'label': 'neutral', 'score': 0.00464835949242115}, {'label': 'positive', 'score': 0.0011017329525202513}]","(0.00464835949242115, 0.0011017329525202513, 0.9942499399185181)",-0.9977862438321073,-0.9942499399185181,0,0
2019-05-16,64.00582122802734,75.50572204589844,76.23091888427734,74.16984558105469,74.20801544189453,9910831.0,"5 ASCO Abstracts That Moved Stocks | Iovance Issues Cancer Trial Updates Ahead Of ASCO Meeting, Sending Stock Skyward | The Daily Biotech Pulse: FDA Nod For Roche, Trial Results For Agios, Iovance And MacroGenics | Intec Pharma Announces Research Collaboration Agreement With Merck",-0.005181330396862142,0.020169124180093364,0.159805616954729,"[{'label': 'positive', 'score': 0.9980497360229492}, {'label': 'neutral', 'score': 0.001655444735661149}, {'label': 'negative', 'score': 0.0002948781766463071}]","(0.001655444735661149, 0.9980497360229492, 0.0002948781766463071)",0.9994092657536241,0.9980497360229492,0,0,"[{'label': 'neutral', 'score': 0.7084730267524719}, {'label': 'positive', 'score': 0.2650993764400482}, {'label': 'negative', 'score': 0.026427660137414932}]","(0.7084730267524719, 0.2650993764400482, 0.026427660137414932)",0.8186949625827058,0.2650993764400482,0,1,"[{'label': 'neutral', 'score': 0.8390263319015503}, {'label': 'positive', 'score': 0.15901347994804382}, {'label': 'negative', 'score': 0.0019602139946073294}]","(0.8390263319015503, 0.15901347994804382, 0.0019602139946073294)",0.9756455362786707,0.15901347994804382,0,1
2019-05-17,63.67419052124024,75.114501953125,75.44847106933594,74.28434753417969,74.8187026977539,8259707.0,,0.0006775070503257919,-0.005194800036449997,0.16235365276565697,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-18,63.717333475748696,75.16539255777995,75.5120849609375,74.41157531738281,74.80279795328777,8266868.333333333,,0.0006770483452982518,0.0006772776460336469,0.1512126911410048,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-19,63.76047643025717,75.21628316243489,75.57569885253906,74.53880310058594,74.78689320882161,8274029.666666667,,0.0006765902609817982,0.0006768192514665466,0.15322533255455495,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-20,63.803619384765625,75.26717376708984,75.63931274414062,74.66603088378906,74.77098846435547,8281191.0,"UPDATE: Merck Says KEYTRUDA Trial Did Not Meet Primary Endpoint Of Superior Overall Survival | Merck Offers Update On Phase 3 KEYNOTE-19 Study Of KEYTRUDA in Previously-Treated Patients with Metastatic Triple-Negative Breast Cancer | Argus Questions Logic Behind Bristol-Myers' Proposed Celgene Buy, Steps To Sidelines",0.007860081766420666,0.000676361476980676,0.15417924147685605,"[{'label': 'negative', 'score': 0.7382961511611938}, {'label': 'neutral', 'score': 0.22489286959171295}, {'label': 'positive', 'score': 0.036810990422964096}]","(0.22489286959171295, 0.036810990422964096, 0.7382961511611938)",-0.9050170268132737,-0.7382961511611938,0,0,"[{'label': 'neutral', 'score': 0.4438433349132538}, {'label': 'negative', 'score': 0.4089827239513397}, {'label': 'positive', 'score': 0.1471739411354065}]","(0.4438433349132538, 0.1471739411354065, 0.4089827239513397)",-0.47074646273473636,-0.4089827239513397,1,1,"[{'label': 'negative', 'score': 0.9836652874946594}, {'label': 'neutral', 'score': 0.008355331607162952}, {'label': 'positive', 'score': 0.007979322224855423}]","(0.008355331607162952, 0.007979322224855423, 0.9836652874946594)",-0.9839068913466643,-0.9836652874946594,0,0
2019-05-21,64.30509185791016,75.85877990722656,76.0782470703125,74.9332046508789,75.45801544189453,10873734.0,"Merck To Buy Clinical-Stage Biopharma Peloton Therapeutics For More Than $1B | The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails | Merck To Purchase Peloton Therapeutics For $1.05B In Cash, Will Be Eligible To Receive Further $1.15B Based On Regulatory, Sales Milestones",0.018616283558159027,0.007829352243078569,0.07330967932513222,"[{'label': 'positive', 'score': 0.9529742002487183}, {'label': 'neutral', 'score': 0.043408751487731934}, {'label': 'negative', 'score': 0.003617081791162491}]","(0.043408751487731934, 0.9529742002487183, 0.003617081791162491)",0.9924375606195172,0.9529742002487183,1,1,"[{'label': 'positive', 'score': 0.7749288082122803}, {'label': 'neutral', 'score': 0.20349900424480438}, {'label': 'negative', 'score': 0.02157222293317318}]","(0.20349900424480438, 0.7749288082122803, 0.02157222293317318)",0.9458325298031315,0.7749288082122803,1,1,"[{'label': 'positive', 'score': 0.8450281620025635}, {'label': 'neutral', 'score': 0.12357442080974579}, {'label': 'negative', 'score': 0.03139739856123924}]","(0.12357442080974579, 0.8450281620025635, 0.03139739856123924)",0.9283512485851249,0.8450281620025635,1,1
2019-05-22,65.50223541259766,77.27098846435547,77.4332046508789,75.67748260498047,75.71565246582031,13491847.0,Merck's Keytruda Vs. Bristol-Myers Squibb's Opdivo In Q1 And Beyond,0.0004939740205012548,0.01844512155515698,0.12364338242740489,"[{'label': 'neutral', 'score': 0.9998470544815063}, {'label': 'positive', 'score': 8.825519762467593e-05}, {'label': 'negative', 'score': 6.47304841550067e-05}]","(0.9998470544815063, 8.825519762467593e-05, 6.47304841550067e-05)",0.1537706875310565,8.825519762467593e-05,1,1,"[{'label': 'positive', 'score': 0.8548765778541565}, {'label': 'neutral', 'score': 0.12553000450134277}, {'label': 'negative', 'score': 0.019593415781855583}]","(0.12553000450134277, 0.8548765778541565, 0.019593415781855583)",0.9551879059900342,0.8548765778541565,0,0,"[{'label': 'neutral', 'score': 0.9993734955787659}, {'label': 'positive', 'score': 0.00047665051533840597}, {'label': 'negative', 'score': 0.0001498308265581727}]","(0.9993734955787659, 0.00047665051533840597, 0.0001498308265581727)",0.5216750554626822,0.00047665051533840597,0,1
2019-05-23,65.53459167480469,77.30915832519531,77.47137451171875,76.72709655761719,76.90839385986328,9831498.0,,0.001851463318209908,0.0004938520554981305,0.12411512127499948,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-24,65.65589904785156,77.4522933959961,78.18701934814453,77.39503479003906,77.57633972167969,6071588.0,,-0.0028027713632235852,0.001849751472621034,0.1214195883488376,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-25,65.47188377380371,77.2352123260498,78.18701934814453,77.18511199951172,77.59542274475098,7998624.25,,-0.002810648969667844,-0.0028067064814251857,0.13277271841924582,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-26,65.28786849975586,77.01813125610352,78.18701934814453,76.97518920898438,77.61450576782227,9925660.5,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,-0.0028185709832979863,-0.0028146062602590655,0.14057625374490526,"[{'label': 'neutral', 'score': 0.9998798370361328}, {'label': 'negative', 'score': 6.434687384171411e-05}, {'label': 'positive', 'score': 5.5785483709769323e-05}]","(0.9998798370361328, 5.5785483709769323e-05, 6.434687384171411e-05)",-0.07126631247768325,-6.434687384171411e-05,1,1,"[{'label': 'neutral', 'score': 0.9418089985847473}, {'label': 'positive', 'score': 0.040044575929641724}, {'label': 'negative', 'score': 0.01814647763967514}]","(0.9418089985847473, 0.040044575929641724, 0.01814647763967514)",0.37631383085170794,0.040044575929641724,1,1,"[{'label': 'neutral', 'score': 0.9995445609092712}, {'label': 'positive', 'score': 0.0002858107618521899}, {'label': 'negative', 'score': 0.00016952971054706722}]","(0.9995445609092712, 0.0002858107618521899, 0.00016952971054706722)",0.25537165781117677,0.0002858107618521899,1,1
2019-05-27,65.10385322570801,76.80105018615723,78.18701934814453,76.76526641845703,77.63358879089355,11852696.75,,-0.0028265377806697776,-0.0028225506342033583,0.03548692715418569,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-28,64.91983795166016,76.58396911621094,78.18701934814453,76.55534362792969,77.65267181396484,13779733.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Radar Tool For Tue., May 28, 2019 | Goldman Sachs Initiates Coverage On Merck & Co with Neutral Rating, Announces $85 Price Target",-0.011213572724644537,-0.00283053998194368,0.033142313620547065,"[{'label': 'neutral', 'score': 0.99921715259552}, {'label': 'negative', 'score': 0.00042467613820917904}, {'label': 'positive', 'score': 0.00035823971848003566}]","(0.99921715259552, 0.00035823971848003566, 0.00042467613820917904)",-0.08485767552350891,-0.00042467613820917904,0,0,"[{'label': 'neutral', 'score': 0.5242596864700317}, {'label': 'positive', 'score': 0.4208652973175049}, {'label': 'negative', 'score': 0.054874978959560394}]","(0.5242596864700317, 0.4208652973175049, 0.054874978959560394)",0.769306986623088,0.4208652973175049,0,0,"[{'label': 'neutral', 'score': 0.6578204035758972}, {'label': 'positive', 'score': 0.3391677737236023}, {'label': 'negative', 'score': 0.00301177566871047}]","(0.6578204035758972, 0.3391677737236023, 0.00301177566871047)",0.9823965185876293,0.3391677737236023,0,0
2019-05-29,64.1918716430664,75.72518920898438,76.68893432617188,75.14312744140625,76.45037841796875,11278890.0,,0.004032259689533534,-0.011276918833927257,0.06004826644800561,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-30,64.4507064819336,76.03053283691406,76.16412353515625,75.56298065185547,75.91603088378906,7483768.0,,-0.005898565386854655,0.004024151918216604,0.08616102389361904,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-05-31,64.07054138183594,75.58206176757812,76.2595443725586,75.19084167480469,75.69656372070312,7142749.0,Merck Reports KEYTRUDA Showed Improved Overall Survival as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma at Final Analysis of Pivotal Phase 3 KEYNOTE-048 Trial,0.004418629346708266,-0.005916030637480711,0.0882029175844891,"[{'label': 'positive', 'score': 0.9996589422225952}, {'label': 'negative', 'score': 0.0002122288424288854}, {'label': 'neutral', 'score': 0.00012888950004708022}]","(0.00012888950004708022, 0.9996589422225952, 0.0002122288424288854)",0.9995754876256652,0.9996589422225952,0,0,"[{'label': 'positive', 'score': 0.9557056427001953}, {'label': 'neutral', 'score': 0.023899076506495476}, {'label': 'negative', 'score': 0.02039518393576145}]","(0.023899076506495476, 0.9557056427001953, 0.02039518393576145)",0.9582109073587171,0.9557056427001953,0,0,"[{'label': 'positive', 'score': 0.9987181425094604}, {'label': 'neutral', 'score': 0.0008527783211320639}, {'label': 'negative', 'score': 0.0004291340010240674}]","(0.0008527783211320639, 0.9987181425094604, 0.0004291340010240674)",0.9991409995080549,0.9987181425094604,0,0
2019-06-01,64.35364023844402,75.91603088378906,76.57760874430339,75.4198481241862,75.79834493001302,7834533.666666667,The Week Ahead In Biotech: ASCO Presentations Pick Up The Pace | Merck Announces Five-Year Survival Data for KEYTRUDA in Advanced Non-Small Cell Lung Cancer from First KEYNOTE Trial at #ASCO19,0.004399190952463935,0.004408895865952754,0.10617683522624377,"[{'label': 'positive', 'score': 0.9907110333442688}, {'label': 'neutral', 'score': 0.00902256928384304}, {'label': 'negative', 'score': 0.00026643741875886917}]","(0.00902256928384304, 0.9907110333442688, 0.00026643741875886917)",0.9994622735095002,0.9907110333442688,0,0,"[{'label': 'positive', 'score': 0.8738084435462952}, {'label': 'neutral', 'score': 0.10747473686933517}, {'label': 'negative', 'score': 0.018716899678111076}]","(0.10747473686933517, 0.8738084435462952, 0.018716899678111076)",0.9580585586276061,0.8738084435462952,0,0,"[{'label': 'positive', 'score': 0.9963763356208801}, {'label': 'neutral', 'score': 0.0032742484472692013}, {'label': 'negative', 'score': 0.00034935257281176746}]","(0.0032742484472692013, 0.9963763356208801, 0.00034935257281176746)",0.9992989995603607,0.9963763356208801,0,0
2019-06-02,64.63673909505208,76.25,76.89567311604817,75.6488545735677,75.90012613932292,8526318.333333334,,0.004379922835553279,0.004389542797646973,0.1159079767992774,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-06-03,64.91983795166016,76.58396911621094,77.21373748779297,75.87786102294922,76.00190734863281,9218103.0,Merck Reports LYNPARZA Phase 3 SOLO3 Trial Showed 72% Objective Response Rate in Patients with Platinum-Sensitive Relapsed Germline BRCA-mutated Advanced Ovarian Cancer Compared to 51% of Patients Receiving Chemotherapy | FDA Grants Approval Of Zerbaxa To Merck & Co Inc | Dynavax Highlights Presentation Of Results Showing 76% OVerall Response Rate In Advanced Melanoma Patients With SD-101 In Combination With KEYTRUDA | Merck Sat. Highlighted 5-Year Survival Data From KEYTRUDA In NSCLC As First Keynote Trial At ASCO,0.010216762000929667,0.004370358889591577,0.0725579296254219,"[{'label': 'positive', 'score': 0.993247389793396}, {'label': 'neutral', 'score': 0.006397875025868416}, {'label': 'negative', 'score': 0.00035467560519464314}]","(0.006397875025868416, 0.993247389793396, 0.00035467560519464314)",0.9992860811837134,0.993247389793396,0,0,"[{'label': 'positive', 'score': 0.900084376335144}, {'label': 'neutral', 'score': 0.07920186966657639}, {'label': 'negative', 'score': 0.020713796839118004}]","(0.07920186966657639, 0.900084376335144, 0.020713796839118004)",0.9550090401076461,0.900084376335144,0,0,"[{'label': 'positive', 'score': 0.9895139932632446}, {'label': 'neutral', 'score': 0.010008381679654121}, {'label': 'negative', 'score': 0.0004776173154823482}]","(0.010008381679654121, 0.9895139932632446, 0.0004776173154823482)",0.9990351083577301,0.9895139932632446,0,0
2019-06-04,65.58313751220703,77.36640930175781,77.60496520996094,76.44084167480469,77.05152893066406,9368806.0,"Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook. | 'I believe it is wrong to charge Americans astronomical prices for life-saving drugs developed with taxpayer dollars. You will not find me encouraging pharmaceutical companies to continue ripping off Americans like my Republican colleagues.' -Sen Sanders | The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer",0.007523442962279241,0.010164923668987335,0.09237831161102329,"[{'label': 'positive', 'score': 0.9996473789215088}, {'label': 'negative', 'score': 0.00024867543834261596}, {'label': 'neutral', 'score': 0.00010391534306108952}]","(0.00010391534306108952, 0.9996473789215088, 0.00024867543834261596)",0.9995025974204852,0.9996473789215088,0,0,"[{'label': 'positive', 'score': 0.7094294428825378}, {'label': 'neutral', 'score': 0.15582655370235443}, {'label': 'negative', 'score': 0.13474400341510773}]","(0.15582655370235443, 0.7094294428825378, 0.13474400341510773)",0.6807670177116693,0.7094294428825378,0,0,"[{'label': 'positive', 'score': 0.9959773421287537}, {'label': 'neutral', 'score': 0.0032358213793486357}, {'label': 'negative', 'score': 0.0007868052925914526}]","(0.0032358213793486357, 0.9959773421287537, 0.0007868052925914526)",0.9984212809125871,0.9959773421287537,0,0
2019-06-05,66.0765380859375,77.94847106933594,78.50190734863281,77.36640930175781,77.65267181396484,9821961.0,,-0.0030603330063575292,0.007495283016907241,0.04141537545436027,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-06-06,65.87431335449219,77.70992279052734,78.66412353515625,77.70037841796875,78.3969497680664,11393961.0,,0.012524550603082097,-0.0030650254013855492,0.07864511578781054,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-06-07,66.69935607910156,78.6832046508789,79.08396911621094,78.07251739501953,78.07251739501953,8797436.0,Sanofi's Leadership Transition: What You Need To Know,8.086751254343357e-05,0.01244676721380784,0.0957664343966825,"[{'label': 'neutral', 'score': 0.9998410940170288}, {'label': 'negative', 'score': 8.610377699369565e-05}, {'label': 'positive', 'score': 7.280799763975665e-05}]","(0.9998410940170288, 7.280799763975665e-05, 8.610377699369565e-05)",-0.08366767902886486,-8.610377699369565e-05,1,1,"[{'label': 'neutral', 'score': 0.9276376962661743}, {'label': 'positive', 'score': 0.0506209172308445}, {'label': 'negative', 'score': 0.021741414442658424}]","(0.9276376962661743, 0.0506209172308445, 0.021741414442658424)",0.3990958019220509,0.0506209172308445,1,1,"[{'label': 'neutral', 'score': 0.9994658827781677}, {'label': 'positive', 'score': 0.00037706151488237083}, {'label': 'negative', 'score': 0.00015703753160778433}]","(0.9994658827781677, 0.00037706151488237083, 0.00015703753160778433)",0.4119535219552992,0.00037706151488237083,1,1
2019-06-08,66.70475006103516,78.68956756591797,79.02035522460938,78.01844533284505,78.34605407714844,8377048.333333333,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trial Readouts",8.086097351764335e-05,8.08642429424126e-05,0.10550831369924647,"[{'label': 'neutral', 'score': 0.9998745918273926}, {'label': 'negative', 'score': 6.597369065275416e-05}, {'label': 'positive', 'score': 5.952307765255682e-05}]","(0.9998745918273926, 5.952307765255682e-05, 6.597369065275416e-05)",-0.05140063036925508,-6.597369065275416e-05,1,1,"[{'label': 'neutral', 'score': 0.9472860097885132}, {'label': 'positive', 'score': 0.028436310589313507}, {'label': 'negative', 'score': 0.02427767403423786}]","(0.9472860097885132, 0.028436310589313507, 0.02427767403423786)",0.07889057495413968,0.028436310589313507,1,1,"[{'label': 'neutral', 'score': 0.9995656609535217}, {'label': 'positive', 'score': 0.0002920630795415491}, {'label': 'negative', 'score': 0.00014227964857127517}]","(0.9995656609535217, 0.0002920630795415491, 0.00014227964857127517)",0.34485078551002324,0.0002920630795415491,1,1
2019-06-09,66.71014404296875,78.69593048095703,78.95674133300781,77.96437327067058,78.61959075927734,7956660.666666667,,8.085443554927161e-05,8.085770444537791e-05,0.10116339525331317,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-06-10,66.71553802490234,78.7022933959961,78.89312744140625,77.9103012084961,78.89312744140625,7536273.0,Merck Strikes $773M Deal For Privately Held Tilos Therapeutics | A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street | Merck Reports Purchase Of Tilos Therapeutics For Total Potential Consideration OF $773M,0.006062041359031849,8.085116700559139e-05,0.09584395041490244,"[{'label': 'positive', 'score': 0.9988969564437866}, {'label': 'neutral', 'score': 0.0008320407359860837}, {'label': 'negative', 'score': 0.0002709886757656932}]","(0.0008320407359860837, 0.9988969564437866, 0.0002709886757656932)",0.9994575713180365,0.9988969564437866,0,0,"[{'label': 'positive', 'score': 0.7624770402908325}, {'label': 'neutral', 'score': 0.17612884938716888}, {'label': 'negative', 'score': 0.061394013464450836}]","(0.17612884938716888, 0.7624770402908325, 0.061394013464450836)",0.8509620815427098,0.7624770402908325,0,0,"[{'label': 'positive', 'score': 0.9977027773857117}, {'label': 'neutral', 'score': 0.002069741953164339}, {'label': 'negative', 'score': 0.00022750819334760308}]","(0.002069741953164339, 0.9977027773857117, 0.00022750819334760308)",0.9995440399061232,0.9977027773857117,0,0
2019-06-11,67.11996459960938,79.17938995361328,79.5896987915039,78.67366027832031,79.09351348876953,7789679.0,"FDA Greenlights Merck's Blockbuster Drug Keytruda For First-Line Treatment Of Head, Neck Cancer | FDA Approves Two New Indications For Merck's KEYTRUDA",0.00879728577236074,0.006043741106994603,0.08741175145154215,"[{'label': 'positive', 'score': 0.9982190728187561}, {'label': 'neutral', 'score': 0.0015020961873233318}, {'label': 'negative', 'score': 0.0002788510755635798}]","(0.0015020961873233318, 0.9982190728187561, 0.0002788510755635798)",0.9994414588775988,0.9982190728187561,0,0,"[{'label': 'positive', 'score': 0.817499041557312}, {'label': 'neutral', 'score': 0.1513679176568985}, {'label': 'negative', 'score': 0.031132934615015984}]","(0.1513679176568985, 0.817499041557312, 0.031132934615015984)",0.9266279482999497,0.817499041557312,0,0,"[{'label': 'positive', 'score': 0.9969632029533386}, {'label': 'neutral', 'score': 0.002783759729936719}, {'label': 'negative', 'score': 0.00025307052419520915}]","(0.002783759729936719, 0.9969632029533386, 0.00025307052419520915)",0.9994924460602459,0.9969632029533386,0,0
2019-06-12,67.71044921875,79.8759536743164,80.4103012084961,79.33206176757812,79.33206176757812,11057762.0,"WHO Emergency Committee Meeting To Decide If Ebola Outbreak Constitutes An Int'l. Emergency Will Begin Jun. 14, 2019 | The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana",-0.00967629689323302,0.008758815114161014,0.06544846062350229,"[{'label': 'neutral', 'score': 0.9998354911804199}, {'label': 'negative', 'score': 9.837787365540862e-05}, {'label': 'positive', 'score': 6.616384780500084e-05}]","(0.9998354911804199, 6.616384780500084e-05, 9.837787365540862e-05)",-0.19578028942743755,-9.837787365540862e-05,1,1,"[{'label': 'neutral', 'score': 0.8318208456039429}, {'label': 'positive', 'score': 0.15520095825195312}, {'label': 'negative', 'score': 0.012978211976587772}]","(0.8318208456039429, 0.15520095825195312, 0.012978211976587772)",0.8456620762374852,0.15520095825195312,0,1,"[{'label': 'neutral', 'score': 0.998337984085083}, {'label': 'positive', 'score': 0.0014343294315040112}, {'label': 'negative', 'score': 0.00022767258633393794}]","(0.998337984085083, 0.0014343294315040112, 0.00022767258633393794)",0.7260261011835465,0.0014343294315040112,0,1
2019-06-13,67.05525970458984,79.1030502319336,80.32442474365234,78.75,80.20992279052734,10194001.0,"IBM, Walmart, Merck Included In FDA Program To Test Blockchain Usage In US Drug Supply Chain | IBM, KPMG, Merck, Walmart Report Have Been Selected By FDA To Be Included In Blockchain Program In Support Of US Drug Supply Chain Security Act To Address Requirement To Identify, Track, Trace Medicines, Vaccines Distributed In US",-0.001447503639736714,-0.009723416462351229,0.11289561508842821,"[{'label': 'neutral', 'score': 0.9998250603675842}, {'label': 'positive', 'score': 0.00010586492862785235}, {'label': 'negative', 'score': 6.914966070326045e-05}]","(0.9998250603675842, 0.00010586492862785235, 6.914966070326045e-05)",0.20978404180425048,0.00010586492862785235,1,1,"[{'label': 'neutral', 'score': 0.7505161166191101}, {'label': 'positive', 'score': 0.24143634736537933}, {'label': 'negative', 'score': 0.008047512732446194}]","(0.7505161166191101, 0.24143634736537933, 0.008047512732446194)",0.9354867066006541,0.24143634736537933,0,1,"[{'label': 'neutral', 'score': 0.9958640336990356}, {'label': 'positive', 'score': 0.003950603771954775}, {'label': 'negative', 'score': 0.00018537035793997347}]","(0.9958640336990356, 0.003950603771954775, 0.00018537035793997347)",0.9103619354869172,0.003950603771954775,0,1
2019-06-14,67.4053955078125,78.9885482788086,79.55152893066406,78.6832046508789,78.9217529296875,7989952.0,"From Earlier: 'Drug makers Amgen, Merck, Lilly and the Association of National Advertisers file suit to prevent the disclosure of drug prices in television ads.' | JP Morgan Maintains Overweight on Merck & Co, Raises Price Target to $93",0.002093912402689727,-0.0014485522851977696,0.11423535700591682,"[{'label': 'negative', 'score': 0.9388381242752075}, {'label': 'positive', 'score': 0.0592019222676754}, {'label': 'neutral', 'score': 0.0019599348306655884}]","(0.0019599348306655884, 0.0592019222676754, 0.9388381242752075)",-0.8813636337083962,-0.9388381242752075,0,0,"[{'label': 'positive', 'score': 0.5613744854927063}, {'label': 'neutral', 'score': 0.250893235206604}, {'label': 'negative', 'score': 0.1877322942018509}]","(0.250893235206604, 0.5613744854927063, 0.1877322942018509)",0.49878361993093334,0.5613744854927063,1,0,"[{'label': 'positive', 'score': 0.9889683723449707}, {'label': 'negative', 'score': 0.00805601291358471}, {'label': 'neutral', 'score': 0.0029756007716059685}]","(0.0029756007716059685, 0.9889683723449707, 0.00805601291358471)",0.9838398879050575,0.9889683723449707,0,0
2019-06-15,67.54653676350911,79.15394337972005,79.53880564371745,78.70546976725261,78.91857401529948,7469061.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs",0.0020895370950506998,0.002091723223548265,0.11439373432444182,"[{'label': 'neutral', 'score': 0.9998630285263062}, {'label': 'negative', 'score': 7.0218913606368e-05}, {'label': 'positive', 'score': 6.679204670945182e-05}]","(0.9998630285263062, 6.679204670945182e-05, 7.0218913606368e-05)",-0.02501162599705172,-7.0218913606368e-05,1,1,"[{'label': 'neutral', 'score': 0.951564610004425}, {'label': 'positive', 'score': 0.030196044594049454}, {'label': 'negative', 'score': 0.018239319324493408}]","(0.951564610004425, 0.030196044594049454, 0.018239319324493408)",0.2468594081313089,0.030196044594049454,1,1,"[{'label': 'neutral', 'score': 0.9995514750480652}, {'label': 'positive', 'score': 0.0003043725446332246}, {'label': 'negative', 'score': 0.00014422945969272405}]","(0.9995514750480652, 0.0003043725446332246, 0.00014422945969272405)",0.3569825444296111,0.0003043725446332246,1,1
2019-06-16,67.68767801920573,79.31933848063152,79.52608235677083,78.7277348836263,78.91539510091145,6948170.0,,0.0020851800340195774,0.0020873570487450702,0.10692298304718509,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-06-17,67.82881927490234,79.48473358154297,79.51335906982422,78.75,78.91221618652344,6427279.0,"'Measles cases in United States rise to 1,044- CNN",0.01428573759651718,0.0020830090635181858,0.08129121448200394,"[{'label': 'positive', 'score': 0.9992519021034241}, {'label': 'negative', 'score': 0.0003820694691967219}, {'label': 'neutral', 'score': 0.0003660342190414667}]","(0.0003660342190414667, 0.9992519021034241, 0.0003820694691967219)",0.9992355812626182,0.9992519021034241,1,1,"[{'label': 'positive', 'score': 0.8667047023773193}, {'label': 'negative', 'score': 0.08389654010534286}, {'label': 'neutral', 'score': 0.04939865320920944}]","(0.04939865320920944, 0.8667047023773193, 0.08389654010534286)",0.823487417529074,0.8667047023773193,1,1,"[{'label': 'negative', 'score': 0.5506346821784973}, {'label': 'neutral', 'score': 0.26648661494255066}, {'label': 'positive', 'score': 0.18287867307662964}]","(0.26648661494255066, 0.18287867307662964, 0.5506346821784973)",-0.5013623902920713,-0.5506346821784973,0,0
2019-06-18,68.79780578613281,80.62023162841797,80.79198455810547,79.41793823242188,79.41793823242188,11425086.0,"Merck Reports FDA Approved KEYTRUDA As Monotherapy for Patients with Metastatic Small Cell Lung Cancer (SCLC) with Disease Progression on or After Platinum-Based Chemotherapy and at Least One Other Prior Line of Therapy | AstraZeneca, Merck Report LYNPARZA Approved In EU For Use as First-Line Maintenance Therapy in Patients With BRCA-Mutated Advanced Ovarian Cancer | AstraZeneca, Merck Announce Lynparza Approved in the EU for 1st-line Maintenance Treatment Of BRCA-mutated Advanced Ovarian Cancer",0.01029700328047881,0.014184657974437794,0.09530914753586262,"[{'label': 'positive', 'score': 0.9991790652275085}, {'label': 'neutral', 'score': 0.0005763259832747281}, {'label': 'negative', 'score': 0.00024463445879518986}]","(0.0005763259832747281, 0.9991790652275085, 0.00024463445879518986)",0.9995104489539882,0.9991790652275085,0,0,"[{'label': 'neutral', 'score': 0.4976630210876465}, {'label': 'positive', 'score': 0.4896882474422455}, {'label': 'negative', 'score': 0.012648683972656727}]","(0.4976630210876465, 0.4896882474422455, 0.012648683972656727)",0.949640636864863,0.4896882474422455,0,1,"[{'label': 'positive', 'score': 0.9129558205604553}, {'label': 'neutral', 'score': 0.08610542863607407}, {'label': 'negative', 'score': 0.0009387117461301386}]","(0.08610542863607407, 0.9129558205604553, 0.0009387117461301386)",0.9979456891075583,0.9129558205604553,0,0
2019-06-19,69.5062026977539,81.45037841796875,81.64122009277344,80.3530502319336,80.39122009277344,9825419.0,"Report: Merck Searching Internally For Next CEO | Merck Prepping For CEO Departure, Has Begun Internal Successor Hunt | The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut | AstraZeneca,Merck Announce Lynparza Approved in Japan for 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer",-0.00890344800196031,0.010244350279159521,0.09078838828455921,"[{'label': 'positive', 'score': 0.9991497993469238}, {'label': 'neutral', 'score': 0.0005164692993275821}, {'label': 'negative', 'score': 0.0003336638037580997}]","(0.0005164692993275821, 0.9991497993469238, 0.0003336638037580997)",0.9993323275150421,0.9991497993469238,0,0,"[{'label': 'neutral', 'score': 0.8044803738594055}, {'label': 'positive', 'score': 0.1113368347287178}, {'label': 'negative', 'score': 0.08418277651071548}]","(0.8044803738594055, 0.1113368347287178, 0.08418277651071548)",0.13888150680061176,0.1113368347287178,1,1,"[{'label': 'positive', 'score': 0.9812803864479065}, {'label': 'neutral', 'score': 0.018349524587392807}, {'label': 'negative', 'score': 0.0003700297966133803}]","(0.018349524587392807, 0.9812803864479065, 0.0003700297966133803)",0.9992461067799899,0.9812803864479065,0,0
2019-06-20,68.88735961914062,80.72518920898438,82.53816986083984,80.45801544189453,82.04198455810547,12490483.0,"Merck CEO Frazier At Investor Day Says The Company Has Less Appetite For Big Deals Than Mid Or Small-Sized Deals; Says Most Big Pharma Deals Have Not Created The Value They Said They Were Going To Create | The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge | Merck Highlights 2019 Investor Day Presentation",-0.00035460416459530706,-0.008943320540272436,0.14144313731351268,"[{'label': 'negative', 'score': 0.9753873348236084}, {'label': 'neutral', 'score': 0.016116131097078323}, {'label': 'positive', 'score': 0.008496617898344994}]","(0.016116131097078323, 0.008496617898344994, 0.9753873348236084)",-0.982728414515068,-0.9753873348236084,0,0,"[{'label': 'neutral', 'score': 0.6601732969284058}, {'label': 'positive', 'score': 0.30933061242103577}, {'label': 'negative', 'score': 0.030496107414364815}]","(0.6601732969284058, 0.30933061242103577, 0.030496107414364815)",0.8205196611429731,0.30933061242103577,0,1,"[{'label': 'negative', 'score': 0.7857383489608765}, {'label': 'neutral', 'score': 0.19520527124404907}, {'label': 'positive', 'score': 0.019056331366300583}]","(0.19520527124404907, 0.019056331366300583, 0.7857383489608765)",-0.9526429986874329,-0.7857383489608765,0,0
2019-06-21,68.86294555664062,80.69656372070312,80.88740539550781,79.80915832519531,80.57251739501953,15034294.0,"Morgan Stanley Maintains Overweight on Merck & Co, Raises Price Target to $90 | The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy",0.0037050308245707175,-0.0003546670515191749,0.14447859775029298,"[{'label': 'positive', 'score': 0.9993758797645569}, {'label': 'negative', 'score': 0.0004140464880038053}, {'label': 'neutral', 'score': 0.00021006078168284148}]","(0.00021006078168284148, 0.9993758797645569, 0.0004140464880038053)",0.9991717330268455,0.9993758797645569,0,0,"[{'label': 'positive', 'score': 0.8482563495635986}, {'label': 'negative', 'score': 0.091295026242733}, {'label': 'neutral', 'score': 0.060448601841926575}]","(0.060448601841926575, 0.8482563495635986, 0.091295026242733)",0.8056625138473502,0.8482563495635986,0,0,"[{'label': 'positive', 'score': 0.995941698551178}, {'label': 'negative', 'score': 0.0022185775451362133}, {'label': 'neutral', 'score': 0.0018396740779280663}]","(0.0018396740779280663, 0.995941698551178, 0.0022185775451362133)",0.9955546667238395,0.995941698551178,0,0
2019-06-22,69.11808268229167,80.99554697672527,81.28816986083984,80.15903218587239,80.74109395345052,12653342.666666668,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",0.003691354243314651,0.0036981841041940737,0.14397504362472188,"[{'label': 'neutral', 'score': 0.9998718500137329}, {'label': 'negative', 'score': 6.773663335479796e-05}, {'label': 'positive', 'score': 6.037568164174445e-05}]","(0.9998718500137329, 6.037568164174445e-05, 6.773663335479796e-05)",-0.057457018970051184,-6.773663335479796e-05,1,1,"[{'label': 'neutral', 'score': 0.9485922455787659}, {'label': 'positive', 'score': 0.03102446347475052}, {'label': 'negative', 'score': 0.020383309572935104}]","(0.9485922455787659, 0.03102446347475052, 0.020383309572935104)",0.20699503734473632,0.03102446347475052,1,1,"[{'label': 'neutral', 'score': 0.9995594620704651}, {'label': 'positive', 'score': 0.0003061683673877269}, {'label': 'negative', 'score': 0.0001343813055427745}]","(0.9995594620704651, 0.0003061683673877269, 0.0001343813055427745)",0.3899380079032599,0.0003061683673877269,1,1
2019-06-23,69.3732198079427,81.29453023274739,81.68893432617188,80.50890604654948,80.90967051188152,10272391.333333334,,0.003677778260925389,0.0036845579152080636,0.11180918037436226,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-06-24,69.62835693359375,81.59351348876953,82.0896987915039,80.85877990722656,81.0782470703125,7891440.0,,-0.003157567469640123,0.0036710317707939286,0.08702836847015846,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-06-25,69.40850067138672,81.33587646484375,82.30915832519531,80.92557525634766,81.63167572021484,9348894.0,Intensity Therapeutics Announces Clinical Collaboration With Merck For A Phase 1/2 Clinical Trial To Evaluate Co'S Int230-6 In Combination With Keytruda For Multiple Solid Tumor Types,-0.019943708084979292,-0.0031625631046108735,0.04988278554790616,"[{'label': 'neutral', 'score': 0.9995885491371155}, {'label': 'positive', 'score': 0.00035795781877823174}, {'label': 'negative', 'score': 5.353074811864644e-05}]","(0.9995885491371155, 0.00035795781877823174, 5.353074811864644e-05)",0.7398190257273339,0.00035795781877823174,0,0,"[{'label': 'positive', 'score': 0.8645954728126526}, {'label': 'neutral', 'score': 0.12704753875732422}, {'label': 'negative', 'score': 0.008356922306120396}]","(0.12704753875732422, 0.8645954728126526, 0.008356922306120396)",0.9808536585663795,0.8645954728126526,0,0,"[{'label': 'positive', 'score': 0.9335117936134338}, {'label': 'neutral', 'score': 0.06612912565469742}, {'label': 'negative', 'score': 0.0003590329724829644}]","(0.06612912565469742, 0.9335117936134338, 0.0003590329724829644)",0.9992310864366638,0.9335117936134338,0,0
2019-06-26,68.02423095703125,79.71373748779297,81.2977066040039,79.28434753417969,81.27862548828125,12604401.0,,0.003471398385890675,-0.020145268237561978,0.16392500219099673,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-06-27,68.26038360595703,79.9904556274414,80.81106567382812,79.58015441894531,79.83778381347656,11721670.0,"The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO",0.0002386377845638742,0.0034653869904624677,0.16338229011605057,"[{'label': 'negative', 'score': 0.993216335773468}, {'label': 'neutral', 'score': 0.005924247205257416}, {'label': 'positive', 'score': 0.0008593521197326481}]","(0.005924247205257416, 0.0008593521197326481, 0.993216335773468)",-0.9982710529385264,-0.993216335773468,0,0,"[{'label': 'neutral', 'score': 0.8749921917915344}, {'label': 'positive', 'score': 0.11323439329862595}, {'label': 'negative', 'score': 0.011773379519581795}]","(0.8749921917915344, 0.11323439329862595, 0.011773379519581795)",0.8116376405377095,0.11323439329862595,0,1,"[{'label': 'neutral', 'score': 0.9967083930969238}, {'label': 'negative', 'score': 0.0020532782655209303}, {'label': 'positive', 'score': 0.0012383392313495278}]","(0.9967083930969238, 0.0012383392313495278, 0.0020532782655209303)",-0.24758011371194094,-0.0020532782655209303,1,1
2019-06-28,68.27667236328125,80.0095443725586,80.59160614013672,79.17938995361328,80.1240463256836,46684837.0,,0.003577822762526524,0.00023860931509684833,0.15686976093025984,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-06-29,68.52095286051433,80.29580434163411,80.74109649658203,79.46882883707683,80.23855082194011,34543512.333333336,,0.0035650675825798024,0.003571437580168106,0.15659682879867962,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-06-30,68.76523335774739,80.58206431070964,80.89058685302734,79.75826772054036,80.35305531819661,22402187.666666668,,0.0035524030257123996,0.0035587277925309357,0.16381885325747655,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-01,69.00951385498047,80.86832427978516,81.04007720947266,80.0477066040039,80.46755981445312,10260863.0,Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates,0.008967531050543263,0.0035461081456462256,0.02341422944235896,"[{'label': 'neutral', 'score': 0.9998815059661865}, {'label': 'negative', 'score': 6.529314123326913e-05}, {'label': 'positive', 'score': 5.3132120228838176e-05}]","(0.9998815059661865, 5.3132120228838176e-05, 6.529314123326913e-05)",-0.10268941655089467,-6.529314123326913e-05,0,0,"[{'label': 'neutral', 'score': 0.9478203058242798}, {'label': 'positive', 'score': 0.031513363122940063}, {'label': 'negative', 'score': 0.020666249096393585}]","(0.9478203058242798, 0.031513363122940063, 0.020666249096393585)",0.20788031120184128,0.031513363122940063,0,0,"[{'label': 'neutral', 'score': 0.9995600581169128}, {'label': 'positive', 'score': 0.0002714806469157338}, {'label': 'negative', 'score': 0.00016851535474415869}]","(0.9995600581169128, 0.0002714806469157338, 0.00016851535474415869)",0.23401415418125798,0.0002714806469157338,0,0
2019-07-02,69.62835693359375,81.59351348876953,81.59351348876953,80.24809265136719,80.59160614013672,10381593.0,"Mizuho Initiates Coverage On Merck With Buy Rating, $97 Price Target",0.016255361922461048,0.008927561518268188,0.04957344883321255,"[{'label': 'neutral', 'score': 0.9998495578765869}, {'label': 'positive', 'score': 8.654989505885169e-05}, {'label': 'negative', 'score': 6.393399962689728e-05}]","(0.9998495578765869, 8.654989505885169e-05, 6.393399962689728e-05)",0.1502878130525696,8.654989505885169e-05,0,0,"[{'label': 'neutral', 'score': 0.6539865136146545}, {'label': 'positive', 'score': 0.3363793194293976}, {'label': 'negative', 'score': 0.009634179063141346}]","(0.6539865136146545, 0.3363793194293976, 0.009634179063141346)",0.9443132761865412,0.3363793194293976,1,0,"[{'label': 'positive', 'score': 0.9963076114654541}, {'label': 'neutral', 'score': 0.0034426080528646708}, {'label': 'negative', 'score': 0.0002498442481737584}]","(0.0034426080528646708, 0.9963076114654541, 0.0002498442481737584)",0.9994985853615538,0.9963076114654541,1,1
2019-07-03,70.76018524169922,82.91984558105469,83.08206176757812,82.05152893066406,82.11832427978516,6533232.0,"Benzinga's Top Upgrades, Downgrades For July 3, 2019 | Mizuho Initiates Coverage On Merck & Co with Buy Rating, Announces $97 Price Target",-0.007479847669451174,0.016124658050427773,0.08781182477729957,"[{'label': 'neutral', 'score': 0.9998108744621277}, {'label': 'positive', 'score': 0.00011792092118412256}, {'label': 'negative', 'score': 7.128893776098266e-05}]","(0.9998108744621277, 0.00011792092118412256, 7.128893776098266e-05)",0.24645641449724387,0.00011792092118412256,1,1,"[{'label': 'positive', 'score': 0.7907693982124329}, {'label': 'neutral', 'score': 0.17626166343688965}, {'label': 'negative', 'score': 0.03296896442770958}]","(0.17626166343688965, 0.7907693982124329, 0.03296896442770958)",0.9199528250158422,0.7907693982124329,0,0,"[{'label': 'positive', 'score': 0.8148785829544067}, {'label': 'neutral', 'score': 0.18240304291248322}, {'label': 'negative', 'score': 0.002718373667448759}]","(0.18240304291248322, 0.8148785829544067, 0.002718373667448759)",0.9933503332040752,0.8148785829544067,0,0
2019-07-04,70.23091506958008,82.29961776733398,82.95324325561523,81.8129768371582,82.41412353515625,7650295.0,,-0.007536217427815094,-0.007507962011764964,0.13743127928420296,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-05,69.70164489746094,81.67938995361328,82.82442474365234,81.57442474365234,82.70992279052734,8767358.0,"The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight",-0.006074760840949572,-0.007564758197757056,0.16445397974035014,"[{'label': 'positive', 'score': 0.9506428241729736}, {'label': 'neutral', 'score': 0.048792917281389236}, {'label': 'negative', 'score': 0.000564244925044477}]","(0.048792917281389236, 0.9506428241729736, 0.000564244925044477)",0.9988136233563119,0.9506428241729736,0,0,"[{'label': 'neutral', 'score': 0.837661862373352}, {'label': 'positive', 'score': 0.15197491645812988}, {'label': 'negative', 'score': 0.010363193228840828}]","(0.837661862373352, 0.15197491645812988, 0.010363193228840828)",0.8723258112488348,0.15197491645812988,0,1,"[{'label': 'positive', 'score': 0.9699576497077942}, {'label': 'neutral', 'score': 0.029626784846186638}, {'label': 'negative', 'score': 0.0004155739152338356}]","(0.029626784846186638, 0.9699576497077942, 0.0004155739152338356)",0.9991434761283247,0.9699576497077942,0,0
2019-07-06,69.27822367350261,81.18320719401042,82.4109395345052,80.94147491455078,82.17875162760417,10409329.666666666,,-0.006111889105552382,-0.006093287267767253,0.1752333982816313,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-07,68.85480244954427,80.68702443440755,81.99745432535808,80.30852508544922,81.64758046468098,12051301.333333332,,-0.006149474008751171,-0.006130643153928395,0.16331271923806523,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-08,68.43138122558594,80.19084167480469,81.58396911621094,79.67557525634766,81.11640930175781,13693273.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",0.00975722625184406,-0.006168459899556678,0.012232563306348677,"[{'label': 'negative', 'score': 0.9747718572616577}, {'label': 'positive', 'score': 0.021135976538062096}, {'label': 'neutral', 'score': 0.004092138260602951}]","(0.004092138260602951, 0.021135976538062096, 0.9747718572616577)",-0.9575543522789226,-0.9747718572616577,0,0,"[{'label': 'negative', 'score': 0.9662870168685913}, {'label': 'neutral', 'score': 0.021670863032341003}, {'label': 'positive', 'score': 0.012042166665196419}]","(0.021670863032341003, 0.012042166665196419, 0.9662870168685913)",-0.9753821783753821,-0.9662870168685913,0,0,"[{'label': 'negative', 'score': 0.9946179986000061}, {'label': 'neutral', 'score': 0.004903867375105619}, {'label': 'positive', 'score': 0.0004782368487212807}]","(0.004903867375105619, 0.0004782368487212807, 0.9946179986000061)",-0.9990388128671683,-0.9946179986000061,0,0
2019-07-09,69.09907531738281,80.97328186035156,81.3072509765625,80.2385482788086,80.38167572021484,8490791.0,Judge Rules Against Trump Proposal Forcing Pharma Companies To Disclose Drug Prices In Commercials | FDA Accepts Merck's Supplemental Biologics License Applications For KEYTRUDA Six-Week Dosing Schedule For Melanoma And Multiple Other Indications,-0.0004713883390038753,0.009709931911978945,0.11542545801078678,"[{'label': 'neutral', 'score': 0.9983593821525574}, {'label': 'positive', 'score': 0.0012603478971868753}, {'label': 'negative', 'score': 0.00038020158535800874}]","(0.9983593821525574, 0.0012603478971868753, 0.00038020158535800874)",0.536494827613215,0.0012603478971868753,0,1,"[{'label': 'neutral', 'score': 0.5721549987792969}, {'label': 'negative', 'score': 0.2589949071407318}, {'label': 'positive', 'score': 0.16885007917881012}]","(0.5721549987792969, 0.16885007917881012, 0.2589949071407318)",-0.21069506677494587,-0.2589949071407318,1,1,"[{'label': 'neutral', 'score': 0.7289354205131531}, {'label': 'positive', 'score': 0.2673778533935547}, {'label': 'negative', 'score': 0.0036867514718323946}]","(0.7289354205131531, 0.2673778533935547, 0.0036867514718323946)",0.9727979868587914,0.2673778533935547,0,1
2019-07-10,69.06649017333984,80.93511199951172,81.21183013916016,80.48664093017578,80.91603088378906,5996132.0,Merck To Present Results From Studies Evaluating Investigational Anti-HIV Agent MK-8591 At IAS 2019 On Jul. 21-24,-0.04503650764159137,-0.00047149947741452264,0.10955392641893277,"[{'label': 'neutral', 'score': 0.9998667240142822}, {'label': 'positive', 'score': 7.066645048325881e-05}, {'label': 'negative', 'score': 6.263417890295386e-05}]","(0.9998667240142822, 7.066645048325881e-05, 6.263417890295386e-05)",0.06025681662037022,7.066645048325881e-05,0,0,"[{'label': 'neutral', 'score': 0.9282588958740234}, {'label': 'positive', 'score': 0.05950611084699631}, {'label': 'negative', 'score': 0.012235005386173725}]","(0.9282588958740234, 0.05950611084699631, 0.012235005386173725)",0.6589123217317107,0.05950611084699631,0,0,"[{'label': 'neutral', 'score': 0.9994164705276489}, {'label': 'positive', 'score': 0.00046061998000368476}, {'label': 'negative', 'score': 0.00012292632891330868}]","(0.9994164705276489, 0.00046061998000368476, 0.00012292632891330868)",0.5786921207968969,0.00046061998000368476,0,0
2019-07-11,65.95599365234375,77.29007720947266,79.83778381347656,76.1259536743164,79.67557525634766,22146126.0,Shares of several drug manufacturing companies are trading lower. The Trump Administration earlier rolled back a proposal to eliminate rebates from government drug plans and commented on continued efforts to lower drug prices.,-0.01567898730228768,-0.04608216712906582,0.3377487802556934,"[{'label': 'negative', 'score': 0.9982972741127014}, {'label': 'neutral', 'score': 0.0011348857078701258}, {'label': 'positive', 'score': 0.0005678708548657596}]","(0.0011348857078701258, 0.0005678708548657596, 0.9982972741127014)",-0.9988629679236947,-0.9982972741127014,0,0,"[{'label': 'negative', 'score': 0.9693491458892822}, {'label': 'neutral', 'score': 0.02059945836663246}, {'label': 'positive', 'score': 0.010051356628537178}]","(0.02059945836663246, 0.010051356628537178, 0.9693491458892822)",-0.9794744711633343,-0.9693491458892822,0,0,"[{'label': 'negative', 'score': 0.9965499639511108}, {'label': 'neutral', 'score': 0.0030575552955269814}, {'label': 'positive', 'score': 0.00039246122469194233}]","(0.0030575552955269814, 0.00039246122469194233, 0.9965499639511108)",-0.9992126702309359,-0.9965499639511108,0,0
2019-07-12,64.921875,76.0782470703125,77.19465637207031,75.02862548828125,77.1469497680664,18910636.0,"Washington Worries Trigger Bearish Merck Options Trades | Novartis, Amgen Scrap Pivotal Study Of Alzheimer's Prevention Drug | Stock Market Eyes Records On Dovish Commentary From Federal Reserve | Shares of several drug manufacturing companies are trading lower, potentially on continued weakness after the Trump Administration on Thursday rolled back a proposal to eliminate rebates from government drug plans.",0.005142338419178702,-0.015803202715733513,0.3380573393833368,"[{'label': 'negative', 'score': 0.9985677003860474}, {'label': 'neutral', 'score': 0.0007601151592098176}, {'label': 'positive', 'score': 0.0006721866084262729}]","(0.0007601151592098176, 0.0006721866084262729, 0.9985677003860474)",-0.9986546041302493,-0.9985677003860474,0,0,"[{'label': 'negative', 'score': 0.9684462547302246}, {'label': 'neutral', 'score': 0.021001553162932396}, {'label': 'positive', 'score': 0.01055213063955307}]","(0.021001553162932396, 0.01055213063955307, 0.9684462547302246)",-0.978443007062637,-0.9684462547302246,0,0,"[{'label': 'negative', 'score': 0.9982189536094666}, {'label': 'neutral', 'score': 0.001401212066411972}, {'label': 'positive', 'score': 0.0003798304533120245}]","(0.001401212066411972, 0.0003798304533120245, 0.9982189536094666)",-0.999239273150791,-0.9982189536094666,0,0
2019-07-13,65.25572204589844,76.46946716308594,77.31233978271484,75.50254313151042,77.0674311319987,16247947.333333334,"The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings | Bulls & Bears Of The Week: Costco, DuPont, IBM, Merck And More",0.005116030061241109,0.005129161750259045,0.35871935373138336,"[{'label': 'neutral', 'score': 0.999788224697113}, {'label': 'positive', 'score': 0.00013169895100872964}, {'label': 'negative', 'score': 8.010480087250471e-05}]","(0.999788224697113, 0.00013169895100872964, 8.010480087250471e-05)",0.24359412747870274,0.00013169895100872964,1,1,"[{'label': 'neutral', 'score': 0.6447532773017883}, {'label': 'positive', 'score': 0.332387775182724}, {'label': 'negative', 'score': 0.02285887859761715}]","(0.6447532773017883, 0.332387775182724, 0.02285887859761715)",0.8713070011814865,0.332387775182724,0,1,"[{'label': 'neutral', 'score': 0.9970544576644897}, {'label': 'positive', 'score': 0.002806060016155243}, {'label': 'negative', 'score': 0.00013953693269286305}]","(0.9970544576644897, 0.002806060016155243, 0.00013953693269286305)",0.9052572805336251,0.002806060016155243,0,1
2019-07-14,65.58956909179688,76.86068725585938,77.43002319335938,75.97646077473958,76.98791249593098,13585258.666666668,,0.005089989521835993,0.0051029876441327,0.344378153525574,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-15,65.92341613769531,77.25190734863281,77.5477066040039,76.45037841796875,76.90839385986328,10922570.0,World Health Organization Chief Says Ebola Case In Congolese City Of Goma Could Be A Gamechanger,0.007781592764925048,0.0050770793151823125,0.3565201607303942,"[{'label': 'neutral', 'score': 0.4447955787181854}, {'label': 'negative', 'score': 0.35540536046028137}, {'label': 'positive', 'score': 0.19979901611804962}]","(0.4447955787181854, 0.19979901611804962, 0.35540536046028137)",-0.28026858379830877,-0.35540536046028137,1,1,"[{'label': 'negative', 'score': 0.7724221348762512}, {'label': 'neutral', 'score': 0.20695725083351135}, {'label': 'positive', 'score': 0.020620686933398247}]","(0.20695725083351135, 0.020620686933398247, 0.7724221348762512)",-0.9479960315728128,-0.7724221348762512,0,0,"[{'label': 'neutral', 'score': 0.5177596807479858}, {'label': 'positive', 'score': 0.47913652658462524}, {'label': 'negative', 'score': 0.0031037521548569202}]","(0.5177596807479858, 0.47913652658462524, 0.0031037521548569202)",0.9871277772028095,0.47913652658462524,0,1
2019-07-16,66.4364013671875,77.8530502319336,78.03434753417969,77.18511199951172,77.59542083740234,8448662.0,,0.004044645643943199,0.007751472327687671,0.15419896701927957,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-17,66.70511627197266,78.16793823242188,78.5687026977539,77.84351348876953,78.20610809326172,9848999.0,"WHO Emergency Committee Says It Recognises Shortage Of Supply Of Merck's Ebola Vaccine, Says Who Should Work With Member States And Manufacturers To 'Take All Measures' To Increase Supply | WHO Emergency Committee Chairman Says Ebola Is A Regional Emergency And In No Way A Global Threat | World Health Organization's Emergency Committee Says Congo's Ebola Outbreak Constitutes A Public Health Emergency Of International Concern | Merck's Novel Antibiotic For Abdominal, Urinary Tract Infections Receives FDA Nod | FDA Approves Merck's RECARBRIO For the Treatment of Adults with Complicated Urinary Tract And Complicated Intra-Abdominal Bacterial Infections Where Limited Or No Alternative Treatment Options Are Available",0.009399423832292173,0.004036488053727078,0.02195701143631431,"[{'label': 'negative', 'score': 0.5852393507957458}, {'label': 'neutral', 'score': 0.3750108778476715}, {'label': 'positive', 'score': 0.03974973037838936}]","(0.3750108778476715, 0.03974973037838936, 0.5852393507957458)",-0.8727986405659646,-0.5852393507957458,0,0,"[{'label': 'neutral', 'score': 0.596207320690155}, {'label': 'positive', 'score': 0.3441426157951355}, {'label': 'negative', 'score': 0.05965010076761246}]","(0.596207320690155, 0.3441426157951355, 0.05965010076761246)",0.7045508830601057,0.3441426157951355,1,0,"[{'label': 'neutral', 'score': 0.48122796416282654}, {'label': 'positive', 'score': 0.4071241021156311}, {'label': 'negative', 'score': 0.11164794117212296}]","(0.48122796416282654, 0.4071241021156311, 0.11164794117212296)",0.5695683966909769,0.4071241021156311,1,0
2019-07-18,67.33211517333984,78.90267181396484,79.1603012084961,77.86259460449219,78.635498046875,8472661.0,,-0.015721338693905424,0.009355524121694507,0.03503974683552504,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-07-19,66.27357482910156,77.66221618652344,79.02671813964844,77.4332046508789,78.91221618652344,12053782.0,,-0.0007372120254269828,-0.015846229637035584,0.16252169602128133,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-20,66.22471364339192,77.60496266682942,78.70865122477214,77.40139770507812,78.58778889973958,10456420.333333334,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,-0.0007377559079539733,-0.0007374838998398011,0.1609899275425576,"[{'label': 'positive', 'score': 0.9995624423027039}, {'label': 'negative', 'score': 0.00022665964206680655}, {'label': 'neutral', 'score': 0.0002108623884851113}]","(0.0002108623884851113, 0.9995624423027039, 0.00022665964206680655)",0.9995465850915439,0.9995624423027039,0,0,"[{'label': 'positive', 'score': 0.937285840511322}, {'label': 'negative', 'score': 0.040172964334487915}, {'label': 'neutral', 'score': 0.022541163489222527}]","(0.022541163489222527, 0.937285840511322, 0.040172964334487915)",0.9178012124187166,0.937285840511322,0,0,"[{'label': 'positive', 'score': 0.9988993406295776}, {'label': 'neutral', 'score': 0.0006837195833213627}, {'label': 'negative', 'score': 0.00041695075924508274}]","(0.0006837195833213627, 0.9988993406295776, 0.00041695075924508274)",0.9991655279457806,0.9988993406295776,0,0
2019-07-21,66.1758524576823,77.54770914713542,78.39058430989583,77.36959075927734,78.26336161295573,8859058.666666668,,-0.0007383005935789152,-0.0007380281837674865,0.14911100121780277,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-22,66.12699127197266,77.4904556274414,78.07251739501953,77.33778381347656,77.93893432617188,7261697.0,,0.010097344358165328,-0.0007385732716827041,0.14311469891263745,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-23,66.79469299316406,78.27290344238281,78.65457916259766,77.18511199951172,77.74809265136719,7420469.0,"Merck Reports Results From Phase 1 Study Of Investigational Nucleoside Reverse Transcriptase Translocation Inhibitor Presented At International AIDS Society Conference on HIV Science | Eisai's Cancer Drug Combo Gets Breakthrough Therapy Designation For Liver Cancer | The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation | Merck And Eisai Receive Third Breakthrough Therapy Designation From FDA For KEYTRUDA Plus LENVIMA Combination Treatment",-0.0034134596358885417,0.01004670676149998,0.14653421613042533,"[{'label': 'neutral', 'score': 0.9565006494522095}, {'label': 'positive', 'score': 0.04267299547791481}, {'label': 'negative', 'score': 0.0008262742194347084}]","(0.9565006494522095, 0.04267299547791481, 0.0008262742194347084)",0.9620097429136814,0.04267299547791481,0,1,"[{'label': 'positive', 'score': 0.8633472323417664}, {'label': 'neutral', 'score': 0.10987504571676254}, {'label': 'negative', 'score': 0.026777738705277443}]","(0.10987504571676254, 0.8633472323417664, 0.026777738705277443)",0.9398337546383423,0.8633472323417664,0,0,"[{'label': 'positive', 'score': 0.8464915156364441}, {'label': 'neutral', 'score': 0.15126396715641022}, {'label': 'negative', 'score': 0.0022445281501859426}]","(0.15126396715641022, 0.8464915156364441, 0.0022445281501859426)",0.9947108923519449,0.8464915156364441,0,0
2019-07-24,66.56670379638672,78.00572204589844,78.54007720947266,77.40457916259766,78.24427795410156,7720197.0,"Merck Highlights Presentation Of Phase 2b Results For Investigational HIV-1 Therapy Islatravir (MK-8591) At IAS 2019 | The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",0.0,-0.0034192987808084946,0.08338518608480197,"[{'label': 'negative', 'score': 0.9960206151008606}, {'label': 'positive', 'score': 0.0031606846023350954}, {'label': 'neutral', 'score': 0.0008186761406250298}]","(0.0008186761406250298, 0.0031606846023350954, 0.9960206151008606)",-0.9936734512479888,-0.9960206151008606,0,0,"[{'label': 'positive', 'score': 0.7838563323020935}, {'label': 'neutral', 'score': 0.15271979570388794}, {'label': 'negative', 'score': 0.06342387199401855}]","(0.15271979570388794, 0.7838563323020935, 0.06342387199401855)",0.8502883186166053,0.7838563323020935,0,0,"[{'label': 'positive', 'score': 0.9953286647796631}, {'label': 'neutral', 'score': 0.004310936201363802}, {'label': 'negative', 'score': 0.00036044063745066524}]","(0.004310936201363802, 0.9953286647796631, 0.00036044063745066524)",0.9992759976271918,0.9953286647796631,0,0
2019-07-25,66.56670379638672,78.00572204589844,79.25572204589844,77.33778381347656,77.71946716308594,9670106.0,,-0.0039143747397149126,0.0,0.0826435232235673,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-26,66.30613708496094,77.70037841796875,77.89122009277344,77.2042007446289,77.84351348876953,7638977.0,,0.004339111090513046,-0.003922055955840854,0.08972337658540123,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-27,66.5938491821289,78.03752899169922,78.26335906982422,77.42684682210286,78.00890858968098,8800545.333333334,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",0.004320364548784357,0.00432972429176436,0.09285518445522409,"[{'label': 'neutral', 'score': 0.9991508722305298}, {'label': 'positive', 'score': 0.000782630464527756}, {'label': 'negative', 'score': 6.65176848997362e-05}]","(0.9991508722305298, 0.000782630464527756, 6.65176848997362e-05)",0.8433307899343987,0.000782630464527756,0,1,"[{'label': 'neutral', 'score': 0.8945525884628296}, {'label': 'positive', 'score': 0.06325723975896835}, {'label': 'negative', 'score': 0.04219009727239609}]","(0.8945525884628296, 0.06325723975896835, 0.04219009727239609)",0.1997882837032292,0.06325723975896835,1,1,"[{'label': 'positive', 'score': 0.9921913743019104}, {'label': 'neutral', 'score': 0.0062601882964372635}, {'label': 'negative', 'score': 0.0015484814066439867}]","(0.0062601882964372635, 0.9921913743019104, 0.0015484814066439867)",0.9968835276199325,0.9921913743019104,0,0
2019-07-28,66.88156127929688,78.37467956542969,78.635498046875,77.64949289957683,78.17430369059245,9962113.666666666,,0.004301779294025753,0.004311058567726383,0.06353183655822026,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-07-29,67.16927337646484,78.71183013916016,79.00763702392578,77.87213897705078,78.3396987915039,11123682.0,Merck Q2 Earnings Preview | Merck's Keytruda Gets A Double Dose Of Positive News | Merck's KEYTRUDA in Combination with Chemotherapy Met One of the Dual Primary Endpoints in Pivotal Phase 3 KEYNOTE-522 | Merck's KEYTRUDA in Combination with Inlyta as First-Line Treatment for Advanced Renal Cell Carcinoma Receives a Positive Opinion From the European Medicines Agency,0.009455731784989643,0.004292553091406478,0.05881052046089082,"[{'label': 'positive', 'score': 0.9994162321090698}, {'label': 'negative', 'score': 0.00034702278207987547}, {'label': 'neutral', 'score': 0.00023679797595832497}]","(0.00023679797595832497, 0.9994162321090698, 0.00034702278207987547)",0.9993057900850384,0.9994162321090698,1,1,"[{'label': 'positive', 'score': 0.9475824236869812}, {'label': 'neutral', 'score': 0.033050794154405594}, {'label': 'negative', 'score': 0.019366782158613205}]","(0.033050794154405594, 0.9475824236869812, 0.019366782158613205)",0.9599425036154262,0.9475824236869812,1,1,"[{'label': 'positive', 'score': 0.9986016154289246}, {'label': 'neutral', 'score': 0.0010835535358637571}, {'label': 'negative', 'score': 0.0003147951210848987}]","(0.0010835535358637571, 0.9986016154289246, 0.0003147951210848987)",0.9993697268004406,0.9986016154289246,1,1
2019-07-30,67.80440521240234,79.45610809326172,81.26908111572266,79.02671813964844,80.14312744140625,14286965.0,"Apple On Today's Menu, With Starring Roles From China Talks, Fed Meeting | 33 Healthcare Stocks Moving In Today's Pre-Market Session | Merck & Co shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also issued FY19 guidance above analyst estimates. | A Peek Into The Markets: US Stock Futures Down Ahead of Fed Meeting, Apple Earnings | Merck Reports Q2 Earnings Beat | The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings | Merck & Co. Sees FY19 Adj. EPS $4.84-$4.94 vs $4.75 Est., Sees Sales $45.2B-$46.2B vs $44.74B Est. | Merck & Co Q2 Adj. EPS $1.3 Beats $1.16 Estimate, Sales $11.76B Beat $10.96B Estimate | 15 Stocks To Watch For July 30, 2019 | Earnings Scheduled For July 30, 2019",-0.0033625327681069926,0.009411306184667723,0.07606300765706515,"[{'label': 'positive', 'score': 0.9995922446250916}, {'label': 'negative', 'score': 0.0002925109874922782}, {'label': 'neutral', 'score': 0.00011527915194164962}]","(0.00011527915194164962, 0.9995922446250916, 0.0002925109874922782)",0.9994149105967456,0.9995922446250916,0,0,"[{'label': 'positive', 'score': 0.8960341215133667}, {'label': 'negative', 'score': 0.060453739017248154}, {'label': 'neutral', 'score': 0.04351207613945007}]","(0.04351207613945007, 0.8960341215133667, 0.060453739017248154)",0.8735922503319358,0.8960341215133667,0,0,"[{'label': 'positive', 'score': 0.9876697659492493}, {'label': 'neutral', 'score': 0.011269809678196907}, {'label': 'negative', 'score': 0.0010605023708194494}]","(0.011269809678196907, 0.9876697659492493, 0.0010605023708194494)",0.9978548196514276,0.9876697659492493,0,0
2019-07-31,67.57640838623047,79.18893432617188,80.77290344238281,79.0457992553711,79.1030502319336,12443428.0,SELLAS Advances Galinpepimut-S (GPS) In Combination With KEYTRUDA Program With Dosing Of First Patient In Phase 1/2 Basket Study | Merck Reports FDA Approved New Monotherapy Indication For KEYTRUDA: 'Recurrent Locally Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus in Patients Whose Tumors Express PD-L1 (CPS 10) With Disease Progression After One or More Prior Lines',0.008434742026843035,-0.0033681987864289014,0.07259620777242441,"[{'label': 'positive', 'score': 0.9990862607955933}, {'label': 'neutral', 'score': 0.0006739424425177276}, {'label': 'negative', 'score': 0.00023976981174200773}]","(0.0006739424425177276, 0.9990862607955933, 0.00023976981174200773)",0.9995201369635167,0.9990862607955933,0,0,"[{'label': 'positive', 'score': 0.8824312090873718}, {'label': 'neutral', 'score': 0.10401973873376846}, {'label': 'negative', 'score': 0.01354906801134348}]","(0.10401973873376846, 0.8824312090873718, 0.01354906801134348)",0.9697558788789037,0.8824312090873718,0,0,"[{'label': 'neutral', 'score': 0.9616414308547974}, {'label': 'positive', 'score': 0.037668585777282715}, {'label': 'negative', 'score': 0.0006899593863636255}]","(0.9616414308547974, 0.037668585777282715, 0.0006899593863636255)",0.9640257792145087,0.037668585777282715,0,1
2019-08-01,68.14640045166016,79.85687255859375,80.62976837158203,78.85496520996094,79.25572204589844,10550006.0,,0.009320053501480845,0.008399368362944519,0.07986851466741324,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-02,68.7815170288086,80.60114288330078,80.88740539550781,79.72328186035156,80.03816986083984,10913767.0,,-0.005327311687173707,0.009276889787659136,0.08622795920432418,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-03,68.41509501139323,80.17175547281902,80.75063578287761,79.28117116292317,80.02862803141277,11237704.0,"Bulls And Bears Of The Week: Boeing, GM, Pfizer, Starbucks And More | The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts",-0.005355843937175074,-0.005341552411113663,0.11706061101107487,"[{'label': 'negative', 'score': 0.8011057376861572}, {'label': 'neutral', 'score': 0.1956348419189453}, {'label': 'positive', 'score': 0.003259452525526285}]","(0.1956348419189453, 0.003259452525526285, 0.8011057376861572)",-0.9918955902985596,-0.8011057376861572,0,0,"[{'label': 'neutral', 'score': 0.9196829199790955}, {'label': 'positive', 'score': 0.05867500975728035}, {'label': 'negative', 'score': 0.021642033010721207}]","(0.9196829199790955, 0.05867500975728035, 0.021642033010721207)",0.4610849138647961,0.05867500975728035,1,1,"[{'label': 'neutral', 'score': 0.9987083673477173}, {'label': 'positive', 'score': 0.001062612165696919}, {'label': 'negative', 'score': 0.00022903995704837143}]","(0.9987083673477173, 0.001062612165696919, 0.00022903995704837143)",0.6453534926082611,0.001062612165696919,0,1
2019-08-04,68.04867299397786,79.74236806233723,80.61386617024739,78.8390604654948,80.01908620198567,11561641.0,,-0.005384683461445487,-0.005370237886817494,0.11845931836495487,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-05,67.6822509765625,79.31298065185547,80.47709655761719,78.3969497680664,80.0095443725586,11885578.0,Universal Display and Merck Announce Research and Development Collaboration for OLED,0.01479783345266139,-0.005399233123155134,0.12363873381982289,"[{'label': 'neutral', 'score': 0.9998595714569092}, {'label': 'positive', 'score': 9.063731704372913e-05}, {'label': 'negative', 'score': 4.9869096983456984e-05}]","(0.9998595714569092, 9.063731704372913e-05, 4.9869096983456984e-05)",0.29015202147557506,9.063731704372913e-05,1,1,"[{'label': 'positive', 'score': 0.640414834022522}, {'label': 'neutral', 'score': 0.34788036346435547}, {'label': 'negative', 'score': 0.011704839766025543}]","(0.34788036346435547, 0.640414834022522, 0.011704839766025543)",0.964102172541352,0.640414834022522,0,0,"[{'label': 'positive', 'score': 0.9938908815383911}, {'label': 'neutral', 'score': 0.005805909633636475}, {'label': 'negative', 'score': 0.00030321336816996336}]","(0.005805909633636475, 0.9938908815383911, 0.00030321336816996336)",0.9993900318464506,0.9938908815383911,0,0
2019-08-06,68.6838150024414,80.48664093017578,80.61068725585938,79.29389190673828,79.31298065185547,11025274.0,"Merck 10-Q Out; Shows Co. Received Set Of Investigative Interrogatories From California Attorney General's Office On Apr. 15, 2019 Related To Conduct, Deal That Allegedly Affected, Delayed Competition To Lantus In Insulin Market | The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",-0.0011855487606337524,0.014689413790633394,0.1539135322327045,"[{'label': 'negative', 'score': 0.8572350144386292}, {'label': 'neutral', 'score': 0.13859625160694122}, {'label': 'positive', 'score': 0.0041687097400426865}]","(0.13859625160694122, 0.0041687097400426865, 0.8572350144386292)",-0.9903211244088422,-0.8572350144386292,0,0,"[{'label': 'neutral', 'score': 0.7470908761024475}, {'label': 'positive', 'score': 0.2336890697479248}, {'label': 'negative', 'score': 0.019220104441046715}]","(0.7470908761024475, 0.2336890697479248, 0.019220104441046715)",0.8480078510185983,0.2336890697479248,0,1,"[{'label': 'negative', 'score': 0.969776451587677}, {'label': 'neutral', 'score': 0.017539067193865776}, {'label': 'positive', 'score': 0.012684410437941551}]","(0.017539067193865776, 0.012684410437941551, 0.969776451587677)",-0.9741782885645153,-0.969776451587677,0,0
2019-08-07,68.60236358642578,80.39122009277344,80.81106567382812,79.00763702392578,80.3530502319336,11509660.0,,0.005697331641017144,-0.0011862520794997833,0.13801449930986617,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-08,68.99321746826172,80.84923553466797,81.15457916259766,80.45801544189453,80.86832427978516,8699762.0,,0.009323708409616204,0.00568116322923757,0.1359313324687627,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-09,69.6364974975586,81.6030502319336,82.16603088378906,80.83015441894531,81.2022933959961,8968260.0,,-0.0019488509978534759,0.009280510939845017,0.12757438460574014,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-10,69.50078582763672,81.4440180460612,82.10877990722656,80.76972198486328,81.24364217122395,8899476.333333334,,-0.001952656434294089,-0.00195075247882975,0.11191125038859044,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-11,69.36507415771484,81.2849858601888,82.05152893066406,80.70928955078125,81.28499094645183,8830692.666666666,,-0.0019564767612302776,-0.0019545653532493266,0.08246828313781171,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-12,69.22936248779297,81.1259536743164,81.99427795410156,80.64885711669922,81.32633972167969,8761909.0,,0.012467671261553636,-0.0019583931618923803,0.08448981325435684,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-13,70.09246826171875,82.13740539550781,82.81488800048828,81.5457992553711,81.5457992553711,8413658.0,Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,-0.031133817342401213,0.012390589870577456,0.11256944479421149,"[{'label': 'positive', 'score': 0.9996492862701416}, {'label': 'neutral', 'score': 0.00018520178855396807}, {'label': 'negative', 'score': 0.0001655532541917637}]","(0.00018520178855396807, 0.9996492862701416, 0.0001655532541917637)",0.999668832172424,0.9996492862701416,0,0,"[{'label': 'positive', 'score': 0.9259809851646423}, {'label': 'negative', 'score': 0.052216291427612305}, {'label': 'neutral', 'score': 0.021802663803100586}]","(0.021802663803100586, 0.9259809851646423, 0.052216291427612305)",0.8932397530086811,0.9259809851646423,0,0,"[{'label': 'positive', 'score': 0.987342357635498}, {'label': 'neutral', 'score': 0.012064128182828426}, {'label': 'negative', 'score': 0.0005935295484960079}]","(0.012064128182828426, 0.987342357635498, 0.0005935295484960079)",0.9987984452104726,0.987342357635498,0,0
2019-08-14,67.91024017333984,79.58015441894531,81.90839385986328,79.53244018554688,81.45992279052734,11411148.0,"The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics Offering | AstraZeneca And Merck Announce LYNPARZA) Phase 3 PAOLA-1 Trial Met Primary Endpoint In Ovarian Cancer Patients | Lynparza Phase Iii Paola-1 Trial Met Primary Endpoint as 1st-line Maintenance Treatment With Bevacizumab for Advanced Ovarian Cancer | AstraZeneca, Merck Announce Lynparza Phase III PAOLA-1 Trial Met Primary Endpoint",0.0007194127352543878,-0.03162877502040269,0.25588827183295726,"[{'label': 'negative', 'score': 0.954961359500885}, {'label': 'neutral', 'score': 0.04357666149735451}, {'label': 'positive', 'score': 0.0014619590947404504}]","(0.04357666149735451, 0.0014619590947404504, 0.954961359500885)",-0.9969428618765023,-0.954961359500885,0,0,"[{'label': 'neutral', 'score': 0.750687837600708}, {'label': 'positive', 'score': 0.23355306684970856}, {'label': 'negative', 'score': 0.015759052708745003}]","(0.750687837600708, 0.23355306684970856, 0.015759052708745003)",0.8735797302060148,0.23355306684970856,0,1,"[{'label': 'neutral', 'score': 0.9969203472137451}, {'label': 'positive', 'score': 0.0028106113895773888}, {'label': 'negative', 'score': 0.00026910481392405927}]","(0.9969203472137451, 0.0028106113895773888, 0.00026910481392405927)",0.8252405116951337,0.0028106113895773888,0,1
2019-08-15,67.95911407470703,79.63740539550781,80.0095443725586,79.09351348876953,79.69465637207031,9543612.0,,0.019170867409180517,0.0007191540819573922,0.2585937485046591,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-16,69.26192474365234,81.16412353515625,81.45037841796875,80.2957992553711,80.58206176757812,9156271.0,"Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal. | Benzinga's Top Upgrades, Downgrades For August 16, 2019 | SVB Leerink Initiates Coverage On Merck & Co with Outperform Rating, Announces $103 Price Target",0.004428226799208599,0.018989421645036638,0.3092896325062298,"[{'label': 'positive', 'score': 0.9994781613349915}, {'label': 'negative', 'score': 0.00040055980207398534}, {'label': 'neutral', 'score': 0.00012130694813095033}]","(0.00012130694813095033, 0.9994781613349915, 0.00040055980207398534)",0.9991987832251926,0.9994781613349915,0,0,"[{'label': 'positive', 'score': 0.8647711873054504}, {'label': 'negative', 'score': 0.09281270951032639}, {'label': 'neutral', 'score': 0.04241614043712616}]","(0.04241614043712616, 0.8647711873054504, 0.09281270951032639)",0.8061523176842186,0.8647711873054504,0,0,"[{'label': 'positive', 'score': 0.9961671233177185}, {'label': 'neutral', 'score': 0.0031929826363921165}, {'label': 'negative', 'score': 0.000639907259028405}]","(0.0031929826363921165, 0.9961671233177185, 0.000639907259028405)",0.9987160859837472,0.9961671233177185,0,0
2019-08-17,69.56863657633464,81.5235366821289,81.82251739501953,80.70928700764973,80.94465637207031,8655921.0,,0.004408704057750289,0.0044184510517759025,0.3104434440070943,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-18,69.87534840901692,81.88294982910156,82.19465637207031,81.12277475992839,81.3072509765625,8155571.0,,0.00438935270068787,0.004399014191412509,0.29681969664836183,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-19,70.18206024169922,82.24236297607422,82.5667953491211,81.53626251220703,81.66984558105469,7655221.0,Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.,-0.006265219040544002,0.004379747588681769,0.11298071301750813,"[{'label': 'positive', 'score': 0.9996845722198486}, {'label': 'negative', 'score': 0.00019478349713608623}, {'label': 'neutral', 'score': 0.0001206452288897708}]","(0.0001206452288897708, 0.9996845722198486, 0.00019478349713608623)",0.9996103860010263,0.9996845722198486,0,0,"[{'label': 'positive', 'score': 0.9457775354385376}, {'label': 'neutral', 'score': 0.02712174691259861}, {'label': 'negative', 'score': 0.027100685983896255}]","(0.02712174691259861, 0.9457775354385376, 0.027100685983896255)",0.9442876088966764,0.9457775354385376,0,0,"[{'label': 'positive', 'score': 0.9986178874969482}, {'label': 'neutral', 'score': 0.0010172048350796103}, {'label': 'negative', 'score': 0.0003648592974059284}]","(0.0010172048350796103, 0.9986178874969482, 0.0003648592974059284)",0.9992695383407236,0.9986178874969482,0,0
2019-08-20,69.74236297607422,81.72709655761719,82.75763702392578,81.6603012084961,82.07061004638672,6176598.0,,0.014711074376030024,-0.006284927888647623,0.14286505796740243,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-21,70.76834106445312,82.92938995361328,83.25381469726562,82.18511199951172,82.33778381347656,6486072.0,"The Daily Biotech Pulse: Ra Pharma Earns Milestone, Aimmune Doses Patient In Egg Allergy Trial, Cara In-Licenses Platform",-0.0021861646678879797,0.01460391618443934,0.11725705229816874,"[{'label': 'positive', 'score': 0.9993883371353149}, {'label': 'neutral', 'score': 0.0003464780456852168}, {'label': 'negative', 'score': 0.0002652094408404082}]","(0.0003464780456852168, 0.9993883371353149, 0.0002652094408404082)",0.9994693972891934,0.9993883371353149,0,0,"[{'label': 'positive', 'score': 0.5744751691818237}, {'label': 'neutral', 'score': 0.41476425528526306}, {'label': 'negative', 'score': 0.010760612785816193}]","(0.41476425528526306, 0.5744751691818237, 0.010760612785816193)",0.9632264016747657,0.5744751691818237,0,0,"[{'label': 'positive', 'score': 0.9973472356796265}, {'label': 'neutral', 'score': 0.002438544761389494}, {'label': 'negative', 'score': 0.00021419537370093167}]","(0.002438544761389494, 0.9973472356796265, 0.00021419537370093167)",0.9995705620385208,0.9973472356796265,0,0
2019-08-22,70.6136245727539,82.74809265136719,83.20610809326172,82.29962158203125,82.77671813964844,6588776.0,"Jim Cramer Weighs In On Pfizer, Teva And More | Analysts Share Stocks To Buy On Fed Uncertainty | The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study",-0.020525803253156612,-0.002188557814376604,0.125910263998732,"[{'label': 'positive', 'score': 0.9906761646270752}, {'label': 'neutral', 'score': 0.006941400934010744}, {'label': 'negative', 'score': 0.0023824686650186777}]","(0.006941400934010744, 0.9906761646270752, 0.0023824686650186777)",0.9952017563008932,0.9906761646270752,0,0,"[{'label': 'neutral', 'score': 0.7605574727058411}, {'label': 'positive', 'score': 0.2223394215106964}, {'label': 'negative', 'score': 0.01710308901965618}]","(0.7605574727058411, 0.2223394215106964, 0.01710308901965618)",0.8571424181798484,0.2223394215106964,0,0,"[{'label': 'neutral', 'score': 0.8629299998283386}, {'label': 'positive', 'score': 0.13101069629192352}, {'label': 'negative', 'score': 0.006059343460947275}]","(0.8629299998283386, 0.13101069629192352, 0.006059343460947275)",0.9115876310844891,0.13101069629192352,0,0
2019-08-23,69.16423034667969,81.04962158203125,82.95801544189453,80.61068725585938,82.27098846435547,10608694.0,,0.0036888600718267784,-0.020739385235146332,0.20788051799957427,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-24,69.41937001546223,81.34860229492188,82.62722778320312,80.80152638753255,82.00381469726562,9086404.333333334,10 Biopharmaceutical Companies Trying To Cure Cancer,0.003675302395567879,0.0036820729136423386,0.20657683231439194,"[{'label': 'neutral', 'score': 0.9998420476913452}, {'label': 'positive', 'score': 8.044482092373073e-05}, {'label': 'negative', 'score': 7.744888716842979e-05}]","(0.9998420476913452, 8.044482092373073e-05, 7.744888716842979e-05)",0.018974370742830683,8.044482092373073e-05,1,1,"[{'label': 'neutral', 'score': 0.8510980010032654}, {'label': 'positive', 'score': 0.12426883727312088}, {'label': 'negative', 'score': 0.024633202701807022}]","(0.8510980010032654, 0.12426883727312088, 0.024633202701807022)",0.6691354570299406,0.12426883727312088,0,1,"[{'label': 'neutral', 'score': 0.9989525079727173}, {'label': 'positive', 'score': 0.0008660433813929558}, {'label': 'negative', 'score': 0.0001813275011954829}]","(0.9989525079727173, 0.0008660433813929558, 0.0001813275011954829)",0.6537472938958243,0.0008660433813929558,0,1
2019-08-25,69.6745096842448,81.6475830078125,82.29644012451172,80.99236551920573,81.73664093017578,7564114.666666667,,0.003661844011500216,0.003668564974711585,0.2062178593355073,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-26,69.92964935302734,81.94656372070312,81.96565246582031,81.1832046508789,81.46946716308594,6041825.0,,-0.004191920602556583,0.0036551557832442487,0.16778621706541677,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-27,69.6364974975586,81.6030502319336,82.93893432617188,81.53626251220703,82.46183013916016,6527049.0,,0.011225449063307117,-0.004200731332934384,0.16824570154114413,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-08-28,70.418212890625,82.51908111572266,82.60496520996094,81.14503479003906,81.35496520996094,6159934.0,Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates,0.0027752555233058317,0.011162911284537887,0.08624377406968746,"[{'label': 'neutral', 'score': 0.9998811483383179}, {'label': 'negative', 'score': 6.542917981278151e-05}, {'label': 'positive', 'score': 5.345861063688062e-05}]","(0.9998811483383179, 5.345861063688062e-05, 6.542917981278151e-05)",-0.10068796072856033,-6.542917981278151e-05,1,1,"[{'label': 'neutral', 'score': 0.948746383190155}, {'label': 'positive', 'score': 0.02967340126633644}, {'label': 'negative', 'score': 0.021580159664154053}]","(0.948746383190155, 0.02967340126633644, 0.021580159664154053)",0.15790593775832185,0.02967340126633644,1,1,"[{'label': 'neutral', 'score': 0.9995595812797546}, {'label': 'positive', 'score': 0.0002710800326894969}, {'label': 'negative', 'score': 0.00016938050976023078}]","(0.9995595812797546, 0.0002710800326894969, 0.00016938050976023078)",0.23089360595988836,0.0002710800326894969,1,1
2019-08-29,70.6136245727539,82.74809265136719,83.34923553466797,82.23282623291016,83.08206176757812,6321012.0,Uganda Confirms Another Case Of Ebola - A 9-Year Old Girl Who Traveled Democratic Republic Of Congo | Stocks That Hit 52-Week Highs On Thursday,-0.002882825104061808,0.0027714116119444783,0.08642703978615451,"[{'label': 'positive', 'score': 0.9973293542861938}, {'label': 'negative', 'score': 0.0016184800770133734}, {'label': 'neutral', 'score': 0.0010521431686356664}]","(0.0010521431686356664, 0.9973293542861938, 0.0016184800770133734)",0.9967596304404722,0.9973293542861938,0,0,"[{'label': 'negative', 'score': 0.6802074909210205}, {'label': 'positive', 'score': 0.2152784764766693}, {'label': 'neutral', 'score': 0.1045139953494072}]","(0.1045139953494072, 0.2152784764766693, 0.6802074909210205)",-0.519191848193277,-0.6802074909210205,0,0,"[{'label': 'neutral', 'score': 0.7964627742767334}, {'label': 'negative', 'score': 0.13332659006118774}, {'label': 'positive', 'score': 0.07021061331033707}]","(0.7964627742767334, 0.07021061331033707, 0.13332659006118774)",-0.3100955290008702,-0.13332659006118774,1,1
2019-08-30,70.41004943847656,82.5095443725586,83.22518920898438,82.22328186035156,83.12976837158203,6795127.0,"Xynomic Pharma ReportsInterim Data From Phase 1b Study Of Abexinostat Combined With Keytruda In Multiple Solid Tumors | Deaths from E. Congo Ebola Outbreak Top 2,000; Cases Top 3,000",0.0005204032181779396,-0.002886988447738404,0.09707327514666216,"[{'label': 'neutral', 'score': 0.9998711347579956}, {'label': 'negative', 'score': 7.46988516766578e-05}, {'label': 'positive', 'score': 5.415537452790886e-05}]","(0.9998711347579956, 5.415537452790886e-05, 7.46988516766578e-05)",-0.15943192360749175,-7.46988516766578e-05,1,1,"[{'label': 'neutral', 'score': 0.8222154378890991}, {'label': 'negative', 'score': 0.090339794754982}, {'label': 'positive', 'score': 0.0874447226524353}]","(0.8222154378890991, 0.0874447226524353, 0.090339794754982)",-0.01628416323741084,-0.090339794754982,1,1,"[{'label': 'neutral', 'score': 0.9978151321411133}, {'label': 'negative', 'score': 0.0011148907942697406}, {'label': 'positive', 'score': 0.001069975201971829}]","(0.9978151321411133, 0.001069975201971829, 0.0011148907942697406)",-0.020557595923583385,-0.0011148907942697406,1,1
2019-08-31,70.44669532775879,82.55248260498047,83.17509460449219,82.19227027893066,82.91984558105469,6770315.75,,0.0005201325395304888,0.0005202678553834087,0.09645924890216763,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-01,70.48334121704102,82.59542083740234,83.125,82.16125869750977,82.70992279052734,6745504.5,,0.0005198621423142013,0.0005199973174880897,0.0839794009351656,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-02,70.51998710632324,82.63835906982422,83.07490539550781,82.13024711608887,82.5,6720693.25,,0.0005195920260903886,0.0005197270608044512,0.03215258962870315,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-03,70.55663299560547,82.6812973022461,83.02481079101562,82.09923553466797,82.29007720947266,6695882.0,,-0.006924388147015424,0.000519457084894411,0.024186241685345715,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-09-04,70.06807708740234,82.10877990722656,83.17748260498047,81.50763702392578,83.14885711669922,7868070.0,Aduro Biotech Announces First Patient Dosed In Phase 2 Study Of ADU-S100 In Combination With KEYTRUDA For First-Line Treatment Of Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma | European Commission Approves Merck's KEYTRUDA In Combination With Inlyta As First-Line Treatment For Patients With Advanced Renal Cell Carcinoma,0.0005810170856004583,-0.006948472968783775,0.053019921183882206,"[{'label': 'positive', 'score': 0.9633097052574158}, {'label': 'neutral', 'score': 0.03624582290649414}, {'label': 'negative', 'score': 0.0004444348451215774}]","(0.03624582290649414, 0.9633097052574158, 0.0004444348451215774)",0.9990777007814995,0.9633097052574158,0,0,"[{'label': 'positive', 'score': 0.8449617028236389}, {'label': 'neutral', 'score': 0.1451244354248047}, {'label': 'negative', 'score': 0.009913927875459194}]","(0.1451244354248047, 0.8449617028236389, 0.009913927875459194)",0.9768061516331872,0.8449617028236389,0,0,"[{'label': 'neutral', 'score': 0.9415925741195679}, {'label': 'positive', 'score': 0.05782273784279823}, {'label': 'negative', 'score': 0.00058473035460338}]","(0.9415925741195679, 0.05782273784279823, 0.00058473035460338)",0.9799775483290203,0.05782273784279823,0,1
2019-09-05,70.10877227783203,82.15648651123047,82.69084167480469,81.58396911621094,82.6717529296875,7524954.0,,0.005458834935317779,0.0005808483605251572,0.05312910201470726,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-06,70.49148559570312,82.60496520996094,82.94847106933594,82.35687255859375,82.57633972167969,7047695.0,,-0.011936390806436352,0.005443989497250956,0.0704553530364853,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-09-07,69.6500752766927,81.61896006266277,82.8180643717448,81.27862803141277,82.56361643473308,8712058.666666666,,-0.0120805894432027,-0.012008201531824792,0.10995574718150557,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-08,68.8086649576823,80.63295491536458,82.68765767415364,80.20038350423177,82.55089314778645,10376422.333333332,,-0.01222831469258594,-0.012154152823491743,0.1240637844020165,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-09,67.96725463867188,79.6469497680664,82.5572509765625,79.12213897705078,82.53816986083984,12040786.0,Merck & Co shares are trading lower. Not seeing any news to justify the price action. | Merck to Present Data From its Phase 3 Trial for KEYTRUDA as Neoadjuvant Therapy at the European Society for Medical Oncology,-0.02132509410186422,-0.012303695684688781,0.13468614594186049,"[{'label': 'negative', 'score': 0.9959859251976013}, {'label': 'neutral', 'score': 0.0035987193696200848}, {'label': 'positive', 'score': 0.0004152696637902409}]","(0.0035987193696200848, 0.0004152696637902409, 0.9959859251976013)",-0.999166460927723,-0.9959859251976013,1,1,"[{'label': 'negative', 'score': 0.7235474586486816}, {'label': 'neutral', 'score': 0.24483418464660645}, {'label': 'positive', 'score': 0.0316183939576149}]","(0.24483418464660645, 0.0316183939576149, 0.7235474586486816)",-0.9162610601406548,-0.7235474586486816,1,1,"[{'label': 'negative', 'score': 0.9979727864265442}, {'label': 'neutral', 'score': 0.0017224702751263976}, {'label': 'positive', 'score': 0.0003048407088499516}]","(0.0017224702751263976, 0.0003048407088499516, 0.9979727864265442)",-0.9993892666717881,-0.9979727864265442,1,1
2019-09-10,66.51785278320312,77.94847106933594,78.61640930175781,75.2385482788086,78.61640930175781,18087432.0,Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed bill would set US drug prices based on prices in other wealthy countries.,0.015056971504557858,-0.021555759118033722,0.15568020908672678,"[{'label': 'negative', 'score': 0.9976173043251038}, {'label': 'neutral', 'score': 0.0019354711985215545}, {'label': 'positive', 'score': 0.00044721015729010105}]","(0.0019354711985215545, 0.00044721015729010105, 0.9976173043251038)",-0.999103845190765,-0.9976173043251038,0,0,"[{'label': 'negative', 'score': 0.968090295791626}, {'label': 'neutral', 'score': 0.021479986608028412}, {'label': 'positive', 'score': 0.010429800488054752}]","(0.021479986608028412, 0.010429800488054752, 0.968090295791626)",-0.9786825012021547,-0.968090295791626,0,0,"[{'label': 'negative', 'score': 0.9969466328620911}, {'label': 'neutral', 'score': 0.0026909573934972286}, {'label': 'positive', 'score': 0.0003623023512773216}]","(0.0026909573934972286, 0.0003623023512773216, 0.9969466328620911)",-0.9992734400776229,-0.9969466328620911,0,0
2019-09-11,67.51939392089844,79.12213897705078,79.30343627929688,77.88167572021484,78.11068725585938,10602197.0,,0.004703348289897969,0.01494474047968654,0.21883953545663581,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-12,67.83696746826172,79.49427795410156,80.22901153564453,78.99809265136719,79.65648651123047,8416698.0,Oracle Reports Early In Surprise Move As Trump Surprises With Positive Trade Tweet,-0.008402343534807994,0.00469232210713149,0.23411183616772338,"[{'label': 'positive', 'score': 0.998728334903717}, {'label': 'neutral', 'score': 0.0010104869725182652}, {'label': 'negative', 'score': 0.0002611882227938622}]","(0.0010104869725182652, 0.998728334903717, 0.0002611882227938622)",0.9994770951711757,0.998728334903717,0,0,"[{'label': 'positive', 'score': 0.8177798986434937}, {'label': 'neutral', 'score': 0.1491970270872116}, {'label': 'negative', 'score': 0.03302304074168205}]","(0.1491970270872116, 0.8177798986434937, 0.03302304074168205)",0.9223720577045824,0.8177798986434937,0,0,"[{'label': 'positive', 'score': 0.9943787455558777}, {'label': 'neutral', 'score': 0.005282228346914053}, {'label': 'negative', 'score': 0.0003390523779671639}]","(0.005282228346914053, 0.9943787455558777, 0.0003390523779671639)",0.999318294337004,0.9943787455558777,0,0
2019-09-13,67.7140121459961,78.82633972167969,79.74236297607422,78.35877990722656,79.16984558105469,7521496.0,,-0.0023403187363130553,-0.008437842211155363,0.22865557175296405,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-14,67.5555419921875,78.64186096191406,79.38612874348958,78.22201029459636,79.00445048014323,7078087.333333333,,-0.0023458086763100293,-0.002343061562434,0.21801384925078687,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-15,67.3970718383789,78.45738220214844,79.02989451090495,78.08524068196614,78.83905537923177,6634678.666666667,"The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck",-0.0023513244335671107,-0.002348564395920488,0.14178527808334723,"[{'label': 'neutral', 'score': 0.9997066855430603}, {'label': 'negative', 'score': 0.00015932589303702116}, {'label': 'positive', 'score': 0.00013397277507465333}]","(0.9997066855430603, 0.00013397277507465333, 0.00015932589303702116)",-0.08644129932671411,-0.00015932589303702116,1,1,"[{'label': 'neutral', 'score': 0.8447849154472351}, {'label': 'negative', 'score': 0.11444579064846039}, {'label': 'positive', 'score': 0.040769271552562714}]","(0.8447849154472351, 0.040769271552562714, 0.11444579064846039)",-0.47467377232035174,-0.11444579064846039,1,1,"[{'label': 'neutral', 'score': 0.9876043796539307}, {'label': 'positive', 'score': 0.01202789694070816}, {'label': 'negative', 'score': 0.0003676460182759911}]","(0.9876043796539307, 0.01202789694070816, 0.0003676460182759911)",0.9406809335432095,0.01202789694070816,0,1
2019-09-16,67.23860168457031,78.27290344238281,78.67366027832031,77.94847106933594,78.67366027832031,6191270.0,,0.005851519769311731,-0.002354093137795807,0.07380892760979155,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-17,67.63204193115234,78.73091888427734,79.67557525634766,78.36832427978516,78.36832427978516,7375405.0,"Merck Press Release Confirms FDA Approval Of KEYTRUDA Plus LENVIMA Combo Treatment For Patients With Certain Types Of Endometrial Carcinoma | FDA Says Granted Accelerated Approval To Lenvima In Combo With Keytruda For Treatment Of Patients With Advanced Endometrial Carcinoma | Merck Reports FDA Accepted Biologics License Application, Granted Priority Review For V920 For Ebola Zaire Virus",0.006181065038642195,0.005834466121671286,0.08061867500594391,"[{'label': 'positive', 'score': 0.999427318572998}, {'label': 'neutral', 'score': 0.000314581033308059}, {'label': 'negative', 'score': 0.00025808095233514905}]","(0.000314581033308059, 0.999427318572998, 0.00025808095233514905)",0.9994836756594471,0.999427318572998,0,0,"[{'label': 'positive', 'score': 0.9194375276565552}, {'label': 'neutral', 'score': 0.06672119349241257}, {'label': 'negative', 'score': 0.013841355219483376}]","(0.06672119349241257, 0.9194375276565552, 0.013841355219483376)",0.9703382226396697,0.9194375276565552,0,0,"[{'label': 'positive', 'score': 0.9896357655525208}, {'label': 'neutral', 'score': 0.010025673545897007}, {'label': 'negative', 'score': 0.0003385646268725395}]","(0.010025673545897007, 0.9896357655525208, 0.0003385646268725395)",0.9993160133216562,0.9896357655525208,0,0
2019-09-18,68.05008697509766,79.21755981445312,79.46565246582031,78.60687255859375,78.88359069824219,6943734.0,"NewLink Genetics Rallies After Ebola Vaccine Granted Priority Review Status | The Daily Biotech Pulse: NewLink Genetics Rallies, Breakthrough Designation For Roche, IGM Biosciences Debuts | FDA Approves LENVIMA Plus KEYTRUDA Combination Treatment for Patients with Certain Types of Endometrial Carcinoma",0.011442999675244751,0.006162040610042583,0.07259751350880511,"[{'label': 'positive', 'score': 0.7706453800201416}, {'label': 'neutral', 'score': 0.228567972779274}, {'label': 'negative', 'score': 0.0007866753148846328}]","(0.228567972779274, 0.7706453800201416, 0.0007866753148846328)",0.9979604806166812,0.7706453800201416,1,1,"[{'label': 'positive', 'score': 0.867620587348938}, {'label': 'neutral', 'score': 0.12278707325458527}, {'label': 'negative', 'score': 0.009592323563992977}]","(0.12278707325458527, 0.867620587348938, 0.009592323563992977)",0.9781299991264149,0.867620587348938,1,1,"[{'label': 'positive', 'score': 0.991831362247467}, {'label': 'neutral', 'score': 0.007905558682978153}, {'label': 'negative', 'score': 0.00026307327789254487}]","(0.007905558682978153, 0.991831362247467, 0.00026307327789254487)",0.9994696608135832,0.991831362247467,1,1
2019-09-19,68.82877349853516,80.1240463256836,80.43893432617188,79.08396911621094,79.21755981445312,6922774.0,,0.014171751165180714,0.011378023764205339,0.09484965493704588,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-20,69.80419921875,81.2595443725586,81.93701934814453,80.45801544189453,80.85877990722656,23631247.0,"Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival. | The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary Offering | Merck's PIFELTRO And DELSTRIGO Receive FDA Approval For Use In Appropriate Adults Living With HIV-1 Who Are Virologically Suppressed",-0.003131361678673943,0.014072270673162888,0.10000375802421192,"[{'label': 'positive', 'score': 0.9987442493438721}, {'label': 'negative', 'score': 0.0006338392267934978}, {'label': 'neutral', 'score': 0.0006218627677299082}]","(0.0006218627677299082, 0.9987442493438721, 0.0006338392267934978)",0.998731532672084,0.9987442493438721,0,0,"[{'label': 'negative', 'score': 0.7096133828163147}, {'label': 'neutral', 'score': 0.24381870031356812}, {'label': 'positive', 'score': 0.046567901968955994}]","(0.24381870031356812, 0.046567901968955994, 0.7096133828163147)",-0.8768340266919469,-0.7096133828163147,0,0,"[{'label': 'positive', 'score': 0.9935460686683655}, {'label': 'neutral', 'score': 0.005678659770637751}, {'label': 'negative', 'score': 0.000775191409047693}]","(0.005678659770637751, 0.9935460686683655, 0.000775191409047693)",0.9984407626786792,0.9935460686683655,0,0
2019-09-21,69.5856196085612,81.00509134928386,81.73027801513672,80.46437581380208,80.91284942626953,18724022.0,,-0.003141197905420282,-0.0031362746505305614,0.10466759547491292,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-22,69.36703999837239,80.75063832600911,81.5235366821289,80.47073618570964,80.9669189453125,13816797.0,The Week Ahead In Biotech: Spotlight On ESMO Conference,-0.0031510961219581796,-0.0031461418234922456,0.1272122789802077,"[{'label': 'neutral', 'score': 0.9998762607574463}, {'label': 'negative', 'score': 6.195537571329623e-05}, {'label': 'positive', 'score': 6.174296868266538e-05}]","(0.9998762607574463, 6.174296868266538e-05, 6.195537571329623e-05)",-0.0017171372152802332,-6.195537571329623e-05,1,1,"[{'label': 'neutral', 'score': 0.9075203537940979}, {'label': 'positive', 'score': 0.07792457193136215}, {'label': 'negative', 'score': 0.014555075205862522}]","(0.9075203537940979, 0.07792457193136215, 0.014555075205862522)",0.6852264112931752,0.07792457193136215,0,1,"[{'label': 'neutral', 'score': 0.9995267391204834}, {'label': 'positive', 'score': 0.00034238066291436553}, {'label': 'negative', 'score': 0.00013091675646137446}]","(0.9995267391204834, 0.00034238066291436553, 0.00013091675646137446)",0.4467886318330308,0.00034238066291436553,1,1
2019-09-23,69.1484603881836,80.49618530273438,81.3167953491211,80.47709655761719,81.02098846435547,8909572.0,,-0.009009083295705841,-0.0031560712795587293,0.13882432959331595,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-24,68.5254898071289,79.77098846435547,80.99236297607422,79.57061004638672,80.67748260498047,9377085.0,,-0.005980827952638086,-0.009049910481951138,0.13878271095133804,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-25,68.11565399169922,79.29389190673828,80.1812973022461,79.15076446533203,79.6469497680664,7290936.0,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",0.0093863213950571,-0.0059987847375638035,0.041742021488008804,"[{'label': 'neutral', 'score': 0.9998873472213745}, {'label': 'negative', 'score': 6.067706272006035e-05}, {'label': 'positive', 'score': 5.199218503548764e-05}]","(0.9998873472213745, 5.199218503548764e-05, 6.067706272006035e-05)",-0.07708294727782149,-6.067706272006035e-05,0,0,"[{'label': 'neutral', 'score': 0.9140211343765259}, {'label': 'positive', 'score': 0.0764942392706871}, {'label': 'negative', 'score': 0.009484667330980301}]","(0.9140211343765259, 0.0764942392706871, 0.009484667330980301)",0.7793722273086836,0.0764942392706871,1,0,"[{'label': 'neutral', 'score': 0.9983394145965576}, {'label': 'positive', 'score': 0.0015489908400923014}, {'label': 'negative', 'score': 0.0001115862833103165}]","(0.9983394145965576, 0.0015489908400923014, 0.0001115862833103165)",0.8656054190585623,0.0015489908400923014,1,0
2019-09-26,68.7550048828125,80.03816986083984,80.2385482788086,79.23664093017578,79.79007720947266,8104918.0,,-0.011564173168338661,0.009342543608763784,0.11117490578093062,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-27,67.95991516113281,79.11259460449219,80.14312744140625,78.7977066040039,80.03816986083984,7827093.0,,0.005105930120728344,-0.011631558224254244,0.1295559082074812,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-09-28,68.30691528320312,79.51653798421223,80.49618275960286,78.99809010823567,79.82506561279297,8487053.333333334,"AstraZeneca , Merck Announced LYNPARZA Phase 3 PAOLA-1 Trial Significantly Increased Progression-Free Survival as First-Line Maintenance Treatment with Bevacizumab for Newly-Diagnosed Advanced Ovarian Cancer at ESMO 2019",0.005079992036376927,0.005092939061724427,0.14558181153314848,"[{'label': 'positive', 'score': 0.9996064305305481}, {'label': 'neutral', 'score': 0.0002119850687449798}, {'label': 'negative', 'score': 0.00018161049229092896}]","(0.0002119850687449798, 0.9996064305305481, 0.00018161049229092896)",0.9996367020111481,0.9996064305305481,0,0,"[{'label': 'positive', 'score': 0.9535932540893555}, {'label': 'neutral', 'score': 0.02912742644548416}, {'label': 'negative', 'score': 0.017279401421546936}]","(0.02912742644548416, 0.9535932540893555, 0.017279401421546936)",0.9644043916090025,0.9535932540893555,0,0,"[{'label': 'positive', 'score': 0.9983060359954834}, {'label': 'neutral', 'score': 0.0013718102127313614}, {'label': 'negative', 'score': 0.0003221289662178606}]","(0.0013718102127313614, 0.9983060359954834, 0.0003221289662178606)",0.9993548570378441,0.9983060359954834,0,0
2019-09-29,68.65391540527344,79.9204813639323,80.84923807779948,79.19847361246745,79.6119613647461,9147013.666666666,"The Week Ahead In Biotech (Sept. 29-Oct. 5): Conference Presentations, IPOs Hit Top Gear",0.005054316150582458,0.005067132409646117,0.13963126897686085,"[{'label': 'neutral', 'score': 0.9998413324356079}, {'label': 'positive', 'score': 8.607292693341151e-05}, {'label': 'negative', 'score': 7.254366937559098e-05}]","(0.9998413324356079, 8.607292693341151e-05, 7.254366937559098e-05)",0.08529534659452694,8.607292693341151e-05,1,1,"[{'label': 'positive', 'score': 0.8668355941772461}, {'label': 'neutral', 'score': 0.11748768389225006}, {'label': 'negative', 'score': 0.015676675364375114}]","(0.11748768389225006, 0.8668355941772461, 0.015676675364375114)",0.9644726177631103,0.8668355941772461,0,0,"[{'label': 'neutral', 'score': 0.9993446469306946}, {'label': 'positive', 'score': 0.0005164045724086463}, {'label': 'negative', 'score': 0.00013895354641135782}]","(0.9993446469306946, 0.0005164045724086463, 0.00013895354641135782)",0.5759462119381425,0.0005164045724086463,0,1
2019-09-30,69.00091552734375,80.32442474365234,81.2022933959961,79.39885711669922,79.39885711669922,9806974.0,"Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates | Merck shares trading higher over the $82 level. The company announced its RESTORE-IMI study of RECARBRIO met its primary endpoint. Separately, the company and AstraZeneca highlighted new LYNPARZA data. | Movers And Shakers At ESMO 2019: Immunomedics, G1 Therapeutics, Seattle Genetics And More | Merck, AstraZeneca Highlight Data LYNPARZA More Than Doubled Median Radiographic Progression-Free Survival In BRCA1/2, ATM Metastatic Castration-Resistant Prostate Cancer | Merck's Pivotal RESTORE-IMI 2 Phase 3 Study of RECARBRIO Met its Primary Endpoint",-0.006771189566237914,0.005041585971588512,0.12951605370497463,"[{'label': 'positive', 'score': 0.9993619322776794}, {'label': 'neutral', 'score': 0.00035215867683291435}, {'label': 'negative', 'score': 0.0002859021769836545}]","(0.00035215867683291435, 0.9993619322776794, 0.0002859021769836545)",0.9994279942053,0.9993619322776794,0,0,"[{'label': 'positive', 'score': 0.7481895685195923}, {'label': 'neutral', 'score': 0.23630142211914062}, {'label': 'negative', 'score': 0.015509042888879776}]","(0.23630142211914062, 0.7481895685195923, 0.015509042888879776)",0.9593843889272581,0.7481895685195923,0,0,"[{'label': 'positive', 'score': 0.9952349066734314}, {'label': 'neutral', 'score': 0.0042382837273180485}, {'label': 'negative', 'score': 0.0005268297391012311}]","(0.0042382837273180485, 0.9952349066734314, 0.0005268297391012311)",0.9989418558278825,0.9952349066734314,0,0
2019-10-01,68.53369903564453,79.78053283691406,80.72518920898438,79.71373748779297,80.32442474365234,7050001.0,"The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines",-0.02380100820560861,-0.006794218082813213,0.12709697623518887,"[{'label': 'positive', 'score': 0.9992285966873169}, {'label': 'neutral', 'score': 0.00048251773114316165}, {'label': 'negative', 'score': 0.00028893319540657103}]","(0.00048251773114316165, 0.9992285966873169, 0.00028893319540657103)",0.9994218546713424,0.9992285966873169,0,0,"[{'label': 'neutral', 'score': 0.8694126605987549}, {'label': 'negative', 'score': 0.08667201548814774}, {'label': 'positive', 'score': 0.04391535744071007}]","(0.8694126605987549, 0.04391535744071007, 0.08667201548814774)",-0.32741801208246146,-0.08667201548814774,0,0,"[{'label': 'neutral', 'score': 0.8478121757507324}, {'label': 'positive', 'score': 0.12943844497203827}, {'label': 'negative', 'score': 0.022749371826648712}]","(0.8478121757507324, 0.12943844497203827, 0.022749371826648712)",0.7010355716352588,0.12943844497203827,0,0
2019-10-02,66.90251922607422,77.88167572021484,79.39885711669922,76.85114288330078,79.26526641845703,8762433.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued fears of a recession amid a weak ADP jobs report. There is also uncertainty in the market over the upcoming U.S.-China meeting next week. | Merck's KEYTRUDA Now Approved as Monotherapy In China For First-Line Treatment Of Certain Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Express PD-L1 | FDA Accepts Two Applications For Merck's DIFICID To Treat Children Aged Six Months Up To 18 years With Clostridium difficile Infections,0.013722132810716032,-0.024088828315536596,0.20302671803128797,"[{'label': 'negative', 'score': 0.9985764026641846}, {'label': 'neutral', 'score': 0.0007975384942255914}, {'label': 'positive', 'score': 0.0006260045920498669}]","(0.0007975384942255914, 0.0006260045920498669, 0.9985764026641846)",-0.9987469914253533,-0.9985764026641846,0,0,"[{'label': 'negative', 'score': 0.9665539860725403}, {'label': 'neutral', 'score': 0.022609783336520195}, {'label': 'positive', 'score': 0.010836204513907433}]","(0.022609783336520195, 0.010836204513907433, 0.9665539860725403)",-0.9778262466346106,-0.9665539860725403,0,0,"[{'label': 'negative', 'score': 0.9972163438796997}, {'label': 'neutral', 'score': 0.002189892577007413}, {'label': 'positive', 'score': 0.0005937811220064759}]","(0.002189892577007413, 0.0005937811220064759, 0.9972163438796997)",-0.9988098314356041,-0.9972163438796997,0,0
2019-10-03,67.82057189941406,78.95037841796875,79.08396911621094,77.89122009277344,78.17748260498047,5790095.0,"Biotech Stock On The Radar: FDA Verdict Ahead For Pfenex's Osteoporosis Biosimilar | What's Behind PDS Biotech's Rally? | PDS Biotech Reports Clinical Collaboration With Merck For Evaluation Of Combo Of PDS0101, Merck's KEYTRUDA",0.027314551036201135,0.013628836857039684,0.2318248981807076,"[{'label': 'neutral', 'score': 0.6030325293540955}, {'label': 'positive', 'score': 0.395458459854126}, {'label': 'negative', 'score': 0.001508970744907856}]","(0.6030325293540955, 0.395458459854126, 0.001508970744907856)",0.992397508568243,0.395458459854126,0,1,"[{'label': 'neutral', 'score': 0.6700414419174194}, {'label': 'positive', 'score': 0.31839776039123535}, {'label': 'negative', 'score': 0.011560744605958462}]","(0.6700414419174194, 0.31839776039123535, 0.011560744605958462)",0.9299260699095677,0.31839776039123535,0,1,"[{'label': 'positive', 'score': 0.9906246066093445}, {'label': 'neutral', 'score': 0.00898588914424181}, {'label': 'negative', 'score': 0.000389576714951545}]","(0.00898588914424181, 0.9906246066093445, 0.000389576714951545)",0.9992137817570991,0.9906246066093445,0,0
2019-10-04,69.6730728149414,81.10687255859375,81.22137451171875,79.35114288330078,79.59923553466797,7504518.0,,-0.0023921596662790567,0.026948165489228383,0.30948901373772064,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-05,69.5063985188802,80.91285196940105,81.21819305419922,79.6024169921875,80.11132303873698,6698396.666666667,,-0.0023978958159340483,-0.0023950254514028134,0.31081856051847984,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-06,69.33972422281902,80.71883138020833,81.21501159667969,79.85369110107422,80.62341054280598,5892275.333333334,,-0.0024036595410903833,-0.0024007753722778786,0.30497838469803146,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-07,69.17304992675781,80.52481079101562,81.21183013916016,80.10496520996094,81.135498046875,5086154.0,,-0.013034759991616884,-0.002406552968157378,0.21096778257865018,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-08,68.2713851928711,79.47518920898438,80.54389190673828,79.27481079101562,79.9522933959961,6416694.0,"Goldman Recommends Selling Puma Biotech, Clovis Oncology; Cites Company-Specific, Competitive Risks | Shares of several healthcare companies are trading lower with the broader market after the US expanded its trade blacklist to include China's top AI firms. The US also will increase its tariffs on $250 billion worth of goods from 25% to 30% on Oct 15.",0.010685542785369876,-0.01312045799213758,0.23902369705563797,"[{'label': 'negative', 'score': 0.9979368448257446}, {'label': 'neutral', 'score': 0.001560862991027534}, {'label': 'positive', 'score': 0.0005022663972340524}]","(0.001560862991027534, 0.0005022663972340524, 0.9979368448257446)",-0.9989938967903234,-0.9979368448257446,0,0,"[{'label': 'negative', 'score': 0.8796496391296387}, {'label': 'positive', 'score': 0.086723193526268}, {'label': 'neutral', 'score': 0.033627141267061234}]","(0.033627141267061234, 0.086723193526268, 0.8796496391296387)",-0.8205181466289269,-0.8796496391296387,0,0,"[{'label': 'negative', 'score': 0.9955464601516724}, {'label': 'neutral', 'score': 0.0038579185493290424}, {'label': 'positive', 'score': 0.0005956480163149536}]","(0.0038579185493290424, 0.0005956480163149536, 0.9955464601516724)",-0.998804090277018,-0.9955464601516724,0,0
2019-10-09,69.00091552734375,80.32442474365234,80.62023162841797,79.7042007446289,80.31488800048828,4660875.0,,-0.004989322570451421,0.01062885583605742,0.1336704742192421,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-10,68.65663146972656,79.92366027832031,80.96373748779297,79.7614517211914,80.28626251220703,8580290.0,,0.006924561229673778,-0.005001810796148466,0.13549956717581108,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-11,69.13206481933594,80.47709655761719,81.52671813964844,80.40076446533203,80.43893432617188,6229626.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,0.0013832884571982876,0.006900696560465636,0.15096421040192767,"[{'label': 'positive', 'score': 0.9996594190597534}, {'label': 'negative', 'score': 0.0002546650357544422}, {'label': 'neutral', 'score': 8.588385389884934e-05}]","(8.588385389884934e-05, 0.9996594190597534, 0.0002546650357544422)",0.9994906261651774,0.9996594190597534,0,0,"[{'label': 'positive', 'score': 0.9280929565429688}, {'label': 'neutral', 'score': 0.043957918882369995}, {'label': 'negative', 'score': 0.027949057519435883}]","(0.043957918882369995, 0.9280929565429688, 0.027949057519435883)",0.9415317379187657,0.9280929565429688,0,0,"[{'label': 'positive', 'score': 0.998018741607666}, {'label': 'neutral', 'score': 0.0016083350637927651}, {'label': 'negative', 'score': 0.0003729659365490079}]","(0.0016083350637927651, 0.998018741607666, 0.0003729659365490079)",0.999252866517759,0.998018741607666,0,0
2019-10-12,69.22768910725911,80.58841959635417,81.42175547281902,80.41030629475911,80.46119689941406,5990822.0,,0.0013813776134903378,0.0013823325951074796,0.15050315738523048,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-13,69.3233133951823,80.69974263509114,81.31679280598958,80.4198481241862,80.48345947265625,5752018.0,"The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings",0.0013794720416936827,0.001380424389175646,0.09480512279051997,"[{'label': 'neutral', 'score': 0.9998637437820435}, {'label': 'negative', 'score': 7.091501902323216e-05}, {'label': 'positive', 'score': 6.528798985527828e-05}]","(0.9998637437820435, 6.528798985527828e-05, 7.091501902323216e-05)",-0.04131354523139091,-7.091501902323216e-05,1,1,"[{'label': 'neutral', 'score': 0.919123649597168}, {'label': 'positive', 'score': 0.05955485254526138}, {'label': 'negative', 'score': 0.02132146619260311}]","(0.919123649597168, 0.05955485254526138, 0.02132146619260311)",0.47273895436042207,0.05955485254526138,1,1,"[{'label': 'neutral', 'score': 0.9991199374198914}, {'label': 'positive', 'score': 0.0007399338064715266}, {'label': 'negative', 'score': 0.00014019345690030605}]","(0.9991199374198914, 0.0007399338064715266, 0.00014019345690030605)",0.6814245786155639,0.0007399338064715266,0,1
2019-10-14,69.41893768310547,80.81106567382812,81.21183013916016,80.42938995361328,80.50572204589844,5513214.0,,0.004132715160061284,0.0013785214442514856,0.0669076816336482,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-15,69.70584106445312,81.14503479003906,81.2022933959961,80.71565246582031,81.0114517211914,5205102.0,"The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings",-0.006937861619230523,0.00412419894808679,0.039161159228577096,"[{'label': 'positive', 'score': 0.9872080683708191}, {'label': 'neutral', 'score': 0.01182793639600277}, {'label': 'negative', 'score': 0.0009639572817832232}]","(0.01182793639600277, 0.9872080683708191, 0.0009639572817832232)",0.9980490091669078,0.9872080683708191,0,0,"[{'label': 'positive', 'score': 0.521422803401947}, {'label': 'neutral', 'score': 0.45570701360702515}, {'label': 'negative', 'score': 0.022870218381285667}]","(0.45570701360702515, 0.521422803401947, 0.022870218381285667)",0.9159635804024919,0.521422803401947,0,0,"[{'label': 'positive', 'score': 0.995866060256958}, {'label': 'neutral', 'score': 0.0037825366016477346}, {'label': 'negative', 'score': 0.0003513686533551663}]","(0.0037825366016477346, 0.995866060256958, 0.0003513686533551663)",0.999294594446637,0.995866060256958,0,0
2019-10-16,69.22224426269531,80.58206176757812,81.1927490234375,80.55343627929688,81.16412353515625,5686134.0,Biotech Stock On The Radar: Assessing Mirati's Oncology Franchise With An Eye On Multiple Readouts,-0.007696894504969299,-0.00696204047910742,0.06681262001275179,"[{'label': 'neutral', 'score': 0.9998358488082886}, {'label': 'positive', 'score': 8.622403402114287e-05}, {'label': 'negative', 'score': 7.792478572810069e-05}]","(0.9998358488082886, 8.622403402114287e-05, 7.792478572810069e-05)",0.05055929312023231,8.622403402114287e-05,1,1,"[{'label': 'neutral', 'score': 0.90081787109375}, {'label': 'positive', 'score': 0.08756907284259796}, {'label': 'negative', 'score': 0.011613092385232449}]","(0.90081787109375, 0.08756907284259796, 0.011613092385232449)",0.7658229711247758,0.08756907284259796,0,1,"[{'label': 'neutral', 'score': 0.9962194561958313}, {'label': 'positive', 'score': 0.003614585381001234}, {'label': 'negative', 'score': 0.00016598992806393653}]","(0.9962194561958313, 0.003614585381001234, 0.00016598992806393653)",0.9121880060603892,0.003614585381001234,0,1
2019-10-17,68.6894302368164,79.96183013916016,80.77290344238281,79.90457916259766,80.55343627929688,7178486.0,"Bank of America Reinstates Neutral on Merck & Co, Announces $90 Price Target",0.010501245282187155,-0.0077266684739424486,0.08578146813842477,"[{'label': 'neutral', 'score': 0.9976420998573303}, {'label': 'positive', 'score': 0.0021267232950776815}, {'label': 'negative', 'score': 0.00023125566076487303}]","(0.9976420998573303, 0.0021267232950776815, 0.00023125566076487303)",0.8038526508543494,0.0021267232950776815,0,1,"[{'label': 'neutral', 'score': 0.7567797303199768}, {'label': 'negative', 'score': 0.16563759744167328}, {'label': 'positive', 'score': 0.07758272439241409}]","(0.7567797303199768, 0.07758272439241409, 0.16563759744167328)",-0.3620374826628417,-0.16563759744167328,1,1,"[{'label': 'neutral', 'score': 0.8334327340126038}, {'label': 'negative', 'score': 0.1590619534254074}, {'label': 'positive', 'score': 0.007505312561988831}]","(0.8334327340126038, 0.007505312561988831, 0.1590619534254074)",-0.9098825028135271,-0.1590619534254074,0,1
2019-10-18,69.41075897216797,80.80152893066406,81.02098846435547,79.8282470703125,79.8759536743164,7883056.0,"WHO Says Ebola Concentrated In Congo Mining Area, Still An Emergency | Merck Reports Positive EU CHMP Opinion For 2 New Regimens Of KEYTRUDA As First-Line Treatment For Metastatic Or Unresectable Recurrent Head, Neck Squamous Cell Carcinoma | Merck Reports Received EU CHMP Positive Opinion For Investigational V920 Ebola Vaccine For Protection Against Ebola Virus",-0.0006298222982713851,0.01044649020336922,0.12190654039478131,"[{'label': 'positive', 'score': 0.9993177652359009}, {'label': 'neutral', 'score': 0.0003619735362008214}, {'label': 'negative', 'score': 0.000320248567732051}]","(0.0003619735362008214, 0.9993177652359009, 0.000320248567732051)",0.9993592709294568,0.9993177652359009,0,0,"[{'label': 'positive', 'score': 0.9362725615501404}, {'label': 'neutral', 'score': 0.04294200614094734}, {'label': 'negative', 'score': 0.020785517990589142}]","(0.04294200614094734, 0.9362725615501404, 0.020785517990589142)",0.9565637270403409,0.9362725615501404,0,0,"[{'label': 'positive', 'score': 0.8104828596115112}, {'label': 'neutral', 'score': 0.18475839495658875}, {'label': 'negative', 'score': 0.0047587561421096325}]","(0.18475839495658875, 0.8104828596115112, 0.0047587561421096325)",0.9883255318419667,0.8104828596115112,0,0
2019-10-19,69.36703745524089,80.75063832600911,81.06870015462239,79.96183522542317,80.27671813964844,7039416.0,,-0.0006302192243915303,-0.000630020719652902,0.12157080186633423,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-20,69.3233159383138,80.69974772135417,81.11641184488933,80.09542338053386,80.67748260498047,6195776.0,,-0.0006306166511284688,-0.0006304178960024422,0.11557881205365649,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-21,69.27959442138672,80.64885711669922,81.16412353515625,80.22901153564453,81.0782470703125,5352136.0,NewLink Genetics Announces EU Regulatory Committee Recommendation For Conditional Marketing Authorization For Ebola Vaccine V920 | Exclusive: Plus Products Hires The Wonderful Company's Mackler As Chief Scientific Officer,-0.038097469757985364,-0.0006308155734423982,0.10345428455255509,"[{'label': 'neutral', 'score': 0.9997490048408508}, {'label': 'positive', 'score': 0.00020272802794352174}, {'label': 'negative', 'score': 4.821136099053547e-05}]","(0.9997490048408508, 0.00020272802794352174, 4.821136099053547e-05)",0.6157529418133346,0.00020272802794352174,0,0,"[{'label': 'neutral', 'score': 0.8922162055969238}, {'label': 'positive', 'score': 0.09118025004863739}, {'label': 'negative', 'score': 0.016603529453277588}]","(0.8922162055969238, 0.09118025004863739, 0.016603529453277588)",0.6919104241843255,0.09118025004863739,0,0,"[{'label': 'neutral', 'score': 0.9762225151062012}, {'label': 'positive', 'score': 0.02357756532728672}, {'label': 'negative', 'score': 0.00019996846094727516}]","(0.9762225151062012, 0.02357756532728672, 0.00019996846094727516)",0.9831800503173944,0.02357756532728672,0,0
2019-10-22,66.64022064208984,77.57633972167969,78.89312744140625,76.57442474365234,78.24427795410156,18629038.0,"Jim Cramer Gives His Take On AMD, Merck And More | Merck & Co shares are trading lower on seemingly no company-specific news. The stock touched the $85 resistance level and traded lower. | The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug | 8 Healthcare Stocks Moving In Tuesday's Pre-Market Session",0.019311107321476235,-0.03884215336438553,0.3007344595848573,"[{'label': 'negative', 'score': 0.992276132106781}, {'label': 'neutral', 'score': 0.004819411318749189}, {'label': 'positive', 'score': 0.0029044828843325377}]","(0.004819411318749189, 0.0029044828843325377, 0.992276132106781)",-0.9941629030136233,-0.992276132106781,0,0,"[{'label': 'negative', 'score': 0.9586789011955261}, {'label': 'neutral', 'score': 0.028090374544262886}, {'label': 'positive', 'score': 0.013230719603598118}]","(0.028090374544262886, 0.013230719603598118, 0.9586789011955261)",-0.9727737655426859,-0.9586789011955261,0,0,"[{'label': 'positive', 'score': 0.436154842376709}, {'label': 'neutral', 'score': 0.2863812744617462}, {'label': 'negative', 'score': 0.2774638235569}]","(0.2863812744617462, 0.436154842376709, 0.2774638235569)",0.22237509526491656,0.436154842376709,1,1
2019-10-23,67.92711639404297,79.07442474365234,79.07442474365234,77.4427490234375,77.5667953491211,8511961.0,,-0.0034994644671209056,0.01912701414205677,0.3350969660501493,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-24,67.68939971923828,78.7977066040039,79.80915832519531,78.28244018554688,79.30343627929688,5232769.0,,-0.003875031915131553,-0.0035056019156045584,0.3337203980779351,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-25,67.42711639404297,78.49236297607422,79.05534362792969,78.27290344238281,78.50190734863281,7868384.0,,-0.0002431275875843924,-0.003882559303509082,0.3318949942722555,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-26,67.41073099772136,78.47327931722005,79.25254567464192,77.73536936442058,78.64821879069011,10431477.666666666,,-0.0002431867129830715,-0.00024315714788768257,0.33226793930702275,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-10-27,67.39434560139973,78.45419565836589,79.44974772135417,77.19783528645833,78.79453023274739,12994571.333333332,"The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings",-0.00024324586714613057,-0.00024321628766663082,0.15226309643632607,"[{'label': 'neutral', 'score': 0.9997738003730774}, {'label': 'positive', 'score': 0.00015182109200395644}, {'label': 'negative', 'score': 7.43199052521959e-05}]","(0.9997738003730774, 0.00015182109200395644, 7.43199052521959e-05)",0.3427117934921553,0.00015182109200395644,1,1,"[{'label': 'neutral', 'score': 0.7431529760360718}, {'label': 'positive', 'score': 0.24674350023269653}, {'label': 'negative', 'score': 0.010103539563715458}]","(0.7431529760360718, 0.24674350023269653, 0.010103539563715458)",0.921326408342304,0.24674350023269653,0,1,"[{'label': 'neutral', 'score': 0.9932912588119507}, {'label': 'positive', 'score': 0.006358536425977945}, {'label': 'negative', 'score': 0.00035016052424907684}]","(0.9932912588119507, 0.006358536425977945, 0.00035016052424907684)",0.8956099740837966,0.006358536425977945,0,1
2019-10-28,67.37796020507812,78.43511199951172,79.6469497680664,76.6603012084961,78.94084167480469,15557665.0,"More Earnings And A Fed Decision In Week Four Of The WeTrader Competition | Merck Shares Fall 2% Following Report AstraZeneca Trial Of Imfinzi, Imfinzi Plus Tremelimumab Delayed Disease Progression In Phase 3 Trial",0.035279880731241914,-0.00024327545622039934,0.030079161694792845,"[{'label': 'negative', 'score': 0.9970583915710449}, {'label': 'neutral', 'score': 0.0023982173297554255}, {'label': 'positive', 'score': 0.0005434216582216322}]","(0.0023982173297554255, 0.0005434216582216322, 0.9970583915710449)",-0.9989105439645051,-0.9970583915710449,0,0,"[{'label': 'negative', 'score': 0.9634436964988708}, {'label': 'neutral', 'score': 0.02200290933251381}, {'label': 'positive', 'score': 0.014553407207131386}]","(0.02200290933251381, 0.014553407207131386, 0.9634436964988708)",-0.9702383429317265,-0.9634436964988708,0,0,"[{'label': 'negative', 'score': 0.9940502047538757}, {'label': 'neutral', 'score': 0.005191651172935963}, {'label': 'positive', 'score': 0.0007581236422993243}]","(0.005191651172935963, 0.0007581236422993243, 0.9940502047538757)",-0.9984758397760469,-0.9940502047538757,0,0
2019-10-29,69.75504302978516,81.2022933959961,81.84160614013672,78.91221618652344,80.20037841796875,17371019.0,"Alphabet Misses On Earnings, But Drugmakers, Mastercard Beat Expectations | 28 Healthcare Stocks Moving In Tuesday's Pre-Market Session | Merck & Co Inc Sees Increased Pricing Pressure In 2020; Says Demand For Gardasil Continues To Outpace Supply | Pharma Earnings: Merck, Pfizer Trade Higher On Q3 Beats | The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study | Merck & Co shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY19 EPS and sales guidance above analyst estimates. | Merck Sees FY19 Adj. EPS $5.12-$5.17 vs $4.92 Est., Sales $46.5B-$47.0B vs $45.98B Est. | Merck & Co Q3 Adj. EPS $1.51 Beats $1.24 Estimate, Sales $12.4B Beat $11.63B Estimate | 12 Stocks To Watch For October 29, 2019 | Earnings Scheduled For October 29, 2019",0.01316089760110236,0.034671806326922384,0.2555586228271047,"[{'label': 'positive', 'score': 0.9992426633834839}, {'label': 'negative', 'score': 0.0006476187263615429}, {'label': 'neutral', 'score': 0.00010970398579956964}]","(0.00010970398579956964, 0.9992426633834839, 0.0006476187263615429)",0.9987046204209625,0.9992426633834839,0,0,"[{'label': 'positive', 'score': 0.9309288263320923}, {'label': 'negative', 'score': 0.04380868747830391}, {'label': 'neutral', 'score': 0.025262540206313133}]","(0.025262540206313133, 0.9309288263320923, 0.04380868747830391)",0.9101118262966014,0.9309288263320923,0,0,"[{'label': 'positive', 'score': 0.9626878499984741}, {'label': 'neutral', 'score': 0.01987823098897934}, {'label': 'negative', 'score': 0.017433853819966316}]","(0.01987823098897934, 0.9626878499984741, 0.017433853819966316)",0.9644251244472068,0.9626878499984741,0,0
2019-10-30,70.6730728149414,82.27098846435547,82.52862548828125,80.45801544189453,81.10687255859375,10026845.0,"US Appeals Court Upholds Lower Court Ruling That Tossed $2.54B Jury Verdict For Merck In Patent Case Against Gilead | Decision Day: Fed On Tap Later, Followed by Apple, Facebook After Close",0.005103296049872105,0.01307504542898367,0.24220266772740112,"[{'label': 'negative', 'score': 0.853726327419281}, {'label': 'positive', 'score': 0.10037603229284286}, {'label': 'neutral', 'score': 0.0458977110683918}]","(0.0458977110683918, 0.10037603229284286, 0.853726327419281)",-0.7895906424062743,-0.853726327419281,0,0,"[{'label': 'neutral', 'score': 0.8265796303749084}, {'label': 'negative', 'score': 0.11071788519620895}, {'label': 'positive', 'score': 0.0627024918794632}]","(0.8265796303749084, 0.0627024918794632, 0.11071788519620895)",-0.27687284577748433,-0.11071788519620895,1,1,"[{'label': 'positive', 'score': 0.8518351912498474}, {'label': 'neutral', 'score': 0.13177087903022766}, {'label': 'negative', 'score': 0.016393965110182762}]","(0.13177087903022766, 0.8518351912498474, 0.016393965110182762)",0.9622358567664027,0.8518351912498474,0,0
2019-10-31,71.0337142944336,82.69084167480469,83.00572204589844,81.59351348876953,82.15648651123047,12419429.0,,-0.01984766462080293,0.005090318368493064,0.23154507596828744,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-01,69.62387084960938,81.04962158203125,83.24427795410156,80.90648651123047,83.08206176757812,9281298.0,WeTrader Competition: Round Four Wrap-up,-0.00408132938027508,-0.02004727513324044,0.3164066833760202,"[{'label': 'neutral', 'score': 0.9998687505722046}, {'label': 'negative', 'score': 7.268242188729346e-05}, {'label': 'positive', 'score': 5.853590846527368e-05}]","(0.9998687505722046, 5.853590846527368e-05, 7.268242188729346e-05)",-0.1078089729080524,-7.268242188729346e-05,1,1,"[{'label': 'neutral', 'score': 0.9075162410736084}, {'label': 'negative', 'score': 0.05526871979236603}, {'label': 'positive', 'score': 0.03721502795815468}]","(0.9075162410736084, 0.03721502795815468, 0.05526871979236603)",-0.19520934513718063,-0.05526871979236603,1,1,"[{'label': 'neutral', 'score': 0.9995001554489136}, {'label': 'positive', 'score': 0.0003648113051895052}, {'label': 'negative', 'score': 0.00013496127212420106}]","(0.9995001554489136, 0.0003648113051895052, 0.00013496127212420106)",0.45990925372647595,0.0003648113051895052,1,1
2019-11-02,69.33971913655598,80.71883138020833,82.75445556640625,80.61704762776692,82.61132303873698,9169930.333333334,,-0.004098054892108046,-0.004089680735864059,0.3226940909922181,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-03,69.05556742350261,80.38804117838542,82.26463317871094,80.32760874430339,82.14058430989583,9058562.666666666,"The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight",-0.00411491805216251,-0.004106474930784311,0.1963626785705381,"[{'label': 'negative', 'score': 0.9926377534866333}, {'label': 'neutral', 'score': 0.005475126672536135}, {'label': 'positive', 'score': 0.0018870998173952103}]","(0.005475126672536135, 0.0018870998173952103, 0.9926377534866333)",-0.9962050223056249,-0.9926377534866333,0,0,"[{'label': 'neutral', 'score': 0.6019046306610107}, {'label': 'negative', 'score': 0.34605011343955994}, {'label': 'positive', 'score': 0.05204526707530022}]","(0.6019046306610107, 0.05204526707530022, 0.34605011343955994)",-0.7385286560824211,-0.34605011343955994,0,1,"[{'label': 'neutral', 'score': 0.9978379607200623}, {'label': 'positive', 'score': 0.0015290019800886512}, {'label': 'negative', 'score': 0.0006330043543130159}]","(0.9978379607200623, 0.0015290019800886512, 0.0006330043543130159)",0.41442876994326733,0.0015290019800886512,1,1
2019-11-04,68.77141571044922,80.0572509765625,81.77481079101562,80.03816986083984,81.66984558105469,8947195.0,,-0.011680540964184262,-0.004123407624717737,0.14409865095296168,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-05,67.96810913085938,79.12213897705078,79.91412353515625,78.94084167480469,79.83778381347656,9937974.0,BioLineRx Announces Data Showing BL-8040 In Combination With KEYTRUDA Shows Clinical Activity In Heavily Pretreated Metastatic Pancreatic Cancer Patients,0.003979674654461508,-0.011749294392015563,0.11260936586054199,"[{'label': 'neutral', 'score': 0.9734830856323242}, {'label': 'positive', 'score': 0.026307309046387672}, {'label': 'negative', 'score': 0.00020960340043529868}]","(0.9734830856323242, 0.026307309046387672, 0.00020960340043529868)",0.9841909648526662,0.026307309046387672,0,1,"[{'label': 'positive', 'score': 0.9200905561447144}, {'label': 'neutral', 'score': 0.06774058192968369}, {'label': 'negative', 'score': 0.012168915942311287}]","(0.06774058192968369, 0.9200905561447144, 0.012168915942311287)",0.973893714557667,0.9200905561447144,0,0,"[{'label': 'neutral', 'score': 0.9934170246124268}, {'label': 'positive', 'score': 0.006446058861911297}, {'label': 'negative', 'score': 0.00013685000885743648}]","(0.9934170246124268, 0.006446058861911297, 0.00013685000885743648)",0.95842263305053,0.006446058861911297,0,1
2019-11-06,68.23860168457031,79.43701934814453,80.114501953125,79.32251739501953,79.73282623291016,9735606.0,AstraZeneca Named The Most Innovative Global Pharma Company,-0.004444404319682473,0.003971776696551317,0.08825480844118627,"[{'label': 'neutral', 'score': 0.9979414343833923}, {'label': 'positive', 'score': 0.001971794990822673}, {'label': 'negative', 'score': 8.67037961143069e-05}]","(0.9979414343833923, 0.001971794990822673, 8.67037961143069e-05)",0.9157601678810595,0.001971794990822673,0,1,"[{'label': 'positive', 'score': 0.8761462569236755}, {'label': 'neutral', 'score': 0.11362069100141525}, {'label': 'negative', 'score': 0.01023305207490921}]","(0.11362069100141525, 0.8761462569236755, 0.01023305207490921)",0.976910444612092,0.8761462569236755,0,0,"[{'label': 'positive', 'score': 0.9979977011680603}, {'label': 'neutral', 'score': 0.0015190828125923872}, {'label': 'negative', 'score': 0.0004832260019611567}]","(0.0015190828125923872, 0.9979977011680603, 0.0004832260019611567)",0.9990320776515366,0.9979977011680603,0,0
2019-11-07,67.93533325195312,79.08396911621094,80.14312744140625,78.88359069824219,79.41793823242188,9251325.0,Biotech Stock On The Radar: Alkermes At A Crossroads,0.00856662371086779,-0.004454310045490762,0.08831104294343053,"[{'label': 'neutral', 'score': 0.9998286962509155}, {'label': 'negative', 'score': 8.736091695027426e-05}, {'label': 'positive', 'score': 8.390464790863916e-05}]","(0.9998286962509155, 8.390464790863916e-05, 8.736091695027426e-05)",-0.020180758721009273,-8.736091695027426e-05,1,1,"[{'label': 'neutral', 'score': 0.9121115803718567}, {'label': 'positive', 'score': 0.0698183998465538}, {'label': 'negative', 'score': 0.018070075660943985}]","(0.9121115803718567, 0.0698183998465538, 0.018070075660943985)",0.5887953327987258,0.0698183998465538,0,1,"[{'label': 'neutral', 'score': 0.9994713664054871}, {'label': 'positive', 'score': 0.0003832598158624023}, {'label': 'negative', 'score': 0.00014539419498760253}]","(0.9994713664054871, 0.0003832598158624023, 0.00014539419498760253)",0.44994574143558225,0.0003832598158624023,1,1
2019-11-08,68.51730346679688,79.7614517211914,79.8759536743164,78.9217529296875,79.11259460449219,6653123.0,"The Daily Biotech Pulse: Therapix Calls Off Merger, Alimera's Reverse Split, 2 Biotechs To Debut",-0.0012361830140080485,0.008530138412437533,0.12579511595480322,"[{'label': 'neutral', 'score': 0.9942122101783752}, {'label': 'negative', 'score': 0.0051067597232759}, {'label': 'positive', 'score': 0.0006810067570768297}]","(0.9942122101783752, 0.0006810067570768297, 0.0051067597232759)",-0.7646737271143923,-0.0051067597232759,0,1,"[{'label': 'neutral', 'score': 0.9040411710739136}, {'label': 'positive', 'score': 0.08252476155757904}, {'label': 'negative', 'score': 0.013434105552732944}]","(0.9040411710739136, 0.08252476155757904, 0.013434105552732944)",0.7200028312695809,0.08252476155757904,0,1,"[{'label': 'neutral', 'score': 0.998611330986023}, {'label': 'positive', 'score': 0.001001026015728712}, {'label': 'negative', 'score': 0.00038764564669691026}]","(0.998611330986023, 0.001001026015728712, 0.00038764564669691026)",0.44170294939294524,0.001001026015728712,1,1
2019-11-09,68.4325942993164,79.66285196940105,79.8536885579427,79.0012690226237,79.19211069742839,5677155.666666667,,-0.0012377130538616264,-0.001236947718504906,0.12374916597728466,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-10,68.34788513183594,79.56425221761067,79.83142344156902,79.08078511555989,79.27162679036458,4701188.333333334,,-0.0012392468859090953,-0.0012384796532822094,0.08142291354908357,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-11,68.26317596435547,79.46565246582031,79.80915832519531,79.1603012084961,79.35114288330078,3725221.0,Merck Reports Its ERVEBO Granted Conditional Approval In EU | NextCure Shares Give Back Some Gains After Data Readout,0.010086386714238341,-0.0012400153873054099,0.0782452517798746,"[{'label': 'positive', 'score': 0.9994224309921265}, {'label': 'neutral', 'score': 0.00031308247707784176}, {'label': 'negative', 'score': 0.00026450896984897554}]","(0.00031308247707784176, 0.9994224309921265, 0.00026450896984897554)",0.9994708163940622,0.9994224309921265,0,0,"[{'label': 'positive', 'score': 0.7505713105201721}, {'label': 'negative', 'score': 0.16496434807777405}, {'label': 'neutral', 'score': 0.08446431905031204}]","(0.08446431905031204, 0.7505713105201721, 0.16496434807777405)",0.6396331556754417,0.7505713105201721,0,0,"[{'label': 'positive', 'score': 0.9986602067947388}, {'label': 'neutral', 'score': 0.001074894331395626}, {'label': 'negative', 'score': 0.0002648396184667945}]","(0.001074894331395626, 0.9986602067947388, 0.0002648396184667945)",0.9994697507697544,0.9986602067947388,0,0
2019-11-12,68.95172119140625,80.26717376708984,80.93511199951172,79.75190734863281,79.75190734863281,8616656.0,,0.008321437034272842,0.010035858595802517,0.09187193530645335,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-13,69.52549743652344,80.93511199951172,81.21183013916016,80.25763702392578,80.67748260498047,6516883.0,"Morgan Stanley Maintains Overweight on Merck & Co, Raises Price Target to $95 | The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",-0.0031831597951307495,0.008287004762558973,0.09095659012403658,"[{'label': 'positive', 'score': 0.9974738955497742}, {'label': 'negative', 'score': 0.002074882388114929}, {'label': 'neutral', 'score': 0.00045119691640138626}]","(0.00045119691640138626, 0.9974738955497742, 0.002074882388114929)",0.9958483619130715,0.9974738955497742,0,0,"[{'label': 'positive', 'score': 0.5753074288368225}, {'label': 'neutral', 'score': 0.2520409822463989}, {'label': 'negative', 'score': 0.17265157401561737}]","(0.2520409822463989, 0.5753074288368225, 0.17265157401561737)",0.53833947219784,0.5753074288368225,0,0,"[{'label': 'positive', 'score': 0.9987138509750366}, {'label': 'neutral', 'score': 0.000897646532393992}, {'label': 'negative', 'score': 0.0003884710022248328}]","(0.000897646532393992, 0.9987138509750366, 0.0003884710022248328)",0.9992223599251455,0.9987138509750366,0,0
2019-11-14,69.30420684814453,80.67748260498047,81.27862548828125,79.86640930175781,81.03053283691406,7911247.0,"AstraZeneca, Merck Report FDA Acceptance Of Regulatory Submission For New Drug Application For Selumetinib In Neurofibromatosis Type 1, Priority Review Granted | AstraZeneca Announces FDA Accepts NDA for Selumetinib",0.004139557971164566,-0.0031882368251327274,0.09740330027082017,"[{'label': 'positive', 'score': 0.9761867523193359}, {'label': 'neutral', 'score': 0.023239947855472565}, {'label': 'negative', 'score': 0.0005732571007683873}]","(0.023239947855472565, 0.9761867523193359, 0.0005732571007683873)",0.9988262068568743,0.9761867523193359,0,0,"[{'label': 'positive', 'score': 0.790346086025238}, {'label': 'neutral', 'score': 0.19016864895820618}, {'label': 'negative', 'score': 0.019485197961330414}]","(0.19016864895820618, 0.790346086025238, 0.019485197961330414)",0.951878376776431,0.790346086025238,0,0,"[{'label': 'positive', 'score': 0.9920612573623657}, {'label': 'neutral', 'score': 0.00765655655413866}, {'label': 'negative', 'score': 0.0002822116657625884}]","(0.00765655655413866, 0.9920612573623657, 0.0002822116657625884)",0.9994312218005748,0.9920612573623657,0,0
2019-11-15,69.5910873413086,81.0114517211914,81.67938995361328,80.76335906982422,80.81106567382812,9675870.0,Merck Reports Its Animal Health Unit Announced US Approval Of BRAVECTO PLUS,-0.0030231675725370453,0.004131013572970955,0.09159743789956384,"[{'label': 'positive', 'score': 0.9798011779785156}, {'label': 'neutral', 'score': 0.019825562834739685}, {'label': 'negative', 'score': 0.00037324283039197326}]","(0.019825562834739685, 0.9798011779785156, 0.00037324283039197326)",0.9992384154851053,0.9798011779785156,0,0,"[{'label': 'positive', 'score': 0.8824342489242554}, {'label': 'neutral', 'score': 0.10774128139019012}, {'label': 'negative', 'score': 0.009824437089264393}]","(0.10774128139019012, 0.8824342489242554, 0.009824437089264393)",0.9779785005329373,0.8824342489242554,0,0,"[{'label': 'positive', 'score': 0.9954261183738708}, {'label': 'neutral', 'score': 0.004341749008744955}, {'label': 'negative', 'score': 0.00023211323423311114}]","(0.004341749008744955, 0.9954261183738708, 0.00023211323423311114)",0.9995337491784541,0.9954261183738708,0,0
2019-11-16,69.38069915771484,80.76654052734375,81.4312973022461,80.51208750406902,80.80152384440105,10017832.333333334,,-0.0030323348288607316,-0.0030277465746788345,0.09819651740724439,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-17,69.1703109741211,80.5216293334961,81.1832046508789,80.2608159383138,80.79198201497395,10359794.666666666,,-0.003041557850665299,-0.00303694167146796,0.08410915760883834,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-18,68.95992279052734,80.27671813964844,80.93511199951172,80.0095443725586,80.78244018554688,10701757.0,Merck and Bayer's Investigational Drug Vericiguat Meets Primary Endpoint in Phase 3 Study of Patients with Worsening Chronic Heart Failure,0.006180936568323793,-0.0030461927884182917,0.05116672806599418,"[{'label': 'neutral', 'score': 0.9998612403869629}, {'label': 'negative', 'score': 7.010777335381135e-05}, {'label': 'positive', 'score': 6.865584145998582e-05}]","(0.9998612403869629, 6.865584145998582e-05, 7.010777335381135e-05)",-0.010463347295858759,-7.010777335381135e-05,1,1,"[{'label': 'positive', 'score': 0.7850725650787354}, {'label': 'neutral', 'score': 0.20432347059249878}, {'label': 'negative', 'score': 0.010604004375636578}]","(0.20432347059249878, 0.7850725650787354, 0.010604004375636578)",0.9733459428548759,0.7850725650787354,0,0,"[{'label': 'neutral', 'score': 0.9791313409805298}, {'label': 'positive', 'score': 0.020062625408172607}, {'label': 'negative', 'score': 0.0008059741812758148}]","(0.9791313409805298, 0.020062625408172607, 0.0008059741812758148)",0.9227572336302498,0.020062625408172607,0,1
2019-11-19,69.38616180419922,80.77290344238281,81.05915832519531,80.1240463256836,80.53434753417969,9691380.0,Merck Raises Quarterly Dividend From $0.55 To $0.61/Share,0.007324219949134161,0.0061619129289213126,0.07206071604275648,"[{'label': 'positive', 'score': 0.9952071309089661}, {'label': 'neutral', 'score': 0.0044855293817818165}, {'label': 'negative', 'score': 0.0003073714906349778}]","(0.0044855293817818165, 0.9952071309089661, 0.0003073714906349778)",0.9993824871663967,0.9952071309089661,0,0,"[{'label': 'positive', 'score': 0.6628413200378418}, {'label': 'negative', 'score': 0.17298509180545807}, {'label': 'neutral', 'score': 0.16417357325553894}]","(0.16417357325553894, 0.6628413200378418, 0.17298509180545807)",0.5860741193282866,0.6628413200378418,0,0,"[{'label': 'positive', 'score': 0.998960018157959}, {'label': 'neutral', 'score': 0.0007293997914530337}, {'label': 'negative', 'score': 0.00031061898334883153}]","(0.0007293997914530337, 0.998960018157959, 0.00031061898334883153)",0.9993783085946817,0.998960018157959,0,0
2019-11-20,69.89435577392578,81.364501953125,81.56488800048828,80.58206176757812,80.65839385986328,8160147.0,European Commission Approves Two New Regimens Of Merck's KEYTRUDA As First-Line Treatment For Metastatic Or Unresectable Recurrent Head And Neck Squamous Cell Carcinoma,0.0022282112947798927,0.007297528102268682,0.08515850377948861,"[{'label': 'positive', 'score': 0.917687177658081}, {'label': 'neutral', 'score': 0.08177629858255386}, {'label': 'negative', 'score': 0.0005365652614273131}]","(0.08177629858255386, 0.917687177658081, 0.0005365652614273131)",0.9988312973486804,0.917687177658081,0,0,"[{'label': 'positive', 'score': 0.9130923748016357}, {'label': 'neutral', 'score': 0.07495338469743729}, {'label': 'negative', 'score': 0.01195424422621727}]","(0.07495338469743729, 0.9130923748016357, 0.01195424422621727)",0.9741542880535465,0.9130923748016357,0,0,"[{'label': 'positive', 'score': 0.7967068552970886}, {'label': 'neutral', 'score': 0.20260868966579437}, {'label': 'negative', 'score': 0.0006844081217423081}]","(0.20260868966579437, 0.7967068552970886, 0.0006844081217423081)",0.9982833819402337,0.7967068552970886,0,0
2019-11-21,70.05010986328125,81.5457992553711,81.84160614013672,80.4103012084961,81.77481079101562,7195568.0,,-0.00011694953328248056,0.002225732513475457,0.07786581504682734,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-22,70.04190063476562,81.53626251220703,82.40457916259766,81.41221618652344,81.72709655761719,7800159.0,"AstraZeneca CEO: Closing In On A Cancer Cure | Trump Says he Will Release a Plan to Let States Import Prescription Drugs Which are ""MUCH CHEAPER""",0.0009752236671910007,-0.00011695637241234578,0.06832944127323291,"[{'label': 'neutral', 'score': 0.9993904829025269}, {'label': 'positive', 'score': 0.0004946303088217974}, {'label': 'negative', 'score': 0.00011479920794954523}]","(0.9993904829025269, 0.0004946303088217974, 0.00011479920794954523)",0.6232568171041909,0.0004946303088217974,0,1,"[{'label': 'positive', 'score': 0.6705465316772461}, {'label': 'neutral', 'score': 0.3117798864841461}, {'label': 'negative', 'score': 0.017673512920737267}]","(0.3117798864841461, 0.6705465316772461, 0.017673512920737267)",0.9486399355570614,0.6705465316772461,0,0,"[{'label': 'positive', 'score': 0.8098690509796143}, {'label': 'neutral', 'score': 0.18841545283794403}, {'label': 'negative', 'score': 0.001715533435344696}]","(0.18841545283794403, 0.8098690509796143, 0.001715533435344696)",0.9957723853599774,0.8098690509796143,0,0
2019-11-23,70.11021423339844,81.61577860514323,82.4777348836263,81.41857655843098,81.85114288330078,8207202.333333333,,0.0009742735325835332,0.0009747484455302583,0.05168782397497582,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-24,70.17852783203125,81.69529469807942,82.55089060465495,81.42493693033855,81.97518920898438,8614245.666666666,,0.0009733252475564177,0.0009737992361633238,0.04650808692729735,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-25,70.24684143066406,81.77481079101562,82.6240463256836,81.4312973022461,82.09923553466797,9021289.0,,0.019136552996588667,0.0009728518736771658,0.013166970717009781,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2019-11-26,71.59111022949219,83.3396987915039,83.43511199951172,81.97518920898438,82.06106567382812,19233420.0,Merck Reports KEYTRUDA Now Approved In China For First-Line Treatment of Metastatic Squamous Non-Small Cell Lung Cancer in Combination with Chemotherapy,0.0030913166026166885,0.018955752128601806,0.12981180624985086,"[{'label': 'positive', 'score': 0.9993652701377869}, {'label': 'neutral', 'score': 0.0003987034142483026}, {'label': 'negative', 'score': 0.00023607273760717362}]","(0.0003987034142483026, 0.9993652701377869, 0.00023607273760717362)",0.9995276662255613,0.9993652701377869,0,0,"[{'label': 'positive', 'score': 0.879052460193634}, {'label': 'neutral', 'score': 0.11146887391805649}, {'label': 'negative', 'score': 0.009478707797825336}]","(0.11146887391805649, 0.879052460193634, 0.009478707797825336)",0.9786643212094582,0.879052460193634,0,0,"[{'label': 'positive', 'score': 0.9978099465370178}, {'label': 'neutral', 'score': 0.0018904285971075296}, {'label': 'negative', 'score': 0.00029964986606501043}]","(0.0018904285971075296, 0.9978099465370178, 0.00029964986606501043)",0.9993995652037715,0.9978099465370178,0,0
2019-11-27,71.81242370605469,83.59732818603516,83.84542083740234,83.00572204589844,83.3969497680664,6037318.0,"Stocks That Hit 52-Week Highs On Wednesday | The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",-0.0024540786577385296,0.0030865483077932416,0.12475760381190255,"[{'label': 'positive', 'score': 0.9934695959091187}, {'label': 'neutral', 'score': 0.004064028616994619}, {'label': 'negative', 'score': 0.00246631377376616}]","(0.004064028616994619, 0.9934695959091187, 0.00246631377376616)",0.9950472440047845,0.9934695959091187,0,0,"[{'label': 'neutral', 'score': 0.8819286227226257}, {'label': 'positive', 'score': 0.09721793979406357}, {'label': 'negative', 'score': 0.020853441208600998}]","(0.8819286227226257, 0.09721793979406357, 0.020853441208600998)",0.6467655238464537,0.09721793979406357,0,1,"[{'label': 'positive', 'score': 0.8123242259025574}, {'label': 'neutral', 'score': 0.1866770088672638}, {'label': 'negative', 'score': 0.0009988198289647698}]","(0.1866770088672638, 0.8123242259025574, 0.0009988198289647698)",0.9975438545994565,0.8123242259025574,0,0
2019-11-28,71.63619995117188,83.39217376708984,83.79771041870117,83.02480697631836,83.28721618652344,5458770.0,,-0.0024601159758504258,-0.0024570948444177453,0.13377397703823002,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-11-29,71.45997619628906,83.18701934814453,83.75,83.04389190673828,83.17748260498047,4880222.0,"National Business Daily Reports Drugmakers including Johnson & Johnson, Roche, Novartis and Merck have Agreed to Massively Cut the Prices of Some Drugs to Get Included in China's Medical Reimbursement List",-0.0005352720889005303,-0.0024631470333468268,0.14118788805843316,"[{'label': 'positive', 'score': 0.9986141920089722}, {'label': 'neutral', 'score': 0.0010566199198365211}, {'label': 'negative', 'score': 0.00032919447403401136}]","(0.0010566199198365211, 0.9986141920089722, 0.00032919447403401136)",0.999340914653446,0.9986141920089722,0,0,"[{'label': 'negative', 'score': 0.9309155941009521}, {'label': 'positive', 'score': 0.04591065272688866}, {'label': 'neutral', 'score': 0.02317381091415882}]","(0.02317381091415882, 0.04591065272688866, 0.9309155941009521)",-0.9060003703299752,-0.9309155941009521,0,0,"[{'label': 'neutral', 'score': 0.9554083943367004}, {'label': 'positive', 'score': 0.031083010137081146}, {'label': 'negative', 'score': 0.013508541509509087}]","(0.9554083943367004, 0.031083010137081146, 0.013508541509509087)",0.3941210381477255,0.031083010137081146,1,1
2019-11-30,71.42171986897786,83.14249165852864,83.81997426350911,82.89122009277344,83.295166015625,5119480.333333333,,-0.0005355587585557806,-0.0005354153981470709,0.1433581117755172,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-01,71.38346354166667,83.09796396891277,83.88994852701823,82.7385482788086,83.41284942626953,5358738.666666667,,-0.0005358457354327973,-0.0005357022213718855,0.03595256227474595,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-02,71.34520721435547,83.05343627929688,83.95992279052734,82.58587646484375,83.53053283691406,5597997.0,"Shares of several healthcare stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US Stocks further fell on worse-than-expected manufacturing data. | Stocks That Hit 52-Week Highs On Monday | Seattle Genetics Announces Collaboration with Merck to Evaluate its Enfortumab in Combination with KEYTRUDA | Merck's KEYTRUDA Granted Priority Review by the FDA for Patients with High-Risk, Non-Muscle Invasive Bladder Cancer",0.0039062169873543768,-0.0005359893520653719,0.016732519888868907,"[{'label': 'negative', 'score': 0.9986502528190613}, {'label': 'neutral', 'score': 0.0008190562366507947}, {'label': 'positive', 'score': 0.0005307472310960293}]","(0.0008190562366507947, 0.0005307472310960293, 0.9986502528190613)",-0.998937635461304,-0.9986502528190613,0,0,"[{'label': 'negative', 'score': 0.9610758423805237}, {'label': 'positive', 'score': 0.02693456970155239}, {'label': 'neutral', 'score': 0.011989651247859001}]","(0.011989651247859001, 0.02693456970155239, 0.9610758423805237)",-0.9454771541429567,-0.9610758423805237,0,0,"[{'label': 'negative', 'score': 0.9974333643913269}, {'label': 'neutral', 'score': 0.002125188708305359}, {'label': 'positive', 'score': 0.00044147748849354684}]","(0.002125188708305359, 0.00044147748849354684, 0.9974333643913269)",-0.9991151646078944,-0.9974333643913269,0,0
2019-12-03,71.6239013671875,83.37786102294922,83.46373748779297,82.53816986083984,82.70992279052734,7466162.0,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",0.014763138190107099,0.0038986075314649286,0.037331490372358785,"[{'label': 'neutral', 'score': 0.9995530247688293}, {'label': 'positive', 'score': 0.00036441610427573323}, {'label': 'negative', 'score': 8.255648572230712e-05}]","(0.9995530247688293, 0.00036441610427573323, 8.255648572230712e-05)",0.6305970989287327,0.00036441610427573323,1,0,"[{'label': 'neutral', 'score': 0.5953482985496521}, {'label': 'negative', 'score': 0.3743254542350769}, {'label': 'positive', 'score': 0.030326245352625847}]","(0.5953482985496521, 0.030326245352625847, 0.3743254542350769)",-0.850111859737522,-0.3743254542350769,0,0,"[{'label': 'neutral', 'score': 0.9989997744560242}, {'label': 'positive', 'score': 0.000580781779717654}, {'label': 'negative', 'score': 0.0004194179200567305}]","(0.9989997744560242, 0.000580781779717654, 0.0004194179200567305)",0.16133164176846124,0.000580781779717654,0,0
2019-12-04,72.68128967285156,84.60877990722656,84.66603088378906,83.18701934814453,83.52098846435547,7293766.0,Stocks That Hit 52-Week Highs On Wednesday,0.0009021769651903066,0.014655223871687719,0.10451810358846578,"[{'label': 'positive', 'score': 0.9563050270080566}, {'label': 'neutral', 'score': 0.04012599587440491}, {'label': 'negative', 'score': 0.003568998770788312}]","(0.04012599587440491, 0.9563050270080566, 0.003568998770788312)",0.9925636100677016,0.9563050270080566,0,0,"[{'label': 'neutral', 'score': 0.6686744689941406}, {'label': 'positive', 'score': 0.2616553008556366}, {'label': 'negative', 'score': 0.06967020034790039}]","(0.6686744689941406, 0.2616553008556366, 0.06967020034790039)",0.5794455899420721,0.2616553008556366,0,1,"[{'label': 'neutral', 'score': 0.9305849075317383}, {'label': 'positive', 'score': 0.0687793418765068}, {'label': 'negative', 'score': 0.0006357358652167022}]","(0.9305849075317383, 0.0687793418765068, 0.0006357358652167022)",0.9816830612051716,0.0687793418765068,0,1
2019-12-05,72.74687194824219,84.68511199951172,84.72328186035156,83.94084167480469,84.66603088378906,8267462.0,"Stocks That Hit 52-Week Highs On Thursday | The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission | AstraZeneca, Merck Announce Lynparza Approved in China as a 1st-line Maintenance Therapy in BRCA-mutated Advanced Ovarian Cancer",0.0011267722879423473,0.00090177024815409,0.10157469446403845,"[{'label': 'positive', 'score': 0.9994887113571167}, {'label': 'neutral', 'score': 0.0002720033808145672}, {'label': 'negative', 'score': 0.00023922421678435057}]","(0.0002720033808145672, 0.9994887113571167, 0.00023922421678435057)",0.9995214213622089,0.9994887113571167,0,0,"[{'label': 'positive', 'score': 0.9131451845169067}, {'label': 'neutral', 'score': 0.06293011456727982}, {'label': 'negative', 'score': 0.023924674838781357}]","(0.06293011456727982, 0.9131451845169067, 0.023924674838781357)",0.9489372652424622,0.9131451845169067,0,0,"[{'label': 'positive', 'score': 0.9987078905105591}, {'label': 'neutral', 'score': 0.000993315945379436}, {'label': 'negative', 'score': 0.000298788130749017}]","(0.000993315945379436, 0.9987078905105591, 0.000298788130749017)",0.9994018295630308,0.9987078905105591,0,0
2019-12-06,72.82882690429688,84.78053283691406,85.15267181396484,84.68511199951172,84.92366027832031,7245872.0,"Stocks That Hit 52-Week Highs On Friday | The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend",-0.00048771544415036146,0.0011261379565013524,0.0978496242182758,"[{'label': 'positive', 'score': 0.999208390712738}, {'label': 'neutral', 'score': 0.0004369039088487625}, {'label': 'negative', 'score': 0.0003547061060089618}]","(0.0004369039088487625, 0.999208390712738, 0.0003547061060089618)",0.9992902777080549,0.999208390712738,0,0,"[{'label': 'positive', 'score': 0.8515921235084534}, {'label': 'negative', 'score': 0.09239398688077927}, {'label': 'neutral', 'score': 0.05601385608315468}]","(0.05601385608315468, 0.8515921235084534, 0.09239398688077927)",0.8042471475715197,0.8515921235084534,0,0,"[{'label': 'positive', 'score': 0.9983043670654297}, {'label': 'neutral', 'score': 0.0013888137182220817}, {'label': 'negative', 'score': 0.0003067975048907101}]","(0.0013888137182220817, 0.9983043670654297, 0.0003067975048907101)",0.9993855516225423,0.9983043670654297,0,0
2019-12-07,72.79330952962239,84.7391840616862,85.07633463541667,84.51017506917317,84.89185587565105,7515522.333333333,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling",-0.00048795342657269466,-0.0004878344160121297,0.09770920171124405,"[{'label': 'positive', 'score': 0.9876011610031128}, {'label': 'neutral', 'score': 0.011989430524408817}, {'label': 'negative', 'score': 0.00040940818144008517}]","(0.011989430524408817, 0.9876011610031128, 0.00040940818144008517)",0.9991712473647362,0.9876011610031128,0,0,"[{'label': 'neutral', 'score': 0.6856780648231506}, {'label': 'positive', 'score': 0.30052852630615234}, {'label': 'negative', 'score': 0.01379341259598732}]","(0.6856780648231506, 0.30052852630615234, 0.01379341259598732)",0.912233853964093,0.30052852630615234,0,1,"[{'label': 'neutral', 'score': 0.8538933396339417}, {'label': 'positive', 'score': 0.1456197053194046}, {'label': 'negative', 'score': 0.00048694663564674556}]","(0.8538933396339417, 0.1456197053194046, 0.00048694663564674556)",0.9933343673387772,0.1456197053194046,0,1
2019-12-08,72.75779215494792,84.69783528645833,84.99999745686848,84.33523813883464,84.86005147298177,7785172.666666667,,-0.00048819164135675114,-0.00048807251458713786,0.10287543865481258,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-09,72.72227478027344,84.65648651123047,84.92366027832031,84.1603012084961,84.8282470703125,8054823.0,"Mid-Afternoon Market Update: Dow Falls 90 Points; XBiotech Shares Spike Higher | PreMarket Prep Recap: Small Biotech Firms Looking Healthy, Street Fades Macy's Downgrade | 48 Stocks Moving In Monday's Mid-Day Session | Mid-Day Market Update: Synthorx Jumps Following Acquisition News; Biocept Shares Plunge | Mid-Morning Market Update: Markets Mixed; Merck To Acquire ArQule For $20/Share | KalVista Shares Sink On Failed Mid-Stage Study Of Diabetic Macular Edema Drug | Benzinga Pro's Top 5 Stocks To Watch For Mon., Dec. 9, 2019: MRK, PCG, M, DPLO, CHWY | 20 Stocks Moving In Monday's Pre-Market Session | ArQule To Be Acquired By Merck For $2.7B | A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls 1% | ArQule to be Acquired by Merck for $20/Share Cash",0.004283128433922024,-0.0004883108456940148,0.01312043098877694,"[{'label': 'negative', 'score': 0.949280321598053}, {'label': 'positive', 'score': 0.04871087148785591}, {'label': 'neutral', 'score': 0.002008710289373994}]","(0.002008710289373994, 0.04871087148785591, 0.949280321598053)",-0.9023821616356432,-0.949280321598053,0,0,"[{'label': 'negative', 'score': 0.5818543434143066}, {'label': 'positive', 'score': 0.37820348143577576}, {'label': 'neutral', 'score': 0.03994220495223999}]","(0.03994220495223999, 0.37820348143577576, 0.5818543434143066)",-0.21212353746539375,-0.5818543434143066,0,0,"[{'label': 'neutral', 'score': 0.8244137763977051}, {'label': 'positive', 'score': 0.09502355754375458}, {'label': 'negative', 'score': 0.08056269586086273}]","(0.8244137763977051, 0.09502355754375458, 0.08056269586086273)",0.08235759578267518,0.09502355754375458,0,0
2019-12-10,73.03374481201172,85.01908111572266,85.42938995361328,84.45610809326172,84.54198455810547,8663711.0,"Stocks That Hit 52-Week Highs On Tuesday | The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares | 80 Biggest Movers From Yesterday",-0.0013467794714123891,0.00427398194708249,0.03287162516184411,"[{'label': 'positive', 'score': 0.9982420206069946}, {'label': 'neutral', 'score': 0.001309731975197792}, {'label': 'negative', 'score': 0.00044819622416980565}]","(0.001309731975197792, 0.9982420206069946, 0.00044819622416980565)",0.9991024319321122,0.9982420206069946,0,0,"[{'label': 'positive', 'score': 0.6813310384750366}, {'label': 'neutral', 'score': 0.3051970303058624}, {'label': 'negative', 'score': 0.01347189862281084}]","(0.3051970303058624, 0.6813310384750366, 0.01347189862281084)",0.9612209508523893,0.6813310384750366,0,0,"[{'label': 'positive', 'score': 0.9954702854156494}, {'label': 'neutral', 'score': 0.004252193029969931}, {'label': 'negative', 'score': 0.0002775257744360715}]","(0.004252193029969931, 0.9954702854156494, 0.0002775257744360715)",0.9994425781883379,0.9954702854156494,0,0
2019-12-11,72.93538665771484,84.90457916259766,85.39122009277344,84.78053283691406,85.0572509765625,6821746.0,"Cantor Fitzgerald Says Thinks ArQule May See Other Bidders But Thinks Merck Makes A 'Great Strategic Fit,' Says Thinks Merck's Proposed Acquisition Is 'Fair' | The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",0.006630745448691584,-0.0013476871939776284,0.03582357434801602,"[{'label': 'positive', 'score': 0.9989125728607178}, {'label': 'neutral', 'score': 0.0006785569130443037}, {'label': 'negative', 'score': 0.0004088847490493208}]","(0.0006785569130443037, 0.9989125728607178, 0.0004088847490493208)",0.9991816752338586,0.9989125728607178,1,1,"[{'label': 'negative', 'score': 0.6929882168769836}, {'label': 'neutral', 'score': 0.17911280691623688}, {'label': 'positive', 'score': 0.1278989464044571}]","(0.17911280691623688, 0.1278989464044571, 0.6929882168769836)",-0.6883884847384146,-0.6929882168769836,0,0,"[{'label': 'positive', 'score': 0.9858998656272888}, {'label': 'neutral', 'score': 0.009468019008636475}, {'label': 'negative', 'score': 0.004632136784493923}]","(0.009468019008636475, 0.9858998656272888, 0.004632136784493923)",0.9906471738960166,0.9858998656272888,1,1
2019-12-12,73.41900634765625,85.46755981445312,85.8396987915039,84.83778381347656,84.96183013916016,6863876.0,Traders Circulating Materials From Merck's Keytruda Presentation At ESMO | Stocks That Hit 52-Week Highs On Thursday | Merck Highlights Exploratory Analysis Of KEYTRUDA Which Showed Improved Overall Survival As Monotherapy for the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer Regardless of KRAS Mutational Status,-0.004242482238633779,0.006608858752889118,0.05589221784389256,"[{'label': 'positive', 'score': 0.9995972514152527}, {'label': 'negative', 'score': 0.00024712440790608525}, {'label': 'neutral', 'score': 0.0001556948118377477}]","(0.0001556948118377477, 0.9995972514152527, 0.00024712440790608525)",0.9995056742551507,0.9995972514152527,0,0,"[{'label': 'positive', 'score': 0.9537627696990967}, {'label': 'neutral', 'score': 0.031792979687452316}, {'label': 'negative', 'score': 0.014444177970290184}]","(0.031792979687452316, 0.9537627696990967, 0.014444177970290184)",0.9701630358983492,0.9537627696990967,0,0,"[{'label': 'positive', 'score': 0.998325765132904}, {'label': 'neutral', 'score': 0.0013235987862572074}, {'label': 'negative', 'score': 0.00035062897950410843}]","(0.0013235987862572074, 0.998325765132904, 0.00035062897950410843)",0.9992978126216436,0.998325765132904,0,0
2019-12-13,73.60883331298828,85.10496520996094,85.48664093017578,84.38931274414062,85.114501953125,7571800.0,"OncoSec Reports Interim Data From KEYNOTE-890 Study Evaluation TAVO In Combination With KEYTRUDA | The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer | EMA Reports Positive Opinion For Merck's Recarbrio By CHMP For Treatment Of Infections From Aerobic Gram-Negative Organisms In Adults",0.0003737079568836204,-0.004251507100662237,0.06986357563994809,"[{'label': 'positive', 'score': 0.9834527373313904}, {'label': 'negative', 'score': 0.0155823715031147}, {'label': 'neutral', 'score': 0.0009648636914789677}]","(0.0009648636914789677, 0.9834527373313904, 0.0155823715031147)",0.9688051573657037,0.9834527373313904,0,0,"[{'label': 'positive', 'score': 0.6586777567863464}, {'label': 'neutral', 'score': 0.32636797428131104}, {'label': 'negative', 'score': 0.014954335056245327}]","(0.32636797428131104, 0.6586777567863464, 0.014954335056245327)",0.9556008829230787,0.6586777567863464,0,0,"[{'label': 'positive', 'score': 0.9945346117019653}, {'label': 'neutral', 'score': 0.0048591881059110165}, {'label': 'negative', 'score': 0.0006062351167201996}]","(0.0048591881059110165, 0.9945346117019653, 0.0006062351167201996)",0.9987816094200972,0.9945346117019653,0,0
2019-12-14,73.63634236653645,85.1367696126302,85.61704762776692,84.6246821085612,85.25763193766277,8499594.333333334,,0.0003735683514184224,0.0003736381454571809,0.06900123821006934,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-15,73.66385142008464,85.16857401529948,85.74745432535808,84.86005147298177,85.40076192220052,9427388.666666666,"The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week",0.00037342885021830735,0.0003734985921344387,0.06311510683914652,"[{'label': 'neutral', 'score': 0.9998705387115479}, {'label': 'negative', 'score': 6.660719373030588e-05}, {'label': 'positive', 'score': 6.284364644670859e-05}]","(0.9998705387115479, 6.284364644670859e-05, 6.660719373030588e-05)",-0.029073177728710896,-6.660719373030588e-05,1,1,"[{'label': 'neutral', 'score': 0.9036554098129272}, {'label': 'positive', 'score': 0.0754314661026001}, {'label': 'negative', 'score': 0.02091308683156967}]","(0.9036554098129272, 0.0754314661026001, 0.02091308683156967)",0.565868828186703,0.0754314661026001,0,1,"[{'label': 'neutral', 'score': 0.9995260238647461}, {'label': 'positive', 'score': 0.00034716713707894087}, {'label': 'negative', 'score': 0.00012674402387347072}]","(0.9995260238647461, 0.00034716713707894087, 0.00012674402387347072)",0.4651148387442266,0.00034716713707894087,1,1
2019-12-16,73.69136047363281,85.20037841796875,85.87786102294922,85.09542083740234,85.54389190673828,10355183.0,,-0.0030238057543288564,0.00037335914301856333,0.06135438025689712,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-17,73.4685287475586,84.9427490234375,85.3530502319336,84.46565246582031,85.2385482788086,11690545.0,"Merck Reports FDA's Oncologic Drugs AdCom Recommends KEYTRUDA For Treatment Of Certain Patients with High-Risk, Non-Muscle Invasive Bladder Cancer | The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",0.006740038456508649,-0.0030283866918563293,0.03556501459723526,"[{'label': 'positive', 'score': 0.9509397149085999}, {'label': 'neutral', 'score': 0.04827512428164482}, {'label': 'negative', 'score': 0.0007851663394831121}]","(0.04827512428164482, 0.9509397149085999, 0.0007851663394831121)",0.9983500140535289,0.9509397149085999,1,1,"[{'label': 'positive', 'score': 0.6412659883499146}, {'label': 'neutral', 'score': 0.34510156512260437}, {'label': 'negative', 'score': 0.013632399961352348}]","(0.34510156512260437, 0.6412659883499146, 0.013632399961352348)",0.9583678927764501,0.6412659883499146,1,1,"[{'label': 'positive', 'score': 0.9727927446365356}, {'label': 'neutral', 'score': 0.02642451599240303}, {'label': 'negative', 'score': 0.0007827085792087018}]","(0.02642451599240303, 0.9727927446365356, 0.0007827085792087018)",0.9983920946720187,0.9727927446365356,1,1
2019-12-18,73.96369171142578,85.51526641845703,85.87786102294922,85.0477066040039,85.25763702392578,11578199.0,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",0.004128594531887272,0.00671742594657055,0.05617373290415633,"[{'label': 'positive', 'score': 0.9741800427436829}, {'label': 'neutral', 'score': 0.024749532341957092}, {'label': 'negative', 'score': 0.0010704586748033762}]","(0.024749532341957092, 0.9741800427436829, 0.0010704586748033762)",0.997804751346969,0.9741800427436829,0,0,"[{'label': 'positive', 'score': 0.8534744381904602}, {'label': 'neutral', 'score': 0.07442940026521683}, {'label': 'negative', 'score': 0.07209614664316177}]","(0.07442940026521683, 0.8534744381904602, 0.07209614664316177)",0.8442125369484995,0.8534744381904602,0,0,"[{'label': 'positive', 'score': 0.9966945648193359}, {'label': 'neutral', 'score': 0.0016800430603325367}, {'label': 'negative', 'score': 0.0016253686044365168}]","(0.0016800430603325367, 0.9966945648193359, 0.0016253686044365168)",0.9967437921451447,0.9966945648193359,0,0
2019-12-19,74.26907348632812,85.86832427978516,85.96373748779297,85.39122009277344,85.77290344238281,7602716.0,"Stocks That Hit 52-Week Highs On Thursday | The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",0.01766860806723594,0.004120095270787299,0.05987658350598647,"[{'label': 'positive', 'score': 0.9993311166763306}, {'label': 'neutral', 'score': 0.00039168307557702065}, {'label': 'negative', 'score': 0.00027717158081941307}]","(0.00039168307557702065, 0.9993311166763306, 0.00027717158081941307)",0.9994454396105446,0.9993311166763306,1,1,"[{'label': 'positive', 'score': 0.6449947953224182}, {'label': 'neutral', 'score': 0.3358393907546997}, {'label': 'negative', 'score': 0.019165856763720512}]","(0.3358393907546997, 0.6449947953224182, 0.019165856763720512)",0.9422854795642582,0.6449947953224182,1,1,"[{'label': 'positive', 'score': 0.997520387172699}, {'label': 'neutral', 'score': 0.0022150676231831312}, {'label': 'negative', 'score': 0.00026452954625710845}]","(0.0022150676231831312, 0.997520387172699, 0.00026452954625710845)",0.9994697663958942,0.997520387172699,1,1
2019-12-20,75.58129119873047,87.385498046875,88.3969497680664,86.67938995361328,87.27098846435547,17849641.0,"Stocks That Hit 52-Week Highs On Friday | NewLink Genetics Announces FDA Approval Of Ebola Vaccine V920 | The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering | Merck Reports FDA Approval For ERVEBO | Merck Reports KEYTRUDA Approved In Japan For 3 New First-Line Indications Across Advanced Renal Cell Carcinoma, Recurrent or Distant Metastatic Head and Neck Cancer | FDA Approves First Ebola Vaccine",0.0005823689947690646,0.017514332780717685,0.12451525061921634,"[{'label': 'positive', 'score': 0.9993256330490112}, {'label': 'neutral', 'score': 0.0003595580637920648}, {'label': 'negative', 'score': 0.0003148377873003483}]","(0.0003595580637920648, 0.9993256330490112, 0.0003148377873003483)",0.9993700979572446,0.9993256330490112,0,0,"[{'label': 'positive', 'score': 0.8899031281471252}, {'label': 'neutral', 'score': 0.09198545664548874}, {'label': 'negative', 'score': 0.018111448734998703}]","(0.09198545664548874, 0.8899031281471252, 0.018111448734998703)",0.960107581538639,0.8899031281471252,0,0,"[{'label': 'positive', 'score': 0.9974324107170105}, {'label': 'neutral', 'score': 0.0022669045720249414}, {'label': 'negative', 'score': 0.0003007303748745471}]","(0.0022669045720249414, 0.9974324107170105, 0.0003007303748745471)",0.9993971727258745,0.9974324107170105,0,0
2019-12-21,75.62531026204427,87.43638865152995,88.19974772135417,86.87022908528645,87.38867441813152,14531742.666666668,,0.0005820300385204434,0.0005821994837547903,0.12401948906955257,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-22,75.66932932535808,87.48727925618489,88.00254567464192,87.06106821695964,87.50636037190755,11213844.333333334,How The Dow Jones Industrial Average Changed Over The Past Decade,0.0005816914766080687,0.0005818607247315054,0.11092025661081428,"[{'label': 'neutral', 'score': 0.8979296684265137}, {'label': 'positive', 'score': 0.10056200623512268}, {'label': 'negative', 'score': 0.0015083313919603825}]","(0.8979296684265137, 0.10056200623512268, 0.0015083313919603825)",0.9704452551637262,0.10056200623512268,0,1,"[{'label': 'neutral', 'score': 0.8818134069442749}, {'label': 'negative', 'score': 0.08554254472255707}, {'label': 'positive', 'score': 0.03264399617910385}]","(0.8818134069442749, 0.03264399617910385, 0.08554254472255707)",-0.44758521689426833,-0.08554254472255707,1,1,"[{'label': 'neutral', 'score': 0.9984719157218933}, {'label': 'positive', 'score': 0.0011169015197083354}, {'label': 'negative', 'score': 0.00041116029024124146}]","(0.9984719157218933, 0.0011169015197083354, 0.00041116029024124146)",0.46185384967534926,0.0011169015197083354,1,1
2019-12-23,75.71334838867188,87.53816986083984,87.80534362792969,87.25190734863281,87.6240463256836,7895946.0,A Perspective On Biopharma's Record M&A Run In 2019,-0.0032701450425809122,0.0005815223597005556,0.11649599961865921,"[{'label': 'neutral', 'score': 0.9998290538787842}, {'label': 'positive', 'score': 0.00010758171993074939}, {'label': 'negative', 'score': 6.329255120363086e-05}]","(0.9998290538787842, 0.00010758171993074939, 6.329255120363086e-05)",0.2591915589930347,0.00010758171993074939,1,1,"[{'label': 'neutral', 'score': 0.8628881573677063}, {'label': 'positive', 'score': 0.12213285267353058}, {'label': 'negative', 'score': 0.014978926628828049}]","(0.8628881573677063, 0.12213285267353058, 0.014978926628828049)",0.7815078076436227,0.12213285267353058,0,1,"[{'label': 'neutral', 'score': 0.6867532134056091}, {'label': 'positive', 'score': 0.3119400143623352}, {'label': 'negative', 'score': 0.0013067948166280985}]","(0.6867532134056091, 0.3119400143623352, 0.0013067948166280985)",0.9916564524947387,0.3119400143623352,0,1
2019-12-24,75.46575164794922,87.25190734863281,87.52862548828125,86.89885711669922,87.4427490234375,2343223.0,,-0.0005468123293916676,-0.0032755036523572914,0.12979198485197546,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-25,75.42448806762695,87.20419692993164,87.52385330200195,86.89885711669922,87.42366409301758,2702949.0,,-0.0005471114967036171,-0.000546961885775477,0.026540697544120938,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-26,75.38322448730469,87.15648651123047,87.51908111572266,86.89885711669922,87.40457916259766,3062675.0,,0.0017516976656140374,-0.0005472612168100758,0.02503469347713504,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-27,75.51527404785156,87.30915832519531,87.5,87.0896987915039,87.48091888427734,3758966.0,Merck & Co Option Alert: Jun 19 $92.5 Calls Sweep (49) above Ask!: 4764 @ $4.107 vs 5293 OI; Earnings 1/31 Before Open [est] Ref=$91.46,-0.001712195596806861,0.0017501652325700812,0.02959021912775806,"[{'label': 'neutral', 'score': 0.9998666048049927}, {'label': 'negative', 'score': 7.511700096074492e-05}, {'label': 'positive', 'score': 5.8284054830437526e-05}]","(0.9998666048049927, 5.8284054830437526e-05, 7.511700096074492e-05)",-0.12618300530287122,-7.511700096074492e-05,1,1,"[{'label': 'neutral', 'score': 0.8105806112289429}, {'label': 'positive', 'score': 0.1156102865934372}, {'label': 'negative', 'score': 0.07380905002355576}]","(0.8105806112289429, 0.1156102865934372, 0.07380905002355576)",0.22068093636292155,0.1156102865934372,1,1,"[{'label': 'positive', 'score': 0.658997118473053}, {'label': 'neutral', 'score': 0.3090686500072479}, {'label': 'negative', 'score': 0.03193426504731178}]","(0.3090686500072479, 0.658997118473053, 0.03193426504731178)",0.9075616890215538,0.658997118473053,0,0
2019-12-28,75.38597615559895,87.15966796875,87.49681854248047,86.91794077555339,87.43320719401042,3816955.3333333335,,-0.0017151322386738598,-0.0017136630790047002,0.029240932601762082,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2019-12-29,75.25667826334636,87.01017761230469,87.49363708496094,86.74618275960286,87.38549550374348,3874944.6666666665,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus",-0.0017180789713061345,-0.0017166047619274864,0.02245799246292937,"[{'label': 'neutral', 'score': 0.9998120665550232}, {'label': 'negative', 'score': 9.626676182961091e-05}, {'label': 'positive', 'score': 9.165414667222649e-05}]","(0.9998120665550232, 9.165414667222649e-05, 9.626676182961091e-05)",-0.024545513291509686,-9.626676182961091e-05,1,1,"[{'label': 'neutral', 'score': 0.9215837121009827}, {'label': 'positive', 'score': 0.05918610841035843}, {'label': 'negative', 'score': 0.019230125471949577}]","(0.9215837121009827, 0.05918610841035843, 0.019230125471949577)",0.5095371323032076,0.05918610841035843,0,1,"[{'label': 'neutral', 'score': 0.9989878535270691}, {'label': 'positive', 'score': 0.0007932549342513084}, {'label': 'negative', 'score': 0.00021883960289414972}]","(0.9989878535270691, 0.0007932549342513084, 0.00021883960289414972)",0.567551063932483,0.0007932549342513084,0,1
2019-12-30,75.12738037109375,86.86068725585938,87.4904556274414,86.57442474365234,87.33778381347656,3932934.0,Merck-AstraZeneca's Lynparza Snags FDA Nod For Pancreatic Cancer | Merck's LYNPARZA Approved By FDA As First-Line Maintenance Treatment Of Germline BRCA-Mutated Metastatic Pancreatic Cancer | AstraZeneca Says FDA Approved Lynparza for Pancreatic Cancer,-0.000878875404874693,-0.00171955656163576,0.023926818605945033,"[{'label': 'positive', 'score': 0.998836100101471}, {'label': 'negative', 'score': 0.0007578670629300177}, {'label': 'neutral', 'score': 0.00040604660171084106}]","(0.00040604660171084106, 0.998836100101471, 0.0007578670629300177)",0.9984836501863253,0.998836100101471,0,0,"[{'label': 'positive', 'score': 0.9052293300628662}, {'label': 'neutral', 'score': 0.08004772663116455}, {'label': 'negative', 'score': 0.01472292561084032}]","(0.08004772663116455, 0.9052293300628662, 0.01472292561084032)",0.9679919788879515,0.9052293300628662,0,0,"[{'label': 'positive', 'score': 0.9900140762329102}, {'label': 'neutral', 'score': 0.008625784888863564}, {'label': 'negative', 'score': 0.0013601460959762335}]","(0.008625784888863564, 0.9900140762329102, 0.0013601460959762335)",0.9972560390106149,0.9900140762329102,0,0
2019-12-31,75.06134033203125,86.78434753417969,86.82251739501953,86.2977066040039,86.75572204589844,4710760.0,,0.005992308745900439,-0.0008792618423002161,0.023831060751663986,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2020-01-01,75.51113891601562,87.30438613891602,87.37118148803711,86.26431274414062,86.83205795288086,6481094.0,Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates,0.005956614870515886,0.005974426266512635,0.05342575049275704,"[{'label': 'neutral', 'score': 0.9998801946640015}, {'label': 'negative', 'score': 6.648629641858861e-05}, {'label': 'positive', 'score': 5.333924127626233e-05}]","(0.9998801946640015, 5.333924127626233e-05, 6.648629641858861e-05)",-0.10971830709248907,-6.648629641858861e-05,1,1,"[{'label': 'neutral', 'score': 0.947795569896698}, {'label': 'positive', 'score': 0.029710624366998672}, {'label': 'negative', 'score': 0.022493811324238777}]","(0.947795569896698, 0.029710624366998672, 0.022493811324238777)",0.1382413763735261,0.029710624366998672,1,1,"[{'label': 'neutral', 'score': 0.9995591044425964}, {'label': 'positive', 'score': 0.0002712681598495692}, {'label': 'negative', 'score': 0.0001695712999207899}]","(0.9995591044425964, 0.0002712681598495692, 0.0001695712999207899)",0.23068910387866584,0.0002712681598495692,1,1
2020-01-02,75.9609375,87.82442474365234,87.91984558105469,86.23091888427734,86.90839385986328,8251428.0,"Speaker Of The House Nancy Pelosi Says ""Enough is enough. @HouseDemocrats passed the bipartisan #LowerDrugCosts Now Act last year to stop Big Pharma from charging Americans more for our medicines than what they charge for the same drugs overseas.""",-0.008583201079493643,0.005938944376322225,0.06452932599913054,"[{'label': 'positive', 'score': 0.966155469417572}, {'label': 'neutral', 'score': 0.03308619186282158}, {'label': 'negative', 'score': 0.0007583473343402147}]","(0.03308619186282158, 0.966155469417572, 0.0007583473343402147)",0.9984314065613672,0.966155469417572,0,0,"[{'label': 'neutral', 'score': 0.5644758343696594}, {'label': 'positive', 'score': 0.33006227016448975}, {'label': 'negative', 'score': 0.10546181350946426}]","(0.5644758343696594, 0.33006227016448975, 0.10546181350946426)",0.5157015767310997,0.33006227016448975,0,1,"[{'label': 'neutral', 'score': 0.569599449634552}, {'label': 'positive', 'score': 0.4194765090942383}, {'label': 'negative', 'score': 0.010924096219241619}]","(0.569599449634552, 0.4194765090942383, 0.010924096219241619)",0.9492375424923712,0.4194765090942383,0,1
2020-01-03,75.30894470214844,87.07061004638672,87.8530502319336,86.364501953125,86.52671813964844,5903698.0,,0.001424663564634591,-0.008620248894773763,0.0968563181787201,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-04,75.41623433430989,87.19465637207031,87.74809010823567,86.51717376708984,86.70165506998698,6443453.0,,0.001422636785840096,0.0014236496943336146,0.09561940480861908,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-05,75.52352396647136,87.3187026977539,87.64312998453777,86.66984558105469,86.87659200032552,6983208.0,,0.0014206157655934184,0.0014216257968610326,0.09451177751674847,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-06,75.63081359863281,87.4427490234375,87.53816986083984,86.82251739501953,87.05152893066406,7522963.0,Merck's Announces Phase 3 Of KEYNOTE-604 Study Did Not Meet Other Dual Primary Endpoint of Overall Survival; Results to be Presented at Upcoming Medical Meeting | Merck Buys Exclusive Global License from Taiho and Astex for its Small Molecule Inhibitor Candidates for $50M Upfront and Milestone Payments,-0.026625959228345555,0.0014196076456710802,0.08516983827227555,"[{'label': 'neutral', 'score': 0.9998167157173157}, {'label': 'negative', 'score': 9.963737102225423e-05}, {'label': 'positive', 'score': 8.371230069315061e-05}]","(0.9998167157173157, 8.371230069315061e-05, 9.963737102225423e-05)",-0.0868562794801318,-9.963737102225423e-05,0,0,"[{'label': 'positive', 'score': 0.8831937909126282}, {'label': 'neutral', 'score': 0.10436224937438965}, {'label': 'negative', 'score': 0.012443986721336842}]","(0.10436224937438965, 0.8831937909126282, 0.012443986721336842)",0.9722120101851655,0.8831937909126282,0,0,"[{'label': 'positive', 'score': 0.7370983958244324}, {'label': 'negative', 'score': 0.18787162005901337}, {'label': 'neutral', 'score': 0.07502999156713486}]","(0.07502999156713486, 0.7370983958244324, 0.18787162005901337)",0.5937779239696201,0.7370983958244324,0,0
2020-01-07,73.61708068847656,85.114501953125,86.94656372070312,85.03816986083984,86.64122009277344,11132275.0,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",-0.006726437703117067,-0.02698685055186059,0.19638809362572907,"[{'label': 'positive', 'score': 0.9992965459823608}, {'label': 'neutral', 'score': 0.0004138888616580516}, {'label': 'negative', 'score': 0.000289563846308738}]","(0.0004138888616580516, 0.9992965459823608, 0.000289563846308738)",0.999420632512874,0.9992965459823608,0,0,"[{'label': 'positive', 'score': 0.9098910093307495}, {'label': 'negative', 'score': 0.060526568442583084}, {'label': 'neutral', 'score': 0.029582476243376732}]","(0.029582476243376732, 0.9098910093307495, 0.060526568442583084)",0.8752566527464104,0.9098910093307495,0,0,"[{'label': 'positive', 'score': 0.9986710548400879}, {'label': 'neutral', 'score': 0.0010203856509178877}, {'label': 'negative', 'score': 0.0003086119540967047}]","(0.0010203856509178877, 0.9986710548400879, 0.0003086119540967047)",0.999382145674522,0.9986710548400879,0,0
2020-01-08,73.12191772460938,84.54198455810547,85.40076446533203,84.36068725585938,85.0095443725586,15200506.0,"Merck Reports FDA Approval Of KEYTRUDA For Patients BCG-Unresponsive, High-Risk, Non-Muscle Invasive Bladder Cancer With Carcinoma In Situ With or Without Papillary Tumors Who Are Ineligible for or Have Elected Not to Undergo Cystectomy | Merck Announces FDA Approves Pembrolizumab For BCG-Unresponsive, High-risk Non-muscle Invasive Bladder Cancer",0.008803648956099704,-0.006749162145561186,0.19542332897701434,"[{'label': 'positive', 'score': 0.9978234767913818}, {'label': 'neutral', 'score': 0.001876607770100236}, {'label': 'negative', 'score': 0.0002999080461449921}]","(0.001876607770100236, 0.9978234767913818, 0.0002999080461449921)",0.999399056167402,0.9978234767913818,0,0,"[{'label': 'positive', 'score': 0.7386417388916016}, {'label': 'neutral', 'score': 0.2337713986635208}, {'label': 'negative', 'score': 0.027586864307522774}]","(0.2337713986635208, 0.7386417388916016, 0.027586864307522774)",0.9279931232210771,0.7386417388916016,0,0,"[{'label': 'positive', 'score': 0.8768664002418518}, {'label': 'neutral', 'score': 0.12091421335935593}, {'label': 'negative', 'score': 0.002219422021880746}]","(0.12091421335935593, 0.8768664002418518, 0.002219422021880746)",0.994950613544954,0.8768664002418518,0,0
2020-01-09,73.76564025878906,85.28626251220703,85.92557525634766,84.71373748779297,84.8759536743164,9714750.0,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results",0.0016782004181009123,0.008765122787427124,0.21834816258200607,"[{'label': 'positive', 'score': 0.9993451237678528}, {'label': 'negative', 'score': 0.0003872677334584296}, {'label': 'neutral', 'score': 0.00026762456400319934}]","(0.00026762456400319934, 0.9993451237678528, 0.0003872677334584296)",0.999225257205327,0.9993451237678528,0,0,"[{'label': 'positive', 'score': 0.8081923127174377}, {'label': 'neutral', 'score': 0.1359003335237503}, {'label': 'negative', 'score': 0.055907417088747025}]","(0.1359003335237503, 0.8081923127174377, 0.055907417088747025)",0.8705996190942291,0.8081923127174377,0,0,"[{'label': 'positive', 'score': 0.9986306428909302}, {'label': 'neutral', 'score': 0.0009872163645923138}, {'label': 'negative', 'score': 0.00038212205981835723}]","(0.0009872163645923138, 0.9986306428909302, 0.00038212205981835723)",0.9992350006461885,0.9986306428909302,0,0
2020-01-10,73.88943481445312,85.42938995361328,85.98282623291016,85.3530502319336,85.61068725585938,5945304.0,"'California Gov. Gavin Newsom wants the state to become the first to create its own generic drug label, an attempt to create more competition and bring down prices.' -Axios, From Earlier",-7.44815694284772e-05,0.0016767938132691844,0.21878575704452433,"[{'label': 'positive', 'score': 0.9920509457588196}, {'label': 'neutral', 'score': 0.00765960942953825}, {'label': 'negative', 'score': 0.0002895189682021737}]","(0.00765960942953825, 0.9920509457588196, 0.0002895189682021737)",0.9994164926686088,0.9920509457588196,0,0,"[{'label': 'neutral', 'score': 0.5890649557113647}, {'label': 'positive', 'score': 0.39304134249687195}, {'label': 'negative', 'score': 0.017893701791763306}]","(0.5890649557113647, 0.39304134249687195, 0.017893701791763306)",0.9129122617286687,0.39304134249687195,0,1,"[{'label': 'neutral', 'score': 0.8956587314605713}, {'label': 'positive', 'score': 0.1003023236989975}, {'label': 'negative', 'score': 0.00403889873996377}]","(0.8956587314605713, 0.1003023236989975, 0.00403889873996377)",0.9225828748110271,0.1003023236989975,0,1
2020-01-11,73.88392384847005,85.42302703857422,85.83015441894531,85.21628316243489,85.54707336425781,7384033.333333333,,-7.448711734587932e-05,-7.448434331829285e-05,0.21653837518822774,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-12,73.87841288248698,85.41666412353516,85.67748260498047,85.0795160929362,85.48345947265625,8822762.666666666,,-7.449266608983977e-05,-7.448989164901539e-05,0.08791727029385027,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-13,73.8729019165039,85.4103012084961,85.52481079101562,84.9427490234375,85.41984558105469,10261492.0,AstraZeneca and Merck's Supplemental New Drug Application for LYNPARZA Granted Priority Review by the FDA,0.004692226343444456,-7.449544080628031e-05,0.06084945990361647,"[{'label': 'neutral', 'score': 0.9616362452507019}, {'label': 'positive', 'score': 0.0379868783056736}, {'label': 'negative', 'score': 0.00037675295607186854}]","(0.9616362452507019, 0.0379868783056736, 0.00037675295607186854)",0.9803588480192932,0.0379868783056736,0,1,"[{'label': 'positive', 'score': 0.5516884922981262}, {'label': 'neutral', 'score': 0.42958080768585205}, {'label': 'negative', 'score': 0.018730634823441505}]","(0.42958080768585205, 0.5516884922981262, 0.018730634823441505)",0.9343267645390523,0.5516884922981262,0,0,"[{'label': 'neutral', 'score': 0.7929950952529907}, {'label': 'positive', 'score': 0.20650018751621246}, {'label': 'negative', 'score': 0.0005046871956437826}]","(0.7929950952529907, 0.20650018751621246, 0.0005046871956437826)",0.9951239100398356,0.20650018751621246,0,1
2020-01-14,74.21954345703125,85.81106567382812,85.81106567382812,84.79962158203125,85.1812973022461,8625669.0,,0.017902848544573923,0.004681252164911946,0.03293319628045012,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2020-01-15,75.54827117919922,87.34732818603516,87.41412353515625,85.96373748779297,85.97328186035156,9614038.0,,-0.003932730352528988,0.017744479924519684,0.12250380569471939,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-16,75.25119018554688,87.00381469726562,87.84351348876953,86.87976837158203,87.65267181396484,7252474.0,,-0.002303099222326944,-0.003940483871551026,0.13401401459109957,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-17,75.07786560058594,86.80343627929688,87.4332046508789,86.69847106933594,87.09923553466797,10131226.0,"Cannabis Media Company The Fresh Toast Expands Again, Announces It's Now Cash Positive",-0.002748165238409141,-0.0023057554344713556,0.13878986372367963,"[{'label': 'positive', 'score': 0.9991636276245117}, {'label': 'neutral', 'score': 0.0005689043318852782}, {'label': 'negative', 'score': 0.0002675127179827541}]","(0.0005689043318852782, 0.9991636276245117, 0.0002675127179827541)",0.9994646700364147,0.9991636276245117,0,0,"[{'label': 'positive', 'score': 0.5126277804374695}, {'label': 'neutral', 'score': 0.473522424697876}, {'label': 'negative', 'score': 0.013849781826138496}]","(0.473522424697876, 0.5126277804374695, 0.013849781826138496)",0.9473870006288932,0.5126277804374695,0,0,"[{'label': 'positive', 'score': 0.9989761114120483}, {'label': 'neutral', 'score': 0.000641359540168196}, {'label': 'negative', 'score': 0.00038253856473602355}]","(0.000641359540168196, 0.9989761114120483, 0.00038253856473602355)",0.9992344318733922,0.9989761114120483,0,0
2020-01-18,74.87154197692871,86.56488609313965,87.2757625579834,86.42413902282715,86.96564865112305,10103951.75,,-0.0027557384630594677,-0.002751948377214643,0.14399894646566416,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-19,74.66521835327148,86.32633590698242,87.11832046508789,86.14980697631836,86.83206176757812,10076677.5,,-0.002763353542704129,-0.0027595425005266638,0.14715646299997268,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-20,74.45889472961426,86.0877857208252,86.96087837219238,85.87547492980957,86.6984748840332,10049403.25,"The Week Ahead In Biotech: Focus On Epizyme, Merck Ahead Of PDUFA Dates, J&J To Kickstart Big Pharma Earnings",-0.002771010825285052,-0.002767178652484064,0.0097045655799874,"[{'label': 'neutral', 'score': 0.9669643044471741}, {'label': 'positive', 'score': 0.032721471041440964}, {'label': 'negative', 'score': 0.0003141829511150718}]","(0.9669643044471741, 0.032721471041440964, 0.0003141829511150718)",0.980979159596122,0.032721471041440964,0,0,"[{'label': 'positive', 'score': 0.5046830177307129}, {'label': 'neutral', 'score': 0.4815744161605835}, {'label': 'negative', 'score': 0.013742510229349136}]","(0.4815744161605835, 0.5046830177307129, 0.013742510229349136)",0.9469836669369884,0.5046830177307129,0,0,"[{'label': 'neutral', 'score': 0.9984167814254761}, {'label': 'positive', 'score': 0.001367569318972528}, {'label': 'negative', 'score': 0.00021569566160906106}]","(0.9984167814254761, 0.001367569318972528, 0.00021569566160906106)",0.7275305596289656,0.001367569318972528,0,0
2020-01-21,74.25257110595703,85.84923553466797,86.80343627929688,85.60114288330078,86.56488800048828,10022129.0,FDA Accepts Regulatory Submission Of Supplemental New Drug Application For Merck's LYNPARZA In HRR-Mutated Metastatic Castration-Resistant Prostate Cancer And Grants Priority Review,-0.003556742538567888,-0.002774857182957725,0.0032516497640097744,"[{'label': 'neutral', 'score': 0.9692827463150024}, {'label': 'positive', 'score': 0.030399151146411896}, {'label': 'negative', 'score': 0.0003180826606694609}]","(0.9692827463150024, 0.030399151146411896, 0.0003180826606694609)",0.9792896285735122,0.030399151146411896,0,0,"[{'label': 'positive', 'score': 0.707741916179657}, {'label': 'neutral', 'score': 0.28122660517692566}, {'label': 'negative', 'score': 0.01103142835199833}]","(0.28122660517692566, 0.707741916179657, 0.01103142835199833)",0.9693048485007849,0.707741916179657,0,0,"[{'label': 'positive', 'score': 0.5032521486282349}, {'label': 'neutral', 'score': 0.4961386024951935}, {'label': 'negative', 'score': 0.0006092533585615456}]","(0.4961386024951935, 0.5032521486282349, 0.0006092533585615456)",0.9975816629090493,0.5032521486282349,0,0
2020-01-22,73.98846435546875,85.54389190673828,86.3167953491211,85.51526641845703,86.04007720947266,7800474.0,,-0.01215840413955645,-0.0035630827855257985,0.0056789321455650455,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2020-01-23,73.0888900756836,84.50381469726562,85.55343627929688,84.21755981445312,85.55343627929688,13198093.0,"UBS Maintains Buy on Merck & Co, Raises Price Target to $99",-0.029132769307275028,-0.012232922164663384,0.06601458733923105,"[{'label': 'positive', 'score': 0.9995545744895935}, {'label': 'neutral', 'score': 0.00023284440976567566}, {'label': 'negative', 'score': 0.00021260981156956404}]","(0.00023284440976567566, 0.9995545744895935, 0.00021260981156956404)",0.9995746813560036,0.9995545744895935,0,0,"[{'label': 'positive', 'score': 0.7371730208396912}, {'label': 'neutral', 'score': 0.23793700337409973}, {'label': 'negative', 'score': 0.02489001676440239}]","(0.23793700337409973, 0.7371730208396912, 0.02489001676440239)",0.9346772759307262,0.7371730208396912,0,0,"[{'label': 'positive', 'score': 0.9988346695899963}, {'label': 'neutral', 'score': 0.0007360716699622571}, {'label': 'negative', 'score': 0.0004292230005376041}]","(0.0007360716699622571, 0.9988346695899963, 0.0004292230005376041)",0.9991409216249676,0.9988346695899963,0,0
2020-01-24,70.9595947265625,82.04198455810547,84.7614517211914,81.6603012084961,84.57061004638672,14954960.0,"Shares of several companies in the healthcare and pharmaceutical space are trading lower, not currently seeing sector-specific news. NOTE: The global spread of the Wuhan coronavirus has caused equities across to sell off. | The Daily Biotech Pulse: FDA Nod For Epizyme, Sonoma Explores Options For Dermatology Business, Roche's Cancer Drug Flunks Study",0.00046521689978497473,-0.02956555465083516,0.18334607658779134,"[{'label': 'negative', 'score': 0.9979026317596436}, {'label': 'neutral', 'score': 0.001657959190197289}, {'label': 'positive', 'score': 0.0004394757270347327}]","(0.001657959190197289, 0.0004394757270347327, 0.9979026317596436)",-0.9991195889189907,-0.9979026317596436,0,0,"[{'label': 'negative', 'score': 0.923664391040802}, {'label': 'neutral', 'score': 0.0633459985256195}, {'label': 'positive', 'score': 0.012989593669772148}]","(0.0633459985256195, 0.012989593669772148, 0.923664391040802)",-0.9722638372722325,-0.923664391040802,0,0,"[{'label': 'negative', 'score': 0.9982590079307556}, {'label': 'neutral', 'score': 0.001401017652824521}, {'label': 'positive', 'score': 0.0003399818961042911}]","(0.001401017652824521, 0.0003399818961042911, 0.9982590079307556)",-0.9993190822350757,-0.9982590079307556,0,0
2020-01-25,70.9926045735677,82.0801518758138,84.0235366821289,81.38358561197917,83.44783782958984,13585818.0,,0.00046500057365987164,0.0004651087199531268,0.19277356221845768,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-26,71.02561442057292,82.11831919352214,83.2856216430664,81.10687001546223,82.32506561279297,12216676.0,,0.00046478444862446,0.00046489249439650904,0.20112157927131358,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-27,71.05862426757812,82.15648651123047,82.5477066040039,80.83015441894531,81.2022933959961,10847534.0,A Peek Into The Markets: US Stock Futures Down; Dow Futures Tumble Over 400 Points | Merck's DIFICID Receives FDA Approval to Treat Clostridioides in Children Aged Six Months and Older,0.0017422248306737807,0.00046467646978930736,0.2096879759462948,"[{'label': 'negative', 'score': 0.9962126016616821}, {'label': 'neutral', 'score': 0.0029966055881232023}, {'label': 'positive', 'score': 0.0007908624829724431}]","(0.0029966055881232023, 0.0007908624829724431, 0.9962126016616821)",-0.9984135210931269,-0.9962126016616821,0,0,"[{'label': 'negative', 'score': 0.9615582227706909}, {'label': 'neutral', 'score': 0.026021121069788933}, {'label': 'positive', 'score': 0.012420556508004665}]","(0.026021121069788933, 0.012420556508004665, 0.9615582227706909)",-0.9744952215135467,-0.9615582227706909,0,0,"[{'label': 'negative', 'score': 0.4213056266307831}, {'label': 'positive', 'score': 0.3166329562664032}, {'label': 'neutral', 'score': 0.2620614469051361}]","(0.2620614469051361, 0.3166329562664032, 0.4213056266307831)",-0.14184469113056725,-0.4213056266307831,1,1
2020-01-28,71.18244171142578,82.29962158203125,82.7385482788086,81.96565246582031,82.48091888427734,9496347.0,Turnaround Tuesday? Stocks Look To Bounce Back As Apple Earnings Loom Later,0.011478258999389646,0.0017407089174458444,0.21563777871751155,"[{'label': 'positive', 'score': 0.9990150928497314}, {'label': 'neutral', 'score': 0.0005033608758822083}, {'label': 'negative', 'score': 0.0004815743595827371}]","(0.0005033608758822083, 0.9990150928497314, 0.0004815743595827371)",0.9990363662523711,0.9990150928497314,0,0,"[{'label': 'positive', 'score': 0.9219213128089905}, {'label': 'negative', 'score': 0.04519616439938545}, {'label': 'neutral', 'score': 0.032882582396268845}]","(0.032882582396268845, 0.9219213128089905, 0.04519616439938545)",0.9065342826192201,0.9219213128089905,0,0,"[{'label': 'positive', 'score': 0.9790521860122681}, {'label': 'neutral', 'score': 0.019940128549933434}, {'label': 'negative', 'score': 0.001007713028229773}]","(0.019940128549933434, 0.9790521860122681, 0.001007713028229773)",0.9979435684916476,0.9790521860122681,0,0
2020-01-29,71.99949645996094,83.24427795410156,84.12213897705078,82.47137451171875,82.63359069824219,8511227.0,"February Market Outlook: Coronavirus, D.C. Proceedings, Earnings Season Could Mean Volatility",-0.008482361918629961,0.011412883573006304,0.07596657847236171,"[{'label': 'negative', 'score': 0.9921013712882996}, {'label': 'neutral', 'score': 0.006293118931353092}, {'label': 'positive', 'score': 0.0016054254956543446}]","(0.006293118931353092, 0.0016054254956543446, 0.9921013712882996)",-0.996768814501722,-0.9921013712882996,0,0,"[{'label': 'negative', 'score': 0.9622794985771179}, {'label': 'neutral', 'score': 0.02753659337759018}, {'label': 'positive', 'score': 0.010183969512581825}]","(0.02753659337759018, 0.010183969512581825, 0.9622794985771179)",-0.979055317044275,-0.9622794985771179,0,0,"[{'label': 'negative', 'score': 0.8370503187179565}, {'label': 'neutral', 'score': 0.16127435863018036}, {'label': 'positive', 'score': 0.001675320789217949}]","(0.16127435863018036, 0.001675320789217949, 0.8370503187179565)",-0.9960050803020584,-0.8370503187179565,0,0
2020-01-30,71.38875579833984,82.53816986083984,83.13931274414062,82.25190734863281,82.96755981445312,11016471.0,,-0.012254351203773039,-0.008518541890176005,0.11227457823412058,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-01-31,70.51392364501953,81.52671813964844,82.70037841796875,81.10687255859375,82.42366027832031,9621583.0,"Position Scrimmage: Coronavirus, End-Of-Month Profit Taking Influencing Markets",0.007412623710875573,-0.012330054867409368,0.14799098486853915,"[{'label': 'neutral', 'score': 0.9998268485069275}, {'label': 'positive', 'score': 8.899361273506656e-05}, {'label': 'negative', 'score': 8.418646757490933e-05}]","(0.9998268485069275, 8.899361273506656e-05, 8.418646757490933e-05)",0.027758072126730166,8.899361273506656e-05,1,1,"[{'label': 'negative', 'score': 0.8191770315170288}, {'label': 'neutral', 'score': 0.16507022082805634}, {'label': 'positive', 'score': 0.015752742066979408}]","(0.16507022082805634, 0.015752742066979408, 0.8191770315170288)",-0.9622657076909369,-0.8191770315170288,0,0,"[{'label': 'neutral', 'score': 0.9978418350219727}, {'label': 'positive', 'score': 0.0013906137319281697}, {'label': 'negative', 'score': 0.0007675195811316371}]","(0.9978418350219727, 0.0013906137319281697, 0.0007675195811316371)",0.28871902723799214,0.0013906137319281697,1,1
2020-02-01,71.03662618001302,82.13104502360027,83.1933822631836,81.43766021728516,82.31551869710286,9657494.666666666,,0.007358081025002918,0.007385285232512652,0.16118744233611204,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-02-02,71.55932871500652,82.73537190755208,83.68638610839844,81.76844787597656,82.20737711588542,9693406.333333334,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",0.007304335135244189,0.007331142410445804,0.1697831527522191,"[{'label': 'neutral', 'score': 0.999853253364563}, {'label': 'negative', 'score': 7.668932812521234e-05}, {'label': 'positive', 'score': 7.006197120063007e-05}]","(0.999853253364563, 7.006197120063007e-05, 7.668932812521234e-05)",-0.045160465052286033,-7.668932812521234e-05,1,1,"[{'label': 'neutral', 'score': 0.9349881410598755}, {'label': 'negative', 'score': 0.03333667293190956}, {'label': 'positive', 'score': 0.03167516365647316}]","(0.9349881410598755, 0.03167516365647316, 0.03333667293190956)",-0.02555702719115775,-0.03333667293190956,1,1,"[{'label': 'neutral', 'score': 0.9995586276054382}, {'label': 'positive', 'score': 0.00029807857936248183}, {'label': 'negative', 'score': 0.00014322370407171547}]","(0.9995586276054382, 0.00029807857936248183, 0.00014322370407171547)",0.35090431457932125,0.00029807857936248183,1,1
2020-02-03,72.08203125,83.3396987915039,84.17938995361328,82.09923553466797,82.09923553466797,9729318.0,"Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates | Merck & Co shares are trading higher after the company's RECARBRIO supplemental new drug application was accepted for FDA review. | Surprise, Surprise: Stocks Wearing Their Rally Hats Despite China Market Tanking | Merck's RECARBRIO Supplemental New Drug Application Accepted for FDA Review",0.011678490256924039,0.007277787675339473,0.15585897107926097,"[{'label': 'positive', 'score': 0.9994682669639587}, {'label': 'neutral', 'score': 0.00030308065470308065}, {'label': 'negative', 'score': 0.0002286557573825121}]","(0.00030308065470308065, 0.9994682669639587, 0.0002286557573825121)",0.9995425498424861,0.9994682669639587,0,0,"[{'label': 'positive', 'score': 0.868130087852478}, {'label': 'negative', 'score': 0.09113386273384094}, {'label': 'neutral', 'score': 0.04073600843548775}]","(0.04073600843548775, 0.868130087852478, 0.09113386273384094)",0.8099921034702945,0.868130087852478,0,0,"[{'label': 'positive', 'score': 0.9941347241401672}, {'label': 'neutral', 'score': 0.004734695423394442}, {'label': 'negative', 'score': 0.0011306561063975096}]","(0.004734695423394442, 0.9941347241401672, 0.0011306561063975096)",0.9977279304016032,0.9941347241401672,0,0
2020-02-04,72.923828125,84.31298065185547,85.114501953125,84.02671813964844,84.37976837158203,15091305.0,,-0.028632880921677185,0.011610823014190771,0.15008983275641488,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2020-02-05,70.83580780029297,81.89885711669922,82.76717376708984,80.15267181396484,80.80152893066406,29290133.0,"Merck To Spin Off Slow-Growing Women's Health, Legacy, Biosimilars Businesses: What You Need To Know | Earnings Bonanza: Results Keep Pouring In, With Investors Looking Over Merck, Disney | Merck & Co shares are trading lower after the company reported worse-than-expected Q4 sales results. | The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data | Merck Reports Mixed Q4 Earnings | Merck Sees FY20 Adj. EPS $5.62-$5.77 vs $5.61 Est., Sales $48.8B-$50.3B vs $49.53B Est. | Merck & Co Q4 Adj. EPS $1.16 Beats $1.15 Estimate, Sales $11.87B Miss $11.98B Estimate | Merck To Spin Off Products From Its Women's Health, Trusted Legacy Brands And Biosimilars Business Into New Independent Publicly-Traded Co.; Co. Says Transaction Enables It To Achieve $2.4$B n Operating Efficiencies By 2024 | 10 Stocks To Watch For February 5, 2020 | Earnings Scheduled For February 5, 2020",-0.0017477053507208946,-0.029050798646550788,0.26750620356015137,"[{'label': 'negative', 'score': 0.9983745813369751}, {'label': 'positive', 'score': 0.0010071933502331376}, {'label': 'neutral', 'score': 0.0006181193166412413}]","(0.0006181193166412413, 0.0010071933502331376, 0.9983745813369751)",-0.9979843671843057,-0.9983745813369751,0,0,"[{'label': 'negative', 'score': 0.9589036703109741}, {'label': 'neutral', 'score': 0.025336816906929016}, {'label': 'positive', 'score': 0.015759438276290894}]","(0.025336816906929016, 0.015759438276290894, 0.9589036703109741)",-0.9676617733092749,-0.9589036703109741,0,0,"[{'label': 'positive', 'score': 0.6366532444953918}, {'label': 'negative', 'score': 0.2502959668636322}, {'label': 'neutral', 'score': 0.11305081844329834}]","(0.11305081844329834, 0.6366532444953918, 0.2502959668636322)",0.4356024817247037,0.6366532444953918,1,0
2020-02-06,70.71200561523438,81.75572204589844,82.28053283691406,81.35496520996094,82.08015441894531,16110170.0,"Twitter Up, Tesla Down: Strong User Numbers Help TWTR, But TSLA Selling Continues | UBS Maintains Buy on Merck & Co, Lowers Price Target to $96",-0.007002780731336635,-0.0017492343694932534,0.2613678766945762,"[{'label': 'negative', 'score': 0.9923918843269348}, {'label': 'positive', 'score': 0.007002209313213825}, {'label': 'neutral', 'score': 0.0006059895968064666}]","(0.0006059895968064666, 0.007002209313213825, 0.9923918843269348)",-0.9859870908628061,-0.9923918843269348,0,0,"[{'label': 'negative', 'score': 0.6785768270492554}, {'label': 'positive', 'score': 0.28074103593826294}, {'label': 'neutral', 'score': 0.0406821183860302}]","(0.0406821183860302, 0.28074103593826294, 0.6785768270492554)",-0.41470695632837257,-0.6785768270492554,1,0,"[{'label': 'negative', 'score': 0.861314058303833}, {'label': 'neutral', 'score': 0.10392127931118011}, {'label': 'positive', 'score': 0.03476467356085777}]","(0.10392127931118011, 0.03476467356085777, 0.861314058303833)",-0.9224071003481705,-0.861314058303833,0,0
2020-02-07,70.21682739257812,81.1832046508789,82.00381469726562,80.94465637207031,81.95610809326172,11419427.0,"The Daily Biotech Pulse: Assertio To Sell Opioid Pain Drug, Milestone Payment For Aduro, Myriad Genetics CEO Resigns",0.0022723759250322696,-0.007027415274557752,0.2525537389760323,"[{'label': 'positive', 'score': 0.7789260149002075}, {'label': 'neutral', 'score': 0.21930480003356934}, {'label': 'negative', 'score': 0.0017691976390779018}]","(0.21930480003356934, 0.7789260149002075, 0.0017691976390779018)",0.9954676354852403,0.7789260149002075,0,0,"[{'label': 'negative', 'score': 0.5826417803764343}, {'label': 'neutral', 'score': 0.3909580409526825}, {'label': 'positive', 'score': 0.026400169357657433}]","(0.3909580409526825, 0.026400169357657433, 0.5826417803764343)",-0.913305908175344,-0.5826417803764343,0,0,"[{'label': 'positive', 'score': 0.7370472550392151}, {'label': 'neutral', 'score': 0.2578795552253723}, {'label': 'negative', 'score': 0.005073224194347858}]","(0.2578795552253723, 0.7370472550392151, 0.005073224194347858)",0.986327761229316,0.7370472550392151,0,0
2020-02-08,70.37638600667317,81.36768341064453,82.01653798421223,80.97964477539062,81.69847361246745,11143279.0,"Barron's Picks And Pans: GM, Kraft Heinz, Tesla, Under Armour And More",0.0022672239399345057,0.002269797983489488,0.24096676453852275,"[{'label': 'neutral', 'score': 0.9998795986175537}, {'label': 'negative', 'score': 6.384744483511895e-05}, {'label': 'positive', 'score': 5.650354069075547e-05}]","(0.9998795986175537, 5.650354069075547e-05, 6.384744483511895e-05)",-0.06102072294858443,-6.384744483511895e-05,1,1,"[{'label': 'neutral', 'score': 0.944262683391571}, {'label': 'positive', 'score': 0.032026033848524094}, {'label': 'negative', 'score': 0.023711299523711205}]","(0.944262683391571, 0.032026033848524094, 0.023711299523711205)",0.1491771102374759,0.032026033848524094,1,1,"[{'label': 'neutral', 'score': 0.9993991851806641}, {'label': 'positive', 'score': 0.000501721806358546}, {'label': 'negative', 'score': 9.917019633576274e-05}]","(0.9993991851806641, 0.000501721806358546, 9.917019633576274e-05)",0.6699233942502194,0.000501721806358546,0,1
2020-02-09,70.53594462076823,81.55216217041016,82.02926127115886,81.01463317871094,81.44083913167317,10867131.0,The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight,0.002262095263398915,0.0022646576658843782,0.20773618906269595,"[{'label': 'neutral', 'score': 0.9997664093971252}, {'label': 'positive', 'score': 0.00017280771862715483}, {'label': 'negative', 'score': 6.077969374018721e-05}]","(0.9997664093971252, 0.00017280771862715483, 6.077969374018721e-05)",0.4795978676744411,0.00017280771862715483,1,1,"[{'label': 'positive', 'score': 0.5474108457565308}, {'label': 'neutral', 'score': 0.3726827800273895}, {'label': 'negative', 'score': 0.07990634441375732}]","(0.3726827800273895, 0.5474108457565308, 0.07990634441375732)",0.7452442060704048,0.5474108457565308,0,0,"[{'label': 'neutral', 'score': 0.9645821452140808}, {'label': 'positive', 'score': 0.03447651490569115}, {'label': 'negative', 'score': 0.0009413586813025177}]","(0.9645821452140808, 0.03447651490569115, 0.0009413586813025177)",0.9468427330065231,0.03447651490569115,0,1
2020-02-10,70.69550323486328,81.73664093017578,82.04198455810547,81.04962158203125,81.1832046508789,10590983.0,"KalVista Pharma Reports Option Deal Between Co., Merck Related To Intravitreal Diabetic Macular Edema Candidate KVD001, Future Oral DME Molecules Has Expired",-0.004786349039075885,0.0022595405778113226,0.06499073940405244,"[{'label': 'negative', 'score': 0.716349720954895}, {'label': 'positive', 'score': 0.2581571340560913}, {'label': 'neutral', 'score': 0.025493156164884567}]","(0.025493156164884567, 0.2581571340560913, 0.716349720954895)",-0.4701789264413519,-0.716349720954895,1,0,"[{'label': 'positive', 'score': 0.668304443359375}, {'label': 'neutral', 'score': 0.19048072397708893}, {'label': 'negative', 'score': 0.14121489226818085}]","(0.19048072397708893, 0.668304443359375, 0.14121489226818085)",0.6511142203695278,0.668304443359375,0,0,"[{'label': 'neutral', 'score': 0.7974430918693542}, {'label': 'negative', 'score': 0.1979021579027176}, {'label': 'positive', 'score': 0.004654770251363516}]","(0.7974430918693542, 0.004654770251363516, 0.1979021579027176)",-0.9540398810963135,-0.1979021579027176,0,1
2020-02-11,70.35713195800781,81.34542083740234,82.06106567382812,81.05915832519531,81.92748260498047,10252689.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",-0.023460466116125078,-0.004797840289724906,0.07219293683627022,"[{'label': 'positive', 'score': 0.5739247798919678}, {'label': 'negative', 'score': 0.423498272895813}, {'label': 'neutral', 'score': 0.00257693394087255}]","(0.00257693394087255, 0.5739247798919678, 0.423498272895813)",0.15081514967567194,0.5739247798919678,0,0,"[{'label': 'neutral', 'score': 0.8345738649368286}, {'label': 'positive', 'score': 0.1514112502336502}, {'label': 'negative', 'score': 0.014014948159456253}]","(0.8345738649368286, 0.1514112502336502, 0.014014948159456253)",0.8305595087647221,0.1514112502336502,0,0,"[{'label': 'positive', 'score': 0.971515953540802}, {'label': 'neutral', 'score': 0.02762872725725174}, {'label': 'negative', 'score': 0.0008553454536013305}]","(0.02762872725725174, 0.971515953540802, 0.0008553454536013305)",0.9982407019736476,0.971515953540802,0,0
2020-02-12,68.70651245117188,79.43701934814453,81.32633972167969,79.1030502319336,81.14503479003906,19630926.0,Merck Says Keytruda In Combination With Chemotherapy Met Primary Endpoint Of Progression-Free Survival As First-Line Treatment For Metastatic Triple-Negative Breast Cancer,-0.015375285884927242,-0.023740044196764214,0.1787972493425109,"[{'label': 'neutral', 'score': 0.9997705817222595}, {'label': 'positive', 'score': 0.0001842329656938091}, {'label': 'negative', 'score': 4.5210916141513735e-05}]","(0.9997705817222595, 0.0001842329656938091, 4.5210916141513735e-05)",0.6059087234763344,0.0001842329656938091,0,1,"[{'label': 'positive', 'score': 0.8314087390899658}, {'label': 'neutral', 'score': 0.1603395789861679}, {'label': 'negative', 'score': 0.008251737803220749}]","(0.1603395789861679, 0.8314087390899658, 0.008251737803220749)",0.980345060818504,0.8314087390899658,0,0,"[{'label': 'neutral', 'score': 0.996442973613739}, {'label': 'positive', 'score': 0.0033442657440900803}, {'label': 'negative', 'score': 0.00021269512944854796}]","(0.996442973613739, 0.0033442657440900803, 0.00021269512944854796)",0.8804062585951646,0.0033442657440900803,0,1
2020-02-13,67.65013122558594,78.21565246582031,79.13167572021484,77.71946716308594,79.13167572021484,19388734.0,,0.00829564756988034,-0.015494711307734561,0.181821430838104,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-02-14,68.21134185791016,78.864501953125,79.00763702392578,77.92938995361328,78.46373748779297,8743464.0,"Ervebo Now Registered In Four African Countries, Within 90 Days Of Reference Country Approval And WHO Prequalification",-0.0005747113649238923,0.00826142780539565,0.20628401151329517,"[{'label': 'neutral', 'score': 0.9991244673728943}, {'label': 'positive', 'score': 0.000822501431684941}, {'label': 'negative', 'score': 5.2982388297095895e-05}]","(0.9991244673728943, 0.000822501431684941, 5.2982388297095895e-05)",0.8789643232968418,0.000822501431684941,0,1,"[{'label': 'neutral', 'score': 0.878635048866272}, {'label': 'positive', 'score': 0.11255688220262527}, {'label': 'negative', 'score': 0.00880810059607029}]","(0.878635048866272, 0.11255688220262527, 0.00880810059607029)",0.8548493907722952,0.11255688220262527,0,1,"[{'label': 'positive', 'score': 0.9982848763465881}, {'label': 'neutral', 'score': 0.0015030049253255129}, {'label': 'negative', 'score': 0.00021207565441727638}]","(0.0015030049253255129, 0.9982848763465881, 0.00021207565441727638)",0.9995752102117242,0.9982848763465881,0,0
2020-02-15,68.17213821411133,78.81917762756348,79.08158683776855,78.07013320922852,78.61879539489746,9061925.0,,-0.00057504184800925,-0.0005748765748021118,0.1993925599844077,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-02-16,68.1329345703125,78.77385330200195,79.15553665161133,78.21087646484375,78.77385330200195,9380386.0,"The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions",-0.0005753727113965056,-0.0005752072479837307,0.20486813503531875,"[{'label': 'neutral', 'score': 0.9997461438179016}, {'label': 'negative', 'score': 0.00016928226978052408}, {'label': 'positive', 'score': 8.464892016490921e-05}]","(0.9997461438179016, 8.464892016490921e-05, 0.00016928226978052408)",-0.33329245467562113,-0.00016928226978052408,1,1,"[{'label': 'neutral', 'score': 0.9400288462638855}, {'label': 'positive', 'score': 0.04416680335998535}, {'label': 'negative', 'score': 0.015804285183548927}]","(0.9400288462638855, 0.04416680335998535, 0.015804285183548927)",0.47293652433618033,0.04416680335998535,1,1,"[{'label': 'neutral', 'score': 0.999427318572998}, {'label': 'positive', 'score': 0.0004645284789148718}, {'label': 'negative', 'score': 0.00010817169822985306}]","(0.999427318572998, 0.0004645284789148718, 0.00010817169822985306)",0.6222396899922125,0.0004645284789148718,0,1
2020-02-17,68.09373092651367,78.72852897644043,79.2294864654541,78.35161972045898,78.92891120910645,9698847.0,,-0.0005757039557424828,-0.0005755383017955366,0.13592821643335304,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-02-18,68.05452728271484,78.6832046508789,79.30343627929688,78.49236297607422,79.08396911621094,10017308.0,,-0.0055784039138324654,-0.0005758697368950939,0.0627350623397896,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-02-19,67.67488861083984,78.24427795410156,79.30343627929688,77.83396911621094,79.27481079101562,11740220.0,"Elanco Signs Agreement with Merck Animal Health to Divest Worldwide Rights for Vecoxan | The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA | Merck Receives CRL from FDA for sBLAs for KEYTRUDA Six-Week Dosing Schedule",0.005975544759105093,-0.00559402131614433,0.03562886934028855,"[{'label': 'positive', 'score': 0.9978442192077637}, {'label': 'neutral', 'score': 0.0014822452794760466}, {'label': 'negative', 'score': 0.000673540635034442}]","(0.0014822452794760466, 0.9978442192077637, 0.000673540635034442)",0.9986509190679984,0.9978442192077637,1,1,"[{'label': 'neutral', 'score': 0.5654959678649902}, {'label': 'positive', 'score': 0.36552563309669495}, {'label': 'negative', 'score': 0.06897842139005661}]","(0.5654959678649902, 0.36552563309669495, 0.06897842139005661)",0.6824958447325152,0.36552563309669495,1,0,"[{'label': 'positive', 'score': 0.9112395644187927}, {'label': 'neutral', 'score': 0.08391457796096802}, {'label': 'negative', 'score': 0.00484584691002965}]","(0.08391457796096802, 0.9112395644187927, 0.00484584691002965)",0.9894205347010154,0.9112395644187927,1,1
2020-02-20,68.07927703857422,78.71183013916016,79.03626251220703,77.97709655761719,78.4542007446289,10941330.0,"Why Merck Has Had Underwhelming Start To 2020 | The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study",-0.0018183726785821772,0.005957761997482111,0.06516782792378385,"[{'label': 'negative', 'score': 0.9973969459533691}, {'label': 'positive', 'score': 0.0016422157641500235}, {'label': 'neutral', 'score': 0.0009608456748537719}]","(0.0009608456748537719, 0.0016422157641500235, 0.9973969459533691)",-0.9967124096290144,-0.9973969459533691,0,0,"[{'label': 'negative', 'score': 0.43308040499687195}, {'label': 'neutral', 'score': 0.4267021417617798}, {'label': 'positive', 'score': 0.14021742343902588}]","(0.4267021417617798, 0.14021742343902588, 0.43308040499687195)",-0.5108391607846322,-0.43308040499687195,0,1,"[{'label': 'negative', 'score': 0.9988240599632263}, {'label': 'neutral', 'score': 0.0007870423141866922}, {'label': 'positive', 'score': 0.0003889042418450117}]","(0.0007870423141866922, 0.0003889042418450117, 0.9988240599632263)",-0.9992215788710179,-0.9988240599632263,0,0
2020-02-21,67.95549011230469,78.5687026977539,78.84542083740234,77.96755981445312,78.42557525634766,9295970.0,,-0.004088725131432154,-0.0018200279250556387,0.06612421378628631,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-02-22,67.67763264973958,78.24745686848958,78.83269755045573,77.60496266682942,77.92302958170573,10775361.666666666,"Benzinga's Bulls And Bears Of The Week: Merck, Nike, Target And More",-0.004105511439230939,-0.004097106822788631,0.07086187188146711,"[{'label': 'neutral', 'score': 0.9998691082000732}, {'label': 'negative', 'score': 6.662723171757534e-05}, {'label': 'positive', 'score': 6.419166311388835e-05}]","(0.9998691082000732, 6.419166311388835e-05, 6.662723171757534e-05)",-0.01861786561356274,-6.662723171757534e-05,1,1,"[{'label': 'neutral', 'score': 0.9399361610412598}, {'label': 'positive', 'score': 0.0363977812230587}, {'label': 'negative', 'score': 0.02366604097187519}]","(0.9399361610412598, 0.0363977812230587, 0.02366604097187519)",0.211970197465345,0.0363977812230587,1,1,"[{'label': 'neutral', 'score': 0.9994931221008301}, {'label': 'positive', 'score': 0.00038922729436308146}, {'label': 'negative', 'score': 0.00011759341577999294}]","(0.9994931221008301, 0.00038922729436308146, 0.00011759341577999294)",0.5359565486311852,0.00038922729436308146,0,1
2020-02-23,67.39977518717448,77.92621103922527,78.81997426350911,77.24236551920573,77.4204839070638,12254753.333333332,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,-0.00412243614799421,-0.004113962189017097,0.07322946696498127,"[{'label': 'positive', 'score': 0.9995720982551575}, {'label': 'negative', 'score': 0.00022649196034763008}, {'label': 'neutral', 'score': 0.00020135681552346796}]","(0.00020135681552346796, 0.9995720982551575, 0.00022649196034763008)",0.9995469248255315,0.9995720982551575,0,0,"[{'label': 'positive', 'score': 0.9313042759895325}, {'label': 'negative', 'score': 0.04808949679136276}, {'label': 'neutral', 'score': 0.02060621604323387}]","(0.02060621604323387, 0.9313042759895325, 0.04808949679136276)",0.9017974217769075,0.9313042759895325,0,0,"[{'label': 'positive', 'score': 0.998910665512085}, {'label': 'neutral', 'score': 0.0006635101744905114}, {'label': 'negative', 'score': 0.0004258170956745744}]","(0.0006635101744905114, 0.998910665512085, 0.0004258170956745744)",0.9991478003593677,0.998910665512085,0,0
2020-02-24,67.12191772460938,77.60496520996094,78.8072509765625,76.87976837158203,76.91793823242188,13734145.0,What Drove Merck's Keytruda Shortfall In Q4,-0.013033337731096386,-0.0041309568132193485,0.06925049251469907,"[{'label': 'negative', 'score': 0.9971581697463989}, {'label': 'neutral', 'score': 0.0022809323854744434}, {'label': 'positive', 'score': 0.0005609281361103058}]","(0.0022809323854744434, 0.0005609281361103058, 0.9971581697463989)",-0.9988755790336162,-0.9971581697463989,1,1,"[{'label': 'negative', 'score': 0.5052750706672668}, {'label': 'neutral', 'score': 0.46433061361312866}, {'label': 'positive', 'score': 0.030394334346055984}]","(0.46433061361312866, 0.030394334346055984, 0.5052750706672668)",-0.8865183112509476,-0.5052750706672668,1,1,"[{'label': 'negative', 'score': 0.9390298128128052}, {'label': 'neutral', 'score': 0.05933811888098717}, {'label': 'positive', 'score': 0.001631938386708498}]","(0.05933811888098717, 0.001631938386708498, 0.9390298128128052)",-0.9965302333498147,-0.9390298128128052,1,1
2020-02-25,66.24710845947266,76.59351348876953,78.18701934814453,76.1927490234375,77.7957992553711,13171683.0,,-0.004111157539919506,-0.01311901694899032,0.06980521165961928,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-02-26,65.97476959228516,76.27862548828125,77.89122009277344,76.11640930175781,76.96565246582031,11940283.0,"The Daily Biotech Pulse: Menlo Flunks Midstage Trial, GW Pharma's Earnings, COVID-19 Updates",-0.023267472108399367,-0.0041196315814661846,0.06391953158458537,"[{'label': 'neutral', 'score': 0.7737674713134766}, {'label': 'negative', 'score': 0.22532540559768677}, {'label': 'positive', 'score': 0.0009070947417058051}]","(0.7737674713134766, 0.0009070947417058051, 0.22532540559768677)",-0.9919808626935123,-0.22532540559768677,1,0,"[{'label': 'neutral', 'score': 0.9269061088562012}, {'label': 'positive', 'score': 0.05247294157743454}, {'label': 'negative', 'score': 0.020620975643396378}]","(0.9269061088562012, 0.05247294157743454, 0.020620975643396378)",0.43576766911817283,0.05247294157743454,0,0,"[{'label': 'neutral', 'score': 0.999413013458252}, {'label': 'positive', 'score': 0.00041577679803594947}, {'label': 'negative', 'score': 0.00017115224909503013}]","(0.999413013458252, 0.00041577679803594947, 0.00017115224909503013)",0.4167872592721224,0.00041577679803594947,0,0
2020-02-27,64.439697265625,74.50381469726562,78.00572204589844,74.42748260498047,77.01335906982422,15734253.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",-0.019467169887369278,-0.023542433211453478,0.1366973659791159,"[{'label': 'positive', 'score': 0.9979040622711182}, {'label': 'neutral', 'score': 0.0017837161431089044}, {'label': 'negative', 'score': 0.0003122132329735905}]","(0.0017837161431089044, 0.9979040622711182, 0.0003122132329735905)",0.9993744577389987,0.9979040622711182,0,0,"[{'label': 'neutral', 'score': 0.5340954065322876}, {'label': 'positive', 'score': 0.44724878668785095}, {'label': 'negative', 'score': 0.018655799329280853}]","(0.5340954065322876, 0.44724878668785095, 0.018655799329280853)",0.9199157943957441,0.44724878668785095,0,1,"[{'label': 'positive', 'score': 0.9341344833374023}, {'label': 'neutral', 'score': 0.06551102548837662}, {'label': 'negative', 'score': 0.00035451684379950166}]","(0.06551102548837662, 0.9341344833374023, 0.00035451684379950166)",0.9992412605311978,0.9341344833374023,0,0
2020-02-28,63.18525314331055,73.05343627929688,73.94084167480469,70.78244018554688,73.16793823242188,29246117.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,0.020942164146630592,-0.019659150874530452,0.14042109252237428,"[{'label': 'negative', 'score': 0.9985301494598389}, {'label': 'neutral', 'score': 0.0009677583002485335}, {'label': 'positive', 'score': 0.0005020400276407599}]","(0.0009677583002485335, 0.0005020400276407599, 0.9985301494598389)",-0.9989949472440957,-0.9985301494598389,0,0,"[{'label': 'negative', 'score': 0.9733036160469055}, {'label': 'neutral', 'score': 0.018505269661545753}, {'label': 'positive', 'score': 0.008191188797354698}]","(0.018505269661545753, 0.008191188797354698, 0.9733036160469055)",-0.9833087475207687,-0.9733036160469055,0,0,"[{'label': 'negative', 'score': 0.9987421631813049}, {'label': 'neutral', 'score': 0.0009257349302060902}, {'label': 'positive', 'score': 0.00033216841984540224}]","(0.0009257349302060902, 0.00033216841984540224, 0.9987421631813049)",-0.9993350476349181,-0.9987421631813049,0,0
2020-02-29,64.50848134358723,74.58333333333333,75.23219045003255,71.704833984375,73.31106821695964,25777586.33333333,,0.020512586199371637,0.020725891296608474,0.2799415714161351,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-01,65.83170954386394,76.1132303873698,76.52353922526042,72.62722778320312,73.45419820149739,22309055.666666668,,0.020100277524028518,0.020305036557088364,0.3359665553159208,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-02,67.15493774414062,77.64312744140625,77.81488800048828,73.54962158203125,73.59732818603516,18840525.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates | Merck shares are trading higher after the company's KEYNOTE-204 of KEYTRUDA met one of its primary endpoints of progression-free survival. | Merck Announces New Data from Broad HIV Program at CROI 2020 | A Peek Into The Markets: US Stock Futures Down Ahead Of Manufacturing Reports | Merck's Phase 3 KEYNOTE-204 Trial of KEYTRUDA Met One of its Primary Endpoints,-0.027528584511498658,0.019900933762007845,0.36509298055043365,"[{'label': 'positive', 'score': 0.999066174030304}, {'label': 'neutral', 'score': 0.0006111182156018913}, {'label': 'negative', 'score': 0.00032273074612021446}]","(0.0006111182156018913, 0.999066174030304, 0.00032273074612021446)",0.9993541438281378,0.999066174030304,0,0,"[{'label': 'positive', 'score': 0.9394901394844055}, {'label': 'negative', 'score': 0.03273900970816612}, {'label': 'neutral', 'score': 0.027770811691880226}]","(0.027770811691880226, 0.9394901394844055, 0.03273900970816612)",0.9326516598780121,0.9394901394844055,0,0,"[{'label': 'positive', 'score': 0.9503344893455505}, {'label': 'neutral', 'score': 0.04477363079786301}, {'label': 'negative', 'score': 0.004891944583505392}]","(0.04477363079786301, 0.9503344893455505, 0.004891944583505392)",0.9897575184066384,0.9503344893455505,0,0
2020-03-03,65.30626678466797,75.50572204589844,78.6259536743164,74.34160614013672,77.6717529296875,17394599.0,,0.04852775969652871,-0.027914596735393267,0.38623719338659146,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-04,68.47543334960938,79.16984558105469,79.26526641845703,76.22137451171875,77.76717376708984,20224199.0,"FDA Issues Warning On Merck's Singulair, Warns Of Mental Health Side Effects | Shares of several healthcare-related companies are trading higher after Joe Biden secured several key wins in Super Tuesday. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.",-0.01675299582247192,0.0473870466379087,0.4325395939895893,"[{'label': 'positive', 'score': 0.9995874762535095}, {'label': 'negative', 'score': 0.0003235384647268802}, {'label': 'neutral', 'score': 8.89930161065422e-05}]","(8.89930161065422e-05, 0.9995874762535095, 0.0003235384647268802)",0.999352865485099,0.9995874762535095,0,0,"[{'label': 'positive', 'score': 0.9448050856590271}, {'label': 'negative', 'score': 0.030176520347595215}, {'label': 'neutral', 'score': 0.02501843310892582}]","(0.02501843310892582, 0.9448050856590271, 0.030176520347595215)",0.9380982776255776,0.9448050856590271,0,0,"[{'label': 'positive', 'score': 0.9942833781242371}, {'label': 'neutral', 'score': 0.004694035742431879}, {'label': 'negative', 'score': 0.0010225058067589998}]","(0.004694035742431879, 0.9942833781242371, 0.0010225058067589998)",0.9979453435908153,0.9942833781242371,0,0
2020-03-05,67.32828521728516,77.84351348876953,78.97901153564453,77.23282623291016,77.7957992553711,15017840.0,,0.007599843381009996,-0.016894914532192048,0.48621437194007444,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-06,67.83995056152344,78.43511199951172,78.83587646484375,75.79198455810547,76.3072509765625,14208574.0,,-0.013138667245359168,0.0075711100586422905,0.4751073704279773,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-07,66.94862365722656,77.40457916259766,78.23155212402344,75.01590220133464,75.68066151936848,15786652.666666666,"Barron's Picks And Pans: Coronavirus Picks, Bonds, Safe Havens And More",-0.013313590075198315,-0.013225743081792495,0.47228617285726066,"[{'label': 'neutral', 'score': 0.9998482465744019}, {'label': 'positive', 'score': 8.281510235974565e-05}, {'label': 'negative', 'score': 6.893549289088696e-05}]","(0.9998482465744019, 8.281510235974565e-05, 6.893549289088696e-05)",0.09146329505946915,8.281510235974565e-05,1,1,"[{'label': 'neutral', 'score': 0.9354087114334106}, {'label': 'positive', 'score': 0.03272760659456253}, {'label': 'negative', 'score': 0.031863629817962646}]","(0.9354087114334106, 0.03272760659456253, 0.031863629817962646)",0.013376068095088305,0.03272760659456253,1,1,"[{'label': 'neutral', 'score': 0.9994644522666931}, {'label': 'positive', 'score': 0.00042588129872456193}, {'label': 'negative', 'score': 0.00010972885502269492}]","(0.9994644522666931, 0.00042588129872456193, 0.00010972885502269492)",0.5902659639478245,0.00042588129872456193,0,1
2020-03-08,66.05729675292969,76.3740463256836,77.62722778320312,74.2398198445638,75.05407206217448,17364731.333333332,,-0.01349323345419644,-0.013403010473418582,0.42866341148089904,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-09,65.16596984863281,75.34351348876953,77.02290344238281,73.46373748779297,74.42748260498047,18942810.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,0.038753775153980714,-0.013585094398739846,0.15696505204667038,"[{'label': 'neutral', 'score': 0.9997770190238953}, {'label': 'negative', 'score': 0.00011669763625832275}, {'label': 'positive', 'score': 0.00010628977906890213}]","(0.9997770190238953, 0.00010628977906890213, 0.00011669763625832275)",-0.046674639347460516,-0.00011669763625832275,0,0,"[{'label': 'neutral', 'score': 0.8271929025650024}, {'label': 'negative', 'score': 0.11482252180576324}, {'label': 'positive', 'score': 0.05798456817865372}]","(0.8271929025650024, 0.05798456817865372, 0.11482252180576324)",-0.3289098475776367,-0.11482252180576324,0,0,"[{'label': 'neutral', 'score': 0.9937340617179871}, {'label': 'positive', 'score': 0.005958708934485912}, {'label': 'negative', 'score': 0.0003073423577006906}]","(0.9937340617179871, 0.005958708934485912, 0.0003073423577006906)",0.9019023805043127,0.005958708934485912,1,0
2020-03-10,67.69140625,78.26335906982422,78.41603088378906,73.95037841796875,76.79389190673828,17527486.0,CDC's Redfield Says Will Know By April If Ebola-Tied Drug Helps Coronavirus,-0.033772220778923265,0.038021701504845344,0.35817165990979033,"[{'label': 'neutral', 'score': 0.9972527623176575}, {'label': 'positive', 'score': 0.0025565102696418762}, {'label': 'negative', 'score': 0.00019065845117438585}]","(0.9972527623176575, 0.0025565102696418762, 0.00019065845117438585)",0.8611964021505488,0.0025565102696418762,0,1,"[{'label': 'neutral', 'score': 0.8285749554634094}, {'label': 'positive', 'score': 0.15847647190093994}, {'label': 'negative', 'score': 0.012948557734489441}]","(0.8285749554634094, 0.15847647190093994, 0.012948557734489441)",0.848930371929616,0.15847647190093994,0,1,"[{'label': 'neutral', 'score': 0.9957356452941895}, {'label': 'positive', 'score': 0.004080096259713173}, {'label': 'negative', 'score': 0.00018422637367621064}]","(0.9957356452941895, 0.004080096259713173, 0.00018422637367621064)",0.9135964186979055,0.004080096259713173,0,1
2020-03-11,65.40531921386719,75.62023162841797,76.4885482788086,74.45610809326172,76.17366027832031,14274179.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,-0.06056784434952851,-0.034355676270085664,0.4272815818328484,"[{'label': 'negative', 'score': 0.9981491565704346}, {'label': 'neutral', 'score': 0.0014238021103665233}, {'label': 'positive', 'score': 0.0004270085191819817}]","(0.0014238021103665233, 0.0004270085191819817, 0.9981491565704346)",-0.9991447652485403,-0.9981491565704346,0,0,"[{'label': 'negative', 'score': 0.9720318913459778}, {'label': 'neutral', 'score': 0.019217029213905334}, {'label': 'positive', 'score': 0.008751136250793934}]","(0.019217029213905334, 0.008751136250793934, 0.9720318913459778)",-0.9821547967194396,-0.9720318913459778,0,0,"[{'label': 'negative', 'score': 0.9981385469436646}, {'label': 'neutral', 'score': 0.0015602682251483202}, {'label': 'positive', 'score': 0.00030118616996333003}]","(0.0015602682251483202, 0.00030118616996333003, 0.9981385469436646)",-0.9993966863297316,-0.9981385469436646,0,0
2020-03-12,61.4438591003418,71.04007720947266,74.48473358154297,69.90457916259766,70.99236297607422,22664782.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO | Merck & Co shares are trading lower after the company announced its Phase 3 GY004 trial for Cediranib and LYNPARZA did not meet its primary endpoint. | WebMD Acquires Merck Subsidiary Staywell | AstraZeneca and Merck Announce Phase 3 GY004 for Cediranib and LYNPARZA in Platinum-Sensitive Relapsed Ovarian Cancer Did Not Meet the Primary Endpoint of Progression-Free Survival vs. Platinum-Based Chemotherapy",0.03089321490458166,-0.062479675987347244,0.5844255325753378,"[{'label': 'negative', 'score': 0.997958779335022}, {'label': 'neutral', 'score': 0.0015960653545334935}, {'label': 'positive', 'score': 0.00044513936154544353}]","(0.0015960653545334935, 0.00044513936154544353, 0.997958779335022)",-0.9991082980480954,-0.997958779335022,0,0,"[{'label': 'negative', 'score': 0.9678301811218262}, {'label': 'neutral', 'score': 0.019966790452599525}, {'label': 'positive', 'score': 0.012203014455735683}]","(0.019966790452599525, 0.012203014455735683, 0.9678301811218262)",-0.9750967324151829,-0.9678301811218262,0,0,"[{'label': 'negative', 'score': 0.9968233108520508}, {'label': 'neutral', 'score': 0.002719257026910782}, {'label': 'positive', 'score': 0.00045746503747068346}]","(0.002719257026910782, 0.00045746503747068346, 0.9968233108520508)",-0.9990825752415359,-0.9968233108520508,0,0
2020-03-13,63.865325927734375,73.23473358154297,73.6927490234375,68.95037841796875,72.72901153564453,25857094.0,"Intec Pharma Posts Q4 Net Loss Of $6.6M, Down By Nearly Half Year-Over-Year | Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.",-0.029663400813464667,0.030425625378280214,0.6775829228948907,"[{'label': 'negative', 'score': 0.9979944229125977}, {'label': 'positive', 'score': 0.0016013261629268527}, {'label': 'neutral', 'score': 0.00040422313031740487}]","(0.00040422313031740487, 0.0016013261629268527, 0.9979944229125977)",-0.9967960524753975,-0.9979944229125977,0,0,"[{'label': 'negative', 'score': 0.9722683429718018}, {'label': 'neutral', 'score': 0.0165046788752079}, {'label': 'positive', 'score': 0.01122693344950676}]","(0.0165046788752079, 0.01122693344950676, 0.9722683429718018)",-0.9771693190223368,-0.9722683429718018,0,0,"[{'label': 'negative', 'score': 0.987828254699707}, {'label': 'neutral', 'score': 0.010506139136850834}, {'label': 'positive', 'score': 0.0016656189691275358}]","(0.010506139136850834, 0.0016656189691275358, 0.987828254699707)",-0.9966333920533499,-0.987828254699707,0,0
2020-03-14,61.97085952758789,71.06234232584636,73.33015441894531,67.31551869710286,70.99554951985677,24174180.666666668,"Barron's Picks And Pans: Roundtable Picks, Airline And Oil Stocks, And More",-0.03057021742592483,-0.03011225820791507,0.6954811187946507,"[{'label': 'neutral', 'score': 0.9998708963394165}, {'label': 'negative', 'score': 6.679888610960916e-05}, {'label': 'positive', 'score': 6.231395673239604e-05}]","(0.9998708963394165, 6.231395673239604e-05, 6.679888610960916e-05)",-0.03473650861131846,-6.679888610960916e-05,1,1,"[{'label': 'neutral', 'score': 0.9352402091026306}, {'label': 'negative', 'score': 0.04041295498609543}, {'label': 'positive', 'score': 0.024346882477402687}]","(0.9352402091026306, 0.024346882477402687, 0.04041295498609543)",-0.2480869801093677,-0.04041295498609543,1,1,"[{'label': 'neutral', 'score': 0.999372661113739}, {'label': 'positive', 'score': 0.0005250376416370273}, {'label': 'negative', 'score': 0.0001023608710966073}]","(0.999372661113739, 0.0005250376416370273, 0.0001023608710966073)",0.6736974378513862,0.0005250376416370273,0,1
2020-03-15,60.076393127441406,68.88995107014973,72.96755981445312,65.68065897623698,69.26208750406902,22491267.33333333,,-0.03153422555757794,-0.031047233354455216,0.5398289015934745,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-16,58.18192672729492,66.71755981445312,72.60496520996094,64.0457992553711,67.52862548828125,20808354.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,0.06521735650107195,-0.03204213548700798,0.5376872316292115,"[{'label': 'negative', 'score': 0.9988287091255188}, {'label': 'neutral', 'score': 0.0006423593149520457}, {'label': 'positive', 'score': 0.0005289358668960631}]","(0.0006423593149520457, 0.0005289358668960631, 0.9988287091255188)",-0.9989414483002227,-0.9988287091255188,0,0,"[{'label': 'negative', 'score': 0.9730124473571777}, {'label': 'neutral', 'score': 0.01924378238618374}, {'label': 'positive', 'score': 0.007743767462670803}]","(0.01924378238618374, 0.007743767462670803, 0.9730124473571777)",-0.9842085783487118,-0.9730124473571777,0,0,"[{'label': 'negative', 'score': 0.9986670017242432}, {'label': 'neutral', 'score': 0.001025605946779251}, {'label': 'positive', 'score': 0.0003074013802688569}]","(0.001025605946779251, 0.0003074013802688569, 0.9986670017242432)",-0.9993845660523162,-0.9986670017242432,0,0
2020-03-17,61.97640609741211,71.0687026977539,72.58587646484375,68.11068725585938,68.36832427978516,24745795.0,"Shares of several healthcare companies are trading higher, rebounding from Monday's crash. Stocks may also potentially be getting a boost from expectations of further stimulus proposals. | The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment | Merck Announces Top-Line Results From Phase 3 Trials Evaluating Gefapixant For Refractory Of Unexplained Chronic Cough; Gefapixant Demonstrated Statistically Significant Decrease In 24-Hour Coughs Per Hour Compared To Placebo At Week 12 And 24",-0.038265327209524046,0.06317886894906792,0.7016565222909515,"[{'label': 'positive', 'score': 0.9996758699417114}, {'label': 'negative', 'score': 0.000227735610678792}, {'label': 'neutral', 'score': 9.640707139624283e-05}]","(9.640707139624283e-05, 0.9996758699417114, 0.000227735610678792)",0.9995444848695131,0.9996758699417114,0,0,"[{'label': 'positive', 'score': 0.9232978820800781}, {'label': 'negative', 'score': 0.0549691841006279}, {'label': 'neutral', 'score': 0.02173294499516487}]","(0.02173294499516487, 0.9232978820800781, 0.0549691841006279)",0.8876192688051221,0.9232978820800781,0,0,"[{'label': 'positive', 'score': 0.9980500936508179}, {'label': 'neutral', 'score': 0.001450069947168231}, {'label': 'negative', 'score': 0.0004998797085136175}]","(0.001450069947168231, 0.9980500936508179, 0.0004998797085136175)",0.9989987888000599,0.9980500936508179,0,0
2020-03-18,59.6048698425293,68.34923553466797,71.2404556274414,65.67748260498047,68.17748260498047,18558508.0,,-0.012564586867851269,-0.039016674268535355,0.6854570838041949,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-19,58.85594177246094,67.4904556274414,69.52290344238281,65.75381469726562,68.08206176757812,19268738.0,,0.00890719298168268,-0.012644188768963147,0.6703317063324651,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-20,59.38019561767578,68.09160614013672,69.17938995361328,65.36259460449219,66.364501953125,23075912.0,,-0.023168916607086257,0.008867757935657226,0.6522040755016549,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-21,58.00442250569662,66.51399739583333,68.8963114420573,64.3288803100586,66.59351094563802,21508942.33333333,,-0.02371844733545067,-0.023441535036623214,0.63000105052172,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-22,56.628649393717446,64.93638865152995,68.6132329305013,63.295166015625,66.82251993815105,19941972.666666668,Merck Donates a Half a Million Masks to Support COVID-19 Emergency Response in New York City,-0.024294679409558147,-0.024004258079544837,0.2815109928765469,"[{'label': 'neutral', 'score': 0.9984435439109802}, {'label': 'positive', 'score': 0.0013795499689877033}, {'label': 'negative', 'score': 0.00017687851504888386}]","(0.9984435439109802, 0.0013795499689877033, 0.00017687851504888386)",0.7727123130127372,0.0013795499689877033,0,1,"[{'label': 'positive', 'score': 0.7384045720100403}, {'label': 'neutral', 'score': 0.25293442606925964}, {'label': 'negative', 'score': 0.008661013096570969}]","(0.25293442606925964, 0.7384045720100403, 0.008661013096570969)",0.9768132456661486,0.7384045720100403,0,0,"[{'label': 'neutral', 'score': 0.9269043803215027}, {'label': 'positive', 'score': 0.07198046147823334}, {'label': 'negative', 'score': 0.0011151161743327975}]","(0.9269043803215027, 0.07198046147823334, 0.0011151161743327975)",0.9694888197030713,0.07198046147823334,0,1
2020-03-23,55.25287628173828,63.35877990722656,68.33015441894531,62.261451721191406,67.05152893066406,18375003.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,0.03990963039351142,-0.02459466378230967,0.22721628528635668,"[{'label': 'negative', 'score': 0.9979221224784851}, {'label': 'neutral', 'score': 0.0016150703886523843}, {'label': 'positive', 'score': 0.00046293751802295446}]","(0.0016150703886523843, 0.00046293751802295446, 0.9979221224784851)",-0.9990726273127032,-0.9979221224784851,0,0,"[{'label': 'negative', 'score': 0.9696812629699707}, {'label': 'neutral', 'score': 0.021164605394005775}, {'label': 'positive', 'score': 0.009154039435088634}]","(0.021164605394005775, 0.009154039435088634, 0.9696812629699707)",-0.9812960578503931,-0.9696812629699707,0,0,"[{'label': 'negative', 'score': 0.9972483515739441}, {'label': 'neutral', 'score': 0.0023912854958325624}, {'label': 'positive', 'score': 0.0003602849319577217}]","(0.0023912854958325624, 0.0003602849319577217, 0.9972483515739441)",-0.9992777028610746,-0.9972483515739441,0,0
2020-03-24,57.4579963684082,65.88740539550781,66.55534362792969,64.11259460449219,65.83015441894531,19901939.0,"10 Biggest Price Target Changes For Tuesday | Argus Research Maintains Buy on Merck & Co, Lowers Price Target to $95 | The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",-0.012020272362393952,0.03913381552539887,0.45075821779560604,"[{'label': 'negative', 'score': 0.9250636696815491}, {'label': 'positive', 'score': 0.07313336431980133}, {'label': 'neutral', 'score': 0.0018029508646577597}]","(0.0018029508646577597, 0.07313336431980133, 0.9250636696815491)",-0.8534690810958623,-0.9250636696815491,0,0,"[{'label': 'neutral', 'score': 0.7615175843238831}, {'label': 'positive', 'score': 0.18509691953659058}, {'label': 'negative', 'score': 0.05338555574417114}]","(0.7615175843238831, 0.18509691953659058, 0.05338555574417114)",0.5522894864176401,0.18509691953659058,0,1,"[{'label': 'negative', 'score': 0.4679553508758545}, {'label': 'neutral', 'score': 0.395920991897583}, {'label': 'positive', 'score': 0.1361236423254013}]","(0.395920991897583, 0.1361236423254013, 0.4679553508758545)",-0.5493184041907242,-0.4679553508758545,0,1
2020-03-25,56.76732635498047,65.09542083740234,67.15648651123047,63.6927490234375,65.27671813964844,18311494.0,UPS Seeks To Accelerate Growth Of Drone-Delivery,0.07783643279267086,-0.012093100030197321,0.4349811191028651,"[{'label': 'positive', 'score': 0.9995833039283752}, {'label': 'negative', 'score': 0.00021589080279227346}, {'label': 'neutral', 'score': 0.00020076389773748815}]","(0.00020076389773748815, 0.9995833039283752, 0.00021589080279227346)",0.99956813167298,0.9995833039283752,1,1,"[{'label': 'positive', 'score': 0.8496605157852173}, {'label': 'neutral', 'score': 0.14319342374801636}, {'label': 'negative', 'score': 0.0071461498737335205}]","(0.14319342374801636, 0.8496605157852173, 0.0071461498737335205)",0.9833191076583477,0.8496605157852173,1,1,"[{'label': 'positive', 'score': 0.9875078797340393}, {'label': 'neutral', 'score': 0.012204861268401146}, {'label': 'negative', 'score': 0.0002872782642953098}]","(0.012204861268401146, 0.9875078797340393, 0.0002872782642953098)",0.9994183444574127,0.9875078797340393,1,1
2020-03-26,61.18588638305664,70.16221618652344,70.78244018554688,64.98091888427734,65.01908111572266,18052848.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",-0.02447983983127131,0.07495572887105145,0.7057867024018475,"[{'label': 'positive', 'score': 0.9996458292007446}, {'label': 'negative', 'score': 0.00020190489885862917}, {'label': 'neutral', 'score': 0.0001522560341982171}]","(0.0001522560341982171, 0.9996458292007446, 0.00020190489885862917)",0.9995961287064565,0.9996458292007446,0,0,"[{'label': 'positive', 'score': 0.9245803952217102}, {'label': 'negative', 'score': 0.04909573867917061}, {'label': 'neutral', 'score': 0.026323800906538963}]","(0.026323800906538963, 0.9245803952217102, 0.04909573867917061)",0.899153862419373,0.9245803952217102,0,0,"[{'label': 'positive', 'score': 0.9988349080085754}, {'label': 'neutral', 'score': 0.0007070330902934074}, {'label': 'negative', 'score': 0.00045807225978933275}]","(0.0007070330902934074, 0.9988349080085754, 0.00045807225978933275)",0.9990832072898854,0.9988349080085754,0,0
2020-03-27,59.68806457519531,68.44465637207031,70.0667953491211,67.98664093017578,68.5114517211914,12467218.0,"Cramer Reveals Stock Favorites, Says Intuitive Surgical A 'Winner' | Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",0.024257646728965365,-0.024784452634592377,0.7082196822793178,"[{'label': 'negative', 'score': 0.9975348711013794}, {'label': 'positive', 'score': 0.002088705310598016}, {'label': 'neutral', 'score': 0.0003764064167626202}]","(0.0003764064167626202, 0.002088705310598016, 0.9975348711013794)",-0.9958210163107694,-0.9975348711013794,0,0,"[{'label': 'negative', 'score': 0.971569299697876}, {'label': 'neutral', 'score': 0.01721177250146866}, {'label': 'positive', 'score': 0.011218920350074768}]","(0.01721177250146866, 0.011218920350074768, 0.971569299697876)",-0.9771692006045262,-0.971569299697876,0,0,"[{'label': 'positive', 'score': 0.5289138555526733}, {'label': 'neutral', 'score': 0.24142573773860931}, {'label': 'negative', 'score': 0.22966037690639496}]","(0.24142573773860931, 0.5289138555526733, 0.22966037690639496)",0.3944946530495626,0.5289138555526733,1,0
2020-03-28,61.13595581054688,70.10496266682942,71.38995107014973,68.50508880615234,69.09033203125,13579250.666666666,,0.023683149260768494,0.023968103103053383,0.6368288207029408,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-03-29,62.58384704589844,71.76526896158855,72.71310679117839,69.0235366821289,69.6692123413086,14691283.333333332,"Barron's Picks And Pans: Tech Picks, SoftBank, REITs, Tesla And More",0.023135234059357707,0.023407054185631805,0.6169028182964332,"[{'label': 'neutral', 'score': 0.9998723268508911}, {'label': 'negative', 'score': 6.78800352034159e-05}, {'label': 'positive', 'score': 5.9870275435969234e-05}]","(0.9998723268508911, 5.9870275435969234e-05, 6.78800352034159e-05)",-0.06269855413547054,-6.78800352034159e-05,1,1,"[{'label': 'neutral', 'score': 0.9363232254981995}, {'label': 'negative', 'score': 0.03444209694862366}, {'label': 'positive', 'score': 0.029234634712338448}]","(0.9363232254981995, 0.029234634712338448, 0.03444209694862366)",-0.08177967211023986,-0.03444209694862366,1,1,"[{'label': 'neutral', 'score': 0.9994814991950989}, {'label': 'positive', 'score': 0.0004189048777334392}, {'label': 'negative', 'score': 9.966306242858991e-05}]","(0.9994814991950989, 0.0004189048777334392, 9.966306242858991e-05)",0.6156219669212497,0.0004189048777334392,0,1
2020-03-30,64.03173828125,73.42557525634766,74.03626251220703,69.54198455810547,70.24809265136719,15803316.0,Shares of several healthcare companies are trading higher as the market rebounds on extended measures to help curb the coronavirus. NOTE: The sector could also be trading higher due to increased demand for medical products amid the coronavirus outbreak.,-0.000129987031429742,0.022871671839094963,0.5600124935497947,"[{'label': 'positive', 'score': 0.9996196031570435}, {'label': 'negative', 'score': 0.0002030448376899585}, {'label': 'neutral', 'score': 0.0001772881078068167}]","(0.0001772881078068167, 0.9996196031570435, 0.0002030448376899585)",0.9995938382910265,0.9996196031570435,0,0,"[{'label': 'positive', 'score': 0.9101018309593201}, {'label': 'negative', 'score': 0.07106176018714905}, {'label': 'neutral', 'score': 0.01883639767765999}]","(0.01883639767765999, 0.9101018309593201, 0.07106176018714905)",0.8551479879025783,0.9101018309593201,0,0,"[{'label': 'positive', 'score': 0.998370349407196}, {'label': 'neutral', 'score': 0.0012957468861714005}, {'label': 'negative', 'score': 0.0003339520771987736}]","(0.0012957468861714005, 0.998370349407196, 0.0003339520771987736)",0.9993312293204256,0.998370349407196,0,0
2020-03-31,64.02342224121094,73.41603088378906,74.0457992553711,72.06106567382812,72.75763702392578,15079672.0,,-0.04081104993917562,-0.0001299954804761013,0.34127926603316944,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-01,61.41056442260742,70.41984558105469,72.01335906982422,69.6469497680664,71.2404556274414,11665288.0,"RBC Capital Maintains Sector Perform on Merck & Co, Lowers Price Target to $89 | Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.",0.04159892611865349,-0.04166719528845672,0.4503836805867639,"[{'label': 'negative', 'score': 0.9986863732337952}, {'label': 'neutral', 'score': 0.0008119556587189436}, {'label': 'positive', 'score': 0.000501672679092735}]","(0.0008119556587189436, 0.000501672679092735, 0.9986863732337952)",-0.9989958393094377,-0.9986863732337952,0,0,"[{'label': 'negative', 'score': 0.9680028557777405}, {'label': 'neutral', 'score': 0.01966847851872444}, {'label': 'positive', 'score': 0.012328695505857468}]","(0.01966847851872444, 0.012328695505857468, 0.9680028557777405)",-0.9748479063237027,-0.9680028557777405,0,0,"[{'label': 'negative', 'score': 0.9982301592826843}, {'label': 'neutral', 'score': 0.0014734716387465596}, {'label': 'positive', 'score': 0.000296413287287578}]","(0.0014734716387465596, 0.000296413287287578, 0.9982301592826843)",-0.9994062986495699,-0.9982301592826843,0,0
2020-04-02,63.96517562866211,73.34923553466797,73.58778381347656,70.63931274414062,72.5,12843345.0,"Cannabis Opportunity In The Time Of The Coronavirus | Morgan Stanley Maintains Overweight on Merck & Co, Lowers Price Target to $89 | Merck Reports KEYTRUDA Significantly Improved Progression-Free Survival As First-Line Treatment For MSI-H, dMMR Colorectal Cancer",-0.008065503429310764,0.040756961479560205,0.5056847598654999,"[{'label': 'positive', 'score': 0.9995829463005066}, {'label': 'negative', 'score': 0.00029039449873380363}, {'label': 'neutral', 'score': 0.00012669032730627805}]","(0.00012669032730627805, 0.9995829463005066, 0.00029039449873380363)",0.9994191374309437,0.9995829463005066,0,0,"[{'label': 'positive', 'score': 0.903809130191803}, {'label': 'negative', 'score': 0.0697384774684906}, {'label': 'neutral', 'score': 0.02645242214202881}]","(0.02645242214202881, 0.903809130191803, 0.0697384774684906)",0.8567332980539255,0.903809130191803,0,0,"[{'label': 'positive', 'score': 0.9910992980003357}, {'label': 'neutral', 'score': 0.005576895084232092}, {'label': 'negative', 'score': 0.0033238024916499853}]","(0.005576895084232092, 0.9910992980003357, 0.0033238024916499853)",0.9933151140797,0.9910992980003357,0,0
2020-04-03,63.44926834106445,72.75763702392578,73.89312744140625,71.87023162841797,72.78626251220703,10039211.0,,0.017748600489481396,-0.008098205560224765,0.49873979468169494,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-04,64.57540639241536,74.04898325602214,74.9777348836263,72.69084167480469,73.43829600016277,11464176.666666666,,0.017439081204282763,0.017592933297555544,0.4865801119526049,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-05,65.70154444376628,75.34032948811848,76.06234232584636,73.5114517211914,74.09032948811848,12889142.333333332,,0.01714017234687048,0.01728876548996813,0.4980520026823564,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-06,66.82768249511719,76.63167572021484,77.1469497680664,74.33206176757812,74.74236297607422,14314108.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,-0.021790539817390358,0.01699493681847139,0.2743472468328633,"[{'label': 'positive', 'score': 0.9996342658996582}, {'label': 'negative', 'score': 0.0002316812169738114}, {'label': 'neutral', 'score': 0.00013408795348368585}]","(0.00013408795348368585, 0.9996342658996582, 0.0002316812169738114)",0.9995365754426543,0.9996342658996582,0,0,"[{'label': 'positive', 'score': 0.9354943633079529}, {'label': 'negative', 'score': 0.041293032467365265}, {'label': 'neutral', 'score': 0.023212609812617302}]","(0.023212609812617302, 0.9354943633079529, 0.041293032467365265)",0.9154513404944395,0.9354943633079529,0,0,"[{'label': 'positive', 'score': 0.9971598386764526}, {'label': 'neutral', 'score': 0.00226121605373919}, {'label': 'negative', 'score': 0.0005789118586108088}]","(0.00226121605373919, 0.9971598386764526, 0.0005789118586108088)",0.9988395522208587,0.9971598386764526,0,0
2020-04-07,65.3714599609375,74.96183013916016,78.21565246582031,74.80915832519531,77.93893432617188,10657950.0,"Merck Receives Priority Review From FDA For Second Application For KEYTRUDA Based On Biomarker, Regardless Of Tumor Type",0.03895109785385771,-0.022031459913002493,0.2920241400249245,"[{'label': 'neutral', 'score': 0.9686943292617798}, {'label': 'positive', 'score': 0.031032375991344452}, {'label': 'negative', 'score': 0.0002733530418481678}]","(0.9686943292617798, 0.031032375991344452, 0.0002733530418481678)",0.9825365484024768,0.031032375991344452,0,1,"[{'label': 'positive', 'score': 0.5997501611709595}, {'label': 'neutral', 'score': 0.38630613684654236}, {'label': 'negative', 'score': 0.013943656347692013}]","(0.38630613684654236, 0.5997501611709595, 0.013943656347692013)",0.9545582635846963,0.5997501611709595,0,0,"[{'label': 'positive', 'score': 0.9365110993385315}, {'label': 'neutral', 'score': 0.06315166503190994}, {'label': 'negative', 'score': 0.00033725486719049513}]","(0.06315166503190994, 0.9365110993385315, 0.00033725486719049513)",0.9992800225016643,0.9365110993385315,0,0
2020-04-08,67.9177474975586,77.88167572021484,79.19847106933594,74.75190734863281,75.55343627929688,11481888.0,FDA Approves Generic Version Of Merck's Proventil HFA Metered-Dose Inhaler,0.010659175104649667,0.03821164445875912,0.34746768837530695,"[{'label': 'positive', 'score': 0.9941405653953552}, {'label': 'neutral', 'score': 0.005442681256681681}, {'label': 'negative', 'score': 0.0004167569859419018}]","(0.005442681256681681, 0.9941405653953552, 0.0004167569859419018)",0.9991619246541887,0.9941405653953552,0,0,"[{'label': 'positive', 'score': 0.6646098494529724}, {'label': 'neutral', 'score': 0.3243500888347626}, {'label': 'negative', 'score': 0.011040061712265015}]","(0.3243500888347626, 0.6646098494529724, 0.011040061712265015)",0.9673201712016061,0.6646098494529724,0,0,"[{'label': 'positive', 'score': 0.9716421961784363}, {'label': 'neutral', 'score': 0.027862252667546272}, {'label': 'negative', 'score': 0.0004955381155014038}]","(0.027862252667546272, 0.9716421961784363, 0.0004955381155014038)",0.9989805187104247,0.9716421961784363,0,0
2020-04-09,68.64169311523438,78.71183013916016,79.47518920898438,76.50763702392578,77.4522933959961,13876568.0,,-0.0059098081335732374,0.010602766589143423,0.3459619198949473,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-10,68.23603439331055,78.24665832519531,79.27957916259766,76.42414283752441,77.60734939575195,12334095.5,,-0.005944941597781424,-0.005927340157719084,0.36332879388273465,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-11,67.83037567138672,77.78148651123047,79.08396911621094,76.34064865112305,77.76240539550781,10791623.0,,-0.005980495293024259,-0.00596268311287506,0.36236504683205706,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-12,67.42471694946289,77.31631469726562,78.88835906982422,76.25715446472168,77.91746139526367,9249150.5,,-0.006016476804232562,-0.005998450076455098,0.3061696357937894,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-13,67.01905822753906,76.85114288330078,78.6927490234375,76.17366027832031,78.07251739501953,7706678.0,"UBS Maintains Buy on Merck & Co, Lowers Price Target to $92 | AstraZeneca and Merck Announce Approval of KOSELUGO for Pediatric Patients Two Years and Older With Neurofibromatosis Type 1 and Symptomatic, Inoperable Plexiform Neurofibromas",0.028557237924267696,-0.006034648724754145,0.11773321698564064,"[{'label': 'positive', 'score': 0.9994331002235413}, {'label': 'neutral', 'score': 0.00032830206328071654}, {'label': 'negative', 'score': 0.0002385168190812692}]","(0.00032830206328071654, 0.9994331002235413, 0.0002385168190812692)",0.9995228096606626,0.9994331002235413,1,1,"[{'label': 'negative', 'score': 0.44162607192993164}, {'label': 'positive', 'score': 0.36566469073295593}, {'label': 'neutral', 'score': 0.19270920753479004}]","(0.19270920753479004, 0.36566469073295593, 0.44162607192993164)",-0.09409420336535677,-0.44162607192993164,0,0,"[{'label': 'negative', 'score': 0.4597072899341583}, {'label': 'positive', 'score': 0.40232470631599426}, {'label': 'neutral', 'score': 0.1379680335521698}]","(0.1379680335521698, 0.40232470631599426, 0.4597072899341583)",-0.06656665166464684,-0.4597072899341583,0,0
2020-04-14,68.93292999267578,79.0457992553711,79.38931274414062,77.03244018554688,78.55915832519531,12155333.0,,-0.009295036402494775,0.02815708040900683,0.2423556021389819,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-15,68.29220581054688,78.31106567382812,79.1603012084961,76.87023162841797,77.5095443725586,10809072.0,"Every Member Of Trump's 'Great American Economic Revival' Industry Groups | The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US | Merck Announces US Launch Of ONTRUZANT (trastuzumab-dttb), A Biosimilar Of Herceptin (trastuzumab)",0.011331800785395096,-0.00933850482340987,0.24946795805109764,"[{'label': 'neutral', 'score': 0.9996132254600525}, {'label': 'positive', 'score': 0.0003357318928465247}, {'label': 'negative', 'score': 5.1106875616824254e-05}]","(0.9996132254600525, 0.0003357318928465247, 5.1106875616824254e-05)",0.7357716972379081,0.0003357318928465247,0,1,"[{'label': 'positive', 'score': 0.5618077516555786}, {'label': 'neutral', 'score': 0.4276193380355835}, {'label': 'negative', 'score': 0.010572914965450764}]","(0.4276193380355835, 0.5618077516555786, 0.010572914965450764)",0.9630563518929928,0.5618077516555786,0,0,"[{'label': 'neutral', 'score': 0.9929218888282776}, {'label': 'positive', 'score': 0.006856932304799557}, {'label': 'negative', 'score': 0.00022126879775896668}]","(0.9929218888282776, 0.006856932304799557, 0.00022126879775896668)",0.9374788044157192,0.006856932304799557,0,1
2020-04-16,69.06607818603516,79.19847106933594,79.51335906982422,78.49236297607422,78.864501953125,9145058.0,"Gilead's Encouraging Remdesivir Data: Rapid Reaction On The Stock | S&P 500 Futures Up 3.2% After Hours; Many Other Stocks Moving Higher With Futures; Investors Reacting Favorably To White Phase Guidelines On Reopening Economy | Next 45 Days Will Be 'Most Critical Period' For US, Says Alan Lancz Who Predicted 1987 and 2008 Crises",0.005542207068462229,0.011268076883379686,0.25277513719797856,"[{'label': 'positive', 'score': 0.9993197917938232}, {'label': 'neutral', 'score': 0.0004328575450927019}, {'label': 'negative', 'score': 0.0002473754866514355}]","(0.0004328575450927019, 0.9993197917938232, 0.0002473754866514355)",0.999505034789559,0.9993197917938232,0,0,"[{'label': 'positive', 'score': 0.9404194355010986}, {'label': 'neutral', 'score': 0.03613869100809097}, {'label': 'negative', 'score': 0.023441806435585022}]","(0.03613869100809097, 0.9404194355010986, 0.023441806435585022)",0.9513585453680377,0.9404194355010986,0,0,"[{'label': 'positive', 'score': 0.9978787899017334}, {'label': 'neutral', 'score': 0.0018474565586075187}, {'label': 'negative', 'score': 0.00027374530327506363}]","(0.0018474565586075187, 0.9978787899017334, 0.00027374530327506363)",0.9994514960517155,0.9978787899017334,0,0
2020-04-17,69.44886779785156,79.63740539550781,80.30534362792969,78.66412353515625,80.10496520996094,15433162.0,,-0.0014378230391591102,0.005526905548959482,0.23798260689333425,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-18,69.34900919596355,79.5229008992513,80.29580179850261,78.12977091471355,79.74554951985677,14180697.333333334,,-0.0014398933509929212,-0.001438857698595412,0.2253444087918469,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-19,69.24915059407552,79.4083964029948,80.28625996907552,77.59541829427083,79.38613382975261,12928232.666666668,"Barron's Picks And Pans: Dropbox, Ford, Johnson & Johnson, Teladoc And More",-0.0014419696334806826,-0.0014409309936067878,0.12415684173173262,"[{'label': 'neutral', 'score': 0.9998831748962402}, {'label': 'negative', 'score': 6.182901415741071e-05}, {'label': 'positive', 'score': 5.4958622058620676e-05}]","(0.9998831748962402, 5.4958622058620676e-05, 6.182901415741071e-05)",-0.05882807736669422,-6.182901415741071e-05,1,1,"[{'label': 'neutral', 'score': 0.9444931745529175}, {'label': 'negative', 'score': 0.032387614250183105}, {'label': 'positive', 'score': 0.02311921864748001}]","(0.9444931745529175, 0.02311921864748001, 0.032387614250183105)",-0.16697756147952195,-0.032387614250183105,1,1,"[{'label': 'neutral', 'score': 0.9995344877243042}, {'label': 'positive', 'score': 0.00035340621252544224}, {'label': 'negative', 'score': 0.0001120920933317393}]","(0.9995344877243042, 0.00035340621252544224, 0.0001120920933317393)",0.5183995648476967,0.00035340621252544224,0,1
2020-04-20,69.1492919921875,79.29389190673828,80.27671813964844,77.06106567382812,79.02671813964844,11675768.0,Cue Biopharma Announces Clinical Trial Collaboration Agreement With Merck To Evaluate CUE-101 In Combination With KEYTRUDA As First-line Treatment For HPV+ Recurrent/Metastatic Head And Neck Cancer,-0.05463298197890565,-0.0014430102721925012,0.09141085619679822,"[{'label': 'positive', 'score': 0.9773659706115723}, {'label': 'neutral', 'score': 0.022227928042411804}, {'label': 'negative', 'score': 0.00040615422767587006}]","(0.022227928042411804, 0.9773659706115723, 0.00040615422767587006)",0.9991692251857913,0.9773659706115723,0,0,"[{'label': 'positive', 'score': 0.9385688900947571}, {'label': 'neutral', 'score': 0.04715394228696823}, {'label': 'negative', 'score': 0.014277085661888123}]","(0.04715394228696823, 0.9385688900947571, 0.014277085661888123)",0.9700327523542285,0.9385688900947571,0,0,"[{'label': 'positive', 'score': 0.9938012957572937}, {'label': 'neutral', 'score': 0.005943124182522297}, {'label': 'negative', 'score': 0.0002556493564043194}]","(0.005943124182522297, 0.9938012957572937, 0.0002556493564043194)",0.9994856444438903,0.9938012957572937,0,0
2020-04-21,65.3714599609375,74.96183013916016,78.53053283691406,74.62786102294922,77.88167572021484,17876574.0,"Shares of several healthcare companies are trading lower with the overall market on continued downward momentum after oil prices fell to historic lows, partially stemming from weak demand caused by the coronavirus pandemic. | Merck Broadens Patient Support And Assistance Programs As Part Of Overall COVID-19 Relief Efforts",0.018075401940501744,-0.05618204802964042,0.4038403718555037,"[{'label': 'negative', 'score': 0.9986935257911682}, {'label': 'positive', 'score': 0.0007213064818643034}, {'label': 'neutral', 'score': 0.0005851286696270108}]","(0.0005851286696270108, 0.0007213064818643034, 0.9986935257911682)",-0.998556542371452,-0.9986935257911682,0,0,"[{'label': 'negative', 'score': 0.9439473152160645}, {'label': 'positive', 'score': 0.030810728669166565}, {'label': 'neutral', 'score': 0.025241930037736893}]","(0.025241930037736893, 0.030810728669166565, 0.9439473152160645)",-0.9367828173105197,-0.9439473152160645,0,0,"[{'label': 'negative', 'score': 0.9980350136756897}, {'label': 'neutral', 'score': 0.0015383564168587327}, {'label': 'positive', 'score': 0.0004265862808097154}]","(0.0015383564168587327, 0.0004265862808097154, 0.9980350136756897)",-0.9991455128953817,-0.9980350136756897,0,0
2020-04-22,66.5530776977539,76.3167953491211,76.95610809326172,75.21946716308594,75.57251739501953,11933890.0,,0.011252829777481644,0.017913984089212843,0.4434052904507896,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-23,67.30198669433594,77.17557525634766,78.12976837158203,76.49809265136719,76.51717376708984,8152497.0,Shares of several healthcare companies are trading higher. Movement appears market-related as equities gain amid a rebound in oil prices. | Merck Reports Resubmission Of Supplemental Biologics License Applications For KEYTRUDA 6-Week Dosing Schedule,0.006800119854991672,0.011189987683293573,0.46466254818250213,"[{'label': 'positive', 'score': 0.9994533658027649}, {'label': 'neutral', 'score': 0.00037821338628418744}, {'label': 'negative', 'score': 0.00016846974904183298}]","(0.00037821338628418744, 0.9994533658027649, 0.00016846974904183298)",0.9996629330351736,0.9994533658027649,0,0,"[{'label': 'positive', 'score': 0.7924262285232544}, {'label': 'negative', 'score': 0.13640032708644867}, {'label': 'neutral', 'score': 0.07117346674203873}]","(0.07117346674203873, 0.7924262285232544, 0.13640032708644867)",0.7062953761116092,0.7924262285232544,0,0,"[{'label': 'positive', 'score': 0.9979192614555359}, {'label': 'neutral', 'score': 0.001763078966178}, {'label': 'negative', 'score': 0.0003176168829668313}]","(0.001763078966178, 0.9979192614555359, 0.0003176168829668313)",0.9993636442614793,0.9979192614555359,0,0
2020-04-24,67.75965118408203,77.70037841796875,78.3396987915039,77.30915832519531,77.86259460449219,7686451.0,"AstraZeneca, Merck Announce Lynparza Demonstrated Overall Survival Benefit in Phase III PROfound Trial for BRCA1/2 or ATM-mutated Metastatic Castration-resistant Prostate Cancer",0.010438440283111612,0.006777103324499012,0.473315989947828,"[{'label': 'positive', 'score': 0.9995074272155762}, {'label': 'negative', 'score': 0.0002718839969020337}, {'label': 'neutral', 'score': 0.00022065805387683213}]","(0.00022065805387683213, 0.9995074272155762, 0.0002718839969020337)",0.9994561119762074,0.9995074272155762,0,0,"[{'label': 'positive', 'score': 0.9471780061721802}, {'label': 'neutral', 'score': 0.03817320242524147}, {'label': 'negative', 'score': 0.01464878860861063}]","(0.03817320242524147, 0.9471780061721802, 0.01464878860861063)",0.9695396537337074,0.9471780061721802,0,0,"[{'label': 'positive', 'score': 0.9984844326972961}, {'label': 'neutral', 'score': 0.001215592841617763}, {'label': 'negative', 'score': 0.00030002088169567287}]","(0.001215592841617763, 0.9984844326972961, 0.00030002088169567287)",0.9993992279703181,0.9984844326972961,0,0
2020-04-25,68.46695709228516,78.51144917805989,79.1571273803711,77.24872589111328,77.74491119384766,9386551.666666666,,0.010330604880973333,0.010384335949539468,0.48518926424680003,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-04-26,69.17426300048828,79.32251993815105,79.97455596923828,77.18829345703125,77.62722778320312,11086652.333333332,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",0.010224974707353536,0.010277608857199196,0.06452984359635566,"[{'label': 'neutral', 'score': 0.999874472618103}, {'label': 'negative', 'score': 7.105679105734453e-05}, {'label': 'positive', 'score': 5.451319520943798e-05}]","(0.999874472618103, 5.451319520943798e-05, 7.105679105734453e-05)",-0.13174801033073683,-7.105679105734453e-05,0,0,"[{'label': 'neutral', 'score': 0.933672308921814}, {'label': 'positive', 'score': 0.03686017915606499}, {'label': 'negative', 'score': 0.0294675100594759}]","(0.933672308921814, 0.03686017915606499, 0.0294675100594759)",0.11145675635654365,0.03686017915606499,0,0,"[{'label': 'neutral', 'score': 0.9992607235908508}, {'label': 'positive', 'score': 0.0005474984645843506}, {'label': 'negative', 'score': 0.00019183725817129016}]","(0.9992607235908508, 0.0005474984645843506, 0.00019183725817129016)",0.4810550815635493,0.0005474984645843506,0,0
2020-04-27,69.8815689086914,80.13359069824219,80.79198455810547,77.12786102294922,77.5095443725586,12786753.0,"Apple And Amazon Earnings, Fed Meeting Among Highlights In Busy Week Ahead | Merck and Institute for Systems Biology Collaborate to Define Molecular Mechanisms of SARS-CoV-2 Infection and Identify Potential Prognostic Biomarkers for Coronavirus | Lynparza Demonstrated Overall Survival Benefit in Phase III PROfound Trial for BRCA1/2 or ATM-mutated Metastatic Castration-resistant Prostate Cancer",-0.03334133084268042,0.010173053283689556,0.027231680436958658,"[{'label': 'positive', 'score': 0.9990591406822205}, {'label': 'neutral', 'score': 0.0006956526776775718}, {'label': 'negative', 'score': 0.00024521490558981895}]","(0.0006956526776775718, 0.9990591406822205, 0.00024521490558981895)",0.9995092287865681,0.9990591406822205,0,0,"[{'label': 'positive', 'score': 0.9243372082710266}, {'label': 'neutral', 'score': 0.06390219181776047}, {'label': 'negative', 'score': 0.011760535649955273}]","(0.06390219181776047, 0.9243372082710266, 0.011760535649955273)",0.9748732742358837,0.9243372082710266,0,0,"[{'label': 'positive', 'score': 0.9913250207901001}, {'label': 'neutral', 'score': 0.00829952210187912}, {'label': 'negative', 'score': 0.0003755193902179599}]","(0.00829952210187912, 0.9913250207901001, 0.0003755193902179599)",0.999242675838112,0.9913250207901001,0,0
2020-04-28,67.55162048339844,77.46183013916016,78.46373748779297,76.49809265136719,77.46183013916016,20273560.0,"FDA Approves Merck's KEYTRUDA For Use At An Additional Recommended Dose Of 400 mg Every Six Weeks For All Approved Adult Indications | A CURE For The Common Earnings Play | Morning Market Stats in 5 Minutes | Earnings Feast: Bring a Plate With Healthcare and Caterpillar in Morning, GOOGL And AMD Later | Merck shares are trading lower after the company issued FY20 guidance below consensus estimates. | The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update | Merck Sees FY20 EPS $5.17-$5.37 vs $5.56 Est., Sales $46.1B-$48.1B vs $48.72B Est. | Merck & Co Q1 Adj. EPS $1.500 Beats $1.340 Estimate, Sales $12.100B Beat $11.460B Estimate | Earnings Scheduled For April 28, 2020",-0.0050504886351201705,-0.03390982499543664,0.30843342373668065,"[{'label': 'negative', 'score': 0.9966993927955627}, {'label': 'neutral', 'score': 0.002152049448341131}, {'label': 'positive', 'score': 0.0011485693976283073}]","(0.002152049448341131, 0.0011485693976283073, 0.9966993927955627)",-0.9976979070136018,-0.9966993927955627,0,0,"[{'label': 'negative', 'score': 0.9091720581054688}, {'label': 'neutral', 'score': 0.06739729642868042}, {'label': 'positive', 'score': 0.02343057654798031}]","(0.06739729642868042, 0.02343057654798031, 0.9091720581054688)",-0.9497522831753805,-0.9091720581054688,0,0,"[{'label': 'neutral', 'score': 0.5239140391349792}, {'label': 'positive', 'score': 0.24451196193695068}, {'label': 'negative', 'score': 0.23157402873039246}]","(0.5239140391349792, 0.24451196193695068, 0.23157402873039246)",0.027175622597973872,0.24451196193695068,1,1
2020-04-29,67.21044921875,77.07061004638672,78.42557525634766,75.4103012084961,78.42557525634766,13687194.0,"Guggenheim Maintains Buy on Merck & Co, Lowers Price Target to $93 | Barclays Maintains Overweight on Merck & Co, Lowers Price Target to $90 | Merck Analysts Focus On Fundamentals, Keytruda Strength Following Guidance Cut | The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda | SVB Leerink Maintains Outperform on Merck & Co, Lowers Price Target to $95",-0.01770456925543658,-0.005063285457835131,0.3052719875762958,"[{'label': 'positive', 'score': 0.997310996055603}, {'label': 'negative', 'score': 0.002379377605393529}, {'label': 'neutral', 'score': 0.0003096410946454853}]","(0.0003096410946454853, 0.997310996055603, 0.002379377605393529)",0.995239770896903,0.997310996055603,0,0,"[{'label': 'positive', 'score': 0.4991234540939331}, {'label': 'negative', 'score': 0.3079295754432678}, {'label': 'neutral', 'score': 0.19294697046279907}]","(0.19294697046279907, 0.4991234540939331, 0.3079295754432678)",0.23690373699520603,0.4991234540939331,1,1,"[{'label': 'positive', 'score': 0.7942939400672913}, {'label': 'neutral', 'score': 0.12826380133628845}, {'label': 'negative', 'score': 0.0774422362446785}]","(0.12826380133628845, 0.7942939400672913, 0.0774422362446785)",0.8223264369449224,0.7942939400672913,0,0
2020-04-30,66.02051544189453,75.70610809326172,76.71755981445312,75.51526641845703,76.16412353515625,11638878.0,"ServiceNow CEO Bill McDermott Says Company 'Hungry And Humble,' With $10B Ambitions",-0.021048677958804794,-0.017863169900685844,0.30108710248109993,"[{'label': 'negative', 'score': 0.9866136908531189}, {'label': 'neutral', 'score': 0.010896744206547737}, {'label': 'positive', 'score': 0.002489544916898012}]","(0.010896744206547737, 0.002489544916898012, 0.9866136908531189)",-0.994966056470415,-0.9866136908531189,0,0,"[{'label': 'neutral', 'score': 0.678530216217041}, {'label': 'positive', 'score': 0.3049255907535553}, {'label': 'negative', 'score': 0.016544168815016747}]","(0.678530216217041, 0.3049255907535553, 0.016544168815016747)",0.8970716944746541,0.3049255907535553,0,1,"[{'label': 'neutral', 'score': 0.9983550906181335}, {'label': 'positive', 'score': 0.0014892477774992585}, {'label': 'negative', 'score': 0.00015561289910692722}]","(0.9983550906181335, 0.0014892477774992585, 0.00015561289910692722)",0.81078896064559,0.0014892477774992585,0,1
2020-05-01,64.630859375,74.11259460449219,75.24809265136719,73.40648651123047,75.24809265136719,9518565.0,,-0.0034762234278483796,-0.02127335981120857,0.2665283084874925,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-02,64.40619277954102,73.85496266682942,74.98409779866536,73.18066151936848,74.98091634114583,9295795.0,,-0.0034883497108375294,-0.00348227953149471,0.19888163633085967,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-03,64.18152618408203,73.59733072916667,74.72010294596355,72.95483652750652,74.71374003092448,9073025.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates | The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,-0.0035005608914110446,-0.0034944481892374727,0.1369757708404362,"[{'label': 'positive', 'score': 0.9994463324546814}, {'label': 'neutral', 'score': 0.00035309087252244353}, {'label': 'negative', 'score': 0.00020060471433680505}]","(0.00035309087252244353, 0.9994463324546814, 0.00020060471433680505)",0.99959864886916,0.9994463324546814,0,0,"[{'label': 'positive', 'score': 0.910772979259491}, {'label': 'neutral', 'score': 0.06691265851259232}, {'label': 'negative', 'score': 0.02231438457965851}]","(0.06691265851259232, 0.910772979259491, 0.02231438457965851)",0.9521708567826985,0.910772979259491,0,0,"[{'label': 'positive', 'score': 0.9986103773117065}, {'label': 'neutral', 'score': 0.0010343160247430205}, {'label': 'negative', 'score': 0.0003552222915459424}]","(0.0010343160247430205, 0.9986103773117065, 0.0003552222915459424)",0.999288819771798,0.9986103773117065,0,0
2020-05-04,63.95685958862305,73.3396987915039,74.45610809326172,72.72901153564453,74.44656372070312,8850255.0,,0.014962163394755378,-0.0035067021908720825,0.14106333618832567,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-05,64.9137954711914,74.43701934814453,75.19084167480469,73.25381469726562,73.71183013916016,7401395.0,Why Shares Of Gene Therapy Company Genprex Are Surging Higher,-0.011408779423260684,0.014851334355338771,0.20276436949243273,"[{'label': 'positive', 'score': 0.9989462494850159}, {'label': 'neutral', 'score': 0.000788255303632468}, {'label': 'negative', 'score': 0.00026548909954726696}]","(0.000788255303632468, 0.9989462494850159, 0.00026548909954726696)",0.9994686029210919,0.9989462494850159,0,0,"[{'label': 'neutral', 'score': 0.5958168506622314}, {'label': 'positive', 'score': 0.36950618028640747}, {'label': 'negative', 'score': 0.03467698022723198}]","(0.5958168506622314, 0.36950618028640747, 0.03467698022723198)",0.8284095745940322,0.36950618028640747,0,1,"[{'label': 'positive', 'score': 0.9980278611183167}, {'label': 'neutral', 'score': 0.0016432468546554446}, {'label': 'negative', 'score': 0.00032888574060052633}]","(0.0016432468546554446, 0.9980278611183167, 0.00032888574060052633)",0.999341145854655,0.9980278611183167,0,0
2020-05-06,64.17321014404297,73.58778381347656,75.03816986083984,73.54962158203125,74.7614517211914,12414922.0,Merck Announces RECARBRIO Demonstrated Noninferiority Compared To Piperacillin And Tazobactam In Primary And Key Secondary Endpoints,-0.019709499903476285,-0.011474358811528246,0.15447231942427142,"[{'label': 'positive', 'score': 0.987966001033783}, {'label': 'neutral', 'score': 0.006555764004588127}, {'label': 'negative', 'score': 0.005478245671838522}]","(0.006555764004588127, 0.987966001033783, 0.005478245671838522)",0.9889712066077084,0.987966001033783,0,0,"[{'label': 'positive', 'score': 0.5480220317840576}, {'label': 'negative', 'score': 0.4214445948600769}, {'label': 'neutral', 'score': 0.030533378943800926}]","(0.030533378943800926, 0.5480220317840576, 0.4214445948600769)",0.13056399616574313,0.5480220317840576,1,0,"[{'label': 'positive', 'score': 0.9967882633209229}, {'label': 'neutral', 'score': 0.0026680391747504473}, {'label': 'negative', 'score': 0.000543733942322433}]","(0.0026680391747504473, 0.9967882633209229, 0.000543733942322433)",0.998909622986499,0.9967882633209229,0,0
2020-05-07,62.90838241577149,72.13740539550781,73.58778381347656,71.97518920898438,73.47328186035156,12602410.0,,0.010582014499120801,-0.019906322573894977,0.20425995008100847,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-08,63.574100494384766,72.90076446533203,73.43511199951172,72.4904556274414,72.99618530273438,8791672.0,5 Biopharmas Where BofA Would Put Its Money To Work,0.006588141589333146,0.010526416863080926,0.23188473908002136,"[{'label': 'neutral', 'score': 0.999869704246521}, {'label': 'negative', 'score': 6.832317740190774e-05}, {'label': 'positive', 'score': 6.195768219185993e-05}]","(0.999869704246521, 6.195768219185993e-05, 6.832317740190774e-05)",-0.048859788229032544,-6.832317740190774e-05,1,1,"[{'label': 'neutral', 'score': 0.9219481348991394}, {'label': 'positive', 'score': 0.06805572658777237}, {'label': 'negative', 'score': 0.009996125474572182}]","(0.9219481348991394, 0.06805572658777237, 0.009996125474572182)",0.7438593650132044,0.06805572658777237,0,1,"[{'label': 'neutral', 'score': 0.9989959597587585}, {'label': 'positive', 'score': 0.0009123401250690222}, {'label': 'negative', 'score': 9.16658464120701e-05}]","(0.9989959597587585, 0.0009123401250690222, 9.16658464120701e-05)",0.8173997983760072,0.0009123401250690222,0,1
2020-05-09,63.99293263753256,73.38104502360027,73.78816731770833,72.47455342610677,72.84669240315755,9401957.333333334,,0.006545022057314057,0.006566534632408177,0.2384277652533016,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-10,64.41176478068034,73.86132558186848,74.14122263590495,72.45865122477214,72.69719950358073,10012242.666666666,,0.006502463291643569,0.006523696401133229,0.2118443988299305,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-11,64.83059692382812,74.34160614013672,74.49427795410156,72.4427490234375,72.5477066040039,10622528.0,"UPDATE: Cocrystal Says Collaboration With Merck For Discovery, Development Of Certain Proprietary Flu A/B Antiviral Agents Ongoing | AstraZeneca And Merck Announce LYNPARZA Approved In US As 1st-line Maintenance Treatment With bevacizumab For HRD-Positive Advanced Ovarian Cancer | AstraZeneca Announces Lynparza Approved in the U.S, as 1st-line Maintenance Treatment With Bevacizumab for HED-positive Advanced Ovarian Cancer",-0.009241486876729443,0.006481413478364062,0.19667412310772237,"[{'label': 'positive', 'score': 0.9953527450561523}, {'label': 'neutral', 'score': 0.004384096246212721}, {'label': 'negative', 'score': 0.00026312231784686446}]","(0.004384096246212721, 0.9953527450561523, 0.00026312231784686446)",0.9994714380787424,0.9953527450561523,0,0,"[{'label': 'positive', 'score': 0.7790822386741638}, {'label': 'neutral', 'score': 0.20761628448963165}, {'label': 'negative', 'score': 0.013301508501172066}]","(0.20761628448963165, 0.7790822386741638, 0.013301508501172066)",0.9664265993627738,0.7790822386741638,0,0,"[{'label': 'positive', 'score': 0.9741663932800293}, {'label': 'neutral', 'score': 0.02542014978826046}, {'label': 'negative', 'score': 0.00041350946412421763}]","(0.02542014978826046, 0.9741663932800293, 0.00041350946412421763)",0.9991514098270242,0.9741663932800293,0,0
2020-05-12,64.23145294189453,73.65457916259766,75.09542083740234,73.58778381347656,74.57061004638672,9544660.0,,0.009068522826630432,-0.009284454343643304,0.12246336836707587,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-13,64.81393432617188,74.32251739501953,75.19084167480469,73.07251739501953,73.14885711669922,10935146.0,"Merck Reports KEYTRUDA Plus Chemo Showed Statistically Significant Improvement In Progression-Free Survival vs Chemo In Certain Patients With Metastatic Triple-Negative Breast Cancer | Merck Reports KEYTRUDA Superior To Brentuximab Vedotin In Patients With Classical Hodgkin Lymphoma In Head-To-Head Phase 3 Trial | Merck Reports New Combo Data For KEYTRUDA Showed Benefit In Stage 3 Non-Small Cell Lung Cancer | Merck Reports Novel HIF-2a Inhibitor Showed Objective Response Rate Of Nearly 30% In Patients With von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma | AbbVie's Potential Is 'Underappreciated,' Says Morgan Stanley Analyst | The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter | Merck Animal Health to Acquire U.S. Rights to SENTINEL Brand of Combination Parasiticides for Companion Animals for ~$400M in Cash",0.027731478634774716,0.009027650687614318,0.11793532543330265,"[{'label': 'positive', 'score': 0.9995787739753723}, {'label': 'negative', 'score': 0.00027145721833221614}, {'label': 'neutral', 'score': 0.00014978573017288}]","(0.00014978573017288, 0.9995787739753723, 0.00027145721833221614)",0.9994570042395087,0.9995787739753723,1,1,"[{'label': 'positive', 'score': 0.9468424916267395}, {'label': 'neutral', 'score': 0.029155874624848366}, {'label': 'negative', 'score': 0.02400161325931549}]","(0.029155874624848366, 0.9468424916267395, 0.02400161325931549)",0.95055516505993,0.9468424916267395,1,1,"[{'label': 'positive', 'score': 0.998515784740448}, {'label': 'neutral', 'score': 0.0011725642252713442}, {'label': 'negative', 'score': 0.0003115968138445169}]","(0.0011725642252713442, 0.998515784740448, 0.0003115968138445169)",0.9993760747460494,0.998515784740448,1,1
2020-05-14,66.61132049560547,76.38359069824219,76.45992279052734,73.72137451171875,73.7404556274414,11407585.0,,-0.0033729367992608684,0.02735392535861731,0.20680565642873316,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-15,66.38666534423828,76.1259536743164,76.86068725585938,75.21946716308594,76.44084167480469,9367234.0,,-0.00025068531733363236,-0.003378637973998018,0.22266140080954455,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-16,66.3700180053711,76.10687001546223,77.00381724039714,75.34669240315755,76.72392018636067,10429032.666666666,,-0.0002507481762195721,-0.0002507167441500661,0.22690936778575366,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-17,66.3533706665039,76.08778635660808,77.14694722493489,75.47391764322917,77.00699869791667,11490831.333333332,,-0.0002508110666372938,-0.00025077961879977896,0.19922474337633253,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-18,66.33672332763672,76.0687026977539,77.29007720947266,75.60114288330078,77.29007720947266,12552630.0,,-0.027220262380626324,-0.0002508425249930217,0.20266904537192973,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-19,64.53103637695312,73.99809265136719,76.0782470703125,73.8072509765625,75.83015441894531,10591822.0,Telemedicine A COVID-19 Winner | Merck And UPMC Announces Infectious Disease Connect Has Combined  Merck's ILM Health Solutions To 'Advance Precision Treatment of Infectious Diseases and Antimicrobial Stewardship ',-0.00851060276038609,-0.027597596914612697,0.1898133735504141,"[{'label': 'positive', 'score': 0.9991372227668762}, {'label': 'neutral', 'score': 0.0006579793407581747}, {'label': 'negative', 'score': 0.00020488101290538907}]","(0.0006579793407581747, 0.9991372227668762, 0.00020488101290538907)",0.9995899682158282,0.9991372227668762,0,0,"[{'label': 'positive', 'score': 0.8148072957992554}, {'label': 'neutral', 'score': 0.1778383105993271}, {'label': 'negative', 'score': 0.0073543814942240715}]","(0.1778383105993271, 0.8148072957992554, 0.0073543814942240715)",0.9821096465638379,0.8148072957992554,0,0,"[{'label': 'positive', 'score': 0.9950538873672485}, {'label': 'neutral', 'score': 0.004720399156212807}, {'label': 'negative', 'score': 0.00022570634610019624}]","(0.004720399156212807, 0.9950538873672485, 0.00022570634610019624)",0.9995464463503002,0.9950538873672485,0,0
2020-05-20,63.98179626464844,73.36832427978516,74.65648651123047,73.16793823242188,74.45610809326172,11027685.0,"Mid-Afternoon Market Update: Crude Oil Up 5%; Surface Oncology Shares Spike Higher | Why Surface Oncology's Stock Is Surging Higher | Checkpoint Therapeutics CEO On Tapping Into A $25 Billion Cancer Treatment Market | The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test | AstraZeneca And Merck Announce LYNPARZA Approved By FDA For Treatment Of HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer That Has Progressed Following Prior Treatment With Enzalutamide Or Abiraterone | AstraZeneca Says Lynparza Approved in the U.S. for Prostate Cancer",-0.0044219678755326895,-0.008547024735929963,0.1882636521163694,"[{'label': 'positive', 'score': 0.9994325041770935}, {'label': 'negative', 'score': 0.0002926210581790656}, {'label': 'neutral', 'score': 0.0002747992693912238}]","(0.0002747992693912238, 0.9994325041770935, 0.0002926210581790656)",0.999414596971122,0.9994325041770935,0,0,"[{'label': 'positive', 'score': 0.9436560869216919}, {'label': 'neutral', 'score': 0.037663958966732025}, {'label': 'negative', 'score': 0.018679942935705185}]","(0.037663958966732025, 0.9436560869216919, 0.018679942935705185)",0.9611779204848575,0.9436560869216919,0,0,"[{'label': 'positive', 'score': 0.9969280362129211}, {'label': 'neutral', 'score': 0.002746863290667534}, {'label': 'negative', 'score': 0.0003250729641877115}]","(0.002746863290667534, 0.9969280362129211, 0.0003250729641877115)",0.999348063272611,0.9969280362129211,0,0
2020-05-21,63.69890213012695,73.04389190673828,73.50190734863281,72.77671813964844,73.24427795410156,9000329.0,"Mid-Afternoon Market Update: Dow Falls 50 Points; L Brands Shares Spike Higher | 51 Stocks Moving In Thursday's Mid-Day Session | Mid-Day Market Update: Crude Oil Rises Over 1%; Aurora Cannabis Shares Jump | Mid-Morning Market Update: Markets Mixed; Best Buy Tops Q1 Expectations | The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",-0.0023513660787241792,-0.0044317736934976785,0.18046821592054552,"[{'label': 'positive', 'score': 0.9746620059013367}, {'label': 'negative', 'score': 0.02385791949927807}, {'label': 'neutral', 'score': 0.0014800484059378505}]","(0.0014800484059378505, 0.9746620059013367, 0.02385791949927807)",0.9522134333179059,0.9746620059013367,0,0,"[{'label': 'positive', 'score': 0.8992539048194885}, {'label': 'negative', 'score': 0.059908460825681686}, {'label': 'neutral', 'score': 0.040837615728378296}]","(0.040837615728378296, 0.8992539048194885, 0.059908460825681686)",0.8750817109355935,0.8992539048194885,0,0,"[{'label': 'positive', 'score': 0.9194663763046265}, {'label': 'neutral', 'score': 0.07927125692367554}, {'label': 'negative', 'score': 0.0012623619986698031}]","(0.07927125692367554, 0.9194663763046265, 0.0012623619986698031)",0.9972579068162984,0.9194663763046265,0,0
2020-05-22,63.54910659790039,72.87213897705078,73.14885711669922,72.58587646484375,72.6812973022461,6357482.0,"US Health Official Says Vaccines From J&J, Sanofi, Merck May Be Added This Summer As They Complete Phase 1 Safety Studies | US Says Will Test Experimental Coronavirus Vaccines In 100,000+ People, Health Official Says Oxford Vaccine May Be Tested ""Side By Side"" With Moderna's Starting In July | 64 Biggest Movers From Yesterday",0.002913443829799664,-0.002354134881105842,0.17515961902019556,"[{'label': 'neutral', 'score': 0.9968680739402771}, {'label': 'positive', 'score': 0.0030068045016378164}, {'label': 'negative', 'score': 0.00012516172137111425}]","(0.9968680739402771, 0.0030068045016378164, 0.00012516172137111425)",0.9200746671840737,0.0030068045016378164,0,1,"[{'label': 'positive', 'score': 0.6449211239814758}, {'label': 'neutral', 'score': 0.3456697165966034}, {'label': 'negative', 'score': 0.009409215301275253}]","(0.3456697165966034, 0.6449211239814758, 0.009409215301275253)",0.9712401680423707,0.6449211239814758,0,0,"[{'label': 'neutral', 'score': 0.9859138131141663}, {'label': 'positive', 'score': 0.013683488592505455}, {'label': 'negative', 'score': 0.0004027354880236089}]","(0.9859138131141663, 0.013683488592505455, 0.0004027354880236089)",0.9428185316773007,0.013683488592505455,0,1
2020-05-23,63.73425769805908,73.08444786071777,73.61164283752441,72.78625869750977,73.17986679077148,9554615.75,,0.0029049803327734556,0.0029092079776089535,0.1858036044759692,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-24,63.91940879821777,73.29675674438477,74.07442855834961,72.98664093017578,73.67843627929688,12751749.5,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,0.002896565865900432,0.0029007690312672306,0.07816273574230677,"[{'label': 'neutral', 'score': 0.9998798370361328}, {'label': 'negative', 'score': 6.434687384171411e-05}, {'label': 'positive', 'score': 5.5785483709769323e-05}]","(0.9998798370361328, 5.5785483709769323e-05, 6.434687384171411e-05)",-0.07126631247768325,-6.434687384171411e-05,1,1,"[{'label': 'neutral', 'score': 0.9418089985847473}, {'label': 'positive', 'score': 0.040044575929641724}, {'label': 'negative', 'score': 0.01814647763967514}]","(0.9418089985847473, 0.040044575929641724, 0.01814647763967514)",0.37631383085170794,0.040044575929641724,1,1,"[{'label': 'neutral', 'score': 0.9995445609092712}, {'label': 'positive', 'score': 0.0002858107618521899}, {'label': 'negative', 'score': 0.00016952971054706722}]","(0.9995445609092712, 0.0002858107618521899, 0.00016952971054706722)",0.25537165781117677,0.0002858107618521899,1,1
2020-05-25,64.10455989837646,73.50906562805176,74.5372142791748,73.1870231628418,74.17700576782227,15948883.25,,0.002888200004353927,0.0028923789022546687,0.055951629420097855,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-05-26,64.28971099853516,73.72137451171875,75.0,73.38740539550781,74.67557525634766,19146017.0,"Merck CEO Can't Give A Timeline Or Date For COVID-19 Approval | Merck CEO Ken Frazier To Appear On CNBC | 'Merck chief casts doubt on coronavirus vaccine timeframe' -Financial Times | Merck's Coronavirus Plan Of Attack: 2 Partnerships, M&A Deal Aimed At Treatment, Vaccine Development | Benzinga Pro's Top 5 Stocks To Watch For Tues., May 26, 2020: NVAX, EWJ, SNY, SOXX, MRK | Merck To Acquire Vaccine Company Themis Bioscience; Also Announces Collaboration With IAVI For Coronavirus Vaccine And Collaboration With Ridgeback Bio For Coronavirus Antiviral Candidate",0.0037535672860311412,0.0028840371681974567,0.03727680492717863,"[{'label': 'neutral', 'score': 0.7435414791107178}, {'label': 'negative', 'score': 0.25531888008117676}, {'label': 'positive', 'score': 0.0011397384805604815}]","(0.7435414791107178, 0.0011397384805604815, 0.25531888008117676)",-0.9911117162920683,-0.25531888008117676,0,1,"[{'label': 'neutral', 'score': 0.5770471692085266}, {'label': 'positive', 'score': 0.4127548933029175}, {'label': 'negative', 'score': 0.010197922587394714}]","(0.5770471692085266, 0.4127548933029175, 0.010197922587394714)",0.9517774928821402,0.4127548933029175,0,1,"[{'label': 'neutral', 'score': 0.972211480140686}, {'label': 'positive', 'score': 0.02498381771147251}, {'label': 'negative', 'score': 0.002804661402478814}]","(0.972211480140686, 0.02498381771147251, 0.002804661402478814)",0.7981421443773278,0.02498381771147251,0,1
2020-05-27,64.53103637695312,73.99809265136719,74.08396911621094,72.51908111572266,73.47328186035156,12828987.0,,0.019213372652534602,0.0037465402312051644,0.006035826574074366,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,0,0
2020-05-28,65.77088928222656,75.41984558105469,76.61259460449219,74.91412353515625,75.0,13180906.0,Merck's Keytruda (Pembrolizumab) Superior To Standard Of Care Chemotherapy In Patients With MSI-H Colorectal Cancer,0.021255119908795066,0.019031126484119178,0.11321005911313488,"[{'label': 'positive', 'score': 0.9960718154907227}, {'label': 'neutral', 'score': 0.003690396435558796}, {'label': 'negative', 'score': 0.00023784730001352727}]","(0.003690396435558796, 0.9960718154907227, 0.00023784730001352727)",0.9995225434242054,0.9960718154907227,1,1,"[{'label': 'positive', 'score': 0.9352797269821167}, {'label': 'neutral', 'score': 0.052041761577129364}, {'label': 'negative', 'score': 0.01267851609736681}]","(0.052041761577129364, 0.9352797269821167, 0.01267851609736681)",0.9732508975159494,0.9352797269821167,1,1,"[{'label': 'positive', 'score': 0.9874957799911499}, {'label': 'neutral', 'score': 0.01188668329268694}, {'label': 'negative', 'score': 0.0006175628514029086}]","(0.01188668329268694, 0.9874957799911499, 0.0006175628514029086)",0.99875001616793,0.9874957799911499,1,1
2020-05-29,67.16886138916016,77.02290344238281,77.23282623291016,74.72328186035156,75.82061004638672,13517104.0,"Merck Yesterday Announced KEYTRUDA plus LENVIMA Combination Demonstrated Clinically Meaningful Tumor Response Rates in Unresectable Hepatocellular Carcinoma and Advanced Renal Cell Carcinoma | The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant | Cramer Shares His Thoughts On Teva, Oxford Industries And More",-0.0047902312564372445,0.02103238055409387,0.14710740951373583,"[{'label': 'positive', 'score': 0.7948713302612305}, {'label': 'neutral', 'score': 0.2044408917427063}, {'label': 'negative', 'score': 0.0006878161802887917}]","(0.2044408917427063, 0.7948713302612305, 0.0006878161802887917)",0.9982708609828311,0.7948713302612305,0,0,"[{'label': 'positive', 'score': 0.4991793930530548}, {'label': 'neutral', 'score': 0.4918859302997589}, {'label': 'negative', 'score': 0.008934724144637585}]","(0.4918859302997589, 0.4991793930530548, 0.008934724144637585)",0.9648318208755403,0.4991793930530548,0,1,"[{'label': 'positive', 'score': 0.9803897738456726}, {'label': 'neutral', 'score': 0.01928778924047947}, {'label': 'negative', 'score': 0.0003224642132408917}]","(0.01928778924047947, 0.9803897738456726, 0.0003224642132408917)",0.9993423877041054,0.9803897738456726,0,0
2020-05-30,66.84710439046223,76.65394592285156,77.08015441894531,74.98409525553386,76.04961903889973,11101149.666666668,"The Week Ahead In Biotech: ASCO, Menlo And Merck FDA Decisions, IPOs In The Spotlight",-0.004813288019152826,-0.004801741185708076,0.17729808436376918,"[{'label': 'neutral', 'score': 0.9998544454574585}, {'label': 'positive', 'score': 7.499168714275584e-05}, {'label': 'negative', 'score': 7.058764458633959e-05}]","(0.9998544454574585, 7.499168714275584e-05, 7.058764458633959e-05)",0.03025183935183605,7.499168714275584e-05,1,1,"[{'label': 'neutral', 'score': 0.939157247543335}, {'label': 'positive', 'score': 0.03144022449851036}, {'label': 'negative', 'score': 0.029402494430541992}]","(0.939157247543335, 0.03144022449851036, 0.029402494430541992)",0.03349176538846876,0.03144022449851036,1,1,"[{'label': 'neutral', 'score': 0.9995052814483643}, {'label': 'positive', 'score': 0.00036575619014911354}, {'label': 'negative', 'score': 0.0001289771607844159}]","(0.9995052814483643, 0.00036575619014911354, 0.0001289771607844159)",0.4785992877130905,0.00036575619014911354,1,1
2020-05-31,66.52534739176433,76.28498840332031,76.92748260498047,75.24490865071614,76.27862803141277,8685195.333333334,,-0.004836567813061254,-0.0048249091956396074,0.19941581065650738,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-06-01,66.2035903930664,75.91603088378906,76.77481079101562,75.50572204589844,76.50763702392578,6269241.0,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates | 'New Ebola epidemic' in northwest DR Congo: health ministry' -AFP | Merck and AstraZeneca's LYNPARZA Receives a Positive Opinion from the European Medicines Agency | AstraZeneca Announces Lynparza Recommended for Approval in EU by CHMP for BRCA-mutated Metastatic Pancreatic Cancer,0.01608849273993801,-0.004848301857456182,0.21641683413697774,"[{'label': 'positive', 'score': 0.9993807077407837}, {'label': 'negative', 'score': 0.0003640769573394209}, {'label': 'neutral', 'score': 0.00025518276379443705}]","(0.00025518276379443705, 0.9993807077407837, 0.0003640769573394209)",0.9992716602018598,0.9993807077407837,0,0,"[{'label': 'positive', 'score': 0.9275215864181519}, {'label': 'neutral', 'score': 0.05287858098745346}, {'label': 'negative', 'score': 0.019599802792072296}]","(0.05287858098745346, 0.9275215864181519, 0.019599802792072296)",0.9586118463475606,0.9275215864181519,0,0,"[{'label': 'positive', 'score': 0.9940754175186157}, {'label': 'neutral', 'score': 0.005091692321002483}, {'label': 'negative', 'score': 0.0008328650146722794}]","(0.005091692321002483, 0.9940754175186157, 0.0008328650146722794)",0.9983257451379305,0.9940754175186157,0,0
2020-06-02,67.2686996459961,77.13740539550781,77.15648651123047,75.21946716308594,75.8969497680664,11352984.0,Pharma Large And Mid-Caps Race Against COVID-19,0.015091556802920987,0.015960444516861468,0.20476398408134108,"[{'label': 'neutral', 'score': 0.9997739195823669}, {'label': 'positive', 'score': 0.00013912012218497694}, {'label': 'negative', 'score': 8.705880463821813e-05}]","(0.9997739195823669, 0.00013912012218497694, 8.705880463821813e-05)",0.2301775778936971,0.00013912012218497694,1,1,"[{'label': 'positive', 'score': 0.5770044326782227}, {'label': 'neutral', 'score': 0.3339502513408661}, {'label': 'negative', 'score': 0.08904530853033066}]","(0.3339502513408661, 0.5770044326782227, 0.08904530853033066)",0.7326166410071502,0.5770044326782227,0,0,"[{'label': 'neutral', 'score': 0.9871881008148193}, {'label': 'positive', 'score': 0.01256296131759882}, {'label': 'negative', 'score': 0.0002490284969098866}]","(0.9871881008148193, 0.01256296131759882, 0.0002490284969098866)",0.961125711069817,0.01256296131759882,0,1
2020-06-03,68.28390502929688,78.30152893066406,78.5782470703125,77.15648651123047,77.29007720947266,13675457.0,"Revisiting The Coronavirus Vaccine Race: Updates On The 10 Candidates In Clinics | Traders Share Their Health Care Picks | UPDATE: Five Companies Chosen For 'Vaccine Finalist' Are Moderna, Johnson & Johnson, Merck, Pfizer And AstraZeneca",-0.0062149607654111245,0.014978812172357596,0.17654430474779137,"[{'label': 'neutral', 'score': 0.9998434782028198}, {'label': 'positive', 'score': 8.372587763005868e-05}, {'label': 'negative', 'score': 7.283977174665779e-05}]","(0.9998434782028198, 8.372587763005868e-05, 7.283977174665779e-05)",0.06953061496399865,8.372587763005868e-05,1,1,"[{'label': 'neutral', 'score': 0.8940014839172363}, {'label': 'positive', 'score': 0.09312504529953003}, {'label': 'negative', 'score': 0.012873534113168716}]","(0.8940014839172363, 0.09312504529953003, 0.012873534113168716)",0.7570998746493304,0.09312504529953003,0,1,"[{'label': 'neutral', 'score': 0.9863114953041077}, {'label': 'positive', 'score': 0.01318898145109415}, {'label': 'negative', 'score': 0.0004994269111193717}]","(0.9863114953041077, 0.01318898145109415, 0.0004994269111193717)",0.9270292209431703,0.01318898145109415,0,1
2020-06-04,67.85951232910156,77.81488800048828,78.3969497680664,77.13740539550781,77.5477066040039,9292930.0,"Ex-FDA Chief On White House's Coronavirus Vaccine Shortlist: 'They Chose Very Novel Platforms' | The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",0.008706238523169067,-0.0062343540280673185,0.1809212031806704,"[{'label': 'positive', 'score': 0.9979054927825928}, {'label': 'neutral', 'score': 0.0016513285227119923}, {'label': 'negative', 'score': 0.00044313992839306593}]","(0.0016513285227119923, 0.9979054927825928, 0.00044313992839306593)",0.9991122541487542,0.9979054927825928,0,0,"[{'label': 'neutral', 'score': 0.6858966946601868}, {'label': 'positive', 'score': 0.3050183951854706}, {'label': 'negative', 'score': 0.009084921330213547}]","(0.6858966946601868, 0.3050183951854706, 0.009084921330213547)",0.9421532925472316,0.3050183951854706,0,1,"[{'label': 'positive', 'score': 0.8983256220817566}, {'label': 'neutral', 'score': 0.1009615883231163}, {'label': 'negative', 'score': 0.0007127614226192236}]","(0.1009615883231163, 0.8983256220817566, 0.0007127614226192236)",0.9984143915639264,0.8983256220817566,0,0
2020-06-05,68.45030212402344,78.49236297607422,79.32251739501953,77.75763702392578,78.34923553466797,10413347.0,"The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid | Merck Reports FDA Approved RECARBIO For Treatment Of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia",0.0025934041338753636,0.00866855777566607,0.1690990482572376,"[{'label': 'positive', 'score': 0.9992780089378357}, {'label': 'neutral', 'score': 0.0004478341725189239}, {'label': 'negative', 'score': 0.00027420310652814806}]","(0.0004478341725189239, 0.9992780089378357, 0.00027420310652814806)",0.9994513481072342,0.9992780089378357,0,0,"[{'label': 'positive', 'score': 0.915307343006134}, {'label': 'neutral', 'score': 0.06631530076265335}, {'label': 'negative', 'score': 0.018377413973212242}]","(0.06631530076265335, 0.915307343006134, 0.018377413973212242)",0.9606346492521377,0.915307343006134,0,0,"[{'label': 'positive', 'score': 0.997944176197052}, {'label': 'neutral', 'score': 0.0017643972532823682}, {'label': 'negative', 'score': 0.00029144802829250693}]","(0.0017643972532823682, 0.997944176197052, 0.00029144802829250693)",0.9994160736779581,0.997944176197052,0,0
2020-06-06,68.62782796223958,78.69592539469402,79.34478251139323,77.64949289957683,78.04389190673828,10261177.333333334,,0.0025866957863298367,0.0025900470642806514,0.14660201197905956,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-06-07,68.80535380045573,78.8994878133138,79.36704762776692,77.54134877522786,77.7385482788086,10109007.666666666,"The Week Ahead In Biotech: Viela FDA Decision, Hematology Conference Take Center Stage",0.002580022054153899,0.002583356046804714,0.1254308860903489,"[{'label': 'neutral', 'score': 0.9998606443405151}, {'label': 'negative', 'score': 7.066850957926363e-05}, {'label': 'positive', 'score': 6.868135096738115e-05}]","(0.9998606443405151, 6.868135096738115e-05, 7.066850957926363e-05)",-0.014260212418492615,-7.066850957926363e-05,1,1,"[{'label': 'neutral', 'score': 0.9277438521385193}, {'label': 'positive', 'score': 0.05509350448846817}, {'label': 'negative', 'score': 0.017162630334496498}]","(0.9277438521385193, 0.05509350448846817, 0.017162630334496498)",0.5249502239070275,0.05509350448846817,0,1,"[{'label': 'neutral', 'score': 0.9995222091674805}, {'label': 'positive', 'score': 0.0003308543819002807}, {'label': 'negative', 'score': 0.00014691548130940646}]","(0.9995222091674805, 0.0003308543819002807, 0.00014691548130940646)",0.3849947741683861,0.0003308543819002807,1,1
2020-06-08,68.98287963867188,79.1030502319336,79.38931274414062,77.4332046508789,77.4332046508789,9956838.0,,-0.007720148010333524,0.0025766995108502263,0.08448180477924098,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1,"[{'label': 'neutral', 'score': 1.0}, {'label': 'negative', 'score': 0}, {'label': 'positive', 'score': 0}]","(1.0, 0, 0)",0.0,0.0,1,1
2020-06-09,68.45030212402344,78.49236297607422,79.68511199951172,78.35877990722656,79.37976837158203,8846168.0,Merck Announces That The Phase 3 KEYNOTE-361 Trial Evaluating KEYTRUDA As Monotherapy And In Combination With Chemotherapy In Patients With Advanced Or Metastatic Urothelial Carcinoma,-0.005956658295547956,-0.007750102621935613,0.09398213383231731,"[{'label': 'neutral', 'score': 0.9995535016059875}, {'label': 'positive', 'score': 0.0003885948390234262}, {'label': 'negative', 'score': 5.7886132708517835e-05}]","(0.9995535016059875, 0.0003885948390234262, 5.7886132708517835e-05)",0.74070056117298,0.0003885948390234262,0,1,"[{'label': 'positive', 'score': 0.5433545112609863}, {'label': 'neutral', 'score': 0.44355523586273193}, {'label': 'negative', 'score': 0.013090278021991253}]","(0.44355523586273193, 0.5433545112609863, 0.013090278021991253)",0.9529503078324838,0.5433545112609863,0,0,"[{'label': 'neutral', 'score': 0.9851747155189514}, {'label': 'positive', 'score': 0.01457507349550724}, {'label': 'negative', 'score': 0.0002503002469893545}]","(0.9851747155189514, 0.01457507349550724, 0.0002503002469893545)",0.9662335329500835,0.01457507349550724,0,1
2020-06-10,68.04258728027344,78.02481079101562,78.9885482788086,77.28053283691406,78.66412353515625,9080920.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",0.0,-0.005974469951761865,0.08273077724351173,"[{'label': 'neutral', 'score': 0.5943123698234558}, {'label': 'positive', 'score': 0.38753798604011536}, {'label': 'negative', 'score': 0.018149685114622116}]","(0.5943123698234558, 0.38753798604011536, 0.018149685114622116)",0.91052385169625,0.38753798604011536,0,1,"[{'label': 'negative', 'score': 0.7724604606628418}, {'label': 'neutral', 'score': 0.13460475206375122}, {'label': 'positive', 'score': 0.09293477237224579}]","(0.13460475206375122, 0.09293477237224579, 0.7724604606628418)",-0.7852200501583356,-0.7724604606628418,0,0,"[{'label': 'negative', 'score': 0.9396530389785767}, {'label': 'neutral', 'score': 0.05932958051562309}, {'label': 'positive', 'score': 0.0010173432528972626}]","(0.05932958051562309, 0.0010173432528972626, 0.9396530389785767)",-0.9978369824922436,-0.9396530389785767,0,0
2020-06-11,68.04258728027344,78.02481079101562,78.9885482788086,77.28053283691406,78.66412353515625,9080920.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market following an increase in coronavirus cases in some US states that have reopened, leading to concerns of a second wave of the virus. | Johnson & Johnson To Start Coronavirus Vaccine Human Trials Ahead Of Schedule In July",,0.0,0.07711862240566535,"[{'label': 'negative', 'score': 0.9986883997917175}, {'label': 'positive', 'score': 0.0007744370959699154}, {'label': 'neutral', 'score': 0.0005372168379835784}]","(0.0005372168379835784, 0.0007744370959699154, 0.9986883997917175)",-0.9984502933628198,-0.9986883997917175,0,0,"[{'label': 'negative', 'score': 0.9702393412590027}, {'label': 'neutral', 'score': 0.018562480807304382}, {'label': 'positive', 'score': 0.011198061518371105}]","(0.018562480807304382, 0.011198061518371105, 0.9702393412590027)",-0.9771802837619972,-0.9702393412590027,0,0,"[{'label': 'negative', 'score': 0.9981004595756531}, {'label': 'neutral', 'score': 0.0015531843528151512}, {'label': 'positive', 'score': 0.0003463618631940335}]","(0.0015531843528151512, 0.0003463618631940335, 0.9981004595756531)",-0.9993061986762702,-0.9981004595756531,0,0
